"","pmid","doi","title","abstract","year","month","day","jabbrv","journal","keywords","lastname","firstname","address","email"
"1","34219155","10.1093/ehjci/jeab127","Left ventricular longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection.","Compared with adult patients, clinical manifestations of children's coronavirus disease-2019 (COVID-19) are generally perceived as less severe. The objective of this study was to evaluate cardiac involvement in previously healthy children with asymptomatic or mildly symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We analysed a cohort of 53 paediatric patients (29 males, 55%), mean age 7.5 ± 4.7 years, who had a confirmed diagnosis of SARS-CoV-2 infection and w","2021","07","05","Eur Heart J Cardiovasc Imaging","European heart journal. Cardiovascular Imaging","COVID-19; SARS-CoV-2; longitudinal strain; paediatric cardiology; speckle tracking echocardiography","Sirico","Domenico","Department for Women's and Children's Health, University Hospital of Padova, Pediatric and Congenital Cardiology Unit, Via Nicolò Giustiniani, 2, 35128 Padova, Italy",NA
"2","34219155","10.1093/ehjci/jeab127","Left ventricular longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection.","Compared with adult patients, clinical manifestations of children's coronavirus disease-2019 (COVID-19) are generally perceived as less severe. The objective of this study was to evaluate cardiac involvement in previously healthy children with asymptomatic or mildly symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We analysed a cohort of 53 paediatric patients (29 males, 55%), mean age 7.5 ± 4.7 years, who had a confirmed diagnosis of SARS-CoV-2 infection and w","2021","07","05","Eur Heart J Cardiovasc Imaging","European heart journal. Cardiovascular Imaging","COVID-19; SARS-CoV-2; longitudinal strain; paediatric cardiology; speckle tracking echocardiography","Di Chiara","Costanza","Department for Women's and Children's Health, University Hospital of Padova, Division of Pediatric Infectious Diseases, Via Nicolò Giustiniani, 2, 35128 Padova, Italy",NA
"3","34219155","10.1093/ehjci/jeab127","Left ventricular longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection.","Compared with adult patients, clinical manifestations of children's coronavirus disease-2019 (COVID-19) are generally perceived as less severe. The objective of this study was to evaluate cardiac involvement in previously healthy children with asymptomatic or mildly symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We analysed a cohort of 53 paediatric patients (29 males, 55%), mean age 7.5 ± 4.7 years, who had a confirmed diagnosis of SARS-CoV-2 infection and w","2021","07","05","Eur Heart J Cardiovasc Imaging","European heart journal. Cardiovascular Imaging","COVID-19; SARS-CoV-2; longitudinal strain; paediatric cardiology; speckle tracking echocardiography","Costenaro","Paola","Department for Women's and Children's Health, University Hospital of Padova, Division of Pediatric Infectious Diseases, Via Nicolò Giustiniani, 2, 35128 Padova, Italy",NA
"4","34219155","10.1093/ehjci/jeab127","Left ventricular longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection.","Compared with adult patients, clinical manifestations of children's coronavirus disease-2019 (COVID-19) are generally perceived as less severe. The objective of this study was to evaluate cardiac involvement in previously healthy children with asymptomatic or mildly symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We analysed a cohort of 53 paediatric patients (29 males, 55%), mean age 7.5 ± 4.7 years, who had a confirmed diagnosis of SARS-CoV-2 infection and w","2021","07","05","Eur Heart J Cardiovasc Imaging","European heart journal. Cardiovascular Imaging","COVID-19; SARS-CoV-2; longitudinal strain; paediatric cardiology; speckle tracking echocardiography","Bonfante","Francesco","Laboratory of Experimental Animal Models, Division of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Università 10, 35020 Legnaro, Italy",NA
"5","34219155","10.1093/ehjci/jeab127","Left ventricular longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection.","Compared with adult patients, clinical manifestations of children's coronavirus disease-2019 (COVID-19) are generally perceived as less severe. The objective of this study was to evaluate cardiac involvement in previously healthy children with asymptomatic or mildly symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We analysed a cohort of 53 paediatric patients (29 males, 55%), mean age 7.5 ± 4.7 years, who had a confirmed diagnosis of SARS-CoV-2 infection and w","2021","07","05","Eur Heart J Cardiovasc Imaging","European heart journal. Cardiovascular Imaging","COVID-19; SARS-CoV-2; longitudinal strain; paediatric cardiology; speckle tracking echocardiography","Cozzani","Sandra","Department for Women's and Children's Health, University Hospital of Padova, Division of Pediatric Infectious Diseases, Via Nicolò Giustiniani, 2, 35128 Padova, Italy",NA
"6","34219155","10.1093/ehjci/jeab127","Left ventricular longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection.","Compared with adult patients, clinical manifestations of children's coronavirus disease-2019 (COVID-19) are generally perceived as less severe. The objective of this study was to evaluate cardiac involvement in previously healthy children with asymptomatic or mildly symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We analysed a cohort of 53 paediatric patients (29 males, 55%), mean age 7.5 ± 4.7 years, who had a confirmed diagnosis of SARS-CoV-2 infection and w","2021","07","05","Eur Heart J Cardiovasc Imaging","European heart journal. Cardiovascular Imaging","COVID-19; SARS-CoV-2; longitudinal strain; paediatric cardiology; speckle tracking echocardiography","Plebani","Mario","Department of Laboratory Medicine, University Hospital of Padova, Via Nicolò Giustiniani, 2, 35128 Padova, Italy",NA
"7","34219155","10.1093/ehjci/jeab127","Left ventricular longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection.","Compared with adult patients, clinical manifestations of children's coronavirus disease-2019 (COVID-19) are generally perceived as less severe. The objective of this study was to evaluate cardiac involvement in previously healthy children with asymptomatic or mildly symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We analysed a cohort of 53 paediatric patients (29 males, 55%), mean age 7.5 ± 4.7 years, who had a confirmed diagnosis of SARS-CoV-2 infection and w","2021","07","05","Eur Heart J Cardiovasc Imaging","European heart journal. Cardiovascular Imaging","COVID-19; SARS-CoV-2; longitudinal strain; paediatric cardiology; speckle tracking echocardiography","Reffo","Elena","Department for Women's and Children's Health, University Hospital of Padova, Pediatric and Congenital Cardiology Unit, Via Nicolò Giustiniani, 2, 35128 Padova, Italy",NA
"8","34219155","10.1093/ehjci/jeab127","Left ventricular longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection.","Compared with adult patients, clinical manifestations of children's coronavirus disease-2019 (COVID-19) are generally perceived as less severe. The objective of this study was to evaluate cardiac involvement in previously healthy children with asymptomatic or mildly symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We analysed a cohort of 53 paediatric patients (29 males, 55%), mean age 7.5 ± 4.7 years, who had a confirmed diagnosis of SARS-CoV-2 infection and w","2021","07","05","Eur Heart J Cardiovasc Imaging","European heart journal. Cardiovascular Imaging","COVID-19; SARS-CoV-2; longitudinal strain; paediatric cardiology; speckle tracking echocardiography","Castaldi","Biagio","Department for Women's and Children's Health, University Hospital of Padova, Pediatric and Congenital Cardiology Unit, Via Nicolò Giustiniani, 2, 35128 Padova, Italy",NA
"9","34219155","10.1093/ehjci/jeab127","Left ventricular longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection.","Compared with adult patients, clinical manifestations of children's coronavirus disease-2019 (COVID-19) are generally perceived as less severe. The objective of this study was to evaluate cardiac involvement in previously healthy children with asymptomatic or mildly symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We analysed a cohort of 53 paediatric patients (29 males, 55%), mean age 7.5 ± 4.7 years, who had a confirmed diagnosis of SARS-CoV-2 infection and w","2021","07","05","Eur Heart J Cardiovasc Imaging","European heart journal. Cardiovascular Imaging","COVID-19; SARS-CoV-2; longitudinal strain; paediatric cardiology; speckle tracking echocardiography","Donà","Daniele","Department for Women's and Children's Health, University Hospital of Padova, Division of Pediatric Infectious Diseases, Via Nicolò Giustiniani, 2, 35128 Padova, Italy",NA
"10","34219155","10.1093/ehjci/jeab127","Left ventricular longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection.","Compared with adult patients, clinical manifestations of children's coronavirus disease-2019 (COVID-19) are generally perceived as less severe. The objective of this study was to evaluate cardiac involvement in previously healthy children with asymptomatic or mildly symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We analysed a cohort of 53 paediatric patients (29 males, 55%), mean age 7.5 ± 4.7 years, who had a confirmed diagnosis of SARS-CoV-2 infection and w","2021","07","05","Eur Heart J Cardiovasc Imaging","European heart journal. Cardiovascular Imaging","COVID-19; SARS-CoV-2; longitudinal strain; paediatric cardiology; speckle tracking echocardiography","Da Dalt","Liviana","Department for Women's and Children's Health, University Hospital of Padova, Via Nicolò Giustiniani, 2, 35128 Padova, Italy",NA
"11","34219155","10.1093/ehjci/jeab127","Left ventricular longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection.","Compared with adult patients, clinical manifestations of children's coronavirus disease-2019 (COVID-19) are generally perceived as less severe. The objective of this study was to evaluate cardiac involvement in previously healthy children with asymptomatic or mildly symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We analysed a cohort of 53 paediatric patients (29 males, 55%), mean age 7.5 ± 4.7 years, who had a confirmed diagnosis of SARS-CoV-2 infection and w","2021","07","05","Eur Heart J Cardiovasc Imaging","European heart journal. Cardiovascular Imaging","COVID-19; SARS-CoV-2; longitudinal strain; paediatric cardiology; speckle tracking echocardiography","Giaquinto","Carlo","Department for Women's and Children's Health, University Hospital of Padova, Division of Pediatric Infectious Diseases, Via Nicolò Giustiniani, 2, 35128 Padova, Italy",NA
"12","34219155","10.1093/ehjci/jeab127","Left ventricular longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection.","Compared with adult patients, clinical manifestations of children's coronavirus disease-2019 (COVID-19) are generally perceived as less severe. The objective of this study was to evaluate cardiac involvement in previously healthy children with asymptomatic or mildly symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We analysed a cohort of 53 paediatric patients (29 males, 55%), mean age 7.5 ± 4.7 years, who had a confirmed diagnosis of SARS-CoV-2 infection and w","2021","07","05","Eur Heart J Cardiovasc Imaging","European heart journal. Cardiovascular Imaging","COVID-19; SARS-CoV-2; longitudinal strain; paediatric cardiology; speckle tracking echocardiography","Di Salvo","Giovanni","Department for Women's and Children's Health, University Hospital of Padova, Pediatric and Congenital Cardiology Unit, Via Nicolò Giustiniani, 2, 35128 Padova, Italy",NA
"13","34219154","10.1093/eurjpc/zwaa135","Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19.",NA,"2021","07","05","Eur J Prev Cardiol","European journal of preventive cardiology",NA,"Buckley","Benjamin J R","Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart &amp",NA
"14","34219154","10.1093/eurjpc/zwaa135","Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19.",NA,"2021","07","05","Eur J Prev Cardiol","European journal of preventive cardiology",NA,"Harrison","Stephanie L","Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart &amp",NA
"15","34219154","10.1093/eurjpc/zwaa135","Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19.",NA,"2021","07","05","Eur J Prev Cardiol","European journal of preventive cardiology",NA,"Fazio-Eynullayeva","Elnara","TriNetX Inc, Cambridge, MA, USA",NA
"16","34219154","10.1093/eurjpc/zwaa135","Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19.",NA,"2021","07","05","Eur J Prev Cardiol","European journal of preventive cardiology",NA,"Underhill","Paula","TriNetX Inc, London, UK",NA
"17","34219154","10.1093/eurjpc/zwaa135","Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19.",NA,"2021","07","05","Eur J Prev Cardiol","European journal of preventive cardiology",NA,"Jones","Ian D","Liverpool Centre for Cardiovascular Science, Liverpool John Moores University, Liverpool, UK",NA
"18","34219154","10.1093/eurjpc/zwaa135","Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19.",NA,"2021","07","05","Eur J Prev Cardiol","European journal of preventive cardiology",NA,"Williams","Nefyn","Department of Primary Care and Mental Health, University of Liverpool, UK",NA
"19","34219154","10.1093/eurjpc/zwaa135","Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19.",NA,"2021","07","05","Eur J Prev Cardiol","European journal of preventive cardiology",NA,"Lip","Gregory Y H","Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart &amp",NA
"20","34219150","10.1093/eurheartj/ehab367","Waiting for the light at the end of the COVID-19 tunnel: best and worst moments 1 year into the pandemic.",NA,"2021","07","05","Eur Heart J","European heart journal",NA,"Mapelli","Massimo","Centro Cardiologico Monzino, IRCCS, Via Parea 4, 20138 Milan, Italy",NA
"21","34219150","10.1093/eurheartj/ehab367","Waiting for the light at the end of the COVID-19 tunnel: best and worst moments 1 year into the pandemic.",NA,"2021","07","05","Eur Heart J","European heart journal",NA,"Buzzi","Silvia","Emergency Department, Papa Giovanni XXIII Hospital, Piazza OMS 1, 24127 Bergamo, Italy",NA
"22","34219150","10.1093/eurheartj/ehab367","Waiting for the light at the end of the COVID-19 tunnel: best and worst moments 1 year into the pandemic.",NA,"2021","07","05","Eur Heart J","European heart journal",NA,"Maggioni","Paolo","General Practitioner, ATS della Città Metropolitana di Milano, Via Eugenio Villoresi 6, 20143 Milan, Italy",NA
"23","34219147","10.1093/alcalc/agab047","Inter-Hospital Escalation-of-Care Referrals for Severe Alcohol-Related Liver Disease with Recent Drinking During the COVID-19 Pandemic.","Alcohol sales and consumption have increased during the coronavirus disease 2019 pandemic, but their downstream effects on alcohol-related liver disease (ALD) are unclear. We analyzed inter-hospital escalation-of-care referrals to our tertiary care inpatient liver unit across 18 months through December 2020. There was a significant rise in severe ALD with recent unhealthy drinking in our regional community during the pandemic.","2021","07","05","Alcohol Alcohol","Alcohol and alcoholism (Oxford, Oxfordshire)",NA,"Chen","Po-Hung","Division of Gastroenterology &amp",NA
"24","34219147","10.1093/alcalc/agab047","Inter-Hospital Escalation-of-Care Referrals for Severe Alcohol-Related Liver Disease with Recent Drinking During the COVID-19 Pandemic.","Alcohol sales and consumption have increased during the coronavirus disease 2019 pandemic, but their downstream effects on alcohol-related liver disease (ALD) are unclear. We analyzed inter-hospital escalation-of-care referrals to our tertiary care inpatient liver unit across 18 months through December 2020. There was a significant rise in severe ALD with recent unhealthy drinking in our regional community during the pandemic.","2021","07","05","Alcohol Alcohol","Alcohol and alcoholism (Oxford, Oxfordshire)",NA,"Ting","Peng-Sheng","Division of Gastroenterology &amp",NA
"25","34219147","10.1093/alcalc/agab047","Inter-Hospital Escalation-of-Care Referrals for Severe Alcohol-Related Liver Disease with Recent Drinking During the COVID-19 Pandemic.","Alcohol sales and consumption have increased during the coronavirus disease 2019 pandemic, but their downstream effects on alcohol-related liver disease (ALD) are unclear. We analyzed inter-hospital escalation-of-care referrals to our tertiary care inpatient liver unit across 18 months through December 2020. There was a significant rise in severe ALD with recent unhealthy drinking in our regional community during the pandemic.","2021","07","05","Alcohol Alcohol","Alcohol and alcoholism (Oxford, Oxfordshire)",NA,"Almazan","Erik","Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD 21205, USA",NA
"26","34219147","10.1093/alcalc/agab047","Inter-Hospital Escalation-of-Care Referrals for Severe Alcohol-Related Liver Disease with Recent Drinking During the COVID-19 Pandemic.","Alcohol sales and consumption have increased during the coronavirus disease 2019 pandemic, but their downstream effects on alcohol-related liver disease (ALD) are unclear. We analyzed inter-hospital escalation-of-care referrals to our tertiary care inpatient liver unit across 18 months through December 2020. There was a significant rise in severe ALD with recent unhealthy drinking in our regional community during the pandemic.","2021","07","05","Alcohol Alcohol","Alcohol and alcoholism (Oxford, Oxfordshire)",NA,"Chander","Geetanjali","Division of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, 2024 E. Monument Street, Baltimore, MD 21205, USA",NA
"27","34219147","10.1093/alcalc/agab047","Inter-Hospital Escalation-of-Care Referrals for Severe Alcohol-Related Liver Disease with Recent Drinking During the COVID-19 Pandemic.","Alcohol sales and consumption have increased during the coronavirus disease 2019 pandemic, but their downstream effects on alcohol-related liver disease (ALD) are unclear. We analyzed inter-hospital escalation-of-care referrals to our tertiary care inpatient liver unit across 18 months through December 2020. There was a significant rise in severe ALD with recent unhealthy drinking in our regional community during the pandemic.","2021","07","05","Alcohol Alcohol","Alcohol and alcoholism (Oxford, Oxfordshire)",NA,"Cameron","Andrew M","Division of Transplantation, Department of Surgery, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Blalock 424, Baltimore, MD 21287, USA",NA
"28","34219147","10.1093/alcalc/agab047","Inter-Hospital Escalation-of-Care Referrals for Severe Alcohol-Related Liver Disease with Recent Drinking During the COVID-19 Pandemic.","Alcohol sales and consumption have increased during the coronavirus disease 2019 pandemic, but their downstream effects on alcohol-related liver disease (ALD) are unclear. We analyzed inter-hospital escalation-of-care referrals to our tertiary care inpatient liver unit across 18 months through December 2020. There was a significant rise in severe ALD with recent unhealthy drinking in our regional community during the pandemic.","2021","07","05","Alcohol Alcohol","Alcohol and alcoholism (Oxford, Oxfordshire)",NA,"Gurakar","Ahmet","Division of Gastroenterology &amp",NA
"29","34219142","10.1093/bib/bbab241","Tracking the pipeline: immunoinformatics and the COVID-19 vaccine design.","With the onset of the COVID-19 pandemic, the amount of data on genomic and proteomic sequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stored in various databases has exponentially grown. A large volume of these data has led to the production of equally immense sets of immunological data, which require rigorous computational approaches to sort through and make sense of. Immunoinformatics has emerged in the recent decades as a field capable of offering this approach by bri","2021","07","05","Brief Bioinform","Briefings in bioinformatics","SARS-CoV-2; immunoinformatics; mutations; vaccine","Rezaei","Shokouh","Protein Research Center at Shahid Beheshti University, Tehran, Iran",NA
"30","34219142","10.1093/bib/bbab241","Tracking the pipeline: immunoinformatics and the COVID-19 vaccine design.","With the onset of the COVID-19 pandemic, the amount of data on genomic and proteomic sequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stored in various databases has exponentially grown. A large volume of these data has led to the production of equally immense sets of immunological data, which require rigorous computational approaches to sort through and make sense of. Immunoinformatics has emerged in the recent decades as a field capable of offering this approach by bri","2021","07","05","Brief Bioinform","Briefings in bioinformatics","SARS-CoV-2; immunoinformatics; mutations; vaccine","Sefidbakht","Yahya","Protein Research Center at Shahid Beheshti University, Tehran, Iran",NA
"31","34219142","10.1093/bib/bbab241","Tracking the pipeline: immunoinformatics and the COVID-19 vaccine design.","With the onset of the COVID-19 pandemic, the amount of data on genomic and proteomic sequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stored in various databases has exponentially grown. A large volume of these data has led to the production of equally immense sets of immunological data, which require rigorous computational approaches to sort through and make sense of. Immunoinformatics has emerged in the recent decades as a field capable of offering this approach by bri","2021","07","05","Brief Bioinform","Briefings in bioinformatics","SARS-CoV-2; immunoinformatics; mutations; vaccine","Uskokovic","Vuk","Founder of the biotech startup, TardigradeNano, and formerly a Professor at University of Illinois in Chicago, Chapman University, and University of California in Irvine",NA
"32","34219127","","[Characteristics of COVID-19 cases and contacts reported in an area of Madrid during beginning of de-escalation.]","Deescalation began in May 2020 increases social interaction, which has an influence on COVID-19 epidemiological surveillance. The aim of this study was the characterization of COVID-19 cases detected during this period. We analyzed certain variables of interest coming from the epidemiological surveys carried out in an area of Madrid during May 2020, and stratified the results depending on its temporal relation with the deescalation. Prevalence for each category of response and average duration i","2021","07","07","Rev Esp Salud Publica","Revista espanola de salud publica","COVID-19; Close contacts; Deescalation; Epidemiological surveillance; Healthcare workers; Spain; Adolescent; Adult; Aged; COVID-19; Child; Child, Preschool; Cities; Contact Tracing; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Spain; Young Adult","Pérez Romero","César","MIR Medicina Preventiva y Salud Pública. Escuela Nacional de Sanidad. Instituto de Salud Carlos III. Madrid. España",NA
"33","34219127","","[Characteristics of COVID-19 cases and contacts reported in an area of Madrid during beginning of de-escalation.]","Deescalation began in May 2020 increases social interaction, which has an influence on COVID-19 epidemiological surveillance. The aim of this study was the characterization of COVID-19 cases detected during this period. We analyzed certain variables of interest coming from the epidemiological surveys carried out in an area of Madrid during May 2020, and stratified the results depending on its temporal relation with the deescalation. Prevalence for each category of response and average duration i","2021","07","07","Rev Esp Salud Publica","Revista espanola de salud publica","COVID-19; Close contacts; Deescalation; Epidemiological surveillance; Healthcare workers; Spain; Adolescent; Adult; Aged; COVID-19; Child; Child, Preschool; Cities; Contact Tracing; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Spain; Young Adult","Serrano Pareja","Manuela","MIR Medicina Preventiva y Salud Pública. Hospital Universitario Ramón y Cajal. Madrid. España",NA
"34","34219127","","[Characteristics of COVID-19 cases and contacts reported in an area of Madrid during beginning of de-escalation.]","Deescalation began in May 2020 increases social interaction, which has an influence on COVID-19 epidemiological surveillance. The aim of this study was the characterization of COVID-19 cases detected during this period. We analyzed certain variables of interest coming from the epidemiological surveys carried out in an area of Madrid during May 2020, and stratified the results depending on its temporal relation with the deescalation. Prevalence for each category of response and average duration i","2021","07","07","Rev Esp Salud Publica","Revista espanola de salud publica","COVID-19; Close contacts; Deescalation; Epidemiological surveillance; Healthcare workers; Spain; Adolescent; Adult; Aged; COVID-19; Child; Child, Preschool; Cities; Contact Tracing; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Spain; Young Adult","Rumayor Zarzuelo","Mercedes","Técnico Superior de Salud Pública. Unidad Técnica-2 del Área Única de Salud Pública. Madrid. España",NA
"35","34219127","","[Characteristics of COVID-19 cases and contacts reported in an area of Madrid during beginning of de-escalation.]","Deescalation began in May 2020 increases social interaction, which has an influence on COVID-19 epidemiological surveillance. The aim of this study was the characterization of COVID-19 cases detected during this period. We analyzed certain variables of interest coming from the epidemiological surveys carried out in an area of Madrid during May 2020, and stratified the results depending on its temporal relation with the deescalation. Prevalence for each category of response and average duration i","2021","07","07","Rev Esp Salud Publica","Revista espanola de salud publica","COVID-19; Close contacts; Deescalation; Epidemiological surveillance; Healthcare workers; Spain; Adolescent; Adult; Aged; COVID-19; Child; Child, Preschool; Cities; Contact Tracing; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Spain; Young Adult","Mata Pariente","Nelva","Técnico Superior de Salud Pública. Unidad Técnica-2 del Área Única de Salud Pública. Madrid. España",NA
"36","34219127","","[Characteristics of COVID-19 cases and contacts reported in an area of Madrid during beginning of de-escalation.]","Deescalation began in May 2020 increases social interaction, which has an influence on COVID-19 epidemiological surveillance. The aim of this study was the characterization of COVID-19 cases detected during this period. We analyzed certain variables of interest coming from the epidemiological surveys carried out in an area of Madrid during May 2020, and stratified the results depending on its temporal relation with the deescalation. Prevalence for each category of response and average duration i","2021","07","07","Rev Esp Salud Publica","Revista espanola de salud publica","COVID-19; Close contacts; Deescalation; Epidemiological surveillance; Healthcare workers; Spain; Adolescent; Adult; Aged; COVID-19; Child; Child, Preschool; Cities; Contact Tracing; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Spain; Young Adult","Hernando García","Margarita","Técnico Superior de Salud Pública. Unidad Técnica-2 del Área Única de Salud Pública. Madrid. España",NA
"37","34219126","10.12659/MSM.933831","Editorial: Maternal SARS-CoV-2 Infection and Pregnancy Outcomes from Current Global Study Data.","During the global COVID-19 pandemic, data from clinical studies, systematic review, and population registry data have shown that when compared with non-pregnant women, SARS-CoV-2 infection in pregnancy is associated with a small increase in risk to the mother. Large cohort studies and registry data collected from 2020 have included the US Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET), COVI-PREG, the UK and Global Pregnancy and Neonatal Outcomes in COVID-19 (PAN-COVID)","2021","07","12","Med Sci Monit","Medical science monitor : international medical journal of experimental and clinical research","COVID-19; COVID-19 Vaccines; Cesarean Section; Female; Hospitalization; Humans; Infectious Disease Transmission, Vertical; Intensive Care Units; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Respiration, Artificial; SARS-CoV-2","Parums","Dinah V","Science Editor, Medical Science Monitor, International Scientific Information, Inc., Mellville, NY, USA",NA
"38","34219114","10.2169/internalmedicine.8014-21","Great Psychological Distress Induced by COVID-19 on Healthcare Workers in Japan.",NA,"2021","07","05","Intern Med","Internal medicine (Tokyo, Japan)","COVID-19; health care worker; pandemic; psychological distress","Sengoku","Renpei","Department of Neurology, The Jikei University School of Medicine, Japan",NA
"39","34219107","10.2169/internalmedicine.7207-21","Psychological Effects on Healthcare Workers During the COVID-19 Outbreak: A Single-center Study at a Tertiary Hospital in Tokyo, Japan.","Objective The present study analyzed the psychological status of healthcare workers in Japan and the influencing factors during the 2019 coronavirus disease pandemic. Methods An online survey was conducted from July 22 to August 21, 2020. A total of 328 of the 1,029 medical staff members in our university hospital participated in the study. Their mental health was assessed using the 12-item General Health Questionnaire. A multivariate regression analysis was performed to identify the factors ass","2021","07","05","Intern Med","Internal medicine (Tokyo, Japan)","12-item General Health Questionnaire; COVID-19; Healthcare workers; Health survey; Psychological distress","Ishikawa","Motonao","Department of Medicine, Tokyo Women's Medical University, Medical Center East, Japan",NA
"40","34219107","10.2169/internalmedicine.7207-21","Psychological Effects on Healthcare Workers During the COVID-19 Outbreak: A Single-center Study at a Tertiary Hospital in Tokyo, Japan.","Objective The present study analyzed the psychological status of healthcare workers in Japan and the influencing factors during the 2019 coronavirus disease pandemic. Methods An online survey was conducted from July 22 to August 21, 2020. A total of 328 of the 1,029 medical staff members in our university hospital participated in the study. Their mental health was assessed using the 12-item General Health Questionnaire. A multivariate regression analysis was performed to identify the factors ass","2021","07","05","Intern Med","Internal medicine (Tokyo, Japan)","12-item General Health Questionnaire; COVID-19; Healthcare workers; Health survey; Psychological distress","Ogasawara","Tomoko","Department of Medicine, Tokyo Women's Medical University, Medical Center East, Japan",NA
"41","34219107","10.2169/internalmedicine.7207-21","Psychological Effects on Healthcare Workers During the COVID-19 Outbreak: A Single-center Study at a Tertiary Hospital in Tokyo, Japan.","Objective The present study analyzed the psychological status of healthcare workers in Japan and the influencing factors during the 2019 coronavirus disease pandemic. Methods An online survey was conducted from July 22 to August 21, 2020. A total of 328 of the 1,029 medical staff members in our university hospital participated in the study. Their mental health was assessed using the 12-item General Health Questionnaire. A multivariate regression analysis was performed to identify the factors ass","2021","07","05","Intern Med","Internal medicine (Tokyo, Japan)","12-item General Health Questionnaire; COVID-19; Healthcare workers; Health survey; Psychological distress","Takahashi","Kenichiro","Department of Pediatrics, Tokyo Women's Medical University, Medical Center East, Japan",NA
"42","34219107","10.2169/internalmedicine.7207-21","Psychological Effects on Healthcare Workers During the COVID-19 Outbreak: A Single-center Study at a Tertiary Hospital in Tokyo, Japan.","Objective The present study analyzed the psychological status of healthcare workers in Japan and the influencing factors during the 2019 coronavirus disease pandemic. Methods An online survey was conducted from July 22 to August 21, 2020. A total of 328 of the 1,029 medical staff members in our university hospital participated in the study. Their mental health was assessed using the 12-item General Health Questionnaire. A multivariate regression analysis was performed to identify the factors ass","2021","07","05","Intern Med","Internal medicine (Tokyo, Japan)","12-item General Health Questionnaire; COVID-19; Healthcare workers; Health survey; Psychological distress","Ono","Takuya","Department of Medicine, Tokyo Women's Medical University, Medical Center East, Japan",NA
"43","34219107","10.2169/internalmedicine.7207-21","Psychological Effects on Healthcare Workers During the COVID-19 Outbreak: A Single-center Study at a Tertiary Hospital in Tokyo, Japan.","Objective The present study analyzed the psychological status of healthcare workers in Japan and the influencing factors during the 2019 coronavirus disease pandemic. Methods An online survey was conducted from July 22 to August 21, 2020. A total of 328 of the 1,029 medical staff members in our university hospital participated in the study. Their mental health was assessed using the 12-item General Health Questionnaire. A multivariate regression analysis was performed to identify the factors ass","2021","07","05","Intern Med","Internal medicine (Tokyo, Japan)","12-item General Health Questionnaire; COVID-19; Healthcare workers; Health survey; Psychological distress","Matsui","Kazuhiro","Department of Medicine, Tokyo Women's Medical University, Medical Center East, Japan",NA
"44","34219107","10.2169/internalmedicine.7207-21","Psychological Effects on Healthcare Workers During the COVID-19 Outbreak: A Single-center Study at a Tertiary Hospital in Tokyo, Japan.","Objective The present study analyzed the psychological status of healthcare workers in Japan and the influencing factors during the 2019 coronavirus disease pandemic. Methods An online survey was conducted from July 22 to August 21, 2020. A total of 328 of the 1,029 medical staff members in our university hospital participated in the study. Their mental health was assessed using the 12-item General Health Questionnaire. A multivariate regression analysis was performed to identify the factors ass","2021","07","05","Intern Med","Internal medicine (Tokyo, Japan)","12-item General Health Questionnaire; COVID-19; Healthcare workers; Health survey; Psychological distress","Marshall","Shoko","Department of Medicine, Tokyo Women's Medical University, Medical Center East, Japan",NA
"45","34219107","10.2169/internalmedicine.7207-21","Psychological Effects on Healthcare Workers During the COVID-19 Outbreak: A Single-center Study at a Tertiary Hospital in Tokyo, Japan.","Objective The present study analyzed the psychological status of healthcare workers in Japan and the influencing factors during the 2019 coronavirus disease pandemic. Methods An online survey was conducted from July 22 to August 21, 2020. A total of 328 of the 1,029 medical staff members in our university hospital participated in the study. Their mental health was assessed using the 12-item General Health Questionnaire. A multivariate regression analysis was performed to identify the factors ass","2021","07","05","Intern Med","Internal medicine (Tokyo, Japan)","12-item General Health Questionnaire; COVID-19; Healthcare workers; Health survey; Psychological distress","Sakurai","Ayana","Department of Medicine, Tokyo Women's Medical University, Medical Center East, Japan",NA
"46","34219107","10.2169/internalmedicine.7207-21","Psychological Effects on Healthcare Workers During the COVID-19 Outbreak: A Single-center Study at a Tertiary Hospital in Tokyo, Japan.","Objective The present study analyzed the psychological status of healthcare workers in Japan and the influencing factors during the 2019 coronavirus disease pandemic. Methods An online survey was conducted from July 22 to August 21, 2020. A total of 328 of the 1,029 medical staff members in our university hospital participated in the study. Their mental health was assessed using the 12-item General Health Questionnaire. A multivariate regression analysis was performed to identify the factors ass","2021","07","05","Intern Med","Internal medicine (Tokyo, Japan)","12-item General Health Questionnaire; COVID-19; Healthcare workers; Health survey; Psychological distress","Aoka","Yoshikazu","General Medical Department, Tokyo Women's Medical University, Medical Center East, Japan",NA
"47","34219107","10.2169/internalmedicine.7207-21","Psychological Effects on Healthcare Workers During the COVID-19 Outbreak: A Single-center Study at a Tertiary Hospital in Tokyo, Japan.","Objective The present study analyzed the psychological status of healthcare workers in Japan and the influencing factors during the 2019 coronavirus disease pandemic. Methods An online survey was conducted from July 22 to August 21, 2020. A total of 328 of the 1,029 medical staff members in our university hospital participated in the study. Their mental health was assessed using the 12-item General Health Questionnaire. A multivariate regression analysis was performed to identify the factors ass","2021","07","05","Intern Med","Internal medicine (Tokyo, Japan)","12-item General Health Questionnaire; COVID-19; Healthcare workers; Health survey; Psychological distress","Otsubo","Tempei","Department of Psychiatry, Tokyo Women's Medical University, Medical Center East, Japan",NA
"48","34219107","10.2169/internalmedicine.7207-21","Psychological Effects on Healthcare Workers During the COVID-19 Outbreak: A Single-center Study at a Tertiary Hospital in Tokyo, Japan.","Objective The present study analyzed the psychological status of healthcare workers in Japan and the influencing factors during the 2019 coronavirus disease pandemic. Methods An online survey was conducted from July 22 to August 21, 2020. A total of 328 of the 1,029 medical staff members in our university hospital participated in the study. Their mental health was assessed using the 12-item General Health Questionnaire. A multivariate regression analysis was performed to identify the factors ass","2021","07","05","Intern Med","Internal medicine (Tokyo, Japan)","12-item General Health Questionnaire; COVID-19; Healthcare workers; Health survey; Psychological distress","Sato","Yasuto","Department of Public Health, School of Medicine, Tokyo Women's Medical University, Japan",NA
"49","34219107","10.2169/internalmedicine.7207-21","Psychological Effects on Healthcare Workers During the COVID-19 Outbreak: A Single-center Study at a Tertiary Hospital in Tokyo, Japan.","Objective The present study analyzed the psychological status of healthcare workers in Japan and the influencing factors during the 2019 coronavirus disease pandemic. Methods An online survey was conducted from July 22 to August 21, 2020. A total of 328 of the 1,029 medical staff members in our university hospital participated in the study. Their mental health was assessed using the 12-item General Health Questionnaire. A multivariate regression analysis was performed to identify the factors ass","2021","07","05","Intern Med","Internal medicine (Tokyo, Japan)","12-item General Health Questionnaire; COVID-19; Healthcare workers; Health survey; Psychological distress","Sakura","Hiroshi","Department of Medicine, Tokyo Women's Medical University, Medical Center East, Japan",NA
"50","34219107","10.2169/internalmedicine.7207-21","Psychological Effects on Healthcare Workers During the COVID-19 Outbreak: A Single-center Study at a Tertiary Hospital in Tokyo, Japan.","Objective The present study analyzed the psychological status of healthcare workers in Japan and the influencing factors during the 2019 coronavirus disease pandemic. Methods An online survey was conducted from July 22 to August 21, 2020. A total of 328 of the 1,029 medical staff members in our university hospital participated in the study. Their mental health was assessed using the 12-item General Health Questionnaire. A multivariate regression analysis was performed to identify the factors ass","2021","07","05","Intern Med","Internal medicine (Tokyo, Japan)","12-item General Health Questionnaire; COVID-19; Healthcare workers; Health survey; Psychological distress","Uchigata","Yasuko","Director, Tokyo Women's Medical University, Medical Center East, Japan",NA
"51","34219035","10.1016/j.orcp.2021.06.012","Influence of polish national COVID-19 lockdown on the patient characteristics and outcomes of bariatric surgery at a high-volume center-A cohort study.","As a result of the COVID-19 pandemic, the health care systems around the world have been overburdened resulting in significant reduction of planned surgical procedures such as bariatric surgeries. The primary aim of this study is to assess the influence of the COVID-19 national lockdown in Poland on the short-term outcomes and intraoperative course of bariatric patients in a high volume IFSO certified bariatric center. This is a retrospective analysis of 158 bariatric surgery patients, who under","2021","07","19","Obes Res Clin Pract","Obesity research &amp; clinical practice","Bariatric; Lockdown; Outcomes; Surgery, COVID-19","Szymanski","Michal","Department of General, Endocrine and Transplant Surgery, Faculty of Medicine, Medical University of Gdansk, Poland. Electronic address: szymanski@gumed.edu","szymanski@gumed.edu.pl"
"52","34219035","10.1016/j.orcp.2021.06.012","Influence of polish national COVID-19 lockdown on the patient characteristics and outcomes of bariatric surgery at a high-volume center-A cohort study.","As a result of the COVID-19 pandemic, the health care systems around the world have been overburdened resulting in significant reduction of planned surgical procedures such as bariatric surgeries. The primary aim of this study is to assess the influence of the COVID-19 national lockdown in Poland on the short-term outcomes and intraoperative course of bariatric patients in a high volume IFSO certified bariatric center. This is a retrospective analysis of 158 bariatric surgery patients, who under","2021","07","19","Obes Res Clin Pract","Obesity research &amp; clinical practice","Bariatric; Lockdown; Outcomes; Surgery, COVID-19","Wilczynski","Maciej","Department of General, Endocrine and Transplant Surgery, Faculty of Medicine, Medical University of Gdansk, Poland",NA
"53","34219035","10.1016/j.orcp.2021.06.012","Influence of polish national COVID-19 lockdown on the patient characteristics and outcomes of bariatric surgery at a high-volume center-A cohort study.","As a result of the COVID-19 pandemic, the health care systems around the world have been overburdened resulting in significant reduction of planned surgical procedures such as bariatric surgeries. The primary aim of this study is to assess the influence of the COVID-19 national lockdown in Poland on the short-term outcomes and intraoperative course of bariatric patients in a high volume IFSO certified bariatric center. This is a retrospective analysis of 158 bariatric surgery patients, who under","2021","07","19","Obes Res Clin Pract","Obesity research &amp; clinical practice","Bariatric; Lockdown; Outcomes; Surgery, COVID-19","Lacka","Monika","Department of General, Endocrine and Transplant Surgery, Faculty of Medicine, Medical University of Gdansk, Poland",NA
"54","34219035","10.1016/j.orcp.2021.06.012","Influence of polish national COVID-19 lockdown on the patient characteristics and outcomes of bariatric surgery at a high-volume center-A cohort study.","As a result of the COVID-19 pandemic, the health care systems around the world have been overburdened resulting in significant reduction of planned surgical procedures such as bariatric surgeries. The primary aim of this study is to assess the influence of the COVID-19 national lockdown in Poland on the short-term outcomes and intraoperative course of bariatric patients in a high volume IFSO certified bariatric center. This is a retrospective analysis of 158 bariatric surgery patients, who under","2021","07","19","Obes Res Clin Pract","Obesity research &amp; clinical practice","Bariatric; Lockdown; Outcomes; Surgery, COVID-19","Patel","Agastya","Department of General, Endocrine and Transplant Surgery, Faculty of Medicine, Medical University of Gdansk, Poland",NA
"55","34219035","10.1016/j.orcp.2021.06.012","Influence of polish national COVID-19 lockdown on the patient characteristics and outcomes of bariatric surgery at a high-volume center-A cohort study.","As a result of the COVID-19 pandemic, the health care systems around the world have been overburdened resulting in significant reduction of planned surgical procedures such as bariatric surgeries. The primary aim of this study is to assess the influence of the COVID-19 national lockdown in Poland on the short-term outcomes and intraoperative course of bariatric patients in a high volume IFSO certified bariatric center. This is a retrospective analysis of 158 bariatric surgery patients, who under","2021","07","19","Obes Res Clin Pract","Obesity research &amp; clinical practice","Bariatric; Lockdown; Outcomes; Surgery, COVID-19","Bigda","Justyna","Department of General, Endocrine and Transplant Surgery, Faculty of Medicine, Medical University of Gdansk, Poland",NA
"56","34219035","10.1016/j.orcp.2021.06.012","Influence of polish national COVID-19 lockdown on the patient characteristics and outcomes of bariatric surgery at a high-volume center-A cohort study.","As a result of the COVID-19 pandemic, the health care systems around the world have been overburdened resulting in significant reduction of planned surgical procedures such as bariatric surgeries. The primary aim of this study is to assess the influence of the COVID-19 national lockdown in Poland on the short-term outcomes and intraoperative course of bariatric patients in a high volume IFSO certified bariatric center. This is a retrospective analysis of 158 bariatric surgery patients, who under","2021","07","19","Obes Res Clin Pract","Obesity research &amp; clinical practice","Bariatric; Lockdown; Outcomes; Surgery, COVID-19","Kaska","Lukasz","Department of General, Endocrine and Transplant Surgery, Faculty of Medicine, Medical University of Gdansk, Poland",NA
"57","34219035","10.1016/j.orcp.2021.06.012","Influence of polish national COVID-19 lockdown on the patient characteristics and outcomes of bariatric surgery at a high-volume center-A cohort study.","As a result of the COVID-19 pandemic, the health care systems around the world have been overburdened resulting in significant reduction of planned surgical procedures such as bariatric surgeries. The primary aim of this study is to assess the influence of the COVID-19 national lockdown in Poland on the short-term outcomes and intraoperative course of bariatric patients in a high volume IFSO certified bariatric center. This is a retrospective analysis of 158 bariatric surgery patients, who under","2021","07","19","Obes Res Clin Pract","Obesity research &amp; clinical practice","Bariatric; Lockdown; Outcomes; Surgery, COVID-19","Proczko-Stepaniak","Monika","Department of General, Endocrine and Transplant Surgery, Faculty of Medicine, Medical University of Gdansk, Poland",NA
"58","34218997","10.1053/j.jvca.2021.05.058","How Should ECMO Be Used Under Conditions of Severe Scarcity? A Population Study of Public Perception.","To assess societal preferences regarding allocation of extracorporeal membrane oxygenation (ECMO) as a rescue option for select patients with coronavirus disease 2019 (COVID-19). Cross-sectional survey of a nationally representative sample. Amazon Mechanical Turk platform. In total, responses from 1,041 members of Amazon Mechanical Turk crowd-sourcing platform were included. Participants were 37.9 ± 12.6 years old, generally white (65%), and college-educated (66.1%). Many reported working in a h","2021","07","08","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia","COVID-19; ECMO; bioethics; justice; resource allocation","Han","Jason J","Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA",NA
"59","34218997","10.1053/j.jvca.2021.05.058","How Should ECMO Be Used Under Conditions of Severe Scarcity? A Population Study of Public Perception.","To assess societal preferences regarding allocation of extracorporeal membrane oxygenation (ECMO) as a rescue option for select patients with coronavirus disease 2019 (COVID-19). Cross-sectional survey of a nationally representative sample. Amazon Mechanical Turk platform. In total, responses from 1,041 members of Amazon Mechanical Turk crowd-sourcing platform were included. Participants were 37.9 ± 12.6 years old, generally white (65%), and college-educated (66.1%). Many reported working in a h","2021","07","08","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia","COVID-19; ECMO; bioethics; justice; resource allocation","Shin","Max","Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA",NA
"60","34218997","10.1053/j.jvca.2021.05.058","How Should ECMO Be Used Under Conditions of Severe Scarcity? A Population Study of Public Perception.","To assess societal preferences regarding allocation of extracorporeal membrane oxygenation (ECMO) as a rescue option for select patients with coronavirus disease 2019 (COVID-19). Cross-sectional survey of a nationally representative sample. Amazon Mechanical Turk platform. In total, responses from 1,041 members of Amazon Mechanical Turk crowd-sourcing platform were included. Participants were 37.9 ± 12.6 years old, generally white (65%), and college-educated (66.1%). Many reported working in a h","2021","07","08","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia","COVID-19; ECMO; bioethics; justice; resource allocation","Patrick","William L","Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA",NA
"61","34218997","10.1053/j.jvca.2021.05.058","How Should ECMO Be Used Under Conditions of Severe Scarcity? A Population Study of Public Perception.","To assess societal preferences regarding allocation of extracorporeal membrane oxygenation (ECMO) as a rescue option for select patients with coronavirus disease 2019 (COVID-19). Cross-sectional survey of a nationally representative sample. Amazon Mechanical Turk platform. In total, responses from 1,041 members of Amazon Mechanical Turk crowd-sourcing platform were included. Participants were 37.9 ± 12.6 years old, generally white (65%), and college-educated (66.1%). Many reported working in a h","2021","07","08","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia","COVID-19; ECMO; bioethics; justice; resource allocation","Rao","Akhil","Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA",NA
"62","34218997","10.1053/j.jvca.2021.05.058","How Should ECMO Be Used Under Conditions of Severe Scarcity? A Population Study of Public Perception.","To assess societal preferences regarding allocation of extracorporeal membrane oxygenation (ECMO) as a rescue option for select patients with coronavirus disease 2019 (COVID-19). Cross-sectional survey of a nationally representative sample. Amazon Mechanical Turk platform. In total, responses from 1,041 members of Amazon Mechanical Turk crowd-sourcing platform were included. Participants were 37.9 ± 12.6 years old, generally white (65%), and college-educated (66.1%). Many reported working in a h","2021","07","08","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia","COVID-19; ECMO; bioethics; justice; resource allocation","Olia","Salim E","Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA",NA
"63","34218997","10.1053/j.jvca.2021.05.058","How Should ECMO Be Used Under Conditions of Severe Scarcity? A Population Study of Public Perception.","To assess societal preferences regarding allocation of extracorporeal membrane oxygenation (ECMO) as a rescue option for select patients with coronavirus disease 2019 (COVID-19). Cross-sectional survey of a nationally representative sample. Amazon Mechanical Turk platform. In total, responses from 1,041 members of Amazon Mechanical Turk crowd-sourcing platform were included. Participants were 37.9 ± 12.6 years old, generally white (65%), and college-educated (66.1%). Many reported working in a h","2021","07","08","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia","COVID-19; ECMO; bioethics; justice; resource allocation","Helmers","Mark R","Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA",NA
"64","34218997","10.1053/j.jvca.2021.05.058","How Should ECMO Be Used Under Conditions of Severe Scarcity? A Population Study of Public Perception.","To assess societal preferences regarding allocation of extracorporeal membrane oxygenation (ECMO) as a rescue option for select patients with coronavirus disease 2019 (COVID-19). Cross-sectional survey of a nationally representative sample. Amazon Mechanical Turk platform. In total, responses from 1,041 members of Amazon Mechanical Turk crowd-sourcing platform were included. Participants were 37.9 ± 12.6 years old, generally white (65%), and college-educated (66.1%). Many reported working in a h","2021","07","08","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia","COVID-19; ECMO; bioethics; justice; resource allocation","Iyengar","Amit","Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA",NA
"65","34218997","10.1053/j.jvca.2021.05.058","How Should ECMO Be Used Under Conditions of Severe Scarcity? A Population Study of Public Perception.","To assess societal preferences regarding allocation of extracorporeal membrane oxygenation (ECMO) as a rescue option for select patients with coronavirus disease 2019 (COVID-19). Cross-sectional survey of a nationally representative sample. Amazon Mechanical Turk platform. In total, responses from 1,041 members of Amazon Mechanical Turk crowd-sourcing platform were included. Participants were 37.9 ± 12.6 years old, generally white (65%), and college-educated (66.1%). Many reported working in a h","2021","07","08","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia","COVID-19; ECMO; bioethics; justice; resource allocation","Kelly","John J","Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA",NA
"66","34218997","10.1053/j.jvca.2021.05.058","How Should ECMO Be Used Under Conditions of Severe Scarcity? A Population Study of Public Perception.","To assess societal preferences regarding allocation of extracorporeal membrane oxygenation (ECMO) as a rescue option for select patients with coronavirus disease 2019 (COVID-19). Cross-sectional survey of a nationally representative sample. Amazon Mechanical Turk platform. In total, responses from 1,041 members of Amazon Mechanical Turk crowd-sourcing platform were included. Participants were 37.9 ± 12.6 years old, generally white (65%), and college-educated (66.1%). Many reported working in a h","2021","07","08","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia","COVID-19; ECMO; bioethics; justice; resource allocation","Smood","Benjamin","Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA",NA
"67","34218997","10.1053/j.jvca.2021.05.058","How Should ECMO Be Used Under Conditions of Severe Scarcity? A Population Study of Public Perception.","To assess societal preferences regarding allocation of extracorporeal membrane oxygenation (ECMO) as a rescue option for select patients with coronavirus disease 2019 (COVID-19). Cross-sectional survey of a nationally representative sample. Amazon Mechanical Turk platform. In total, responses from 1,041 members of Amazon Mechanical Turk crowd-sourcing platform were included. Participants were 37.9 ± 12.6 years old, generally white (65%), and college-educated (66.1%). Many reported working in a h","2021","07","08","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia","COVID-19; ECMO; bioethics; justice; resource allocation","Gutsche","Jacob T","Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA",NA
"68","34218997","10.1053/j.jvca.2021.05.058","How Should ECMO Be Used Under Conditions of Severe Scarcity? A Population Study of Public Perception.","To assess societal preferences regarding allocation of extracorporeal membrane oxygenation (ECMO) as a rescue option for select patients with coronavirus disease 2019 (COVID-19). Cross-sectional survey of a nationally representative sample. Amazon Mechanical Turk platform. In total, responses from 1,041 members of Amazon Mechanical Turk crowd-sourcing platform were included. Participants were 37.9 ± 12.6 years old, generally white (65%), and college-educated (66.1%). Many reported working in a h","2021","07","08","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia","COVID-19; ECMO; bioethics; justice; resource allocation","Bermudez","Christian","Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA",NA
"69","34218997","10.1053/j.jvca.2021.05.058","How Should ECMO Be Used Under Conditions of Severe Scarcity? A Population Study of Public Perception.","To assess societal preferences regarding allocation of extracorporeal membrane oxygenation (ECMO) as a rescue option for select patients with coronavirus disease 2019 (COVID-19). Cross-sectional survey of a nationally representative sample. Amazon Mechanical Turk platform. In total, responses from 1,041 members of Amazon Mechanical Turk crowd-sourcing platform were included. Participants were 37.9 ± 12.6 years old, generally white (65%), and college-educated (66.1%). Many reported working in a h","2021","07","08","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia","COVID-19; ECMO; bioethics; justice; resource allocation","Cevasco","Marisa","Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA","Marisa.cevasco@pennmedicine.upenn.edu"
"70","34218995","10.1053/j.jvca.2021.06.002","Understanding ST-Elevation Myocardial Infarction in COVID-19: The Marriage of Bench Work and Big Data.",NA,"2021","07","08","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia",NA,"Siscel","Jordan","Department of Anesthesiology, The University of Kansas Health System, Kansas City, KS",NA
"71","34218995","10.1053/j.jvca.2021.06.002","Understanding ST-Elevation Myocardial Infarction in COVID-19: The Marriage of Bench Work and Big Data.",NA,"2021","07","08","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia",NA,"Short","Margo","Department of Anesthesiology, The University of Kansas Health System, Kansas City, KS",NA
"72","34218995","10.1053/j.jvca.2021.06.002","Understanding ST-Elevation Myocardial Infarction in COVID-19: The Marriage of Bench Work and Big Data.",NA,"2021","07","08","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia",NA,"Flynn","Brigid","Department of Anesthesiology, The University of Kansas Health System, Kansas City, KS. Electronic address: bflynn@kumc","bflynn@kumc.edu"
"73","34218984","10.1016/j.asjsur.2021.06.010","Clinical manifestation and dynamic changes of computerized tomography features of novel coronavirus pneumonia.",NA,"2021","07","08","Asian J Surg","Asian journal of surgery","Chest; Clinical presentation; Novel coronavirus pneumonia; Tomography","Wang","Weijian","Medical Imaging Center of the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450002, China",NA
"74","34218984","10.1016/j.asjsur.2021.06.010","Clinical manifestation and dynamic changes of computerized tomography features of novel coronavirus pneumonia.",NA,"2021","07","08","Asian J Surg","Asian journal of surgery","Chest; Clinical presentation; Novel coronavirus pneumonia; Tomography","Wang","Xiao","Medical Imaging Center of the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450002, China",NA
"75","34218984","10.1016/j.asjsur.2021.06.010","Clinical manifestation and dynamic changes of computerized tomography features of novel coronavirus pneumonia.",NA,"2021","07","08","Asian J Surg","Asian journal of surgery","Chest; Clinical presentation; Novel coronavirus pneumonia; Tomography","Zhang","Yong","Medical Imaging Center of the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450002, China",NA
"76","34218984","10.1016/j.asjsur.2021.06.010","Clinical manifestation and dynamic changes of computerized tomography features of novel coronavirus pneumonia.",NA,"2021","07","08","Asian J Surg","Asian journal of surgery","Chest; Clinical presentation; Novel coronavirus pneumonia; Tomography","Cheng","Jingliang","Medical Imaging Center of the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450002, China. Electronic address: jingliangchengdoc@yeah","jingliangchengdoc@yeah.net"
"77","34218963","10.1016/j.vaccine.2021.06.048","Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia.","There is widespread hesitancy towards COVID-19 vaccines in the United States, United Kingdom, and Australia. To identify predictors of willingness to vaccinate against COVID-19 in five cities with varying COVID-19 incidence in the US, UK, and Australia. Online, cross-sectional survey of adults from Dynata's research panel in July-September 2020. Adults aged 18 and over in Sydney, Melbourne, London, New York City, or Phoenix. Willingness to receive a COVID-19 vaccine; reason for vaccine intention","2021","07","08","Vaccine","Vaccine","COVID-19; Coronavirus; SARS-CoV-2; Vaccine hesitancy","Trent","Mallory","Biosecurity Research Program, The Kirby Institute, University of New South Wales, Sydney, Australia. Electronic address: mjtrent@protonmail","mjtrent@protonmail.com"
"78","34218963","10.1016/j.vaccine.2021.06.048","Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia.","There is widespread hesitancy towards COVID-19 vaccines in the United States, United Kingdom, and Australia. To identify predictors of willingness to vaccinate against COVID-19 in five cities with varying COVID-19 incidence in the US, UK, and Australia. Online, cross-sectional survey of adults from Dynata's research panel in July-September 2020. Adults aged 18 and over in Sydney, Melbourne, London, New York City, or Phoenix. Willingness to receive a COVID-19 vaccine; reason for vaccine intention","2021","07","08","Vaccine","Vaccine","COVID-19; Coronavirus; SARS-CoV-2; Vaccine hesitancy","Seale","Holly","School of Population Health, University of New South Wales, Sydney, Australia. Electronic address: h.seale@unsw.edu","h.seale@unsw.edu.au"
"79","34218963","10.1016/j.vaccine.2021.06.048","Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia.","There is widespread hesitancy towards COVID-19 vaccines in the United States, United Kingdom, and Australia. To identify predictors of willingness to vaccinate against COVID-19 in five cities with varying COVID-19 incidence in the US, UK, and Australia. Online, cross-sectional survey of adults from Dynata's research panel in July-September 2020. Adults aged 18 and over in Sydney, Melbourne, London, New York City, or Phoenix. Willingness to receive a COVID-19 vaccine; reason for vaccine intention","2021","07","08","Vaccine","Vaccine","COVID-19; Coronavirus; SARS-CoV-2; Vaccine hesitancy","Chughtai","Abrar Ahmad","School of Population Health, University of New South Wales, Sydney, Australia. Electronic address: abrar.chughtai@protonmail","abrar.chughtai@protonmail.com"
"80","34218963","10.1016/j.vaccine.2021.06.048","Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia.","There is widespread hesitancy towards COVID-19 vaccines in the United States, United Kingdom, and Australia. To identify predictors of willingness to vaccinate against COVID-19 in five cities with varying COVID-19 incidence in the US, UK, and Australia. Online, cross-sectional survey of adults from Dynata's research panel in July-September 2020. Adults aged 18 and over in Sydney, Melbourne, London, New York City, or Phoenix. Willingness to receive a COVID-19 vaccine; reason for vaccine intention","2021","07","08","Vaccine","Vaccine","COVID-19; Coronavirus; SARS-CoV-2; Vaccine hesitancy","Salmon","Daniel","Institute for Vaccine Safety, Departments of International Health and Health, Behavior and Society, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States",NA
"81","34218963","10.1016/j.vaccine.2021.06.048","Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia.","There is widespread hesitancy towards COVID-19 vaccines in the United States, United Kingdom, and Australia. To identify predictors of willingness to vaccinate against COVID-19 in five cities with varying COVID-19 incidence in the US, UK, and Australia. Online, cross-sectional survey of adults from Dynata's research panel in July-September 2020. Adults aged 18 and over in Sydney, Melbourne, London, New York City, or Phoenix. Willingness to receive a COVID-19 vaccine; reason for vaccine intention","2021","07","08","Vaccine","Vaccine","COVID-19; Coronavirus; SARS-CoV-2; Vaccine hesitancy","MacIntyre","C Raina","Biosecurity Research Program, The Kirby Institute, University of New South Wales, Sydney, Australia. Electronic address: rainam@protonmail","rainam@protonmail.com"
"82","34218957","10.1016/j.tig.2021.06.013","Research and leaders: a twisted tale!","Good leadership is important for the efficient functioning of an organization. PhD and postdoctoral research is a mentally challenging job, and a good mentor must be able to both treat students with compassion and provide motivation. Coronavirus disease 2019 (COVID-19) has resulted in the decline of the mental health of a large fraction of mentees.","2021","07","05","Trends Genet","Trends in genetics : TIG","COVID-19; good leadership; mental health; stress-free","Prasad","Ashish","National Institute of Plant Genome Research, Aruna Asaf Ali Marg, New Delhi, 110067, India",NA
"83","34218957","10.1016/j.tig.2021.06.013","Research and leaders: a twisted tale!","Good leadership is important for the efficient functioning of an organization. PhD and postdoctoral research is a mentally challenging job, and a good mentor must be able to both treat students with compassion and provide motivation. Coronavirus disease 2019 (COVID-19) has resulted in the decline of the mental health of a large fraction of mentees.","2021","07","05","Trends Genet","Trends in genetics : TIG","COVID-19; good leadership; mental health; stress-free","Prasad","Manoj","National Institute of Plant Genome Research, Aruna Asaf Ali Marg, New Delhi, 110067, India","prasad@nipgr.ac.in"
"84","34218944","10.1016/j.medcli.2021.06.001","Changes in antihypertensive treatment in surviving patients SARS-CoV-2 respiratory infection and its cardiovascular impact after one year of follow-up.",NA,"2021","07","08","Med Clin (Barc)","Medicina clinica",NA,"Águila Gordo","Daniel","Servicio de Cardiología, Hospital General Universitario de Ciudad Real, Ciudad Real, España. Electronic address: danielaguilagordo@gmail","danielaguilagordo@gmail.com"
"85","34218944","10.1016/j.medcli.2021.06.001","Changes in antihypertensive treatment in surviving patients SARS-CoV-2 respiratory infection and its cardiovascular impact after one year of follow-up.",NA,"2021","07","08","Med Clin (Barc)","Medicina clinica",NA,"Martínez Del Rio","Jorge","Servicio de Cardiología, Hospital General Universitario de Ciudad Real, Ciudad Real, España",NA
"86","34218944","10.1016/j.medcli.2021.06.001","Changes in antihypertensive treatment in surviving patients SARS-CoV-2 respiratory infection and its cardiovascular impact after one year of follow-up.",NA,"2021","07","08","Med Clin (Barc)","Medicina clinica",NA,"Piqueras Flores","Jesús","Servicio de Cardiología, Hospital General Universitario de Ciudad Real, Ciudad Real, España",NA
"87","34218943","10.1016/j.medcli.2021.05.015","Benefits of early use of high-flow-nasal-cannula (HFNC) in patients with COVID-19 associated pneumonia.","Severe COVID-19 is associated with hypoxemic bilateral pneumonia that leads to mechanical ventilation in a considerable proportion of patients. To the best of our knowledge, there are no recommendations about the best time to initiate high flow nasal cannula (HFNC). Retrospective study of all patients admitted for COVID-19 pneumonia who required HNFO between March 2020 and February 2021. Patients were grouped in early HNFC or late HNFC, according to the modified Kirby index. 53 patients were inc","2021","07","08","Med Clin (Barc)","Medicina clinica","COVID-19; HNFC; Kirby index; Neumonía; ONAF; Pneumonia; Índice de Kirby","García-Pereña","Laura","Servicio de Medicina Interna, Hospital HLA Inmaculada, Granada, España",NA
"88","34218943","10.1016/j.medcli.2021.05.015","Benefits of early use of high-flow-nasal-cannula (HFNC) in patients with COVID-19 associated pneumonia.","Severe COVID-19 is associated with hypoxemic bilateral pneumonia that leads to mechanical ventilation in a considerable proportion of patients. To the best of our knowledge, there are no recommendations about the best time to initiate high flow nasal cannula (HFNC). Retrospective study of all patients admitted for COVID-19 pneumonia who required HNFO between March 2020 and February 2021. Patients were grouped in early HNFC or late HNFC, according to the modified Kirby index. 53 patients were inc","2021","07","08","Med Clin (Barc)","Medicina clinica","COVID-19; HNFC; Kirby index; Neumonía; ONAF; Pneumonia; Índice de Kirby","Ramos Sesma","Violeta","Servicio de Medicina Interna, Hospital HLA Inmaculada, Granada, España",NA
"89","34218943","10.1016/j.medcli.2021.05.015","Benefits of early use of high-flow-nasal-cannula (HFNC) in patients with COVID-19 associated pneumonia.","Severe COVID-19 is associated with hypoxemic bilateral pneumonia that leads to mechanical ventilation in a considerable proportion of patients. To the best of our knowledge, there are no recommendations about the best time to initiate high flow nasal cannula (HFNC). Retrospective study of all patients admitted for COVID-19 pneumonia who required HNFO between March 2020 and February 2021. Patients were grouped in early HNFC or late HNFC, according to the modified Kirby index. 53 patients were inc","2021","07","08","Med Clin (Barc)","Medicina clinica","COVID-19; HNFC; Kirby index; Neumonía; ONAF; Pneumonia; Índice de Kirby","Tornero Divieso","María Lucía","Servicio de Medicina Interna, Hospital HLA Inmaculada, Granada, España",NA
"90","34218943","10.1016/j.medcli.2021.05.015","Benefits of early use of high-flow-nasal-cannula (HFNC) in patients with COVID-19 associated pneumonia.","Severe COVID-19 is associated with hypoxemic bilateral pneumonia that leads to mechanical ventilation in a considerable proportion of patients. To the best of our knowledge, there are no recommendations about the best time to initiate high flow nasal cannula (HFNC). Retrospective study of all patients admitted for COVID-19 pneumonia who required HNFO between March 2020 and February 2021. Patients were grouped in early HNFC or late HNFC, according to the modified Kirby index. 53 patients were inc","2021","07","08","Med Clin (Barc)","Medicina clinica","COVID-19; HNFC; Kirby index; Neumonía; ONAF; Pneumonia; Índice de Kirby","Lluna Carrascosa","Alfonso","Servicio de Medicina Interna, Hospital HLA Inmaculada, Granada, España",NA
"91","34218943","10.1016/j.medcli.2021.05.015","Benefits of early use of high-flow-nasal-cannula (HFNC) in patients with COVID-19 associated pneumonia.","Severe COVID-19 is associated with hypoxemic bilateral pneumonia that leads to mechanical ventilation in a considerable proportion of patients. To the best of our knowledge, there are no recommendations about the best time to initiate high flow nasal cannula (HFNC). Retrospective study of all patients admitted for COVID-19 pneumonia who required HNFO between March 2020 and February 2021. Patients were grouped in early HNFC or late HNFC, according to the modified Kirby index. 53 patients were inc","2021","07","08","Med Clin (Barc)","Medicina clinica","COVID-19; HNFC; Kirby index; Neumonía; ONAF; Pneumonia; Índice de Kirby","Velasco Fuentes","Sara","Servicio de Medicina Interna, Hospital HLA Inmaculada, Granada, España",NA
"92","34218943","10.1016/j.medcli.2021.05.015","Benefits of early use of high-flow-nasal-cannula (HFNC) in patients with COVID-19 associated pneumonia.","Severe COVID-19 is associated with hypoxemic bilateral pneumonia that leads to mechanical ventilation in a considerable proportion of patients. To the best of our knowledge, there are no recommendations about the best time to initiate high flow nasal cannula (HFNC). Retrospective study of all patients admitted for COVID-19 pneumonia who required HNFO between March 2020 and February 2021. Patients were grouped in early HNFC or late HNFC, according to the modified Kirby index. 53 patients were inc","2021","07","08","Med Clin (Barc)","Medicina clinica","COVID-19; HNFC; Kirby index; Neumonía; ONAF; Pneumonia; Índice de Kirby","Parra-Ruiz","Jorge","Servicio de Medicina Interna, Hospital HLA Inmaculada, Granada, España. Electronic address: jorge.parra@grupohla","jorge.parra@grupohla.com"
"93","34218936","10.1016/j.annder.2021.04.008","Is it safe to vaccinate within a tattoo?",NA,"2021","07","08","Ann Dermatol Venereol","Annales de dermatologie et de venereologie","COVID-19; SARS-CoV-2; Tattooing; Tattoos; Vaccination","Kluger","N","Department of Dermatology, Allergology and Venereology, University of Helsinki and Helsinki University Hospital, Meilahdentie 2, 00029 Helsinki, Finland","nicolas.kluger@hus.fi"
"94","34218924","10.1016/j.crad.2021.06.003","Can training in diagnostic radiology be moved online during the COVID-19 pandemic? UK trainee perceptions of the Radiology-Integrated Training Initiative (R-ITI) e-learning platform.","To assess trainee perceptions of the Radiology-Integrated Training Initiative (R-ITI)) e-learning modules. A mixed methodology approach was used, with triangulation between a thematic analysis of eight semi-structured interviews from radiology trainees and trainers, and a contextual analysis of 60 free-text feedback comments and module ratings from trainees after completion of R-ITI modules. Three broad themes emerged: ""learning the subject matter"", ""learning the role,"" and ""e-learning preferenc","2021","07","05","Clin Radiol","Clinical radiology",NA,"Upadhyay","N","Charing Cross Hospital, Imperial College Healthcare NHS Trust, Fulham Palace Rd, Hammersmith, London, W6 8RF, UK",NA
"95","34218924","10.1016/j.crad.2021.06.003","Can training in diagnostic radiology be moved online during the COVID-19 pandemic? UK trainee perceptions of the Radiology-Integrated Training Initiative (R-ITI) e-learning platform.","To assess trainee perceptions of the Radiology-Integrated Training Initiative (R-ITI)) e-learning modules. A mixed methodology approach was used, with triangulation between a thematic analysis of eight semi-structured interviews from radiology trainees and trainers, and a contextual analysis of 60 free-text feedback comments and module ratings from trainees after completion of R-ITI modules. Three broad themes emerged: ""learning the subject matter"", ""learning the role,"" and ""e-learning preferenc","2021","07","05","Clin Radiol","Clinical radiology",NA,"Wadkin","J C R","Charing Cross Hospital, Imperial College Healthcare NHS Trust, Fulham Palace Rd, Hammersmith, London, W6 8RF, UK. Electronic address: james.wadkin1@nhs","james.wadkin1@nhs.net"
"96","34218906","10.1016/j.bja.2021.06.002","Improved oxygenation with inhaled milrinone in mechanically ventilated patients with severe COVID-19.",NA,"2021","07","08","Br J Anaesth","British journal of anaesthesia","COVID-19; acute respiratory distress syndrome; hypoxaemia; milrinone; phosphodiesterase 3 inhibitor; pulmonary vasodilator","Vogel","Dominik J","Intensive Care Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK. Electronic address: dominik.vogel@gstt.nhs","dominik.vogel@gstt.nhs.uk"
"97","34218906","10.1016/j.bja.2021.06.002","Improved oxygenation with inhaled milrinone in mechanically ventilated patients with severe COVID-19.",NA,"2021","07","08","Br J Anaesth","British journal of anaesthesia","COVID-19; acute respiratory distress syndrome; hypoxaemia; milrinone; phosphodiesterase 3 inhibitor; pulmonary vasodilator","Brame","Aimee","Intensive Care Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"98","34218906","10.1016/j.bja.2021.06.002","Improved oxygenation with inhaled milrinone in mechanically ventilated patients with severe COVID-19.",NA,"2021","07","08","Br J Anaesth","British journal of anaesthesia","COVID-19; acute respiratory distress syndrome; hypoxaemia; milrinone; phosphodiesterase 3 inhibitor; pulmonary vasodilator","Hanks","Fraser","Intensive Care Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"99","34218906","10.1016/j.bja.2021.06.002","Improved oxygenation with inhaled milrinone in mechanically ventilated patients with severe COVID-19.",NA,"2021","07","08","Br J Anaesth","British journal of anaesthesia","COVID-19; acute respiratory distress syndrome; hypoxaemia; milrinone; phosphodiesterase 3 inhibitor; pulmonary vasodilator","Remmington","Chris","Intensive Care Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"100","34218906","10.1016/j.bja.2021.06.002","Improved oxygenation with inhaled milrinone in mechanically ventilated patients with severe COVID-19.",NA,"2021","07","08","Br J Anaesth","British journal of anaesthesia","COVID-19; acute respiratory distress syndrome; hypoxaemia; milrinone; phosphodiesterase 3 inhibitor; pulmonary vasodilator","Chung","Natali","Adult Congenital Heart Disease Service, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"101","34218906","10.1016/j.bja.2021.06.002","Improved oxygenation with inhaled milrinone in mechanically ventilated patients with severe COVID-19.",NA,"2021","07","08","Br J Anaesth","British journal of anaesthesia","COVID-19; acute respiratory distress syndrome; hypoxaemia; milrinone; phosphodiesterase 3 inhibitor; pulmonary vasodilator","Camporota","Luigi","Intensive Care Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"102","34218888","10.1016/j.remnie.2020.08.004","SARS-CoV-2 (COVID-19) pneumonia: Incidental finding on <sup>18</sup>F-FDG PET/CT study for vasculitis diagnosis.",NA,"2021","07","15","Rev Esp Med Nucl Imagen Mol (Engl Ed)","Revista espanola de medicina nuclear e imagen molecular","Aged; Arteries; COVID-19; COVID-19 Serological Testing; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Systemic Vasculitis","Salvat Dávila","Carmen","Hospital Universitario Central de Asturias, Oviedo, Spain. Electronic address: carmensd@usal","carmensd@usal.es"
"103","34218888","10.1016/j.remnie.2020.08.004","SARS-CoV-2 (COVID-19) pneumonia: Incidental finding on <sup>18</sup>F-FDG PET/CT study for vasculitis diagnosis.",NA,"2021","07","15","Rev Esp Med Nucl Imagen Mol (Engl Ed)","Revista espanola de medicina nuclear e imagen molecular","Aged; Arteries; COVID-19; COVID-19 Serological Testing; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Systemic Vasculitis","Suárez Fernández","Juan Pablo","Hospital Universitario Central de Asturias, Oviedo, Spain",NA
"104","34218888","10.1016/j.remnie.2020.08.004","SARS-CoV-2 (COVID-19) pneumonia: Incidental finding on <sup>18</sup>F-FDG PET/CT study for vasculitis diagnosis.",NA,"2021","07","15","Rev Esp Med Nucl Imagen Mol (Engl Ed)","Revista espanola de medicina nuclear e imagen molecular","Aged; Arteries; COVID-19; COVID-19 Serological Testing; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Systemic Vasculitis","Domínguez Grande","María Luz","Hospital Universitario Central de Asturias, Oviedo, Spain",NA
"105","34218888","10.1016/j.remnie.2020.08.004","SARS-CoV-2 (COVID-19) pneumonia: Incidental finding on <sup>18</sup>F-FDG PET/CT study for vasculitis diagnosis.",NA,"2021","07","15","Rev Esp Med Nucl Imagen Mol (Engl Ed)","Revista espanola de medicina nuclear e imagen molecular","Aged; Arteries; COVID-19; COVID-19 Serological Testing; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Systemic Vasculitis","Vigil Díaz","Carmen","Hospital Universitario Central de Asturias, Oviedo, Spain",NA
"106","34218888","10.1016/j.remnie.2020.08.004","SARS-CoV-2 (COVID-19) pneumonia: Incidental finding on <sup>18</sup>F-FDG PET/CT study for vasculitis diagnosis.",NA,"2021","07","15","Rev Esp Med Nucl Imagen Mol (Engl Ed)","Revista espanola de medicina nuclear e imagen molecular","Aged; Arteries; COVID-19; COVID-19 Serological Testing; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Systemic Vasculitis","Fernández Llana","Belén","Hospital Universitario Central de Asturias, Oviedo, Spain",NA
"107","34218888","10.1016/j.remnie.2020.08.004","SARS-CoV-2 (COVID-19) pneumonia: Incidental finding on <sup>18</sup>F-FDG PET/CT study for vasculitis diagnosis.",NA,"2021","07","15","Rev Esp Med Nucl Imagen Mol (Engl Ed)","Revista espanola de medicina nuclear e imagen molecular","Aged; Arteries; COVID-19; COVID-19 Serological Testing; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Systemic Vasculitis","Martín Fernández","Noelia","Hospital Universitario Central de Asturias, Oviedo, Spain",NA
"108","34218888","10.1016/j.remnie.2020.08.004","SARS-CoV-2 (COVID-19) pneumonia: Incidental finding on <sup>18</sup>F-FDG PET/CT study for vasculitis diagnosis.",NA,"2021","07","15","Rev Esp Med Nucl Imagen Mol (Engl Ed)","Revista espanola de medicina nuclear e imagen molecular","Aged; Arteries; COVID-19; COVID-19 Serological Testing; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Systemic Vasculitis","González García","Francisco Javier","Hospital Universitario Central de Asturias, Oviedo, Spain",NA
"109","34218871","10.1016/j.mayocp.2021.05.002","Seeking Joy in Medicine During Uncertain Times: COVID-19 and Social Unrest.",NA,"2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; Civil Disorders; Happiness; Humans; Medicine; Uncertainty; United States","Warsame","Rahma","Department of Hematology, Mayo Clinic, Rochester, Minnesota",NA
"110","34218871","10.1016/j.mayocp.2021.05.002","Seeking Joy in Medicine During Uncertain Times: COVID-19 and Social Unrest.",NA,"2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; Civil Disorders; Happiness; Humans; Medicine; Uncertainty; United States","Price","Katharine A","Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota",NA
"111","34218863","10.1016/j.mayocp.2021.04.009","COVID-19 Gender Disparities and Mitigation Recommendations: A Narrative Review.","The coronavirus disease 2019 (COVID-19) pandemic has rapidly created widespread impacts on global health and the economy. Data suggest that women are less susceptible to severe illness. However, sex-disaggregated data are incomplete, leaving room for misinterpretation, and focusing only on biologic sex underestimates the gendered impact of the pandemic on women. This narrative review summarizes what is known about gender disparities during the COVID-19 pandemic and the economic, domestic, and he","2021","07","13","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; Female; Global Health; Humans; Male; Mental Health; Pandemics; SARS-CoV-2; Sex Distribution; Sex Factors","Nordhues","Hannah C","Division of General Internal Medicine, Mayo Clinic, Rochester, MN. Electronic address: https://twitter.com/@HannahNordhues",NA
"112","34218863","10.1016/j.mayocp.2021.04.009","COVID-19 Gender Disparities and Mitigation Recommendations: A Narrative Review.","The coronavirus disease 2019 (COVID-19) pandemic has rapidly created widespread impacts on global health and the economy. Data suggest that women are less susceptible to severe illness. However, sex-disaggregated data are incomplete, leaving room for misinterpretation, and focusing only on biologic sex underestimates the gendered impact of the pandemic on women. This narrative review summarizes what is known about gender disparities during the COVID-19 pandemic and the economic, domestic, and he","2021","07","13","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; Female; Global Health; Humans; Male; Mental Health; Pandemics; SARS-CoV-2; Sex Distribution; Sex Factors","Bhagra","Anjali","Division of General Internal Medicine, Mayo Clinic, Rochester, MN",NA
"113","34218863","10.1016/j.mayocp.2021.04.009","COVID-19 Gender Disparities and Mitigation Recommendations: A Narrative Review.","The coronavirus disease 2019 (COVID-19) pandemic has rapidly created widespread impacts on global health and the economy. Data suggest that women are less susceptible to severe illness. However, sex-disaggregated data are incomplete, leaving room for misinterpretation, and focusing only on biologic sex underestimates the gendered impact of the pandemic on women. This narrative review summarizes what is known about gender disparities during the COVID-19 pandemic and the economic, domestic, and he","2021","07","13","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; Female; Global Health; Humans; Male; Mental Health; Pandemics; SARS-CoV-2; Sex Distribution; Sex Factors","Stroud","Natya N","Division of General Internal Medicine, Mayo Clinic, Rochester, MN",NA
"114","34218863","10.1016/j.mayocp.2021.04.009","COVID-19 Gender Disparities and Mitigation Recommendations: A Narrative Review.","The coronavirus disease 2019 (COVID-19) pandemic has rapidly created widespread impacts on global health and the economy. Data suggest that women are less susceptible to severe illness. However, sex-disaggregated data are incomplete, leaving room for misinterpretation, and focusing only on biologic sex underestimates the gendered impact of the pandemic on women. This narrative review summarizes what is known about gender disparities during the COVID-19 pandemic and the economic, domestic, and he","2021","07","13","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; Female; Global Health; Humans; Male; Mental Health; Pandemics; SARS-CoV-2; Sex Distribution; Sex Factors","Vencill","Jennifer A","Division of General Internal Medicine, Mayo Clinic, Rochester, MN",NA
"115","34218863","10.1016/j.mayocp.2021.04.009","COVID-19 Gender Disparities and Mitigation Recommendations: A Narrative Review.","The coronavirus disease 2019 (COVID-19) pandemic has rapidly created widespread impacts on global health and the economy. Data suggest that women are less susceptible to severe illness. However, sex-disaggregated data are incomplete, leaving room for misinterpretation, and focusing only on biologic sex underestimates the gendered impact of the pandemic on women. This narrative review summarizes what is known about gender disparities during the COVID-19 pandemic and the economic, domestic, and he","2021","07","13","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; Female; Global Health; Humans; Male; Mental Health; Pandemics; SARS-CoV-2; Sex Distribution; Sex Factors","Kuhle","Carol L","Division of General Internal Medicine, Mayo Clinic, Rochester, MN",NA
"116","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Storlie","Curtis B","Department of Health Sciences Research, Mayo Clinic, Rochester, MN. Electronic address: storlie.curt@mayo","storlie.curt@mayo.edu"
"117","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Pollock","Benjamin D","Department of Health Sciences Research, Mayo Clinic, Rochester, MN",NA
"118","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Rojas","Ricardo L","Department of Health Sciences Research, Mayo Clinic, Rochester, MN",NA
"119","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Demuth","Gabriel O","Department of Health Sciences Research, Mayo Clinic, Rochester, MN",NA
"120","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Johnson","Patrick W","Department of Health Sciences Research, Mayo Clinic, Rochester, MN",NA
"121","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Wilson","Patrick M","Department of Health Sciences Research, Mayo Clinic, Rochester, MN",NA
"122","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Heinzen","Ethan P","Department of Health Sciences Research, Mayo Clinic, Rochester, MN",NA
"123","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Liu","Hongfang","Department of Health Sciences Research, Mayo Clinic, Rochester, MN",NA
"124","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Carter","Rickey E","Department of Health Sciences Research, Mayo Clinic, Rochester, MN",NA
"125","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Habermann","Elizabeth B","Division of Health Care Policy and Research, Mayo Clinic, Rochester, MN",NA
"126","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Kor","Daryl J","Department of Anesthesiology, Mayo Clinic, Rochester, MN",NA
"127","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Neville","Matthew R","Biostatistics, Mayo Clinic, Phoenix, AZ",NA
"128","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Limper","Andrew H","Department of Pulmonary and Critical Care Medicine",NA
"129","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Noe","Katherine H","Department of Neurology",NA
"130","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Bydon","Mohamad","Department of Neurologic Surgery, Mayo Clinic, Rochester, MN",NA
"131","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Franco","Pablo Moreno","Department of Transplant Critical Care Medicine, Mayo Clinic, Rochester, MN",NA
"132","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Sampathkumar","Priya","Division of Infectious Diseases, Mayo Clinic, Rochester, MN",NA
"133","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Shah","Nilay D","Department of Health Sciences Research, Mayo Clinic, Rochester, MN",NA
"134","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Dunlay","Shannon M","Department of Gynecologic Surgery, Mayo Clinic College of Medicine, Rochester, MN",NA
"135","34218862","10.1016/j.mayocp.2021.04.012","Quantifying the Importance of COVID-19 Vaccination to Our Future Outlook.","Predictive models have played a critical role in local, national, and international response to the COVID-19 pandemic. In the United States, health care systems and governmental agencies have relied on several models, such as the Institute for Health Metrics and Evaluation, Youyang Gu (YYG), Massachusetts Institute of Technology, and Centers for Disease Control and Prevention ensemble, to predict short- and long-term trends in disease activity. The Mayo Clinic Bayesian SIR model, recently made p","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; COVID-19 Vaccines; Forecasting; Hospitalization; Humans; United States","Dowdy","Sean C","Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN",NA
"136","34218858","10.1016/j.mayocp.2021.05.007","Combined Effects of Masking and Distance on Aerosol Exposure Potential.","To quantify the efficacy of masking and ""social distancing"" on the transmission of airborne particles from a phantom aerosol source (simulating an infected individual) to a nearby target (simulating a healthy bystander) in a well-controlled setting. An aerosol was created using monodisperse polystyrene latex beads in place of infectious respiratory secretions. Detection was by aerodynamic particle spectrometry. Both reusable cloth masks and disposable paper masks were studied. Transmission was s","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Aerosols; COVID-19; Manikins; Masks; Physical Distancing","Tomshine","Jonathan R","Division of Engineering, Mayo Clinic, Rochester, MN",NA
"137","34218858","10.1016/j.mayocp.2021.05.007","Combined Effects of Masking and Distance on Aerosol Exposure Potential.","To quantify the efficacy of masking and ""social distancing"" on the transmission of airborne particles from a phantom aerosol source (simulating an infected individual) to a nearby target (simulating a healthy bystander) in a well-controlled setting. An aerosol was created using monodisperse polystyrene latex beads in place of infectious respiratory secretions. Detection was by aerodynamic particle spectrometry. Both reusable cloth masks and disposable paper masks were studied. Transmission was s","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Aerosols; COVID-19; Manikins; Masks; Physical Distancing","Dennis","Kendall D","Division of Engineering, Mayo Clinic, Rochester, MN",NA
"138","34218858","10.1016/j.mayocp.2021.05.007","Combined Effects of Masking and Distance on Aerosol Exposure Potential.","To quantify the efficacy of masking and ""social distancing"" on the transmission of airborne particles from a phantom aerosol source (simulating an infected individual) to a nearby target (simulating a healthy bystander) in a well-controlled setting. An aerosol was created using monodisperse polystyrene latex beads in place of infectious respiratory secretions. Detection was by aerodynamic particle spectrometry. Both reusable cloth masks and disposable paper masks were studied. Transmission was s","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Aerosols; COVID-19; Manikins; Masks; Physical Distancing","Bruhnke","Russell E","Division of Engineering, Mayo Clinic, Rochester, MN",NA
"139","34218858","10.1016/j.mayocp.2021.05.007","Combined Effects of Masking and Distance on Aerosol Exposure Potential.","To quantify the efficacy of masking and ""social distancing"" on the transmission of airborne particles from a phantom aerosol source (simulating an infected individual) to a nearby target (simulating a healthy bystander) in a well-controlled setting. An aerosol was created using monodisperse polystyrene latex beads in place of infectious respiratory secretions. Detection was by aerodynamic particle spectrometry. Both reusable cloth masks and disposable paper masks were studied. Transmission was s","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Aerosols; COVID-19; Manikins; Masks; Physical Distancing","Christensen","James H","Division of Engineering, Mayo Clinic, Rochester, MN",NA
"140","34218858","10.1016/j.mayocp.2021.05.007","Combined Effects of Masking and Distance on Aerosol Exposure Potential.","To quantify the efficacy of masking and ""social distancing"" on the transmission of airborne particles from a phantom aerosol source (simulating an infected individual) to a nearby target (simulating a healthy bystander) in a well-controlled setting. An aerosol was created using monodisperse polystyrene latex beads in place of infectious respiratory secretions. Detection was by aerodynamic particle spectrometry. Both reusable cloth masks and disposable paper masks were studied. Transmission was s","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Aerosols; COVID-19; Manikins; Masks; Physical Distancing","Halvorsen","Tom G","Division of Engineering, Mayo Clinic, Rochester, MN",NA
"141","34218858","10.1016/j.mayocp.2021.05.007","Combined Effects of Masking and Distance on Aerosol Exposure Potential.","To quantify the efficacy of masking and ""social distancing"" on the transmission of airborne particles from a phantom aerosol source (simulating an infected individual) to a nearby target (simulating a healthy bystander) in a well-controlled setting. An aerosol was created using monodisperse polystyrene latex beads in place of infectious respiratory secretions. Detection was by aerodynamic particle spectrometry. Both reusable cloth masks and disposable paper masks were studied. Transmission was s","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Aerosols; COVID-19; Manikins; Masks; Physical Distancing","Hogan","Christopher J","Department of Mechanical Engineering, University of Minnesota, Minneapolis",NA
"142","34218858","10.1016/j.mayocp.2021.05.007","Combined Effects of Masking and Distance on Aerosol Exposure Potential.","To quantify the efficacy of masking and ""social distancing"" on the transmission of airborne particles from a phantom aerosol source (simulating an infected individual) to a nearby target (simulating a healthy bystander) in a well-controlled setting. An aerosol was created using monodisperse polystyrene latex beads in place of infectious respiratory secretions. Detection was by aerodynamic particle spectrometry. Both reusable cloth masks and disposable paper masks were studied. Transmission was s","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Aerosols; COVID-19; Manikins; Masks; Physical Distancing","O'Horo","John C","Department of Infectious Diseases, Mayo Clinic, Rochester, MN",NA
"143","34218858","10.1016/j.mayocp.2021.05.007","Combined Effects of Masking and Distance on Aerosol Exposure Potential.","To quantify the efficacy of masking and ""social distancing"" on the transmission of airborne particles from a phantom aerosol source (simulating an infected individual) to a nearby target (simulating a healthy bystander) in a well-controlled setting. An aerosol was created using monodisperse polystyrene latex beads in place of infectious respiratory secretions. Detection was by aerodynamic particle spectrometry. Both reusable cloth masks and disposable paper masks were studied. Transmission was s","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Aerosols; COVID-19; Manikins; Masks; Physical Distancing","Breeher","Laura E","Department of Preventive Medicine, Mayo Clinic, Rochester, MN",NA
"144","34218858","10.1016/j.mayocp.2021.05.007","Combined Effects of Masking and Distance on Aerosol Exposure Potential.","To quantify the efficacy of masking and ""social distancing"" on the transmission of airborne particles from a phantom aerosol source (simulating an infected individual) to a nearby target (simulating a healthy bystander) in a well-controlled setting. An aerosol was created using monodisperse polystyrene latex beads in place of infectious respiratory secretions. Detection was by aerodynamic particle spectrometry. Both reusable cloth masks and disposable paper masks were studied. Transmission was s","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Aerosols; COVID-19; Manikins; Masks; Physical Distancing","Callstrom","Matthew R","Department of Radiology, Mayo Clinic, Rochester, MN",NA
"145","34218858","10.1016/j.mayocp.2021.05.007","Combined Effects of Masking and Distance on Aerosol Exposure Potential.","To quantify the efficacy of masking and ""social distancing"" on the transmission of airborne particles from a phantom aerosol source (simulating an infected individual) to a nearby target (simulating a healthy bystander) in a well-controlled setting. An aerosol was created using monodisperse polystyrene latex beads in place of infectious respiratory secretions. Detection was by aerodynamic particle spectrometry. Both reusable cloth masks and disposable paper masks were studied. Transmission was s","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Aerosols; COVID-19; Manikins; Masks; Physical Distancing","Wehde","Mark B","Division of Engineering, Mayo Clinic, Rochester, MN. Electronic address: mwehde@mayo","mwehde@mayo.edu"
"146","34218857","10.1016/j.mayocp.2021.04.024","Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort.","To describe characteristics of a series of patients reporting prolonged symptoms after an infection with coronavirus disease 2019 (COVID-19). This study describes the multidisciplinary COVID-19 Activity Rehabilitation Program, established at Mayo Clinic to evaluate and treat patients with post-COVID syndrome, and reports the clinical characteristics of the first 100 patients receiving evaluation and management during the timeframe of June 1, 2020, and December 31, 2020. The cohort consisted of 1","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Academic Medical Centers; Adult; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Minnesota","Vanichkachorn","Greg","Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Rochester, MN. Electronic address: Vanichkachorn.greg@mayo","Vanichkachorn.greg@mayo.edu"
"147","34218857","10.1016/j.mayocp.2021.04.024","Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort.","To describe characteristics of a series of patients reporting prolonged symptoms after an infection with coronavirus disease 2019 (COVID-19). This study describes the multidisciplinary COVID-19 Activity Rehabilitation Program, established at Mayo Clinic to evaluate and treat patients with post-COVID syndrome, and reports the clinical characteristics of the first 100 patients receiving evaluation and management during the timeframe of June 1, 2020, and December 31, 2020. The cohort consisted of 1","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Academic Medical Centers; Adult; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Minnesota","Newcomb","Richard","Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Rochester, MN",NA
"148","34218857","10.1016/j.mayocp.2021.04.024","Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort.","To describe characteristics of a series of patients reporting prolonged symptoms after an infection with coronavirus disease 2019 (COVID-19). This study describes the multidisciplinary COVID-19 Activity Rehabilitation Program, established at Mayo Clinic to evaluate and treat patients with post-COVID syndrome, and reports the clinical characteristics of the first 100 patients receiving evaluation and management during the timeframe of June 1, 2020, and December 31, 2020. The cohort consisted of 1","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Academic Medical Centers; Adult; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Minnesota","Cowl","Clayton T","Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Rochester, MN",NA
"149","34218857","10.1016/j.mayocp.2021.04.024","Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort.","To describe characteristics of a series of patients reporting prolonged symptoms after an infection with coronavirus disease 2019 (COVID-19). This study describes the multidisciplinary COVID-19 Activity Rehabilitation Program, established at Mayo Clinic to evaluate and treat patients with post-COVID syndrome, and reports the clinical characteristics of the first 100 patients receiving evaluation and management during the timeframe of June 1, 2020, and December 31, 2020. The cohort consisted of 1","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Academic Medical Centers; Adult; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Minnesota","Murad","M Hassan","Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Rochester, MN",NA
"150","34218857","10.1016/j.mayocp.2021.04.024","Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort.","To describe characteristics of a series of patients reporting prolonged symptoms after an infection with coronavirus disease 2019 (COVID-19). This study describes the multidisciplinary COVID-19 Activity Rehabilitation Program, established at Mayo Clinic to evaluate and treat patients with post-COVID syndrome, and reports the clinical characteristics of the first 100 patients receiving evaluation and management during the timeframe of June 1, 2020, and December 31, 2020. The cohort consisted of 1","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Academic Medical Centers; Adult; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Minnesota","Breeher","Laura","Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Rochester, MN",NA
"151","34218857","10.1016/j.mayocp.2021.04.024","Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort.","To describe characteristics of a series of patients reporting prolonged symptoms after an infection with coronavirus disease 2019 (COVID-19). This study describes the multidisciplinary COVID-19 Activity Rehabilitation Program, established at Mayo Clinic to evaluate and treat patients with post-COVID syndrome, and reports the clinical characteristics of the first 100 patients receiving evaluation and management during the timeframe of June 1, 2020, and December 31, 2020. The cohort consisted of 1","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Academic Medical Centers; Adult; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Minnesota","Miller","Sara","Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Rochester, MN",NA
"152","34218857","10.1016/j.mayocp.2021.04.024","Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort.","To describe characteristics of a series of patients reporting prolonged symptoms after an infection with coronavirus disease 2019 (COVID-19). This study describes the multidisciplinary COVID-19 Activity Rehabilitation Program, established at Mayo Clinic to evaluate and treat patients with post-COVID syndrome, and reports the clinical characteristics of the first 100 patients receiving evaluation and management during the timeframe of June 1, 2020, and December 31, 2020. The cohort consisted of 1","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Academic Medical Centers; Adult; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Minnesota","Trenary","Michael","Division of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN",NA
"153","34218857","10.1016/j.mayocp.2021.04.024","Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort.","To describe characteristics of a series of patients reporting prolonged symptoms after an infection with coronavirus disease 2019 (COVID-19). This study describes the multidisciplinary COVID-19 Activity Rehabilitation Program, established at Mayo Clinic to evaluate and treat patients with post-COVID syndrome, and reports the clinical characteristics of the first 100 patients receiving evaluation and management during the timeframe of June 1, 2020, and December 31, 2020. The cohort consisted of 1","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Academic Medical Centers; Adult; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Minnesota","Neveau","Daniel","Division of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN",NA
"154","34218857","10.1016/j.mayocp.2021.04.024","Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort.","To describe characteristics of a series of patients reporting prolonged symptoms after an infection with coronavirus disease 2019 (COVID-19). This study describes the multidisciplinary COVID-19 Activity Rehabilitation Program, established at Mayo Clinic to evaluate and treat patients with post-COVID syndrome, and reports the clinical characteristics of the first 100 patients receiving evaluation and management during the timeframe of June 1, 2020, and December 31, 2020. The cohort consisted of 1","2021","07","15","Mayo Clin Proc","Mayo Clinic proceedings","Academic Medical Centers; Adult; COVID-19; Cohort Studies; Female; Humans; Male; Middle Aged; Minnesota","Higgins","Steven","Division of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN",NA
"155","34218854","10.1016/j.mayocp.2021.04.022","Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19-Positive Compared With COVID-19-Negative Patients.","To determine the difference in the rate of thromboembolic complications between hospitalized coronavirus disease 2019 (COVID-19)-positive compared with COVID-19-negative patients. Adult patients hospitalized from January 1, 2020, through May 8, 2020, who had COVID-19 testing by polymerase chain reaction assay were identified through electronic health records across multiple hospitals in the Mayo Clinic enterprise. Thrombotic outcomes (venous and arterial) were identified from the hospital proble","2021","07","13","Mayo Clin Proc","Mayo Clinic proceedings","Aged; COVID-19; Female; Follow-Up Studies; Hospitalization; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Thrombosis; United States","Chaudhary","Rahul","Division of Hospital Internal Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN","rahul.chaudhary.md@outlook.com"
"156","34218854","10.1016/j.mayocp.2021.04.022","Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19-Positive Compared With COVID-19-Negative Patients.","To determine the difference in the rate of thromboembolic complications between hospitalized coronavirus disease 2019 (COVID-19)-positive compared with COVID-19-negative patients. Adult patients hospitalized from January 1, 2020, through May 8, 2020, who had COVID-19 testing by polymerase chain reaction assay were identified through electronic health records across multiple hospitals in the Mayo Clinic enterprise. Thrombotic outcomes (venous and arterial) were identified from the hospital proble","2021","07","13","Mayo Clin Proc","Mayo Clinic proceedings","Aged; COVID-19; Female; Follow-Up Studies; Hospitalization; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Thrombosis; United States","Padrnos","Leslie","Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, AZ",NA
"157","34218854","10.1016/j.mayocp.2021.04.022","Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19-Positive Compared With COVID-19-Negative Patients.","To determine the difference in the rate of thromboembolic complications between hospitalized coronavirus disease 2019 (COVID-19)-positive compared with COVID-19-negative patients. Adult patients hospitalized from January 1, 2020, through May 8, 2020, who had COVID-19 testing by polymerase chain reaction assay were identified through electronic health records across multiple hospitals in the Mayo Clinic enterprise. Thrombotic outcomes (venous and arterial) were identified from the hospital proble","2021","07","13","Mayo Clin Proc","Mayo Clinic proceedings","Aged; COVID-19; Female; Follow-Up Studies; Hospitalization; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Thrombosis; United States","Wysokinska","Ewa","Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL",NA
"158","34218854","10.1016/j.mayocp.2021.04.022","Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19-Positive Compared With COVID-19-Negative Patients.","To determine the difference in the rate of thromboembolic complications between hospitalized coronavirus disease 2019 (COVID-19)-positive compared with COVID-19-negative patients. Adult patients hospitalized from January 1, 2020, through May 8, 2020, who had COVID-19 testing by polymerase chain reaction assay were identified through electronic health records across multiple hospitals in the Mayo Clinic enterprise. Thrombotic outcomes (venous and arterial) were identified from the hospital proble","2021","07","13","Mayo Clin Proc","Mayo Clinic proceedings","Aged; COVID-19; Female; Follow-Up Studies; Hospitalization; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Thrombosis; United States","Pruthi","Rajiv","Division of Hematology/Oncology, Mayo Clinic, Rochester, MN",NA
"159","34218854","10.1016/j.mayocp.2021.04.022","Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19-Positive Compared With COVID-19-Negative Patients.","To determine the difference in the rate of thromboembolic complications between hospitalized coronavirus disease 2019 (COVID-19)-positive compared with COVID-19-negative patients. Adult patients hospitalized from January 1, 2020, through May 8, 2020, who had COVID-19 testing by polymerase chain reaction assay were identified through electronic health records across multiple hospitals in the Mayo Clinic enterprise. Thrombotic outcomes (venous and arterial) were identified from the hospital proble","2021","07","13","Mayo Clin Proc","Mayo Clinic proceedings","Aged; COVID-19; Female; Follow-Up Studies; Hospitalization; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Thrombosis; United States","Misra","Sanjay","Department of Radiology, Mayo Clinic, Rochester, MN",NA
"160","34218854","10.1016/j.mayocp.2021.04.022","Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19-Positive Compared With COVID-19-Negative Patients.","To determine the difference in the rate of thromboembolic complications between hospitalized coronavirus disease 2019 (COVID-19)-positive compared with COVID-19-negative patients. Adult patients hospitalized from January 1, 2020, through May 8, 2020, who had COVID-19 testing by polymerase chain reaction assay were identified through electronic health records across multiple hospitals in the Mayo Clinic enterprise. Thrombotic outcomes (venous and arterial) were identified from the hospital proble","2021","07","13","Mayo Clin Proc","Mayo Clinic proceedings","Aged; COVID-19; Female; Follow-Up Studies; Hospitalization; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Thrombosis; United States","Sridharan","Meera","Division of Hematology/Oncology, Mayo Clinic, Rochester, MN",NA
"161","34218854","10.1016/j.mayocp.2021.04.022","Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19-Positive Compared With COVID-19-Negative Patients.","To determine the difference in the rate of thromboembolic complications between hospitalized coronavirus disease 2019 (COVID-19)-positive compared with COVID-19-negative patients. Adult patients hospitalized from January 1, 2020, through May 8, 2020, who had COVID-19 testing by polymerase chain reaction assay were identified through electronic health records across multiple hospitals in the Mayo Clinic enterprise. Thrombotic outcomes (venous and arterial) were identified from the hospital proble","2021","07","13","Mayo Clin Proc","Mayo Clinic proceedings","Aged; COVID-19; Female; Follow-Up Studies; Hospitalization; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Thrombosis; United States","Wysokinski","Waldemar","Division of Vascular Medicine, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN",NA
"162","34218854","10.1016/j.mayocp.2021.04.022","Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19-Positive Compared With COVID-19-Negative Patients.","To determine the difference in the rate of thromboembolic complications between hospitalized coronavirus disease 2019 (COVID-19)-positive compared with COVID-19-negative patients. Adult patients hospitalized from January 1, 2020, through May 8, 2020, who had COVID-19 testing by polymerase chain reaction assay were identified through electronic health records across multiple hospitals in the Mayo Clinic enterprise. Thrombotic outcomes (venous and arterial) were identified from the hospital proble","2021","07","13","Mayo Clin Proc","Mayo Clinic proceedings","Aged; COVID-19; Female; Follow-Up Studies; Hospitalization; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Thrombosis; United States","McBane","Robert D","Division of Vascular Medicine, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN",NA
"163","34218854","10.1016/j.mayocp.2021.04.022","Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19-Positive Compared With COVID-19-Negative Patients.","To determine the difference in the rate of thromboembolic complications between hospitalized coronavirus disease 2019 (COVID-19)-positive compared with COVID-19-negative patients. Adult patients hospitalized from January 1, 2020, through May 8, 2020, who had COVID-19 testing by polymerase chain reaction assay were identified through electronic health records across multiple hospitals in the Mayo Clinic enterprise. Thrombotic outcomes (venous and arterial) were identified from the hospital proble","2021","07","13","Mayo Clin Proc","Mayo Clinic proceedings","Aged; COVID-19; Female; Follow-Up Studies; Hospitalization; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Thrombosis; United States","Houghton","Damon E","Division of Hematology/Oncology, Mayo Clinic, Rochester, MN",NA
"164","34218853","10.1016/j.mayocp.2020.12.028","Executive Order on Ensuring Essential Medicines-All Bark, No Bite?",NA,"2021","07","22","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; Civil Defense; Disaster Planning; Drug Industry; Drugs, Essential; Health Planning; Humans; Legislation, Drug; Needs Assessment; SARS-CoV-2; Strategic Stockpile; Surge Capacity; United States","Guharoy","Roy","Department of Pharmacy, Baptist Health, Montgomery, AL","Rguharoy@baptistfirst.org"
"165","34218853","10.1016/j.mayocp.2020.12.028","Executive Order on Ensuring Essential Medicines-All Bark, No Bite?",NA,"2021","07","22","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; Civil Defense; Disaster Planning; Drug Industry; Drugs, Essential; Health Planning; Humans; Legislation, Drug; Needs Assessment; SARS-CoV-2; Strategic Stockpile; Surge Capacity; United States","Noviasky","John","Departments of Pharmacy and Medicine, SUNY-Upstate Medical University, Syracuse, NY",NA
"166","34218852","10.1016/j.mayocp.2021.05.004","Vaccination Safety: Don't Toss the Champagne With the Cork.",NA,"2021","07","22","Mayo Clin Proc","Mayo Clinic proceedings","Adverse Drug Reaction Reporting Systems; COVID-19; COVID-19 Vaccines; Humans; Mass Vaccination; Risk Assessment; SARS-CoV-2; Vaccination Refusal; Venous Thromboembolism","Shah","Aditya","Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN. Electronic address: Shah.aditya@mayo","Shah.aditya@mayo.edu"
"167","34218852","10.1016/j.mayocp.2021.05.004","Vaccination Safety: Don't Toss the Champagne With the Cork.",NA,"2021","07","22","Mayo Clin Proc","Mayo Clinic proceedings","Adverse Drug Reaction Reporting Systems; COVID-19; COVID-19 Vaccines; Humans; Mass Vaccination; Risk Assessment; SARS-CoV-2; Vaccination Refusal; Venous Thromboembolism","Challener","Douglas W","Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN",NA
"168","34218852","10.1016/j.mayocp.2021.05.004","Vaccination Safety: Don't Toss the Champagne With the Cork.",NA,"2021","07","22","Mayo Clin Proc","Mayo Clinic proceedings","Adverse Drug Reaction Reporting Systems; COVID-19; COVID-19 Vaccines; Humans; Mass Vaccination; Risk Assessment; SARS-CoV-2; Vaccination Refusal; Venous Thromboembolism","O'Horo","John C","Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN",NA
"169","34218852","10.1016/j.mayocp.2021.05.004","Vaccination Safety: Don't Toss the Champagne With the Cork.",NA,"2021","07","22","Mayo Clin Proc","Mayo Clinic proceedings","Adverse Drug Reaction Reporting Systems; COVID-19; COVID-19 Vaccines; Humans; Mass Vaccination; Risk Assessment; SARS-CoV-2; Vaccination Refusal; Venous Thromboembolism","Badley","Andrew D","Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN",NA
"170","34218847","10.1016/j.mayocp.2021.05.019","The Only Way Around Is Through the Co-Vital Impacts of the Shadow Pandemic of COVID-19.",NA,"2021","07","08","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; Humans; Pandemics; SARS-CoV-2","Joshi","Avni Y","Pediatric and Adult Allergy/Immunology, Mayo Clinic, Rochester, MN. Electronic address: Joshi.avni@mayo","Joshi.avni@mayo.edu"
"171","34218846","10.1016/j.mayocp.2021.05.015","Prothrombotic State in COVID-19: Myth or Reality?",NA,"2021","07","08","Mayo Clin Proc","Mayo Clinic proceedings","COVID-19; Humans; SARS-CoV-2","Bauer","Philippe R","Division of Pulmonary and Critical Care, Mayo Clinic, Rochester, MN. Electronic address: Bauer.Philippe@mayo","Bauer.Philippe@mayo.edu"
"172","34218826","10.1017/ice.2021.306","The use of antibody tests to determine level of immunity against coronavirus disease 2019 (COVID-19) after vaccination: A recent trend in India.",NA,"2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Jamal","Saad Ahmed",NA,NA
"173","34218826","10.1017/ice.2021.306","The use of antibody tests to determine level of immunity against coronavirus disease 2019 (COVID-19) after vaccination: A recent trend in India.",NA,"2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Pingali","Vivek",NA,NA
"174","34218826","10.1017/ice.2021.306","The use of antibody tests to determine level of immunity against coronavirus disease 2019 (COVID-19) after vaccination: A recent trend in India.",NA,"2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Rayapati","Aashish",NA,NA
"175","34218826","10.1017/ice.2021.306","The use of antibody tests to determine level of immunity against coronavirus disease 2019 (COVID-19) after vaccination: A recent trend in India.",NA,"2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Bidari","Vishwanath",NA,NA
"176","34218826","10.1017/ice.2021.306","The use of antibody tests to determine level of immunity against coronavirus disease 2019 (COVID-19) after vaccination: A recent trend in India.",NA,"2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Venkatesh","Varun",NA,NA
"177","34218826","10.1017/ice.2021.306","The use of antibody tests to determine level of immunity against coronavirus disease 2019 (COVID-19) after vaccination: A recent trend in India.",NA,"2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Farooq","Mir Umar",NA,NA
"178","34218826","10.1017/ice.2021.306","The use of antibody tests to determine level of immunity against coronavirus disease 2019 (COVID-19) after vaccination: A recent trend in India.",NA,"2021","07","16","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Pathi","Jawahar",NA,NA
"179","34218808","10.1186/s12913-021-06613-y","Measurement and determinants of financial protection in health in Afghanistan.","Out of pocket (OOP) payments for health are significant health financing challenges in Afghanistan as it is a source of incurrence of catastrophic health expenditure (CHE) and impoverishment. Measuring and understanding the drivers and impacts of this financial health hardship is an economic and public health priority, particularly in the time of COVID-19. This is the first study that measures the financial hardship and determines associated factors in Afghanistan. Afghanistan Living Conditions ","2021","07","06","BMC Health Serv Res","BMC health services research","Afghanistan; COVID-19; Catastrophic health expenditure; Health financial protection; Poverty; Afghanistan; Aged; COVID-19; Catastrophic Illness; Female; Health Expenditures; Humans; SARS-CoV-2","Dastan","Ilker","World Health Organization, Tajikistan Country Office, Dushanbe, Tajikistan. ilkerdastan@gmail","ilkerdastan@gmail.com"
"180","34218808","10.1186/s12913-021-06613-y","Measurement and determinants of financial protection in health in Afghanistan.","Out of pocket (OOP) payments for health are significant health financing challenges in Afghanistan as it is a source of incurrence of catastrophic health expenditure (CHE) and impoverishment. Measuring and understanding the drivers and impacts of this financial health hardship is an economic and public health priority, particularly in the time of COVID-19. This is the first study that measures the financial hardship and determines associated factors in Afghanistan. Afghanistan Living Conditions ","2021","07","06","BMC Health Serv Res","BMC health services research","Afghanistan; COVID-19; Catastrophic health expenditure; Health financial protection; Poverty; Afghanistan; Aged; COVID-19; Catastrophic Illness; Female; Health Expenditures; Humans; SARS-CoV-2","Abbasi","Asiyeh","Statistical Centre of Iran, Tehran, Iran",NA
"181","34218808","10.1186/s12913-021-06613-y","Measurement and determinants of financial protection in health in Afghanistan.","Out of pocket (OOP) payments for health are significant health financing challenges in Afghanistan as it is a source of incurrence of catastrophic health expenditure (CHE) and impoverishment. Measuring and understanding the drivers and impacts of this financial health hardship is an economic and public health priority, particularly in the time of COVID-19. This is the first study that measures the financial hardship and determines associated factors in Afghanistan. Afghanistan Living Conditions ","2021","07","06","BMC Health Serv Res","BMC health services research","Afghanistan; COVID-19; Catastrophic health expenditure; Health financial protection; Poverty; Afghanistan; Aged; COVID-19; Catastrophic Illness; Female; Health Expenditures; Humans; SARS-CoV-2","Arfa","Chokri","National Institute of Labor and Social Studies, University of Carthage, Tunis, Tunisia",NA
"182","34218808","10.1186/s12913-021-06613-y","Measurement and determinants of financial protection in health in Afghanistan.","Out of pocket (OOP) payments for health are significant health financing challenges in Afghanistan as it is a source of incurrence of catastrophic health expenditure (CHE) and impoverishment. Measuring and understanding the drivers and impacts of this financial health hardship is an economic and public health priority, particularly in the time of COVID-19. This is the first study that measures the financial hardship and determines associated factors in Afghanistan. Afghanistan Living Conditions ","2021","07","06","BMC Health Serv Res","BMC health services research","Afghanistan; COVID-19; Catastrophic health expenditure; Health financial protection; Poverty; Afghanistan; Aged; COVID-19; Catastrophic Illness; Female; Health Expenditures; Humans; SARS-CoV-2","Hashimi","Mir Najmuddin","World Health Organization, Afghanistan Country Office, Kabul, Afghanistan",NA
"183","34218808","10.1186/s12913-021-06613-y","Measurement and determinants of financial protection in health in Afghanistan.","Out of pocket (OOP) payments for health are significant health financing challenges in Afghanistan as it is a source of incurrence of catastrophic health expenditure (CHE) and impoverishment. Measuring and understanding the drivers and impacts of this financial health hardship is an economic and public health priority, particularly in the time of COVID-19. This is the first study that measures the financial hardship and determines associated factors in Afghanistan. Afghanistan Living Conditions ","2021","07","06","BMC Health Serv Res","BMC health services research","Afghanistan; COVID-19; Catastrophic health expenditure; Health financial protection; Poverty; Afghanistan; Aged; COVID-19; Catastrophic Illness; Female; Health Expenditures; Humans; SARS-CoV-2","Alawi","Said Mohammad Karim","Ministry of Public Health (Afghanistan), Kabul, Afghanistan",NA
"184","34218807","10.1186/s12889-021-11361-z","Factors associated with the intention of Syrian adult population to accept COVID19 vaccination: a cross-sectional study.","With global efforts to develop and deliver a COVID-19 vaccine rapidly, vaccine hesitancy stands as a barrier to these efforts. We aimed to estimate the proportion of Syrian adult population intending to be vaccinated against COVID-19 and, principally, to assess the demographic and attitudinal factors associated with it in order to approach suitable solutions. An anonymous online questionnaire was conducted between 23rd December 2020 and 5th January 2021 in various provinces in Syria. A total of ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Pandemic; Syria; Vaccine hesitancy; Adult; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Humans; Intention; Male; SARS-CoV-2; Syria; Vaccination","Mohamad","Okbah","Faculty of Medicine, Tishreen University, Latakia, Syria",NA
"185","34218807","10.1186/s12889-021-11361-z","Factors associated with the intention of Syrian adult population to accept COVID19 vaccination: a cross-sectional study.","With global efforts to develop and deliver a COVID-19 vaccine rapidly, vaccine hesitancy stands as a barrier to these efforts. We aimed to estimate the proportion of Syrian adult population intending to be vaccinated against COVID-19 and, principally, to assess the demographic and attitudinal factors associated with it in order to approach suitable solutions. An anonymous online questionnaire was conducted between 23rd December 2020 and 5th January 2021 in various provinces in Syria. A total of ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Pandemic; Syria; Vaccine hesitancy; Adult; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Humans; Intention; Male; SARS-CoV-2; Syria; Vaccination","Zamlout","Ali","Faculty of Medicine, Tishreen University, Latakia, Syria",NA
"186","34218807","10.1186/s12889-021-11361-z","Factors associated with the intention of Syrian adult population to accept COVID19 vaccination: a cross-sectional study.","With global efforts to develop and deliver a COVID-19 vaccine rapidly, vaccine hesitancy stands as a barrier to these efforts. We aimed to estimate the proportion of Syrian adult population intending to be vaccinated against COVID-19 and, principally, to assess the demographic and attitudinal factors associated with it in order to approach suitable solutions. An anonymous online questionnaire was conducted between 23rd December 2020 and 5th January 2021 in various provinces in Syria. A total of ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Pandemic; Syria; Vaccine hesitancy; Adult; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Humans; Intention; Male; SARS-CoV-2; Syria; Vaccination","AlKhoury","Naseem","Faculty of Medicine, Tishreen University, Latakia, Syria. Naseem.AlKhoury@outlook","Naseem.AlKhoury@outlook.com"
"187","34218807","10.1186/s12889-021-11361-z","Factors associated with the intention of Syrian adult population to accept COVID19 vaccination: a cross-sectional study.","With global efforts to develop and deliver a COVID-19 vaccine rapidly, vaccine hesitancy stands as a barrier to these efforts. We aimed to estimate the proportion of Syrian adult population intending to be vaccinated against COVID-19 and, principally, to assess the demographic and attitudinal factors associated with it in order to approach suitable solutions. An anonymous online questionnaire was conducted between 23rd December 2020 and 5th January 2021 in various provinces in Syria. A total of ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Pandemic; Syria; Vaccine hesitancy; Adult; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Humans; Intention; Male; SARS-CoV-2; Syria; Vaccination","Mazloum","Abd Aljawad","Faculty of Medicine, Tishreen University, Latakia, Syria",NA
"188","34218807","10.1186/s12889-021-11361-z","Factors associated with the intention of Syrian adult population to accept COVID19 vaccination: a cross-sectional study.","With global efforts to develop and deliver a COVID-19 vaccine rapidly, vaccine hesitancy stands as a barrier to these efforts. We aimed to estimate the proportion of Syrian adult population intending to be vaccinated against COVID-19 and, principally, to assess the demographic and attitudinal factors associated with it in order to approach suitable solutions. An anonymous online questionnaire was conducted between 23rd December 2020 and 5th January 2021 in various provinces in Syria. A total of ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Pandemic; Syria; Vaccine hesitancy; Adult; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Humans; Intention; Male; SARS-CoV-2; Syria; Vaccination","Alsalkini","Marah","Faculty of Medicine, Albaath University, Homs, Syria",NA
"189","34218807","10.1186/s12889-021-11361-z","Factors associated with the intention of Syrian adult population to accept COVID19 vaccination: a cross-sectional study.","With global efforts to develop and deliver a COVID-19 vaccine rapidly, vaccine hesitancy stands as a barrier to these efforts. We aimed to estimate the proportion of Syrian adult population intending to be vaccinated against COVID-19 and, principally, to assess the demographic and attitudinal factors associated with it in order to approach suitable solutions. An anonymous online questionnaire was conducted between 23rd December 2020 and 5th January 2021 in various provinces in Syria. A total of ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Pandemic; Syria; Vaccine hesitancy; Adult; COVID-19; COVID-19 Vaccines; Child; Cross-Sectional Studies; Humans; Intention; Male; SARS-CoV-2; Syria; Vaccination","Shaaban","Rafea","Faculty of Medicine, Al-Andalus University for Medical Sciences, Tartus, Syria",NA
"190","34218774","10.2174/1381612827666210701150315","Nanotechnology-Based Approaches and Investigational Therapeutics against COVID-19.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus which is currently responsible for the global pandemic since December 2019. This class of coronavirus has affected 217 countries around the world. Most of the countries have taken some non-remedial preventive actions like country lockdown, work from home, travel bans, and the most significant one is social isolation. Pharmacists, doctors, nurses, technologists, and all other healthcare professionals are playing a","2021","07","05","Curr Pharm Des","Current pharmaceutical design","COVID-19; SARS-COV-2; antiviral drugs; nanotechnology; vaccines","Rahman","Md Mominur","Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka. Bangladesh",NA
"191","34218774","10.2174/1381612827666210701150315","Nanotechnology-Based Approaches and Investigational Therapeutics against COVID-19.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus which is currently responsible for the global pandemic since December 2019. This class of coronavirus has affected 217 countries around the world. Most of the countries have taken some non-remedial preventive actions like country lockdown, work from home, travel bans, and the most significant one is social isolation. Pharmacists, doctors, nurses, technologists, and all other healthcare professionals are playing a","2021","07","05","Curr Pharm Des","Current pharmaceutical design","COVID-19; SARS-COV-2; antiviral drugs; nanotechnology; vaccines","Ahmed","Muniruddin","Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka. Bangladesh",NA
"192","34218774","10.2174/1381612827666210701150315","Nanotechnology-Based Approaches and Investigational Therapeutics against COVID-19.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus which is currently responsible for the global pandemic since December 2019. This class of coronavirus has affected 217 countries around the world. Most of the countries have taken some non-remedial preventive actions like country lockdown, work from home, travel bans, and the most significant one is social isolation. Pharmacists, doctors, nurses, technologists, and all other healthcare professionals are playing a","2021","07","05","Curr Pharm Des","Current pharmaceutical design","COVID-19; SARS-COV-2; antiviral drugs; nanotechnology; vaccines","Islam","Mohammad Touhidul","Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka. Bangladesh",NA
"193","34218774","10.2174/1381612827666210701150315","Nanotechnology-Based Approaches and Investigational Therapeutics against COVID-19.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus which is currently responsible for the global pandemic since December 2019. This class of coronavirus has affected 217 countries around the world. Most of the countries have taken some non-remedial preventive actions like country lockdown, work from home, travel bans, and the most significant one is social isolation. Pharmacists, doctors, nurses, technologists, and all other healthcare professionals are playing a","2021","07","05","Curr Pharm Des","Current pharmaceutical design","COVID-19; SARS-COV-2; antiviral drugs; nanotechnology; vaccines","Khan","Md Robin","Bangladesh Reference Institute for Chemical Measurements, Dhaka. Bangladesh",NA
"194","34218774","10.2174/1381612827666210701150315","Nanotechnology-Based Approaches and Investigational Therapeutics against COVID-19.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus which is currently responsible for the global pandemic since December 2019. This class of coronavirus has affected 217 countries around the world. Most of the countries have taken some non-remedial preventive actions like country lockdown, work from home, travel bans, and the most significant one is social isolation. Pharmacists, doctors, nurses, technologists, and all other healthcare professionals are playing a","2021","07","05","Curr Pharm Des","Current pharmaceutical design","COVID-19; SARS-COV-2; antiviral drugs; nanotechnology; vaccines","Sultana","Sharifa","Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka. Bangladesh",NA
"195","34218774","10.2174/1381612827666210701150315","Nanotechnology-Based Approaches and Investigational Therapeutics against COVID-19.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus which is currently responsible for the global pandemic since December 2019. This class of coronavirus has affected 217 countries around the world. Most of the countries have taken some non-remedial preventive actions like country lockdown, work from home, travel bans, and the most significant one is social isolation. Pharmacists, doctors, nurses, technologists, and all other healthcare professionals are playing a","2021","07","05","Curr Pharm Des","Current pharmaceutical design","COVID-19; SARS-COV-2; antiviral drugs; nanotechnology; vaccines","Maeesa","Saila Kabir","Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka. Bangladesh",NA
"196","34218774","10.2174/1381612827666210701150315","Nanotechnology-Based Approaches and Investigational Therapeutics against COVID-19.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus which is currently responsible for the global pandemic since December 2019. This class of coronavirus has affected 217 countries around the world. Most of the countries have taken some non-remedial preventive actions like country lockdown, work from home, travel bans, and the most significant one is social isolation. Pharmacists, doctors, nurses, technologists, and all other healthcare professionals are playing a","2021","07","05","Curr Pharm Des","Current pharmaceutical design","COVID-19; SARS-COV-2; antiviral drugs; nanotechnology; vaccines","Hasan","Sakib","Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka. Bangladesh",NA
"197","34218774","10.2174/1381612827666210701150315","Nanotechnology-Based Approaches and Investigational Therapeutics against COVID-19.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus which is currently responsible for the global pandemic since December 2019. This class of coronavirus has affected 217 countries around the world. Most of the countries have taken some non-remedial preventive actions like country lockdown, work from home, travel bans, and the most significant one is social isolation. Pharmacists, doctors, nurses, technologists, and all other healthcare professionals are playing a","2021","07","05","Curr Pharm Des","Current pharmaceutical design","COVID-19; SARS-COV-2; antiviral drugs; nanotechnology; vaccines","Hossain","Md Abid","Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka. Bangladesh",NA
"198","34218774","10.2174/1381612827666210701150315","Nanotechnology-Based Approaches and Investigational Therapeutics against COVID-19.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus which is currently responsible for the global pandemic since December 2019. This class of coronavirus has affected 217 countries around the world. Most of the countries have taken some non-remedial preventive actions like country lockdown, work from home, travel bans, and the most significant one is social isolation. Pharmacists, doctors, nurses, technologists, and all other healthcare professionals are playing a","2021","07","05","Curr Pharm Des","Current pharmaceutical design","COVID-19; SARS-COV-2; antiviral drugs; nanotechnology; vaccines","Ferdous","Kazi Sayma","Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka. Bangladesh",NA
"199","34218774","10.2174/1381612827666210701150315","Nanotechnology-Based Approaches and Investigational Therapeutics against COVID-19.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus which is currently responsible for the global pandemic since December 2019. This class of coronavirus has affected 217 countries around the world. Most of the countries have taken some non-remedial preventive actions like country lockdown, work from home, travel bans, and the most significant one is social isolation. Pharmacists, doctors, nurses, technologists, and all other healthcare professionals are playing a","2021","07","05","Curr Pharm Des","Current pharmaceutical design","COVID-19; SARS-COV-2; antiviral drugs; nanotechnology; vaccines","Mathew","Bijo","Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682041, India",NA
"200","34218774","10.2174/1381612827666210701150315","Nanotechnology-Based Approaches and Investigational Therapeutics against COVID-19.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus which is currently responsible for the global pandemic since December 2019. This class of coronavirus has affected 217 countries around the world. Most of the countries have taken some non-remedial preventive actions like country lockdown, work from home, travel bans, and the most significant one is social isolation. Pharmacists, doctors, nurses, technologists, and all other healthcare professionals are playing a","2021","07","05","Curr Pharm Des","Current pharmaceutical design","COVID-19; SARS-COV-2; antiviral drugs; nanotechnology; vaccines","Rauf","Abdur","Department of Chemistry, University of Swabi, Swabi, Anbar, Khyber Pakhtunkhwa. Bangladesh",NA
"201","34218774","10.2174/1381612827666210701150315","Nanotechnology-Based Approaches and Investigational Therapeutics against COVID-19.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus which is currently responsible for the global pandemic since December 2019. This class of coronavirus has affected 217 countries around the world. Most of the countries have taken some non-remedial preventive actions like country lockdown, work from home, travel bans, and the most significant one is social isolation. Pharmacists, doctors, nurses, technologists, and all other healthcare professionals are playing a","2021","07","05","Curr Pharm Des","Current pharmaceutical design","COVID-19; SARS-COV-2; antiviral drugs; nanotechnology; vaccines","Uddin","Md Sahab","Department of Pharmacy, Southeast University, Dhaka. Bangladesh",NA
"202","34218767","10.7399/fh.11686","Time to review how injectable medicines are prepared and administered in European hospitals.","It has been known, for decades, that the use of injectable medicines in European hospitals has been associated with frequent medication errors, some of which cause preventable severe harms and deaths. There have been national and European inquiries and reports concerning improving patient safety by recommending greater use of pharmacy aseptic preparation services and provision of ready-to administer injectables, which have not been widely implemented.In England experience of treating patients wi","2021","07","08","Farm Hosp","Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria","COVID-19; Drug Compounding; England; Europe; Home Care Services; Hospitals; Humans; Infusion Pumps; Injections; Medication Errors; Patient Safety; Pharmaceutical Preparations; Pharmacy Service, Hospital","Cousins","David H","Independent Consultant on Safe Medication Practice, Derby. United Kingdom.. mjotero@telefonica","mjotero@telefonica.net"
"203","34218767","10.7399/fh.11686","Time to review how injectable medicines are prepared and administered in European hospitals.","It has been known, for decades, that the use of injectable medicines in European hospitals has been associated with frequent medication errors, some of which cause preventable severe harms and deaths. There have been national and European inquiries and reports concerning improving patient safety by recommending greater use of pharmacy aseptic preparation services and provision of ready-to administer injectables, which have not been widely implemented.In England experience of treating patients wi","2021","07","08","Farm Hosp","Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria","COVID-19; Drug Compounding; England; Europe; Home Care Services; Hospitals; Humans; Infusion Pumps; Injections; Medication Errors; Patient Safety; Pharmaceutical Preparations; Pharmacy Service, Hospital","Otero","María José","Instituto para el Uso Seguro de los Medicamentos (ISMP-España). Servicio de Farmacia, Instituto de Investigación Biomédica de Salamanca (IBSAL)-Hospital Universitario de Salamanca, Salamanca. Spain.. mjotero@telefonica","mjotero@telefonica.net"
"204","34218767","10.7399/fh.11686","Time to review how injectable medicines are prepared and administered in European hospitals.","It has been known, for decades, that the use of injectable medicines in European hospitals has been associated with frequent medication errors, some of which cause preventable severe harms and deaths. There have been national and European inquiries and reports concerning improving patient safety by recommending greater use of pharmacy aseptic preparation services and provision of ready-to administer injectables, which have not been widely implemented.In England experience of treating patients wi","2021","07","08","Farm Hosp","Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria","COVID-19; Drug Compounding; England; Europe; Home Care Services; Hospitals; Humans; Infusion Pumps; Injections; Medication Errors; Patient Safety; Pharmaceutical Preparations; Pharmacy Service, Hospital","Schmitt","Étienne","Prescrire Programme Éviter l'Évitable, Paris. France.. mjotero@telefonica","mjotero@telefonica.net"
"205","34218765","10.7399/fh.11553","Face masks against the background of the COVID 19 pandemic: legal considerations about their use.","The objective of this article is to review the quality equirements and recommended uses of the different types of face masks with a view to helping optimize their use and facilitating identification of nonconforming products. A literature search was conducted in PubMed, the Spanish Official State Gazette and Eudralex. The websites of the Ministry of Industry, Commerce and Tourism and of the Ministry of Health, as well as the relevant UNE standards were also reviewed. The different types of face ","2021","07","08","Farm Hosp","Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria","COVID-19; Humans; Masks; Pandemics; Personal Protective Equipment; Spain","Fraga-García","Miriam","Healthcare Department, Government's Deputy Delegate's Office in the Valencia Region, Ministry of Regional Policy and Civil Service, Valencia. Spain.. f.garcia.miriam@gmail","f.garcia.miriam@gmail.com"
"206","34218765","10.7399/fh.11553","Face masks against the background of the COVID 19 pandemic: legal considerations about their use.","The objective of this article is to review the quality equirements and recommended uses of the different types of face masks with a view to helping optimize their use and facilitating identification of nonconforming products. A literature search was conducted in PubMed, the Spanish Official State Gazette and Eudralex. The websites of the Ministry of Industry, Commerce and Tourism and of the Ministry of Health, as well as the relevant UNE standards were also reviewed. The different types of face ","2021","07","08","Farm Hosp","Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria","COVID-19; Humans; Masks; Pandemics; Personal Protective Equipment; Spain","Nácher-Alonso","Amparo","Department of Pharmacy, Pharmaceutical Technology and Parasitology, School of Pharmacy, University of Valencia, Valencia. Spain. Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat Politècnica de València, Universitat de València, Valencia. Spain.. amparo.nacher@uv",NA
"207","34218765","10.7399/fh.11553","Face masks against the background of the COVID 19 pandemic: legal considerations about their use.","The objective of this article is to review the quality equirements and recommended uses of the different types of face masks with a view to helping optimize their use and facilitating identification of nonconforming products. A literature search was conducted in PubMed, the Spanish Official State Gazette and Eudralex. The websites of the Ministry of Industry, Commerce and Tourism and of the Ministry of Health, as well as the relevant UNE standards were also reviewed. The different types of face ","2021","07","08","Farm Hosp","Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria","COVID-19; Humans; Masks; Pandemics; Personal Protective Equipment; Spain","Díez-Sales","Octavio","Department of Pharmacy, Pharmaceutical Technology and Parasitology, School of Pharmacy, University of Valencia, Valencia. Spain. Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico, Universitat Politècnica de València, Universitat de València, Valencia. Spain.. octavio.diez@uv",NA
"208","34218753","10.1080/00015385.2021.1945765","Clinical characteristics and in-hospital outcomes of COVID-19 patients with history of heart failure: a propensity score-matched study.","Data on the clinical course and outcomes of COVID-19 disease among patients with a history of heart failure (HF) are scarce. Therefore, the aim of this study was to assess the clinical characteristics, prognostic biomarkers and in-hospital outcomes of patients with a history of HF hospitalised with confirmed COVID-19. A total of 8321 consecutive patients hospitalised with suspected COVID-19 disease were screened. Furthermore, 3849 patients with laboratory-confirmed SARS-CoV-2 infection were incl","2021","07","14","Acta Cardiol","Acta cardiologica","COVID-19; Heart failure; coronavirus; hospitalization; mortality; outcome","Murat","Bektas","Department of Cardiology, Eskisehir City Hospital, Eskisehir, Turkey",NA
"209","34218753","10.1080/00015385.2021.1945765","Clinical characteristics and in-hospital outcomes of COVID-19 patients with history of heart failure: a propensity score-matched study.","Data on the clinical course and outcomes of COVID-19 disease among patients with a history of heart failure (HF) are scarce. Therefore, the aim of this study was to assess the clinical characteristics, prognostic biomarkers and in-hospital outcomes of patients with a history of HF hospitalised with confirmed COVID-19. A total of 8321 consecutive patients hospitalised with suspected COVID-19 disease were screened. Furthermore, 3849 patients with laboratory-confirmed SARS-CoV-2 infection were incl","2021","07","14","Acta Cardiol","Acta cardiologica","COVID-19; Heart failure; coronavirus; hospitalization; mortality; outcome","Murat","Selda","Medical Faculty Department of Cardiology, Eskisehir Osmangazi University, Eskisehir, Turkey",NA
"210","34218753","10.1080/00015385.2021.1945765","Clinical characteristics and in-hospital outcomes of COVID-19 patients with history of heart failure: a propensity score-matched study.","Data on the clinical course and outcomes of COVID-19 disease among patients with a history of heart failure (HF) are scarce. Therefore, the aim of this study was to assess the clinical characteristics, prognostic biomarkers and in-hospital outcomes of patients with a history of HF hospitalised with confirmed COVID-19. A total of 8321 consecutive patients hospitalised with suspected COVID-19 disease were screened. Furthermore, 3849 patients with laboratory-confirmed SARS-CoV-2 infection were incl","2021","07","14","Acta Cardiol","Acta cardiologica","COVID-19; Heart failure; coronavirus; hospitalization; mortality; outcome","Mert","Kadir Ugur","Medical Faculty Department of Cardiology, Eskisehir Osmangazi University, Eskisehir, Turkey",NA
"211","34218753","10.1080/00015385.2021.1945765","Clinical characteristics and in-hospital outcomes of COVID-19 patients with history of heart failure: a propensity score-matched study.","Data on the clinical course and outcomes of COVID-19 disease among patients with a history of heart failure (HF) are scarce. Therefore, the aim of this study was to assess the clinical characteristics, prognostic biomarkers and in-hospital outcomes of patients with a history of HF hospitalised with confirmed COVID-19. A total of 8321 consecutive patients hospitalised with suspected COVID-19 disease were screened. Furthermore, 3849 patients with laboratory-confirmed SARS-CoV-2 infection were incl","2021","07","14","Acta Cardiol","Acta cardiologica","COVID-19; Heart failure; coronavirus; hospitalization; mortality; outcome","Bilgin","Muzaffer","Medical Faculty Department of Biostatistics and Medical Informatics, Eskisehir Osmangazi University, Eskisehir, Turkey",NA
"212","34218753","10.1080/00015385.2021.1945765","Clinical characteristics and in-hospital outcomes of COVID-19 patients with history of heart failure: a propensity score-matched study.","Data on the clinical course and outcomes of COVID-19 disease among patients with a history of heart failure (HF) are scarce. Therefore, the aim of this study was to assess the clinical characteristics, prognostic biomarkers and in-hospital outcomes of patients with a history of HF hospitalised with confirmed COVID-19. A total of 8321 consecutive patients hospitalised with suspected COVID-19 disease were screened. Furthermore, 3849 patients with laboratory-confirmed SARS-CoV-2 infection were incl","2021","07","14","Acta Cardiol","Acta cardiologica","COVID-19; Heart failure; coronavirus; hospitalization; mortality; outcome","Cavusoglu","Yuksel","Medical Faculty Department of Cardiology, Eskisehir Osmangazi University, Eskisehir, Turkey",NA
"213","34218752","10.1080/00185868.2021.1942360","The Use of Telehealth to Provide Continuity of Cancer Care during the COVID-19 Pandemic: Advantages, Disparities, and Implications to Promote Health Equity.","Perceptions of oncology health care providers use of telehealth to provide care to patients during the COVID-19 pandemic were explored. A qualitative study using semi-structured interviews and purposive sampling (N = 30) was conducted. Four themes emerged: 1) telehealth provided continuity of cancer care and used to decrease the risk of COVID-19 exposure; 2) advantages brought about convenience and inclusion of family caregivers; 3) telehealth revealed geographic, aging, and racial/ethnic dispar","2021","07","05","Hosp Top","Hospital topics","COVID-19; cancer; coronavirus; disparities; telehealth","Marshall","Victoria K","College of Nursing, University of South Florida, Tampa, FL, USA",NA
"214","34218752","10.1080/00185868.2021.1942360","The Use of Telehealth to Provide Continuity of Cancer Care during the COVID-19 Pandemic: Advantages, Disparities, and Implications to Promote Health Equity.","Perceptions of oncology health care providers use of telehealth to provide care to patients during the COVID-19 pandemic were explored. A qualitative study using semi-structured interviews and purposive sampling (N = 30) was conducted. Four themes emerged: 1) telehealth provided continuity of cancer care and used to decrease the risk of COVID-19 exposure; 2) advantages brought about convenience and inclusion of family caregivers; 3) telehealth revealed geographic, aging, and racial/ethnic dispar","2021","07","05","Hosp Top","Hospital topics","COVID-19; cancer; coronavirus; disparities; telehealth","Chavez","Melody N","College of Public Health, University of South Florida, Tampa, FL, USA",NA
"215","34218752","10.1080/00185868.2021.1942360","The Use of Telehealth to Provide Continuity of Cancer Care during the COVID-19 Pandemic: Advantages, Disparities, and Implications to Promote Health Equity.","Perceptions of oncology health care providers use of telehealth to provide care to patients during the COVID-19 pandemic were explored. A qualitative study using semi-structured interviews and purposive sampling (N = 30) was conducted. Four themes emerged: 1) telehealth provided continuity of cancer care and used to decrease the risk of COVID-19 exposure; 2) advantages brought about convenience and inclusion of family caregivers; 3) telehealth revealed geographic, aging, and racial/ethnic dispar","2021","07","05","Hosp Top","Hospital topics","COVID-19; cancer; coronavirus; disparities; telehealth","Mason","Tina M","H. Lee Moffitt Cancer Center &amp",NA
"216","34218752","10.1080/00185868.2021.1942360","The Use of Telehealth to Provide Continuity of Cancer Care during the COVID-19 Pandemic: Advantages, Disparities, and Implications to Promote Health Equity.","Perceptions of oncology health care providers use of telehealth to provide care to patients during the COVID-19 pandemic were explored. A qualitative study using semi-structured interviews and purposive sampling (N = 30) was conducted. Four themes emerged: 1) telehealth provided continuity of cancer care and used to decrease the risk of COVID-19 exposure; 2) advantages brought about convenience and inclusion of family caregivers; 3) telehealth revealed geographic, aging, and racial/ethnic dispar","2021","07","05","Hosp Top","Hospital topics","COVID-19; cancer; coronavirus; disparities; telehealth","Martinez Tyson","Dinorah","College of Public Health, University of South Florida, Tampa, FL, USA",NA
"217","34218751","10.1080/19371918.2021.1941477","The Views of People Who Experienced the Reduction of the Concerns in the COVID-19 Quarantine Process by Making Physical Activity at Home.","COVID-19 affects the whole world and restricts the social life globally. The obligation to stay at home can cause psychological disorders for people. For this reason, physical activities at home are crucial to reduce the level of anxiety, protect against negative feelings, and strengthen the mental health. This study aims to investigate how COVID-19 affects the social life and the anxiety levels of people at home during the quarantine process within the framework of a solution-oriented approach.","2021","07","05","Soc Work Public Health","Social work in public health","Anxiety; COVID 19; physical activity; quarantine","Ercan","Özge","Faculty of Sport Sciences, Sinop University, Sinop, Turkey",NA
"218","34218738","10.1177/00332941211028999","Effect of the Lockdown Due to COVID-19 on Sexuality: The Mediating Role of Sexual Practices and Arousal in the Relationship Between Gender and Sexual Self-Esteem.","The scientific evidence suggests that COVID-19 is affecting much more than the physical health of individuals, particularly in places where a lockdown has been established to slow down the spread of the virus. An area that may be particularly affected is human sexuality. This study explored the impact of the situation generated by COVID-19 on the sexuality of 201 adults living in Spain. We collected data cross-sectionally through an online survey during the month of April 2020. Results showed a ","2021","07","05","Psychol Rep","Psychological reports","COVID-19; arousal; gender; masturbation; sexual self-esteem","Rodríguez-Domínguez","Carmen","Department of Social Psychology, 16778Universidad de Sevilla, Sevilla, Spain",NA
"219","34218738","10.1177/00332941211028999","Effect of the Lockdown Due to COVID-19 on Sexuality: The Mediating Role of Sexual Practices and Arousal in the Relationship Between Gender and Sexual Self-Esteem.","The scientific evidence suggests that COVID-19 is affecting much more than the physical health of individuals, particularly in places where a lockdown has been established to slow down the spread of the virus. An area that may be particularly affected is human sexuality. This study explored the impact of the situation generated by COVID-19 on the sexuality of 201 adults living in Spain. We collected data cross-sectionally through an online survey during the month of April 2020. Results showed a ","2021","07","05","Psychol Rep","Psychological reports","COVID-19; arousal; gender; masturbation; sexual self-esteem","Lafuente-Bacedoni","Cristina","Department of Psychology, Universidad Loyola Andalucía, Sevilla, Spain",NA
"220","34218738","10.1177/00332941211028999","Effect of the Lockdown Due to COVID-19 on Sexuality: The Mediating Role of Sexual Practices and Arousal in the Relationship Between Gender and Sexual Self-Esteem.","The scientific evidence suggests that COVID-19 is affecting much more than the physical health of individuals, particularly in places where a lockdown has been established to slow down the spread of the virus. An area that may be particularly affected is human sexuality. This study explored the impact of the situation generated by COVID-19 on the sexuality of 201 adults living in Spain. We collected data cross-sectionally through an online survey during the month of April 2020. Results showed a ","2021","07","05","Psychol Rep","Psychological reports","COVID-19; arousal; gender; masturbation; sexual self-esteem","Durán","Mercedes","Department of Social Psychology, 16778Universidad de Sevilla, Sevilla, Spain",NA
"221","34218707","10.1177/01455613211029748","Online Otolaryngology: A Comprehensive Model for Medical Student Engagement in the Virtual Era and Beyond.","When in-person experiences were taken away from medical students and residency applicants during the COVID-19 pandemic, institutions had to pivot to virtual experiences. We present here a comprehensive overview of virtual engagement for medical students. As we increasingly embrace virtual opportunities, it may be possible to continue utilizing these programs for many years to come.","2021","07","05","Ear Nose Throat J","Ear, nose, &amp; throat journal","curriculum development; medical students; mentoring; recruitment; social media; virtual education","Landeen","Kelly C","Department of Otolaryngology, Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"222","34218707","10.1177/01455613211029748","Online Otolaryngology: A Comprehensive Model for Medical Student Engagement in the Virtual Era and Beyond.","When in-person experiences were taken away from medical students and residency applicants during the COVID-19 pandemic, institutions had to pivot to virtual experiences. We present here a comprehensive overview of virtual engagement for medical students. As we increasingly embrace virtual opportunities, it may be possible to continue utilizing these programs for many years to come.","2021","07","05","Ear Nose Throat J","Ear, nose, &amp; throat journal","curriculum development; medical students; mentoring; recruitment; social media; virtual education","Esianor","Brandon","Department of Otolaryngology, Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"223","34218707","10.1177/01455613211029748","Online Otolaryngology: A Comprehensive Model for Medical Student Engagement in the Virtual Era and Beyond.","When in-person experiences were taken away from medical students and residency applicants during the COVID-19 pandemic, institutions had to pivot to virtual experiences. We present here a comprehensive overview of virtual engagement for medical students. As we increasingly embrace virtual opportunities, it may be possible to continue utilizing these programs for many years to come.","2021","07","05","Ear Nose Throat J","Ear, nose, &amp; throat journal","curriculum development; medical students; mentoring; recruitment; social media; virtual education","Stevens","Madelyn N","Department of Otolaryngology, Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"224","34218707","10.1177/01455613211029748","Online Otolaryngology: A Comprehensive Model for Medical Student Engagement in the Virtual Era and Beyond.","When in-person experiences were taken away from medical students and residency applicants during the COVID-19 pandemic, institutions had to pivot to virtual experiences. We present here a comprehensive overview of virtual engagement for medical students. As we increasingly embrace virtual opportunities, it may be possible to continue utilizing these programs for many years to come.","2021","07","05","Ear Nose Throat J","Ear, nose, &amp; throat journal","curriculum development; medical students; mentoring; recruitment; social media; virtual education","Fernando","Shanik","Department of Otolaryngology, Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"225","34218707","10.1177/01455613211029748","Online Otolaryngology: A Comprehensive Model for Medical Student Engagement in the Virtual Era and Beyond.","When in-person experiences were taken away from medical students and residency applicants during the COVID-19 pandemic, institutions had to pivot to virtual experiences. We present here a comprehensive overview of virtual engagement for medical students. As we increasingly embrace virtual opportunities, it may be possible to continue utilizing these programs for many years to come.","2021","07","05","Ear Nose Throat J","Ear, nose, &amp; throat journal","curriculum development; medical students; mentoring; recruitment; social media; virtual education","Merriam","Joanne","Division of Pediatrics, Department of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"226","34218707","10.1177/01455613211029748","Online Otolaryngology: A Comprehensive Model for Medical Student Engagement in the Virtual Era and Beyond.","When in-person experiences were taken away from medical students and residency applicants during the COVID-19 pandemic, institutions had to pivot to virtual experiences. We present here a comprehensive overview of virtual engagement for medical students. As we increasingly embrace virtual opportunities, it may be possible to continue utilizing these programs for many years to come.","2021","07","05","Ear Nose Throat J","Ear, nose, &amp; throat journal","curriculum development; medical students; mentoring; recruitment; social media; virtual education","Kreth","Kimberly","Division of Pediatrics, Department of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"227","34218707","10.1177/01455613211029748","Online Otolaryngology: A Comprehensive Model for Medical Student Engagement in the Virtual Era and Beyond.","When in-person experiences were taken away from medical students and residency applicants during the COVID-19 pandemic, institutions had to pivot to virtual experiences. We present here a comprehensive overview of virtual engagement for medical students. As we increasingly embrace virtual opportunities, it may be possible to continue utilizing these programs for many years to come.","2021","07","05","Ear Nose Throat J","Ear, nose, &amp; throat journal","curriculum development; medical students; mentoring; recruitment; social media; virtual education","Whigham","Amy S","Division of Pediatrics, Department of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"228","34218707","10.1177/01455613211029748","Online Otolaryngology: A Comprehensive Model for Medical Student Engagement in the Virtual Era and Beyond.","When in-person experiences were taken away from medical students and residency applicants during the COVID-19 pandemic, institutions had to pivot to virtual experiences. We present here a comprehensive overview of virtual engagement for medical students. As we increasingly embrace virtual opportunities, it may be possible to continue utilizing these programs for many years to come.","2021","07","05","Ear Nose Throat J","Ear, nose, &amp; throat journal","curriculum development; medical students; mentoring; recruitment; social media; virtual education","Haynes","David","Division of Otology, Department of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"229","34218707","10.1177/01455613211029748","Online Otolaryngology: A Comprehensive Model for Medical Student Engagement in the Virtual Era and Beyond.","When in-person experiences were taken away from medical students and residency applicants during the COVID-19 pandemic, institutions had to pivot to virtual experiences. We present here a comprehensive overview of virtual engagement for medical students. As we increasingly embrace virtual opportunities, it may be possible to continue utilizing these programs for many years to come.","2021","07","05","Ear Nose Throat J","Ear, nose, &amp; throat journal","curriculum development; medical students; mentoring; recruitment; social media; virtual education","Eavey","Roland","Guy M. Maness Professor and Chair of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA",NA
"230","34218701","10.1177/21501327211029800","Polio Supplementary Immunization Activities During COVID-19 Pandemic: Experience from Penampang District, Sabah, Malaysia.","Polio Supplementary Immunization Activities (SIAs) were carried out in the State of Sabah in response to the Vaccine Derived Poliovirus outbreak declared in December 2019. Prior to this, Malaysia had been polio-free over the past 27 years. This paper reported on the successful implementation of SIAs in the district of Penampang, Sabah, adapting (vaccine administration) to the COVID-19 pandemic. A series of meticulous planning, healthcare staff training, advocacy, and community engagement activit","2021","07","08","J Prim Care Community Health","Journal of primary care &amp; community health","Malaysia; Sabah; Supplementary Immunization Activities; collaboration; community engagement; drive-through vaccination; health promotion; polio; COVID-19; Child; Humans; Immunization; Malaysia; Pandemics; Poliomyelitis; SARS-CoV-2","Jiee","Sam Froze","Penampang District Health Office, Sabah State Health Department, Ministry of Health Malaysia",NA
"231","34218701","10.1177/21501327211029800","Polio Supplementary Immunization Activities During COVID-19 Pandemic: Experience from Penampang District, Sabah, Malaysia.","Polio Supplementary Immunization Activities (SIAs) were carried out in the State of Sabah in response to the Vaccine Derived Poliovirus outbreak declared in December 2019. Prior to this, Malaysia had been polio-free over the past 27 years. This paper reported on the successful implementation of SIAs in the district of Penampang, Sabah, adapting (vaccine administration) to the COVID-19 pandemic. A series of meticulous planning, healthcare staff training, advocacy, and community engagement activit","2021","07","08","J Prim Care Community Health","Journal of primary care &amp; community health","Malaysia; Sabah; Supplementary Immunization Activities; collaboration; community engagement; drive-through vaccination; health promotion; polio; COVID-19; Child; Humans; Immunization; Malaysia; Pandemics; Poliomyelitis; SARS-CoV-2","Bondi","Melvin Ebin","Penampang District Health Office, Sabah State Health Department, Ministry of Health Malaysia",NA
"232","34218701","10.1177/21501327211029800","Polio Supplementary Immunization Activities During COVID-19 Pandemic: Experience from Penampang District, Sabah, Malaysia.","Polio Supplementary Immunization Activities (SIAs) were carried out in the State of Sabah in response to the Vaccine Derived Poliovirus outbreak declared in December 2019. Prior to this, Malaysia had been polio-free over the past 27 years. This paper reported on the successful implementation of SIAs in the district of Penampang, Sabah, adapting (vaccine administration) to the COVID-19 pandemic. A series of meticulous planning, healthcare staff training, advocacy, and community engagement activit","2021","07","08","J Prim Care Community Health","Journal of primary care &amp; community health","Malaysia; Sabah; Supplementary Immunization Activities; collaboration; community engagement; drive-through vaccination; health promotion; polio; COVID-19; Child; Humans; Immunization; Malaysia; Pandemics; Poliomyelitis; SARS-CoV-2","Emiral","Muhammad Ezmeer","Penampang District Health Office, Sabah State Health Department, Ministry of Health Malaysia",NA
"233","34218701","10.1177/21501327211029800","Polio Supplementary Immunization Activities During COVID-19 Pandemic: Experience from Penampang District, Sabah, Malaysia.","Polio Supplementary Immunization Activities (SIAs) were carried out in the State of Sabah in response to the Vaccine Derived Poliovirus outbreak declared in December 2019. Prior to this, Malaysia had been polio-free over the past 27 years. This paper reported on the successful implementation of SIAs in the district of Penampang, Sabah, adapting (vaccine administration) to the COVID-19 pandemic. A series of meticulous planning, healthcare staff training, advocacy, and community engagement activit","2021","07","08","J Prim Care Community Health","Journal of primary care &amp; community health","Malaysia; Sabah; Supplementary Immunization Activities; collaboration; community engagement; drive-through vaccination; health promotion; polio; COVID-19; Child; Humans; Immunization; Malaysia; Pandemics; Poliomyelitis; SARS-CoV-2","Jantim","Anisah","Penampang District Health Office, Sabah State Health Department, Ministry of Health Malaysia",NA
"234","34218691","10.1177/00302228211029144","The Relationship Between Anxiety and Hopelessness Levels Among Nursing Students During the COVID-19 Pandemic and Related Factors.","Outbreaks caused by environmental effects such as COVID-19, MERS, SARS, or Ebola cause problems such as fear, anxiety, loneliness, depression, and hopelessness for people with or without a high risk of illness. This study aims to determine the levels of hopelessness and anxiety experienced by nursing students during the COVID-19 outbreak. This descriptive and cross-sectional study was conducted with students of a state university. In the collection of the data, Descriptive Characteristics Form p","2021","07","05","Omega (Westport)","Omega","COVID-19; anxiety; hopelessness; nursing student","Kaplan Serin","Emine","The Faculty of Health Sciences, Gaziantep University, Gaziantep, Turkey",NA
"235","34218691","10.1177/00302228211029144","The Relationship Between Anxiety and Hopelessness Levels Among Nursing Students During the COVID-19 Pandemic and Related Factors.","Outbreaks caused by environmental effects such as COVID-19, MERS, SARS, or Ebola cause problems such as fear, anxiety, loneliness, depression, and hopelessness for people with or without a high risk of illness. This study aims to determine the levels of hopelessness and anxiety experienced by nursing students during the COVID-19 outbreak. This descriptive and cross-sectional study was conducted with students of a state university. In the collection of the data, Descriptive Characteristics Form p","2021","07","05","Omega (Westport)","Omega","COVID-19; anxiety; hopelessness; nursing student","Dogan","Runida","Faculty of Nursing, Inönü University, Malatya, Turkey",NA
"236","34218683","10.1177/17407745211027246","What do we do with our under-enrolled single-center COVID-19 clinical trials?",NA,"2021","07","08","Clin Trials","Clinical trials (London, England)",NA,"Lee","Shing M","Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA",NA
"237","34218683","10.1177/17407745211027246","What do we do with our under-enrolled single-center COVID-19 clinical trials?",NA,"2021","07","08","Clin Trials","Clinical trials (London, England)",NA,"Esserman","Denise","Department of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT, USA",NA
"238","34218683","10.1177/17407745211027246","What do we do with our under-enrolled single-center COVID-19 clinical trials?",NA,"2021","07","08","Clin Trials","Clinical trials (London, England)",NA,"Cheung","Ken","Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA",NA
"239","34218683","10.1177/17407745211027246","What do we do with our under-enrolled single-center COVID-19 clinical trials?",NA,"2021","07","08","Clin Trials","Clinical trials (London, England)",NA,"Dziura","James","Department of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT, USA",NA
"240","34218683","10.1177/17407745211027246","What do we do with our under-enrolled single-center COVID-19 clinical trials?",NA,"2021","07","08","Clin Trials","Clinical trials (London, England)",NA,"Peduzzi","Peter","Department of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT, USA",NA
"241","34218683","10.1177/17407745211027246","What do we do with our under-enrolled single-center COVID-19 clinical trials?",NA,"2021","07","08","Clin Trials","Clinical trials (London, England)",NA,"Sobieszczyk","Magdalena","Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA",NA
"242","34218666","10.1177/10547738211024884","The Effect of COVID-19 Pandemic on the Lifestyle Behaviors of Individuals.","The study was planned and administered as a descriptive study to determine how COVID-19 pandemic affected the lifestyle behaviors of individuals. The study was administered from 30 June to 30 September by including 615 adult individuals who had been exposed to the COVID-19 pandemic. Of the healthy lifestyle behaviors scale II, the total mean score was found to be 126.37 ± 18.58. The health responsibility (p = .032) and nutrition (p = .004) subscale mean scores of women were found t","2021","07","05","Clin Nurs Res","Clinical nursing research","COVID-19 virus infection; health; life style; pandemics; physical activity","Uysal","Hilal","Istanbul University-Cerrahpasa, Florence Nightingale Faculty of Nursing, Medical Nursing Department, Istanbul, Turkey",NA
"243","34218666","10.1177/10547738211024884","The Effect of COVID-19 Pandemic on the Lifestyle Behaviors of Individuals.","The study was planned and administered as a descriptive study to determine how COVID-19 pandemic affected the lifestyle behaviors of individuals. The study was administered from 30 June to 30 September by including 615 adult individuals who had been exposed to the COVID-19 pandemic. Of the healthy lifestyle behaviors scale II, the total mean score was found to be 126.37 ± 18.58. The health responsibility (p = .032) and nutrition (p = .004) subscale mean scores of women were found t","2021","07","05","Clin Nurs Res","Clinical nursing research","COVID-19 virus infection; health; life style; pandemics; physical activity","Argin MScN","Esra","Republic of Turkey Ministry of Health, Istanbul Provincial Health Directorate, Marmara University, the Pendik Training and Research Hospital, Emergency Department, Istanbul, Turkey",NA
"244","34218651","10.24171/j.phrp.2021.0037","Review of the early reports of the epidemiological characteristics of the B.1.1.7 variant of SARS-CoV-2 and its spread worldwide.","The variant B.1.1.7 of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the RNA virus causing the pandemic more than a year worldwide, was reported from United Kingdom (UK) in late December 2020. It was reported that mortality increases by 65% and transmissibility increases by 70%, which may result in an increase of reproduction number to 1.13-1.55 from 0.75-0.85. To analyze the global increasing trend of the variant B.1.1.7, we extracted results of B.1.1.7 from GISAID on May 11 and","2021","07","13","Osong Public Health Res Perspect","Osong public health and research perspectives"," Epidemics;  Epidemiology;  SARS-CoV-2;  Variant; COVID-19","Kim","Yeonju","Division of Public Health Emergency Response Research, Korea Disease Control and Prevention Agency, Cheongju, Korea",NA
"245","34218651","10.24171/j.phrp.2021.0037","Review of the early reports of the epidemiological characteristics of the B.1.1.7 variant of SARS-CoV-2 and its spread worldwide.","The variant B.1.1.7 of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the RNA virus causing the pandemic more than a year worldwide, was reported from United Kingdom (UK) in late December 2020. It was reported that mortality increases by 65% and transmissibility increases by 70%, which may result in an increase of reproduction number to 1.13-1.55 from 0.75-0.85. To analyze the global increasing trend of the variant B.1.1.7, we extracted results of B.1.1.7 from GISAID on May 11 and","2021","07","13","Osong Public Health Res Perspect","Osong public health and research perspectives"," Epidemics;  Epidemiology;  SARS-CoV-2;  Variant; COVID-19","Kim","Eun-Jin","Division of Emerging Infectious Diseases, Korea Disease Control and Prevention Agency, Cheongju, Korea",NA
"246","34218651","10.24171/j.phrp.2021.0037","Review of the early reports of the epidemiological characteristics of the B.1.1.7 variant of SARS-CoV-2 and its spread worldwide.","The variant B.1.1.7 of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the RNA virus causing the pandemic more than a year worldwide, was reported from United Kingdom (UK) in late December 2020. It was reported that mortality increases by 65% and transmissibility increases by 70%, which may result in an increase of reproduction number to 1.13-1.55 from 0.75-0.85. To analyze the global increasing trend of the variant B.1.1.7, we extracted results of B.1.1.7 from GISAID on May 11 and","2021","07","13","Osong Public Health Res Perspect","Osong public health and research perspectives"," Epidemics;  Epidemiology;  SARS-CoV-2;  Variant; COVID-19","Lee","Sang-Won","Director General for Public Health Emergency Preparedness, Korea Disease Control and Prevention Agency, Cheongju, Korea",NA
"247","34218651","10.24171/j.phrp.2021.0037","Review of the early reports of the epidemiological characteristics of the B.1.1.7 variant of SARS-CoV-2 and its spread worldwide.","The variant B.1.1.7 of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the RNA virus causing the pandemic more than a year worldwide, was reported from United Kingdom (UK) in late December 2020. It was reported that mortality increases by 65% and transmissibility increases by 70%, which may result in an increase of reproduction number to 1.13-1.55 from 0.75-0.85. To analyze the global increasing trend of the variant B.1.1.7, we extracted results of B.1.1.7 from GISAID on May 11 and","2021","07","13","Osong Public Health Res Perspect","Osong public health and research perspectives"," Epidemics;  Epidemiology;  SARS-CoV-2;  Variant; COVID-19","Kwon","Donghyok","Division of Public Health Emergency Response Research, Korea Disease Control and Prevention Agency, Cheongju, Korea",NA
"248","34218650","10.24171/j.phrp.2021.0150","The policy art of the ""trade-off"" for combatting COVID-19.",NA,"2021","07","13","Osong Public Health Res Perspect","Osong public health and research perspectives",NA,"Lee","Jong-Koo","Department of Family Medicine, Seoul National University College of Medicine, Seoul, Korea",NA
"249","34218643","10.30773/pi.2021.0016","Traumatic Effects of the COVID-19 Outbreak in Middle School Students and Caregivers.","To investigate the traumatic effects of the COVID-19 pandemic on middle-school students and their parents. This epidemiological cross-sectional study was conducted with middle-school students in Denizli. A questionnaire consisting of the IES-R, CRIES-13 and a sociodemographic data form was delivered online. A total of 1059 participants who fully completed the questionnaire were included for analysis. The IES-R total and subdimension scores and the CRIES-13 scores were found to be significantly h","2021","07","20","Psychiatry Investig","Psychiatry investigation","COVID-19; Child and adolescence psychiatry.; Trauma related disorder","Terzioglu","Merve Aktas","Department of Child and Adolescent Psychiatry, Pamukkale University Faculty of Medicine, Denizli, Turkey",NA
"250","34218643","10.30773/pi.2021.0016","Traumatic Effects of the COVID-19 Outbreak in Middle School Students and Caregivers.","To investigate the traumatic effects of the COVID-19 pandemic on middle-school students and their parents. This epidemiological cross-sectional study was conducted with middle-school students in Denizli. A questionnaire consisting of the IES-R, CRIES-13 and a sociodemographic data form was delivered online. A total of 1059 participants who fully completed the questionnaire were included for analysis. The IES-R total and subdimension scores and the CRIES-13 scores were found to be significantly h","2021","07","20","Psychiatry Investig","Psychiatry investigation","COVID-19; Child and adolescence psychiatry.; Trauma related disorder","Büber","Ahmet","Department of Child and Adolescent Psychiatry, Pamukkale University Faculty of Medicine, Denizli, Turkey",NA
"251","34218641","10.30773/pi.2021.0064","Association between Dementia and Clinical Outcome after COVID-19: A Nationwide Cohort Study with Propensity Score Matched Control in South Korea.","Despite a high prevalence of dementia in older adults hospitalized with severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2), or so called COVID-19, research investigating association between preexisting diagnoses of dementia and prognosis of COVID-19 is scarce. We aimed to investigate treatment outcome of patients with dementia after COVID-19. We explored a nationwide cohort with a total of 2,800 subjects older than 50 years who were diagnosed with COVID-19 between January and","2021","07","20","Psychiatry Investig","Psychiatry investigation","COVID-19; Dementia; Mortality.; SARS-CoV-2","Wang","Sheng-Min","Department of Psychiatry, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea",NA
"252","34218641","10.30773/pi.2021.0064","Association between Dementia and Clinical Outcome after COVID-19: A Nationwide Cohort Study with Propensity Score Matched Control in South Korea.","Despite a high prevalence of dementia in older adults hospitalized with severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2), or so called COVID-19, research investigating association between preexisting diagnoses of dementia and prognosis of COVID-19 is scarce. We aimed to investigate treatment outcome of patients with dementia after COVID-19. We explored a nationwide cohort with a total of 2,800 subjects older than 50 years who were diagnosed with COVID-19 between January and","2021","07","20","Psychiatry Investig","Psychiatry investigation","COVID-19; Dementia; Mortality.; SARS-CoV-2","Park","See Hyun","Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea",NA
"253","34218641","10.30773/pi.2021.0064","Association between Dementia and Clinical Outcome after COVID-19: A Nationwide Cohort Study with Propensity Score Matched Control in South Korea.","Despite a high prevalence of dementia in older adults hospitalized with severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2), or so called COVID-19, research investigating association between preexisting diagnoses of dementia and prognosis of COVID-19 is scarce. We aimed to investigate treatment outcome of patients with dementia after COVID-19. We explored a nationwide cohort with a total of 2,800 subjects older than 50 years who were diagnosed with COVID-19 between January and","2021","07","20","Psychiatry Investig","Psychiatry investigation","COVID-19; Dementia; Mortality.; SARS-CoV-2","Kim","Nak-Young","Department of Psychiatry, Keyo Hospital, Uiwang, Republic of Korea",NA
"254","34218641","10.30773/pi.2021.0064","Association between Dementia and Clinical Outcome after COVID-19: A Nationwide Cohort Study with Propensity Score Matched Control in South Korea.","Despite a high prevalence of dementia in older adults hospitalized with severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2), or so called COVID-19, research investigating association between preexisting diagnoses of dementia and prognosis of COVID-19 is scarce. We aimed to investigate treatment outcome of patients with dementia after COVID-19. We explored a nationwide cohort with a total of 2,800 subjects older than 50 years who were diagnosed with COVID-19 between January and","2021","07","20","Psychiatry Investig","Psychiatry investigation","COVID-19; Dementia; Mortality.; SARS-CoV-2","Kang","Dong Woo","Department of Psychiatry, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea",NA
"255","34218641","10.30773/pi.2021.0064","Association between Dementia and Clinical Outcome after COVID-19: A Nationwide Cohort Study with Propensity Score Matched Control in South Korea.","Despite a high prevalence of dementia in older adults hospitalized with severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2), or so called COVID-19, research investigating association between preexisting diagnoses of dementia and prognosis of COVID-19 is scarce. We aimed to investigate treatment outcome of patients with dementia after COVID-19. We explored a nationwide cohort with a total of 2,800 subjects older than 50 years who were diagnosed with COVID-19 between January and","2021","07","20","Psychiatry Investig","Psychiatry investigation","COVID-19; Dementia; Mortality.; SARS-CoV-2","Na","Hae-Ran","Department of Psychiatry, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea",NA
"256","34218641","10.30773/pi.2021.0064","Association between Dementia and Clinical Outcome after COVID-19: A Nationwide Cohort Study with Propensity Score Matched Control in South Korea.","Despite a high prevalence of dementia in older adults hospitalized with severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2), or so called COVID-19, research investigating association between preexisting diagnoses of dementia and prognosis of COVID-19 is scarce. We aimed to investigate treatment outcome of patients with dementia after COVID-19. We explored a nationwide cohort with a total of 2,800 subjects older than 50 years who were diagnosed with COVID-19 between January and","2021","07","20","Psychiatry Investig","Psychiatry investigation","COVID-19; Dementia; Mortality.; SARS-CoV-2","Um","Yoo Hyun","Department of Psychiatry, St. Vincent Hospital, College of Medicine, The Catholic University of Korea, Suwon, Republic of Korea",NA
"257","34218641","10.30773/pi.2021.0064","Association between Dementia and Clinical Outcome after COVID-19: A Nationwide Cohort Study with Propensity Score Matched Control in South Korea.","Despite a high prevalence of dementia in older adults hospitalized with severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2), or so called COVID-19, research investigating association between preexisting diagnoses of dementia and prognosis of COVID-19 is scarce. We aimed to investigate treatment outcome of patients with dementia after COVID-19. We explored a nationwide cohort with a total of 2,800 subjects older than 50 years who were diagnosed with COVID-19 between January and","2021","07","20","Psychiatry Investig","Psychiatry investigation","COVID-19; Dementia; Mortality.; SARS-CoV-2","Han","Seunghoon","Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea",NA
"258","34218641","10.30773/pi.2021.0064","Association between Dementia and Clinical Outcome after COVID-19: A Nationwide Cohort Study with Propensity Score Matched Control in South Korea.","Despite a high prevalence of dementia in older adults hospitalized with severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2), or so called COVID-19, research investigating association between preexisting diagnoses of dementia and prognosis of COVID-19 is scarce. We aimed to investigate treatment outcome of patients with dementia after COVID-19. We explored a nationwide cohort with a total of 2,800 subjects older than 50 years who were diagnosed with COVID-19 between January and","2021","07","20","Psychiatry Investig","Psychiatry investigation","COVID-19; Dementia; Mortality.; SARS-CoV-2","Park","Sung-Soo","Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea",NA
"259","34218641","10.30773/pi.2021.0064","Association between Dementia and Clinical Outcome after COVID-19: A Nationwide Cohort Study with Propensity Score Matched Control in South Korea.","Despite a high prevalence of dementia in older adults hospitalized with severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2), or so called COVID-19, research investigating association between preexisting diagnoses of dementia and prognosis of COVID-19 is scarce. We aimed to investigate treatment outcome of patients with dementia after COVID-19. We explored a nationwide cohort with a total of 2,800 subjects older than 50 years who were diagnosed with COVID-19 between January and","2021","07","20","Psychiatry Investig","Psychiatry investigation","COVID-19; Dementia; Mortality.; SARS-CoV-2","Lim","Hyun Kook","Department of Psychiatry, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea",NA
"260","34218612","10.14245/ns.2040684.342","Telemedicine in Neurosurgery: Standardizing the Spinal Physical Examination Using A Modified Delphi Method.","The use of telemedicine has dramatically increased due to the coronavirus disease 2019 pandemic. Many neurosurgeons are now using telemedicine technologies for preoperative evaluations and routine outpatient visits. Our goal was to standardize the telemedicine motor neurologic examination, summarize the evidence surrounding clinical use of telehealth technologies, and discuss financial and legal considerations. We identified a 12-member panel composed of spine surgeons, fellows, and senior resid","2021","07","17","Neurospine","Neurospine","Delphi method; Neurologic exam; Neurosurgery; Telehealth; Telemedicine","Haddad","Alexander F","Department of Neurological Surgery, University of California, San Francisco, CA, USA",NA
"261","34218612","10.14245/ns.2040684.342","Telemedicine in Neurosurgery: Standardizing the Spinal Physical Examination Using A Modified Delphi Method.","The use of telemedicine has dramatically increased due to the coronavirus disease 2019 pandemic. Many neurosurgeons are now using telemedicine technologies for preoperative evaluations and routine outpatient visits. Our goal was to standardize the telemedicine motor neurologic examination, summarize the evidence surrounding clinical use of telehealth technologies, and discuss financial and legal considerations. We identified a 12-member panel composed of spine surgeons, fellows, and senior resid","2021","07","17","Neurospine","Neurospine","Delphi method; Neurologic exam; Neurosurgery; Telehealth; Telemedicine","Burke","John F","Department of Neurological Surgery, University of California, San Francisco, CA, USA",NA
"262","34218612","10.14245/ns.2040684.342","Telemedicine in Neurosurgery: Standardizing the Spinal Physical Examination Using A Modified Delphi Method.","The use of telemedicine has dramatically increased due to the coronavirus disease 2019 pandemic. Many neurosurgeons are now using telemedicine technologies for preoperative evaluations and routine outpatient visits. Our goal was to standardize the telemedicine motor neurologic examination, summarize the evidence surrounding clinical use of telehealth technologies, and discuss financial and legal considerations. We identified a 12-member panel composed of spine surgeons, fellows, and senior resid","2021","07","17","Neurospine","Neurospine","Delphi method; Neurologic exam; Neurosurgery; Telehealth; Telemedicine","Mummaneni","Praveen V","Department of Neurological Surgery, University of California, San Francisco, CA, USA",NA
"263","34218612","10.14245/ns.2040684.342","Telemedicine in Neurosurgery: Standardizing the Spinal Physical Examination Using A Modified Delphi Method.","The use of telemedicine has dramatically increased due to the coronavirus disease 2019 pandemic. Many neurosurgeons are now using telemedicine technologies for preoperative evaluations and routine outpatient visits. Our goal was to standardize the telemedicine motor neurologic examination, summarize the evidence surrounding clinical use of telehealth technologies, and discuss financial and legal considerations. We identified a 12-member panel composed of spine surgeons, fellows, and senior resid","2021","07","17","Neurospine","Neurospine","Delphi method; Neurologic exam; Neurosurgery; Telehealth; Telemedicine","Chan","Andrew K","Department of Neurological Surgery, University of California, San Francisco, CA, USA",NA
"264","34218612","10.14245/ns.2040684.342","Telemedicine in Neurosurgery: Standardizing the Spinal Physical Examination Using A Modified Delphi Method.","The use of telemedicine has dramatically increased due to the coronavirus disease 2019 pandemic. Many neurosurgeons are now using telemedicine technologies for preoperative evaluations and routine outpatient visits. Our goal was to standardize the telemedicine motor neurologic examination, summarize the evidence surrounding clinical use of telehealth technologies, and discuss financial and legal considerations. We identified a 12-member panel composed of spine surgeons, fellows, and senior resid","2021","07","17","Neurospine","Neurospine","Delphi method; Neurologic exam; Neurosurgery; Telehealth; Telemedicine","Safaee","Michael M","Department of Neurological Surgery, University of California, San Francisco, CA, USA",NA
"265","34218612","10.14245/ns.2040684.342","Telemedicine in Neurosurgery: Standardizing the Spinal Physical Examination Using A Modified Delphi Method.","The use of telemedicine has dramatically increased due to the coronavirus disease 2019 pandemic. Many neurosurgeons are now using telemedicine technologies for preoperative evaluations and routine outpatient visits. Our goal was to standardize the telemedicine motor neurologic examination, summarize the evidence surrounding clinical use of telehealth technologies, and discuss financial and legal considerations. We identified a 12-member panel composed of spine surgeons, fellows, and senior resid","2021","07","17","Neurospine","Neurospine","Delphi method; Neurologic exam; Neurosurgery; Telehealth; Telemedicine","Knightly","John J","Atlantic Neurosurgical Specialists, Morristown, NJ, USA",NA
"266","34218612","10.14245/ns.2040684.342","Telemedicine in Neurosurgery: Standardizing the Spinal Physical Examination Using A Modified Delphi Method.","The use of telemedicine has dramatically increased due to the coronavirus disease 2019 pandemic. Many neurosurgeons are now using telemedicine technologies for preoperative evaluations and routine outpatient visits. Our goal was to standardize the telemedicine motor neurologic examination, summarize the evidence surrounding clinical use of telehealth technologies, and discuss financial and legal considerations. We identified a 12-member panel composed of spine surgeons, fellows, and senior resid","2021","07","17","Neurospine","Neurospine","Delphi method; Neurologic exam; Neurosurgery; Telehealth; Telemedicine","Mayer","Rory R","Department of Neurological Surgery, University of California, San Francisco, CA, USA",NA
"267","34218612","10.14245/ns.2040684.342","Telemedicine in Neurosurgery: Standardizing the Spinal Physical Examination Using A Modified Delphi Method.","The use of telemedicine has dramatically increased due to the coronavirus disease 2019 pandemic. Many neurosurgeons are now using telemedicine technologies for preoperative evaluations and routine outpatient visits. Our goal was to standardize the telemedicine motor neurologic examination, summarize the evidence surrounding clinical use of telehealth technologies, and discuss financial and legal considerations. We identified a 12-member panel composed of spine surgeons, fellows, and senior resid","2021","07","17","Neurospine","Neurospine","Delphi method; Neurologic exam; Neurosurgery; Telehealth; Telemedicine","Pennicooke","Brenton H","Department of Neurological Surgery, University of California, San Francisco, CA, USA",NA
"268","34218612","10.14245/ns.2040684.342","Telemedicine in Neurosurgery: Standardizing the Spinal Physical Examination Using A Modified Delphi Method.","The use of telemedicine has dramatically increased due to the coronavirus disease 2019 pandemic. Many neurosurgeons are now using telemedicine technologies for preoperative evaluations and routine outpatient visits. Our goal was to standardize the telemedicine motor neurologic examination, summarize the evidence surrounding clinical use of telehealth technologies, and discuss financial and legal considerations. We identified a 12-member panel composed of spine surgeons, fellows, and senior resid","2021","07","17","Neurospine","Neurospine","Delphi method; Neurologic exam; Neurosurgery; Telehealth; Telemedicine","Digiorgio","Anthony M","Department of Neurological Surgery, University of California, San Francisco, CA, USA",NA
"269","34218612","10.14245/ns.2040684.342","Telemedicine in Neurosurgery: Standardizing the Spinal Physical Examination Using A Modified Delphi Method.","The use of telemedicine has dramatically increased due to the coronavirus disease 2019 pandemic. Many neurosurgeons are now using telemedicine technologies for preoperative evaluations and routine outpatient visits. Our goal was to standardize the telemedicine motor neurologic examination, summarize the evidence surrounding clinical use of telehealth technologies, and discuss financial and legal considerations. We identified a 12-member panel composed of spine surgeons, fellows, and senior resid","2021","07","17","Neurospine","Neurospine","Delphi method; Neurologic exam; Neurosurgery; Telehealth; Telemedicine","Weinstein","Philip R","Department of Neurological Surgery, University of California, San Francisco, CA, USA",NA
"270","34218612","10.14245/ns.2040684.342","Telemedicine in Neurosurgery: Standardizing the Spinal Physical Examination Using A Modified Delphi Method.","The use of telemedicine has dramatically increased due to the coronavirus disease 2019 pandemic. Many neurosurgeons are now using telemedicine technologies for preoperative evaluations and routine outpatient visits. Our goal was to standardize the telemedicine motor neurologic examination, summarize the evidence surrounding clinical use of telehealth technologies, and discuss financial and legal considerations. We identified a 12-member panel composed of spine surgeons, fellows, and senior resid","2021","07","17","Neurospine","Neurospine","Delphi method; Neurologic exam; Neurosurgery; Telehealth; Telemedicine","Clark","Aaron J","Department of Neurological Surgery, University of California, San Francisco, CA, USA",NA
"271","34218612","10.14245/ns.2040684.342","Telemedicine in Neurosurgery: Standardizing the Spinal Physical Examination Using A Modified Delphi Method.","The use of telemedicine has dramatically increased due to the coronavirus disease 2019 pandemic. Many neurosurgeons are now using telemedicine technologies for preoperative evaluations and routine outpatient visits. Our goal was to standardize the telemedicine motor neurologic examination, summarize the evidence surrounding clinical use of telehealth technologies, and discuss financial and legal considerations. We identified a 12-member panel composed of spine surgeons, fellows, and senior resid","2021","07","17","Neurospine","Neurospine","Delphi method; Neurologic exam; Neurosurgery; Telehealth; Telemedicine","Chou","Dean","Department of Neurological Surgery, University of California, San Francisco, CA, USA",NA
"272","34218612","10.14245/ns.2040684.342","Telemedicine in Neurosurgery: Standardizing the Spinal Physical Examination Using A Modified Delphi Method.","The use of telemedicine has dramatically increased due to the coronavirus disease 2019 pandemic. Many neurosurgeons are now using telemedicine technologies for preoperative evaluations and routine outpatient visits. Our goal was to standardize the telemedicine motor neurologic examination, summarize the evidence surrounding clinical use of telehealth technologies, and discuss financial and legal considerations. We identified a 12-member panel composed of spine surgeons, fellows, and senior resid","2021","07","17","Neurospine","Neurospine","Delphi method; Neurologic exam; Neurosurgery; Telehealth; Telemedicine","Dhall","Sanjay S","Department of Neurological Surgery, University of California, San Francisco, CA, USA",NA
"273","34218545","10.1515/jbcpp-2020-0495","A new application of mTOR inhibitor drugs as potential therapeutic agents for COVID-19.","Since December 2019, the COVID-19 emerging pandemic caused by SARS-CoV-2 has resulted in one of the most important global health threats. Concerning the absence of an approved effective vaccine or drug for the treatment and outcome improvement of COVID-19 patients, and the role of SARS-CoV-2 in activation of mammalian target of rapamycin (mTOR) pathway, we decided to review the previous data regarding the therapeutic effect of mTOR inhibitor drugs in COVID-19 patients. We searched the scientific","2021","07","04","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; SARS-CoV-2; coronavirus; mTOR inhibitors; metformin; rapamycin; sirolimus","Mashayekhi-Sardoo","Habibeh","Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"274","34218545","10.1515/jbcpp-2020-0495","A new application of mTOR inhibitor drugs as potential therapeutic agents for COVID-19.","Since December 2019, the COVID-19 emerging pandemic caused by SARS-CoV-2 has resulted in one of the most important global health threats. Concerning the absence of an approved effective vaccine or drug for the treatment and outcome improvement of COVID-19 patients, and the role of SARS-CoV-2 in activation of mammalian target of rapamycin (mTOR) pathway, we decided to review the previous data regarding the therapeutic effect of mTOR inhibitor drugs in COVID-19 patients. We searched the scientific","2021","07","04","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; SARS-CoV-2; coronavirus; mTOR inhibitors; metformin; rapamycin; sirolimus","Hosseinjani","Hesamoddin","Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"275","34218535","10.1922/CDH_00015Elsherif06","Impact of cancelled General Anaesthetic dental extraction appointments on children due to the COVID-19 pandemic.","COVID-19 has resulted in the cancellation of general anaesthetic procedures including dental extractions (GAX) for children in the UK, exacerbating existing inequalities. There is robust evidence that children from deprived and some ethnic backgrounds are at greater risk of caries and are, therefore, more likely to be affected by cancellations. To identify the impact of, and possible mitigations for, cancelled general anaesthetic procedures on children in the South East of England. Data were col","2021","07","04","Community Dent Health","Community dental health","Dental Public Health; Oral health inequalities; Paediatric extractions; Prevention","Elsherif","N","Dental Public Health, Thames Valley and Wessex, UK",NA
"276","34218535","10.1922/CDH_00015Elsherif06","Impact of cancelled General Anaesthetic dental extraction appointments on children due to the COVID-19 pandemic.","COVID-19 has resulted in the cancellation of general anaesthetic procedures including dental extractions (GAX) for children in the UK, exacerbating existing inequalities. There is robust evidence that children from deprived and some ethnic backgrounds are at greater risk of caries and are, therefore, more likely to be affected by cancellations. To identify the impact of, and possible mitigations for, cancelled general anaesthetic procedures on children in the South East of England. Data were col","2021","07","04","Community Dent Health","Community dental health","Dental Public Health; Oral health inequalities; Paediatric extractions; Prevention","Lewney","J","Public Health England, UK",NA
"277","34218535","10.1922/CDH_00015Elsherif06","Impact of cancelled General Anaesthetic dental extraction appointments on children due to the COVID-19 pandemic.","COVID-19 has resulted in the cancellation of general anaesthetic procedures including dental extractions (GAX) for children in the UK, exacerbating existing inequalities. There is robust evidence that children from deprived and some ethnic backgrounds are at greater risk of caries and are, therefore, more likely to be affected by cancellations. To identify the impact of, and possible mitigations for, cancelled general anaesthetic procedures on children in the South East of England. Data were col","2021","07","04","Community Dent Health","Community dental health","Dental Public Health; Oral health inequalities; Paediatric extractions; Prevention","John","J H","Public Health England, UK",NA
"278","34218521","10.1002/psp4.12681","Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations.","A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The 'Anti-SARS-CoV-2 Repurposing Drug Database' is a database that includes both in vitro anti-SARS-CoV-2 activity and in vivo pharmacokinetic data to facilitate the extrapolation from in vitro antiviral activity to potential in vivo antiviral activity for a large set of drugs/compounds. In addition to serving as a data source for in vitro anti-SAR","2021","07","04","CPT Pharmacometrics Syst Pharmacol","CPT: pharmacometrics &amp; systems pharmacology",NA,"Zhang","Xinyuan","Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration",NA
"279","34218521","10.1002/psp4.12681","Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations.","A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The 'Anti-SARS-CoV-2 Repurposing Drug Database' is a database that includes both in vitro anti-SARS-CoV-2 activity and in vivo pharmacokinetic data to facilitate the extrapolation from in vitro antiviral activity to potential in vivo antiviral activity for a large set of drugs/compounds. In addition to serving as a data source for in vitro anti-SAR","2021","07","04","CPT Pharmacometrics Syst Pharmacol","CPT: pharmacometrics &amp; systems pharmacology",NA,"Yang","Yuching","Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration",NA
"280","34218521","10.1002/psp4.12681","Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations.","A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The 'Anti-SARS-CoV-2 Repurposing Drug Database' is a database that includes both in vitro anti-SARS-CoV-2 activity and in vivo pharmacokinetic data to facilitate the extrapolation from in vitro antiviral activity to potential in vivo antiviral activity for a large set of drugs/compounds. In addition to serving as a data source for in vitro anti-SAR","2021","07","04","CPT Pharmacometrics Syst Pharmacol","CPT: pharmacometrics &amp; systems pharmacology",NA,"Grimstein","Manuela","Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration",NA
"281","34218521","10.1002/psp4.12681","Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations.","A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The 'Anti-SARS-CoV-2 Repurposing Drug Database' is a database that includes both in vitro anti-SARS-CoV-2 activity and in vivo pharmacokinetic data to facilitate the extrapolation from in vitro antiviral activity to potential in vivo antiviral activity for a large set of drugs/compounds. In addition to serving as a data source for in vitro anti-SAR","2021","07","04","CPT Pharmacometrics Syst Pharmacol","CPT: pharmacometrics &amp; systems pharmacology",NA,"Liu","Guansheng","Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration",NA
"282","34218521","10.1002/psp4.12681","Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations.","A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The 'Anti-SARS-CoV-2 Repurposing Drug Database' is a database that includes both in vitro anti-SARS-CoV-2 activity and in vivo pharmacokinetic data to facilitate the extrapolation from in vitro antiviral activity to potential in vivo antiviral activity for a large set of drugs/compounds. In addition to serving as a data source for in vitro anti-SAR","2021","07","04","CPT Pharmacometrics Syst Pharmacol","CPT: pharmacometrics &amp; systems pharmacology",NA,"Kitabi","Eliford","Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration",NA
"283","34218521","10.1002/psp4.12681","Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations.","A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The 'Anti-SARS-CoV-2 Repurposing Drug Database' is a database that includes both in vitro anti-SARS-CoV-2 activity and in vivo pharmacokinetic data to facilitate the extrapolation from in vitro antiviral activity to potential in vivo antiviral activity for a large set of drugs/compounds. In addition to serving as a data source for in vitro anti-SAR","2021","07","04","CPT Pharmacometrics Syst Pharmacol","CPT: pharmacometrics &amp; systems pharmacology",NA,"Fan","Jianghong","Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration",NA
"284","34218521","10.1002/psp4.12681","Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations.","A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The 'Anti-SARS-CoV-2 Repurposing Drug Database' is a database that includes both in vitro anti-SARS-CoV-2 activity and in vivo pharmacokinetic data to facilitate the extrapolation from in vitro antiviral activity to potential in vivo antiviral activity for a large set of drugs/compounds. In addition to serving as a data source for in vitro anti-SAR","2021","07","04","CPT Pharmacometrics Syst Pharmacol","CPT: pharmacometrics &amp; systems pharmacology",NA,"Wang","Ying-Hong","Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration",NA
"285","34218521","10.1002/psp4.12681","Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations.","A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The 'Anti-SARS-CoV-2 Repurposing Drug Database' is a database that includes both in vitro anti-SARS-CoV-2 activity and in vivo pharmacokinetic data to facilitate the extrapolation from in vitro antiviral activity to potential in vivo antiviral activity for a large set of drugs/compounds. In addition to serving as a data source for in vitro anti-SAR","2021","07","04","CPT Pharmacometrics Syst Pharmacol","CPT: pharmacometrics &amp; systems pharmacology",NA,"Earp","Justin","Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration",NA
"286","34218521","10.1002/psp4.12681","Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations.","A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The 'Anti-SARS-CoV-2 Repurposing Drug Database' is a database that includes both in vitro anti-SARS-CoV-2 activity and in vivo pharmacokinetic data to facilitate the extrapolation from in vitro antiviral activity to potential in vivo antiviral activity for a large set of drugs/compounds. In addition to serving as a data source for in vitro anti-SAR","2021","07","04","CPT Pharmacometrics Syst Pharmacol","CPT: pharmacometrics &amp; systems pharmacology",NA,"Weaver","James","Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration",NA
"287","34218521","10.1002/psp4.12681","Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations.","A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The 'Anti-SARS-CoV-2 Repurposing Drug Database' is a database that includes both in vitro anti-SARS-CoV-2 activity and in vivo pharmacokinetic data to facilitate the extrapolation from in vitro antiviral activity to potential in vivo antiviral activity for a large set of drugs/compounds. In addition to serving as a data source for in vitro anti-SAR","2021","07","04","CPT Pharmacometrics Syst Pharmacol","CPT: pharmacometrics &amp; systems pharmacology",NA,"Zhu","Hao","Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration",NA
"288","34218521","10.1002/psp4.12681","Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations.","A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The 'Anti-SARS-CoV-2 Repurposing Drug Database' is a database that includes both in vitro anti-SARS-CoV-2 activity and in vivo pharmacokinetic data to facilitate the extrapolation from in vitro antiviral activity to potential in vivo antiviral activity for a large set of drugs/compounds. In addition to serving as a data source for in vitro anti-SAR","2021","07","04","CPT Pharmacometrics Syst Pharmacol","CPT: pharmacometrics &amp; systems pharmacology",NA,"Liu","Jiang","Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration",NA
"289","34218521","10.1002/psp4.12681","Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations.","A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The 'Anti-SARS-CoV-2 Repurposing Drug Database' is a database that includes both in vitro anti-SARS-CoV-2 activity and in vivo pharmacokinetic data to facilitate the extrapolation from in vitro antiviral activity to potential in vivo antiviral activity for a large set of drugs/compounds. In addition to serving as a data source for in vitro anti-SAR","2021","07","04","CPT Pharmacometrics Syst Pharmacol","CPT: pharmacometrics &amp; systems pharmacology",NA,"Reynolds","Kellie","Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration",NA
"290","34218521","10.1002/psp4.12681","Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations.","A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The 'Anti-SARS-CoV-2 Repurposing Drug Database' is a database that includes both in vitro anti-SARS-CoV-2 activity and in vivo pharmacokinetic data to facilitate the extrapolation from in vitro antiviral activity to potential in vivo antiviral activity for a large set of drugs/compounds. In addition to serving as a data source for in vitro anti-SAR","2021","07","04","CPT Pharmacometrics Syst Pharmacol","CPT: pharmacometrics &amp; systems pharmacology",NA,"Huang","Shiew-Mei","Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration",NA
"291","34218521","10.1002/psp4.12681","Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations.","A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The 'Anti-SARS-CoV-2 Repurposing Drug Database' is a database that includes both in vitro anti-SARS-CoV-2 activity and in vivo pharmacokinetic data to facilitate the extrapolation from in vitro antiviral activity to potential in vivo antiviral activity for a large set of drugs/compounds. In addition to serving as a data source for in vitro anti-SAR","2021","07","04","CPT Pharmacometrics Syst Pharmacol","CPT: pharmacometrics &amp; systems pharmacology",NA,"Wang","Yaning","Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration",NA
"292","34218517","10.1002/pmrj.12668","Public health adherence and information-seeking for people with chronic conditions during the early phase of the COVID-19 pandemic.","People with chronic conditions, common among rehabilitation populations, may have risk factors that put them at higher risk for more severe illness due to COVID-19. To describe and compare adherence to public health guidelines, willingness to adhere to public health guidelines (including vaccination), information-seeking, and perceived trustworthiness of information among people with and without chronic conditions during the early stages of the COVID-19 pandemic. National cross-sectional online ","2021","07","04","PM R","PM &amp; R : the journal of injury, function, and rehabilitation","COVID-19; Chronic condition; health care delivery; health policy; health services research; information sources; public health adherence; risk factor","Roberts","Michelle K","Department of Rehabilitation Medicine, University of Washington, Seattle, WA",NA
"293","34218517","10.1002/pmrj.12668","Public health adherence and information-seeking for people with chronic conditions during the early phase of the COVID-19 pandemic.","People with chronic conditions, common among rehabilitation populations, may have risk factors that put them at higher risk for more severe illness due to COVID-19. To describe and compare adherence to public health guidelines, willingness to adhere to public health guidelines (including vaccination), information-seeking, and perceived trustworthiness of information among people with and without chronic conditions during the early stages of the COVID-19 pandemic. National cross-sectional online ","2021","07","04","PM R","PM &amp; R : the journal of injury, function, and rehabilitation","COVID-19; Chronic condition; health care delivery; health policy; health services research; information sources; public health adherence; risk factor","Ehde","Dawn M","Department of Rehabilitation Medicine, University of Washington, Seattle, WA",NA
"294","34218517","10.1002/pmrj.12668","Public health adherence and information-seeking for people with chronic conditions during the early phase of the COVID-19 pandemic.","People with chronic conditions, common among rehabilitation populations, may have risk factors that put them at higher risk for more severe illness due to COVID-19. To describe and compare adherence to public health guidelines, willingness to adhere to public health guidelines (including vaccination), information-seeking, and perceived trustworthiness of information among people with and without chronic conditions during the early stages of the COVID-19 pandemic. National cross-sectional online ","2021","07","04","PM R","PM &amp; R : the journal of injury, function, and rehabilitation","COVID-19; Chronic condition; health care delivery; health policy; health services research; information sources; public health adherence; risk factor","Herring","Tracy E","Department of Rehabilitation Medicine, University of Washington, Seattle, WA",NA
"295","34218517","10.1002/pmrj.12668","Public health adherence and information-seeking for people with chronic conditions during the early phase of the COVID-19 pandemic.","People with chronic conditions, common among rehabilitation populations, may have risk factors that put them at higher risk for more severe illness due to COVID-19. To describe and compare adherence to public health guidelines, willingness to adhere to public health guidelines (including vaccination), information-seeking, and perceived trustworthiness of information among people with and without chronic conditions during the early stages of the COVID-19 pandemic. National cross-sectional online ","2021","07","04","PM R","PM &amp; R : the journal of injury, function, and rehabilitation","COVID-19; Chronic condition; health care delivery; health policy; health services research; information sources; public health adherence; risk factor","Alschuler","Kevin N","Department of Rehabilitation Medicine, University of Washington, Seattle, WA",NA
"296","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Klassen","Terry P","Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, Canada",NA
"297","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Dalziel","Stuart R","Departments of Surgery and Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand",NA
"298","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Babl","Franz E","Departments of Paediatrics and Critical Care, The University of Melbourne, Melbourne, Victoria, Australia",NA
"299","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Benito","Javier","Pediatric Emergency Department, Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Bilbao, Spain",NA
"300","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Bressan","Silvia","Department of Women's and Children's Health, University of Padova, Padova, Italy",NA
"301","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Chamberlain","James","Children's National Medical Center, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA",NA
"302","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Chang","Todd P","Pediatric Emergency Care Applied Research Network (PECARN)",NA
"303","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Freedman","Stephen B","Pediatric Emergency Research Canada (PERC)",NA
"304","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Kohn Loncarica","Guillermo","Latin American Pediatric Emergency Medicine Society, University of Buenos Aires, Buenos Aires, Argentina",NA
"305","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Lyttle","Mark D","Emergency Department, Bristol Royal Hospital for Children, Bristol, UK",NA
"306","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Mintegi","Santiago","Red de Investigación de la Sociedad Española de Urgencias de Pediatría/Spanish Pediatric Emergency Research Group (RISeuP/SPERG)",NA
"307","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Mistry","Rakesh D","Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics (PEM CRC)",NA
"308","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Nigrovic","Lise E","Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics (PEM CRC)",NA
"309","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Oostenbrink","Rianne","Research in European Pediatric Emergency Medicine (REPEM)",NA
"310","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Plint","Amy C","Pediatric Emergency Research Canada (PERC)",NA
"311","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Rino","Pedro","Latin American Pediatric Emergency Medicine Society, University of Buenos Aires, Buenos Aires, Argentina",NA
"312","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Roland","Damian","Paediatric Emergency Research in the United Kingdom and Ireland (PERUKI)",NA
"313","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Van de Mosselaer","Greg","Department of Emergency Medicine, University of Manitoba, Winnipeg, Manitoba, Canada",NA
"314","34218513","10.1111/1742-6723.13801","The Pediatric Emergency Research Network (PERN): A decade of global research cooperation in paediatric emergency care.","The Pediatric Emergency Research Network (PERN) was launched in 2009 with the intent for existing national and regional research networks in paediatric emergency care to organise globally for the conduct of collaborative research across networks. PERN has grown from five to eight member networks over the past decade. With an executive committee comprising representatives from all member networks, PERN plays a supportive and collaborative rather than governing role. The full impact of PERN's faci","2021","07","04","Emerg Med Australas","Emergency medicine Australasia : EMA","health equity; healthcare disparities; implementation; multicentre randomised controlled trials; paediatric emergency medicine","Kuppermann","Nathan","Pediatric Emergency Care Applied Research Network (PECARN)",NA
"315","34218496","10.1002/hec.4378","Income gradient of pharmaceutical panic buying at the outbreak of the COVID-19 pandemic.","We analyze the timing, magnitude, and income dependence of pharmaceutical panic buying around the outbreak of the COVID-19 pandemic in Hungary. We use district-level monthly and daily administrative data on detailed categories of pharmaceutical purchases, merge them to income statistics, and estimate multilevel panel models. Our main results are as follows. First, the days of therapy (DOT) of pharmaceutical purchases increased by more than 30% in March 2020, when major lockdown measures were ann","2021","07","04","Health Econ","Health economics","COVID-19; inequality; panic buying; pharmaceutical demand","Elek","Péter","Centre for Economic and Regional Studies, Budapest, Hungary",NA
"316","34218496","10.1002/hec.4378","Income gradient of pharmaceutical panic buying at the outbreak of the COVID-19 pandemic.","We analyze the timing, magnitude, and income dependence of pharmaceutical panic buying around the outbreak of the COVID-19 pandemic in Hungary. We use district-level monthly and daily administrative data on detailed categories of pharmaceutical purchases, merge them to income statistics, and estimate multilevel panel models. Our main results are as follows. First, the days of therapy (DOT) of pharmaceutical purchases increased by more than 30% in March 2020, when major lockdown measures were ann","2021","07","04","Health Econ","Health economics","COVID-19; inequality; panic buying; pharmaceutical demand","Bíró","Anikó","Centre for Economic and Regional Studies, Budapest, Hungary",NA
"317","34218496","10.1002/hec.4378","Income gradient of pharmaceutical panic buying at the outbreak of the COVID-19 pandemic.","We analyze the timing, magnitude, and income dependence of pharmaceutical panic buying around the outbreak of the COVID-19 pandemic in Hungary. We use district-level monthly and daily administrative data on detailed categories of pharmaceutical purchases, merge them to income statistics, and estimate multilevel panel models. Our main results are as follows. First, the days of therapy (DOT) of pharmaceutical purchases increased by more than 30% in March 2020, when major lockdown measures were ann","2021","07","04","Health Econ","Health economics","COVID-19; inequality; panic buying; pharmaceutical demand","Fadgyas-Freyler","Petra","National Health Insurance Fund Administration, Budapest, Hungary",NA
"318","34218495","10.1002/jgc4.1461","The evolution of genetic counseling graduate education in New York city during the COVID-19 pandemic: In the eye of the storm.","The COVID-19 pandemic has ravaged the globe in the past year, demanding shifts in all aspects of life including health profession education. The New York City area was the first major United States epicenter and is home to four genetic counseling graduate programs. We set out to explore the multifaceted programmatic changes required from the four institutions in an early pandemic epicenter, providing the longest time horizon available for assessing the implications of this restructuring on gradu","2021","07","13","J Genet Couns","Journal of genetic counseling","COVID-19; curriculum; education; genetic counseling; practitioner-based enquiry; program evaluation","Bergner","Amanda L","Department of Genetics and Development, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA",NA
"319","34218495","10.1002/jgc4.1461","The evolution of genetic counseling graduate education in New York city during the COVID-19 pandemic: In the eye of the storm.","The COVID-19 pandemic has ravaged the globe in the past year, demanding shifts in all aspects of life including health profession education. The New York City area was the first major United States epicenter and is home to four genetic counseling graduate programs. We set out to explore the multifaceted programmatic changes required from the four institutions in an early pandemic epicenter, providing the longest time horizon available for assessing the implications of this restructuring on gradu","2021","07","13","J Genet Couns","Journal of genetic counseling","COVID-19; curriculum; education; genetic counseling; practitioner-based enquiry; program evaluation","Ecker","Lindsey Alico","Joan H. Marks Graduate Program in Human Genetics, Sarah Lawrence College, Bronxville, NY, USA",NA
"320","34218495","10.1002/jgc4.1461","The evolution of genetic counseling graduate education in New York city during the COVID-19 pandemic: In the eye of the storm.","The COVID-19 pandemic has ravaged the globe in the past year, demanding shifts in all aspects of life including health profession education. The New York City area was the first major United States epicenter and is home to four genetic counseling graduate programs. We set out to explore the multifaceted programmatic changes required from the four institutions in an early pandemic epicenter, providing the longest time horizon available for assessing the implications of this restructuring on gradu","2021","07","13","J Genet Couns","Journal of genetic counseling","COVID-19; curriculum; education; genetic counseling; practitioner-based enquiry; program evaluation","Ernst","Michelle E","Department of Genetics and Development, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA",NA
"321","34218495","10.1002/jgc4.1461","The evolution of genetic counseling graduate education in New York city during the COVID-19 pandemic: In the eye of the storm.","The COVID-19 pandemic has ravaged the globe in the past year, demanding shifts in all aspects of life including health profession education. The New York City area was the first major United States epicenter and is home to four genetic counseling graduate programs. We set out to explore the multifaceted programmatic changes required from the four institutions in an early pandemic epicenter, providing the longest time horizon available for assessing the implications of this restructuring on gradu","2021","07","13","J Genet Couns","Journal of genetic counseling","COVID-19; curriculum; education; genetic counseling; practitioner-based enquiry; program evaluation","Goelz","Monika Zak","Genetic Counseling Graduate Program, Long Island University Post, Brookville, NY, USA",NA
"322","34218495","10.1002/jgc4.1461","The evolution of genetic counseling graduate education in New York city during the COVID-19 pandemic: In the eye of the storm.","The COVID-19 pandemic has ravaged the globe in the past year, demanding shifts in all aspects of life including health profession education. The New York City area was the first major United States epicenter and is home to four genetic counseling graduate programs. We set out to explore the multifaceted programmatic changes required from the four institutions in an early pandemic epicenter, providing the longest time horizon available for assessing the implications of this restructuring on gradu","2021","07","13","J Genet Couns","Journal of genetic counseling","COVID-19; curriculum; education; genetic counseling; practitioner-based enquiry; program evaluation","Habermann","Kristina","Genetic Counseling Graduate Program, Long Island University Post, Brookville, NY, USA",NA
"323","34218495","10.1002/jgc4.1461","The evolution of genetic counseling graduate education in New York city during the COVID-19 pandemic: In the eye of the storm.","The COVID-19 pandemic has ravaged the globe in the past year, demanding shifts in all aspects of life including health profession education. The New York City area was the first major United States epicenter and is home to four genetic counseling graduate programs. We set out to explore the multifaceted programmatic changes required from the four institutions in an early pandemic epicenter, providing the longest time horizon available for assessing the implications of this restructuring on gradu","2021","07","13","J Genet Couns","Journal of genetic counseling","COVID-19; curriculum; education; genetic counseling; practitioner-based enquiry; program evaluation","Karger","Lisa","Department of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"324","34218495","10.1002/jgc4.1461","The evolution of genetic counseling graduate education in New York city during the COVID-19 pandemic: In the eye of the storm.","The COVID-19 pandemic has ravaged the globe in the past year, demanding shifts in all aspects of life including health profession education. The New York City area was the first major United States epicenter and is home to four genetic counseling graduate programs. We set out to explore the multifaceted programmatic changes required from the four institutions in an early pandemic epicenter, providing the longest time horizon available for assessing the implications of this restructuring on gradu","2021","07","13","J Genet Couns","Journal of genetic counseling","COVID-19; curriculum; education; genetic counseling; practitioner-based enquiry; program evaluation","Zinberg","Randi E","Department of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"325","34218488","10.1111/jam.15202","A review of the antiviral activity of Chitosan, including patented applications, and its potential use against COVID-19.","Chitosan is a plentiful organic polysaccharide, which can be relatively easily obtained by chemical modification of animal or fungal source materials. Chitosan and its derivatives have been shown to exhibit direct anti-viral activity, to be useful vaccine adjuvants and to have potential anti-SARS-CoV-2 activity. This thorough and timely review looks at the recent history of investigations into the role of chitosan and its derivatives as an antiviral agent and proposes a future application in the","2021","07","04","J Appl Microbiol","Journal of applied microbiology","COVID; adjuvant; antimicrobial; antiviral; chitosan; coronavirus; nanoparticles; vaccine","Jaber","Nisrein","Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan",NA
"326","34218488","10.1111/jam.15202","A review of the antiviral activity of Chitosan, including patented applications, and its potential use against COVID-19.","Chitosan is a plentiful organic polysaccharide, which can be relatively easily obtained by chemical modification of animal or fungal source materials. Chitosan and its derivatives have been shown to exhibit direct anti-viral activity, to be useful vaccine adjuvants and to have potential anti-SARS-CoV-2 activity. This thorough and timely review looks at the recent history of investigations into the role of chitosan and its derivatives as an antiviral agent and proposes a future application in the","2021","07","04","J Appl Microbiol","Journal of applied microbiology","COVID; adjuvant; antimicrobial; antiviral; chitosan; coronavirus; nanoparticles; vaccine","Al-Remawi","Mayyas","Faculty of Pharmacy &amp",NA
"327","34218488","10.1111/jam.15202","A review of the antiviral activity of Chitosan, including patented applications, and its potential use against COVID-19.","Chitosan is a plentiful organic polysaccharide, which can be relatively easily obtained by chemical modification of animal or fungal source materials. Chitosan and its derivatives have been shown to exhibit direct anti-viral activity, to be useful vaccine adjuvants and to have potential anti-SARS-CoV-2 activity. This thorough and timely review looks at the recent history of investigations into the role of chitosan and its derivatives as an antiviral agent and proposes a future application in the","2021","07","04","J Appl Microbiol","Journal of applied microbiology","COVID; adjuvant; antimicrobial; antiviral; chitosan; coronavirus; nanoparticles; vaccine","Al-Akayleh","Faisal","Faculty of Pharmacy &amp",NA
"328","34218488","10.1111/jam.15202","A review of the antiviral activity of Chitosan, including patented applications, and its potential use against COVID-19.","Chitosan is a plentiful organic polysaccharide, which can be relatively easily obtained by chemical modification of animal or fungal source materials. Chitosan and its derivatives have been shown to exhibit direct anti-viral activity, to be useful vaccine adjuvants and to have potential anti-SARS-CoV-2 activity. This thorough and timely review looks at the recent history of investigations into the role of chitosan and its derivatives as an antiviral agent and proposes a future application in the","2021","07","04","J Appl Microbiol","Journal of applied microbiology","COVID; adjuvant; antimicrobial; antiviral; chitosan; coronavirus; nanoparticles; vaccine","Al-Muhtaseb","Najah","Faculty of Pharmacy &amp",NA
"329","34218488","10.1111/jam.15202","A review of the antiviral activity of Chitosan, including patented applications, and its potential use against COVID-19.","Chitosan is a plentiful organic polysaccharide, which can be relatively easily obtained by chemical modification of animal or fungal source materials. Chitosan and its derivatives have been shown to exhibit direct anti-viral activity, to be useful vaccine adjuvants and to have potential anti-SARS-CoV-2 activity. This thorough and timely review looks at the recent history of investigations into the role of chitosan and its derivatives as an antiviral agent and proposes a future application in the","2021","07","04","J Appl Microbiol","Journal of applied microbiology","COVID; adjuvant; antimicrobial; antiviral; chitosan; coronavirus; nanoparticles; vaccine","Al-Adham","Ibrahim Si","Faculty of Pharmacy &amp",NA
"330","34218488","10.1111/jam.15202","A review of the antiviral activity of Chitosan, including patented applications, and its potential use against COVID-19.","Chitosan is a plentiful organic polysaccharide, which can be relatively easily obtained by chemical modification of animal or fungal source materials. Chitosan and its derivatives have been shown to exhibit direct anti-viral activity, to be useful vaccine adjuvants and to have potential anti-SARS-CoV-2 activity. This thorough and timely review looks at the recent history of investigations into the role of chitosan and its derivatives as an antiviral agent and proposes a future application in the","2021","07","04","J Appl Microbiol","Journal of applied microbiology","COVID; adjuvant; antimicrobial; antiviral; chitosan; coronavirus; nanoparticles; vaccine","Collier","Phillip J","Faculty of Pharmacy &amp",NA
"331","34218413","10.1007/s11739-020-02621-8","Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.","Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thro","2021","07","08","Intern Emerg Med","Internal and emergency medicine","Covid-19; Mortality; SARS-cov-2; Thrombosis","Violi","Francesco","I Clinica Medica, Department of Clinical Internal, Anaesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico 155, 00161, Roma, Italy. francesco.violi@uniroma1","francesco.violi@uniroma1.it"
"332","34218413","10.1007/s11739-020-02621-8","Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.","Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thro","2021","07","08","Intern Emerg Med","Internal and emergency medicine","Covid-19; Mortality; SARS-cov-2; Thrombosis","Ceccarelli","Giancarlo","Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy",NA
"333","34218413","10.1007/s11739-020-02621-8","Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.","Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thro","2021","07","08","Intern Emerg Med","Internal and emergency medicine","Covid-19; Mortality; SARS-cov-2; Thrombosis","Cangemi","Roberto","Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy",NA
"334","34218413","10.1007/s11739-020-02621-8","Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.","Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thro","2021","07","08","Intern Emerg Med","Internal and emergency medicine","Covid-19; Mortality; SARS-cov-2; Thrombosis","Cipollone","Francesco","Clinica Medica, Department of Medicine and Aging, ""G. D'Annunzio, University of Chieti-Pescara, Chieti, Italy",NA
"335","34218413","10.1007/s11739-020-02621-8","Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.","Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thro","2021","07","08","Intern Emerg Med","Internal and emergency medicine","Covid-19; Mortality; SARS-cov-2; Thrombosis","D'Ardes","Damiano","Clinica Medica, Department of Medicine and Aging, ""G. D'Annunzio, University of Chieti-Pescara, Chieti, Italy",NA
"336","34218413","10.1007/s11739-020-02621-8","Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.","Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thro","2021","07","08","Intern Emerg Med","Internal and emergency medicine","Covid-19; Mortality; SARS-cov-2; Thrombosis","Oliva","Alessandra","Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy",NA
"337","34218413","10.1007/s11739-020-02621-8","Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.","Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thro","2021","07","08","Intern Emerg Med","Internal and emergency medicine","Covid-19; Mortality; SARS-cov-2; Thrombosis","Pirro","Matteo","Unit of Internal Medicine, Department of Medicine, University of Perugia, Perugia, Italy",NA
"338","34218413","10.1007/s11739-020-02621-8","Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.","Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thro","2021","07","08","Intern Emerg Med","Internal and emergency medicine","Covid-19; Mortality; SARS-cov-2; Thrombosis","Rocco","Monica","Dipartimento Emergenza E Accettazione, Ospedale Universitario Sant'Andrea, Rome, Italy",NA
"339","34218413","10.1007/s11739-020-02621-8","Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.","Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thro","2021","07","08","Intern Emerg Med","Internal and emergency medicine","Covid-19; Mortality; SARS-cov-2; Thrombosis","Alessandri","Francesco","Department of General Surgery Paride Stefanini, Sapienza University of Rome, Rome, Italy",NA
"340","34218413","10.1007/s11739-020-02621-8","Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.","Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thro","2021","07","08","Intern Emerg Med","Internal and emergency medicine","Covid-19; Mortality; SARS-cov-2; Thrombosis","D'Ettorre","Gabriella","Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy",NA
"341","34218413","10.1007/s11739-020-02621-8","Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.","Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thro","2021","07","08","Intern Emerg Med","Internal and emergency medicine","Covid-19; Mortality; SARS-cov-2; Thrombosis","Lichtner","Miriam","Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy",NA
"342","34218413","10.1007/s11739-020-02621-8","Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.","Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thro","2021","07","08","Intern Emerg Med","Internal and emergency medicine","Covid-19; Mortality; SARS-cov-2; Thrombosis","Pignatelli","Pasquale","I Clinica Medica, Department of Clinical Internal, Anaesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico 155, 00161, Roma, Italy",NA
"343","34218413","10.1007/s11739-020-02621-8","Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.","Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thro","2021","07","08","Intern Emerg Med","Internal and emergency medicine","Covid-19; Mortality; SARS-cov-2; Thrombosis","Ferro","Domenico","I Clinica Medica, Department of Clinical Internal, Anaesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico 155, 00161, Roma, Italy",NA
"344","34218413","10.1007/s11739-020-02621-8","Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.","Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thro","2021","07","08","Intern Emerg Med","Internal and emergency medicine","Covid-19; Mortality; SARS-cov-2; Thrombosis","Ruberto","Franco","Department of General Surgery Paride Stefanini, Sapienza University of Rome, Rome, Italy",NA
"345","34218413","10.1007/s11739-020-02621-8","Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.","Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thro","2021","07","08","Intern Emerg Med","Internal and emergency medicine","Covid-19; Mortality; SARS-cov-2; Thrombosis","Lip","Gregory Y H","Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart &amp",NA
"346","34218413","10.1007/s11739-020-02621-8","Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.","Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thro","2021","07","08","Intern Emerg Med","Internal and emergency medicine","Covid-19; Mortality; SARS-cov-2; Thrombosis","Pugliese","Francesco","Department of General Surgery Paride Stefanini, Sapienza University of Rome, Rome, Italy",NA
"347","34218413","10.1007/s11739-020-02621-8","Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.","Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thro","2021","07","08","Intern Emerg Med","Internal and emergency medicine","Covid-19; Mortality; SARS-cov-2; Thrombosis","Mastroianni","Claudio Maria","Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy",NA
"348","34218409","10.1007/s11845-021-02693-1","Collaboration, supervision and patient safety in the era of COVID-19: an analysis of medical wards and ICU.","COVID-19 resulted in significant changes across medical wards and ICU in St James's Hospital Dublin. This included the implementation of ward-based medical teams (WBMT). The purpose of this study was to identify how these structural changes affected inter-professional collaboration, supervision and patient safety. Questionnaires were distributed to doctors working on medical wards and ICU at the height of the first wave of COVID-19. The sense of collaboration, patient safety and supervision were","2021","07","08","Ir J Med Sci","Irish journal of medical science","COVID-19; Collaboration; Patient safety; Supervision; Ward-based medical care","Lincoln","Marc","Department of Therapeutics and Clinical Pharmacology, St James's Hospital, Dublin, Ireland. Lincolnm@tcd","Lincolnm@tcd.ie"
"349","34218409","10.1007/s11845-021-02693-1","Collaboration, supervision and patient safety in the era of COVID-19: an analysis of medical wards and ICU.","COVID-19 resulted in significant changes across medical wards and ICU in St James's Hospital Dublin. This included the implementation of ward-based medical teams (WBMT). The purpose of this study was to identify how these structural changes affected inter-professional collaboration, supervision and patient safety. Questionnaires were distributed to doctors working on medical wards and ICU at the height of the first wave of COVID-19. The sense of collaboration, patient safety and supervision were","2021","07","08","Ir J Med Sci","Irish journal of medical science","COVID-19; Collaboration; Patient safety; Supervision; Ward-based medical care","Gabr","Ahmed","Department of Therapeutics and Clinical Pharmacology, St James's Hospital, Dublin, Ireland. Gabr.ahmed@gmail","Gabr.ahmed@gmail.com"
"350","34218409","10.1007/s11845-021-02693-1","Collaboration, supervision and patient safety in the era of COVID-19: an analysis of medical wards and ICU.","COVID-19 resulted in significant changes across medical wards and ICU in St James's Hospital Dublin. This included the implementation of ward-based medical teams (WBMT). The purpose of this study was to identify how these structural changes affected inter-professional collaboration, supervision and patient safety. Questionnaires were distributed to doctors working on medical wards and ICU at the height of the first wave of COVID-19. The sense of collaboration, patient safety and supervision were","2021","07","08","Ir J Med Sci","Irish journal of medical science","COVID-19; Collaboration; Patient safety; Supervision; Ward-based medical care","Kennedy","Cormac","Department of Therapeutics and Clinical Pharmacology, St James's Hospital, Dublin, Ireland",NA
"351","34218409","10.1007/s11845-021-02693-1","Collaboration, supervision and patient safety in the era of COVID-19: an analysis of medical wards and ICU.","COVID-19 resulted in significant changes across medical wards and ICU in St James's Hospital Dublin. This included the implementation of ward-based medical teams (WBMT). The purpose of this study was to identify how these structural changes affected inter-professional collaboration, supervision and patient safety. Questionnaires were distributed to doctors working on medical wards and ICU at the height of the first wave of COVID-19. The sense of collaboration, patient safety and supervision were","2021","07","08","Ir J Med Sci","Irish journal of medical science","COVID-19; Collaboration; Patient safety; Supervision; Ward-based medical care","Murphy","Catherine","Department of Therapeutics and Clinical Pharmacology, St James's Hospital, Dublin, Ireland",NA
"352","34218409","10.1007/s11845-021-02693-1","Collaboration, supervision and patient safety in the era of COVID-19: an analysis of medical wards and ICU.","COVID-19 resulted in significant changes across medical wards and ICU in St James's Hospital Dublin. This included the implementation of ward-based medical teams (WBMT). The purpose of this study was to identify how these structural changes affected inter-professional collaboration, supervision and patient safety. Questionnaires were distributed to doctors working on medical wards and ICU at the height of the first wave of COVID-19. The sense of collaboration, patient safety and supervision were","2021","07","08","Ir J Med Sci","Irish journal of medical science","COVID-19; Collaboration; Patient safety; Supervision; Ward-based medical care","Patterson","Aileen","School of Medicine, Trinity College Dublin, Dublin, Ireland",NA
"353","34218409","10.1007/s11845-021-02693-1","Collaboration, supervision and patient safety in the era of COVID-19: an analysis of medical wards and ICU.","COVID-19 resulted in significant changes across medical wards and ICU in St James's Hospital Dublin. This included the implementation of ward-based medical teams (WBMT). The purpose of this study was to identify how these structural changes affected inter-professional collaboration, supervision and patient safety. Questionnaires were distributed to doctors working on medical wards and ICU at the height of the first wave of COVID-19. The sense of collaboration, patient safety and supervision were","2021","07","08","Ir J Med Sci","Irish journal of medical science","COVID-19; Collaboration; Patient safety; Supervision; Ward-based medical care","O'Connor","Enda","Intensive Care Unit, St James's Hospital, Dublin, Ireland",NA
"354","34218409","10.1007/s11845-021-02693-1","Collaboration, supervision and patient safety in the era of COVID-19: an analysis of medical wards and ICU.","COVID-19 resulted in significant changes across medical wards and ICU in St James's Hospital Dublin. This included the implementation of ward-based medical teams (WBMT). The purpose of this study was to identify how these structural changes affected inter-professional collaboration, supervision and patient safety. Questionnaires were distributed to doctors working on medical wards and ICU at the height of the first wave of COVID-19. The sense of collaboration, patient safety and supervision were","2021","07","08","Ir J Med Sci","Irish journal of medical science","COVID-19; Collaboration; Patient safety; Supervision; Ward-based medical care","Hennessy","Martina","Department of Therapeutics and Clinical Pharmacology, St James's Hospital, Dublin, Ireland",NA
"355","34218402","10.1007/s11096-021-01301-7","Pharmacists' involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy.","One year since the emergence of the COVID-19 pandemic, rapid response measures have been implemented internationally to mitigate the spread of the virus. Following rapid and successful pre-clinical and human trials, several vaccines have been authorised for use across Europe through the European Medicines Agency and national regulatory authorities. Clinical trials have shown promising results including important reductions in disease severity, hospitalisation and mortality. In order to maximise ","2021","07","08","Int J Clin Pharm","International journal of clinical pharmacy","COVID-19; Coronavirus; Pharmacist; Pharmacy; Public health; Vaccine","Paudyal","Vibhu","School of Pharmacy, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. v.paudyal@bham.ac","v.paudyal@bham.ac.uk"
"356","34218402","10.1007/s11096-021-01301-7","Pharmacists' involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy.","One year since the emergence of the COVID-19 pandemic, rapid response measures have been implemented internationally to mitigate the spread of the virus. Following rapid and successful pre-clinical and human trials, several vaccines have been authorised for use across Europe through the European Medicines Agency and national regulatory authorities. Clinical trials have shown promising results including important reductions in disease severity, hospitalisation and mortality. In order to maximise ","2021","07","08","Int J Clin Pharm","International journal of clinical pharmacy","COVID-19; Coronavirus; Pharmacist; Pharmacy; Public health; Vaccine","Fialová","Daniela","Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Prague, Czech Republic",NA
"357","34218402","10.1007/s11096-021-01301-7","Pharmacists' involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy.","One year since the emergence of the COVID-19 pandemic, rapid response measures have been implemented internationally to mitigate the spread of the virus. Following rapid and successful pre-clinical and human trials, several vaccines have been authorised for use across Europe through the European Medicines Agency and national regulatory authorities. Clinical trials have shown promising results including important reductions in disease severity, hospitalisation and mortality. In order to maximise ","2021","07","08","Int J Clin Pharm","International journal of clinical pharmacy","COVID-19; Coronavirus; Pharmacist; Pharmacy; Public health; Vaccine","Henman","Martin C","School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland",NA
"358","34218402","10.1007/s11096-021-01301-7","Pharmacists' involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy.","One year since the emergence of the COVID-19 pandemic, rapid response measures have been implemented internationally to mitigate the spread of the virus. Following rapid and successful pre-clinical and human trials, several vaccines have been authorised for use across Europe through the European Medicines Agency and national regulatory authorities. Clinical trials have shown promising results including important reductions in disease severity, hospitalisation and mortality. In order to maximise ","2021","07","08","Int J Clin Pharm","International journal of clinical pharmacy","COVID-19; Coronavirus; Pharmacist; Pharmacy; Public health; Vaccine","Hazen","Ankie","Centre for Pharmacy Postgraduate Education, University of Manchester, Manchester, UK",NA
"359","34218402","10.1007/s11096-021-01301-7","Pharmacists' involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy.","One year since the emergence of the COVID-19 pandemic, rapid response measures have been implemented internationally to mitigate the spread of the virus. Following rapid and successful pre-clinical and human trials, several vaccines have been authorised for use across Europe through the European Medicines Agency and national regulatory authorities. Clinical trials have shown promising results including important reductions in disease severity, hospitalisation and mortality. In order to maximise ","2021","07","08","Int J Clin Pharm","International journal of clinical pharmacy","COVID-19; Coronavirus; Pharmacist; Pharmacy; Public health; Vaccine","Okuyan","Betul","Clinical Pharmacy Department, Faculty of Pharmacy, Marmara University, Istanbul, Turkey",NA
"360","34218402","10.1007/s11096-021-01301-7","Pharmacists' involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy.","One year since the emergence of the COVID-19 pandemic, rapid response measures have been implemented internationally to mitigate the spread of the virus. Following rapid and successful pre-clinical and human trials, several vaccines have been authorised for use across Europe through the European Medicines Agency and national regulatory authorities. Clinical trials have shown promising results including important reductions in disease severity, hospitalisation and mortality. In order to maximise ","2021","07","08","Int J Clin Pharm","International journal of clinical pharmacy","COVID-19; Coronavirus; Pharmacist; Pharmacy; Public health; Vaccine","Lutters","Monika","Clinical Pharmacy, Cantonal Hospital Baden, Baden, Switzerland",NA
"361","34218402","10.1007/s11096-021-01301-7","Pharmacists' involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy.","One year since the emergence of the COVID-19 pandemic, rapid response measures have been implemented internationally to mitigate the spread of the virus. Following rapid and successful pre-clinical and human trials, several vaccines have been authorised for use across Europe through the European Medicines Agency and national regulatory authorities. Clinical trials have shown promising results including important reductions in disease severity, hospitalisation and mortality. In order to maximise ","2021","07","08","Int J Clin Pharm","International journal of clinical pharmacy","COVID-19; Coronavirus; Pharmacist; Pharmacy; Public health; Vaccine","Cadogan","Cathal","School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland",NA
"362","34218402","10.1007/s11096-021-01301-7","Pharmacists' involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy.","One year since the emergence of the COVID-19 pandemic, rapid response measures have been implemented internationally to mitigate the spread of the virus. Following rapid and successful pre-clinical and human trials, several vaccines have been authorised for use across Europe through the European Medicines Agency and national regulatory authorities. Clinical trials have shown promising results including important reductions in disease severity, hospitalisation and mortality. In order to maximise ","2021","07","08","Int J Clin Pharm","International journal of clinical pharmacy","COVID-19; Coronavirus; Pharmacist; Pharmacy; Public health; Vaccine","da Costa","Filipa Alves","Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal",NA
"363","34218402","10.1007/s11096-021-01301-7","Pharmacists' involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy.","One year since the emergence of the COVID-19 pandemic, rapid response measures have been implemented internationally to mitigate the spread of the virus. Following rapid and successful pre-clinical and human trials, several vaccines have been authorised for use across Europe through the European Medicines Agency and national regulatory authorities. Clinical trials have shown promising results including important reductions in disease severity, hospitalisation and mortality. In order to maximise ","2021","07","08","Int J Clin Pharm","International journal of clinical pharmacy","COVID-19; Coronavirus; Pharmacist; Pharmacy; Public health; Vaccine","Galfrascoli","Elena","Hospital Pharmacy, ASST Settelaghi, Varese, Italy",NA
"364","34218402","10.1007/s11096-021-01301-7","Pharmacists' involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy.","One year since the emergence of the COVID-19 pandemic, rapid response measures have been implemented internationally to mitigate the spread of the virus. Following rapid and successful pre-clinical and human trials, several vaccines have been authorised for use across Europe through the European Medicines Agency and national regulatory authorities. Clinical trials have shown promising results including important reductions in disease severity, hospitalisation and mortality. In order to maximise ","2021","07","08","Int J Clin Pharm","International journal of clinical pharmacy","COVID-19; Coronavirus; Pharmacist; Pharmacy; Public health; Vaccine","Pudritz","Yvonne Marina","LMU Hospital Pharmacy, Marchioninistr, 15, 81377, Munich, Germany",NA
"365","34218402","10.1007/s11096-021-01301-7","Pharmacists' involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy.","One year since the emergence of the COVID-19 pandemic, rapid response measures have been implemented internationally to mitigate the spread of the virus. Following rapid and successful pre-clinical and human trials, several vaccines have been authorised for use across Europe through the European Medicines Agency and national regulatory authorities. Clinical trials have shown promising results including important reductions in disease severity, hospitalisation and mortality. In order to maximise ","2021","07","08","Int J Clin Pharm","International journal of clinical pharmacy","COVID-19; Coronavirus; Pharmacist; Pharmacy; Public health; Vaccine","Rydant","Silas","Meduca, Koninklijke Apothekersvereniging Antwerpen (KAVA), Lange Leemstraat 187, 2018, Antwerpen, Belgium",NA
"366","34218402","10.1007/s11096-021-01301-7","Pharmacists' involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy.","One year since the emergence of the COVID-19 pandemic, rapid response measures have been implemented internationally to mitigate the spread of the virus. Following rapid and successful pre-clinical and human trials, several vaccines have been authorised for use across Europe through the European Medicines Agency and national regulatory authorities. Clinical trials have shown promising results including important reductions in disease severity, hospitalisation and mortality. In order to maximise ","2021","07","08","Int J Clin Pharm","International journal of clinical pharmacy","COVID-19; Coronavirus; Pharmacist; Pharmacy; Public health; Vaccine","Acosta-Gómez","Jaime","Farmácia Acosta, Calle Vitoria, 9, 28941, Fuenlabrada, Madrid, Spain",NA
"367","34218393","10.1007/s10067-021-05805-5","Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemic.","The majority of the medical fraternity is continuously involved in finding new therapeutic schemes, including antimalarial medications (AMDs), which can be useful in combating the 2019-nCoV: coronavirus disease (COVID-19). For many decades, AMDs have been widely used in the treatment of malaria and various other anti-inflammatory diseases, particularly to treat autoimmune disorders of the connective tissue. The review comprises in vitro and in vivo studies, original studies, clinical trials, and","2021","07","08","Clin Rheumatol","Clinical rheumatology","Antimalarial drugs; COVID-19; Rheumatic diseases; Viral diseases","Grygiel-Górniak","Bogna","Department of Rheumatology, Rehabilitation and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland. bgrygiel@ump.edu","bgrygiel@ump.edu.pl"
"368","34218365","10.1007/s10140-021-01946-x","Diagnostic performance of chest radiography in high COVID-19 prevalence setting: experience from a European reference hospital.","The study's aim is to analyse the diagnostic performance of chest radiography (CXR) in patients with suspected coronavirus disease 19 (COVID-19). We retrospectively considered 826 consecutive patients with suspected COVID-19 presenting to our emergency department (ED) from February 21 to March 31, 2020, in a high disease prevalence setting. We enrolled patients who underwent CXR and rhino-oropharyngeal swab for real-time reverse transcription-polymerase chain reaction (rRT-PCR). CXRs were evalua","2021","07","08","Emerg Radiol","Emergency radiology","Pneumonia; Radiology/radiography","Flor","Nicola","U.O. di Radiodiagnostica, Ospedale L. Sacco ASST Fatebenefratelli Sacco, Via Giovanni Battista Grassi, 74, 20157, Milan, MI, Italy. nicola.flor@unimi","nicola.flor@unimi.it"
"369","34218365","10.1007/s10140-021-01946-x","Diagnostic performance of chest radiography in high COVID-19 prevalence setting: experience from a European reference hospital.","The study's aim is to analyse the diagnostic performance of chest radiography (CXR) in patients with suspected coronavirus disease 19 (COVID-19). We retrospectively considered 826 consecutive patients with suspected COVID-19 presenting to our emergency department (ED) from February 21 to March 31, 2020, in a high disease prevalence setting. We enrolled patients who underwent CXR and rhino-oropharyngeal swab for real-time reverse transcription-polymerase chain reaction (rRT-PCR). CXRs were evalua","2021","07","08","Emerg Radiol","Emergency radiology","Pneumonia; Radiology/radiography","Saggiante","Lorenzo","Postgraduation School in Radiodiagnostics, Università degli Studi di Milano, Via Festa del Perdono, 7, 20122, Milan, MI, Italy",NA
"370","34218365","10.1007/s10140-021-01946-x","Diagnostic performance of chest radiography in high COVID-19 prevalence setting: experience from a European reference hospital.","The study's aim is to analyse the diagnostic performance of chest radiography (CXR) in patients with suspected coronavirus disease 19 (COVID-19). We retrospectively considered 826 consecutive patients with suspected COVID-19 presenting to our emergency department (ED) from February 21 to March 31, 2020, in a high disease prevalence setting. We enrolled patients who underwent CXR and rhino-oropharyngeal swab for real-time reverse transcription-polymerase chain reaction (rRT-PCR). CXRs were evalua","2021","07","08","Emerg Radiol","Emergency radiology","Pneumonia; Radiology/radiography","Savoldi","Anna Paola","Postgraduation School in Radiodiagnostics, Università degli Studi di Milano, Via Festa del Perdono, 7, 20122, Milan, MI, Italy",NA
"371","34218365","10.1007/s10140-021-01946-x","Diagnostic performance of chest radiography in high COVID-19 prevalence setting: experience from a European reference hospital.","The study's aim is to analyse the diagnostic performance of chest radiography (CXR) in patients with suspected coronavirus disease 19 (COVID-19). We retrospectively considered 826 consecutive patients with suspected COVID-19 presenting to our emergency department (ED) from February 21 to March 31, 2020, in a high disease prevalence setting. We enrolled patients who underwent CXR and rhino-oropharyngeal swab for real-time reverse transcription-polymerase chain reaction (rRT-PCR). CXRs were evalua","2021","07","08","Emerg Radiol","Emergency radiology","Pneumonia; Radiology/radiography","Vitale","Renato","Postgraduation School in Radiodiagnostics, Università degli Studi di Milano, Via Festa del Perdono, 7, 20122, Milan, MI, Italy",NA
"372","34218365","10.1007/s10140-021-01946-x","Diagnostic performance of chest radiography in high COVID-19 prevalence setting: experience from a European reference hospital.","The study's aim is to analyse the diagnostic performance of chest radiography (CXR) in patients with suspected coronavirus disease 19 (COVID-19). We retrospectively considered 826 consecutive patients with suspected COVID-19 presenting to our emergency department (ED) from February 21 to March 31, 2020, in a high disease prevalence setting. We enrolled patients who underwent CXR and rhino-oropharyngeal swab for real-time reverse transcription-polymerase chain reaction (rRT-PCR). CXRs were evalua","2021","07","08","Emerg Radiol","Emergency radiology","Pneumonia; Radiology/radiography","Casazza","Giovanni","Dipartimento di Scienze Biomediche e Cliniche ""L. Sacco"", Università degli Studi di, Milan, MI, Italy",NA
"373","34218365","10.1007/s10140-021-01946-x","Diagnostic performance of chest radiography in high COVID-19 prevalence setting: experience from a European reference hospital.","The study's aim is to analyse the diagnostic performance of chest radiography (CXR) in patients with suspected coronavirus disease 19 (COVID-19). We retrospectively considered 826 consecutive patients with suspected COVID-19 presenting to our emergency department (ED) from February 21 to March 31, 2020, in a high disease prevalence setting. We enrolled patients who underwent CXR and rhino-oropharyngeal swab for real-time reverse transcription-polymerase chain reaction (rRT-PCR). CXRs were evalua","2021","07","08","Emerg Radiol","Emergency radiology","Pneumonia; Radiology/radiography","Villa","Paolo","U.O. di Medicina e Chirurgia d'Accettazione e d'Urgenza, Ospedale L. Sacco ASST Fatebenefratelli Sacco, Via Giovanni Battista Grassi, 74, 20157, Milan, MI, Italy",NA
"374","34218365","10.1007/s10140-021-01946-x","Diagnostic performance of chest radiography in high COVID-19 prevalence setting: experience from a European reference hospital.","The study's aim is to analyse the diagnostic performance of chest radiography (CXR) in patients with suspected coronavirus disease 19 (COVID-19). We retrospectively considered 826 consecutive patients with suspected COVID-19 presenting to our emergency department (ED) from February 21 to March 31, 2020, in a high disease prevalence setting. We enrolled patients who underwent CXR and rhino-oropharyngeal swab for real-time reverse transcription-polymerase chain reaction (rRT-PCR). CXRs were evalua","2021","07","08","Emerg Radiol","Emergency radiology","Pneumonia; Radiology/radiography","Brambilla","Anna Maria","U.O. di Medicina e Chirurgia d'Accettazione e d'Urgenza, Ospedale L. Sacco ASST Fatebenefratelli Sacco, Via Giovanni Battista Grassi, 74, 20157, Milan, MI, Italy",NA
"375","34218350","10.1007/s11926-021-01029-3","Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?","COVID-19 patients have a procoagulant state with a high prevalence of thrombotic events. The hypothesis of an involvement of antiphospholipid antibodies (aPL) has been suggested by several reports. Here, we reviewed 48 studies investigating aPL in COVID-19 patients. Prevalence of Lupus Anticoagulant (LA) ranged from 35% to 92% in ICU patients. Anti-cardiolipin (aCL) IgG and IgM were found in up to 52% and up to 40% of patients respectively. Anti-ß2-glycoprotein I (aß2-GPI) IgG and IgM were found","2021","07","12","Curr Rheumatol Rep","Current rheumatology reports","Antiphospholipid antibodies; COVID-19; Lupus anticoagulant; Thrombosis; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; C-Reactive Protein; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Lupus Coagulation Inhibitor; SARS-CoV-2; Severity of Illness Index; Thrombosis; beta 2-Glycoprotein I","Foret","Thomas","Université de Lorraine, INSERM, DCAC, F-54000, Nancy, France",NA
"376","34218350","10.1007/s11926-021-01029-3","Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?","COVID-19 patients have a procoagulant state with a high prevalence of thrombotic events. The hypothesis of an involvement of antiphospholipid antibodies (aPL) has been suggested by several reports. Here, we reviewed 48 studies investigating aPL in COVID-19 patients. Prevalence of Lupus Anticoagulant (LA) ranged from 35% to 92% in ICU patients. Anti-cardiolipin (aCL) IgG and IgM were found in up to 52% and up to 40% of patients respectively. Anti-ß2-glycoprotein I (aß2-GPI) IgG and IgM were found","2021","07","12","Curr Rheumatol Rep","Current rheumatology reports","Antiphospholipid antibodies; COVID-19; Lupus anticoagulant; Thrombosis; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; C-Reactive Protein; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Lupus Coagulation Inhibitor; SARS-CoV-2; Severity of Illness Index; Thrombosis; beta 2-Glycoprotein I","Dufrost","Virginie","Université de Lorraine, INSERM, DCAC, F-54000, Nancy, France",NA
"377","34218350","10.1007/s11926-021-01029-3","Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?","COVID-19 patients have a procoagulant state with a high prevalence of thrombotic events. The hypothesis of an involvement of antiphospholipid antibodies (aPL) has been suggested by several reports. Here, we reviewed 48 studies investigating aPL in COVID-19 patients. Prevalence of Lupus Anticoagulant (LA) ranged from 35% to 92% in ICU patients. Anti-cardiolipin (aCL) IgG and IgM were found in up to 52% and up to 40% of patients respectively. Anti-ß2-glycoprotein I (aß2-GPI) IgG and IgM were found","2021","07","12","Curr Rheumatol Rep","Current rheumatology reports","Antiphospholipid antibodies; COVID-19; Lupus anticoagulant; Thrombosis; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; C-Reactive Protein; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Lupus Coagulation Inhibitor; SARS-CoV-2; Severity of Illness Index; Thrombosis; beta 2-Glycoprotein I","du Mont","Lucie Salomon","CHRU-Besancon, Vascular and Endovascular Surgery Department, F-25000, Besancon, France",NA
"378","34218350","10.1007/s11926-021-01029-3","Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?","COVID-19 patients have a procoagulant state with a high prevalence of thrombotic events. The hypothesis of an involvement of antiphospholipid antibodies (aPL) has been suggested by several reports. Here, we reviewed 48 studies investigating aPL in COVID-19 patients. Prevalence of Lupus Anticoagulant (LA) ranged from 35% to 92% in ICU patients. Anti-cardiolipin (aCL) IgG and IgM were found in up to 52% and up to 40% of patients respectively. Anti-ß2-glycoprotein I (aß2-GPI) IgG and IgM were found","2021","07","12","Curr Rheumatol Rep","Current rheumatology reports","Antiphospholipid antibodies; COVID-19; Lupus anticoagulant; Thrombosis; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; C-Reactive Protein; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Lupus Coagulation Inhibitor; SARS-CoV-2; Severity of Illness Index; Thrombosis; beta 2-Glycoprotein I","Costa","Patricia","CHRU-Besancon, Vascular Medicine Unit, Vascular and Endovascular Surgery Department, F-25000, Besancon, France",NA
"379","34218350","10.1007/s11926-021-01029-3","Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?","COVID-19 patients have a procoagulant state with a high prevalence of thrombotic events. The hypothesis of an involvement of antiphospholipid antibodies (aPL) has been suggested by several reports. Here, we reviewed 48 studies investigating aPL in COVID-19 patients. Prevalence of Lupus Anticoagulant (LA) ranged from 35% to 92% in ICU patients. Anti-cardiolipin (aCL) IgG and IgM were found in up to 52% and up to 40% of patients respectively. Anti-ß2-glycoprotein I (aß2-GPI) IgG and IgM were found","2021","07","12","Curr Rheumatol Rep","Current rheumatology reports","Antiphospholipid antibodies; COVID-19; Lupus anticoagulant; Thrombosis; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; C-Reactive Protein; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Lupus Coagulation Inhibitor; SARS-CoV-2; Severity of Illness Index; Thrombosis; beta 2-Glycoprotein I","Lefevre","Benjamin","Université de Lorraine, CHRU-Nancy, Infectious and Tropical Diseases, F-54000, Nancy, France",NA
"380","34218350","10.1007/s11926-021-01029-3","Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?","COVID-19 patients have a procoagulant state with a high prevalence of thrombotic events. The hypothesis of an involvement of antiphospholipid antibodies (aPL) has been suggested by several reports. Here, we reviewed 48 studies investigating aPL in COVID-19 patients. Prevalence of Lupus Anticoagulant (LA) ranged from 35% to 92% in ICU patients. Anti-cardiolipin (aCL) IgG and IgM were found in up to 52% and up to 40% of patients respectively. Anti-ß2-glycoprotein I (aß2-GPI) IgG and IgM were found","2021","07","12","Curr Rheumatol Rep","Current rheumatology reports","Antiphospholipid antibodies; COVID-19; Lupus anticoagulant; Thrombosis; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; C-Reactive Protein; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Lupus Coagulation Inhibitor; SARS-CoV-2; Severity of Illness Index; Thrombosis; beta 2-Glycoprotein I","Lacolley","Patrick","Université de Lorraine, INSERM, DCAC, F-54000, Nancy, France",NA
"381","34218350","10.1007/s11926-021-01029-3","Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?","COVID-19 patients have a procoagulant state with a high prevalence of thrombotic events. The hypothesis of an involvement of antiphospholipid antibodies (aPL) has been suggested by several reports. Here, we reviewed 48 studies investigating aPL in COVID-19 patients. Prevalence of Lupus Anticoagulant (LA) ranged from 35% to 92% in ICU patients. Anti-cardiolipin (aCL) IgG and IgM were found in up to 52% and up to 40% of patients respectively. Anti-ß2-glycoprotein I (aß2-GPI) IgG and IgM were found","2021","07","12","Curr Rheumatol Rep","Current rheumatology reports","Antiphospholipid antibodies; COVID-19; Lupus anticoagulant; Thrombosis; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; C-Reactive Protein; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Lupus Coagulation Inhibitor; SARS-CoV-2; Severity of Illness Index; Thrombosis; beta 2-Glycoprotein I","Regnault","Veronique","Université de Lorraine, INSERM, DCAC, F-54000, Nancy, France",NA
"382","34218350","10.1007/s11926-021-01029-3","Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?","COVID-19 patients have a procoagulant state with a high prevalence of thrombotic events. The hypothesis of an involvement of antiphospholipid antibodies (aPL) has been suggested by several reports. Here, we reviewed 48 studies investigating aPL in COVID-19 patients. Prevalence of Lupus Anticoagulant (LA) ranged from 35% to 92% in ICU patients. Anti-cardiolipin (aCL) IgG and IgM were found in up to 52% and up to 40% of patients respectively. Anti-ß2-glycoprotein I (aß2-GPI) IgG and IgM were found","2021","07","12","Curr Rheumatol Rep","Current rheumatology reports","Antiphospholipid antibodies; COVID-19; Lupus anticoagulant; Thrombosis; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; C-Reactive Protein; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Lupus Coagulation Inhibitor; SARS-CoV-2; Severity of Illness Index; Thrombosis; beta 2-Glycoprotein I","Zuily","Stephane","Université de Lorraine, INSERM, DCAC, F-54000, Nancy, France",NA
"383","34218350","10.1007/s11926-021-01029-3","Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?","COVID-19 patients have a procoagulant state with a high prevalence of thrombotic events. The hypothesis of an involvement of antiphospholipid antibodies (aPL) has been suggested by several reports. Here, we reviewed 48 studies investigating aPL in COVID-19 patients. Prevalence of Lupus Anticoagulant (LA) ranged from 35% to 92% in ICU patients. Anti-cardiolipin (aCL) IgG and IgM were found in up to 52% and up to 40% of patients respectively. Anti-ß2-glycoprotein I (aß2-GPI) IgG and IgM were found","2021","07","12","Curr Rheumatol Rep","Current rheumatology reports","Antiphospholipid antibodies; COVID-19; Lupus anticoagulant; Thrombosis; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; C-Reactive Protein; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Lupus Coagulation Inhibitor; SARS-CoV-2; Severity of Illness Index; Thrombosis; beta 2-Glycoprotein I","Wahl","Denis","Université de Lorraine, INSERM, DCAC, F-54000, Nancy, France. d.wahl@chru-nancy",NA
"384","34218343","10.1007/s10654-021-00777-x","Longitudinal variability in mortality predicts COVID-19 deaths.","Within Europe, death rates due to COVID-19 vary greatly, with some countries being severely hit while others to date are almost unaffected. This has created a heated debate in particular regarding how effective the different measures applied by the governments are in limiting the spread of the disease and ultimately deaths. It would be of considerable interest to pinpoint the factors that determine a country's susceptibility to a pandemic such as COVID-19. Here we present data demonstrating that","2021","07","08","Eur J Epidemiol","European journal of epidemiology","All-cause mortality; COVID-19; Corona; Influenza; SARS-CoV-2; Virus","Lundberg","Jon O","Department of Physiology and Pharmacology, Karolinska Institutet, SE-17177, Stockholm, Sweden. jon.lundberg@ki",NA
"385","34218343","10.1007/s10654-021-00777-x","Longitudinal variability in mortality predicts COVID-19 deaths.","Within Europe, death rates due to COVID-19 vary greatly, with some countries being severely hit while others to date are almost unaffected. This has created a heated debate in particular regarding how effective the different measures applied by the governments are in limiting the spread of the disease and ultimately deaths. It would be of considerable interest to pinpoint the factors that determine a country's susceptibility to a pandemic such as COVID-19. Here we present data demonstrating that","2021","07","08","Eur J Epidemiol","European journal of epidemiology","All-cause mortality; COVID-19; Corona; Influenza; SARS-CoV-2; Virus","Zeberg","Hugo","Department of Neuroscience, Karolinska Institutet, SE-17177, Stockholm, Sweden. hugo.zeberg@ki",NA
"386","34218318","10.1007/s00431-021-04191-z","COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation.","The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis and kidney transplant (KTx) groups. This multicenter observational study was conducted between 1 April and 31 December 2020 in Istanbul. Members of the Istanbul branch of the Turkish Pediatric Nephrology Association were asked to report all confirmed cases of COVID-19 who were on RRT, as well as the numbe","2021","07","08","Eur J Pediatr","European journal of pediatrics","COVID-19; Children; Dialysis; Kidney transplantation; Pediatric; RRT; Renal replacement therapy","Canpolat","Nur","Department of Pediatric Nephrology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey. nur.canpolat@iuc.edu","nur.canpolat@iuc.edu.tr"
"387","34218318","10.1007/s00431-021-04191-z","COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation.","The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis and kidney transplant (KTx) groups. This multicenter observational study was conducted between 1 April and 31 December 2020 in Istanbul. Members of the Istanbul branch of the Turkish Pediatric Nephrology Association were asked to report all confirmed cases of COVID-19 who were on RRT, as well as the numbe","2021","07","08","Eur J Pediatr","European journal of pediatrics","COVID-19; Children; Dialysis; Kidney transplantation; Pediatric; RRT; Renal replacement therapy","Yildirim","Zeynep Yürük","Department of Pediatric Nephrology, Faculty of Medicine, Istanbul University, Istanbul, Turkey",NA
"388","34218318","10.1007/s00431-021-04191-z","COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation.","The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis and kidney transplant (KTx) groups. This multicenter observational study was conducted between 1 April and 31 December 2020 in Istanbul. Members of the Istanbul branch of the Turkish Pediatric Nephrology Association were asked to report all confirmed cases of COVID-19 who were on RRT, as well as the numbe","2021","07","08","Eur J Pediatr","European journal of pediatrics","COVID-19; Children; Dialysis; Kidney transplantation; Pediatric; RRT; Renal replacement therapy","Yildiz","Nurdan","Department of Pediatric Nephrology, Faculty of Medicine, Marmara University, Istanbul, Turkey",NA
"389","34218318","10.1007/s00431-021-04191-z","COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation.","The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis and kidney transplant (KTx) groups. This multicenter observational study was conducted between 1 April and 31 December 2020 in Istanbul. Members of the Istanbul branch of the Turkish Pediatric Nephrology Association were asked to report all confirmed cases of COVID-19 who were on RRT, as well as the numbe","2021","07","08","Eur J Pediatr","European journal of pediatrics","COVID-19; Children; Dialysis; Kidney transplantation; Pediatric; RRT; Renal replacement therapy","Tasdemir","Mehmet","Department of Pediatric Nephrology, Koç University Hospital, Istanbul, Turkey",NA
"390","34218318","10.1007/s00431-021-04191-z","COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation.","The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis and kidney transplant (KTx) groups. This multicenter observational study was conducted between 1 April and 31 December 2020 in Istanbul. Members of the Istanbul branch of the Turkish Pediatric Nephrology Association were asked to report all confirmed cases of COVID-19 who were on RRT, as well as the numbe","2021","07","08","Eur J Pediatr","European journal of pediatrics","COVID-19; Children; Dialysis; Kidney transplantation; Pediatric; RRT; Renal replacement therapy","Göknar","Nilüfer","Department of Pediatric Nephrology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey",NA
"391","34218318","10.1007/s00431-021-04191-z","COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation.","The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis and kidney transplant (KTx) groups. This multicenter observational study was conducted between 1 April and 31 December 2020 in Istanbul. Members of the Istanbul branch of the Turkish Pediatric Nephrology Association were asked to report all confirmed cases of COVID-19 who were on RRT, as well as the numbe","2021","07","08","Eur J Pediatr","European journal of pediatrics","COVID-19; Children; Dialysis; Kidney transplantation; Pediatric; RRT; Renal replacement therapy","Evrengül","Havva","Department of Pediatric Nephrology, Istinye University Liv Hospital Bahçesehir, Istanbul, Turkey",NA
"392","34218318","10.1007/s00431-021-04191-z","COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation.","The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis and kidney transplant (KTx) groups. This multicenter observational study was conducted between 1 April and 31 December 2020 in Istanbul. Members of the Istanbul branch of the Turkish Pediatric Nephrology Association were asked to report all confirmed cases of COVID-19 who were on RRT, as well as the numbe","2021","07","08","Eur J Pediatr","European journal of pediatrics","COVID-19; Children; Dialysis; Kidney transplantation; Pediatric; RRT; Renal replacement therapy","Gülmez","Rüveyda","Department of Pediatric Nephrology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey",NA
"393","34218318","10.1007/s00431-021-04191-z","COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation.","The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis and kidney transplant (KTx) groups. This multicenter observational study was conducted between 1 April and 31 December 2020 in Istanbul. Members of the Istanbul branch of the Turkish Pediatric Nephrology Association were asked to report all confirmed cases of COVID-19 who were on RRT, as well as the numbe","2021","07","08","Eur J Pediatr","European journal of pediatrics","COVID-19; Children; Dialysis; Kidney transplantation; Pediatric; RRT; Renal replacement therapy","Aksu","Bagdagül","Department of Pediatric Nephrology, Faculty of Medicine, Istanbul University, Istanbul, Turkey",NA
"394","34218318","10.1007/s00431-021-04191-z","COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation.","The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis and kidney transplant (KTx) groups. This multicenter observational study was conducted between 1 April and 31 December 2020 in Istanbul. Members of the Istanbul branch of the Turkish Pediatric Nephrology Association were asked to report all confirmed cases of COVID-19 who were on RRT, as well as the numbe","2021","07","08","Eur J Pediatr","European journal of pediatrics","COVID-19; Children; Dialysis; Kidney transplantation; Pediatric; RRT; Renal replacement therapy","Dursun","Hasan","Department of Pediatric Nephrology, Cemil Tasçioglu City Hospital, Prof. Dr, Istanbul, Turkey",NA
"395","34218318","10.1007/s00431-021-04191-z","COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation.","The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis and kidney transplant (KTx) groups. This multicenter observational study was conducted between 1 April and 31 December 2020 in Istanbul. Members of the Istanbul branch of the Turkish Pediatric Nephrology Association were asked to report all confirmed cases of COVID-19 who were on RRT, as well as the numbe","2021","07","08","Eur J Pediatr","European journal of pediatrics","COVID-19; Children; Dialysis; Kidney transplantation; Pediatric; RRT; Renal replacement therapy","Özçelik","Gül","Department of Pediatric Nephrology, Istanbul Sisli Hamidiye Etfal Education and Research Hospital, Istanbul, Turkey",NA
"396","34218318","10.1007/s00431-021-04191-z","COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation.","The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis and kidney transplant (KTx) groups. This multicenter observational study was conducted between 1 April and 31 December 2020 in Istanbul. Members of the Istanbul branch of the Turkish Pediatric Nephrology Association were asked to report all confirmed cases of COVID-19 who were on RRT, as well as the numbe","2021","07","08","Eur J Pediatr","European journal of pediatrics","COVID-19; Children; Dialysis; Kidney transplantation; Pediatric; RRT; Renal replacement therapy","Yavascan","Önder","Department of Pediatric Nephrology, Medipol University Hospital, Istanbul, Turkey",NA
"397","34218318","10.1007/s00431-021-04191-z","COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation.","The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis and kidney transplant (KTx) groups. This multicenter observational study was conducted between 1 April and 31 December 2020 in Istanbul. Members of the Istanbul branch of the Turkish Pediatric Nephrology Association were asked to report all confirmed cases of COVID-19 who were on RRT, as well as the numbe","2021","07","08","Eur J Pediatr","European journal of pediatrics","COVID-19; Children; Dialysis; Kidney transplantation; Pediatric; RRT; Renal replacement therapy","Çiçek","Rümeysa Yasemin","Department of Pediatric Nephrology, Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey",NA
"398","34218318","10.1007/s00431-021-04191-z","COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation.","The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis and kidney transplant (KTx) groups. This multicenter observational study was conducted between 1 April and 31 December 2020 in Istanbul. Members of the Istanbul branch of the Turkish Pediatric Nephrology Association were asked to report all confirmed cases of COVID-19 who were on RRT, as well as the numbe","2021","07","08","Eur J Pediatr","European journal of pediatrics","COVID-19; Children; Dialysis; Kidney transplantation; Pediatric; RRT; Renal replacement therapy","Tülpar","Sebahat","Department of Pediatric Nephrology, Sadi Konuk Training and Research Hospital, Bakirkoy Dr, Istanbul, Turkey",NA
"399","34218318","10.1007/s00431-021-04191-z","COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation.","The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis and kidney transplant (KTx) groups. This multicenter observational study was conducted between 1 April and 31 December 2020 in Istanbul. Members of the Istanbul branch of the Turkish Pediatric Nephrology Association were asked to report all confirmed cases of COVID-19 who were on RRT, as well as the numbe","2021","07","08","Eur J Pediatr","European journal of pediatrics","COVID-19; Children; Dialysis; Kidney transplantation; Pediatric; RRT; Renal replacement therapy","Hacihamdioglu","Duygu Övünç","Department of Pediatric Nephrology, Acibadem University Hospital, Istanbul, Turkey",NA
"400","34218318","10.1007/s00431-021-04191-z","COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation.","The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis and kidney transplant (KTx) groups. This multicenter observational study was conducted between 1 April and 31 December 2020 in Istanbul. Members of the Istanbul branch of the Turkish Pediatric Nephrology Association were asked to report all confirmed cases of COVID-19 who were on RRT, as well as the numbe","2021","07","08","Eur J Pediatr","European journal of pediatrics","COVID-19; Children; Dialysis; Kidney transplantation; Pediatric; RRT; Renal replacement therapy","Nayir","Ahmet","Department of Pediatric Nephrology, Faculty of Medicine, Istanbul University, Istanbul, Turkey",NA
"401","34218318","10.1007/s00431-021-04191-z","COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation.","The study aims to present the incidence of COVID-19 in pediatric patients undergoing renal replacement therapy (RRT) and to compare the severity and outcomes of the disease between the dialysis and kidney transplant (KTx) groups. This multicenter observational study was conducted between 1 April and 31 December 2020 in Istanbul. Members of the Istanbul branch of the Turkish Pediatric Nephrology Association were asked to report all confirmed cases of COVID-19 who were on RRT, as well as the numbe","2021","07","08","Eur J Pediatr","European journal of pediatrics","COVID-19; Children; Dialysis; Kidney transplantation; Pediatric; RRT; Renal replacement therapy","Alpay","Harika","Department of Pediatric Nephrology, Faculty of Medicine, Marmara University, Istanbul, Turkey",NA
"402","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Iannella","Giannicola","Otolaryngology, Head-Neck and Oral Surgery Unit, Department of Head-Neck Surgery, Morgagni Pierantoni Hospital, Via Carlo Forlanini, 34, 47121, Forli, Italy. giannicolaiannella@hotmail","giannicolaiannella@hotmail.it"
"403","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Magliulo","Giuseppe","Department of 'Organi di Senso', University ""Sapienza"", Viale dell'Università, 33, 00185, Rome, Italy",NA
"404","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Lechien","Jerome R","Laboratory of Anatomy and Cell Biology, Faculty of Medicine, University of Mons (UMONS), Avenue du Champ de mars, 6, 7000, Mons, Belgium",NA
"405","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Maniaci","Antonino","Department of Medical and Surgical Sciences and Advanced Technologies ""GF Ingrassia"", ENT Section, University of Catania, Via S. Sofia, 78, 95125, Catania, Italy",NA
"406","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Perrone","Tiziano","Department ENT and Audiology, University of Ferrara, Via Savonarola, 9, 44121, Ferrara, Italy",NA
"407","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Frasconi","Pier Carlo","Otolaryngology, Head-Neck and Oral Surgery Unit, Department of Head-Neck Surgery, Morgagni Pierantoni Hospital, Via Carlo Forlanini, 34, 47121, Forli, Italy",NA
"408","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","De Vito","Andrea","Otolaryngology, Head-Neck and Oral Surgery Unit, Department of Head-Neck Surgery, Ospedale ""Santa Maria Delle Croci"", Viale Vincenzo Randi, 5, 48121, Ravenna, Italy",NA
"409","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Martone","Chiara","Otolaryngology, Head-Neck and Oral Surgery Unit, Department of Head-Neck Surgery, Ospedale ""Santa Maria Delle Croci"", Viale Vincenzo Randi, 5, 48121, Ravenna, Italy",NA
"410","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Ferlito","Salvatore","Department of Medical and Surgical Sciences and Advanced Technologies ""GF Ingrassia"", ENT Section, University of Catania, Via S. Sofia, 78, 95125, Catania, Italy",NA
"411","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Cocuzza","Salvatore","Department of Medical and Surgical Sciences and Advanced Technologies ""GF Ingrassia"", ENT Section, University of Catania, Via S. Sofia, 78, 95125, Catania, Italy",NA
"412","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Cammaroto","Giovanni","Otolaryngology, Head-Neck and Oral Surgery Unit, Department of Head-Neck Surgery, Morgagni Pierantoni Hospital, Via Carlo Forlanini, 34, 47121, Forli, Italy",NA
"413","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Meccariello","Giuseppe","Otolaryngology, Head-Neck and Oral Surgery Unit, Department of Head-Neck Surgery, Morgagni Pierantoni Hospital, Via Carlo Forlanini, 34, 47121, Forli, Italy",NA
"414","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Monticone","Valentina","Otolaryngology Department, Azienda Sanitaria Locale CN2, Alba, Italy",NA
"415","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Greco","Antonio","Department of 'Organi di Senso', University ""Sapienza"", Viale dell'Università, 33, 00185, Rome, Italy",NA
"416","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","de Vincentiis","Marco","Department of 'Organi di Senso', University ""Sapienza"", Viale dell'Università, 33, 00185, Rome, Italy",NA
"417","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Ralli","Massimo","Department of 'Organi di Senso', University ""Sapienza"", Viale dell'Università, 33, 00185, Rome, Italy",NA
"418","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Savastano","Vincenzo","Department of 'Organi di Senso', University ""Sapienza"", Viale dell'Università, 33, 00185, Rome, Italy",NA
"419","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Bertin","Serena","Department of 'Organi di Senso', University ""Sapienza"", Viale dell'Università, 33, 00185, Rome, Italy",NA
"420","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Pace","Annalisa","Department of 'Organi di Senso', University ""Sapienza"", Viale dell'Università, 33, 00185, Rome, Italy",NA
"421","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Milani","Alessandro","Department of 'Organi di Senso', University ""Sapienza"", Viale dell'Università, 33, 00185, Rome, Italy",NA
"422","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Polimeni","Roberta","Department of 'Organi di Senso', University ""Sapienza"", Viale dell'Università, 33, 00185, Rome, Italy",NA
"423","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Pelucchi","Stefano","Department ENT and Audiology, University of Ferrara, Via Savonarola, 9, 44121, Ferrara, Italy",NA
"424","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Ciorba","Andrea","Department ENT and Audiology, University of Ferrara, Via Savonarola, 9, 44121, Ferrara, Italy",NA
"425","34218309","10.1007/s00405-021-06958-4","Impact of COVID-19 pandemic on the incidence of otitis media with effusion in adults and children: a multicenter study.","To compare and analyze the incidence of otitis media with effusion (OME), before and during the COVID-19-related pandemic period, to evaluate the effects of the social changes (lockdown, continuous use of facial masks, social distancing, reduction of social activities) in the OME incidence in children and adults. The number of diagnosed OME in e five referral centers, between 1 March 2018 and 1 March 2021, has been reviewed and collected. To estimate the reduction of OME incidence in children an","2021","07","08","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","COVID-19; Eustachian tube dysfunction; OME; Otitis media effusion; Upper airways respiratory infections","Vicini","Claudio","Otolaryngology, Head-Neck and Oral Surgery Unit, Department of Head-Neck Surgery, Morgagni Pierantoni Hospital, Via Carlo Forlanini, 34, 47121, Forli, Italy",NA
"426","34218297","10.1007/s00264-021-05119-w","Percutaneous Achilles tenotomy under local anaesthetic in the clubfoot clinic was safe during the COVID-19 pandemic, for both children and parents.","An Achilles tenotomy is routinely required to correct the equinus deformity in Congenital talipes equinovarus (CTEV) patients as part of the gold standard treatment using the Ponseti method. This procedure can be performed in clinic under local anaesthetic or in theatre under general anaesthetic. The COVID-19 pandemic reduced theatre capacity and caused a delay to CTEV patients' treatment. A new standard operating procedure that allowed the tenotomies to be performed under local anaesthetic in t","2021","07","08","Int Orthop","International orthopaedics","COVID-19; Clubfoot; Local anaethesia; Tenotomy","Barkham","Benjamin","Trauma and Orthopaedic Department, St Georges Hospital, Blackshaw Road, Tooting, London, SW17 0QT, UK",NA
"427","34218297","10.1007/s00264-021-05119-w","Percutaneous Achilles tenotomy under local anaesthetic in the clubfoot clinic was safe during the COVID-19 pandemic, for both children and parents.","An Achilles tenotomy is routinely required to correct the equinus deformity in Congenital talipes equinovarus (CTEV) patients as part of the gold standard treatment using the Ponseti method. This procedure can be performed in clinic under local anaesthetic or in theatre under general anaesthetic. The COVID-19 pandemic reduced theatre capacity and caused a delay to CTEV patients' treatment. A new standard operating procedure that allowed the tenotomies to be performed under local anaesthetic in t","2021","07","08","Int Orthop","International orthopaedics","COVID-19; Clubfoot; Local anaethesia; Tenotomy","McNally","Thomas","Trauma and Orthopaedic Department, St Georges Hospital, Blackshaw Road, Tooting, London, SW17 0QT, UK",NA
"428","34218297","10.1007/s00264-021-05119-w","Percutaneous Achilles tenotomy under local anaesthetic in the clubfoot clinic was safe during the COVID-19 pandemic, for both children and parents.","An Achilles tenotomy is routinely required to correct the equinus deformity in Congenital talipes equinovarus (CTEV) patients as part of the gold standard treatment using the Ponseti method. This procedure can be performed in clinic under local anaesthetic or in theatre under general anaesthetic. The COVID-19 pandemic reduced theatre capacity and caused a delay to CTEV patients' treatment. A new standard operating procedure that allowed the tenotomies to be performed under local anaesthetic in t","2021","07","08","Int Orthop","International orthopaedics","COVID-19; Clubfoot; Local anaethesia; Tenotomy","Russell","Aishling","Paediatric Physiotherapy Department, St Georges Hospital, London, UK",NA
"429","34218297","10.1007/s00264-021-05119-w","Percutaneous Achilles tenotomy under local anaesthetic in the clubfoot clinic was safe during the COVID-19 pandemic, for both children and parents.","An Achilles tenotomy is routinely required to correct the equinus deformity in Congenital talipes equinovarus (CTEV) patients as part of the gold standard treatment using the Ponseti method. This procedure can be performed in clinic under local anaesthetic or in theatre under general anaesthetic. The COVID-19 pandemic reduced theatre capacity and caused a delay to CTEV patients' treatment. A new standard operating procedure that allowed the tenotomies to be performed under local anaesthetic in t","2021","07","08","Int Orthop","International orthopaedics","COVID-19; Clubfoot; Local anaethesia; Tenotomy","Bridgens","Anna","Trauma and Orthopaedic Department, St Georges Hospital, Blackshaw Road, Tooting, London, SW17 0QT, UK",NA
"430","34218297","10.1007/s00264-021-05119-w","Percutaneous Achilles tenotomy under local anaesthetic in the clubfoot clinic was safe during the COVID-19 pandemic, for both children and parents.","An Achilles tenotomy is routinely required to correct the equinus deformity in Congenital talipes equinovarus (CTEV) patients as part of the gold standard treatment using the Ponseti method. This procedure can be performed in clinic under local anaesthetic or in theatre under general anaesthetic. The COVID-19 pandemic reduced theatre capacity and caused a delay to CTEV patients' treatment. A new standard operating procedure that allowed the tenotomies to be performed under local anaesthetic in t","2021","07","08","Int Orthop","International orthopaedics","COVID-19; Clubfoot; Local anaethesia; Tenotomy","Gelfer","Yael","Trauma and Orthopaedic Department, St Georges Hospital, Blackshaw Road, Tooting, London, SW17 0QT, UK. yaelgelfer@gmail","yaelgelfer@gmail.com"
"431","34218285","10.1093/pubmed/fdab253","The vulnerable in time of pandemic: toward a preferential option for the vulnerable and marginalized.","The disproportionate impact of the pandemic on certain populations has highlighted numerous inequities and injustices in our world. In considering the most vulnerable during the COVID-19 pandemic, an inclusive approach is not only a humanitarian approach but also a global public health imperative. The rights of the most vulnerable groups, such as women, youth, indigenous people and persons with disabilities and with co-morbidity, among others need to be protected.","2021","07","04","J Public Health (Oxf)","Journal of public health (Oxford, England)","COVID-19; WHO; inequality; pandemic; vulnerable","Corpuz","Jeff Clyde G","Department of Theology and Religious Education, De La Salle University, Manila 1004, Philippines",NA
"432","34218284","10.1093/cid/ciab607","Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.","Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been shown to neutralize the virus in-vitro and prevent disease in animal challenge models upon re-exposure. However, current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Partici","2021","07","04","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; ELISA; Immunity; SARS-CoV-2; antibody; kinetics; neutralization; nucleoprotein; serology; virus;  spike protein","Grandjean","Louis","Department of Infection, Inflammation and Immunity, Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, UK",NA
"433","34218284","10.1093/cid/ciab607","Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.","Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been shown to neutralize the virus in-vitro and prevent disease in animal challenge models upon re-exposure. However, current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Partici","2021","07","04","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; ELISA; Immunity; SARS-CoV-2; antibody; kinetics; neutralization; nucleoprotein; serology; virus;  spike protein","Saso","Anja","Department of Infectious Diseases, Great Ormond Street Hospital, Great Ormond Street, London",NA
"434","34218284","10.1093/cid/ciab607","Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.","Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been shown to neutralize the virus in-vitro and prevent disease in animal challenge models upon re-exposure. However, current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Partici","2021","07","04","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; ELISA; Immunity; SARS-CoV-2; antibody; kinetics; neutralization; nucleoprotein; serology; virus;  spike protein","Ortiz","Arturo Torres","Department of Infection, Inflammation and Immunity, Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, UK",NA
"435","34218284","10.1093/cid/ciab607","Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.","Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been shown to neutralize the virus in-vitro and prevent disease in animal challenge models upon re-exposure. However, current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Partici","2021","07","04","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; ELISA; Immunity; SARS-CoV-2; antibody; kinetics; neutralization; nucleoprotein; serology; virus;  spike protein","Lam","Tanya","Department of Infectious Diseases, Great Ormond Street Hospital, Great Ormond Street, London",NA
"436","34218284","10.1093/cid/ciab607","Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.","Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been shown to neutralize the virus in-vitro and prevent disease in animal challenge models upon re-exposure. However, current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Partici","2021","07","04","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; ELISA; Immunity; SARS-CoV-2; antibody; kinetics; neutralization; nucleoprotein; serology; virus;  spike protein","Hatcher","James","Department of Microbiology, Great Ormond Street Hospital, Great Ormond Street, London",NA
"437","34218284","10.1093/cid/ciab607","Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.","Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been shown to neutralize the virus in-vitro and prevent disease in animal challenge models upon re-exposure. However, current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Partici","2021","07","04","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; ELISA; Immunity; SARS-CoV-2; antibody; kinetics; neutralization; nucleoprotein; serology; virus;  spike protein","Thistlethwayte","Rosie","Management, Great Ormond Street Hospital, Great Ormond Street, London",NA
"438","34218284","10.1093/cid/ciab607","Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.","Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been shown to neutralize the virus in-vitro and prevent disease in animal challenge models upon re-exposure. However, current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Partici","2021","07","04","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; ELISA; Immunity; SARS-CoV-2; antibody; kinetics; neutralization; nucleoprotein; serology; virus;  spike protein","Harris","Mark","Quality Improvement, Great Ormond Street Hospital, Great Ormond Street, London",NA
"439","34218284","10.1093/cid/ciab607","Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.","Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been shown to neutralize the virus in-vitro and prevent disease in animal challenge models upon re-exposure. However, current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Partici","2021","07","04","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; ELISA; Immunity; SARS-CoV-2; antibody; kinetics; neutralization; nucleoprotein; serology; virus;  spike protein","Best","Timothy","Department of Medicine, Imperial College, Paddington, London",NA
"440","34218284","10.1093/cid/ciab607","Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.","Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been shown to neutralize the virus in-vitro and prevent disease in animal challenge models upon re-exposure. However, current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Partici","2021","07","04","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; ELISA; Immunity; SARS-CoV-2; antibody; kinetics; neutralization; nucleoprotein; serology; virus;  spike protein","Johnson","Marina","Department of Infection, Inflammation and Immunity, Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, UK",NA
"441","34218284","10.1093/cid/ciab607","Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.","Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been shown to neutralize the virus in-vitro and prevent disease in animal challenge models upon re-exposure. However, current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Partici","2021","07","04","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; ELISA; Immunity; SARS-CoV-2; antibody; kinetics; neutralization; nucleoprotein; serology; virus;  spike protein","Wagstaffe","Helen","Department of Infection, Inflammation and Immunity, Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, UK",NA
"442","34218284","10.1093/cid/ciab607","Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.","Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been shown to neutralize the virus in-vitro and prevent disease in animal challenge models upon re-exposure. However, current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Partici","2021","07","04","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; ELISA; Immunity; SARS-CoV-2; antibody; kinetics; neutralization; nucleoprotein; serology; virus;  spike protein","Ralph","Elizabeth","Clinical Immunology, Camelia Botnar Laboratories, Great Ormond Street Hospital, Great Ormond Street, London",NA
"443","34218284","10.1093/cid/ciab607","Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.","Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been shown to neutralize the virus in-vitro and prevent disease in animal challenge models upon re-exposure. However, current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Partici","2021","07","04","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; ELISA; Immunity; SARS-CoV-2; antibody; kinetics; neutralization; nucleoprotein; serology; virus;  spike protein","Mai","Annabelle","Clinical Immunology, Camelia Botnar Laboratories, Great Ormond Street Hospital, Great Ormond Street, London",NA
"444","34218284","10.1093/cid/ciab607","Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.","Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been shown to neutralize the virus in-vitro and prevent disease in animal challenge models upon re-exposure. However, current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Partici","2021","07","04","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; ELISA; Immunity; SARS-CoV-2; antibody; kinetics; neutralization; nucleoprotein; serology; virus;  spike protein","Colijn","Caroline","Department of Mathematics, Simon Fraser University, Vancouver, British Colombia, Canada",NA
"445","34218284","10.1093/cid/ciab607","Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.","Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been shown to neutralize the virus in-vitro and prevent disease in animal challenge models upon re-exposure. However, current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Partici","2021","07","04","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; ELISA; Immunity; SARS-CoV-2; antibody; kinetics; neutralization; nucleoprotein; serology; virus;  spike protein","Breuer","Judith","Department of Infection, Inflammation and Immunity, Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, UK",NA
"446","34218284","10.1093/cid/ciab607","Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.","Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been shown to neutralize the virus in-vitro and prevent disease in animal challenge models upon re-exposure. However, current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Partici","2021","07","04","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; ELISA; Immunity; SARS-CoV-2; antibody; kinetics; neutralization; nucleoprotein; serology; virus;  spike protein","Buckland","Matthew","Clinical Immunology, Camelia Botnar Laboratories, Great Ormond Street Hospital, Great Ormond Street, London",NA
"447","34218284","10.1093/cid/ciab607","Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.","Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been shown to neutralize the virus in-vitro and prevent disease in animal challenge models upon re-exposure. However, current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Partici","2021","07","04","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; ELISA; Immunity; SARS-CoV-2; antibody; kinetics; neutralization; nucleoprotein; serology; virus;  spike protein","Gilmour","Kimberly","Clinical Immunology, Camelia Botnar Laboratories, Great Ormond Street Hospital, Great Ormond Street, London",NA
"448","34218284","10.1093/cid/ciab607","Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.","Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been shown to neutralize the virus in-vitro and prevent disease in animal challenge models upon re-exposure. However, current understanding of SARS-CoV-2 humoral dynamics and longevity is conflicting. The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Partici","2021","07","04","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; ELISA; Immunity; SARS-CoV-2; antibody; kinetics; neutralization; nucleoprotein; serology; virus;  spike protein","Goldblatt","David","Department of Infection, Inflammation and Immunity, Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, UK",NA
"449","34218282","10.1093/pubmed/fdab259","Public health activism amid the Covid-19 pandemic: the case of the Alliance of Health Workers.","In an editorial, the editors note how crucial the role is of public health activism in enforcing efficient and effective public health management. The government is the lead institution in any national response to the pandemic and to ensure transparency on its end, it is important for any network of health organizations and associations not to shy away from embracing an activist role. In this correspondence, the author explores the case of the Alliance of Health Workers, a union of government an","2021","07","04","J Public Health (Oxf)","Journal of public health (Oxford, England)","accountability; healthcare workers; transparency","Macaraan","Willard Enrique R","Theology and Religious Education Department, De La Salle University, 1004 Manila, Philippines",NA
"450","34218279","10.1093/pubmed/fdab260","The Covid-19 pandemic and its concomitant benefits: improved hygiene habits.","In an editorial, the editor has explored how state response to the pandemic has collateral damages not only in the public health in general but also in economy and education. Ironically, it also shows that the adjustments and adaptations in peoples' behavior have resulted in improved habits in personal hygiene and self-care. Not all is bad though as people have (re)learned the basic value of handwashing and preventive measures to avoid any diseases and spread of germs. In the long run, this is g","2021","07","04","J Public Health (Oxf)","Journal of public health (Oxford, England)","hand hygiene compliance; hand washing; self-care","Macaraan","Willard Enrique R","Theology and Religious Education Department, De La Salle University, 1004 Manila, Philippines",NA
"451","34218278","10.1093/pubmed/fdab262","The environment in the post-pandemic scenario: sustaining the gains.","In a recent correspondence, the authors noted how temporary the experience of improved air quality in the Philippines during the pandemic. They argued that beyond the crafting of policies and guidelines, there must be a solid attitudinal change in the way a person looks, behaves and lives with his/her surroundings. I support that stance and would further argue that community-based approaches can reinforce that desired change and outcome especially in remote villages and communities where group/c","2021","07","04","J Public Health (Oxf)","Journal of public health (Oxford, England)","Covid-19; climate change; community-based approaches; pandemic","Macaraan","Willard Enrique R","Theology and Religious Education Department, De La Salle University, Manila 1004, Philippines",NA
"452","34218262","10.1038/s41366-021-00890-7","Changes in sleep phase and body weight of mobile health App users during COVID-19 mild lockdown in Japan.","The stay-at-home order during the COVID-19 pandemic has restricted individuals' social behaviors, and therefore, effected their lifestyle including sleep, diet, and physical activity. Using the cross-sectional study design with a large sample size (N = 30,275) from the mobile health App users in Japan, we show age-dependent lifestyle changes during a nonpunitive ""mild lockdown"" (from April to May 2020). Sleep onset and offset were delayed on work-days but not on free-days with increased sleep du","2021","07","08","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Tahara","Yu","Laboratory of Physiology and Pharmacology, School of Advanced Science and Engineering, Waseda University, Shinjuku-ku, Tokyo, Japan",NA
"453","34218262","10.1038/s41366-021-00890-7","Changes in sleep phase and body weight of mobile health App users during COVID-19 mild lockdown in Japan.","The stay-at-home order during the COVID-19 pandemic has restricted individuals' social behaviors, and therefore, effected their lifestyle including sleep, diet, and physical activity. Using the cross-sectional study design with a large sample size (N = 30,275) from the mobile health App users in Japan, we show age-dependent lifestyle changes during a nonpunitive ""mild lockdown"" (from April to May 2020). Sleep onset and offset were delayed on work-days but not on free-days with increased sleep du","2021","07","08","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Shinto","Takae","Laboratory of Physiology and Pharmacology, School of Advanced Science and Engineering, Waseda University, Shinjuku-ku, Tokyo, Japan",NA
"454","34218262","10.1038/s41366-021-00890-7","Changes in sleep phase and body weight of mobile health App users during COVID-19 mild lockdown in Japan.","The stay-at-home order during the COVID-19 pandemic has restricted individuals' social behaviors, and therefore, effected their lifestyle including sleep, diet, and physical activity. Using the cross-sectional study design with a large sample size (N = 30,275) from the mobile health App users in Japan, we show age-dependent lifestyle changes during a nonpunitive ""mild lockdown"" (from April to May 2020). Sleep onset and offset were delayed on work-days but not on free-days with increased sleep du","2021","07","08","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Inoue","Kosuke","Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA), Los Angeles, CA, USA",NA
"455","34218262","10.1038/s41366-021-00890-7","Changes in sleep phase and body weight of mobile health App users during COVID-19 mild lockdown in Japan.","The stay-at-home order during the COVID-19 pandemic has restricted individuals' social behaviors, and therefore, effected their lifestyle including sleep, diet, and physical activity. Using the cross-sectional study design with a large sample size (N = 30,275) from the mobile health App users in Japan, we show age-dependent lifestyle changes during a nonpunitive ""mild lockdown"" (from April to May 2020). Sleep onset and offset were delayed on work-days but not on free-days with increased sleep du","2021","07","08","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Roshanmehr","Farnaz","Laboratory of Physiology and Pharmacology, School of Advanced Science and Engineering, Waseda University, Shinjuku-ku, Tokyo, Japan",NA
"456","34218262","10.1038/s41366-021-00890-7","Changes in sleep phase and body weight of mobile health App users during COVID-19 mild lockdown in Japan.","The stay-at-home order during the COVID-19 pandemic has restricted individuals' social behaviors, and therefore, effected their lifestyle including sleep, diet, and physical activity. Using the cross-sectional study design with a large sample size (N = 30,275) from the mobile health App users in Japan, we show age-dependent lifestyle changes during a nonpunitive ""mild lockdown"" (from April to May 2020). Sleep onset and offset were delayed on work-days but not on free-days with increased sleep du","2021","07","08","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Ito","Akito","Laboratory of Physiology and Pharmacology, School of Advanced Science and Engineering, Waseda University, Shinjuku-ku, Tokyo, Japan",NA
"457","34218262","10.1038/s41366-021-00890-7","Changes in sleep phase and body weight of mobile health App users during COVID-19 mild lockdown in Japan.","The stay-at-home order during the COVID-19 pandemic has restricted individuals' social behaviors, and therefore, effected their lifestyle including sleep, diet, and physical activity. Using the cross-sectional study design with a large sample size (N = 30,275) from the mobile health App users in Japan, we show age-dependent lifestyle changes during a nonpunitive ""mild lockdown"" (from April to May 2020). Sleep onset and offset were delayed on work-days but not on free-days with increased sleep du","2021","07","08","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Michie","Mikiko","Asken Inc., Shinjuku-ku, Tokyo, Japan",NA
"458","34218262","10.1038/s41366-021-00890-7","Changes in sleep phase and body weight of mobile health App users during COVID-19 mild lockdown in Japan.","The stay-at-home order during the COVID-19 pandemic has restricted individuals' social behaviors, and therefore, effected their lifestyle including sleep, diet, and physical activity. Using the cross-sectional study design with a large sample size (N = 30,275) from the mobile health App users in Japan, we show age-dependent lifestyle changes during a nonpunitive ""mild lockdown"" (from April to May 2020). Sleep onset and offset were delayed on work-days but not on free-days with increased sleep du","2021","07","08","Int J Obes (Lond)","International journal of obesity (2005)",NA,"Shibata","Shigenobu","Laboratory of Physiology and Pharmacology, School of Advanced Science and Engineering, Waseda University, Shinjuku-ku, Tokyo, Japan. shibatas@waseda","shibatas@waseda.jp"
"459","34218247","","[Mental health protection associated with COVID-19].","Mental health is a state of mental well-being in which people are able to cope with stressful situations in life and can bring their life potential to their communities. Good mental health enables people to fulfill their roles in both family and society. When crises affect social life, people should be expected to experience high levels of stress. The COVID-19 pandemic, in addition to the physical health crisis, may also contribute to the exacerbation of stress and the emergence of mental illnes","2021","07","06","Pol Merkur Lekarski","Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego","coronavirus; mental health; pandemic; Adolescent; Anxiety; COVID-19; Child; Humans; Mental Health; Pandemics; SARS-CoV-2","Oglodek","Ewa A","Faculty of Health Science, Jan Dlugosz University in Czestochowa, Poland",NA
"460","34218245","","The presence of anti-leucocyte antibodies in the plasma of convalescent women after SARS-CoV-2 infection as a reason for disqualification for plasma therapy - analysis based on a literature review.","According to the data from November 29 2020, the SARS-CoV-2 coronavirus was responsible for 61 866 635 cases of infections and 1 448 990 deaths worldwide, and the number is still growing rapidly. The main problem is the rapid increase in the number of patients with pneumonia complicated by respiratory failure. In the treatment of COVID- 19 patients, a significant effect of convalescent plasma (CP) therapy from convalescent patients with SARS-CoV-2 IgG neutralizing antibodies is indicated. After ","2021","07","06","Pol Merkur Lekarski","Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego","SARS CoV-2 coronavirus; convalescent plasma; neutralizing antibodies; Antibodies, Viral; COVID-19; Coronavirus Infections; Female; Humans; Immunization, Passive; Pregnancy; Pregnancy Complications, Infectious; SARS-CoV-2","Wendlocha","Dominika","Department of Immunology and Serology, Faculty of Pharmaceutical Science in Sosnowiec, Medical University of Silesia, Poland",NA
"461","34218245","","The presence of anti-leucocyte antibodies in the plasma of convalescent women after SARS-CoV-2 infection as a reason for disqualification for plasma therapy - analysis based on a literature review.","According to the data from November 29 2020, the SARS-CoV-2 coronavirus was responsible for 61 866 635 cases of infections and 1 448 990 deaths worldwide, and the number is still growing rapidly. The main problem is the rapid increase in the number of patients with pneumonia complicated by respiratory failure. In the treatment of COVID- 19 patients, a significant effect of convalescent plasma (CP) therapy from convalescent patients with SARS-CoV-2 IgG neutralizing antibodies is indicated. After ","2021","07","06","Pol Merkur Lekarski","Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego","SARS CoV-2 coronavirus; convalescent plasma; neutralizing antibodies; Antibodies, Viral; COVID-19; Coronavirus Infections; Female; Humans; Immunization, Passive; Pregnancy; Pregnancy Complications, Infectious; SARS-CoV-2","Janusz","Aleksandra","Department of Immunology and Serology, Faculty of Pharmaceutical Science in Sosnowiec, Medical University of Silesia, Poland",NA
"462","34218245","","The presence of anti-leucocyte antibodies in the plasma of convalescent women after SARS-CoV-2 infection as a reason for disqualification for plasma therapy - analysis based on a literature review.","According to the data from November 29 2020, the SARS-CoV-2 coronavirus was responsible for 61 866 635 cases of infections and 1 448 990 deaths worldwide, and the number is still growing rapidly. The main problem is the rapid increase in the number of patients with pneumonia complicated by respiratory failure. In the treatment of COVID- 19 patients, a significant effect of convalescent plasma (CP) therapy from convalescent patients with SARS-CoV-2 IgG neutralizing antibodies is indicated. After ","2021","07","06","Pol Merkur Lekarski","Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego","SARS CoV-2 coronavirus; convalescent plasma; neutralizing antibodies; Antibodies, Viral; COVID-19; Coronavirus Infections; Female; Humans; Immunization, Passive; Pregnancy; Pregnancy Complications, Infectious; SARS-CoV-2","Janusz","Joanna","Department of Immunology and Serology, Faculty of Pharmaceutical Science in Sosnowiec, Medical University of Silesia, Poland",NA
"463","34218245","","The presence of anti-leucocyte antibodies in the plasma of convalescent women after SARS-CoV-2 infection as a reason for disqualification for plasma therapy - analysis based on a literature review.","According to the data from November 29 2020, the SARS-CoV-2 coronavirus was responsible for 61 866 635 cases of infections and 1 448 990 deaths worldwide, and the number is still growing rapidly. The main problem is the rapid increase in the number of patients with pneumonia complicated by respiratory failure. In the treatment of COVID- 19 patients, a significant effect of convalescent plasma (CP) therapy from convalescent patients with SARS-CoV-2 IgG neutralizing antibodies is indicated. After ","2021","07","06","Pol Merkur Lekarski","Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego","SARS CoV-2 coronavirus; convalescent plasma; neutralizing antibodies; Antibodies, Viral; COVID-19; Coronavirus Infections; Female; Humans; Immunization, Passive; Pregnancy; Pregnancy Complications, Infectious; SARS-CoV-2","Krolewska-Daszczynska","Patrycja","Department of Immunology and Serology, Faculty of Pharmaceutical Science in Sosnowiec, Medical University of Silesia, Poland",NA
"464","34218245","","The presence of anti-leucocyte antibodies in the plasma of convalescent women after SARS-CoV-2 infection as a reason for disqualification for plasma therapy - analysis based on a literature review.","According to the data from November 29 2020, the SARS-CoV-2 coronavirus was responsible for 61 866 635 cases of infections and 1 448 990 deaths worldwide, and the number is still growing rapidly. The main problem is the rapid increase in the number of patients with pneumonia complicated by respiratory failure. In the treatment of COVID- 19 patients, a significant effect of convalescent plasma (CP) therapy from convalescent patients with SARS-CoV-2 IgG neutralizing antibodies is indicated. After ","2021","07","06","Pol Merkur Lekarski","Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego","SARS CoV-2 coronavirus; convalescent plasma; neutralizing antibodies; Antibodies, Viral; COVID-19; Coronavirus Infections; Female; Humans; Immunization, Passive; Pregnancy; Pregnancy Complications, Infectious; SARS-CoV-2","Englisz","Aleksandra","Department of Immunology and Serology, Faculty of Pharmaceutical Science in Sosnowiec, Medical University of Silesia, Poland",NA
"465","34218245","","The presence of anti-leucocyte antibodies in the plasma of convalescent women after SARS-CoV-2 infection as a reason for disqualification for plasma therapy - analysis based on a literature review.","According to the data from November 29 2020, the SARS-CoV-2 coronavirus was responsible for 61 866 635 cases of infections and 1 448 990 deaths worldwide, and the number is still growing rapidly. The main problem is the rapid increase in the number of patients with pneumonia complicated by respiratory failure. In the treatment of COVID- 19 patients, a significant effect of convalescent plasma (CP) therapy from convalescent patients with SARS-CoV-2 IgG neutralizing antibodies is indicated. After ","2021","07","06","Pol Merkur Lekarski","Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego","SARS CoV-2 coronavirus; convalescent plasma; neutralizing antibodies; Antibodies, Viral; COVID-19; Coronavirus Infections; Female; Humans; Immunization, Passive; Pregnancy; Pregnancy Complications, Infectious; SARS-CoV-2","Smycz-Kubanska","Marta","Department of Immunology and Serology, Faculty of Pharmaceutical Science in Sosnowiec, Medical University of Silesia, Poland",NA
"466","34218245","","The presence of anti-leucocyte antibodies in the plasma of convalescent women after SARS-CoV-2 infection as a reason for disqualification for plasma therapy - analysis based on a literature review.","According to the data from November 29 2020, the SARS-CoV-2 coronavirus was responsible for 61 866 635 cases of infections and 1 448 990 deaths worldwide, and the number is still growing rapidly. The main problem is the rapid increase in the number of patients with pneumonia complicated by respiratory failure. In the treatment of COVID- 19 patients, a significant effect of convalescent plasma (CP) therapy from convalescent patients with SARS-CoV-2 IgG neutralizing antibodies is indicated. After ","2021","07","06","Pol Merkur Lekarski","Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego","SARS CoV-2 coronavirus; convalescent plasma; neutralizing antibodies; Antibodies, Viral; COVID-19; Coronavirus Infections; Female; Humans; Immunization, Passive; Pregnancy; Pregnancy Complications, Infectious; SARS-CoV-2","Mielczarek-Palacz","Aleksandra","Department of Immunology and Serology, Faculty of Pharmaceutical Science in Sosnowiec, Medical University of Silesia, Poland",NA
"467","34218241","","[Negative pressure wound therapy in the treatment of diabetic foot syndrome - a case report].","Diabetic foot syndrome is in the variety of diabetes complications. It is one of the most severe and common, is usually observed in the elderly mainly in poorly controlled diabetes. The proper treatment requires involvement of doctors of various specialities and, although numerous newest, supportive therapies and rehabilitation are used, the diabetic foot syndrom may lead to limb amputation and, consequently, serious disability. A patient was hospitalized in the Department of Oncological Surgery","2021","07","06","Pol Merkur Lekarski","Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego","amputation; diabetic foot syndrome; hyperbaric oxygen; negative pressure wound therapy; Aged; COVID-19; Diabetes Mellitus; Diabetic Foot; Humans; Male; Negative-Pressure Wound Therapy; Quality of Life; SARS-CoV-2","Cichon","Paulina","Department of Oncological Surgery, Academic Clinical Centre of Gdansk, Poland",NA
"468","34218241","","[Negative pressure wound therapy in the treatment of diabetic foot syndrome - a case report].","Diabetic foot syndrome is in the variety of diabetes complications. It is one of the most severe and common, is usually observed in the elderly mainly in poorly controlled diabetes. The proper treatment requires involvement of doctors of various specialities and, although numerous newest, supportive therapies and rehabilitation are used, the diabetic foot syndrom may lead to limb amputation and, consequently, serious disability. A patient was hospitalized in the Department of Oncological Surgery","2021","07","06","Pol Merkur Lekarski","Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego","amputation; diabetic foot syndrome; hyperbaric oxygen; negative pressure wound therapy; Aged; COVID-19; Diabetes Mellitus; Diabetic Foot; Humans; Male; Negative-Pressure Wound Therapy; Quality of Life; SARS-CoV-2","Ekmana","Marcin","Department of Oncological Surgery, Academic Clinical Centre of Gdansk, Poland",NA
"469","34218204","10.1016/j.ejogrb.2021.06.020","Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-1) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in pregnancy - An overview.","Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-1) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections, like most other viruses that affect the respiratory tract can cause severe maternal illness and adverse pregnancy outcomes. They are not only highly transmissible (acquired through droplets), but Host reservoirs such as dromedary camels for MERS-CoV and masked palm civet for SARS-CoV-1 are critical links in the onset of outbreaks. Clinically they present with flu-lik","2021","07","20","Eur J Obstet Gynecol Reprod Biol","European journal of obstetrics, gynecology, and reproductive biology","Coronaviruses; Pregnancy; Respiratory syndrome; Viral infection","Babarinsa","Isaac A","Women Wellness and Research Centre, Hamad Medial Corporation, Qatar","IBabarinsa@hamad.qa"
"470","34218204","10.1016/j.ejogrb.2021.06.020","Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-1) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in pregnancy - An overview.","Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-1) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections, like most other viruses that affect the respiratory tract can cause severe maternal illness and adverse pregnancy outcomes. They are not only highly transmissible (acquired through droplets), but Host reservoirs such as dromedary camels for MERS-CoV and masked palm civet for SARS-CoV-1 are critical links in the onset of outbreaks. Clinically they present with flu-lik","2021","07","20","Eur J Obstet Gynecol Reprod Biol","European journal of obstetrics, gynecology, and reproductive biology","Coronaviruses; Pregnancy; Respiratory syndrome; Viral infection","Okunoye","Gbemisola O","Sidra Medicine, Qatar",NA
"471","34218204","10.1016/j.ejogrb.2021.06.020","Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-1) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in pregnancy - An overview.","Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-1) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections, like most other viruses that affect the respiratory tract can cause severe maternal illness and adverse pregnancy outcomes. They are not only highly transmissible (acquired through droplets), but Host reservoirs such as dromedary camels for MERS-CoV and masked palm civet for SARS-CoV-1 are critical links in the onset of outbreaks. Clinically they present with flu-lik","2021","07","20","Eur J Obstet Gynecol Reprod Biol","European journal of obstetrics, gynecology, and reproductive biology","Coronaviruses; Pregnancy; Respiratory syndrome; Viral infection","Odukoya","Olusegun","Al Wakra Hospital, Qatar",NA
"472","34218168","10.1016/j.rmed.2021.106516","Respiratory care for the critical patients with 2019 novel coronavirus.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted through respiratory droplets, aerosols and close contact. Cross infections occur because viruses spread rapidly among humans. Nineteen percent (19%) of the infected patients developed severe pneumonia and acute respiratory distress syndrome (ARDS). Hypoxemia usually occurs and patients may require oxygen therapy or mechanical ventilation (MV) support. In this article, recently published clinical experience and observatio","2021","07","21","Respir Med","Respiratory medicine","2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Infection control; Mechanical ventilation; Oxygen therapy; Respiratory care","Wang","Yao-Chen","Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, 402306, Taiwan","wang5717@ms21.hinet.net"
"473","34218168","10.1016/j.rmed.2021.106516","Respiratory care for the critical patients with 2019 novel coronavirus.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted through respiratory droplets, aerosols and close contact. Cross infections occur because viruses spread rapidly among humans. Nineteen percent (19%) of the infected patients developed severe pneumonia and acute respiratory distress syndrome (ARDS). Hypoxemia usually occurs and patients may require oxygen therapy or mechanical ventilation (MV) support. In this article, recently published clinical experience and observatio","2021","07","21","Respir Med","Respiratory medicine","2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Infection control; Mechanical ventilation; Oxygen therapy; Respiratory care","Lu","Min-Chi","Division of Infectious Diseases, Department of Internal Medicine, China Medical University Hospital, Taichung, 404332, Taiwan","luminchi@cmu.edu.tw"
"474","34218168","10.1016/j.rmed.2021.106516","Respiratory care for the critical patients with 2019 novel coronavirus.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted through respiratory droplets, aerosols and close contact. Cross infections occur because viruses spread rapidly among humans. Nineteen percent (19%) of the infected patients developed severe pneumonia and acute respiratory distress syndrome (ARDS). Hypoxemia usually occurs and patients may require oxygen therapy or mechanical ventilation (MV) support. In this article, recently published clinical experience and observatio","2021","07","21","Respir Med","Respiratory medicine","2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Infection control; Mechanical ventilation; Oxygen therapy; Respiratory care","Yang","Shun-Fa","Institute of Medicine, Chung San Medical University, Taichung, 402306, Taiwan","ysf@csmu.edu.tw"
"475","34218168","10.1016/j.rmed.2021.106516","Respiratory care for the critical patients with 2019 novel coronavirus.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted through respiratory droplets, aerosols and close contact. Cross infections occur because viruses spread rapidly among humans. Nineteen percent (19%) of the infected patients developed severe pneumonia and acute respiratory distress syndrome (ARDS). Hypoxemia usually occurs and patients may require oxygen therapy or mechanical ventilation (MV) support. In this article, recently published clinical experience and observatio","2021","07","21","Respir Med","Respiratory medicine","2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Infection control; Mechanical ventilation; Oxygen therapy; Respiratory care","Bien","Mauo-Ying","Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei, 116081, Taiwan","mybien@tmu.edu.tw"
"476","34218168","10.1016/j.rmed.2021.106516","Respiratory care for the critical patients with 2019 novel coronavirus.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted through respiratory droplets, aerosols and close contact. Cross infections occur because viruses spread rapidly among humans. Nineteen percent (19%) of the infected patients developed severe pneumonia and acute respiratory distress syndrome (ARDS). Hypoxemia usually occurs and patients may require oxygen therapy or mechanical ventilation (MV) support. In this article, recently published clinical experience and observatio","2021","07","21","Respir Med","Respiratory medicine","2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Infection control; Mechanical ventilation; Oxygen therapy; Respiratory care","Chen","Yi-Fang","Division of Respiratory Therapy, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, 402306, Taiwan. Electronic address: rtyifang@yahoo.com","rtyifang@yahoo.com.tw"
"477","34218168","10.1016/j.rmed.2021.106516","Respiratory care for the critical patients with 2019 novel coronavirus.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted through respiratory droplets, aerosols and close contact. Cross infections occur because viruses spread rapidly among humans. Nineteen percent (19%) of the infected patients developed severe pneumonia and acute respiratory distress syndrome (ARDS). Hypoxemia usually occurs and patients may require oxygen therapy or mechanical ventilation (MV) support. In this article, recently published clinical experience and observatio","2021","07","21","Respir Med","Respiratory medicine","2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Infection control; Mechanical ventilation; Oxygen therapy; Respiratory care","Li","Yia-Ting","Institute of Medicine, Chung San Medical University, Taichung, 402306, Taiwan","miki2700@gmail.com"
"478","34218165","10.1016/j.diagmicrobio.2021.115387","Evaluation of PCR cycle threshold values by patient population with the quidel lyra SARS-CoV-2 assay.","The Lyra SARS-CoV-2 assay was the primary method for molecular testing performed at Barnes-Jewish Healthcare System in St. Louis, Missouri during the initial COVID-19 surge from mid-March to late-April 2020. We performed a retrospective analysis of 1,043 positive Lyra SARS-CoV-2 results during these 36 days to investigate associations between cycle threshold (CT) value and patient characteristics. Total RNA were extracted from NP or OP swabs using either the EasyMag or KingFisher auto","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","Clinical virology; Molecular assays; SARS-CoV-2","Potter","Robert F","Department of Pathology &amp",NA
"479","34218165","10.1016/j.diagmicrobio.2021.115387","Evaluation of PCR cycle threshold values by patient population with the quidel lyra SARS-CoV-2 assay.","The Lyra SARS-CoV-2 assay was the primary method for molecular testing performed at Barnes-Jewish Healthcare System in St. Louis, Missouri during the initial COVID-19 surge from mid-March to late-April 2020. We performed a retrospective analysis of 1,043 positive Lyra SARS-CoV-2 results during these 36 days to investigate associations between cycle threshold (CT) value and patient characteristics. Total RNA were extracted from NP or OP swabs using either the EasyMag or KingFisher auto","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","Clinical virology; Molecular assays; SARS-CoV-2","Abro","Brooj","Department of Pathology &amp",NA
"480","34218165","10.1016/j.diagmicrobio.2021.115387","Evaluation of PCR cycle threshold values by patient population with the quidel lyra SARS-CoV-2 assay.","The Lyra SARS-CoV-2 assay was the primary method for molecular testing performed at Barnes-Jewish Healthcare System in St. Louis, Missouri during the initial COVID-19 surge from mid-March to late-April 2020. We performed a retrospective analysis of 1,043 positive Lyra SARS-CoV-2 results during these 36 days to investigate associations between cycle threshold (CT) value and patient characteristics. Total RNA were extracted from NP or OP swabs using either the EasyMag or KingFisher auto","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","Clinical virology; Molecular assays; SARS-CoV-2","Eby","Charles S","Department of Pathology &amp",NA
"481","34218165","10.1016/j.diagmicrobio.2021.115387","Evaluation of PCR cycle threshold values by patient population with the quidel lyra SARS-CoV-2 assay.","The Lyra SARS-CoV-2 assay was the primary method for molecular testing performed at Barnes-Jewish Healthcare System in St. Louis, Missouri during the initial COVID-19 surge from mid-March to late-April 2020. We performed a retrospective analysis of 1,043 positive Lyra SARS-CoV-2 results during these 36 days to investigate associations between cycle threshold (CT) value and patient characteristics. Total RNA were extracted from NP or OP swabs using either the EasyMag or KingFisher auto","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","Clinical virology; Molecular assays; SARS-CoV-2","Burnham","Carey-Ann D","Department of Pathology &amp",NA
"482","34218165","10.1016/j.diagmicrobio.2021.115387","Evaluation of PCR cycle threshold values by patient population with the quidel lyra SARS-CoV-2 assay.","The Lyra SARS-CoV-2 assay was the primary method for molecular testing performed at Barnes-Jewish Healthcare System in St. Louis, Missouri during the initial COVID-19 surge from mid-March to late-April 2020. We performed a retrospective analysis of 1,043 positive Lyra SARS-CoV-2 results during these 36 days to investigate associations between cycle threshold (CT) value and patient characteristics. Total RNA were extracted from NP or OP swabs using either the EasyMag or KingFisher auto","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","Clinical virology; Molecular assays; SARS-CoV-2","Anderson","Neil W","Department of Pathology &amp","nwanderson@wustl.edu"
"483","34218165","10.1016/j.diagmicrobio.2021.115387","Evaluation of PCR cycle threshold values by patient population with the quidel lyra SARS-CoV-2 assay.","The Lyra SARS-CoV-2 assay was the primary method for molecular testing performed at Barnes-Jewish Healthcare System in St. Louis, Missouri during the initial COVID-19 surge from mid-March to late-April 2020. We performed a retrospective analysis of 1,043 positive Lyra SARS-CoV-2 results during these 36 days to investigate associations between cycle threshold (CT) value and patient characteristics. Total RNA were extracted from NP or OP swabs using either the EasyMag or KingFisher auto","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","Clinical virology; Molecular assays; SARS-CoV-2","Parikh","Bijal A","Department of Pathology &amp","bparikh@wustl.edu"
"484","34218099","10.1016/j.jiph.2021.06.014","Lessons for and from the COVID-19 pandemic response - An appraisal of guidance for the public health management of Invasive Meningococcal Disease.","COVID-19 has focussed public attention on the management of communicable disease like never before. Surveillance, contact tracing, and case management are recognised as key components of outbreak prevention. Development of guidance for COVID-19 has drawn from existing management of other communicable diseases, including Invasive Meningococcal Disease (IMD). IMD is a rare but severe outcome of Neisseria meningitidis infection that can be prevented through vaccination. Cases still occur sporadical","2021","07","23","J Infect Public Health","Journal of infection and public health","COVID-19; Communicable diseases; Contact tracing; Guidelines; Meningococcal disease","Morello","Brianna R","School of Public Health, The University of Adelaide, Adelaide Health and Medical Sciences Building, Corner of North Terrace and George Street, Adelaide, SA 5005, Australia",NA
"485","34218099","10.1016/j.jiph.2021.06.014","Lessons for and from the COVID-19 pandemic response - An appraisal of guidance for the public health management of Invasive Meningococcal Disease.","COVID-19 has focussed public attention on the management of communicable disease like never before. Surveillance, contact tracing, and case management are recognised as key components of outbreak prevention. Development of guidance for COVID-19 has drawn from existing management of other communicable diseases, including Invasive Meningococcal Disease (IMD). IMD is a rare but severe outcome of Neisseria meningitidis infection that can be prevented through vaccination. Cases still occur sporadical","2021","07","23","J Infect Public Health","Journal of infection and public health","COVID-19; Communicable diseases; Contact tracing; Guidelines; Meningococcal disease","Milazzo","Adriana","School of Public Health, The University of Adelaide, Adelaide Health and Medical Sciences Building, Corner of North Terrace and George Street, Adelaide, SA 5005, Australia",NA
"486","34218099","10.1016/j.jiph.2021.06.014","Lessons for and from the COVID-19 pandemic response - An appraisal of guidance for the public health management of Invasive Meningococcal Disease.","COVID-19 has focussed public attention on the management of communicable disease like never before. Surveillance, contact tracing, and case management are recognised as key components of outbreak prevention. Development of guidance for COVID-19 has drawn from existing management of other communicable diseases, including Invasive Meningococcal Disease (IMD). IMD is a rare but severe outcome of Neisseria meningitidis infection that can be prevented through vaccination. Cases still occur sporadical","2021","07","23","J Infect Public Health","Journal of infection and public health","COVID-19; Communicable diseases; Contact tracing; Guidelines; Meningococcal disease","Marshall","Helen S","Adelaide Medical School, The University of Adelaide, Adelaide Health and Medical Sciences Building, Corner of North Terrace &amp",NA
"487","34218099","10.1016/j.jiph.2021.06.014","Lessons for and from the COVID-19 pandemic response - An appraisal of guidance for the public health management of Invasive Meningococcal Disease.","COVID-19 has focussed public attention on the management of communicable disease like never before. Surveillance, contact tracing, and case management are recognised as key components of outbreak prevention. Development of guidance for COVID-19 has drawn from existing management of other communicable diseases, including Invasive Meningococcal Disease (IMD). IMD is a rare but severe outcome of Neisseria meningitidis infection that can be prevented through vaccination. Cases still occur sporadical","2021","07","23","J Infect Public Health","Journal of infection and public health","COVID-19; Communicable diseases; Contact tracing; Guidelines; Meningococcal disease","Giles","Lynne C","School of Public Health, The University of Adelaide, Adelaide Health and Medical Sciences Building, Corner of North Terrace and George Street, Adelaide, SA 5005, Australia","lynne.giles@adelaide.edu.au"
"488","34218058","10.1016/j.thromres.2021.06.014","Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes.","It is unclear if direct-acting oral anticoagulants (DOACs) use before hospitalization due to COVID-19 diagnosis would potentially impact the severity and clinical outcomes thereafter. We compared 30-day hospitalization/re-hospitalization and clinical outcomes between patients on chronic DOAC therapy and patients not on oral anticoagulation (OAC) therapy at time of COVID-19 diagnosis. We used data from TriNetX, a global federated health research network. Patients aged =18 years who were treated w","2021","07","23","Thromb Res","Thrombosis research","Anticoagulant; Bleeding; Coronavirus disease 2019; Direct-acting oral anticoagulants; Mortality; SARS-CoV-2; Thrombosis","Rivera-Caravaca","José Miguel","Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart &amp",NA
"489","34218058","10.1016/j.thromres.2021.06.014","Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes.","It is unclear if direct-acting oral anticoagulants (DOACs) use before hospitalization due to COVID-19 diagnosis would potentially impact the severity and clinical outcomes thereafter. We compared 30-day hospitalization/re-hospitalization and clinical outcomes between patients on chronic DOAC therapy and patients not on oral anticoagulation (OAC) therapy at time of COVID-19 diagnosis. We used data from TriNetX, a global federated health research network. Patients aged =18 years who were treated w","2021","07","23","Thromb Res","Thrombosis research","Anticoagulant; Bleeding; Coronavirus disease 2019; Direct-acting oral anticoagulants; Mortality; SARS-CoV-2; Thrombosis","Buckley","Benjamin J R","Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart &amp",NA
"490","34218058","10.1016/j.thromres.2021.06.014","Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes.","It is unclear if direct-acting oral anticoagulants (DOACs) use before hospitalization due to COVID-19 diagnosis would potentially impact the severity and clinical outcomes thereafter. We compared 30-day hospitalization/re-hospitalization and clinical outcomes between patients on chronic DOAC therapy and patients not on oral anticoagulation (OAC) therapy at time of COVID-19 diagnosis. We used data from TriNetX, a global federated health research network. Patients aged =18 years who were treated w","2021","07","23","Thromb Res","Thrombosis research","Anticoagulant; Bleeding; Coronavirus disease 2019; Direct-acting oral anticoagulants; Mortality; SARS-CoV-2; Thrombosis","Harrison","Stephanie L","Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart &amp",NA
"491","34218058","10.1016/j.thromres.2021.06.014","Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes.","It is unclear if direct-acting oral anticoagulants (DOACs) use before hospitalization due to COVID-19 diagnosis would potentially impact the severity and clinical outcomes thereafter. We compared 30-day hospitalization/re-hospitalization and clinical outcomes between patients on chronic DOAC therapy and patients not on oral anticoagulation (OAC) therapy at time of COVID-19 diagnosis. We used data from TriNetX, a global federated health research network. Patients aged =18 years who were treated w","2021","07","23","Thromb Res","Thrombosis research","Anticoagulant; Bleeding; Coronavirus disease 2019; Direct-acting oral anticoagulants; Mortality; SARS-CoV-2; Thrombosis","Fazio-Eynullayeva","Elnara","TriNetX LLC., Cambridge, MA, United States",NA
"492","34218058","10.1016/j.thromres.2021.06.014","Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes.","It is unclear if direct-acting oral anticoagulants (DOACs) use before hospitalization due to COVID-19 diagnosis would potentially impact the severity and clinical outcomes thereafter. We compared 30-day hospitalization/re-hospitalization and clinical outcomes between patients on chronic DOAC therapy and patients not on oral anticoagulation (OAC) therapy at time of COVID-19 diagnosis. We used data from TriNetX, a global federated health research network. Patients aged =18 years who were treated w","2021","07","23","Thromb Res","Thrombosis research","Anticoagulant; Bleeding; Coronavirus disease 2019; Direct-acting oral anticoagulants; Mortality; SARS-CoV-2; Thrombosis","Underhill","Paula","TriNetX LLC., London, United Kingdom",NA
"493","34218058","10.1016/j.thromres.2021.06.014","Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes.","It is unclear if direct-acting oral anticoagulants (DOACs) use before hospitalization due to COVID-19 diagnosis would potentially impact the severity and clinical outcomes thereafter. We compared 30-day hospitalization/re-hospitalization and clinical outcomes between patients on chronic DOAC therapy and patients not on oral anticoagulation (OAC) therapy at time of COVID-19 diagnosis. We used data from TriNetX, a global federated health research network. Patients aged =18 years who were treated w","2021","07","23","Thromb Res","Thrombosis research","Anticoagulant; Bleeding; Coronavirus disease 2019; Direct-acting oral anticoagulants; Mortality; SARS-CoV-2; Thrombosis","Marín","Francisco","Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain",NA
"494","34218058","10.1016/j.thromres.2021.06.014","Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes.","It is unclear if direct-acting oral anticoagulants (DOACs) use before hospitalization due to COVID-19 diagnosis would potentially impact the severity and clinical outcomes thereafter. We compared 30-day hospitalization/re-hospitalization and clinical outcomes between patients on chronic DOAC therapy and patients not on oral anticoagulation (OAC) therapy at time of COVID-19 diagnosis. We used data from TriNetX, a global federated health research network. Patients aged =18 years who were treated w","2021","07","23","Thromb Res","Thrombosis research","Anticoagulant; Bleeding; Coronavirus disease 2019; Direct-acting oral anticoagulants; Mortality; SARS-CoV-2; Thrombosis","Lip","Gregory Y H","Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart &amp","gregory.lip@liverpool.ac.uk"
"495","34218034","10.1016/j.marpolbul.2021.112620","Twitter data analysis to assess the interest of citizens on the impact of marine plastic pollution.","Few studies have mined social media platforms to assess environmental concerns. In this study, Twitter was scraped to obtain a ~140,000 tweet dataset related specifically to marine plastic pollution. The goal is to understand what kind of users profiles are tweeting and how and when they do it. In addition, topic modelling and graph theory techniques have allowed us to identify main concerns on this topic: i) impact on wildlife, ii) microplastics/water pollution, iii) estimates/reports, iv) legi","2021","07","12","Mar Pollut Bull","Marine pollution bulletin","COVID-19; Marine litter; Plastic pollution; Social media; Topic modelling; Twitter","Otero","P","Centro Oceanográfico de Vigo (IEO, CSIC), Subida a Radio Faro, 50, 36390 Vigo, Spain. Electronic address: pablo.otero@ieo","pablo.otero@ieo.es"
"496","34218034","10.1016/j.marpolbul.2021.112620","Twitter data analysis to assess the interest of citizens on the impact of marine plastic pollution.","Few studies have mined social media platforms to assess environmental concerns. In this study, Twitter was scraped to obtain a ~140,000 tweet dataset related specifically to marine plastic pollution. The goal is to understand what kind of users profiles are tweeting and how and when they do it. In addition, topic modelling and graph theory techniques have allowed us to identify main concerns on this topic: i) impact on wildlife, ii) microplastics/water pollution, iii) estimates/reports, iv) legi","2021","07","12","Mar Pollut Bull","Marine pollution bulletin","COVID-19; Marine litter; Plastic pollution; Social media; Topic modelling; Twitter","Gago","J","Centro Oceanográfico de Vigo (IEO, CSIC), Subida a Radio Faro, 50, 36390 Vigo, Spain",NA
"497","34218034","10.1016/j.marpolbul.2021.112620","Twitter data analysis to assess the interest of citizens on the impact of marine plastic pollution.","Few studies have mined social media platforms to assess environmental concerns. In this study, Twitter was scraped to obtain a ~140,000 tweet dataset related specifically to marine plastic pollution. The goal is to understand what kind of users profiles are tweeting and how and when they do it. In addition, topic modelling and graph theory techniques have allowed us to identify main concerns on this topic: i) impact on wildlife, ii) microplastics/water pollution, iii) estimates/reports, iv) legi","2021","07","12","Mar Pollut Bull","Marine pollution bulletin","COVID-19; Marine litter; Plastic pollution; Social media; Topic modelling; Twitter","Quintas","P","Centro Oceanográfico de Vigo (IEO, CSIC), Subida a Radio Faro, 50, 36390 Vigo, Spain",NA
"498","34218023","10.1016/j.midw.2021.103072","Triggering of postpartum depression and insomnia with cognitive impairment in Argentinian women during the pandemic COVID-19 social isolation in relation to reproductive and health factors.","The 2019 coronavirus disease pandemic (COVID-19) required strict confinement measures that differentially impacted the individual's daily life. Thus, this work aimed to study postpartum women's mental health in Argentina during mandatory social isolation. A cross-sectional survey was conducted from May to July 2020, which included five validated questionnaires to assess postpartum depression (Postpartum Depression Screening Scale-Short Form), insomnia (Insomnia Severity Index), memory complaints","2021","07","23","Midwifery","Midwifery","Cognitive dysfunction; Depression, Postpartum; Metacognition; Pandemics; Self efficacy; Sleep","Miranda","Agustín Ramiro","Universidad Nacional de Córdoba, Facultad de Ciencias Médicas, Escuela de Fonoaudiología. Bv. de la Reforma, Ciudad Universitaria, 5014 Córdoba, Argentina",NA
"499","34218023","10.1016/j.midw.2021.103072","Triggering of postpartum depression and insomnia with cognitive impairment in Argentinian women during the pandemic COVID-19 social isolation in relation to reproductive and health factors.","The 2019 coronavirus disease pandemic (COVID-19) required strict confinement measures that differentially impacted the individual's daily life. Thus, this work aimed to study postpartum women's mental health in Argentina during mandatory social isolation. A cross-sectional survey was conducted from May to July 2020, which included five validated questionnaires to assess postpartum depression (Postpartum Depression Screening Scale-Short Form), insomnia (Insomnia Severity Index), memory complaints","2021","07","23","Midwifery","Midwifery","Cognitive dysfunction; Depression, Postpartum; Metacognition; Pandemics; Self efficacy; Sleep","Scotta","Ana Veronica","Universidad Nacional de Córdoba, Facultad de Ciencias Médicas, Escuela de Fonoaudiología. Bv. de la Reforma, Ciudad Universitaria, 5014 Córdoba, Argentina",NA
"500","34218023","10.1016/j.midw.2021.103072","Triggering of postpartum depression and insomnia with cognitive impairment in Argentinian women during the pandemic COVID-19 social isolation in relation to reproductive and health factors.","The 2019 coronavirus disease pandemic (COVID-19) required strict confinement measures that differentially impacted the individual's daily life. Thus, this work aimed to study postpartum women's mental health in Argentina during mandatory social isolation. A cross-sectional survey was conducted from May to July 2020, which included five validated questionnaires to assess postpartum depression (Postpartum Depression Screening Scale-Short Form), insomnia (Insomnia Severity Index), memory complaints","2021","07","23","Midwifery","Midwifery","Cognitive dysfunction; Depression, Postpartum; Metacognition; Pandemics; Self efficacy; Sleep","Cortez","Mariela Valentina","Universidad Nacional de Córdoba, Facultad de Ciencias Médicas, Escuela de Fonoaudiología. Bv. de la Reforma, Ciudad Universitaria, 5014 Córdoba, Argentina",NA
"501","34218023","10.1016/j.midw.2021.103072","Triggering of postpartum depression and insomnia with cognitive impairment in Argentinian women during the pandemic COVID-19 social isolation in relation to reproductive and health factors.","The 2019 coronavirus disease pandemic (COVID-19) required strict confinement measures that differentially impacted the individual's daily life. Thus, this work aimed to study postpartum women's mental health in Argentina during mandatory social isolation. A cross-sectional survey was conducted from May to July 2020, which included five validated questionnaires to assess postpartum depression (Postpartum Depression Screening Scale-Short Form), insomnia (Insomnia Severity Index), memory complaints","2021","07","23","Midwifery","Midwifery","Cognitive dysfunction; Depression, Postpartum; Metacognition; Pandemics; Self efficacy; Sleep","Soria","Elio Andrés","Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET, INICSA. Bv. de la Reforma, Ciudad Universitaria, 5014 Córdoba, Argentina","easoria@fcm.unc.edu.ar"
"502","34218010","10.1016/j.coviro.2021.06.004","Progress and pitfalls of a year of drug repurposing screens against COVID-19.","Near the end of 2019, a new betacoronavirus started to efficiently transmit between humans, resulting in the current COVID-19 pandemic. Unprecedented worldwide efforts were made to identify and repurpose antiviral therapeutics from collections of approved drugs and known bioactive compounds. Typical pitfalls of this approach (promiscuous/cytotoxic compounds leading to false positives), combined with bypassing antiviral drug development parameters due to urgency have resulted in often disappointi","2021","07","24","Curr Opin Virol","Current opinion in virology",NA,"Sourimant","Julien","Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, United States. Electronic address: jsourimant@gsu","jsourimant@gsu.edu"
"503","34218010","10.1016/j.coviro.2021.06.004","Progress and pitfalls of a year of drug repurposing screens against COVID-19.","Near the end of 2019, a new betacoronavirus started to efficiently transmit between humans, resulting in the current COVID-19 pandemic. Unprecedented worldwide efforts were made to identify and repurpose antiviral therapeutics from collections of approved drugs and known bioactive compounds. Typical pitfalls of this approach (promiscuous/cytotoxic compounds leading to false positives), combined with bypassing antiviral drug development parameters due to urgency have resulted in often disappointi","2021","07","24","Curr Opin Virol","Current opinion in virology",NA,"Aggarwal","Megha","Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, United States",NA
"504","34218010","10.1016/j.coviro.2021.06.004","Progress and pitfalls of a year of drug repurposing screens against COVID-19.","Near the end of 2019, a new betacoronavirus started to efficiently transmit between humans, resulting in the current COVID-19 pandemic. Unprecedented worldwide efforts were made to identify and repurpose antiviral therapeutics from collections of approved drugs and known bioactive compounds. Typical pitfalls of this approach (promiscuous/cytotoxic compounds leading to false positives), combined with bypassing antiviral drug development parameters due to urgency have resulted in often disappointi","2021","07","24","Curr Opin Virol","Current opinion in virology",NA,"Plemper","Richard K","Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, United States",NA
"505","34217989","10.1016/j.hrtlng.2021.05.008","COVID-19 variants in India: Potential role in second wave and impact on vaccination.",NA,"2021","07","19","Heart Lung","Heart &amp; lung : the journal of critical care",NA,"Kunal","Shekhar","Department of Cardiology, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, New Delhi, India. Electronic address: shekhar.kunal09@gmail","shekhar.kunal09@gmail.com"
"506","34217989","10.1016/j.hrtlng.2021.05.008","COVID-19 variants in India: Potential role in second wave and impact on vaccination.",NA,"2021","07","19","Heart Lung","Heart &amp; lung : the journal of critical care",NA,"Aditi","Department of Pathology, Holy Family Hospital, New Delhi, India","Department of Cardiology, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, New Delhi, India. Electronic address: shekhar.kunal09@gmail","34217989"
"507","34217989","10.1016/j.hrtlng.2021.05.008","COVID-19 variants in India: Potential role in second wave and impact on vaccination.",NA,"2021","07","19","Heart Lung","Heart &amp; lung : the journal of critical care",NA,"Gupta","Kashish","Department of Medicine, SG Diabetes Center, New Delhi, India",NA
"508","34217989","10.1016/j.hrtlng.2021.05.008","COVID-19 variants in India: Potential role in second wave and impact on vaccination.",NA,"2021","07","19","Heart Lung","Heart &amp; lung : the journal of critical care",NA,"Ish","Pranav","Department of Pulmonary, Critical Care and Sleep Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India",NA
"509","34217985","10.1016/j.hrtlng.2021.06.005","Grip strength as a predictor of disease severity in hospitalized COVID-19 patients.","Grip strength is one of the main components for the physical functioning in sarcopenia and physical frailty. To explore the role of grip strength measurement at admission for predicting disease severity in COVID-19. Demographic data, smoking status, comorbidities, COVID-19 related symptoms, grip strength, laboratory and computed tomography (CT) findings at admission were all noted. Using a Smedley hand dynamometer, the maximum grip strength value (kg) after three measurements on the dominant sid","2021","07","19","Heart Lung","Heart &amp; lung : the journal of critical care","Coronavirus; Frailty; Hand; Muscle; Sarcopenia","Kara","Özgür","Geriatrics Unit, Yenimahalle Training and Research Hospital, Yildirim Beyazit University, Ankara, Turkey",NA
"510","34217985","10.1016/j.hrtlng.2021.06.005","Grip strength as a predictor of disease severity in hospitalized COVID-19 patients.","Grip strength is one of the main components for the physical functioning in sarcopenia and physical frailty. To explore the role of grip strength measurement at admission for predicting disease severity in COVID-19. Demographic data, smoking status, comorbidities, COVID-19 related symptoms, grip strength, laboratory and computed tomography (CT) findings at admission were all noted. Using a Smedley hand dynamometer, the maximum grip strength value (kg) after three measurements on the dominant sid","2021","07","19","Heart Lung","Heart &amp; lung : the journal of critical care","Coronavirus; Frailty; Hand; Muscle; Sarcopenia","Kara","Murat","Department of Physical and Rehabilitation Medicine, Hacettepe University Medical School, Ankara, Turkey. Electronic address: mkaraftr@yahoo","mkaraftr@yahoo.com"
"511","34217985","10.1016/j.hrtlng.2021.06.005","Grip strength as a predictor of disease severity in hospitalized COVID-19 patients.","Grip strength is one of the main components for the physical functioning in sarcopenia and physical frailty. To explore the role of grip strength measurement at admission for predicting disease severity in COVID-19. Demographic data, smoking status, comorbidities, COVID-19 related symptoms, grip strength, laboratory and computed tomography (CT) findings at admission were all noted. Using a Smedley hand dynamometer, the maximum grip strength value (kg) after three measurements on the dominant sid","2021","07","19","Heart Lung","Heart &amp; lung : the journal of critical care","Coronavirus; Frailty; Hand; Muscle; Sarcopenia","Akin","Mustafa Emre","Radiology Unit, Yenimahalle Training and Research Hospital, Yildirim Beyazit University, Ankara, Turkey",NA
"512","34217985","10.1016/j.hrtlng.2021.06.005","Grip strength as a predictor of disease severity in hospitalized COVID-19 patients.","Grip strength is one of the main components for the physical functioning in sarcopenia and physical frailty. To explore the role of grip strength measurement at admission for predicting disease severity in COVID-19. Demographic data, smoking status, comorbidities, COVID-19 related symptoms, grip strength, laboratory and computed tomography (CT) findings at admission were all noted. Using a Smedley hand dynamometer, the maximum grip strength value (kg) after three measurements on the dominant sid","2021","07","19","Heart Lung","Heart &amp; lung : the journal of critical care","Coronavirus; Frailty; Hand; Muscle; Sarcopenia","Özçakar","Levent","Department of Physical and Rehabilitation Medicine, Hacettepe University Medical School, Ankara, Turkey",NA
"513","34217962","10.1016/j.jad.2021.06.045","Anxiety, depressive, and trauma symptoms during the COVID-19 pandemic: Evaluating the role of disappointment with God.","The COVID-19 pandemic has led to pervasive social and economic disruptions. This cross-sectional investigation aimed to evaluate associations between religious/spiritual factors and mental health symptoms among community residents in a southern US state. In particular, we focused on perceptions of God's distance, a salient aspect of religious/spiritual struggle that has received little scrutiny in health research. Participants included 551 respondents assessed during a period of gradual reopenin","2021","07","21","J Affect Disord","Journal of affective disorders","Anxiety; COVID-19; Depression; Relationships with God; Religiousness; Trauma","Sherman","Allen C","Behavioral Medicine Division, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address: ShermanAllenC@uams","ShermanAllenC@uams.edu"
"514","34217962","10.1016/j.jad.2021.06.045","Anxiety, depressive, and trauma symptoms during the COVID-19 pandemic: Evaluating the role of disappointment with God.","The COVID-19 pandemic has led to pervasive social and economic disruptions. This cross-sectional investigation aimed to evaluate associations between religious/spiritual factors and mental health symptoms among community residents in a southern US state. In particular, we focused on perceptions of God's distance, a salient aspect of religious/spiritual struggle that has received little scrutiny in health research. Participants included 551 respondents assessed during a period of gradual reopenin","2021","07","21","J Affect Disord","Journal of affective disorders","Anxiety; COVID-19; Depression; Relationships with God; Religiousness; Trauma","Park","Crystal L","Department of Psychology, University of Connecticut, Storrs, Connecticut, USA",NA
"515","34217962","10.1016/j.jad.2021.06.045","Anxiety, depressive, and trauma symptoms during the COVID-19 pandemic: Evaluating the role of disappointment with God.","The COVID-19 pandemic has led to pervasive social and economic disruptions. This cross-sectional investigation aimed to evaluate associations between religious/spiritual factors and mental health symptoms among community residents in a southern US state. In particular, we focused on perceptions of God's distance, a salient aspect of religious/spiritual struggle that has received little scrutiny in health research. Participants included 551 respondents assessed during a period of gradual reopenin","2021","07","21","J Affect Disord","Journal of affective disorders","Anxiety; COVID-19; Depression; Relationships with God; Religiousness; Trauma","Salsman","John M","Wake Forest School of Medicine and the Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, USA",NA
"516","34217962","10.1016/j.jad.2021.06.045","Anxiety, depressive, and trauma symptoms during the COVID-19 pandemic: Evaluating the role of disappointment with God.","The COVID-19 pandemic has led to pervasive social and economic disruptions. This cross-sectional investigation aimed to evaluate associations between religious/spiritual factors and mental health symptoms among community residents in a southern US state. In particular, we focused on perceptions of God's distance, a salient aspect of religious/spiritual struggle that has received little scrutiny in health research. Participants included 551 respondents assessed during a period of gradual reopenin","2021","07","21","J Affect Disord","Journal of affective disorders","Anxiety; COVID-19; Depression; Relationships with God; Religiousness; Trauma","Williams","Mark L","Department of Health Promotion and Disease Prevention, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, USA",NA
"517","34217962","10.1016/j.jad.2021.06.045","Anxiety, depressive, and trauma symptoms during the COVID-19 pandemic: Evaluating the role of disappointment with God.","The COVID-19 pandemic has led to pervasive social and economic disruptions. This cross-sectional investigation aimed to evaluate associations between religious/spiritual factors and mental health symptoms among community residents in a southern US state. In particular, we focused on perceptions of God's distance, a salient aspect of religious/spiritual struggle that has received little scrutiny in health research. Participants included 551 respondents assessed during a period of gradual reopenin","2021","07","21","J Affect Disord","Journal of affective disorders","Anxiety; COVID-19; Depression; Relationships with God; Religiousness; Trauma","Amick","Benjamin C","Department of Epidemiology, Fay W Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, USA",NA
"518","34217962","10.1016/j.jad.2021.06.045","Anxiety, depressive, and trauma symptoms during the COVID-19 pandemic: Evaluating the role of disappointment with God.","The COVID-19 pandemic has led to pervasive social and economic disruptions. This cross-sectional investigation aimed to evaluate associations between religious/spiritual factors and mental health symptoms among community residents in a southern US state. In particular, we focused on perceptions of God's distance, a salient aspect of religious/spiritual struggle that has received little scrutiny in health research. Participants included 551 respondents assessed during a period of gradual reopenin","2021","07","21","J Affect Disord","Journal of affective disorders","Anxiety; COVID-19; Depression; Relationships with God; Religiousness; Trauma","Hudson","Teresa J","Center for Health Services Research, Department of Psychiatry, University of Arkansas for Medical Sciences, Little Rock, AR, USA",NA
"519","34217962","10.1016/j.jad.2021.06.045","Anxiety, depressive, and trauma symptoms during the COVID-19 pandemic: Evaluating the role of disappointment with God.","The COVID-19 pandemic has led to pervasive social and economic disruptions. This cross-sectional investigation aimed to evaluate associations between religious/spiritual factors and mental health symptoms among community residents in a southern US state. In particular, we focused on perceptions of God's distance, a salient aspect of religious/spiritual struggle that has received little scrutiny in health research. Participants included 551 respondents assessed during a period of gradual reopenin","2021","07","21","J Affect Disord","Journal of affective disorders","Anxiety; COVID-19; Depression; Relationships with God; Religiousness; Trauma","Messias","Erick L","Faculty Affairs, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA",NA
"520","34217962","10.1016/j.jad.2021.06.045","Anxiety, depressive, and trauma symptoms during the COVID-19 pandemic: Evaluating the role of disappointment with God.","The COVID-19 pandemic has led to pervasive social and economic disruptions. This cross-sectional investigation aimed to evaluate associations between religious/spiritual factors and mental health symptoms among community residents in a southern US state. In particular, we focused on perceptions of God's distance, a salient aspect of religious/spiritual struggle that has received little scrutiny in health research. Participants included 551 respondents assessed during a period of gradual reopenin","2021","07","21","J Affect Disord","Journal of affective disorders","Anxiety; COVID-19; Depression; Relationships with God; Religiousness; Trauma","Simonton-Atchley","Stephanie","Behavioral Medicine Division, University of Arkansas for Medical Sciences, Little Rock, AR, USA",NA
"521","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Ferreira","Nuno","University of Nicosia, Department of Social Sciences, Nicosia, Cyprus. Electronic address: ferreira.n@unic.ac","ferreira.n@unic.ac.cy"
"522","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Mikocka-Walus","Antonina","Deakin University Geelong, School of Psychology, Melbourne, Victoria, Australia",NA
"523","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","van Tilburg","Miranda A L","Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA",NA
"524","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Graff","Lesley A","Max Rady College of Medicine, University of Manitoba Winnipeg, Manitoba, Canada",NA
"525","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Apputhurai","Pragalathan","Swinburne University of Technology, Melbourne, Victoria, Australia",NA
"526","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Barreiro-de Acosta","Manuel","IBD Unit, University Hospital Santiago de Compostela, Spain",NA
"527","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Evertsz","Floor Bennebroek","Amsterdam University Medical Centers, the Netherlands",NA
"528","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Burisch","Johan","Gastrounit, Medical Division, Hvidovre University Hospital, Denmark",NA
"529","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Lo","Bobby","Gastrounit, Medical Division, Hvidovre University Hospital, Denmark",NA
"530","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Petrik","Megan","University of Minnesota Medical School, USA",NA
"531","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Trindade","Inês A","University of Coimbra, Portugal",NA
"532","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Jedel","Sharon","Rush University Medical Center, USA",NA
"533","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Moser","Gabriele","Medical University of Vienna, Austria",NA
"534","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Mokrowiecka","Anna","Medical University of Lodz, Poland",NA
"535","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Bernstein","Charles N","Max Rady College of Medicine, University of Manitoba Winnipeg, Manitoba, Canada",NA
"536","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Dumitrascu","Dan","Iuliu Hatieganu University of Medicine and Pharmacy, Romania",NA
"537","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Ford","Alexander C","Leeds Institute of Medical Research at St. James's, University of Leeds, UK",NA
"538","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Stengel","Andreas","Department of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany",NA
"539","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Gearry","Richard","University of Otago, Christchurch, New Zealand",NA
"540","34217956","10.1016/j.jpsychores.2021.110561","The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study.","The COVID-19 pandemic has had a significant impact on mental health across the globe. People living with a chronic gastrointestinal (GI) disorder might be particularly at risk of mental health complications given higher rates of comorbid anxiety and depression compared to the healthy population. As GI disorders affect up to 40% of the population worldwide, this international collaborative study seeks to evaluate the extent of the impact of the COVID-19 pandemic on GI symptoms specifically and mo","2021","07","24","J Psychosom Res","Journal of psychosomatic research","Anxiety; COVID-19; Depression; Gastrointestinal disorders; Mental health; Quality of life; Stress","Knowles","Simon R","Swinburne University of Technology, Melbourne, Victoria, Australia",NA
"541","34217923","10.1016/j.virol.2021.06.009","Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability.","The fall of 2020 brought several new variants of SARS-CoV-2 circulating across the globe, and the steadily increasing COVID-19 cases are responsible for the emergence of these variants. All the SARS-CoV-2 variants reported to date have multiple mutations in the spike (S) protein, specifically in the receptor-binding domain (RBD). Here, we employed an integrated computational approach involving structure and sequence based predictions to study the effect of naturally occurring variations in the S","2021","07","14","Virology","Virology","COVID-19; Hotspot residues; Mutation; RBD-ACE2 interactions; Receptor binding domain; SARS-CoV-2; SARS-CoV-2 variants; Spike protein","Verma","Jyoti","School of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi, 110067, India. Electronic address: jyoti32_sit@jnu.ac","sit@jnu.ac.in"
"542","34217923","10.1016/j.virol.2021.06.009","Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability.","The fall of 2020 brought several new variants of SARS-CoV-2 circulating across the globe, and the steadily increasing COVID-19 cases are responsible for the emergence of these variants. All the SARS-CoV-2 variants reported to date have multiple mutations in the spike (S) protein, specifically in the receptor-binding domain (RBD). Here, we employed an integrated computational approach involving structure and sequence based predictions to study the effect of naturally occurring variations in the S","2021","07","14","Virology","Virology","COVID-19; Hotspot residues; Mutation; RBD-ACE2 interactions; Receptor binding domain; SARS-CoV-2; SARS-CoV-2 variants; Spike protein","Subbarao","Naidu","School of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi, 110067, India. Electronic address: nsrao.jnu@gmail","nsrao.jnu@gmail.com"
"543","34217909","10.1016/j.ejca.2021.05.036","High levels of anti-SARS-CoV-2 IgG antibodies in previously infected patients with cancer after a single dose of BNT 162b2 vaccine.",NA,"2021","07","23","Eur J Cancer","European journal of cancer (Oxford, England : 1990)",NA,"Fong","Dominic","Department of Oncology and Haematology, Franz Tappeiner Hospital, Merano, Italy. Electronic address: dominic.fong@i-med.ac",NA
"544","34217909","10.1016/j.ejca.2021.05.036","High levels of anti-SARS-CoV-2 IgG antibodies in previously infected patients with cancer after a single dose of BNT 162b2 vaccine.",NA,"2021","07","23","Eur J Cancer","European journal of cancer (Oxford, England : 1990)",NA,"Mair","Maximilian J","Division of Oncology, Department of Medicine I, Medical University of Vienna, Austria",NA
"545","34217909","10.1016/j.ejca.2021.05.036","High levels of anti-SARS-CoV-2 IgG antibodies in previously infected patients with cancer after a single dose of BNT 162b2 vaccine.",NA,"2021","07","23","Eur J Cancer","European journal of cancer (Oxford, England : 1990)",NA,"Mitterer","Manfred","Department of Oncology and Haematology, Franz Tappeiner Hospital, Merano, Italy",NA
"546","34217888","10.1016/j.cct.2021.106500","An innovative protocol for the artificial speech-directed, contactless administration of laboratory-based comprehensive cognitive assessments: PAAD-2 trial management during the COVID-19 pandemic.","The COVID-19 pandemic resulted in suspending in-person human subject research across most institutions in the US. Our extensive cognitive assessment for a phase-2 clinical trial, Physical Activity and Alzheimer's Disease-2 (PAAD-2), was also paused in March 2020. It was important to identify strategies to mitigate the risk of COVID-19 transmission during our testing, which initially required substantial human speech and close person-to-person contact for test directions and instant feedback on p","2021","07","22","Contemp Clin Trials","Contemporary clinical trials","Alzheimer's disease; Artificial intelligence; Executive function; Neuropsychological tests; Physical activity; Speech synthesis; Text-to-speech; Working memory","Park","K Shin","Department of Kinesiology, University of North Carolina at Greensboro, United States of America. Electronic address: k_park4@uncg","park4@uncg.edu"
"547","34217888","10.1016/j.cct.2021.106500","An innovative protocol for the artificial speech-directed, contactless administration of laboratory-based comprehensive cognitive assessments: PAAD-2 trial management during the COVID-19 pandemic.","The COVID-19 pandemic resulted in suspending in-person human subject research across most institutions in the US. Our extensive cognitive assessment for a phase-2 clinical trial, Physical Activity and Alzheimer's Disease-2 (PAAD-2), was also paused in March 2020. It was important to identify strategies to mitigate the risk of COVID-19 transmission during our testing, which initially required substantial human speech and close person-to-person contact for test directions and instant feedback on p","2021","07","22","Contemp Clin Trials","Contemporary clinical trials","Alzheimer's disease; Artificial intelligence; Executive function; Neuropsychological tests; Physical activity; Speech synthesis; Text-to-speech; Working memory","Etnier","Jennifer L","Department of Kinesiology, University of North Carolina at Greensboro, United States of America",NA
"548","34217880","10.1016/j.cgh.2021.06.046","Gastrointestinal sequelae three and six months after hospitalization for Coronavirus Disease 2019.",NA,"2021","07","08","Clin Gastroenterol Hepatol","Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association",NA,"Rizvi","Anam","Division of Gastroenterology, Long Island Jewish Medical Center, Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, New Hyde Park, NY, USA",NA
"549","34217880","10.1016/j.cgh.2021.06.046","Gastrointestinal sequelae three and six months after hospitalization for Coronavirus Disease 2019.",NA,"2021","07","08","Clin Gastroenterol Hepatol","Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association",NA,"Patel","Zankesh","Division of Gastroenterology, Long Island Jewish Medical Center, Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, New Hyde Park, NY, USA",NA
"550","34217880","10.1016/j.cgh.2021.06.046","Gastrointestinal sequelae three and six months after hospitalization for Coronavirus Disease 2019.",NA,"2021","07","08","Clin Gastroenterol Hepatol","Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association",NA,"Liu","Yan","Division of Gastroenterology, Long Island Jewish Medical Center, Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, New Hyde Park, NY, USA",NA
"551","34217880","10.1016/j.cgh.2021.06.046","Gastrointestinal sequelae three and six months after hospitalization for Coronavirus Disease 2019.",NA,"2021","07","08","Clin Gastroenterol Hepatol","Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association",NA,"Satapathy","Sanjaya K","Division of Gastroenterology, Long Island Jewish Medical Center, Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, New Hyde Park, NY, USA",NA
"552","34217880","10.1016/j.cgh.2021.06.046","Gastrointestinal sequelae three and six months after hospitalization for Coronavirus Disease 2019.",NA,"2021","07","08","Clin Gastroenterol Hepatol","Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association",NA,"Sultan","Keith","Division of Gastroenterology, Long Island Jewish Medical Center, Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, New Hyde Park, NY, USA",NA
"553","34217880","10.1016/j.cgh.2021.06.046","Gastrointestinal sequelae three and six months after hospitalization for Coronavirus Disease 2019.",NA,"2021","07","08","Clin Gastroenterol Hepatol","Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association",NA,"Trindade","Arvind J","Division of Gastroenterology, Long Island Jewish Medical Center, Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, New Hyde Park, NY, USA. Electronic address: arvind.trindade@gmail","arvind.trindade@gmail.com"
"554","34217815","10.1016/j.tracli.2021.06.007","SARS-CoV-2 infection in patients with ß-thalassemia: The French experience.","Because of iron overload complications, thrombosis and infectious predisposition, patients with severe forms of thalassemia are likely to be at increased risk of COVID-19 complications. A national survey conducted during the year 2020 across the French reference centers for hemoglobinopathies identified 16 cases of COVID-19 confirmed by RT-PCR in beta-thalassemia patients. Their age ranged from 11 months to 60 years. 15 patients were transfusion-dependent and 6 were splenectomized. Concerning ir","2021","07","20","Transfus Clin Biol","Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","COVID-19; SARS-CoV-2; Thalassemia","Jean-Mignard","Estelle","Département de médecine interne, hôpital de la Timone, Assistance Publique des hôpitaux de Marseille, Marseille, France",NA
"555","34217815","10.1016/j.tracli.2021.06.007","SARS-CoV-2 infection in patients with ß-thalassemia: The French experience.","Because of iron overload complications, thrombosis and infectious predisposition, patients with severe forms of thalassemia are likely to be at increased risk of COVID-19 complications. A national survey conducted during the year 2020 across the French reference centers for hemoglobinopathies identified 16 cases of COVID-19 confirmed by RT-PCR in beta-thalassemia patients. Their age ranged from 11 months to 60 years. 15 patients were transfusion-dependent and 6 were splenectomized. Concerning ir","2021","07","20","Transfus Clin Biol","Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","COVID-19; SARS-CoV-2; Thalassemia","De Luna","Gonzalo","Service de médecine interne, centre de référence des syndromes drépanocytaires majeurs, thalassémies et autres pathologies rares du globule rouge et de l'Erythropoïèse, hôpital Henri Mondor, APHP, Paris, France",NA
"556","34217815","10.1016/j.tracli.2021.06.007","SARS-CoV-2 infection in patients with ß-thalassemia: The French experience.","Because of iron overload complications, thrombosis and infectious predisposition, patients with severe forms of thalassemia are likely to be at increased risk of COVID-19 complications. A national survey conducted during the year 2020 across the French reference centers for hemoglobinopathies identified 16 cases of COVID-19 confirmed by RT-PCR in beta-thalassemia patients. Their age ranged from 11 months to 60 years. 15 patients were transfusion-dependent and 6 were splenectomized. Concerning ir","2021","07","20","Transfus Clin Biol","Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","COVID-19; SARS-CoV-2; Thalassemia","Pascal","Laurent","Service d'onco-hématologie adulte, hôpital Saint-Vincent de Paul, GH de l'institut catholique de Lille, Lille, France",NA
"557","34217815","10.1016/j.tracli.2021.06.007","SARS-CoV-2 infection in patients with ß-thalassemia: The French experience.","Because of iron overload complications, thrombosis and infectious predisposition, patients with severe forms of thalassemia are likely to be at increased risk of COVID-19 complications. A national survey conducted during the year 2020 across the French reference centers for hemoglobinopathies identified 16 cases of COVID-19 confirmed by RT-PCR in beta-thalassemia patients. Their age ranged from 11 months to 60 years. 15 patients were transfusion-dependent and 6 were splenectomized. Concerning ir","2021","07","20","Transfus Clin Biol","Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","COVID-19; SARS-CoV-2; Thalassemia","Agouti","Imane","Centre de référence des syndromes drépanocytaires majeurs, thalassémies et autres pathologies rares du globule rouge et de l'erythropoïèse, Assistance Publique des hôpitaux de Marseille, 264, rue Saint-Pierre, 13005 Marseille, France. Electronic address: imane.agouti@ap-hm",NA
"558","34217815","10.1016/j.tracli.2021.06.007","SARS-CoV-2 infection in patients with ß-thalassemia: The French experience.","Because of iron overload complications, thrombosis and infectious predisposition, patients with severe forms of thalassemia are likely to be at increased risk of COVID-19 complications. A national survey conducted during the year 2020 across the French reference centers for hemoglobinopathies identified 16 cases of COVID-19 confirmed by RT-PCR in beta-thalassemia patients. Their age ranged from 11 months to 60 years. 15 patients were transfusion-dependent and 6 were splenectomized. Concerning ir","2021","07","20","Transfus Clin Biol","Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","COVID-19; SARS-CoV-2; Thalassemia","Thuret","Isabelle","Centre de référence des syndromes drépanocytaires majeurs, thalassémies et autres pathologies rares du globule rouge et de l'erythropoïèse, Assistance Publique des hôpitaux de Marseille, 264, rue Saint-Pierre, 13005 Marseille, France",NA
"559","34217786","10.1053/j.semtcvs.2021.06.022","Esophagectomy for Esophageal Cancer Performed During the Early Phase of the COVID-19 Pandemic.","Delay in time to esophagectomy for esophageal cancer has been shown to have worse peri-operative and long-term outcomes. We hypothesized that COVID-19 would cause a delay to surgery, with worse perioperative outcomes, compared to standard operations. All esophagectomies for esophageal cancer at a single institution from March-June 2020, COVID-19 group, and from 2019 were reviewed and peri-operative details were compared between groups. Ninety-six esophagectomies were performed in 2019 vs 37 duri","2021","07","08","Semin Thorac Cardiovasc Surg","Seminars in thoracic and cardiovascular surgery","COVID-19; delays of surgery; esophageal cancer; esophagectomy","Dolan","Daniel P","Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, 02115. Electronic address: daniel.dolan@ilcoud","daniel.dolan@ilcoud.com"
"560","34217786","10.1053/j.semtcvs.2021.06.022","Esophagectomy for Esophageal Cancer Performed During the Early Phase of the COVID-19 Pandemic.","Delay in time to esophagectomy for esophageal cancer has been shown to have worse peri-operative and long-term outcomes. We hypothesized that COVID-19 would cause a delay to surgery, with worse perioperative outcomes, compared to standard operations. All esophagectomies for esophageal cancer at a single institution from March-June 2020, COVID-19 group, and from 2019 were reviewed and peri-operative details were compared between groups. Ninety-six esophagectomies were performed in 2019 vs 37 duri","2021","07","08","Semin Thorac Cardiovasc Surg","Seminars in thoracic and cardiovascular surgery","COVID-19; delays of surgery; esophageal cancer; esophagectomy","Swanson","Scott J","Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, 02115",NA
"561","34217786","10.1053/j.semtcvs.2021.06.022","Esophagectomy for Esophageal Cancer Performed During the Early Phase of the COVID-19 Pandemic.","Delay in time to esophagectomy for esophageal cancer has been shown to have worse peri-operative and long-term outcomes. We hypothesized that COVID-19 would cause a delay to surgery, with worse perioperative outcomes, compared to standard operations. All esophagectomies for esophageal cancer at a single institution from March-June 2020, COVID-19 group, and from 2019 were reviewed and peri-operative details were compared between groups. Ninety-six esophagectomies were performed in 2019 vs 37 duri","2021","07","08","Semin Thorac Cardiovasc Surg","Seminars in thoracic and cardiovascular surgery","COVID-19; delays of surgery; esophageal cancer; esophagectomy","Lee","Daniel N","Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, 02115",NA
"562","34217786","10.1053/j.semtcvs.2021.06.022","Esophagectomy for Esophageal Cancer Performed During the Early Phase of the COVID-19 Pandemic.","Delay in time to esophagectomy for esophageal cancer has been shown to have worse peri-operative and long-term outcomes. We hypothesized that COVID-19 would cause a delay to surgery, with worse perioperative outcomes, compared to standard operations. All esophagectomies for esophageal cancer at a single institution from March-June 2020, COVID-19 group, and from 2019 were reviewed and peri-operative details were compared between groups. Ninety-six esophagectomies were performed in 2019 vs 37 duri","2021","07","08","Semin Thorac Cardiovasc Surg","Seminars in thoracic and cardiovascular surgery","COVID-19; delays of surgery; esophageal cancer; esophagectomy","Polhemus","Emily","Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, 02115",NA
"563","34217786","10.1053/j.semtcvs.2021.06.022","Esophagectomy for Esophageal Cancer Performed During the Early Phase of the COVID-19 Pandemic.","Delay in time to esophagectomy for esophageal cancer has been shown to have worse peri-operative and long-term outcomes. We hypothesized that COVID-19 would cause a delay to surgery, with worse perioperative outcomes, compared to standard operations. All esophagectomies for esophageal cancer at a single institution from March-June 2020, COVID-19 group, and from 2019 were reviewed and peri-operative details were compared between groups. Ninety-six esophagectomies were performed in 2019 vs 37 duri","2021","07","08","Semin Thorac Cardiovasc Surg","Seminars in thoracic and cardiovascular surgery","COVID-19; delays of surgery; esophageal cancer; esophagectomy","Kucukak","Suden","Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, 02115",NA
"564","34217786","10.1053/j.semtcvs.2021.06.022","Esophagectomy for Esophageal Cancer Performed During the Early Phase of the COVID-19 Pandemic.","Delay in time to esophagectomy for esophageal cancer has been shown to have worse peri-operative and long-term outcomes. We hypothesized that COVID-19 would cause a delay to surgery, with worse perioperative outcomes, compared to standard operations. All esophagectomies for esophageal cancer at a single institution from March-June 2020, COVID-19 group, and from 2019 were reviewed and peri-operative details were compared between groups. Ninety-six esophagectomies were performed in 2019 vs 37 duri","2021","07","08","Semin Thorac Cardiovasc Surg","Seminars in thoracic and cardiovascular surgery","COVID-19; delays of surgery; esophageal cancer; esophagectomy","Wiener","Daniel C","Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, 02115",NA
"565","34217786","10.1053/j.semtcvs.2021.06.022","Esophagectomy for Esophageal Cancer Performed During the Early Phase of the COVID-19 Pandemic.","Delay in time to esophagectomy for esophageal cancer has been shown to have worse peri-operative and long-term outcomes. We hypothesized that COVID-19 would cause a delay to surgery, with worse perioperative outcomes, compared to standard operations. All esophagectomies for esophageal cancer at a single institution from March-June 2020, COVID-19 group, and from 2019 were reviewed and peri-operative details were compared between groups. Ninety-six esophagectomies were performed in 2019 vs 37 duri","2021","07","08","Semin Thorac Cardiovasc Surg","Seminars in thoracic and cardiovascular surgery","COVID-19; delays of surgery; esophageal cancer; esophagectomy","Bueno","Raphael","Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, 02115",NA
"566","34217786","10.1053/j.semtcvs.2021.06.022","Esophagectomy for Esophageal Cancer Performed During the Early Phase of the COVID-19 Pandemic.","Delay in time to esophagectomy for esophageal cancer has been shown to have worse peri-operative and long-term outcomes. We hypothesized that COVID-19 would cause a delay to surgery, with worse perioperative outcomes, compared to standard operations. All esophagectomies for esophageal cancer at a single institution from March-June 2020, COVID-19 group, and from 2019 were reviewed and peri-operative details were compared between groups. Ninety-six esophagectomies were performed in 2019 vs 37 duri","2021","07","08","Semin Thorac Cardiovasc Surg","Seminars in thoracic and cardiovascular surgery","COVID-19; delays of surgery; esophageal cancer; esophagectomy","Wee","Jon O","Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, 02115",NA
"567","34217786","10.1053/j.semtcvs.2021.06.022","Esophagectomy for Esophageal Cancer Performed During the Early Phase of the COVID-19 Pandemic.","Delay in time to esophagectomy for esophageal cancer has been shown to have worse peri-operative and long-term outcomes. We hypothesized that COVID-19 would cause a delay to surgery, with worse perioperative outcomes, compared to standard operations. All esophagectomies for esophageal cancer at a single institution from March-June 2020, COVID-19 group, and from 2019 were reviewed and peri-operative details were compared between groups. Ninety-six esophagectomies were performed in 2019 vs 37 duri","2021","07","08","Semin Thorac Cardiovasc Surg","Seminars in thoracic and cardiovascular surgery","COVID-19; delays of surgery; esophageal cancer; esophagectomy","White","Abby","Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, 02115",NA
"568","34217780","10.1016/j.jinf.2021.06.025","Outcomes of Covid-19 organizing pneumonia in critically ill patients.",NA,"2021","07","14","J Infect","The Journal of infection","Corticosteroids; Covid-19; Critically ill; Organizing pneumonia","Rocha","Ana Silva","Department of Internal Medicine, Centro Hospitalar Tâmega e Sousa, Avenida do Hospital Padre Américo 210, Penafiel 4564-007, Portugal",NA
"569","34217780","10.1016/j.jinf.2021.06.025","Outcomes of Covid-19 organizing pneumonia in critically ill patients.",NA,"2021","07","14","J Infect","The Journal of infection","Corticosteroids; Covid-19; Critically ill; Organizing pneumonia","Meireles","Mariana","Department of Internal Medicine, Centro Hospitalar Tâmega e Sousa, Avenida do Hospital Padre Américo 210, Penafiel 4564-007, Portugal. Electronic address: 74270@chts.min-saude","74270@chts.min"
"570","34217780","10.1016/j.jinf.2021.06.025","Outcomes of Covid-19 organizing pneumonia in critically ill patients.",NA,"2021","07","14","J Infect","The Journal of infection","Corticosteroids; Covid-19; Critically ill; Organizing pneumonia","Vilaça","Helena","Department of Internal Medicine, Centro Hospitalar Tâmega e Sousa, Avenida do Hospital Padre Américo 210, Penafiel 4564-007, Portugal",NA
"571","34217780","10.1016/j.jinf.2021.06.025","Outcomes of Covid-19 organizing pneumonia in critically ill patients.",NA,"2021","07","14","J Infect","The Journal of infection","Corticosteroids; Covid-19; Critically ill; Organizing pneumonia","Guimarães","Teresa C","Department of Intensive Care Medicine, Centro Hospitalar Tâmega e Sousa, Penafiel, Portugal",NA
"572","34217780","10.1016/j.jinf.2021.06.025","Outcomes of Covid-19 organizing pneumonia in critically ill patients.",NA,"2021","07","14","J Infect","The Journal of infection","Corticosteroids; Covid-19; Critically ill; Organizing pneumonia","Martins","Marta Dalila","Department of Internal Medicine, Centro Hospitalar Tâmega e Sousa, Avenida do Hospital Padre Américo 210, Penafiel 4564-007, Portugal",NA
"573","34217780","10.1016/j.jinf.2021.06.025","Outcomes of Covid-19 organizing pneumonia in critically ill patients.",NA,"2021","07","14","J Infect","The Journal of infection","Corticosteroids; Covid-19; Critically ill; Organizing pneumonia","Santos","Lígia Rodrigues","Department of Internal Medicine, Centro Hospitalar Tâmega e Sousa, Avenida do Hospital Padre Américo 210, Penafiel 4564-007, Portugal",NA
"574","34217780","10.1016/j.jinf.2021.06.025","Outcomes of Covid-19 organizing pneumonia in critically ill patients.",NA,"2021","07","14","J Infect","The Journal of infection","Corticosteroids; Covid-19; Critically ill; Organizing pneumonia","Castro","Alice","Department of Internal Medicine, Centro Hospitalar Tâmega e Sousa, Avenida do Hospital Padre Américo 210, Penafiel 4564-007, Portugal",NA
"575","34217780","10.1016/j.jinf.2021.06.025","Outcomes of Covid-19 organizing pneumonia in critically ill patients.",NA,"2021","07","14","J Infect","The Journal of infection","Corticosteroids; Covid-19; Critically ill; Organizing pneumonia","Mesquita","Mari","Department of Internal Medicine, Centro Hospitalar Tâmega e Sousa, Avenida do Hospital Padre Américo 210, Penafiel 4564-007, Portugal",NA
"576","34217778","10.1016/j.virusres.2021.198497","Identification of a novel B cell epitope on the nucleocapsid protein of porcine deltacoronavirus.","Porcine deltacoronavirus (PDCoV) is an emerging coronavirus that causes vomiting, diarrhea, dehydration, and even death of piglets, resulting in significant losses to the pig industry worldwide. However, the epitopes of PDCoV remain largely unknown. In this study, a monoclonal antibody (mAb) against the PDCoV nucleocapsid (N) protein, termed 9G1, was prepared using the lymphocyte hybridoma technique, and was identified as a type IgG1 with a <U+03BA> light chain and reacted with the native N protein of ","2021","07","15","Virus Res","Virus research","Epitopes; N protein; Porcine deltacoronavirus","Wei","Shan","Laboratory for the Prevention and Control of Swine Infectious Diseases, College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, 163319, China",NA
"577","34217778","10.1016/j.virusres.2021.198497","Identification of a novel B cell epitope on the nucleocapsid protein of porcine deltacoronavirus.","Porcine deltacoronavirus (PDCoV) is an emerging coronavirus that causes vomiting, diarrhea, dehydration, and even death of piglets, resulting in significant losses to the pig industry worldwide. However, the epitopes of PDCoV remain largely unknown. In this study, a monoclonal antibody (mAb) against the PDCoV nucleocapsid (N) protein, termed 9G1, was prepared using the lymphocyte hybridoma technique, and was identified as a type IgG1 with a <U+03BA> light chain and reacted with the native N protein of ","2021","07","15","Virus Res","Virus research","Epitopes; N protein; Porcine deltacoronavirus","Shi","Da","State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, 150069, China",NA
"578","34217778","10.1016/j.virusres.2021.198497","Identification of a novel B cell epitope on the nucleocapsid protein of porcine deltacoronavirus.","Porcine deltacoronavirus (PDCoV) is an emerging coronavirus that causes vomiting, diarrhea, dehydration, and even death of piglets, resulting in significant losses to the pig industry worldwide. However, the epitopes of PDCoV remain largely unknown. In this study, a monoclonal antibody (mAb) against the PDCoV nucleocapsid (N) protein, termed 9G1, was prepared using the lymphocyte hybridoma technique, and was identified as a type IgG1 with a <U+03BA> light chain and reacted with the native N protein of ","2021","07","15","Virus Res","Virus research","Epitopes; N protein; Porcine deltacoronavirus","Wu","Haoyang","Laboratory for the Prevention and Control of Swine Infectious Diseases, College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, 163319, China",NA
"579","34217778","10.1016/j.virusres.2021.198497","Identification of a novel B cell epitope on the nucleocapsid protein of porcine deltacoronavirus.","Porcine deltacoronavirus (PDCoV) is an emerging coronavirus that causes vomiting, diarrhea, dehydration, and even death of piglets, resulting in significant losses to the pig industry worldwide. However, the epitopes of PDCoV remain largely unknown. In this study, a monoclonal antibody (mAb) against the PDCoV nucleocapsid (N) protein, termed 9G1, was prepared using the lymphocyte hybridoma technique, and was identified as a type IgG1 with a <U+03BA> light chain and reacted with the native N protein of ","2021","07","15","Virus Res","Virus research","Epitopes; N protein; Porcine deltacoronavirus","Sun","Haibo","Laboratory for the Prevention and Control of Swine Infectious Diseases, College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, 163319, China",NA
"580","34217778","10.1016/j.virusres.2021.198497","Identification of a novel B cell epitope on the nucleocapsid protein of porcine deltacoronavirus.","Porcine deltacoronavirus (PDCoV) is an emerging coronavirus that causes vomiting, diarrhea, dehydration, and even death of piglets, resulting in significant losses to the pig industry worldwide. However, the epitopes of PDCoV remain largely unknown. In this study, a monoclonal antibody (mAb) against the PDCoV nucleocapsid (N) protein, termed 9G1, was prepared using the lymphocyte hybridoma technique, and was identified as a type IgG1 with a <U+03BA> light chain and reacted with the native N protein of ","2021","07","15","Virus Res","Virus research","Epitopes; N protein; Porcine deltacoronavirus","Chen","Jianfei","State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, 150069, China",NA
"581","34217778","10.1016/j.virusres.2021.198497","Identification of a novel B cell epitope on the nucleocapsid protein of porcine deltacoronavirus.","Porcine deltacoronavirus (PDCoV) is an emerging coronavirus that causes vomiting, diarrhea, dehydration, and even death of piglets, resulting in significant losses to the pig industry worldwide. However, the epitopes of PDCoV remain largely unknown. In this study, a monoclonal antibody (mAb) against the PDCoV nucleocapsid (N) protein, termed 9G1, was prepared using the lymphocyte hybridoma technique, and was identified as a type IgG1 with a <U+03BA> light chain and reacted with the native N protein of ","2021","07","15","Virus Res","Virus research","Epitopes; N protein; Porcine deltacoronavirus","Feng","Li","State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, 150069, China",NA
"582","34217778","10.1016/j.virusres.2021.198497","Identification of a novel B cell epitope on the nucleocapsid protein of porcine deltacoronavirus.","Porcine deltacoronavirus (PDCoV) is an emerging coronavirus that causes vomiting, diarrhea, dehydration, and even death of piglets, resulting in significant losses to the pig industry worldwide. However, the epitopes of PDCoV remain largely unknown. In this study, a monoclonal antibody (mAb) against the PDCoV nucleocapsid (N) protein, termed 9G1, was prepared using the lymphocyte hybridoma technique, and was identified as a type IgG1 with a <U+03BA> light chain and reacted with the native N protein of ","2021","07","15","Virus Res","Virus research","Epitopes; N protein; Porcine deltacoronavirus","Su","Mingjun","Laboratory for the Prevention and Control of Swine Infectious Diseases, College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, 163319, China. Electronic address: mingjunsu@163","mingjunsu@163.com"
"583","34217778","10.1016/j.virusres.2021.198497","Identification of a novel B cell epitope on the nucleocapsid protein of porcine deltacoronavirus.","Porcine deltacoronavirus (PDCoV) is an emerging coronavirus that causes vomiting, diarrhea, dehydration, and even death of piglets, resulting in significant losses to the pig industry worldwide. However, the epitopes of PDCoV remain largely unknown. In this study, a monoclonal antibody (mAb) against the PDCoV nucleocapsid (N) protein, termed 9G1, was prepared using the lymphocyte hybridoma technique, and was identified as a type IgG1 with a <U+03BA> light chain and reacted with the native N protein of ","2021","07","15","Virus Res","Virus research","Epitopes; N protein; Porcine deltacoronavirus","Sun","Dongbo","Laboratory for the Prevention and Control of Swine Infectious Diseases, College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, 163319, China. Electronic address: dongbosun@126","dongbosun@126.com"
"584","34217771","10.1016/j.diabres.2021.108936","Is diabetes mellitus a wrongdoer to COVID-19 severity?","The coronavirus disease 19 (COVID-19) has turned out to be a pandemic in short period of time due to the high transmissibility of its causative agent, severe acute respiratory syndrome coronavirus 2. Various reports have suggested the promising link between overexpression of angiotensin converting enzyme 2 (ACE2) and COVID-19 pathogenesis. The severity of COVID-19 pathophysiology is greatly depended on several comorbidities, like hypertension, diabetes mellitus (DM), respiratory and cardiovascul","2021","07","24","Diabetes Res Clin Pract","Diabetes research and clinical practice","Angiotensin converting enzyme 2 (ACE2); COVID-19; Cytokine storm; Diabetes Mellitus","Sarkar","Sanjib","Biotechnology Group, Biological Sciences and Technology Division, CSIR-North East Institute of Science and Technology, Jorhat 785006, Assam, India",NA
"585","34217771","10.1016/j.diabres.2021.108936","Is diabetes mellitus a wrongdoer to COVID-19 severity?","The coronavirus disease 19 (COVID-19) has turned out to be a pandemic in short period of time due to the high transmissibility of its causative agent, severe acute respiratory syndrome coronavirus 2. Various reports have suggested the promising link between overexpression of angiotensin converting enzyme 2 (ACE2) and COVID-19 pathogenesis. The severity of COVID-19 pathophysiology is greatly depended on several comorbidities, like hypertension, diabetes mellitus (DM), respiratory and cardiovascul","2021","07","24","Diabetes Res Clin Pract","Diabetes research and clinical practice","Angiotensin converting enzyme 2 (ACE2); COVID-19; Cytokine storm; Diabetes Mellitus","Das","Dibyendu","Biotechnology Group, Biological Sciences and Technology Division, CSIR-North East Institute of Science and Technology, Jorhat 785006, Assam, India",NA
"586","34217771","10.1016/j.diabres.2021.108936","Is diabetes mellitus a wrongdoer to COVID-19 severity?","The coronavirus disease 19 (COVID-19) has turned out to be a pandemic in short period of time due to the high transmissibility of its causative agent, severe acute respiratory syndrome coronavirus 2. Various reports have suggested the promising link between overexpression of angiotensin converting enzyme 2 (ACE2) and COVID-19 pathogenesis. The severity of COVID-19 pathophysiology is greatly depended on several comorbidities, like hypertension, diabetes mellitus (DM), respiratory and cardiovascul","2021","07","24","Diabetes Res Clin Pract","Diabetes research and clinical practice","Angiotensin converting enzyme 2 (ACE2); COVID-19; Cytokine storm; Diabetes Mellitus","Borsingh Wann","Sawlang","Biotechnology Group, Biological Sciences and Technology Division, CSIR-North East Institute of Science and Technology, Jorhat 785006, Assam, India",NA
"587","34217771","10.1016/j.diabres.2021.108936","Is diabetes mellitus a wrongdoer to COVID-19 severity?","The coronavirus disease 19 (COVID-19) has turned out to be a pandemic in short period of time due to the high transmissibility of its causative agent, severe acute respiratory syndrome coronavirus 2. Various reports have suggested the promising link between overexpression of angiotensin converting enzyme 2 (ACE2) and COVID-19 pathogenesis. The severity of COVID-19 pathophysiology is greatly depended on several comorbidities, like hypertension, diabetes mellitus (DM), respiratory and cardiovascul","2021","07","24","Diabetes Res Clin Pract","Diabetes research and clinical practice","Angiotensin converting enzyme 2 (ACE2); COVID-19; Cytokine storm; Diabetes Mellitus","Kalita","Jatin","Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India","kalitajk74@gmail.com"
"588","34217771","10.1016/j.diabres.2021.108936","Is diabetes mellitus a wrongdoer to COVID-19 severity?","The coronavirus disease 19 (COVID-19) has turned out to be a pandemic in short period of time due to the high transmissibility of its causative agent, severe acute respiratory syndrome coronavirus 2. Various reports have suggested the promising link between overexpression of angiotensin converting enzyme 2 (ACE2) and COVID-19 pathogenesis. The severity of COVID-19 pathophysiology is greatly depended on several comorbidities, like hypertension, diabetes mellitus (DM), respiratory and cardiovascul","2021","07","24","Diabetes Res Clin Pract","Diabetes research and clinical practice","Angiotensin converting enzyme 2 (ACE2); COVID-19; Cytokine storm; Diabetes Mellitus","Manna","Prasenjit","Biotechnology Group, Biological Sciences and Technology Division, CSIR-North East Institute of Science and Technology, Jorhat 785006, Assam, India","pmanna2012@gmail.com"
"589","34217761","10.1016/j.appet.2021.105586","Self-reported dietary changes among Los Angeles County adults during the COVID-19 pandemic.","Poor diets are historically the leading cause of morbidity and mortality in the United States (U.S.), causing over 44,000 deaths each month. Dietary patterns have likely changed during the COVID-19 pandemic due to major shifts and crises in social, economic, and food systems. This study examines self-reported dietary changes in Los Angeles (L.A.) County during COVID-19, and identifies factors associated with making healthy and unhealthy changes. Data are from the Understanding Coronavirus in Ame","2021","07","22","Appetite","Appetite","COVID-19 pandemic; Diet; Eating; Ecological model","Miller","Sydney","Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, USA. Electronic address: sydneynm@usc","sydneynm@usc.edu"
"590","34217761","10.1016/j.appet.2021.105586","Self-reported dietary changes among Los Angeles County adults during the COVID-19 pandemic.","Poor diets are historically the leading cause of morbidity and mortality in the United States (U.S.), causing over 44,000 deaths each month. Dietary patterns have likely changed during the COVID-19 pandemic due to major shifts and crises in social, economic, and food systems. This study examines self-reported dietary changes in Los Angeles (L.A.) County during COVID-19, and identifies factors associated with making healthy and unhealthy changes. Data are from the Understanding Coronavirus in Ame","2021","07","22","Appetite","Appetite","COVID-19 pandemic; Diet; Eating; Ecological model","Bruine de Bruin","Wandi","Sol Price School of Public Policy and Dornsife Department of Psychology, University of Southern California, USA",NA
"591","34217761","10.1016/j.appet.2021.105586","Self-reported dietary changes among Los Angeles County adults during the COVID-19 pandemic.","Poor diets are historically the leading cause of morbidity and mortality in the United States (U.S.), causing over 44,000 deaths each month. Dietary patterns have likely changed during the COVID-19 pandemic due to major shifts and crises in social, economic, and food systems. This study examines self-reported dietary changes in Los Angeles (L.A.) County during COVID-19, and identifies factors associated with making healthy and unhealthy changes. Data are from the Understanding Coronavirus in Ame","2021","07","22","Appetite","Appetite","COVID-19 pandemic; Diet; Eating; Ecological model","Livings","Michelle","Spatial Sciences Institute, Dornsife College of Letters, Arts and Sciences, University of Southern California, USA",NA
"592","34217761","10.1016/j.appet.2021.105586","Self-reported dietary changes among Los Angeles County adults during the COVID-19 pandemic.","Poor diets are historically the leading cause of morbidity and mortality in the United States (U.S.), causing over 44,000 deaths each month. Dietary patterns have likely changed during the COVID-19 pandemic due to major shifts and crises in social, economic, and food systems. This study examines self-reported dietary changes in Los Angeles (L.A.) County during COVID-19, and identifies factors associated with making healthy and unhealthy changes. Data are from the Understanding Coronavirus in Ame","2021","07","22","Appetite","Appetite","COVID-19 pandemic; Diet; Eating; Ecological model","Wilson","John","Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, USA",NA
"593","34217761","10.1016/j.appet.2021.105586","Self-reported dietary changes among Los Angeles County adults during the COVID-19 pandemic.","Poor diets are historically the leading cause of morbidity and mortality in the United States (U.S.), causing over 44,000 deaths each month. Dietary patterns have likely changed during the COVID-19 pandemic due to major shifts and crises in social, economic, and food systems. This study examines self-reported dietary changes in Los Angeles (L.A.) County during COVID-19, and identifies factors associated with making healthy and unhealthy changes. Data are from the Understanding Coronavirus in Ame","2021","07","22","Appetite","Appetite","COVID-19 pandemic; Diet; Eating; Ecological model","Weber","Kate","Dornsife Public Exchange, University of Southern California, USA",NA
"594","34217761","10.1016/j.appet.2021.105586","Self-reported dietary changes among Los Angeles County adults during the COVID-19 pandemic.","Poor diets are historically the leading cause of morbidity and mortality in the United States (U.S.), causing over 44,000 deaths each month. Dietary patterns have likely changed during the COVID-19 pandemic due to major shifts and crises in social, economic, and food systems. This study examines self-reported dietary changes in Los Angeles (L.A.) County during COVID-19, and identifies factors associated with making healthy and unhealthy changes. Data are from the Understanding Coronavirus in Ame","2021","07","22","Appetite","Appetite","COVID-19 pandemic; Diet; Eating; Ecological model","Frazzini","Alison","Chief Sustainability Office, County of Los Angeles, USA",NA
"595","34217761","10.1016/j.appet.2021.105586","Self-reported dietary changes among Los Angeles County adults during the COVID-19 pandemic.","Poor diets are historically the leading cause of morbidity and mortality in the United States (U.S.), causing over 44,000 deaths each month. Dietary patterns have likely changed during the COVID-19 pandemic due to major shifts and crises in social, economic, and food systems. This study examines self-reported dietary changes in Los Angeles (L.A.) County during COVID-19, and identifies factors associated with making healthy and unhealthy changes. Data are from the Understanding Coronavirus in Ame","2021","07","22","Appetite","Appetite","COVID-19 pandemic; Diet; Eating; Ecological model","Babboni","Marianna","Dornsife Public Exchange, University of Southern California, USA",NA
"596","34217761","10.1016/j.appet.2021.105586","Self-reported dietary changes among Los Angeles County adults during the COVID-19 pandemic.","Poor diets are historically the leading cause of morbidity and mortality in the United States (U.S.), causing over 44,000 deaths each month. Dietary patterns have likely changed during the COVID-19 pandemic due to major shifts and crises in social, economic, and food systems. This study examines self-reported dietary changes in Los Angeles (L.A.) County during COVID-19, and identifies factors associated with making healthy and unhealthy changes. Data are from the Understanding Coronavirus in Ame","2021","07","22","Appetite","Appetite","COVID-19 pandemic; Diet; Eating; Ecological model","de la Haye","Kayla","Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, USA",NA
"597","34217752","10.1016/j.antiviral.2021.105127","Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.","In this study, a series of 10 quinoline analogues was evaluated for their in vitro antiviral activity against a panel of alpha- and beta-coronaviruses, including the severe acute respiratory syndrome coronaviruses 1 and 2 (SARS-CoV-1 and SARS-CoV-2), as well as the human coronaviruses (HCoV) 229E and OC43. Chloroquine and hydroxychloroquine were the most potent with antiviral EC50 values in the range of 0.12-12 µM. Chloroquine displayed the most favorable selectivity index (i.e. ratio","2021","07","23","Antiviral Res","Antiviral research","Antiviral; COVID-19; Chloroquine; Coronavirus; Quinoline","Persoons","Leentje","KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Leuven, Belgium",NA
"598","34217752","10.1016/j.antiviral.2021.105127","Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.","In this study, a series of 10 quinoline analogues was evaluated for their in vitro antiviral activity against a panel of alpha- and beta-coronaviruses, including the severe acute respiratory syndrome coronaviruses 1 and 2 (SARS-CoV-1 and SARS-CoV-2), as well as the human coronaviruses (HCoV) 229E and OC43. Chloroquine and hydroxychloroquine were the most potent with antiviral EC50 values in the range of 0.12-12 µM. Chloroquine displayed the most favorable selectivity index (i.e. ratio","2021","07","23","Antiviral Res","Antiviral research","Antiviral; COVID-19; Chloroquine; Coronavirus; Quinoline","Vanderlinden","Evelien","KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Leuven, Belgium. Electronic address: evelien.vanderlinden@kuleuven","evelien.vanderlinden@kuleuven.be"
"599","34217752","10.1016/j.antiviral.2021.105127","Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.","In this study, a series of 10 quinoline analogues was evaluated for their in vitro antiviral activity against a panel of alpha- and beta-coronaviruses, including the severe acute respiratory syndrome coronaviruses 1 and 2 (SARS-CoV-1 and SARS-CoV-2), as well as the human coronaviruses (HCoV) 229E and OC43. Chloroquine and hydroxychloroquine were the most potent with antiviral EC50 values in the range of 0.12-12 µM. Chloroquine displayed the most favorable selectivity index (i.e. ratio","2021","07","23","Antiviral Res","Antiviral research","Antiviral; COVID-19; Chloroquine; Coronavirus; Quinoline","Vangeel","Laura","KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Leuven, Belgium",NA
"600","34217752","10.1016/j.antiviral.2021.105127","Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.","In this study, a series of 10 quinoline analogues was evaluated for their in vitro antiviral activity against a panel of alpha- and beta-coronaviruses, including the severe acute respiratory syndrome coronaviruses 1 and 2 (SARS-CoV-1 and SARS-CoV-2), as well as the human coronaviruses (HCoV) 229E and OC43. Chloroquine and hydroxychloroquine were the most potent with antiviral EC50 values in the range of 0.12-12 µM. Chloroquine displayed the most favorable selectivity index (i.e. ratio","2021","07","23","Antiviral Res","Antiviral research","Antiviral; COVID-19; Chloroquine; Coronavirus; Quinoline","Wang","Xinyu","KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Leuven, Belgium",NA
"601","34217752","10.1016/j.antiviral.2021.105127","Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.","In this study, a series of 10 quinoline analogues was evaluated for their in vitro antiviral activity against a panel of alpha- and beta-coronaviruses, including the severe acute respiratory syndrome coronaviruses 1 and 2 (SARS-CoV-1 and SARS-CoV-2), as well as the human coronaviruses (HCoV) 229E and OC43. Chloroquine and hydroxychloroquine were the most potent with antiviral EC50 values in the range of 0.12-12 µM. Chloroquine displayed the most favorable selectivity index (i.e. ratio","2021","07","23","Antiviral Res","Antiviral research","Antiviral; COVID-19; Chloroquine; Coronavirus; Quinoline","Do","Nguyen Dan Thuc","KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Leuven, Belgium",NA
"602","34217752","10.1016/j.antiviral.2021.105127","Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.","In this study, a series of 10 quinoline analogues was evaluated for their in vitro antiviral activity against a panel of alpha- and beta-coronaviruses, including the severe acute respiratory syndrome coronaviruses 1 and 2 (SARS-CoV-1 and SARS-CoV-2), as well as the human coronaviruses (HCoV) 229E and OC43. Chloroquine and hydroxychloroquine were the most potent with antiviral EC50 values in the range of 0.12-12 µM. Chloroquine displayed the most favorable selectivity index (i.e. ratio","2021","07","23","Antiviral Res","Antiviral research","Antiviral; COVID-19; Chloroquine; Coronavirus; Quinoline","Foo","Shi-Yan Caroline","KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Leuven, Belgium",NA
"603","34217752","10.1016/j.antiviral.2021.105127","Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.","In this study, a series of 10 quinoline analogues was evaluated for their in vitro antiviral activity against a panel of alpha- and beta-coronaviruses, including the severe acute respiratory syndrome coronaviruses 1 and 2 (SARS-CoV-1 and SARS-CoV-2), as well as the human coronaviruses (HCoV) 229E and OC43. Chloroquine and hydroxychloroquine were the most potent with antiviral EC50 values in the range of 0.12-12 µM. Chloroquine displayed the most favorable selectivity index (i.e. ratio","2021","07","23","Antiviral Res","Antiviral research","Antiviral; COVID-19; Chloroquine; Coronavirus; Quinoline","Leyssen","Pieter","KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Leuven, Belgium",NA
"604","34217752","10.1016/j.antiviral.2021.105127","Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.","In this study, a series of 10 quinoline analogues was evaluated for their in vitro antiviral activity against a panel of alpha- and beta-coronaviruses, including the severe acute respiratory syndrome coronaviruses 1 and 2 (SARS-CoV-1 and SARS-CoV-2), as well as the human coronaviruses (HCoV) 229E and OC43. Chloroquine and hydroxychloroquine were the most potent with antiviral EC50 values in the range of 0.12-12 µM. Chloroquine displayed the most favorable selectivity index (i.e. ratio","2021","07","23","Antiviral Res","Antiviral research","Antiviral; COVID-19; Chloroquine; Coronavirus; Quinoline","Neyts","Johan","KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Leuven, Belgium",NA
"605","34217752","10.1016/j.antiviral.2021.105127","Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.","In this study, a series of 10 quinoline analogues was evaluated for their in vitro antiviral activity against a panel of alpha- and beta-coronaviruses, including the severe acute respiratory syndrome coronaviruses 1 and 2 (SARS-CoV-1 and SARS-CoV-2), as well as the human coronaviruses (HCoV) 229E and OC43. Chloroquine and hydroxychloroquine were the most potent with antiviral EC50 values in the range of 0.12-12 µM. Chloroquine displayed the most favorable selectivity index (i.e. ratio","2021","07","23","Antiviral Res","Antiviral research","Antiviral; COVID-19; Chloroquine; Coronavirus; Quinoline","Jochmans","Dirk","KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Leuven, Belgium",NA
"606","34217752","10.1016/j.antiviral.2021.105127","Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.","In this study, a series of 10 quinoline analogues was evaluated for their in vitro antiviral activity against a panel of alpha- and beta-coronaviruses, including the severe acute respiratory syndrome coronaviruses 1 and 2 (SARS-CoV-1 and SARS-CoV-2), as well as the human coronaviruses (HCoV) 229E and OC43. Chloroquine and hydroxychloroquine were the most potent with antiviral EC50 values in the range of 0.12-12 µM. Chloroquine displayed the most favorable selectivity index (i.e. ratio","2021","07","23","Antiviral Res","Antiviral research","Antiviral; COVID-19; Chloroquine; Coronavirus; Quinoline","Schols","Dominique","KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Leuven, Belgium",NA
"607","34217752","10.1016/j.antiviral.2021.105127","Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.","In this study, a series of 10 quinoline analogues was evaluated for their in vitro antiviral activity against a panel of alpha- and beta-coronaviruses, including the severe acute respiratory syndrome coronaviruses 1 and 2 (SARS-CoV-1 and SARS-CoV-2), as well as the human coronaviruses (HCoV) 229E and OC43. Chloroquine and hydroxychloroquine were the most potent with antiviral EC50 values in the range of 0.12-12 µM. Chloroquine displayed the most favorable selectivity index (i.e. ratio","2021","07","23","Antiviral Res","Antiviral research","Antiviral; COVID-19; Chloroquine; Coronavirus; Quinoline","De Jonghe","Steven","KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, Leuven, Belgium",NA
"608","34217695","10.1016/j.pulmoe.2021.05.009","Comparative bench study evaluation of a modified snorkeling mask used during COVID-19 pandemic and standard interfaces for non-invasive ventilation.","The aim of this bench study is to compare the standard NIV and nCPAP devices (Helmet, H; Full face mask, FFM) with a modified full face snorkeling mask used during COVID-19 pandemic. A mannequin was connected to an active lung simulator. The inspiratory and expiratory variations in airways pressure observed with a high simulated effort, were determined relative to the preset CPAP level. NIV was applied in Pressure Support Mode at two simulated respiratory rates and two cycling-off flow threshold","2021","07","08","Pulmonology","Pulmonology","ARDS; Covid-19; Mechanical ventilation; Non-invasive ventilation","Ferrone","Giuliano","Department of Emergency, Intensive Care Medicine and Anesthesia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy","giuliano.ferrone@policlinicogemelli.it"
"609","34217695","10.1016/j.pulmoe.2021.05.009","Comparative bench study evaluation of a modified snorkeling mask used during COVID-19 pandemic and standard interfaces for non-invasive ventilation.","The aim of this bench study is to compare the standard NIV and nCPAP devices (Helmet, H; Full face mask, FFM) with a modified full face snorkeling mask used during COVID-19 pandemic. A mannequin was connected to an active lung simulator. The inspiratory and expiratory variations in airways pressure observed with a high simulated effort, were determined relative to the preset CPAP level. NIV was applied in Pressure Support Mode at two simulated respiratory rates and two cycling-off flow threshold","2021","07","08","Pulmonology","Pulmonology","ARDS; Covid-19; Mechanical ventilation; Non-invasive ventilation","Spinazzola","Giorgia","Department of Emergency, Intensive Care Medicine and Anesthesia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"610","34217695","10.1016/j.pulmoe.2021.05.009","Comparative bench study evaluation of a modified snorkeling mask used during COVID-19 pandemic and standard interfaces for non-invasive ventilation.","The aim of this bench study is to compare the standard NIV and nCPAP devices (Helmet, H; Full face mask, FFM) with a modified full face snorkeling mask used during COVID-19 pandemic. A mannequin was connected to an active lung simulator. The inspiratory and expiratory variations in airways pressure observed with a high simulated effort, were determined relative to the preset CPAP level. NIV was applied in Pressure Support Mode at two simulated respiratory rates and two cycling-off flow threshold","2021","07","08","Pulmonology","Pulmonology","ARDS; Covid-19; Mechanical ventilation; Non-invasive ventilation","Costa","Roberta","Istituto di Anestesiologia e Rianimazione, Università Cattolica del Sacro Cuore, Rome, Italy",NA
"611","34217695","10.1016/j.pulmoe.2021.05.009","Comparative bench study evaluation of a modified snorkeling mask used during COVID-19 pandemic and standard interfaces for non-invasive ventilation.","The aim of this bench study is to compare the standard NIV and nCPAP devices (Helmet, H; Full face mask, FFM) with a modified full face snorkeling mask used during COVID-19 pandemic. A mannequin was connected to an active lung simulator. The inspiratory and expiratory variations in airways pressure observed with a high simulated effort, were determined relative to the preset CPAP level. NIV was applied in Pressure Support Mode at two simulated respiratory rates and two cycling-off flow threshold","2021","07","08","Pulmonology","Pulmonology","ARDS; Covid-19; Mechanical ventilation; Non-invasive ventilation","Gullì","Antonio","Department of Emergency, Intensive Care Medicine and Anesthesia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"612","34217695","10.1016/j.pulmoe.2021.05.009","Comparative bench study evaluation of a modified snorkeling mask used during COVID-19 pandemic and standard interfaces for non-invasive ventilation.","The aim of this bench study is to compare the standard NIV and nCPAP devices (Helmet, H; Full face mask, FFM) with a modified full face snorkeling mask used during COVID-19 pandemic. A mannequin was connected to an active lung simulator. The inspiratory and expiratory variations in airways pressure observed with a high simulated effort, were determined relative to the preset CPAP level. NIV was applied in Pressure Support Mode at two simulated respiratory rates and two cycling-off flow threshold","2021","07","08","Pulmonology","Pulmonology","ARDS; Covid-19; Mechanical ventilation; Non-invasive ventilation","Scapigliati","Andrea","Department of Emergency, Intensive Care Medicine and Anesthesia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"613","34217695","10.1016/j.pulmoe.2021.05.009","Comparative bench study evaluation of a modified snorkeling mask used during COVID-19 pandemic and standard interfaces for non-invasive ventilation.","The aim of this bench study is to compare the standard NIV and nCPAP devices (Helmet, H; Full face mask, FFM) with a modified full face snorkeling mask used during COVID-19 pandemic. A mannequin was connected to an active lung simulator. The inspiratory and expiratory variations in airways pressure observed with a high simulated effort, were determined relative to the preset CPAP level. NIV was applied in Pressure Support Mode at two simulated respiratory rates and two cycling-off flow threshold","2021","07","08","Pulmonology","Pulmonology","ARDS; Covid-19; Mechanical ventilation; Non-invasive ventilation","Antonelli","Massimo","Department of Emergency, Intensive Care Medicine and Anesthesia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"614","34217695","10.1016/j.pulmoe.2021.05.009","Comparative bench study evaluation of a modified snorkeling mask used during COVID-19 pandemic and standard interfaces for non-invasive ventilation.","The aim of this bench study is to compare the standard NIV and nCPAP devices (Helmet, H; Full face mask, FFM) with a modified full face snorkeling mask used during COVID-19 pandemic. A mannequin was connected to an active lung simulator. The inspiratory and expiratory variations in airways pressure observed with a high simulated effort, were determined relative to the preset CPAP level. NIV was applied in Pressure Support Mode at two simulated respiratory rates and two cycling-off flow threshold","2021","07","08","Pulmonology","Pulmonology","ARDS; Covid-19; Mechanical ventilation; Non-invasive ventilation","Conti","Giorgio","Department of Emergency, Intensive Care Medicine and Anesthesia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"615","34217692","10.1016/j.athoracsur.2021.06.016","Lung Cancer Surgery in the early phase after acute COVID-19 pneumonitis.","A 65-year-old female was diagnosed with early-stage lung cancer in 2020 and scheduled for robotic assisted left upper lobectomy. Unfortunately, the patient contracted symptomatic COVID-19, resulting in postponement of lung resection. 6 weeks following acute infection she was admitted for surgery. A pre-operative computed tomography scan showed widespread interstitial pneumonitis. However, the surgery went ahead given concerns over tumour progression, albeit with a lesser resection to preserve lu","2021","07","08","Ann Thorac Surg","The Annals of thoracic surgery",NA,"Robinson","Dean P","Guy's King's and St Thomas' School of Medical Education, London, United Kingdom. Electronic address: Dean.robinson@kcl.ac","Dean.robinson@kcl.ac.uk"
"616","34217692","10.1016/j.athoracsur.2021.06.016","Lung Cancer Surgery in the early phase after acute COVID-19 pneumonitis.","A 65-year-old female was diagnosed with early-stage lung cancer in 2020 and scheduled for robotic assisted left upper lobectomy. Unfortunately, the patient contracted symptomatic COVID-19, resulting in postponement of lung resection. 6 weeks following acute infection she was admitted for surgery. A pre-operative computed tomography scan showed widespread interstitial pneumonitis. However, the surgery went ahead given concerns over tumour progression, albeit with a lesser resection to preserve lu","2021","07","08","Ann Thorac Surg","The Annals of thoracic surgery",NA,"Smith","Alexander E","Department of Thoracic Surgery, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom",NA
"617","34217692","10.1016/j.athoracsur.2021.06.016","Lung Cancer Surgery in the early phase after acute COVID-19 pneumonitis.","A 65-year-old female was diagnosed with early-stage lung cancer in 2020 and scheduled for robotic assisted left upper lobectomy. Unfortunately, the patient contracted symptomatic COVID-19, resulting in postponement of lung resection. 6 weeks following acute infection she was admitted for surgery. A pre-operative computed tomography scan showed widespread interstitial pneumonitis. However, the surgery went ahead given concerns over tumour progression, albeit with a lesser resection to preserve lu","2021","07","08","Ann Thorac Surg","The Annals of thoracic surgery",NA,"Okiror","Lawrence","Department of Thoracic Surgery, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom",NA
"618","34217677","10.1016/j.clml.2021.05.013","Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell-Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy.",NA,"2021","07","15","Clin Lymphoma Myeloma Leuk","Clinical lymphoma, myeloma &amp; leukemia","B cell depletion convalescent hyperimmune plasma remdesivir; Rituximab; SARS-CoV-2; non-Hodgkin lymphoma","Furlan","Anna","Hematology Unit, Azienda ULSS2 Marca Trevigiana, Italy. Electronic address: anna.furlan@aulss2.veneto","anna.furlan@aulss2.veneto.it"
"619","34217677","10.1016/j.clml.2021.05.013","Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell-Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy.",NA,"2021","07","15","Clin Lymphoma Myeloma Leuk","Clinical lymphoma, myeloma &amp; leukemia","B cell depletion convalescent hyperimmune plasma remdesivir; Rituximab; SARS-CoV-2; non-Hodgkin lymphoma","Forner","Gabriella","Infectious Disease Unit, Azienda ULSS2 Marca Trevigiana, Italy",NA
"620","34217677","10.1016/j.clml.2021.05.013","Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell-Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy.",NA,"2021","07","15","Clin Lymphoma Myeloma Leuk","Clinical lymphoma, myeloma &amp; leukemia","B cell depletion convalescent hyperimmune plasma remdesivir; Rituximab; SARS-CoV-2; non-Hodgkin lymphoma","Cipriani","Ludovica","Infectious Disease Unit, Azienda ULSS2 Marca Trevigiana, Italy",NA
"621","34217677","10.1016/j.clml.2021.05.013","Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell-Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy.",NA,"2021","07","15","Clin Lymphoma Myeloma Leuk","Clinical lymphoma, myeloma &amp; leukemia","B cell depletion convalescent hyperimmune plasma remdesivir; Rituximab; SARS-CoV-2; non-Hodgkin lymphoma","Vian","Elisa","Microbiology Unit, Azienda ULSS2 Marca Trevigiana, Italy",NA
"622","34217677","10.1016/j.clml.2021.05.013","Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell-Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy.",NA,"2021","07","15","Clin Lymphoma Myeloma Leuk","Clinical lymphoma, myeloma &amp; leukemia","B cell depletion convalescent hyperimmune plasma remdesivir; Rituximab; SARS-CoV-2; non-Hodgkin lymphoma","Rigoli","Roberto","Microbiology Unit, Azienda ULSS2 Marca Trevigiana, Italy",NA
"623","34217677","10.1016/j.clml.2021.05.013","Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell-Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy.",NA,"2021","07","15","Clin Lymphoma Myeloma Leuk","Clinical lymphoma, myeloma &amp; leukemia","B cell depletion convalescent hyperimmune plasma remdesivir; Rituximab; SARS-CoV-2; non-Hodgkin lymphoma","Gherlinzoni","Filippo","Hematology Unit, Azienda ULSS2 Marca Trevigiana, Italy",NA
"624","34217677","10.1016/j.clml.2021.05.013","Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell-Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy.",NA,"2021","07","15","Clin Lymphoma Myeloma Leuk","Clinical lymphoma, myeloma &amp; leukemia","B cell depletion convalescent hyperimmune plasma remdesivir; Rituximab; SARS-CoV-2; non-Hodgkin lymphoma","Scotton","Piergiorgio","Infectious Disease Unit, Azienda ULSS2 Marca Trevigiana, Italy",NA
"625","34217672","10.1016/j.rceng.2021.01.006","Changes in the Objective Structured Clinical Examination (OSCE) of University Schools of Medicine during COVID-19. Experience with a computer-based case simulation OSCE (CCS-OSCE).","The COVID-19 pandemic has forced universities to move the completion of university studies online. Spain's National Conference of Medical School Deans coordinates an objective, structured clinical competency assessment called the Objective Structured Clinical Examination (OSCE), which consists of 20 face-to-face test sections for students in their sixth year of study. As a result of the pandemic, a computer-based case simulation OSCE (CCS-OSCE) has been designed. The objective of this article is","2021","07","04","Rev Clin Esp (Barc)","Revista clinica espanola","Casos clínicos computarizados simulados; Computer-based case simulation; ECOE; España; Examen clínico objetivo y estructurado; OSCE; Objective structured clinical examination; Online; Spain; Virtual","García-Seoane","J J","Coordinador General de la ECOE-CNDFME, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain",NA
"626","34217672","10.1016/j.rceng.2021.01.006","Changes in the Objective Structured Clinical Examination (OSCE) of University Schools of Medicine during COVID-19. Experience with a computer-based case simulation OSCE (CCS-OSCE).","The COVID-19 pandemic has forced universities to move the completion of university studies online. Spain's National Conference of Medical School Deans coordinates an objective, structured clinical competency assessment called the Objective Structured Clinical Examination (OSCE), which consists of 20 face-to-face test sections for students in their sixth year of study. As a result of the pandemic, a computer-based case simulation OSCE (CCS-OSCE) has been designed. The objective of this article is","2021","07","04","Rev Clin Esp (Barc)","Revista clinica espanola","Casos clínicos computarizados simulados; Computer-based case simulation; ECOE; España; Examen clínico objetivo y estructurado; OSCE; Objective structured clinical examination; Online; Spain; Virtual","Ramos-Rincón","J M","Facultad de Medicina, Universidad Miguel Hernández de Elche, Sant Joan d'Alacant, Alicante, Spain. Electronic address: jose.ramosr@umh","jose.ramosr@umh.es"
"627","34217672","10.1016/j.rceng.2021.01.006","Changes in the Objective Structured Clinical Examination (OSCE) of University Schools of Medicine during COVID-19. Experience with a computer-based case simulation OSCE (CCS-OSCE).","The COVID-19 pandemic has forced universities to move the completion of university studies online. Spain's National Conference of Medical School Deans coordinates an objective, structured clinical competency assessment called the Objective Structured Clinical Examination (OSCE), which consists of 20 face-to-face test sections for students in their sixth year of study. As a result of the pandemic, a computer-based case simulation OSCE (CCS-OSCE) has been designed. The objective of this article is","2021","07","04","Rev Clin Esp (Barc)","Revista clinica espanola","Casos clínicos computarizados simulados; Computer-based case simulation; ECOE; España; Examen clínico objetivo y estructurado; OSCE; Objective structured clinical examination; Online; Spain; Virtual","Lara-Muñoz","J P","Presidente CNDFME, Facultad de Medicina, Universidad de Málaga, Málaga, Spain",NA
"628","34217670","10.1016/j.intimp.2021.107693","Comment on: Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia.",NA,"2021","07","08","Int Immunopharmacol","International immunopharmacology",NA,"Hashemian","Seyed MohammadReza","Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran","Iran.criticalcare@yahoo.com"
"629","34217670","10.1016/j.intimp.2021.107693","Comment on: Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia.",NA,"2021","07","08","Int Immunopharmacol","International immunopharmacology",NA,"Khoundabi","Batoul","Iran Helal Institute of Applied Science and Technology, Research Center for Health Management in Mass Gathering, Red Crescent Society of the Islamic Republic of Iran, Tehran, Iran",NA
"630","34217670","10.1016/j.intimp.2021.107693","Comment on: Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia.",NA,"2021","07","08","Int Immunopharmacol","International immunopharmacology",NA,"Velayati","Ali Akbar","Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"631","34217662","10.1016/j.jacep.2021.04.011","Prone and Supine 12-Lead ECG Comparisons: Implications for Cardiac Assessment During Prone Ventilation for COVID-19.","This study sought to describe expected changes in a mirror-image prone electrocardiogram (ECG) compared with normal supine, including a range of cardiac conditions. Unwell COVID-19 patients are at risk of cardiac complications. Prone ventilation is recommended but poses practical challenges to acquisition of a 12-lead ECG. The effects of prone positioning on the ECG remain unknown. 100 patients each underwent 3 ECGs: standard supine front (SF); prone position with precordial leads attached to fr","2021","07","08","JACC Clin Electrophysiol","JACC. Clinical electrophysiology","COVID-19; electrocardiogram; prone; supine","Chieng","David","Baker Heart and Diabetes Research Institute, Melbourne, Australia",NA
"632","34217662","10.1016/j.jacep.2021.04.011","Prone and Supine 12-Lead ECG Comparisons: Implications for Cardiac Assessment During Prone Ventilation for COVID-19.","This study sought to describe expected changes in a mirror-image prone electrocardiogram (ECG) compared with normal supine, including a range of cardiac conditions. Unwell COVID-19 patients are at risk of cardiac complications. Prone ventilation is recommended but poses practical challenges to acquisition of a 12-lead ECG. The effects of prone positioning on the ECG remain unknown. 100 patients each underwent 3 ECGs: standard supine front (SF); prone position with precordial leads attached to fr","2021","07","08","JACC Clin Electrophysiol","JACC. Clinical electrophysiology","COVID-19; electrocardiogram; prone; supine","Sugumar","Hariharan","Baker Heart and Diabetes Research Institute, Melbourne, Australia",NA
"633","34217662","10.1016/j.jacep.2021.04.011","Prone and Supine 12-Lead ECG Comparisons: Implications for Cardiac Assessment During Prone Ventilation for COVID-19.","This study sought to describe expected changes in a mirror-image prone electrocardiogram (ECG) compared with normal supine, including a range of cardiac conditions. Unwell COVID-19 patients are at risk of cardiac complications. Prone ventilation is recommended but poses practical challenges to acquisition of a 12-lead ECG. The effects of prone positioning on the ECG remain unknown. 100 patients each underwent 3 ECGs: standard supine front (SF); prone position with precordial leads attached to fr","2021","07","08","JACC Clin Electrophysiol","JACC. Clinical electrophysiology","COVID-19; electrocardiogram; prone; supine","Kaye","David","Baker Heart and Diabetes Research Institute, Melbourne, Australia",NA
"634","34217662","10.1016/j.jacep.2021.04.011","Prone and Supine 12-Lead ECG Comparisons: Implications for Cardiac Assessment During Prone Ventilation for COVID-19.","This study sought to describe expected changes in a mirror-image prone electrocardiogram (ECG) compared with normal supine, including a range of cardiac conditions. Unwell COVID-19 patients are at risk of cardiac complications. Prone ventilation is recommended but poses practical challenges to acquisition of a 12-lead ECG. The effects of prone positioning on the ECG remain unknown. 100 patients each underwent 3 ECGs: standard supine front (SF); prone position with precordial leads attached to fr","2021","07","08","JACC Clin Electrophysiol","JACC. Clinical electrophysiology","COVID-19; electrocardiogram; prone; supine","Azzopardi","Sonia","Baker Heart and Diabetes Research Institute, Melbourne, Australia",NA
"635","34217662","10.1016/j.jacep.2021.04.011","Prone and Supine 12-Lead ECG Comparisons: Implications for Cardiac Assessment During Prone Ventilation for COVID-19.","This study sought to describe expected changes in a mirror-image prone electrocardiogram (ECG) compared with normal supine, including a range of cardiac conditions. Unwell COVID-19 patients are at risk of cardiac complications. Prone ventilation is recommended but poses practical challenges to acquisition of a 12-lead ECG. The effects of prone positioning on the ECG remain unknown. 100 patients each underwent 3 ECGs: standard supine front (SF); prone position with precordial leads attached to fr","2021","07","08","JACC Clin Electrophysiol","JACC. Clinical electrophysiology","COVID-19; electrocardiogram; prone; supine","Vizi","Donna","Department of Cardiology, Alfred Hospital, Melbourne, Australia",NA
"636","34217662","10.1016/j.jacep.2021.04.011","Prone and Supine 12-Lead ECG Comparisons: Implications for Cardiac Assessment During Prone Ventilation for COVID-19.","This study sought to describe expected changes in a mirror-image prone electrocardiogram (ECG) compared with normal supine, including a range of cardiac conditions. Unwell COVID-19 patients are at risk of cardiac complications. Prone ventilation is recommended but poses practical challenges to acquisition of a 12-lead ECG. The effects of prone positioning on the ECG remain unknown. 100 patients each underwent 3 ECGs: standard supine front (SF); prone position with precordial leads attached to fr","2021","07","08","JACC Clin Electrophysiol","JACC. Clinical electrophysiology","COVID-19; electrocardiogram; prone; supine","Rossi","Erina","Department of Cardiology, Alfred Hospital, Melbourne, Australia",NA
"637","34217662","10.1016/j.jacep.2021.04.011","Prone and Supine 12-Lead ECG Comparisons: Implications for Cardiac Assessment During Prone Ventilation for COVID-19.","This study sought to describe expected changes in a mirror-image prone electrocardiogram (ECG) compared with normal supine, including a range of cardiac conditions. Unwell COVID-19 patients are at risk of cardiac complications. Prone ventilation is recommended but poses practical challenges to acquisition of a 12-lead ECG. The effects of prone positioning on the ECG remain unknown. 100 patients each underwent 3 ECGs: standard supine front (SF); prone position with precordial leads attached to fr","2021","07","08","JACC Clin Electrophysiol","JACC. Clinical electrophysiology","COVID-19; electrocardiogram; prone; supine","Voskoboinik","Aleksandr","Baker Heart and Diabetes Research Institute, Melbourne, Australia",NA
"638","34217662","10.1016/j.jacep.2021.04.011","Prone and Supine 12-Lead ECG Comparisons: Implications for Cardiac Assessment During Prone Ventilation for COVID-19.","This study sought to describe expected changes in a mirror-image prone electrocardiogram (ECG) compared with normal supine, including a range of cardiac conditions. Unwell COVID-19 patients are at risk of cardiac complications. Prone ventilation is recommended but poses practical challenges to acquisition of a 12-lead ECG. The effects of prone positioning on the ECG remain unknown. 100 patients each underwent 3 ECGs: standard supine front (SF); prone position with precordial leads attached to fr","2021","07","08","JACC Clin Electrophysiol","JACC. Clinical electrophysiology","COVID-19; electrocardiogram; prone; supine","Prabhu","Sandeep","Baker Heart and Diabetes Research Institute, Melbourne, Australia",NA
"639","34217662","10.1016/j.jacep.2021.04.011","Prone and Supine 12-Lead ECG Comparisons: Implications for Cardiac Assessment During Prone Ventilation for COVID-19.","This study sought to describe expected changes in a mirror-image prone electrocardiogram (ECG) compared with normal supine, including a range of cardiac conditions. Unwell COVID-19 patients are at risk of cardiac complications. Prone ventilation is recommended but poses practical challenges to acquisition of a 12-lead ECG. The effects of prone positioning on the ECG remain unknown. 100 patients each underwent 3 ECGs: standard supine front (SF); prone position with precordial leads attached to fr","2021","07","08","JACC Clin Electrophysiol","JACC. Clinical electrophysiology","COVID-19; electrocardiogram; prone; supine","Ling","Liang-Han","Baker Heart and Diabetes Research Institute, Melbourne, Australia",NA
"640","34217662","10.1016/j.jacep.2021.04.011","Prone and Supine 12-Lead ECG Comparisons: Implications for Cardiac Assessment During Prone Ventilation for COVID-19.","This study sought to describe expected changes in a mirror-image prone electrocardiogram (ECG) compared with normal supine, including a range of cardiac conditions. Unwell COVID-19 patients are at risk of cardiac complications. Prone ventilation is recommended but poses practical challenges to acquisition of a 12-lead ECG. The effects of prone positioning on the ECG remain unknown. 100 patients each underwent 3 ECGs: standard supine front (SF); prone position with precordial leads attached to fr","2021","07","08","JACC Clin Electrophysiol","JACC. Clinical electrophysiology","COVID-19; electrocardiogram; prone; supine","Lee","Geoffrey","University of Melbourne, Melbourne, Australia",NA
"641","34217662","10.1016/j.jacep.2021.04.011","Prone and Supine 12-Lead ECG Comparisons: Implications for Cardiac Assessment During Prone Ventilation for COVID-19.","This study sought to describe expected changes in a mirror-image prone electrocardiogram (ECG) compared with normal supine, including a range of cardiac conditions. Unwell COVID-19 patients are at risk of cardiac complications. Prone ventilation is recommended but poses practical challenges to acquisition of a 12-lead ECG. The effects of prone positioning on the ECG remain unknown. 100 patients each underwent 3 ECGs: standard supine front (SF); prone position with precordial leads attached to fr","2021","07","08","JACC Clin Electrophysiol","JACC. Clinical electrophysiology","COVID-19; electrocardiogram; prone; supine","Kalman","Jonathan M","University of Melbourne, Melbourne, Australia",NA
"642","34217662","10.1016/j.jacep.2021.04.011","Prone and Supine 12-Lead ECG Comparisons: Implications for Cardiac Assessment During Prone Ventilation for COVID-19.","This study sought to describe expected changes in a mirror-image prone electrocardiogram (ECG) compared with normal supine, including a range of cardiac conditions. Unwell COVID-19 patients are at risk of cardiac complications. Prone ventilation is recommended but poses practical challenges to acquisition of a 12-lead ECG. The effects of prone positioning on the ECG remain unknown. 100 patients each underwent 3 ECGs: standard supine front (SF); prone position with precordial leads attached to fr","2021","07","08","JACC Clin Electrophysiol","JACC. Clinical electrophysiology","COVID-19; electrocardiogram; prone; supine","Kistler","Peter M","Baker Heart and Diabetes Research Institute, Melbourne, Australia","Peter.kistler@baker.edu.au"
"643","34217634","10.1016/j.jmii.2021.05.006","The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak.","Coronavirus disease 2019 (COVID-19) manifests symptoms as common etiologies of respiratory tract infections (RTIs). During the pandemic of COVID-19, identifying the etiologies correctly from patients with RTI symptoms was crucial in not only disease control but preventing healthcare system from collapsing. By applying sensitive PCR-based molecular assays, we detected the etiologic agents and delineated the epidemiologic picture of RTIs in the early phase of COVID-19 pandemic. From December 2019 ","2021","07","08","J Microbiol Immunol Infect","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","Coronavirus disease 2019; Epidemiology; Etiologies; Respiratory tract infections; Seasonal coronavirus","Chen","Andrew Po-Liang","Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan",NA
"644","34217634","10.1016/j.jmii.2021.05.006","The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak.","Coronavirus disease 2019 (COVID-19) manifests symptoms as common etiologies of respiratory tract infections (RTIs). During the pandemic of COVID-19, identifying the etiologies correctly from patients with RTI symptoms was crucial in not only disease control but preventing healthcare system from collapsing. By applying sensitive PCR-based molecular assays, we detected the etiologic agents and delineated the epidemiologic picture of RTIs in the early phase of COVID-19 pandemic. From December 2019 ","2021","07","08","J Microbiol Immunol Infect","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","Coronavirus disease 2019; Epidemiology; Etiologies; Respiratory tract infections; Seasonal coronavirus","Chuang","Chien","Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan",NA
"645","34217634","10.1016/j.jmii.2021.05.006","The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak.","Coronavirus disease 2019 (COVID-19) manifests symptoms as common etiologies of respiratory tract infections (RTIs). During the pandemic of COVID-19, identifying the etiologies correctly from patients with RTI symptoms was crucial in not only disease control but preventing healthcare system from collapsing. By applying sensitive PCR-based molecular assays, we detected the etiologic agents and delineated the epidemiologic picture of RTIs in the early phase of COVID-19 pandemic. From December 2019 ","2021","07","08","J Microbiol Immunol Infect","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","Coronavirus disease 2019; Epidemiology; Etiologies; Respiratory tract infections; Seasonal coronavirus","Huang","Ying-Chi","Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan",NA
"646","34217634","10.1016/j.jmii.2021.05.006","The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak.","Coronavirus disease 2019 (COVID-19) manifests symptoms as common etiologies of respiratory tract infections (RTIs). During the pandemic of COVID-19, identifying the etiologies correctly from patients with RTI symptoms was crucial in not only disease control but preventing healthcare system from collapsing. By applying sensitive PCR-based molecular assays, we detected the etiologic agents and delineated the epidemiologic picture of RTIs in the early phase of COVID-19 pandemic. From December 2019 ","2021","07","08","J Microbiol Immunol Infect","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","Coronavirus disease 2019; Epidemiology; Etiologies; Respiratory tract infections; Seasonal coronavirus","Wu","Ping-Feng","Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan",NA
"647","34217634","10.1016/j.jmii.2021.05.006","The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak.","Coronavirus disease 2019 (COVID-19) manifests symptoms as common etiologies of respiratory tract infections (RTIs). During the pandemic of COVID-19, identifying the etiologies correctly from patients with RTI symptoms was crucial in not only disease control but preventing healthcare system from collapsing. By applying sensitive PCR-based molecular assays, we detected the etiologic agents and delineated the epidemiologic picture of RTIs in the early phase of COVID-19 pandemic. From December 2019 ","2021","07","08","J Microbiol Immunol Infect","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","Coronavirus disease 2019; Epidemiology; Etiologies; Respiratory tract infections; Seasonal coronavirus","Huang","Shiang-Fen","Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan",NA
"648","34217634","10.1016/j.jmii.2021.05.006","The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak.","Coronavirus disease 2019 (COVID-19) manifests symptoms as common etiologies of respiratory tract infections (RTIs). During the pandemic of COVID-19, identifying the etiologies correctly from patients with RTI symptoms was crucial in not only disease control but preventing healthcare system from collapsing. By applying sensitive PCR-based molecular assays, we detected the etiologic agents and delineated the epidemiologic picture of RTIs in the early phase of COVID-19 pandemic. From December 2019 ","2021","07","08","J Microbiol Immunol Infect","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","Coronavirus disease 2019; Epidemiology; Etiologies; Respiratory tract infections; Seasonal coronavirus","Cheng","Nai-Cheng","Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan",NA
"649","34217634","10.1016/j.jmii.2021.05.006","The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak.","Coronavirus disease 2019 (COVID-19) manifests symptoms as common etiologies of respiratory tract infections (RTIs). During the pandemic of COVID-19, identifying the etiologies correctly from patients with RTI symptoms was crucial in not only disease control but preventing healthcare system from collapsing. By applying sensitive PCR-based molecular assays, we detected the etiologic agents and delineated the epidemiologic picture of RTIs in the early phase of COVID-19 pandemic. From December 2019 ","2021","07","08","J Microbiol Immunol Infect","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","Coronavirus disease 2019; Epidemiology; Etiologies; Respiratory tract infections; Seasonal coronavirus","Lin","Yi-Tsung","Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan",NA
"650","34217634","10.1016/j.jmii.2021.05.006","The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak.","Coronavirus disease 2019 (COVID-19) manifests symptoms as common etiologies of respiratory tract infections (RTIs). During the pandemic of COVID-19, identifying the etiologies correctly from patients with RTI symptoms was crucial in not only disease control but preventing healthcare system from collapsing. By applying sensitive PCR-based molecular assays, we detected the etiologic agents and delineated the epidemiologic picture of RTIs in the early phase of COVID-19 pandemic. From December 2019 ","2021","07","08","J Microbiol Immunol Infect","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","Coronavirus disease 2019; Epidemiology; Etiologies; Respiratory tract infections; Seasonal coronavirus","Chen","Su-Jung","Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan",NA
"651","34217634","10.1016/j.jmii.2021.05.006","The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak.","Coronavirus disease 2019 (COVID-19) manifests symptoms as common etiologies of respiratory tract infections (RTIs). During the pandemic of COVID-19, identifying the etiologies correctly from patients with RTI symptoms was crucial in not only disease control but preventing healthcare system from collapsing. By applying sensitive PCR-based molecular assays, we detected the etiologic agents and delineated the epidemiologic picture of RTIs in the early phase of COVID-19 pandemic. From December 2019 ","2021","07","08","J Microbiol Immunol Infect","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","Coronavirus disease 2019; Epidemiology; Etiologies; Respiratory tract infections; Seasonal coronavirus","Huang","Ling-Ju","Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan",NA
"652","34217634","10.1016/j.jmii.2021.05.006","The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak.","Coronavirus disease 2019 (COVID-19) manifests symptoms as common etiologies of respiratory tract infections (RTIs). During the pandemic of COVID-19, identifying the etiologies correctly from patients with RTI symptoms was crucial in not only disease control but preventing healthcare system from collapsing. By applying sensitive PCR-based molecular assays, we detected the etiologic agents and delineated the epidemiologic picture of RTIs in the early phase of COVID-19 pandemic. From December 2019 ","2021","07","08","J Microbiol Immunol Infect","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","Coronavirus disease 2019; Epidemiology; Etiologies; Respiratory tract infections; Seasonal coronavirus","Lee","Chia-Lin","Division Microbiology, Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan",NA
"653","34217634","10.1016/j.jmii.2021.05.006","The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak.","Coronavirus disease 2019 (COVID-19) manifests symptoms as common etiologies of respiratory tract infections (RTIs). During the pandemic of COVID-19, identifying the etiologies correctly from patients with RTI symptoms was crucial in not only disease control but preventing healthcare system from collapsing. By applying sensitive PCR-based molecular assays, we detected the etiologic agents and delineated the epidemiologic picture of RTIs in the early phase of COVID-19 pandemic. From December 2019 ","2021","07","08","J Microbiol Immunol Infect","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","Coronavirus disease 2019; Epidemiology; Etiologies; Respiratory tract infections; Seasonal coronavirus","Chen","Hsin-Pai","Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan","chenhp1970tw@gmail.com"
"654","34217634","10.1016/j.jmii.2021.05.006","The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak.","Coronavirus disease 2019 (COVID-19) manifests symptoms as common etiologies of respiratory tract infections (RTIs). During the pandemic of COVID-19, identifying the etiologies correctly from patients with RTI symptoms was crucial in not only disease control but preventing healthcare system from collapsing. By applying sensitive PCR-based molecular assays, we detected the etiologic agents and delineated the epidemiologic picture of RTIs in the early phase of COVID-19 pandemic. From December 2019 ","2021","07","08","J Microbiol Immunol Infect","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","Coronavirus disease 2019; Epidemiology; Etiologies; Respiratory tract infections; Seasonal coronavirus","Chan","Yu-Jiun","Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan",NA
"655","34217634","10.1016/j.jmii.2021.05.006","The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak.","Coronavirus disease 2019 (COVID-19) manifests symptoms as common etiologies of respiratory tract infections (RTIs). During the pandemic of COVID-19, identifying the etiologies correctly from patients with RTI symptoms was crucial in not only disease control but preventing healthcare system from collapsing. By applying sensitive PCR-based molecular assays, we detected the etiologic agents and delineated the epidemiologic picture of RTIs in the early phase of COVID-19 pandemic. From December 2019 ","2021","07","08","J Microbiol Immunol Infect","Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","Coronavirus disease 2019; Epidemiology; Etiologies; Respiratory tract infections; Seasonal coronavirus","Wang","Fu-Der","Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan",NA
"656","34217617","10.1016/j.surge.2021.05.005","The future of orthopaedic surgical education: Where do we go now?","COVID-19 will undoubtedly change the future landscape of medical and surgical education. The economic and environmental advantages of virtual learning are clear, while access to a wider range of resources and subject specialists makes the adoption of virtual learning within surgical education an attractive prospect. This literature review aims to evaluate evidence on the effectiveness of virtual education in orthopaedics and how we might implement positive changes to educational practice in the ","2021","07","04","Surgeon","The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland","Blended approach; E-learning; Face-to-face; Orthopaedic education; Virtual education","Thompson","Joshua W","Department of Trauma and Orthopaedic Surgery, Norfolk and Norwich University Hospitals Foundation Trust, Colney Lane, Norwich, NR4 7UY, United Kingdom. Electronic address: joshua.thompson@doctors.org","joshua.thompson@doctors.org.uk"
"657","34217617","10.1016/j.surge.2021.05.005","The future of orthopaedic surgical education: Where do we go now?","COVID-19 will undoubtedly change the future landscape of medical and surgical education. The economic and environmental advantages of virtual learning are clear, while access to a wider range of resources and subject specialists makes the adoption of virtual learning within surgical education an attractive prospect. This literature review aims to evaluate evidence on the effectiveness of virtual education in orthopaedics and how we might implement positive changes to educational practice in the ","2021","07","04","Surgeon","The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland","Blended approach; E-learning; Face-to-face; Orthopaedic education; Virtual education","Thompson","Emma L","Bryan Cave Leighton Paisner LLP, Governor's House, 5 Laurence, Pountney Hill, London, EC4R 0BR, United Kingdom. Electronic address: emma.thompson@bclplaw","emma.thompson@bclplaw.com"
"658","34217617","10.1016/j.surge.2021.05.005","The future of orthopaedic surgical education: Where do we go now?","COVID-19 will undoubtedly change the future landscape of medical and surgical education. The economic and environmental advantages of virtual learning are clear, while access to a wider range of resources and subject specialists makes the adoption of virtual learning within surgical education an attractive prospect. This literature review aims to evaluate evidence on the effectiveness of virtual education in orthopaedics and how we might implement positive changes to educational practice in the ","2021","07","04","Surgeon","The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland","Blended approach; E-learning; Face-to-face; Orthopaedic education; Virtual education","Sanghrajka","Anish P","Department of Trauma and Orthopaedic Surgery, Norfolk and Norwich University Hospitals Foundation Trust, Colney Lane, Norwich, NR4 7UY, United Kingdom. Electronic address: anish.sanghrajka@nnuh.nhs","anish.sanghrajka@nnuh.nhs.uk"
"659","34217613","10.1016/j.acra.2021.05.024","Incorporation of a Social Virtual Reality Platform into the Residency Recruitment Season.","The Covid-19 pandemic ushered a sudden need for residency programs to develop innovative socially distant and remote approaches to effectively promote their program. Here we describe our experience using the social virtual reality (VR) platform Mozilla Hubs for the pre-interview social during the 2020-2021 radiology residency virtual recruitment season, provide results of a survey sent to assess applicants' attitudes towards the VR pre-interview social, and outline additional use-cases for the e","2021","07","04","Acad Radiol","Academic radiology","Recruitment; Residency; Social VR; Virtual reality","Guichet","Phillip L","Department of Radiology, NYU Langone Health, 660 First Avenue, 3(rd) Floor, New York, NY 10016. Electronic address: phillip.guichet@nyulangone","phillip.guichet@nyulangone.org"
"660","34217613","10.1016/j.acra.2021.05.024","Incorporation of a Social Virtual Reality Platform into the Residency Recruitment Season.","The Covid-19 pandemic ushered a sudden need for residency programs to develop innovative socially distant and remote approaches to effectively promote their program. Here we describe our experience using the social virtual reality (VR) platform Mozilla Hubs for the pre-interview social during the 2020-2021 radiology residency virtual recruitment season, provide results of a survey sent to assess applicants' attitudes towards the VR pre-interview social, and outline additional use-cases for the e","2021","07","04","Acad Radiol","Academic radiology","Recruitment; Residency; Social VR; Virtual reality","Huang","Jeffrey","Department of Radiology, NYU Langone Health, 660 First Avenue, 3(rd) Floor, New York, NY 10016",NA
"661","34217613","10.1016/j.acra.2021.05.024","Incorporation of a Social Virtual Reality Platform into the Residency Recruitment Season.","The Covid-19 pandemic ushered a sudden need for residency programs to develop innovative socially distant and remote approaches to effectively promote their program. Here we describe our experience using the social virtual reality (VR) platform Mozilla Hubs for the pre-interview social during the 2020-2021 radiology residency virtual recruitment season, provide results of a survey sent to assess applicants' attitudes towards the VR pre-interview social, and outline additional use-cases for the e","2021","07","04","Acad Radiol","Academic radiology","Recruitment; Residency; Social VR; Virtual reality","Zhan","Chenyang","Department of Radiology, NYU Langone Health, 660 First Avenue, 3(rd) Floor, New York, NY 10016",NA
"662","34217613","10.1016/j.acra.2021.05.024","Incorporation of a Social Virtual Reality Platform into the Residency Recruitment Season.","The Covid-19 pandemic ushered a sudden need for residency programs to develop innovative socially distant and remote approaches to effectively promote their program. Here we describe our experience using the social virtual reality (VR) platform Mozilla Hubs for the pre-interview social during the 2020-2021 radiology residency virtual recruitment season, provide results of a survey sent to assess applicants' attitudes towards the VR pre-interview social, and outline additional use-cases for the e","2021","07","04","Acad Radiol","Academic radiology","Recruitment; Residency; Social VR; Virtual reality","Millet","Alexandra","Department of Radiology, NYU Langone Health, 660 First Avenue, 3(rd) Floor, New York, NY 10016",NA
"663","34217613","10.1016/j.acra.2021.05.024","Incorporation of a Social Virtual Reality Platform into the Residency Recruitment Season.","The Covid-19 pandemic ushered a sudden need for residency programs to develop innovative socially distant and remote approaches to effectively promote their program. Here we describe our experience using the social virtual reality (VR) platform Mozilla Hubs for the pre-interview social during the 2020-2021 radiology residency virtual recruitment season, provide results of a survey sent to assess applicants' attitudes towards the VR pre-interview social, and outline additional use-cases for the e","2021","07","04","Acad Radiol","Academic radiology","Recruitment; Residency; Social VR; Virtual reality","Kulkarni","Kopal","Department of Radiology, NYU Langone Health, 660 First Avenue, 3(rd) Floor, New York, NY 10016",NA
"664","34217613","10.1016/j.acra.2021.05.024","Incorporation of a Social Virtual Reality Platform into the Residency Recruitment Season.","The Covid-19 pandemic ushered a sudden need for residency programs to develop innovative socially distant and remote approaches to effectively promote their program. Here we describe our experience using the social virtual reality (VR) platform Mozilla Hubs for the pre-interview social during the 2020-2021 radiology residency virtual recruitment season, provide results of a survey sent to assess applicants' attitudes towards the VR pre-interview social, and outline additional use-cases for the e","2021","07","04","Acad Radiol","Academic radiology","Recruitment; Residency; Social VR; Virtual reality","Chhor","Chloe","Department of Radiology, NYU Langone Health, 660 First Avenue, 3(rd) Floor, New York, NY 10016",NA
"665","34217613","10.1016/j.acra.2021.05.024","Incorporation of a Social Virtual Reality Platform into the Residency Recruitment Season.","The Covid-19 pandemic ushered a sudden need for residency programs to develop innovative socially distant and remote approaches to effectively promote their program. Here we describe our experience using the social virtual reality (VR) platform Mozilla Hubs for the pre-interview social during the 2020-2021 radiology residency virtual recruitment season, provide results of a survey sent to assess applicants' attitudes towards the VR pre-interview social, and outline additional use-cases for the e","2021","07","04","Acad Radiol","Academic radiology","Recruitment; Residency; Social VR; Virtual reality","Mercado","Cecilia","Department of Radiology, NYU Langone Health, 660 First Avenue, 3(rd) Floor, New York, NY 10016",NA
"666","34217613","10.1016/j.acra.2021.05.024","Incorporation of a Social Virtual Reality Platform into the Residency Recruitment Season.","The Covid-19 pandemic ushered a sudden need for residency programs to develop innovative socially distant and remote approaches to effectively promote their program. Here we describe our experience using the social virtual reality (VR) platform Mozilla Hubs for the pre-interview social during the 2020-2021 radiology residency virtual recruitment season, provide results of a survey sent to assess applicants' attitudes towards the VR pre-interview social, and outline additional use-cases for the e","2021","07","04","Acad Radiol","Academic radiology","Recruitment; Residency; Social VR; Virtual reality","Fefferman","Nancy","Department of Radiology, NYU Langone Health, 660 First Avenue, 3(rd) Floor, New York, NY 10016",NA
"667","34217601","10.1016/j.transci.2021.103160","Use of face mask by blood donors during the COVID-19 pandemic: Impact on donor hemoglobin concentration: A bane or a boon.","COVID-19 virus has caused the world's deadliest pandemic. Early April 2020, the Delhi Government made it compulsory for people to wear face masks while going outdoors to curb disease spread. Prolonged use of surgical masks during the pandemic has been reported to cause many adverse effects. Intermittent hypoxia has been shown to activate erythropoietin (EPO leading to increased hemoglobin mass. To analyze whether face mask induced intermittent hypoxia has any effect on the hemoglobin levels of h","2021","07","08","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","COVID-19; Donor hemoglobin; Erythropoietin; Face mask; Intermittent hypoxia; Prolonged use","Setia","Rasika","Department of Transfusion Medicine, BLK Superspecialty Hospital, India. Electronic address: rasika_setia@yahoo.co","setia@yahoo.co.in"
"668","34217601","10.1016/j.transci.2021.103160","Use of face mask by blood donors during the COVID-19 pandemic: Impact on donor hemoglobin concentration: A bane or a boon.","COVID-19 virus has caused the world's deadliest pandemic. Early April 2020, the Delhi Government made it compulsory for people to wear face masks while going outdoors to curb disease spread. Prolonged use of surgical masks during the pandemic has been reported to cause many adverse effects. Intermittent hypoxia has been shown to activate erythropoietin (EPO leading to increased hemoglobin mass. To analyze whether face mask induced intermittent hypoxia has any effect on the hemoglobin levels of h","2021","07","08","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","COVID-19; Donor hemoglobin; Erythropoietin; Face mask; Intermittent hypoxia; Prolonged use","Dogra","Mitu","Department of Transfusion Medicine, BLK Superspecialty Hospital, India. Electronic address: drmithu25@yahoo","drmithu25@yahoo.in"
"669","34217601","10.1016/j.transci.2021.103160","Use of face mask by blood donors during the COVID-19 pandemic: Impact on donor hemoglobin concentration: A bane or a boon.","COVID-19 virus has caused the world's deadliest pandemic. Early April 2020, the Delhi Government made it compulsory for people to wear face masks while going outdoors to curb disease spread. Prolonged use of surgical masks during the pandemic has been reported to cause many adverse effects. Intermittent hypoxia has been shown to activate erythropoietin (EPO leading to increased hemoglobin mass. To analyze whether face mask induced intermittent hypoxia has any effect on the hemoglobin levels of h","2021","07","08","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","COVID-19; Donor hemoglobin; Erythropoietin; Face mask; Intermittent hypoxia; Prolonged use","Handoo","Anil","Department of Hematology, BLK Superspecialty Hospital, India. Electronic address: ahhemat@gmail","ahhemat@gmail.com"
"670","34217601","10.1016/j.transci.2021.103160","Use of face mask by blood donors during the COVID-19 pandemic: Impact on donor hemoglobin concentration: A bane or a boon.","COVID-19 virus has caused the world's deadliest pandemic. Early April 2020, the Delhi Government made it compulsory for people to wear face masks while going outdoors to curb disease spread. Prolonged use of surgical masks during the pandemic has been reported to cause many adverse effects. Intermittent hypoxia has been shown to activate erythropoietin (EPO leading to increased hemoglobin mass. To analyze whether face mask induced intermittent hypoxia has any effect on the hemoglobin levels of h","2021","07","08","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","COVID-19; Donor hemoglobin; Erythropoietin; Face mask; Intermittent hypoxia; Prolonged use","Yadav","Ramesh","Department of Transfusion Medicine, BLK Superspecialty Hospital, India. Electronic address: ramesh.yadav@blkhospital","ramesh.yadav@blkhospital.com"
"671","34217601","10.1016/j.transci.2021.103160","Use of face mask by blood donors during the COVID-19 pandemic: Impact on donor hemoglobin concentration: A bane or a boon.","COVID-19 virus has caused the world's deadliest pandemic. Early April 2020, the Delhi Government made it compulsory for people to wear face masks while going outdoors to curb disease spread. Prolonged use of surgical masks during the pandemic has been reported to cause many adverse effects. Intermittent hypoxia has been shown to activate erythropoietin (EPO leading to increased hemoglobin mass. To analyze whether face mask induced intermittent hypoxia has any effect on the hemoglobin levels of h","2021","07","08","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","COVID-19; Donor hemoglobin; Erythropoietin; Face mask; Intermittent hypoxia; Prolonged use","Thangavel","Gokhula Prasath","Department of Transfusion Medicine, BLK Superspecialty Hospital, India. Electronic address: gokhula.prasath@blkhospital","gokhula.prasath@blkhospital.com"
"672","34217601","10.1016/j.transci.2021.103160","Use of face mask by blood donors during the COVID-19 pandemic: Impact on donor hemoglobin concentration: A bane or a boon.","COVID-19 virus has caused the world's deadliest pandemic. Early April 2020, the Delhi Government made it compulsory for people to wear face masks while going outdoors to curb disease spread. Prolonged use of surgical masks during the pandemic has been reported to cause many adverse effects. Intermittent hypoxia has been shown to activate erythropoietin (EPO leading to increased hemoglobin mass. To analyze whether face mask induced intermittent hypoxia has any effect on the hemoglobin levels of h","2021","07","08","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","COVID-19; Donor hemoglobin; Erythropoietin; Face mask; Intermittent hypoxia; Prolonged use","Rahman","Amena Ebadur","Department of Transfusion Medicine, BLK Superspecialty Hospital, India. Electronic address: amena.rahman@blkhospital","amena.rahman@blkhospital.com"
"673","34217573","10.1016/j.vaccine.2021.06.061","Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site.","Healthcare providers can play a key role in reaching the target for vaccine uptake through educating the public on the risk may be of severe allergic reactions to COVID-19 vaccines. Thus, it is important to resolve reports in the literature which present conflicting data on vaccine safety. We performed a prospective study of Pfizer-BioNTech vaccinations administered at the Albany Community Vaccination Center. All potential vaccinees to the site were screened for allergic history prior to triage ","2021","07","19","Vaccine","Vaccine","COVID-19; Mass Vaccination; Pfizer; SARS-CoV-2; COVID-19; COVID-19 Vaccines; Humans; Mass Vaccination; Prospective Studies; RNA, Messenger; SARS-CoV-2; Vaccination; Vaccines","Myles","Ian A","National Institute of Allergy and Infectious Diseases, U.S. Public Health Service, Dept of Health and Human Services, United States. Electronic address: mylesi@niaid.nih","mylesi@niaid.nih.gov"
"674","34217573","10.1016/j.vaccine.2021.06.061","Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site.","Healthcare providers can play a key role in reaching the target for vaccine uptake through educating the public on the risk may be of severe allergic reactions to COVID-19 vaccines. Thus, it is important to resolve reports in the literature which present conflicting data on vaccine safety. We performed a prospective study of Pfizer-BioNTech vaccinations administered at the Albany Community Vaccination Center. All potential vaccinees to the site were screened for allergic history prior to triage ","2021","07","19","Vaccine","Vaccine","COVID-19; Mass Vaccination; Pfizer; SARS-CoV-2; COVID-19; COVID-19 Vaccines; Humans; Mass Vaccination; Prospective Studies; RNA, Messenger; SARS-CoV-2; Vaccination; Vaccines","Vinciguerra","Joshua S","New York State Department of Health, United States",NA
"675","34217573","10.1016/j.vaccine.2021.06.061","Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site.","Healthcare providers can play a key role in reaching the target for vaccine uptake through educating the public on the risk may be of severe allergic reactions to COVID-19 vaccines. Thus, it is important to resolve reports in the literature which present conflicting data on vaccine safety. We performed a prospective study of Pfizer-BioNTech vaccinations administered at the Albany Community Vaccination Center. All potential vaccinees to the site were screened for allergic history prior to triage ","2021","07","19","Vaccine","Vaccine","COVID-19; Mass Vaccination; Pfizer; SARS-CoV-2; COVID-19; COVID-19 Vaccines; Humans; Mass Vaccination; Prospective Studies; RNA, Messenger; SARS-CoV-2; Vaccination; Vaccines","Premus","Robert T","Federal Emergency Management Agency, United States",NA
"676","34217571","10.1016/j.vaccine.2021.06.044","Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students.","COVID-19 continues to ravage the world with economies and life significantly and negatively affected. Fortunately, there has been significant progress in the production of vaccines to stem the infection. However, with controversies and myths surrounding vaccinations, it is timely to examine individuals' willingness to vaccinate. The present study adapted the Motors of Influenza Vaccination Acceptance Scale (MoVac-Flu Scale) into the Motors of COVID-19 Vaccination Acceptance Scale (MoVac-COVID19S","2021","07","19","Vaccine","Vaccine","COVID-19; Confirmatory factor analysis; Psychometrics; Vaccine; Young adults; Adult; COVID-19; COVID-19 Vaccines; China; Humans; Influenza, Human; Psychometrics; Reproducibility of Results; SARS-CoV-2; Students; Surveys and Questionnaires; Universities; Vaccination; Young Adult","Chen","I-Hua","Chinese Academy of Education Big Data, Qufu Normal University, Qufu, China",NA
"677","34217571","10.1016/j.vaccine.2021.06.044","Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students.","COVID-19 continues to ravage the world with economies and life significantly and negatively affected. Fortunately, there has been significant progress in the production of vaccines to stem the infection. However, with controversies and myths surrounding vaccinations, it is timely to examine individuals' willingness to vaccinate. The present study adapted the Motors of Influenza Vaccination Acceptance Scale (MoVac-Flu Scale) into the Motors of COVID-19 Vaccination Acceptance Scale (MoVac-COVID19S","2021","07","19","Vaccine","Vaccine","COVID-19; Confirmatory factor analysis; Psychometrics; Vaccine; Young adults; Adult; COVID-19; COVID-19 Vaccines; China; Humans; Influenza, Human; Psychometrics; Reproducibility of Results; SARS-CoV-2; Students; Surveys and Questionnaires; Universities; Vaccination; Young Adult","Ahorsu","Daniel Kwasi","Department of Rehabilitation Sciences, Faculty of Health &amp",NA
"678","34217571","10.1016/j.vaccine.2021.06.044","Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students.","COVID-19 continues to ravage the world with economies and life significantly and negatively affected. Fortunately, there has been significant progress in the production of vaccines to stem the infection. However, with controversies and myths surrounding vaccinations, it is timely to examine individuals' willingness to vaccinate. The present study adapted the Motors of Influenza Vaccination Acceptance Scale (MoVac-Flu Scale) into the Motors of COVID-19 Vaccination Acceptance Scale (MoVac-COVID19S","2021","07","19","Vaccine","Vaccine","COVID-19; Confirmatory factor analysis; Psychometrics; Vaccine; Young adults; Adult; COVID-19; COVID-19 Vaccines; China; Humans; Influenza, Human; Psychometrics; Reproducibility of Results; SARS-CoV-2; Students; Surveys and Questionnaires; Universities; Vaccination; Young Adult","Ko","Nai-Ying","Department of Nursing, College of Medicine, National Cheng Kung University, Tainan, Taiwan",NA
"679","34217571","10.1016/j.vaccine.2021.06.044","Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students.","COVID-19 continues to ravage the world with economies and life significantly and negatively affected. Fortunately, there has been significant progress in the production of vaccines to stem the infection. However, with controversies and myths surrounding vaccinations, it is timely to examine individuals' willingness to vaccinate. The present study adapted the Motors of Influenza Vaccination Acceptance Scale (MoVac-Flu Scale) into the Motors of COVID-19 Vaccination Acceptance Scale (MoVac-COVID19S","2021","07","19","Vaccine","Vaccine","COVID-19; Confirmatory factor analysis; Psychometrics; Vaccine; Young adults; Adult; COVID-19; COVID-19 Vaccines; China; Humans; Influenza, Human; Psychometrics; Reproducibility of Results; SARS-CoV-2; Students; Surveys and Questionnaires; Universities; Vaccination; Young Adult","Yen","Cheng-Fang","Department of Psychiatry, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan","p03132006@gmail.com"
"680","34217571","10.1016/j.vaccine.2021.06.044","Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students.","COVID-19 continues to ravage the world with economies and life significantly and negatively affected. Fortunately, there has been significant progress in the production of vaccines to stem the infection. However, with controversies and myths surrounding vaccinations, it is timely to examine individuals' willingness to vaccinate. The present study adapted the Motors of Influenza Vaccination Acceptance Scale (MoVac-Flu Scale) into the Motors of COVID-19 Vaccination Acceptance Scale (MoVac-COVID19S","2021","07","19","Vaccine","Vaccine","COVID-19; Confirmatory factor analysis; Psychometrics; Vaccine; Young adults; Adult; COVID-19; COVID-19 Vaccines; China; Humans; Influenza, Human; Psychometrics; Reproducibility of Results; SARS-CoV-2; Students; Surveys and Questionnaires; Universities; Vaccination; Young Adult","Lin","Chung-Ying","Institute of Allied Health Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan","cylin36933@gmail.com"
"681","34217571","10.1016/j.vaccine.2021.06.044","Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students.","COVID-19 continues to ravage the world with economies and life significantly and negatively affected. Fortunately, there has been significant progress in the production of vaccines to stem the infection. However, with controversies and myths surrounding vaccinations, it is timely to examine individuals' willingness to vaccinate. The present study adapted the Motors of Influenza Vaccination Acceptance Scale (MoVac-Flu Scale) into the Motors of COVID-19 Vaccination Acceptance Scale (MoVac-COVID19S","2021","07","19","Vaccine","Vaccine","COVID-19; Confirmatory factor analysis; Psychometrics; Vaccine; Young adults; Adult; COVID-19; COVID-19 Vaccines; China; Humans; Influenza, Human; Psychometrics; Reproducibility of Results; SARS-CoV-2; Students; Surveys and Questionnaires; Universities; Vaccination; Young Adult","Griffiths","Mark D","International Gaming Research Unit, Psychology Department, Nottingham Trent University, Nottingham, UK",NA
"682","34217571","10.1016/j.vaccine.2021.06.044","Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students.","COVID-19 continues to ravage the world with economies and life significantly and negatively affected. Fortunately, there has been significant progress in the production of vaccines to stem the infection. However, with controversies and myths surrounding vaccinations, it is timely to examine individuals' willingness to vaccinate. The present study adapted the Motors of Influenza Vaccination Acceptance Scale (MoVac-Flu Scale) into the Motors of COVID-19 Vaccination Acceptance Scale (MoVac-COVID19S","2021","07","19","Vaccine","Vaccine","COVID-19; Confirmatory factor analysis; Psychometrics; Vaccine; Young adults; Adult; COVID-19; COVID-19 Vaccines; China; Humans; Influenza, Human; Psychometrics; Reproducibility of Results; SARS-CoV-2; Students; Surveys and Questionnaires; Universities; Vaccination; Young Adult","Pakpour","Amir H","Department of Nursing, School of Health and Welfare, Jönköping University, Jönköping, Sweden",NA
"683","34217553","10.1016/j.pedhc.2021.04.005","Parents' Intentions to Vaccinate Their Children Against COVID-19.","With the COVID-19 vaccine rollout is well underway now beginning in children ages 12 and over, it is unknown what percent of parents plan to vaccinate their children against COVID-19. The purpose of this descriptive correlational study was to examine parents' attitudes, beliefs, and behaviors in administering a COVID-19 vaccine. Only 21.93% of the subjects reported overall VH. Half of parents (49.45%) say they want the COVID vaccine for their child, and 44.17% plan to vaccinate against COVID onc","2021","07","08","J Pediatr Health Care","Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates &amp; Practitioners","COVID-19; parent-perceptions; vaccinations; vaccine hesitancy","Ruggiero","Kristine M",NA,NA
"684","34217553","10.1016/j.pedhc.2021.04.005","Parents' Intentions to Vaccinate Their Children Against COVID-19.","With the COVID-19 vaccine rollout is well underway now beginning in children ages 12 and over, it is unknown what percent of parents plan to vaccinate their children against COVID-19. The purpose of this descriptive correlational study was to examine parents' attitudes, beliefs, and behaviors in administering a COVID-19 vaccine. Only 21.93% of the subjects reported overall VH. Half of parents (49.45%) say they want the COVID vaccine for their child, and 44.17% plan to vaccinate against COVID onc","2021","07","08","J Pediatr Health Care","Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates &amp; Practitioners","COVID-19; parent-perceptions; vaccinations; vaccine hesitancy","Wong","John",NA,NA
"685","34217553","10.1016/j.pedhc.2021.04.005","Parents' Intentions to Vaccinate Their Children Against COVID-19.","With the COVID-19 vaccine rollout is well underway now beginning in children ages 12 and over, it is unknown what percent of parents plan to vaccinate their children against COVID-19. The purpose of this descriptive correlational study was to examine parents' attitudes, beliefs, and behaviors in administering a COVID-19 vaccine. Only 21.93% of the subjects reported overall VH. Half of parents (49.45%) say they want the COVID vaccine for their child, and 44.17% plan to vaccinate against COVID onc","2021","07","08","J Pediatr Health Care","Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates &amp; Practitioners","COVID-19; parent-perceptions; vaccinations; vaccine hesitancy","Sweeney","Casey Fryer",NA,NA
"686","34217553","10.1016/j.pedhc.2021.04.005","Parents' Intentions to Vaccinate Their Children Against COVID-19.","With the COVID-19 vaccine rollout is well underway now beginning in children ages 12 and over, it is unknown what percent of parents plan to vaccinate their children against COVID-19. The purpose of this descriptive correlational study was to examine parents' attitudes, beliefs, and behaviors in administering a COVID-19 vaccine. Only 21.93% of the subjects reported overall VH. Half of parents (49.45%) say they want the COVID vaccine for their child, and 44.17% plan to vaccinate against COVID onc","2021","07","08","J Pediatr Health Care","Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates &amp; Practitioners","COVID-19; parent-perceptions; vaccinations; vaccine hesitancy","Avola","Alicia",NA,NA
"687","34217553","10.1016/j.pedhc.2021.04.005","Parents' Intentions to Vaccinate Their Children Against COVID-19.","With the COVID-19 vaccine rollout is well underway now beginning in children ages 12 and over, it is unknown what percent of parents plan to vaccinate their children against COVID-19. The purpose of this descriptive correlational study was to examine parents' attitudes, beliefs, and behaviors in administering a COVID-19 vaccine. Only 21.93% of the subjects reported overall VH. Half of parents (49.45%) say they want the COVID vaccine for their child, and 44.17% plan to vaccinate against COVID onc","2021","07","08","J Pediatr Health Care","Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates &amp; Practitioners","COVID-19; parent-perceptions; vaccinations; vaccine hesitancy","Auger","Andria",NA,NA
"688","34217553","10.1016/j.pedhc.2021.04.005","Parents' Intentions to Vaccinate Their Children Against COVID-19.","With the COVID-19 vaccine rollout is well underway now beginning in children ages 12 and over, it is unknown what percent of parents plan to vaccinate their children against COVID-19. The purpose of this descriptive correlational study was to examine parents' attitudes, beliefs, and behaviors in administering a COVID-19 vaccine. Only 21.93% of the subjects reported overall VH. Half of parents (49.45%) say they want the COVID vaccine for their child, and 44.17% plan to vaccinate against COVID onc","2021","07","08","J Pediatr Health Care","Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates &amp; Practitioners","COVID-19; parent-perceptions; vaccinations; vaccine hesitancy","Macaluso","Madeline",NA,NA
"689","34217553","10.1016/j.pedhc.2021.04.005","Parents' Intentions to Vaccinate Their Children Against COVID-19.","With the COVID-19 vaccine rollout is well underway now beginning in children ages 12 and over, it is unknown what percent of parents plan to vaccinate their children against COVID-19. The purpose of this descriptive correlational study was to examine parents' attitudes, beliefs, and behaviors in administering a COVID-19 vaccine. Only 21.93% of the subjects reported overall VH. Half of parents (49.45%) say they want the COVID vaccine for their child, and 44.17% plan to vaccinate against COVID onc","2021","07","08","J Pediatr Health Care","Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates &amp; Practitioners","COVID-19; parent-perceptions; vaccinations; vaccine hesitancy","Reidy","Patricia",NA,NA
"690","34217513","10.1016/j.neurol.2021.04.005","Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report.",NA,"2021","07","04","Rev Neurol (Paris)","Revue neurologique",NA,"Theuriet","J","Hospices civils de Lyon, hôpital Neurologique Pierre-Wertheimer, service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Lyon/Bron, France. Electronic address: julian.t@hotmail","julian.t@hotmail.fr"
"691","34217513","10.1016/j.neurol.2021.04.005","Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report.",NA,"2021","07","04","Rev Neurol (Paris)","Revue neurologique",NA,"Richard","C","Hospices civils de Lyon, hôpital Neurologique Pierre-Wertheimer, service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Lyon/Bron, France",NA
"692","34217513","10.1016/j.neurol.2021.04.005","Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report.",NA,"2021","07","04","Rev Neurol (Paris)","Revue neurologique",NA,"Becker","J","Hospices civils de Lyon, hôpital neurologique Pierre-Wertheimer, service d'explorations fonctionnelles neurologiques, Lyon/Bron, France",NA
"693","34217513","10.1016/j.neurol.2021.04.005","Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report.",NA,"2021","07","04","Rev Neurol (Paris)","Revue neurologique",NA,"Pegat","A","Hospices civils de Lyon, hôpital neurologique Pierre-Wertheimer, service d'explorations fonctionnelles neurologiques, Lyon/Bron, France",NA
"694","34217513","10.1016/j.neurol.2021.04.005","Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report.",NA,"2021","07","04","Rev Neurol (Paris)","Revue neurologique",NA,"Bernard","E","Hospices civils de Lyon, hôpital neurologique Pierre-Wertheimer, service d'explorations fonctionnelles neurologiques, Lyon/Bron, France",NA
"695","34217513","10.1016/j.neurol.2021.04.005","Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report.",NA,"2021","07","04","Rev Neurol (Paris)","Revue neurologique",NA,"Vukusic","S","Hospices civils de Lyon, hôpital Neurologique Pierre-Wertheimer, service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Lyon/Bron, France",NA
"696","34217512","10.1016/j.neurol.2021.05.002","Clozapine-related immunodeficiency: Implications for Parkinson's disease psychosis in the context of the COVID-19 pandemic.",NA,"2021","07","08","Rev Neurol (Paris)","Revue neurologique",NA,"Aubignat","M","Department of Neurology and Expert Center for Parkinson's disease, University Hospital of Amiens, Amiens, France. Electronic address: aubignat.mickael@chu-amiens",NA
"697","34217504","10.1016/j.nefro.2021.04.004","SARS CoV-2 seropositivity in hemodialysis patients.",NA,"2021","07","04","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia",NA,"Toapanta","Nestor","Hospital Universitario Valle de Hebrón, Barcelona, España",NA
"698","34217504","10.1016/j.nefro.2021.04.004","SARS CoV-2 seropositivity in hemodialysis patients.",NA,"2021","07","04","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia",NA,"Castañeda","Zaira","Hospital Universitario Valle de Hebrón, Barcelona, España",NA
"699","34217504","10.1016/j.nefro.2021.04.004","SARS CoV-2 seropositivity in hemodialysis patients.",NA,"2021","07","04","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia",NA,"Zúñiga","José","Hospital Universitario Valle de Hebrón, Barcelona, España",NA
"700","34217504","10.1016/j.nefro.2021.04.004","SARS CoV-2 seropositivity in hemodialysis patients.",NA,"2021","07","04","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia",NA,"León-Román","Juan","Hospital Universitario Valle de Hebrón, Barcelona, España",NA
"701","34217504","10.1016/j.nefro.2021.04.004","SARS CoV-2 seropositivity in hemodialysis patients.",NA,"2021","07","04","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia",NA,"Ramos","Natalia","Hospital Universitario Valle de Hebrón, Barcelona, España",NA
"702","34217504","10.1016/j.nefro.2021.04.004","SARS CoV-2 seropositivity in hemodialysis patients.",NA,"2021","07","04","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia",NA,"Azancot","María","Hospital Universitario Valle de Hebrón, Barcelona, España",NA
"703","34217504","10.1016/j.nefro.2021.04.004","SARS CoV-2 seropositivity in hemodialysis patients.",NA,"2021","07","04","Nefrologia","Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia",NA,"Soler","María José","Hospital Universitario Valle de Hebrón, Barcelona, España. Electronic address: m.soler@vhebron","m.soler@vhebron.net"
"704","34217480","10.1016/j.oftale.2020.11.002","Impact on elective ophthalmic surgery caused by the COVID-19 pandemic after the lockdown at the Clinical Institute of Ophthalmology of the Hospital Clinic de Barcelona.",NA,"2021","07","08","Arch Soc Esp Oftalmol (Engl Ed)","Archivos de la Sociedad Espanola de Oftalmologia","COVID-19; Communicable Disease Control; Hospitals; Humans; Ophthalmology; Pandemics; SARS-CoV-2","García Tirado","A","Servicio de Oftalmología, Instituto Clínico de Oftalmología, Hospital Clínic de Barcelona, Barcelona, Spain. Electronic address: GARCIA95@clinic","GARCIA95@clinic.cat"
"705","34217480","10.1016/j.oftale.2020.11.002","Impact on elective ophthalmic surgery caused by the COVID-19 pandemic after the lockdown at the Clinical Institute of Ophthalmology of the Hospital Clinic de Barcelona.",NA,"2021","07","08","Arch Soc Esp Oftalmol (Engl Ed)","Archivos de la Sociedad Espanola de Oftalmologia","COVID-19; Communicable Disease Control; Hospitals; Humans; Ophthalmology; Pandemics; SARS-CoV-2","Sánchez-Dalmau","B","Servicio de Oftalmología, Instituto Clínico de Oftalmología, Hospital Clínic de Barcelona, Barcelona, Spain",NA
"706","34217480","10.1016/j.oftale.2020.11.002","Impact on elective ophthalmic surgery caused by the COVID-19 pandemic after the lockdown at the Clinical Institute of Ophthalmology of the Hospital Clinic de Barcelona.",NA,"2021","07","08","Arch Soc Esp Oftalmol (Engl Ed)","Archivos de la Sociedad Espanola de Oftalmologia","COVID-19; Communicable Disease Control; Hospitals; Humans; Ophthalmology; Pandemics; SARS-CoV-2","Adán","A","Servicio de Oftalmología, Instituto Clínico de Oftalmología, Hospital Clínic de Barcelona, Barcelona, Spain",NA
"707","34217472","10.1016/j.oftale.2021.01.001","Tonic pupil after COVID-19 infection.","The latest global health threat is the ongoing outbreak of respiratory disease, which was named COVID-19 and multiple ever-evolving neurological complications have since been reported. We present the case of a patient with a bilateral tonic pupil in the postinfectious context of COVID 19. Brain magnetic resonance imaging and laboratory tests were normal, a 0.125% pilocarpine test confirmed the diagnosis.","2021","07","22","Arch Soc Esp Oftalmol (Engl Ed)","Archivos de la Sociedad Espanola de Oftalmologia","Bilateral tonic pupil; COVID-19; Pilocarpina; Pilocarpine; Pupila tónica bilateral; Adult; COVID-19; Female; Humans; Tonic Pupil","Quijano-Nieto","B A","Retina and Vitreous Unit, Instituto Mácula y Retina, Oftalmocenter. Ophthalmology Unit, Universidad Nacional de Colombia and Universidad Militar Nueva Granada, Bogotá, Colombia",NA
"708","34217472","10.1016/j.oftale.2021.01.001","Tonic pupil after COVID-19 infection.","The latest global health threat is the ongoing outbreak of respiratory disease, which was named COVID-19 and multiple ever-evolving neurological complications have since been reported. We present the case of a patient with a bilateral tonic pupil in the postinfectious context of COVID 19. Brain magnetic resonance imaging and laboratory tests were normal, a 0.125% pilocarpine test confirmed the diagnosis.","2021","07","22","Arch Soc Esp Oftalmol (Engl Ed)","Archivos de la Sociedad Espanola de Oftalmologia","Bilateral tonic pupil; COVID-19; Pilocarpina; Pilocarpine; Pupila tónica bilateral; Adult; COVID-19; Female; Humans; Tonic Pupil","Córdoba-Ortega","C M","Ophthalmology Unit, Universidad Nacional de Colombia Medical School, Bogotá, Colombia. Electronic address: cmcordobao@gmail","cmcordobao@gmail.com"
"709","34217471","10.1016/j.oftale.2020.12.007","Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: Result of the COVID-19-GEAS patient survey.","The objective of these study is to know the characteristics of COVID-19 in patients with uveitis associated with Systemic Autoimmune Disease (SAD) through telematic survey. Internal Medicine Society and Group of Systemic Autoimmune disease conducted a telematic survey of patients with SAD to learn about the characteristics of COVID-19 in this population. A total of 2,789 patients answered the survey, of which 28 had a diagnosis of uveitis associated with SAE. The majority (82%) were female and c","2021","07","22","Arch Soc Esp Oftalmol (Engl Ed)","Archivos de la Sociedad Espanola de Oftalmologia","Anti-TNF-alpha therapy; COVID-19; Corticoides; Corticosteroids; Immunosuppression; Inmunosupresión; Tratamiento anti-TNF alfa; Uveitis; Uveítis; Adult; Aged; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Self Report; Uveitis","Fanlo","P","Unidad de Enfermedades Autoinmunes Sistémicas, Servicio de Medicina Interna, Complejo Hospitalario de Navarra, Pamplona, Spain. Electronic address: patriciafanlo@yahoo","patriciafanlo@yahoo.es"
"710","34217471","10.1016/j.oftale.2020.12.007","Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: Result of the COVID-19-GEAS patient survey.","The objective of these study is to know the characteristics of COVID-19 in patients with uveitis associated with Systemic Autoimmune Disease (SAD) through telematic survey. Internal Medicine Society and Group of Systemic Autoimmune disease conducted a telematic survey of patients with SAD to learn about the characteristics of COVID-19 in this population. A total of 2,789 patients answered the survey, of which 28 had a diagnosis of uveitis associated with SAE. The majority (82%) were female and c","2021","07","22","Arch Soc Esp Oftalmol (Engl Ed)","Archivos de la Sociedad Espanola de Oftalmologia","Anti-TNF-alpha therapy; COVID-19; Corticoides; Corticosteroids; Immunosuppression; Inmunosupresión; Tratamiento anti-TNF alfa; Uveitis; Uveítis; Adult; Aged; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Self Report; Uveitis","Espinosa","G","Servicio de Enfermedades Autoinmunes, Institut Clínic de Medicina i Dermatología, Hospital Clínic, Barcelona, Spain",NA
"711","34217471","10.1016/j.oftale.2020.12.007","Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: Result of the COVID-19-GEAS patient survey.","The objective of these study is to know the characteristics of COVID-19 in patients with uveitis associated with Systemic Autoimmune Disease (SAD) through telematic survey. Internal Medicine Society and Group of Systemic Autoimmune disease conducted a telematic survey of patients with SAD to learn about the characteristics of COVID-19 in this population. A total of 2,789 patients answered the survey, of which 28 had a diagnosis of uveitis associated with SAE. The majority (82%) were female and c","2021","07","22","Arch Soc Esp Oftalmol (Engl Ed)","Archivos de la Sociedad Espanola de Oftalmologia","Anti-TNF-alpha therapy; COVID-19; Corticoides; Corticosteroids; Immunosuppression; Inmunosupresión; Tratamiento anti-TNF alfa; Uveitis; Uveítis; Adult; Aged; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Self Report; Uveitis","Adán","A","Institut Clínic de Oftalmología, Hospital Clínic, Barcelona, Spain",NA
"712","34217471","10.1016/j.oftale.2020.12.007","Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: Result of the COVID-19-GEAS patient survey.","The objective of these study is to know the characteristics of COVID-19 in patients with uveitis associated with Systemic Autoimmune Disease (SAD) through telematic survey. Internal Medicine Society and Group of Systemic Autoimmune disease conducted a telematic survey of patients with SAD to learn about the characteristics of COVID-19 in this population. A total of 2,789 patients answered the survey, of which 28 had a diagnosis of uveitis associated with SAE. The majority (82%) were female and c","2021","07","22","Arch Soc Esp Oftalmol (Engl Ed)","Archivos de la Sociedad Espanola de Oftalmologia","Anti-TNF-alpha therapy; COVID-19; Corticoides; Corticosteroids; Immunosuppression; Inmunosupresión; Tratamiento anti-TNF alfa; Uveitis; Uveítis; Adult; Aged; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Self Report; Uveitis","Arnáez","R","Unidad de Enfermedades Autoinmunes Sistémicas, Servicio de Medicina Interna, Complejo Hospitalario de Navarra, Pamplona, Spain",NA
"713","34217471","10.1016/j.oftale.2020.12.007","Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: Result of the COVID-19-GEAS patient survey.","The objective of these study is to know the characteristics of COVID-19 in patients with uveitis associated with Systemic Autoimmune Disease (SAD) through telematic survey. Internal Medicine Society and Group of Systemic Autoimmune disease conducted a telematic survey of patients with SAD to learn about the characteristics of COVID-19 in this population. A total of 2,789 patients answered the survey, of which 28 had a diagnosis of uveitis associated with SAE. The majority (82%) were female and c","2021","07","22","Arch Soc Esp Oftalmol (Engl Ed)","Archivos de la Sociedad Espanola de Oftalmologia","Anti-TNF-alpha therapy; COVID-19; Corticoides; Corticosteroids; Immunosuppression; Inmunosupresión; Tratamiento anti-TNF alfa; Uveitis; Uveítis; Adult; Aged; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Self Report; Uveitis","Fonollosa","A","Servicio de Oftalmología, Hospital Universitario Cruces, Barakaldo, Spain",NA
"714","34217471","10.1016/j.oftale.2020.12.007","Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: Result of the COVID-19-GEAS patient survey.","The objective of these study is to know the characteristics of COVID-19 in patients with uveitis associated with Systemic Autoimmune Disease (SAD) through telematic survey. Internal Medicine Society and Group of Systemic Autoimmune disease conducted a telematic survey of patients with SAD to learn about the characteristics of COVID-19 in this population. A total of 2,789 patients answered the survey, of which 28 had a diagnosis of uveitis associated with SAE. The majority (82%) were female and c","2021","07","22","Arch Soc Esp Oftalmol (Engl Ed)","Archivos de la Sociedad Espanola de Oftalmologia","Anti-TNF-alpha therapy; COVID-19; Corticoides; Corticosteroids; Immunosuppression; Inmunosupresión; Tratamiento anti-TNF alfa; Uveitis; Uveítis; Adult; Aged; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Self Report; Uveitis","Heras","H","Servicio de Oftalmología, Complejo Hospitalario de Navarra, Pamplona, Spain",NA
"715","34217471","10.1016/j.oftale.2020.12.007","Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: Result of the COVID-19-GEAS patient survey.","The objective of these study is to know the characteristics of COVID-19 in patients with uveitis associated with Systemic Autoimmune Disease (SAD) through telematic survey. Internal Medicine Society and Group of Systemic Autoimmune disease conducted a telematic survey of patients with SAD to learn about the characteristics of COVID-19 in this population. A total of 2,789 patients answered the survey, of which 28 had a diagnosis of uveitis associated with SAE. The majority (82%) were female and c","2021","07","22","Arch Soc Esp Oftalmol (Engl Ed)","Archivos de la Sociedad Espanola de Oftalmologia","Anti-TNF-alpha therapy; COVID-19; Corticoides; Corticosteroids; Immunosuppression; Inmunosupresión; Tratamiento anti-TNF alfa; Uveitis; Uveítis; Adult; Aged; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Self Report; Uveitis","Oteiza","J","Unidad de Enfermedades Autoinmunes Sistémicas, Servicio de Medicina Interna, Complejo Hospitalario de Navarra, Pamplona, Spain",NA
"716","34217471","10.1016/j.oftale.2020.12.007","Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: Result of the COVID-19-GEAS patient survey.","The objective of these study is to know the characteristics of COVID-19 in patients with uveitis associated with Systemic Autoimmune Disease (SAD) through telematic survey. Internal Medicine Society and Group of Systemic Autoimmune disease conducted a telematic survey of patients with SAD to learn about the characteristics of COVID-19 in this population. A total of 2,789 patients answered the survey, of which 28 had a diagnosis of uveitis associated with SAE. The majority (82%) were female and c","2021","07","22","Arch Soc Esp Oftalmol (Engl Ed)","Archivos de la Sociedad Espanola de Oftalmologia","Anti-TNF-alpha therapy; COVID-19; Corticoides; Corticosteroids; Immunosuppression; Inmunosupresión; Tratamiento anti-TNF alfa; Uveitis; Uveítis; Adult; Aged; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Self Report; Uveitis","Del Carmelo Gracia Tello","B","Unidad de Enfermedades Autoinmunes Sistémicas, Servicio de Medicina Interna, Hospital Universitario Clínico Lozano Blesa, Zaragoza, Spain",NA
"717","34217471","10.1016/j.oftale.2020.12.007","Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: Result of the COVID-19-GEAS patient survey.","The objective of these study is to know the characteristics of COVID-19 in patients with uveitis associated with Systemic Autoimmune Disease (SAD) through telematic survey. Internal Medicine Society and Group of Systemic Autoimmune disease conducted a telematic survey of patients with SAD to learn about the characteristics of COVID-19 in this population. A total of 2,789 patients answered the survey, of which 28 had a diagnosis of uveitis associated with SAE. The majority (82%) were female and c","2021","07","22","Arch Soc Esp Oftalmol (Engl Ed)","Archivos de la Sociedad Espanola de Oftalmologia","Anti-TNF-alpha therapy; COVID-19; Corticoides; Corticosteroids; Immunosuppression; Inmunosupresión; Tratamiento anti-TNF alfa; Uveitis; Uveítis; Adult; Aged; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Self Report; Uveitis","Sáez Comet","L","Unidad de Enfermedades Autoinmunes Sistémicas, Servicio de Medicina Interna, Hospital Universitario Miguel Servet, Zaragoza, Spain",NA
"718","34217471","10.1016/j.oftale.2020.12.007","Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: Result of the COVID-19-GEAS patient survey.","The objective of these study is to know the characteristics of COVID-19 in patients with uveitis associated with Systemic Autoimmune Disease (SAD) through telematic survey. Internal Medicine Society and Group of Systemic Autoimmune disease conducted a telematic survey of patients with SAD to learn about the characteristics of COVID-19 in this population. A total of 2,789 patients answered the survey, of which 28 had a diagnosis of uveitis associated with SAE. The majority (82%) were female and c","2021","07","22","Arch Soc Esp Oftalmol (Engl Ed)","Archivos de la Sociedad Espanola de Oftalmologia","Anti-TNF-alpha therapy; COVID-19; Corticoides; Corticosteroids; Immunosuppression; Inmunosupresión; Tratamiento anti-TNF alfa; Uveitis; Uveítis; Adult; Aged; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Self Report; Uveitis","Pallarés","L","Unidad de Enfermedades Autoinmunes Sistémicas, Servicio de Medicina Interna, Hospital Son Espases, Balearic Islands, Spain",NA
"719","34217469","10.1016/j.bja.2021.06.001","Humidification via high-flow nasal cannula oxygen therapy does not generate aerosols.",NA,"2021","07","04","Br J Anaesth","British journal of anaesthesia","COVID-19; aerosol; aerosol generating procedure; high-flow nasal cannula; humidification","Hamada","Satoshi","Department of Advanced Medicine for Respiratory Failure, Graduate School of Medicine, Kyoto University, Kyoto, Japan",NA
"720","34217469","10.1016/j.bja.2021.06.001","Humidification via high-flow nasal cannula oxygen therapy does not generate aerosols.",NA,"2021","07","04","Br J Anaesth","British journal of anaesthesia","COVID-19; aerosol; aerosol generating procedure; high-flow nasal cannula; humidification","Tanabe","Naoya","Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Electronic address: ntana@kuhp.kyoto-u.ac","ntana@kuhp.kyoto"
"721","34217469","10.1016/j.bja.2021.06.001","Humidification via high-flow nasal cannula oxygen therapy does not generate aerosols.",NA,"2021","07","04","Br J Anaesth","British journal of anaesthesia","COVID-19; aerosol; aerosol generating procedure; high-flow nasal cannula; humidification","Hirai","Toyohiro","Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan",NA
"722","34217468","10.1016/j.bja.2021.05.024","Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19: a narrative review.","COVID-19 pneumonia is associated with hypoxaemic respiratory failure, ranging from mild to severe. Because of the worldwide shortage of ICU beds, a relatively high number of patients with respiratory failure are receiving prolonged noninvasive respiratory support, even when their clinical status would have required invasive mechanical ventilation. There are few experimental and clinical data reporting that vigorous breathing effort during spontaneous ventilation can worsen lung injury and cause ","2021","07","08","Br J Anaesth","British journal of anaesthesia","ARDS; COVID-19; P-SILI; SARS-CoV-2; high-flow nasal oxygen therapy; lung injury; noninvasive ventialtion; spontaneous breathing","Battaglini","Denise","Anesthesia and Intensive Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, Genoa, Italy",NA
"723","34217468","10.1016/j.bja.2021.05.024","Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19: a narrative review.","COVID-19 pneumonia is associated with hypoxaemic respiratory failure, ranging from mild to severe. Because of the worldwide shortage of ICU beds, a relatively high number of patients with respiratory failure are receiving prolonged noninvasive respiratory support, even when their clinical status would have required invasive mechanical ventilation. There are few experimental and clinical data reporting that vigorous breathing effort during spontaneous ventilation can worsen lung injury and cause ","2021","07","08","Br J Anaesth","British journal of anaesthesia","ARDS; COVID-19; P-SILI; SARS-CoV-2; high-flow nasal oxygen therapy; lung injury; noninvasive ventialtion; spontaneous breathing","Robba","Chiara","Anesthesia and Intensive Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, Genoa, Italy",NA
"724","34217468","10.1016/j.bja.2021.05.024","Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19: a narrative review.","COVID-19 pneumonia is associated with hypoxaemic respiratory failure, ranging from mild to severe. Because of the worldwide shortage of ICU beds, a relatively high number of patients with respiratory failure are receiving prolonged noninvasive respiratory support, even when their clinical status would have required invasive mechanical ventilation. There are few experimental and clinical data reporting that vigorous breathing effort during spontaneous ventilation can worsen lung injury and cause ","2021","07","08","Br J Anaesth","British journal of anaesthesia","ARDS; COVID-19; P-SILI; SARS-CoV-2; high-flow nasal oxygen therapy; lung injury; noninvasive ventialtion; spontaneous breathing","Ball","Lorenzo","Anesthesia and Intensive Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, Genoa, Italy",NA
"725","34217468","10.1016/j.bja.2021.05.024","Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19: a narrative review.","COVID-19 pneumonia is associated with hypoxaemic respiratory failure, ranging from mild to severe. Because of the worldwide shortage of ICU beds, a relatively high number of patients with respiratory failure are receiving prolonged noninvasive respiratory support, even when their clinical status would have required invasive mechanical ventilation. There are few experimental and clinical data reporting that vigorous breathing effort during spontaneous ventilation can worsen lung injury and cause ","2021","07","08","Br J Anaesth","British journal of anaesthesia","ARDS; COVID-19; P-SILI; SARS-CoV-2; high-flow nasal oxygen therapy; lung injury; noninvasive ventialtion; spontaneous breathing","Silva","Pedro L","Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil",NA
"726","34217468","10.1016/j.bja.2021.05.024","Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19: a narrative review.","COVID-19 pneumonia is associated with hypoxaemic respiratory failure, ranging from mild to severe. Because of the worldwide shortage of ICU beds, a relatively high number of patients with respiratory failure are receiving prolonged noninvasive respiratory support, even when their clinical status would have required invasive mechanical ventilation. There are few experimental and clinical data reporting that vigorous breathing effort during spontaneous ventilation can worsen lung injury and cause ","2021","07","08","Br J Anaesth","British journal of anaesthesia","ARDS; COVID-19; P-SILI; SARS-CoV-2; high-flow nasal oxygen therapy; lung injury; noninvasive ventialtion; spontaneous breathing","Cruz","Fernanda F","Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil",NA
"727","34217468","10.1016/j.bja.2021.05.024","Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19: a narrative review.","COVID-19 pneumonia is associated with hypoxaemic respiratory failure, ranging from mild to severe. Because of the worldwide shortage of ICU beds, a relatively high number of patients with respiratory failure are receiving prolonged noninvasive respiratory support, even when their clinical status would have required invasive mechanical ventilation. There are few experimental and clinical data reporting that vigorous breathing effort during spontaneous ventilation can worsen lung injury and cause ","2021","07","08","Br J Anaesth","British journal of anaesthesia","ARDS; COVID-19; P-SILI; SARS-CoV-2; high-flow nasal oxygen therapy; lung injury; noninvasive ventialtion; spontaneous breathing","Pelosi","Paolo","Anesthesia and Intensive Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, Genoa, Italy",NA
"728","34217468","10.1016/j.bja.2021.05.024","Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19: a narrative review.","COVID-19 pneumonia is associated with hypoxaemic respiratory failure, ranging from mild to severe. Because of the worldwide shortage of ICU beds, a relatively high number of patients with respiratory failure are receiving prolonged noninvasive respiratory support, even when their clinical status would have required invasive mechanical ventilation. There are few experimental and clinical data reporting that vigorous breathing effort during spontaneous ventilation can worsen lung injury and cause ","2021","07","08","Br J Anaesth","British journal of anaesthesia","ARDS; COVID-19; P-SILI; SARS-CoV-2; high-flow nasal oxygen therapy; lung injury; noninvasive ventialtion; spontaneous breathing","Rocco","Patricia R M","Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil","prmrocco@gmail.com"
"729","34217435","10.1053/j.semnuclmed.2021.06.002","Telehealth in Multidisciplinary Target Delineation for Radiotherapy During the COVID-19 Pandemic. A Review and a Case.","Like all other medical specialties, radiotherapy has been deeply influenced by the COVID-19 pandemic. The pandemic has had severe influence on the entire patient trajectory in oncology, from diagnosis to treatment and follow-up. Many examples of how to deal with patient and staff safety, shortness of staff and other resources and the quest to continue high-quality, evidence-based treatment have been presented. The use of telemedicine and telehealth is frequently presented as a part of the soluti","2021","07","08","Semin Nucl Med","Seminars in nuclear medicine",NA,"Jensen","Kenneth","Danish Center for Particle Therapy, Aarhus University Hospital, Denmark. Electronic address: Kenneth.jensen@auh.rm","Kenneth.jensen@auh.rm.dk"
"730","34217435","10.1053/j.semnuclmed.2021.06.002","Telehealth in Multidisciplinary Target Delineation for Radiotherapy During the COVID-19 Pandemic. A Review and a Case.","Like all other medical specialties, radiotherapy has been deeply influenced by the COVID-19 pandemic. The pandemic has had severe influence on the entire patient trajectory in oncology, from diagnosis to treatment and follow-up. Many examples of how to deal with patient and staff safety, shortness of staff and other resources and the quest to continue high-quality, evidence-based treatment have been presented. The use of telemedicine and telehealth is frequently presented as a part of the soluti","2021","07","08","Semin Nucl Med","Seminars in nuclear medicine",NA,"Dalby","Rikke Beese","Department of Radiology, Aarhus University Hospital, Denmark",NA
"731","34217435","10.1053/j.semnuclmed.2021.06.002","Telehealth in Multidisciplinary Target Delineation for Radiotherapy During the COVID-19 Pandemic. A Review and a Case.","Like all other medical specialties, radiotherapy has been deeply influenced by the COVID-19 pandemic. The pandemic has had severe influence on the entire patient trajectory in oncology, from diagnosis to treatment and follow-up. Many examples of how to deal with patient and staff safety, shortness of staff and other resources and the quest to continue high-quality, evidence-based treatment have been presented. The use of telemedicine and telehealth is frequently presented as a part of the soluti","2021","07","08","Semin Nucl Med","Seminars in nuclear medicine",NA,"Bouchelouche","Kirsten","Department of Nuclear Medicine &amp",NA
"732","34217435","10.1053/j.semnuclmed.2021.06.002","Telehealth in Multidisciplinary Target Delineation for Radiotherapy During the COVID-19 Pandemic. A Review and a Case.","Like all other medical specialties, radiotherapy has been deeply influenced by the COVID-19 pandemic. The pandemic has had severe influence on the entire patient trajectory in oncology, from diagnosis to treatment and follow-up. Many examples of how to deal with patient and staff safety, shortness of staff and other resources and the quest to continue high-quality, evidence-based treatment have been presented. The use of telemedicine and telehealth is frequently presented as a part of the soluti","2021","07","08","Semin Nucl Med","Seminars in nuclear medicine",NA,"Pedersen","Erik Morre","Department of Radiology, Aarhus University Hospital, Denmark",NA
"733","34217435","10.1053/j.semnuclmed.2021.06.002","Telehealth in Multidisciplinary Target Delineation for Radiotherapy During the COVID-19 Pandemic. A Review and a Case.","Like all other medical specialties, radiotherapy has been deeply influenced by the COVID-19 pandemic. The pandemic has had severe influence on the entire patient trajectory in oncology, from diagnosis to treatment and follow-up. Many examples of how to deal with patient and staff safety, shortness of staff and other resources and the quest to continue high-quality, evidence-based treatment have been presented. The use of telemedicine and telehealth is frequently presented as a part of the soluti","2021","07","08","Semin Nucl Med","Seminars in nuclear medicine",NA,"Kalmar","Stefan","Department of IT, Central Denmark Region, Denmark",NA
"734","34217431","10.1016/S1473-3099(21)00390-X","Vaccine hesitancy in the COVID-19 era.",NA,"2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Adhikari","Bipin",NA,NA
"735","34217431","10.1016/S1473-3099(21)00390-X","Vaccine hesitancy in the COVID-19 era.",NA,"2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Cheah","Phaik Yeong",NA,NA
"736","34217425","10.1016/S0140-6736(21)00439-6","Acute respiratory distress syndrome.","Acute respiratory distress syndrome (ARDS) is an acute respiratory illness characterised by bilateral chest radiographical opacities with severe hypoxaemia due to non-cardiogenic pulmonary oedema. The COVID-19 pandemic has caused an increase in ARDS and highlighted challenges associated with this syndrome, including its unacceptably high mortality and the lack of effective pharmacotherapy. In this Seminar, we summarise current knowledge regarding ARDS epidemiology and risk factors, differential ","2021","07","08","Lancet","Lancet (London, England)",NA,"Meyer","Nuala J","Pulmonary, Allergy and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. Electronic address: nuala.meyer@pennmedicine.upenn","nuala.meyer@pennmedicine.upenn.edu"
"737","34217425","10.1016/S0140-6736(21)00439-6","Acute respiratory distress syndrome.","Acute respiratory distress syndrome (ARDS) is an acute respiratory illness characterised by bilateral chest radiographical opacities with severe hypoxaemia due to non-cardiogenic pulmonary oedema. The COVID-19 pandemic has caused an increase in ARDS and highlighted challenges associated with this syndrome, including its unacceptably high mortality and the lack of effective pharmacotherapy. In this Seminar, we summarise current knowledge regarding ARDS epidemiology and risk factors, differential ","2021","07","08","Lancet","Lancet (London, England)",NA,"Gattinoni","Luciano","Department of Anesthesiology, Intensive Care and Emergency Medicine, University Medical Center Göttingen, Göttingen, Germany",NA
"738","34217425","10.1016/S0140-6736(21)00439-6","Acute respiratory distress syndrome.","Acute respiratory distress syndrome (ARDS) is an acute respiratory illness characterised by bilateral chest radiographical opacities with severe hypoxaemia due to non-cardiogenic pulmonary oedema. The COVID-19 pandemic has caused an increase in ARDS and highlighted challenges associated with this syndrome, including its unacceptably high mortality and the lack of effective pharmacotherapy. In this Seminar, we summarise current knowledge regarding ARDS epidemiology and risk factors, differential ","2021","07","08","Lancet","Lancet (London, England)",NA,"Calfee","Carolyn S","Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Departments of Medicine and Anesthesia, University of California San Francisco, San Francisco, CA, USA",NA
"739","34217424","10.1016/j.ypmed.2021.106540","Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium.","The COVID-19 pandemic disrupted breast cancer screening and diagnostic imaging in the United States. We sought to evaluate how medical facilities prioritized breast imaging services during periods of reduced capacity or upon re-opening after closures. In fall 2020, we surveyed 77 breast imaging facilities within the Breast Cancer Surveillance Consortium in the United States. The survey ascertained the pandemic's impact on clinical practices during March-September 2020. Nearly all facilities (97%","2021","07","08","Prev Med","Preventive medicine","Breast cancer; Breast imaging; COVID-19; Diagnostic imaging; Health services research; Healthcare delivery; Mammography; Preventive services; Radiology; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mammography; Mass Screening; Pandemics; SARS-CoV-2; United States","Sprague","Brian L","Office of Health Promotion Research, Department of Surgery, University of Vermont Larner College of Medicine, Burlington, VT, USA","bsprague@uvm.edu"
"740","34217424","10.1016/j.ypmed.2021.106540","Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium.","The COVID-19 pandemic disrupted breast cancer screening and diagnostic imaging in the United States. We sought to evaluate how medical facilities prioritized breast imaging services during periods of reduced capacity or upon re-opening after closures. In fall 2020, we surveyed 77 breast imaging facilities within the Breast Cancer Surveillance Consortium in the United States. The survey ascertained the pandemic's impact on clinical practices during March-September 2020. Nearly all facilities (97%","2021","07","08","Prev Med","Preventive medicine","Breast cancer; Breast imaging; COVID-19; Diagnostic imaging; Health services research; Healthcare delivery; Mammography; Preventive services; Radiology; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mammography; Mass Screening; Pandemics; SARS-CoV-2; United States","O'Meara","Ellen S","Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA, USA",NA
"741","34217424","10.1016/j.ypmed.2021.106540","Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium.","The COVID-19 pandemic disrupted breast cancer screening and diagnostic imaging in the United States. We sought to evaluate how medical facilities prioritized breast imaging services during periods of reduced capacity or upon re-opening after closures. In fall 2020, we surveyed 77 breast imaging facilities within the Breast Cancer Surveillance Consortium in the United States. The survey ascertained the pandemic's impact on clinical practices during March-September 2020. Nearly all facilities (97%","2021","07","08","Prev Med","Preventive medicine","Breast cancer; Breast imaging; COVID-19; Diagnostic imaging; Health services research; Healthcare delivery; Mammography; Preventive services; Radiology; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mammography; Mass Screening; Pandemics; SARS-CoV-2; United States","Lee","Christoph I","Department of Radiology, University of Washington and Seattle Cancer Care Alliance, Seattle, WA, USA",NA
"742","34217424","10.1016/j.ypmed.2021.106540","Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium.","The COVID-19 pandemic disrupted breast cancer screening and diagnostic imaging in the United States. We sought to evaluate how medical facilities prioritized breast imaging services during periods of reduced capacity or upon re-opening after closures. In fall 2020, we surveyed 77 breast imaging facilities within the Breast Cancer Surveillance Consortium in the United States. The survey ascertained the pandemic's impact on clinical practices during March-September 2020. Nearly all facilities (97%","2021","07","08","Prev Med","Preventive medicine","Breast cancer; Breast imaging; COVID-19; Diagnostic imaging; Health services research; Healthcare delivery; Mammography; Preventive services; Radiology; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mammography; Mass Screening; Pandemics; SARS-CoV-2; United States","Lee","Janie M","Department of Radiology, University of Washington and Seattle Cancer Care Alliance, Seattle, WA, USA",NA
"743","34217424","10.1016/j.ypmed.2021.106540","Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium.","The COVID-19 pandemic disrupted breast cancer screening and diagnostic imaging in the United States. We sought to evaluate how medical facilities prioritized breast imaging services during periods of reduced capacity or upon re-opening after closures. In fall 2020, we surveyed 77 breast imaging facilities within the Breast Cancer Surveillance Consortium in the United States. The survey ascertained the pandemic's impact on clinical practices during March-September 2020. Nearly all facilities (97%","2021","07","08","Prev Med","Preventive medicine","Breast cancer; Breast imaging; COVID-19; Diagnostic imaging; Health services research; Healthcare delivery; Mammography; Preventive services; Radiology; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mammography; Mass Screening; Pandemics; SARS-CoV-2; United States","Henderson","Louise M","Departments of Radiology and Epidemiology, University of North Carolina, Chapel Hill, NC, USA",NA
"744","34217424","10.1016/j.ypmed.2021.106540","Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium.","The COVID-19 pandemic disrupted breast cancer screening and diagnostic imaging in the United States. We sought to evaluate how medical facilities prioritized breast imaging services during periods of reduced capacity or upon re-opening after closures. In fall 2020, we surveyed 77 breast imaging facilities within the Breast Cancer Surveillance Consortium in the United States. The survey ascertained the pandemic's impact on clinical practices during March-September 2020. Nearly all facilities (97%","2021","07","08","Prev Med","Preventive medicine","Breast cancer; Breast imaging; COVID-19; Diagnostic imaging; Health services research; Healthcare delivery; Mammography; Preventive services; Radiology; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mammography; Mass Screening; Pandemics; SARS-CoV-2; United States","Buist","Diana S M","Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA, USA",NA
"745","34217424","10.1016/j.ypmed.2021.106540","Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium.","The COVID-19 pandemic disrupted breast cancer screening and diagnostic imaging in the United States. We sought to evaluate how medical facilities prioritized breast imaging services during periods of reduced capacity or upon re-opening after closures. In fall 2020, we surveyed 77 breast imaging facilities within the Breast Cancer Surveillance Consortium in the United States. The survey ascertained the pandemic's impact on clinical practices during March-September 2020. Nearly all facilities (97%","2021","07","08","Prev Med","Preventive medicine","Breast cancer; Breast imaging; COVID-19; Diagnostic imaging; Health services research; Healthcare delivery; Mammography; Preventive services; Radiology; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mammography; Mass Screening; Pandemics; SARS-CoV-2; United States","Alsheik","Nila","Advocate Aurora Health, System Breast Imaging, Downers Grove, IL, USA",NA
"746","34217424","10.1016/j.ypmed.2021.106540","Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium.","The COVID-19 pandemic disrupted breast cancer screening and diagnostic imaging in the United States. We sought to evaluate how medical facilities prioritized breast imaging services during periods of reduced capacity or upon re-opening after closures. In fall 2020, we surveyed 77 breast imaging facilities within the Breast Cancer Surveillance Consortium in the United States. The survey ascertained the pandemic's impact on clinical practices during March-September 2020. Nearly all facilities (97%","2021","07","08","Prev Med","Preventive medicine","Breast cancer; Breast imaging; COVID-19; Diagnostic imaging; Health services research; Healthcare delivery; Mammography; Preventive services; Radiology; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mammography; Mass Screening; Pandemics; SARS-CoV-2; United States","Macarol","Teresita","Advocate Aurora Health, System Breast Imaging, Downers Grove, IL, USA",NA
"747","34217424","10.1016/j.ypmed.2021.106540","Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium.","The COVID-19 pandemic disrupted breast cancer screening and diagnostic imaging in the United States. We sought to evaluate how medical facilities prioritized breast imaging services during periods of reduced capacity or upon re-opening after closures. In fall 2020, we surveyed 77 breast imaging facilities within the Breast Cancer Surveillance Consortium in the United States. The survey ascertained the pandemic's impact on clinical practices during March-September 2020. Nearly all facilities (97%","2021","07","08","Prev Med","Preventive medicine","Breast cancer; Breast imaging; COVID-19; Diagnostic imaging; Health services research; Healthcare delivery; Mammography; Preventive services; Radiology; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mammography; Mass Screening; Pandemics; SARS-CoV-2; United States","Perry","Hannah","Department of Radiology and University of Vermont Cancer Center, University of Vermont Larner College of Medicine, Burlington, VT, USA",NA
"748","34217424","10.1016/j.ypmed.2021.106540","Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium.","The COVID-19 pandemic disrupted breast cancer screening and diagnostic imaging in the United States. We sought to evaluate how medical facilities prioritized breast imaging services during periods of reduced capacity or upon re-opening after closures. In fall 2020, we surveyed 77 breast imaging facilities within the Breast Cancer Surveillance Consortium in the United States. The survey ascertained the pandemic's impact on clinical practices during March-September 2020. Nearly all facilities (97%","2021","07","08","Prev Med","Preventive medicine","Breast cancer; Breast imaging; COVID-19; Diagnostic imaging; Health services research; Healthcare delivery; Mammography; Preventive services; Radiology; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mammography; Mass Screening; Pandemics; SARS-CoV-2; United States","Tosteson","Anna N A","The Dartmouth Institute for Health Policy and Clinical Practice and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA",NA
"749","34217424","10.1016/j.ypmed.2021.106540","Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium.","The COVID-19 pandemic disrupted breast cancer screening and diagnostic imaging in the United States. We sought to evaluate how medical facilities prioritized breast imaging services during periods of reduced capacity or upon re-opening after closures. In fall 2020, we surveyed 77 breast imaging facilities within the Breast Cancer Surveillance Consortium in the United States. The survey ascertained the pandemic's impact on clinical practices during March-September 2020. Nearly all facilities (97%","2021","07","08","Prev Med","Preventive medicine","Breast cancer; Breast imaging; COVID-19; Diagnostic imaging; Health services research; Healthcare delivery; Mammography; Preventive services; Radiology; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mammography; Mass Screening; Pandemics; SARS-CoV-2; United States","Onega","Tracy","Department of Population Health Sciences, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA",NA
"750","34217424","10.1016/j.ypmed.2021.106540","Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium.","The COVID-19 pandemic disrupted breast cancer screening and diagnostic imaging in the United States. We sought to evaluate how medical facilities prioritized breast imaging services during periods of reduced capacity or upon re-opening after closures. In fall 2020, we surveyed 77 breast imaging facilities within the Breast Cancer Surveillance Consortium in the United States. The survey ascertained the pandemic's impact on clinical practices during March-September 2020. Nearly all facilities (97%","2021","07","08","Prev Med","Preventive medicine","Breast cancer; Breast imaging; COVID-19; Diagnostic imaging; Health services research; Healthcare delivery; Mammography; Preventive services; Radiology; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mammography; Mass Screening; Pandemics; SARS-CoV-2; United States","Kerlikowske","Karla","Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco, CA, USA",NA
"751","34217424","10.1016/j.ypmed.2021.106540","Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium.","The COVID-19 pandemic disrupted breast cancer screening and diagnostic imaging in the United States. We sought to evaluate how medical facilities prioritized breast imaging services during periods of reduced capacity or upon re-opening after closures. In fall 2020, we surveyed 77 breast imaging facilities within the Breast Cancer Surveillance Consortium in the United States. The survey ascertained the pandemic's impact on clinical practices during March-September 2020. Nearly all facilities (97%","2021","07","08","Prev Med","Preventive medicine","Breast cancer; Breast imaging; COVID-19; Diagnostic imaging; Health services research; Healthcare delivery; Mammography; Preventive services; Radiology; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mammography; Mass Screening; Pandemics; SARS-CoV-2; United States","Miglioretti","Diana L","Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA, USA",NA
"752","34217422","10.1016/j.ypmed.2021.106681","Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in ""Back on track with screening"" quality improvement projects.","The COVID-19 pandemic has contributed to decreases in breast, colorectal, and cervical cancer screenings between 86 and 94% compared to three-year averages. These postponed screenings have created backlogs that systems will need to address as healthcare facilities re-open for preventive care. The American Cancer Society is leading a 17-month intervention with 22 federally qualified health centers (FQHCs) across the United States aimed at reducing cancer incidence and mortality disparities and al","2021","07","07","Prev Med","Preventive medicine","COVID-19; Cancer screening; FQHC; COVID-19; Colorectal Neoplasms; Early Detection of Cancer; Female; Humans; Pandemics; Quality Improvement; SARS-CoV-2; Telemedicine; United States","Fisher-Borne","Marcie","Office of Cancer Research and Implementation, American Cancer Society, Atlanta, GA, USA. Electronic address: Marcie.fisherborne@cancer","Marcie.fisherborne@cancer.org"
"753","34217422","10.1016/j.ypmed.2021.106681","Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in ""Back on track with screening"" quality improvement projects.","The COVID-19 pandemic has contributed to decreases in breast, colorectal, and cervical cancer screenings between 86 and 94% compared to three-year averages. These postponed screenings have created backlogs that systems will need to address as healthcare facilities re-open for preventive care. The American Cancer Society is leading a 17-month intervention with 22 federally qualified health centers (FQHCs) across the United States aimed at reducing cancer incidence and mortality disparities and al","2021","07","07","Prev Med","Preventive medicine","COVID-19; Cancer screening; FQHC; COVID-19; Colorectal Neoplasms; Early Detection of Cancer; Female; Humans; Pandemics; Quality Improvement; SARS-CoV-2; Telemedicine; United States","Isher-Witt","Jennifer","Office of Cancer Research and Implementation, American Cancer Society, Atlanta, GA, USA",NA
"754","34217422","10.1016/j.ypmed.2021.106681","Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in ""Back on track with screening"" quality improvement projects.","The COVID-19 pandemic has contributed to decreases in breast, colorectal, and cervical cancer screenings between 86 and 94% compared to three-year averages. These postponed screenings have created backlogs that systems will need to address as healthcare facilities re-open for preventive care. The American Cancer Society is leading a 17-month intervention with 22 federally qualified health centers (FQHCs) across the United States aimed at reducing cancer incidence and mortality disparities and al","2021","07","07","Prev Med","Preventive medicine","COVID-19; Cancer screening; FQHC; COVID-19; Colorectal Neoplasms; Early Detection of Cancer; Female; Humans; Pandemics; Quality Improvement; SARS-CoV-2; Telemedicine; United States","Comstock","Sara","Office of Cancer Research and Implementation, American Cancer Society, Atlanta, GA, USA",NA
"755","34217422","10.1016/j.ypmed.2021.106681","Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in ""Back on track with screening"" quality improvement projects.","The COVID-19 pandemic has contributed to decreases in breast, colorectal, and cervical cancer screenings between 86 and 94% compared to three-year averages. These postponed screenings have created backlogs that systems will need to address as healthcare facilities re-open for preventive care. The American Cancer Society is leading a 17-month intervention with 22 federally qualified health centers (FQHCs) across the United States aimed at reducing cancer incidence and mortality disparities and al","2021","07","07","Prev Med","Preventive medicine","COVID-19; Cancer screening; FQHC; COVID-19; Colorectal Neoplasms; Early Detection of Cancer; Female; Humans; Pandemics; Quality Improvement; SARS-CoV-2; Telemedicine; United States","Perkins","Rebecca B","Department of Obstetrics and Gynecology, Boston University School of Medicine/Boston Medical Center, Boston, MA, USA",NA
"756","34217421","10.1016/j.ypmed.2021.106643","The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic.","The COVID-19 pandemic has affected many healthcare services worldwide. Like many other nations, the Netherlands experienced large numbers of individuals affected by COVID-19 in 2020, leading to increased demands on hospitals and intensive care units. The Dutch Ministry of Health decided to suspend the Dutch biennial fecal immunochemical test (FIT) based colorectal cancer (CRC) screening program from March 16, 2020. FIT invitations were resumed on June 3. In this study, we describe the short-term","2021","07","08","Prev Med","Preventive medicine","COVID-19; Colorectal Cancer; Screening; COVID-19; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Mass Screening; Netherlands; Occult Blood; Pandemics; SARS-CoV-2","Kortlever","Tim L","Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, location AMC, Amsterdam, the Netherlands",NA
"757","34217421","10.1016/j.ypmed.2021.106643","The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic.","The COVID-19 pandemic has affected many healthcare services worldwide. Like many other nations, the Netherlands experienced large numbers of individuals affected by COVID-19 in 2020, leading to increased demands on hospitals and intensive care units. The Dutch Ministry of Health decided to suspend the Dutch biennial fecal immunochemical test (FIT) based colorectal cancer (CRC) screening program from March 16, 2020. FIT invitations were resumed on June 3. In this study, we describe the short-term","2021","07","08","Prev Med","Preventive medicine","COVID-19; Colorectal Cancer; Screening; COVID-19; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Mass Screening; Netherlands; Occult Blood; Pandemics; SARS-CoV-2","de Jonge","Lucie","Department of Public Health, Erasmus MC University Medical Center, Rotterdam, the Netherlands",NA
"758","34217421","10.1016/j.ypmed.2021.106643","The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic.","The COVID-19 pandemic has affected many healthcare services worldwide. Like many other nations, the Netherlands experienced large numbers of individuals affected by COVID-19 in 2020, leading to increased demands on hospitals and intensive care units. The Dutch Ministry of Health decided to suspend the Dutch biennial fecal immunochemical test (FIT) based colorectal cancer (CRC) screening program from March 16, 2020. FIT invitations were resumed on June 3. In this study, we describe the short-term","2021","07","08","Prev Med","Preventive medicine","COVID-19; Colorectal Cancer; Screening; COVID-19; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Mass Screening; Netherlands; Occult Blood; Pandemics; SARS-CoV-2","Wisse","Pieter H A","Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands",NA
"759","34217421","10.1016/j.ypmed.2021.106643","The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic.","The COVID-19 pandemic has affected many healthcare services worldwide. Like many other nations, the Netherlands experienced large numbers of individuals affected by COVID-19 in 2020, leading to increased demands on hospitals and intensive care units. The Dutch Ministry of Health decided to suspend the Dutch biennial fecal immunochemical test (FIT) based colorectal cancer (CRC) screening program from March 16, 2020. FIT invitations were resumed on June 3. In this study, we describe the short-term","2021","07","08","Prev Med","Preventive medicine","COVID-19; Colorectal Cancer; Screening; COVID-19; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Mass Screening; Netherlands; Occult Blood; Pandemics; SARS-CoV-2","Seriese","Iris","Center for Population Screening, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands",NA
"760","34217421","10.1016/j.ypmed.2021.106643","The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic.","The COVID-19 pandemic has affected many healthcare services worldwide. Like many other nations, the Netherlands experienced large numbers of individuals affected by COVID-19 in 2020, leading to increased demands on hospitals and intensive care units. The Dutch Ministry of Health decided to suspend the Dutch biennial fecal immunochemical test (FIT) based colorectal cancer (CRC) screening program from March 16, 2020. FIT invitations were resumed on June 3. In this study, we describe the short-term","2021","07","08","Prev Med","Preventive medicine","COVID-19; Colorectal Cancer; Screening; COVID-19; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Mass Screening; Netherlands; Occult Blood; Pandemics; SARS-CoV-2","Otto-Terlouw","Patricia","Dutch Foundations of Population Screening, Population Screening South-West, Rotterdam, the Netherlands",NA
"761","34217421","10.1016/j.ypmed.2021.106643","The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic.","The COVID-19 pandemic has affected many healthcare services worldwide. Like many other nations, the Netherlands experienced large numbers of individuals affected by COVID-19 in 2020, leading to increased demands on hospitals and intensive care units. The Dutch Ministry of Health decided to suspend the Dutch biennial fecal immunochemical test (FIT) based colorectal cancer (CRC) screening program from March 16, 2020. FIT invitations were resumed on June 3. In this study, we describe the short-term","2021","07","08","Prev Med","Preventive medicine","COVID-19; Colorectal Cancer; Screening; COVID-19; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Mass Screening; Netherlands; Occult Blood; Pandemics; SARS-CoV-2","van Leerdam","Monique E","Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands",NA
"762","34217421","10.1016/j.ypmed.2021.106643","The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic.","The COVID-19 pandemic has affected many healthcare services worldwide. Like many other nations, the Netherlands experienced large numbers of individuals affected by COVID-19 in 2020, leading to increased demands on hospitals and intensive care units. The Dutch Ministry of Health decided to suspend the Dutch biennial fecal immunochemical test (FIT) based colorectal cancer (CRC) screening program from March 16, 2020. FIT invitations were resumed on June 3. In this study, we describe the short-term","2021","07","08","Prev Med","Preventive medicine","COVID-19; Colorectal Cancer; Screening; COVID-19; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Mass Screening; Netherlands; Occult Blood; Pandemics; SARS-CoV-2","Spaander","Manon C W","Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands",NA
"763","34217421","10.1016/j.ypmed.2021.106643","The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic.","The COVID-19 pandemic has affected many healthcare services worldwide. Like many other nations, the Netherlands experienced large numbers of individuals affected by COVID-19 in 2020, leading to increased demands on hospitals and intensive care units. The Dutch Ministry of Health decided to suspend the Dutch biennial fecal immunochemical test (FIT) based colorectal cancer (CRC) screening program from March 16, 2020. FIT invitations were resumed on June 3. In this study, we describe the short-term","2021","07","08","Prev Med","Preventive medicine","COVID-19; Colorectal Cancer; Screening; COVID-19; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Mass Screening; Netherlands; Occult Blood; Pandemics; SARS-CoV-2","Dekker","Evelien","Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, location AMC, Amsterdam, the Netherlands. Electronic address: e.dekker@amsterdamumc","e.dekker@amsterdamumc.nl"
"764","34217421","10.1016/j.ypmed.2021.106643","The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic.","The COVID-19 pandemic has affected many healthcare services worldwide. Like many other nations, the Netherlands experienced large numbers of individuals affected by COVID-19 in 2020, leading to increased demands on hospitals and intensive care units. The Dutch Ministry of Health decided to suspend the Dutch biennial fecal immunochemical test (FIT) based colorectal cancer (CRC) screening program from March 16, 2020. FIT invitations were resumed on June 3. In this study, we describe the short-term","2021","07","08","Prev Med","Preventive medicine","COVID-19; Colorectal Cancer; Screening; COVID-19; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Mass Screening; Netherlands; Occult Blood; Pandemics; SARS-CoV-2","Lansdorp-Vogelaar","Iris","Department of Public Health, Erasmus MC University Medical Center, Rotterdam, the Netherlands",NA
"765","34217420","10.1016/j.ypmed.2021.106642","Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.","Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-19 pandemic led many countries to suspend cancer screening services as part of their response to the pandemic. The International Cancer Screening Network (ICSN) carried out an online survey to assess the effects of the first wave of the COVID-19 pandemic on cancer screening. A 33-item survey was distributed to 834 email addresses to gather information about settings and assess decision-making processes that ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disruption; Health care services; COVID-19; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Puricelli Perin","Douglas M","Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. Electronic address: douglas.puricelliperin@nih","douglas.puricelliperin@nih.gov"
"766","34217420","10.1016/j.ypmed.2021.106642","Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.","Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-19 pandemic led many countries to suspend cancer screening services as part of their response to the pandemic. The International Cancer Screening Network (ICSN) carried out an online survey to assess the effects of the first wave of the COVID-19 pandemic on cancer screening. A 33-item survey was distributed to 834 email addresses to gather information about settings and assess decision-making processes that ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disruption; Health care services; COVID-19; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Elfström","K Miriam","Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden",NA
"767","34217420","10.1016/j.ypmed.2021.106642","Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.","Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-19 pandemic led many countries to suspend cancer screening services as part of their response to the pandemic. The International Cancer Screening Network (ICSN) carried out an online survey to assess the effects of the first wave of the COVID-19 pandemic on cancer screening. A 33-item survey was distributed to 834 email addresses to gather information about settings and assess decision-making processes that ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disruption; Health care services; COVID-19; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Bulliard","Jean-Luc","Center for Primary Care and Public Health (unisanté), University of Lausanne, Lausanne, Switzerland",NA
"768","34217420","10.1016/j.ypmed.2021.106642","Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.","Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-19 pandemic led many countries to suspend cancer screening services as part of their response to the pandemic. The International Cancer Screening Network (ICSN) carried out an online survey to assess the effects of the first wave of the COVID-19 pandemic on cancer screening. A 33-item survey was distributed to 834 email addresses to gather information about settings and assess decision-making processes that ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disruption; Health care services; COVID-19; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Burón","Andrea","Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain",NA
"769","34217420","10.1016/j.ypmed.2021.106642","Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.","Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-19 pandemic led many countries to suspend cancer screening services as part of their response to the pandemic. The International Cancer Screening Network (ICSN) carried out an online survey to assess the effects of the first wave of the COVID-19 pandemic on cancer screening. A 33-item survey was distributed to 834 email addresses to gather information about settings and assess decision-making processes that ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disruption; Health care services; COVID-19; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Campbell","Christine","Usher Institute, University of Edinburgh, Scotland, UK",NA
"770","34217420","10.1016/j.ypmed.2021.106642","Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.","Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-19 pandemic led many countries to suspend cancer screening services as part of their response to the pandemic. The International Cancer Screening Network (ICSN) carried out an online survey to assess the effects of the first wave of the COVID-19 pandemic on cancer screening. A 33-item survey was distributed to 834 email addresses to gather information about settings and assess decision-making processes that ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disruption; Health care services; COVID-19; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Flugelman","Anath A","Department of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center, Haifa, Israel",NA
"771","34217420","10.1016/j.ypmed.2021.106642","Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.","Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-19 pandemic led many countries to suspend cancer screening services as part of their response to the pandemic. The International Cancer Screening Network (ICSN) carried out an online survey to assess the effects of the first wave of the COVID-19 pandemic on cancer screening. A 33-item survey was distributed to 834 email addresses to gather information about settings and assess decision-making processes that ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disruption; Health care services; COVID-19; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Giordano","Livia","SSD Epidemiologia e screening - CPO, University Hospital 'Città della Salute e della Scienza', Turin, Italy",NA
"772","34217420","10.1016/j.ypmed.2021.106642","Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.","Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-19 pandemic led many countries to suspend cancer screening services as part of their response to the pandemic. The International Cancer Screening Network (ICSN) carried out an online survey to assess the effects of the first wave of the COVID-19 pandemic on cancer screening. A 33-item survey was distributed to 834 email addresses to gather information about settings and assess decision-making processes that ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disruption; Health care services; COVID-19; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Kamineni","Aruna","Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA",NA
"773","34217420","10.1016/j.ypmed.2021.106642","Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.","Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-19 pandemic led many countries to suspend cancer screening services as part of their response to the pandemic. The International Cancer Screening Network (ICSN) carried out an online survey to assess the effects of the first wave of the COVID-19 pandemic on cancer screening. A 33-item survey was distributed to 834 email addresses to gather information about settings and assess decision-making processes that ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disruption; Health care services; COVID-19; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Ponti","Antonio","SSD Epidemiologia e screening - CPO, University Hospital 'Città della Salute e della Scienza', Turin, Italy",NA
"774","34217420","10.1016/j.ypmed.2021.106642","Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.","Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-19 pandemic led many countries to suspend cancer screening services as part of their response to the pandemic. The International Cancer Screening Network (ICSN) carried out an online survey to assess the effects of the first wave of the COVID-19 pandemic on cancer screening. A 33-item survey was distributed to 834 email addresses to gather information about settings and assess decision-making processes that ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disruption; Health care services; COVID-19; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Rabeneck","Linda","Prevention and Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada",NA
"775","34217420","10.1016/j.ypmed.2021.106642","Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.","Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-19 pandemic led many countries to suspend cancer screening services as part of their response to the pandemic. The International Cancer Screening Network (ICSN) carried out an online survey to assess the effects of the first wave of the COVID-19 pandemic on cancer screening. A 33-item survey was distributed to 834 email addresses to gather information about settings and assess decision-making processes that ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disruption; Health care services; COVID-19; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Saraiya","Mona","Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA",NA
"776","34217420","10.1016/j.ypmed.2021.106642","Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.","Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-19 pandemic led many countries to suspend cancer screening services as part of their response to the pandemic. The International Cancer Screening Network (ICSN) carried out an online survey to assess the effects of the first wave of the COVID-19 pandemic on cancer screening. A 33-item survey was distributed to 834 email addresses to gather information about settings and assess decision-making processes that ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disruption; Health care services; COVID-19; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Smith","Robert A","American Cancer Society, Atlanta, GA, USA",NA
"777","34217420","10.1016/j.ypmed.2021.106642","Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.","Screening can decrease the burden of breast, cervical, and colorectal cancers. The COVID-19 pandemic led many countries to suspend cancer screening services as part of their response to the pandemic. The International Cancer Screening Network (ICSN) carried out an online survey to assess the effects of the first wave of the COVID-19 pandemic on cancer screening. A 33-item survey was distributed to 834 email addresses to gather information about settings and assess decision-making processes that ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disruption; Health care services; COVID-19; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2; Surveys and Questionnaires","Broeders","Mireille J M","Radboud university medical center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands",NA
"778","34217419","10.1016/j.ypmed.2021.106640","The trajectory of racial/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: A large U.S. academic center analysis.","Cancer screening rates declined sharply early in the COVID-19 pandemic. The impact of the pandemic may have exacerbated existing disparities in cancer screening due to the disproportionate burden of illness and job loss among racial/ ethnic minorities, and potentially, uneven resumption of care between different racial/ ethnic groups. Using electronic health record data from Mass General Brigham (MGB), we assessed changes in rates of breast, cervical, colorectal and lung cancer screening before ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disparities; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Healthcare Disparities; Humans; Lung Neoplasms; Pandemics; SARS-CoV-2; United States","Marcondes","Felippe O","Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, United States",NA
"779","34217419","10.1016/j.ypmed.2021.106640","The trajectory of racial/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: A large U.S. academic center analysis.","Cancer screening rates declined sharply early in the COVID-19 pandemic. The impact of the pandemic may have exacerbated existing disparities in cancer screening due to the disproportionate burden of illness and job loss among racial/ ethnic minorities, and potentially, uneven resumption of care between different racial/ ethnic groups. Using electronic health record data from Mass General Brigham (MGB), we assessed changes in rates of breast, cervical, colorectal and lung cancer screening before ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disparities; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Healthcare Disparities; Humans; Lung Neoplasms; Pandemics; SARS-CoV-2; United States","Cheng","David","Division of Biostatistics, Massachusetts General Hospital, Boston, MA, United States",NA
"780","34217419","10.1016/j.ypmed.2021.106640","The trajectory of racial/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: A large U.S. academic center analysis.","Cancer screening rates declined sharply early in the COVID-19 pandemic. The impact of the pandemic may have exacerbated existing disparities in cancer screening due to the disproportionate burden of illness and job loss among racial/ ethnic minorities, and potentially, uneven resumption of care between different racial/ ethnic groups. Using electronic health record data from Mass General Brigham (MGB), we assessed changes in rates of breast, cervical, colorectal and lung cancer screening before ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disparities; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Healthcare Disparities; Humans; Lung Neoplasms; Pandemics; SARS-CoV-2; United States","Warner","Erica T","Mongan Institute, Clinical Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, United States",NA
"781","34217419","10.1016/j.ypmed.2021.106640","The trajectory of racial/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: A large U.S. academic center analysis.","Cancer screening rates declined sharply early in the COVID-19 pandemic. The impact of the pandemic may have exacerbated existing disparities in cancer screening due to the disproportionate burden of illness and job loss among racial/ ethnic minorities, and potentially, uneven resumption of care between different racial/ ethnic groups. Using electronic health record data from Mass General Brigham (MGB), we assessed changes in rates of breast, cervical, colorectal and lung cancer screening before ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disparities; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Healthcare Disparities; Humans; Lung Neoplasms; Pandemics; SARS-CoV-2; United States","Kamran","Sophia C","Department of Radiation Oncology, Mass General Cancer Center, Massachusetts General Hospital, Boston, MA, United States",NA
"782","34217419","10.1016/j.ypmed.2021.106640","The trajectory of racial/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: A large U.S. academic center analysis.","Cancer screening rates declined sharply early in the COVID-19 pandemic. The impact of the pandemic may have exacerbated existing disparities in cancer screening due to the disproportionate burden of illness and job loss among racial/ ethnic minorities, and potentially, uneven resumption of care between different racial/ ethnic groups. Using electronic health record data from Mass General Brigham (MGB), we assessed changes in rates of breast, cervical, colorectal and lung cancer screening before ","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Disparities; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Healthcare Disparities; Humans; Lung Neoplasms; Pandemics; SARS-CoV-2; United States","Haas","Jennifer S","Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, United States","Jennifer.Haas@mgh.harvard.edu"
"783","34217418","10.1016/j.ypmed.2021.106606","COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm.","Screening is an important component of cancer control internationally. In Scotland, the National Health Service Scotland provides screening programmes for cervical, bowel and breast cancers. The COVID-19 pandemic resulted in the suspension of these programmes in March 2020. We describe the integrated approach to managing the impact of the pandemic on cancer screening programmes in Scotland throughout 2020. We outline the policy context and decision-making process leading to suspension, and the c","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Impact of pandemic; Monitoring impact; Programmatic screening; Screening restart; Screening suspension; COVID-19; Early Detection of Cancer; Female; Humans; Pandemics; SARS-CoV-2; Scotland; State Medicine; Uterine Cervical Neoplasms","Campbell","Christine","Usher Institute, University of Edinburgh, Scotland EH8 9AG, UK. Electronic address: Christine.Campbell@ed.ac","Christine.Campbell@ed.ac.uk"
"784","34217418","10.1016/j.ypmed.2021.106606","COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm.","Screening is an important component of cancer control internationally. In Scotland, the National Health Service Scotland provides screening programmes for cervical, bowel and breast cancers. The COVID-19 pandemic resulted in the suspension of these programmes in March 2020. We describe the integrated approach to managing the impact of the pandemic on cancer screening programmes in Scotland throughout 2020. We outline the policy context and decision-making process leading to suspension, and the c","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Impact of pandemic; Monitoring impact; Programmatic screening; Screening restart; Screening suspension; COVID-19; Early Detection of Cancer; Female; Humans; Pandemics; SARS-CoV-2; Scotland; State Medicine; Uterine Cervical Neoplasms","Sommerfield","Tasmin","Consultant in Public Health Medicine for National Screening Programmes, NHS National Services Scotland, 1 South Gyle Crescent, Edinburgh EH12 9EB, UK",NA
"785","34217418","10.1016/j.ypmed.2021.106606","COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm.","Screening is an important component of cancer control internationally. In Scotland, the National Health Service Scotland provides screening programmes for cervical, bowel and breast cancers. The COVID-19 pandemic resulted in the suspension of these programmes in March 2020. We describe the integrated approach to managing the impact of the pandemic on cancer screening programmes in Scotland throughout 2020. We outline the policy context and decision-making process leading to suspension, and the c","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Impact of pandemic; Monitoring impact; Programmatic screening; Screening restart; Screening suspension; COVID-19; Early Detection of Cancer; Female; Humans; Pandemics; SARS-CoV-2; Scotland; State Medicine; Uterine Cervical Neoplasms","Clark","Gavin R C","Public Health Scotland, Edinburgh, Gyle Square, 1 South Gyle Crescent, Edinburgh EH12 9EB, UK",NA
"786","34217418","10.1016/j.ypmed.2021.106606","COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm.","Screening is an important component of cancer control internationally. In Scotland, the National Health Service Scotland provides screening programmes for cervical, bowel and breast cancers. The COVID-19 pandemic resulted in the suspension of these programmes in March 2020. We describe the integrated approach to managing the impact of the pandemic on cancer screening programmes in Scotland throughout 2020. We outline the policy context and decision-making process leading to suspension, and the c","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Impact of pandemic; Monitoring impact; Programmatic screening; Screening restart; Screening suspension; COVID-19; Early Detection of Cancer; Female; Humans; Pandemics; SARS-CoV-2; Scotland; State Medicine; Uterine Cervical Neoplasms","Porteous","Lorna","GP Lead Cancer and Palliative Care, NHS Lothian, Waverley Gate, 2-4 Waterloo Place, Edinburgh EH1 3EG, UK",NA
"787","34217418","10.1016/j.ypmed.2021.106606","COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm.","Screening is an important component of cancer control internationally. In Scotland, the National Health Service Scotland provides screening programmes for cervical, bowel and breast cancers. The COVID-19 pandemic resulted in the suspension of these programmes in March 2020. We describe the integrated approach to managing the impact of the pandemic on cancer screening programmes in Scotland throughout 2020. We outline the policy context and decision-making process leading to suspension, and the c","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Impact of pandemic; Monitoring impact; Programmatic screening; Screening restart; Screening suspension; COVID-19; Early Detection of Cancer; Female; Humans; Pandemics; SARS-CoV-2; Scotland; State Medicine; Uterine Cervical Neoplasms","Milne","Alison M","Detect Cancer Early, NHS Lothian, Waverley Gate, 2-4 Waterloo Place, Edinburgh EH1 3EG, UK",NA
"788","34217418","10.1016/j.ypmed.2021.106606","COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm.","Screening is an important component of cancer control internationally. In Scotland, the National Health Service Scotland provides screening programmes for cervical, bowel and breast cancers. The COVID-19 pandemic resulted in the suspension of these programmes in March 2020. We describe the integrated approach to managing the impact of the pandemic on cancer screening programmes in Scotland throughout 2020. We outline the policy context and decision-making process leading to suspension, and the c","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Impact of pandemic; Monitoring impact; Programmatic screening; Screening restart; Screening suspension; COVID-19; Early Detection of Cancer; Female; Humans; Pandemics; SARS-CoV-2; Scotland; State Medicine; Uterine Cervical Neoplasms","Millar","Rosemary","Consultant in Public Health Medicine for NHS Lothian, Public Health &amp",NA
"789","34217418","10.1016/j.ypmed.2021.106606","COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm.","Screening is an important component of cancer control internationally. In Scotland, the National Health Service Scotland provides screening programmes for cervical, bowel and breast cancers. The COVID-19 pandemic resulted in the suspension of these programmes in March 2020. We describe the integrated approach to managing the impact of the pandemic on cancer screening programmes in Scotland throughout 2020. We outline the policy context and decision-making process leading to suspension, and the c","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Impact of pandemic; Monitoring impact; Programmatic screening; Screening restart; Screening suspension; COVID-19; Early Detection of Cancer; Female; Humans; Pandemics; SARS-CoV-2; Scotland; State Medicine; Uterine Cervical Neoplasms","Syme","Tracey","National Specialist and Screening Directorate (NSD), NHS National Services Scotland, 1 South Gyle Crescent, Edinburgh EH12 9EB, UK",NA
"790","34217418","10.1016/j.ypmed.2021.106606","COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm.","Screening is an important component of cancer control internationally. In Scotland, the National Health Service Scotland provides screening programmes for cervical, bowel and breast cancers. The COVID-19 pandemic resulted in the suspension of these programmes in March 2020. We describe the integrated approach to managing the impact of the pandemic on cancer screening programmes in Scotland throughout 2020. We outline the policy context and decision-making process leading to suspension, and the c","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Impact of pandemic; Monitoring impact; Programmatic screening; Screening restart; Screening suspension; COVID-19; Early Detection of Cancer; Female; Humans; Pandemics; SARS-CoV-2; Scotland; State Medicine; Uterine Cervical Neoplasms","Thomson","Catherine S","Public Health Scotland, Edinburgh, Gyle Square, 1 South Gyle Crescent, Edinburgh EH12 9EB, UK",NA
"791","34217417","10.1016/j.ypmed.2021.106602","Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.","The COVID-19 pandemic forced the Dutch national breast screening program to a halt in week 12, 2020. In week 26, the breast program was resumed at 40% capacity, which increased to 60% in week 34. We examined the impact of the suspension and restart of the screening program on the incidence of screen-detected and non-screen-detected breast cancer. We selected women aged 50-74, diagnosed during weeks 2-35 of 2018 (n = 7250), 2019 (n = 7302), or 2020 (n = 5306), from the Netherlands Cancer Registry","2021","07","08","Prev Med","Preventive medicine","Breast cancer incidence; Breast cancer screening; COVID-19; Clinical tumor stage; cT-stage; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Incidence; Mammography; Mass Screening; Netherlands; Pandemics; SARS-CoV-2","Eijkelboom","Anouk H","Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, the Netherlands. Electronic address: a.eijkelboom@iknl","a.eijkelboom@iknl.nl"
"792","34217417","10.1016/j.ypmed.2021.106602","Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.","The COVID-19 pandemic forced the Dutch national breast screening program to a halt in week 12, 2020. In week 26, the breast program was resumed at 40% capacity, which increased to 60% in week 34. We examined the impact of the suspension and restart of the screening program on the incidence of screen-detected and non-screen-detected breast cancer. We selected women aged 50-74, diagnosed during weeks 2-35 of 2018 (n = 7250), 2019 (n = 7302), or 2020 (n = 5306), from the Netherlands Cancer Registry","2021","07","08","Prev Med","Preventive medicine","Breast cancer incidence; Breast cancer screening; COVID-19; Clinical tumor stage; cT-stage; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Incidence; Mammography; Mass Screening; Netherlands; Pandemics; SARS-CoV-2","de Munck","Linda","Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, the Netherlands. Electronic address: l.demunck@iknl","l.demunck@iknl.nl"
"793","34217417","10.1016/j.ypmed.2021.106602","Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.","The COVID-19 pandemic forced the Dutch national breast screening program to a halt in week 12, 2020. In week 26, the breast program was resumed at 40% capacity, which increased to 60% in week 34. We examined the impact of the suspension and restart of the screening program on the incidence of screen-detected and non-screen-detected breast cancer. We selected women aged 50-74, diagnosed during weeks 2-35 of 2018 (n = 7250), 2019 (n = 7302), or 2020 (n = 5306), from the Netherlands Cancer Registry","2021","07","08","Prev Med","Preventive medicine","Breast cancer incidence; Breast cancer screening; COVID-19; Clinical tumor stage; cT-stage; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Incidence; Mammography; Mass Screening; Netherlands; Pandemics; SARS-CoV-2","Lobbes","Marc B I","Department of Medical Imaging, Zuyderland Medical Center Sittard-Geleen, Dr. H. van der Hoffplein 1, 6162 BG Sittard-Geleen, the Netherlands","marc.lobbes@mumc.nl"
"794","34217417","10.1016/j.ypmed.2021.106602","Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.","The COVID-19 pandemic forced the Dutch national breast screening program to a halt in week 12, 2020. In week 26, the breast program was resumed at 40% capacity, which increased to 60% in week 34. We examined the impact of the suspension and restart of the screening program on the incidence of screen-detected and non-screen-detected breast cancer. We selected women aged 50-74, diagnosed during weeks 2-35 of 2018 (n = 7250), 2019 (n = 7302), or 2020 (n = 5306), from the Netherlands Cancer Registry","2021","07","08","Prev Med","Preventive medicine","Breast cancer incidence; Breast cancer screening; COVID-19; Clinical tumor stage; cT-stage; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Incidence; Mammography; Mass Screening; Netherlands; Pandemics; SARS-CoV-2","van Gils","Carla H","Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands. Electronic address: C.vanGils@umcutrecht","C.vanGils@umcutrecht.nl"
"795","34217417","10.1016/j.ypmed.2021.106602","Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.","The COVID-19 pandemic forced the Dutch national breast screening program to a halt in week 12, 2020. In week 26, the breast program was resumed at 40% capacity, which increased to 60% in week 34. We examined the impact of the suspension and restart of the screening program on the incidence of screen-detected and non-screen-detected breast cancer. We selected women aged 50-74, diagnosed during weeks 2-35 of 2018 (n = 7250), 2019 (n = 7302), or 2020 (n = 5306), from the Netherlands Cancer Registry","2021","07","08","Prev Med","Preventive medicine","Breast cancer incidence; Breast cancer screening; COVID-19; Clinical tumor stage; cT-stage; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Incidence; Mammography; Mass Screening; Netherlands; Pandemics; SARS-CoV-2","Wesseling","Jelle","Divisions of Diagnostic Oncology and Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands","j.wesseling@nki.nl"
"796","34217417","10.1016/j.ypmed.2021.106602","Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.","The COVID-19 pandemic forced the Dutch national breast screening program to a halt in week 12, 2020. In week 26, the breast program was resumed at 40% capacity, which increased to 60% in week 34. We examined the impact of the suspension and restart of the screening program on the incidence of screen-detected and non-screen-detected breast cancer. We selected women aged 50-74, diagnosed during weeks 2-35 of 2018 (n = 7250), 2019 (n = 7302), or 2020 (n = 5306), from the Netherlands Cancer Registry","2021","07","08","Prev Med","Preventive medicine","Breast cancer incidence; Breast cancer screening; COVID-19; Clinical tumor stage; cT-stage; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Incidence; Mammography; Mass Screening; Netherlands; Pandemics; SARS-CoV-2","Westenend","Pieter J","Laboratory of Pathology, Karel Lotsyweg 145, 3318 AL Dordrecht, the Netherlands. Electronic address: PWestenend@paldordrecht","PWestenend@paldordrecht.nl"
"797","34217417","10.1016/j.ypmed.2021.106602","Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.","The COVID-19 pandemic forced the Dutch national breast screening program to a halt in week 12, 2020. In week 26, the breast program was resumed at 40% capacity, which increased to 60% in week 34. We examined the impact of the suspension and restart of the screening program on the incidence of screen-detected and non-screen-detected breast cancer. We selected women aged 50-74, diagnosed during weeks 2-35 of 2018 (n = 7250), 2019 (n = 7302), or 2020 (n = 5306), from the Netherlands Cancer Registry","2021","07","08","Prev Med","Preventive medicine","Breast cancer incidence; Breast cancer screening; COVID-19; Clinical tumor stage; cT-stage; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Incidence; Mammography; Mass Screening; Netherlands; Pandemics; SARS-CoV-2","Guerrero Paez","Cristina","Dutch Breast Cancer Society (BVN), Godebaldkwartier 363, 3511 DT Utrecht, the Netherlands. Electronic address: guerrero@borstkanker","guerrero@borstkanker.nl"
"798","34217417","10.1016/j.ypmed.2021.106602","Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.","The COVID-19 pandemic forced the Dutch national breast screening program to a halt in week 12, 2020. In week 26, the breast program was resumed at 40% capacity, which increased to 60% in week 34. We examined the impact of the suspension and restart of the screening program on the incidence of screen-detected and non-screen-detected breast cancer. We selected women aged 50-74, diagnosed during weeks 2-35 of 2018 (n = 7250), 2019 (n = 7302), or 2020 (n = 5306), from the Netherlands Cancer Registry","2021","07","08","Prev Med","Preventive medicine","Breast cancer incidence; Breast cancer screening; COVID-19; Clinical tumor stage; cT-stage; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Incidence; Mammography; Mass Screening; Netherlands; Pandemics; SARS-CoV-2","Pijnappel","Ruud M","Department of Radiology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands. Electronic address: r.pijnappel@lrcb","r.pijnappel@lrcb.nl"
"799","34217417","10.1016/j.ypmed.2021.106602","Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.","The COVID-19 pandemic forced the Dutch national breast screening program to a halt in week 12, 2020. In week 26, the breast program was resumed at 40% capacity, which increased to 60% in week 34. We examined the impact of the suspension and restart of the screening program on the incidence of screen-detected and non-screen-detected breast cancer. We selected women aged 50-74, diagnosed during weeks 2-35 of 2018 (n = 7250), 2019 (n = 7302), or 2020 (n = 5306), from the Netherlands Cancer Registry","2021","07","08","Prev Med","Preventive medicine","Breast cancer incidence; Breast cancer screening; COVID-19; Clinical tumor stage; cT-stage; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Incidence; Mammography; Mass Screening; Netherlands; Pandemics; SARS-CoV-2","Verkooijen","Helena M","Division of Imaging and Oncology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands. Electronic address: H.M.Verkooijen@umcutrecht","H.M.Verkooijen@umcutrecht.nl"
"800","34217417","10.1016/j.ypmed.2021.106602","Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.","The COVID-19 pandemic forced the Dutch national breast screening program to a halt in week 12, 2020. In week 26, the breast program was resumed at 40% capacity, which increased to 60% in week 34. We examined the impact of the suspension and restart of the screening program on the incidence of screen-detected and non-screen-detected breast cancer. We selected women aged 50-74, diagnosed during weeks 2-35 of 2018 (n = 7250), 2019 (n = 7302), or 2020 (n = 5306), from the Netherlands Cancer Registry","2021","07","08","Prev Med","Preventive medicine","Breast cancer incidence; Breast cancer screening; COVID-19; Clinical tumor stage; cT-stage; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Incidence; Mammography; Mass Screening; Netherlands; Pandemics; SARS-CoV-2","Broeders","Mireille J M","Department for Health Evidence, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, the Netherlands","Mireille.Broeders@radboudumc.nl"
"801","34217417","10.1016/j.ypmed.2021.106602","Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.","The COVID-19 pandemic forced the Dutch national breast screening program to a halt in week 12, 2020. In week 26, the breast program was resumed at 40% capacity, which increased to 60% in week 34. We examined the impact of the suspension and restart of the screening program on the incidence of screen-detected and non-screen-detected breast cancer. We selected women aged 50-74, diagnosed during weeks 2-35 of 2018 (n = 7250), 2019 (n = 7302), or 2020 (n = 5306), from the Netherlands Cancer Registry","2021","07","08","Prev Med","Preventive medicine","Breast cancer incidence; Breast cancer screening; COVID-19; Clinical tumor stage; cT-stage; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Incidence; Mammography; Mass Screening; Netherlands; Pandemics; SARS-CoV-2","Siesling","Sabine","Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, the Netherlands","s.siesling@iknl.nl"
"802","34217416","10.1016/j.ypmed.2021.106597","Modelling the impacts of COVID-19 pandemic on the quality of population-based colorectal cancer screening.","COVID-19 pandemic has severely affected regular public health interventions including population-based cancer screening. Impacts of such screening delays on the changes in structure and screening process and the resultant long-term outcomes are unknown. It is therefore necessary to develop a systematic framework to assess theses impacts related to these components of quality. Using population-based cancer screening with fecal immunochemical test (FIT) as an illustration, the main analysis was to","2021","07","08","Prev Med","Preventive medicine","COVID-19; Colorectal cancer; Fecal immunochemical test; Screening; Social distancing; COVID-19; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Mass Screening; Occult Blood; Pandemics; SARS-CoV-2; Taiwan","Jen","Grace Hsiao-Hsuan","Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan",NA
"803","34217416","10.1016/j.ypmed.2021.106597","Modelling the impacts of COVID-19 pandemic on the quality of population-based colorectal cancer screening.","COVID-19 pandemic has severely affected regular public health interventions including population-based cancer screening. Impacts of such screening delays on the changes in structure and screening process and the resultant long-term outcomes are unknown. It is therefore necessary to develop a systematic framework to assess theses impacts related to these components of quality. Using population-based cancer screening with fecal immunochemical test (FIT) as an illustration, the main analysis was to","2021","07","08","Prev Med","Preventive medicine","COVID-19; Colorectal cancer; Fecal immunochemical test; Screening; Social distancing; COVID-19; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Mass Screening; Occult Blood; Pandemics; SARS-CoV-2; Taiwan","Yen","Amy Ming-Fang","School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan",NA
"804","34217416","10.1016/j.ypmed.2021.106597","Modelling the impacts of COVID-19 pandemic on the quality of population-based colorectal cancer screening.","COVID-19 pandemic has severely affected regular public health interventions including population-based cancer screening. Impacts of such screening delays on the changes in structure and screening process and the resultant long-term outcomes are unknown. It is therefore necessary to develop a systematic framework to assess theses impacts related to these components of quality. Using population-based cancer screening with fecal immunochemical test (FIT) as an illustration, the main analysis was to","2021","07","08","Prev Med","Preventive medicine","COVID-19; Colorectal cancer; Fecal immunochemical test; Screening; Social distancing; COVID-19; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Mass Screening; Occult Blood; Pandemics; SARS-CoV-2; Taiwan","Hsu","Chen-Yang","Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan",NA
"805","34217416","10.1016/j.ypmed.2021.106597","Modelling the impacts of COVID-19 pandemic on the quality of population-based colorectal cancer screening.","COVID-19 pandemic has severely affected regular public health interventions including population-based cancer screening. Impacts of such screening delays on the changes in structure and screening process and the resultant long-term outcomes are unknown. It is therefore necessary to develop a systematic framework to assess theses impacts related to these components of quality. Using population-based cancer screening with fecal immunochemical test (FIT) as an illustration, the main analysis was to","2021","07","08","Prev Med","Preventive medicine","COVID-19; Colorectal cancer; Fecal immunochemical test; Screening; Social distancing; COVID-19; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Mass Screening; Occult Blood; Pandemics; SARS-CoV-2; Taiwan","Chiu","Han-Mo","Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan",NA
"806","34217416","10.1016/j.ypmed.2021.106597","Modelling the impacts of COVID-19 pandemic on the quality of population-based colorectal cancer screening.","COVID-19 pandemic has severely affected regular public health interventions including population-based cancer screening. Impacts of such screening delays on the changes in structure and screening process and the resultant long-term outcomes are unknown. It is therefore necessary to develop a systematic framework to assess theses impacts related to these components of quality. Using population-based cancer screening with fecal immunochemical test (FIT) as an illustration, the main analysis was to","2021","07","08","Prev Med","Preventive medicine","COVID-19; Colorectal cancer; Fecal immunochemical test; Screening; Social distancing; COVID-19; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Mass Screening; Occult Blood; Pandemics; SARS-CoV-2; Taiwan","Chen","Sam Li-Sheng","School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan. Electronic address: samchen@tmu.edu","samchen@tmu.edu.tw"
"807","34217416","10.1016/j.ypmed.2021.106597","Modelling the impacts of COVID-19 pandemic on the quality of population-based colorectal cancer screening.","COVID-19 pandemic has severely affected regular public health interventions including population-based cancer screening. Impacts of such screening delays on the changes in structure and screening process and the resultant long-term outcomes are unknown. It is therefore necessary to develop a systematic framework to assess theses impacts related to these components of quality. Using population-based cancer screening with fecal immunochemical test (FIT) as an illustration, the main analysis was to","2021","07","08","Prev Med","Preventive medicine","COVID-19; Colorectal cancer; Fecal immunochemical test; Screening; Social distancing; COVID-19; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Mass Screening; Occult Blood; Pandemics; SARS-CoV-2; Taiwan","Chen","Tony Hsiu-Hsi","Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan. Electronic address: chenlin@ntu.edu","chenlin@ntu.edu.tw"
"808","34217415","10.1016/j.ypmed.2021.106596","Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities.","The COVID-19 pandemic has a major impact on a wide range of health outcomes. Disruptions of elective health services related to cervical screening, management of abnormal screening test results, and treatment of precancers, may lead to increases in cervical cancer incidence and exacerbate existing health disparities. Modeling studies suggest that a short delay of cervical screening in subjects with previously negative HPV results has minor effects on cancer outcomes, while delay of management an","2021","07","07","Prev Med","Preventive medicine","COVID-19; Cervical cancer; Cervical precancer; HPV; Health disparities; Pandemic; SARS-CoV-2; Screening; COVID-19; Early Detection of Cancer; Female; Humans; Mass Screening; Pandemics; Papillomaviridae; Papillomavirus Infections; SARS-CoV-2; Uterine Cervical Neoplasms","Wentzensen","Nicolas","Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. Electronic address: wentzenn@mail.nih","wentzenn@mail.nih.gov"
"809","34217415","10.1016/j.ypmed.2021.106596","Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities.","The COVID-19 pandemic has a major impact on a wide range of health outcomes. Disruptions of elective health services related to cervical screening, management of abnormal screening test results, and treatment of precancers, may lead to increases in cervical cancer incidence and exacerbate existing health disparities. Modeling studies suggest that a short delay of cervical screening in subjects with previously negative HPV results has minor effects on cancer outcomes, while delay of management an","2021","07","07","Prev Med","Preventive medicine","COVID-19; Cervical cancer; Cervical precancer; HPV; Health disparities; Pandemic; SARS-CoV-2; Screening; COVID-19; Early Detection of Cancer; Female; Humans; Mass Screening; Pandemics; Papillomaviridae; Papillomavirus Infections; SARS-CoV-2; Uterine Cervical Neoplasms","Clarke","Megan A","Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA",NA
"810","34217415","10.1016/j.ypmed.2021.106596","Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities.","The COVID-19 pandemic has a major impact on a wide range of health outcomes. Disruptions of elective health services related to cervical screening, management of abnormal screening test results, and treatment of precancers, may lead to increases in cervical cancer incidence and exacerbate existing health disparities. Modeling studies suggest that a short delay of cervical screening in subjects with previously negative HPV results has minor effects on cancer outcomes, while delay of management an","2021","07","07","Prev Med","Preventive medicine","COVID-19; Cervical cancer; Cervical precancer; HPV; Health disparities; Pandemic; SARS-CoV-2; Screening; COVID-19; Early Detection of Cancer; Female; Humans; Mass Screening; Pandemics; Papillomaviridae; Papillomavirus Infections; SARS-CoV-2; Uterine Cervical Neoplasms","Perkins","Rebecca B","Boston University School of Medicine, Boston Medical Center, Boston, MA, USA",NA
"811","34217414","10.1016/j.ypmed.2021.106595","Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond.","COVID-19 has proved enormously disruptive to the provision of cancer screening, which does not just represent an initial test but an entire process, including risk detection, diagnostic follow-up, and treatment. Successful delivery of services at all points in the process has been negatively affected by the pandemic. There is a void in empirical high-quality evidence to support a specific strategy for administering cancer screening during a pandemic and its resolution phase, but several pragmati","2021","07","08","Prev Med","Preventive medicine","COVID-19; Delivery of Health Care; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2","Croswell","Jennifer M","Division of Cancer Control and Population Sciences, National Cancer Institute, USA. Electronic address: croswellj@nih","croswellj@nih.gov"
"812","34217414","10.1016/j.ypmed.2021.106595","Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond.","COVID-19 has proved enormously disruptive to the provision of cancer screening, which does not just represent an initial test but an entire process, including risk detection, diagnostic follow-up, and treatment. Successful delivery of services at all points in the process has been negatively affected by the pandemic. There is a void in empirical high-quality evidence to support a specific strategy for administering cancer screening during a pandemic and its resolution phase, but several pragmati","2021","07","08","Prev Med","Preventive medicine","COVID-19; Delivery of Health Care; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2","Corley","Douglas A","The Permanente Medical Group, Kaiser Permanente, Northern California, USA",NA
"813","34217414","10.1016/j.ypmed.2021.106595","Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond.","COVID-19 has proved enormously disruptive to the provision of cancer screening, which does not just represent an initial test but an entire process, including risk detection, diagnostic follow-up, and treatment. Successful delivery of services at all points in the process has been negatively affected by the pandemic. There is a void in empirical high-quality evidence to support a specific strategy for administering cancer screening during a pandemic and its resolution phase, but several pragmati","2021","07","08","Prev Med","Preventive medicine","COVID-19; Delivery of Health Care; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2","Lafata","Jennifer Elston","University of North Carolina Lineberger Comprehensive Cancer Center and Eshelman School of Pharmacy, USA",NA
"814","34217414","10.1016/j.ypmed.2021.106595","Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond.","COVID-19 has proved enormously disruptive to the provision of cancer screening, which does not just represent an initial test but an entire process, including risk detection, diagnostic follow-up, and treatment. Successful delivery of services at all points in the process has been negatively affected by the pandemic. There is a void in empirical high-quality evidence to support a specific strategy for administering cancer screening during a pandemic and its resolution phase, but several pragmati","2021","07","08","Prev Med","Preventive medicine","COVID-19; Delivery of Health Care; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2","Haas","Jennifer S","Division of General Internal Medicine, Massachusetts General Hospital, USA",NA
"815","34217414","10.1016/j.ypmed.2021.106595","Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond.","COVID-19 has proved enormously disruptive to the provision of cancer screening, which does not just represent an initial test but an entire process, including risk detection, diagnostic follow-up, and treatment. Successful delivery of services at all points in the process has been negatively affected by the pandemic. There is a void in empirical high-quality evidence to support a specific strategy for administering cancer screening during a pandemic and its resolution phase, but several pragmati","2021","07","08","Prev Med","Preventive medicine","COVID-19; Delivery of Health Care; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2","Inadomi","John M","Department of Internal Medicine, University of Utah School of Medicine, USA",NA
"816","34217414","10.1016/j.ypmed.2021.106595","Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond.","COVID-19 has proved enormously disruptive to the provision of cancer screening, which does not just represent an initial test but an entire process, including risk detection, diagnostic follow-up, and treatment. Successful delivery of services at all points in the process has been negatively affected by the pandemic. There is a void in empirical high-quality evidence to support a specific strategy for administering cancer screening during a pandemic and its resolution phase, but several pragmati","2021","07","08","Prev Med","Preventive medicine","COVID-19; Delivery of Health Care; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2","Kamineni","Aruna","Kaiser Permanente Washington Health Research Institute, USA",NA
"817","34217414","10.1016/j.ypmed.2021.106595","Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond.","COVID-19 has proved enormously disruptive to the provision of cancer screening, which does not just represent an initial test but an entire process, including risk detection, diagnostic follow-up, and treatment. Successful delivery of services at all points in the process has been negatively affected by the pandemic. There is a void in empirical high-quality evidence to support a specific strategy for administering cancer screening during a pandemic and its resolution phase, but several pragmati","2021","07","08","Prev Med","Preventive medicine","COVID-19; Delivery of Health Care; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2","Ritzwoller","Debra P","Institute for Health Research, Kaiser Permanente Colorado, USA",NA
"818","34217414","10.1016/j.ypmed.2021.106595","Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond.","COVID-19 has proved enormously disruptive to the provision of cancer screening, which does not just represent an initial test but an entire process, including risk detection, diagnostic follow-up, and treatment. Successful delivery of services at all points in the process has been negatively affected by the pandemic. There is a void in empirical high-quality evidence to support a specific strategy for administering cancer screening during a pandemic and its resolution phase, but several pragmati","2021","07","08","Prev Med","Preventive medicine","COVID-19; Delivery of Health Care; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2","Vachani","Anil","Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, USA",NA
"819","34217414","10.1016/j.ypmed.2021.106595","Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond.","COVID-19 has proved enormously disruptive to the provision of cancer screening, which does not just represent an initial test but an entire process, including risk detection, diagnostic follow-up, and treatment. Successful delivery of services at all points in the process has been negatively affected by the pandemic. There is a void in empirical high-quality evidence to support a specific strategy for administering cancer screening during a pandemic and its resolution phase, but several pragmati","2021","07","08","Prev Med","Preventive medicine","COVID-19; Delivery of Health Care; Early Detection of Cancer; Humans; Neoplasms; Pandemics; SARS-CoV-2","Zheng","Yingye","Public Health Sciences Division, Fred Hutchinson Cancer Research Center, USA",NA
"820","34217413","10.1016/j.ypmed.2021.106586","Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.","It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening, including for vulnerable sub-populations, to inform the development of evidence-based, targeted pandemic recovery strategies. We undertook a population-based retrospective observational study in Ontario, Canada to assess the impact of the pandemic on organized cancer screening and diagnostic services, and assess whether patterns of cancer screening service use and diagnostic delay differ across population sub-g","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Diagnostic assessment; Disparity; Aftercare; COVID-19; Delayed Diagnosis; Early Detection of Cancer; Female; Humans; Lung Neoplasms; Ontario; Pandemics; SARS-CoV-2; Uterine Cervical Neoplasms","Walker","Meghan J","Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada","meghan.walker@ontariohealth.ca"
"821","34217413","10.1016/j.ypmed.2021.106586","Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.","It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening, including for vulnerable sub-populations, to inform the development of evidence-based, targeted pandemic recovery strategies. We undertook a population-based retrospective observational study in Ontario, Canada to assess the impact of the pandemic on organized cancer screening and diagnostic services, and assess whether patterns of cancer screening service use and diagnostic delay differ across population sub-g","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Diagnostic assessment; Disparity; Aftercare; COVID-19; Delayed Diagnosis; Early Detection of Cancer; Female; Humans; Lung Neoplasms; Ontario; Pandemics; SARS-CoV-2; Uterine Cervical Neoplasms","Meggetto","Olivia","Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada",NA
"822","34217413","10.1016/j.ypmed.2021.106586","Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.","It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening, including for vulnerable sub-populations, to inform the development of evidence-based, targeted pandemic recovery strategies. We undertook a population-based retrospective observational study in Ontario, Canada to assess the impact of the pandemic on organized cancer screening and diagnostic services, and assess whether patterns of cancer screening service use and diagnostic delay differ across population sub-g","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Diagnostic assessment; Disparity; Aftercare; COVID-19; Delayed Diagnosis; Early Detection of Cancer; Female; Humans; Lung Neoplasms; Ontario; Pandemics; SARS-CoV-2; Uterine Cervical Neoplasms","Gao","Julia","Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada",NA
"823","34217413","10.1016/j.ypmed.2021.106586","Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.","It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening, including for vulnerable sub-populations, to inform the development of evidence-based, targeted pandemic recovery strategies. We undertook a population-based retrospective observational study in Ontario, Canada to assess the impact of the pandemic on organized cancer screening and diagnostic services, and assess whether patterns of cancer screening service use and diagnostic delay differ across population sub-g","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Diagnostic assessment; Disparity; Aftercare; COVID-19; Delayed Diagnosis; Early Detection of Cancer; Female; Humans; Lung Neoplasms; Ontario; Pandemics; SARS-CoV-2; Uterine Cervical Neoplasms","Espino-Hernández","Gabriela","Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada",NA
"824","34217413","10.1016/j.ypmed.2021.106586","Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.","It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening, including for vulnerable sub-populations, to inform the development of evidence-based, targeted pandemic recovery strategies. We undertook a population-based retrospective observational study in Ontario, Canada to assess the impact of the pandemic on organized cancer screening and diagnostic services, and assess whether patterns of cancer screening service use and diagnostic delay differ across population sub-g","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Diagnostic assessment; Disparity; Aftercare; COVID-19; Delayed Diagnosis; Early Detection of Cancer; Female; Humans; Lung Neoplasms; Ontario; Pandemics; SARS-CoV-2; Uterine Cervical Neoplasms","Jembere","Nathaniel","Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada",NA
"825","34217413","10.1016/j.ypmed.2021.106586","Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.","It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening, including for vulnerable sub-populations, to inform the development of evidence-based, targeted pandemic recovery strategies. We undertook a population-based retrospective observational study in Ontario, Canada to assess the impact of the pandemic on organized cancer screening and diagnostic services, and assess whether patterns of cancer screening service use and diagnostic delay differ across population sub-g","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Diagnostic assessment; Disparity; Aftercare; COVID-19; Delayed Diagnosis; Early Detection of Cancer; Female; Humans; Lung Neoplasms; Ontario; Pandemics; SARS-CoV-2; Uterine Cervical Neoplasms","Bravo","Caroline A","Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada",NA
"826","34217413","10.1016/j.ypmed.2021.106586","Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.","It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening, including for vulnerable sub-populations, to inform the development of evidence-based, targeted pandemic recovery strategies. We undertook a population-based retrospective observational study in Ontario, Canada to assess the impact of the pandemic on organized cancer screening and diagnostic services, and assess whether patterns of cancer screening service use and diagnostic delay differ across population sub-g","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Diagnostic assessment; Disparity; Aftercare; COVID-19; Delayed Diagnosis; Early Detection of Cancer; Female; Humans; Lung Neoplasms; Ontario; Pandemics; SARS-CoV-2; Uterine Cervical Neoplasms","Rey","Michelle","Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada",NA
"827","34217413","10.1016/j.ypmed.2021.106586","Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.","It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening, including for vulnerable sub-populations, to inform the development of evidence-based, targeted pandemic recovery strategies. We undertook a population-based retrospective observational study in Ontario, Canada to assess the impact of the pandemic on organized cancer screening and diagnostic services, and assess whether patterns of cancer screening service use and diagnostic delay differ across population sub-g","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Diagnostic assessment; Disparity; Aftercare; COVID-19; Delayed Diagnosis; Early Detection of Cancer; Female; Humans; Lung Neoplasms; Ontario; Pandemics; SARS-CoV-2; Uterine Cervical Neoplasms","Aslam","Usman","Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada",NA
"828","34217413","10.1016/j.ypmed.2021.106586","Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.","It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening, including for vulnerable sub-populations, to inform the development of evidence-based, targeted pandemic recovery strategies. We undertook a population-based retrospective observational study in Ontario, Canada to assess the impact of the pandemic on organized cancer screening and diagnostic services, and assess whether patterns of cancer screening service use and diagnostic delay differ across population sub-g","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Diagnostic assessment; Disparity; Aftercare; COVID-19; Delayed Diagnosis; Early Detection of Cancer; Female; Humans; Lung Neoplasms; Ontario; Pandemics; SARS-CoV-2; Uterine Cervical Neoplasms","Sheppard","Amanda J","Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada",NA
"829","34217413","10.1016/j.ypmed.2021.106586","Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.","It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening, including for vulnerable sub-populations, to inform the development of evidence-based, targeted pandemic recovery strategies. We undertook a population-based retrospective observational study in Ontario, Canada to assess the impact of the pandemic on organized cancer screening and diagnostic services, and assess whether patterns of cancer screening service use and diagnostic delay differ across population sub-g","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Diagnostic assessment; Disparity; Aftercare; COVID-19; Delayed Diagnosis; Early Detection of Cancer; Female; Humans; Lung Neoplasms; Ontario; Pandemics; SARS-CoV-2; Uterine Cervical Neoplasms","Lofters","Aisha K","Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada",NA
"830","34217413","10.1016/j.ypmed.2021.106586","Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.","It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening, including for vulnerable sub-populations, to inform the development of evidence-based, targeted pandemic recovery strategies. We undertook a population-based retrospective observational study in Ontario, Canada to assess the impact of the pandemic on organized cancer screening and diagnostic services, and assess whether patterns of cancer screening service use and diagnostic delay differ across population sub-g","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Diagnostic assessment; Disparity; Aftercare; COVID-19; Delayed Diagnosis; Early Detection of Cancer; Female; Humans; Lung Neoplasms; Ontario; Pandemics; SARS-CoV-2; Uterine Cervical Neoplasms","Tammemägi","Martin C","Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada",NA
"831","34217413","10.1016/j.ypmed.2021.106586","Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.","It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening, including for vulnerable sub-populations, to inform the development of evidence-based, targeted pandemic recovery strategies. We undertook a population-based retrospective observational study in Ontario, Canada to assess the impact of the pandemic on organized cancer screening and diagnostic services, and assess whether patterns of cancer screening service use and diagnostic delay differ across population sub-g","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Diagnostic assessment; Disparity; Aftercare; COVID-19; Delayed Diagnosis; Early Detection of Cancer; Female; Humans; Lung Neoplasms; Ontario; Pandemics; SARS-CoV-2; Uterine Cervical Neoplasms","Tinmouth","Jill","Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada",NA
"832","34217413","10.1016/j.ypmed.2021.106586","Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.","It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening, including for vulnerable sub-populations, to inform the development of evidence-based, targeted pandemic recovery strategies. We undertook a population-based retrospective observational study in Ontario, Canada to assess the impact of the pandemic on organized cancer screening and diagnostic services, and assess whether patterns of cancer screening service use and diagnostic delay differ across population sub-g","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Diagnostic assessment; Disparity; Aftercare; COVID-19; Delayed Diagnosis; Early Detection of Cancer; Female; Humans; Lung Neoplasms; Ontario; Pandemics; SARS-CoV-2; Uterine Cervical Neoplasms","Kupets","Rachel","Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada",NA
"833","34217413","10.1016/j.ypmed.2021.106586","Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.","It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening, including for vulnerable sub-populations, to inform the development of evidence-based, targeted pandemic recovery strategies. We undertook a population-based retrospective observational study in Ontario, Canada to assess the impact of the pandemic on organized cancer screening and diagnostic services, and assess whether patterns of cancer screening service use and diagnostic delay differ across population sub-g","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Diagnostic assessment; Disparity; Aftercare; COVID-19; Delayed Diagnosis; Early Detection of Cancer; Female; Humans; Lung Neoplasms; Ontario; Pandemics; SARS-CoV-2; Uterine Cervical Neoplasms","Chiarelli","Anna M","Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada",NA
"834","34217413","10.1016/j.ypmed.2021.106586","Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.","It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening, including for vulnerable sub-populations, to inform the development of evidence-based, targeted pandemic recovery strategies. We undertook a population-based retrospective observational study in Ontario, Canada to assess the impact of the pandemic on organized cancer screening and diagnostic services, and assess whether patterns of cancer screening service use and diagnostic delay differ across population sub-g","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cancer screening; Diagnostic assessment; Disparity; Aftercare; COVID-19; Delayed Diagnosis; Early Detection of Cancer; Female; Humans; Lung Neoplasms; Ontario; Pandemics; SARS-CoV-2; Uterine Cervical Neoplasms","Rabeneck","Linda","Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada",NA
"835","34217412","10.1016/j.ypmed.2021.106585","The impact of the Covid-19 pandemic on breast cancer early detection and screening.","The COVID-19 pandemic affects mortality and morbidity, with disruptions expected to continue for some time, with access to timely cancer-related services a concern. For breast cancer, early detection and treatment is key to improved survival and longer-term quality of life. Health services generally have been strained and in many settings with population breast mammography screening, efforts to diagnose and treat breast cancers earlier have been paused or have had reduced capacity. The resulting","2021","07","08","Prev Med","Preventive medicine","Breast; COVID-19; Incidence; Modelling; Mortality; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mass Screening; Pandemics; Quality of Life; SARS-CoV-2","Figueroa","Jonine D","Usher Institute, University of Edinburgh, UK","Jonine.figueroa@ed.ac.uk"
"836","34217412","10.1016/j.ypmed.2021.106585","The impact of the Covid-19 pandemic on breast cancer early detection and screening.","The COVID-19 pandemic affects mortality and morbidity, with disruptions expected to continue for some time, with access to timely cancer-related services a concern. For breast cancer, early detection and treatment is key to improved survival and longer-term quality of life. Health services generally have been strained and in many settings with population breast mammography screening, efforts to diagnose and treat breast cancers earlier have been paused or have had reduced capacity. The resulting","2021","07","08","Prev Med","Preventive medicine","Breast; COVID-19; Incidence; Modelling; Mortality; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mass Screening; Pandemics; Quality of Life; SARS-CoV-2","Gray","Ewan","Institute of Genetics and Cancer, Cancer Research UK Edinburgh Centre, UK",NA
"837","34217412","10.1016/j.ypmed.2021.106585","The impact of the Covid-19 pandemic on breast cancer early detection and screening.","The COVID-19 pandemic affects mortality and morbidity, with disruptions expected to continue for some time, with access to timely cancer-related services a concern. For breast cancer, early detection and treatment is key to improved survival and longer-term quality of life. Health services generally have been strained and in many settings with population breast mammography screening, efforts to diagnose and treat breast cancers earlier have been paused or have had reduced capacity. The resulting","2021","07","08","Prev Med","Preventive medicine","Breast; COVID-19; Incidence; Modelling; Mortality; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mass Screening; Pandemics; Quality of Life; SARS-CoV-2","Pashayan","Nora","Department of Applied Health Research, Institute of Epidemiology and Healthcare, University College London, London, UK",NA
"838","34217412","10.1016/j.ypmed.2021.106585","The impact of the Covid-19 pandemic on breast cancer early detection and screening.","The COVID-19 pandemic affects mortality and morbidity, with disruptions expected to continue for some time, with access to timely cancer-related services a concern. For breast cancer, early detection and treatment is key to improved survival and longer-term quality of life. Health services generally have been strained and in many settings with population breast mammography screening, efforts to diagnose and treat breast cancers earlier have been paused or have had reduced capacity. The resulting","2021","07","08","Prev Med","Preventive medicine","Breast; COVID-19; Incidence; Modelling; Mortality; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mass Screening; Pandemics; Quality of Life; SARS-CoV-2","Deandrea","Silvia","Directorate General for Health, Lombardy Region, Milano, Italy",NA
"839","34217412","10.1016/j.ypmed.2021.106585","The impact of the Covid-19 pandemic on breast cancer early detection and screening.","The COVID-19 pandemic affects mortality and morbidity, with disruptions expected to continue for some time, with access to timely cancer-related services a concern. For breast cancer, early detection and treatment is key to improved survival and longer-term quality of life. Health services generally have been strained and in many settings with population breast mammography screening, efforts to diagnose and treat breast cancers earlier have been paused or have had reduced capacity. The resulting","2021","07","08","Prev Med","Preventive medicine","Breast; COVID-19; Incidence; Modelling; Mortality; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mass Screening; Pandemics; Quality of Life; SARS-CoV-2","Karch","Andre","Institute of Epidemiology and Social Medicine, University of Münster, Germany",NA
"840","34217412","10.1016/j.ypmed.2021.106585","The impact of the Covid-19 pandemic on breast cancer early detection and screening.","The COVID-19 pandemic affects mortality and morbidity, with disruptions expected to continue for some time, with access to timely cancer-related services a concern. For breast cancer, early detection and treatment is key to improved survival and longer-term quality of life. Health services generally have been strained and in many settings with population breast mammography screening, efforts to diagnose and treat breast cancers earlier have been paused or have had reduced capacity. The resulting","2021","07","08","Prev Med","Preventive medicine","Breast; COVID-19; Incidence; Modelling; Mortality; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mass Screening; Pandemics; Quality of Life; SARS-CoV-2","Vale","Diama Bhadra","Department of Obstetrics and Gynecology, University of Campinas, Campinas, Brazil",NA
"841","34217412","10.1016/j.ypmed.2021.106585","The impact of the Covid-19 pandemic on breast cancer early detection and screening.","The COVID-19 pandemic affects mortality and morbidity, with disruptions expected to continue for some time, with access to timely cancer-related services a concern. For breast cancer, early detection and treatment is key to improved survival and longer-term quality of life. Health services generally have been strained and in many settings with population breast mammography screening, efforts to diagnose and treat breast cancers earlier have been paused or have had reduced capacity. The resulting","2021","07","08","Prev Med","Preventive medicine","Breast; COVID-19; Incidence; Modelling; Mortality; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mass Screening; Pandemics; Quality of Life; SARS-CoV-2","Elder","Kenneth","NHS Lothian, Edinburgh, UK",NA
"842","34217412","10.1016/j.ypmed.2021.106585","The impact of the Covid-19 pandemic on breast cancer early detection and screening.","The COVID-19 pandemic affects mortality and morbidity, with disruptions expected to continue for some time, with access to timely cancer-related services a concern. For breast cancer, early detection and treatment is key to improved survival and longer-term quality of life. Health services generally have been strained and in many settings with population breast mammography screening, efforts to diagnose and treat breast cancers earlier have been paused or have had reduced capacity. The resulting","2021","07","08","Prev Med","Preventive medicine","Breast; COVID-19; Incidence; Modelling; Mortality; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mass Screening; Pandemics; Quality of Life; SARS-CoV-2","Procopio","Pietro","The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council New South Wales, Australia",NA
"843","34217412","10.1016/j.ypmed.2021.106585","The impact of the Covid-19 pandemic on breast cancer early detection and screening.","The COVID-19 pandemic affects mortality and morbidity, with disruptions expected to continue for some time, with access to timely cancer-related services a concern. For breast cancer, early detection and treatment is key to improved survival and longer-term quality of life. Health services generally have been strained and in many settings with population breast mammography screening, efforts to diagnose and treat breast cancers earlier have been paused or have had reduced capacity. The resulting","2021","07","08","Prev Med","Preventive medicine","Breast; COVID-19; Incidence; Modelling; Mortality; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mass Screening; Pandemics; Quality of Life; SARS-CoV-2","van Ravesteyn","Nicolien T","Department of Public Health, Erasmus MC University Medical Center Rotterdam, the Netherlands",NA
"844","34217412","10.1016/j.ypmed.2021.106585","The impact of the Covid-19 pandemic on breast cancer early detection and screening.","The COVID-19 pandemic affects mortality and morbidity, with disruptions expected to continue for some time, with access to timely cancer-related services a concern. For breast cancer, early detection and treatment is key to improved survival and longer-term quality of life. Health services generally have been strained and in many settings with population breast mammography screening, efforts to diagnose and treat breast cancers earlier have been paused or have had reduced capacity. The resulting","2021","07","08","Prev Med","Preventive medicine","Breast; COVID-19; Incidence; Modelling; Mortality; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mass Screening; Pandemics; Quality of Life; SARS-CoV-2","Mutabi","Miriam","Aga Khan University, Nairobi, Kenya",NA
"845","34217412","10.1016/j.ypmed.2021.106585","The impact of the Covid-19 pandemic on breast cancer early detection and screening.","The COVID-19 pandemic affects mortality and morbidity, with disruptions expected to continue for some time, with access to timely cancer-related services a concern. For breast cancer, early detection and treatment is key to improved survival and longer-term quality of life. Health services generally have been strained and in many settings with population breast mammography screening, efforts to diagnose and treat breast cancers earlier have been paused or have had reduced capacity. The resulting","2021","07","08","Prev Med","Preventive medicine","Breast; COVID-19; Incidence; Modelling; Mortality; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mass Screening; Pandemics; Quality of Life; SARS-CoV-2","Canfell","Karen","The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council New South Wales, Australia",NA
"846","34217412","10.1016/j.ypmed.2021.106585","The impact of the Covid-19 pandemic on breast cancer early detection and screening.","The COVID-19 pandemic affects mortality and morbidity, with disruptions expected to continue for some time, with access to timely cancer-related services a concern. For breast cancer, early detection and treatment is key to improved survival and longer-term quality of life. Health services generally have been strained and in many settings with population breast mammography screening, efforts to diagnose and treat breast cancers earlier have been paused or have had reduced capacity. The resulting","2021","07","08","Prev Med","Preventive medicine","Breast; COVID-19; Incidence; Modelling; Mortality; Screening; Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Humans; Mass Screening; Pandemics; Quality of Life; SARS-CoV-2","Nickson","Carolyn","The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council New South Wales, Australia",NA
"847","34217411","10.1016/j.ypmed.2021.106569","Prioritizing cervical cancer screening services during the COVID-19 pandemic: Response of an academic medical center and a public safety net hospital in California.","The expeditious diagnosis and treatment of high-grade cervical precancers are fundamental to cervical cancer prevention. However, during the COVID-19 pandemic healthcare systems have at times restricted in-person visits to those deemed urgent. Professional societies provided some guidance to clinicians regarding ways in which traditional cervical cancer screening might be modified, but many gaps remained. To address these gaps, leaders of screening programs at an academic medical center and an u","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cervical cancer screening; Consensus guidelines; Academic Medical Centers; COVID-19; California; Early Detection of Cancer; Female; Humans; Pandemics; SARS-CoV-2; Safety-net Providers; Uterine Cervical Neoplasms","Sawaya","George F","Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco (UCSF), United States of America","George.Sawaya@ucsf.edu"
"848","34217411","10.1016/j.ypmed.2021.106569","Prioritizing cervical cancer screening services during the COVID-19 pandemic: Response of an academic medical center and a public safety net hospital in California.","The expeditious diagnosis and treatment of high-grade cervical precancers are fundamental to cervical cancer prevention. However, during the COVID-19 pandemic healthcare systems have at times restricted in-person visits to those deemed urgent. Professional societies provided some guidance to clinicians regarding ways in which traditional cervical cancer screening might be modified, but many gaps remained. To address these gaps, leaders of screening programs at an academic medical center and an u","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cervical cancer screening; Consensus guidelines; Academic Medical Centers; COVID-19; California; Early Detection of Cancer; Female; Humans; Pandemics; SARS-CoV-2; Safety-net Providers; Uterine Cervical Neoplasms","Holt","Hunter K","Department of Family and Community Medicine, UCSF, United States of America",NA
"849","34217411","10.1016/j.ypmed.2021.106569","Prioritizing cervical cancer screening services during the COVID-19 pandemic: Response of an academic medical center and a public safety net hospital in California.","The expeditious diagnosis and treatment of high-grade cervical precancers are fundamental to cervical cancer prevention. However, during the COVID-19 pandemic healthcare systems have at times restricted in-person visits to those deemed urgent. Professional societies provided some guidance to clinicians regarding ways in which traditional cervical cancer screening might be modified, but many gaps remained. To address these gaps, leaders of screening programs at an academic medical center and an u","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cervical cancer screening; Consensus guidelines; Academic Medical Centers; COVID-19; California; Early Detection of Cancer; Female; Humans; Pandemics; SARS-CoV-2; Safety-net Providers; Uterine Cervical Neoplasms","Lamar","Robyn","Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco (UCSF), United States of America",NA
"850","34217411","10.1016/j.ypmed.2021.106569","Prioritizing cervical cancer screening services during the COVID-19 pandemic: Response of an academic medical center and a public safety net hospital in California.","The expeditious diagnosis and treatment of high-grade cervical precancers are fundamental to cervical cancer prevention. However, during the COVID-19 pandemic healthcare systems have at times restricted in-person visits to those deemed urgent. Professional societies provided some guidance to clinicians regarding ways in which traditional cervical cancer screening might be modified, but many gaps remained. To address these gaps, leaders of screening programs at an academic medical center and an u","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cervical cancer screening; Consensus guidelines; Academic Medical Centers; COVID-19; California; Early Detection of Cancer; Female; Humans; Pandemics; SARS-CoV-2; Safety-net Providers; Uterine Cervical Neoplasms","Perron-Burdick","Misa","Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco (UCSF), United States of America",NA
"851","34217411","10.1016/j.ypmed.2021.106569","Prioritizing cervical cancer screening services during the COVID-19 pandemic: Response of an academic medical center and a public safety net hospital in California.","The expeditious diagnosis and treatment of high-grade cervical precancers are fundamental to cervical cancer prevention. However, during the COVID-19 pandemic healthcare systems have at times restricted in-person visits to those deemed urgent. Professional societies provided some guidance to clinicians regarding ways in which traditional cervical cancer screening might be modified, but many gaps remained. To address these gaps, leaders of screening programs at an academic medical center and an u","2021","07","08","Prev Med","Preventive medicine","COVID-19; Cervical cancer screening; Consensus guidelines; Academic Medical Centers; COVID-19; California; Early Detection of Cancer; Female; Humans; Pandemics; SARS-CoV-2; Safety-net Providers; Uterine Cervical Neoplasms","Smith-McCune","Karen","Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco (UCSF), United States of America",NA
"852","34217410","10.1016/j.ypmed.2021.106559","COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.","Women from racial and ethnic minority groups face a disproportionate burden of cervical and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) pandemic might exacerbate these disparities as supply and demand for screening services are reduced. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides cancer screening services to women with low income and inadequate health insurance. We examined COVID-19's impact on NBCCEDP screening services dur","2021","07","08","Prev Med","Preventive medicine","Breast cancer screening; COVID-19; Cervical cancer screening; Medically underserved; Public health; Breast Neoplasms; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Humans; Mass Screening; Medically Uninsured; Minority Groups; New York; SARS-CoV-2; United States; Uterine Cervical Neoplasms","DeGroff","A","Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, USA. Electronic address: adegroff@cdc","adegroff@cdc.gov"
"853","34217410","10.1016/j.ypmed.2021.106559","COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.","Women from racial and ethnic minority groups face a disproportionate burden of cervical and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) pandemic might exacerbate these disparities as supply and demand for screening services are reduced. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides cancer screening services to women with low income and inadequate health insurance. We examined COVID-19's impact on NBCCEDP screening services dur","2021","07","08","Prev Med","Preventive medicine","Breast cancer screening; COVID-19; Cervical cancer screening; Medically underserved; Public health; Breast Neoplasms; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Humans; Mass Screening; Medically Uninsured; Minority Groups; New York; SARS-CoV-2; United States; Uterine Cervical Neoplasms","Miller","J","Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, USA",NA
"854","34217410","10.1016/j.ypmed.2021.106559","COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.","Women from racial and ethnic minority groups face a disproportionate burden of cervical and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) pandemic might exacerbate these disparities as supply and demand for screening services are reduced. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides cancer screening services to women with low income and inadequate health insurance. We examined COVID-19's impact on NBCCEDP screening services dur","2021","07","08","Prev Med","Preventive medicine","Breast cancer screening; COVID-19; Cervical cancer screening; Medically underserved; Public health; Breast Neoplasms; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Humans; Mass Screening; Medically Uninsured; Minority Groups; New York; SARS-CoV-2; United States; Uterine Cervical Neoplasms","Sharma","K","Totally Joined for Achieving Collaborative Techniques, LLC, USA",NA
"855","34217410","10.1016/j.ypmed.2021.106559","COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.","Women from racial and ethnic minority groups face a disproportionate burden of cervical and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) pandemic might exacerbate these disparities as supply and demand for screening services are reduced. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides cancer screening services to women with low income and inadequate health insurance. We examined COVID-19's impact on NBCCEDP screening services dur","2021","07","08","Prev Med","Preventive medicine","Breast cancer screening; COVID-19; Cervical cancer screening; Medically underserved; Public health; Breast Neoplasms; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Humans; Mass Screening; Medically Uninsured; Minority Groups; New York; SARS-CoV-2; United States; Uterine Cervical Neoplasms","Sun","J","Totally Joined for Achieving Collaborative Techniques, LLC, USA",NA
"856","34217410","10.1016/j.ypmed.2021.106559","COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.","Women from racial and ethnic minority groups face a disproportionate burden of cervical and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) pandemic might exacerbate these disparities as supply and demand for screening services are reduced. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides cancer screening services to women with low income and inadequate health insurance. We examined COVID-19's impact on NBCCEDP screening services dur","2021","07","08","Prev Med","Preventive medicine","Breast cancer screening; COVID-19; Cervical cancer screening; Medically underserved; Public health; Breast Neoplasms; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Humans; Mass Screening; Medically Uninsured; Minority Groups; New York; SARS-CoV-2; United States; Uterine Cervical Neoplasms","Helsel","W","Information Management Services, Inc., USA",NA
"857","34217410","10.1016/j.ypmed.2021.106559","COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.","Women from racial and ethnic minority groups face a disproportionate burden of cervical and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) pandemic might exacerbate these disparities as supply and demand for screening services are reduced. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides cancer screening services to women with low income and inadequate health insurance. We examined COVID-19's impact on NBCCEDP screening services dur","2021","07","08","Prev Med","Preventive medicine","Breast cancer screening; COVID-19; Cervical cancer screening; Medically underserved; Public health; Breast Neoplasms; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Humans; Mass Screening; Medically Uninsured; Minority Groups; New York; SARS-CoV-2; United States; Uterine Cervical Neoplasms","Kammerer","W","Information Management Services, Inc., USA",NA
"858","34217410","10.1016/j.ypmed.2021.106559","COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.","Women from racial and ethnic minority groups face a disproportionate burden of cervical and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) pandemic might exacerbate these disparities as supply and demand for screening services are reduced. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides cancer screening services to women with low income and inadequate health insurance. We examined COVID-19's impact on NBCCEDP screening services dur","2021","07","08","Prev Med","Preventive medicine","Breast cancer screening; COVID-19; Cervical cancer screening; Medically underserved; Public health; Breast Neoplasms; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Humans; Mass Screening; Medically Uninsured; Minority Groups; New York; SARS-CoV-2; United States; Uterine Cervical Neoplasms","Rockwell","T","Information Management Services, Inc., USA",NA
"859","34217410","10.1016/j.ypmed.2021.106559","COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.","Women from racial and ethnic minority groups face a disproportionate burden of cervical and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) pandemic might exacerbate these disparities as supply and demand for screening services are reduced. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides cancer screening services to women with low income and inadequate health insurance. We examined COVID-19's impact on NBCCEDP screening services dur","2021","07","08","Prev Med","Preventive medicine","Breast cancer screening; COVID-19; Cervical cancer screening; Medically underserved; Public health; Breast Neoplasms; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Humans; Mass Screening; Medically Uninsured; Minority Groups; New York; SARS-CoV-2; United States; Uterine Cervical Neoplasms","Sheu","A","Information Management Services, Inc., USA",NA
"860","34217410","10.1016/j.ypmed.2021.106559","COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.","Women from racial and ethnic minority groups face a disproportionate burden of cervical and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) pandemic might exacerbate these disparities as supply and demand for screening services are reduced. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides cancer screening services to women with low income and inadequate health insurance. We examined COVID-19's impact on NBCCEDP screening services dur","2021","07","08","Prev Med","Preventive medicine","Breast cancer screening; COVID-19; Cervical cancer screening; Medically underserved; Public health; Breast Neoplasms; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Humans; Mass Screening; Medically Uninsured; Minority Groups; New York; SARS-CoV-2; United States; Uterine Cervical Neoplasms","Melillo","S","Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, USA",NA
"861","34217410","10.1016/j.ypmed.2021.106559","COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.","Women from racial and ethnic minority groups face a disproportionate burden of cervical and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) pandemic might exacerbate these disparities as supply and demand for screening services are reduced. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides cancer screening services to women with low income and inadequate health insurance. We examined COVID-19's impact on NBCCEDP screening services dur","2021","07","08","Prev Med","Preventive medicine","Breast cancer screening; COVID-19; Cervical cancer screening; Medically underserved; Public health; Breast Neoplasms; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Humans; Mass Screening; Medically Uninsured; Minority Groups; New York; SARS-CoV-2; United States; Uterine Cervical Neoplasms","Uhd","J","Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, USA",NA
"862","34217410","10.1016/j.ypmed.2021.106559","COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.","Women from racial and ethnic minority groups face a disproportionate burden of cervical and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) pandemic might exacerbate these disparities as supply and demand for screening services are reduced. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides cancer screening services to women with low income and inadequate health insurance. We examined COVID-19's impact on NBCCEDP screening services dur","2021","07","08","Prev Med","Preventive medicine","Breast cancer screening; COVID-19; Cervical cancer screening; Medically underserved; Public health; Breast Neoplasms; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Humans; Mass Screening; Medically Uninsured; Minority Groups; New York; SARS-CoV-2; United States; Uterine Cervical Neoplasms","Kenney","K","Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, USA",NA
"863","34217410","10.1016/j.ypmed.2021.106559","COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.","Women from racial and ethnic minority groups face a disproportionate burden of cervical and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) pandemic might exacerbate these disparities as supply and demand for screening services are reduced. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides cancer screening services to women with low income and inadequate health insurance. We examined COVID-19's impact on NBCCEDP screening services dur","2021","07","08","Prev Med","Preventive medicine","Breast cancer screening; COVID-19; Cervical cancer screening; Medically underserved; Public health; Breast Neoplasms; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Humans; Mass Screening; Medically Uninsured; Minority Groups; New York; SARS-CoV-2; United States; Uterine Cervical Neoplasms","Wong","F","Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, USA",NA
"864","34217410","10.1016/j.ypmed.2021.106559","COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.","Women from racial and ethnic minority groups face a disproportionate burden of cervical and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) pandemic might exacerbate these disparities as supply and demand for screening services are reduced. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides cancer screening services to women with low income and inadequate health insurance. We examined COVID-19's impact on NBCCEDP screening services dur","2021","07","08","Prev Med","Preventive medicine","Breast cancer screening; COVID-19; Cervical cancer screening; Medically underserved; Public health; Breast Neoplasms; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Humans; Mass Screening; Medically Uninsured; Minority Groups; New York; SARS-CoV-2; United States; Uterine Cervical Neoplasms","Saraiya","M","Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, USA",NA
"865","34217410","10.1016/j.ypmed.2021.106559","COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.","Women from racial and ethnic minority groups face a disproportionate burden of cervical and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) pandemic might exacerbate these disparities as supply and demand for screening services are reduced. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides cancer screening services to women with low income and inadequate health insurance. We examined COVID-19's impact on NBCCEDP screening services dur","2021","07","08","Prev Med","Preventive medicine","Breast cancer screening; COVID-19; Cervical cancer screening; Medically underserved; Public health; Breast Neoplasms; COVID-19; Early Detection of Cancer; Ethnic Groups; Female; Humans; Mass Screening; Medically Uninsured; Minority Groups; New York; SARS-CoV-2; United States; Uterine Cervical Neoplasms","Richardson","L C","Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, USA",NA
"866","34217409","10.1016/j.ypmed.2021.106542","Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study.","The COVID-19 pandemic resulted in numerous changes in delivery of healthcare services, including breast cancer screening and surveillance. Although facilities have implemented a number of strategies to provide services, women's thoughts and experiences related to breast cancer screening and surveillance during a pandemic are not well known. This focus group study with women across seven states recruited through the Breast Cancer Surveillance Consortium aims to remedy this gap in information. Thi","2021","07","08","Prev Med","Preventive medicine","Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Focus Groups; Humans; Pandemics; SARS-CoV-2; United States","Schifferdecker","Karen E","Geisel School of Medicine at Dartmouth, United States of America. Electronic address: karen.e.schifferdecker@dartmouth","karen.e.schifferdecker@dartmouth.edu"
"867","34217409","10.1016/j.ypmed.2021.106542","Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study.","The COVID-19 pandemic resulted in numerous changes in delivery of healthcare services, including breast cancer screening and surveillance. Although facilities have implemented a number of strategies to provide services, women's thoughts and experiences related to breast cancer screening and surveillance during a pandemic are not well known. This focus group study with women across seven states recruited through the Breast Cancer Surveillance Consortium aims to remedy this gap in information. Thi","2021","07","08","Prev Med","Preventive medicine","Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Focus Groups; Humans; Pandemics; SARS-CoV-2; United States","Vaclavik","Danielle","Geisel School of Medicine at Dartmouth, United States of America",NA
"868","34217409","10.1016/j.ypmed.2021.106542","Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study.","The COVID-19 pandemic resulted in numerous changes in delivery of healthcare services, including breast cancer screening and surveillance. Although facilities have implemented a number of strategies to provide services, women's thoughts and experiences related to breast cancer screening and surveillance during a pandemic are not well known. This focus group study with women across seven states recruited through the Breast Cancer Surveillance Consortium aims to remedy this gap in information. Thi","2021","07","08","Prev Med","Preventive medicine","Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Focus Groups; Humans; Pandemics; SARS-CoV-2; United States","Wernli","Karen J","Kaiser Permanente Washington Health Research Institute, Seattle, United States of America",NA
"869","34217409","10.1016/j.ypmed.2021.106542","Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study.","The COVID-19 pandemic resulted in numerous changes in delivery of healthcare services, including breast cancer screening and surveillance. Although facilities have implemented a number of strategies to provide services, women's thoughts and experiences related to breast cancer screening and surveillance during a pandemic are not well known. This focus group study with women across seven states recruited through the Breast Cancer Surveillance Consortium aims to remedy this gap in information. Thi","2021","07","08","Prev Med","Preventive medicine","Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Focus Groups; Humans; Pandemics; SARS-CoV-2; United States","Buist","Diana S M","Kaiser Permanente Washington Health Research Institute, Seattle, United States of America",NA
"870","34217409","10.1016/j.ypmed.2021.106542","Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study.","The COVID-19 pandemic resulted in numerous changes in delivery of healthcare services, including breast cancer screening and surveillance. Although facilities have implemented a number of strategies to provide services, women's thoughts and experiences related to breast cancer screening and surveillance during a pandemic are not well known. This focus group study with women across seven states recruited through the Breast Cancer Surveillance Consortium aims to remedy this gap in information. Thi","2021","07","08","Prev Med","Preventive medicine","Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Focus Groups; Humans; Pandemics; SARS-CoV-2; United States","Kerlikowske","Karla","University of California, San Francisco, United States of America",NA
"871","34217409","10.1016/j.ypmed.2021.106542","Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study.","The COVID-19 pandemic resulted in numerous changes in delivery of healthcare services, including breast cancer screening and surveillance. Although facilities have implemented a number of strategies to provide services, women's thoughts and experiences related to breast cancer screening and surveillance during a pandemic are not well known. This focus group study with women across seven states recruited through the Breast Cancer Surveillance Consortium aims to remedy this gap in information. Thi","2021","07","08","Prev Med","Preventive medicine","Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Focus Groups; Humans; Pandemics; SARS-CoV-2; United States","Sprague","Brian L","University of Vermont, United States of America",NA
"872","34217409","10.1016/j.ypmed.2021.106542","Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study.","The COVID-19 pandemic resulted in numerous changes in delivery of healthcare services, including breast cancer screening and surveillance. Although facilities have implemented a number of strategies to provide services, women's thoughts and experiences related to breast cancer screening and surveillance during a pandemic are not well known. This focus group study with women across seven states recruited through the Breast Cancer Surveillance Consortium aims to remedy this gap in information. Thi","2021","07","08","Prev Med","Preventive medicine","Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Focus Groups; Humans; Pandemics; SARS-CoV-2; United States","Henderson","Louise M","University of North Carolina, United States of America",NA
"873","34217409","10.1016/j.ypmed.2021.106542","Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study.","The COVID-19 pandemic resulted in numerous changes in delivery of healthcare services, including breast cancer screening and surveillance. Although facilities have implemented a number of strategies to provide services, women's thoughts and experiences related to breast cancer screening and surveillance during a pandemic are not well known. This focus group study with women across seven states recruited through the Breast Cancer Surveillance Consortium aims to remedy this gap in information. Thi","2021","07","08","Prev Med","Preventive medicine","Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Focus Groups; Humans; Pandemics; SARS-CoV-2; United States","Johnson","Dianne","patient partners",NA
"874","34217409","10.1016/j.ypmed.2021.106542","Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study.","The COVID-19 pandemic resulted in numerous changes in delivery of healthcare services, including breast cancer screening and surveillance. Although facilities have implemented a number of strategies to provide services, women's thoughts and experiences related to breast cancer screening and surveillance during a pandemic are not well known. This focus group study with women across seven states recruited through the Breast Cancer Surveillance Consortium aims to remedy this gap in information. Thi","2021","07","08","Prev Med","Preventive medicine","Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Focus Groups; Humans; Pandemics; SARS-CoV-2; United States","Budesky","Jill","patient partners",NA
"875","34217409","10.1016/j.ypmed.2021.106542","Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study.","The COVID-19 pandemic resulted in numerous changes in delivery of healthcare services, including breast cancer screening and surveillance. Although facilities have implemented a number of strategies to provide services, women's thoughts and experiences related to breast cancer screening and surveillance during a pandemic are not well known. This focus group study with women across seven states recruited through the Breast Cancer Surveillance Consortium aims to remedy this gap in information. Thi","2021","07","08","Prev Med","Preventive medicine","Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Focus Groups; Humans; Pandemics; SARS-CoV-2; United States","Jackson-Nefertiti","Gloria","patient partners",NA
"876","34217409","10.1016/j.ypmed.2021.106542","Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study.","The COVID-19 pandemic resulted in numerous changes in delivery of healthcare services, including breast cancer screening and surveillance. Although facilities have implemented a number of strategies to provide services, women's thoughts and experiences related to breast cancer screening and surveillance during a pandemic are not well known. This focus group study with women across seven states recruited through the Breast Cancer Surveillance Consortium aims to remedy this gap in information. Thi","2021","07","08","Prev Med","Preventive medicine","Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Focus Groups; Humans; Pandemics; SARS-CoV-2; United States","Miglioretti","Diana L","Kaiser Permanente Washington Health Research Institute, Seattle, United States of America",NA
"877","34217409","10.1016/j.ypmed.2021.106542","Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study.","The COVID-19 pandemic resulted in numerous changes in delivery of healthcare services, including breast cancer screening and surveillance. Although facilities have implemented a number of strategies to provide services, women's thoughts and experiences related to breast cancer screening and surveillance during a pandemic are not well known. This focus group study with women across seven states recruited through the Breast Cancer Surveillance Consortium aims to remedy this gap in information. Thi","2021","07","08","Prev Med","Preventive medicine","Breast Neoplasms; COVID-19; Early Detection of Cancer; Female; Focus Groups; Humans; Pandemics; SARS-CoV-2; United States","Tosteson","Anna N A","Geisel School of Medicine at Dartmouth, United States of America",NA
"878","34217408","10.1016/j.ypmed.2021.106687","COVID-19 and the disruption of cancer screening programs: Key lessons for the recovery.",NA,"2021","07","08","Prev Med","Preventive medicine","COVID-19; Early Detection of Cancer; Humans; Neoplasms; SARS-CoV-2","Rabeneck","Linda","Dalla Lana School of Public Health and Department of Medicine, University of Toronto, and Cancer Care Ontario, Toronto, Canada. Electronic address: Linda.Rabeneck@ontariohealth","Linda.Rabeneck@ontariohealth.ca"
"879","34217408","10.1016/j.ypmed.2021.106687","COVID-19 and the disruption of cancer screening programs: Key lessons for the recovery.",NA,"2021","07","08","Prev Med","Preventive medicine","COVID-19; Early Detection of Cancer; Humans; Neoplasms; SARS-CoV-2","Saraiya","Mona","Division of Cancer Prevention and Control, Epidemiology and Applied Research Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA",NA
"880","34217407","10.1016/j.ypmed.2021.106539","Colorectal cancer screening and the COVID-19 pandemic - Lessons learnt.",NA,"2021","07","08","Prev Med","Preventive medicine","COVID-19; Colorectal Neoplasms; Early Detection of Cancer; Humans; Pandemics; SARS-CoV-2","Halloran","Stephen P","Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, UK","s.halloran@surrey.ac.uk"
"881","34217399","10.1016/S0140-6736(21)00668-1","Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.","Little evidence is available on the use of telehealth for antenatal care. In response to the COVID-19 pandemic, we developed and implemented a new antenatal care schedule integrating telehealth across all models of pregnancy care. To inform this clinical initiative, we aimed to assess the effectiveness and safety of telehealth in antenatal care. We analysed routinely collected health data on all women giving birth at Monash Health, a large health service in Victoria (Australia), using an interru","2021","07","15","Lancet","Lancet (London, England)","Adult; COVID-19; Female; Humans; Interrupted Time Series Analysis; Pregnancy; Pregnancy Complications; Prenatal Care; Retrospective Studies; Telemedicine; Victoria","Palmer","Kirsten R","Monash Women's and Newborn, Monash Health, Melbourne, VIC, Australia","kirsten.palmer@monash.edu"
"882","34217399","10.1016/S0140-6736(21)00668-1","Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.","Little evidence is available on the use of telehealth for antenatal care. In response to the COVID-19 pandemic, we developed and implemented a new antenatal care schedule integrating telehealth across all models of pregnancy care. To inform this clinical initiative, we aimed to assess the effectiveness and safety of telehealth in antenatal care. We analysed routinely collected health data on all women giving birth at Monash Health, a large health service in Victoria (Australia), using an interru","2021","07","15","Lancet","Lancet (London, England)","Adult; COVID-19; Female; Humans; Interrupted Time Series Analysis; Pregnancy; Pregnancy Complications; Prenatal Care; Retrospective Studies; Telemedicine; Victoria","Tanner","Michael","Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia",NA
"883","34217399","10.1016/S0140-6736(21)00668-1","Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.","Little evidence is available on the use of telehealth for antenatal care. In response to the COVID-19 pandemic, we developed and implemented a new antenatal care schedule integrating telehealth across all models of pregnancy care. To inform this clinical initiative, we aimed to assess the effectiveness and safety of telehealth in antenatal care. We analysed routinely collected health data on all women giving birth at Monash Health, a large health service in Victoria (Australia), using an interru","2021","07","15","Lancet","Lancet (London, England)","Adult; COVID-19; Female; Humans; Interrupted Time Series Analysis; Pregnancy; Pregnancy Complications; Prenatal Care; Retrospective Studies; Telemedicine; Victoria","Davies-Tuck","Miranda","Hudson Institute of Medical Research, Clayton, VIC, Australia",NA
"884","34217399","10.1016/S0140-6736(21)00668-1","Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.","Little evidence is available on the use of telehealth for antenatal care. In response to the COVID-19 pandemic, we developed and implemented a new antenatal care schedule integrating telehealth across all models of pregnancy care. To inform this clinical initiative, we aimed to assess the effectiveness and safety of telehealth in antenatal care. We analysed routinely collected health data on all women giving birth at Monash Health, a large health service in Victoria (Australia), using an interru","2021","07","15","Lancet","Lancet (London, England)","Adult; COVID-19; Female; Humans; Interrupted Time Series Analysis; Pregnancy; Pregnancy Complications; Prenatal Care; Retrospective Studies; Telemedicine; Victoria","Rindt","Andrea","Monash Women's and Newborn, Monash Health, Melbourne, VIC, Australia",NA
"885","34217399","10.1016/S0140-6736(21)00668-1","Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.","Little evidence is available on the use of telehealth for antenatal care. In response to the COVID-19 pandemic, we developed and implemented a new antenatal care schedule integrating telehealth across all models of pregnancy care. To inform this clinical initiative, we aimed to assess the effectiveness and safety of telehealth in antenatal care. We analysed routinely collected health data on all women giving birth at Monash Health, a large health service in Victoria (Australia), using an interru","2021","07","15","Lancet","Lancet (London, England)","Adult; COVID-19; Female; Humans; Interrupted Time Series Analysis; Pregnancy; Pregnancy Complications; Prenatal Care; Retrospective Studies; Telemedicine; Victoria","Papacostas","Kerrie","Monash Women's and Newborn, Monash Health, Melbourne, VIC, Australia",NA
"886","34217399","10.1016/S0140-6736(21)00668-1","Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.","Little evidence is available on the use of telehealth for antenatal care. In response to the COVID-19 pandemic, we developed and implemented a new antenatal care schedule integrating telehealth across all models of pregnancy care. To inform this clinical initiative, we aimed to assess the effectiveness and safety of telehealth in antenatal care. We analysed routinely collected health data on all women giving birth at Monash Health, a large health service in Victoria (Australia), using an interru","2021","07","15","Lancet","Lancet (London, England)","Adult; COVID-19; Female; Humans; Interrupted Time Series Analysis; Pregnancy; Pregnancy Complications; Prenatal Care; Retrospective Studies; Telemedicine; Victoria","Giles","Michelle L","Monash Women's and Newborn, Monash Health, Melbourne, VIC, Australia",NA
"887","34217399","10.1016/S0140-6736(21)00668-1","Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.","Little evidence is available on the use of telehealth for antenatal care. In response to the COVID-19 pandemic, we developed and implemented a new antenatal care schedule integrating telehealth across all models of pregnancy care. To inform this clinical initiative, we aimed to assess the effectiveness and safety of telehealth in antenatal care. We analysed routinely collected health data on all women giving birth at Monash Health, a large health service in Victoria (Australia), using an interru","2021","07","15","Lancet","Lancet (London, England)","Adult; COVID-19; Female; Humans; Interrupted Time Series Analysis; Pregnancy; Pregnancy Complications; Prenatal Care; Retrospective Studies; Telemedicine; Victoria","Brown","Kate","Monash Women's and Newborn, Monash Health, Melbourne, VIC, Australia",NA
"888","34217399","10.1016/S0140-6736(21)00668-1","Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.","Little evidence is available on the use of telehealth for antenatal care. In response to the COVID-19 pandemic, we developed and implemented a new antenatal care schedule integrating telehealth across all models of pregnancy care. To inform this clinical initiative, we aimed to assess the effectiveness and safety of telehealth in antenatal care. We analysed routinely collected health data on all women giving birth at Monash Health, a large health service in Victoria (Australia), using an interru","2021","07","15","Lancet","Lancet (London, England)","Adult; COVID-19; Female; Humans; Interrupted Time Series Analysis; Pregnancy; Pregnancy Complications; Prenatal Care; Retrospective Studies; Telemedicine; Victoria","Diamandis","Helen","Monash Women's and Newborn, Monash Health, Melbourne, VIC, Australia",NA
"889","34217399","10.1016/S0140-6736(21)00668-1","Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.","Little evidence is available on the use of telehealth for antenatal care. In response to the COVID-19 pandemic, we developed and implemented a new antenatal care schedule integrating telehealth across all models of pregnancy care. To inform this clinical initiative, we aimed to assess the effectiveness and safety of telehealth in antenatal care. We analysed routinely collected health data on all women giving birth at Monash Health, a large health service in Victoria (Australia), using an interru","2021","07","15","Lancet","Lancet (London, England)","Adult; COVID-19; Female; Humans; Interrupted Time Series Analysis; Pregnancy; Pregnancy Complications; Prenatal Care; Retrospective Studies; Telemedicine; Victoria","Fradkin","Rebecca","Monash Women's and Newborn, Monash Health, Melbourne, VIC, Australia",NA
"890","34217399","10.1016/S0140-6736(21)00668-1","Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.","Little evidence is available on the use of telehealth for antenatal care. In response to the COVID-19 pandemic, we developed and implemented a new antenatal care schedule integrating telehealth across all models of pregnancy care. To inform this clinical initiative, we aimed to assess the effectiveness and safety of telehealth in antenatal care. We analysed routinely collected health data on all women giving birth at Monash Health, a large health service in Victoria (Australia), using an interru","2021","07","15","Lancet","Lancet (London, England)","Adult; COVID-19; Female; Humans; Interrupted Time Series Analysis; Pregnancy; Pregnancy Complications; Prenatal Care; Retrospective Studies; Telemedicine; Victoria","Stewart","Alice E","Monash Women's and Newborn, Monash Health, Melbourne, VIC, Australia",NA
"891","34217399","10.1016/S0140-6736(21)00668-1","Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.","Little evidence is available on the use of telehealth for antenatal care. In response to the COVID-19 pandemic, we developed and implemented a new antenatal care schedule integrating telehealth across all models of pregnancy care. To inform this clinical initiative, we aimed to assess the effectiveness and safety of telehealth in antenatal care. We analysed routinely collected health data on all women giving birth at Monash Health, a large health service in Victoria (Australia), using an interru","2021","07","15","Lancet","Lancet (London, England)","Adult; COVID-19; Female; Humans; Interrupted Time Series Analysis; Pregnancy; Pregnancy Complications; Prenatal Care; Retrospective Studies; Telemedicine; Victoria","Rolnik","Daniel L","Monash Women's and Newborn, Monash Health, Melbourne, VIC, Australia",NA
"892","34217399","10.1016/S0140-6736(21)00668-1","Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.","Little evidence is available on the use of telehealth for antenatal care. In response to the COVID-19 pandemic, we developed and implemented a new antenatal care schedule integrating telehealth across all models of pregnancy care. To inform this clinical initiative, we aimed to assess the effectiveness and safety of telehealth in antenatal care. We analysed routinely collected health data on all women giving birth at Monash Health, a large health service in Victoria (Australia), using an interru","2021","07","15","Lancet","Lancet (London, England)","Adult; COVID-19; Female; Humans; Interrupted Time Series Analysis; Pregnancy; Pregnancy Complications; Prenatal Care; Retrospective Studies; Telemedicine; Victoria","Stripp","Andrew","Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia",NA
"893","34217399","10.1016/S0140-6736(21)00668-1","Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.","Little evidence is available on the use of telehealth for antenatal care. In response to the COVID-19 pandemic, we developed and implemented a new antenatal care schedule integrating telehealth across all models of pregnancy care. To inform this clinical initiative, we aimed to assess the effectiveness and safety of telehealth in antenatal care. We analysed routinely collected health data on all women giving birth at Monash Health, a large health service in Victoria (Australia), using an interru","2021","07","15","Lancet","Lancet (London, England)","Adult; COVID-19; Female; Humans; Interrupted Time Series Analysis; Pregnancy; Pregnancy Complications; Prenatal Care; Retrospective Studies; Telemedicine; Victoria","Wallace","Euan M","Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia",NA
"894","34217399","10.1016/S0140-6736(21)00668-1","Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.","Little evidence is available on the use of telehealth for antenatal care. In response to the COVID-19 pandemic, we developed and implemented a new antenatal care schedule integrating telehealth across all models of pregnancy care. To inform this clinical initiative, we aimed to assess the effectiveness and safety of telehealth in antenatal care. We analysed routinely collected health data on all women giving birth at Monash Health, a large health service in Victoria (Australia), using an interru","2021","07","15","Lancet","Lancet (London, England)","Adult; COVID-19; Female; Humans; Interrupted Time Series Analysis; Pregnancy; Pregnancy Complications; Prenatal Care; Retrospective Studies; Telemedicine; Victoria","Mol","Ben W","Monash Women's and Newborn, Monash Health, Melbourne, VIC, Australia",NA
"895","34217399","10.1016/S0140-6736(21)00668-1","Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.","Little evidence is available on the use of telehealth for antenatal care. In response to the COVID-19 pandemic, we developed and implemented a new antenatal care schedule integrating telehealth across all models of pregnancy care. To inform this clinical initiative, we aimed to assess the effectiveness and safety of telehealth in antenatal care. We analysed routinely collected health data on all women giving birth at Monash Health, a large health service in Victoria (Australia), using an interru","2021","07","15","Lancet","Lancet (London, England)","Adult; COVID-19; Female; Humans; Interrupted Time Series Analysis; Pregnancy; Pregnancy Complications; Prenatal Care; Retrospective Studies; Telemedicine; Victoria","Hodges","Ryan J","Monash Women's and Newborn, Monash Health, Melbourne, VIC, Australia",NA
"896","34217387","10.1016/S0140-6736(21)01439-2","Sparks through the stubble: dying in a pandemic.",NA,"2021","07","22","Lancet","Lancet (London, England)","Advance Care Planning; COVID-19; Death; Health Personnel; Humans; Palliative Care; Pandemics; SARS-CoV-2; Terminal Care","Clarke","Rachel",NA,NA
"897","34217384","10.1016/S0140-6736(21)01457-4","Levelling up health in the UK.",NA,"2021","07","22","Lancet","Lancet (London, England)","COVID-19; Health Equity; Humans; Pandemics; Politics; Public Health Administration; SARS-CoV-2; State Medicine; United Kingdom","Thornton","Jacqui",NA,NA
"898","34217383","10.1016/S0140-6736(21)01456-2","North Korean health at risk due to border closures.",NA,"2021","07","22","Lancet","Lancet (London, England)","COVID-19; Democratic People's Republic of Korea; Health Status; Humans; Pandemics; SARS-CoV-2","Devi","Sharmila",NA,NA
"900","34217380","10.1016/S2213-2600(21)00319-2","COVID-19 and the mental health of children with respiratory illness.",NA,"2021","07","04","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Sinha","Ian P","Alder Hey Children's Hospital, Liverpool, UK",NA
"901","34217380","10.1016/S2213-2600(21)00319-2","COVID-19 and the mental health of children with respiratory illness.",NA,"2021","07","04","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Murphy","Ruth","Department of Women's and Children's Health, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK",NA
"902","34217380","10.1016/S2213-2600(21)00319-2","COVID-19 and the mental health of children with respiratory illness.",NA,"2021","07","04","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Biffin","Holly","Alder Hey Children's Hospital, Liverpool, UK",NA
"903","34217380","10.1016/S2213-2600(21)00319-2","COVID-19 and the mental health of children with respiratory illness.",NA,"2021","07","04","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Gait","Lucy","Alder Hey Children's Hospital, Liverpool, UK",NA
"904","34217380","10.1016/S2213-2600(21)00319-2","COVID-19 and the mental health of children with respiratory illness.",NA,"2021","07","04","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Abrams","Elissa M","Department of Pediatrics, Section of Allergy and Clinical Immunology, University of Manitoba, Thompson, MB, Canada",NA
"905","34217380","10.1016/S2213-2600(21)00319-2","COVID-19 and the mental health of children with respiratory illness.",NA,"2021","07","04","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Lee","Alice R","Royal Manchester Children's Hospital, Manchester, UK",NA
"906","34217380","10.1016/S2213-2600(21)00319-2","COVID-19 and the mental health of children with respiratory illness.",NA,"2021","07","04","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Gray-Ffrench","Madeleine","Alder Hey Children's Hospital, Liverpool, UK",NA
"907","34217380","10.1016/S2213-2600(21)00319-2","COVID-19 and the mental health of children with respiratory illness.",NA,"2021","07","04","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Fernandes","Ricardo M","Clinical Pharmacology Unit, Faculty of Medicine and Instituto de Medicina Molecular, Universidade de Lisboa, Lisbon, Portugal",NA
"908","34217380","10.1016/S2213-2600(21)00319-2","COVID-19 and the mental health of children with respiratory illness.",NA,"2021","07","04","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Watson","Edward","West Cheshire Child and Adolescent Mental Health Services, Chester, UK",NA
"909","34217380","10.1016/S2213-2600(21)00319-2","COVID-19 and the mental health of children with respiratory illness.",NA,"2021","07","04","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Hawcut","Daniel B","Alder Hey Children's Hospital, Liverpool, UK",NA
"910","34217380","10.1016/S2213-2600(21)00319-2","COVID-19 and the mental health of children with respiratory illness.",NA,"2021","07","04","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Southern","Kevin W","Alder Hey Children's Hospital, Liverpool, UK",NA
"911","34217380","10.1016/S2213-2600(21)00319-2","COVID-19 and the mental health of children with respiratory illness.",NA,"2021","07","04","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Brown","Alexandra","Alder Hey Children's Hospital, Liverpool, UK. Electronic address: Alexandra.brown@alderhey.nhs","Alexandra.brown@alderhey.nhs.uk"
"912","34217378","10.1016/S2214-109X(21)00284-9","Responsive and agile vaccination strategies against COVID-19 in India.",NA,"2021","07","08","Lancet Glob Health","The Lancet. Global health",NA,"Mandal","Sandip","Division of Epidemiology and Communicable Disease, New Delhi, India",NA
"913","34217378","10.1016/S2214-109X(21)00284-9","Responsive and agile vaccination strategies against COVID-19 in India.",NA,"2021","07","08","Lancet Glob Health","The Lancet. Global health",NA,"Arinaminpathy","Nimalan","MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK",NA
"914","34217378","10.1016/S2214-109X(21)00284-9","Responsive and agile vaccination strategies against COVID-19 in India.",NA,"2021","07","08","Lancet Glob Health","The Lancet. Global health",NA,"Bhargava","Balram","Indian Council of Medical Research, New Delhi, India",NA
"915","34217378","10.1016/S2214-109X(21)00284-9","Responsive and agile vaccination strategies against COVID-19 in India.",NA,"2021","07","08","Lancet Glob Health","The Lancet. Global health",NA,"Panda","Samiran","Division of Epidemiology and Communicable Disease, New Delhi, India","pandas.hq@icmr.gov.in"
"916","34217371","10.1186/s40779-021-00331-6","Meta-analysis with zero-event studies: a comparative study with application to COVID-19 data.","Meta-analysis is a statistical method to synthesize evidence from a number of independent studies, including those from clinical studies with binary outcomes. In practice, when there are zero events in one or both groups, it may cause statistical problems in the subsequent analysis. In this paper, by considering the relative risk as the effect size, we conduct a comparative study that consists of four continuity correction methods and another state-of-the-art method without the continuity correc","2021","07","14","Mil Med Res","Military Medical Research","Continuity correction; Coronavirus disease 2019 data; Meta-analysis; Relative risk; Zero-event studies; COVID-19; Data Analysis; Humans; Linear Models; Meta-Analysis as Topic; Research Design","Wei","Jia-Jin","Department of Mathematics, Hong Kong Baptist University, Hong Kong, China",NA
"917","34217371","10.1186/s40779-021-00331-6","Meta-analysis with zero-event studies: a comparative study with application to COVID-19 data.","Meta-analysis is a statistical method to synthesize evidence from a number of independent studies, including those from clinical studies with binary outcomes. In practice, when there are zero events in one or both groups, it may cause statistical problems in the subsequent analysis. In this paper, by considering the relative risk as the effect size, we conduct a comparative study that consists of four continuity correction methods and another state-of-the-art method without the continuity correc","2021","07","14","Mil Med Res","Military Medical Research","Continuity correction; Coronavirus disease 2019 data; Meta-analysis; Relative risk; Zero-event studies; COVID-19; Data Analysis; Humans; Linear Models; Meta-Analysis as Topic; Research Design","Lin","En-Xuan","Shenzhen Research Institute of Big Data, Shenzhen, China",NA
"918","34217371","10.1186/s40779-021-00331-6","Meta-analysis with zero-event studies: a comparative study with application to COVID-19 data.","Meta-analysis is a statistical method to synthesize evidence from a number of independent studies, including those from clinical studies with binary outcomes. In practice, when there are zero events in one or both groups, it may cause statistical problems in the subsequent analysis. In this paper, by considering the relative risk as the effect size, we conduct a comparative study that consists of four continuity correction methods and another state-of-the-art method without the continuity correc","2021","07","14","Mil Med Res","Military Medical Research","Continuity correction; Coronavirus disease 2019 data; Meta-analysis; Relative risk; Zero-event studies; COVID-19; Data Analysis; Humans; Linear Models; Meta-Analysis as Topic; Research Design","Shi","Jian-Dong","Department of Mathematics, Hong Kong Baptist University, Hong Kong, China",NA
"919","34217371","10.1186/s40779-021-00331-6","Meta-analysis with zero-event studies: a comparative study with application to COVID-19 data.","Meta-analysis is a statistical method to synthesize evidence from a number of independent studies, including those from clinical studies with binary outcomes. In practice, when there are zero events in one or both groups, it may cause statistical problems in the subsequent analysis. In this paper, by considering the relative risk as the effect size, we conduct a comparative study that consists of four continuity correction methods and another state-of-the-art method without the continuity correc","2021","07","14","Mil Med Res","Military Medical Research","Continuity correction; Coronavirus disease 2019 data; Meta-analysis; Relative risk; Zero-event studies; COVID-19; Data Analysis; Humans; Linear Models; Meta-Analysis as Topic; Research Design","Yang","Ke","Department of Mathematics, Hong Kong Baptist University, Hong Kong, China",NA
"920","34217371","10.1186/s40779-021-00331-6","Meta-analysis with zero-event studies: a comparative study with application to COVID-19 data.","Meta-analysis is a statistical method to synthesize evidence from a number of independent studies, including those from clinical studies with binary outcomes. In practice, when there are zero events in one or both groups, it may cause statistical problems in the subsequent analysis. In this paper, by considering the relative risk as the effect size, we conduct a comparative study that consists of four continuity correction methods and another state-of-the-art method without the continuity correc","2021","07","14","Mil Med Res","Military Medical Research","Continuity correction; Coronavirus disease 2019 data; Meta-analysis; Relative risk; Zero-event studies; COVID-19; Data Analysis; Humans; Linear Models; Meta-Analysis as Topic; Research Design","Hu","Zong-Liang","College of Mathematics and Statistics, Shenzhen University, Shenzhen, China",NA
"921","34217371","10.1186/s40779-021-00331-6","Meta-analysis with zero-event studies: a comparative study with application to COVID-19 data.","Meta-analysis is a statistical method to synthesize evidence from a number of independent studies, including those from clinical studies with binary outcomes. In practice, when there are zero events in one or both groups, it may cause statistical problems in the subsequent analysis. In this paper, by considering the relative risk as the effect size, we conduct a comparative study that consists of four continuity correction methods and another state-of-the-art method without the continuity correc","2021","07","14","Mil Med Res","Military Medical Research","Continuity correction; Coronavirus disease 2019 data; Meta-analysis; Relative risk; Zero-event studies; COVID-19; Data Analysis; Humans; Linear Models; Meta-Analysis as Topic; Research Design","Zeng","Xian-Tao","Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"922","34217371","10.1186/s40779-021-00331-6","Meta-analysis with zero-event studies: a comparative study with application to COVID-19 data.","Meta-analysis is a statistical method to synthesize evidence from a number of independent studies, including those from clinical studies with binary outcomes. In practice, when there are zero events in one or both groups, it may cause statistical problems in the subsequent analysis. In this paper, by considering the relative risk as the effect size, we conduct a comparative study that consists of four continuity correction methods and another state-of-the-art method without the continuity correc","2021","07","14","Mil Med Res","Military Medical Research","Continuity correction; Coronavirus disease 2019 data; Meta-analysis; Relative risk; Zero-event studies; COVID-19; Data Analysis; Humans; Linear Models; Meta-Analysis as Topic; Research Design","Tong","Tie-Jun","Department of Mathematics, Hong Kong Baptist University, Hong Kong, China. tongt@hkbu.edu","tongt@hkbu.edu.hk"
"923","34217366","10.1186/s40001-021-00539-1","Effects of COVID-19 prevention procedures on other common infections: a systematic review.","Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the i","2021","07","09","Eur J Med Res","European journal of medical research","COVID-19; Infection; Prevention; SARS-CoV-2; COVID-19; Communicable Disease Control; Humans; Incidence; Influenza, Human; Respiratory Tract Diseases; Tuberculosis","Dadras","Omid","School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand",NA
"924","34217366","10.1186/s40001-021-00539-1","Effects of COVID-19 prevention procedures on other common infections: a systematic review.","Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the i","2021","07","09","Eur J Med Res","European journal of medical research","COVID-19; Infection; Prevention; SARS-CoV-2; COVID-19; Communicable Disease Control; Humans; Incidence; Influenza, Human; Respiratory Tract Diseases; Tuberculosis","Alinaghi","Seyed Ahmad Seyed","Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran",NA
"925","34217366","10.1186/s40001-021-00539-1","Effects of COVID-19 prevention procedures on other common infections: a systematic review.","Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the i","2021","07","09","Eur J Med Res","European journal of medical research","COVID-19; Infection; Prevention; SARS-CoV-2; COVID-19; Communicable Disease Control; Humans; Incidence; Influenza, Human; Respiratory Tract Diseases; Tuberculosis","Karimi","Amirali","School of Medicine, Tehran University of Medical Sciences, Tehran, Iran",NA
"926","34217366","10.1186/s40001-021-00539-1","Effects of COVID-19 prevention procedures on other common infections: a systematic review.","Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the i","2021","07","09","Eur J Med Res","European journal of medical research","COVID-19; Infection; Prevention; SARS-CoV-2; COVID-19; Communicable Disease Control; Humans; Incidence; Influenza, Human; Respiratory Tract Diseases; Tuberculosis","MohsseniPour","Mehrzad","Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran",NA
"927","34217366","10.1186/s40001-021-00539-1","Effects of COVID-19 prevention procedures on other common infections: a systematic review.","Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the i","2021","07","09","Eur J Med Res","European journal of medical research","COVID-19; Infection; Prevention; SARS-CoV-2; COVID-19; Communicable Disease Control; Humans; Incidence; Influenza, Human; Respiratory Tract Diseases; Tuberculosis","Barzegary","Alireza","School of Medicine, Islamic Azad University, Tehran, Iran",NA
"928","34217366","10.1186/s40001-021-00539-1","Effects of COVID-19 prevention procedures on other common infections: a systematic review.","Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the i","2021","07","09","Eur J Med Res","European journal of medical research","COVID-19; Infection; Prevention; SARS-CoV-2; COVID-19; Communicable Disease Control; Humans; Incidence; Influenza, Human; Respiratory Tract Diseases; Tuberculosis","Vahedi","Farzin","School of Medicine, Tehran University of Medical Sciences, Tehran, Iran",NA
"929","34217366","10.1186/s40001-021-00539-1","Effects of COVID-19 prevention procedures on other common infections: a systematic review.","Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the i","2021","07","09","Eur J Med Res","European journal of medical research","COVID-19; Infection; Prevention; SARS-CoV-2; COVID-19; Communicable Disease Control; Humans; Incidence; Influenza, Human; Respiratory Tract Diseases; Tuberculosis","Pashaei","Zahra","Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran",NA
"930","34217366","10.1186/s40001-021-00539-1","Effects of COVID-19 prevention procedures on other common infections: a systematic review.","Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the i","2021","07","09","Eur J Med Res","European journal of medical research","COVID-19; Infection; Prevention; SARS-CoV-2; COVID-19; Communicable Disease Control; Humans; Incidence; Influenza, Human; Respiratory Tract Diseases; Tuberculosis","Mirzapour","Pegah","Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran",NA
"931","34217366","10.1186/s40001-021-00539-1","Effects of COVID-19 prevention procedures on other common infections: a systematic review.","Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the i","2021","07","09","Eur J Med Res","European journal of medical research","COVID-19; Infection; Prevention; SARS-CoV-2; COVID-19; Communicable Disease Control; Humans; Incidence; Influenza, Human; Respiratory Tract Diseases; Tuberculosis","Fakhfouri","Amirata","School of Medicine, Islamic Azad University, Tehran, Iran",NA
"932","34217366","10.1186/s40001-021-00539-1","Effects of COVID-19 prevention procedures on other common infections: a systematic review.","Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the i","2021","07","09","Eur J Med Res","European journal of medical research","COVID-19; Infection; Prevention; SARS-CoV-2; COVID-19; Communicable Disease Control; Humans; Incidence; Influenza, Human; Respiratory Tract Diseases; Tuberculosis","Zargari","Ghazal","School of Medicine, Iran University of Medical Sciences, Tehran, Iran",NA
"933","34217366","10.1186/s40001-021-00539-1","Effects of COVID-19 prevention procedures on other common infections: a systematic review.","Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the i","2021","07","09","Eur J Med Res","European journal of medical research","COVID-19; Infection; Prevention; SARS-CoV-2; COVID-19; Communicable Disease Control; Humans; Incidence; Influenza, Human; Respiratory Tract Diseases; Tuberculosis","Saeidi","Solmaz","Department of Nursing, Khalkhal University of Medical Sciences, Khalkhal, Iran",NA
"934","34217366","10.1186/s40001-021-00539-1","Effects of COVID-19 prevention procedures on other common infections: a systematic review.","Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the i","2021","07","09","Eur J Med Res","European journal of medical research","COVID-19; Infection; Prevention; SARS-CoV-2; COVID-19; Communicable Disease Control; Humans; Incidence; Influenza, Human; Respiratory Tract Diseases; Tuberculosis","Mojdeganlou","Hengameh","Department of Pathology, Urmia University of Medical Sciences, Urmia, Iran",NA
"935","34217366","10.1186/s40001-021-00539-1","Effects of COVID-19 prevention procedures on other common infections: a systematic review.","Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the i","2021","07","09","Eur J Med Res","European journal of medical research","COVID-19; Infection; Prevention; SARS-CoV-2; COVID-19; Communicable Disease Control; Humans; Incidence; Influenza, Human; Respiratory Tract Diseases; Tuberculosis","Badri","Hajar","School of Health, Guilan University of Medical Sciences, Rasht, Iran",NA
"936","34217366","10.1186/s40001-021-00539-1","Effects of COVID-19 prevention procedures on other common infections: a systematic review.","Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the i","2021","07","09","Eur J Med Res","European journal of medical research","COVID-19; Infection; Prevention; SARS-CoV-2; COVID-19; Communicable Disease Control; Humans; Incidence; Influenza, Human; Respiratory Tract Diseases; Tuberculosis","Qaderi","Kowsar","Kermanshah University of Medical Sciences, Kermanshah, Iran",NA
"937","34217366","10.1186/s40001-021-00539-1","Effects of COVID-19 prevention procedures on other common infections: a systematic review.","Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the i","2021","07","09","Eur J Med Res","European journal of medical research","COVID-19; Infection; Prevention; SARS-CoV-2; COVID-19; Communicable Disease Control; Humans; Incidence; Influenza, Human; Respiratory Tract Diseases; Tuberculosis","Behnezhad","Farzane","Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran",NA
"938","34217366","10.1186/s40001-021-00539-1","Effects of COVID-19 prevention procedures on other common infections: a systematic review.","Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the i","2021","07","09","Eur J Med Res","European journal of medical research","COVID-19; Infection; Prevention; SARS-CoV-2; COVID-19; Communicable Disease Control; Humans; Incidence; Influenza, Human; Respiratory Tract Diseases; Tuberculosis","Mehraeen","Esmaeil","Department of Health Information Technology, Khalkhal University of Medical Sciences, 1419733141, Khalkhal, Iran. es.mehraeen@gmail","es.mehraeen@gmail.com"
"939","34217339","10.1186/s13054-021-03661-y","The predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019.","The coronavirus disease 2019 (COVID-19) has induced a worldwide epidemiological event with a high infectivity and mortality. However, the predicting biomarkers and their potential mechanism in the progression of COVID-19 are not well known. The aim of this study is to identify the candidate predictors of COVID-19 and investigate their underlying mechanism. The retrospective study was conducted to identify the potential laboratory indicators with prognostic values of COVID-19 disease. Then, the p","2021","07","08","Crit Care","Critical care (London, England)","Carcinoembryonic antigen; Carcinoembryonic antigen-related cell adhesion molecules; Coronavirus disease 2019; Developing neutrophils; Type II pneumocyte; Adult; Aged; Biomarkers; Bronchoalveolar Lavage Fluid; COVID-19; Carcinoembryonic Antigen; Cell Communication; China; Disease Progression; Hospitalization; Humans; Male; Middle Aged; Neutrophils; Nomograms; Pneumonia, Viral; Predictive Value of Tests; Prognosis; Retrospective Studies; SARS-CoV-2; Survival Analysis","Huang","Runzhi","Department of Respiratory and Critical Care Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China",NA
"940","34217339","10.1186/s13054-021-03661-y","The predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019.","The coronavirus disease 2019 (COVID-19) has induced a worldwide epidemiological event with a high infectivity and mortality. However, the predicting biomarkers and their potential mechanism in the progression of COVID-19 are not well known. The aim of this study is to identify the candidate predictors of COVID-19 and investigate their underlying mechanism. The retrospective study was conducted to identify the potential laboratory indicators with prognostic values of COVID-19 disease. Then, the p","2021","07","08","Crit Care","Critical care (London, England)","Carcinoembryonic antigen; Carcinoembryonic antigen-related cell adhesion molecules; Coronavirus disease 2019; Developing neutrophils; Type II pneumocyte; Adult; Aged; Biomarkers; Bronchoalveolar Lavage Fluid; COVID-19; Carcinoembryonic Antigen; Cell Communication; China; Disease Progression; Hospitalization; Humans; Male; Middle Aged; Neutrophils; Nomograms; Pneumonia, Viral; Predictive Value of Tests; Prognosis; Retrospective Studies; SARS-CoV-2; Survival Analysis","Meng","Tong","Shanghai General Hospital, 100 Haining Road, Shanghai, 200080, China",NA
"941","34217339","10.1186/s13054-021-03661-y","The predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019.","The coronavirus disease 2019 (COVID-19) has induced a worldwide epidemiological event with a high infectivity and mortality. However, the predicting biomarkers and their potential mechanism in the progression of COVID-19 are not well known. The aim of this study is to identify the candidate predictors of COVID-19 and investigate their underlying mechanism. The retrospective study was conducted to identify the potential laboratory indicators with prognostic values of COVID-19 disease. Then, the p","2021","07","08","Crit Care","Critical care (London, England)","Carcinoembryonic antigen; Carcinoembryonic antigen-related cell adhesion molecules; Coronavirus disease 2019; Developing neutrophils; Type II pneumocyte; Adult; Aged; Biomarkers; Bronchoalveolar Lavage Fluid; COVID-19; Carcinoembryonic Antigen; Cell Communication; China; Disease Progression; Hospitalization; Humans; Male; Middle Aged; Neutrophils; Nomograms; Pneumonia, Viral; Predictive Value of Tests; Prognosis; Retrospective Studies; SARS-CoV-2; Survival Analysis","Zha","Qiongfang","Department of Respiratory and Critical Care Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China",NA
"942","34217339","10.1186/s13054-021-03661-y","The predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019.","The coronavirus disease 2019 (COVID-19) has induced a worldwide epidemiological event with a high infectivity and mortality. However, the predicting biomarkers and their potential mechanism in the progression of COVID-19 are not well known. The aim of this study is to identify the candidate predictors of COVID-19 and investigate their underlying mechanism. The retrospective study was conducted to identify the potential laboratory indicators with prognostic values of COVID-19 disease. Then, the p","2021","07","08","Crit Care","Critical care (London, England)","Carcinoembryonic antigen; Carcinoembryonic antigen-related cell adhesion molecules; Coronavirus disease 2019; Developing neutrophils; Type II pneumocyte; Adult; Aged; Biomarkers; Bronchoalveolar Lavage Fluid; COVID-19; Carcinoembryonic Antigen; Cell Communication; China; Disease Progression; Hospitalization; Humans; Male; Middle Aged; Neutrophils; Nomograms; Pneumonia, Viral; Predictive Value of Tests; Prognosis; Retrospective Studies; SARS-CoV-2; Survival Analysis","Cheng","Kebin","Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China",NA
"943","34217339","10.1186/s13054-021-03661-y","The predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019.","The coronavirus disease 2019 (COVID-19) has induced a worldwide epidemiological event with a high infectivity and mortality. However, the predicting biomarkers and their potential mechanism in the progression of COVID-19 are not well known. The aim of this study is to identify the candidate predictors of COVID-19 and investigate their underlying mechanism. The retrospective study was conducted to identify the potential laboratory indicators with prognostic values of COVID-19 disease. Then, the p","2021","07","08","Crit Care","Critical care (London, England)","Carcinoembryonic antigen; Carcinoembryonic antigen-related cell adhesion molecules; Coronavirus disease 2019; Developing neutrophils; Type II pneumocyte; Adult; Aged; Biomarkers; Bronchoalveolar Lavage Fluid; COVID-19; Carcinoembryonic Antigen; Cell Communication; China; Disease Progression; Hospitalization; Humans; Male; Middle Aged; Neutrophils; Nomograms; Pneumonia, Viral; Predictive Value of Tests; Prognosis; Retrospective Studies; SARS-CoV-2; Survival Analysis","Zhou","Xin","Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, 100 Haining Road, Shanghai, 200080, China",NA
"944","34217339","10.1186/s13054-021-03661-y","The predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019.","The coronavirus disease 2019 (COVID-19) has induced a worldwide epidemiological event with a high infectivity and mortality. However, the predicting biomarkers and their potential mechanism in the progression of COVID-19 are not well known. The aim of this study is to identify the candidate predictors of COVID-19 and investigate their underlying mechanism. The retrospective study was conducted to identify the potential laboratory indicators with prognostic values of COVID-19 disease. Then, the p","2021","07","08","Crit Care","Critical care (London, England)","Carcinoembryonic antigen; Carcinoembryonic antigen-related cell adhesion molecules; Coronavirus disease 2019; Developing neutrophils; Type II pneumocyte; Adult; Aged; Biomarkers; Bronchoalveolar Lavage Fluid; COVID-19; Carcinoembryonic Antigen; Cell Communication; China; Disease Progression; Hospitalization; Humans; Male; Middle Aged; Neutrophils; Nomograms; Pneumonia, Viral; Predictive Value of Tests; Prognosis; Retrospective Studies; SARS-CoV-2; Survival Analysis","Zheng","Junhua","Tongji University Cancer Center, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 301 Yanchang Road, Shanghai, 200072, China",NA
"945","34217339","10.1186/s13054-021-03661-y","The predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019.","The coronavirus disease 2019 (COVID-19) has induced a worldwide epidemiological event with a high infectivity and mortality. However, the predicting biomarkers and their potential mechanism in the progression of COVID-19 are not well known. The aim of this study is to identify the candidate predictors of COVID-19 and investigate their underlying mechanism. The retrospective study was conducted to identify the potential laboratory indicators with prognostic values of COVID-19 disease. Then, the p","2021","07","08","Crit Care","Critical care (London, England)","Carcinoembryonic antigen; Carcinoembryonic antigen-related cell adhesion molecules; Coronavirus disease 2019; Developing neutrophils; Type II pneumocyte; Adult; Aged; Biomarkers; Bronchoalveolar Lavage Fluid; COVID-19; Carcinoembryonic Antigen; Cell Communication; China; Disease Progression; Hospitalization; Humans; Male; Middle Aged; Neutrophils; Nomograms; Pneumonia, Viral; Predictive Value of Tests; Prognosis; Retrospective Studies; SARS-CoV-2; Survival Analysis","Zhang","Dingyu","Wuhan Jinyintan Hospital, Wuhan, 430023, China. 1813886398@qq",NA
"946","34217339","10.1186/s13054-021-03661-y","The predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019.","The coronavirus disease 2019 (COVID-19) has induced a worldwide epidemiological event with a high infectivity and mortality. However, the predicting biomarkers and their potential mechanism in the progression of COVID-19 are not well known. The aim of this study is to identify the candidate predictors of COVID-19 and investigate their underlying mechanism. The retrospective study was conducted to identify the potential laboratory indicators with prognostic values of COVID-19 disease. Then, the p","2021","07","08","Crit Care","Critical care (London, England)","Carcinoembryonic antigen; Carcinoembryonic antigen-related cell adhesion molecules; Coronavirus disease 2019; Developing neutrophils; Type II pneumocyte; Adult; Aged; Biomarkers; Bronchoalveolar Lavage Fluid; COVID-19; Carcinoembryonic Antigen; Cell Communication; China; Disease Progression; Hospitalization; Humans; Male; Middle Aged; Neutrophils; Nomograms; Pneumonia, Viral; Predictive Value of Tests; Prognosis; Retrospective Studies; SARS-CoV-2; Survival Analysis","Liu","Ruilin","Department of Respiratory and Critical Care Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China. 18721881628@163","18721881628@163.com"
"947","34217301","10.1186/s12985-021-01609-w","Transmission frequency of COVID-19 through pre-symptomatic and asymptomatic patients in AJK: a report of 201 cases.","The COVID-19 pandemic is a catastrophic global phenomenon, affecting human life in a way unseen since the 1918 influenza pandemic. Effective management of this threat requires halting transmission, a strategy requiring accurate knowledge of SARS-CoV-2 transmission patterns. This was a retrospective contact study aiming to estimate the transmission rate of COVID-19 by tracing contacts in symptomatic, pre-symptomatic, and asymptomatic patients. History of patients' contacts during 24 h before appe","2021","07","13","Virol J","Virology journal","AJK; Asymptomatic; COVID-19; COVID-19 patients; COVID-19 transmission; Pakistan; Pre-symptomatic; Adult; Aged; Asymptomatic Infections; COVID-19; Contact Tracing; Female; Humans; Incidence; Male; Middle Aged; Pakistan; Retrospective Studies; Risk Factors; Young Adult","Mahmood","Majid","Department of Zoology, University of Poonch Rawalakot, Rawalakot, AJK, Pakistan. drmajid@upr.edu","drmajid@upr.edu.pk"
"948","34217301","10.1186/s12985-021-01609-w","Transmission frequency of COVID-19 through pre-symptomatic and asymptomatic patients in AJK: a report of 201 cases.","The COVID-19 pandemic is a catastrophic global phenomenon, affecting human life in a way unseen since the 1918 influenza pandemic. Effective management of this threat requires halting transmission, a strategy requiring accurate knowledge of SARS-CoV-2 transmission patterns. This was a retrospective contact study aiming to estimate the transmission rate of COVID-19 by tracing contacts in symptomatic, pre-symptomatic, and asymptomatic patients. History of patients' contacts during 24 h before appe","2021","07","13","Virol J","Virology journal","AJK; Asymptomatic; COVID-19; COVID-19 patients; COVID-19 transmission; Pakistan; Pre-symptomatic; Adult; Aged; Asymptomatic Infections; COVID-19; Contact Tracing; Female; Humans; Incidence; Male; Middle Aged; Pakistan; Retrospective Studies; Risk Factors; Young Adult","Ilyas","Noor-Ul-Ain","Department of Zoology, University of Poonch Rawalakot, Rawalakot, AJK, Pakistan",NA
"949","34217301","10.1186/s12985-021-01609-w","Transmission frequency of COVID-19 through pre-symptomatic and asymptomatic patients in AJK: a report of 201 cases.","The COVID-19 pandemic is a catastrophic global phenomenon, affecting human life in a way unseen since the 1918 influenza pandemic. Effective management of this threat requires halting transmission, a strategy requiring accurate knowledge of SARS-CoV-2 transmission patterns. This was a retrospective contact study aiming to estimate the transmission rate of COVID-19 by tracing contacts in symptomatic, pre-symptomatic, and asymptomatic patients. History of patients' contacts during 24 h before appe","2021","07","13","Virol J","Virology journal","AJK; Asymptomatic; COVID-19; COVID-19 patients; COVID-19 transmission; Pakistan; Pre-symptomatic; Adult; Aged; Asymptomatic Infections; COVID-19; Contact Tracing; Female; Humans; Incidence; Male; Middle Aged; Pakistan; Retrospective Studies; Risk Factors; Young Adult","Khan","Muhammad Faraz","Department of Botany, University of Poonch Rawalakot, Rawalakot, AJK, Pakistan",NA
"950","34217301","10.1186/s12985-021-01609-w","Transmission frequency of COVID-19 through pre-symptomatic and asymptomatic patients in AJK: a report of 201 cases.","The COVID-19 pandemic is a catastrophic global phenomenon, affecting human life in a way unseen since the 1918 influenza pandemic. Effective management of this threat requires halting transmission, a strategy requiring accurate knowledge of SARS-CoV-2 transmission patterns. This was a retrospective contact study aiming to estimate the transmission rate of COVID-19 by tracing contacts in symptomatic, pre-symptomatic, and asymptomatic patients. History of patients' contacts during 24 h before appe","2021","07","13","Virol J","Virology journal","AJK; Asymptomatic; COVID-19; COVID-19 patients; COVID-19 transmission; Pakistan; Pre-symptomatic; Adult; Aged; Asymptomatic Infections; COVID-19; Contact Tracing; Female; Humans; Incidence; Male; Middle Aged; Pakistan; Retrospective Studies; Risk Factors; Young Adult","Hasrat","Muhammad Naseem","Sheikh Khalifa Bin Zayd Al-Nahyan DHQ Hospital, Rawalakot, AJK, Pakistan",NA
"951","34217301","10.1186/s12985-021-01609-w","Transmission frequency of COVID-19 through pre-symptomatic and asymptomatic patients in AJK: a report of 201 cases.","The COVID-19 pandemic is a catastrophic global phenomenon, affecting human life in a way unseen since the 1918 influenza pandemic. Effective management of this threat requires halting transmission, a strategy requiring accurate knowledge of SARS-CoV-2 transmission patterns. This was a retrospective contact study aiming to estimate the transmission rate of COVID-19 by tracing contacts in symptomatic, pre-symptomatic, and asymptomatic patients. History of patients' contacts during 24 h before appe","2021","07","13","Virol J","Virology journal","AJK; Asymptomatic; COVID-19; COVID-19 patients; COVID-19 transmission; Pakistan; Pre-symptomatic; Adult; Aged; Asymptomatic Infections; COVID-19; Contact Tracing; Female; Humans; Incidence; Male; Middle Aged; Pakistan; Retrospective Studies; Risk Factors; Young Adult","Richwagen","Nicholas","College of Medicine, University of Central Florida, Florida, USA",NA
"952","34217292","10.1186/s12913-021-06690-z","Are preventive measures adequate? An evaluation of the implementation of COVID-19 prevention and control measures in nursing homes in China.","The novel coronavirus disease 2019 (COVID-19) pandemic has become a challenge for nursing homes in China. Nursing homes are particularly dangerous places in terms of the spread of COVID-19 given that they house vulnerable, high-risk populations. As such, several useful guidelines for coping with COVID-19 in nursing homes have been provided. However, the actual implementation rates of such guidelines are unknown. This study aims to document the adherence of nursing homes to the Ministry of Civil ","2021","07","06","BMC Health Serv Res","BMC health services research","COVID-2019; Evaluation; Implementation; Nursing homes; Prevention and control; Prevention resource; Transformational leadership; COVID-19; China; Cross-Sectional Studies; Humans; Nursing Homes; SARS-CoV-2","Shi","Meihong","West China School of Nursing, Sichuan University/ Innovation Center of Nursing Research, West China Hospital, Sichuan University, PO Box 610041, Chengdu, Sichuan Province, People's Republic of China",NA
"953","34217292","10.1186/s12913-021-06690-z","Are preventive measures adequate? An evaluation of the implementation of COVID-19 prevention and control measures in nursing homes in China.","The novel coronavirus disease 2019 (COVID-19) pandemic has become a challenge for nursing homes in China. Nursing homes are particularly dangerous places in terms of the spread of COVID-19 given that they house vulnerable, high-risk populations. As such, several useful guidelines for coping with COVID-19 in nursing homes have been provided. However, the actual implementation rates of such guidelines are unknown. This study aims to document the adherence of nursing homes to the Ministry of Civil ","2021","07","06","BMC Health Serv Res","BMC health services research","COVID-2019; Evaluation; Implementation; Nursing homes; Prevention and control; Prevention resource; Transformational leadership; COVID-19; China; Cross-Sectional Studies; Humans; Nursing Homes; SARS-CoV-2","Zhang","Fengying","West China School of Nursing, Sichuan University/ Innovation Center of Nursing Research, West China Hospital, Sichuan University, PO Box 610041, Chengdu, Sichuan Province, People's Republic of China",NA
"954","34217292","10.1186/s12913-021-06690-z","Are preventive measures adequate? An evaluation of the implementation of COVID-19 prevention and control measures in nursing homes in China.","The novel coronavirus disease 2019 (COVID-19) pandemic has become a challenge for nursing homes in China. Nursing homes are particularly dangerous places in terms of the spread of COVID-19 given that they house vulnerable, high-risk populations. As such, several useful guidelines for coping with COVID-19 in nursing homes have been provided. However, the actual implementation rates of such guidelines are unknown. This study aims to document the adherence of nursing homes to the Ministry of Civil ","2021","07","06","BMC Health Serv Res","BMC health services research","COVID-2019; Evaluation; Implementation; Nursing homes; Prevention and control; Prevention resource; Transformational leadership; COVID-19; China; Cross-Sectional Studies; Humans; Nursing Homes; SARS-CoV-2","He","Xinxin","Nursing Department of Southwest Medical University, No. 1 Xianglin Rode, Longmatan District, PO Box 646000, Luzhou, Sichuan, People's Republic of China",NA
"955","34217292","10.1186/s12913-021-06690-z","Are preventive measures adequate? An evaluation of the implementation of COVID-19 prevention and control measures in nursing homes in China.","The novel coronavirus disease 2019 (COVID-19) pandemic has become a challenge for nursing homes in China. Nursing homes are particularly dangerous places in terms of the spread of COVID-19 given that they house vulnerable, high-risk populations. As such, several useful guidelines for coping with COVID-19 in nursing homes have been provided. However, the actual implementation rates of such guidelines are unknown. This study aims to document the adherence of nursing homes to the Ministry of Civil ","2021","07","06","BMC Health Serv Res","BMC health services research","COVID-2019; Evaluation; Implementation; Nursing homes; Prevention and control; Prevention resource; Transformational leadership; COVID-19; China; Cross-Sectional Studies; Humans; Nursing Homes; SARS-CoV-2","Huang","Siyuan","Nursing Department of Southwest Medical University, No. 1 Xianglin Rode, Longmatan District, PO Box 646000, Luzhou, Sichuan, People's Republic of China",NA
"956","34217292","10.1186/s12913-021-06690-z","Are preventive measures adequate? An evaluation of the implementation of COVID-19 prevention and control measures in nursing homes in China.","The novel coronavirus disease 2019 (COVID-19) pandemic has become a challenge for nursing homes in China. Nursing homes are particularly dangerous places in terms of the spread of COVID-19 given that they house vulnerable, high-risk populations. As such, several useful guidelines for coping with COVID-19 in nursing homes have been provided. However, the actual implementation rates of such guidelines are unknown. This study aims to document the adherence of nursing homes to the Ministry of Civil ","2021","07","06","BMC Health Serv Res","BMC health services research","COVID-2019; Evaluation; Implementation; Nursing homes; Prevention and control; Prevention resource; Transformational leadership; COVID-19; China; Cross-Sectional Studies; Humans; Nursing Homes; SARS-CoV-2","Zhang","Mingfeng","Nursing Department of Southwest Medical University, No. 1 Xianglin Rode, Longmatan District, PO Box 646000, Luzhou, Sichuan, People's Republic of China",NA
"957","34217292","10.1186/s12913-021-06690-z","Are preventive measures adequate? An evaluation of the implementation of COVID-19 prevention and control measures in nursing homes in China.","The novel coronavirus disease 2019 (COVID-19) pandemic has become a challenge for nursing homes in China. Nursing homes are particularly dangerous places in terms of the spread of COVID-19 given that they house vulnerable, high-risk populations. As such, several useful guidelines for coping with COVID-19 in nursing homes have been provided. However, the actual implementation rates of such guidelines are unknown. This study aims to document the adherence of nursing homes to the Ministry of Civil ","2021","07","06","BMC Health Serv Res","BMC health services research","COVID-2019; Evaluation; Implementation; Nursing homes; Prevention and control; Prevention resource; Transformational leadership; COVID-19; China; Cross-Sectional Studies; Humans; Nursing Homes; SARS-CoV-2","Hu","Xiuying","West China School of Nursing, Sichuan University/ Innovation Center of Nursing Research, West China Hospital, Sichuan University, PO Box 610041, Chengdu, Sichuan Province, People's Republic of China. westchinahuxiuying@163","westchinahuxiuying@163.com"
"958","34217279","10.1186/s12909-021-02806-5","Dental education changed by COVID-19: Student's perceptions and attitudes.","Dental students have encountered changes in the teaching format amid the SARS CoV-2 pandemic. This study aims to evaluate the attitudes of dental students of one medical university toward online courses and compare them with those of non-dental students amid the SARS CoV-2 pandemic. A cross-sectional survey with a self-report online questionnaire was conducted at the medical university in May 2020 in Taipei. Students from the School of Dentistry, School of Dental Technology, and School of Oral H","2021","07","06","BMC Med Educ","BMC medical education","Attitudes; COVID-19; Dental education; Infection control; Online education; Perceptions; Attitude; COVID-19; Cross-Sectional Studies; Education, Dental; Education, Distance; Humans; Pandemics; Perception; SARS-CoV-2; Students","Cheng","Hsin-Chung","School of Dentistry, College of Oral Medicine, Taipei Medical University, No.250, Wuxing St., Xinyi Dist, Taipei, 110, Taiwan. g4808@tmu.edu","g4808@tmu.edu.tw"
"959","34217279","10.1186/s12909-021-02806-5","Dental education changed by COVID-19: Student's perceptions and attitudes.","Dental students have encountered changes in the teaching format amid the SARS CoV-2 pandemic. This study aims to evaluate the attitudes of dental students of one medical university toward online courses and compare them with those of non-dental students amid the SARS CoV-2 pandemic. A cross-sectional survey with a self-report online questionnaire was conducted at the medical university in May 2020 in Taipei. Students from the School of Dentistry, School of Dental Technology, and School of Oral H","2021","07","06","BMC Med Educ","BMC medical education","Attitudes; COVID-19; Dental education; Infection control; Online education; Perceptions; Attitude; COVID-19; Cross-Sectional Studies; Education, Dental; Education, Distance; Humans; Pandemics; Perception; SARS-CoV-2; Students","Lu","Sao-Lun","School of Dentistry, College of Oral Medicine, Taipei Medical University, No.250, Wuxing St., Xinyi Dist, Taipei, 110, Taiwan",NA
"960","34217279","10.1186/s12909-021-02806-5","Dental education changed by COVID-19: Student's perceptions and attitudes.","Dental students have encountered changes in the teaching format amid the SARS CoV-2 pandemic. This study aims to evaluate the attitudes of dental students of one medical university toward online courses and compare them with those of non-dental students amid the SARS CoV-2 pandemic. A cross-sectional survey with a self-report online questionnaire was conducted at the medical university in May 2020 in Taipei. Students from the School of Dentistry, School of Dental Technology, and School of Oral H","2021","07","06","BMC Med Educ","BMC medical education","Attitudes; COVID-19; Dental education; Infection control; Online education; Perceptions; Attitude; COVID-19; Cross-Sectional Studies; Education, Dental; Education, Distance; Humans; Pandemics; Perception; SARS-CoV-2; Students","Yen","Yu-Chun","Research Center of Biostatistics, College of Management, Taipei Medical University, Taipei, Taiwan",NA
"961","34217279","10.1186/s12909-021-02806-5","Dental education changed by COVID-19: Student's perceptions and attitudes.","Dental students have encountered changes in the teaching format amid the SARS CoV-2 pandemic. This study aims to evaluate the attitudes of dental students of one medical university toward online courses and compare them with those of non-dental students amid the SARS CoV-2 pandemic. A cross-sectional survey with a self-report online questionnaire was conducted at the medical university in May 2020 in Taipei. Students from the School of Dentistry, School of Dental Technology, and School of Oral H","2021","07","06","BMC Med Educ","BMC medical education","Attitudes; COVID-19; Dental education; Infection control; Online education; Perceptions; Attitude; COVID-19; Cross-Sectional Studies; Education, Dental; Education, Distance; Humans; Pandemics; Perception; SARS-CoV-2; Students","Siewchaisakul","Pallop","Faculty of Public Health, Chiang Mai University, Chiang Mai, Thailand",NA
"962","34217279","10.1186/s12909-021-02806-5","Dental education changed by COVID-19: Student's perceptions and attitudes.","Dental students have encountered changes in the teaching format amid the SARS CoV-2 pandemic. This study aims to evaluate the attitudes of dental students of one medical university toward online courses and compare them with those of non-dental students amid the SARS CoV-2 pandemic. A cross-sectional survey with a self-report online questionnaire was conducted at the medical university in May 2020 in Taipei. Students from the School of Dentistry, School of Dental Technology, and School of Oral H","2021","07","06","BMC Med Educ","BMC medical education","Attitudes; COVID-19; Dental education; Infection control; Online education; Perceptions; Attitude; COVID-19; Cross-Sectional Studies; Education, Dental; Education, Distance; Humans; Pandemics; Perception; SARS-CoV-2; Students","Yen","Amy Ming-Fang","School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, No.250, Wuxing St., Xinyi Dist, Taipei, 110, Taiwan",NA
"963","34217279","10.1186/s12909-021-02806-5","Dental education changed by COVID-19: Student's perceptions and attitudes.","Dental students have encountered changes in the teaching format amid the SARS CoV-2 pandemic. This study aims to evaluate the attitudes of dental students of one medical university toward online courses and compare them with those of non-dental students amid the SARS CoV-2 pandemic. A cross-sectional survey with a self-report online questionnaire was conducted at the medical university in May 2020 in Taipei. Students from the School of Dentistry, School of Dental Technology, and School of Oral H","2021","07","06","BMC Med Educ","BMC medical education","Attitudes; COVID-19; Dental education; Infection control; Online education; Perceptions; Attitude; COVID-19; Cross-Sectional Studies; Education, Dental; Education, Distance; Humans; Pandemics; Perception; SARS-CoV-2; Students","Chen","Sam Li-Sheng","School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, No.250, Wuxing St., Xinyi Dist, Taipei, 110, Taiwan. samchen@tmu.edu","samchen@tmu.edu.tw"
"964","34217276","10.1186/s12902-021-00805-7","Increasing adiposity and the presence of cardiometabolic morbidity is associated with increased Covid-19-related mortality: results from the UK Biobank.","Although obesity, defined by body mass index (BMI), has been associated with a higher risk of hospitalisation and more severe course of illness in Covid-19 positive patients amongst the British population, it is unclear if this translates into increased mortality. Furthermore, given that BMI is an insensitive indicator of adiposity, the effect of adipose volume on Covid-19 outcomes is also unknown. We used the UK Biobank repository, which contains clinical and anthropometric data and is linked t","2021","07","07","BMC Endocr Disord","BMC endocrine disorders","Adiposity; Covid-19; Mortality; Obesity; Adiposity; Aged; Aged, 80 and over; Biological Specimen Banks; Body Mass Index; COVID-19; Cardiometabolic Risk Factors; Cardiovascular Diseases; Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Female; Hospital Mortality; Humans; Male; Metabolic Syndrome; Middle Aged; Morbidity; Mortality; Obesity; Risk Factors; SARS-CoV-2; United Kingdom","Patel","Kiran H K","National Heart and Lung Institute, Imperial College London, 4th Floor, ICTEM Building, 72 Du Cane Road, London, W12 0NN, UK",NA
"965","34217276","10.1186/s12902-021-00805-7","Increasing adiposity and the presence of cardiometabolic morbidity is associated with increased Covid-19-related mortality: results from the UK Biobank.","Although obesity, defined by body mass index (BMI), has been associated with a higher risk of hospitalisation and more severe course of illness in Covid-19 positive patients amongst the British population, it is unclear if this translates into increased mortality. Furthermore, given that BMI is an insensitive indicator of adiposity, the effect of adipose volume on Covid-19 outcomes is also unknown. We used the UK Biobank repository, which contains clinical and anthropometric data and is linked t","2021","07","07","BMC Endocr Disord","BMC endocrine disorders","Adiposity; Covid-19; Mortality; Obesity; Adiposity; Aged; Aged, 80 and over; Biological Specimen Banks; Body Mass Index; COVID-19; Cardiometabolic Risk Factors; Cardiovascular Diseases; Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Female; Hospital Mortality; Humans; Male; Metabolic Syndrome; Middle Aged; Morbidity; Mortality; Obesity; Risk Factors; SARS-CoV-2; United Kingdom","Li","Xinyang","National Heart and Lung Institute, Imperial College London, 4th Floor, ICTEM Building, 72 Du Cane Road, London, W12 0NN, UK",NA
"966","34217276","10.1186/s12902-021-00805-7","Increasing adiposity and the presence of cardiometabolic morbidity is associated with increased Covid-19-related mortality: results from the UK Biobank.","Although obesity, defined by body mass index (BMI), has been associated with a higher risk of hospitalisation and more severe course of illness in Covid-19 positive patients amongst the British population, it is unclear if this translates into increased mortality. Furthermore, given that BMI is an insensitive indicator of adiposity, the effect of adipose volume on Covid-19 outcomes is also unknown. We used the UK Biobank repository, which contains clinical and anthropometric data and is linked t","2021","07","07","BMC Endocr Disord","BMC endocrine disorders","Adiposity; Covid-19; Mortality; Obesity; Adiposity; Aged; Aged, 80 and over; Biological Specimen Banks; Body Mass Index; COVID-19; Cardiometabolic Risk Factors; Cardiovascular Diseases; Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Female; Hospital Mortality; Humans; Male; Metabolic Syndrome; Middle Aged; Morbidity; Mortality; Obesity; Risk Factors; SARS-CoV-2; United Kingdom","Quint","Jennifer K","National Heart and Lung Institute, Imperial College London, 4th Floor, ICTEM Building, 72 Du Cane Road, London, W12 0NN, UK",NA
"967","34217276","10.1186/s12902-021-00805-7","Increasing adiposity and the presence of cardiometabolic morbidity is associated with increased Covid-19-related mortality: results from the UK Biobank.","Although obesity, defined by body mass index (BMI), has been associated with a higher risk of hospitalisation and more severe course of illness in Covid-19 positive patients amongst the British population, it is unclear if this translates into increased mortality. Furthermore, given that BMI is an insensitive indicator of adiposity, the effect of adipose volume on Covid-19 outcomes is also unknown. We used the UK Biobank repository, which contains clinical and anthropometric data and is linked t","2021","07","07","BMC Endocr Disord","BMC endocrine disorders","Adiposity; Covid-19; Mortality; Obesity; Adiposity; Aged; Aged, 80 and over; Biological Specimen Banks; Body Mass Index; COVID-19; Cardiometabolic Risk Factors; Cardiovascular Diseases; Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Female; Hospital Mortality; Humans; Male; Metabolic Syndrome; Middle Aged; Morbidity; Mortality; Obesity; Risk Factors; SARS-CoV-2; United Kingdom","Ware","James S","National Heart and Lung Institute, Imperial College London, 4th Floor, ICTEM Building, 72 Du Cane Road, London, W12 0NN, UK",NA
"968","34217276","10.1186/s12902-021-00805-7","Increasing adiposity and the presence of cardiometabolic morbidity is associated with increased Covid-19-related mortality: results from the UK Biobank.","Although obesity, defined by body mass index (BMI), has been associated with a higher risk of hospitalisation and more severe course of illness in Covid-19 positive patients amongst the British population, it is unclear if this translates into increased mortality. Furthermore, given that BMI is an insensitive indicator of adiposity, the effect of adipose volume on Covid-19 outcomes is also unknown. We used the UK Biobank repository, which contains clinical and anthropometric data and is linked t","2021","07","07","BMC Endocr Disord","BMC endocrine disorders","Adiposity; Covid-19; Mortality; Obesity; Adiposity; Aged; Aged, 80 and over; Biological Specimen Banks; Body Mass Index; COVID-19; Cardiometabolic Risk Factors; Cardiovascular Diseases; Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Female; Hospital Mortality; Humans; Male; Metabolic Syndrome; Middle Aged; Morbidity; Mortality; Obesity; Risk Factors; SARS-CoV-2; United Kingdom","Peters","Nicholas S","National Heart and Lung Institute, Imperial College London, 4th Floor, ICTEM Building, 72 Du Cane Road, London, W12 0NN, UK",NA
"969","34217276","10.1186/s12902-021-00805-7","Increasing adiposity and the presence of cardiometabolic morbidity is associated with increased Covid-19-related mortality: results from the UK Biobank.","Although obesity, defined by body mass index (BMI), has been associated with a higher risk of hospitalisation and more severe course of illness in Covid-19 positive patients amongst the British population, it is unclear if this translates into increased mortality. Furthermore, given that BMI is an insensitive indicator of adiposity, the effect of adipose volume on Covid-19 outcomes is also unknown. We used the UK Biobank repository, which contains clinical and anthropometric data and is linked t","2021","07","07","BMC Endocr Disord","BMC endocrine disorders","Adiposity; Covid-19; Mortality; Obesity; Adiposity; Aged; Aged, 80 and over; Biological Specimen Banks; Body Mass Index; COVID-19; Cardiometabolic Risk Factors; Cardiovascular Diseases; Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Female; Hospital Mortality; Humans; Male; Metabolic Syndrome; Middle Aged; Morbidity; Mortality; Obesity; Risk Factors; SARS-CoV-2; United Kingdom","Ng","Fu Siong","National Heart and Lung Institute, Imperial College London, 4th Floor, ICTEM Building, 72 Du Cane Road, London, W12 0NN, UK. f.ng@imperial.ac","f.ng@imperial.ac.uk"
"970","34217235","10.1186/s12889-021-11384-6","Potentials of community-based early detection of cardiovascular disease risk during the COVID-19 pandemic.","The Coronavirus Disease 2019 (COVID-19) pandemic has led to a significant decline in Non Communicable Diseases (NCD) screening and early detection activities, especially Cardiovascular Disease (CVD). This study aims to assess the potential of community-based self-screening of CVD risk through the mhealth application. This is operational research by actively involving the community to carry out self-screening through the mHealth application. Community health workers were recruited as facilitators","2021","07","08","BMC Public Health","BMC public health","COVID-19; Cardiovascular disease; Community-based; Early detection; Mhealth; COVID-19; Cardiovascular Diseases; Community Health Workers; Humans; Pandemics; SARS-CoV-2","Siregar","Kemal Nazarudin","Department of Biostatistics and Population Studies, Faculty of Public Health, Universitas Indonesia, Depok, Indonesia. nazarudin.kemal51@gmail","nazarudin.kemal51@gmail.com"
"971","34217235","10.1186/s12889-021-11384-6","Potentials of community-based early detection of cardiovascular disease risk during the COVID-19 pandemic.","The Coronavirus Disease 2019 (COVID-19) pandemic has led to a significant decline in Non Communicable Diseases (NCD) screening and early detection activities, especially Cardiovascular Disease (CVD). This study aims to assess the potential of community-based self-screening of CVD risk through the mhealth application. This is operational research by actively involving the community to carry out self-screening through the mHealth application. Community health workers were recruited as facilitators","2021","07","08","BMC Public Health","BMC public health","COVID-19; Cardiovascular disease; Community-based; Early detection; Mhealth; COVID-19; Cardiovascular Diseases; Community Health Workers; Humans; Pandemics; SARS-CoV-2","Kurniawan","Rico","Department of Biostatistics and Population Studies, Faculty of Public Health, Universitas Indonesia, Depok, Indonesia",NA
"972","34217235","10.1186/s12889-021-11384-6","Potentials of community-based early detection of cardiovascular disease risk during the COVID-19 pandemic.","The Coronavirus Disease 2019 (COVID-19) pandemic has led to a significant decline in Non Communicable Diseases (NCD) screening and early detection activities, especially Cardiovascular Disease (CVD). This study aims to assess the potential of community-based self-screening of CVD risk through the mhealth application. This is operational research by actively involving the community to carry out self-screening through the mHealth application. Community health workers were recruited as facilitators","2021","07","08","BMC Public Health","BMC public health","COVID-19; Cardiovascular disease; Community-based; Early detection; Mhealth; COVID-19; Cardiovascular Diseases; Community Health Workers; Humans; Pandemics; SARS-CoV-2","BaharuddinNur","Ryza Jazid","Research Center of Biostatistics and Health Informatics, Faculty of Public Health, Universitas Indonesia, Depok, Indonesia",NA
"973","34217235","10.1186/s12889-021-11384-6","Potentials of community-based early detection of cardiovascular disease risk during the COVID-19 pandemic.","The Coronavirus Disease 2019 (COVID-19) pandemic has led to a significant decline in Non Communicable Diseases (NCD) screening and early detection activities, especially Cardiovascular Disease (CVD). This study aims to assess the potential of community-based self-screening of CVD risk through the mhealth application. This is operational research by actively involving the community to carry out self-screening through the mHealth application. Community health workers were recruited as facilitators","2021","07","08","BMC Public Health","BMC public health","COVID-19; Cardiovascular disease; Community-based; Early detection; Mhealth; COVID-19; Cardiovascular Diseases; Community Health Workers; Humans; Pandemics; SARS-CoV-2","Nuridzin","Dion Zein","Research Center of Biostatistics and Health Informatics, Faculty of Public Health, Universitas Indonesia, Depok, Indonesia",NA
"974","34217235","10.1186/s12889-021-11384-6","Potentials of community-based early detection of cardiovascular disease risk during the COVID-19 pandemic.","The Coronavirus Disease 2019 (COVID-19) pandemic has led to a significant decline in Non Communicable Diseases (NCD) screening and early detection activities, especially Cardiovascular Disease (CVD). This study aims to assess the potential of community-based self-screening of CVD risk through the mhealth application. This is operational research by actively involving the community to carry out self-screening through the mHealth application. Community health workers were recruited as facilitators","2021","07","08","BMC Public Health","BMC public health","COVID-19; Cardiovascular disease; Community-based; Early detection; Mhealth; COVID-19; Cardiovascular Diseases; Community Health Workers; Humans; Pandemics; SARS-CoV-2","Handayani","Yolanda","Health Informatics Research Cluster, Faculty of Public Health, Universitas Indonesia, Depok, Indonesia",NA
"975","34217235","10.1186/s12889-021-11384-6","Potentials of community-based early detection of cardiovascular disease risk during the COVID-19 pandemic.","The Coronavirus Disease 2019 (COVID-19) pandemic has led to a significant decline in Non Communicable Diseases (NCD) screening and early detection activities, especially Cardiovascular Disease (CVD). This study aims to assess the potential of community-based self-screening of CVD risk through the mhealth application. This is operational research by actively involving the community to carry out self-screening through the mHealth application. Community health workers were recruited as facilitators","2021","07","08","BMC Public Health","BMC public health","COVID-19; Cardiovascular disease; Community-based; Early detection; Mhealth; COVID-19; Cardiovascular Diseases; Community Health Workers; Humans; Pandemics; SARS-CoV-2","Retnowati","Research Center of Biostatistics and Health Informatics, Faculty of Public Health, Universitas Indonesia, Depok, Indonesia","Health Informatics Research Cluster, Faculty of Public Health, Universitas Indonesia, Depok, Indonesia","34217235"
"976","34217235","10.1186/s12889-021-11384-6","Potentials of community-based early detection of cardiovascular disease risk during the COVID-19 pandemic.","The Coronavirus Disease 2019 (COVID-19) pandemic has led to a significant decline in Non Communicable Diseases (NCD) screening and early detection activities, especially Cardiovascular Disease (CVD). This study aims to assess the potential of community-based self-screening of CVD risk through the mhealth application. This is operational research by actively involving the community to carry out self-screening through the mHealth application. Community health workers were recruited as facilitators","2021","07","08","BMC Public Health","BMC public health","COVID-19; Cardiovascular disease; Community-based; Early detection; Mhealth; COVID-19; Cardiovascular Diseases; Community Health Workers; Humans; Pandemics; SARS-CoV-2","Rohjayanti","Head of Section of NCD Control Program, District Health Office, Bogor District, Indonesia","Health Informatics Research Cluster, Faculty of Public Health, Universitas Indonesia, Depok, Indonesia","34217235"
"977","34217235","10.1186/s12889-021-11384-6","Potentials of community-based early detection of cardiovascular disease risk during the COVID-19 pandemic.","The Coronavirus Disease 2019 (COVID-19) pandemic has led to a significant decline in Non Communicable Diseases (NCD) screening and early detection activities, especially Cardiovascular Disease (CVD). This study aims to assess the potential of community-based self-screening of CVD risk through the mhealth application. This is operational research by actively involving the community to carry out self-screening through the mHealth application. Community health workers were recruited as facilitators","2021","07","08","BMC Public Health","BMC public health","COVID-19; Cardiovascular disease; Community-based; Early detection; Mhealth; COVID-19; Cardiovascular Diseases; Community Health Workers; Humans; Pandemics; SARS-CoV-2","Halim","Lindawati","Coordinator of Health Centers, Babakan Madang Sub-district, Bogor District, Indonesia",NA
"978","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Xu","Hanmei","Mental Health Center, West China Hospital of Sichuan University, No. 28 South Dianxin Street, Chengdu, 610041, Sichuan, China",NA
"979","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Zhang","Hang","Mental Health Center, West China Hospital of Sichuan University, No. 28 South Dianxin Street, Chengdu, 610041, Sichuan, China",NA
"980","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Huang","Lijuan","Mental Health Center, West China Hospital of Sichuan University, No. 28 South Dianxin Street, Chengdu, 610041, Sichuan, China",NA
"981","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Wang","Xiaolan","Mental Health Center, West China Hospital of Sichuan University, No. 28 South Dianxin Street, Chengdu, 610041, Sichuan, China",NA
"982","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Tang","Xiaowei","Mental Health Center, West China Hospital of Sichuan University, No. 28 South Dianxin Street, Chengdu, 610041, Sichuan, China",NA
"983","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Wang","Yanping","Mental Health Center, West China Hospital of Sichuan University, No. 28 South Dianxin Street, Chengdu, 610041, Sichuan, China",NA
"984","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Xiao","Qingqing","Mental Health Center, West China Hospital of Sichuan University, No. 28 South Dianxin Street, Chengdu, 610041, Sichuan, China",NA
"985","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Xiong","Ping","Chengdu Engineering Technical Vocational School, Chengdu, 610300, Sichuan, China",NA
"986","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Jiang","Rongqiu","Chengdu Vocational &amp",NA
"987","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Zhan","Jie","Xuchuan Middle School, Zigong, 643000, Sichuan, China",NA
"988","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Deng","Fang","The Fourth People's Hospital of Chengdu, Chengdu, 610036, Sichuan, China",NA
"989","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Yu","Mingya","Jiangsu Academy of Educational Sciences, Nanjing, 210013, Jiangsu, China",NA
"990","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Liu","Dong","Wenquan Second Central Primary School, Donghai County, Lianyungang, 222315, Jiangsu, China",NA
"991","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Liu","Xuejun","Jiangsu Shuangdian Primary School, Rudong County, Nantong, 226404, Jiangsu, China",NA
"992","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Zhang","Chunli","The Sixth Middle School of Jianshui County, Honghe Prefecture, Jianshui County, 654300, Yunnan, China",NA
"993","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Wang","Wenjun","Egongyan Primary School, Jiulongpo District, Chongqing, 404000, China",NA
"994","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Li","Lu","The 12th Elementary School of Nanyang City, Nanyang, 473002, Henan, China",NA
"995","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Cao","Hongmei","Hou Central School, Xuzhou, 221000, Jiangsu, China",NA
"996","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Zhang","Wenchao","The primary School Attached to SouthWest University, Chongqing, 400700, China",NA
"997","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Zhou","Hongping","Chengdu Shuangliu Yongan Middle School, Chengdu, 610219, Sichuan, China",NA
"998","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Wang","Wo","University-Town Hospital of Chongqing Medical University, Chongqing, 401331, China",NA
"999","34217234","10.1186/s12888-021-03339-3","Increased symptoms of post-traumatic stress in school students soon after the start of the COVID-19 outbreak in China.","The outbreak of Coronavirus Disease 2019(COVID-19) caused psychological stress in Chinese adults population. But we are unaware of whether the pandemic causes psychological stress on children. We used the Children's Impact of Event Scale questionnaire (CRIES-13) to investigate the degree of Post-traumatic Stress (PTSD) symptoms caused by the pandemic in students selected from schools in Sichuan, Jiangsu, Henan, Yunnan, and Chongqing provinces of China. A total of 7769 students(3692 male and 4077","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; CRIES-13; China; Post-traumatic stress; School students; Stress; Adult; COVID-19; Child; China; Depression; Disease Outbreaks; Female; Humans; Male; SARS-CoV-2; Schools; Stress Disorders, Post-Traumatic; Students; Surveys and Questionnaires","Yin","Li","Mental Health Center, West China Hospital of Sichuan University, No. 28 South Dianxin Street, Chengdu, 610041, Sichuan, China. yli009@163","yli009@163.com"
"1000","34217220","10.1186/s12872-021-02137-9","Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19.","The relative association between cardiovascular (CV) risk factors, such as diabetes and hypertension, established CV disease (CVD), and susceptibility to CV complications or mortality in COVID-19 remains unclear. We conducted a cohort study of consecutive adults hospitalised for severe COVID-19 between 1st March and 30th June 2020. Pre-existing CVD, CV risk factors and associations with mortality and CV complications were ascertained. Among 1721 patients (median age 71 years, 57% male), 349 (20.","2021","07","12","BMC Cardiovasc Disord","BMC cardiovascular disorders","COVID-19; Cardiovascular disease; Cardiovascular risk factors; Diabetes; Hypertension; Age Factors; Aged; COVID-19; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Female; Heart Disease Risk Factors; Hospital Mortality; Humans; Hypertension; Male; Mortality; Outcome and Process Assessment, Health Care; Risk Assessment; SARS-CoV-2; United Kingdom; Venous Thromboembolism","O'Gallagher","Kevin","Department of Cardiology, King's College London British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine and Sciences, London, UK",NA
"1001","34217220","10.1186/s12872-021-02137-9","Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19.","The relative association between cardiovascular (CV) risk factors, such as diabetes and hypertension, established CV disease (CVD), and susceptibility to CV complications or mortality in COVID-19 remains unclear. We conducted a cohort study of consecutive adults hospitalised for severe COVID-19 between 1st March and 30th June 2020. Pre-existing CVD, CV risk factors and associations with mortality and CV complications were ascertained. Among 1721 patients (median age 71 years, 57% male), 349 (20.","2021","07","12","BMC Cardiovasc Disord","BMC cardiovascular disorders","COVID-19; Cardiovascular disease; Cardiovascular risk factors; Diabetes; Hypertension; Age Factors; Aged; COVID-19; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Female; Heart Disease Risk Factors; Hospital Mortality; Humans; Hypertension; Male; Mortality; Outcome and Process Assessment, Health Care; Risk Assessment; SARS-CoV-2; United Kingdom; Venous Thromboembolism","Shek","Anthony","Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK",NA
"1002","34217220","10.1186/s12872-021-02137-9","Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19.","The relative association between cardiovascular (CV) risk factors, such as diabetes and hypertension, established CV disease (CVD), and susceptibility to CV complications or mortality in COVID-19 remains unclear. We conducted a cohort study of consecutive adults hospitalised for severe COVID-19 between 1st March and 30th June 2020. Pre-existing CVD, CV risk factors and associations with mortality and CV complications were ascertained. Among 1721 patients (median age 71 years, 57% male), 349 (20.","2021","07","12","BMC Cardiovasc Disord","BMC cardiovascular disorders","COVID-19; Cardiovascular disease; Cardiovascular risk factors; Diabetes; Hypertension; Age Factors; Aged; COVID-19; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Female; Heart Disease Risk Factors; Hospital Mortality; Humans; Hypertension; Male; Mortality; Outcome and Process Assessment, Health Care; Risk Assessment; SARS-CoV-2; United Kingdom; Venous Thromboembolism","Bean","Daniel M","Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK",NA
"1003","34217220","10.1186/s12872-021-02137-9","Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19.","The relative association between cardiovascular (CV) risk factors, such as diabetes and hypertension, established CV disease (CVD), and susceptibility to CV complications or mortality in COVID-19 remains unclear. We conducted a cohort study of consecutive adults hospitalised for severe COVID-19 between 1st March and 30th June 2020. Pre-existing CVD, CV risk factors and associations with mortality and CV complications were ascertained. Among 1721 patients (median age 71 years, 57% male), 349 (20.","2021","07","12","BMC Cardiovasc Disord","BMC cardiovascular disorders","COVID-19; Cardiovascular disease; Cardiovascular risk factors; Diabetes; Hypertension; Age Factors; Aged; COVID-19; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Female; Heart Disease Risk Factors; Hospital Mortality; Humans; Hypertension; Male; Mortality; Outcome and Process Assessment, Health Care; Risk Assessment; SARS-CoV-2; United Kingdom; Venous Thromboembolism","Bendayan","Rebecca","Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK",NA
"1004","34217220","10.1186/s12872-021-02137-9","Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19.","The relative association between cardiovascular (CV) risk factors, such as diabetes and hypertension, established CV disease (CVD), and susceptibility to CV complications or mortality in COVID-19 remains unclear. We conducted a cohort study of consecutive adults hospitalised for severe COVID-19 between 1st March and 30th June 2020. Pre-existing CVD, CV risk factors and associations with mortality and CV complications were ascertained. Among 1721 patients (median age 71 years, 57% male), 349 (20.","2021","07","12","BMC Cardiovasc Disord","BMC cardiovascular disorders","COVID-19; Cardiovascular disease; Cardiovascular risk factors; Diabetes; Hypertension; Age Factors; Aged; COVID-19; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Female; Heart Disease Risk Factors; Hospital Mortality; Humans; Hypertension; Male; Mortality; Outcome and Process Assessment, Health Care; Risk Assessment; SARS-CoV-2; United Kingdom; Venous Thromboembolism","Papachristidis","Alexandros","King's College Hospital NHS Foundation Trust, London, UK",NA
"1005","34217220","10.1186/s12872-021-02137-9","Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19.","The relative association between cardiovascular (CV) risk factors, such as diabetes and hypertension, established CV disease (CVD), and susceptibility to CV complications or mortality in COVID-19 remains unclear. We conducted a cohort study of consecutive adults hospitalised for severe COVID-19 between 1st March and 30th June 2020. Pre-existing CVD, CV risk factors and associations with mortality and CV complications were ascertained. Among 1721 patients (median age 71 years, 57% male), 349 (20.","2021","07","12","BMC Cardiovasc Disord","BMC cardiovascular disorders","COVID-19; Cardiovascular disease; Cardiovascular risk factors; Diabetes; Hypertension; Age Factors; Aged; COVID-19; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Female; Heart Disease Risk Factors; Hospital Mortality; Humans; Hypertension; Male; Mortality; Outcome and Process Assessment, Health Care; Risk Assessment; SARS-CoV-2; United Kingdom; Venous Thromboembolism","Teo","James T H","King's College Hospital NHS Foundation Trust, London, UK",NA
"1006","34217220","10.1186/s12872-021-02137-9","Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19.","The relative association between cardiovascular (CV) risk factors, such as diabetes and hypertension, established CV disease (CVD), and susceptibility to CV complications or mortality in COVID-19 remains unclear. We conducted a cohort study of consecutive adults hospitalised for severe COVID-19 between 1st March and 30th June 2020. Pre-existing CVD, CV risk factors and associations with mortality and CV complications were ascertained. Among 1721 patients (median age 71 years, 57% male), 349 (20.","2021","07","12","BMC Cardiovasc Disord","BMC cardiovascular disorders","COVID-19; Cardiovascular disease; Cardiovascular risk factors; Diabetes; Hypertension; Age Factors; Aged; COVID-19; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Female; Heart Disease Risk Factors; Hospital Mortality; Humans; Hypertension; Male; Mortality; Outcome and Process Assessment, Health Care; Risk Assessment; SARS-CoV-2; United Kingdom; Venous Thromboembolism","Dobson","Richard J B","Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK",NA
"1007","34217220","10.1186/s12872-021-02137-9","Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19.","The relative association between cardiovascular (CV) risk factors, such as diabetes and hypertension, established CV disease (CVD), and susceptibility to CV complications or mortality in COVID-19 remains unclear. We conducted a cohort study of consecutive adults hospitalised for severe COVID-19 between 1st March and 30th June 2020. Pre-existing CVD, CV risk factors and associations with mortality and CV complications were ascertained. Among 1721 patients (median age 71 years, 57% male), 349 (20.","2021","07","12","BMC Cardiovasc Disord","BMC cardiovascular disorders","COVID-19; Cardiovascular disease; Cardiovascular risk factors; Diabetes; Hypertension; Age Factors; Aged; COVID-19; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Female; Heart Disease Risk Factors; Hospital Mortality; Humans; Hypertension; Male; Mortality; Outcome and Process Assessment, Health Care; Risk Assessment; SARS-CoV-2; United Kingdom; Venous Thromboembolism","Shah","Ajay M","Department of Cardiology, King's College London British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine and Sciences, London, UK. ajay.shah@kcl.ac","ajay.shah@kcl.ac.uk"
"1008","34217220","10.1186/s12872-021-02137-9","Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19.","The relative association between cardiovascular (CV) risk factors, such as diabetes and hypertension, established CV disease (CVD), and susceptibility to CV complications or mortality in COVID-19 remains unclear. We conducted a cohort study of consecutive adults hospitalised for severe COVID-19 between 1st March and 30th June 2020. Pre-existing CVD, CV risk factors and associations with mortality and CV complications were ascertained. Among 1721 patients (median age 71 years, 57% male), 349 (20.","2021","07","12","BMC Cardiovasc Disord","BMC cardiovascular disorders","COVID-19; Cardiovascular disease; Cardiovascular risk factors; Diabetes; Hypertension; Age Factors; Aged; COVID-19; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Female; Heart Disease Risk Factors; Hospital Mortality; Humans; Hypertension; Male; Mortality; Outcome and Process Assessment, Health Care; Risk Assessment; SARS-CoV-2; United Kingdom; Venous Thromboembolism","Zakeri","Rosita","Department of Cardiology, King's College London British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine and Sciences, London, UK. rosita.zakeri@kcl.ac","rosita.zakeri@kcl.ac.uk"
"1009","34217208","10.1186/s12875-021-01469-x","A mixed-methods study describing behavioral factors that influenced general practitioners' experiences using triage during the COVID-19 pandemic.","Early in the COVID-19 pandemic, general practices were asked to expand triage and to reduce unnecessary face-to-face contact by prioritizing other consultation modes, e.g., online messaging, video, or telephone. The current study explores the potential barriers and facilitators general practitioners experienced to expanding triage systems and their attitudes towards triage during the COVID-19 pandemic. A mixed-method study design was used in which a quantitative online survey was conducted along","2021","07","13","BMC Fam Pract","BMC family practice","Digital triage; General practice; Telephone triage; Theoretical domains framework; Triage; Attitude of Health Personnel; COVID-19; Clinical Competence; England; Female; General Practice; General Practitioners; Health Knowledge, Attitudes, Practice; Humans; Infection Control; Male; Practice Patterns, Physicians'; Remote Consultation; Risk Management; SARS-CoV-2; Triage","Lackey","Shaun","Freelance GP and Clinical Director at NHS North Tyneside Clinical Commissioning Group, North Shields, England",NA
"1010","34217208","10.1186/s12875-021-01469-x","A mixed-methods study describing behavioral factors that influenced general practitioners' experiences using triage during the COVID-19 pandemic.","Early in the COVID-19 pandemic, general practices were asked to expand triage and to reduce unnecessary face-to-face contact by prioritizing other consultation modes, e.g., online messaging, video, or telephone. The current study explores the potential barriers and facilitators general practitioners experienced to expanding triage systems and their attitudes towards triage during the COVID-19 pandemic. A mixed-method study design was used in which a quantitative online survey was conducted along","2021","07","13","BMC Fam Pract","BMC family practice","Digital triage; General practice; Telephone triage; Theoretical domains framework; Triage; Attitude of Health Personnel; COVID-19; Clinical Competence; England; Female; General Practice; General Practitioners; Health Knowledge, Attitudes, Practice; Humans; Infection Control; Male; Practice Patterns, Physicians'; Remote Consultation; Risk Management; SARS-CoV-2; Triage","Schmidtke","Kelly Ann","University of Warwick, Medical School Building, Coventry, CV4 7HL, England. Kelly.A.Schmidtke@warwick.ac","Kelly.A.Schmidtke@warwick.ac.uk"
"1011","34217208","10.1186/s12875-021-01469-x","A mixed-methods study describing behavioral factors that influenced general practitioners' experiences using triage during the COVID-19 pandemic.","Early in the COVID-19 pandemic, general practices were asked to expand triage and to reduce unnecessary face-to-face contact by prioritizing other consultation modes, e.g., online messaging, video, or telephone. The current study explores the potential barriers and facilitators general practitioners experienced to expanding triage systems and their attitudes towards triage during the COVID-19 pandemic. A mixed-method study design was used in which a quantitative online survey was conducted along","2021","07","13","BMC Fam Pract","BMC family practice","Digital triage; General practice; Telephone triage; Theoretical domains framework; Triage; Attitude of Health Personnel; COVID-19; Clinical Competence; England; Female; General Practice; General Practitioners; Health Knowledge, Attitudes, Practice; Humans; Infection Control; Male; Practice Patterns, Physicians'; Remote Consultation; Risk Management; SARS-CoV-2; Triage","Vlaev","Ivo","University of Warwick, Business School, Coventry, England",NA
"1012","34217150","10.1002/jcop.22652","Vaccination-hesitancy and vaccination-inequality as challenges in Pakistan's COVID-19 response.","This study explores the mechanism for timely and equitable distribution of coronavirus disease 2019 (COVID-19) vaccination among the various communities in Pakistan. It examines the factors that support and/or impede peoples' access and response towards COVID-19 vaccination in Pakistan. The study uses a literature synthesis approach to examine and analyze the situation of the COVID-19 vaccination in Pakistan. The research results show ""hesitancy"" and ""inequality"" as two fundamental challenges th","2021","07","03","J Community Psychol","Journal of community psychology","COVID-19; Pakistan; hesitancy; inequality; vaccine","Perveen","Shama","Center for Justice and Peacebuilding, Eastern Mennonite University, Harrisonburg, Virginia, USA",NA
"1013","34217150","10.1002/jcop.22652","Vaccination-hesitancy and vaccination-inequality as challenges in Pakistan's COVID-19 response.","This study explores the mechanism for timely and equitable distribution of coronavirus disease 2019 (COVID-19) vaccination among the various communities in Pakistan. It examines the factors that support and/or impede peoples' access and response towards COVID-19 vaccination in Pakistan. The study uses a literature synthesis approach to examine and analyze the situation of the COVID-19 vaccination in Pakistan. The research results show ""hesitancy"" and ""inequality"" as two fundamental challenges th","2021","07","03","J Community Psychol","Journal of community psychology","COVID-19; Pakistan; hesitancy; inequality; vaccine","Akram","Muhammad","Center for Justice and Peacebuilding, Eastern Mennonite University, Harrisonburg, Virginia, USA",NA
"1014","34217150","10.1002/jcop.22652","Vaccination-hesitancy and vaccination-inequality as challenges in Pakistan's COVID-19 response.","This study explores the mechanism for timely and equitable distribution of coronavirus disease 2019 (COVID-19) vaccination among the various communities in Pakistan. It examines the factors that support and/or impede peoples' access and response towards COVID-19 vaccination in Pakistan. The study uses a literature synthesis approach to examine and analyze the situation of the COVID-19 vaccination in Pakistan. The research results show ""hesitancy"" and ""inequality"" as two fundamental challenges th","2021","07","03","J Community Psychol","Journal of community psychology","COVID-19; Pakistan; hesitancy; inequality; vaccine","Nasar","Asim","Azman Hashim International Business School, Universiti Teknologi Malaysia, Kuala Lumpur, Malaysia",NA
"1015","34217150","10.1002/jcop.22652","Vaccination-hesitancy and vaccination-inequality as challenges in Pakistan's COVID-19 response.","This study explores the mechanism for timely and equitable distribution of coronavirus disease 2019 (COVID-19) vaccination among the various communities in Pakistan. It examines the factors that support and/or impede peoples' access and response towards COVID-19 vaccination in Pakistan. The study uses a literature synthesis approach to examine and analyze the situation of the COVID-19 vaccination in Pakistan. The research results show ""hesitancy"" and ""inequality"" as two fundamental challenges th","2021","07","03","J Community Psychol","Journal of community psychology","COVID-19; Pakistan; hesitancy; inequality; vaccine","Arshad-Ayaz","Adeela","Department of Education, Concordia University, Montreal, Quebec, Canada",NA
"1016","34217150","10.1002/jcop.22652","Vaccination-hesitancy and vaccination-inequality as challenges in Pakistan's COVID-19 response.","This study explores the mechanism for timely and equitable distribution of coronavirus disease 2019 (COVID-19) vaccination among the various communities in Pakistan. It examines the factors that support and/or impede peoples' access and response towards COVID-19 vaccination in Pakistan. The study uses a literature synthesis approach to examine and analyze the situation of the COVID-19 vaccination in Pakistan. The research results show ""hesitancy"" and ""inequality"" as two fundamental challenges th","2021","07","03","J Community Psychol","Journal of community psychology","COVID-19; Pakistan; hesitancy; inequality; vaccine","Naseem","Ayaz","Department of Education, Concordia University, Montreal, Quebec, Canada",NA
"1017","34217144","10.1016/j.dsx.2021.102189","""Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis"".","Vitamin-D is an immune-modulator which might be linked to disease severity by SARS-CoV-2. Meta-analysis of RCTs and quasi-experimental studies, evaluating the role of vitamin-D supplementation in COVID patients was done. Total 5 studies (3 RCTs and 2 Quasi-experimental) including n = 467 patients were included. Vitamin D didn't reduce mortality (RR 0.55, 95%CI 0.22 to 1.39, p = 0.21), ICU admission rates (RR 0.20, 95% CI 0.01-4.26, p = 0.3) and need for invasive ventilation (RR 0.24, 95% CI 0.01","2021","07","19","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","COVID pneumonia; COVID-19; SARS-CoV-2; Vitamin-D","Rawat","Dimple","Clinical Epidemiology Unit, All India Institute of Medical Sciences, New Delhi, India. Electronic address: rawat.dimple96@gmail","rawat.dimple96@gmail.com"
"1018","34217144","10.1016/j.dsx.2021.102189","""Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis"".","Vitamin-D is an immune-modulator which might be linked to disease severity by SARS-CoV-2. Meta-analysis of RCTs and quasi-experimental studies, evaluating the role of vitamin-D supplementation in COVID patients was done. Total 5 studies (3 RCTs and 2 Quasi-experimental) including n = 467 patients were included. Vitamin D didn't reduce mortality (RR 0.55, 95%CI 0.22 to 1.39, p = 0.21), ICU admission rates (RR 0.20, 95% CI 0.01-4.26, p = 0.3) and need for invasive ventilation (RR 0.24, 95% CI 0.01","2021","07","19","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","COVID pneumonia; COVID-19; SARS-CoV-2; Vitamin-D","Roy","Avishek","Department of Anaesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, New Delhi, India. Electronic address: roy.avishek1992@gmail","roy.avishek1992@gmail.com"
"1019","34217144","10.1016/j.dsx.2021.102189","""Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis"".","Vitamin-D is an immune-modulator which might be linked to disease severity by SARS-CoV-2. Meta-analysis of RCTs and quasi-experimental studies, evaluating the role of vitamin-D supplementation in COVID patients was done. Total 5 studies (3 RCTs and 2 Quasi-experimental) including n = 467 patients were included. Vitamin D didn't reduce mortality (RR 0.55, 95%CI 0.22 to 1.39, p = 0.21), ICU admission rates (RR 0.20, 95% CI 0.01-4.26, p = 0.3) and need for invasive ventilation (RR 0.24, 95% CI 0.01","2021","07","19","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","COVID pneumonia; COVID-19; SARS-CoV-2; Vitamin-D","Maitra","Souvik","Department of Anaesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, New Delhi, India. Electronic address: souvikmaitra@live","souvikmaitra@live.com"
"1020","34217144","10.1016/j.dsx.2021.102189","""Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis"".","Vitamin-D is an immune-modulator which might be linked to disease severity by SARS-CoV-2. Meta-analysis of RCTs and quasi-experimental studies, evaluating the role of vitamin-D supplementation in COVID patients was done. Total 5 studies (3 RCTs and 2 Quasi-experimental) including n = 467 patients were included. Vitamin D didn't reduce mortality (RR 0.55, 95%CI 0.22 to 1.39, p = 0.21), ICU admission rates (RR 0.20, 95% CI 0.01-4.26, p = 0.3) and need for invasive ventilation (RR 0.24, 95% CI 0.01","2021","07","19","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","COVID pneumonia; COVID-19; SARS-CoV-2; Vitamin-D","Shankar","Vivek","Department of Orthopaedics, All India Institute of Medical Sciences, New Delhi, India. Electronic address: drshankarvivek@gmail","drshankarvivek@gmail.com"
"1021","34217144","10.1016/j.dsx.2021.102189","""Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis"".","Vitamin-D is an immune-modulator which might be linked to disease severity by SARS-CoV-2. Meta-analysis of RCTs and quasi-experimental studies, evaluating the role of vitamin-D supplementation in COVID patients was done. Total 5 studies (3 RCTs and 2 Quasi-experimental) including n = 467 patients were included. Vitamin D didn't reduce mortality (RR 0.55, 95%CI 0.22 to 1.39, p = 0.21), ICU admission rates (RR 0.20, 95% CI 0.01-4.26, p = 0.3) and need for invasive ventilation (RR 0.24, 95% CI 0.01","2021","07","19","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","COVID pneumonia; COVID-19; SARS-CoV-2; Vitamin-D","Khanna","Puneet","Department of Anaesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, New Delhi, India. Electronic address: k.punit@yahoo","k.punit@yahoo.com"
"1022","34217144","10.1016/j.dsx.2021.102189","""Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis"".","Vitamin-D is an immune-modulator which might be linked to disease severity by SARS-CoV-2. Meta-analysis of RCTs and quasi-experimental studies, evaluating the role of vitamin-D supplementation in COVID patients was done. Total 5 studies (3 RCTs and 2 Quasi-experimental) including n = 467 patients were included. Vitamin D didn't reduce mortality (RR 0.55, 95%CI 0.22 to 1.39, p = 0.21), ICU admission rates (RR 0.20, 95% CI 0.01-4.26, p = 0.3) and need for invasive ventilation (RR 0.24, 95% CI 0.01","2021","07","19","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","COVID pneumonia; COVID-19; SARS-CoV-2; Vitamin-D","Baidya","Dalim Kumar","Department of Anaesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, New Delhi, India. Electronic address: dalimkumar.ab8@gmail","dalimkumar.ab8@gmail.com"
"1023","34217143","10.1016/j.dsx.2021.102188","Daily glucose variation influenced by the use of corticosteroids in COVID-19 patients treated in Lima-Peru.","The pandemic has generated the need for COVID-19 patients to be treated as best as possible; however, the effect of these treatments on glycemic control has not yet been taken into account. This article aims to determine whether the daily variation of glucose is influenced by the use of corticosteroids in COVID-19 patients treated in Lima-Peru. A prospective cohort study was undertook, in which glucose was measured four times a day in 53 patients hospitalized due to COVID-19. These values were a","2021","07","07","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","Blood glucose; COVID-19; Dexamethasone; Glycemic variability; Hyperglycemia; Type 2 diabetes mellitus","Cardoza-Jiménez","Kennlly J","Endocrinology Resident Physician - Hospital Nacional Arzobispo Loayza, Lima, Peru. Electronic address: kjossephcj@gmail","kjossephcj@gmail.com"
"1024","34217143","10.1016/j.dsx.2021.102188","Daily glucose variation influenced by the use of corticosteroids in COVID-19 patients treated in Lima-Peru.","The pandemic has generated the need for COVID-19 patients to be treated as best as possible; however, the effect of these treatments on glycemic control has not yet been taken into account. This article aims to determine whether the daily variation of glucose is influenced by the use of corticosteroids in COVID-19 patients treated in Lima-Peru. A prospective cohort study was undertook, in which glucose was measured four times a day in 53 patients hospitalized due to COVID-19. These values were a","2021","07","07","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","Blood glucose; COVID-19; Dexamethasone; Glycemic variability; Hyperglycemia; Type 2 diabetes mellitus","Carranza-Zavala","Blanca","Endocrinology Resident Physician - Hospital Nacional Arzobispo Loayza, Lima, Peru. Electronic address: bcarranza.zavala7034@gmail","bcarranza.zavala7034@gmail.com"
"1025","34217143","10.1016/j.dsx.2021.102188","Daily glucose variation influenced by the use of corticosteroids in COVID-19 patients treated in Lima-Peru.","The pandemic has generated the need for COVID-19 patients to be treated as best as possible; however, the effect of these treatments on glycemic control has not yet been taken into account. This article aims to determine whether the daily variation of glucose is influenced by the use of corticosteroids in COVID-19 patients treated in Lima-Peru. A prospective cohort study was undertook, in which glucose was measured four times a day in 53 patients hospitalized due to COVID-19. These values were a","2021","07","07","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","Blood glucose; COVID-19; Dexamethasone; Glycemic variability; Hyperglycemia; Type 2 diabetes mellitus","Manrique-Franco","Katty","Endocrine Assistant Physician - Hospital Nacional Arzobispo Loayza, Lima, Peru. Electronic address: manrique_fr@yahoo",NA
"1026","34217143","10.1016/j.dsx.2021.102188","Daily glucose variation influenced by the use of corticosteroids in COVID-19 patients treated in Lima-Peru.","The pandemic has generated the need for COVID-19 patients to be treated as best as possible; however, the effect of these treatments on glycemic control has not yet been taken into account. This article aims to determine whether the daily variation of glucose is influenced by the use of corticosteroids in COVID-19 patients treated in Lima-Peru. A prospective cohort study was undertook, in which glucose was measured four times a day in 53 patients hospitalized due to COVID-19. These values were a","2021","07","07","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","Blood glucose; COVID-19; Dexamethasone; Glycemic variability; Hyperglycemia; Type 2 diabetes mellitus","Espinoza-Morales","Frank","Physician Nutrition Specialist - Center for Applied Diabetes Technologies (CAVIMEDIC), Lima, Peru. Electronic address: drespinozamorales@gmail","drespinozamorales@gmail.com"
"1027","34217143","10.1016/j.dsx.2021.102188","Daily glucose variation influenced by the use of corticosteroids in COVID-19 patients treated in Lima-Peru.","The pandemic has generated the need for COVID-19 patients to be treated as best as possible; however, the effect of these treatments on glycemic control has not yet been taken into account. This article aims to determine whether the daily variation of glucose is influenced by the use of corticosteroids in COVID-19 patients treated in Lima-Peru. A prospective cohort study was undertook, in which glucose was measured four times a day in 53 patients hospitalized due to COVID-19. These values were a","2021","07","07","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","Blood glucose; COVID-19; Dexamethasone; Glycemic variability; Hyperglycemia; Type 2 diabetes mellitus","Mejia","Christian R","Translational Medicine Research Center, Norbert Wiener University, Lima, Peru. Electronic address: christian.mejia.md@gmail","christian.mejia.md@gmail.com"
"1028","34217135","10.1016/j.coviro.2021.06.005","Natural killer cells and unconventional T cells in COVID-19.","NK cells and diverse populations of unconventional T cells, such as MAIT cells, <U+03B3>d T cells, invariant NKT cells, and DNT<U+0251>ß cells are important early effector lymphocytes. While some of these cells, such as NK cell and MAIT cells, have well-established roles in antiviral defense, the function of other populations remains more elusive. Here, we summarize and discuss current knowledge on NK cell and unconventional T cell responses to SARS-CoV-2 infection. Also covered is the role of thes","2021","07","12","Curr Opin Virol","Current opinion in virology",NA,"Björkström","Niklas K","Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden",NA
"1029","34217135","10.1016/j.coviro.2021.06.005","Natural killer cells and unconventional T cells in COVID-19.","NK cells and diverse populations of unconventional T cells, such as MAIT cells, <U+03B3>d T cells, invariant NKT cells, and DNT<U+0251>ß cells are important early effector lymphocytes. While some of these cells, such as NK cell and MAIT cells, have well-established roles in antiviral defense, the function of other populations remains more elusive. Here, we summarize and discuss current knowledge on NK cell and unconventional T cell responses to SARS-CoV-2 infection. Also covered is the role of thes","2021","07","12","Curr Opin Virol","Current opinion in virology",NA,"Ponzetta","Andrea","Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden",NA
"1030","34217129","10.1016/j.esmoop.2021.100199","The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.","The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology. This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measu","2021","07","19","ESMO Open","ESMO open","COVID-19; burnout; job performance; oncology professionals; resilience; well-being","Lim","K H J","Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK",NA
"1031","34217129","10.1016/j.esmoop.2021.100199","The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.","The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology. This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measu","2021","07","19","ESMO Open","ESMO open","COVID-19; burnout; job performance; oncology professionals; resilience; well-being","Murali","K","Victorian Clinical Genetics Services, The Royal Children's Hospital, Melbourne, Australia",NA
"1032","34217129","10.1016/j.esmoop.2021.100199","The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.","The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology. This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measu","2021","07","19","ESMO Open","ESMO open","COVID-19; burnout; job performance; oncology professionals; resilience; well-being","Kamposioras","K","Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK",NA
"1033","34217129","10.1016/j.esmoop.2021.100199","The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.","The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology. This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measu","2021","07","19","ESMO Open","ESMO open","COVID-19; burnout; job performance; oncology professionals; resilience; well-being","Punie","K","Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium",NA
"1034","34217129","10.1016/j.esmoop.2021.100199","The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.","The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology. This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measu","2021","07","19","ESMO Open","ESMO open","COVID-19; burnout; job performance; oncology professionals; resilience; well-being","Oing","C","Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, Mildred Scheel Cancer Career Centre HaTriCs4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"1035","34217129","10.1016/j.esmoop.2021.100199","The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.","The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology. This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measu","2021","07","19","ESMO Open","ESMO open","COVID-19; burnout; job performance; oncology professionals; resilience; well-being","O'Connor","M","University Hospital Waterford, Waterford, Ireland",NA
"1036","34217129","10.1016/j.esmoop.2021.100199","The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.","The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology. This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measu","2021","07","19","ESMO Open","ESMO open","COVID-19; burnout; job performance; oncology professionals; resilience; well-being","Thorne","E","Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK",NA
"1037","34217129","10.1016/j.esmoop.2021.100199","The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.","The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology. This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measu","2021","07","19","ESMO Open","ESMO open","COVID-19; burnout; job performance; oncology professionals; resilience; well-being","Amaral","T","Department of Dermatology, University Hospital Tübingen, Tübingen, Germany",NA
"1038","34217129","10.1016/j.esmoop.2021.100199","The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.","The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology. This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measu","2021","07","19","ESMO Open","ESMO open","COVID-19; burnout; job performance; oncology professionals; resilience; well-being","Garrido","P","Medical Oncology, Hospital Ramón y Cajal, IRYCIS, Alcalá University, Madrid, Spain",NA
"1039","34217129","10.1016/j.esmoop.2021.100199","The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.","The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology. This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measu","2021","07","19","ESMO Open","ESMO open","COVID-19; burnout; job performance; oncology professionals; resilience; well-being","Lambertini","M","Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy",NA
"1040","34217129","10.1016/j.esmoop.2021.100199","The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.","The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology. This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measu","2021","07","19","ESMO Open","ESMO open","COVID-19; burnout; job performance; oncology professionals; resilience; well-being","Devnani","B","Department of Radiotherapy and Oncology, All India Institute of Medical Sciences, Jodhpur, India",NA
"1041","34217129","10.1016/j.esmoop.2021.100199","The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.","The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology. This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measu","2021","07","19","ESMO Open","ESMO open","COVID-19; burnout; job performance; oncology professionals; resilience; well-being","Westphalen","C B","Department of Internal Medicine III, University Hospital, LMU Munich and Comprehensive Cancer Center, Munich, Germany",NA
"1042","34217129","10.1016/j.esmoop.2021.100199","The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.","The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology. This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measu","2021","07","19","ESMO Open","ESMO open","COVID-19; burnout; job performance; oncology professionals; resilience; well-being","Morgan","G","Department of Medical and Radiation Oncology, Skåne University Hospital, Lund, Sweden",NA
"1043","34217129","10.1016/j.esmoop.2021.100199","The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.","The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology. This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measu","2021","07","19","ESMO Open","ESMO open","COVID-19; burnout; job performance; oncology professionals; resilience; well-being","Haanen","J B A G","Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands",NA
"1044","34217129","10.1016/j.esmoop.2021.100199","The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.","The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology. This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measu","2021","07","19","ESMO Open","ESMO open","COVID-19; burnout; job performance; oncology professionals; resilience; well-being","Hardy","C","Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK",NA
"1045","34217129","10.1016/j.esmoop.2021.100199","The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.","The COVID-19 pandemic has resulted in significant changes to professional and personal lives of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration aimed to provide contemporaneous reports on the impact of COVID-19 on the lived experiences and well-being in oncology. This online anonymous survey (July-August 2020) is the second of a series of global surveys launched during the course of the pandemic. Longitudinal key outcome measu","2021","07","19","ESMO Open","ESMO open","COVID-19; burnout; job performance; oncology professionals; resilience; well-being","Banerjee","S","Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London, UK","susana.banerjee@rmh.nhs.uk"
"1046","34217126","10.1016/j.mehy.2021.110638","Carpal, cubital or tarsal tunnel syndrome after SARS-CoV-2 infection: A causal link?","COVID-19 is a complex disease with many clinicopathological issues, including respiratory, gastrointestinal, neurological, renal, cutaneous, and coagulative ones; in addition, reactive arthritis has been reported by different authors. Here, we hypothesize that a peripheral microangiopathy involving nerve supply, a viral demyelination, or an immune-mediated irritating antigenic stimulus on synovial sheaths after SARS-CoV-2 infection may all induce a carpal, cubital or tarsal tunnel syndrome of va","2021","07","19","Med Hypotheses","Medical hypotheses","Carpal tunnel syndrome; Coronavirus disease 2019 (COVID-19); Cubital tunnel syndrome; Histopathology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Tarsal tunnel syndrome","Roncati","Luca","Institute of Pathology, University of Modena and Reggio Emilia, Modena, Italy. Electronic address: luca.roncati@unimore","luca.roncati@unimore.it"
"1047","34217126","10.1016/j.mehy.2021.110638","Carpal, cubital or tarsal tunnel syndrome after SARS-CoV-2 infection: A causal link?","COVID-19 is a complex disease with many clinicopathological issues, including respiratory, gastrointestinal, neurological, renal, cutaneous, and coagulative ones; in addition, reactive arthritis has been reported by different authors. Here, we hypothesize that a peripheral microangiopathy involving nerve supply, a viral demyelination, or an immune-mediated irritating antigenic stimulus on synovial sheaths after SARS-CoV-2 infection may all induce a carpal, cubital or tarsal tunnel syndrome of va","2021","07","19","Med Hypotheses","Medical hypotheses","Carpal tunnel syndrome; Coronavirus disease 2019 (COVID-19); Cubital tunnel syndrome; Histopathology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Tarsal tunnel syndrome","Gianotti","Greta","Institute of Pathology, University of Modena and Reggio Emilia, Modena, Italy",NA
"1048","34217126","10.1016/j.mehy.2021.110638","Carpal, cubital or tarsal tunnel syndrome after SARS-CoV-2 infection: A causal link?","COVID-19 is a complex disease with many clinicopathological issues, including respiratory, gastrointestinal, neurological, renal, cutaneous, and coagulative ones; in addition, reactive arthritis has been reported by different authors. Here, we hypothesize that a peripheral microangiopathy involving nerve supply, a viral demyelination, or an immune-mediated irritating antigenic stimulus on synovial sheaths after SARS-CoV-2 infection may all induce a carpal, cubital or tarsal tunnel syndrome of va","2021","07","19","Med Hypotheses","Medical hypotheses","Carpal tunnel syndrome; Coronavirus disease 2019 (COVID-19); Cubital tunnel syndrome; Histopathology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Tarsal tunnel syndrome","Gravina","Davide","Unit of Orthopedics and Traumatology, University Hospital of Modena, Modena, Italy",NA
"1049","34217126","10.1016/j.mehy.2021.110638","Carpal, cubital or tarsal tunnel syndrome after SARS-CoV-2 infection: A causal link?","COVID-19 is a complex disease with many clinicopathological issues, including respiratory, gastrointestinal, neurological, renal, cutaneous, and coagulative ones; in addition, reactive arthritis has been reported by different authors. Here, we hypothesize that a peripheral microangiopathy involving nerve supply, a viral demyelination, or an immune-mediated irritating antigenic stimulus on synovial sheaths after SARS-CoV-2 infection may all induce a carpal, cubital or tarsal tunnel syndrome of va","2021","07","19","Med Hypotheses","Medical hypotheses","Carpal tunnel syndrome; Coronavirus disease 2019 (COVID-19); Cubital tunnel syndrome; Histopathology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Tarsal tunnel syndrome","Attolini","Giovanna","Institute of Pathology, University of Modena and Reggio Emilia, Modena, Italy",NA
"1050","34217126","10.1016/j.mehy.2021.110638","Carpal, cubital or tarsal tunnel syndrome after SARS-CoV-2 infection: A causal link?","COVID-19 is a complex disease with many clinicopathological issues, including respiratory, gastrointestinal, neurological, renal, cutaneous, and coagulative ones; in addition, reactive arthritis has been reported by different authors. Here, we hypothesize that a peripheral microangiopathy involving nerve supply, a viral demyelination, or an immune-mediated irritating antigenic stimulus on synovial sheaths after SARS-CoV-2 infection may all induce a carpal, cubital or tarsal tunnel syndrome of va","2021","07","19","Med Hypotheses","Medical hypotheses","Carpal tunnel syndrome; Coronavirus disease 2019 (COVID-19); Cubital tunnel syndrome; Histopathology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Tarsal tunnel syndrome","Zanelli","Giuliana","Institute of Pathology, University of Modena and Reggio Emilia, Modena, Italy",NA
"1051","34217126","10.1016/j.mehy.2021.110638","Carpal, cubital or tarsal tunnel syndrome after SARS-CoV-2 infection: A causal link?","COVID-19 is a complex disease with many clinicopathological issues, including respiratory, gastrointestinal, neurological, renal, cutaneous, and coagulative ones; in addition, reactive arthritis has been reported by different authors. Here, we hypothesize that a peripheral microangiopathy involving nerve supply, a viral demyelination, or an immune-mediated irritating antigenic stimulus on synovial sheaths after SARS-CoV-2 infection may all induce a carpal, cubital or tarsal tunnel syndrome of va","2021","07","19","Med Hypotheses","Medical hypotheses","Carpal tunnel syndrome; Coronavirus disease 2019 (COVID-19); Cubital tunnel syndrome; Histopathology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Tarsal tunnel syndrome","Rosa","Norman Della","Unit of Hand Surgery and Microsurgery, University Hospital of Modena, Modena, Italy",NA
"1052","34217126","10.1016/j.mehy.2021.110638","Carpal, cubital or tarsal tunnel syndrome after SARS-CoV-2 infection: A causal link?","COVID-19 is a complex disease with many clinicopathological issues, including respiratory, gastrointestinal, neurological, renal, cutaneous, and coagulative ones; in addition, reactive arthritis has been reported by different authors. Here, we hypothesize that a peripheral microangiopathy involving nerve supply, a viral demyelination, or an immune-mediated irritating antigenic stimulus on synovial sheaths after SARS-CoV-2 infection may all induce a carpal, cubital or tarsal tunnel syndrome of va","2021","07","19","Med Hypotheses","Medical hypotheses","Carpal tunnel syndrome; Coronavirus disease 2019 (COVID-19); Cubital tunnel syndrome; Histopathology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Tarsal tunnel syndrome","Adani","Roberto","Unit of Hand Surgery and Microsurgery, University Hospital of Modena, Modena, Italy",NA
"1053","34217121","10.1016/j.placenta.2021.06.007","Evaluation of vertical transmission of SARS-CoV-2 in utero: Nine pregnant women and their newborns.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly transmitted by droplets and close contact, has caused a pandemic worldwide as of March 2020. According to the current case reports and cohort studies, the symptoms of pregnant women infected with SARS-CoV-2 were similar to normal adults and may cause a series of adverse consequences of pregnancy (placental abruption, fetal distress, epilepsy during pregnancy, etc.). However, whether SARS-CoV-2 can be transmitted to the fetus th","2021","07","21","Placenta","Placenta","COVID-19; Placenta infection; SARS-CoV-2; Targeted receptor protein expression; Vertical transmission","Dong","Liang","Hunan Engineering Research Center of Gynecology Disease, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, China",NA
"1054","34217121","10.1016/j.placenta.2021.06.007","Evaluation of vertical transmission of SARS-CoV-2 in utero: Nine pregnant women and their newborns.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly transmitted by droplets and close contact, has caused a pandemic worldwide as of March 2020. According to the current case reports and cohort studies, the symptoms of pregnant women infected with SARS-CoV-2 were similar to normal adults and may cause a series of adverse consequences of pregnancy (placental abruption, fetal distress, epilepsy during pregnancy, etc.). However, whether SARS-CoV-2 can be transmitted to the fetus th","2021","07","21","Placenta","Placenta","COVID-19; Placenta infection; SARS-CoV-2; Targeted receptor protein expression; Vertical transmission","Pei","Shiyao","Hunan Engineering Research Center of Gynecology Disease, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, China",NA
"1055","34217121","10.1016/j.placenta.2021.06.007","Evaluation of vertical transmission of SARS-CoV-2 in utero: Nine pregnant women and their newborns.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly transmitted by droplets and close contact, has caused a pandemic worldwide as of March 2020. According to the current case reports and cohort studies, the symptoms of pregnant women infected with SARS-CoV-2 were similar to normal adults and may cause a series of adverse consequences of pregnancy (placental abruption, fetal distress, epilepsy during pregnancy, etc.). However, whether SARS-CoV-2 can be transmitted to the fetus th","2021","07","21","Placenta","Placenta","COVID-19; Placenta infection; SARS-CoV-2; Targeted receptor protein expression; Vertical transmission","Ren","Qin","Hunan Engineering Research Center of Gynecology Disease, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, China",NA
"1056","34217121","10.1016/j.placenta.2021.06.007","Evaluation of vertical transmission of SARS-CoV-2 in utero: Nine pregnant women and their newborns.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly transmitted by droplets and close contact, has caused a pandemic worldwide as of March 2020. According to the current case reports and cohort studies, the symptoms of pregnant women infected with SARS-CoV-2 were similar to normal adults and may cause a series of adverse consequences of pregnancy (placental abruption, fetal distress, epilepsy during pregnancy, etc.). However, whether SARS-CoV-2 can be transmitted to the fetus th","2021","07","21","Placenta","Placenta","COVID-19; Placenta infection; SARS-CoV-2; Targeted receptor protein expression; Vertical transmission","Fu","Shuxiang","Hunan Yuantai Biotechnology Co.Ltd, Changsha, Hunan Province, 410013, China",NA
"1057","34217121","10.1016/j.placenta.2021.06.007","Evaluation of vertical transmission of SARS-CoV-2 in utero: Nine pregnant women and their newborns.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly transmitted by droplets and close contact, has caused a pandemic worldwide as of March 2020. According to the current case reports and cohort studies, the symptoms of pregnant women infected with SARS-CoV-2 were similar to normal adults and may cause a series of adverse consequences of pregnancy (placental abruption, fetal distress, epilepsy during pregnancy, etc.). However, whether SARS-CoV-2 can be transmitted to the fetus th","2021","07","21","Placenta","Placenta","COVID-19; Placenta infection; SARS-CoV-2; Targeted receptor protein expression; Vertical transmission","Yu","Liang","Hunan Yuantai Biotechnology Co.Ltd, Changsha, Hunan Province, 410013, China",NA
"1058","34217121","10.1016/j.placenta.2021.06.007","Evaluation of vertical transmission of SARS-CoV-2 in utero: Nine pregnant women and their newborns.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly transmitted by droplets and close contact, has caused a pandemic worldwide as of March 2020. According to the current case reports and cohort studies, the symptoms of pregnant women infected with SARS-CoV-2 were similar to normal adults and may cause a series of adverse consequences of pregnancy (placental abruption, fetal distress, epilepsy during pregnancy, etc.). However, whether SARS-CoV-2 can be transmitted to the fetus th","2021","07","21","Placenta","Placenta","COVID-19; Placenta infection; SARS-CoV-2; Targeted receptor protein expression; Vertical transmission","Chen","Hui","Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430022, China. Electronic address: chinachen67@hust.edu","chinachen67@hust.edu.cn"
"1059","34217121","10.1016/j.placenta.2021.06.007","Evaluation of vertical transmission of SARS-CoV-2 in utero: Nine pregnant women and their newborns.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly transmitted by droplets and close contact, has caused a pandemic worldwide as of March 2020. According to the current case reports and cohort studies, the symptoms of pregnant women infected with SARS-CoV-2 were similar to normal adults and may cause a series of adverse consequences of pregnancy (placental abruption, fetal distress, epilepsy during pregnancy, etc.). However, whether SARS-CoV-2 can be transmitted to the fetus th","2021","07","21","Placenta","Placenta","COVID-19; Placenta infection; SARS-CoV-2; Targeted receptor protein expression; Vertical transmission","Chen","Xiang","Hunan Engineering Research Center of Gynecology Disease, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, China","chenxiangck@126.com"
"1060","34217121","10.1016/j.placenta.2021.06.007","Evaluation of vertical transmission of SARS-CoV-2 in utero: Nine pregnant women and their newborns.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly transmitted by droplets and close contact, has caused a pandemic worldwide as of March 2020. According to the current case reports and cohort studies, the symptoms of pregnant women infected with SARS-CoV-2 were similar to normal adults and may cause a series of adverse consequences of pregnancy (placental abruption, fetal distress, epilepsy during pregnancy, etc.). However, whether SARS-CoV-2 can be transmitted to the fetus th","2021","07","21","Placenta","Placenta","COVID-19; Placenta infection; SARS-CoV-2; Targeted receptor protein expression; Vertical transmission","Yin","Mingzhu","Hunan Engineering Research Center of Gynecology Disease, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, China","yinmingzhu2008@126.com"
"1061","34217111","10.1016/j.diagmicrobio.2021.115426","The challenge of COVID-19 for a Clinical Microbiology Department.","To quantify the workload and cost overload that the COVID-19 pandemic has meant for a Clinical Microbiology laboratory in a real-life scenario. We compared the number of samples received, their distribution, the human resources, and the budget of a Microbiology laboratory in the COVID pandemic (March-December 2020) with the same months of the previous year. the total number of samples processed in the Clinical Microbiology laboratory in March to December 2020 increased 96.70% with respect to 201","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Clinical Microbiology Department; Cost; Laboratory workload; PCR; SARS CoV-2","Catalán","Pilar","Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain",NA
"1062","34217111","10.1016/j.diagmicrobio.2021.115426","The challenge of COVID-19 for a Clinical Microbiology Department.","To quantify the workload and cost overload that the COVID-19 pandemic has meant for a Clinical Microbiology laboratory in a real-life scenario. We compared the number of samples received, their distribution, the human resources, and the budget of a Microbiology laboratory in the COVID pandemic (March-December 2020) with the same months of the previous year. the total number of samples processed in the Clinical Microbiology laboratory in March to December 2020 increased 96.70% with respect to 201","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Clinical Microbiology Department; Cost; Laboratory workload; PCR; SARS CoV-2","Alonso","Roberto","Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain","roberto.alonso@salud.madrid.org"
"1063","34217111","10.1016/j.diagmicrobio.2021.115426","The challenge of COVID-19 for a Clinical Microbiology Department.","To quantify the workload and cost overload that the COVID-19 pandemic has meant for a Clinical Microbiology laboratory in a real-life scenario. We compared the number of samples received, their distribution, the human resources, and the budget of a Microbiology laboratory in the COVID pandemic (March-December 2020) with the same months of the previous year. the total number of samples processed in the Clinical Microbiology laboratory in March to December 2020 increased 96.70% with respect to 201","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Clinical Microbiology Department; Cost; Laboratory workload; PCR; SARS CoV-2","Alcalá","Luís","Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain",NA
"1064","34217111","10.1016/j.diagmicrobio.2021.115426","The challenge of COVID-19 for a Clinical Microbiology Department.","To quantify the workload and cost overload that the COVID-19 pandemic has meant for a Clinical Microbiology laboratory in a real-life scenario. We compared the number of samples received, their distribution, the human resources, and the budget of a Microbiology laboratory in the COVID pandemic (March-December 2020) with the same months of the previous year. the total number of samples processed in the Clinical Microbiology laboratory in March to December 2020 increased 96.70% with respect to 201","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Clinical Microbiology Department; Cost; Laboratory workload; PCR; SARS CoV-2","Marín","Mercedes","Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain",NA
"1065","34217111","10.1016/j.diagmicrobio.2021.115426","The challenge of COVID-19 for a Clinical Microbiology Department.","To quantify the workload and cost overload that the COVID-19 pandemic has meant for a Clinical Microbiology laboratory in a real-life scenario. We compared the number of samples received, their distribution, the human resources, and the budget of a Microbiology laboratory in the COVID pandemic (March-December 2020) with the same months of the previous year. the total number of samples processed in the Clinical Microbiology laboratory in March to December 2020 increased 96.70% with respect to 201","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Clinical Microbiology Department; Cost; Laboratory workload; PCR; SARS CoV-2","Moure","Zaira","Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain",NA
"1066","34217111","10.1016/j.diagmicrobio.2021.115426","The challenge of COVID-19 for a Clinical Microbiology Department.","To quantify the workload and cost overload that the COVID-19 pandemic has meant for a Clinical Microbiology laboratory in a real-life scenario. We compared the number of samples received, their distribution, the human resources, and the budget of a Microbiology laboratory in the COVID pandemic (March-December 2020) with the same months of the previous year. the total number of samples processed in the Clinical Microbiology laboratory in March to December 2020 increased 96.70% with respect to 201","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Clinical Microbiology Department; Cost; Laboratory workload; PCR; SARS CoV-2","Pescador","Paula","Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain",NA
"1067","34217111","10.1016/j.diagmicrobio.2021.115426","The challenge of COVID-19 for a Clinical Microbiology Department.","To quantify the workload and cost overload that the COVID-19 pandemic has meant for a Clinical Microbiology laboratory in a real-life scenario. We compared the number of samples received, their distribution, the human resources, and the budget of a Microbiology laboratory in the COVID pandemic (March-December 2020) with the same months of the previous year. the total number of samples processed in the Clinical Microbiology laboratory in March to December 2020 increased 96.70% with respect to 201","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Clinical Microbiology Department; Cost; Laboratory workload; PCR; SARS CoV-2","Bouza","Emilio","Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain",NA
"1068","34217111","10.1016/j.diagmicrobio.2021.115426","The challenge of COVID-19 for a Clinical Microbiology Department.","To quantify the workload and cost overload that the COVID-19 pandemic has meant for a Clinical Microbiology laboratory in a real-life scenario. We compared the number of samples received, their distribution, the human resources, and the budget of a Microbiology laboratory in the COVID pandemic (March-December 2020) with the same months of the previous year. the total number of samples processed in the Clinical Microbiology laboratory in March to December 2020 increased 96.70% with respect to 201","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Clinical Microbiology Department; Cost; Laboratory workload; PCR; SARS CoV-2","Muñoz","Patricia","Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain",NA
"1069","34217106","10.1016/j.aprim.2021.102127","Rapid antigen tests for the detection of SARS-CoV-2: A narrative review.","The rapid identificationand isolation of COVID-19 patients has become the cornerstone for the control of the recent outbreak. Real-time quantitative polymerase chain reaction is routinely used to confirm COVID-19 diagnosis and is considered the gold standard due to high sensitivity and specificity. Nevertheless, it usually takes several days and a relatively higher cost. Antigen tests based have emerged to cope with such disadvantages, by offering rapid results, an easy-to-use procedure, and low","2021","07","23","Aten Primaria","Atencion primaria","Antigen test; COVID-19; Centró de atención médica; Diagnosis; Diagnóstico; Point-of-care; Rapid; Rápido; SARS-CoV-2; Test de antígenos","Aguilar-Shea","Antonio L","Centro de Salud Puerta de Madrid, Atención Primaria de Madrid, Spain","antonio.aguilar@salud.madrid.org"
"1070","34217106","10.1016/j.aprim.2021.102127","Rapid antigen tests for the detection of SARS-CoV-2: A narrative review.","The rapid identificationand isolation of COVID-19 patients has become the cornerstone for the control of the recent outbreak. Real-time quantitative polymerase chain reaction is routinely used to confirm COVID-19 diagnosis and is considered the gold standard due to high sensitivity and specificity. Nevertheless, it usually takes several days and a relatively higher cost. Antigen tests based have emerged to cope with such disadvantages, by offering rapid results, an easy-to-use procedure, and low","2021","07","23","Aten Primaria","Atencion primaria","Antigen test; COVID-19; Centró de atención médica; Diagnosis; Diagnóstico; Point-of-care; Rapid; Rápido; SARS-CoV-2; Test de antígenos","Vera-García","Mar","Centro Sanitario Sandoval, Calle de Sandoval, 7, 28010 Madrid, Spain",NA
"1071","34217106","10.1016/j.aprim.2021.102127","Rapid antigen tests for the detection of SARS-CoV-2: A narrative review.","The rapid identificationand isolation of COVID-19 patients has become the cornerstone for the control of the recent outbreak. Real-time quantitative polymerase chain reaction is routinely used to confirm COVID-19 diagnosis and is considered the gold standard due to high sensitivity and specificity. Nevertheless, it usually takes several days and a relatively higher cost. Antigen tests based have emerged to cope with such disadvantages, by offering rapid results, an easy-to-use procedure, and low","2021","07","23","Aten Primaria","Atencion primaria","Antigen test; COVID-19; Centró de atención médica; Diagnosis; Diagnóstico; Point-of-care; Rapid; Rápido; SARS-CoV-2; Test de antígenos","Güerri-Fernández","Robert","Hospital del Mar - Parc de Salut MAR, Paseo Marítimo de la Barceloneta, 25-29, 08003 Barcelona, Spain",NA
"1072","34217101","10.1016/j.psychres.2021.114071","100 Years apart: Psychiatric admissions during Spanish flu and COVID-19 pandemic.","The last pandemic comparable to the current COVID-19 pandemic was the Spanish flu. Using the admission record books for the years 1917 and 1918 and electronic health records for the years 2019 and 2020, we extracted the relevant data and explored how they affected the numbers of emergency psychiatric admissions. The general trend in both pandemics was that they did not cause a rise in psychiatric admissions, findings which go along with reports around Europe. The causes for these similarities ar","2021","07","23","Psychiatry Res","Psychiatry research","COVID-19; Emergency admissions; Influenza; Mental health; Psychiatry; SARS-CoV-2; Spanish flu","Vukojevic","Jaka","University psychiatric hospital Vrapce, Zagreb, Croatia. Electronic address: jaksa.vukojevic@bolnica-vrapce",NA
"1073","34217101","10.1016/j.psychres.2021.114071","100 Years apart: Psychiatric admissions during Spanish flu and COVID-19 pandemic.","The last pandemic comparable to the current COVID-19 pandemic was the Spanish flu. Using the admission record books for the years 1917 and 1918 and electronic health records for the years 2019 and 2020, we extracted the relevant data and explored how they affected the numbers of emergency psychiatric admissions. The general trend in both pandemics was that they did not cause a rise in psychiatric admissions, findings which go along with reports around Europe. The causes for these similarities ar","2021","07","23","Psychiatry Res","Psychiatry research","COVID-19; Emergency admissions; Influenza; Mental health; Psychiatry; SARS-CoV-2; Spanish flu","Ðuran","Nataa","University psychiatric hospital Vrapce, Zagreb, Croatia",NA
"1074","34217101","10.1016/j.psychres.2021.114071","100 Years apart: Psychiatric admissions during Spanish flu and COVID-19 pandemic.","The last pandemic comparable to the current COVID-19 pandemic was the Spanish flu. Using the admission record books for the years 1917 and 1918 and electronic health records for the years 2019 and 2020, we extracted the relevant data and explored how they affected the numbers of emergency psychiatric admissions. The general trend in both pandemics was that they did not cause a rise in psychiatric admissions, findings which go along with reports around Europe. The causes for these similarities ar","2021","07","23","Psychiatry Res","Psychiatry research","COVID-19; Emergency admissions; Influenza; Mental health; Psychiatry; SARS-CoV-2; Spanish flu","aja","Nikola","University psychiatric hospital Vrapce, Zagreb, Croatia",NA
"1075","34217101","10.1016/j.psychres.2021.114071","100 Years apart: Psychiatric admissions during Spanish flu and COVID-19 pandemic.","The last pandemic comparable to the current COVID-19 pandemic was the Spanish flu. Using the admission record books for the years 1917 and 1918 and electronic health records for the years 2019 and 2020, we extracted the relevant data and explored how they affected the numbers of emergency psychiatric admissions. The general trend in both pandemics was that they did not cause a rise in psychiatric admissions, findings which go along with reports around Europe. The causes for these similarities ar","2021","07","23","Psychiatry Res","Psychiatry research","COVID-19; Emergency admissions; Influenza; Mental health; Psychiatry; SARS-CoV-2; Spanish flu","Suac","Jelena","University psychiatric hospital Vrapce, Zagreb, Croatia",NA
"1076","34217101","10.1016/j.psychres.2021.114071","100 Years apart: Psychiatric admissions during Spanish flu and COVID-19 pandemic.","The last pandemic comparable to the current COVID-19 pandemic was the Spanish flu. Using the admission record books for the years 1917 and 1918 and electronic health records for the years 2019 and 2020, we extracted the relevant data and explored how they affected the numbers of emergency psychiatric admissions. The general trend in both pandemics was that they did not cause a rise in psychiatric admissions, findings which go along with reports around Europe. The causes for these similarities ar","2021","07","23","Psychiatry Res","Psychiatry research","COVID-19; Emergency admissions; Influenza; Mental health; Psychiatry; SARS-CoV-2; Spanish flu","ekerija","Mario","Croatian Institute of Public Health, Zagreb, Croatia",NA
"1077","34217101","10.1016/j.psychres.2021.114071","100 Years apart: Psychiatric admissions during Spanish flu and COVID-19 pandemic.","The last pandemic comparable to the current COVID-19 pandemic was the Spanish flu. Using the admission record books for the years 1917 and 1918 and electronic health records for the years 2019 and 2020, we extracted the relevant data and explored how they affected the numbers of emergency psychiatric admissions. The general trend in both pandemics was that they did not cause a rise in psychiatric admissions, findings which go along with reports around Europe. The causes for these similarities ar","2021","07","23","Psychiatry Res","Psychiatry research","COVID-19; Emergency admissions; Influenza; Mental health; Psychiatry; SARS-CoV-2; Spanish flu","Savic","Aleksandar","University psychiatric hospital Vrapce, Zagreb, Croatia",NA
"1078","34217100","10.1016/j.psychres.2021.114070","Mental health issues and health disparities amid COVID-19 outbreak in China: Comparison of residents inside and outside the epicenter.","The Coronavirus Disease-2019 (COVID-19) has exerted an impact on not only individuals who have contracted the virus but also the general public. This study compared the mental health condition of residents in the epicenter province of Hubei with that of other Chinese residents during the initial stage of the COVID-19 outbreak, and to examine emerging issues revolving around health disparities in disease prevention. A survey was administered in February 2020 to 433 Chinese adults spanning 28 regi","2021","07","23","Psychiatry Res","Psychiatry research","Coronavirus disease; Epidemic; Pandemic; Preventive measure; Psychological well-being","Cheng","Cecilia","Department of Psychology, The University of Hong Kong, Pokfulam, Hong Kong. Electronic address: ceccheng@hku","ceccheng@hku.hk"
"1079","34217100","10.1016/j.psychres.2021.114070","Mental health issues and health disparities amid COVID-19 outbreak in China: Comparison of residents inside and outside the epicenter.","The Coronavirus Disease-2019 (COVID-19) has exerted an impact on not only individuals who have contracted the virus but also the general public. This study compared the mental health condition of residents in the epicenter province of Hubei with that of other Chinese residents during the initial stage of the COVID-19 outbreak, and to examine emerging issues revolving around health disparities in disease prevention. A survey was administered in February 2020 to 433 Chinese adults spanning 28 regi","2021","07","23","Psychiatry Res","Psychiatry research","Coronavirus disease; Epidemic; Pandemic; Preventive measure; Psychological well-being","Wang","Hsin-Yi","Department of Psychology, The University of Hong Kong, Pokfulam, Hong Kong",NA
"1080","34217100","10.1016/j.psychres.2021.114070","Mental health issues and health disparities amid COVID-19 outbreak in China: Comparison of residents inside and outside the epicenter.","The Coronavirus Disease-2019 (COVID-19) has exerted an impact on not only individuals who have contracted the virus but also the general public. This study compared the mental health condition of residents in the epicenter province of Hubei with that of other Chinese residents during the initial stage of the COVID-19 outbreak, and to examine emerging issues revolving around health disparities in disease prevention. A survey was administered in February 2020 to 433 Chinese adults spanning 28 regi","2021","07","23","Psychiatry Res","Psychiatry research","Coronavirus disease; Epidemic; Pandemic; Preventive measure; Psychological well-being","Chau","Chor-Lam","Department of Psychology, The University of Hong Kong, Pokfulam, Hong Kong",NA
"1081","34217071","10.1016/j.jstrokecerebrovasdis.2021.105915","COVID-19 Encephalitis with SARS-CoV-2 Detected in Cerebrospinal Fluid Presenting as a Stroke Mimic.","We report the case of a 35-year-old male with COVID-19 encephalitis presenting as a stroke mimic with sudden-onset expressive and receptive dysphasia, mild confusion and right arm incoordination. The patient received thrombolysis for a suspected ischaemic stroke, but later became febrile and SARS-CoV-2 was detected in cerebrospinal fluid. Electroencephalography demonstrated excess in slow waves, but neuroimaging was reported as normal. Respiratory symptoms were absent throughout and nasopharynge","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","COVID-19; Encephalitis; SARS-Cov-2; Stroke mimic","Glavin","Diarmuid","Department of Stroke Medicine, South West Acute Hospital, Enniskillen, Northern Ireland, UK",NA
"1082","34217071","10.1016/j.jstrokecerebrovasdis.2021.105915","COVID-19 Encephalitis with SARS-CoV-2 Detected in Cerebrospinal Fluid Presenting as a Stroke Mimic.","We report the case of a 35-year-old male with COVID-19 encephalitis presenting as a stroke mimic with sudden-onset expressive and receptive dysphasia, mild confusion and right arm incoordination. The patient received thrombolysis for a suspected ischaemic stroke, but later became febrile and SARS-CoV-2 was detected in cerebrospinal fluid. Electroencephalography demonstrated excess in slow waves, but neuroimaging was reported as normal. Respiratory symptoms were absent throughout and nasopharynge","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","COVID-19; Encephalitis; SARS-Cov-2; Stroke mimic","Kelly","Denise","Department of Stroke Medicine, South West Acute Hospital, Enniskillen, Northern Ireland, UK",NA
"1083","34217071","10.1016/j.jstrokecerebrovasdis.2021.105915","COVID-19 Encephalitis with SARS-CoV-2 Detected in Cerebrospinal Fluid Presenting as a Stroke Mimic.","We report the case of a 35-year-old male with COVID-19 encephalitis presenting as a stroke mimic with sudden-onset expressive and receptive dysphasia, mild confusion and right arm incoordination. The patient received thrombolysis for a suspected ischaemic stroke, but later became febrile and SARS-CoV-2 was detected in cerebrospinal fluid. Electroencephalography demonstrated excess in slow waves, but neuroimaging was reported as normal. Respiratory symptoms were absent throughout and nasopharynge","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","COVID-19; Encephalitis; SARS-Cov-2; Stroke mimic","Wood","Greta Karen","Department of Clinical Infection Microbiology and Immunology, Institute of Infection, Veterinary, and Ecological Science, Liverpool, UK",NA
"1084","34217071","10.1016/j.jstrokecerebrovasdis.2021.105915","COVID-19 Encephalitis with SARS-CoV-2 Detected in Cerebrospinal Fluid Presenting as a Stroke Mimic.","We report the case of a 35-year-old male with COVID-19 encephalitis presenting as a stroke mimic with sudden-onset expressive and receptive dysphasia, mild confusion and right arm incoordination. The patient received thrombolysis for a suspected ischaemic stroke, but later became febrile and SARS-CoV-2 was detected in cerebrospinal fluid. Electroencephalography demonstrated excess in slow waves, but neuroimaging was reported as normal. Respiratory symptoms were absent throughout and nasopharynge","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","COVID-19; Encephalitis; SARS-Cov-2; Stroke mimic","McCausland","Beth Ms","Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, UK",NA
"1085","34217071","10.1016/j.jstrokecerebrovasdis.2021.105915","COVID-19 Encephalitis with SARS-CoV-2 Detected in Cerebrospinal Fluid Presenting as a Stroke Mimic.","We report the case of a 35-year-old male with COVID-19 encephalitis presenting as a stroke mimic with sudden-onset expressive and receptive dysphasia, mild confusion and right arm incoordination. The patient received thrombolysis for a suspected ischaemic stroke, but later became febrile and SARS-CoV-2 was detected in cerebrospinal fluid. Electroencephalography demonstrated excess in slow waves, but neuroimaging was reported as normal. Respiratory symptoms were absent throughout and nasopharynge","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","COVID-19; Encephalitis; SARS-Cov-2; Stroke mimic","Ellul","Mark Alexander","Department of Clinical Infection Microbiology and Immunology, Institute of Infection, Veterinary, and Ecological Science, Liverpool, UK",NA
"1086","34217071","10.1016/j.jstrokecerebrovasdis.2021.105915","COVID-19 Encephalitis with SARS-CoV-2 Detected in Cerebrospinal Fluid Presenting as a Stroke Mimic.","We report the case of a 35-year-old male with COVID-19 encephalitis presenting as a stroke mimic with sudden-onset expressive and receptive dysphasia, mild confusion and right arm incoordination. The patient received thrombolysis for a suspected ischaemic stroke, but later became febrile and SARS-CoV-2 was detected in cerebrospinal fluid. Electroencephalography demonstrated excess in slow waves, but neuroimaging was reported as normal. Respiratory symptoms were absent throughout and nasopharynge","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","COVID-19; Encephalitis; SARS-Cov-2; Stroke mimic","Varatharaj","Aravinthan","Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, UK",NA
"1087","34217071","10.1016/j.jstrokecerebrovasdis.2021.105915","COVID-19 Encephalitis with SARS-CoV-2 Detected in Cerebrospinal Fluid Presenting as a Stroke Mimic.","We report the case of a 35-year-old male with COVID-19 encephalitis presenting as a stroke mimic with sudden-onset expressive and receptive dysphasia, mild confusion and right arm incoordination. The patient received thrombolysis for a suspected ischaemic stroke, but later became febrile and SARS-CoV-2 was detected in cerebrospinal fluid. Electroencephalography demonstrated excess in slow waves, but neuroimaging was reported as normal. Respiratory symptoms were absent throughout and nasopharynge","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","COVID-19; Encephalitis; SARS-Cov-2; Stroke mimic","Galea","Ian","Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, UK",NA
"1088","34217071","10.1016/j.jstrokecerebrovasdis.2021.105915","COVID-19 Encephalitis with SARS-CoV-2 Detected in Cerebrospinal Fluid Presenting as a Stroke Mimic.","We report the case of a 35-year-old male with COVID-19 encephalitis presenting as a stroke mimic with sudden-onset expressive and receptive dysphasia, mild confusion and right arm incoordination. The patient received thrombolysis for a suspected ischaemic stroke, but later became febrile and SARS-CoV-2 was detected in cerebrospinal fluid. Electroencephalography demonstrated excess in slow waves, but neuroimaging was reported as normal. Respiratory symptoms were absent throughout and nasopharynge","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","COVID-19; Encephalitis; SARS-Cov-2; Stroke mimic","Thomas","Rhys Huw","Translational and Clinical Research Institute, Newcastle University, Newcastle, UK",NA
"1089","34217071","10.1016/j.jstrokecerebrovasdis.2021.105915","COVID-19 Encephalitis with SARS-CoV-2 Detected in Cerebrospinal Fluid Presenting as a Stroke Mimic.","We report the case of a 35-year-old male with COVID-19 encephalitis presenting as a stroke mimic with sudden-onset expressive and receptive dysphasia, mild confusion and right arm incoordination. The patient received thrombolysis for a suspected ischaemic stroke, but later became febrile and SARS-CoV-2 was detected in cerebrospinal fluid. Electroencephalography demonstrated excess in slow waves, but neuroimaging was reported as normal. Respiratory symptoms were absent throughout and nasopharynge","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","COVID-19; Encephalitis; SARS-Cov-2; Stroke mimic","Michael","Benedict Daniel","Department of Clinical Infection Microbiology and Immunology, Institute of Infection, Veterinary, and Ecological Science, Liverpool, UK",NA
"1090","34217071","10.1016/j.jstrokecerebrovasdis.2021.105915","COVID-19 Encephalitis with SARS-CoV-2 Detected in Cerebrospinal Fluid Presenting as a Stroke Mimic.","We report the case of a 35-year-old male with COVID-19 encephalitis presenting as a stroke mimic with sudden-onset expressive and receptive dysphasia, mild confusion and right arm incoordination. The patient received thrombolysis for a suspected ischaemic stroke, but later became febrile and SARS-CoV-2 was detected in cerebrospinal fluid. Electroencephalography demonstrated excess in slow waves, but neuroimaging was reported as normal. Respiratory symptoms were absent throughout and nasopharynge","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","COVID-19; Encephalitis; SARS-Cov-2; Stroke mimic","Gallen","Brian","Department of Stroke Medicine, South West Acute Hospital, Enniskillen, Northern Ireland, UK. Electronic address: brian.gallen@westerntrust.hscni","brian.gallen@westerntrust.hscni.net"
"1091","34217004","10.1016/j.cellimm.2021.104398","An outlook on antigen-specific adoptive immunotherapy for viral infections with a focus on COVID-19.","Although not a standard-of-care yet, adoptive immunotherapeutic approaches have gradually earned a place within the list of antiviral therapies for some of fatal and hard-to-treat viral diseases. To maintain robust antiviral immunity and to effectively target the viral particles and virally-infected cells, immune cells capable of recognizing the viral antigens are required. While conventional vaccination can induce these cells in vivo; another option is to prime and generate antigen-specific imm","2021","07","20","Cell Immunol","Cellular immunology","Adoptive immunotherapy; Antigen-specific immune cells; COVID-19; SARS-CoV-2; Virus diseases","Monzavi","Seyed Mostafa","Gene Therapy Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran",NA
"1092","34217004","10.1016/j.cellimm.2021.104398","An outlook on antigen-specific adoptive immunotherapy for viral infections with a focus on COVID-19.","Although not a standard-of-care yet, adoptive immunotherapeutic approaches have gradually earned a place within the list of antiviral therapies for some of fatal and hard-to-treat viral diseases. To maintain robust antiviral immunity and to effectively target the viral particles and virally-infected cells, immune cells capable of recognizing the viral antigens are required. While conventional vaccination can induce these cells in vivo; another option is to prime and generate antigen-specific imm","2021","07","20","Cell Immunol","Cellular immunology","Adoptive immunotherapy; Antigen-specific immune cells; COVID-19; SARS-CoV-2; Virus diseases","Naderi","Mahmood","Gene Therapy Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran",NA
"1093","34217004","10.1016/j.cellimm.2021.104398","An outlook on antigen-specific adoptive immunotherapy for viral infections with a focus on COVID-19.","Although not a standard-of-care yet, adoptive immunotherapeutic approaches have gradually earned a place within the list of antiviral therapies for some of fatal and hard-to-treat viral diseases. To maintain robust antiviral immunity and to effectively target the viral particles and virally-infected cells, immune cells capable of recognizing the viral antigens are required. While conventional vaccination can induce these cells in vivo; another option is to prime and generate antigen-specific imm","2021","07","20","Cell Immunol","Cellular immunology","Adoptive immunotherapy; Antigen-specific immune cells; COVID-19; SARS-CoV-2; Virus diseases","Ahmadbeigi","Naser","Gene Therapy Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran",NA
"1094","34217004","10.1016/j.cellimm.2021.104398","An outlook on antigen-specific adoptive immunotherapy for viral infections with a focus on COVID-19.","Although not a standard-of-care yet, adoptive immunotherapeutic approaches have gradually earned a place within the list of antiviral therapies for some of fatal and hard-to-treat viral diseases. To maintain robust antiviral immunity and to effectively target the viral particles and virally-infected cells, immune cells capable of recognizing the viral antigens are required. While conventional vaccination can induce these cells in vivo; another option is to prime and generate antigen-specific imm","2021","07","20","Cell Immunol","Cellular immunology","Adoptive immunotherapy; Antigen-specific immune cells; COVID-19; SARS-CoV-2; Virus diseases","Kajbafzadeh","Abdol-Mohammad","Pediatric Urology and Regenerative Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran","kajbafzd@tums.ac.ir"
"1095","34217004","10.1016/j.cellimm.2021.104398","An outlook on antigen-specific adoptive immunotherapy for viral infections with a focus on COVID-19.","Although not a standard-of-care yet, adoptive immunotherapeutic approaches have gradually earned a place within the list of antiviral therapies for some of fatal and hard-to-treat viral diseases. To maintain robust antiviral immunity and to effectively target the viral particles and virally-infected cells, immune cells capable of recognizing the viral antigens are required. While conventional vaccination can induce these cells in vivo; another option is to prime and generate antigen-specific imm","2021","07","20","Cell Immunol","Cellular immunology","Adoptive immunotherapy; Antigen-specific immune cells; COVID-19; SARS-CoV-2; Virus diseases","Muhammadnejad","Samad","Gene Therapy Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: smuhammadnejad@gmail","smuhammadnejad@gmail.com"
"1096","34216998","10.1016/j.msard.2021.103104","Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.","When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity and risk factors of the more severe COVID-19 course among MS and NMOSD patients. From March 1, 2020, to February 28, 2021, 12 MS centres, representing 70% of the Czech MS and NMOSD population, reported laboratory-confirmed COVID-19 cases via the Czech nationwid","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","B-cell depleting therapies; COVID-19; Disease-modifying therapies; Multiple sclerosis; Neuromyelitis optica spectrum disorder","Stastna","Dominika","Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia",NA
"1097","34216998","10.1016/j.msard.2021.103104","Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.","When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity and risk factors of the more severe COVID-19 course among MS and NMOSD patients. From March 1, 2020, to February 28, 2021, 12 MS centres, representing 70% of the Czech MS and NMOSD population, reported laboratory-confirmed COVID-19 cases via the Czech nationwid","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","B-cell depleting therapies; COVID-19; Disease-modifying therapies; Multiple sclerosis; Neuromyelitis optica spectrum disorder","Menkyova","Ingrid","Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia",NA
"1098","34216998","10.1016/j.msard.2021.103104","Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.","When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity and risk factors of the more severe COVID-19 course among MS and NMOSD patients. From March 1, 2020, to February 28, 2021, 12 MS centres, representing 70% of the Czech MS and NMOSD population, reported laboratory-confirmed COVID-19 cases via the Czech nationwid","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","B-cell depleting therapies; COVID-19; Disease-modifying therapies; Multiple sclerosis; Neuromyelitis optica spectrum disorder","Drahota","Jiri","Endowment Fund IMPULS, Prague, Czechia",NA
"1099","34216998","10.1016/j.msard.2021.103104","Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.","When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity and risk factors of the more severe COVID-19 course among MS and NMOSD patients. From March 1, 2020, to February 28, 2021, 12 MS centres, representing 70% of the Czech MS and NMOSD population, reported laboratory-confirmed COVID-19 cases via the Czech nationwid","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","B-cell depleting therapies; COVID-19; Disease-modifying therapies; Multiple sclerosis; Neuromyelitis optica spectrum disorder","Mazouchova","Aneta","Endowment Fund IMPULS, Prague, Czechia",NA
"1100","34216998","10.1016/j.msard.2021.103104","Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.","When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity and risk factors of the more severe COVID-19 course among MS and NMOSD patients. From March 1, 2020, to February 28, 2021, 12 MS centres, representing 70% of the Czech MS and NMOSD population, reported laboratory-confirmed COVID-19 cases via the Czech nationwid","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","B-cell depleting therapies; COVID-19; Disease-modifying therapies; Multiple sclerosis; Neuromyelitis optica spectrum disorder","Adamkova","Jana","Department of Neurology, Hospital Ceske Budejovice, Ceske Budejovice, Czechia",NA
"1101","34216998","10.1016/j.msard.2021.103104","Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.","When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity and risk factors of the more severe COVID-19 course among MS and NMOSD patients. From March 1, 2020, to February 28, 2021, 12 MS centres, representing 70% of the Czech MS and NMOSD population, reported laboratory-confirmed COVID-19 cases via the Czech nationwid","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","B-cell depleting therapies; COVID-19; Disease-modifying therapies; Multiple sclerosis; Neuromyelitis optica spectrum disorder","Ampapa","Radek","Department of Neurology, Hospital of Jihlava, Jihlava, Czechia",NA
"1102","34216998","10.1016/j.msard.2021.103104","Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.","When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity and risk factors of the more severe COVID-19 course among MS and NMOSD patients. From March 1, 2020, to February 28, 2021, 12 MS centres, representing 70% of the Czech MS and NMOSD population, reported laboratory-confirmed COVID-19 cases via the Czech nationwid","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","B-cell depleting therapies; COVID-19; Disease-modifying therapies; Multiple sclerosis; Neuromyelitis optica spectrum disorder","Grunermelova","Marketa","Department of Neurology, Thomayer Hospital, Prague, Czechia",NA
"1103","34216998","10.1016/j.msard.2021.103104","Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.","When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity and risk factors of the more severe COVID-19 course among MS and NMOSD patients. From March 1, 2020, to February 28, 2021, 12 MS centres, representing 70% of the Czech MS and NMOSD population, reported laboratory-confirmed COVID-19 cases via the Czech nationwid","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","B-cell depleting therapies; COVID-19; Disease-modifying therapies; Multiple sclerosis; Neuromyelitis optica spectrum disorder","Peterka","Marek","Department of Neurology, Charles University in Prague, Faculty of Medicine in Pilsen and University Hospital Pilsen, Pilsen, Czechia",NA
"1104","34216998","10.1016/j.msard.2021.103104","Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.","When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity and risk factors of the more severe COVID-19 course among MS and NMOSD patients. From March 1, 2020, to February 28, 2021, 12 MS centres, representing 70% of the Czech MS and NMOSD population, reported laboratory-confirmed COVID-19 cases via the Czech nationwid","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","B-cell depleting therapies; COVID-19; Disease-modifying therapies; Multiple sclerosis; Neuromyelitis optica spectrum disorder","Recmanova","Eva","Department of Neurology, Tomas Bata Regional Hospital, Zlin, Czechia",NA
"1105","34216998","10.1016/j.msard.2021.103104","Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.","When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity and risk factors of the more severe COVID-19 course among MS and NMOSD patients. From March 1, 2020, to February 28, 2021, 12 MS centres, representing 70% of the Czech MS and NMOSD population, reported laboratory-confirmed COVID-19 cases via the Czech nationwid","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","B-cell depleting therapies; COVID-19; Disease-modifying therapies; Multiple sclerosis; Neuromyelitis optica spectrum disorder","Rockova","Petra","Department of Neurology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czechia",NA
"1106","34216998","10.1016/j.msard.2021.103104","Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.","When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity and risk factors of the more severe COVID-19 course among MS and NMOSD patients. From March 1, 2020, to February 28, 2021, 12 MS centres, representing 70% of the Czech MS and NMOSD population, reported laboratory-confirmed COVID-19 cases via the Czech nationwid","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","B-cell depleting therapies; COVID-19; Disease-modifying therapies; Multiple sclerosis; Neuromyelitis optica spectrum disorder","Rous","Matous","Department of Neurology, Faculty of Medicine, Palacky University and University Hospital Olomouc, Olomouc, Czechia",NA
"1107","34216998","10.1016/j.msard.2021.103104","Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.","When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity and risk factors of the more severe COVID-19 course among MS and NMOSD patients. From March 1, 2020, to February 28, 2021, 12 MS centres, representing 70% of the Czech MS and NMOSD population, reported laboratory-confirmed COVID-19 cases via the Czech nationwid","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","B-cell depleting therapies; COVID-19; Disease-modifying therapies; Multiple sclerosis; Neuromyelitis optica spectrum disorder","Stetkarova","Ivana","Charles University in Prague, Third Faculty of Medicine, Charles University and Hospital Kralovske Vinohrady, Prague, Czechia",NA
"1108","34216998","10.1016/j.msard.2021.103104","Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.","When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity and risk factors of the more severe COVID-19 course among MS and NMOSD patients. From March 1, 2020, to February 28, 2021, 12 MS centres, representing 70% of the Czech MS and NMOSD population, reported laboratory-confirmed COVID-19 cases via the Czech nationwid","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","B-cell depleting therapies; COVID-19; Disease-modifying therapies; Multiple sclerosis; Neuromyelitis optica spectrum disorder","Valis","Martin","Department of Neurology, Charles University in Prague, Faculty of Medicine and University Hospital Hradec Kralove, Hradec Kralove, Czechia",NA
"1109","34216998","10.1016/j.msard.2021.103104","Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.","When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity and risk factors of the more severe COVID-19 course among MS and NMOSD patients. From March 1, 2020, to February 28, 2021, 12 MS centres, representing 70% of the Czech MS and NMOSD population, reported laboratory-confirmed COVID-19 cases via the Czech nationwid","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","B-cell depleting therapies; COVID-19; Disease-modifying therapies; Multiple sclerosis; Neuromyelitis optica spectrum disorder","Vachova","Marta","Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia",NA
"1110","34216998","10.1016/j.msard.2021.103104","Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.","When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity and risk factors of the more severe COVID-19 course among MS and NMOSD patients. From March 1, 2020, to February 28, 2021, 12 MS centres, representing 70% of the Czech MS and NMOSD population, reported laboratory-confirmed COVID-19 cases via the Czech nationwid","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","B-cell depleting therapies; COVID-19; Disease-modifying therapies; Multiple sclerosis; Neuromyelitis optica spectrum disorder","Woznicova","Ivana","Department of Neurology, University Hospital Ostrava, Ostrava, Czechia",NA
"1111","34216998","10.1016/j.msard.2021.103104","Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.","When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity and risk factors of the more severe COVID-19 course among MS and NMOSD patients. From March 1, 2020, to February 28, 2021, 12 MS centres, representing 70% of the Czech MS and NMOSD population, reported laboratory-confirmed COVID-19 cases via the Czech nationwid","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","B-cell depleting therapies; COVID-19; Disease-modifying therapies; Multiple sclerosis; Neuromyelitis optica spectrum disorder","Horakova","Dana","Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia. Electronic address: dana.horakova@vfn","dana.horakova@vfn.cz"
"1112","34216996","10.1016/j.msard.2021.103113","Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine.","Considering the potential COVID-19 impact on pwMS health and the importance of vaccination for this population, we decided to assess: (a) pwMS' beliefs and knowledge on COVID-19 pandemic; (b) their acceptance towards COVID-19 vaccination and (c) pwMS' opinions on general vaccination. Observational study, based on a cross-sectional (10-20<sup>th</sup> September 2020) online survey, conducted in a cohort of pwMS' followed at two Portuguese hospitals. The survey included measures to characterize th","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","COVID-19 pandemic; multiple sclerosis; opinions; questionnaire; vaccines","Moniz Dionísio","Joana","Neurology Departments of the Hospital Prof. Doutor Fernando Fonseca. Electronic address: joana.dionisio@hff.min-saude","joana.dionisio@hff.min"
"1113","34216996","10.1016/j.msard.2021.103113","Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine.","Considering the potential COVID-19 impact on pwMS health and the importance of vaccination for this population, we decided to assess: (a) pwMS' beliefs and knowledge on COVID-19 pandemic; (b) their acceptance towards COVID-19 vaccination and (c) pwMS' opinions on general vaccination. Observational study, based on a cross-sectional (10-20<sup>th</sup> September 2020) online survey, conducted in a cohort of pwMS' followed at two Portuguese hospitals. The survey included measures to characterize th","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","COVID-19 pandemic; multiple sclerosis; opinions; questionnaire; vaccines","Santos","Mariana","Neurology Departments of the Hospital Prof. Doutor Fernando Fonseca",NA
"1114","34216996","10.1016/j.msard.2021.103113","Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine.","Considering the potential COVID-19 impact on pwMS health and the importance of vaccination for this population, we decided to assess: (a) pwMS' beliefs and knowledge on COVID-19 pandemic; (b) their acceptance towards COVID-19 vaccination and (c) pwMS' opinions on general vaccination. Observational study, based on a cross-sectional (10-20<sup>th</sup> September 2020) online survey, conducted in a cohort of pwMS' followed at two Portuguese hospitals. The survey included measures to characterize th","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","COVID-19 pandemic; multiple sclerosis; opinions; questionnaire; vaccines","Rodrigues","Ana Martins","Hospital Beatriz Ângelo",NA
"1115","34216996","10.1016/j.msard.2021.103113","Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine.","Considering the potential COVID-19 impact on pwMS health and the importance of vaccination for this population, we decided to assess: (a) pwMS' beliefs and knowledge on COVID-19 pandemic; (b) their acceptance towards COVID-19 vaccination and (c) pwMS' opinions on general vaccination. Observational study, based on a cross-sectional (10-20<sup>th</sup> September 2020) online survey, conducted in a cohort of pwMS' followed at two Portuguese hospitals. The survey included measures to characterize th","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","COVID-19 pandemic; multiple sclerosis; opinions; questionnaire; vaccines","Rêgo","André","Neurology Departments of the Hospital Prof. Doutor Fernando Fonseca",NA
"1116","34216996","10.1016/j.msard.2021.103113","Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine.","Considering the potential COVID-19 impact on pwMS health and the importance of vaccination for this population, we decided to assess: (a) pwMS' beliefs and knowledge on COVID-19 pandemic; (b) their acceptance towards COVID-19 vaccination and (c) pwMS' opinions on general vaccination. Observational study, based on a cross-sectional (10-20<sup>th</sup> September 2020) online survey, conducted in a cohort of pwMS' followed at two Portuguese hospitals. The survey included measures to characterize th","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","COVID-19 pandemic; multiple sclerosis; opinions; questionnaire; vaccines","Vítor","Joana","Hospital Beatriz Ângelo",NA
"1117","34216996","10.1016/j.msard.2021.103113","Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine.","Considering the potential COVID-19 impact on pwMS health and the importance of vaccination for this population, we decided to assess: (a) pwMS' beliefs and knowledge on COVID-19 pandemic; (b) their acceptance towards COVID-19 vaccination and (c) pwMS' opinions on general vaccination. Observational study, based on a cross-sectional (10-20<sup>th</sup> September 2020) online survey, conducted in a cohort of pwMS' followed at two Portuguese hospitals. The survey included measures to characterize th","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","COVID-19 pandemic; multiple sclerosis; opinions; questionnaire; vaccines","Delgado","Sofia","Neurology Departments of the Hospital Prof. Doutor Fernando Fonseca",NA
"1118","34216996","10.1016/j.msard.2021.103113","Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine.","Considering the potential COVID-19 impact on pwMS health and the importance of vaccination for this population, we decided to assess: (a) pwMS' beliefs and knowledge on COVID-19 pandemic; (b) their acceptance towards COVID-19 vaccination and (c) pwMS' opinions on general vaccination. Observational study, based on a cross-sectional (10-20<sup>th</sup> September 2020) online survey, conducted in a cohort of pwMS' followed at two Portuguese hospitals. The survey included measures to characterize th","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","COVID-19 pandemic; multiple sclerosis; opinions; questionnaire; vaccines","Pinheiro","Rita","Neurology Departments of the Hospital Prof. Doutor Fernando Fonseca",NA
"1119","34216996","10.1016/j.msard.2021.103113","Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine.","Considering the potential COVID-19 impact on pwMS health and the importance of vaccination for this population, we decided to assess: (a) pwMS' beliefs and knowledge on COVID-19 pandemic; (b) their acceptance towards COVID-19 vaccination and (c) pwMS' opinions on general vaccination. Observational study, based on a cross-sectional (10-20<sup>th</sup> September 2020) online survey, conducted in a cohort of pwMS' followed at two Portuguese hospitals. The survey included measures to characterize th","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","COVID-19 pandemic; multiple sclerosis; opinions; questionnaire; vaccines","Neves","Pedro","Neurology Departments of the Hospital Prof. Doutor Fernando Fonseca",NA
"1120","34216996","10.1016/j.msard.2021.103113","Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine.","Considering the potential COVID-19 impact on pwMS health and the importance of vaccination for this population, we decided to assess: (a) pwMS' beliefs and knowledge on COVID-19 pandemic; (b) their acceptance towards COVID-19 vaccination and (c) pwMS' opinions on general vaccination. Observational study, based on a cross-sectional (10-20<sup>th</sup> September 2020) online survey, conducted in a cohort of pwMS' followed at two Portuguese hospitals. The survey included measures to characterize th","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","COVID-19 pandemic; multiple sclerosis; opinions; questionnaire; vaccines","Figueiredo","Carlos","Neurology Departments of the Hospital Prof. Doutor Fernando Fonseca",NA
"1121","34216996","10.1016/j.msard.2021.103113","Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine.","Considering the potential COVID-19 impact on pwMS health and the importance of vaccination for this population, we decided to assess: (a) pwMS' beliefs and knowledge on COVID-19 pandemic; (b) their acceptance towards COVID-19 vaccination and (c) pwMS' opinions on general vaccination. Observational study, based on a cross-sectional (10-20<sup>th</sup> September 2020) online survey, conducted in a cohort of pwMS' followed at two Portuguese hospitals. The survey included measures to characterize th","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","COVID-19 pandemic; multiple sclerosis; opinions; questionnaire; vaccines","Costa","José Bandeira","Neurology Departments of the Hospital Prof. Doutor Fernando Fonseca",NA
"1122","34216996","10.1016/j.msard.2021.103113","Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine.","Considering the potential COVID-19 impact on pwMS health and the importance of vaccination for this population, we decided to assess: (a) pwMS' beliefs and knowledge on COVID-19 pandemic; (b) their acceptance towards COVID-19 vaccination and (c) pwMS' opinions on general vaccination. Observational study, based on a cross-sectional (10-20<sup>th</sup> September 2020) online survey, conducted in a cohort of pwMS' followed at two Portuguese hospitals. The survey included measures to characterize th","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","COVID-19 pandemic; multiple sclerosis; opinions; questionnaire; vaccines","Vale","José","Hospital Beatriz Ângelo",NA
"1123","34216996","10.1016/j.msard.2021.103113","Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine.","Considering the potential COVID-19 impact on pwMS health and the importance of vaccination for this population, we decided to assess: (a) pwMS' beliefs and knowledge on COVID-19 pandemic; (b) their acceptance towards COVID-19 vaccination and (c) pwMS' opinions on general vaccination. Observational study, based on a cross-sectional (10-20<sup>th</sup> September 2020) online survey, conducted in a cohort of pwMS' followed at two Portuguese hospitals. The survey included measures to characterize th","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","COVID-19 pandemic; multiple sclerosis; opinions; questionnaire; vaccines","Salgado","Vasco","Neurology Departments of the Hospital Prof. Doutor Fernando Fonseca",NA
"1124","34216996","10.1016/j.msard.2021.103113","Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine.","Considering the potential COVID-19 impact on pwMS health and the importance of vaccination for this population, we decided to assess: (a) pwMS' beliefs and knowledge on COVID-19 pandemic; (b) their acceptance towards COVID-19 vaccination and (c) pwMS' opinions on general vaccination. Observational study, based on a cross-sectional (10-20<sup>th</sup> September 2020) online survey, conducted in a cohort of pwMS' followed at two Portuguese hospitals. The survey included measures to characterize th","2021","07","23","Mult Scler Relat Disord","Multiple sclerosis and related disorders","COVID-19 pandemic; multiple sclerosis; opinions; questionnaire; vaccines","Timóteo","Ângela","Hospital Beatriz Ângelo",NA
"1125","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","Charlie-Silva","Ives","Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil",NA
"1126","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","Araújo","Amanda P C","Post-graduation Program in Biotechnology and Biodiversity, Goiano Federal Institution and Federal University of Goiás, GO, Brazil",NA
"1127","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","Guimarães","Abraão T B","Post-graduation Program in Biotechnology and Biodiversity, Goiano Federal Institution and Federal University of Goiás, GO, Brazil",NA
"1128","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","Veras","Flávio P","Center of Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil",NA
"1129","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","Braz","Helyson L B","Postgraduate Program in Morphological Science, Department of Morphology, School of Medicine, Federal University of Ceara, Delmiro de Farias St., 60.430-170 Fortaleza, CE, Brazil",NA
"1130","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","de Pontes","Letícia G","Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil",NA
"1131","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","Jorge","Roberta J B","Department of Physiology and Pharmacology, School of Medicine, Federal University of Ceara, Coronel Nunes de Melo St., 1127, 60.430-275 Fortaleza, CE, Brazil",NA
"1132","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","Belo","Marco A A","Laboratory of Animal Pharmacology and Toxicology, Brazil University, Descalvado, SP, Brazil",NA
"1133","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","Fernandes","Bianca H V","Laboratório de Controle Genético e Sanitário, Diretoria Técnica de Apoio ao Ensino e Pesquisa, Faculdade de Medicina da Universidade de São Paulo, Brazil",NA
"1134","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","Nóbrega","Rafael H","Reproductive and Molecular Biology Group, Institute of Biosciences, São Paulo State University, Botucatu, SP, Brazil",NA
"1135","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","Galdino","Giovane","Institute of Motricity Sciences, Federal University of Alfenas, Alfenas, MG, Brazil",NA
"1136","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","Condino-Neto","Antônio","Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, SP, Brazil",NA
"1137","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","Galindo-Villegas","Jorge","Faculty of Biosciences and Aquaculture, Nord University, 8049 Bodø, Norway",NA
"1138","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","Machado-Santelli","Glaucia M","Department of Cell Biology, Institute of Biomedical Sciences, University of São Paulo, SP, Brazil",NA
"1139","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","Sanches","Paulo R S","Institute of Chemistry, São Paulo State University (UNESP), Araraquara SP, Brazil",NA
"1140","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","Rezende","Rafael M","Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, United States",NA
"1141","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","Cilli","Eduardo M","Institute of Chemistry, São Paulo State University (UNESP), Araraquara SP, Brazil",NA
"1142","34216962","10.1016/j.jhazmat.2021.126463","Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?","The Spike protein (S protein) is a critical component in the infection of the new coronavirus (SARS-CoV-2). The objective of this work was to evaluate whether peptides from S protein could cause negative impact in the aquatic animals. The aquatic toxicity of SARS-CoV-2 Spike protein peptides derivatives has been evaluated in tadpoles (n = 50 tadpoles/5 replicates of 10 animals) from species Physalaemus cuvieri (Leptodactylidae). After synthesis, purification, and characterization of peptides (PS","2021","07","06","J Hazard Mater","Journal of hazardous materials","Acetylcholinesterase; Amphibians; Coronavirus; Oxidative stress; SARS-Cov-2","Malafaia","Guilherme","Post-graduation Program in Biotechnology and Biodiversity, Goiano Federal Institution and Federal University of Goiás, GO, Brazil","guilherme.malafaia@ifgoiano.edu.br"
"1143","34216889","10.1016/j.compbiomed.2021.104591","In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs.","The continued sustained threat of the SARS-CoV-2 virus world-wide, urgently calls for far-reaching effective therapeutic strategies for treating this emerging infection. Accordingly, this study explores mode of action and therapeutic potential of existing antiviral drugs. Multiple sequence alignment and phylogenetic analyses indicate that the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 was mutable and similar to bat coronavirus RaTG13. Successive interactions between RdRp (nsp12 alone or i","2021","07","21","Comput Biol Med","Computers in biology and medicine","Computational biology; Molecular modelling; RdRp; Remdesivir; SARS-CoV-2; Sofosbuvir","Mondal","Sunil Kanti","Department of Biotechnology, The University of Burdwan, Burdwan, 713104, West Bengal, India. Electronic address: skmondal@biotech.buruniv.ac","skmondal@biotech.buruniv.ac.in"
"1144","34216889","10.1016/j.compbiomed.2021.104591","In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs.","The continued sustained threat of the SARS-CoV-2 virus world-wide, urgently calls for far-reaching effective therapeutic strategies for treating this emerging infection. Accordingly, this study explores mode of action and therapeutic potential of existing antiviral drugs. Multiple sequence alignment and phylogenetic analyses indicate that the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 was mutable and similar to bat coronavirus RaTG13. Successive interactions between RdRp (nsp12 alone or i","2021","07","21","Comput Biol Med","Computers in biology and medicine","Computational biology; Molecular modelling; RdRp; Remdesivir; SARS-CoV-2; Sofosbuvir","Mukhoty","Samyabrata","Department of Biotechnology, The University of Burdwan, Burdwan, 713104, West Bengal, India",NA
"1145","34216889","10.1016/j.compbiomed.2021.104591","In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs.","The continued sustained threat of the SARS-CoV-2 virus world-wide, urgently calls for far-reaching effective therapeutic strategies for treating this emerging infection. Accordingly, this study explores mode of action and therapeutic potential of existing antiviral drugs. Multiple sequence alignment and phylogenetic analyses indicate that the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 was mutable and similar to bat coronavirus RaTG13. Successive interactions between RdRp (nsp12 alone or i","2021","07","21","Comput Biol Med","Computers in biology and medicine","Computational biology; Molecular modelling; RdRp; Remdesivir; SARS-CoV-2; Sofosbuvir","Kundu","Himangsu","Department of Biotechnology, The University of Burdwan, Burdwan, 713104, West Bengal, India",NA
"1146","34216889","10.1016/j.compbiomed.2021.104591","In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs.","The continued sustained threat of the SARS-CoV-2 virus world-wide, urgently calls for far-reaching effective therapeutic strategies for treating this emerging infection. Accordingly, this study explores mode of action and therapeutic potential of existing antiviral drugs. Multiple sequence alignment and phylogenetic analyses indicate that the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 was mutable and similar to bat coronavirus RaTG13. Successive interactions between RdRp (nsp12 alone or i","2021","07","21","Comput Biol Med","Computers in biology and medicine","Computational biology; Molecular modelling; RdRp; Remdesivir; SARS-CoV-2; Sofosbuvir","Ghosh","Subhajit","Department of Biotechnology, The University of Burdwan, Burdwan, 713104, West Bengal, India",NA
"1147","34216889","10.1016/j.compbiomed.2021.104591","In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs.","The continued sustained threat of the SARS-CoV-2 virus world-wide, urgently calls for far-reaching effective therapeutic strategies for treating this emerging infection. Accordingly, this study explores mode of action and therapeutic potential of existing antiviral drugs. Multiple sequence alignment and phylogenetic analyses indicate that the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 was mutable and similar to bat coronavirus RaTG13. Successive interactions between RdRp (nsp12 alone or i","2021","07","21","Comput Biol Med","Computers in biology and medicine","Computational biology; Molecular modelling; RdRp; Remdesivir; SARS-CoV-2; Sofosbuvir","Sen","Madhab Kumar","Department of Agroecology and Crop Production, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Prague, Czech Republic",NA
"1148","34216889","10.1016/j.compbiomed.2021.104591","In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs.","The continued sustained threat of the SARS-CoV-2 virus world-wide, urgently calls for far-reaching effective therapeutic strategies for treating this emerging infection. Accordingly, this study explores mode of action and therapeutic potential of existing antiviral drugs. Multiple sequence alignment and phylogenetic analyses indicate that the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 was mutable and similar to bat coronavirus RaTG13. Successive interactions between RdRp (nsp12 alone or i","2021","07","21","Comput Biol Med","Computers in biology and medicine","Computational biology; Molecular modelling; RdRp; Remdesivir; SARS-CoV-2; Sofosbuvir","Das","Suvankar","Department of Genetics, University of Calcutta, 35 Ballygunge Circular Road, Kolkata, 700019, India",NA
"1149","34216889","10.1016/j.compbiomed.2021.104591","In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs.","The continued sustained threat of the SARS-CoV-2 virus world-wide, urgently calls for far-reaching effective therapeutic strategies for treating this emerging infection. Accordingly, this study explores mode of action and therapeutic potential of existing antiviral drugs. Multiple sequence alignment and phylogenetic analyses indicate that the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 was mutable and similar to bat coronavirus RaTG13. Successive interactions between RdRp (nsp12 alone or i","2021","07","21","Comput Biol Med","Computers in biology and medicine","Computational biology; Molecular modelling; RdRp; Remdesivir; SARS-CoV-2; Sofosbuvir","Brogi","Simone","Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126, Pisa, Italy. Electronic address: simone.brogi@unipi","simone.brogi@unipi.it"
"1150","34216884","10.1016/j.socscimed.2021.114181","The mark of mental health problems. A field experiment on hiring discrimination before and during COVID-19.","Mental health problems are associated with poor labour market outcomes. Based on data from a field experiment, this article investigates the extent to which hiring discrimination limits the job opportunities of young applicants who disclose a history of mental health problems. From September 2019 to December 2020, 1398 job applications were sent in pairs to 699 employers with job openings in a broad selection of occupations in the Norwegian labour market. The applicants were equally qualified ex","2021","07","20","Soc Sci Med","Social science &amp; medicine (1982)","COVID-19; Field experiment; Hiring discrimination; Mental health; Recession","Bjørnshagen","Vegar","Norwegian Social Research, Oslo Metropolitan University, Pb. 4 St. Olavs plass, 0130, Oslo, Norway. Electronic address: vegar.bjornshagen@oslomet","vegar.bjornshagen@oslomet.no"
"1151","34216835","10.1016/j.drudis.2021.06.009","AI-based language models powering drug discovery and development.","The discovery and development of new medicines is expensive, time-consuming, and often inefficient, with many failures along the way. Powered by artificial intelligence (AI), language models (LMs) have changed the landscape of natural language processing (NLP), offering possibilities to transform treatment development more effectively. Here, we summarize advances in AI-powered LMs and their potential to aid drug discovery and development. We highlight opportunities for AI-powered LMs in target i","2021","07","17","Drug Discov Today","Drug discovery today","Artificial intelligence; COVID-19; Drug development; Drug discovery; Language models; Natural language processing","Liu","Zhichao","National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR 72079, USA. Electronic address: zhichao.liu@fda.hhs","zhichao.liu@fda.hhs.gov"
"1152","34216835","10.1016/j.drudis.2021.06.009","AI-based language models powering drug discovery and development.","The discovery and development of new medicines is expensive, time-consuming, and often inefficient, with many failures along the way. Powered by artificial intelligence (AI), language models (LMs) have changed the landscape of natural language processing (NLP), offering possibilities to transform treatment development more effectively. Here, we summarize advances in AI-powered LMs and their potential to aid drug discovery and development. We highlight opportunities for AI-powered LMs in target i","2021","07","17","Drug Discov Today","Drug discovery today","Artificial intelligence; COVID-19; Drug development; Drug discovery; Language models; Natural language processing","Roberts","Ruth A","National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR 72079, USA",NA
"1153","34216835","10.1016/j.drudis.2021.06.009","AI-based language models powering drug discovery and development.","The discovery and development of new medicines is expensive, time-consuming, and often inefficient, with many failures along the way. Powered by artificial intelligence (AI), language models (LMs) have changed the landscape of natural language processing (NLP), offering possibilities to transform treatment development more effectively. Here, we summarize advances in AI-powered LMs and their potential to aid drug discovery and development. We highlight opportunities for AI-powered LMs in target i","2021","07","17","Drug Discov Today","Drug discovery today","Artificial intelligence; COVID-19; Drug development; Drug discovery; Language models; Natural language processing","Lal-Nag","Madhu","Office of Translational Sciences, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD 20993, USA",NA
"1154","34216835","10.1016/j.drudis.2021.06.009","AI-based language models powering drug discovery and development.","The discovery and development of new medicines is expensive, time-consuming, and often inefficient, with many failures along the way. Powered by artificial intelligence (AI), language models (LMs) have changed the landscape of natural language processing (NLP), offering possibilities to transform treatment development more effectively. Here, we summarize advances in AI-powered LMs and their potential to aid drug discovery and development. We highlight opportunities for AI-powered LMs in target i","2021","07","17","Drug Discov Today","Drug discovery today","Artificial intelligence; COVID-19; Drug development; Drug discovery; Language models; Natural language processing","Chen","Xi","National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR 72079, USA",NA
"1155","34216835","10.1016/j.drudis.2021.06.009","AI-based language models powering drug discovery and development.","The discovery and development of new medicines is expensive, time-consuming, and often inefficient, with many failures along the way. Powered by artificial intelligence (AI), language models (LMs) have changed the landscape of natural language processing (NLP), offering possibilities to transform treatment development more effectively. Here, we summarize advances in AI-powered LMs and their potential to aid drug discovery and development. We highlight opportunities for AI-powered LMs in target i","2021","07","17","Drug Discov Today","Drug discovery today","Artificial intelligence; COVID-19; Drug development; Drug discovery; Language models; Natural language processing","Huang","Ruili","National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA",NA
"1156","34216835","10.1016/j.drudis.2021.06.009","AI-based language models powering drug discovery and development.","The discovery and development of new medicines is expensive, time-consuming, and often inefficient, with many failures along the way. Powered by artificial intelligence (AI), language models (LMs) have changed the landscape of natural language processing (NLP), offering possibilities to transform treatment development more effectively. Here, we summarize advances in AI-powered LMs and their potential to aid drug discovery and development. We highlight opportunities for AI-powered LMs in target i","2021","07","17","Drug Discov Today","Drug discovery today","Artificial intelligence; COVID-19; Drug development; Drug discovery; Language models; Natural language processing","Tong","Weida","National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR 72079, USA. Electronic address: weida.tong@fda.hhs","weida.tong@fda.hhs.gov"
"1157","34216827","10.1016/j.jcmgh.2021.06.014","Gut ACE2 Expression, Tryptophan Deficiency, and Inflammatory Responses: The Potential Connection That Should Not Be Ignored During SARS-CoV-2 Infection.",NA,"2021","07","22","Cell Mol Gastroenterol Hepatol","Cellular and molecular gastroenterology and hepatology",NA,"Qin","W-H","International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China",NA
"1158","34216827","10.1016/j.jcmgh.2021.06.014","Gut ACE2 Expression, Tryptophan Deficiency, and Inflammatory Responses: The Potential Connection That Should Not Be Ignored During SARS-CoV-2 Infection.",NA,"2021","07","22","Cell Mol Gastroenterol Hepatol","Cellular and molecular gastroenterology and hepatology",NA,"Liu","C-L","International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China",NA
"1159","34216827","10.1016/j.jcmgh.2021.06.014","Gut ACE2 Expression, Tryptophan Deficiency, and Inflammatory Responses: The Potential Connection That Should Not Be Ignored During SARS-CoV-2 Infection.",NA,"2021","07","22","Cell Mol Gastroenterol Hepatol","Cellular and molecular gastroenterology and hepatology",NA,"Jiang","Y-H","International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China",NA
"1160","34216827","10.1016/j.jcmgh.2021.06.014","Gut ACE2 Expression, Tryptophan Deficiency, and Inflammatory Responses: The Potential Connection That Should Not Be Ignored During SARS-CoV-2 Infection.",NA,"2021","07","22","Cell Mol Gastroenterol Hepatol","Cellular and molecular gastroenterology and hepatology",NA,"Hu","B","Department of Gastroenterology and Endoscopy, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China",NA
"1161","34216827","10.1016/j.jcmgh.2021.06.014","Gut ACE2 Expression, Tryptophan Deficiency, and Inflammatory Responses: The Potential Connection That Should Not Be Ignored During SARS-CoV-2 Infection.",NA,"2021","07","22","Cell Mol Gastroenterol Hepatol","Cellular and molecular gastroenterology and hepatology",NA,"Wang","H-Y","International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China","hywangk@vip.sina.com"
"1162","34216827","10.1016/j.jcmgh.2021.06.014","Gut ACE2 Expression, Tryptophan Deficiency, and Inflammatory Responses: The Potential Connection That Should Not Be Ignored During SARS-CoV-2 Infection.",NA,"2021","07","22","Cell Mol Gastroenterol Hepatol","Cellular and molecular gastroenterology and hepatology",NA,"Fu","J","International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China","724@163.com"
"1163","34216818","10.1016/j.anr.2021.06.003","Behavioral responses of pregnant women to the early stage of COVID-19 pandemic in the network Era in China: online questionnaire study.","The aim of the present study was to examine the behavioral responses of pregnant women during the early stage of Coronavirus Disease 2019 (COVID-19) outbreak. We recruited 1,099 women to complete an online questionnaire survey from February 10 to February 25, 2020. The subjects were divided into two groups (the pregnant women group and the control group). Concerns about infection: most of the participants watched the COVID-19 news at least once a day. Protective behaviors: the utilization rate o","2021","07","24","Asian Nurs Res (Korean Soc Nurs Sci)","Asian nursing research","COVID-19; behavior; pregnant women; public health","Hu","Wen-Sheng","Department of Obstetrics and Gynecology, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Zhejiang, China. Electronic address: huws@zju.edu","huws@zju.edu.cn"
"1164","34216818","10.1016/j.anr.2021.06.003","Behavioral responses of pregnant women to the early stage of COVID-19 pandemic in the network Era in China: online questionnaire study.","The aim of the present study was to examine the behavioral responses of pregnant women during the early stage of Coronavirus Disease 2019 (COVID-19) outbreak. We recruited 1,099 women to complete an online questionnaire survey from February 10 to February 25, 2020. The subjects were divided into two groups (the pregnant women group and the control group). Concerns about infection: most of the participants watched the COVID-19 news at least once a day. Protective behaviors: the utilization rate o","2021","07","24","Asian Nurs Res (Korean Soc Nurs Sci)","Asian nursing research","COVID-19; behavior; pregnant women; public health","Lu","Sha","Department of Obstetrics and Gynecology, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Zhejiang, China",NA
"1165","34216818","10.1016/j.anr.2021.06.003","Behavioral responses of pregnant women to the early stage of COVID-19 pandemic in the network Era in China: online questionnaire study.","The aim of the present study was to examine the behavioral responses of pregnant women during the early stage of Coronavirus Disease 2019 (COVID-19) outbreak. We recruited 1,099 women to complete an online questionnaire survey from February 10 to February 25, 2020. The subjects were divided into two groups (the pregnant women group and the control group). Concerns about infection: most of the participants watched the COVID-19 news at least once a day. Protective behaviors: the utilization rate o","2021","07","24","Asian Nurs Res (Korean Soc Nurs Sci)","Asian nursing research","COVID-19; behavior; pregnant women; public health","Xu","Meng-Yan","Department of Nursing, Hangzhou Women's Hospital, Hangzhou 310008, China",NA
"1166","34216818","10.1016/j.anr.2021.06.003","Behavioral responses of pregnant women to the early stage of COVID-19 pandemic in the network Era in China: online questionnaire study.","The aim of the present study was to examine the behavioral responses of pregnant women during the early stage of Coronavirus Disease 2019 (COVID-19) outbreak. We recruited 1,099 women to complete an online questionnaire survey from February 10 to February 25, 2020. The subjects were divided into two groups (the pregnant women group and the control group). Concerns about infection: most of the participants watched the COVID-19 news at least once a day. Protective behaviors: the utilization rate o","2021","07","24","Asian Nurs Res (Korean Soc Nurs Sci)","Asian nursing research","COVID-19; behavior; pregnant women; public health","Zhou","Min-Cong","Department of Psychology, Hangzhou Women's Hospital, Hangzhou 310008, China",NA
"1167","34216818","10.1016/j.anr.2021.06.003","Behavioral responses of pregnant women to the early stage of COVID-19 pandemic in the network Era in China: online questionnaire study.","The aim of the present study was to examine the behavioral responses of pregnant women during the early stage of Coronavirus Disease 2019 (COVID-19) outbreak. We recruited 1,099 women to complete an online questionnaire survey from February 10 to February 25, 2020. The subjects were divided into two groups (the pregnant women group and the control group). Concerns about infection: most of the participants watched the COVID-19 news at least once a day. Protective behaviors: the utilization rate o","2021","07","24","Asian Nurs Res (Korean Soc Nurs Sci)","Asian nursing research","COVID-19; behavior; pregnant women; public health","Yuan","Zhen-Ming","Hangzhou institute of service engineering, Hangzhou Normal University, Hangzhou 311121, China",NA
"1168","34216818","10.1016/j.anr.2021.06.003","Behavioral responses of pregnant women to the early stage of COVID-19 pandemic in the network Era in China: online questionnaire study.","The aim of the present study was to examine the behavioral responses of pregnant women during the early stage of Coronavirus Disease 2019 (COVID-19) outbreak. We recruited 1,099 women to complete an online questionnaire survey from February 10 to February 25, 2020. The subjects were divided into two groups (the pregnant women group and the control group). Concerns about infection: most of the participants watched the COVID-19 news at least once a day. Protective behaviors: the utilization rate o","2021","07","24","Asian Nurs Res (Korean Soc Nurs Sci)","Asian nursing research","COVID-19; behavior; pregnant women; public health","Deng","Yue-Yue","Department of Obstetrics and Gynecology, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Zhejiang, China",NA
"1169","34216816","10.1016/j.cct.2021.106496","Promoting physical activity participation and nutrition education through a telehealth intervention for children on the autism spectrum and their caregivers.","There is growing empirical support which suggests children on the autism spectrum, as well as their caregivers experience significant health disparities. The global COVID-19 pandemic has only magnified the need to address health among vulnerable populations. While there has been a growing trend in the delivery of telehealth interventions, the delivery of such methods for children on the autism spectrum, and their caregivers remains relatively under examined. The primary goal of PLANE (Physical L","2021","07","22","Contemp Clin Trials","Contemporary clinical trials","Autism spectrum disorders; Health; Nutrition; Physical activity; Telehealth","Ketcheson","Leah R","Wayne State University, Detroit, MI, United States of America. Electronic address: leah.ketcheson@wayne","leah.ketcheson@wayne.edu"
"1170","34216816","10.1016/j.cct.2021.106496","Promoting physical activity participation and nutrition education through a telehealth intervention for children on the autism spectrum and their caregivers.","There is growing empirical support which suggests children on the autism spectrum, as well as their caregivers experience significant health disparities. The global COVID-19 pandemic has only magnified the need to address health among vulnerable populations. While there has been a growing trend in the delivery of telehealth interventions, the delivery of such methods for children on the autism spectrum, and their caregivers remains relatively under examined. The primary goal of PLANE (Physical L","2021","07","22","Contemp Clin Trials","Contemporary clinical trials","Autism spectrum disorders; Health; Nutrition; Physical activity; Telehealth","Pitchford","E Andrew","Iowa State University, 111D Forker, 534 Wallace Rd, Ames, IA 50011, United States of America. Electronic address: eapitch@iastate","eapitch@iastate.edu"
"1171","34216804","10.1016/j.acap.2021.06.012","Let's not settle for getting back to ""normal"" - Addressing ACEs and health behaviors in the wake of the COVID-19 pandemic.",NA,"2021","07","03","Acad Pediatr","Academic pediatrics",NA,"Brown","Callie L","Department of Pediatrics, Wake Forest School of Medicine, Winston-Salem, NC, United States","calbrown@wakehealth.edu"
"1172","34216804","10.1016/j.acap.2021.06.012","Let's not settle for getting back to ""normal"" - Addressing ACEs and health behaviors in the wake of the COVID-19 pandemic.",NA,"2021","07","03","Acad Pediatr","Academic pediatrics",NA,"Palakshappa","Deepak","Department of Pediatrics, Wake Forest School of Medicine, Winston-Salem, NC, United States",NA
"1173","34216759","10.1016/j.trim.2021.101435","Acute graft-versus-host disease after liver transplantation in a close contact with COVID-19: A case report.","Acute graft-versus-host disease (aGVHD) is a rare complication after liver transplantation that characterized by high mortality. We presented a case of aGVHD after orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC). The patient suffered from fever, oral ulcer, rashes and diarrhea and had a co-infection with Cytomegalovirus (CMV). Short tandem repeat (STR) analysis for cluster of differentiation (CD3) cells and skin biopsy indicated aGVHD. His regimens included high dose of","2021","07","22","Transpl Immunol","Transplant immunology","COVID-19; Close contact; Orthotopic live transplantation; aGVHD","Wang","Lu","Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1905 Jiefang Avenue, Wuhan City, Hubei Province, Wuhan 430030, China",NA
"1174","34216759","10.1016/j.trim.2021.101435","Acute graft-versus-host disease after liver transplantation in a close contact with COVID-19: A case report.","Acute graft-versus-host disease (aGVHD) is a rare complication after liver transplantation that characterized by high mortality. We presented a case of aGVHD after orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC). The patient suffered from fever, oral ulcer, rashes and diarrhea and had a co-infection with Cytomegalovirus (CMV). Short tandem repeat (STR) analysis for cluster of differentiation (CD3) cells and skin biopsy indicated aGVHD. His regimens included high dose of","2021","07","22","Transpl Immunol","Transplant immunology","COVID-19; Close contact; Orthotopic live transplantation; aGVHD","Yang","Bo","Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1905 Jiefang Avenue, Wuhan City, Hubei Province, Wuhan 430030, China. Electronic address: yangbo@tjh.tjmu.edu","yangbo@tjh.tjmu.edu.cn"
"1175","34216759","10.1016/j.trim.2021.101435","Acute graft-versus-host disease after liver transplantation in a close contact with COVID-19: A case report.","Acute graft-versus-host disease (aGVHD) is a rare complication after liver transplantation that characterized by high mortality. We presented a case of aGVHD after orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC). The patient suffered from fever, oral ulcer, rashes and diarrhea and had a co-infection with Cytomegalovirus (CMV). Short tandem repeat (STR) analysis for cluster of differentiation (CD3) cells and skin biopsy indicated aGVHD. His regimens included high dose of","2021","07","22","Transpl Immunol","Transplant immunology","COVID-19; Close contact; Orthotopic live transplantation; aGVHD","Wei","Lai","Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1905 Jiefang Avenue, Wuhan City, Hubei Province, Wuhan 430030, China. Electronic address: weilai@tjh.tjmu.edu","weilai@tjh.tjmu.edu.cn"
"1176","34216759","10.1016/j.trim.2021.101435","Acute graft-versus-host disease after liver transplantation in a close contact with COVID-19: A case report.","Acute graft-versus-host disease (aGVHD) is a rare complication after liver transplantation that characterized by high mortality. We presented a case of aGVHD after orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC). The patient suffered from fever, oral ulcer, rashes and diarrhea and had a co-infection with Cytomegalovirus (CMV). Short tandem repeat (STR) analysis for cluster of differentiation (CD3) cells and skin biopsy indicated aGVHD. His regimens included high dose of","2021","07","22","Transpl Immunol","Transplant immunology","COVID-19; Close contact; Orthotopic live transplantation; aGVHD","Chen","Dong","Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1905 Jiefang Avenue, Wuhan City, Hubei Province, Wuhan 430030, China",NA
"1177","34216759","10.1016/j.trim.2021.101435","Acute graft-versus-host disease after liver transplantation in a close contact with COVID-19: A case report.","Acute graft-versus-host disease (aGVHD) is a rare complication after liver transplantation that characterized by high mortality. We presented a case of aGVHD after orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC). The patient suffered from fever, oral ulcer, rashes and diarrhea and had a co-infection with Cytomegalovirus (CMV). Short tandem repeat (STR) analysis for cluster of differentiation (CD3) cells and skin biopsy indicated aGVHD. His regimens included high dose of","2021","07","22","Transpl Immunol","Transplant immunology","COVID-19; Close contact; Orthotopic live transplantation; aGVHD","Zhao","Yuanyuan","Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1905 Jiefang Avenue, Wuhan City, Hubei Province, Wuhan 430030, China",NA
"1178","34216759","10.1016/j.trim.2021.101435","Acute graft-versus-host disease after liver transplantation in a close contact with COVID-19: A case report.","Acute graft-versus-host disease (aGVHD) is a rare complication after liver transplantation that characterized by high mortality. We presented a case of aGVHD after orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC). The patient suffered from fever, oral ulcer, rashes and diarrhea and had a co-infection with Cytomegalovirus (CMV). Short tandem repeat (STR) analysis for cluster of differentiation (CD3) cells and skin biopsy indicated aGVHD. His regimens included high dose of","2021","07","22","Transpl Immunol","Transplant immunology","COVID-19; Close contact; Orthotopic live transplantation; aGVHD","Chen","Zhishui","Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1905 Jiefang Avenue, Wuhan City, Hubei Province, Wuhan 430030, China. Electronic address: zschen@tjh.tjmu.edu","zschen@tjh.tjmu.edu.cn"
"1179","34216738","10.1016/j.ijid.2021.06.054","Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report.","We describe the case of a 44-year-old female on Rituximab for treatment of multiple sclerosis with undetectable SARS-CoV-2 IgG specific antibodies eighteen days after second dose of SARS-CoV-2 vaccine. Interferon-gamma release assay testing for SARS-CoV-2 was positive on day nineteen, demonstrating robust T-cell mediated response despite lack of antibody-mediated response.","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Ferguson","Jessica","Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA. Electronic address: jferg1@stanford","jferg1@stanford.edu"
"1180","34216738","10.1016/j.ijid.2021.06.054","Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report.","We describe the case of a 44-year-old female on Rituximab for treatment of multiple sclerosis with undetectable SARS-CoV-2 IgG specific antibodies eighteen days after second dose of SARS-CoV-2 vaccine. Interferon-gamma release assay testing for SARS-CoV-2 was positive on day nineteen, demonstrating robust T-cell mediated response despite lack of antibody-mediated response.","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Murugesan","Kanagavel","Department of Pathology, Stanford University School of Medicine, Stanford, CA",NA
"1181","34216738","10.1016/j.ijid.2021.06.054","Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report.","We describe the case of a 44-year-old female on Rituximab for treatment of multiple sclerosis with undetectable SARS-CoV-2 IgG specific antibodies eighteen days after second dose of SARS-CoV-2 vaccine. Interferon-gamma release assay testing for SARS-CoV-2 was positive on day nineteen, demonstrating robust T-cell mediated response despite lack of antibody-mediated response.","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Banaei","Niaz","Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA",NA
"1182","34216738","10.1016/j.ijid.2021.06.054","Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report.","We describe the case of a 44-year-old female on Rituximab for treatment of multiple sclerosis with undetectable SARS-CoV-2 IgG specific antibodies eighteen days after second dose of SARS-CoV-2 vaccine. Interferon-gamma release assay testing for SARS-CoV-2 was positive on day nineteen, demonstrating robust T-cell mediated response despite lack of antibody-mediated response.","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Liu","Anne","Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA",NA
"1183","34216737","10.1016/j.ijid.2021.06.057","Evaluation of potassium peroxymonosulfate (MPS) efficacy against SARS-CoV-2 virus using RT-qPCR-based method.","The SARS-CoV-2 virus spreads mostly through the respiratory droplet and contaminated fomites has been proposed as possible viral transmission. Several disinfectants were previously recommended for SARS-CoV-2 decontamination including alcohol, hydrogen peroxide, and sodium hypochlorite with some limitations. Potassium peroxymonosulfate (MPS) is a broadspectrum disinfectants and acts on bacterial and viral protein capsids by oxidation. It is widely used as multipurpose virucidal disinfection in li","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; MPS; disinfection; outbreak; viral transmission","W","Tulalamba","Siriraj Thalassemia Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand",NA
"1184","34216737","10.1016/j.ijid.2021.06.057","Evaluation of potassium peroxymonosulfate (MPS) efficacy against SARS-CoV-2 virus using RT-qPCR-based method.","The SARS-CoV-2 virus spreads mostly through the respiratory droplet and contaminated fomites has been proposed as possible viral transmission. Several disinfectants were previously recommended for SARS-CoV-2 decontamination including alcohol, hydrogen peroxide, and sodium hypochlorite with some limitations. Potassium peroxymonosulfate (MPS) is a broadspectrum disinfectants and acts on bacterial and viral protein capsids by oxidation. It is widely used as multipurpose virucidal disinfection in li","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; MPS; disinfection; outbreak; viral transmission","A","Assawamakin","Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand",NA
"1185","34216737","10.1016/j.ijid.2021.06.057","Evaluation of potassium peroxymonosulfate (MPS) efficacy against SARS-CoV-2 virus using RT-qPCR-based method.","The SARS-CoV-2 virus spreads mostly through the respiratory droplet and contaminated fomites has been proposed as possible viral transmission. Several disinfectants were previously recommended for SARS-CoV-2 decontamination including alcohol, hydrogen peroxide, and sodium hypochlorite with some limitations. Potassium peroxymonosulfate (MPS) is a broadspectrum disinfectants and acts on bacterial and viral protein capsids by oxidation. It is widely used as multipurpose virucidal disinfection in li","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; MPS; disinfection; outbreak; viral transmission","A","Thayananuphat","Department of Companion Animal Clinical Sciences, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Thailand",NA
"1186","34216737","10.1016/j.ijid.2021.06.057","Evaluation of potassium peroxymonosulfate (MPS) efficacy against SARS-CoV-2 virus using RT-qPCR-based method.","The SARS-CoV-2 virus spreads mostly through the respiratory droplet and contaminated fomites has been proposed as possible viral transmission. Several disinfectants were previously recommended for SARS-CoV-2 decontamination including alcohol, hydrogen peroxide, and sodium hypochlorite with some limitations. Potassium peroxymonosulfate (MPS) is a broadspectrum disinfectants and acts on bacterial and viral protein capsids by oxidation. It is widely used as multipurpose virucidal disinfection in li","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; MPS; disinfection; outbreak; viral transmission","V","Viprakasit","Siriraj Thalassemia Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand","vip.vip@mahidol.edu"
"1187","34216735","10.1016/j.ijid.2021.06.056","Immunological predictors of disease severity in patients with COVID-19.","Identifying immune cells involved in COVID-19 disease progression and predictors of poor outcomes is important to manage patients adequately. A prospective observational cohort study enrolled 53 mild non-hospitalized and 48 hospitalized confirmed COVID-19 patients to a tertiary hospital in Oman. Hospitalized patients were older (58 years vs 36 years, p &lt;0.001) and had more comorbid conditions like diabetes (65 % Vs 21% p&lt;0.001). Hospitalized patients had significantly higher inflammatory m","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Immunological predictors; Inflammatory markers; lymphocyte subsets; mortality predictors","Balushi","Asma Al","Conceptualized, designed the study, wrote the research proposal, data collection for inpatients and field visits, communicated with patients, drafted and reviewed the manuscript, and overall workflow and integrity supervision. Address: Tropical and Infectious Diseases Unit, Internal Medicine department, The Royal Liverpool University Hospital, Suhar hospital, Prescot street, Liverpool L7 8XP, Oman. P. O. Box 49, Suhar, Muwailih 311, United Kingdom. Electronic address: thebrightsoul2@gmail","thebrightsoul2@gmail.com"
"1188","34216735","10.1016/j.ijid.2021.06.056","Immunological predictors of disease severity in patients with COVID-19.","Identifying immune cells involved in COVID-19 disease progression and predictors of poor outcomes is important to manage patients adequately. A prospective observational cohort study enrolled 53 mild non-hospitalized and 48 hospitalized confirmed COVID-19 patients to a tertiary hospital in Oman. Hospitalized patients were older (58 years vs 36 years, p &lt;0.001) and had more comorbid conditions like diabetes (65 % Vs 21% p&lt;0.001). Hospitalized patients had significantly higher inflammatory m","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Immunological predictors; Inflammatory markers; lymphocyte subsets; mortality predictors","AlShekaili","Jalila","Reviewed study design, reviewed research proposal, supervised receiving blood samples at the immunology lab, supervised the flow cytometry work and IL-6 assessment run and analysis, and interpreted the data, wrote up the first few drafts and approved the final draft of the manuscript. Address: Department of Microbiology and Immunology, Sultan Qaboos University Hospital, Seeb, Oman. P. O. Box 38, Alkhoudh 123. Electronic address: jalila@squ.edu","jalila@squ.edu.om"
"1189","34216735","10.1016/j.ijid.2021.06.056","Immunological predictors of disease severity in patients with COVID-19.","Identifying immune cells involved in COVID-19 disease progression and predictors of poor outcomes is important to manage patients adequately. A prospective observational cohort study enrolled 53 mild non-hospitalized and 48 hospitalized confirmed COVID-19 patients to a tertiary hospital in Oman. Hospitalized patients were older (58 years vs 36 years, p &lt;0.001) and had more comorbid conditions like diabetes (65 % Vs 21% p&lt;0.001). Hospitalized patients had significantly higher inflammatory m","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Immunological predictors; Inflammatory markers; lymphocyte subsets; mortality predictors","Kindi","Mahmood Al","Reviewed study design, reviewed research proposal, supervised receiving blood samples at the immunology lab, supervised the flow cytometry work and IL-6 assessment run and analysis, analyzed the data, wrote up the first few drafts, and approved the final draft of the manuscript. Address: Department of Microbiology and Immunology, Sultan Qaboos University Hospital, Seeb, Oman. P. O. Box 38, Alkhoudh 123. Electronic address: dralkindi@squ.edu","dralkindi@squ.edu.om"
"1190","34216735","10.1016/j.ijid.2021.06.056","Immunological predictors of disease severity in patients with COVID-19.","Identifying immune cells involved in COVID-19 disease progression and predictors of poor outcomes is important to manage patients adequately. A prospective observational cohort study enrolled 53 mild non-hospitalized and 48 hospitalized confirmed COVID-19 patients to a tertiary hospital in Oman. Hospitalized patients were older (58 years vs 36 years, p &lt;0.001) and had more comorbid conditions like diabetes (65 % Vs 21% p&lt;0.001). Hospitalized patients had significantly higher inflammatory m","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Immunological predictors; Inflammatory markers; lymphocyte subsets; mortality predictors","Ansari","Zainab","Field visits, data, and sample collection from outpatients and inpatients and data entry. Address: Internal Medicine department, Royal Hospital, Muscat, Oman. P.O. Box 1331, Al Ghubra area 111. Electronic address: zainabahameed99@gmail","zainabahameed99@gmail.com"
"1191","34216735","10.1016/j.ijid.2021.06.056","Immunological predictors of disease severity in patients with COVID-19.","Identifying immune cells involved in COVID-19 disease progression and predictors of poor outcomes is important to manage patients adequately. A prospective observational cohort study enrolled 53 mild non-hospitalized and 48 hospitalized confirmed COVID-19 patients to a tertiary hospital in Oman. Hospitalized patients were older (58 years vs 36 years, p &lt;0.001) and had more comorbid conditions like diabetes (65 % Vs 21% p&lt;0.001). Hospitalized patients had significantly higher inflammatory m","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Immunological predictors; Inflammatory markers; lymphocyte subsets; mortality predictors","Al-Khabori","Murtadha","Data analysis, writing up results, and manuscript review. Address: Clinical Haematology Department, Sultan Qaboos University, Muscat, Oman. P. O. Box 35, Alkhoudh 123. Electronic address: khabori@squ.edu","khabori@squ.edu.om"
"1192","34216735","10.1016/j.ijid.2021.06.056","Immunological predictors of disease severity in patients with COVID-19.","Identifying immune cells involved in COVID-19 disease progression and predictors of poor outcomes is important to manage patients adequately. A prospective observational cohort study enrolled 53 mild non-hospitalized and 48 hospitalized confirmed COVID-19 patients to a tertiary hospital in Oman. Hospitalized patients were older (58 years vs 36 years, p &lt;0.001) and had more comorbid conditions like diabetes (65 % Vs 21% p&lt;0.001). Hospitalized patients had significantly higher inflammatory m","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Immunological predictors; Inflammatory markers; lymphocyte subsets; mortality predictors","Khamis","Faryal","Manuscript review and facilitating research work for inpatients. Address: Internal Medicine department, Royal Hospital, Muscat, Oman. P.O. Box 1331, Al Ghubra area 111. Electronic address: khami001@gmail","khami001@gmail.com"
"1193","34216735","10.1016/j.ijid.2021.06.056","Immunological predictors of disease severity in patients with COVID-19.","Identifying immune cells involved in COVID-19 disease progression and predictors of poor outcomes is important to manage patients adequately. A prospective observational cohort study enrolled 53 mild non-hospitalized and 48 hospitalized confirmed COVID-19 patients to a tertiary hospital in Oman. Hospitalized patients were older (58 years vs 36 years, p &lt;0.001) and had more comorbid conditions like diabetes (65 % Vs 21% p&lt;0.001). Hospitalized patients had significantly higher inflammatory m","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Immunological predictors; Inflammatory markers; lymphocyte subsets; mortality predictors","Ambusaidi","Zaiyana","Data and sample collection from inpatients and data entry. Address: Internal Medicine department, Royal Hospital, Muscat, Oman. P. O. Box 1331, Al Ghubra area 111. Electronic address: z_ambusaidi@hotmail","ambusaidi@hotmail.com"
"1194","34216735","10.1016/j.ijid.2021.06.056","Immunological predictors of disease severity in patients with COVID-19.","Identifying immune cells involved in COVID-19 disease progression and predictors of poor outcomes is important to manage patients adequately. A prospective observational cohort study enrolled 53 mild non-hospitalized and 48 hospitalized confirmed COVID-19 patients to a tertiary hospital in Oman. Hospitalized patients were older (58 years vs 36 years, p &lt;0.001) and had more comorbid conditions like diabetes (65 % Vs 21% p&lt;0.001). Hospitalized patients had significantly higher inflammatory m","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Immunological predictors; Inflammatory markers; lymphocyte subsets; mortality predictors","Balushi","Afra Al","Data and sample collection from inpatients and data entry. Address: Internal Medicine department, Royal Hospital, Muscat, Oman. P.O. Box 1331, Al Ghubra area 111. Electronic address: afraa.albalushi@gmail","afraa.albalushi@gmail.com"
"1195","34216735","10.1016/j.ijid.2021.06.056","Immunological predictors of disease severity in patients with COVID-19.","Identifying immune cells involved in COVID-19 disease progression and predictors of poor outcomes is important to manage patients adequately. A prospective observational cohort study enrolled 53 mild non-hospitalized and 48 hospitalized confirmed COVID-19 patients to a tertiary hospital in Oman. Hospitalized patients were older (58 years vs 36 years, p &lt;0.001) and had more comorbid conditions like diabetes (65 % Vs 21% p&lt;0.001). Hospitalized patients had significantly higher inflammatory m","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Immunological predictors; Inflammatory markers; lymphocyte subsets; mortality predictors","Huraizi","Aisha Al","Data and sample collection from inpatients and data entry. Address: Internal Medicine department, Royal Hospital, Muscat, Oman. P.O. Box 1331, Al Ghubra area 111. Electronic address: aisha.huraizi@gmail","aisha.huraizi@gmail.com"
"1196","34216735","10.1016/j.ijid.2021.06.056","Immunological predictors of disease severity in patients with COVID-19.","Identifying immune cells involved in COVID-19 disease progression and predictors of poor outcomes is important to manage patients adequately. A prospective observational cohort study enrolled 53 mild non-hospitalized and 48 hospitalized confirmed COVID-19 patients to a tertiary hospital in Oman. Hospitalized patients were older (58 years vs 36 years, p &lt;0.001) and had more comorbid conditions like diabetes (65 % Vs 21% p&lt;0.001). Hospitalized patients had significantly higher inflammatory m","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Immunological predictors; Inflammatory markers; lymphocyte subsets; mortality predictors","Sulaimi","Sumaiya Al","Data and sample collection from inpatients and data entry. Address: Internal Medicine department, Royal Hospital, Muscat, Oman. P.O. Box 1331, Al Ghubra area 111. Electronic address: samasoomi@hotmail","samasoomi@hotmail.com"
"1197","34216735","10.1016/j.ijid.2021.06.056","Immunological predictors of disease severity in patients with COVID-19.","Identifying immune cells involved in COVID-19 disease progression and predictors of poor outcomes is important to manage patients adequately. A prospective observational cohort study enrolled 53 mild non-hospitalized and 48 hospitalized confirmed COVID-19 patients to a tertiary hospital in Oman. Hospitalized patients were older (58 years vs 36 years, p &lt;0.001) and had more comorbid conditions like diabetes (65 % Vs 21% p&lt;0.001). Hospitalized patients had significantly higher inflammatory m","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Immunological predictors; Inflammatory markers; lymphocyte subsets; mortality predictors","Fahdi","Fatma Al","Data and sample collection from inpatients and data entry. Address: Internal Medicine department, Royal Hospital, Muscat, Oman. P.O. Box 1331, Al Ghubra area 111. Electronic address: alfahdi56370@yahoo","alfahdi56370@yahoo.com"
"1198","34216735","10.1016/j.ijid.2021.06.056","Immunological predictors of disease severity in patients with COVID-19.","Identifying immune cells involved in COVID-19 disease progression and predictors of poor outcomes is important to manage patients adequately. A prospective observational cohort study enrolled 53 mild non-hospitalized and 48 hospitalized confirmed COVID-19 patients to a tertiary hospital in Oman. Hospitalized patients were older (58 years vs 36 years, p &lt;0.001) and had more comorbid conditions like diabetes (65 % Vs 21% p&lt;0.001). Hospitalized patients had significantly higher inflammatory m","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Immunological predictors; Inflammatory markers; lymphocyte subsets; mortality predictors","Balushi","Iman Al","Data collection and entry for outpatients and second review of all data. Address: Sultan Qaboos University Hospital, Muscat, Oman. P. O. Box 35, Alkhoudh 123. Electronic address: emanalbeloshi@gmail","emanalbeloshi@gmail.com"
"1199","34216735","10.1016/j.ijid.2021.06.056","Immunological predictors of disease severity in patients with COVID-19.","Identifying immune cells involved in COVID-19 disease progression and predictors of poor outcomes is important to manage patients adequately. A prospective observational cohort study enrolled 53 mild non-hospitalized and 48 hospitalized confirmed COVID-19 patients to a tertiary hospital in Oman. Hospitalized patients were older (58 years vs 36 years, p &lt;0.001) and had more comorbid conditions like diabetes (65 % Vs 21% p&lt;0.001). Hospitalized patients had significantly higher inflammatory m","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Immunological predictors; Inflammatory markers; lymphocyte subsets; mortality predictors","Pandak","Nenad","Manuscript review and facilitating research work for inpatients. Address: Internal Medicine department, Royal Hospital, Muscat, Oman. P.O. Box 1331, Al Ghubra area 111. Electronic address: npandak@gmail","npandak@gmail.com"
"1200","34216735","10.1016/j.ijid.2021.06.056","Immunological predictors of disease severity in patients with COVID-19.","Identifying immune cells involved in COVID-19 disease progression and predictors of poor outcomes is important to manage patients adequately. A prospective observational cohort study enrolled 53 mild non-hospitalized and 48 hospitalized confirmed COVID-19 patients to a tertiary hospital in Oman. Hospitalized patients were older (58 years vs 36 years, p &lt;0.001) and had more comorbid conditions like diabetes (65 % Vs 21% p&lt;0.001). Hospitalized patients had significantly higher inflammatory m","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Immunological predictors; Inflammatory markers; lymphocyte subsets; mortality predictors","Fletcher","Tom","Overall supervision of the study and manuscript review. Address: Tropical and Infectious Diseases Unit, Royal Liverpool University Hospital, Prescot St, Liverpool L7 8XP, United Kingdom. Electronic address: tom.fletcher@lstmed.ac","tom.fletcher@lstmed.ac.uk"
"1201","34216735","10.1016/j.ijid.2021.06.056","Immunological predictors of disease severity in patients with COVID-19.","Identifying immune cells involved in COVID-19 disease progression and predictors of poor outcomes is important to manage patients adequately. A prospective observational cohort study enrolled 53 mild non-hospitalized and 48 hospitalized confirmed COVID-19 patients to a tertiary hospital in Oman. Hospitalized patients were older (58 years vs 36 years, p &lt;0.001) and had more comorbid conditions like diabetes (65 % Vs 21% p&lt;0.001). Hospitalized patients had significantly higher inflammatory m","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Immunological predictors; Inflammatory markers; lymphocyte subsets; mortality predictors","Nasr","Iman","Proposal review, registered the study, communication with laboratories and companies, manuscript review, and overall workflow and integrity supervision. Address: Internal Medicine department, Royal Hospital, Muscat, Oman. P.O. Box 1331, Al Ghubra area 111",NA
"1202","34216734","10.1016/j.ijid.2021.06.059","Relative risks of Covid-19 fatality between the first and second waves of the pandemic in Ontario, Canada.","To examine whether the case fatality rate (CFR) of coronavirus disease 2019 (Covid-19) decreased overtime, and whether the Covid-19 testing rate is a driving factor for the changes if the CFR decreased. Analyzing Covid-19 cases, deaths, and tests in Ontario, Canada, we compared the CFR between the first wave and the second wave across 26 Public Health Units in Ontario. We also explored whether a high testing rate was associated with a large CFR decrease. The first wave CFR ranged from 0.004 to 0","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Hsu","Sylvia H","Schulich School of Business, York University, Toronto, Ontario, Canada",NA
"1203","34216734","10.1016/j.ijid.2021.06.059","Relative risks of Covid-19 fatality between the first and second waves of the pandemic in Ontario, Canada.","To examine whether the case fatality rate (CFR) of coronavirus disease 2019 (Covid-19) decreased overtime, and whether the Covid-19 testing rate is a driving factor for the changes if the CFR decreased. Analyzing Covid-19 cases, deaths, and tests in Ontario, Canada, we compared the CFR between the first wave and the second wave across 26 Public Health Units in Ontario. We also explored whether a high testing rate was associated with a large CFR decrease. The first wave CFR ranged from 0.004 to 0","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Chang","Su-Hsin","Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA",NA
"1204","34216734","10.1016/j.ijid.2021.06.059","Relative risks of Covid-19 fatality between the first and second waves of the pandemic in Ontario, Canada.","To examine whether the case fatality rate (CFR) of coronavirus disease 2019 (Covid-19) decreased overtime, and whether the Covid-19 testing rate is a driving factor for the changes if the CFR decreased. Analyzing Covid-19 cases, deaths, and tests in Ontario, Canada, we compared the CFR between the first wave and the second wave across 26 Public Health Units in Ontario. We also explored whether a high testing rate was associated with a large CFR decrease. The first wave CFR ranged from 0.004 to 0","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Gross","Cary","Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA",NA
"1205","34216734","10.1016/j.ijid.2021.06.059","Relative risks of Covid-19 fatality between the first and second waves of the pandemic in Ontario, Canada.","To examine whether the case fatality rate (CFR) of coronavirus disease 2019 (Covid-19) decreased overtime, and whether the Covid-19 testing rate is a driving factor for the changes if the CFR decreased. Analyzing Covid-19 cases, deaths, and tests in Ontario, Canada, we compared the CFR between the first wave and the second wave across 26 Public Health Units in Ontario. We also explored whether a high testing rate was associated with a large CFR decrease. The first wave CFR ranged from 0.004 to 0","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Wang","Shi-Yi","Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA","shiyi.wang@yale.edu"
"1206","34216732","10.1016/j.ijid.2021.06.060","Danish Citizen´s Preferences for at-home Oropharyngeal/nasal SARS-CoV-2 Specimen Collection.","Diagnostic confirmation of SARS-CoV-2 by self-collection of specimens is a reliable method compared to healthcare worker collected samples. Citizen's preferences for collection method are unknown, but at-home collection could have several advantages. This study investigated the preference for guided at-home self-collection versus at-hospital specimen collection by healthcare workers. Among the 3,709 participants, an at-home swab collection was the preferred setting for 2,362 (63.7%), as compared","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Diagnostic testing; Patient-reported Outcome; Randomized Clinical Trial","Bundgaard","Johan S","Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: johan.bundgaard@gmail","johan.bundgaard@gmail.com"
"1207","34216732","10.1016/j.ijid.2021.06.060","Danish Citizen´s Preferences for at-home Oropharyngeal/nasal SARS-CoV-2 Specimen Collection.","Diagnostic confirmation of SARS-CoV-2 by self-collection of specimens is a reliable method compared to healthcare worker collected samples. Citizen's preferences for collection method are unknown, but at-home collection could have several advantages. This study investigated the preference for guided at-home self-collection versus at-hospital specimen collection by healthcare workers. Among the 3,709 participants, an at-home swab collection was the preferred setting for 2,362 (63.7%), as compared","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Diagnostic testing; Patient-reported Outcome; Randomized Clinical Trial","Raaschou-Pedersen","Daniel T","Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark",NA
"1208","34216732","10.1016/j.ijid.2021.06.060","Danish Citizen´s Preferences for at-home Oropharyngeal/nasal SARS-CoV-2 Specimen Collection.","Diagnostic confirmation of SARS-CoV-2 by self-collection of specimens is a reliable method compared to healthcare worker collected samples. Citizen's preferences for collection method are unknown, but at-home collection could have several advantages. This study investigated the preference for guided at-home self-collection versus at-hospital specimen collection by healthcare workers. Among the 3,709 participants, an at-home swab collection was the preferred setting for 2,362 (63.7%), as compared","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Diagnostic testing; Patient-reported Outcome; Randomized Clinical Trial","Todsen","Tobias","Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark",NA
"1209","34216732","10.1016/j.ijid.2021.06.060","Danish Citizen´s Preferences for at-home Oropharyngeal/nasal SARS-CoV-2 Specimen Collection.","Diagnostic confirmation of SARS-CoV-2 by self-collection of specimens is a reliable method compared to healthcare worker collected samples. Citizen's preferences for collection method are unknown, but at-home collection could have several advantages. This study investigated the preference for guided at-home self-collection versus at-hospital specimen collection by healthcare workers. Among the 3,709 participants, an at-home swab collection was the preferred setting for 2,362 (63.7%), as compared","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Diagnostic testing; Patient-reported Outcome; Randomized Clinical Trial","Ringgaard","Anna","Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark",NA
"1210","34216732","10.1016/j.ijid.2021.06.060","Danish Citizen´s Preferences for at-home Oropharyngeal/nasal SARS-CoV-2 Specimen Collection.","Diagnostic confirmation of SARS-CoV-2 by self-collection of specimens is a reliable method compared to healthcare worker collected samples. Citizen's preferences for collection method are unknown, but at-home collection could have several advantages. This study investigated the preference for guided at-home self-collection versus at-hospital specimen collection by healthcare workers. Among the 3,709 participants, an at-home swab collection was the preferred setting for 2,362 (63.7%), as compared","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Diagnostic testing; Patient-reported Outcome; Randomized Clinical Trial","Torp-Pedersen","Christian","Department of Clinical Research and Cardiology, Nordsjaellands Hospital, Hillerød, Denmark",NA
"1211","34216732","10.1016/j.ijid.2021.06.060","Danish Citizen´s Preferences for at-home Oropharyngeal/nasal SARS-CoV-2 Specimen Collection.","Diagnostic confirmation of SARS-CoV-2 by self-collection of specimens is a reliable method compared to healthcare worker collected samples. Citizen's preferences for collection method are unknown, but at-home collection could have several advantages. This study investigated the preference for guided at-home self-collection versus at-hospital specimen collection by healthcare workers. Among the 3,709 participants, an at-home swab collection was the preferred setting for 2,362 (63.7%), as compared","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Diagnostic testing; Patient-reported Outcome; Randomized Clinical Trial","Von Buchwald","Christian","Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark",NA
"1212","34216732","10.1016/j.ijid.2021.06.060","Danish Citizen´s Preferences for at-home Oropharyngeal/nasal SARS-CoV-2 Specimen Collection.","Diagnostic confirmation of SARS-CoV-2 by self-collection of specimens is a reliable method compared to healthcare worker collected samples. Citizen's preferences for collection method are unknown, but at-home collection could have several advantages. This study investigated the preference for guided at-home self-collection versus at-hospital specimen collection by healthcare workers. Among the 3,709 participants, an at-home swab collection was the preferred setting for 2,362 (63.7%), as compared","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Diagnostic testing; Patient-reported Outcome; Randomized Clinical Trial","Iversen","Kasper","Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark",NA
"1213","34216732","10.1016/j.ijid.2021.06.060","Danish Citizen´s Preferences for at-home Oropharyngeal/nasal SARS-CoV-2 Specimen Collection.","Diagnostic confirmation of SARS-CoV-2 by self-collection of specimens is a reliable method compared to healthcare worker collected samples. Citizen's preferences for collection method are unknown, but at-home collection could have several advantages. This study investigated the preference for guided at-home self-collection versus at-hospital specimen collection by healthcare workers. Among the 3,709 participants, an at-home swab collection was the preferred setting for 2,362 (63.7%), as compared","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Diagnostic testing; Patient-reported Outcome; Randomized Clinical Trial","Bundgaard","Henning","Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark",NA
"1214","34216731","10.1016/j.ijid.2021.06.058","The indirect impact of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia in the elderly: a region-wide population-based study in Tuscany, Italy.","to evaluate the indirect effect of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia (CAP) in the elderly during the first epidemic wave of COVID-19 in Tuscany, Italy. a population based study was carried out on data from the Tuscany healthcare system. The outcome measures were: hospitalization rate for CAP, severity of CAP hospitalizations, and outpatient consumptions of antibacterials for CAP in people aged 65 years and older. Outcome comparisons betwee","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","Community-acquired pneumonia, Elderly population, COVID-19, Pandemic, Containment measures; Indirect effect","Lastrucci","Vieri","Epidemiology Unit, Meyer Children's University Hospital, Viale Gaetano Pieraccini 24, 50139, Florence, Italy","vieri.lastrucci@meyer.it"
"1215","34216731","10.1016/j.ijid.2021.06.058","The indirect impact of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia in the elderly: a region-wide population-based study in Tuscany, Italy.","to evaluate the indirect effect of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia (CAP) in the elderly during the first epidemic wave of COVID-19 in Tuscany, Italy. a population based study was carried out on data from the Tuscany healthcare system. The outcome measures were: hospitalization rate for CAP, severity of CAP hospitalizations, and outpatient consumptions of antibacterials for CAP in people aged 65 years and older. Outcome comparisons betwee","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","Community-acquired pneumonia, Elderly population, COVID-19, Pandemic, Containment measures; Indirect effect","Bonaccorsi","Guglielmo","Department of Health Sciences, University of Florence, Viale GB Morgagni 48, 50134, Florence, Italy",NA
"1216","34216731","10.1016/j.ijid.2021.06.058","The indirect impact of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia in the elderly: a region-wide population-based study in Tuscany, Italy.","to evaluate the indirect effect of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia (CAP) in the elderly during the first epidemic wave of COVID-19 in Tuscany, Italy. a population based study was carried out on data from the Tuscany healthcare system. The outcome measures were: hospitalization rate for CAP, severity of CAP hospitalizations, and outpatient consumptions of antibacterials for CAP in people aged 65 years and older. Outcome comparisons betwee","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","Community-acquired pneumonia, Elderly population, COVID-19, Pandemic, Containment measures; Indirect effect","Forni","Silvia","Quality and Equity Unit, Regional Health Agency of Tuscany, Via Pietro Dazzi 1, 50141, Florence, Italy",NA
"1217","34216731","10.1016/j.ijid.2021.06.058","The indirect impact of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia in the elderly: a region-wide population-based study in Tuscany, Italy.","to evaluate the indirect effect of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia (CAP) in the elderly during the first epidemic wave of COVID-19 in Tuscany, Italy. a population based study was carried out on data from the Tuscany healthcare system. The outcome measures were: hospitalization rate for CAP, severity of CAP hospitalizations, and outpatient consumptions of antibacterials for CAP in people aged 65 years and older. Outcome comparisons betwee","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","Community-acquired pneumonia, Elderly population, COVID-19, Pandemic, Containment measures; Indirect effect","D'Arienzo","Sara","Quality and Equity Unit, Regional Health Agency of Tuscany, Via Pietro Dazzi 1, 50141, Florence, Italy",NA
"1218","34216731","10.1016/j.ijid.2021.06.058","The indirect impact of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia in the elderly: a region-wide population-based study in Tuscany, Italy.","to evaluate the indirect effect of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia (CAP) in the elderly during the first epidemic wave of COVID-19 in Tuscany, Italy. a population based study was carried out on data from the Tuscany healthcare system. The outcome measures were: hospitalization rate for CAP, severity of CAP hospitalizations, and outpatient consumptions of antibacterials for CAP in people aged 65 years and older. Outcome comparisons betwee","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","Community-acquired pneumonia, Elderly population, COVID-19, Pandemic, Containment measures; Indirect effect","Bachini","Letizia","Quality and Equity Unit, Regional Health Agency of Tuscany, Via Pietro Dazzi 1, 50141, Florence, Italy",NA
"1219","34216731","10.1016/j.ijid.2021.06.058","The indirect impact of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia in the elderly: a region-wide population-based study in Tuscany, Italy.","to evaluate the indirect effect of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia (CAP) in the elderly during the first epidemic wave of COVID-19 in Tuscany, Italy. a population based study was carried out on data from the Tuscany healthcare system. The outcome measures were: hospitalization rate for CAP, severity of CAP hospitalizations, and outpatient consumptions of antibacterials for CAP in people aged 65 years and older. Outcome comparisons betwee","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","Community-acquired pneumonia, Elderly population, COVID-19, Pandemic, Containment measures; Indirect effect","Paoli","Sonia","Medical Specialization School of Hygiene and Preventive Medicine, University of Florence, 50134 Florence, Italy",NA
"1220","34216731","10.1016/j.ijid.2021.06.058","The indirect impact of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia in the elderly: a region-wide population-based study in Tuscany, Italy.","to evaluate the indirect effect of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia (CAP) in the elderly during the first epidemic wave of COVID-19 in Tuscany, Italy. a population based study was carried out on data from the Tuscany healthcare system. The outcome measures were: hospitalization rate for CAP, severity of CAP hospitalizations, and outpatient consumptions of antibacterials for CAP in people aged 65 years and older. Outcome comparisons betwee","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","Community-acquired pneumonia, Elderly population, COVID-19, Pandemic, Containment measures; Indirect effect","Lorini","Chiara","Department of Health Sciences, University of Florence, Viale GB Morgagni 48, 50134, Florence, Italy",NA
"1221","34216731","10.1016/j.ijid.2021.06.058","The indirect impact of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia in the elderly: a region-wide population-based study in Tuscany, Italy.","to evaluate the indirect effect of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia (CAP) in the elderly during the first epidemic wave of COVID-19 in Tuscany, Italy. a population based study was carried out on data from the Tuscany healthcare system. The outcome measures were: hospitalization rate for CAP, severity of CAP hospitalizations, and outpatient consumptions of antibacterials for CAP in people aged 65 years and older. Outcome comparisons betwee","2021","07","05","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","Community-acquired pneumonia, Elderly population, COVID-19, Pandemic, Containment measures; Indirect effect","Gemmi","Fabrizio","Quality and Equity Unit, Regional Health Agency of Tuscany, Via Pietro Dazzi 1, 50141, Florence, Italy",NA
"1222","34216675","10.1016/j.kint.2021.06.025","Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis.",NA,"2021","07","17","Kidney Int","Kidney international",NA,"Ducloux","Didier","Department of Nephrology, Dialysis, and Renal Transplantation, CHU Besançon, Federation Hospitalo-Universitaire INCREASE, Besançon, France. Electronic address: didier.ducloux@univ-fcomte",NA
"1223","34216675","10.1016/j.kint.2021.06.025","Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis.",NA,"2021","07","17","Kidney Int","Kidney international",NA,"Colladant","M","Department of Nephrology, Dialysis, and Renal Transplantation, CHU Besançon, Federation Hospitalo-Universitaire INCREASE, Besançon, France",NA
"1224","34216675","10.1016/j.kint.2021.06.025","Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis.",NA,"2021","07","17","Kidney Int","Kidney international",NA,"Chabannes","M","Department of Nephrology, Dialysis, and Renal Transplantation, CHU Besançon, Federation Hospitalo-Universitaire INCREASE, Besançon, France",NA
"1225","34216675","10.1016/j.kint.2021.06.025","Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis.",NA,"2021","07","17","Kidney Int","Kidney international",NA,"Yannaraki","M","Department of Nephrology, Dialysis, and Renal Transplantation, CHU Besançon, Federation Hospitalo-Universitaire INCREASE, Besançon, France",NA
"1226","34216675","10.1016/j.kint.2021.06.025","Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis.",NA,"2021","07","17","Kidney Int","Kidney international",NA,"Courivaud","C","Department of Nephrology, Dialysis, and Renal Transplantation, CHU Besançon, Federation Hospitalo-Universitaire INCREASE, Besançon, France",NA
"1227","34216637","10.1016/j.jinf.2021.06.020","A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV.",NA,"2021","07","12","J Infect","The Journal of infection",NA,"Xie","Dongying","Department of Biology, Hong Kong Baptist University, Hong Kong, China",NA
"1228","34216637","10.1016/j.jinf.2021.06.020","A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV.",NA,"2021","07","12","J Infect","The Journal of infection",NA,"Chu","Hin","Department of Microbiology, the University of Hong Kong, Hong Kong, China",NA
"1229","34216637","10.1016/j.jinf.2021.06.020","A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV.",NA,"2021","07","12","J Infect","The Journal of infection",NA,"Yang","Dong","Department of Microbiology, the University of Hong Kong, Hong Kong, China",NA
"1230","34216637","10.1016/j.jinf.2021.06.020","A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV.",NA,"2021","07","12","J Infect","The Journal of infection",NA,"Ding","Qiutao","Department of Biology, Hong Kong Baptist University, Hong Kong, China",NA
"1231","34216637","10.1016/j.jinf.2021.06.020","A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV.",NA,"2021","07","12","J Infect","The Journal of infection",NA,"Huang","Gefei","Department of Biology, Hong Kong Baptist University, Hong Kong, China",NA
"1232","34216637","10.1016/j.jinf.2021.06.020","A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV.",NA,"2021","07","12","J Infect","The Journal of infection",NA,"Chen","Luo","Department of Biology, Hong Kong Baptist University, Hong Kong, China",NA
"1233","34216637","10.1016/j.jinf.2021.06.020","A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV.",NA,"2021","07","12","J Infect","The Journal of infection",NA,"Cai","Zongwei","State Key Laboratory of Environmental and Biological Analysis, Hong Kong Baptist University, Hong Kong, China","zwcai@hkbu.edu.hk"
"1234","34216637","10.1016/j.jinf.2021.06.020","A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV.",NA,"2021","07","12","J Infect","The Journal of infection",NA,"Huang","Jiandong","School of Biomedical Sciences, the University of Hong Kong, China","jdhuang@hku.hk"
"1235","34216637","10.1016/j.jinf.2021.06.020","A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV.",NA,"2021","07","12","J Infect","The Journal of infection",NA,"Zhao","Zhongying","Department of Biology, Hong Kong Baptist University, Hong Kong, China","zyzhao@hkbu.edu.hk"
"1236","34216636","10.1016/j.mbs.2021.108654","Optimal allocation of limited vaccine to minimize the effective reproduction number.","We examine the problem of allocating a limited supply of vaccine for controlling an infectious disease with the goal of minimizing the effective reproduction number Re. We consider an SIR model with two interacting populations and develop an analytical expression that the optimal vaccine allocation must satisfy. With limited vaccine supplies, we find that an all-or-nothing approach is optimal. For certain special cases, we determine the conditions under which the optimal Re","2021","07","16","Math Biosci","Mathematical biosciences","COVID-19; Dynamic disease model; Epidemic control; Health policy; Optimization; Vaccine allocation","Rao","Isabelle J","Department of Management Science and Engineering, Stanford University, Stanford, CA, United States of America. Electronic address: isarao@stanford","isarao@stanford.edu"
"1237","34216636","10.1016/j.mbs.2021.108654","Optimal allocation of limited vaccine to minimize the effective reproduction number.","We examine the problem of allocating a limited supply of vaccine for controlling an infectious disease with the goal of minimizing the effective reproduction number Re. We consider an SIR model with two interacting populations and develop an analytical expression that the optimal vaccine allocation must satisfy. With limited vaccine supplies, we find that an all-or-nothing approach is optimal. For certain special cases, we determine the conditions under which the optimal Re","2021","07","16","Math Biosci","Mathematical biosciences","COVID-19; Dynamic disease model; Epidemic control; Health policy; Optimization; Vaccine allocation","Brandeau","Margaret L","Department of Management Science and Engineering, Stanford University, Stanford, CA, United States of America. Electronic address: brandeau@stanford","brandeau@stanford.edu"
"1238","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Kühn","Martin J","Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany. Electronic address: Martin.Kuehn@DLR","Martin.Kuehn@DLR.de"
"1239","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Abele","Daniel","Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany",NA
"1240","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Mitra","Tanmay","Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany",NA
"1241","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Koslow","Wadim","Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany",NA
"1242","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Abedi","Majid","Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany",NA
"1243","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Rack","Kathrin","Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany",NA
"1244","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Siggel","Martin","Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany",NA
"1245","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Khailaie","Sahamoddin","Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany",NA
"1246","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Klitz","Margrit","Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany",NA
"1247","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Binder","Sebastian","Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany",NA
"1248","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Spataro","Luca","Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany",NA
"1249","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Gilg","Jonas","Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany",NA
"1250","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Kleinert","Jan","Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany",NA
"1251","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Häberle","Matthias","Earth Observation Center, Department EO Data Science, German Aerospace Center, Weßling, Germany",NA
"1252","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Plötzke","Lena","Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany",NA
"1253","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Spinner","Christoph D","Technical University of Munich, School of Medicine, University Hospital rechts der Isar, Department of Internal Medicine II, Munich, Germany",NA
"1254","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Stecher","Melanie","University Hospital of Cologne, Department I for Internal Medicine, University of Cologne",NA
"1255","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Zhu","Xiao Xiang","Earth Observation Center, Department EO Data Science, German Aerospace Center, Weßling, Germany",NA
"1256","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Basermann","Achim","Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany. Electronic address: Achim.Basermann@DLR","Achim.Basermann@DLR.de"
"1257","34216635","10.1016/j.mbs.2021.108648","Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.","Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependenc","2021","07","16","Math Biosci","Mathematical biosciences","Coronavirus disease; Covid-19; Forecast; Mitigation; Non-pharmaceutical interventions; SARS-CoV-2","Meyer-Hermann","Michael","Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany. Electronic address: MMH@Theoretical-Biology",NA
"1258","34216613","10.1016/j.envres.2021.111609","Impact of sewer overflow on public health: A comprehensive scientometric analysis and systematic review.","Sewer overflow (SO), which has attracted global attention, poses serious threat to public health and ecosystem. SO impacts public health via consumption of contaminated drinking water, aerosolization of pathogens, food-chain transmission, and direct contact with fecally-polluted rivers and beach sediments during recreation. However, no study has attempted to map the linkage between SO and public health including Covid-19 using scientometric analysis and systematic review of literature. Results s","2021","07","03","Environ Res","Environmental research","Covid-19; Public health; Scientometric; Sewer overflow; Systematic review","Ao","Sojobi","Department of Building and Real Estate, The Hong Kong Polytechnic University, Hong Kong, China. Electronic address: adebayo-olatunbosun.sojobi@polyu.edu","olatunbosun.sojobi@polyu.edu.hk"
"1259","34216613","10.1016/j.envres.2021.111609","Impact of sewer overflow on public health: A comprehensive scientometric analysis and systematic review.","Sewer overflow (SO), which has attracted global attention, poses serious threat to public health and ecosystem. SO impacts public health via consumption of contaminated drinking water, aerosolization of pathogens, food-chain transmission, and direct contact with fecally-polluted rivers and beach sediments during recreation. However, no study has attempted to map the linkage between SO and public health including Covid-19 using scientometric analysis and systematic review of literature. Results s","2021","07","03","Environ Res","Environmental research","Covid-19; Public health; Scientometric; Sewer overflow; Systematic review","Zayed","Tarek","Department of Building and Real Estate, The Hong Kong Polytechnic University, Hong Kong, China. Electronic address: tarek.zayed@polyu.edu","tarek.zayed@polyu.edu.hk"
"1260","34216593","10.1016/j.physbeh.2021.113513","Implications of surgical mask use in physical education lessons.","COVID-19 is being a huge challenge for education systems. Mandatory use of face masks in presential classes may lead to psychophysiological impairment of students, which affect lessons. Thus, the aim of the present research was to analyze the effect of mask use in basal psychophysiological status of physical education students prior to a physical education lesson. We analyzed 72 physical education students in two moments prior to two physical education lessons with 48 h between them. Blood oxyge","2021","07","23","Physiol Behav","Physiology &amp; behavior","Blood oxygen saturation; Covid-19; Education; Fatigue; Heart rate variability; Surgical mask","Tornero-Aguilera","José F","Faculty of Sport Sciences, Universidad Europea de Madrid, 28670 Villaviciosa de Odón, Spain",NA
"1261","34216593","10.1016/j.physbeh.2021.113513","Implications of surgical mask use in physical education lessons.","COVID-19 is being a huge challenge for education systems. Mandatory use of face masks in presential classes may lead to psychophysiological impairment of students, which affect lessons. Thus, the aim of the present research was to analyze the effect of mask use in basal psychophysiological status of physical education students prior to a physical education lesson. We analyzed 72 physical education students in two moments prior to two physical education lessons with 48 h between them. Blood oxyge","2021","07","23","Physiol Behav","Physiology &amp; behavior","Blood oxygen saturation; Covid-19; Education; Fatigue; Heart rate variability; Surgical mask","Rubio-Zarapuz","Alejandro","Faculty of Sport Sciences, Universidad Europea de Madrid, 28670 Villaviciosa de Odón, Spain. Electronic address: alejandro.rubio.z@hotmail","alejandro.rubio.z@hotmail.com"
"1262","34216593","10.1016/j.physbeh.2021.113513","Implications of surgical mask use in physical education lessons.","COVID-19 is being a huge challenge for education systems. Mandatory use of face masks in presential classes may lead to psychophysiological impairment of students, which affect lessons. Thus, the aim of the present research was to analyze the effect of mask use in basal psychophysiological status of physical education students prior to a physical education lesson. We analyzed 72 physical education students in two moments prior to two physical education lessons with 48 h between them. Blood oxyge","2021","07","23","Physiol Behav","Physiology &amp; behavior","Blood oxygen saturation; Covid-19; Education; Fatigue; Heart rate variability; Surgical mask","Clemente-Suárez","Vicente J","Faculty of Sport Sciences, Universidad Europea de Madrid, 28670 Villaviciosa de Odón, Spain","vicentejavier.clemente@universidadeuropea.es"
"1263","34216553","10.1016/j.jamda.2021.06.005","Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study.","To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Observational study. Altogether 1785 patients diagnosed with COVID-19 and 6744 hospitalized for non-COVID-19 causes at 7 geriatric clinics in Stockholm from March 6 to July 31, 2020, were included. Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poiss","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; geriatric; mortality","Xu","Hong","Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden. Electronic address: hong.xu.2@ki",NA
"1264","34216553","10.1016/j.jamda.2021.06.005","Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study.","To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Observational study. Altogether 1785 patients diagnosed with COVID-19 and 6744 hospitalized for non-COVID-19 causes at 7 geriatric clinics in Stockholm from March 6 to July 31, 2020, were included. Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poiss","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; geriatric; mortality","Garcia-Ptacek","Sara","Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden",NA
"1265","34216553","10.1016/j.jamda.2021.06.005","Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study.","To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Observational study. Altogether 1785 patients diagnosed with COVID-19 and 6744 hospitalized for non-COVID-19 causes at 7 geriatric clinics in Stockholm from March 6 to July 31, 2020, were included. Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poiss","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; geriatric; mortality","Annetorp","Martin","Theme Aging, Karolinska University Hospital, Stockholm, Sweden",NA
"1266","34216553","10.1016/j.jamda.2021.06.005","Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study.","To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Observational study. Altogether 1785 patients diagnosed with COVID-19 and 6744 hospitalized for non-COVID-19 causes at 7 geriatric clinics in Stockholm from March 6 to July 31, 2020, were included. Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poiss","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; geriatric; mortality","Cederholm","Tommy","Theme Aging, Karolinska University Hospital, Stockholm, Sweden",NA
"1267","34216553","10.1016/j.jamda.2021.06.005","Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study.","To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Observational study. Altogether 1785 patients diagnosed with COVID-19 and 6744 hospitalized for non-COVID-19 causes at 7 geriatric clinics in Stockholm from March 6 to July 31, 2020, were included. Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poiss","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; geriatric; mortality","Engel","Georg","R&amp",NA
"1268","34216553","10.1016/j.jamda.2021.06.005","Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study.","To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Observational study. Altogether 1785 patients diagnosed with COVID-19 and 6744 hospitalized for non-COVID-19 causes at 7 geriatric clinics in Stockholm from March 6 to July 31, 2020, were included. Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poiss","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; geriatric; mortality","Engström","Malin","Department of Geriatric medicine, Sabbatsbergsgeriatriken, Stockholm, Sweden",NA
"1269","34216553","10.1016/j.jamda.2021.06.005","Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study.","To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Observational study. Altogether 1785 patients diagnosed with COVID-19 and 6744 hospitalized for non-COVID-19 causes at 7 geriatric clinics in Stockholm from March 6 to July 31, 2020, were included. Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poiss","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; geriatric; mortality","Erlandsson","Håkan","Department of Geriatric medicine, Jakobsbergsgeriatriken, Stockholm, Sweden",NA
"1270","34216553","10.1016/j.jamda.2021.06.005","Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study.","To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Observational study. Altogether 1785 patients diagnosed with COVID-19 and 6744 hospitalized for non-COVID-19 causes at 7 geriatric clinics in Stockholm from March 6 to July 31, 2020, were included. Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poiss","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; geriatric; mortality","Julius","Charlotte","Department of Geriatric medicine, Dalengeriatriken Aleris Närsjukvård AB, Stockholm, Sweden",NA
"1271","34216553","10.1016/j.jamda.2021.06.005","Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study.","To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Observational study. Altogether 1785 patients diagnosed with COVID-19 and 6744 hospitalized for non-COVID-19 causes at 7 geriatric clinics in Stockholm from March 6 to July 31, 2020, were included. Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poiss","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; geriatric; mortality","Kivipelto","Miia","Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden",NA
"1272","34216553","10.1016/j.jamda.2021.06.005","Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study.","To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Observational study. Altogether 1785 patients diagnosed with COVID-19 and 6744 hospitalized for non-COVID-19 causes at 7 geriatric clinics in Stockholm from March 6 to July 31, 2020, were included. Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poiss","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; geriatric; mortality","Lundberg","Lars Göran","Department of Geriatric medicine, Dalengeriatriken Aleris Närsjukvård AB, Stockholm, Sweden",NA
"1273","34216553","10.1016/j.jamda.2021.06.005","Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study.","To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Observational study. Altogether 1785 patients diagnosed with COVID-19 and 6744 hospitalized for non-COVID-19 causes at 7 geriatric clinics in Stockholm from March 6 to July 31, 2020, were included. Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poiss","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; geriatric; mortality","Metzner","Carina","Theme Aging, Karolinska University Hospital, Stockholm, Sweden",NA
"1274","34216553","10.1016/j.jamda.2021.06.005","Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study.","To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Observational study. Altogether 1785 patients diagnosed with COVID-19 and 6744 hospitalized for non-COVID-19 causes at 7 geriatric clinics in Stockholm from March 6 to July 31, 2020, were included. Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poiss","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; geriatric; mortality","Sandberg","Linda","Department of Geriatric medicine, Dalengeriatriken Aleris Närsjukvård AB, Stockholm, Sweden",NA
"1275","34216553","10.1016/j.jamda.2021.06.005","Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study.","To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Observational study. Altogether 1785 patients diagnosed with COVID-19 and 6744 hospitalized for non-COVID-19 causes at 7 geriatric clinics in Stockholm from March 6 to July 31, 2020, were included. Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poiss","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; geriatric; mortality","Nyvang","Josefina Skogö","Department of Geriatric medicine, Capio Geriatrik Nacka AB, Nacka, Sweden",NA
"1276","34216553","10.1016/j.jamda.2021.06.005","Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study.","To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Observational study. Altogether 1785 patients diagnosed with COVID-19 and 6744 hospitalized for non-COVID-19 causes at 7 geriatric clinics in Stockholm from March 6 to July 31, 2020, were included. Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poiss","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; geriatric; mortality","Öberg","Carina Sühl","Department of Geriatric medicine, Handengeriatriken, Aleris Närsjukvård AB, Stockholm, Sweden",NA
"1277","34216553","10.1016/j.jamda.2021.06.005","Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study.","To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Observational study. Altogether 1785 patients diagnosed with COVID-19 and 6744 hospitalized for non-COVID-19 causes at 7 geriatric clinics in Stockholm from March 6 to July 31, 2020, were included. Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poiss","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; geriatric; mortality","Åkesson","Elisabet","R&amp",NA
"1278","34216553","10.1016/j.jamda.2021.06.005","Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study.","To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Observational study. Altogether 1785 patients diagnosed with COVID-19 and 6744 hospitalized for non-COVID-19 causes at 7 geriatric clinics in Stockholm from March 6 to July 31, 2020, were included. Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poiss","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; geriatric; mortality","Religa","Dorota","Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden",NA
"1279","34216553","10.1016/j.jamda.2021.06.005","Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study.","To describe temporal changes in treatment, care, and short-term mortality outcomes of geriatric patients during the first wave of the COVID-19 pandemic. Observational study. Altogether 1785 patients diagnosed with COVID-19 and 6744 hospitalized for non-COVID-19 causes at 7 geriatric clinics in Stockholm from March 6 to July 31, 2020, were included. Across admission month, patient vital signs and pharmacological treatment in relationship to risk for in-hospital death were analyzed using the Poiss","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; geriatric; mortality","Eriksdotter","Maria","Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden",NA
"1280","34216547","10.1016/S2213-2600(21)00312-X","Implications of the second wave of COVID-19 in India.",NA,"2021","07","05","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Asrani","Purva","Department of Microbiology, University of Delhi, New Delhi, India",NA
"1281","34216547","10.1016/S2213-2600(21)00312-X","Implications of the second wave of COVID-19 in India.",NA,"2021","07","05","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Eapen","Mathew Suji","Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS 7248, Australia",NA
"1282","34216547","10.1016/S2213-2600(21)00312-X","Implications of the second wave of COVID-19 in India.",NA,"2021","07","05","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Hassan","Md Imtaiyaz","Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India",NA
"1283","34216547","10.1016/S2213-2600(21)00312-X","Implications of the second wave of COVID-19 in India.",NA,"2021","07","05","Lancet Respir Med","The Lancet. Respiratory medicine",NA,"Sohal","Sukhwinder Singh","Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS 7248, Australia. Electronic address: sssohal@utas.edu","sssohal@utas.edu.au"
"1284","34216513","10.1002/ca.23762","Performing nasopharyngeal swabs-Guidelines based on an anatomical study.","Nasopharyngeal swabs are performed to collect material for diagnosing diseases affecting the respiratory system, such as Covid-19. Yet, no systematic anatomical study defines concrete prerequisites for successfully targeting the nasopharyngeal mucosa. We therefore aim at simulating nasopharyngeal swabs in human body donors to characterize parameters allowing and supporting to enter the nasopharynx with a swab, while avoiding endangering the cribriform plate. With the aid of metal probes and comm","2021","07","13","Clin Anat","Clinical anatomy (New York, N.Y.)","Covid-19; SARS-CoV-2; anatomy; nasopharynx; respiratory","Pruidze","Paata","Division of Anatomy, Medical University of Vienna, Vienna, Austria",NA
"1285","34216513","10.1002/ca.23762","Performing nasopharyngeal swabs-Guidelines based on an anatomical study.","Nasopharyngeal swabs are performed to collect material for diagnosing diseases affecting the respiratory system, such as Covid-19. Yet, no systematic anatomical study defines concrete prerequisites for successfully targeting the nasopharyngeal mucosa. We therefore aim at simulating nasopharyngeal swabs in human body donors to characterize parameters allowing and supporting to enter the nasopharynx with a swab, while avoiding endangering the cribriform plate. With the aid of metal probes and comm","2021","07","13","Clin Anat","Clinical anatomy (New York, N.Y.)","Covid-19; SARS-CoV-2; anatomy; nasopharynx; respiratory","Mincheva","Plamena","Division of Anatomy, Medical University of Vienna, Vienna, Austria",NA
"1286","34216513","10.1002/ca.23762","Performing nasopharyngeal swabs-Guidelines based on an anatomical study.","Nasopharyngeal swabs are performed to collect material for diagnosing diseases affecting the respiratory system, such as Covid-19. Yet, no systematic anatomical study defines concrete prerequisites for successfully targeting the nasopharyngeal mucosa. We therefore aim at simulating nasopharyngeal swabs in human body donors to characterize parameters allowing and supporting to enter the nasopharynx with a swab, while avoiding endangering the cribriform plate. With the aid of metal probes and comm","2021","07","13","Clin Anat","Clinical anatomy (New York, N.Y.)","Covid-19; SARS-CoV-2; anatomy; nasopharynx; respiratory","Weninger","Jeremias T","Division of Anatomy, Medical University of Vienna, Vienna, Austria",NA
"1287","34216513","10.1002/ca.23762","Performing nasopharyngeal swabs-Guidelines based on an anatomical study.","Nasopharyngeal swabs are performed to collect material for diagnosing diseases affecting the respiratory system, such as Covid-19. Yet, no systematic anatomical study defines concrete prerequisites for successfully targeting the nasopharyngeal mucosa. We therefore aim at simulating nasopharyngeal swabs in human body donors to characterize parameters allowing and supporting to enter the nasopharynx with a swab, while avoiding endangering the cribriform plate. With the aid of metal probes and comm","2021","07","13","Clin Anat","Clinical anatomy (New York, N.Y.)","Covid-19; SARS-CoV-2; anatomy; nasopharynx; respiratory","Reissig","Lukas F","Division of Anatomy, Medical University of Vienna, Vienna, Austria",NA
"1288","34216513","10.1002/ca.23762","Performing nasopharyngeal swabs-Guidelines based on an anatomical study.","Nasopharyngeal swabs are performed to collect material for diagnosing diseases affecting the respiratory system, such as Covid-19. Yet, no systematic anatomical study defines concrete prerequisites for successfully targeting the nasopharyngeal mucosa. We therefore aim at simulating nasopharyngeal swabs in human body donors to characterize parameters allowing and supporting to enter the nasopharynx with a swab, while avoiding endangering the cribriform plate. With the aid of metal probes and comm","2021","07","13","Clin Anat","Clinical anatomy (New York, N.Y.)","Covid-19; SARS-CoV-2; anatomy; nasopharynx; respiratory","Hainfellner","Andreas","Division of Anatomy, Medical University of Vienna, Vienna, Austria",NA
"1289","34216513","10.1002/ca.23762","Performing nasopharyngeal swabs-Guidelines based on an anatomical study.","Nasopharyngeal swabs are performed to collect material for diagnosing diseases affecting the respiratory system, such as Covid-19. Yet, no systematic anatomical study defines concrete prerequisites for successfully targeting the nasopharyngeal mucosa. We therefore aim at simulating nasopharyngeal swabs in human body donors to characterize parameters allowing and supporting to enter the nasopharynx with a swab, while avoiding endangering the cribriform plate. With the aid of metal probes and comm","2021","07","13","Clin Anat","Clinical anatomy (New York, N.Y.)","Covid-19; SARS-CoV-2; anatomy; nasopharynx; respiratory","Weninger","Wolfgang J","Division of Anatomy, Medical University of Vienna, Vienna, Austria",NA
"1290","34216512","10.1111/jocs.15784","Preparing end-stage heart failure patients and care providers in the era of climate change-driven hurricanes.","Patients with end-stage congestive heart failure are at elevated risk for harm when extreme storms threaten and strike their communities. Individuals with compromised heart function require customized hurricane protection and preparedness approaches. We provide mitigation strategies for providers and their teams, as well as the patients themselves to ensure their safety and uninterrupted access to healthcare resources and quality care during hurricane impact and in the aftermath.","2021","07","03","J Card Surg","Journal of cardiac surgery","COVID-19; LVAD; hurricanes; transplant","Alnajar","Ahmed","Department of Surgery, Department of Public Health Sciences, University of Miami, Miami, Florida, USA",NA
"1291","34216512","10.1111/jocs.15784","Preparing end-stage heart failure patients and care providers in the era of climate change-driven hurricanes.","Patients with end-stage congestive heart failure are at elevated risk for harm when extreme storms threaten and strike their communities. Individuals with compromised heart function require customized hurricane protection and preparedness approaches. We provide mitigation strategies for providers and their teams, as well as the patients themselves to ensure their safety and uninterrupted access to healthcare resources and quality care during hurricane impact and in the aftermath.","2021","07","03","J Card Surg","Journal of cardiac surgery","COVID-19; LVAD; hurricanes; transplant","Bud Frazier","O H","Center for Preclinical Surgical &amp",NA
"1292","34216512","10.1111/jocs.15784","Preparing end-stage heart failure patients and care providers in the era of climate change-driven hurricanes.","Patients with end-stage congestive heart failure are at elevated risk for harm when extreme storms threaten and strike their communities. Individuals with compromised heart function require customized hurricane protection and preparedness approaches. We provide mitigation strategies for providers and their teams, as well as the patients themselves to ensure their safety and uninterrupted access to healthcare resources and quality care during hurricane impact and in the aftermath.","2021","07","03","J Card Surg","Journal of cardiac surgery","COVID-19; LVAD; hurricanes; transplant","Elgalad","Abdelmotagaly","Center for Preclinical Surgical &amp",NA
"1293","34216512","10.1111/jocs.15784","Preparing end-stage heart failure patients and care providers in the era of climate change-driven hurricanes.","Patients with end-stage congestive heart failure are at elevated risk for harm when extreme storms threaten and strike their communities. Individuals with compromised heart function require customized hurricane protection and preparedness approaches. We provide mitigation strategies for providers and their teams, as well as the patients themselves to ensure their safety and uninterrupted access to healthcare resources and quality care during hurricane impact and in the aftermath.","2021","07","03","J Card Surg","Journal of cardiac surgery","COVID-19; LVAD; hurricanes; transplant","Smith","P Alex","Center for Preclinical Surgical &amp",NA
"1294","34216512","10.1111/jocs.15784","Preparing end-stage heart failure patients and care providers in the era of climate change-driven hurricanes.","Patients with end-stage congestive heart failure are at elevated risk for harm when extreme storms threaten and strike their communities. Individuals with compromised heart function require customized hurricane protection and preparedness approaches. We provide mitigation strategies for providers and their teams, as well as the patients themselves to ensure their safety and uninterrupted access to healthcare resources and quality care during hurricane impact and in the aftermath.","2021","07","03","J Card Surg","Journal of cardiac surgery","COVID-19; LVAD; hurricanes; transplant","Shultz","James M","Department of Public Health Sciences, University of Miami, Miami, Florida, USA",NA
"1295","34216501","10.1111/jonm.13408","Establishing quality evaluation system of nursing management in fever clinics: A Delphi method.","The aim of this study is to construct a quality evaluation system for fever clinic nursing management. Fever clinic is the first line of defence against the epidemic during COVID-19 in China. Our study combines the Delphi method and the analytic hierarchy process. Delphi method was used to carry out two rounds of consultation for 18 experts, to select and revise indicators at all levels. Analytic hierarchy process was used to calculate the weight of indicators at all levels. A quality evaluation","2021","07","21","J Nurs Manag","Journal of nursing management","Delphi method; analytic hierarchy process; fever clinic; nursing management; quality evaluation","Yang","Xuejiao","Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1296","34216501","10.1111/jonm.13408","Establishing quality evaluation system of nursing management in fever clinics: A Delphi method.","The aim of this study is to construct a quality evaluation system for fever clinic nursing management. Fever clinic is the first line of defence against the epidemic during COVID-19 in China. Our study combines the Delphi method and the analytic hierarchy process. Delphi method was used to carry out two rounds of consultation for 18 experts, to select and revise indicators at all levels. Analytic hierarchy process was used to calculate the weight of indicators at all levels. A quality evaluation","2021","07","21","J Nurs Manag","Journal of nursing management","Delphi method; analytic hierarchy process; fever clinic; nursing management; quality evaluation","Li","Ling","Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1297","34216501","10.1111/jonm.13408","Establishing quality evaluation system of nursing management in fever clinics: A Delphi method.","The aim of this study is to construct a quality evaluation system for fever clinic nursing management. Fever clinic is the first line of defence against the epidemic during COVID-19 in China. Our study combines the Delphi method and the analytic hierarchy process. Delphi method was used to carry out two rounds of consultation for 18 experts, to select and revise indicators at all levels. Analytic hierarchy process was used to calculate the weight of indicators at all levels. A quality evaluation","2021","07","21","J Nurs Manag","Journal of nursing management","Delphi method; analytic hierarchy process; fever clinic; nursing management; quality evaluation","Liu","Yilan","Department of Nursing, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1298","34216501","10.1111/jonm.13408","Establishing quality evaluation system of nursing management in fever clinics: A Delphi method.","The aim of this study is to construct a quality evaluation system for fever clinic nursing management. Fever clinic is the first line of defence against the epidemic during COVID-19 in China. Our study combines the Delphi method and the analytic hierarchy process. Delphi method was used to carry out two rounds of consultation for 18 experts, to select and revise indicators at all levels. Analytic hierarchy process was used to calculate the weight of indicators at all levels. A quality evaluation","2021","07","21","J Nurs Manag","Journal of nursing management","Delphi method; analytic hierarchy process; fever clinic; nursing management; quality evaluation","Wu","Lifen","Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1299","34216501","10.1111/jonm.13408","Establishing quality evaluation system of nursing management in fever clinics: A Delphi method.","The aim of this study is to construct a quality evaluation system for fever clinic nursing management. Fever clinic is the first line of defence against the epidemic during COVID-19 in China. Our study combines the Delphi method and the analytic hierarchy process. Delphi method was used to carry out two rounds of consultation for 18 experts, to select and revise indicators at all levels. Analytic hierarchy process was used to calculate the weight of indicators at all levels. A quality evaluation","2021","07","21","J Nurs Manag","Journal of nursing management","Delphi method; analytic hierarchy process; fever clinic; nursing management; quality evaluation","Lu","Caihong","Department of Nursing, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1300","34216501","10.1111/jonm.13408","Establishing quality evaluation system of nursing management in fever clinics: A Delphi method.","The aim of this study is to construct a quality evaluation system for fever clinic nursing management. Fever clinic is the first line of defence against the epidemic during COVID-19 in China. Our study combines the Delphi method and the analytic hierarchy process. Delphi method was used to carry out two rounds of consultation for 18 experts, to select and revise indicators at all levels. Analytic hierarchy process was used to calculate the weight of indicators at all levels. A quality evaluation","2021","07","21","J Nurs Manag","Journal of nursing management","Delphi method; analytic hierarchy process; fever clinic; nursing management; quality evaluation","Wang","Weixian","Department of Nursing, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1301","34216501","10.1111/jonm.13408","Establishing quality evaluation system of nursing management in fever clinics: A Delphi method.","The aim of this study is to construct a quality evaluation system for fever clinic nursing management. Fever clinic is the first line of defence against the epidemic during COVID-19 in China. Our study combines the Delphi method and the analytic hierarchy process. Delphi method was used to carry out two rounds of consultation for 18 experts, to select and revise indicators at all levels. Analytic hierarchy process was used to calculate the weight of indicators at all levels. A quality evaluation","2021","07","21","J Nurs Manag","Journal of nursing management","Delphi method; analytic hierarchy process; fever clinic; nursing management; quality evaluation","Zheng","Xiaodan","Department of Nursing, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1302","34216501","10.1111/jonm.13408","Establishing quality evaluation system of nursing management in fever clinics: A Delphi method.","The aim of this study is to construct a quality evaluation system for fever clinic nursing management. Fever clinic is the first line of defence against the epidemic during COVID-19 in China. Our study combines the Delphi method and the analytic hierarchy process. Delphi method was used to carry out two rounds of consultation for 18 experts, to select and revise indicators at all levels. Analytic hierarchy process was used to calculate the weight of indicators at all levels. A quality evaluation","2021","07","21","J Nurs Manag","Journal of nursing management","Delphi method; analytic hierarchy process; fever clinic; nursing management; quality evaluation","Wan","Jia","Department of Nursing, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1303","34216501","10.1111/jonm.13408","Establishing quality evaluation system of nursing management in fever clinics: A Delphi method.","The aim of this study is to construct a quality evaluation system for fever clinic nursing management. Fever clinic is the first line of defence against the epidemic during COVID-19 in China. Our study combines the Delphi method and the analytic hierarchy process. Delphi method was used to carry out two rounds of consultation for 18 experts, to select and revise indicators at all levels. Analytic hierarchy process was used to calculate the weight of indicators at all levels. A quality evaluation","2021","07","21","J Nurs Manag","Journal of nursing management","Delphi method; analytic hierarchy process; fever clinic; nursing management; quality evaluation","Jin","Yan","Department of Nursing, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1304","34216501","10.1111/jonm.13408","Establishing quality evaluation system of nursing management in fever clinics: A Delphi method.","The aim of this study is to construct a quality evaluation system for fever clinic nursing management. Fever clinic is the first line of defence against the epidemic during COVID-19 in China. Our study combines the Delphi method and the analytic hierarchy process. Delphi method was used to carry out two rounds of consultation for 18 experts, to select and revise indicators at all levels. Analytic hierarchy process was used to calculate the weight of indicators at all levels. A quality evaluation","2021","07","21","J Nurs Manag","Journal of nursing management","Delphi method; analytic hierarchy process; fever clinic; nursing management; quality evaluation","Yu","Wenjing","Department of Nursing, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1305","34216498","10.1002/rmv.2274","Isothermal amplification-based assays for rapid and sensitive detection of severe acute respiratory syndrome coronavirus 2: Opportunities and recent developments.","The coronavirus disease 2019 (COVID-19) is a global pandemic caused by a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To date, the virus has been detected in 219 countries of the world. Therefore, managing the disease becomes the priority, in which detecting the presence of the virus is a crucial step. Presently, real-time RT polymerase chain reaction (RT-qPCR) is considered a gold standard nucleic acid amplification test (NAAT). The test protocol of RT-","2021","07","03","Rev Med Virol","Reviews in medical virology","SARS-CoV-2; isothermal amplification-based assays; molecular diagnostics; novel coronavirus; rapid detection","Maiti","Biswajit","Nitte (Deemed to be University), Nitte University Centre for Science Education and Research (NUCSER), Division of Infectious Diseases, Paneer Campus, Mangaluru, Karnataka, India",NA
"1306","34216498","10.1002/rmv.2274","Isothermal amplification-based assays for rapid and sensitive detection of severe acute respiratory syndrome coronavirus 2: Opportunities and recent developments.","The coronavirus disease 2019 (COVID-19) is a global pandemic caused by a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To date, the virus has been detected in 219 countries of the world. Therefore, managing the disease becomes the priority, in which detecting the presence of the virus is a crucial step. Presently, real-time RT polymerase chain reaction (RT-qPCR) is considered a gold standard nucleic acid amplification test (NAAT). The test protocol of RT-","2021","07","03","Rev Med Virol","Reviews in medical virology","SARS-CoV-2; isothermal amplification-based assays; molecular diagnostics; novel coronavirus; rapid detection","Anupama","Karanth Padyana","Nitte (Deemed to be University), Nitte University Centre for Science Education and Research (NUCSER), Division of Infectious Diseases, Paneer Campus, Mangaluru, Karnataka, India",NA
"1307","34216498","10.1002/rmv.2274","Isothermal amplification-based assays for rapid and sensitive detection of severe acute respiratory syndrome coronavirus 2: Opportunities and recent developments.","The coronavirus disease 2019 (COVID-19) is a global pandemic caused by a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To date, the virus has been detected in 219 countries of the world. Therefore, managing the disease becomes the priority, in which detecting the presence of the virus is a crucial step. Presently, real-time RT polymerase chain reaction (RT-qPCR) is considered a gold standard nucleic acid amplification test (NAAT). The test protocol of RT-","2021","07","03","Rev Med Virol","Reviews in medical virology","SARS-CoV-2; isothermal amplification-based assays; molecular diagnostics; novel coronavirus; rapid detection","Rai","Praveen","Nitte (Deemed to be University), Nitte University Centre for Science Education and Research (NUCSER), Division of Infectious Diseases, Paneer Campus, Mangaluru, Karnataka, India",NA
"1308","34216498","10.1002/rmv.2274","Isothermal amplification-based assays for rapid and sensitive detection of severe acute respiratory syndrome coronavirus 2: Opportunities and recent developments.","The coronavirus disease 2019 (COVID-19) is a global pandemic caused by a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To date, the virus has been detected in 219 countries of the world. Therefore, managing the disease becomes the priority, in which detecting the presence of the virus is a crucial step. Presently, real-time RT polymerase chain reaction (RT-qPCR) is considered a gold standard nucleic acid amplification test (NAAT). The test protocol of RT-","2021","07","03","Rev Med Virol","Reviews in medical virology","SARS-CoV-2; isothermal amplification-based assays; molecular diagnostics; novel coronavirus; rapid detection","Karunasagar","Indrani","Nitte (Deemed to be University), University Enclave, Medical Sciences Complex, Mangaluru, Karnataka, India",NA
"1309","34216498","10.1002/rmv.2274","Isothermal amplification-based assays for rapid and sensitive detection of severe acute respiratory syndrome coronavirus 2: Opportunities and recent developments.","The coronavirus disease 2019 (COVID-19) is a global pandemic caused by a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To date, the virus has been detected in 219 countries of the world. Therefore, managing the disease becomes the priority, in which detecting the presence of the virus is a crucial step. Presently, real-time RT polymerase chain reaction (RT-qPCR) is considered a gold standard nucleic acid amplification test (NAAT). The test protocol of RT-","2021","07","03","Rev Med Virol","Reviews in medical virology","SARS-CoV-2; isothermal amplification-based assays; molecular diagnostics; novel coronavirus; rapid detection","Karunasagar","Iddya","Nitte (Deemed to be University), University Enclave, Medical Sciences Complex, Mangaluru, Karnataka, India",NA
"1310","34216476","","Introducing a Remote Pre-graduate Medical Education Curriculum Planning Workshop During the COVID-19 Pandemic.","To conduct a thorough online workshop on infection control under COVID-19 and to conduct a questionnaire survey on the online workshop. The Tokai University School of Medicine has held 39 workshops to acquire the curriculum planning ability required as a faculty member of the School of Medicine. Due to the COVID-19 pandemic, this year (2020) we were unable to hold a workshop. Therefore, we attempted an online workshop using Zoom. To shorten the amount of time required for the workshop, we exclud","2021","07","09","Tokai J Exp Clin Med","The Tokai journal of experimental and clinical medicine","COVID-19; Curriculum; Education, Distance; Education, Medical, Graduate; Humans; Japan; Pandemics; Planning Techniques; SARS-CoV-2; Surveys and Questionnaires","Tsuda","Banri","Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. banri@is.icc.u-tokai.ac",NA
"1311","34216476","","Introducing a Remote Pre-graduate Medical Education Curriculum Planning Workshop During the COVID-19 Pandemic.","To conduct a thorough online workshop on infection control under COVID-19 and to conduct a questionnaire survey on the online workshop. The Tokai University School of Medicine has held 39 workshops to acquire the curriculum planning ability required as a faculty member of the School of Medicine. Due to the COVID-19 pandemic, this year (2020) we were unable to hold a workshop. Therefore, we attempted an online workshop using Zoom. To shorten the amount of time required for the workshop, we exclud","2021","07","09","Tokai J Exp Clin Med","The Tokai journal of experimental and clinical medicine","COVID-19; Curriculum; Education, Distance; Education, Medical, Graduate; Humans; Japan; Pandemics; Planning Techniques; SARS-CoV-2; Surveys and Questionnaires","Urano","Tetsuya","Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. banri@is.icc.u-tokai.ac",NA
"1312","34216476","","Introducing a Remote Pre-graduate Medical Education Curriculum Planning Workshop During the COVID-19 Pandemic.","To conduct a thorough online workshop on infection control under COVID-19 and to conduct a questionnaire survey on the online workshop. The Tokai University School of Medicine has held 39 workshops to acquire the curriculum planning ability required as a faculty member of the School of Medicine. Due to the COVID-19 pandemic, this year (2020) we were unable to hold a workshop. Therefore, we attempted an online workshop using Zoom. To shorten the amount of time required for the workshop, we exclud","2021","07","09","Tokai J Exp Clin Med","The Tokai journal of experimental and clinical medicine","COVID-19; Curriculum; Education, Distance; Education, Medical, Graduate; Humans; Japan; Pandemics; Planning Techniques; SARS-CoV-2; Surveys and Questionnaires","Yamato","Ippei","Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. banri@is.icc.u-tokai.ac",NA
"1313","34216476","","Introducing a Remote Pre-graduate Medical Education Curriculum Planning Workshop During the COVID-19 Pandemic.","To conduct a thorough online workshop on infection control under COVID-19 and to conduct a questionnaire survey on the online workshop. The Tokai University School of Medicine has held 39 workshops to acquire the curriculum planning ability required as a faculty member of the School of Medicine. Due to the COVID-19 pandemic, this year (2020) we were unable to hold a workshop. Therefore, we attempted an online workshop using Zoom. To shorten the amount of time required for the workshop, we exclud","2021","07","09","Tokai J Exp Clin Med","The Tokai journal of experimental and clinical medicine","COVID-19; Curriculum; Education, Distance; Education, Medical, Graduate; Humans; Japan; Pandemics; Planning Techniques; SARS-CoV-2; Surveys and Questionnaires","Masuda","Ryota","Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. banri@is.icc.u-tokai.ac",NA
"1314","34216476","","Introducing a Remote Pre-graduate Medical Education Curriculum Planning Workshop During the COVID-19 Pandemic.","To conduct a thorough online workshop on infection control under COVID-19 and to conduct a questionnaire survey on the online workshop. The Tokai University School of Medicine has held 39 workshops to acquire the curriculum planning ability required as a faculty member of the School of Medicine. Due to the COVID-19 pandemic, this year (2020) we were unable to hold a workshop. Therefore, we attempted an online workshop using Zoom. To shorten the amount of time required for the workshop, we exclud","2021","07","09","Tokai J Exp Clin Med","The Tokai journal of experimental and clinical medicine","COVID-19; Curriculum; Education, Distance; Education, Medical, Graduate; Humans; Japan; Pandemics; Planning Techniques; SARS-CoV-2; Surveys and Questionnaires","Seki","Toshiro","Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. banri@is.icc.u-tokai.ac",NA
"1315","34216476","","Introducing a Remote Pre-graduate Medical Education Curriculum Planning Workshop During the COVID-19 Pandemic.","To conduct a thorough online workshop on infection control under COVID-19 and to conduct a questionnaire survey on the online workshop. The Tokai University School of Medicine has held 39 workshops to acquire the curriculum planning ability required as a faculty member of the School of Medicine. Due to the COVID-19 pandemic, this year (2020) we were unable to hold a workshop. Therefore, we attempted an online workshop using Zoom. To shorten the amount of time required for the workshop, we exclud","2021","07","09","Tokai J Exp Clin Med","The Tokai journal of experimental and clinical medicine","COVID-19; Curriculum; Education, Distance; Education, Medical, Graduate; Humans; Japan; Pandemics; Planning Techniques; SARS-CoV-2; Surveys and Questionnaires","Nakagawa","Yoshihide","Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. banri@is.icc.u-tokai.ac",NA
"1316","34216476","","Introducing a Remote Pre-graduate Medical Education Curriculum Planning Workshop During the COVID-19 Pandemic.","To conduct a thorough online workshop on infection control under COVID-19 and to conduct a questionnaire survey on the online workshop. The Tokai University School of Medicine has held 39 workshops to acquire the curriculum planning ability required as a faculty member of the School of Medicine. Due to the COVID-19 pandemic, this year (2020) we were unable to hold a workshop. Therefore, we attempted an online workshop using Zoom. To shorten the amount of time required for the workshop, we exclud","2021","07","09","Tokai J Exp Clin Med","The Tokai journal of experimental and clinical medicine","COVID-19; Curriculum; Education, Distance; Education, Medical, Graduate; Humans; Japan; Pandemics; Planning Techniques; SARS-CoV-2; Surveys and Questionnaires","Izumi","Syunichiro","Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. banri@is.icc.u-tokai.ac",NA
"1317","34216476","","Introducing a Remote Pre-graduate Medical Education Curriculum Planning Workshop During the COVID-19 Pandemic.","To conduct a thorough online workshop on infection control under COVID-19 and to conduct a questionnaire survey on the online workshop. The Tokai University School of Medicine has held 39 workshops to acquire the curriculum planning ability required as a faculty member of the School of Medicine. Due to the COVID-19 pandemic, this year (2020) we were unable to hold a workshop. Therefore, we attempted an online workshop using Zoom. To shorten the amount of time required for the workshop, we exclud","2021","07","09","Tokai J Exp Clin Med","The Tokai journal of experimental and clinical medicine","COVID-19; Curriculum; Education, Distance; Education, Medical, Graduate; Humans; Japan; Pandemics; Planning Techniques; SARS-CoV-2; Surveys and Questionnaires","Hamada","Masashi","Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan. banri@is.icc.u-tokai.ac",NA
"1318","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Lumley","Sheila F","Oxford University Hospitals NHS Foundation Trust, Oxford, UK",NA
"1319","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Rodger","Gillian","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1320","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Constantinides","Bede","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1321","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Sanderson","Nicholas","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1322","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Chau","Kevin K","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1323","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Street","Teresa L","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1324","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","O'Donnell","Denise","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1325","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Howarth","Alison","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1326","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Hatch","Stephanie B","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1327","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Marsden","Brian D","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1328","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Cox","Stuart","Oxford University Hospitals NHS Foundation Trust, Oxford, UK",NA
"1329","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","James","Tim","Oxford University Hospitals NHS Foundation Trust, Oxford, UK",NA
"1330","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Warren","Fiona","Oxford University Hospitals NHS Foundation Trust, Oxford, UK",NA
"1331","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Peck","Liam J","Medical School, University of Oxford, Oxford, UK",NA
"1332","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Ritter","Thomas G","Medical School, University of Oxford, Oxford, UK",NA
"1333","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","de Toledo","Zoe","Medical School, University of Oxford, Oxford, UK",NA
"1334","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Warren","Laura","Oxford University Hospitals NHS Foundation Trust, Oxford, UK",NA
"1335","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Axten","David","Oxford University Hospitals NHS Foundation Trust, Oxford, UK",NA
"1336","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Cornall","Richard J","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1337","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Jones","E Yvonne","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1338","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Stuart","David I","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1339","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Screaton","Gavin","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1340","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Ebner","Daniel","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1341","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Hoosdally","Sarah","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1342","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Chand","Meera","National Infection Service, Public Health England Colindale, UK",NA
"1343","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Crook","Derrick W","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1344","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","O'Donnell","Anne-Marie","Oxford University Hospitals NHS Foundation Trust, Oxford, UK",NA
"1345","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Conlon","Christopher P","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1346","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Pouwels","Koen B","NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, UK",NA
"1347","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Walker","A Sarah","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1348","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Peto","Tim E A","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1349","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Hopkins","Susan","National Infection Service, Public Health England Colindale, UK",NA
"1350","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Walker","Timothy M","Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"1351","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Stoesser","Nicole E","Oxford University Hospitals NHS Foundation Trust, Oxford, UK",NA
"1352","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Matthews","Philippa C","Oxford University Hospitals NHS Foundation Trust, Oxford, UK",NA
"1353","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Jeffery","Katie","Oxford University Hospitals NHS Foundation Trust, Oxford, UK",NA
"1354","34216472","10.1093/cid/ciab608","An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.","Natural and vaccine-induced immunity will play a key role in controlling the SARS-CoV-2 pandemic. SARS-CoV-2 variants have the potential to evade natural and vaccine-induced immunity. In a longitudinal cohort study of healthcare workers (HCWs) in Oxfordshire, UK, we investigated the protection from symptomatic and asymptomatic PCR-confirmed SARS-CoV-2 infection conferred by vaccination (Pfizer-BioNTech BNT162b2, Oxford-AstraZeneca ChAdOx1 nCOV-19) and prior infection (determined using anti-spike","2021","07","03","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","SARS-CoV-2; antibody; healthcare worker; immunity; vaccine","Eyre","David W","NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK",NA
"1355","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Shragai","Talya","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1356","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Smith-Jeffcoat","Sarah E","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1357","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Koh","Mitsuki","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1358","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Schechter","Marcos C","Emory University, Atlanta, GA, USA",NA
"1359","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Rebolledo","Paulina A","Emory University, Atlanta, GA, USA",NA
"1360","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Kasinathan","Vyjayanti","Emory University, Atlanta, GA, USA",NA
"1361","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Wang","Yun","Emory University, Atlanta, GA, USA",NA
"1362","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Hoffman","Adam","Emory University, Atlanta, GA, USA",NA
"1363","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Miller","Halie","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1364","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Tejada-Strop","Alexandra","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1365","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Jain","Shilpi","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1366","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Tamin","Azaibi","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1367","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Harcourt","Jennifer L","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1368","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Thornburg","Natalie J","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1369","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Wong","Phili","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1370","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Medrzycki","Magdalena","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1371","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Folster","Jennifer M","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1372","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Semenova","Vera","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1373","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Steward-Clark","Evelene","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1374","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Drobenuic","Jan","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1375","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Biedron","Caitlin","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1376","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Stewart","Rebekah J","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1377","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","da Silva","Juliana","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1378","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Kirking","Hannah L","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1379","34216468","10.1093/infdis/jiab349","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","The natural history and clinical progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can be better understood using combined serological and reverse transcription polymerase chain reaction (RT-PCR) testing. Nasopharyngeal swabs and serum were collected at a single time-point from patients at an urban, public hospital August - November 2020 and tested for SARS-CoV-2 using RT-PCR, viral culture, and anti-Spike pan-Ig antibody testing. Participant demographics and","2021","07","03","J Infect Dis","The Journal of infectious diseases","COVID-19; SARS-CoV-2; serology; viral culture","Tate","Jacqueline E","Centers for Disease Control and Prevention, Atlanta, GA, 30308, USA",NA
"1380","34216379","10.1007/s40520-021-01924-w","Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients?","Patients hospitalized with COVID-19 experienced an increased risk of venous thromboembolism. To evaluate the effect of chronic oral anticoagulation (OAC) therapy, both with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), on prognosis of COVID-19 older patients. Single-center prospective study conducted in the Emergency Department (ED) of a teaching hospital, referral center for COVID-19 in central Italy. We evaluated all the patients = 65 years, consecutively admitted to our ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Direct oral anticoagulants; Older patients; Oral anticoagulation; Vitamin k antagonists","Covino","Marcello","Emergency Department, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1381","34216379","10.1007/s40520-021-01924-w","Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients?","Patients hospitalized with COVID-19 experienced an increased risk of venous thromboembolism. To evaluate the effect of chronic oral anticoagulation (OAC) therapy, both with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), on prognosis of COVID-19 older patients. Single-center prospective study conducted in the Emergency Department (ED) of a teaching hospital, referral center for COVID-19 in central Italy. We evaluated all the patients = 65 years, consecutively admitted to our ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Direct oral anticoagulants; Older patients; Oral anticoagulation; Vitamin k antagonists","De Matteis","Giuseppe","Department of Internal Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. giuseppe.dematteis@policlinicogemelli","giuseppe.dematteis@policlinicogemelli.it"
"1382","34216379","10.1007/s40520-021-01924-w","Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients?","Patients hospitalized with COVID-19 experienced an increased risk of venous thromboembolism. To evaluate the effect of chronic oral anticoagulation (OAC) therapy, both with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), on prognosis of COVID-19 older patients. Single-center prospective study conducted in the Emergency Department (ED) of a teaching hospital, referral center for COVID-19 in central Italy. We evaluated all the patients = 65 years, consecutively admitted to our ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Direct oral anticoagulants; Older patients; Oral anticoagulation; Vitamin k antagonists","Della Polla","Davide","Emergency Department, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1383","34216379","10.1007/s40520-021-01924-w","Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients?","Patients hospitalized with COVID-19 experienced an increased risk of venous thromboembolism. To evaluate the effect of chronic oral anticoagulation (OAC) therapy, both with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), on prognosis of COVID-19 older patients. Single-center prospective study conducted in the Emergency Department (ED) of a teaching hospital, referral center for COVID-19 in central Italy. We evaluated all the patients = 65 years, consecutively admitted to our ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Direct oral anticoagulants; Older patients; Oral anticoagulation; Vitamin k antagonists","Burzo","Maria Livia","Emergency Department, Ospedale Generale M.G. Vannini, Istituto Figlie di San Camillo, Rome, Italy",NA
"1384","34216379","10.1007/s40520-021-01924-w","Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients?","Patients hospitalized with COVID-19 experienced an increased risk of venous thromboembolism. To evaluate the effect of chronic oral anticoagulation (OAC) therapy, both with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), on prognosis of COVID-19 older patients. Single-center prospective study conducted in the Emergency Department (ED) of a teaching hospital, referral center for COVID-19 in central Italy. We evaluated all the patients = 65 years, consecutively admitted to our ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Direct oral anticoagulants; Older patients; Oral anticoagulation; Vitamin k antagonists","Pascale","Marco Maria","Emergency Department, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1385","34216379","10.1007/s40520-021-01924-w","Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients?","Patients hospitalized with COVID-19 experienced an increased risk of venous thromboembolism. To evaluate the effect of chronic oral anticoagulation (OAC) therapy, both with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), on prognosis of COVID-19 older patients. Single-center prospective study conducted in the Emergency Department (ED) of a teaching hospital, referral center for COVID-19 in central Italy. We evaluated all the patients = 65 years, consecutively admitted to our ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Direct oral anticoagulants; Older patients; Oral anticoagulation; Vitamin k antagonists","Santoro","Michele","Emergency Department, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1386","34216379","10.1007/s40520-021-01924-w","Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients?","Patients hospitalized with COVID-19 experienced an increased risk of venous thromboembolism. To evaluate the effect of chronic oral anticoagulation (OAC) therapy, both with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), on prognosis of COVID-19 older patients. Single-center prospective study conducted in the Emergency Department (ED) of a teaching hospital, referral center for COVID-19 in central Italy. We evaluated all the patients = 65 years, consecutively admitted to our ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Direct oral anticoagulants; Older patients; Oral anticoagulation; Vitamin k antagonists","De Cristofaro","Raimondo","Università Cattolica del Sacro Cuore, Roma, Italia",NA
"1387","34216379","10.1007/s40520-021-01924-w","Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients?","Patients hospitalized with COVID-19 experienced an increased risk of venous thromboembolism. To evaluate the effect of chronic oral anticoagulation (OAC) therapy, both with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), on prognosis of COVID-19 older patients. Single-center prospective study conducted in the Emergency Department (ED) of a teaching hospital, referral center for COVID-19 in central Italy. We evaluated all the patients = 65 years, consecutively admitted to our ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Direct oral anticoagulants; Older patients; Oral anticoagulation; Vitamin k antagonists","Gasbarrini","Antonio","Università Cattolica del Sacro Cuore, Roma, Italia",NA
"1388","34216379","10.1007/s40520-021-01924-w","Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients?","Patients hospitalized with COVID-19 experienced an increased risk of venous thromboembolism. To evaluate the effect of chronic oral anticoagulation (OAC) therapy, both with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), on prognosis of COVID-19 older patients. Single-center prospective study conducted in the Emergency Department (ED) of a teaching hospital, referral center for COVID-19 in central Italy. We evaluated all the patients = 65 years, consecutively admitted to our ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Direct oral anticoagulants; Older patients; Oral anticoagulation; Vitamin k antagonists","De Candia","Erica","Università Cattolica del Sacro Cuore, Roma, Italia",NA
"1389","34216379","10.1007/s40520-021-01924-w","Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients?","Patients hospitalized with COVID-19 experienced an increased risk of venous thromboembolism. To evaluate the effect of chronic oral anticoagulation (OAC) therapy, both with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), on prognosis of COVID-19 older patients. Single-center prospective study conducted in the Emergency Department (ED) of a teaching hospital, referral center for COVID-19 in central Italy. We evaluated all the patients = 65 years, consecutively admitted to our ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID-19; Direct oral anticoagulants; Older patients; Oral anticoagulation; Vitamin k antagonists","Franceschi","Francesco","Emergency Department, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy",NA
"1390","34216373","10.1007/s15010-021-01647-0","Unexpected community-acquired co-infections during an ongoing pandemic: (one) too many diagnoses at once.",NA,"2021","07","07","Infection","Infection",NA,"Cordas Dos Santos","David Manuel","Department of Medicine III, LMU University Hospital, Marchioninistraße 15, Munich, 81377, Germany",NA
"1391","34216373","10.1007/s15010-021-01647-0","Unexpected community-acquired co-infections during an ongoing pandemic: (one) too many diagnoses at once.",NA,"2021","07","07","Infection","Infection",NA,"Fischer","Laura","Department of Medicine III, LMU University Hospital, Marchioninistraße 15, Munich, 81377, Germany",NA
"1392","34216373","10.1007/s15010-021-01647-0","Unexpected community-acquired co-infections during an ongoing pandemic: (one) too many diagnoses at once.",NA,"2021","07","07","Infection","Infection",NA,"von Bergwelt-Baildon","Michael","Department of Medicine III, LMU University Hospital, Marchioninistraße 15, Munich, 81377, Germany",NA
"1393","34216373","10.1007/s15010-021-01647-0","Unexpected community-acquired co-infections during an ongoing pandemic: (one) too many diagnoses at once.",NA,"2021","07","07","Infection","Infection",NA,"Khatamzas","Elham","Department of Medicine III, LMU University Hospital, Marchioninistraße 15, Munich, 81377, Germany. Elham.khatamzas@med.uni-heidelberg","Elham.khatamzas@med.uni"
"1394","34216314","10.1007/s10067-021-05834-0","Depression and anxiety might not be increased during COVID-19 pandemic in patient with axial spondyloarthritis.",NA,"2021","07","07","Clin Rheumatol","Clinical rheumatology",NA,"Erpek","E","Department of Internal Medicine, Division of Rheumatology Ataturk Education and Research Hospital, Internal Medicine Clinic, Izmir Katip Celebi University, 35360, Karabaglar/Izmir, Turkey",NA
"1395","34216314","10.1007/s10067-021-05834-0","Depression and anxiety might not be increased during COVID-19 pandemic in patient with axial spondyloarthritis.",NA,"2021","07","07","Clin Rheumatol","Clinical rheumatology",NA,"Solmaz","D","Department of Internal Medicine, Division of Rheumatology Ataturk Education and Research Hospital, Internal Medicine Clinic, Izmir Katip Celebi University, 35360, Karabaglar/Izmir, Turkey",NA
"1396","34216314","10.1007/s10067-021-05834-0","Depression and anxiety might not be increased during COVID-19 pandemic in patient with axial spondyloarthritis.",NA,"2021","07","07","Clin Rheumatol","Clinical rheumatology",NA,"Bayraktar","D","Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Izmir Katip Celebi University, Izmir, Turkey",NA
"1397","34216314","10.1007/s10067-021-05834-0","Depression and anxiety might not be increased during COVID-19 pandemic in patient with axial spondyloarthritis.",NA,"2021","07","07","Clin Rheumatol","Clinical rheumatology",NA,"Akar","S","Department of Internal Medicine, Division of Rheumatology Ataturk Education and Research Hospital, Internal Medicine Clinic, Izmir Katip Celebi University, 35360, Karabaglar/Izmir, Turkey. servet.akar@gmail","servet.akar@gmail.com"
"1398","34216306","10.1007/s10072-021-05435-4","Predictors of survival in older adults hospitalized with COVID-19.","This study was designed to investigate clinical characteristics associated with mortality and predictors of survival in older adults hospitalized with COVID-19 with a focus on neurological comorbidities and presenting neurological manifestations. We compared clinical characteristics in an age- and gender-matched sample of 75 deceased and 75 recovered patients (MAge = 78) hospitalized with COVID-19 and developed a logistic regression to predict likelihood of survival. Deceased patients were more ","2021","07","07","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Delirium; Dementia; Neurology; Neuropsychology; Psychiatry","Tyson","Brad","EvergreenHealth Medical Center, Evergreen Neuroscience Institute, Kirkland, WA, USA. bradggtyson@gmail","bradggtyson@gmail.com"
"1399","34216306","10.1007/s10072-021-05435-4","Predictors of survival in older adults hospitalized with COVID-19.","This study was designed to investigate clinical characteristics associated with mortality and predictors of survival in older adults hospitalized with COVID-19 with a focus on neurological comorbidities and presenting neurological manifestations. We compared clinical characteristics in an age- and gender-matched sample of 75 deceased and 75 recovered patients (MAge = 78) hospitalized with COVID-19 and developed a logistic regression to predict likelihood of survival. Deceased patients were more ","2021","07","07","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Delirium; Dementia; Neurology; Neuropsychology; Psychiatry","Erdodi","Laszlo","Department of Psychology, University of Windsor, Windsor, ON, Canada",NA
"1400","34216306","10.1007/s10072-021-05435-4","Predictors of survival in older adults hospitalized with COVID-19.","This study was designed to investigate clinical characteristics associated with mortality and predictors of survival in older adults hospitalized with COVID-19 with a focus on neurological comorbidities and presenting neurological manifestations. We compared clinical characteristics in an age- and gender-matched sample of 75 deceased and 75 recovered patients (MAge = 78) hospitalized with COVID-19 and developed a logistic regression to predict likelihood of survival. Deceased patients were more ","2021","07","07","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Delirium; Dementia; Neurology; Neuropsychology; Psychiatry","Shahein","Ayman","Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada",NA
"1401","34216306","10.1007/s10072-021-05435-4","Predictors of survival in older adults hospitalized with COVID-19.","This study was designed to investigate clinical characteristics associated with mortality and predictors of survival in older adults hospitalized with COVID-19 with a focus on neurological comorbidities and presenting neurological manifestations. We compared clinical characteristics in an age- and gender-matched sample of 75 deceased and 75 recovered patients (MAge = 78) hospitalized with COVID-19 and developed a logistic regression to predict likelihood of survival. Deceased patients were more ","2021","07","07","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Delirium; Dementia; Neurology; Neuropsychology; Psychiatry","Kamrun","Sharmin","EvergreenHealth Medical Center, Evergreen Neuroscience Institute, Kirkland, WA, USA",NA
"1402","34216306","10.1007/s10072-021-05435-4","Predictors of survival in older adults hospitalized with COVID-19.","This study was designed to investigate clinical characteristics associated with mortality and predictors of survival in older adults hospitalized with COVID-19 with a focus on neurological comorbidities and presenting neurological manifestations. We compared clinical characteristics in an age- and gender-matched sample of 75 deceased and 75 recovered patients (MAge = 78) hospitalized with COVID-19 and developed a logistic regression to predict likelihood of survival. Deceased patients were more ","2021","07","07","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Delirium; Dementia; Neurology; Neuropsychology; Psychiatry","Eckles","Matthew","EvergreenHealth Medical Center, Evergreen Neuroscience Institute, Kirkland, WA, USA",NA
"1403","34216306","10.1007/s10072-021-05435-4","Predictors of survival in older adults hospitalized with COVID-19.","This study was designed to investigate clinical characteristics associated with mortality and predictors of survival in older adults hospitalized with COVID-19 with a focus on neurological comorbidities and presenting neurological manifestations. We compared clinical characteristics in an age- and gender-matched sample of 75 deceased and 75 recovered patients (MAge = 78) hospitalized with COVID-19 and developed a logistic regression to predict likelihood of survival. Deceased patients were more ","2021","07","07","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Delirium; Dementia; Neurology; Neuropsychology; Psychiatry","Agarwal","Pinky","EvergreenHealth Medical Center, Evergreen Neuroscience Institute, Kirkland, WA, USA",NA
"1404","34216297","10.1007/s11926-021-01023-9","COVID-19 and Myositis: What We Know So Far.","Myositis as a rare manifestation of COVID-19 is only recently being reported. This review examines the current literature on COVID-19-induced myositis focusing on etiopathogenesis, clinical presentations, diagnostic practices, and therapeutic challenges with immunosuppression, and the difficulties experienced by rheumatologists in established myositis in the COVID-19 era. COVID-19 is associated with a viral myositis attributable to direct myocyte invasion or induction of autoimmunity. COVID-19-i","2021","07","12","Curr Rheumatol Rep","Current rheumatology reports","COVID-19; Dermatomyositis; Idiopathic inflammatory myopathy; Immunopathogenesis; Myasthenia; Myositis; Rhabdomyolysis; Tele-triage; Telemedicine; Adaptive Immunity; Angiotensin-Converting Enzyme 2; Autoantibodies; Back Pain; COVID-19; Creatine Kinase; Dermatomyositis; Humans; Immunity, Innate; Interferon-Induced Helicase, IFIH1; Myasthenia Gravis; Myositis; Paraspinal Muscles; Receptors, Coronavirus; Rhabdomyolysis; SARS-CoV-2","Saud","Ahmad","Department of Medicine, Royal College of Surgeons Ireland, Dublin, Ireland",NA
"1405","34216297","10.1007/s11926-021-01023-9","COVID-19 and Myositis: What We Know So Far.","Myositis as a rare manifestation of COVID-19 is only recently being reported. This review examines the current literature on COVID-19-induced myositis focusing on etiopathogenesis, clinical presentations, diagnostic practices, and therapeutic challenges with immunosuppression, and the difficulties experienced by rheumatologists in established myositis in the COVID-19 era. COVID-19 is associated with a viral myositis attributable to direct myocyte invasion or induction of autoimmunity. COVID-19-i","2021","07","12","Curr Rheumatol Rep","Current rheumatology reports","COVID-19; Dermatomyositis; Idiopathic inflammatory myopathy; Immunopathogenesis; Myasthenia; Myositis; Rhabdomyolysis; Tele-triage; Telemedicine; Adaptive Immunity; Angiotensin-Converting Enzyme 2; Autoantibodies; Back Pain; COVID-19; Creatine Kinase; Dermatomyositis; Humans; Immunity, Innate; Interferon-Induced Helicase, IFIH1; Myasthenia Gravis; Myositis; Paraspinal Muscles; Receptors, Coronavirus; Rhabdomyolysis; SARS-CoV-2","Naveen","R","Department of Clinical Immunology and Rheumatology, C Block, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareilley Road, Lucknow, 226014, India",NA
"1406","34216297","10.1007/s11926-021-01023-9","COVID-19 and Myositis: What We Know So Far.","Myositis as a rare manifestation of COVID-19 is only recently being reported. This review examines the current literature on COVID-19-induced myositis focusing on etiopathogenesis, clinical presentations, diagnostic practices, and therapeutic challenges with immunosuppression, and the difficulties experienced by rheumatologists in established myositis in the COVID-19 era. COVID-19 is associated with a viral myositis attributable to direct myocyte invasion or induction of autoimmunity. COVID-19-i","2021","07","12","Curr Rheumatol Rep","Current rheumatology reports","COVID-19; Dermatomyositis; Idiopathic inflammatory myopathy; Immunopathogenesis; Myasthenia; Myositis; Rhabdomyolysis; Tele-triage; Telemedicine; Adaptive Immunity; Angiotensin-Converting Enzyme 2; Autoantibodies; Back Pain; COVID-19; Creatine Kinase; Dermatomyositis; Humans; Immunity, Innate; Interferon-Induced Helicase, IFIH1; Myasthenia Gravis; Myositis; Paraspinal Muscles; Receptors, Coronavirus; Rhabdomyolysis; SARS-CoV-2","Aggarwal","Rohit","Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA",NA
"1407","34216297","10.1007/s11926-021-01023-9","COVID-19 and Myositis: What We Know So Far.","Myositis as a rare manifestation of COVID-19 is only recently being reported. This review examines the current literature on COVID-19-induced myositis focusing on etiopathogenesis, clinical presentations, diagnostic practices, and therapeutic challenges with immunosuppression, and the difficulties experienced by rheumatologists in established myositis in the COVID-19 era. COVID-19 is associated with a viral myositis attributable to direct myocyte invasion or induction of autoimmunity. COVID-19-i","2021","07","12","Curr Rheumatol Rep","Current rheumatology reports","COVID-19; Dermatomyositis; Idiopathic inflammatory myopathy; Immunopathogenesis; Myasthenia; Myositis; Rhabdomyolysis; Tele-triage; Telemedicine; Adaptive Immunity; Angiotensin-Converting Enzyme 2; Autoantibodies; Back Pain; COVID-19; Creatine Kinase; Dermatomyositis; Humans; Immunity, Innate; Interferon-Induced Helicase, IFIH1; Myasthenia Gravis; Myositis; Paraspinal Muscles; Receptors, Coronavirus; Rhabdomyolysis; SARS-CoV-2","Gupta","Latika","Department of Clinical Immunology and Rheumatology, C Block, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareilley Road, Lucknow, 226014, India. drlatikagupta@gmail","drlatikagupta@gmail.com"
"1408","34216296","10.1007/s11926-021-01028-4","Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease.","In this article, I have reviewed current reports that explore differences and similarities between multisystem inflammatory syndrome in children (MIS-C) and other known multisystem inflammatory diseases seen in children, particularly Kawasaki disease. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a human coronavirus causing the COVID-19 disease which emerged in China in December 2019 and spread rapidly to the entire country and quickly to other countries. Currently, there is a ","2021","07","12","Curr Rheumatol Rep","Current rheumatology reports","COVID-19; Kawasaki; MIS-C; Macrophage activation syndrome (MAS); SARS-CoV2; COVID-19; Humans; Immunity, Cellular; Interferon Regulatory Factor-3; Interferon-alpha; Macrophage Activation Syndrome; Mucocutaneous Lymph Node Syndrome; SARS-CoV-2; Severity of Illness Index; Systemic Inflammatory Response Syndrome","Bukulmez","Hulya","Department of Pediatrics, Division of Pediatric Rheumatology, Metro Health Medical Center, Case Western Reserve University, 2500 Metrohealth Drive, Cleveland, OH, 44109, USA. hxb38@case","hxb38@case.edu"
"1409","34216281","10.1007/s11538-021-00922-3","Alternative Strategies for the Estimation of a Disease's Basic Reproduction Number: A Model-Agnostic Study.","This work presents a model-agnostic evaluation of four different models that estimate a disease's basic reproduction number. The evaluation presented is twofold: first, the theory behind each of the models is reviewed and compared; then, each model is tested with eight impartial simulations. All scenarios were constructed in an experimental framework that allows each model to fulfill its assumptions and hence, obtain unbiased results for each case. Among these models is the one proposed by Thomp","2021","07","15","Bull Math Biol","Bulletin of mathematical biology","Basic reproduction number; Bayesian statistics; Kalman filter; Poisson process; Simulations; Basic Reproduction Number; Bayes Theorem; COVID-19; Colombia; Computer Simulation; Confidence Intervals; Epidemics; Humans; Mathematical Concepts; Models, Biological; Models, Statistical; Pandemics; Poisson Distribution; SARS-CoV-2","Páez","Gustavo Nicolás","Myanmar Development Institute, Naypyitaw, Myanmar. gn.paez145@uniandes.edu","gn.paez145@uniandes.edu.co"
"1410","34216281","10.1007/s11538-021-00922-3","Alternative Strategies for the Estimation of a Disease's Basic Reproduction Number: A Model-Agnostic Study.","This work presents a model-agnostic evaluation of four different models that estimate a disease's basic reproduction number. The evaluation presented is twofold: first, the theory behind each of the models is reviewed and compared; then, each model is tested with eight impartial simulations. All scenarios were constructed in an experimental framework that allows each model to fulfill its assumptions and hence, obtain unbiased results for each case. Among these models is the one proposed by Thomp","2021","07","15","Bull Math Biol","Bulletin of mathematical biology","Basic reproduction number; Bayesian statistics; Kalman filter; Poisson process; Simulations; Basic Reproduction Number; Bayes Theorem; COVID-19; Colombia; Computer Simulation; Confidence Intervals; Epidemics; Humans; Mathematical Concepts; Models, Biological; Models, Statistical; Pandemics; Poisson Distribution; SARS-CoV-2","Cerón","Juan Felipe","Factored.Ai, Bogotá, Colombia",NA
"1411","34216281","10.1007/s11538-021-00922-3","Alternative Strategies for the Estimation of a Disease's Basic Reproduction Number: A Model-Agnostic Study.","This work presents a model-agnostic evaluation of four different models that estimate a disease's basic reproduction number. The evaluation presented is twofold: first, the theory behind each of the models is reviewed and compared; then, each model is tested with eight impartial simulations. All scenarios were constructed in an experimental framework that allows each model to fulfill its assumptions and hence, obtain unbiased results for each case. Among these models is the one proposed by Thomp","2021","07","15","Bull Math Biol","Bulletin of mathematical biology","Basic reproduction number; Bayesian statistics; Kalman filter; Poisson process; Simulations; Basic Reproduction Number; Bayes Theorem; COVID-19; Colombia; Computer Simulation; Confidence Intervals; Epidemics; Humans; Mathematical Concepts; Models, Biological; Models, Statistical; Pandemics; Poisson Distribution; SARS-CoV-2","Cortés","Santiago","Factored.Ai, Bogotá, Colombia",NA
"1412","34216281","10.1007/s11538-021-00922-3","Alternative Strategies for the Estimation of a Disease's Basic Reproduction Number: A Model-Agnostic Study.","This work presents a model-agnostic evaluation of four different models that estimate a disease's basic reproduction number. The evaluation presented is twofold: first, the theory behind each of the models is reviewed and compared; then, each model is tested with eight impartial simulations. All scenarios were constructed in an experimental framework that allows each model to fulfill its assumptions and hence, obtain unbiased results for each case. Among these models is the one proposed by Thomp","2021","07","15","Bull Math Biol","Bulletin of mathematical biology","Basic reproduction number; Bayesian statistics; Kalman filter; Poisson process; Simulations; Basic Reproduction Number; Bayes Theorem; COVID-19; Colombia; Computer Simulation; Confidence Intervals; Epidemics; Humans; Mathematical Concepts; Models, Biological; Models, Statistical; Pandemics; Poisson Distribution; SARS-CoV-2","Quiroz","Adolfo J","Universidad de los Andes, Bogotá, Colombia",NA
"1413","34216281","10.1007/s11538-021-00922-3","Alternative Strategies for the Estimation of a Disease's Basic Reproduction Number: A Model-Agnostic Study.","This work presents a model-agnostic evaluation of four different models that estimate a disease's basic reproduction number. The evaluation presented is twofold: first, the theory behind each of the models is reviewed and compared; then, each model is tested with eight impartial simulations. All scenarios were constructed in an experimental framework that allows each model to fulfill its assumptions and hence, obtain unbiased results for each case. Among these models is the one proposed by Thomp","2021","07","15","Bull Math Biol","Bulletin of mathematical biology","Basic reproduction number; Bayesian statistics; Kalman filter; Poisson process; Simulations; Basic Reproduction Number; Bayes Theorem; COVID-19; Colombia; Computer Simulation; Confidence Intervals; Epidemics; Humans; Mathematical Concepts; Models, Biological; Models, Statistical; Pandemics; Poisson Distribution; SARS-CoV-2","Zea","José Fernando","Instituto Nacional de Salud, Bogotá, Colombia",NA
"1414","34216281","10.1007/s11538-021-00922-3","Alternative Strategies for the Estimation of a Disease's Basic Reproduction Number: A Model-Agnostic Study.","This work presents a model-agnostic evaluation of four different models that estimate a disease's basic reproduction number. The evaluation presented is twofold: first, the theory behind each of the models is reviewed and compared; then, each model is tested with eight impartial simulations. All scenarios were constructed in an experimental framework that allows each model to fulfill its assumptions and hence, obtain unbiased results for each case. Among these models is the one proposed by Thomp","2021","07","15","Bull Math Biol","Bulletin of mathematical biology","Basic reproduction number; Bayesian statistics; Kalman filter; Poisson process; Simulations; Basic Reproduction Number; Bayes Theorem; COVID-19; Colombia; Computer Simulation; Confidence Intervals; Epidemics; Humans; Mathematical Concepts; Models, Biological; Models, Statistical; Pandemics; Poisson Distribution; SARS-CoV-2","Franco","Camila","Universidad de los Andes, Bogotá, Colombia",NA
"1415","34216281","10.1007/s11538-021-00922-3","Alternative Strategies for the Estimation of a Disease's Basic Reproduction Number: A Model-Agnostic Study.","This work presents a model-agnostic evaluation of four different models that estimate a disease's basic reproduction number. The evaluation presented is twofold: first, the theory behind each of the models is reviewed and compared; then, each model is tested with eight impartial simulations. All scenarios were constructed in an experimental framework that allows each model to fulfill its assumptions and hence, obtain unbiased results for each case. Among these models is the one proposed by Thomp","2021","07","15","Bull Math Biol","Bulletin of mathematical biology","Basic reproduction number; Bayesian statistics; Kalman filter; Poisson process; Simulations; Basic Reproduction Number; Bayes Theorem; COVID-19; Colombia; Computer Simulation; Confidence Intervals; Epidemics; Humans; Mathematical Concepts; Models, Biological; Models, Statistical; Pandemics; Poisson Distribution; SARS-CoV-2","Cruz","Érica","Instituto Nacional de Salud, Bogotá, Colombia",NA
"1416","34216281","10.1007/s11538-021-00922-3","Alternative Strategies for the Estimation of a Disease's Basic Reproduction Number: A Model-Agnostic Study.","This work presents a model-agnostic evaluation of four different models that estimate a disease's basic reproduction number. The evaluation presented is twofold: first, the theory behind each of the models is reviewed and compared; then, each model is tested with eight impartial simulations. All scenarios were constructed in an experimental framework that allows each model to fulfill its assumptions and hence, obtain unbiased results for each case. Among these models is the one proposed by Thomp","2021","07","15","Bull Math Biol","Bulletin of mathematical biology","Basic reproduction number; Bayesian statistics; Kalman filter; Poisson process; Simulations; Basic Reproduction Number; Bayes Theorem; COVID-19; Colombia; Computer Simulation; Confidence Intervals; Epidemics; Humans; Mathematical Concepts; Models, Biological; Models, Statistical; Pandemics; Poisson Distribution; SARS-CoV-2","Vargas","Gina","Instituto Nacional de Salud, Bogotá, Colombia",NA
"1417","34216281","10.1007/s11538-021-00922-3","Alternative Strategies for the Estimation of a Disease's Basic Reproduction Number: A Model-Agnostic Study.","This work presents a model-agnostic evaluation of four different models that estimate a disease's basic reproduction number. The evaluation presented is twofold: first, the theory behind each of the models is reviewed and compared; then, each model is tested with eight impartial simulations. All scenarios were constructed in an experimental framework that allows each model to fulfill its assumptions and hence, obtain unbiased results for each case. Among these models is the one proposed by Thomp","2021","07","15","Bull Math Biol","Bulletin of mathematical biology","Basic reproduction number; Bayesian statistics; Kalman filter; Poisson process; Simulations; Basic Reproduction Number; Bayes Theorem; COVID-19; Colombia; Computer Simulation; Confidence Intervals; Epidemics; Humans; Mathematical Concepts; Models, Biological; Models, Statistical; Pandemics; Poisson Distribution; SARS-CoV-2","Castañeda","Carlos","Instituto Nacional de Salud, Bogotá, Colombia. ccastanedao@ins.gov","ccastanedao@ins.gov.co"
"1418","34216270","10.1007/s00431-021-04179-9","Implementation of lung ultrasound in low- to middle-income countries: a new challenge global health?","Pneumonia remains the leading cause of death globally in children under the age of five. The poorest children are the ones most at risk of dying. In the recent years, lung ultrasound has been widely documented as a safe and easy tool for the diagnosis and monitoring of pneumonia and several other respiratory infections and diseases. During the pandemic, it played a primary role to achieve early suspicion and prediction of severe COVID-19, reducing the risk of exposure of healthcare workers to po","2021","07","07","Eur J Pediatr","European journal of pediatrics","ALRTI; Children; Global health; LMCIs; Low- to middle-income countries; Lung ultrasound; Personalized medicine; Pneumonia","Buonsenso","Danilo","Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario, Largo A. Gemelli 8, 00168, Rome, Italy. danilobuonsenso@gmail","danilobuonsenso@gmail.com"
"1419","34216270","10.1007/s00431-021-04179-9","Implementation of lung ultrasound in low- to middle-income countries: a new challenge global health?","Pneumonia remains the leading cause of death globally in children under the age of five. The poorest children are the ones most at risk of dying. In the recent years, lung ultrasound has been widely documented as a safe and easy tool for the diagnosis and monitoring of pneumonia and several other respiratory infections and diseases. During the pandemic, it played a primary role to achieve early suspicion and prediction of severe COVID-19, reducing the risk of exposure of healthcare workers to po","2021","07","07","Eur J Pediatr","European journal of pediatrics","ALRTI; Children; Global health; LMCIs; Low- to middle-income countries; Lung ultrasound; Personalized medicine; Pneumonia","De Rose","Cristina","Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario, Largo A. Gemelli 8, 00168, Rome, Italy",NA
"1420","34216264","10.1007/s00415-021-10694-4","COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?",NA,"2021","07","07","J Neurol","Journal of neurology",NA,"Cavallieri","Francesco","Neurology Unit, Neuromotor and Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Viale Risorgimento 80, 42123, Reggio Emilia, Italy. francesco.cavallieri@unimore","francesco.cavallieri@unimore.it"
"1421","34216264","10.1007/s00415-021-10694-4","COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?",NA,"2021","07","07","J Neurol","Journal of neurology",NA,"Fioravanti","Valentina","Neurology Unit, Neuromotor and Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Viale Risorgimento 80, 42123, Reggio Emilia, Italy",NA
"1422","34216264","10.1007/s00415-021-10694-4","COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?",NA,"2021","07","07","J Neurol","Journal of neurology",NA,"Toschi","Giulia","Neurology Unit, Neuromotor and Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Viale Risorgimento 80, 42123, Reggio Emilia, Italy",NA
"1423","34216264","10.1007/s00415-021-10694-4","COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?",NA,"2021","07","07","J Neurol","Journal of neurology",NA,"Grisanti","Sara","Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy",NA
"1424","34216264","10.1007/s00415-021-10694-4","COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?",NA,"2021","07","07","J Neurol","Journal of neurology",NA,"Napoli","Manuela","Neuroradiology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy",NA
"1425","34216264","10.1007/s00415-021-10694-4","COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?",NA,"2021","07","07","J Neurol","Journal of neurology",NA,"Moratti","Claudio","Neuroradiology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy",NA
"1426","34216264","10.1007/s00415-021-10694-4","COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?",NA,"2021","07","07","J Neurol","Journal of neurology",NA,"Pascarella","Rosario","Neuroradiology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy",NA
"1427","34216264","10.1007/s00415-021-10694-4","COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?",NA,"2021","07","07","J Neurol","Journal of neurology",NA,"Versari","Annibale","Nuclear Medicine Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy",NA
"1428","34216264","10.1007/s00415-021-10694-4","COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?",NA,"2021","07","07","J Neurol","Journal of neurology",NA,"Fraternali","Alessandro","Nuclear Medicine Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy",NA
"1429","34216264","10.1007/s00415-021-10694-4","COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?",NA,"2021","07","07","J Neurol","Journal of neurology",NA,"Casali","Massimiliano","Nuclear Medicine Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy",NA
"1430","34216264","10.1007/s00415-021-10694-4","COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?",NA,"2021","07","07","J Neurol","Journal of neurology",NA,"Paul","Jefri J","CENTOGENE GmbH, Rostock, Germany",NA
"1431","34216264","10.1007/s00415-021-10694-4","COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?",NA,"2021","07","07","J Neurol","Journal of neurology",NA,"Moro","Elena","Division of Neurology, Centre Hospitalier Universitaire (CHU), Grenoble Alpes University, Grenoble Institute of Neurosciences, Grenoble, France",NA
"1432","34216264","10.1007/s00415-021-10694-4","COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?",NA,"2021","07","07","J Neurol","Journal of neurology",NA,"Bauer","Peter","CENTOGENE GmbH, Rostock, Germany",NA
"1433","34216264","10.1007/s00415-021-10694-4","COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?",NA,"2021","07","07","J Neurol","Journal of neurology",NA,"Zedde","Marialuisa","Neurology Unit, Neuromotor and Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Viale Risorgimento 80, 42123, Reggio Emilia, Italy",NA
"1434","34216264","10.1007/s00415-021-10694-4","COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?",NA,"2021","07","07","J Neurol","Journal of neurology",NA,"Valzania","Franco","Neurology Unit, Neuromotor and Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Viale Risorgimento 80, 42123, Reggio Emilia, Italy",NA
"1435","34216205","10.1093/ajhp/zxab274","Consequences of rush to emergency use authorization of bamlanivimab.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","03","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","COVID-19; EUA; bamlanivimab; coronavirus; emergency use authorization","Lussier","Mia","Center for Pharmacy Innovation and Outcomes, Geisinger, Forty Fort, PA, USA",NA
"1436","34216205","10.1093/ajhp/zxab274","Consequences of rush to emergency use authorization of bamlanivimab.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","03","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","COVID-19; EUA; bamlanivimab; coronavirus; emergency use authorization","Meyer","Michelle N","Geisinger, Danville, PA, USA",NA
"1437","34216205","10.1093/ajhp/zxab274","Consequences of rush to emergency use authorization of bamlanivimab.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","03","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","COVID-19; EUA; bamlanivimab; coronavirus; emergency use authorization","Wright","Eric","Center for Pharmacy Innovation and Outcomes, Geisinger, Forty Fort, PA, USA",NA
"1438","34216187","10.1111/ggi.14233","Does the COVID-19 pandemic robustly influence the incidence of frailty?",NA,"2021","07","03","Geriatr Gerontol Int","Geriatrics &amp; gerontology international",NA,"Yamada","Minoru","Faculty of Human Sciences, University of Tsukuba, Tokyo, Japan",NA
"1439","34216187","10.1111/ggi.14233","Does the COVID-19 pandemic robustly influence the incidence of frailty?",NA,"2021","07","03","Geriatr Gerontol Int","Geriatrics &amp; gerontology international",NA,"Arai","Hidenori","National Center for Geriatrics and Gerontology, Obu, Japan",NA
"1440","34216170","10.1111/jpc.15585","Seroprevalence of SARS-CoV-2 antibodies in health-care workers at a tertiary paediatric hospital.",NA,"2021","07","08","J Paediatr Child Health","Journal of paediatrics and child health","COVID-19; Child; Health Personnel; Hospitals, Pediatric; Humans; SARS-CoV-2; Seroepidemiologic Studies","Tuckerman","Jane","Infection and Immunity, Murdoch Children's Research Institute, Victoria, Australia",NA
"1441","34216170","10.1111/jpc.15585","Seroprevalence of SARS-CoV-2 antibodies in health-care workers at a tertiary paediatric hospital.",NA,"2021","07","08","J Paediatr Child Health","Journal of paediatrics and child health","COVID-19; Child; Health Personnel; Hospitals, Pediatric; Humans; SARS-CoV-2; Seroepidemiologic Studies","Lee","Lai-Yang","Microbiology, Laboratory Services, The Royal Children's Hospital, Melbourne, Victoria, Australia",NA
"1442","34216170","10.1111/jpc.15585","Seroprevalence of SARS-CoV-2 antibodies in health-care workers at a tertiary paediatric hospital.",NA,"2021","07","08","J Paediatr Child Health","Journal of paediatrics and child health","COVID-19; Child; Health Personnel; Hospitals, Pediatric; Humans; SARS-CoV-2; Seroepidemiologic Studies","Wurzel","Danielle","Infection and Immunity, Murdoch Children's Research Institute, Victoria, Australia",NA
"1443","34216170","10.1111/jpc.15585","Seroprevalence of SARS-CoV-2 antibodies in health-care workers at a tertiary paediatric hospital.",NA,"2021","07","08","J Paediatr Child Health","Journal of paediatrics and child health","COVID-19; Child; Health Personnel; Hospitals, Pediatric; Humans; SARS-CoV-2; Seroepidemiologic Studies","Tosif","Shidan","Infection and Immunity, Murdoch Children's Research Institute, Victoria, Australia",NA
"1444","34216170","10.1111/jpc.15585","Seroprevalence of SARS-CoV-2 antibodies in health-care workers at a tertiary paediatric hospital.",NA,"2021","07","08","J Paediatr Child Health","Journal of paediatrics and child health","COVID-19; Child; Health Personnel; Hospitals, Pediatric; Humans; SARS-CoV-2; Seroepidemiologic Studies","Clifford","Vanessa","Infection and Immunity, Murdoch Children's Research Institute, Victoria, Australia",NA
"1445","34216170","10.1111/jpc.15585","Seroprevalence of SARS-CoV-2 antibodies in health-care workers at a tertiary paediatric hospital.",NA,"2021","07","08","J Paediatr Child Health","Journal of paediatrics and child health","COVID-19; Child; Health Personnel; Hospitals, Pediatric; Humans; SARS-CoV-2; Seroepidemiologic Studies","McMinn","Alissa","Infection and Immunity, Murdoch Children's Research Institute, Victoria, Australia",NA
"1446","34216170","10.1111/jpc.15585","Seroprevalence of SARS-CoV-2 antibodies in health-care workers at a tertiary paediatric hospital.",NA,"2021","07","08","J Paediatr Child Health","Journal of paediatrics and child health","COVID-19; Child; Health Personnel; Hospitals, Pediatric; Humans; SARS-CoV-2; Seroepidemiologic Studies","O'Donaghue","Kate","Infection Prevention and Control, The Royal Children's Hospital, Melbourne, Victoria, Australia",NA
"1447","34216170","10.1111/jpc.15585","Seroprevalence of SARS-CoV-2 antibodies in health-care workers at a tertiary paediatric hospital.",NA,"2021","07","08","J Paediatr Child Health","Journal of paediatrics and child health","COVID-19; Child; Health Personnel; Hospitals, Pediatric; Humans; SARS-CoV-2; Seroepidemiologic Studies","Rautenbacher","Karin","Microbiology, Laboratory Services, The Royal Children's Hospital, Melbourne, Victoria, Australia",NA
"1448","34216170","10.1111/jpc.15585","Seroprevalence of SARS-CoV-2 antibodies in health-care workers at a tertiary paediatric hospital.",NA,"2021","07","08","J Paediatr Child Health","Journal of paediatrics and child health","COVID-19; Child; Health Personnel; Hospitals, Pediatric; Humans; SARS-CoV-2; Seroepidemiologic Studies","Licciardi","Paul V","Infection and Immunity, Murdoch Children's Research Institute, Victoria, Australia",NA
"1449","34216170","10.1111/jpc.15585","Seroprevalence of SARS-CoV-2 antibodies in health-care workers at a tertiary paediatric hospital.",NA,"2021","07","08","J Paediatr Child Health","Journal of paediatrics and child health","COVID-19; Child; Health Personnel; Hospitals, Pediatric; Humans; SARS-CoV-2; Seroepidemiologic Studies","Toh","Ryan","Infection and Immunity, Murdoch Children's Research Institute, Victoria, Australia",NA
"1450","34216170","10.1111/jpc.15585","Seroprevalence of SARS-CoV-2 antibodies in health-care workers at a tertiary paediatric hospital.",NA,"2021","07","08","J Paediatr Child Health","Journal of paediatrics and child health","COVID-19; Child; Health Personnel; Hospitals, Pediatric; Humans; SARS-CoV-2; Seroepidemiologic Studies","Daley","Andrew","Department of Paediatrics, University of Melbourne, Victoria, Australia",NA
"1451","34216170","10.1111/jpc.15585","Seroprevalence of SARS-CoV-2 antibodies in health-care workers at a tertiary paediatric hospital.",NA,"2021","07","08","J Paediatr Child Health","Journal of paediatrics and child health","COVID-19; Child; Health Personnel; Hospitals, Pediatric; Humans; SARS-CoV-2; Seroepidemiologic Studies","Crawford","Nigel W","Infection and Immunity, Murdoch Children's Research Institute, Victoria, Australia",NA
"1452","34216156","10.1111/trf.16580","Assessment of serological assays for identifying high titer convalescent plasma.","The COVID-19 pandemic has been accompanied by the largest mobilization of therapeutic convalescent plasma (CCP) in over a century. Initial identification of high titer units was based on dose-response data using the Ortho VITROS IgG assay. The proliferation of severe acute respiratory syndrome coronavirus 2 serological assays and non-uniform application has led to uncertainty about their interrelationships. The purpose of this study was to establish correlations and analogous cutoffs between mul","2021","07","07","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma; serology","Farnsworth","Christopher W","Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA",NA
"1453","34216156","10.1111/trf.16580","Assessment of serological assays for identifying high titer convalescent plasma.","The COVID-19 pandemic has been accompanied by the largest mobilization of therapeutic convalescent plasma (CCP) in over a century. Initial identification of high titer units was based on dose-response data using the Ortho VITROS IgG assay. The proliferation of severe acute respiratory syndrome coronavirus 2 serological assays and non-uniform application has led to uncertainty about their interrelationships. The purpose of this study was to establish correlations and analogous cutoffs between mul","2021","07","07","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma; serology","Case","James B","Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA",NA
"1454","34216156","10.1111/trf.16580","Assessment of serological assays for identifying high titer convalescent plasma.","The COVID-19 pandemic has been accompanied by the largest mobilization of therapeutic convalescent plasma (CCP) in over a century. Initial identification of high titer units was based on dose-response data using the Ortho VITROS IgG assay. The proliferation of severe acute respiratory syndrome coronavirus 2 serological assays and non-uniform application has led to uncertainty about their interrelationships. The purpose of this study was to establish correlations and analogous cutoffs between mul","2021","07","07","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma; serology","Hock","Karl","Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA",NA
"1455","34216156","10.1111/trf.16580","Assessment of serological assays for identifying high titer convalescent plasma.","The COVID-19 pandemic has been accompanied by the largest mobilization of therapeutic convalescent plasma (CCP) in over a century. Initial identification of high titer units was based on dose-response data using the Ortho VITROS IgG assay. The proliferation of severe acute respiratory syndrome coronavirus 2 serological assays and non-uniform application has led to uncertainty about their interrelationships. The purpose of this study was to establish correlations and analogous cutoffs between mul","2021","07","07","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma; serology","Chen","Rita E","Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA",NA
"1456","34216156","10.1111/trf.16580","Assessment of serological assays for identifying high titer convalescent plasma.","The COVID-19 pandemic has been accompanied by the largest mobilization of therapeutic convalescent plasma (CCP) in over a century. Initial identification of high titer units was based on dose-response data using the Ortho VITROS IgG assay. The proliferation of severe acute respiratory syndrome coronavirus 2 serological assays and non-uniform application has led to uncertainty about their interrelationships. The purpose of this study was to establish correlations and analogous cutoffs between mul","2021","07","07","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma; serology","O'Halloran","Jane A","Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA",NA
"1457","34216156","10.1111/trf.16580","Assessment of serological assays for identifying high titer convalescent plasma.","The COVID-19 pandemic has been accompanied by the largest mobilization of therapeutic convalescent plasma (CCP) in over a century. Initial identification of high titer units was based on dose-response data using the Ortho VITROS IgG assay. The proliferation of severe acute respiratory syndrome coronavirus 2 serological assays and non-uniform application has led to uncertainty about their interrelationships. The purpose of this study was to establish correlations and analogous cutoffs between mul","2021","07","07","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma; serology","Presti","Rachel","Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA",NA
"1458","34216156","10.1111/trf.16580","Assessment of serological assays for identifying high titer convalescent plasma.","The COVID-19 pandemic has been accompanied by the largest mobilization of therapeutic convalescent plasma (CCP) in over a century. Initial identification of high titer units was based on dose-response data using the Ortho VITROS IgG assay. The proliferation of severe acute respiratory syndrome coronavirus 2 serological assays and non-uniform application has led to uncertainty about their interrelationships. The purpose of this study was to establish correlations and analogous cutoffs between mul","2021","07","07","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma; serology","Goss","Charles W","Division of Biostatistics, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA",NA
"1459","34216156","10.1111/trf.16580","Assessment of serological assays for identifying high titer convalescent plasma.","The COVID-19 pandemic has been accompanied by the largest mobilization of therapeutic convalescent plasma (CCP) in over a century. Initial identification of high titer units was based on dose-response data using the Ortho VITROS IgG assay. The proliferation of severe acute respiratory syndrome coronavirus 2 serological assays and non-uniform application has led to uncertainty about their interrelationships. The purpose of this study was to establish correlations and analogous cutoffs between mul","2021","07","07","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma; serology","Rauseo","Adriana M","Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA",NA
"1460","34216156","10.1111/trf.16580","Assessment of serological assays for identifying high titer convalescent plasma.","The COVID-19 pandemic has been accompanied by the largest mobilization of therapeutic convalescent plasma (CCP) in over a century. Initial identification of high titer units was based on dose-response data using the Ortho VITROS IgG assay. The proliferation of severe acute respiratory syndrome coronavirus 2 serological assays and non-uniform application has led to uncertainty about their interrelationships. The purpose of this study was to establish correlations and analogous cutoffs between mul","2021","07","07","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma; serology","Ellebedy","Ali","Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA",NA
"1461","34216156","10.1111/trf.16580","Assessment of serological assays for identifying high titer convalescent plasma.","The COVID-19 pandemic has been accompanied by the largest mobilization of therapeutic convalescent plasma (CCP) in over a century. Initial identification of high titer units was based on dose-response data using the Ortho VITROS IgG assay. The proliferation of severe acute respiratory syndrome coronavirus 2 serological assays and non-uniform application has led to uncertainty about their interrelationships. The purpose of this study was to establish correlations and analogous cutoffs between mul","2021","07","07","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma; serology","Theel","Elitza S","Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA",NA
"1462","34216156","10.1111/trf.16580","Assessment of serological assays for identifying high titer convalescent plasma.","The COVID-19 pandemic has been accompanied by the largest mobilization of therapeutic convalescent plasma (CCP) in over a century. Initial identification of high titer units was based on dose-response data using the Ortho VITROS IgG assay. The proliferation of severe acute respiratory syndrome coronavirus 2 serological assays and non-uniform application has led to uncertainty about their interrelationships. The purpose of this study was to establish correlations and analogous cutoffs between mul","2021","07","07","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma; serology","Diamond","Michael S","Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA",NA
"1463","34216156","10.1111/trf.16580","Assessment of serological assays for identifying high titer convalescent plasma.","The COVID-19 pandemic has been accompanied by the largest mobilization of therapeutic convalescent plasma (CCP) in over a century. Initial identification of high titer units was based on dose-response data using the Ortho VITROS IgG assay. The proliferation of severe acute respiratory syndrome coronavirus 2 serological assays and non-uniform application has led to uncertainty about their interrelationships. The purpose of this study was to establish correlations and analogous cutoffs between mul","2021","07","07","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma; serology","Henderson","Jeffrey P","Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA",NA
"1464","34216143","10.1002/lary.29727","In Reference to ""SARS-CoV-2 presence in the saliva, tears and cerumen of COVID-19 patients"".",NA,"2021","07","03","Laryngoscope","The Laryngoscope",NA,"Cherchi","Marcello","Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, U",NA
"1465","34216143","10.1002/lary.29727","In Reference to ""SARS-CoV-2 presence in the saliva, tears and cerumen of COVID-19 patients"".",NA,"2021","07","03","Laryngoscope","The Laryngoscope",NA,"Yacovino","Darío A","Department of Neurology, Dr. Cesar Milstein Hospital, Buenos Aires, Argentina",NA
"1466","34216142","10.1002/lary.29723","In response to the letter to the editor regarding SARS-CoV-2 Presence in the Saliva, Tears, and Cerumen of COVID-19 Patients.",NA,"2021","07","03","Laryngoscope","The Laryngoscope",NA,"Celik","Serdal","Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey",NA
"1467","34216142","10.1002/lary.29723","In response to the letter to the editor regarding SARS-CoV-2 Presence in the Saliva, Tears, and Cerumen of COVID-19 Patients.",NA,"2021","07","03","Laryngoscope","The Laryngoscope",NA,"Kalcioglu","Mahmut Tayyar","Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey",NA
"1468","34216142","10.1002/lary.29723","In response to the letter to the editor regarding SARS-CoV-2 Presence in the Saliva, Tears, and Cerumen of COVID-19 Patients.",NA,"2021","07","03","Laryngoscope","The Laryngoscope",NA,"Hanege","Fatih Mehmet","Dr Hanege Private Clinic, Istanbul, Turkey",NA
"1469","34216134","10.3947/ic.2021.0304","Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.","Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In ter","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anti-SARS-CoV-2 monoclonal antibody; COVID-19; Korea","Kim","Sun Bean","Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea",NA
"1470","34216134","10.3947/ic.2021.0304","Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.","Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In ter","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anti-SARS-CoV-2 monoclonal antibody; COVID-19; Korea","Kim","Jimin","Division of Healthcare Technology Assessment Research, National Evidence-based Healthcare, Collaborating Agency, Seoul, Korea",NA
"1471","34216134","10.3947/ic.2021.0304","Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.","Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In ter","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anti-SARS-CoV-2 monoclonal antibody; COVID-19; Korea","Huh","Kyungmin","Division of Infectious Diseases, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea",NA
"1472","34216134","10.3947/ic.2021.0304","Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.","Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In ter","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anti-SARS-CoV-2 monoclonal antibody; COVID-19; Korea","Choi","Won Suk","Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea",NA
"1473","34216134","10.3947/ic.2021.0304","Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.","Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In ter","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anti-SARS-CoV-2 monoclonal antibody; COVID-19; Korea","Kim","Yae Jean","Division of Infectious Diseases and Immunodeficiency, Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea",NA
"1474","34216134","10.3947/ic.2021.0304","Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.","Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In ter","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anti-SARS-CoV-2 monoclonal antibody; COVID-19; Korea","Joo","Eun Jeong","Division of Infectious Diseases, Department of Internal Medicine, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, Korea",NA
"1475","34216134","10.3947/ic.2021.0304","Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.","Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In ter","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anti-SARS-CoV-2 monoclonal antibody; COVID-19; Korea","Kim","Youn Jeong","Division of Infectious Diseases, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea",NA
"1476","34216134","10.3947/ic.2021.0304","Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.","Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In ter","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anti-SARS-CoV-2 monoclonal antibody; COVID-19; Korea","Yoon","Young Kyung","Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea",NA
"1477","34216134","10.3947/ic.2021.0304","Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.","Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In ter","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anti-SARS-CoV-2 monoclonal antibody; COVID-19; Korea","Heo","Jung Yeon","Department of Infectious Diseases, Ajou University School of Medicine, Suwon, Korea",NA
"1478","34216134","10.3947/ic.2021.0304","Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.","Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In ter","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anti-SARS-CoV-2 monoclonal antibody; COVID-19; Korea","Seo","Yu Bin","Division of Infectious Diseases, Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea",NA
"1479","34216134","10.3947/ic.2021.0304","Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.","Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In ter","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anti-SARS-CoV-2 monoclonal antibody; COVID-19; Korea","Jeong","Su Jin","Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea",NA
"1480","34216134","10.3947/ic.2021.0304","Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.","Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In ter","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anti-SARS-CoV-2 monoclonal antibody; COVID-19; Korea","Yu","Su Yeon","Division of Healthcare Technology Assessment Research, National Evidence-based Healthcare, Collaborating Agency, Seoul, Korea",NA
"1481","34216134","10.3947/ic.2021.0304","Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.","Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In ter","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anti-SARS-CoV-2 monoclonal antibody; COVID-19; Korea","Peck","Kyong Ran","Division of Infectious Diseases, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea",NA
"1482","34216134","10.3947/ic.2021.0304","Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.","Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In ter","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anti-SARS-CoV-2 monoclonal antibody; COVID-19; Korea","Choi","Miyoung","Division of Healthcare Technology Assessment Research, National Evidence-based Healthcare, Collaborating Agency, Seoul, Korea. mychoi@neca.re","mychoi@neca.re.kr"
"1483","34216134","10.3947/ic.2021.0304","Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.","Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In ter","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anti-SARS-CoV-2 monoclonal antibody; COVID-19; Korea","Yeom","Joon Sup","Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. joonsup.yeom@yuhs","joonsup.yeom@yuhs.ac"
"1484","34216133","10.3947/ic.2020.0154","Range of Varicella Zoster Co-Infections with COVID-19, Singapore.","There have been recent descriptions of the novel coronavirus disease 2019 (COVID-19) presenting as 'varicella-like exanthem'. We report three cases of patients with Varicella-Zoster Virus (VZV) and COVID-19 co-infections, presenting in three varied ways. These cases highlight the need for heightened alertness to how such co-infections can present, to pick up overlapping 'dual pathologies' during this current pandemic given that infection control measures including airborne precautions are crucia","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; Chickenpox; Coinfection; Communicable diseases; Public health","Loh","Jerold","Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore. jerold_loh@nuhs.edu","loh@nuhs.edu.sg"
"1485","34216133","10.3947/ic.2020.0154","Range of Varicella Zoster Co-Infections with COVID-19, Singapore.","There have been recent descriptions of the novel coronavirus disease 2019 (COVID-19) presenting as 'varicella-like exanthem'. We report three cases of patients with Varicella-Zoster Virus (VZV) and COVID-19 co-infections, presenting in three varied ways. These cases highlight the need for heightened alertness to how such co-infections can present, to pick up overlapping 'dual pathologies' during this current pandemic given that infection control measures including airborne precautions are crucia","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; Chickenpox; Coinfection; Communicable diseases; Public health","Tham","Sai Meng","Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore",NA
"1486","34216133","10.3947/ic.2020.0154","Range of Varicella Zoster Co-Infections with COVID-19, Singapore.","There have been recent descriptions of the novel coronavirus disease 2019 (COVID-19) presenting as 'varicella-like exanthem'. We report three cases of patients with Varicella-Zoster Virus (VZV) and COVID-19 co-infections, presenting in three varied ways. These cases highlight the need for heightened alertness to how such co-infections can present, to pick up overlapping 'dual pathologies' during this current pandemic given that infection control measures including airborne precautions are crucia","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; Chickenpox; Coinfection; Communicable diseases; Public health","Tambyah","Paul Anantharajah","Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore",NA
"1487","34216133","10.3947/ic.2020.0154","Range of Varicella Zoster Co-Infections with COVID-19, Singapore.","There have been recent descriptions of the novel coronavirus disease 2019 (COVID-19) presenting as 'varicella-like exanthem'. We report three cases of patients with Varicella-Zoster Virus (VZV) and COVID-19 co-infections, presenting in three varied ways. These cases highlight the need for heightened alertness to how such co-infections can present, to pick up overlapping 'dual pathologies' during this current pandemic given that infection control measures including airborne precautions are crucia","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; Chickenpox; Coinfection; Communicable diseases; Public health","Yan","Gabriel","Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore",NA
"1488","34216133","10.3947/ic.2020.0154","Range of Varicella Zoster Co-Infections with COVID-19, Singapore.","There have been recent descriptions of the novel coronavirus disease 2019 (COVID-19) presenting as 'varicella-like exanthem'. We report three cases of patients with Varicella-Zoster Virus (VZV) and COVID-19 co-infections, presenting in three varied ways. These cases highlight the need for heightened alertness to how such co-infections can present, to pick up overlapping 'dual pathologies' during this current pandemic given that infection control measures including airborne precautions are crucia","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; Chickenpox; Coinfection; Communicable diseases; Public health","Lee","Chun Kiat","Molecular Diagnosis Centre, Department of Laboratory Medicine, National University Health System, Singapore",NA
"1489","34216133","10.3947/ic.2020.0154","Range of Varicella Zoster Co-Infections with COVID-19, Singapore.","There have been recent descriptions of the novel coronavirus disease 2019 (COVID-19) presenting as 'varicella-like exanthem'. We report three cases of patients with Varicella-Zoster Virus (VZV) and COVID-19 co-infections, presenting in three varied ways. These cases highlight the need for heightened alertness to how such co-infections can present, to pick up overlapping 'dual pathologies' during this current pandemic given that infection control measures including airborne precautions are crucia","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; Chickenpox; Coinfection; Communicable diseases; Public health","Chai","Louis Yi Ann","Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore",NA
"1490","34216129","10.3947/ic.2020.0153","Knowledge and Attitudes of School Teachers on Vaccination in Greece.","Few studies have assessed attitudes and beliefs of school teachers on vaccination. Our cross-sectional questionnaire-based prospective survey aims to explore vaccination coverage and relevant knowledge of school teachers in Greece. Out of the 217 respondents, 93% believe that vaccines offer protection but only 69.7% were completely vaccinated as per adults' National Immunization Schedule. In multivariate analysis, female gender, being a parent, beliefs that vaccination should be mandatory and im","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Attitudes; Immunization; Knowledge; School teachers; Vaccination","Gkentzi","Despoina","Department of Paediatrics, Patras Medical School, Patras, Greece. gkentzid@hotmail","gkentzid@hotmail.com"
"1491","34216129","10.3947/ic.2020.0153","Knowledge and Attitudes of School Teachers on Vaccination in Greece.","Few studies have assessed attitudes and beliefs of school teachers on vaccination. Our cross-sectional questionnaire-based prospective survey aims to explore vaccination coverage and relevant knowledge of school teachers in Greece. Out of the 217 respondents, 93% believe that vaccines offer protection but only 69.7% were completely vaccinated as per adults' National Immunization Schedule. In multivariate analysis, female gender, being a parent, beliefs that vaccination should be mandatory and im","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Attitudes; Immunization; Knowledge; School teachers; Vaccination","Benetatou","Eleni","th Primary School, Directorate of Primary Education of Achaia, Patras, Greece",NA
"1492","34216129","10.3947/ic.2020.0153","Knowledge and Attitudes of School Teachers on Vaccination in Greece.","Few studies have assessed attitudes and beliefs of school teachers on vaccination. Our cross-sectional questionnaire-based prospective survey aims to explore vaccination coverage and relevant knowledge of school teachers in Greece. Out of the 217 respondents, 93% believe that vaccines offer protection but only 69.7% were completely vaccinated as per adults' National Immunization Schedule. In multivariate analysis, female gender, being a parent, beliefs that vaccination should be mandatory and im","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Attitudes; Immunization; Knowledge; School teachers; Vaccination","Karatza","Ageliki","Department of Paediatrics, Patras Medical School, Patras, Greece",NA
"1493","34216129","10.3947/ic.2020.0153","Knowledge and Attitudes of School Teachers on Vaccination in Greece.","Few studies have assessed attitudes and beliefs of school teachers on vaccination. Our cross-sectional questionnaire-based prospective survey aims to explore vaccination coverage and relevant knowledge of school teachers in Greece. Out of the 217 respondents, 93% believe that vaccines offer protection but only 69.7% were completely vaccinated as per adults' National Immunization Schedule. In multivariate analysis, female gender, being a parent, beliefs that vaccination should be mandatory and im","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Attitudes; Immunization; Knowledge; School teachers; Vaccination","Marangos","Markos","Division of Infectious Diseases, Patras Medical School, Patras, Greece",NA
"1494","34216129","10.3947/ic.2020.0153","Knowledge and Attitudes of School Teachers on Vaccination in Greece.","Few studies have assessed attitudes and beliefs of school teachers on vaccination. Our cross-sectional questionnaire-based prospective survey aims to explore vaccination coverage and relevant knowledge of school teachers in Greece. Out of the 217 respondents, 93% believe that vaccines offer protection but only 69.7% were completely vaccinated as per adults' National Immunization Schedule. In multivariate analysis, female gender, being a parent, beliefs that vaccination should be mandatory and im","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Attitudes; Immunization; Knowledge; School teachers; Vaccination","Varvarigou","Anastasia","Department of Paediatrics, Patras Medical School, Patras, Greece",NA
"1495","34216129","10.3947/ic.2020.0153","Knowledge and Attitudes of School Teachers on Vaccination in Greece.","Few studies have assessed attitudes and beliefs of school teachers on vaccination. Our cross-sectional questionnaire-based prospective survey aims to explore vaccination coverage and relevant knowledge of school teachers in Greece. Out of the 217 respondents, 93% believe that vaccines offer protection but only 69.7% were completely vaccinated as per adults' National Immunization Schedule. In multivariate analysis, female gender, being a parent, beliefs that vaccination should be mandatory and im","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Attitudes; Immunization; Knowledge; School teachers; Vaccination","Dimitriou","Gabriel","Department of Paediatrics, Patras Medical School, Patras, Greece",NA
"1496","34216126","10.3947/ic.2021.0046","Nosocomial Outbreak of COVID-19 in a Hematologic Ward.","Coronavirus disease 2019 (COVID-19) outbreaks occur in hospitals in many parts of the world. In hospital settings, the possibility of airborne transmission needs to be investigated thoroughly. There was a nosocomial outbreak of COVID-19 in a hematologic ward in a tertiary hospital, Seoul, Korea. We found 11 patients and guardians with COVID-19 through vigorous contact tracing and closed-circuit television monitoring. We found one patient who probably had acquired COVID-19 through airborne-transm","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Airborne transmission; COVID-19; Hematologic malignancy; Multi-patient room; SARS-CoV-2","Jung","Jiwon","Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"1497","34216126","10.3947/ic.2021.0046","Nosocomial Outbreak of COVID-19 in a Hematologic Ward.","Coronavirus disease 2019 (COVID-19) outbreaks occur in hospitals in many parts of the world. In hospital settings, the possibility of airborne transmission needs to be investigated thoroughly. There was a nosocomial outbreak of COVID-19 in a hematologic ward in a tertiary hospital, Seoul, Korea. We found 11 patients and guardians with COVID-19 through vigorous contact tracing and closed-circuit television monitoring. We found one patient who probably had acquired COVID-19 through airborne-transm","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Airborne transmission; COVID-19; Hematologic malignancy; Multi-patient room; SARS-CoV-2","Lee","Jungmin","Department of Microbiology, Institute for Viral Diseases, Biosafety Center, College of Medicine, Korea University, Seoul, Korea",NA
"1498","34216126","10.3947/ic.2021.0046","Nosocomial Outbreak of COVID-19 in a Hematologic Ward.","Coronavirus disease 2019 (COVID-19) outbreaks occur in hospitals in many parts of the world. In hospital settings, the possibility of airborne transmission needs to be investigated thoroughly. There was a nosocomial outbreak of COVID-19 in a hematologic ward in a tertiary hospital, Seoul, Korea. We found 11 patients and guardians with COVID-19 through vigorous contact tracing and closed-circuit television monitoring. We found one patient who probably had acquired COVID-19 through airborne-transm","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Airborne transmission; COVID-19; Hematologic malignancy; Multi-patient room; SARS-CoV-2","Jo","Seongmin","Department of Architectural Engineering, Sejong University, Seoul, Korea",NA
"1499","34216126","10.3947/ic.2021.0046","Nosocomial Outbreak of COVID-19 in a Hematologic Ward.","Coronavirus disease 2019 (COVID-19) outbreaks occur in hospitals in many parts of the world. In hospital settings, the possibility of airborne transmission needs to be investigated thoroughly. There was a nosocomial outbreak of COVID-19 in a hematologic ward in a tertiary hospital, Seoul, Korea. We found 11 patients and guardians with COVID-19 through vigorous contact tracing and closed-circuit television monitoring. We found one patient who probably had acquired COVID-19 through airborne-transm","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Airborne transmission; COVID-19; Hematologic malignancy; Multi-patient room; SARS-CoV-2","Bae","Seongman","Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"1500","34216126","10.3947/ic.2021.0046","Nosocomial Outbreak of COVID-19 in a Hematologic Ward.","Coronavirus disease 2019 (COVID-19) outbreaks occur in hospitals in many parts of the world. In hospital settings, the possibility of airborne transmission needs to be investigated thoroughly. There was a nosocomial outbreak of COVID-19 in a hematologic ward in a tertiary hospital, Seoul, Korea. We found 11 patients and guardians with COVID-19 through vigorous contact tracing and closed-circuit television monitoring. We found one patient who probably had acquired COVID-19 through airborne-transm","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Airborne transmission; COVID-19; Hematologic malignancy; Multi-patient room; SARS-CoV-2","Kim","Ji Yeun","Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"1501","34216126","10.3947/ic.2021.0046","Nosocomial Outbreak of COVID-19 in a Hematologic Ward.","Coronavirus disease 2019 (COVID-19) outbreaks occur in hospitals in many parts of the world. In hospital settings, the possibility of airborne transmission needs to be investigated thoroughly. There was a nosocomial outbreak of COVID-19 in a hematologic ward in a tertiary hospital, Seoul, Korea. We found 11 patients and guardians with COVID-19 through vigorous contact tracing and closed-circuit television monitoring. We found one patient who probably had acquired COVID-19 through airborne-transm","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Airborne transmission; COVID-19; Hematologic malignancy; Multi-patient room; SARS-CoV-2","Cha","Hye Hee","Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"1502","34216126","10.3947/ic.2021.0046","Nosocomial Outbreak of COVID-19 in a Hematologic Ward.","Coronavirus disease 2019 (COVID-19) outbreaks occur in hospitals in many parts of the world. In hospital settings, the possibility of airborne transmission needs to be investigated thoroughly. There was a nosocomial outbreak of COVID-19 in a hematologic ward in a tertiary hospital, Seoul, Korea. We found 11 patients and guardians with COVID-19 through vigorous contact tracing and closed-circuit television monitoring. We found one patient who probably had acquired COVID-19 through airborne-transm","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Airborne transmission; COVID-19; Hematologic malignancy; Multi-patient room; SARS-CoV-2","Lim","Young Ju","Office for Infection Control, Asan Medical Center, Seoul, Korea",NA
"1503","34216126","10.3947/ic.2021.0046","Nosocomial Outbreak of COVID-19 in a Hematologic Ward.","Coronavirus disease 2019 (COVID-19) outbreaks occur in hospitals in many parts of the world. In hospital settings, the possibility of airborne transmission needs to be investigated thoroughly. There was a nosocomial outbreak of COVID-19 in a hematologic ward in a tertiary hospital, Seoul, Korea. We found 11 patients and guardians with COVID-19 through vigorous contact tracing and closed-circuit television monitoring. We found one patient who probably had acquired COVID-19 through airborne-transm","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Airborne transmission; COVID-19; Hematologic malignancy; Multi-patient room; SARS-CoV-2","Kwak","Sun Hee","Office for Infection Control, Asan Medical Center, Seoul, Korea",NA
"1504","34216126","10.3947/ic.2021.0046","Nosocomial Outbreak of COVID-19 in a Hematologic Ward.","Coronavirus disease 2019 (COVID-19) outbreaks occur in hospitals in many parts of the world. In hospital settings, the possibility of airborne transmission needs to be investigated thoroughly. There was a nosocomial outbreak of COVID-19 in a hematologic ward in a tertiary hospital, Seoul, Korea. We found 11 patients and guardians with COVID-19 through vigorous contact tracing and closed-circuit television monitoring. We found one patient who probably had acquired COVID-19 through airborne-transm","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Airborne transmission; COVID-19; Hematologic malignancy; Multi-patient room; SARS-CoV-2","Hong","Min Jee","Office for Infection Control, Asan Medical Center, Seoul, Korea",NA
"1505","34216126","10.3947/ic.2021.0046","Nosocomial Outbreak of COVID-19 in a Hematologic Ward.","Coronavirus disease 2019 (COVID-19) outbreaks occur in hospitals in many parts of the world. In hospital settings, the possibility of airborne transmission needs to be investigated thoroughly. There was a nosocomial outbreak of COVID-19 in a hematologic ward in a tertiary hospital, Seoul, Korea. We found 11 patients and guardians with COVID-19 through vigorous contact tracing and closed-circuit television monitoring. We found one patient who probably had acquired COVID-19 through airborne-transm","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Airborne transmission; COVID-19; Hematologic malignancy; Multi-patient room; SARS-CoV-2","Kim","Eun Ok","Office for Infection Control, Asan Medical Center, Seoul, Korea",NA
"1506","34216126","10.3947/ic.2021.0046","Nosocomial Outbreak of COVID-19 in a Hematologic Ward.","Coronavirus disease 2019 (COVID-19) outbreaks occur in hospitals in many parts of the world. In hospital settings, the possibility of airborne transmission needs to be investigated thoroughly. There was a nosocomial outbreak of COVID-19 in a hematologic ward in a tertiary hospital, Seoul, Korea. We found 11 patients and guardians with COVID-19 through vigorous contact tracing and closed-circuit television monitoring. We found one patient who probably had acquired COVID-19 through airborne-transm","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Airborne transmission; COVID-19; Hematologic malignancy; Multi-patient room; SARS-CoV-2","Bae","Joon Yong","Department of Microbiology, Institute for Viral Diseases, Biosafety Center, College of Medicine, Korea University, Seoul, Korea",NA
"1507","34216126","10.3947/ic.2021.0046","Nosocomial Outbreak of COVID-19 in a Hematologic Ward.","Coronavirus disease 2019 (COVID-19) outbreaks occur in hospitals in many parts of the world. In hospital settings, the possibility of airborne transmission needs to be investigated thoroughly. There was a nosocomial outbreak of COVID-19 in a hematologic ward in a tertiary hospital, Seoul, Korea. We found 11 patients and guardians with COVID-19 through vigorous contact tracing and closed-circuit television monitoring. We found one patient who probably had acquired COVID-19 through airborne-transm","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Airborne transmission; COVID-19; Hematologic malignancy; Multi-patient room; SARS-CoV-2","Kang","Changmin","Department of Microbiology, Institute for Viral Diseases, Biosafety Center, College of Medicine, Korea University, Seoul, Korea",NA
"1508","34216126","10.3947/ic.2021.0046","Nosocomial Outbreak of COVID-19 in a Hematologic Ward.","Coronavirus disease 2019 (COVID-19) outbreaks occur in hospitals in many parts of the world. In hospital settings, the possibility of airborne transmission needs to be investigated thoroughly. There was a nosocomial outbreak of COVID-19 in a hematologic ward in a tertiary hospital, Seoul, Korea. We found 11 patients and guardians with COVID-19 through vigorous contact tracing and closed-circuit television monitoring. We found one patient who probably had acquired COVID-19 through airborne-transm","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Airborne transmission; COVID-19; Hematologic malignancy; Multi-patient room; SARS-CoV-2","Sung","Minki","Department of Architectural Engineering, Sejong University, Seoul, Korea. mksung@sejong.ac","mksung@sejong.ac.kr"
"1509","34216126","10.3947/ic.2021.0046","Nosocomial Outbreak of COVID-19 in a Hematologic Ward.","Coronavirus disease 2019 (COVID-19) outbreaks occur in hospitals in many parts of the world. In hospital settings, the possibility of airborne transmission needs to be investigated thoroughly. There was a nosocomial outbreak of COVID-19 in a hematologic ward in a tertiary hospital, Seoul, Korea. We found 11 patients and guardians with COVID-19 through vigorous contact tracing and closed-circuit television monitoring. We found one patient who probably had acquired COVID-19 through airborne-transm","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Airborne transmission; COVID-19; Hematologic malignancy; Multi-patient room; SARS-CoV-2","Park","Man Seong","Department of Microbiology, Institute for Viral Diseases, Biosafety Center, College of Medicine, Korea University, Seoul, Korea. manseong.park@gmail","manseong.park@gmail.com"
"1510","34216126","10.3947/ic.2021.0046","Nosocomial Outbreak of COVID-19 in a Hematologic Ward.","Coronavirus disease 2019 (COVID-19) outbreaks occur in hospitals in many parts of the world. In hospital settings, the possibility of airborne transmission needs to be investigated thoroughly. There was a nosocomial outbreak of COVID-19 in a hematologic ward in a tertiary hospital, Seoul, Korea. We found 11 patients and guardians with COVID-19 through vigorous contact tracing and closed-circuit television monitoring. We found one patient who probably had acquired COVID-19 through airborne-transm","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Airborne transmission; COVID-19; Hematologic malignancy; Multi-patient room; SARS-CoV-2","Kim","Sung Han","Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea","kimsunghanmd@hotmail.com"
"1511","34216125","10.3947/ic.2021.0026","Is Obesity a Potential Risk factor for Poor Prognosis of COVID-19?","Coronavirus disease 2019 (COVID-19) continues to cause major mortality and morbidity worldwide even after a year of its emergence. In its early days, hypertension, diabetes, and cardiovascular diseases were noted as poor prognostic factors, while obesity gained attention at a later stage. In the present study, unfavorable clinical outcomes (transfer to the intensive care unit, invasive mechanical ventilation, and mortality) were investigated in obese patients with COVID-19. In this retrospective","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Body mass index; COVID-19; Intensive care unit; Obesity, SARS-CoV-2","Agca","Meltem","Department of Pulmonology, University of Health Sciences, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey. agcameltem@yahoo","agcameltem@yahoo.com"
"1512","34216125","10.3947/ic.2021.0026","Is Obesity a Potential Risk factor for Poor Prognosis of COVID-19?","Coronavirus disease 2019 (COVID-19) continues to cause major mortality and morbidity worldwide even after a year of its emergence. In its early days, hypertension, diabetes, and cardiovascular diseases were noted as poor prognostic factors, while obesity gained attention at a later stage. In the present study, unfavorable clinical outcomes (transfer to the intensive care unit, invasive mechanical ventilation, and mortality) were investigated in obese patients with COVID-19. In this retrospective","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Body mass index; COVID-19; Intensive care unit; Obesity, SARS-CoV-2","Tuncay","Eylem","Department of Respiratory Intensive Care Unit, University of Health Sciences, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey",NA
"1513","34216125","10.3947/ic.2021.0026","Is Obesity a Potential Risk factor for Poor Prognosis of COVID-19?","Coronavirus disease 2019 (COVID-19) continues to cause major mortality and morbidity worldwide even after a year of its emergence. In its early days, hypertension, diabetes, and cardiovascular diseases were noted as poor prognostic factors, while obesity gained attention at a later stage. In the present study, unfavorable clinical outcomes (transfer to the intensive care unit, invasive mechanical ventilation, and mortality) were investigated in obese patients with COVID-19. In this retrospective","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Body mass index; COVID-19; Intensive care unit; Obesity, SARS-CoV-2","Yildirim","Elif","Department of Pulmonology, University of Health Sciences, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey",NA
"1514","34216125","10.3947/ic.2021.0026","Is Obesity a Potential Risk factor for Poor Prognosis of COVID-19?","Coronavirus disease 2019 (COVID-19) continues to cause major mortality and morbidity worldwide even after a year of its emergence. In its early days, hypertension, diabetes, and cardiovascular diseases were noted as poor prognostic factors, while obesity gained attention at a later stage. In the present study, unfavorable clinical outcomes (transfer to the intensive care unit, invasive mechanical ventilation, and mortality) were investigated in obese patients with COVID-19. In this retrospective","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Body mass index; COVID-19; Intensive care unit; Obesity, SARS-CoV-2","Yildiz","Reyhan","Department of Pulmonology, University of Health Sciences, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey",NA
"1515","34216125","10.3947/ic.2021.0026","Is Obesity a Potential Risk factor for Poor Prognosis of COVID-19?","Coronavirus disease 2019 (COVID-19) continues to cause major mortality and morbidity worldwide even after a year of its emergence. In its early days, hypertension, diabetes, and cardiovascular diseases were noted as poor prognostic factors, while obesity gained attention at a later stage. In the present study, unfavorable clinical outcomes (transfer to the intensive care unit, invasive mechanical ventilation, and mortality) were investigated in obese patients with COVID-19. In this retrospective","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Body mass index; COVID-19; Intensive care unit; Obesity, SARS-CoV-2","Sevim","Tülin","Department of Pulmonology, University of Health Sciences, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey",NA
"1516","34216125","10.3947/ic.2021.0026","Is Obesity a Potential Risk factor for Poor Prognosis of COVID-19?","Coronavirus disease 2019 (COVID-19) continues to cause major mortality and morbidity worldwide even after a year of its emergence. In its early days, hypertension, diabetes, and cardiovascular diseases were noted as poor prognostic factors, while obesity gained attention at a later stage. In the present study, unfavorable clinical outcomes (transfer to the intensive care unit, invasive mechanical ventilation, and mortality) were investigated in obese patients with COVID-19. In this retrospective","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Body mass index; COVID-19; Intensive care unit; Obesity, SARS-CoV-2","Ernam","Dilek","Department of Pulmonology, University of Health Sciences, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey",NA
"1517","34216125","10.3947/ic.2021.0026","Is Obesity a Potential Risk factor for Poor Prognosis of COVID-19?","Coronavirus disease 2019 (COVID-19) continues to cause major mortality and morbidity worldwide even after a year of its emergence. In its early days, hypertension, diabetes, and cardiovascular diseases were noted as poor prognostic factors, while obesity gained attention at a later stage. In the present study, unfavorable clinical outcomes (transfer to the intensive care unit, invasive mechanical ventilation, and mortality) were investigated in obese patients with COVID-19. In this retrospective","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Body mass index; COVID-19; Intensive care unit; Obesity, SARS-CoV-2","Yilmaz","Nermin Ozer","Department of Infectious Diseases, University of Health Sciences, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey",NA
"1518","34216125","10.3947/ic.2021.0026","Is Obesity a Potential Risk factor for Poor Prognosis of COVID-19?","Coronavirus disease 2019 (COVID-19) continues to cause major mortality and morbidity worldwide even after a year of its emergence. In its early days, hypertension, diabetes, and cardiovascular diseases were noted as poor prognostic factors, while obesity gained attention at a later stage. In the present study, unfavorable clinical outcomes (transfer to the intensive care unit, invasive mechanical ventilation, and mortality) were investigated in obese patients with COVID-19. In this retrospective","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Body mass index; COVID-19; Intensive care unit; Obesity, SARS-CoV-2","Teke","Nazli Huma","Department of Pulmonology, University of Health Sciences, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey",NA
"1519","34216125","10.3947/ic.2021.0026","Is Obesity a Potential Risk factor for Poor Prognosis of COVID-19?","Coronavirus disease 2019 (COVID-19) continues to cause major mortality and morbidity worldwide even after a year of its emergence. In its early days, hypertension, diabetes, and cardiovascular diseases were noted as poor prognostic factors, while obesity gained attention at a later stage. In the present study, unfavorable clinical outcomes (transfer to the intensive care unit, invasive mechanical ventilation, and mortality) were investigated in obese patients with COVID-19. In this retrospective","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Body mass index; COVID-19; Intensive care unit; Obesity, SARS-CoV-2","Yavuz","Simge","Department of Pulmonology, University of Health Sciences, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey",NA
"1520","34216125","10.3947/ic.2021.0026","Is Obesity a Potential Risk factor for Poor Prognosis of COVID-19?","Coronavirus disease 2019 (COVID-19) continues to cause major mortality and morbidity worldwide even after a year of its emergence. In its early days, hypertension, diabetes, and cardiovascular diseases were noted as poor prognostic factors, while obesity gained attention at a later stage. In the present study, unfavorable clinical outcomes (transfer to the intensive care unit, invasive mechanical ventilation, and mortality) were investigated in obese patients with COVID-19. In this retrospective","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Body mass index; COVID-19; Intensive care unit; Obesity, SARS-CoV-2","Karakurt","Zuhal","Department of Pulmonology, University of Health Sciences, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey",NA
"1521","34216125","10.3947/ic.2021.0026","Is Obesity a Potential Risk factor for Poor Prognosis of COVID-19?","Coronavirus disease 2019 (COVID-19) continues to cause major mortality and morbidity worldwide even after a year of its emergence. In its early days, hypertension, diabetes, and cardiovascular diseases were noted as poor prognostic factors, while obesity gained attention at a later stage. In the present study, unfavorable clinical outcomes (transfer to the intensive care unit, invasive mechanical ventilation, and mortality) were investigated in obese patients with COVID-19. In this retrospective","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Body mass index; COVID-19; Intensive care unit; Obesity, SARS-CoV-2","Ozmen","Ipek","Department of Pulmonology, University of Health Sciences, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey",NA
"1522","34216124","10.3947/ic.2021.0024","Chest Computed Tomography Severity Score to Predict Adverse Outcomes of Patients with COVID-19.","The novel coronavirus disease 2019 (COVID-19) continues to wreak havoc worldwide. This study assessed the ability of chest computed tomography (CT) severity score (CSS) to predict intensive care unit (ICU) admission and mortality in patients with COVID-19 pneumonia. A total of 192 consecutive patients with COVID-19 pneumonia aged more than 20 years and typical CT findings and reverse-transcription polymerase chain reaction positive admitted in a tertiary hospital were included. Clinical symptoms","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; CT severity score; Chest CT; Prognosis; SARS-CoV-2","Hajiahmadi","Somayeh","Department of Radiology, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1523","34216124","10.3947/ic.2021.0024","Chest Computed Tomography Severity Score to Predict Adverse Outcomes of Patients with COVID-19.","The novel coronavirus disease 2019 (COVID-19) continues to wreak havoc worldwide. This study assessed the ability of chest computed tomography (CT) severity score (CSS) to predict intensive care unit (ICU) admission and mortality in patients with COVID-19 pneumonia. A total of 192 consecutive patients with COVID-19 pneumonia aged more than 20 years and typical CT findings and reverse-transcription polymerase chain reaction positive admitted in a tertiary hospital were included. Clinical symptoms","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; CT severity score; Chest CT; Prognosis; SARS-CoV-2","Shayganfar","Azin","Department of Radiology, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1524","34216124","10.3947/ic.2021.0024","Chest Computed Tomography Severity Score to Predict Adverse Outcomes of Patients with COVID-19.","The novel coronavirus disease 2019 (COVID-19) continues to wreak havoc worldwide. This study assessed the ability of chest computed tomography (CT) severity score (CSS) to predict intensive care unit (ICU) admission and mortality in patients with COVID-19 pneumonia. A total of 192 consecutive patients with COVID-19 pneumonia aged more than 20 years and typical CT findings and reverse-transcription polymerase chain reaction positive admitted in a tertiary hospital were included. Clinical symptoms","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; CT severity score; Chest CT; Prognosis; SARS-CoV-2","Janghorbani","Mohsen","Department of Epidemiology and Biostatistics, Isfahan University of Medical Sciences, Isfahan, Iran. janghorbani@hlth.mui.ac","janghorbani@hlth.mui.ac.ir"
"1525","34216124","10.3947/ic.2021.0024","Chest Computed Tomography Severity Score to Predict Adverse Outcomes of Patients with COVID-19.","The novel coronavirus disease 2019 (COVID-19) continues to wreak havoc worldwide. This study assessed the ability of chest computed tomography (CT) severity score (CSS) to predict intensive care unit (ICU) admission and mortality in patients with COVID-19 pneumonia. A total of 192 consecutive patients with COVID-19 pneumonia aged more than 20 years and typical CT findings and reverse-transcription polymerase chain reaction positive admitted in a tertiary hospital were included. Clinical symptoms","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; CT severity score; Chest CT; Prognosis; SARS-CoV-2","Esfahani","Mahsa Masjedi","Department of Radiology, Kashan University of Medical Sciences, Kashan, Iran",NA
"1526","34216124","10.3947/ic.2021.0024","Chest Computed Tomography Severity Score to Predict Adverse Outcomes of Patients with COVID-19.","The novel coronavirus disease 2019 (COVID-19) continues to wreak havoc worldwide. This study assessed the ability of chest computed tomography (CT) severity score (CSS) to predict intensive care unit (ICU) admission and mortality in patients with COVID-19 pneumonia. A total of 192 consecutive patients with COVID-19 pneumonia aged more than 20 years and typical CT findings and reverse-transcription polymerase chain reaction positive admitted in a tertiary hospital were included. Clinical symptoms","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; CT severity score; Chest CT; Prognosis; SARS-CoV-2","Mahnam","Mehdi","Department of Industrial and Systems Engineering, Isfahan University of Technology, Isfahan, Iran",NA
"1527","34216124","10.3947/ic.2021.0024","Chest Computed Tomography Severity Score to Predict Adverse Outcomes of Patients with COVID-19.","The novel coronavirus disease 2019 (COVID-19) continues to wreak havoc worldwide. This study assessed the ability of chest computed tomography (CT) severity score (CSS) to predict intensive care unit (ICU) admission and mortality in patients with COVID-19 pneumonia. A total of 192 consecutive patients with COVID-19 pneumonia aged more than 20 years and typical CT findings and reverse-transcription polymerase chain reaction positive admitted in a tertiary hospital were included. Clinical symptoms","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; CT severity score; Chest CT; Prognosis; SARS-CoV-2","Bakhtiarvand","Nagar","Department of Industrial and Systems Engineering, Isfahan University of Technology, Isfahan, Iran",NA
"1528","34216124","10.3947/ic.2021.0024","Chest Computed Tomography Severity Score to Predict Adverse Outcomes of Patients with COVID-19.","The novel coronavirus disease 2019 (COVID-19) continues to wreak havoc worldwide. This study assessed the ability of chest computed tomography (CT) severity score (CSS) to predict intensive care unit (ICU) admission and mortality in patients with COVID-19 pneumonia. A total of 192 consecutive patients with COVID-19 pneumonia aged more than 20 years and typical CT findings and reverse-transcription polymerase chain reaction positive admitted in a tertiary hospital were included. Clinical symptoms","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; CT severity score; Chest CT; Prognosis; SARS-CoV-2","Sami","Ramin","Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1529","34216124","10.3947/ic.2021.0024","Chest Computed Tomography Severity Score to Predict Adverse Outcomes of Patients with COVID-19.","The novel coronavirus disease 2019 (COVID-19) continues to wreak havoc worldwide. This study assessed the ability of chest computed tomography (CT) severity score (CSS) to predict intensive care unit (ICU) admission and mortality in patients with COVID-19 pneumonia. A total of 192 consecutive patients with COVID-19 pneumonia aged more than 20 years and typical CT findings and reverse-transcription polymerase chain reaction positive admitted in a tertiary hospital were included. Clinical symptoms","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; CT severity score; Chest CT; Prognosis; SARS-CoV-2","Khademi","Nilufar","Department of Radiology, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1530","34216124","10.3947/ic.2021.0024","Chest Computed Tomography Severity Score to Predict Adverse Outcomes of Patients with COVID-19.","The novel coronavirus disease 2019 (COVID-19) continues to wreak havoc worldwide. This study assessed the ability of chest computed tomography (CT) severity score (CSS) to predict intensive care unit (ICU) admission and mortality in patients with COVID-19 pneumonia. A total of 192 consecutive patients with COVID-19 pneumonia aged more than 20 years and typical CT findings and reverse-transcription polymerase chain reaction positive admitted in a tertiary hospital were included. Clinical symptoms","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; CT severity score; Chest CT; Prognosis; SARS-CoV-2","Dehghani","Mehrnegar","Department of Radiology, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"1531","34216123","10.3947/ic.2020.0149","Association of Early Favipiravir Use with Reduced COVID-19 Fatality among Hospitalized Patients.","The antiviral agent favipiravir is an RNA-dependent RNA polymerase (RdRp) inhibitor. We examined patients with a clinical, laboratory, and radiological diagnosis of severe coronavirus disease 2019 (COVID-19) pneumonia. We investigated the effect of administering enteral favipiravir at a 2 × 1,600 mg loading dose and 2 × 600 mg maintenance dose for 5 days in addition to the standard COVID-19 treatment. In total, 180 patients, who were hospitalized at the Istanbul Tuzla State Hospital and received","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; Favipiravir; Hospitalization; Time-to-treatment","Karatas","Ercan","Department of Internal Medicine, Tuzla State Hospital, Istanbul, Turkey. canertaskara@hotmail","canertaskara@hotmail.com"
"1532","34216123","10.3947/ic.2020.0149","Association of Early Favipiravir Use with Reduced COVID-19 Fatality among Hospitalized Patients.","The antiviral agent favipiravir is an RNA-dependent RNA polymerase (RdRp) inhibitor. We examined patients with a clinical, laboratory, and radiological diagnosis of severe coronavirus disease 2019 (COVID-19) pneumonia. We investigated the effect of administering enteral favipiravir at a 2 × 1,600 mg loading dose and 2 × 600 mg maintenance dose for 5 days in addition to the standard COVID-19 treatment. In total, 180 patients, who were hospitalized at the Istanbul Tuzla State Hospital and received","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; Favipiravir; Hospitalization; Time-to-treatment","Aksoy","Lacin","Departmant of Family Medicine, Marmara University, Istanbul, Turkey",NA
"1533","34216123","10.3947/ic.2020.0149","Association of Early Favipiravir Use with Reduced COVID-19 Fatality among Hospitalized Patients.","The antiviral agent favipiravir is an RNA-dependent RNA polymerase (RdRp) inhibitor. We examined patients with a clinical, laboratory, and radiological diagnosis of severe coronavirus disease 2019 (COVID-19) pneumonia. We investigated the effect of administering enteral favipiravir at a 2 × 1,600 mg loading dose and 2 × 600 mg maintenance dose for 5 days in addition to the standard COVID-19 treatment. In total, 180 patients, who were hospitalized at the Istanbul Tuzla State Hospital and received","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","COVID-19; Favipiravir; Hospitalization; Time-to-treatment","Ozaslan","Ersin","Department of Medical Oncology, Acibadem Kayseri Hospital, Kayseri, Turkey",NA
"1534","34216120","10.3947/ic.2021.0029","Which Group Should be Vaccinated First?: A Systematic Review.","Since the supply of coronavirus disease 2019 (COVID-19) vaccines will be limited worldwide, it is essential to prioritize vaccination based on scientific evidence. Although several frameworks and studies on vaccine distribution have been published, no published systematic review has evaluated the prioritization of the COVID-19 vaccine. We searched 4 different databases, PubMed, SCOPUS, Web of Science, and EMBASE for articles published between January 2019 and December 31, 2020. Studies were incl","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Coronavirus; Prioritization; Vaccine","Noh","Eun Bi","Department of Health Administration, Yonsei University Graduate School, Wonju, Korea",NA
"1535","34216120","10.3947/ic.2021.0029","Which Group Should be Vaccinated First?: A Systematic Review.","Since the supply of coronavirus disease 2019 (COVID-19) vaccines will be limited worldwide, it is essential to prioritize vaccination based on scientific evidence. Although several frameworks and studies on vaccine distribution have been published, no published systematic review has evaluated the prioritization of the COVID-19 vaccine. We searched 4 different databases, PubMed, SCOPUS, Web of Science, and EMBASE for articles published between January 2019 and December 31, 2020. Studies were incl","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Coronavirus; Prioritization; Vaccine","Nam","Hae Kweun","Department of Preventive Medicine, Wonju College of Medicine, Yonsei University, Wonju, Korea",NA
"1536","34216120","10.3947/ic.2021.0029","Which Group Should be Vaccinated First?: A Systematic Review.","Since the supply of coronavirus disease 2019 (COVID-19) vaccines will be limited worldwide, it is essential to prioritize vaccination based on scientific evidence. Although several frameworks and studies on vaccine distribution have been published, no published systematic review has evaluated the prioritization of the COVID-19 vaccine. We searched 4 different databases, PubMed, SCOPUS, Web of Science, and EMBASE for articles published between January 2019 and December 31, 2020. Studies were incl","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Coronavirus; Prioritization; Vaccine","Lee","Hocheol","Yonsei Global Health Center, Yonsei University, Wonju, Korea. lhc0104@yonsei.ac","lhc0104@yonsei.ac.kr"
"1537","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Sosa","Juan Pablo","Division of Research &amp",NA
"1538","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Ferreira Caceres","Maria Mercedes","Division of Research &amp","mferreira@unab.edu.co"
"1539","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Ross Comptis","Jennifer","Division of Research &amp",NA
"1540","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Quiros","Jorge","Division of Research &amp",NA
"1541","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Príncipe-Meneses","Fortunato S","Division of Research &amp",NA
"1542","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Riva-Moscoso","Adrian","Division of Research &amp",NA
"1543","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Belizaire","Marie Pierre","Division of Research &amp",NA
"1544","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Malanyaon","Freda Q","Division of Research &amp",NA
"1545","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Agadi","Kuchalambal","Division of Research &amp",NA
"1546","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Jaffery","Syeda Sheharbano","Division of Research &amp",NA
"1547","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Sahajwani","Juhi","Division of Research &amp",NA
"1548","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Arshia","Asma","Division of Research &amp",NA
"1549","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Senatus","Andrelle","Division of Research &amp",NA
"1550","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Verdecia","Graciela","Division of Research &amp",NA
"1551","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Akano","Lordstrong","Division of Research &amp",NA
"1552","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Razzack","Aminah Abdul","Division of Research &amp",NA
"1553","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Salam","Sanna","Division of Research &amp",NA
"1554","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Gadamidi","Vinay Kumar","Division of Research &amp",NA
"1555","34216119","10.3947/ic.2021.0028","Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.","The high rate of transmission and infection of coronavirus disease 2019 (COVID-19) is a public health emergency of major epidemiological concern. No definitive treatments have been established, and vaccinations have only recently begun. We aim to review the efficacy and safety of Interferon Beta (IFN-ß) in patients who have a confirmed COVID-19 diagnosis. A search from PubMed, Science Direct, Cochrane, and Clinicaltrials.gov databases were conducted from December 2019 to December 2020 to review ","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Beta-Interferon; COVID-19; Coronavirus; Interferon beta; SARS-CoV-2","Marian","Sheeba","Division of Research &amp",NA
"1556","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Somagutta","Manoj Kumar Reddy","Larkin Community Hospital, Miami, FL, USA","manojleo.go@gmail.com"
"1557","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Lourdes Pormento","Maria Kezia","Larkin Community Hospital, Miami, FL, USA",NA
"1558","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Hamid","Pousette","California Institute of Behavioral Neurosciences &amp",NA
"1559","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Hamdan","Alaa","Larkin Community Hospital, Miami, FL, USA",NA
"1560","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Khan","Muhammad Adnan","Larkin Community Hospital, Miami, FL, USA",NA
"1561","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Desir","Rockeven","Larkin Community Hospital, Miami, FL, USA",NA
"1562","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Vijayan","Rupalakshmi","Larkin Community Hospital, Miami, FL, USA",NA
"1563","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Shirke","Saloni","Larkin Community Hospital, Miami, FL, USA",NA
"1564","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Jeyakumar","Rishan","Larkin Community Hospital, Miami, FL, USA",NA
"1565","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Dogar","Zeryab","Larkin Community Hospital, Miami, FL, USA",NA
"1566","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Makkar","Sarabjot Singh","Larkin Community Hospital, Miami, FL, USA",NA
"1567","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Guntipalli","Prathima","Larkin Community Hospital, Miami, FL, USA",NA
"1568","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Ngardig","Ngaba Neguemadji","Larkin Community Hospital, Miami, FL, USA",NA
"1569","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Nagineni","Manasa Sindhura","Larkin Community Hospital, Miami, FL, USA",NA
"1570","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Paul","Trissa","Larkin Community Hospital, Miami, FL, USA",NA
"1571","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Luvsannyam","Enkhmaa","Larkin Community Hospital, Miami, FL, USA",NA
"1572","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Riddick","Chala","Larkin Community Hospital, Miami, FL, USA",NA
"1573","34216117","10.3947/ic.2021.0016","The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.","This study aims to assess anakinra's safety and efficacy for treating severe coronavirus disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 studies with a total of 3,530 patients, 757 in the anakinra arm, 1,685 in the control arm were included. The pooled adjusted odds ratio (OR) for mortality in the treatment arm was 0.34 (95% confidence interval [CI], 0.21 - 0.54, I² = 48%), indicating a significant association between anakinra and mortality. A significant asso","2021","07","20","Infect Chemother","Infection &amp; chemotherapy","Anakinra; COVID-19; IL-1 antagonist; Kineret; SARS-CoV-2","Sanchez-Gonzalez","Marcos A","Larkin Community Hospital, Miami, FL, USA",NA
"1574","34216110","10.1002/brb3.2197","Profiling COVID-related experiences in the United States with the Epidemic-Pandemic Impacts Inventory: Linkages to psychosocial functioning.","The COVID-19 pandemic has had a profound impact on the lives of individuals, families, and communities around the world with constraints on multiple aspects of daily life. The purpose of the present study was to identify specific profiles of pandemic-related experiences and their relation to psychosocial functioning using the 92-item Epidemic-Pandemic Impacts Inventory (EPII). Data were collected as part of a cross-sectional, online survey of adults (18+) residing in the Northeast region of the ","2021","07","03","Brain Behav","Brain and behavior","COVID-19; disaster; epidemic; mental health; pandemic","Grasso","Damion J","Department of Psychiatry, University of Connecticut School of Medicine, Farmington, CT, USA",NA
"1575","34216110","10.1002/brb3.2197","Profiling COVID-related experiences in the United States with the Epidemic-Pandemic Impacts Inventory: Linkages to psychosocial functioning.","The COVID-19 pandemic has had a profound impact on the lives of individuals, families, and communities around the world with constraints on multiple aspects of daily life. The purpose of the present study was to identify specific profiles of pandemic-related experiences and their relation to psychosocial functioning using the 92-item Epidemic-Pandemic Impacts Inventory (EPII). Data were collected as part of a cross-sectional, online survey of adults (18+) residing in the Northeast region of the ","2021","07","03","Brain Behav","Brain and behavior","COVID-19; disaster; epidemic; mental health; pandemic","Briggs-Gowan","Margaret J","Department of Psychiatry, University of Connecticut School of Medicine, Farmington, CT, USA",NA
"1576","34216110","10.1002/brb3.2197","Profiling COVID-related experiences in the United States with the Epidemic-Pandemic Impacts Inventory: Linkages to psychosocial functioning.","The COVID-19 pandemic has had a profound impact on the lives of individuals, families, and communities around the world with constraints on multiple aspects of daily life. The purpose of the present study was to identify specific profiles of pandemic-related experiences and their relation to psychosocial functioning using the 92-item Epidemic-Pandemic Impacts Inventory (EPII). Data were collected as part of a cross-sectional, online survey of adults (18+) residing in the Northeast region of the ","2021","07","03","Brain Behav","Brain and behavior","COVID-19; disaster; epidemic; mental health; pandemic","Carter","Alice S","Department of Psychology, University of Massachusetts Boston, Boston, MA, USA",NA
"1577","34216110","10.1002/brb3.2197","Profiling COVID-related experiences in the United States with the Epidemic-Pandemic Impacts Inventory: Linkages to psychosocial functioning.","The COVID-19 pandemic has had a profound impact on the lives of individuals, families, and communities around the world with constraints on multiple aspects of daily life. The purpose of the present study was to identify specific profiles of pandemic-related experiences and their relation to psychosocial functioning using the 92-item Epidemic-Pandemic Impacts Inventory (EPII). Data were collected as part of a cross-sectional, online survey of adults (18+) residing in the Northeast region of the ","2021","07","03","Brain Behav","Brain and behavior","COVID-19; disaster; epidemic; mental health; pandemic","Goldstein","Brandon L","Department of Psychiatry, University of Connecticut School of Medicine, Farmington, CT, USA",NA
"1578","34216110","10.1002/brb3.2197","Profiling COVID-related experiences in the United States with the Epidemic-Pandemic Impacts Inventory: Linkages to psychosocial functioning.","The COVID-19 pandemic has had a profound impact on the lives of individuals, families, and communities around the world with constraints on multiple aspects of daily life. The purpose of the present study was to identify specific profiles of pandemic-related experiences and their relation to psychosocial functioning using the 92-item Epidemic-Pandemic Impacts Inventory (EPII). Data were collected as part of a cross-sectional, online survey of adults (18+) residing in the Northeast region of the ","2021","07","03","Brain Behav","Brain and behavior","COVID-19; disaster; epidemic; mental health; pandemic","Ford","Julian D","Department of Psychiatry, University of Connecticut School of Medicine, Farmington, CT, USA",NA
"1579","34216102","10.1111/febs.16105","The role of T cell immunity in COVID-19 severity amongst people living with type II diabetes.","The COVID-19 pandemic has highlighted the vulnerability of people with diabetes mellitus (DM) to respiratory viral infections. Despite the short history of COVID-19, various studies have shown that patients with DM are more likely to have increased hospitalization and mortality rates as compared to patients without. At present, the mechanisms underlying this susceptibility are unclear. However, prior studies show that the course of COVID-19 disease is linked to the efficacy of the host's T cell ","2021","07","03","FEBS J","The FEBS journal","COVID-19; SARS-CoV-2; T cells; Type 2 diabetes","Tong","ZhenWei Marcus","School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia",NA
"1580","34216102","10.1111/febs.16105","The role of T cell immunity in COVID-19 severity amongst people living with type II diabetes.","The COVID-19 pandemic has highlighted the vulnerability of people with diabetes mellitus (DM) to respiratory viral infections. Despite the short history of COVID-19, various studies have shown that patients with DM are more likely to have increased hospitalization and mortality rates as compared to patients without. At present, the mechanisms underlying this susceptibility are unclear. However, prior studies show that the course of COVID-19 disease is linked to the efficacy of the host's T cell ","2021","07","03","FEBS J","The FEBS journal","COVID-19; SARS-CoV-2; T cells; Type 2 diabetes","Grant","Emma","La Trobe University - La Trobe Institute for Molecular Science (LIMS), Melbourne, Victoria, Australia",NA
"1581","34216102","10.1111/febs.16105","The role of T cell immunity in COVID-19 severity amongst people living with type II diabetes.","The COVID-19 pandemic has highlighted the vulnerability of people with diabetes mellitus (DM) to respiratory viral infections. Despite the short history of COVID-19, various studies have shown that patients with DM are more likely to have increased hospitalization and mortality rates as compared to patients without. At present, the mechanisms underlying this susceptibility are unclear. However, prior studies show that the course of COVID-19 disease is linked to the efficacy of the host's T cell ","2021","07","03","FEBS J","The FEBS journal","COVID-19; SARS-CoV-2; T cells; Type 2 diabetes","Gras","Stephanie","La Trobe University - La Trobe Institute for Molecular Science (LIMS), Melbourne, Victoria, Australia",NA
"1582","34216102","10.1111/febs.16105","The role of T cell immunity in COVID-19 severity amongst people living with type II diabetes.","The COVID-19 pandemic has highlighted the vulnerability of people with diabetes mellitus (DM) to respiratory viral infections. Despite the short history of COVID-19, various studies have shown that patients with DM are more likely to have increased hospitalization and mortality rates as compared to patients without. At present, the mechanisms underlying this susceptibility are unclear. However, prior studies show that the course of COVID-19 disease is linked to the efficacy of the host's T cell ","2021","07","03","FEBS J","The FEBS journal","COVID-19; SARS-CoV-2; T cells; Type 2 diabetes","Wu","Melanie","School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia",NA
"1583","34216102","10.1111/febs.16105","The role of T cell immunity in COVID-19 severity amongst people living with type II diabetes.","The COVID-19 pandemic has highlighted the vulnerability of people with diabetes mellitus (DM) to respiratory viral infections. Despite the short history of COVID-19, various studies have shown that patients with DM are more likely to have increased hospitalization and mortality rates as compared to patients without. At present, the mechanisms underlying this susceptibility are unclear. However, prior studies show that the course of COVID-19 disease is linked to the efficacy of the host's T cell ","2021","07","03","FEBS J","The FEBS journal","COVID-19; SARS-CoV-2; T cells; Type 2 diabetes","Smith","Corey","QIMR Berghofer Medical Research Institute - QIMR, Berghofer Centre for Immunotherapy and Vaccine Development Brisbane, QLD, Australia",NA
"1584","34216102","10.1111/febs.16105","The role of T cell immunity in COVID-19 severity amongst people living with type II diabetes.","The COVID-19 pandemic has highlighted the vulnerability of people with diabetes mellitus (DM) to respiratory viral infections. Despite the short history of COVID-19, various studies have shown that patients with DM are more likely to have increased hospitalization and mortality rates as compared to patients without. At present, the mechanisms underlying this susceptibility are unclear. However, prior studies show that the course of COVID-19 disease is linked to the efficacy of the host's T cell ","2021","07","03","FEBS J","The FEBS journal","COVID-19; SARS-CoV-2; T cells; Type 2 diabetes","Barrett","Helen L","Department of Endocrinology, Mater Health, Brisbane, QLD, Australia",NA
"1585","34216102","10.1111/febs.16105","The role of T cell immunity in COVID-19 severity amongst people living with type II diabetes.","The COVID-19 pandemic has highlighted the vulnerability of people with diabetes mellitus (DM) to respiratory viral infections. Despite the short history of COVID-19, various studies have shown that patients with DM are more likely to have increased hospitalization and mortality rates as compared to patients without. At present, the mechanisms underlying this susceptibility are unclear. However, prior studies show that the course of COVID-19 disease is linked to the efficacy of the host's T cell ","2021","07","03","FEBS J","The FEBS journal","COVID-19; SARS-CoV-2; T cells; Type 2 diabetes","Gallo","Linda A","Mater Research Institute, University of Queensland, Brisbane, QLD, Australia",NA
"1586","34216102","10.1111/febs.16105","The role of T cell immunity in COVID-19 severity amongst people living with type II diabetes.","The COVID-19 pandemic has highlighted the vulnerability of people with diabetes mellitus (DM) to respiratory viral infections. Despite the short history of COVID-19, various studies have shown that patients with DM are more likely to have increased hospitalization and mortality rates as compared to patients without. At present, the mechanisms underlying this susceptibility are unclear. However, prior studies show that the course of COVID-19 disease is linked to the efficacy of the host's T cell ","2021","07","03","FEBS J","The FEBS journal","COVID-19; SARS-CoV-2; T cells; Type 2 diabetes","Short","Kirsty R","School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia",NA
"1587","34216091","10.1002/acm2.13330","Multi-institution consensus paper for acquisition of portable chest radiographs through glass barriers.","To conserve personal protective equipment (PPE) and reduce exposure to potentially infected COVID-19 patients, several Californian facilities independently implemented a method of acquiring portable chest radiographs through glass barriers that was originally developed by the University of Washington. This work quantifies the transmission of radiation through a glass barrier using six radiographic systems at five facilities. Patient entrance air kerma (EAK) and effective dose were estimated both","2021","07","03","J Appl Clin Med Phys","Journal of applied clinical medical physics","COVID-19; chest X-ray; infection prevention; radiation safety","McKenney","Sarah E","Department of Environmental Health and Safety, Stanford University, Stanford, CA, USA",NA
"1588","34216091","10.1002/acm2.13330","Multi-institution consensus paper for acquisition of portable chest radiographs through glass barriers.","To conserve personal protective equipment (PPE) and reduce exposure to potentially infected COVID-19 patients, several Californian facilities independently implemented a method of acquiring portable chest radiographs through glass barriers that was originally developed by the University of Washington. This work quantifies the transmission of radiation through a glass barrier using six radiographic systems at five facilities. Patient entrance air kerma (EAK) and effective dose were estimated both","2021","07","03","J Appl Clin Med Phys","Journal of applied clinical medical physics","COVID-19; chest X-ray; infection prevention; radiation safety","Wait","John M S","Medical Imaging Technology and Informatics Department, Southern California Permanente Medical Group, Pasadena, CA, USA",NA
"1589","34216091","10.1002/acm2.13330","Multi-institution consensus paper for acquisition of portable chest radiographs through glass barriers.","To conserve personal protective equipment (PPE) and reduce exposure to potentially infected COVID-19 patients, several Californian facilities independently implemented a method of acquiring portable chest radiographs through glass barriers that was originally developed by the University of Washington. This work quantifies the transmission of radiation through a glass barrier using six radiographic systems at five facilities. Patient entrance air kerma (EAK) and effective dose were estimated both","2021","07","03","J Appl Clin Med Phys","Journal of applied clinical medical physics","COVID-19; chest X-ray; infection prevention; radiation safety","Cooper","Virgil N","Clinical Technology Department, Kaiser Permanente Northern California, Berkeley, CA, USA",NA
"1590","34216091","10.1002/acm2.13330","Multi-institution consensus paper for acquisition of portable chest radiographs through glass barriers.","To conserve personal protective equipment (PPE) and reduce exposure to potentially infected COVID-19 patients, several Californian facilities independently implemented a method of acquiring portable chest radiographs through glass barriers that was originally developed by the University of Washington. This work quantifies the transmission of radiation through a glass barrier using six radiographic systems at five facilities. Patient entrance air kerma (EAK) and effective dose were estimated both","2021","07","03","J Appl Clin Med Phys","Journal of applied clinical medical physics","COVID-19; chest X-ray; infection prevention; radiation safety","Johnson","Amirh M","Clinical Technology Department, Kaiser Permanente Northern California, Berkeley, CA, USA",NA
"1591","34216091","10.1002/acm2.13330","Multi-institution consensus paper for acquisition of portable chest radiographs through glass barriers.","To conserve personal protective equipment (PPE) and reduce exposure to potentially infected COVID-19 patients, several Californian facilities independently implemented a method of acquiring portable chest radiographs through glass barriers that was originally developed by the University of Washington. This work quantifies the transmission of radiation through a glass barrier using six radiographic systems at five facilities. Patient entrance air kerma (EAK) and effective dose were estimated both","2021","07","03","J Appl Clin Med Phys","Journal of applied clinical medical physics","COVID-19; chest X-ray; infection prevention; radiation safety","Wang","Jia","Department of Environmental Health and Safety, Stanford University, Stanford, CA, USA",NA
"1592","34216091","10.1002/acm2.13330","Multi-institution consensus paper for acquisition of portable chest radiographs through glass barriers.","To conserve personal protective equipment (PPE) and reduce exposure to potentially infected COVID-19 patients, several Californian facilities independently implemented a method of acquiring portable chest radiographs through glass barriers that was originally developed by the University of Washington. This work quantifies the transmission of radiation through a glass barrier using six radiographic systems at five facilities. Patient entrance air kerma (EAK) and effective dose were estimated both","2021","07","03","J Appl Clin Med Phys","Journal of applied clinical medical physics","COVID-19; chest X-ray; infection prevention; radiation safety","Leung","Ann N","Rad/Thoracic Imaging Department, Stanford University, Stanford, CA, USA",NA
"1593","34216091","10.1002/acm2.13330","Multi-institution consensus paper for acquisition of portable chest radiographs through glass barriers.","To conserve personal protective equipment (PPE) and reduce exposure to potentially infected COVID-19 patients, several Californian facilities independently implemented a method of acquiring portable chest radiographs through glass barriers that was originally developed by the University of Washington. This work quantifies the transmission of radiation through a glass barrier using six radiographic systems at five facilities. Patient entrance air kerma (EAK) and effective dose were estimated both","2021","07","03","J Appl Clin Med Phys","Journal of applied clinical medical physics","COVID-19; chest X-ray; infection prevention; radiation safety","Clements","Jessica","Medical Imaging Technology and Informatics Department, Southern California Permanente Medical Group, Pasadena, CA, USA",NA
"1594","34216078","10.1111/tid.13681","Moderate acceptance of COVID-19 vaccination in patients pre- and post-heart transplantation: Experiences from a German Transplant Centre.","Patients awaiting heart transplantation (HTx) are at increased risk developing severe coronavirus disease 2019 (COVID-19). Patients supported by a left ventricular assist device (LVAD) face additional risks due to coagulopathies during COVID-19. Following HTx, elevated risk factors for severe COVID-19 persist due to chronic immunosuppression and frequent comorbidities. Taken together, COVID-19 vaccination is of critical importance in all three patient cohorts. Here, we report our experience to d","2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society","COVID-19; LVAD; heart transplantation; vaccination","Oehler","Daniel","Division of Cardiology, Pulmonology, and Vascular Medicine Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany",NA
"1595","34216078","10.1111/tid.13681","Moderate acceptance of COVID-19 vaccination in patients pre- and post-heart transplantation: Experiences from a German Transplant Centre.","Patients awaiting heart transplantation (HTx) are at increased risk developing severe coronavirus disease 2019 (COVID-19). Patients supported by a left ventricular assist device (LVAD) face additional risks due to coagulopathies during COVID-19. Following HTx, elevated risk factors for severe COVID-19 persist due to chronic immunosuppression and frequent comorbidities. Taken together, COVID-19 vaccination is of critical importance in all three patient cohorts. Here, we report our experience to d","2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society","COVID-19; LVAD; heart transplantation; vaccination","Bruno","Raphael Romano","Division of Cardiology, Pulmonology, and Vascular Medicine Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany",NA
"1596","34216078","10.1111/tid.13681","Moderate acceptance of COVID-19 vaccination in patients pre- and post-heart transplantation: Experiences from a German Transplant Centre.","Patients awaiting heart transplantation (HTx) are at increased risk developing severe coronavirus disease 2019 (COVID-19). Patients supported by a left ventricular assist device (LVAD) face additional risks due to coagulopathies during COVID-19. Following HTx, elevated risk factors for severe COVID-19 persist due to chronic immunosuppression and frequent comorbidities. Taken together, COVID-19 vaccination is of critical importance in all three patient cohorts. Here, we report our experience to d","2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society","COVID-19; LVAD; heart transplantation; vaccination","Boeken","Udo","Department of Cardiovascular Surgery, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany",NA
"1597","34216078","10.1111/tid.13681","Moderate acceptance of COVID-19 vaccination in patients pre- and post-heart transplantation: Experiences from a German Transplant Centre.","Patients awaiting heart transplantation (HTx) are at increased risk developing severe coronavirus disease 2019 (COVID-19). Patients supported by a left ventricular assist device (LVAD) face additional risks due to coagulopathies during COVID-19. Following HTx, elevated risk factors for severe COVID-19 persist due to chronic immunosuppression and frequent comorbidities. Taken together, COVID-19 vaccination is of critical importance in all three patient cohorts. Here, we report our experience to d","2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society","COVID-19; LVAD; heart transplantation; vaccination","Westenfeld","Ralf","Division of Cardiology, Pulmonology, and Vascular Medicine Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany",NA
"1598","34216055","10.1111/jocs.15769","Impact of COVID-19 on coronary artery surgery: Hard lessons learned.",NA,"2021","07","03","J Card Surg","Journal of cardiac surgery",NA,"Dallan","Luis Alberto O","Department of Cardiovascular Surgery, Heart Institute from University of São Paulo Medical School (InCor), São Paulo, São Paulo, Brazil",NA
"1599","34216055","10.1111/jocs.15769","Impact of COVID-19 on coronary artery surgery: Hard lessons learned.",NA,"2021","07","03","J Card Surg","Journal of cardiac surgery",NA,"F Lisboa","Luiz Augusto","Department of Cardiovascular Surgery, Heart Institute from University of São Paulo Medical School (InCor), São Paulo, São Paulo, Brazil",NA
"1600","34216055","10.1111/jocs.15769","Impact of COVID-19 on coronary artery surgery: Hard lessons learned.",NA,"2021","07","03","J Card Surg","Journal of cardiac surgery",NA,"Dallan","Luis Roberto P","Department of Cardiovascular Surgery, Heart Institute from University of São Paulo Medical School (InCor), São Paulo, São Paulo, Brazil",NA
"1601","34216055","10.1111/jocs.15769","Impact of COVID-19 on coronary artery surgery: Hard lessons learned.",NA,"2021","07","03","J Card Surg","Journal of cardiac surgery",NA,"Jatene","Fabio B","Department of Cardiovascular Surgery, Heart Institute from University of São Paulo Medical School (InCor), São Paulo, São Paulo, Brazil",NA
"1602","34216045","10.1002/gps.5596","Impact of the COVID-19 pandemic on older adults mental health services: A mixed methods study.","The COVID-19 pandemic has had a significant impact on older adults mental health care. Our study aimed to explore staff perspectives on key challenges and innovations in order to help inform the delivery of older adults mental health care in subsequent waves of the pandemic. A mixed methods online questionnaire developed by National Institute for Health Research Mental Health Policy Research Unit was used to gather staff perspectives on their challenges at work, problems faced by service users a","2021","07","09","Int J Geriatr Psychiatry","International journal of geriatric psychiatry","COVID-19; dementia care; mental health services; mental health staff; older adults mental health; pandemic","Bhome","Rohan","Queen Square Institute of Neurology, University College London, London, UK",NA
"1603","34216045","10.1002/gps.5596","Impact of the COVID-19 pandemic on older adults mental health services: A mixed methods study.","The COVID-19 pandemic has had a significant impact on older adults mental health care. Our study aimed to explore staff perspectives on key challenges and innovations in order to help inform the delivery of older adults mental health care in subsequent waves of the pandemic. A mixed methods online questionnaire developed by National Institute for Health Research Mental Health Policy Research Unit was used to gather staff perspectives on their challenges at work, problems faced by service users a","2021","07","09","Int J Geriatr Psychiatry","International journal of geriatric psychiatry","COVID-19; dementia care; mental health services; mental health staff; older adults mental health; pandemic","Huntley","Jonathan","Division of Psychiatry, University College London, London, UK",NA
"1604","34216045","10.1002/gps.5596","Impact of the COVID-19 pandemic on older adults mental health services: A mixed methods study.","The COVID-19 pandemic has had a significant impact on older adults mental health care. Our study aimed to explore staff perspectives on key challenges and innovations in order to help inform the delivery of older adults mental health care in subsequent waves of the pandemic. A mixed methods online questionnaire developed by National Institute for Health Research Mental Health Policy Research Unit was used to gather staff perspectives on their challenges at work, problems faced by service users a","2021","07","09","Int J Geriatr Psychiatry","International journal of geriatric psychiatry","COVID-19; dementia care; mental health services; mental health staff; older adults mental health; pandemic","Dalton-Locke","Christian","NIHR Mental Health Policy Research Unit, Division of Psychiatry, University College London, London, UK",NA
"1605","34216045","10.1002/gps.5596","Impact of the COVID-19 pandemic on older adults mental health services: A mixed methods study.","The COVID-19 pandemic has had a significant impact on older adults mental health care. Our study aimed to explore staff perspectives on key challenges and innovations in order to help inform the delivery of older adults mental health care in subsequent waves of the pandemic. A mixed methods online questionnaire developed by National Institute for Health Research Mental Health Policy Research Unit was used to gather staff perspectives on their challenges at work, problems faced by service users a","2021","07","09","Int J Geriatr Psychiatry","International journal of geriatric psychiatry","COVID-19; dementia care; mental health services; mental health staff; older adults mental health; pandemic","San Juan","Norha Vera","NIHR Mental Health Policy Research Unit, Institute of Psychiatry, Psychology &amp",NA
"1606","34216045","10.1002/gps.5596","Impact of the COVID-19 pandemic on older adults mental health services: A mixed methods study.","The COVID-19 pandemic has had a significant impact on older adults mental health care. Our study aimed to explore staff perspectives on key challenges and innovations in order to help inform the delivery of older adults mental health care in subsequent waves of the pandemic. A mixed methods online questionnaire developed by National Institute for Health Research Mental Health Policy Research Unit was used to gather staff perspectives on their challenges at work, problems faced by service users a","2021","07","09","Int J Geriatr Psychiatry","International journal of geriatric psychiatry","COVID-19; dementia care; mental health services; mental health staff; older adults mental health; pandemic","Oram","Sian","NIHR Mental Health Policy Research Unit, Institute of Psychiatry, Psychology &amp",NA
"1607","34216045","10.1002/gps.5596","Impact of the COVID-19 pandemic on older adults mental health services: A mixed methods study.","The COVID-19 pandemic has had a significant impact on older adults mental health care. Our study aimed to explore staff perspectives on key challenges and innovations in order to help inform the delivery of older adults mental health care in subsequent waves of the pandemic. A mixed methods online questionnaire developed by National Institute for Health Research Mental Health Policy Research Unit was used to gather staff perspectives on their challenges at work, problems faced by service users a","2021","07","09","Int J Geriatr Psychiatry","International journal of geriatric psychiatry","COVID-19; dementia care; mental health services; mental health staff; older adults mental health; pandemic","Foye","Una","Mental Health Nursing and NIHR Mental Health Policy Research Unit, King's College London, London, UK",NA
"1608","34216045","10.1002/gps.5596","Impact of the COVID-19 pandemic on older adults mental health services: A mixed methods study.","The COVID-19 pandemic has had a significant impact on older adults mental health care. Our study aimed to explore staff perspectives on key challenges and innovations in order to help inform the delivery of older adults mental health care in subsequent waves of the pandemic. A mixed methods online questionnaire developed by National Institute for Health Research Mental Health Policy Research Unit was used to gather staff perspectives on their challenges at work, problems faced by service users a","2021","07","09","Int J Geriatr Psychiatry","International journal of geriatric psychiatry","COVID-19; dementia care; mental health services; mental health staff; older adults mental health; pandemic","Livingston","Gill","Division of Psychiatry, University College London, London, UK",NA
"1609","34215999","10.1007/s40618-021-01627-z","Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection.",NA,"2021","07","07","J Endocrinol Invest","Journal of endocrinological investigation","COVID-19; Diabetes insipidus; Hypophysitis","Misgar","R A","Department of Endocrinology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Kashmir, India. drreyaz07@rediffmail","drreyaz07@rediffmail.com"
"1610","34215999","10.1007/s40618-021-01627-z","Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection.",NA,"2021","07","07","J Endocrinol Invest","Journal of endocrinological investigation","COVID-19; Diabetes insipidus; Hypophysitis","Rasool","A","Department of Endocrinology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Kashmir, India",NA
"1611","34215999","10.1007/s40618-021-01627-z","Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection.",NA,"2021","07","07","J Endocrinol Invest","Journal of endocrinological investigation","COVID-19; Diabetes insipidus; Hypophysitis","Wani","A I","Department of Endocrinology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Kashmir, India",NA
"1612","34215999","10.1007/s40618-021-01627-z","Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection.",NA,"2021","07","07","J Endocrinol Invest","Journal of endocrinological investigation","COVID-19; Diabetes insipidus; Hypophysitis","Bashir","M I","Department of Endocrinology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Kashmir, India",NA
"1613","34215960","10.1007/s11845-021-02701-4","Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).",NA,"2021","07","07","Ir J Med Sci","Irish journal of medical science",NA,"Garcia-Muñoz","Ricardo","Hematología Y Hemoterapia, Hospital San Pedro, Logrono, Spain. rgmunoz@riojasalud","rgmunoz@riojasalud.es"
"1614","34215960","10.1007/s11845-021-02701-4","Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).",NA,"2021","07","07","Ir J Med Sci","Irish journal of medical science",NA,"Feliu","Jesus","Hematología Y Hemoterapia, Hospital San Pedro, Logrono, Spain",NA
"1615","34215960","10.1007/s11845-021-02701-4","Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).",NA,"2021","07","07","Ir J Med Sci","Irish journal of medical science",NA,"Anton-Remirez","Judit","Medicina Física Y Rehabilitación, Complejo Hospitalario de Navarra, Navara, Spain",NA
"1616","34215960","10.1007/s11845-021-02701-4","Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).",NA,"2021","07","07","Ir J Med Sci","Irish journal of medical science",NA,"Metola","Luis","Enfermedades Infecciosas, Hospital San Pedro, Logrono, Spain",NA
"1617","34215960","10.1007/s11845-021-02701-4","Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).",NA,"2021","07","07","Ir J Med Sci","Irish journal of medical science",NA,"Sosa-Campos","Enrique","Enfermedades Infecciosas, Hospital Ángeles Mocel, Ciudad de Mexico, Mexico",NA
"1618","34215960","10.1007/s11845-021-02701-4","Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).",NA,"2021","07","07","Ir J Med Sci","Irish journal of medical science",NA,"Sanz","Maria-Pilar","Análisis Clínicos, Hospital San Pedro, Logrono, Spain",NA
"1619","34215960","10.1007/s11845-021-02701-4","Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).",NA,"2021","07","07","Ir J Med Sci","Irish journal of medical science",NA,"Farfan","Giovanna","Hematología Y Hemoterapia, Hospital San Pedro, Logrono, Spain",NA
"1620","34215960","10.1007/s11845-021-02701-4","Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).",NA,"2021","07","07","Ir J Med Sci","Irish journal of medical science",NA,"Labrador-Sanchez","Eztizen","Reumatología, Hospital San Pedro, Logrono, Spain",NA
"1621","34215960","10.1007/s11845-021-02701-4","Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).",NA,"2021","07","07","Ir J Med Sci","Irish journal of medical science",NA,"Ibarra","Valvanera","Enfermedades Infecciosas, Hospital San Pedro, Logrono, Spain",NA
"1622","34215960","10.1007/s11845-021-02701-4","Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).",NA,"2021","07","07","Ir J Med Sci","Irish journal of medical science",NA,"Peña","Jose-Luis","Medicina Interna, Hospital San Pedro, Logrono, Spain",NA
"1623","34215960","10.1007/s11845-021-02701-4","Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).",NA,"2021","07","07","Ir J Med Sci","Irish journal of medical science",NA,"Pascual","Ana","Digestivo, Hospital San Pedro, Logrono, Spain",NA
"1624","34215960","10.1007/s11845-021-02701-4","Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).",NA,"2021","07","07","Ir J Med Sci","Irish journal of medical science",NA,"Hermosa","María-Jesús","Neumología, Hospital San Pedro, Logrono, Spain",NA
"1625","34215960","10.1007/s11845-021-02701-4","Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).",NA,"2021","07","07","Ir J Med Sci","Irish journal of medical science",NA,"Blasco","Miriam","Microbiología, Hospital San Pedro, Logrono, Spain",NA
"1626","34215960","10.1007/s11845-021-02701-4","Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).",NA,"2021","07","07","Ir J Med Sci","Irish journal of medical science",NA,"Llerena-Garcia","Lorena","Microbiología, Hospital San Pedro, Logrono, Spain",NA
"1627","34215960","10.1007/s11845-021-02701-4","Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).",NA,"2021","07","07","Ir J Med Sci","Irish journal of medical science",NA,"Najera","María-José","Hematología Y Hemoterapia, Hospital San Pedro, Logrono, Spain",NA
"1628","34215960","10.1007/s11845-021-02701-4","Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19).",NA,"2021","07","07","Ir J Med Sci","Irish journal of medical science",NA,"Oteo","José Antonio","Enfermedades Infecciosas, Hospital San Pedro, Logrono, Spain",NA
"1629","34215936","10.1007/s00404-021-06133-4","Most significant barriers and proposed solutions for medical schools to facilitate simulation-based undergraduate curriculum in OBGYN.","Despite having a good understanding of medicine, doctors lack clinical skills, problem-solving abilities, and the ability to apply knowledge to patient care, particularly in unanticipated circumstances. To overcome this, medical education has evolved into a system-oriented core curriculum with cognitive, psychomotor, and affective learning goals. With an emphasis on problem-based learning, the educator's aim is to establish a long-term, predetermined improvement in the learner's behavior, acquir","2021","07","07","Arch Gynecol Obstet","Archives of gynecology and obstetrics","COVID-19; Challenges; Clinical skills; Fidelity; Medical schools; OBGYN; Simulation; Simulation-based curriculum; Strategies; Undergraduates","Salman","Hira","University of Dundee, Dundee, Scotland. drhirasalman@gmail","drhirasalman@gmail.com"
"1630","34215924","10.1007/s10741-021-10129-2","Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020.","Myocardial injury, diagnosed by troponin elevation, is common in COVID-19 patients, but cardiac involvement with clinical manifestations occurs less frequently. We analyzed the literature on COVID-19 (2020) and systematically reviewed the cases where individual patient data were presented. We searched PubMed and Google Scholar for ""COVID,"" ""COVID-19,"" and ""coronavirus"" in combination with ""myocarditis,"" ""heart failure,"" ""takotsubo,"" ""cardiomyopathy,"" and ""cardiogenic shock."" We identified 90 cas","2021","07","05","Heart Fail Rev","Heart failure reviews","Aortic pulsatility index; COVID-19; Coronavirus; Heart failure; Mortality; Myocarditis; Takotsubo","Guglin","Maya","Krannert Institute of Cardiology, Indiana University, 1801 Senate Blvd Suite 2000, IN, 46202, Indianapolis, USA. mguglin@gmail","mguglin@gmail.com"
"1631","34215924","10.1007/s10741-021-10129-2","Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020.","Myocardial injury, diagnosed by troponin elevation, is common in COVID-19 patients, but cardiac involvement with clinical manifestations occurs less frequently. We analyzed the literature on COVID-19 (2020) and systematically reviewed the cases where individual patient data were presented. We searched PubMed and Google Scholar for ""COVID,"" ""COVID-19,"" and ""coronavirus"" in combination with ""myocarditis,"" ""heart failure,"" ""takotsubo,"" ""cardiomyopathy,"" and ""cardiogenic shock."" We identified 90 cas","2021","07","05","Heart Fail Rev","Heart failure reviews","Aortic pulsatility index; COVID-19; Coronavirus; Heart failure; Mortality; Myocarditis; Takotsubo","Ballut","Kareem","Krannert Institute of Cardiology, Indiana University, 1801 Senate Blvd Suite 2000, IN, 46202, Indianapolis, USA",NA
"1632","34215924","10.1007/s10741-021-10129-2","Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020.","Myocardial injury, diagnosed by troponin elevation, is common in COVID-19 patients, but cardiac involvement with clinical manifestations occurs less frequently. We analyzed the literature on COVID-19 (2020) and systematically reviewed the cases where individual patient data were presented. We searched PubMed and Google Scholar for ""COVID,"" ""COVID-19,"" and ""coronavirus"" in combination with ""myocarditis,"" ""heart failure,"" ""takotsubo,"" ""cardiomyopathy,"" and ""cardiogenic shock."" We identified 90 cas","2021","07","05","Heart Fail Rev","Heart failure reviews","Aortic pulsatility index; COVID-19; Coronavirus; Heart failure; Mortality; Myocarditis; Takotsubo","Ilonze","Onyedika","Krannert Institute of Cardiology, Indiana University, 1801 Senate Blvd Suite 2000, IN, 46202, Indianapolis, USA",NA
"1633","34215924","10.1007/s10741-021-10129-2","Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020.","Myocardial injury, diagnosed by troponin elevation, is common in COVID-19 patients, but cardiac involvement with clinical manifestations occurs less frequently. We analyzed the literature on COVID-19 (2020) and systematically reviewed the cases where individual patient data were presented. We searched PubMed and Google Scholar for ""COVID,"" ""COVID-19,"" and ""coronavirus"" in combination with ""myocarditis,"" ""heart failure,"" ""takotsubo,"" ""cardiomyopathy,"" and ""cardiogenic shock."" We identified 90 cas","2021","07","05","Heart Fail Rev","Heart failure reviews","Aortic pulsatility index; COVID-19; Coronavirus; Heart failure; Mortality; Myocarditis; Takotsubo","Jones","Mark","Krannert Institute of Cardiology, Indiana University, 1801 Senate Blvd Suite 2000, IN, 46202, Indianapolis, USA",NA
"1634","34215924","10.1007/s10741-021-10129-2","Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020.","Myocardial injury, diagnosed by troponin elevation, is common in COVID-19 patients, but cardiac involvement with clinical manifestations occurs less frequently. We analyzed the literature on COVID-19 (2020) and systematically reviewed the cases where individual patient data were presented. We searched PubMed and Google Scholar for ""COVID,"" ""COVID-19,"" and ""coronavirus"" in combination with ""myocarditis,"" ""heart failure,"" ""takotsubo,"" ""cardiomyopathy,"" and ""cardiogenic shock."" We identified 90 cas","2021","07","05","Heart Fail Rev","Heart failure reviews","Aortic pulsatility index; COVID-19; Coronavirus; Heart failure; Mortality; Myocarditis; Takotsubo","Rao","Roopa","Krannert Institute of Cardiology, Indiana University, 1801 Senate Blvd Suite 2000, IN, 46202, Indianapolis, USA",NA
"1635","34215906","10.1007/s10067-021-05844-y","A bibliometric analysis of rheumatology and COVID-19 researches.","COVID-19 has had a substantial impact on rheumatology. There were many studies about rheumatology and COVID-19. But there is no study about bibliometric analysis of these studies. This study provides a general overview of studies on rheumatology and COVID-19. Data were taken from the Web of Science (WoS) website. Analysis and network visualization mapping processes were carried out using VOSviewer. We used the following keywords: ""COVID-19"" and ""Rheumatology""; ""Coronavirus"" and ""Rheumatology""; ""","2021","07","07","Clin Rheumatol","Clinical rheumatology","Analysis; Bibliometric; COVID-19; Rheumatology","Pasin","Ozge","Department of Biostatistics, Faculty of Medicine, Bezmialem Foundation University, Fatih, Istanbul, Turkey. ozgepasin90@yahoo.com","ozgepasin90@yahoo.com.tr"
"1636","34215906","10.1007/s10067-021-05844-y","A bibliometric analysis of rheumatology and COVID-19 researches.","COVID-19 has had a substantial impact on rheumatology. There were many studies about rheumatology and COVID-19. But there is no study about bibliometric analysis of these studies. This study provides a general overview of studies on rheumatology and COVID-19. Data were taken from the Web of Science (WoS) website. Analysis and network visualization mapping processes were carried out using VOSviewer. We used the following keywords: ""COVID-19"" and ""Rheumatology""; ""Coronavirus"" and ""Rheumatology""; ""","2021","07","07","Clin Rheumatol","Clinical rheumatology","Analysis; Bibliometric; COVID-19; Rheumatology","Pasin","Tugce","Department of Physical Medicine and Rehabilitation, Istanbul Goztepe Training and Research Hospital, Istanbul, Turkey",NA
"1637","34215897","10.14423/SMJ.0000000000001269","Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 Pneumonia Who Developed Bradycardia.","To assess the clinical characteristics and clinical outcomes of bradycardic patients with coronavirus disease 2019 (COVID-19) pneumonia. The electronic medical records of 221 consecutive patients hospitalized for COVID-19 pneumonia between June and September 2020 were retrospectively reviewed. Patient characteristics, electrocardiographic data, and clinical and laboratory information were retrospectively collected. Patients not treated with drugs that blunt chronotropic response (nodal) were ana","2021","07","12","South Med J","Southern medical journal","Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Bradycardia; COVID-19; Electrocardiography; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Young Adult","Stancampiano","Fernando","From the Division of Community Internal Medicine, the Clinical Research Unit, the Division of Biomedical Statistics and Informatics, and the Division of Infectious Diseases, Mayo Clinic Florida, Jacksonville",NA
"1638","34215897","10.14423/SMJ.0000000000001269","Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 Pneumonia Who Developed Bradycardia.","To assess the clinical characteristics and clinical outcomes of bradycardic patients with coronavirus disease 2019 (COVID-19) pneumonia. The electronic medical records of 221 consecutive patients hospitalized for COVID-19 pneumonia between June and September 2020 were retrospectively reviewed. Patient characteristics, electrocardiographic data, and clinical and laboratory information were retrospectively collected. Patients not treated with drugs that blunt chronotropic response (nodal) were ana","2021","07","12","South Med J","Southern medical journal","Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Bradycardia; COVID-19; Electrocardiography; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Young Adult","Omer","Mohamed","From the Division of Community Internal Medicine, the Clinical Research Unit, the Division of Biomedical Statistics and Informatics, and the Division of Infectious Diseases, Mayo Clinic Florida, Jacksonville",NA
"1639","34215897","10.14423/SMJ.0000000000001269","Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 Pneumonia Who Developed Bradycardia.","To assess the clinical characteristics and clinical outcomes of bradycardic patients with coronavirus disease 2019 (COVID-19) pneumonia. The electronic medical records of 221 consecutive patients hospitalized for COVID-19 pneumonia between June and September 2020 were retrospectively reviewed. Patient characteristics, electrocardiographic data, and clinical and laboratory information were retrospectively collected. Patients not treated with drugs that blunt chronotropic response (nodal) were ana","2021","07","12","South Med J","Southern medical journal","Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Bradycardia; COVID-19; Electrocardiography; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Young Adult","Harris","Dana","From the Division of Community Internal Medicine, the Clinical Research Unit, the Division of Biomedical Statistics and Informatics, and the Division of Infectious Diseases, Mayo Clinic Florida, Jacksonville",NA
"1640","34215897","10.14423/SMJ.0000000000001269","Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 Pneumonia Who Developed Bradycardia.","To assess the clinical characteristics and clinical outcomes of bradycardic patients with coronavirus disease 2019 (COVID-19) pneumonia. The electronic medical records of 221 consecutive patients hospitalized for COVID-19 pneumonia between June and September 2020 were retrospectively reviewed. Patient characteristics, electrocardiographic data, and clinical and laboratory information were retrospectively collected. Patients not treated with drugs that blunt chronotropic response (nodal) were ana","2021","07","12","South Med J","Southern medical journal","Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Bradycardia; COVID-19; Electrocardiography; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Young Adult","Valery","Jose","From the Division of Community Internal Medicine, the Clinical Research Unit, the Division of Biomedical Statistics and Informatics, and the Division of Infectious Diseases, Mayo Clinic Florida, Jacksonville",NA
"1641","34215897","10.14423/SMJ.0000000000001269","Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 Pneumonia Who Developed Bradycardia.","To assess the clinical characteristics and clinical outcomes of bradycardic patients with coronavirus disease 2019 (COVID-19) pneumonia. The electronic medical records of 221 consecutive patients hospitalized for COVID-19 pneumonia between June and September 2020 were retrospectively reviewed. Patient characteristics, electrocardiographic data, and clinical and laboratory information were retrospectively collected. Patients not treated with drugs that blunt chronotropic response (nodal) were ana","2021","07","12","South Med J","Southern medical journal","Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Bradycardia; COVID-19; Electrocardiography; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Young Adult","Heckman","Michael","From the Division of Community Internal Medicine, the Clinical Research Unit, the Division of Biomedical Statistics and Informatics, and the Division of Infectious Diseases, Mayo Clinic Florida, Jacksonville",NA
"1642","34215897","10.14423/SMJ.0000000000001269","Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 Pneumonia Who Developed Bradycardia.","To assess the clinical characteristics and clinical outcomes of bradycardic patients with coronavirus disease 2019 (COVID-19) pneumonia. The electronic medical records of 221 consecutive patients hospitalized for COVID-19 pneumonia between June and September 2020 were retrospectively reviewed. Patient characteristics, electrocardiographic data, and clinical and laboratory information were retrospectively collected. Patients not treated with drugs that blunt chronotropic response (nodal) were ana","2021","07","12","South Med J","Southern medical journal","Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Bradycardia; COVID-19; Electrocardiography; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Young Adult","White","Launia","From the Division of Community Internal Medicine, the Clinical Research Unit, the Division of Biomedical Statistics and Informatics, and the Division of Infectious Diseases, Mayo Clinic Florida, Jacksonville",NA
"1643","34215897","10.14423/SMJ.0000000000001269","Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 Pneumonia Who Developed Bradycardia.","To assess the clinical characteristics and clinical outcomes of bradycardic patients with coronavirus disease 2019 (COVID-19) pneumonia. The electronic medical records of 221 consecutive patients hospitalized for COVID-19 pneumonia between June and September 2020 were retrospectively reviewed. Patient characteristics, electrocardiographic data, and clinical and laboratory information were retrospectively collected. Patients not treated with drugs that blunt chronotropic response (nodal) were ana","2021","07","12","South Med J","Southern medical journal","Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Bradycardia; COVID-19; Electrocardiography; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Young Adult","Libertin","Claudia","From the Division of Community Internal Medicine, the Clinical Research Unit, the Division of Biomedical Statistics and Informatics, and the Division of Infectious Diseases, Mayo Clinic Florida, Jacksonville",NA
"1644","34215866","10.1093/aje/kwab191","Disparities among Racially/Ethnically Marginalized Groups in the COVID-19 Pandemic Persist Regardless of Statewide Shelter-in-Place Policies: An Analysis from Northern California.","To measure COVID-19 disparities among racial/ethnically marginalized groups in hospitalization and ICU (Intensive Care Unit)-transfer pre/post implementation of the California statewide shelter-in-place (SIP) policy. A retrospective cohort study was conducted at a healthcare system in California. COVID-19 patients from 1/1/20-8/31/20 were identified from electronic health records. We examined hospitalizations and ICU transfers by race/ethnicity and pandemic period using logistic regression. Amon","2021","07","03","Am J Epidemiol","American journal of epidemiology","Covid-19; Disparities; Policy","Azar","Kristen M J","Sutter Health Institute for Advancing Health Equity, Sutter Health, Sacramento, California, United States",NA
"1645","34215866","10.1093/aje/kwab191","Disparities among Racially/Ethnically Marginalized Groups in the COVID-19 Pandemic Persist Regardless of Statewide Shelter-in-Place Policies: An Analysis from Northern California.","To measure COVID-19 disparities among racial/ethnically marginalized groups in hospitalization and ICU (Intensive Care Unit)-transfer pre/post implementation of the California statewide shelter-in-place (SIP) policy. A retrospective cohort study was conducted at a healthcare system in California. COVID-19 patients from 1/1/20-8/31/20 were identified from electronic health records. We examined hospitalizations and ICU transfers by race/ethnicity and pandemic period using logistic regression. Amon","2021","07","03","Am J Epidemiol","American journal of epidemiology","Covid-19; Disparities; Policy","Lockhart","Stephen H","Sutter Health Institute for Advancing Health Equity, Sutter Health, Sacramento, California, United States",NA
"1646","34215866","10.1093/aje/kwab191","Disparities among Racially/Ethnically Marginalized Groups in the COVID-19 Pandemic Persist Regardless of Statewide Shelter-in-Place Policies: An Analysis from Northern California.","To measure COVID-19 disparities among racial/ethnically marginalized groups in hospitalization and ICU (Intensive Care Unit)-transfer pre/post implementation of the California statewide shelter-in-place (SIP) policy. A retrospective cohort study was conducted at a healthcare system in California. COVID-19 patients from 1/1/20-8/31/20 were identified from electronic health records. We examined hospitalizations and ICU transfers by race/ethnicity and pandemic period using logistic regression. Amon","2021","07","03","Am J Epidemiol","American journal of epidemiology","Covid-19; Disparities; Policy","Shen","Zijun","Sutter Health Institute for Advancing Health Equity, Sutter Health, Sacramento, California, United States",NA
"1647","34215866","10.1093/aje/kwab191","Disparities among Racially/Ethnically Marginalized Groups in the COVID-19 Pandemic Persist Regardless of Statewide Shelter-in-Place Policies: An Analysis from Northern California.","To measure COVID-19 disparities among racial/ethnically marginalized groups in hospitalization and ICU (Intensive Care Unit)-transfer pre/post implementation of the California statewide shelter-in-place (SIP) policy. A retrospective cohort study was conducted at a healthcare system in California. COVID-19 patients from 1/1/20-8/31/20 were identified from electronic health records. We examined hospitalizations and ICU transfers by race/ethnicity and pandemic period using logistic regression. Amon","2021","07","03","Am J Epidemiol","American journal of epidemiology","Covid-19; Disparities; Policy","Romanelli","Robert","Sutter Health Institute for Advancing Health Equity, Sutter Health, Sacramento, California, United States",NA
"1648","34215866","10.1093/aje/kwab191","Disparities among Racially/Ethnically Marginalized Groups in the COVID-19 Pandemic Persist Regardless of Statewide Shelter-in-Place Policies: An Analysis from Northern California.","To measure COVID-19 disparities among racial/ethnically marginalized groups in hospitalization and ICU (Intensive Care Unit)-transfer pre/post implementation of the California statewide shelter-in-place (SIP) policy. A retrospective cohort study was conducted at a healthcare system in California. COVID-19 patients from 1/1/20-8/31/20 were identified from electronic health records. We examined hospitalizations and ICU transfers by race/ethnicity and pandemic period using logistic regression. Amon","2021","07","03","Am J Epidemiol","American journal of epidemiology","Covid-19; Disparities; Policy","Brown","Stephanie","Sutter Health Institute for Advancing Health Equity, Sutter Health, Sacramento, California, United States",NA
"1649","34215866","10.1093/aje/kwab191","Disparities among Racially/Ethnically Marginalized Groups in the COVID-19 Pandemic Persist Regardless of Statewide Shelter-in-Place Policies: An Analysis from Northern California.","To measure COVID-19 disparities among racial/ethnically marginalized groups in hospitalization and ICU (Intensive Care Unit)-transfer pre/post implementation of the California statewide shelter-in-place (SIP) policy. A retrospective cohort study was conducted at a healthcare system in California. COVID-19 patients from 1/1/20-8/31/20 were identified from electronic health records. We examined hospitalizations and ICU transfers by race/ethnicity and pandemic period using logistic regression. Amon","2021","07","03","Am J Epidemiol","American journal of epidemiology","Covid-19; Disparities; Policy","Smits","Kelly","Sutter Health Institute for Advancing Health Equity, Sutter Health, Sacramento, California, United States",NA
"1650","34215866","10.1093/aje/kwab191","Disparities among Racially/Ethnically Marginalized Groups in the COVID-19 Pandemic Persist Regardless of Statewide Shelter-in-Place Policies: An Analysis from Northern California.","To measure COVID-19 disparities among racial/ethnically marginalized groups in hospitalization and ICU (Intensive Care Unit)-transfer pre/post implementation of the California statewide shelter-in-place (SIP) policy. A retrospective cohort study was conducted at a healthcare system in California. COVID-19 patients from 1/1/20-8/31/20 were identified from electronic health records. We examined hospitalizations and ICU transfers by race/ethnicity and pandemic period using logistic regression. Amon","2021","07","03","Am J Epidemiol","American journal of epidemiology","Covid-19; Disparities; Policy","Pressman","Alice R","Sutter Health Institute for Advancing Health Equity, Sutter Health, Sacramento, California, United States",NA
"1651","34215859","10.1038/d41586-021-01844-9","Coronapod: the biomarker that could change COVID vaccines.",NA,"2021","07","21","Nature","Nature","Public health; SARS-CoV-2; Vaccines","Baker","Noah",NA,NA
"1652","34215859","10.1038/d41586-021-01844-9","Coronapod: the biomarker that could change COVID vaccines.",NA,"2021","07","21","Nature","Nature","Public health; SARS-CoV-2; Vaccines","Callaway","Ewen",NA,NA
"1653","34215857","10.1038/d41586-020-02020-1","Coronapod: Lessons from pandemic 'war-game' simulations.",NA,"2021","07","03","Nature","Nature","Diseases; Infection; Public health; SARS-CoV-2","Baker","Noah",NA,NA
"1654","34215857","10.1038/d41586-020-02020-1","Coronapod: Lessons from pandemic 'war-game' simulations.",NA,"2021","07","03","Nature","Nature","Diseases; Infection; Public health; SARS-CoV-2","Maxmen","Amy",NA,NA
"1655","34215857","10.1038/d41586-020-02020-1","Coronapod: Lessons from pandemic 'war-game' simulations.",NA,"2021","07","03","Nature","Nature","Diseases; Infection; Public health; SARS-CoV-2","Thompson","Benjamin",NA,NA
"1656","34215811","10.1038/s41598-021-93175-y","Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients.","Most patients infected with SARS-CoV-2 are asymptomatic or mildly symptomatic. However, the early and late antibody kinetics, and the association between antibody levels, clinical symptoms, and disease phase in these patients have not yet been fully defined. Confirmed SARS-CoV-2 patients and their household contacts were evaluated over a period four months. The evaluation procedure included symptom monitoring, viral load and serology analysis every ten days. A total of 1334 serum samples were co","2021","07","15","Sci Rep","Scientific reports","Adult; Aged; Antibodies, Viral; COVID-19; Female; Humans; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; SARS-CoV-2; Viral Load","Efrati","Shai","Research and Development Unit, Shamir Medical Center, Zerifin, Israel. efratishai@outlook","efratishai@outlook.com"
"1657","34215811","10.1038/s41598-021-93175-y","Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients.","Most patients infected with SARS-CoV-2 are asymptomatic or mildly symptomatic. However, the early and late antibody kinetics, and the association between antibody levels, clinical symptoms, and disease phase in these patients have not yet been fully defined. Confirmed SARS-CoV-2 patients and their household contacts were evaluated over a period four months. The evaluation procedure included symptom monitoring, viral load and serology analysis every ten days. A total of 1334 serum samples were co","2021","07","15","Sci Rep","Scientific reports","Adult; Aged; Antibodies, Viral; COVID-19; Female; Humans; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; SARS-CoV-2; Viral Load","Catalogna","Merav","Research and Development Unit, Shamir Medical Center, Zerifin, Israel",NA
"1658","34215811","10.1038/s41598-021-93175-y","Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients.","Most patients infected with SARS-CoV-2 are asymptomatic or mildly symptomatic. However, the early and late antibody kinetics, and the association between antibody levels, clinical symptoms, and disease phase in these patients have not yet been fully defined. Confirmed SARS-CoV-2 patients and their household contacts were evaluated over a period four months. The evaluation procedure included symptom monitoring, viral load and serology analysis every ten days. A total of 1334 serum samples were co","2021","07","15","Sci Rep","Scientific reports","Adult; Aged; Antibodies, Viral; COVID-19; Female; Humans; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; SARS-CoV-2; Viral Load","Abu Hamed","Ramzia","Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"1659","34215811","10.1038/s41598-021-93175-y","Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients.","Most patients infected with SARS-CoV-2 are asymptomatic or mildly symptomatic. However, the early and late antibody kinetics, and the association between antibody levels, clinical symptoms, and disease phase in these patients have not yet been fully defined. Confirmed SARS-CoV-2 patients and their household contacts were evaluated over a period four months. The evaluation procedure included symptom monitoring, viral load and serology analysis every ten days. A total of 1334 serum samples were co","2021","07","15","Sci Rep","Scientific reports","Adult; Aged; Antibodies, Viral; COVID-19; Female; Humans; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; SARS-CoV-2; Viral Load","Hadanny","Amir","Research and Development Unit, Shamir Medical Center, Zerifin, Israel",NA
"1660","34215811","10.1038/s41598-021-93175-y","Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients.","Most patients infected with SARS-CoV-2 are asymptomatic or mildly symptomatic. However, the early and late antibody kinetics, and the association between antibody levels, clinical symptoms, and disease phase in these patients have not yet been fully defined. Confirmed SARS-CoV-2 patients and their household contacts were evaluated over a period four months. The evaluation procedure included symptom monitoring, viral load and serology analysis every ten days. A total of 1334 serum samples were co","2021","07","15","Sci Rep","Scientific reports","Adult; Aged; Antibodies, Viral; COVID-19; Female; Humans; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; SARS-CoV-2; Viral Load","Bar-Chaim","Adina","Clinical Chemistry Laboratory, Shamir Medical Center, Zerifin, Israel",NA
"1661","34215811","10.1038/s41598-021-93175-y","Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients.","Most patients infected with SARS-CoV-2 are asymptomatic or mildly symptomatic. However, the early and late antibody kinetics, and the association between antibody levels, clinical symptoms, and disease phase in these patients have not yet been fully defined. Confirmed SARS-CoV-2 patients and their household contacts were evaluated over a period four months. The evaluation procedure included symptom monitoring, viral load and serology analysis every ten days. A total of 1334 serum samples were co","2021","07","15","Sci Rep","Scientific reports","Adult; Aged; Antibodies, Viral; COVID-19; Female; Humans; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; SARS-CoV-2; Viral Load","Benveniste-Levkovitz","Patricia","Clinical Chemistry Laboratory, Shamir Medical Center, Zerifin, Israel",NA
"1662","34215811","10.1038/s41598-021-93175-y","Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients.","Most patients infected with SARS-CoV-2 are asymptomatic or mildly symptomatic. However, the early and late antibody kinetics, and the association between antibody levels, clinical symptoms, and disease phase in these patients have not yet been fully defined. Confirmed SARS-CoV-2 patients and their household contacts were evaluated over a period four months. The evaluation procedure included symptom monitoring, viral load and serology analysis every ten days. A total of 1334 serum samples were co","2021","07","15","Sci Rep","Scientific reports","Adult; Aged; Antibodies, Viral; COVID-19; Female; Humans; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; SARS-CoV-2; Viral Load","Strugo","Refael","Magen David Adom (MDA), Tel Aviv, Israel",NA
"1663","34215811","10.1038/s41598-021-93175-y","Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients.","Most patients infected with SARS-CoV-2 are asymptomatic or mildly symptomatic. However, the early and late antibody kinetics, and the association between antibody levels, clinical symptoms, and disease phase in these patients have not yet been fully defined. Confirmed SARS-CoV-2 patients and their household contacts were evaluated over a period four months. The evaluation procedure included symptom monitoring, viral load and serology analysis every ten days. A total of 1334 serum samples were co","2021","07","15","Sci Rep","Scientific reports","Adult; Aged; Antibodies, Viral; COVID-19; Female; Humans; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; SARS-CoV-2; Viral Load","Levtzion-Korach","Osnat","Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"1664","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Ramos-Martínez","Antonio","Infectious Diseases Unit, Internal Medicine Department, Hospital Universitario Puerta de Hierro-Majadahonda UAM, IDIPHSA, Maestro Rodrigo 2, 28222, Majadahonda, Madrid, Spain. aramos220@gmail","aramos220@gmail.com"
"1665","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Parra-Ramírez","Lina Marcela","Preventive Medicine Department, Hospital Universitario Puerta de Hierro-Majadahonda UAM, IDIPHSA, Maestro Rodrigo 2, 28222, Majadahonda, Madrid, Spain",NA
"1666","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Morrás","Ignacio","Internal Medicine Department, Hospital Universitario Puerta de Hierro-Majadahonda UAM, IDIPHSA, Maestro Rodrigo 2, 28222, Majadahonda, Madrid, Spain",NA
"1667","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Carnevali","María","Internal Medicine Department, 12 de Octubre University Hospital, Av. de Córdoba, s/n, 28041, Madrid, Spain",NA
"1668","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Jiménez-Ibañez","Lorena","Internal Medicine Department, Gregorio Marañon University Hospital, Dr. Esquerdo, 46, 28007, Madrid, Spain",NA
"1669","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Rubio-Rivas","Manuel","Internal Medicine Department, Bellvitge University Hospital, Carrer de La Feixa Llarga, s/n, 08907, L'Hospitalet de Llobregat, Barcelona, Spain",NA
"1670","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Arnalich","Francisco","Internal Medicine Department, La Paz University Hospital, Paseo de La Castellana, 261, 28046, Madrid, Spain",NA
"1671","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Beato","José Luis","Internal Medicine Department, Albacete University Hospital Complex, Hermanos Falco, 37, 02006, Albacete, Spain",NA
"1672","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Monge","Daniel","Internal Medicine Department, Segovia Hospital Complex, Luis Erik Clavería Neurólogo s/n, 40002, Segovia, Spain",NA
"1673","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Asín","Uxua","Internal Medicine Department, Miguel Servet Hospital, Paseo Isabel la Católica, 1-3, 50009, Zaragoza, Spain",NA
"1674","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Suárez","Carmen","Internal Medicine Department, La Princesa University Hospital, Diego de León, 62, 28006, Madrid, Spain",NA
"1675","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Freire","Santiago Jesús","Internal Medicine Department, A Coruña University Hospital, Xubias de Arriba, 84, 15006 A, Coruña, Spain",NA
"1676","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Méndez-Bailón","Manuel","Internal Medicine Department, San Carlos Clinical Hospital, Prof Martín Lagos, s/n, 28040, Madrid, Spain",NA
"1677","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Perales","Isabel","Internal Medicine Department, Infanta Sofía Hospital, Paseo de Europa, 34, 28703, San Sebastián de los Reyes, Madrid, Spain",NA
"1678","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Loureiro-Amigo","José","Internal Medicine Department, Moisès Broggi Hospital, Carrer de Jacint Verdaguer, 90, 08970, Sant Joan Despí, Barcelona, Spain",NA
"1679","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Gómez-Belda","Ana Belén","Internal Medicine Department, Dr. Peset University Hospital, Av. de Gaspar Aguilar, 90, 46017, Valencia, Spain",NA
"1680","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Pesqueira","Paula María","Internal Medicine Department, Santiago Clinical Hospital, Rúa da Choupana, s/n, 15706, Santiago de Compostela, A Coruña, Spain",NA
"1681","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Gómez-Huelgas","Ricardo","Internal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), Av. de Carlos Haya, 84, 29010, Málaga, Spain",NA
"1682","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Mella","Carmen","Internal Medicine Department, Hospital Architect Marcide-Novoa Santos, Rúa Pardo Bazán, s/n, 15404, Ferrol, A Coruña, Spain",NA
"1683","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Díez-García","Luis Felipe","Internal Medicine Department, Torrecárdenas Hospital, Hermandad de Donantes de Sangre, s/n, 04009, Almería, Spain",NA
"1684","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Fernández-Sola","Joaquim","Internal Medicine Department, Clinic Barcelona Hospital, Villarroel, 170, 08036, Barcelona, Spain",NA
"1685","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","González-Ferrer","Ruth","Internal Medicine Department, Tajo Hospital, Av. Amazonas Central, s/n, 28300, Aranjuez, Madrid, Spain",NA
"1686","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Aroza","Marina","Internal Medicine Department, Insular de Gran Canaria Hospital, Av. Marítima del Sur, s/n, 35016, Las Palmas de Gran Canaria, Las Palmas, Spain",NA
"1687","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Antón-Santos","Juan Miguel","Internal Medicine Department, Infanta Cristina University Hospital, Av. 9 de Junio, 2, 28981, Parla, Madrid, Spain",NA
"1688","34215803","10.1038/s41598-021-93076-0","Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.","To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 pati","2021","07","15","Sci Rep","Scientific reports","Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Retrospective Studies; Risk Factors; SARS-CoV-2","Bermejo","Carlos Lumbreras","Internal Medicine Department, 12 de Octubre University Hospital, Av. de Córdoba, s/n, 28041, Madrid, Spain",NA
"1689","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Oh","Juhwan","Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA",NA
"1690","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Lee","Hwa-Young","Department of Global Health and Population, Harvard T.H.Chan School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. hwlee@hsph.harvard","hwlee@hsph.harvard.edu"
"1691","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Khuong","Quynh Long","Hanoi University of Public Health, 1A Duc Thang Road, Duc Thang Ward, North Tu Liem District, Hanoi, Vietnam",NA
"1692","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Markuns","Jeffrey F","Boston University School of Medicine, 72 East Concord St., Boston, MA, 02118, USA",NA
"1693","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Bullen","Chris","The University of Auckland School of Population Health, Private Bag 92019, Auckland, 1142, New Zealand",NA
"1694","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Barrios","Osvaldo Enrique Artaza","The University of the Americas, Av. Manuel Montt 948, Providencia, Región Metropolitana Santiago, Chile",NA
"1695","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Hwang","Seung-Sik","Department of Public Health Sciences, Graduate School of Public Health, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea",NA
"1696","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Suh","Young Sahng","Department of Global Health and Population, Harvard T.H.Chan School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA",NA
"1697","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","McCool","Judith","The University of Auckland School of Population Health, Private Bag 92019, Auckland, 1142, New Zealand",NA
"1698","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Kachur","S Patrick","Mailman School of Public Health, Columbia University, 722 West 168th St., New York, NY, 10032, USA",NA
"1699","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Chan","Chang-Chuan","National Taiwan University College of Public Health, Institute of Environmental and Occupational Health Sciences, 17 Xuzhou Road, Taipei, Taiwan",NA
"1700","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Kwon","Soonman","Department of Public Health Sciences, Graduate School of Public Health, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea",NA
"1701","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Kondo","Naoki","Kyoto University School of Public Health, Yoshida-konoecho, Sakyo-ku, Kyoto, 606-8501, Japan",NA
"1702","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Hoang","Van Minh","Hanoi University of Public Health, 1A Duc Thang Road, Duc Thang Ward, North Tu Liem District, Hanoi, Vietnam",NA
"1703","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Moon","J Robin","City University of New York Graduate School of Public Health and Health Policy, 55 W 125th St, New York, NY, 10027, USA",NA
"1704","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Rostila","Mikael","Stockholm University, 106 91, Stockholm, Sweden",NA
"1705","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Norheim","Ole F","Department of Global Health and Population, Harvard T.H.Chan School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA",NA
"1706","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","You","Myoungsoon","Department of Public Health Sciences, Graduate School of Public Health, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea",NA
"1707","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Withers","Mellissa","University of Southern California, Trousdale Pkwy, Los Angeles, CA, 3551, USA",NA
"1708","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Li","Mu","Sydney School of Public Health, The University of Sydney, Sydney, NSW, 2006, Australia",NA
"1709","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Lee","Eun-Jeung","Freie Universität Berlin, Otto-von-Simson Str. 11, 14195, Berlin, Germany",NA
"1710","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Benski","Caroline","University Hospital of Geneva, Boulevard de la Cluse 30, 1205, Genève, Suisse",NA
"1711","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Park","Sookyung","National Health Insurance Service , 32 Geongang-ro, Wonju, Gangwon-do, Republic of Korea",NA
"1712","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Nam","Eun-Woo","Yonsei University, 1 Yonseidae-gil, Gangwon-do, Wonju, 220-710, Republic of Korea",NA
"1713","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Gottschalk","Katie","Georgetown University, 37th and O St., N.W., Washington, DC, 20057, USA",NA
"1714","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Kavanagh","Matthew M","Georgetown University, 37th and O St., N.W., Washington, DC, 20057, USA",NA
"1715","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Tran","Thi Giang Huong","Hanoi Medical University, No 1, Tong Tung Street, Hanoi, 116001, Vietnam",NA
"1716","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Lee","Jong-Koo","Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, Republic of Korea",NA
"1717","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Subramanian","S V","Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA",NA
"1718","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","McKee","Martin","London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK",NA
"1719","34215764","10.1038/s41598-021-92766-z","Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries.","Most countries have implemented restrictions on mobility to prevent the spread of Coronavirus disease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited evidence of effectiveness. We asked whether mobility restrictions were associated with changes in the occurrence of COVID-19 in 34 OECD countries plus Singapore and Taiwan. Our data sources were the Google Global Mobility Data Source, which reports different types of mobility, and COVID-19 cases retrie","2021","07","15","Sci Rep","Scientific reports","COVID-19; Communicable Disease Control; Humans; Incidence; Pandemics; Transportation; Travel; Travel-Related Illness; Workplace","Gostin","Lawrence O","Georgetown University, 37th and O St., N.W., Washington, DC, 20057, USA",NA
"1720","34215683","10.1212/NXI.0000000000001050","COVID-19 Among Patients With Multiple Sclerosis: A Systematic Review.",NA,"2021","07","06","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology &amp; neuroinflammation",NA,NA,NA,NA,NA
"1721","34215677","10.1542/peds.2020-047795","Pediatric Telehealth in the COVID-19 Pandemic Era and Beyond.",NA,"2021","07","03","Pediatrics","Pediatrics",NA,"Curfman","Alison","Mercy Clinic in St. Louis Department of Pediatrics Alison.curfman@mercy","Alison.curfman@mercy.net"
"1722","34215677","10.1542/peds.2020-047795","Pediatric Telehealth in the COVID-19 Pandemic Era and Beyond.",NA,"2021","07","03","Pediatrics","Pediatrics",NA,"McSwain","S David","Medical University of South Carolina Department of Pediatrics",NA
"1723","34215677","10.1542/peds.2020-047795","Pediatric Telehealth in the COVID-19 Pandemic Era and Beyond.",NA,"2021","07","03","Pediatrics","Pediatrics",NA,"Chuo","John","Children's Hospital of Philadelphia",NA
"1724","34215677","10.1542/peds.2020-047795","Pediatric Telehealth in the COVID-19 Pandemic Era and Beyond.",NA,"2021","07","03","Pediatrics","Pediatrics",NA,"Yeager-McSwain","Brooke","HIMSS Foundation",NA
"1725","34215677","10.1542/peds.2020-047795","Pediatric Telehealth in the COVID-19 Pandemic Era and Beyond.",NA,"2021","07","03","Pediatrics","Pediatrics",NA,"Schinasi","Dana A","Ann &amp",NA
"1726","34215677","10.1542/peds.2020-047795","Pediatric Telehealth in the COVID-19 Pandemic Era and Beyond.",NA,"2021","07","03","Pediatrics","Pediatrics",NA,"Marcin","James","University of California Davis School of Medicine, Department of Pediatrics",NA
"1727","34215677","10.1542/peds.2020-047795","Pediatric Telehealth in the COVID-19 Pandemic Era and Beyond.",NA,"2021","07","03","Pediatrics","Pediatrics",NA,"Herendeen","Neil","Golisano Children's Hospital, University of Rochester Medical Center",NA
"1728","34215677","10.1542/peds.2020-047795","Pediatric Telehealth in the COVID-19 Pandemic Era and Beyond.",NA,"2021","07","03","Pediatrics","Pediatrics",NA,"Chung","Sandy L","Trusted Doctors LLC",NA
"1729","34215677","10.1542/peds.2020-047795","Pediatric Telehealth in the COVID-19 Pandemic Era and Beyond.",NA,"2021","07","03","Pediatrics","Pediatrics",NA,"Rheuban","Karen","University of Virginia Health System Department of Pediatrics",NA
"1730","34215677","10.1542/peds.2020-047795","Pediatric Telehealth in the COVID-19 Pandemic Era and Beyond.",NA,"2021","07","03","Pediatrics","Pediatrics",NA,"Olson","Christina A","Children's Hospital Colorado",NA
"1731","34215666","10.1681/ASN.2021030387","Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.","Although reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rare among individuals with few coronavirus disease 2019 (COVID-19) risk factors, the ability of naturally acquired immunity to prevent reinfection among patients with ESKD is not known. This prospective study was conducted among adults with ESKD treated with in-center hemodialysis (ICHD) in the United States. Exposure was ascribed on the basis of the presence or absence of IgG against SARS-CoV-2 at baselin","2021","07","15","J Am Soc Nephrol","Journal of the American Society of Nephrology : JASN","COVID-19; hemodialysis; immunity","Cohen","Dena E","DaVita Clinical Research, Minneapolis, Minnesota",NA
"1732","34215666","10.1681/ASN.2021030387","Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.","Although reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rare among individuals with few coronavirus disease 2019 (COVID-19) risk factors, the ability of naturally acquired immunity to prevent reinfection among patients with ESKD is not known. This prospective study was conducted among adults with ESKD treated with in-center hemodialysis (ICHD) in the United States. Exposure was ascribed on the basis of the presence or absence of IgG against SARS-CoV-2 at baselin","2021","07","15","J Am Soc Nephrol","Journal of the American Society of Nephrology : JASN","COVID-19; hemodialysis; immunity","Sibbel","Scott","DaVita Clinical Research, Minneapolis, Minnesota",NA
"1733","34215666","10.1681/ASN.2021030387","Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.","Although reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rare among individuals with few coronavirus disease 2019 (COVID-19) risk factors, the ability of naturally acquired immunity to prevent reinfection among patients with ESKD is not known. This prospective study was conducted among adults with ESKD treated with in-center hemodialysis (ICHD) in the United States. Exposure was ascribed on the basis of the presence or absence of IgG against SARS-CoV-2 at baselin","2021","07","15","J Am Soc Nephrol","Journal of the American Society of Nephrology : JASN","COVID-19; hemodialysis; immunity","Marlowe","Gilbert","DaVita Clinical Research, Minneapolis, Minnesota",NA
"1734","34215666","10.1681/ASN.2021030387","Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.","Although reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rare among individuals with few coronavirus disease 2019 (COVID-19) risk factors, the ability of naturally acquired immunity to prevent reinfection among patients with ESKD is not known. This prospective study was conducted among adults with ESKD treated with in-center hemodialysis (ICHD) in the United States. Exposure was ascribed on the basis of the presence or absence of IgG against SARS-CoV-2 at baselin","2021","07","15","J Am Soc Nephrol","Journal of the American Society of Nephrology : JASN","COVID-19; hemodialysis; immunity","Bludorn","Kelsey","DaVita Clinical Research, Minneapolis, Minnesota",NA
"1735","34215666","10.1681/ASN.2021030387","Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.","Although reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rare among individuals with few coronavirus disease 2019 (COVID-19) risk factors, the ability of naturally acquired immunity to prevent reinfection among patients with ESKD is not known. This prospective study was conducted among adults with ESKD treated with in-center hemodialysis (ICHD) in the United States. Exposure was ascribed on the basis of the presence or absence of IgG against SARS-CoV-2 at baselin","2021","07","15","J Am Soc Nephrol","Journal of the American Society of Nephrology : JASN","COVID-19; hemodialysis; immunity","Miller","Dawn","DaVita Labs, DeLand, Florida",NA
"1736","34215666","10.1681/ASN.2021030387","Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.","Although reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rare among individuals with few coronavirus disease 2019 (COVID-19) risk factors, the ability of naturally acquired immunity to prevent reinfection among patients with ESKD is not known. This prospective study was conducted among adults with ESKD treated with in-center hemodialysis (ICHD) in the United States. Exposure was ascribed on the basis of the presence or absence of IgG against SARS-CoV-2 at baselin","2021","07","15","J Am Soc Nephrol","Journal of the American Society of Nephrology : JASN","COVID-19; hemodialysis; immunity","Kelley","Tara","DaVita Clinical Research, Minneapolis, Minnesota",NA
"1737","34215666","10.1681/ASN.2021030387","Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.","Although reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rare among individuals with few coronavirus disease 2019 (COVID-19) risk factors, the ability of naturally acquired immunity to prevent reinfection among patients with ESKD is not known. This prospective study was conducted among adults with ESKD treated with in-center hemodialysis (ICHD) in the United States. Exposure was ascribed on the basis of the presence or absence of IgG against SARS-CoV-2 at baselin","2021","07","15","J Am Soc Nephrol","Journal of the American Society of Nephrology : JASN","COVID-19; hemodialysis; immunity","Connaire","Jeffrey","DaVita Clinical Research, Minneapolis, Minnesota",NA
"1738","34215666","10.1681/ASN.2021030387","Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.","Although reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rare among individuals with few coronavirus disease 2019 (COVID-19) risk factors, the ability of naturally acquired immunity to prevent reinfection among patients with ESKD is not known. This prospective study was conducted among adults with ESKD treated with in-center hemodialysis (ICHD) in the United States. Exposure was ascribed on the basis of the presence or absence of IgG against SARS-CoV-2 at baselin","2021","07","15","J Am Soc Nephrol","Journal of the American Society of Nephrology : JASN","COVID-19; hemodialysis; immunity","Young","Amy","DaVita Clinical Research, Minneapolis, Minnesota",NA
"1739","34215666","10.1681/ASN.2021030387","Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.","Although reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rare among individuals with few coronavirus disease 2019 (COVID-19) risk factors, the ability of naturally acquired immunity to prevent reinfection among patients with ESKD is not known. This prospective study was conducted among adults with ESKD treated with in-center hemodialysis (ICHD) in the United States. Exposure was ascribed on the basis of the presence or absence of IgG against SARS-CoV-2 at baselin","2021","07","15","J Am Soc Nephrol","Journal of the American Society of Nephrology : JASN","COVID-19; hemodialysis; immunity","Tentori","Francesca","DaVita Clinical Research, Minneapolis, Minnesota",NA
"1740","34215666","10.1681/ASN.2021030387","Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.","Although reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rare among individuals with few coronavirus disease 2019 (COVID-19) risk factors, the ability of naturally acquired immunity to prevent reinfection among patients with ESKD is not known. This prospective study was conducted among adults with ESKD treated with in-center hemodialysis (ICHD) in the United States. Exposure was ascribed on the basis of the presence or absence of IgG against SARS-CoV-2 at baselin","2021","07","15","J Am Soc Nephrol","Journal of the American Society of Nephrology : JASN","COVID-19; hemodialysis; immunity","Brunelli","Steven M","DaVita Clinical Research, Minneapolis, Minnesota steven.brunelli@davita","steven.brunelli@davita.com"
"1741","34215647","10.1136/annrheumdis-2021-220959","Response to 'Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey'' by Montero <i>et al</i>.",NA,"2021","07","03","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; giant cell arteritis; systemic vasculitis; ultrasonography","Tomelleri","Alessandro","Unit of Immunology, Rheumatology, Allergy and Rare Diseases, San Raffaele Hospital, Milan, Italy",NA
"1742","34215647","10.1136/annrheumdis-2021-220959","Response to 'Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey'' by Montero <i>et al</i>.",NA,"2021","07","03","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; giant cell arteritis; systemic vasculitis; ultrasonography","Dagna","Lorenzo","Unit of Immunology, Rheumatology, Allergy and Rare Diseases, San Raffaele Hospital, Milan, Italy",NA
"1743","34215647","10.1136/annrheumdis-2021-220959","Response to 'Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey'' by Montero <i>et al</i>.",NA,"2021","07","03","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; giant cell arteritis; systemic vasculitis; ultrasonography","Campochiaro","Corrado","Unit of Immunology, Rheumatology, Allergy and Rare Diseases, San Raffaele Hospital, Milan, Italy campochiaro.corrado@hsr","campochiaro.corrado@hsr.it"
"1744","34215645","10.1136/annrheumdis-2021-220941","Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey'.",NA,"2021","07","03","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; giant cell arteritis; ultrasonography","Montero","Fernando","Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain",NA
"1745","34215645","10.1136/annrheumdis-2021-220941","Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey'.",NA,"2021","07","03","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; giant cell arteritis; ultrasonography","Castrejón","Isabel","Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain",NA
"1746","34215645","10.1136/annrheumdis-2021-220941","Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey'.",NA,"2021","07","03","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; giant cell arteritis; ultrasonography","Martínez-Barrio","Julia","Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain",NA
"1747","34215645","10.1136/annrheumdis-2021-220941","Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey'.",NA,"2021","07","03","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; giant cell arteritis; ultrasonography","Nieto-González","Juan Carlos","Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain",NA
"1748","34215645","10.1136/annrheumdis-2021-220941","Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey'.",NA,"2021","07","03","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; giant cell arteritis; ultrasonography","Rivera","Javier","Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain",NA
"1749","34215645","10.1136/annrheumdis-2021-220941","Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey'.",NA,"2021","07","03","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; giant cell arteritis; ultrasonography","Álvaro-Gracia","José María","Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain",NA
"1750","34215645","10.1136/annrheumdis-2021-220941","Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey'.",NA,"2021","07","03","Ann Rheum Dis","Annals of the rheumatic diseases","COVID-19; giant cell arteritis; ultrasonography","Molina Collada","Juan","Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain molinacolladajuan@gmail","molinacolladajuan@gmail.com"
"1751","34215642","10.1136/bcr-2021-244096","Rare case of gastrointestinal mucormycosis with colonic perforation in an immunocompetent patient with COVID-19.","Primary gastrointestinal mucormycosis is a rare disease associated with an increased mortality and is rarely reported in an immunocompetent host. We report the first case of mucormycosis-associated colonic perforation in a COVID-19 patient with a favourable outcome. A 48-year-old healthy male doctor in home isolation due to COVID-19 was admitted to COVID-19 intensive care unit when his symptoms deteriorated. The patient was put on non-invasive ventilation (NIV) using Bilevel Positive Airway Pres","2021","07","06","BMJ Case Rep","BMJ case reports","COVID-19; adult intensive care; general surgery; infection (gastroenterology); infections; Antifungal Agents; COVID-19; Gastrointestinal Diseases; Humans; Male; Middle Aged; Mucormycosis; SARS-CoV-2","Singh","Ravinder Pal","Department of Liver Transplant, Hepatobiliary and gastro intestinal surgery, Saroj Super Speciality Hospital, New Delhi, Delhi, India",NA
"1752","34215642","10.1136/bcr-2021-244096","Rare case of gastrointestinal mucormycosis with colonic perforation in an immunocompetent patient with COVID-19.","Primary gastrointestinal mucormycosis is a rare disease associated with an increased mortality and is rarely reported in an immunocompetent host. We report the first case of mucormycosis-associated colonic perforation in a COVID-19 patient with a favourable outcome. A 48-year-old healthy male doctor in home isolation due to COVID-19 was admitted to COVID-19 intensive care unit when his symptoms deteriorated. The patient was put on non-invasive ventilation (NIV) using Bilevel Positive Airway Pres","2021","07","06","BMJ Case Rep","BMJ case reports","COVID-19; adult intensive care; general surgery; infection (gastroenterology); infections; Antifungal Agents; COVID-19; Gastrointestinal Diseases; Humans; Male; Middle Aged; Mucormycosis; SARS-CoV-2","Gupta","Nishkarsh","Department of Onco-Anesthesiology and Palliative Medicine, DRBRAIRCH, AIIMS, New Delhi, Delhi, India",NA
"1753","34215642","10.1136/bcr-2021-244096","Rare case of gastrointestinal mucormycosis with colonic perforation in an immunocompetent patient with COVID-19.","Primary gastrointestinal mucormycosis is a rare disease associated with an increased mortality and is rarely reported in an immunocompetent host. We report the first case of mucormycosis-associated colonic perforation in a COVID-19 patient with a favourable outcome. A 48-year-old healthy male doctor in home isolation due to COVID-19 was admitted to COVID-19 intensive care unit when his symptoms deteriorated. The patient was put on non-invasive ventilation (NIV) using Bilevel Positive Airway Pres","2021","07","06","BMJ Case Rep","BMJ case reports","COVID-19; adult intensive care; general surgery; infection (gastroenterology); infections; Antifungal Agents; COVID-19; Gastrointestinal Diseases; Humans; Male; Middle Aged; Mucormycosis; SARS-CoV-2","Kaur","Tanudeep","Department of Urogynaeoncology, Saroj Hospital and Heart Institute, New Delhi, Delhi, India",NA
"1754","34215642","10.1136/bcr-2021-244096","Rare case of gastrointestinal mucormycosis with colonic perforation in an immunocompetent patient with COVID-19.","Primary gastrointestinal mucormycosis is a rare disease associated with an increased mortality and is rarely reported in an immunocompetent host. We report the first case of mucormycosis-associated colonic perforation in a COVID-19 patient with a favourable outcome. A 48-year-old healthy male doctor in home isolation due to COVID-19 was admitted to COVID-19 intensive care unit when his symptoms deteriorated. The patient was put on non-invasive ventilation (NIV) using Bilevel Positive Airway Pres","2021","07","06","BMJ Case Rep","BMJ case reports","COVID-19; adult intensive care; general surgery; infection (gastroenterology); infections; Antifungal Agents; COVID-19; Gastrointestinal Diseases; Humans; Male; Middle Aged; Mucormycosis; SARS-CoV-2","Gupta","Anju","Department of Anesthesiology, Pain Medicine and Critical care, AIIMS, New Delhi, Delhi, India dranjugupta2009@rediffmail","dranjugupta2009@rediffmail.com"
"1755","34215639","10.1136/bcr-2021-242101","Avascular necrosis as a part of 'long COVID-19'.","'Long COVID-19' can affect different body systems. At present, avascular necrosis (AVN) as a sequalae of 'long COVID-19' has yet not been documented. By large-scale use of life-saving corticosteroids in COVID-19 cases, we anticipate that there will be a resurgence of AVN cases. We report a series of three cases in which patients developed AVN of the femoral head after being treated for COVID-19 infection. The mean dose of prednisolone used in these cases was 758 mg (400-1250 mg), which is less t","2021","07","06","BMJ Case Rep","BMJ case reports","COVID-19; drugs: musculoskeletal and joint diseases; groin pain; musculoskeletal and joint disorders; unwanted effects/adverse reactions; COVID-19; COVID-19 Testing; Femur Head Necrosis; Humans; SARS-CoV-2","Agarwala","Sanjay R","Orthopaedics, PD Hinduja National Hospital, Mumbai, Maharashtra, India drsa2011@gmail","drsa2011@gmail.com"
"1756","34215639","10.1136/bcr-2021-242101","Avascular necrosis as a part of 'long COVID-19'.","'Long COVID-19' can affect different body systems. At present, avascular necrosis (AVN) as a sequalae of 'long COVID-19' has yet not been documented. By large-scale use of life-saving corticosteroids in COVID-19 cases, we anticipate that there will be a resurgence of AVN cases. We report a series of three cases in which patients developed AVN of the femoral head after being treated for COVID-19 infection. The mean dose of prednisolone used in these cases was 758 mg (400-1250 mg), which is less t","2021","07","06","BMJ Case Rep","BMJ case reports","COVID-19; drugs: musculoskeletal and joint diseases; groin pain; musculoskeletal and joint disorders; unwanted effects/adverse reactions; COVID-19; COVID-19 Testing; Femur Head Necrosis; Humans; SARS-CoV-2","Vijayvargiya","Mayank","Orthopaedics, PD Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India",NA
"1757","34215639","10.1136/bcr-2021-242101","Avascular necrosis as a part of 'long COVID-19'.","'Long COVID-19' can affect different body systems. At present, avascular necrosis (AVN) as a sequalae of 'long COVID-19' has yet not been documented. By large-scale use of life-saving corticosteroids in COVID-19 cases, we anticipate that there will be a resurgence of AVN cases. We report a series of three cases in which patients developed AVN of the femoral head after being treated for COVID-19 infection. The mean dose of prednisolone used in these cases was 758 mg (400-1250 mg), which is less t","2021","07","06","BMJ Case Rep","BMJ case reports","COVID-19; drugs: musculoskeletal and joint diseases; groin pain; musculoskeletal and joint disorders; unwanted effects/adverse reactions; COVID-19; COVID-19 Testing; Femur Head Necrosis; Humans; SARS-CoV-2","Pandey","Prashant","Orthopaedics, PD Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India",NA
"1758","34215627","10.1136/bmj.n1668","Recognising the value of ""shared pain""-mandatory covid-19 vaccination should include all NHS workers.",NA,"2021","07","15","BMJ","BMJ (Clinical research ed.)","COVID-19; COVID-19 Vaccines; Health Personnel; Humans; Mandatory Programs; State Medicine; United Kingdom","Green","Stephen T","Sheffield Hallam University, Sheffield, UK",NA
"1759","34215626","10.1136/bmj.n1685","Covid-19: Long covid cases are underreported in GP records, research suggests.",NA,"2021","07","06","BMJ","BMJ (Clinical research ed.)",NA,"Wise","Jacqui",NA,NA
"1760","34215614","10.1136/bmjopen-2021-051278","Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain: a protocol for an observational study.","Cough is a common symptom of COVID-19 and other respiratory illnesses. However, objectively measuring its frequency and evolution is hindered by the lack of reliable and scalable monitoring systems. This can be overcome by newly developed artificial intelligence models that exploit the portability of smartphones. In the context of the ongoing COVID-19 pandemic, cough detection for respiratory disease syndromic surveillance represents a simple means for early outbreak detection and disease survei","2021","07","08","BMJ Open","BMJ open","COVID-19; epidemiology; respiratory infections; Acoustics; Artificial Intelligence; COVID-19; Canada; Disease Outbreaks; Humans; Observational Studies as Topic; Pandemics; SARS-CoV-2; Spain","Gabaldon-Figueira","Juan Carlos","Infectious Diseases Area, University of Navarra Clinic, Pamplona, Spain jgabaldonfi@unav","jgabaldonfi@unav.es"
"1761","34215614","10.1136/bmjopen-2021-051278","Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain: a protocol for an observational study.","Cough is a common symptom of COVID-19 and other respiratory illnesses. However, objectively measuring its frequency and evolution is hindered by the lack of reliable and scalable monitoring systems. This can be overcome by newly developed artificial intelligence models that exploit the portability of smartphones. In the context of the ongoing COVID-19 pandemic, cough detection for respiratory disease syndromic surveillance represents a simple means for early outbreak detection and disease survei","2021","07","08","BMJ Open","BMJ open","COVID-19; epidemiology; respiratory infections; Acoustics; Artificial Intelligence; COVID-19; Canada; Disease Outbreaks; Humans; Observational Studies as Topic; Pandemics; SARS-CoV-2; Spain","Brew","Joe","Research and Development Department, Hyfe, Wilmington, Delaware, USA",NA
"1762","34215614","10.1136/bmjopen-2021-051278","Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain: a protocol for an observational study.","Cough is a common symptom of COVID-19 and other respiratory illnesses. However, objectively measuring its frequency and evolution is hindered by the lack of reliable and scalable monitoring systems. This can be overcome by newly developed artificial intelligence models that exploit the portability of smartphones. In the context of the ongoing COVID-19 pandemic, cough detection for respiratory disease syndromic surveillance represents a simple means for early outbreak detection and disease survei","2021","07","08","BMJ Open","BMJ open","COVID-19; epidemiology; respiratory infections; Acoustics; Artificial Intelligence; COVID-19; Canada; Disease Outbreaks; Humans; Observational Studies as Topic; Pandemics; SARS-CoV-2; Spain","Doré","Dominique Hélène","Immunopathology Axis, Research Center of the University of Montreal Hospital Center, Montréal, Québec, Canada",NA
"1763","34215614","10.1136/bmjopen-2021-051278","Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain: a protocol for an observational study.","Cough is a common symptom of COVID-19 and other respiratory illnesses. However, objectively measuring its frequency and evolution is hindered by the lack of reliable and scalable monitoring systems. This can be overcome by newly developed artificial intelligence models that exploit the portability of smartphones. In the context of the ongoing COVID-19 pandemic, cough detection for respiratory disease syndromic surveillance represents a simple means for early outbreak detection and disease survei","2021","07","08","BMJ Open","BMJ open","COVID-19; epidemiology; respiratory infections; Acoustics; Artificial Intelligence; COVID-19; Canada; Disease Outbreaks; Humans; Observational Studies as Topic; Pandemics; SARS-CoV-2; Spain","Umashankar","Nita","Fowler College of Business, San Diego State University, San Diego, California, USA",NA
"1764","34215614","10.1136/bmjopen-2021-051278","Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain: a protocol for an observational study.","Cough is a common symptom of COVID-19 and other respiratory illnesses. However, objectively measuring its frequency and evolution is hindered by the lack of reliable and scalable monitoring systems. This can be overcome by newly developed artificial intelligence models that exploit the portability of smartphones. In the context of the ongoing COVID-19 pandemic, cough detection for respiratory disease syndromic surveillance represents a simple means for early outbreak detection and disease survei","2021","07","08","BMJ Open","BMJ open","COVID-19; epidemiology; respiratory infections; Acoustics; Artificial Intelligence; COVID-19; Canada; Disease Outbreaks; Humans; Observational Studies as Topic; Pandemics; SARS-CoV-2; Spain","Chaccour","Juliane","Infectious Diseases Area, University of Navarra Clinic, Pamplona, Spain",NA
"1765","34215614","10.1136/bmjopen-2021-051278","Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain: a protocol for an observational study.","Cough is a common symptom of COVID-19 and other respiratory illnesses. However, objectively measuring its frequency and evolution is hindered by the lack of reliable and scalable monitoring systems. This can be overcome by newly developed artificial intelligence models that exploit the portability of smartphones. In the context of the ongoing COVID-19 pandemic, cough detection for respiratory disease syndromic surveillance represents a simple means for early outbreak detection and disease survei","2021","07","08","BMJ Open","BMJ open","COVID-19; epidemiology; respiratory infections; Acoustics; Artificial Intelligence; COVID-19; Canada; Disease Outbreaks; Humans; Observational Studies as Topic; Pandemics; SARS-CoV-2; Spain","Orrillo","Virginia","School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain",NA
"1766","34215614","10.1136/bmjopen-2021-051278","Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain: a protocol for an observational study.","Cough is a common symptom of COVID-19 and other respiratory illnesses. However, objectively measuring its frequency and evolution is hindered by the lack of reliable and scalable monitoring systems. This can be overcome by newly developed artificial intelligence models that exploit the portability of smartphones. In the context of the ongoing COVID-19 pandemic, cough detection for respiratory disease syndromic surveillance represents a simple means for early outbreak detection and disease survei","2021","07","08","BMJ Open","BMJ open","COVID-19; epidemiology; respiratory infections; Acoustics; Artificial Intelligence; COVID-19; Canada; Disease Outbreaks; Humans; Observational Studies as Topic; Pandemics; SARS-CoV-2; Spain","Tsang","Lai Yu","Global Health Institute, Stony Brook University, Stony Brook, New York, USA",NA
"1767","34215614","10.1136/bmjopen-2021-051278","Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain: a protocol for an observational study.","Cough is a common symptom of COVID-19 and other respiratory illnesses. However, objectively measuring its frequency and evolution is hindered by the lack of reliable and scalable monitoring systems. This can be overcome by newly developed artificial intelligence models that exploit the portability of smartphones. In the context of the ongoing COVID-19 pandemic, cough detection for respiratory disease syndromic surveillance represents a simple means for early outbreak detection and disease survei","2021","07","08","BMJ Open","BMJ open","COVID-19; epidemiology; respiratory infections; Acoustics; Artificial Intelligence; COVID-19; Canada; Disease Outbreaks; Humans; Observational Studies as Topic; Pandemics; SARS-CoV-2; Spain","Blavia","Isabel","School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain",NA
"1768","34215614","10.1136/bmjopen-2021-051278","Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain: a protocol for an observational study.","Cough is a common symptom of COVID-19 and other respiratory illnesses. However, objectively measuring its frequency and evolution is hindered by the lack of reliable and scalable monitoring systems. This can be overcome by newly developed artificial intelligence models that exploit the portability of smartphones. In the context of the ongoing COVID-19 pandemic, cough detection for respiratory disease syndromic surveillance represents a simple means for early outbreak detection and disease survei","2021","07","08","BMJ Open","BMJ open","COVID-19; epidemiology; respiratory infections; Acoustics; Artificial Intelligence; COVID-19; Canada; Disease Outbreaks; Humans; Observational Studies as Topic; Pandemics; SARS-CoV-2; Spain","Fernández-Montero","Alejandro","Department of Occupational Medicine - COVID-19 area, University of Navarra Clinic, Pamplona, Spain",NA
"1769","34215614","10.1136/bmjopen-2021-051278","Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain: a protocol for an observational study.","Cough is a common symptom of COVID-19 and other respiratory illnesses. However, objectively measuring its frequency and evolution is hindered by the lack of reliable and scalable monitoring systems. This can be overcome by newly developed artificial intelligence models that exploit the portability of smartphones. In the context of the ongoing COVID-19 pandemic, cough detection for respiratory disease syndromic surveillance represents a simple means for early outbreak detection and disease survei","2021","07","08","BMJ Open","BMJ open","COVID-19; epidemiology; respiratory infections; Acoustics; Artificial Intelligence; COVID-19; Canada; Disease Outbreaks; Humans; Observational Studies as Topic; Pandemics; SARS-CoV-2; Spain","Bartolomé","Javier","Primary Healthcare, Navarre Health Service-Osasunbidea, Zizur Mayor, Spain",NA
"1770","34215614","10.1136/bmjopen-2021-051278","Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain: a protocol for an observational study.","Cough is a common symptom of COVID-19 and other respiratory illnesses. However, objectively measuring its frequency and evolution is hindered by the lack of reliable and scalable monitoring systems. This can be overcome by newly developed artificial intelligence models that exploit the portability of smartphones. In the context of the ongoing COVID-19 pandemic, cough detection for respiratory disease syndromic surveillance represents a simple means for early outbreak detection and disease survei","2021","07","08","BMJ Open","BMJ open","COVID-19; epidemiology; respiratory infections; Acoustics; Artificial Intelligence; COVID-19; Canada; Disease Outbreaks; Humans; Observational Studies as Topic; Pandemics; SARS-CoV-2; Spain","Grandjean Lapierre","Simon","Immunopathology Axis, Research Center of the University of Montreal Hospital Center, Montréal, Québec, Canada",NA
"1771","34215614","10.1136/bmjopen-2021-051278","Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain: a protocol for an observational study.","Cough is a common symptom of COVID-19 and other respiratory illnesses. However, objectively measuring its frequency and evolution is hindered by the lack of reliable and scalable monitoring systems. This can be overcome by newly developed artificial intelligence models that exploit the portability of smartphones. In the context of the ongoing COVID-19 pandemic, cough detection for respiratory disease syndromic surveillance represents a simple means for early outbreak detection and disease survei","2021","07","08","BMJ Open","BMJ open","COVID-19; epidemiology; respiratory infections; Acoustics; Artificial Intelligence; COVID-19; Canada; Disease Outbreaks; Humans; Observational Studies as Topic; Pandemics; SARS-CoV-2; Spain","Chaccour","C","Infectious Diseases Area, University of Navarra Clinic, Pamplona, Spain",NA
"1772","34215611","10.1136/bmjopen-2021-048874","India's pragmatic vaccination strategy against COVID-19: a mathematical modelling-based analysis.","To investigate the impact of targeted vaccination strategies on morbidity and mortality due to COVID-19, as well as on the incidence of SARS-CoV-2, in India. Mathematical modelling. Indian epidemic of COVID-19 and vulnerable population. Country-specific and age-segregated pattern of social contact, case fatality rate and demographic data obtained from peer-reviewed literature and public domain. An age-structured dynamical model describing SARS-CoV-2 transmission in India incorporating uncertaint","2021","07","08","BMJ Open","BMJ open","COVID-19; epidemiology; health policy; public health; Adult; COVID-19; Humans; India; Middle Aged; Models, Theoretical; SARS-CoV-2; Vaccination; Young Adult","Mandal","Sandip","Division of Epidemiology and Communicable Diseases (Clinical Studies, Projection &amp",NA
"1773","34215611","10.1136/bmjopen-2021-048874","India's pragmatic vaccination strategy against COVID-19: a mathematical modelling-based analysis.","To investigate the impact of targeted vaccination strategies on morbidity and mortality due to COVID-19, as well as on the incidence of SARS-CoV-2, in India. Mathematical modelling. Indian epidemic of COVID-19 and vulnerable population. Country-specific and age-segregated pattern of social contact, case fatality rate and demographic data obtained from peer-reviewed literature and public domain. An age-structured dynamical model describing SARS-CoV-2 transmission in India incorporating uncertaint","2021","07","08","BMJ Open","BMJ open","COVID-19; epidemiology; health policy; public health; Adult; COVID-19; Humans; India; Middle Aged; Models, Theoretical; SARS-CoV-2; Vaccination; Young Adult","Arinaminpathy","Nimalan","MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK",NA
"1774","34215611","10.1136/bmjopen-2021-048874","India's pragmatic vaccination strategy against COVID-19: a mathematical modelling-based analysis.","To investigate the impact of targeted vaccination strategies on morbidity and mortality due to COVID-19, as well as on the incidence of SARS-CoV-2, in India. Mathematical modelling. Indian epidemic of COVID-19 and vulnerable population. Country-specific and age-segregated pattern of social contact, case fatality rate and demographic data obtained from peer-reviewed literature and public domain. An age-structured dynamical model describing SARS-CoV-2 transmission in India incorporating uncertaint","2021","07","08","BMJ Open","BMJ open","COVID-19; epidemiology; health policy; public health; Adult; COVID-19; Humans; India; Middle Aged; Models, Theoretical; SARS-CoV-2; Vaccination; Young Adult","Bhargava","Balram","Indian Council of Medical Research, New Delhi, India",NA
"1775","34215611","10.1136/bmjopen-2021-048874","India's pragmatic vaccination strategy against COVID-19: a mathematical modelling-based analysis.","To investigate the impact of targeted vaccination strategies on morbidity and mortality due to COVID-19, as well as on the incidence of SARS-CoV-2, in India. Mathematical modelling. Indian epidemic of COVID-19 and vulnerable population. Country-specific and age-segregated pattern of social contact, case fatality rate and demographic data obtained from peer-reviewed literature and public domain. An age-structured dynamical model describing SARS-CoV-2 transmission in India incorporating uncertaint","2021","07","08","BMJ Open","BMJ open","COVID-19; epidemiology; health policy; public health; Adult; COVID-19; Humans; India; Middle Aged; Models, Theoretical; SARS-CoV-2; Vaccination; Young Adult","Panda","Samiran","Division of Epidemiology and Communicable Diseases (Clinical Studies, Projection &amp","pandasamiran@gmail.com"
"1776","34215593","10.1136/bmj.n1686","Covid-19: Millions could be offered booster vaccinations from September.",NA,"2021","07","06","BMJ","BMJ (Clinical research ed.)",NA,"Griffin","Shaun","London, UK",NA
"1777","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"An","Dong","Department of Infectious Diseases, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA",NA
"1778","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"Li","Kun","Department of Pediatrics, University of Iowa, Iowa City, IA 52242, USA",NA
"1779","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"Rowe","Dawne K","Department of Infectious Diseases, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA",NA
"1780","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"Diaz","Maria Cristina Huertas","Department of Infectious Diseases, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA",NA
"1781","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"Griffin","Emily F","Department of Infectious Diseases, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA",NA
"1782","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"Beavis","Ashley C","Department of Infectious Diseases, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA",NA
"1783","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"Johnson","Scott K","Center for Vaccines and Immunology, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA",NA
"1784","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"Padykula","Ian","Department of Infectious Diseases, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA",NA
"1785","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"Jones","Cheryl A","Center for Vaccines and Immunology, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA",NA
"1786","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"Briggs","Kelsey","Department of Infectious Diseases, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA",NA
"1787","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"Li","Geng","Department of Infectious Diseases, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA",NA
"1788","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"Lin","Yuan","Department of Infectious Diseases, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA",NA
"1789","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"Huang","Jiachen","Department of Infectious Diseases, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA",NA
"1790","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"Mousa","Jarrod","Department of Infectious Diseases, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA",NA
"1791","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"Brindley","Melinda","Department of Infectious Diseases, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA",NA
"1792","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"Sakamoto","Kaori","Department of Pathology, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA",NA
"1793","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"Meyerholz","David K","Department of Pathology, University of Iowa, Iowa City, IA 52242, USA",NA
"1794","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"McCray","Paul B","Department of Pediatrics, University of Iowa, Iowa City, IA 52242, USA. paul-mccray@uiowa.edu smt@uga.edu bhe@uga","mccray@uiowa.edu"
"1795","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"Tompkins","S Mark","Department of Infectious Diseases, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA. paul-mccray@uiowa.edu smt@uga.edu bhe@uga","mccray@uiowa.edu"
"1796","34215591","10.1126/sciadv.abi5246","Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.","Transmission-blocking vaccines are urgently needed to reduce transmission of SARS-CoV 2, the cause of the COVID-19 pandemic. The upper respiratory tract is an initial site of SARS-CoV-2 infection and, for many individuals, remains the primary site of virus replication. An ideal COVID-19 vaccine should reduce upper respiratory tract virus replication and block transmission as well as protect against severe disease. Here, we optimized a vaccine candidate, parainfluenza virus 5 (PIV5) expressing th","2021","07","06","Sci Adv","Science advances",NA,"He","Biao","Department of Infectious Diseases, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA. paul-mccray@uiowa.edu smt@uga.edu bhe@uga","mccray@uiowa.edu"
"1797","34215570","10.1136/bmjgast-2021-000670","Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands.","COVID-19 has put a strain on regular healthcare worldwide. For inflammatory bowel disease (IBD), gastrointestinal surgeries were postponed and changes in treatment and diagnostic procedures were made. As abrupt changes in treatment regimens may result in an increased morbidity and consequent well-being of patients with IBD, the aim of this study was to determine the effect of the COVID-19 pandemic on health-related quality of life (HRQoL) in patients with IBD. All patients with IBD who completed","2021","07","12","BMJ Open Gastroenterol","BMJ open gastroenterology","COVID-19; inflammatory bowel disease; quality of life; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Netherlands; Pandemics; Patient Health Questionnaire; Quality of Life; SARS-CoV-2; Sex Factors; Time-to-Treatment; Young Adult","de Bock","Ellen","Surgery, UMC Utrecht, Utrecht, The Netherlands",NA
"1798","34215570","10.1136/bmjgast-2021-000670","Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands.","COVID-19 has put a strain on regular healthcare worldwide. For inflammatory bowel disease (IBD), gastrointestinal surgeries were postponed and changes in treatment and diagnostic procedures were made. As abrupt changes in treatment regimens may result in an increased morbidity and consequent well-being of patients with IBD, the aim of this study was to determine the effect of the COVID-19 pandemic on health-related quality of life (HRQoL) in patients with IBD. All patients with IBD who completed","2021","07","12","BMJ Open Gastroenterol","BMJ open gastroenterology","COVID-19; inflammatory bowel disease; quality of life; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Netherlands; Pandemics; Patient Health Questionnaire; Quality of Life; SARS-CoV-2; Sex Factors; Time-to-Treatment; Young Adult","Filipe","Mando D","Surgery, UMC Utrecht, Utrecht, The Netherlands",NA
"1799","34215570","10.1136/bmjgast-2021-000670","Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands.","COVID-19 has put a strain on regular healthcare worldwide. For inflammatory bowel disease (IBD), gastrointestinal surgeries were postponed and changes in treatment and diagnostic procedures were made. As abrupt changes in treatment regimens may result in an increased morbidity and consequent well-being of patients with IBD, the aim of this study was to determine the effect of the COVID-19 pandemic on health-related quality of life (HRQoL) in patients with IBD. All patients with IBD who completed","2021","07","12","BMJ Open Gastroenterol","BMJ open gastroenterology","COVID-19; inflammatory bowel disease; quality of life; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Netherlands; Pandemics; Patient Health Questionnaire; Quality of Life; SARS-CoV-2; Sex Factors; Time-to-Treatment; Young Adult","Meij","Vincent","Surgery, UMC Utrecht, Utrecht, The Netherlands",NA
"1800","34215570","10.1136/bmjgast-2021-000670","Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands.","COVID-19 has put a strain on regular healthcare worldwide. For inflammatory bowel disease (IBD), gastrointestinal surgeries were postponed and changes in treatment and diagnostic procedures were made. As abrupt changes in treatment regimens may result in an increased morbidity and consequent well-being of patients with IBD, the aim of this study was to determine the effect of the COVID-19 pandemic on health-related quality of life (HRQoL) in patients with IBD. All patients with IBD who completed","2021","07","12","BMJ Open Gastroenterol","BMJ open gastroenterology","COVID-19; inflammatory bowel disease; quality of life; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Netherlands; Pandemics; Patient Health Questionnaire; Quality of Life; SARS-CoV-2; Sex Factors; Time-to-Treatment; Young Adult","Oldenburg","Bas","Gastroenterology and Hepatology, UMC Utrecht, Utrecht, The Netherlands",NA
"1801","34215570","10.1136/bmjgast-2021-000670","Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands.","COVID-19 has put a strain on regular healthcare worldwide. For inflammatory bowel disease (IBD), gastrointestinal surgeries were postponed and changes in treatment and diagnostic procedures were made. As abrupt changes in treatment regimens may result in an increased morbidity and consequent well-being of patients with IBD, the aim of this study was to determine the effect of the COVID-19 pandemic on health-related quality of life (HRQoL) in patients with IBD. All patients with IBD who completed","2021","07","12","BMJ Open Gastroenterol","BMJ open gastroenterology","COVID-19; inflammatory bowel disease; quality of life; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Netherlands; Pandemics; Patient Health Questionnaire; Quality of Life; SARS-CoV-2; Sex Factors; Time-to-Treatment; Young Adult","van Schaik","Fiona D M","Gastroenterology and Hepatology, UMC Utrecht, Utrecht, The Netherlands",NA
"1802","34215570","10.1136/bmjgast-2021-000670","Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands.","COVID-19 has put a strain on regular healthcare worldwide. For inflammatory bowel disease (IBD), gastrointestinal surgeries were postponed and changes in treatment and diagnostic procedures were made. As abrupt changes in treatment regimens may result in an increased morbidity and consequent well-being of patients with IBD, the aim of this study was to determine the effect of the COVID-19 pandemic on health-related quality of life (HRQoL) in patients with IBD. All patients with IBD who completed","2021","07","12","BMJ Open Gastroenterol","BMJ open gastroenterology","COVID-19; inflammatory bowel disease; quality of life; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Netherlands; Pandemics; Patient Health Questionnaire; Quality of Life; SARS-CoV-2; Sex Factors; Time-to-Treatment; Young Adult","Bastian","Okan W","Surgery, UMC Utrecht, Utrecht, The Netherlands",NA
"1803","34215570","10.1136/bmjgast-2021-000670","Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands.","COVID-19 has put a strain on regular healthcare worldwide. For inflammatory bowel disease (IBD), gastrointestinal surgeries were postponed and changes in treatment and diagnostic procedures were made. As abrupt changes in treatment regimens may result in an increased morbidity and consequent well-being of patients with IBD, the aim of this study was to determine the effect of the COVID-19 pandemic on health-related quality of life (HRQoL) in patients with IBD. All patients with IBD who completed","2021","07","12","BMJ Open Gastroenterol","BMJ open gastroenterology","COVID-19; inflammatory bowel disease; quality of life; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Netherlands; Pandemics; Patient Health Questionnaire; Quality of Life; SARS-CoV-2; Sex Factors; Time-to-Treatment; Young Adult","Fidder","Herma F","Gastroenterology and Hepatology, UMC Utrecht, Utrecht, The Netherlands",NA
"1804","34215570","10.1136/bmjgast-2021-000670","Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands.","COVID-19 has put a strain on regular healthcare worldwide. For inflammatory bowel disease (IBD), gastrointestinal surgeries were postponed and changes in treatment and diagnostic procedures were made. As abrupt changes in treatment regimens may result in an increased morbidity and consequent well-being of patients with IBD, the aim of this study was to determine the effect of the COVID-19 pandemic on health-related quality of life (HRQoL) in patients with IBD. All patients with IBD who completed","2021","07","12","BMJ Open Gastroenterol","BMJ open gastroenterology","COVID-19; inflammatory bowel disease; quality of life; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Netherlands; Pandemics; Patient Health Questionnaire; Quality of Life; SARS-CoV-2; Sex Factors; Time-to-Treatment; Young Adult","Vriens","Menno R","Surgery, UMC Utrecht, Utrecht, The Netherlands",NA
"1805","34215570","10.1136/bmjgast-2021-000670","Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands.","COVID-19 has put a strain on regular healthcare worldwide. For inflammatory bowel disease (IBD), gastrointestinal surgeries were postponed and changes in treatment and diagnostic procedures were made. As abrupt changes in treatment regimens may result in an increased morbidity and consequent well-being of patients with IBD, the aim of this study was to determine the effect of the COVID-19 pandemic on health-related quality of life (HRQoL) in patients with IBD. All patients with IBD who completed","2021","07","12","BMJ Open Gastroenterol","BMJ open gastroenterology","COVID-19; inflammatory bowel disease; quality of life; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; COVID-19; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Netherlands; Pandemics; Patient Health Questionnaire; Quality of Life; SARS-CoV-2; Sex Factors; Time-to-Treatment; Young Adult","Richir","Milan C","Surgery, UMC Utrecht, Utrecht, The Netherlands m.richir@vumc","m.richir@vumc.nl"
"1806","34215561","10.1016/j.jiph.2021.06.012","Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study.","The characteristics, outcomes, and risk factors for in-hospital death of critically ill intensive care unit (ICU) patients with coronavirus disease-2019 (COVID-19) have been described in patients from Europe, North America and China, but there are few data from COVID-19 patients in Middle Eastern countries. The aim of this study was to investigate the characteristics, outcomes, and risk factors for in-hospital death of critically ill patients with COVID-19 pneumonia admitted to the ICUs of a Uni","2021","07","05","J Infect Public Health","Journal of infection and public health","COVID-19; Hospital mortality; Intensive care unit; Ischemic heart disease; SARS-CoV-2","Nassar","Yasser","Critical Care Department, Cairo University Hospitals, Kasr-Al-Aini-Street, 11562, Cairo, Egypt",NA
"1807","34215561","10.1016/j.jiph.2021.06.012","Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study.","The characteristics, outcomes, and risk factors for in-hospital death of critically ill intensive care unit (ICU) patients with coronavirus disease-2019 (COVID-19) have been described in patients from Europe, North America and China, but there are few data from COVID-19 patients in Middle Eastern countries. The aim of this study was to investigate the characteristics, outcomes, and risk factors for in-hospital death of critically ill patients with COVID-19 pneumonia admitted to the ICUs of a Uni","2021","07","05","J Infect Public Health","Journal of infection and public health","COVID-19; Hospital mortality; Intensive care unit; Ischemic heart disease; SARS-CoV-2","Mokhtar","Ahmed","Department of Anesthesiology, Cairo University Hospitals, Kasr-Al-Aini-Street, 11562, Cairo, Egypt",NA
"1808","34215561","10.1016/j.jiph.2021.06.012","Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study.","The characteristics, outcomes, and risk factors for in-hospital death of critically ill intensive care unit (ICU) patients with coronavirus disease-2019 (COVID-19) have been described in patients from Europe, North America and China, but there are few data from COVID-19 patients in Middle Eastern countries. The aim of this study was to investigate the characteristics, outcomes, and risk factors for in-hospital death of critically ill patients with COVID-19 pneumonia admitted to the ICUs of a Uni","2021","07","05","J Infect Public Health","Journal of infection and public health","COVID-19; Hospital mortality; Intensive care unit; Ischemic heart disease; SARS-CoV-2","Elhadidy","Amr","Critical Care Department, Cairo University Hospitals, Kasr-Al-Aini-Street, 11562, Cairo, Egypt",NA
"1809","34215561","10.1016/j.jiph.2021.06.012","Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study.","The characteristics, outcomes, and risk factors for in-hospital death of critically ill intensive care unit (ICU) patients with coronavirus disease-2019 (COVID-19) have been described in patients from Europe, North America and China, but there are few data from COVID-19 patients in Middle Eastern countries. The aim of this study was to investigate the characteristics, outcomes, and risk factors for in-hospital death of critically ill patients with COVID-19 pneumonia admitted to the ICUs of a Uni","2021","07","05","J Infect Public Health","Journal of infection and public health","COVID-19; Hospital mortality; Intensive care unit; Ischemic heart disease; SARS-CoV-2","Elsayed","Marwa","Critical Care Department, Cairo University Hospitals, Kasr-Al-Aini-Street, 11562, Cairo, Egypt",NA
"1810","34215561","10.1016/j.jiph.2021.06.012","Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study.","The characteristics, outcomes, and risk factors for in-hospital death of critically ill intensive care unit (ICU) patients with coronavirus disease-2019 (COVID-19) have been described in patients from Europe, North America and China, but there are few data from COVID-19 patients in Middle Eastern countries. The aim of this study was to investigate the characteristics, outcomes, and risk factors for in-hospital death of critically ill patients with COVID-19 pneumonia admitted to the ICUs of a Uni","2021","07","05","J Infect Public Health","Journal of infection and public health","COVID-19; Hospital mortality; Intensive care unit; Ischemic heart disease; SARS-CoV-2","Mostafa","Farouk","Critical Care Department, Cairo University Hospitals, Kasr-Al-Aini-Street, 11562, Cairo, Egypt",NA
"1811","34215561","10.1016/j.jiph.2021.06.012","Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study.","The characteristics, outcomes, and risk factors for in-hospital death of critically ill intensive care unit (ICU) patients with coronavirus disease-2019 (COVID-19) have been described in patients from Europe, North America and China, but there are few data from COVID-19 patients in Middle Eastern countries. The aim of this study was to investigate the characteristics, outcomes, and risk factors for in-hospital death of critically ill patients with COVID-19 pneumonia admitted to the ICUs of a Uni","2021","07","05","J Infect Public Health","Journal of infection and public health","COVID-19; Hospital mortality; Intensive care unit; Ischemic heart disease; SARS-CoV-2","Rady","Ashraf","Department of Anesthesiology, Cairo University Hospitals, Kasr-Al-Aini-Street, 11562, Cairo, Egypt",NA
"1812","34215561","10.1016/j.jiph.2021.06.012","Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study.","The characteristics, outcomes, and risk factors for in-hospital death of critically ill intensive care unit (ICU) patients with coronavirus disease-2019 (COVID-19) have been described in patients from Europe, North America and China, but there are few data from COVID-19 patients in Middle Eastern countries. The aim of this study was to investigate the characteristics, outcomes, and risk factors for in-hospital death of critically ill patients with COVID-19 pneumonia admitted to the ICUs of a Uni","2021","07","05","J Infect Public Health","Journal of infection and public health","COVID-19; Hospital mortality; Intensive care unit; Ischemic heart disease; SARS-CoV-2","Eladawy","Akram","Department of Anesthesiology, Cairo University Hospitals, Kasr-Al-Aini-Street, 11562, Cairo, Egypt",NA
"1813","34215561","10.1016/j.jiph.2021.06.012","Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study.","The characteristics, outcomes, and risk factors for in-hospital death of critically ill intensive care unit (ICU) patients with coronavirus disease-2019 (COVID-19) have been described in patients from Europe, North America and China, but there are few data from COVID-19 patients in Middle Eastern countries. The aim of this study was to investigate the characteristics, outcomes, and risk factors for in-hospital death of critically ill patients with COVID-19 pneumonia admitted to the ICUs of a Uni","2021","07","05","J Infect Public Health","Journal of infection and public health","COVID-19; Hospital mortality; Intensive care unit; Ischemic heart disease; SARS-CoV-2","Elshazly","Mostafa","Department of Chest Diseases, Cairo University Hospitals, Kasr-Al-Aini-Street, 11562, Cairo, Egypt",NA
"1814","34215561","10.1016/j.jiph.2021.06.012","Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study.","The characteristics, outcomes, and risk factors for in-hospital death of critically ill intensive care unit (ICU) patients with coronavirus disease-2019 (COVID-19) have been described in patients from Europe, North America and China, but there are few data from COVID-19 patients in Middle Eastern countries. The aim of this study was to investigate the characteristics, outcomes, and risk factors for in-hospital death of critically ill patients with COVID-19 pneumonia admitted to the ICUs of a Uni","2021","07","05","J Infect Public Health","Journal of infection and public health","COVID-19; Hospital mortality; Intensive care unit; Ischemic heart disease; SARS-CoV-2","Saeed","Mohamed","Department of Chest Diseases, Cairo University Hospitals, Kasr-Al-Aini-Street, 11562, Cairo, Egypt",NA
"1815","34215561","10.1016/j.jiph.2021.06.012","Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study.","The characteristics, outcomes, and risk factors for in-hospital death of critically ill intensive care unit (ICU) patients with coronavirus disease-2019 (COVID-19) have been described in patients from Europe, North America and China, but there are few data from COVID-19 patients in Middle Eastern countries. The aim of this study was to investigate the characteristics, outcomes, and risk factors for in-hospital death of critically ill patients with COVID-19 pneumonia admitted to the ICUs of a Uni","2021","07","05","J Infect Public Health","Journal of infection and public health","COVID-19; Hospital mortality; Intensive care unit; Ischemic heart disease; SARS-CoV-2","Mokhtar","Sherif","Critical Care Department, Cairo University Hospitals, Kasr-Al-Aini-Street, 11562, Cairo, Egypt",NA
"1816","34215561","10.1016/j.jiph.2021.06.012","Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study.","The characteristics, outcomes, and risk factors for in-hospital death of critically ill intensive care unit (ICU) patients with coronavirus disease-2019 (COVID-19) have been described in patients from Europe, North America and China, but there are few data from COVID-19 patients in Middle Eastern countries. The aim of this study was to investigate the characteristics, outcomes, and risk factors for in-hospital death of critically ill patients with COVID-19 pneumonia admitted to the ICUs of a Uni","2021","07","05","J Infect Public Health","Journal of infection and public health","COVID-19; Hospital mortality; Intensive care unit; Ischemic heart disease; SARS-CoV-2","Buschbeck","Samuel","Dept. of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Am Klinikum 1, 07743 Jena, Germany",NA
"1817","34215561","10.1016/j.jiph.2021.06.012","Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study.","The characteristics, outcomes, and risk factors for in-hospital death of critically ill intensive care unit (ICU) patients with coronavirus disease-2019 (COVID-19) have been described in patients from Europe, North America and China, but there are few data from COVID-19 patients in Middle Eastern countries. The aim of this study was to investigate the characteristics, outcomes, and risk factors for in-hospital death of critically ill patients with COVID-19 pneumonia admitted to the ICUs of a Uni","2021","07","05","J Infect Public Health","Journal of infection and public health","COVID-19; Hospital mortality; Intensive care unit; Ischemic heart disease; SARS-CoV-2","Sakr","Yasser","Dept. of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Am Klinikum 1, 07743 Jena, Germany. Electronic address: yasser.sakr@med.uni-jena","yasser.sakr@med.uni"
"1818","34215560","10.1016/j.jiph.2021.06.011","Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience.","Bangladesh is a densely populated country with a substandard healthcare system and a mediocre economic framework. Due to the enormous number of people who have been unaware until now, the development of COVID-19's second-wave infection has become a severe threat. The present investigation aimed to characterize the clinical and socio-demographic characteristics of COVID-19 in Bangladesh. A cross-sectional analysis was carried out from all the other COVID-19 patients and confirmed by RT-PCR underg","2021","07","05","J Infect Public Health","Journal of infection and public health","Asymptomaticsymptomatic; Bangladesh; COVID-19; Clinical manifestations; Second-wave","Ali","Md Roushan","Professor Joarder DNA and Chromosome Research Laboratory, Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi 6205, Bangladesh","aoyongenetics.ru@gmail.com"
"1819","34215560","10.1016/j.jiph.2021.06.011","Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience.","Bangladesh is a densely populated country with a substandard healthcare system and a mediocre economic framework. Due to the enormous number of people who have been unaware until now, the development of COVID-19's second-wave infection has become a severe threat. The present investigation aimed to characterize the clinical and socio-demographic characteristics of COVID-19 in Bangladesh. A cross-sectional analysis was carried out from all the other COVID-19 patients and confirmed by RT-PCR underg","2021","07","05","J Infect Public Health","Journal of infection and public health","Asymptomaticsymptomatic; Bangladesh; COVID-19; Clinical manifestations; Second-wave","Hasan","Md Amit","Professor Joarder DNA and Chromosome Research Laboratory, Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi 6205, Bangladesh",NA
"1820","34215560","10.1016/j.jiph.2021.06.011","Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience.","Bangladesh is a densely populated country with a substandard healthcare system and a mediocre economic framework. Due to the enormous number of people who have been unaware until now, the development of COVID-19's second-wave infection has become a severe threat. The present investigation aimed to characterize the clinical and socio-demographic characteristics of COVID-19 in Bangladesh. A cross-sectional analysis was carried out from all the other COVID-19 patients and confirmed by RT-PCR underg","2021","07","05","J Infect Public Health","Journal of infection and public health","Asymptomaticsymptomatic; Bangladesh; COVID-19; Clinical manifestations; Second-wave","Rahman","Md Siddikur","Professor Joarder DNA and Chromosome Research Laboratory, Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi 6205, Bangladesh",NA
"1821","34215560","10.1016/j.jiph.2021.06.011","Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience.","Bangladesh is a densely populated country with a substandard healthcare system and a mediocre economic framework. Due to the enormous number of people who have been unaware until now, the development of COVID-19's second-wave infection has become a severe threat. The present investigation aimed to characterize the clinical and socio-demographic characteristics of COVID-19 in Bangladesh. A cross-sectional analysis was carried out from all the other COVID-19 patients and confirmed by RT-PCR underg","2021","07","05","J Infect Public Health","Journal of infection and public health","Asymptomaticsymptomatic; Bangladesh; COVID-19; Clinical manifestations; Second-wave","Billah","Mutasim","Professor Joarder DNA and Chromosome Research Laboratory, Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi 6205, Bangladesh",NA
"1822","34215560","10.1016/j.jiph.2021.06.011","Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience.","Bangladesh is a densely populated country with a substandard healthcare system and a mediocre economic framework. Due to the enormous number of people who have been unaware until now, the development of COVID-19's second-wave infection has become a severe threat. The present investigation aimed to characterize the clinical and socio-demographic characteristics of COVID-19 in Bangladesh. A cross-sectional analysis was carried out from all the other COVID-19 patients and confirmed by RT-PCR underg","2021","07","05","J Infect Public Health","Journal of infection and public health","Asymptomaticsymptomatic; Bangladesh; COVID-19; Clinical manifestations; Second-wave","Karmakar","Sumon","Department of Genetic Engineering &amp",NA
"1823","34215560","10.1016/j.jiph.2021.06.011","Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience.","Bangladesh is a densely populated country with a substandard healthcare system and a mediocre economic framework. Due to the enormous number of people who have been unaware until now, the development of COVID-19's second-wave infection has become a severe threat. The present investigation aimed to characterize the clinical and socio-demographic characteristics of COVID-19 in Bangladesh. A cross-sectional analysis was carried out from all the other COVID-19 patients and confirmed by RT-PCR underg","2021","07","05","J Infect Public Health","Journal of infection and public health","Asymptomaticsymptomatic; Bangladesh; COVID-19; Clinical manifestations; Second-wave","Shimu","Ajmeri Sultana","Department of Medical Oncology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui 230027, China",NA
"1824","34215560","10.1016/j.jiph.2021.06.011","Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience.","Bangladesh is a densely populated country with a substandard healthcare system and a mediocre economic framework. Due to the enormous number of people who have been unaware until now, the development of COVID-19's second-wave infection has become a severe threat. The present investigation aimed to characterize the clinical and socio-demographic characteristics of COVID-19 in Bangladesh. A cross-sectional analysis was carried out from all the other COVID-19 patients and confirmed by RT-PCR underg","2021","07","05","J Infect Public Health","Journal of infection and public health","Asymptomaticsymptomatic; Bangladesh; COVID-19; Clinical manifestations; Second-wave","Hossain","Md Firose","Department of Molecular and Functional Genomics, Interdisciplinary Center for Science Research, Shimane University, Matsue 690-8504, Japan",NA
"1825","34215560","10.1016/j.jiph.2021.06.011","Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience.","Bangladesh is a densely populated country with a substandard healthcare system and a mediocre economic framework. Due to the enormous number of people who have been unaware until now, the development of COVID-19's second-wave infection has become a severe threat. The present investigation aimed to characterize the clinical and socio-demographic characteristics of COVID-19 in Bangladesh. A cross-sectional analysis was carried out from all the other COVID-19 patients and confirmed by RT-PCR underg","2021","07","05","J Infect Public Health","Journal of infection and public health","Asymptomaticsymptomatic; Bangladesh; COVID-19; Clinical manifestations; Second-wave","Maruf","Md Mahmudul Hasan","Department of Genetic Engineering &amp",NA
"1826","34215560","10.1016/j.jiph.2021.06.011","Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience.","Bangladesh is a densely populated country with a substandard healthcare system and a mediocre economic framework. Due to the enormous number of people who have been unaware until now, the development of COVID-19's second-wave infection has become a severe threat. The present investigation aimed to characterize the clinical and socio-demographic characteristics of COVID-19 in Bangladesh. A cross-sectional analysis was carried out from all the other COVID-19 patients and confirmed by RT-PCR underg","2021","07","05","J Infect Public Health","Journal of infection and public health","Asymptomaticsymptomatic; Bangladesh; COVID-19; Clinical manifestations; Second-wave","Rahman","Md Sojiur","Professor Joarder DNA and Chromosome Research Laboratory, Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi 6205, Bangladesh",NA
"1827","34215560","10.1016/j.jiph.2021.06.011","Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience.","Bangladesh is a densely populated country with a substandard healthcare system and a mediocre economic framework. Due to the enormous number of people who have been unaware until now, the development of COVID-19's second-wave infection has become a severe threat. The present investigation aimed to characterize the clinical and socio-demographic characteristics of COVID-19 in Bangladesh. A cross-sectional analysis was carried out from all the other COVID-19 patients and confirmed by RT-PCR underg","2021","07","05","J Infect Public Health","Journal of infection and public health","Asymptomaticsymptomatic; Bangladesh; COVID-19; Clinical manifestations; Second-wave","Saju","Md Saifur Rahman","Department of Botany, University of Rajshahi, Rajshahi 6205, Bangladesh",NA
"1828","34215560","10.1016/j.jiph.2021.06.011","Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience.","Bangladesh is a densely populated country with a substandard healthcare system and a mediocre economic framework. Due to the enormous number of people who have been unaware until now, the development of COVID-19's second-wave infection has become a severe threat. The present investigation aimed to characterize the clinical and socio-demographic characteristics of COVID-19 in Bangladesh. A cross-sectional analysis was carried out from all the other COVID-19 patients and confirmed by RT-PCR underg","2021","07","05","J Infect Public Health","Journal of infection and public health","Asymptomaticsymptomatic; Bangladesh; COVID-19; Clinical manifestations; Second-wave","Hasan","Mujtaba Rafid","Udayan Dental College, Rajshahi 6205, Bangladesh",NA
"1829","34215560","10.1016/j.jiph.2021.06.011","Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience.","Bangladesh is a densely populated country with a substandard healthcare system and a mediocre economic framework. Due to the enormous number of people who have been unaware until now, the development of COVID-19's second-wave infection has become a severe threat. The present investigation aimed to characterize the clinical and socio-demographic characteristics of COVID-19 in Bangladesh. A cross-sectional analysis was carried out from all the other COVID-19 patients and confirmed by RT-PCR underg","2021","07","05","J Infect Public Health","Journal of infection and public health","Asymptomaticsymptomatic; Bangladesh; COVID-19; Clinical manifestations; Second-wave","Acharjee","Uzzal Kumar","Professor Joarder DNA and Chromosome Research Laboratory, Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi 6205, Bangladesh",NA
"1830","34215560","10.1016/j.jiph.2021.06.011","Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience.","Bangladesh is a densely populated country with a substandard healthcare system and a mediocre economic framework. Due to the enormous number of people who have been unaware until now, the development of COVID-19's second-wave infection has become a severe threat. The present investigation aimed to characterize the clinical and socio-demographic characteristics of COVID-19 in Bangladesh. A cross-sectional analysis was carried out from all the other COVID-19 patients and confirmed by RT-PCR underg","2021","07","05","J Infect Public Health","Journal of infection and public health","Asymptomaticsymptomatic; Bangladesh; COVID-19; Clinical manifestations; Second-wave","Hasan","Md Faruk","Department of Microbiology, University of Rajshahi, Rajshahi 6205, Bangladesh. Electronic address: faruk_geb@ru.ac","geb@ru.ac.bd"
"1831","34215550","10.1016/j.anorl.2021.06.003","Surgery under COVID: An observational study.","To evaluate the surgery program strategy adopted in an adult otorhinolaryngology and head and neck surgery department in an area badly affected by the Covid-19 epidemic peak. The main objective was to analyze the reasons for not cancelling surgeries and the postoperative course of operated patients. The secondary objective was to assess the situation of postponed patients. A single-center observational study carried out during the COVID-19 period in France included 124 patients scheduled for sur","2021","07","05","Eur Ann Otorhinolaryngol Head Neck Dis","European annals of otorhinolaryngology, head and neck diseases","CoVID-19; ENT; Head and neck cancer; Surgery","Durand","M","Université Paris Centre, Service d'ORL et de Chirurgie Cervico-Faciale, HEGP, AP-HP, 20-40, Rue Leblanc, 75015 Paris, France. Electronic address: margot.durand@hotmail","margot.durand@hotmail.fr"
"1832","34215550","10.1016/j.anorl.2021.06.003","Surgery under COVID: An observational study.","To evaluate the surgery program strategy adopted in an adult otorhinolaryngology and head and neck surgery department in an area badly affected by the Covid-19 epidemic peak. The main objective was to analyze the reasons for not cancelling surgeries and the postoperative course of operated patients. The secondary objective was to assess the situation of postponed patients. A single-center observational study carried out during the COVID-19 period in France included 124 patients scheduled for sur","2021","07","05","Eur Ann Otorhinolaryngol Head Neck Dis","European annals of otorhinolaryngology, head and neck diseases","CoVID-19; ENT; Head and neck cancer; Surgery","Mirghani","H","Université Paris Centre, Service d'ORL et de Chirurgie Cervico-Faciale, HEGP, AP-HP, 20-40, Rue Leblanc, 75015 Paris, France",NA
"1833","34215550","10.1016/j.anorl.2021.06.003","Surgery under COVID: An observational study.","To evaluate the surgery program strategy adopted in an adult otorhinolaryngology and head and neck surgery department in an area badly affected by the Covid-19 epidemic peak. The main objective was to analyze the reasons for not cancelling surgeries and the postoperative course of operated patients. The secondary objective was to assess the situation of postponed patients. A single-center observational study carried out during the COVID-19 period in France included 124 patients scheduled for sur","2021","07","05","Eur Ann Otorhinolaryngol Head Neck Dis","European annals of otorhinolaryngology, head and neck diseases","CoVID-19; ENT; Head and neck cancer; Surgery","Bonfils","P","Université Paris Centre, Service d'ORL et de Chirurgie Cervico-Faciale, HEGP, AP-HP, 20-40, Rue Leblanc, 75015 Paris, France",NA
"1834","34215550","10.1016/j.anorl.2021.06.003","Surgery under COVID: An observational study.","To evaluate the surgery program strategy adopted in an adult otorhinolaryngology and head and neck surgery department in an area badly affected by the Covid-19 epidemic peak. The main objective was to analyze the reasons for not cancelling surgeries and the postoperative course of operated patients. The secondary objective was to assess the situation of postponed patients. A single-center observational study carried out during the COVID-19 period in France included 124 patients scheduled for sur","2021","07","05","Eur Ann Otorhinolaryngol Head Neck Dis","European annals of otorhinolaryngology, head and neck diseases","CoVID-19; ENT; Head and neck cancer; Surgery","Laccourreye","O","Université Paris Centre, Service d'ORL et de Chirurgie Cervico-Faciale, HEGP, AP-HP, 20-40, Rue Leblanc, 75015 Paris, France",NA
"1835","34215541","10.1016/j.prrv.2021.05.002","Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?","There has been growing interest in telemedicine for cystic fibrosis over recent years based largely on convenience for patients and/or increasing the frequency of surveillance and early detection which, it is assumed, could improve treatment outcomes. During 2020, the covid-19 pandemic catalysed the pace of development of this field, as CF patients were presumed to be at high risk of infection. Most clinics adapted to digital platforms with provision of lung function monitoring and sample collec","2021","07","03","Paediatr Respir Rev","Paediatric respiratory reviews","Cystic fibrosis; Home monitoring; Lung function; Physiotherapy; Psychology; Remote care; Spirometry; Telehealth; Telemedicine","Dixon","E","Department of Paediatric Physiotherapy, Royal Brompton Hospital, London, UK",NA
"1836","34215541","10.1016/j.prrv.2021.05.002","Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?","There has been growing interest in telemedicine for cystic fibrosis over recent years based largely on convenience for patients and/or increasing the frequency of surveillance and early detection which, it is assumed, could improve treatment outcomes. During 2020, the covid-19 pandemic catalysed the pace of development of this field, as CF patients were presumed to be at high risk of infection. Most clinics adapted to digital platforms with provision of lung function monitoring and sample collec","2021","07","03","Paediatr Respir Rev","Paediatric respiratory reviews","Cystic fibrosis; Home monitoring; Lung function; Physiotherapy; Psychology; Remote care; Spirometry; Telehealth; Telemedicine","Dick","K","Department of Paediatric Cystic Fibrosis, Royal Brompton Hospital, London, UK",NA
"1837","34215541","10.1016/j.prrv.2021.05.002","Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?","There has been growing interest in telemedicine for cystic fibrosis over recent years based largely on convenience for patients and/or increasing the frequency of surveillance and early detection which, it is assumed, could improve treatment outcomes. During 2020, the covid-19 pandemic catalysed the pace of development of this field, as CF patients were presumed to be at high risk of infection. Most clinics adapted to digital platforms with provision of lung function monitoring and sample collec","2021","07","03","Paediatr Respir Rev","Paediatric respiratory reviews","Cystic fibrosis; Home monitoring; Lung function; Physiotherapy; Psychology; Remote care; Spirometry; Telehealth; Telemedicine","Ollosson","S","Department of Paediatric Respiratory Physiology, Royal Brompton Hospital, London, UK",NA
"1838","34215541","10.1016/j.prrv.2021.05.002","Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?","There has been growing interest in telemedicine for cystic fibrosis over recent years based largely on convenience for patients and/or increasing the frequency of surveillance and early detection which, it is assumed, could improve treatment outcomes. During 2020, the covid-19 pandemic catalysed the pace of development of this field, as CF patients were presumed to be at high risk of infection. Most clinics adapted to digital platforms with provision of lung function monitoring and sample collec","2021","07","03","Paediatr Respir Rev","Paediatric respiratory reviews","Cystic fibrosis; Home monitoring; Lung function; Physiotherapy; Psychology; Remote care; Spirometry; Telehealth; Telemedicine","Jones","D","Department of Paediatric Dietetics, Royal Brompton Hospital, London, UK",NA
"1839","34215541","10.1016/j.prrv.2021.05.002","Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?","There has been growing interest in telemedicine for cystic fibrosis over recent years based largely on convenience for patients and/or increasing the frequency of surveillance and early detection which, it is assumed, could improve treatment outcomes. During 2020, the covid-19 pandemic catalysed the pace of development of this field, as CF patients were presumed to be at high risk of infection. Most clinics adapted to digital platforms with provision of lung function monitoring and sample collec","2021","07","03","Paediatr Respir Rev","Paediatric respiratory reviews","Cystic fibrosis; Home monitoring; Lung function; Physiotherapy; Psychology; Remote care; Spirometry; Telehealth; Telemedicine","Mattock","H","Department of Paediatric Psychology, Royal Brompton Hospital, London, UK",NA
"1840","34215541","10.1016/j.prrv.2021.05.002","Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?","There has been growing interest in telemedicine for cystic fibrosis over recent years based largely on convenience for patients and/or increasing the frequency of surveillance and early detection which, it is assumed, could improve treatment outcomes. During 2020, the covid-19 pandemic catalysed the pace of development of this field, as CF patients were presumed to be at high risk of infection. Most clinics adapted to digital platforms with provision of lung function monitoring and sample collec","2021","07","03","Paediatr Respir Rev","Paediatric respiratory reviews","Cystic fibrosis; Home monitoring; Lung function; Physiotherapy; Psychology; Remote care; Spirometry; Telehealth; Telemedicine","Bentley","S","Department of Pharmacy, Royal Brompton Hospital, London, UK",NA
"1841","34215541","10.1016/j.prrv.2021.05.002","Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?","There has been growing interest in telemedicine for cystic fibrosis over recent years based largely on convenience for patients and/or increasing the frequency of surveillance and early detection which, it is assumed, could improve treatment outcomes. During 2020, the covid-19 pandemic catalysed the pace of development of this field, as CF patients were presumed to be at high risk of infection. Most clinics adapted to digital platforms with provision of lung function monitoring and sample collec","2021","07","03","Paediatr Respir Rev","Paediatric respiratory reviews","Cystic fibrosis; Home monitoring; Lung function; Physiotherapy; Psychology; Remote care; Spirometry; Telehealth; Telemedicine","Saunders","C","National Heart &amp",NA
"1842","34215541","10.1016/j.prrv.2021.05.002","Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?","There has been growing interest in telemedicine for cystic fibrosis over recent years based largely on convenience for patients and/or increasing the frequency of surveillance and early detection which, it is assumed, could improve treatment outcomes. During 2020, the covid-19 pandemic catalysed the pace of development of this field, as CF patients were presumed to be at high risk of infection. Most clinics adapted to digital platforms with provision of lung function monitoring and sample collec","2021","07","03","Paediatr Respir Rev","Paediatric respiratory reviews","Cystic fibrosis; Home monitoring; Lung function; Physiotherapy; Psychology; Remote care; Spirometry; Telehealth; Telemedicine","Matthews","J","Department of Paediatric Cystic Fibrosis, Royal Brompton Hospital, London, UK",NA
"1843","34215541","10.1016/j.prrv.2021.05.002","Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?","There has been growing interest in telemedicine for cystic fibrosis over recent years based largely on convenience for patients and/or increasing the frequency of surveillance and early detection which, it is assumed, could improve treatment outcomes. During 2020, the covid-19 pandemic catalysed the pace of development of this field, as CF patients were presumed to be at high risk of infection. Most clinics adapted to digital platforms with provision of lung function monitoring and sample collec","2021","07","03","Paediatr Respir Rev","Paediatric respiratory reviews","Cystic fibrosis; Home monitoring; Lung function; Physiotherapy; Psychology; Remote care; Spirometry; Telehealth; Telemedicine","Dobra","B","Department of Paediatric Cystic Fibrosis, Royal Brompton Hospital, London, UK",NA
"1844","34215541","10.1016/j.prrv.2021.05.002","Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?","There has been growing interest in telemedicine for cystic fibrosis over recent years based largely on convenience for patients and/or increasing the frequency of surveillance and early detection which, it is assumed, could improve treatment outcomes. During 2020, the covid-19 pandemic catalysed the pace of development of this field, as CF patients were presumed to be at high risk of infection. Most clinics adapted to digital platforms with provision of lung function monitoring and sample collec","2021","07","03","Paediatr Respir Rev","Paediatric respiratory reviews","Cystic fibrosis; Home monitoring; Lung function; Physiotherapy; Psychology; Remote care; Spirometry; Telehealth; Telemedicine","King","J","Department of Paediatric Cystic Fibrosis, Royal Brompton Hospital, London, UK",NA
"1845","34215541","10.1016/j.prrv.2021.05.002","Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?","There has been growing interest in telemedicine for cystic fibrosis over recent years based largely on convenience for patients and/or increasing the frequency of surveillance and early detection which, it is assumed, could improve treatment outcomes. During 2020, the covid-19 pandemic catalysed the pace of development of this field, as CF patients were presumed to be at high risk of infection. Most clinics adapted to digital platforms with provision of lung function monitoring and sample collec","2021","07","03","Paediatr Respir Rev","Paediatric respiratory reviews","Cystic fibrosis; Home monitoring; Lung function; Physiotherapy; Psychology; Remote care; Spirometry; Telehealth; Telemedicine","Edmondson","C","Department of Paediatric Cystic Fibrosis, Royal Brompton Hospital, London, UK",NA
"1846","34215541","10.1016/j.prrv.2021.05.002","Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?","There has been growing interest in telemedicine for cystic fibrosis over recent years based largely on convenience for patients and/or increasing the frequency of surveillance and early detection which, it is assumed, could improve treatment outcomes. During 2020, the covid-19 pandemic catalysed the pace of development of this field, as CF patients were presumed to be at high risk of infection. Most clinics adapted to digital platforms with provision of lung function monitoring and sample collec","2021","07","03","Paediatr Respir Rev","Paediatric respiratory reviews","Cystic fibrosis; Home monitoring; Lung function; Physiotherapy; Psychology; Remote care; Spirometry; Telehealth; Telemedicine","Davies","J C","Department of Paediatric Cystic Fibrosis, Royal Brompton Hospital, London, UK","j.c.davies@imperial.ac.uk"
"1847","34215539","10.1016/j.wombi.2021.05.008","New Zealand maternity and midwifery services and the COVID-19 response: A systematic scoping review.","COVID-19 guidance from professional and health organisations created uncertainty leading to professional and personal stress impacting on midwives providing continuity of care in New Zealand (NZ). The COVID-19 pandemic resulted in massive amounts of international and national information and guidance. This guidance was often conflicting and not suited to New Zealand midwifery. To examine and map the national and international guidance and information provided to midwifery regarding COVID-19 and ","2021","07","05","Women Birth","Women and birth : journal of the Australian College of Midwives","COVID-19; Guidance; Lockdown; Midwives; New Zealand; Practice","Crowther","Susan","Faculty of Health and Environmental Sciences, Center for Midwifery and Women's Health Research, Auckland University of Technology, Auckland, New Zealand. Electronic address: Susan.Crowther@aut.ac","Susan.Crowther@aut.ac.nz"
"1848","34215539","10.1016/j.wombi.2021.05.008","New Zealand maternity and midwifery services and the COVID-19 response: A systematic scoping review.","COVID-19 guidance from professional and health organisations created uncertainty leading to professional and personal stress impacting on midwives providing continuity of care in New Zealand (NZ). The COVID-19 pandemic resulted in massive amounts of international and national information and guidance. This guidance was often conflicting and not suited to New Zealand midwifery. To examine and map the national and international guidance and information provided to midwifery regarding COVID-19 and ","2021","07","05","Women Birth","Women and birth : journal of the Australian College of Midwives","COVID-19; Guidance; Lockdown; Midwives; New Zealand; Practice","Maude","Robyn","School of Nursing, Midwifery and Health Practice, Te Herenga Waka Victoria University of Wellington, New Zealand. Electronic address: Robyn.Maude@vuw.ac","Robyn.Maude@vuw.ac.nz"
"1849","34215539","10.1016/j.wombi.2021.05.008","New Zealand maternity and midwifery services and the COVID-19 response: A systematic scoping review.","COVID-19 guidance from professional and health organisations created uncertainty leading to professional and personal stress impacting on midwives providing continuity of care in New Zealand (NZ). The COVID-19 pandemic resulted in massive amounts of international and national information and guidance. This guidance was often conflicting and not suited to New Zealand midwifery. To examine and map the national and international guidance and information provided to midwifery regarding COVID-19 and ","2021","07","05","Women Birth","Women and birth : journal of the Australian College of Midwives","COVID-19; Guidance; Lockdown; Midwives; New Zealand; Practice","Zhao","Ivy Y","WHO Collaborating Centre for Community Health Services, School of Nursing, The Hong Kong Polytechnic University, Hong Kong. Electronic address: yan-ivy.zhao@polyu.edu","ivy.zhao@polyu.edu.hk"
"1850","34215539","10.1016/j.wombi.2021.05.008","New Zealand maternity and midwifery services and the COVID-19 response: A systematic scoping review.","COVID-19 guidance from professional and health organisations created uncertainty leading to professional and personal stress impacting on midwives providing continuity of care in New Zealand (NZ). The COVID-19 pandemic resulted in massive amounts of international and national information and guidance. This guidance was often conflicting and not suited to New Zealand midwifery. To examine and map the national and international guidance and information provided to midwifery regarding COVID-19 and ","2021","07","05","Women Birth","Women and birth : journal of the Australian College of Midwives","COVID-19; Guidance; Lockdown; Midwives; New Zealand; Practice","Bradford","Billie","School of Nursing, Midwifery and Health Practice, Te Herenga Waka Victoria University of Wellington, New Zealand. Electronic address: Billie.Bradford@vuw.ac","Billie.Bradford@vuw.ac.nz"
"1851","34215539","10.1016/j.wombi.2021.05.008","New Zealand maternity and midwifery services and the COVID-19 response: A systematic scoping review.","COVID-19 guidance from professional and health organisations created uncertainty leading to professional and personal stress impacting on midwives providing continuity of care in New Zealand (NZ). The COVID-19 pandemic resulted in massive amounts of international and national information and guidance. This guidance was often conflicting and not suited to New Zealand midwifery. To examine and map the national and international guidance and information provided to midwifery regarding COVID-19 and ","2021","07","05","Women Birth","Women and birth : journal of the Australian College of Midwives","COVID-19; Guidance; Lockdown; Midwives; New Zealand; Practice","Gilkison","Andrea","Faculty of Health and Environmental Sciences, Center for Midwifery and Women's Health Research, Auckland University of Technology, Auckland, New Zealand. Electronic address: andrea.gilkison@aut.ac","andrea.gilkison@aut.ac.nz"
"1852","34215532","10.1016/j.zefq.2021.05.004","[Smart sensors in pregnancy: Narrative review on the use of smart home technology in routine prenatal care].","Today's routine prenatal care in Germany includes regular in-person appointments of pregnant women with doctors or midwives. Considering an increasing digitalization of the healthcare sector and in view of the global COVID-19 pandemic, the frequency of in-person visits could be reduced by remote monitoring using smart sensor technology. We aim to give an overview of the current international research on the use of smart sensors in prenatal care and its benefits, costs and resource consumption. F","2021","07","03","Z Evid Fortbild Qual Gesundhwes","Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen","Digitalisierung; Digitalization; Mutterpass; Pregnancy; Prenatal care; Remote monitoring; Schwangerschaft; Smart Sensorik; Smart sensor; Vorsorgeuntersuchung","Bossung","Verena","Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Deutschland. Electronic address: verena.bossung@uni-luebeck",NA
"1853","34215532","10.1016/j.zefq.2021.05.004","[Smart sensors in pregnancy: Narrative review on the use of smart home technology in routine prenatal care].","Today's routine prenatal care in Germany includes regular in-person appointments of pregnant women with doctors or midwives. Considering an increasing digitalization of the healthcare sector and in view of the global COVID-19 pandemic, the frequency of in-person visits could be reduced by remote monitoring using smart sensor technology. We aim to give an overview of the current international research on the use of smart sensors in prenatal care and its benefits, costs and resource consumption. F","2021","07","03","Z Evid Fortbild Qual Gesundhwes","Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen","Digitalisierung; Digitalization; Mutterpass; Pregnancy; Prenatal care; Remote monitoring; Schwangerschaft; Smart Sensorik; Smart sensor; Vorsorgeuntersuchung","Kast","Kristina","Rechts- und Wirtschaftswissenschaftliche Fakultät, Lehrstuhl für Gesundheitsmanagement, Friedrich-Alexander Universität Erlangen-Nürnberg, Nürnberg, Deutschland",NA
"1854","34215522","10.1016/j.canrad.2021.06.005","[Implementation of the dematerialization of the patient file in the context of COVID in the ONCORAD radiotherapy units: Transition to ""paperless""].","Paper patient file sharing has clearly been identified as a risk behavior for the COVID-19 virus transmission in radiotherapy units. In order to overcome this, the ONCORAD radiotherapy units worked on total dematerialization of the paper patient file, within 3 weeks. The methodology is based on a quality approch. This work has led to a convincing improvement in the management of risks a priori and a smoother patient care workflow.","2021","07","05","Cancer Radiother","Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","AURA® report; COVID-19 virus; Dematerialization; Dossiers patients; Démarche qualité; Dématérialisation; Patient files; Quality approach; Rapport AURA®; Virus COVID-19","Boutry","C","SCM oncologie, département de physique, clinique du Pont-des-Chaumes, 330, avenue Marcel-Unal, 82000 Montauban, France. Electronic address: c_boutry@yahoo","boutry@yahoo.fr"
"1855","34215522","10.1016/j.canrad.2021.06.005","[Implementation of the dematerialization of the patient file in the context of COVID in the ONCORAD radiotherapy units: Transition to ""paperless""].","Paper patient file sharing has clearly been identified as a risk behavior for the COVID-19 virus transmission in radiotherapy units. In order to overcome this, the ONCORAD radiotherapy units worked on total dematerialization of the paper patient file, within 3 weeks. The methodology is based on a quality approch. This work has led to a convincing improvement in the management of risks a priori and a smoother patient care workflow.","2021","07","05","Cancer Radiother","Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","AURA® report; COVID-19 virus; Dematerialization; Dossiers patients; Démarche qualité; Dématérialisation; Patient files; Quality approach; Rapport AURA®; Virus COVID-19","Sors","A","SCM oncologie, département de physique, clinique du Pont-des-Chaumes, 330, avenue Marcel-Unal, 82000 Montauban, France",NA
"1856","34215522","10.1016/j.canrad.2021.06.005","[Implementation of the dematerialization of the patient file in the context of COVID in the ONCORAD radiotherapy units: Transition to ""paperless""].","Paper patient file sharing has clearly been identified as a risk behavior for the COVID-19 virus transmission in radiotherapy units. In order to overcome this, the ONCORAD radiotherapy units worked on total dematerialization of the paper patient file, within 3 weeks. The methodology is based on a quality approch. This work has led to a convincing improvement in the management of risks a priori and a smoother patient care workflow.","2021","07","05","Cancer Radiother","Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","AURA® report; COVID-19 virus; Dematerialization; Dossiers patients; Démarche qualité; Dématérialisation; Patient files; Quality approach; Rapport AURA®; Virus COVID-19","Meynard","K","SCM oncologie, département de physique, clinique du Pont-des-Chaumes, 330, avenue Marcel-Unal, 82000 Montauban, France",NA
"1857","34215522","10.1016/j.canrad.2021.06.005","[Implementation of the dematerialization of the patient file in the context of COVID in the ONCORAD radiotherapy units: Transition to ""paperless""].","Paper patient file sharing has clearly been identified as a risk behavior for the COVID-19 virus transmission in radiotherapy units. In order to overcome this, the ONCORAD radiotherapy units worked on total dematerialization of the paper patient file, within 3 weeks. The methodology is based on a quality approch. This work has led to a convincing improvement in the management of risks a priori and a smoother patient care workflow.","2021","07","05","Cancer Radiother","Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","AURA® report; COVID-19 virus; Dematerialization; Dossiers patients; Démarche qualité; Dématérialisation; Patient files; Quality approach; Rapport AURA®; Virus COVID-19","Zarate","M D","Cellule qualité, groupe ONCORAD Garonne, Montauban-Toulouse, clinique Pasteur, BP 27617, 31076 Toulouse cedex 3, France",NA
"1858","34215522","10.1016/j.canrad.2021.06.005","[Implementation of the dematerialization of the patient file in the context of COVID in the ONCORAD radiotherapy units: Transition to ""paperless""].","Paper patient file sharing has clearly been identified as a risk behavior for the COVID-19 virus transmission in radiotherapy units. In order to overcome this, the ONCORAD radiotherapy units worked on total dematerialization of the paper patient file, within 3 weeks. The methodology is based on a quality approch. This work has led to a convincing improvement in the management of risks a priori and a smoother patient care workflow.","2021","07","05","Cancer Radiother","Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","AURA® report; COVID-19 virus; Dematerialization; Dossiers patients; Démarche qualité; Dématérialisation; Patient files; Quality approach; Rapport AURA®; Virus COVID-19","Couderc","M S","Cellule qualité, groupe ONCORAD Garonne, Montauban-Toulouse, clinique Pasteur, BP 27617, 31076 Toulouse cedex 3, France",NA
"1859","34215522","10.1016/j.canrad.2021.06.005","[Implementation of the dematerialization of the patient file in the context of COVID in the ONCORAD radiotherapy units: Transition to ""paperless""].","Paper patient file sharing has clearly been identified as a risk behavior for the COVID-19 virus transmission in radiotherapy units. In order to overcome this, the ONCORAD radiotherapy units worked on total dematerialization of the paper patient file, within 3 weeks. The methodology is based on a quality approch. This work has led to a convincing improvement in the management of risks a priori and a smoother patient care workflow.","2021","07","05","Cancer Radiother","Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","AURA® report; COVID-19 virus; Dematerialization; Dossiers patients; Démarche qualité; Dématérialisation; Patient files; Quality approach; Rapport AURA®; Virus COVID-19","Delmas","M V","Cellule qualité, groupe ONCORAD Garonne, Montauban-Toulouse, clinique Pasteur, BP 27617, 31076 Toulouse cedex 3, France",NA
"1860","34215522","10.1016/j.canrad.2021.06.005","[Implementation of the dematerialization of the patient file in the context of COVID in the ONCORAD radiotherapy units: Transition to ""paperless""].","Paper patient file sharing has clearly been identified as a risk behavior for the COVID-19 virus transmission in radiotherapy units. In order to overcome this, the ONCORAD radiotherapy units worked on total dematerialization of the paper patient file, within 3 weeks. The methodology is based on a quality approch. This work has led to a convincing improvement in the management of risks a priori and a smoother patient care workflow.","2021","07","05","Cancer Radiother","Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","AURA® report; COVID-19 virus; Dematerialization; Dossiers patients; Démarche qualité; Dématérialisation; Patient files; Quality approach; Rapport AURA®; Virus COVID-19","Dudouet","P","Cellule qualité, groupe ONCORAD Garonne, Montauban-Toulouse, clinique Pasteur, BP 27617, 31076 Toulouse cedex 3, France",NA
"1861","34215520","10.1016/j.transci.2021.103200","A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic.","Psoriasis is a chronic inflammatory skin disease that is characterized by well-demarcated erythematous plaques with a silver scale. Although many new and emerging therapeutic agents are often sufficient to control the disease, there is still a need for alternative treatment options in challenging cases. Extracorporeal photopheresis (ECP) has been applied to many T-cell-mediated diseases to restore immune homeostasis and treat psoriasis effectively. In this paper, we present a psoriasis patient w","2021","07","05","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","Comorbidity; Extracorporeal photopheresis; Management; Psoriasis; Treatment","Esme","Pelin","Departments of Dermatology and Venereology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey. Electronic address: pelinnesme@gmail","pelinnesme@gmail.com"
"1862","34215520","10.1016/j.transci.2021.103200","A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic.","Psoriasis is a chronic inflammatory skin disease that is characterized by well-demarcated erythematous plaques with a silver scale. Although many new and emerging therapeutic agents are often sufficient to control the disease, there is still a need for alternative treatment options in challenging cases. Extracorporeal photopheresis (ECP) has been applied to many T-cell-mediated diseases to restore immune homeostasis and treat psoriasis effectively. In this paper, we present a psoriasis patient w","2021","07","05","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","Comorbidity; Extracorporeal photopheresis; Management; Psoriasis; Treatment","Coban","Sema Nur","Departments of Dermatology and Venereology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey. Electronic address: semanurcobnn@gmail","semanurcobnn@gmail.com"
"1863","34215520","10.1016/j.transci.2021.103200","A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic.","Psoriasis is a chronic inflammatory skin disease that is characterized by well-demarcated erythematous plaques with a silver scale. Although many new and emerging therapeutic agents are often sufficient to control the disease, there is still a need for alternative treatment options in challenging cases. Extracorporeal photopheresis (ECP) has been applied to many T-cell-mediated diseases to restore immune homeostasis and treat psoriasis effectively. In this paper, we present a psoriasis patient w","2021","07","05","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","Comorbidity; Extracorporeal photopheresis; Management; Psoriasis; Treatment","Ugur","Bilge","Departments of Hematology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey. Electronic address: uurbilge@yahoo","uurbilge@yahoo.com"
"1864","34215520","10.1016/j.transci.2021.103200","A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic.","Psoriasis is a chronic inflammatory skin disease that is characterized by well-demarcated erythematous plaques with a silver scale. Although many new and emerging therapeutic agents are often sufficient to control the disease, there is still a need for alternative treatment options in challenging cases. Extracorporeal photopheresis (ECP) has been applied to many T-cell-mediated diseases to restore immune homeostasis and treat psoriasis effectively. In this paper, we present a psoriasis patient w","2021","07","05","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","Comorbidity; Extracorporeal photopheresis; Management; Psoriasis; Treatment","Ayli","Meltem","Departments of Hematology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey. Electronic address: ayli.meltem@gmail","ayli.meltem@gmail.com"
"1865","34215520","10.1016/j.transci.2021.103200","A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic.","Psoriasis is a chronic inflammatory skin disease that is characterized by well-demarcated erythematous plaques with a silver scale. Although many new and emerging therapeutic agents are often sufficient to control the disease, there is still a need for alternative treatment options in challenging cases. Extracorporeal photopheresis (ECP) has been applied to many T-cell-mediated diseases to restore immune homeostasis and treat psoriasis effectively. In this paper, we present a psoriasis patient w","2021","07","05","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","Comorbidity; Extracorporeal photopheresis; Management; Psoriasis; Treatment","Caliskan","Ercan","Departments of Dermatology and Venereology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey. Electronic address: drecaliskan@yandex","drecaliskan@yandex.com"
"1866","34215508","10.1016/j.urolonc.2021.05.035","COVID-19 Seminars Issue 2 - Introduction.",NA,"2021","07","05","Urol Oncol","Urologic oncology",NA,"Gore","John L","Department of Urology, University of Washington School of Medicine, Seattle, WA. Electronic address: jlgore@uw",NA
"1867","34215475","10.1016/j.jsat.2021.108550","COVID-19 related substance use services policy changes: Policymaker perspectives on policy development &amp; implementation.","Due to the COVID-19 pandemic, regulations for substance use services changed to accommodate stay-at-home orders and physical distancing guidelines. Using in-depth interviews (N = 14) and framework analysis, we describe how policymakers developed, adopted, and implemented regulations governing services for substance use disorders during COVID-19, and how policymakers' perceived the impacts of these regulations in New York State. During the COVID-19 pandemic, policymakers shifted to more inclusive","2021","07","08","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Implementation; Qualitative; Substance use services policy","Henry","Brandy F","Columbia University School of Social Work, 1255 Amsterdam Ave., New York, NY 10027, United States of America","bhenry@brandeis.edu"
"1868","34215475","10.1016/j.jsat.2021.108550","COVID-19 related substance use services policy changes: Policymaker perspectives on policy development &amp; implementation.","Due to the COVID-19 pandemic, regulations for substance use services changed to accommodate stay-at-home orders and physical distancing guidelines. Using in-depth interviews (N = 14) and framework analysis, we describe how policymakers developed, adopted, and implemented regulations governing services for substance use disorders during COVID-19, and how policymakers' perceived the impacts of these regulations in New York State. During the COVID-19 pandemic, policymakers shifted to more inclusive","2021","07","08","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Implementation; Qualitative; Substance use services policy","Campbell","Aimee","Clinical Psychiatric Social Work at Columbia University Irving Medical Center, Department of Psychiatry and Research Scientist at New York State Psychiatric Institute in the Division on Substance Use Disorders, 1051 Riverside Drive, New York, NY 10032, United States of America. Electronic address: anc2002@cumc.columbia","anc2002@cumc.columbia.edu"
"1869","34215475","10.1016/j.jsat.2021.108550","COVID-19 related substance use services policy changes: Policymaker perspectives on policy development &amp; implementation.","Due to the COVID-19 pandemic, regulations for substance use services changed to accommodate stay-at-home orders and physical distancing guidelines. Using in-depth interviews (N = 14) and framework analysis, we describe how policymakers developed, adopted, and implemented regulations governing services for substance use disorders during COVID-19, and how policymakers' perceived the impacts of these regulations in New York State. During the COVID-19 pandemic, policymakers shifted to more inclusive","2021","07","08","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Implementation; Qualitative; Substance use services policy","Hunt","Timothy","Columbia University School of Social Work, 1255 Amsterdam Ave., New York, NY 10027, United States of America. Electronic address: th2258@columbia","th2258@columbia.edu"
"1870","34215475","10.1016/j.jsat.2021.108550","COVID-19 related substance use services policy changes: Policymaker perspectives on policy development &amp; implementation.","Due to the COVID-19 pandemic, regulations for substance use services changed to accommodate stay-at-home orders and physical distancing guidelines. Using in-depth interviews (N = 14) and framework analysis, we describe how policymakers developed, adopted, and implemented regulations governing services for substance use disorders during COVID-19, and how policymakers' perceived the impacts of these regulations in New York State. During the COVID-19 pandemic, policymakers shifted to more inclusive","2021","07","08","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Implementation; Qualitative; Substance use services policy","Johnson","Jessica K","Columbia University School of Social Work, 1255 Amsterdam Ave., New York, NY 10027, United States of America. Electronic address: jlk2227@columbia","jlk2227@columbia.edu"
"1871","34215475","10.1016/j.jsat.2021.108550","COVID-19 related substance use services policy changes: Policymaker perspectives on policy development &amp; implementation.","Due to the COVID-19 pandemic, regulations for substance use services changed to accommodate stay-at-home orders and physical distancing guidelines. Using in-depth interviews (N = 14) and framework analysis, we describe how policymakers developed, adopted, and implemented regulations governing services for substance use disorders during COVID-19, and how policymakers' perceived the impacts of these regulations in New York State. During the COVID-19 pandemic, policymakers shifted to more inclusive","2021","07","08","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Implementation; Qualitative; Substance use services policy","Mandavia","Amar D","Columbia University Teachers College, 525 West 120th Street, New York, NY 10027, United States of America. Electronic address: adm2183@tc.columbia","adm2183@tc.columbia.edu"
"1872","34215475","10.1016/j.jsat.2021.108550","COVID-19 related substance use services policy changes: Policymaker perspectives on policy development &amp; implementation.","Due to the COVID-19 pandemic, regulations for substance use services changed to accommodate stay-at-home orders and physical distancing guidelines. Using in-depth interviews (N = 14) and framework analysis, we describe how policymakers developed, adopted, and implemented regulations governing services for substance use disorders during COVID-19, and how policymakers' perceived the impacts of these regulations in New York State. During the COVID-19 pandemic, policymakers shifted to more inclusive","2021","07","08","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Implementation; Qualitative; Substance use services policy","Chaple","Michael","Division on Substance Use Disorders New York State Psychiatric Institute, Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY 10032, United States of America. Electronic address: Michael.Chaple@nyspi.columbia","Michael.Chaple@nyspi.columbia.edu"
"1873","34215475","10.1016/j.jsat.2021.108550","COVID-19 related substance use services policy changes: Policymaker perspectives on policy development &amp; implementation.","Due to the COVID-19 pandemic, regulations for substance use services changed to accommodate stay-at-home orders and physical distancing guidelines. Using in-depth interviews (N = 14) and framework analysis, we describe how policymakers developed, adopted, and implemented regulations governing services for substance use disorders during COVID-19, and how policymakers' perceived the impacts of these regulations in New York State. During the COVID-19 pandemic, policymakers shifted to more inclusive","2021","07","08","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Implementation; Qualitative; Substance use services policy","Arout","Caroline","Clinical Neurobiology, Columbia University Irving Medical Center, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, United States of America. Electronic address: Caroline.Arout@nyspi.columbia","Caroline.Arout@nyspi.columbia.edu"
"1874","34215475","10.1016/j.jsat.2021.108550","COVID-19 related substance use services policy changes: Policymaker perspectives on policy development &amp; implementation.","Due to the COVID-19 pandemic, regulations for substance use services changed to accommodate stay-at-home orders and physical distancing guidelines. Using in-depth interviews (N = 14) and framework analysis, we describe how policymakers developed, adopted, and implemented regulations governing services for substance use disorders during COVID-19, and how policymakers' perceived the impacts of these regulations in New York State. During the COVID-19 pandemic, policymakers shifted to more inclusive","2021","07","08","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Implementation; Qualitative; Substance use services policy","Wu","Elwin","Columbia University School of Social Work, 1255 Amsterdam Ave., New York, NY 10027, United States of America. Electronic address: ew157@columbia","ew157@columbia.edu"
"1875","34215475","10.1016/j.jsat.2021.108550","COVID-19 related substance use services policy changes: Policymaker perspectives on policy development &amp; implementation.","Due to the COVID-19 pandemic, regulations for substance use services changed to accommodate stay-at-home orders and physical distancing guidelines. Using in-depth interviews (N = 14) and framework analysis, we describe how policymakers developed, adopted, and implemented regulations governing services for substance use disorders during COVID-19, and how policymakers' perceived the impacts of these regulations in New York State. During the COVID-19 pandemic, policymakers shifted to more inclusive","2021","07","08","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Implementation; Qualitative; Substance use services policy","Pincus","Harold A","Department of Psychiatry, Irving Institute for Clinical and Translational Research, Columbia University, RAND Corporation, 1051 Riverside Drive, New York, NY 10032, United States of America. Electronic address: Harold.Pincus@nyspi.columbia","Harold.Pincus@nyspi.columbia.edu"
"1876","34215475","10.1016/j.jsat.2021.108550","COVID-19 related substance use services policy changes: Policymaker perspectives on policy development &amp; implementation.","Due to the COVID-19 pandemic, regulations for substance use services changed to accommodate stay-at-home orders and physical distancing guidelines. Using in-depth interviews (N = 14) and framework analysis, we describe how policymakers developed, adopted, and implemented regulations governing services for substance use disorders during COVID-19, and how policymakers' perceived the impacts of these regulations in New York State. During the COVID-19 pandemic, policymakers shifted to more inclusive","2021","07","08","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Implementation; Qualitative; Substance use services policy","Nunes","Edward V","Columbia University Irving Medical Center, Department of Psychiatry, Division on Substance Use Disorders, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, United States of America. Electronic address: edward.nunes@nyspi.columbia","edward.nunes@nyspi.columbia.edu"
"1877","34215475","10.1016/j.jsat.2021.108550","COVID-19 related substance use services policy changes: Policymaker perspectives on policy development &amp; implementation.","Due to the COVID-19 pandemic, regulations for substance use services changed to accommodate stay-at-home orders and physical distancing guidelines. Using in-depth interviews (N = 14) and framework analysis, we describe how policymakers developed, adopted, and implemented regulations governing services for substance use disorders during COVID-19, and how policymakers' perceived the impacts of these regulations in New York State. During the COVID-19 pandemic, policymakers shifted to more inclusive","2021","07","08","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Implementation; Qualitative; Substance use services policy","Lincourt","Pat","Addiction Treatment and Recovery Division, Office of Addiction Services and Supports, 1450 Western Ave, Albany, NY 12203, United States of America. Electronic address: Pat.Lincourt@oasas.ny","Pat.Lincourt@oasas.ny.gov"
"1878","34215475","10.1016/j.jsat.2021.108550","COVID-19 related substance use services policy changes: Policymaker perspectives on policy development &amp; implementation.","Due to the COVID-19 pandemic, regulations for substance use services changed to accommodate stay-at-home orders and physical distancing guidelines. Using in-depth interviews (N = 14) and framework analysis, we describe how policymakers developed, adopted, and implemented regulations governing services for substance use disorders during COVID-19, and how policymakers' perceived the impacts of these regulations in New York State. During the COVID-19 pandemic, policymakers shifted to more inclusive","2021","07","08","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Implementation; Qualitative; Substance use services policy","Levin","Frances R","Columbia University Irving Medical Center, Department of Psychiatry, Division on Substance Use Disorders, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, United States of America. Electronic address: Frances.Levin@nyspi.columbia","Frances.Levin@nyspi.columbia.edu"
"1879","34215475","10.1016/j.jsat.2021.108550","COVID-19 related substance use services policy changes: Policymaker perspectives on policy development &amp; implementation.","Due to the COVID-19 pandemic, regulations for substance use services changed to accommodate stay-at-home orders and physical distancing guidelines. Using in-depth interviews (N = 14) and framework analysis, we describe how policymakers developed, adopted, and implemented regulations governing services for substance use disorders during COVID-19, and how policymakers' perceived the impacts of these regulations in New York State. During the COVID-19 pandemic, policymakers shifted to more inclusive","2021","07","08","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Implementation; Qualitative; Substance use services policy","El-Bassel","Nabila","Columbia University School of Social Work, 1255 Amsterdam Ave., New York, NY 10027, United States of America. Electronic address: ne5@columbia","ne5@columbia.edu"
"1880","34215466","10.1016/j.schres.2021.06.019","An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses.",NA,"2021","07","05","Schizophr Res","Schizophrenia research",NA,"Prokopez","Cintia R","Braulio Aurelio Moyano Neuropsychiatric Hospital, Buenos Aires, Argentina","cprokopez@gmail.com"
"1881","34215466","10.1016/j.schres.2021.06.019","An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses.",NA,"2021","07","05","Schizophr Res","Schizophrenia research",NA,"Vallejos","Miguel","José Tiburcio Borda Hospital, Buenos Aires, Argentina",NA
"1882","34215466","10.1016/j.schres.2021.06.019","An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses.",NA,"2021","07","05","Schizophr Res","Schizophrenia research",NA,"Lopredo","Lorena S","Braulio Aurelio Moyano Neuropsychiatric Hospital, Buenos Aires, Argentina",NA
"1883","34215466","10.1016/j.schres.2021.06.019","An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses.",NA,"2021","07","05","Schizophr Res","Schizophrenia research",NA,"Sfriso","Luciano E","Braulio Aurelio Moyano Neuropsychiatric Hospital, Buenos Aires, Argentina",NA
"1884","34215466","10.1016/j.schres.2021.06.019","An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses.",NA,"2021","07","05","Schizophr Res","Schizophrenia research",NA,"Chiapella","Luciana C","National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina",NA
"1885","34215466","10.1016/j.schres.2021.06.019","An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses.",NA,"2021","07","05","Schizophr Res","Schizophrenia research",NA,"Arce","Claudio","Braulio Aurelio Moyano Neuropsychiatric Hospital, Buenos Aires, Argentina",NA
"1886","34215466","10.1016/j.schres.2021.06.019","An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses.",NA,"2021","07","05","Schizophr Res","Schizophrenia research",NA,"Corral","Ricardo M","José Tiburcio Borda Hospital, Buenos Aires, Argentina",NA
"1887","34215466","10.1016/j.schres.2021.06.019","An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses.",NA,"2021","07","05","Schizophr Res","Schizophrenia research",NA,"Cuesta","Manuel J","Department of Psychiatry, Complejo Hospitalario de Navarra, Pamplona, Spain",NA
"1888","34215466","10.1016/j.schres.2021.06.019","An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses.",NA,"2021","07","05","Schizophr Res","Schizophrenia research",NA,"Farinola","Romina","José Tiburcio Borda Hospital, Buenos Aires, Argentina",NA
"1889","34215466","10.1016/j.schres.2021.06.019","An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses.",NA,"2021","07","05","Schizophr Res","Schizophrenia research",NA,"Alomo","Martín","Braulio Aurelio Moyano Neuropsychiatric Hospital, Buenos Aires, Argentina",NA
"1890","34215453","10.1016/j.vaccine.2021.06.058","Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.","Two mRNA vaccines for COVID-19, Pfizer-BioNTech and Moderna, are approved for emergency use in the United States. After their approval and dosing in millions of recipients, reports of anaphylaxis began to appear in the Vaccine Adverse Reporting System (VAERS). Here we provide an analysis of the relationship between prior history of allergy and/or anaphylaxis and anaphylaxis rates following the administration of mRNA COVID-19 vaccines. Overall reported incidence of anaphylaxis was estimated to be","2021","07","19","Vaccine","Vaccine","Anaphylaxis following COVID-19 vaccine; COVID-19; mRNA vaccine; Anaphylaxis; COVID-19; COVID-19 Vaccines; Humans; RNA, Messenger; SARS-CoV-2; United States; Vaccines","Desai","Aditya P","Indiana University School of Medicine, West Lafayette, IN, USA. Electronic address: adidesai@iu",NA
"1891","34215453","10.1016/j.vaccine.2021.06.058","Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.","Two mRNA vaccines for COVID-19, Pfizer-BioNTech and Moderna, are approved for emergency use in the United States. After their approval and dosing in millions of recipients, reports of anaphylaxis began to appear in the Vaccine Adverse Reporting System (VAERS). Here we provide an analysis of the relationship between prior history of allergy and/or anaphylaxis and anaphylaxis rates following the administration of mRNA COVID-19 vaccines. Overall reported incidence of anaphylaxis was estimated to be","2021","07","19","Vaccine","Vaccine","Anaphylaxis following COVID-19 vaccine; COVID-19; mRNA vaccine; Anaphylaxis; COVID-19; COVID-19 Vaccines; Humans; RNA, Messenger; SARS-CoV-2; United States; Vaccines","Desai","Aryan P","Hamilton Southeastern High School, Fishers, IN, USA",NA
"1892","34215453","10.1016/j.vaccine.2021.06.058","Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.","Two mRNA vaccines for COVID-19, Pfizer-BioNTech and Moderna, are approved for emergency use in the United States. After their approval and dosing in millions of recipients, reports of anaphylaxis began to appear in the Vaccine Adverse Reporting System (VAERS). Here we provide an analysis of the relationship between prior history of allergy and/or anaphylaxis and anaphylaxis rates following the administration of mRNA COVID-19 vaccines. Overall reported incidence of anaphylaxis was estimated to be","2021","07","19","Vaccine","Vaccine","Anaphylaxis following COVID-19 vaccine; COVID-19; mRNA vaccine; Anaphylaxis; COVID-19; COVID-19 Vaccines; Humans; RNA, Messenger; SARS-CoV-2; United States; Vaccines","Loomis","Gregory J","Indiana University School of Medicine, West Lafayette, IN, USA. Electronic address: gjloomis@iu",NA
"1893","34215435","10.1016/j.genhosppsych.2021.06.007","Somatic symptom disorders and long COVID: A critical but overlooked topic.",NA,"2021","07","05","Gen Hosp Psychiatry","General hospital psychiatry","COVID-19; Consultation-liaison psychiatry; Mental health; Somatic symptom disorders","Horn","Mathilde","Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience &amp",NA
"1894","34215435","10.1016/j.genhosppsych.2021.06.007","Somatic symptom disorders and long COVID: A critical but overlooked topic.",NA,"2021","07","05","Gen Hosp Psychiatry","General hospital psychiatry","COVID-19; Consultation-liaison psychiatry; Mental health; Somatic symptom disorders","Fovet","Thomas","Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience &amp",NA
"1895","34215435","10.1016/j.genhosppsych.2021.06.007","Somatic symptom disorders and long COVID: A critical but overlooked topic.",NA,"2021","07","05","Gen Hosp Psychiatry","General hospital psychiatry","COVID-19; Consultation-liaison psychiatry; Mental health; Somatic symptom disorders","Vaiva","Guillaume","Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience &amp",NA
"1896","34215435","10.1016/j.genhosppsych.2021.06.007","Somatic symptom disorders and long COVID: A critical but overlooked topic.",NA,"2021","07","05","Gen Hosp Psychiatry","General hospital psychiatry","COVID-19; Consultation-liaison psychiatry; Mental health; Somatic symptom disorders","D'Hondt","Fabien","Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience &amp",NA
"1897","34215435","10.1016/j.genhosppsych.2021.06.007","Somatic symptom disorders and long COVID: A critical but overlooked topic.",NA,"2021","07","05","Gen Hosp Psychiatry","General hospital psychiatry","COVID-19; Consultation-liaison psychiatry; Mental health; Somatic symptom disorders","Amad","Ali","Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience &amp",NA
"1898","34215432","10.1016/j.bulcan.2021.05.002","[How to deal with an unexpected event that could alter the normal activity of cellular therapy? Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].","The SARS-CoV-2 (COVID-19) pandemic has rapidly impacted cell therapy activities across the globe. Not only was this, unexpected event, a threat to patients who had previously received hematopoietic cell transplantation or other cell therapy such as CAR-T cells, but also, it was responsible for a disruption of cell therapy activities due to the danger of the virus and to the lack of solid scientific data on the management of patients and donors. The Francophone Society of Bone Marrow Transplantat","2021","07","05","Bull Cancer","Bulletin du cancer","Allogeneic/autologous hematopoietic cell transplantation; Allogreffe/autogreffe de cellules souches hématopoïétiques; CAR-T Cells; Cellules CAR-T; Disaster plan; Plan durgence sanitaire; SARS-CoV-2; Unexpected event; Évènements inattendus","Bay","Jacques Olivier","CHU Clermont-Ferrand, Service de thérapie cellulaire et d'hématologie clinique adulte, 1 place Lucie Aubrac, 63000 Clermont-Ferrand, France. Electronic address: jobay@chu-clermontferrand",NA
"1899","34215432","10.1016/j.bulcan.2021.05.002","[How to deal with an unexpected event that could alter the normal activity of cellular therapy? Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].","The SARS-CoV-2 (COVID-19) pandemic has rapidly impacted cell therapy activities across the globe. Not only was this, unexpected event, a threat to patients who had previously received hematopoietic cell transplantation or other cell therapy such as CAR-T cells, but also, it was responsible for a disruption of cell therapy activities due to the danger of the virus and to the lack of solid scientific data on the management of patients and donors. The Francophone Society of Bone Marrow Transplantat","2021","07","05","Bull Cancer","Bulletin du cancer","Allogeneic/autologous hematopoietic cell transplantation; Allogreffe/autogreffe de cellules souches hématopoïétiques; CAR-T Cells; Cellules CAR-T; Disaster plan; Plan durgence sanitaire; SARS-CoV-2; Unexpected event; Évènements inattendus","Beguin","Yves","CHU de Liège et Université de Liège, Service d'Hématologie, Liège, Belgique",NA
"1900","34215432","10.1016/j.bulcan.2021.05.002","[How to deal with an unexpected event that could alter the normal activity of cellular therapy? Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].","The SARS-CoV-2 (COVID-19) pandemic has rapidly impacted cell therapy activities across the globe. Not only was this, unexpected event, a threat to patients who had previously received hematopoietic cell transplantation or other cell therapy such as CAR-T cells, but also, it was responsible for a disruption of cell therapy activities due to the danger of the virus and to the lack of solid scientific data on the management of patients and donors. The Francophone Society of Bone Marrow Transplantat","2021","07","05","Bull Cancer","Bulletin du cancer","Allogeneic/autologous hematopoietic cell transplantation; Allogreffe/autogreffe de cellules souches hématopoïétiques; CAR-T Cells; Cellules CAR-T; Disaster plan; Plan durgence sanitaire; SARS-CoV-2; Unexpected event; Évènements inattendus","Carpentier","Alexandre","Laboratoire de Thérapie Cellulaire, Tour-4E du CHU de Liège, route 1159, Domaine du Sart-Tilman, 4000 Liège, Belgique",NA
"1901","34215432","10.1016/j.bulcan.2021.05.002","[How to deal with an unexpected event that could alter the normal activity of cellular therapy? Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].","The SARS-CoV-2 (COVID-19) pandemic has rapidly impacted cell therapy activities across the globe. Not only was this, unexpected event, a threat to patients who had previously received hematopoietic cell transplantation or other cell therapy such as CAR-T cells, but also, it was responsible for a disruption of cell therapy activities due to the danger of the virus and to the lack of solid scientific data on the management of patients and donors. The Francophone Society of Bone Marrow Transplantat","2021","07","05","Bull Cancer","Bulletin du cancer","Allogeneic/autologous hematopoietic cell transplantation; Allogreffe/autogreffe de cellules souches hématopoïétiques; CAR-T Cells; Cellules CAR-T; Disaster plan; Plan durgence sanitaire; SARS-CoV-2; Unexpected event; Évènements inattendus","Dard","Céline","Laboratoire d'histocompatibilité, EFS Auvergne Rhône Alpes, Site de la Tronche, 29, avenue du Maquis du Grésivaudan, 38701 La Tronche cedex",NA
"1902","34215432","10.1016/j.bulcan.2021.05.002","[How to deal with an unexpected event that could alter the normal activity of cellular therapy? Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].","The SARS-CoV-2 (COVID-19) pandemic has rapidly impacted cell therapy activities across the globe. Not only was this, unexpected event, a threat to patients who had previously received hematopoietic cell transplantation or other cell therapy such as CAR-T cells, but also, it was responsible for a disruption of cell therapy activities due to the danger of the virus and to the lack of solid scientific data on the management of patients and donors. The Francophone Society of Bone Marrow Transplantat","2021","07","05","Bull Cancer","Bulletin du cancer","Allogeneic/autologous hematopoietic cell transplantation; Allogreffe/autogreffe de cellules souches hématopoïétiques; CAR-T Cells; Cellules CAR-T; Disaster plan; Plan durgence sanitaire; SARS-CoV-2; Unexpected event; Évènements inattendus","Guillaume","Thierry","CHU de Nantes, Service d'hématologie clinique, Hôtel Dieu, 1, place Ricordeau, 44000 Nantes, France",NA
"1903","34215432","10.1016/j.bulcan.2021.05.002","[How to deal with an unexpected event that could alter the normal activity of cellular therapy? Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].","The SARS-CoV-2 (COVID-19) pandemic has rapidly impacted cell therapy activities across the globe. Not only was this, unexpected event, a threat to patients who had previously received hematopoietic cell transplantation or other cell therapy such as CAR-T cells, but also, it was responsible for a disruption of cell therapy activities due to the danger of the virus and to the lack of solid scientific data on the management of patients and donors. The Francophone Society of Bone Marrow Transplantat","2021","07","05","Bull Cancer","Bulletin du cancer","Allogeneic/autologous hematopoietic cell transplantation; Allogreffe/autogreffe de cellules souches hématopoïétiques; CAR-T Cells; Cellules CAR-T; Disaster plan; Plan durgence sanitaire; SARS-CoV-2; Unexpected event; Évènements inattendus","Labussiere-Wallet","Hélène","Hôpital Lyon Sud, Service d'hématologie clinique, Hospices Civils de Lyon, Pierre Bénite, France",NA
"1904","34215432","10.1016/j.bulcan.2021.05.002","[How to deal with an unexpected event that could alter the normal activity of cellular therapy? Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].","The SARS-CoV-2 (COVID-19) pandemic has rapidly impacted cell therapy activities across the globe. Not only was this, unexpected event, a threat to patients who had previously received hematopoietic cell transplantation or other cell therapy such as CAR-T cells, but also, it was responsible for a disruption of cell therapy activities due to the danger of the virus and to the lack of solid scientific data on the management of patients and donors. The Francophone Society of Bone Marrow Transplantat","2021","07","05","Bull Cancer","Bulletin du cancer","Allogeneic/autologous hematopoietic cell transplantation; Allogreffe/autogreffe de cellules souches hématopoïétiques; CAR-T Cells; Cellules CAR-T; Disaster plan; Plan durgence sanitaire; SARS-CoV-2; Unexpected event; Évènements inattendus","Lacassagne","Marie Noëlle","Laboratoire de thérapie cellulaire CHU Amiens Picardie, 1, rond point du professeur Christian Cabrol, 80054 Amiens cedex 01, France",NA
"1905","34215432","10.1016/j.bulcan.2021.05.002","[How to deal with an unexpected event that could alter the normal activity of cellular therapy? Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].","The SARS-CoV-2 (COVID-19) pandemic has rapidly impacted cell therapy activities across the globe. Not only was this, unexpected event, a threat to patients who had previously received hematopoietic cell transplantation or other cell therapy such as CAR-T cells, but also, it was responsible for a disruption of cell therapy activities due to the danger of the virus and to the lack of solid scientific data on the management of patients and donors. The Francophone Society of Bone Marrow Transplantat","2021","07","05","Bull Cancer","Bulletin du cancer","Allogeneic/autologous hematopoietic cell transplantation; Allogreffe/autogreffe de cellules souches hématopoïétiques; CAR-T Cells; Cellules CAR-T; Disaster plan; Plan durgence sanitaire; SARS-CoV-2; Unexpected event; Évènements inattendus","Sauze","Séverine","CHU d'Angers, Service d'hématologie, rue Larrey, 49000 Angers, France",NA
"1906","34215432","10.1016/j.bulcan.2021.05.002","[How to deal with an unexpected event that could alter the normal activity of cellular therapy? Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].","The SARS-CoV-2 (COVID-19) pandemic has rapidly impacted cell therapy activities across the globe. Not only was this, unexpected event, a threat to patients who had previously received hematopoietic cell transplantation or other cell therapy such as CAR-T cells, but also, it was responsible for a disruption of cell therapy activities due to the danger of the virus and to the lack of solid scientific data on the management of patients and donors. The Francophone Society of Bone Marrow Transplantat","2021","07","05","Bull Cancer","Bulletin du cancer","Allogeneic/autologous hematopoietic cell transplantation; Allogreffe/autogreffe de cellules souches hématopoïétiques; CAR-T Cells; Cellules CAR-T; Disaster plan; Plan durgence sanitaire; SARS-CoV-2; Unexpected event; Évènements inattendus","Yakoub-Agha","Ibrahim","CHU de Lille, Université Lille, Inserm U1286, Infinite, 59000 Lille, France",NA
"1907","34215432","10.1016/j.bulcan.2021.05.002","[How to deal with an unexpected event that could alter the normal activity of cellular therapy? Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].","The SARS-CoV-2 (COVID-19) pandemic has rapidly impacted cell therapy activities across the globe. Not only was this, unexpected event, a threat to patients who had previously received hematopoietic cell transplantation or other cell therapy such as CAR-T cells, but also, it was responsible for a disruption of cell therapy activities due to the danger of the virus and to the lack of solid scientific data on the management of patients and donors. The Francophone Society of Bone Marrow Transplantat","2021","07","05","Bull Cancer","Bulletin du cancer","Allogeneic/autologous hematopoietic cell transplantation; Allogreffe/autogreffe de cellules souches hématopoïétiques; CAR-T Cells; Cellules CAR-T; Disaster plan; Plan durgence sanitaire; SARS-CoV-2; Unexpected event; Évènements inattendus","Chalandon","Yves","Hôpitaux Universitaires de Genève et Faculté de Médecine, Université de Genève, Service d'hématologie, département d'oncologie, Genève, Suisse",NA
"1908","34215399","10.1016/j.emc.2021.04.004","Just Breathe: Tips and Highlights for Managing Pediatric Respiratory Distress and Failure.","Anatomically, the airway is ever changing in size, anteroposterior alignment, and point of most narrow dimension. Special considerations regarding obesity, chronic and acute illness, underlying developmental abnormalities, and age can all affect preparation and intervention toward securing a definitive airway. Mechanical ventilation strategies should focus on limiting peak inspiratory pressures and optimizing lung protective tidal volumes. Emergency physicians should work toward minimizing risk ","2021","07","13","Emerg Med Clin North Am","Emergency medicine clinics of North America","Airway; Intubation; Laryngoscopy; Noninvasive ventilation; Pediatric; Supraglottic airway; Airway Management; COVID-19; Child; Craniofacial Abnormalities; Critical Care; Equipment Design; Functional Residual Capacity; Heart Arrest; Humans; Hypnotics and Sedatives; Intubation, Intratracheal; Laryngoscopes; Laryngoscopy; Larynx; Neuromuscular Diseases; Noninvasive Ventilation; Oxygen Inhalation Therapy; Pediatric Emergency Medicine; Pediatric Obesity; Positive-Pressure Respiration; Respiratory Distress Syndrome; Respiratory Insufficiency; Video Recording","Cobb","Megan J","University of Maryland School of Medicine, Department of Emergency Medicine","Megan.Cobb@som.umaryland.edu"
"1909","34215396","10.1016/j.emc.2021.04.002","Emerging and Re-emerging Infections in Children: COVID/ MIS-C, Zika, Ebola, Measles, Varicella, Pertussis ... Immunizations.","The role of the emergency provider lies at the forefront of recognition and treatment of novel and re-emerging infectious diseases in children. Familiarity with disease presentations that might be considered rare, such as vaccine-preventable and non-endemic illnesses, is essential in identifying and controlling outbreaks. As we have seen thus far in the novel coronavirus pandemic, susceptibility, severity, transmission, and disease presentation can all have unique patterns in children. Emergency","2021","07","12","Emerg Med Clin North Am","Emergency medicine clinics of North America","COVID-19; Emerging infections; Re-emerging infections; Traveler; Vaccine-preventable; COVID-19; Chickenpox; Chikungunya Fever; Child; Communicable Diseases, Emerging; Decision Trees; Dengue; Emergency Medicine; Hemorrhagic Fever, Ebola; Humans; Incidence; Malaria; Measles; Pediatrics; Physician's Role; Public Health; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Travel-Related Illness; Vaccination; Vaccination Refusal; Whooping Cough; Zika Virus Infection","Chen","Carol C","Department of Emergency Medicine, Division of Pediatric Emergency Medicine, University of California San Francisco, 550 16th Street, Box 0632, San Francisco, CA 94143, USA. Electronic address: carol.chen@ucsf","carol.chen@ucsf.edu"
"1910","34215396","10.1016/j.emc.2021.04.002","Emerging and Re-emerging Infections in Children: COVID/ MIS-C, Zika, Ebola, Measles, Varicella, Pertussis ... Immunizations.","The role of the emergency provider lies at the forefront of recognition and treatment of novel and re-emerging infectious diseases in children. Familiarity with disease presentations that might be considered rare, such as vaccine-preventable and non-endemic illnesses, is essential in identifying and controlling outbreaks. As we have seen thus far in the novel coronavirus pandemic, susceptibility, severity, transmission, and disease presentation can all have unique patterns in children. Emergency","2021","07","12","Emerg Med Clin North Am","Emergency medicine clinics of North America","COVID-19; Emerging infections; Re-emerging infections; Traveler; Vaccine-preventable; COVID-19; Chickenpox; Chikungunya Fever; Child; Communicable Diseases, Emerging; Decision Trees; Dengue; Emergency Medicine; Hemorrhagic Fever, Ebola; Humans; Incidence; Malaria; Measles; Pediatrics; Physician's Role; Public Health; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Travel-Related Illness; Vaccination; Vaccination Refusal; Whooping Cough; Zika Virus Infection","Whitehead","Anne","Department of Emergency Medicine, Division of Pediatric Emergency Medicine, Indiana University School of Medicine, 720 Eskenazi Avenue, FT 3rd Floor, FOB, Indianapolis, IN 46202, USA",NA
"1911","34215381","10.1016/j.ncl.2021.05.002","Neurology in a Pandemic.","The adaption of online or virtual technologies to deliver care, to meet professionally, and to interview has transformed child neurology. Although these technologies were brought to bear out of necessity, it is hoped that in a postpandemic world, these useful tools will continue to benefit the field. Here we discuss the tools and their future.","2021","07","12","Neurol Clin","Neurologic clinics","COVID-19; Online; Telemedicine; Teleneurology; Virtual meetings; COVID-19; Child; Humans; Nervous System Diseases; Neurology; Pediatrics; Telemedicine","Clark","Gary D","Neurology and Developmental Neuroscience, Baylor College of Medicine, Neurology Service, Texas Children's Hospital, Texas Neurological Society, 6701 Fannin St., Suite MWT 1250, Houston, TX 77030, USA. Electronic address: gclark@bcm","gclark@bcm.edu"
"1912","34215381","10.1016/j.ncl.2021.05.002","Neurology in a Pandemic.","The adaption of online or virtual technologies to deliver care, to meet professionally, and to interview has transformed child neurology. Although these technologies were brought to bear out of necessity, it is hoped that in a postpandemic world, these useful tools will continue to benefit the field. Here we discuss the tools and their future.","2021","07","12","Neurol Clin","Neurologic clinics","COVID-19; Online; Telemedicine; Teleneurology; Virtual meetings; COVID-19; Child; Humans; Nervous System Diseases; Neurology; Pediatrics; Telemedicine","Lotze","Timothy E","Baylor College of Medicine, Child Neurology, Division of Neurology and Developmental Neuroscience, Texas Children's Hospital, Child Neurology, 6701 Fannin St., Suite MWT 1250, Houston, TX 77030, USA",NA
"1913","34215363","10.1016/j.hlc.2021.06.001","Atrial Fibrillation in COVID-19: Therapeutic Target or Grave Omen?",NA,"2021","07","12","Heart Lung Circ","Heart, lung &amp; circulation","Atrial fibrillation; COVID-19; Atrial Fibrillation; COVID-19; Humans; Prognosis; SARS-CoV-2","Khan","Hassan","Leon H. Charney Division of Cardiology, New York University Langone Health, New York, NY, USA",NA
"1914","34215363","10.1016/j.hlc.2021.06.001","Atrial Fibrillation in COVID-19: Therapeutic Target or Grave Omen?",NA,"2021","07","12","Heart Lung Circ","Heart, lung &amp; circulation","Atrial fibrillation; COVID-19; Atrial Fibrillation; COVID-19; Humans; Prognosis; SARS-CoV-2","Barbhaiya","Chirag","Leon H. Charney Division of Cardiology, New York University Langone Health, New York, NY, USA. Electronic address: chirag.barbhaiya@nyulangone","chirag.barbhaiya@nyulangone.org"
"1915","34215354","10.1016/j.amjcard.2021.05.031","Left Bundle Branch Block and Mortality in COVID-19 Patients.",NA,"2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Zuin","Marco","Department of Translational Medicine, University of Ferrara, Ferrara, Italy. Electronic address: marco.zuin@edu.unife","marco.zuin@edu.unife.it"
"1916","34215354","10.1016/j.amjcard.2021.05.031","Left Bundle Branch Block and Mortality in COVID-19 Patients.",NA,"2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Rigatelli","Gianluca","Department of Cardiology, Rovigo General Hospital, Rovigo, Italy",NA
"1917","34215354","10.1016/j.amjcard.2021.05.031","Left Bundle Branch Block and Mortality in COVID-19 Patients.",NA,"2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Roncon","Loris","Department of Cardiology, Rovigo General Hospital, Rovigo, Italy",NA
"1918","34215354","10.1016/j.amjcard.2021.05.031","Left Bundle Branch Block and Mortality in COVID-19 Patients.",NA,"2021","07","24","Am J Cardiol","The American journal of cardiology",NA,"Zuliani","Giovanni","Department of Translational Medicine, University of Ferrara, Ferrara, Italy",NA
"1919","34215340","10.1186/s40337-021-00437-1","COVID-19 and eating disorder and mental health concerns in patients with eating disorders.","The Coronavirus (COVID-19) pandemic dramatically transformed daily life for adolescents and young adults, altering social and physical environments. Previous research has shown such shifts in daily life to be especially challenging for people living with eating disorders (ED). However, the extent of this environmental change on ED symptoms and mental health (MH) has been relatively unexplored in patients with EDs. This study examines how young people with EDs feel the COVID-19 pandemic has affec","2021","07","07","J Eat Disord","Journal of eating disorders","Adolescents; COVID-19; Comorbidity; Eating disorders; Mental health; Mental health recovery","Vitagliano","Julia A","Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, 300 Longwood Ave, Boston, 02115, MA, USA. julia.a.vitagliano@gmail","julia.a.vitagliano@gmail.com"
"1920","34215340","10.1186/s40337-021-00437-1","COVID-19 and eating disorder and mental health concerns in patients with eating disorders.","The Coronavirus (COVID-19) pandemic dramatically transformed daily life for adolescents and young adults, altering social and physical environments. Previous research has shown such shifts in daily life to be especially challenging for people living with eating disorders (ED). However, the extent of this environmental change on ED symptoms and mental health (MH) has been relatively unexplored in patients with EDs. This study examines how young people with EDs feel the COVID-19 pandemic has affec","2021","07","07","J Eat Disord","Journal of eating disorders","Adolescents; COVID-19; Comorbidity; Eating disorders; Mental health; Mental health recovery","Jhe","Grace","Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, 300 Longwood Ave, Boston, 02115, MA, USA",NA
"1921","34215340","10.1186/s40337-021-00437-1","COVID-19 and eating disorder and mental health concerns in patients with eating disorders.","The Coronavirus (COVID-19) pandemic dramatically transformed daily life for adolescents and young adults, altering social and physical environments. Previous research has shown such shifts in daily life to be especially challenging for people living with eating disorders (ED). However, the extent of this environmental change on ED symptoms and mental health (MH) has been relatively unexplored in patients with EDs. This study examines how young people with EDs feel the COVID-19 pandemic has affec","2021","07","07","J Eat Disord","Journal of eating disorders","Adolescents; COVID-19; Comorbidity; Eating disorders; Mental health; Mental health recovery","Milliren","Carly E","Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, 300 Longwood Ave, Boston, 02115, MA, USA",NA
"1922","34215340","10.1186/s40337-021-00437-1","COVID-19 and eating disorder and mental health concerns in patients with eating disorders.","The Coronavirus (COVID-19) pandemic dramatically transformed daily life for adolescents and young adults, altering social and physical environments. Previous research has shown such shifts in daily life to be especially challenging for people living with eating disorders (ED). However, the extent of this environmental change on ED symptoms and mental health (MH) has been relatively unexplored in patients with EDs. This study examines how young people with EDs feel the COVID-19 pandemic has affec","2021","07","07","J Eat Disord","Journal of eating disorders","Adolescents; COVID-19; Comorbidity; Eating disorders; Mental health; Mental health recovery","Lin","Jessica A","Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, 300 Longwood Ave, Boston, 02115, MA, USA",NA
"1923","34215340","10.1186/s40337-021-00437-1","COVID-19 and eating disorder and mental health concerns in patients with eating disorders.","The Coronavirus (COVID-19) pandemic dramatically transformed daily life for adolescents and young adults, altering social and physical environments. Previous research has shown such shifts in daily life to be especially challenging for people living with eating disorders (ED). However, the extent of this environmental change on ED symptoms and mental health (MH) has been relatively unexplored in patients with EDs. This study examines how young people with EDs feel the COVID-19 pandemic has affec","2021","07","07","J Eat Disord","Journal of eating disorders","Adolescents; COVID-19; Comorbidity; Eating disorders; Mental health; Mental health recovery","Spigel","Rebecca","Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, 300 Longwood Ave, Boston, 02115, MA, USA",NA
"1924","34215340","10.1186/s40337-021-00437-1","COVID-19 and eating disorder and mental health concerns in patients with eating disorders.","The Coronavirus (COVID-19) pandemic dramatically transformed daily life for adolescents and young adults, altering social and physical environments. Previous research has shown such shifts in daily life to be especially challenging for people living with eating disorders (ED). However, the extent of this environmental change on ED symptoms and mental health (MH) has been relatively unexplored in patients with EDs. This study examines how young people with EDs feel the COVID-19 pandemic has affec","2021","07","07","J Eat Disord","Journal of eating disorders","Adolescents; COVID-19; Comorbidity; Eating disorders; Mental health; Mental health recovery","Freizinger","Melissa","Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, 300 Longwood Ave, Boston, 02115, MA, USA",NA
"1925","34215340","10.1186/s40337-021-00437-1","COVID-19 and eating disorder and mental health concerns in patients with eating disorders.","The Coronavirus (COVID-19) pandemic dramatically transformed daily life for adolescents and young adults, altering social and physical environments. Previous research has shown such shifts in daily life to be especially challenging for people living with eating disorders (ED). However, the extent of this environmental change on ED symptoms and mental health (MH) has been relatively unexplored in patients with EDs. This study examines how young people with EDs feel the COVID-19 pandemic has affec","2021","07","07","J Eat Disord","Journal of eating disorders","Adolescents; COVID-19; Comorbidity; Eating disorders; Mental health; Mental health recovery","Woods","Elizabeth R","Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, 300 Longwood Ave, Boston, 02115, MA, USA",NA
"1926","34215340","10.1186/s40337-021-00437-1","COVID-19 and eating disorder and mental health concerns in patients with eating disorders.","The Coronavirus (COVID-19) pandemic dramatically transformed daily life for adolescents and young adults, altering social and physical environments. Previous research has shown such shifts in daily life to be especially challenging for people living with eating disorders (ED). However, the extent of this environmental change on ED symptoms and mental health (MH) has been relatively unexplored in patients with EDs. This study examines how young people with EDs feel the COVID-19 pandemic has affec","2021","07","07","J Eat Disord","Journal of eating disorders","Adolescents; COVID-19; Comorbidity; Eating disorders; Mental health; Mental health recovery","Forman","Sara F","Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, 300 Longwood Ave, Boston, 02115, MA, USA",NA
"1927","34215340","10.1186/s40337-021-00437-1","COVID-19 and eating disorder and mental health concerns in patients with eating disorders.","The Coronavirus (COVID-19) pandemic dramatically transformed daily life for adolescents and young adults, altering social and physical environments. Previous research has shown such shifts in daily life to be especially challenging for people living with eating disorders (ED). However, the extent of this environmental change on ED symptoms and mental health (MH) has been relatively unexplored in patients with EDs. This study examines how young people with EDs feel the COVID-19 pandemic has affec","2021","07","07","J Eat Disord","Journal of eating disorders","Adolescents; COVID-19; Comorbidity; Eating disorders; Mental health; Mental health recovery","Richmond","Tracy K","Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, 300 Longwood Ave, Boston, 02115, MA, USA",NA
"1928","34215337","10.1186/s13643-021-01749-8","Racial and ethnic disparities in viral acute respiratory infections in the United States: protocol of a systematic review.","The COVID-19 pandemic caused by SARS-CoV-2 has highlighted consistent inequities in incidence, disease severity, and mortality across racial and ethnic minority populations in the United States (US) and beyond. While similar patterns have been observed with previous viral respiratory pathogens, to date, no systematic review has comprehensively documented these disparities or potential contributing factors. In response, this review aims to synthesize data on racial and ethnic disparities in morbi","2021","07","08","Syst Rev","Systematic reviews","Acute respiratory infection; Health disparities; Influenza-like illness; Pandemic preparedness; Pandemic response; Racial disparities; Structural racism; COVID-19; Ethnic Groups; Humans; Minority Groups; Pandemics; Respiratory Tract Infections; SARS-CoV-2; Systematic Reviews as Topic; United States","Prata Menezes","Neia","Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. nprata@jhu","nprata@jhu.edu"
"1929","34215337","10.1186/s13643-021-01749-8","Racial and ethnic disparities in viral acute respiratory infections in the United States: protocol of a systematic review.","The COVID-19 pandemic caused by SARS-CoV-2 has highlighted consistent inequities in incidence, disease severity, and mortality across racial and ethnic minority populations in the United States (US) and beyond. While similar patterns have been observed with previous viral respiratory pathogens, to date, no systematic review has comprehensively documented these disparities or potential contributing factors. In response, this review aims to synthesize data on racial and ethnic disparities in morbi","2021","07","08","Syst Rev","Systematic reviews","Acute respiratory infection; Health disparities; Influenza-like illness; Pandemic preparedness; Pandemic response; Racial disparities; Structural racism; COVID-19; Ethnic Groups; Humans; Minority Groups; Pandemics; Respiratory Tract Infections; SARS-CoV-2; Systematic Reviews as Topic; United States","Malone","Jowanna","Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA",NA
"1930","34215337","10.1186/s13643-021-01749-8","Racial and ethnic disparities in viral acute respiratory infections in the United States: protocol of a systematic review.","The COVID-19 pandemic caused by SARS-CoV-2 has highlighted consistent inequities in incidence, disease severity, and mortality across racial and ethnic minority populations in the United States (US) and beyond. While similar patterns have been observed with previous viral respiratory pathogens, to date, no systematic review has comprehensively documented these disparities or potential contributing factors. In response, this review aims to synthesize data on racial and ethnic disparities in morbi","2021","07","08","Syst Rev","Systematic reviews","Acute respiratory infection; Health disparities; Influenza-like illness; Pandemic preparedness; Pandemic response; Racial disparities; Structural racism; COVID-19; Ethnic Groups; Humans; Minority Groups; Pandemics; Respiratory Tract Infections; SARS-CoV-2; Systematic Reviews as Topic; United States","Lyons","Carrie","Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA",NA
"1931","34215337","10.1186/s13643-021-01749-8","Racial and ethnic disparities in viral acute respiratory infections in the United States: protocol of a systematic review.","The COVID-19 pandemic caused by SARS-CoV-2 has highlighted consistent inequities in incidence, disease severity, and mortality across racial and ethnic minority populations in the United States (US) and beyond. While similar patterns have been observed with previous viral respiratory pathogens, to date, no systematic review has comprehensively documented these disparities or potential contributing factors. In response, this review aims to synthesize data on racial and ethnic disparities in morbi","2021","07","08","Syst Rev","Systematic reviews","Acute respiratory infection; Health disparities; Influenza-like illness; Pandemic preparedness; Pandemic response; Racial disparities; Structural racism; COVID-19; Ethnic Groups; Humans; Minority Groups; Pandemics; Respiratory Tract Infections; SARS-CoV-2; Systematic Reviews as Topic; United States","Cadet","Kechna","Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA",NA
"1932","34215337","10.1186/s13643-021-01749-8","Racial and ethnic disparities in viral acute respiratory infections in the United States: protocol of a systematic review.","The COVID-19 pandemic caused by SARS-CoV-2 has highlighted consistent inequities in incidence, disease severity, and mortality across racial and ethnic minority populations in the United States (US) and beyond. While similar patterns have been observed with previous viral respiratory pathogens, to date, no systematic review has comprehensively documented these disparities or potential contributing factors. In response, this review aims to synthesize data on racial and ethnic disparities in morbi","2021","07","08","Syst Rev","Systematic reviews","Acute respiratory infection; Health disparities; Influenza-like illness; Pandemic preparedness; Pandemic response; Racial disparities; Structural racism; COVID-19; Ethnic Groups; Humans; Minority Groups; Pandemics; Respiratory Tract Infections; SARS-CoV-2; Systematic Reviews as Topic; United States","Dean","Lorraine","Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA",NA
"1933","34215337","10.1186/s13643-021-01749-8","Racial and ethnic disparities in viral acute respiratory infections in the United States: protocol of a systematic review.","The COVID-19 pandemic caused by SARS-CoV-2 has highlighted consistent inequities in incidence, disease severity, and mortality across racial and ethnic minority populations in the United States (US) and beyond. While similar patterns have been observed with previous viral respiratory pathogens, to date, no systematic review has comprehensively documented these disparities or potential contributing factors. In response, this review aims to synthesize data on racial and ethnic disparities in morbi","2021","07","08","Syst Rev","Systematic reviews","Acute respiratory infection; Health disparities; Influenza-like illness; Pandemic preparedness; Pandemic response; Racial disparities; Structural racism; COVID-19; Ethnic Groups; Humans; Minority Groups; Pandemics; Respiratory Tract Infections; SARS-CoV-2; Systematic Reviews as Topic; United States","Millett","Gregorio","Public Policy Office, AmfAR, Foundation for AIDS Research, Washington, DC, USA",NA
"1934","34215337","10.1186/s13643-021-01749-8","Racial and ethnic disparities in viral acute respiratory infections in the United States: protocol of a systematic review.","The COVID-19 pandemic caused by SARS-CoV-2 has highlighted consistent inequities in incidence, disease severity, and mortality across racial and ethnic minority populations in the United States (US) and beyond. While similar patterns have been observed with previous viral respiratory pathogens, to date, no systematic review has comprehensively documented these disparities or potential contributing factors. In response, this review aims to synthesize data on racial and ethnic disparities in morbi","2021","07","08","Syst Rev","Systematic reviews","Acute respiratory infection; Health disparities; Influenza-like illness; Pandemic preparedness; Pandemic response; Racial disparities; Structural racism; COVID-19; Ethnic Groups; Humans; Minority Groups; Pandemics; Respiratory Tract Infections; SARS-CoV-2; Systematic Reviews as Topic; United States","Baral","Stefan","Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA",NA
"1935","34215330","10.1186/s13756-021-00971-2","Development of a web-based contact tracing and point-of-care-testing workflow for SARS-CoV-2 at a German University Hospital.","In late 2019, a novel coronavirus was detected in China. Supported by its respiratory transmissibility, even by people infected without symptomatic disease, this coronavirus soon began to rapidly spread worldwide. Many countries have implemented different infection control and containment strategies due to ongoing community transmission. In this context, contact tracing as well as adequate testing and consequent quarantining of high-risk contacts play leading roles in containing the virus by int","2021","07","09","Antimicrob Resist Infect Control","Antimicrobial resistance and infection control","Contact tracing; Digital tools; Hospital environment; SARS-CoV-2; COVID-19; COVID-19 Nucleic Acid Testing; Computer Communication Networks; Contact Tracing; Germany; Hospitals, University; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Infectious Disease Transmission, Professional-to-Patient; Mobile Applications; Pandemics; Personnel, Hospital; Point-of-Care Testing; Real-Time Polymerase Chain Reaction; Retrospective Studies; SARS-CoV-2; Seasons; Software; Workflow","Zirbes","Julian","Division of Infection Control and Hospital Epidemiology, Marburg University Hospital, Baldingerstrasse 1, 35043, Marburg, Germany",NA
"1936","34215330","10.1186/s13756-021-00971-2","Development of a web-based contact tracing and point-of-care-testing workflow for SARS-CoV-2 at a German University Hospital.","In late 2019, a novel coronavirus was detected in China. Supported by its respiratory transmissibility, even by people infected without symptomatic disease, this coronavirus soon began to rapidly spread worldwide. Many countries have implemented different infection control and containment strategies due to ongoing community transmission. In this context, contact tracing as well as adequate testing and consequent quarantining of high-risk contacts play leading roles in containing the virus by int","2021","07","09","Antimicrob Resist Infect Control","Antimicrobial resistance and infection control","Contact tracing; Digital tools; Hospital environment; SARS-CoV-2; COVID-19; COVID-19 Nucleic Acid Testing; Computer Communication Networks; Contact Tracing; Germany; Hospitals, University; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Infectious Disease Transmission, Professional-to-Patient; Mobile Applications; Pandemics; Personnel, Hospital; Point-of-Care Testing; Real-Time Polymerase Chain Reaction; Retrospective Studies; SARS-CoV-2; Seasons; Software; Workflow","Sterr","Christian M","Division of Infection Control and Hospital Epidemiology, Marburg University Hospital, Baldingerstrasse 1, 35043, Marburg, Germany",NA
"1937","34215330","10.1186/s13756-021-00971-2","Development of a web-based contact tracing and point-of-care-testing workflow for SARS-CoV-2 at a German University Hospital.","In late 2019, a novel coronavirus was detected in China. Supported by its respiratory transmissibility, even by people infected without symptomatic disease, this coronavirus soon began to rapidly spread worldwide. Many countries have implemented different infection control and containment strategies due to ongoing community transmission. In this context, contact tracing as well as adequate testing and consequent quarantining of high-risk contacts play leading roles in containing the virus by int","2021","07","09","Antimicrob Resist Infect Control","Antimicrobial resistance and infection control","Contact tracing; Digital tools; Hospital environment; SARS-CoV-2; COVID-19; COVID-19 Nucleic Acid Testing; Computer Communication Networks; Contact Tracing; Germany; Hospitals, University; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Infectious Disease Transmission, Professional-to-Patient; Mobile Applications; Pandemics; Personnel, Hospital; Point-of-Care Testing; Real-Time Polymerase Chain Reaction; Retrospective Studies; SARS-CoV-2; Seasons; Software; Workflow","Steller","Marcus","Division of Information Technology, Marburg University Hospital, Marburg, Germany",NA
"1938","34215330","10.1186/s13756-021-00971-2","Development of a web-based contact tracing and point-of-care-testing workflow for SARS-CoV-2 at a German University Hospital.","In late 2019, a novel coronavirus was detected in China. Supported by its respiratory transmissibility, even by people infected without symptomatic disease, this coronavirus soon began to rapidly spread worldwide. Many countries have implemented different infection control and containment strategies due to ongoing community transmission. In this context, contact tracing as well as adequate testing and consequent quarantining of high-risk contacts play leading roles in containing the virus by int","2021","07","09","Antimicrob Resist Infect Control","Antimicrobial resistance and infection control","Contact tracing; Digital tools; Hospital environment; SARS-CoV-2; COVID-19; COVID-19 Nucleic Acid Testing; Computer Communication Networks; Contact Tracing; Germany; Hospitals, University; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Infectious Disease Transmission, Professional-to-Patient; Mobile Applications; Pandemics; Personnel, Hospital; Point-of-Care Testing; Real-Time Polymerase Chain Reaction; Retrospective Studies; SARS-CoV-2; Seasons; Software; Workflow","Dapper","Laura","Division of Infection Control and Hospital Epidemiology, Marburg University Hospital, Baldingerstrasse 1, 35043, Marburg, Germany",NA
"1939","34215330","10.1186/s13756-021-00971-2","Development of a web-based contact tracing and point-of-care-testing workflow for SARS-CoV-2 at a German University Hospital.","In late 2019, a novel coronavirus was detected in China. Supported by its respiratory transmissibility, even by people infected without symptomatic disease, this coronavirus soon began to rapidly spread worldwide. Many countries have implemented different infection control and containment strategies due to ongoing community transmission. In this context, contact tracing as well as adequate testing and consequent quarantining of high-risk contacts play leading roles in containing the virus by int","2021","07","09","Antimicrob Resist Infect Control","Antimicrobial resistance and infection control","Contact tracing; Digital tools; Hospital environment; SARS-CoV-2; COVID-19; COVID-19 Nucleic Acid Testing; Computer Communication Networks; Contact Tracing; Germany; Hospitals, University; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Infectious Disease Transmission, Professional-to-Patient; Mobile Applications; Pandemics; Personnel, Hospital; Point-of-Care Testing; Real-Time Polymerase Chain Reaction; Retrospective Studies; SARS-CoV-2; Seasons; Software; Workflow","Nonnenmacher-Winter","Claudia","Division of Infection Control and Hospital Epidemiology, Marburg University Hospital, Baldingerstrasse 1, 35043, Marburg, Germany",NA
"1940","34215330","10.1186/s13756-021-00971-2","Development of a web-based contact tracing and point-of-care-testing workflow for SARS-CoV-2 at a German University Hospital.","In late 2019, a novel coronavirus was detected in China. Supported by its respiratory transmissibility, even by people infected without symptomatic disease, this coronavirus soon began to rapidly spread worldwide. Many countries have implemented different infection control and containment strategies due to ongoing community transmission. In this context, contact tracing as well as adequate testing and consequent quarantining of high-risk contacts play leading roles in containing the virus by int","2021","07","09","Antimicrob Resist Infect Control","Antimicrobial resistance and infection control","Contact tracing; Digital tools; Hospital environment; SARS-CoV-2; COVID-19; COVID-19 Nucleic Acid Testing; Computer Communication Networks; Contact Tracing; Germany; Hospitals, University; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Infectious Disease Transmission, Professional-to-Patient; Mobile Applications; Pandemics; Personnel, Hospital; Point-of-Care Testing; Real-Time Polymerase Chain Reaction; Retrospective Studies; SARS-CoV-2; Seasons; Software; Workflow","Günther","Frank","Division of Infection Control and Hospital Epidemiology, Marburg University Hospital, Baldingerstrasse 1, 35043, Marburg, Germany. frank.guenther@staff.uni-marburg","frank.guenther@staff.uni"
"1941","34215311","10.1186/s13052-021-01102-8","Smartphone use and addiction during the coronavirus disease 2019 (COVID-19) pandemic: cohort study on 184 Italian children and adolescents.","The lives of many children and adolescents are today increasingly influenced by new technological devices, including smartphones. The coronavirus disease 2019 (COVID-19) pandemic occurred in a time of outstanding scientific progress and global digitalization. Young people had relevant adverse psychological and behavioral effects due to the COVID-19 pandemic, mainly related to infection control measures, which led them to spend more time at home and with major use of technological tools. The goal","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","Addiction; COVID-19; Italy; School-age children; Smartphone; Adolescent; Behavior, Addictive; COVID-19; Child; Female; Humans; Italy; Male; Pandemics; SARS-CoV-2; Self Report; Smartphone; Social Isolation","Serra","Gregorio","Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties ""G. D'Alessandro"", University of Palermo, Palermo, Italy. gregorio.serra@unipa","gregorio.serra@unipa.it"
"1942","34215311","10.1186/s13052-021-01102-8","Smartphone use and addiction during the coronavirus disease 2019 (COVID-19) pandemic: cohort study on 184 Italian children and adolescents.","The lives of many children and adolescents are today increasingly influenced by new technological devices, including smartphones. The coronavirus disease 2019 (COVID-19) pandemic occurred in a time of outstanding scientific progress and global digitalization. Young people had relevant adverse psychological and behavioral effects due to the COVID-19 pandemic, mainly related to infection control measures, which led them to spend more time at home and with major use of technological tools. The goal","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","Addiction; COVID-19; Italy; School-age children; Smartphone; Adolescent; Behavior, Addictive; COVID-19; Child; Female; Humans; Italy; Male; Pandemics; SARS-CoV-2; Self Report; Smartphone; Social Isolation","Lo Scalzo","Lucia","Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties ""G. D'Alessandro"", University of Palermo, Palermo, Italy",NA
"1943","34215311","10.1186/s13052-021-01102-8","Smartphone use and addiction during the coronavirus disease 2019 (COVID-19) pandemic: cohort study on 184 Italian children and adolescents.","The lives of many children and adolescents are today increasingly influenced by new technological devices, including smartphones. The coronavirus disease 2019 (COVID-19) pandemic occurred in a time of outstanding scientific progress and global digitalization. Young people had relevant adverse psychological and behavioral effects due to the COVID-19 pandemic, mainly related to infection control measures, which led them to spend more time at home and with major use of technological tools. The goal","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","Addiction; COVID-19; Italy; School-age children; Smartphone; Adolescent; Behavior, Addictive; COVID-19; Child; Female; Humans; Italy; Male; Pandemics; SARS-CoV-2; Self Report; Smartphone; Social Isolation","Giuffrè","Mario","Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties ""G. D'Alessandro"", University of Palermo, Palermo, Italy",NA
"1944","34215311","10.1186/s13052-021-01102-8","Smartphone use and addiction during the coronavirus disease 2019 (COVID-19) pandemic: cohort study on 184 Italian children and adolescents.","The lives of many children and adolescents are today increasingly influenced by new technological devices, including smartphones. The coronavirus disease 2019 (COVID-19) pandemic occurred in a time of outstanding scientific progress and global digitalization. Young people had relevant adverse psychological and behavioral effects due to the COVID-19 pandemic, mainly related to infection control measures, which led them to spend more time at home and with major use of technological tools. The goal","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","Addiction; COVID-19; Italy; School-age children; Smartphone; Adolescent; Behavior, Addictive; COVID-19; Child; Female; Humans; Italy; Male; Pandemics; SARS-CoV-2; Self Report; Smartphone; Social Isolation","Ferrara","Pietro","Unit of Pediatrics, Campus Bio-Medico University, Rome, Italy",NA
"1945","34215311","10.1186/s13052-021-01102-8","Smartphone use and addiction during the coronavirus disease 2019 (COVID-19) pandemic: cohort study on 184 Italian children and adolescents.","The lives of many children and adolescents are today increasingly influenced by new technological devices, including smartphones. The coronavirus disease 2019 (COVID-19) pandemic occurred in a time of outstanding scientific progress and global digitalization. Young people had relevant adverse psychological and behavioral effects due to the COVID-19 pandemic, mainly related to infection control measures, which led them to spend more time at home and with major use of technological tools. The goal","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","Addiction; COVID-19; Italy; School-age children; Smartphone; Adolescent; Behavior, Addictive; COVID-19; Child; Female; Humans; Italy; Male; Pandemics; SARS-CoV-2; Self Report; Smartphone; Social Isolation","Corsello","Giovanni","Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties ""G. D'Alessandro"", University of Palermo, Palermo, Italy",NA
"1946","34215274","10.1186/s12939-021-01445-y","Health and socio-demographic implications of the Covid-19 second pandemic wave in Israel, compared with the first wave.","Israel's containment of the first wave of Covid-19 was relatively successful. Soon afterwards, however, in the summer months, a harsher pandemic wave developed, resulting in many more seriously ill and dead Israelis. Israel was the world's first country to impose a second general lockdown. The present study outlines the early months of Israel's second pandemic wave, until the imposition of the second general lockdown, and their impact on various communities. The investigation is conducted in con","2021","07","08","Int J Equity Health","International journal for equity in health","Arab; Covid-19; Elderly population; Israel; Jewish; Minority; Morbidity rate; Population density; Socioeconomic status; Vulnerable populations; Aged; Aged, 80 and over; Arabs; COVID-19; Cross-Sectional Studies; Female; Health Status Disparities; Humans; Israel; Jews; Male; Minority Groups; Morbidity; Pandemics; Population Density; Religion; Social Class","Birenbaum-Carmeli","Daphna","Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel. daphna@research.haifa.ac","daphna@research.haifa.ac.il"
"1947","34215274","10.1186/s12939-021-01445-y","Health and socio-demographic implications of the Covid-19 second pandemic wave in Israel, compared with the first wave.","Israel's containment of the first wave of Covid-19 was relatively successful. Soon afterwards, however, in the summer months, a harsher pandemic wave developed, resulting in many more seriously ill and dead Israelis. Israel was the world's first country to impose a second general lockdown. The present study outlines the early months of Israel's second pandemic wave, until the imposition of the second general lockdown, and their impact on various communities. The investigation is conducted in con","2021","07","08","Int J Equity Health","International journal for equity in health","Arab; Covid-19; Elderly population; Israel; Jewish; Minority; Morbidity rate; Population density; Socioeconomic status; Vulnerable populations; Aged; Aged, 80 and over; Arabs; COVID-19; Cross-Sectional Studies; Female; Health Status Disparities; Humans; Israel; Jews; Male; Minority Groups; Morbidity; Pandemics; Population Density; Religion; Social Class","Chassida","Judith","Department of Education, Herzog College, Jerusalem, Israel",NA
"1948","34215246","10.1186/s12889-021-11294-7","Self-reported changes in physical activity, sedentary behavior, and screen time among informal caregivers during the COVID-19 pandemic.","Informal caregivers providing unpaid assistance may be vulnerable to changes in health behaviors due to modifications in caregiving during the COVID-19 pandemic. Therefore, this cross-sectional study explored self-reported changes in physical activity (PA), sedentary behavior, and screen time among informal caregivers providing care for older adults aged 50+ during the pandemic. Study participants were recruited via Amazon's Mechanical Turk and reported their perceived changes (increased a lot, ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Informal caregivers; Physical activity; Screen time; Sedentary behavior; Aged; COVID-19; Caregivers; Cross-Sectional Studies; Exercise; Female; Humans; Male; Pandemics; SARS-CoV-2; Screen Time; Sedentary Behavior; Self Report","Greaney","Mary L","Department of Health Studies, University of Rhode Island, 25 West Independent Way, Kingston, Rhode Island, 02881, USA. mgreaney@uri","mgreaney@uri.edu"
"1949","34215246","10.1186/s12889-021-11294-7","Self-reported changes in physical activity, sedentary behavior, and screen time among informal caregivers during the COVID-19 pandemic.","Informal caregivers providing unpaid assistance may be vulnerable to changes in health behaviors due to modifications in caregiving during the COVID-19 pandemic. Therefore, this cross-sectional study explored self-reported changes in physical activity (PA), sedentary behavior, and screen time among informal caregivers providing care for older adults aged 50+ during the pandemic. Study participants were recruited via Amazon's Mechanical Turk and reported their perceived changes (increased a lot, ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Informal caregivers; Physical activity; Screen time; Sedentary behavior; Aged; COVID-19; Caregivers; Cross-Sectional Studies; Exercise; Female; Humans; Male; Pandemics; SARS-CoV-2; Screen Time; Sedentary Behavior; Self Report","Kunicki","Zachary J","Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA",NA
"1950","34215246","10.1186/s12889-021-11294-7","Self-reported changes in physical activity, sedentary behavior, and screen time among informal caregivers during the COVID-19 pandemic.","Informal caregivers providing unpaid assistance may be vulnerable to changes in health behaviors due to modifications in caregiving during the COVID-19 pandemic. Therefore, this cross-sectional study explored self-reported changes in physical activity (PA), sedentary behavior, and screen time among informal caregivers providing care for older adults aged 50+ during the pandemic. Study participants were recruited via Amazon's Mechanical Turk and reported their perceived changes (increased a lot, ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Informal caregivers; Physical activity; Screen time; Sedentary behavior; Aged; COVID-19; Caregivers; Cross-Sectional Studies; Exercise; Female; Humans; Male; Pandemics; SARS-CoV-2; Screen Time; Sedentary Behavior; Self Report","Drohan","Megan M","Department of Psychology, University of Rhode Island, Kingston, Rhode Island, USA",NA
"1951","34215246","10.1186/s12889-021-11294-7","Self-reported changes in physical activity, sedentary behavior, and screen time among informal caregivers during the COVID-19 pandemic.","Informal caregivers providing unpaid assistance may be vulnerable to changes in health behaviors due to modifications in caregiving during the COVID-19 pandemic. Therefore, this cross-sectional study explored self-reported changes in physical activity (PA), sedentary behavior, and screen time among informal caregivers providing care for older adults aged 50+ during the pandemic. Study participants were recruited via Amazon's Mechanical Turk and reported their perceived changes (increased a lot, ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Informal caregivers; Physical activity; Screen time; Sedentary behavior; Aged; COVID-19; Caregivers; Cross-Sectional Studies; Exercise; Female; Humans; Male; Pandemics; SARS-CoV-2; Screen Time; Sedentary Behavior; Self Report","Ward-Ritacco","Christie L","Department of Kinesiology, University of Rhode Island, Kingston, Rhode Island, USA",NA
"1952","34215246","10.1186/s12889-021-11294-7","Self-reported changes in physical activity, sedentary behavior, and screen time among informal caregivers during the COVID-19 pandemic.","Informal caregivers providing unpaid assistance may be vulnerable to changes in health behaviors due to modifications in caregiving during the COVID-19 pandemic. Therefore, this cross-sectional study explored self-reported changes in physical activity (PA), sedentary behavior, and screen time among informal caregivers providing care for older adults aged 50+ during the pandemic. Study participants were recruited via Amazon's Mechanical Turk and reported their perceived changes (increased a lot, ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Informal caregivers; Physical activity; Screen time; Sedentary behavior; Aged; COVID-19; Caregivers; Cross-Sectional Studies; Exercise; Female; Humans; Male; Pandemics; SARS-CoV-2; Screen Time; Sedentary Behavior; Self Report","Riebe","Deborah","Department of Kinesiology, University of Rhode Island, Kingston, Rhode Island, USA",NA
"1953","34215246","10.1186/s12889-021-11294-7","Self-reported changes in physical activity, sedentary behavior, and screen time among informal caregivers during the COVID-19 pandemic.","Informal caregivers providing unpaid assistance may be vulnerable to changes in health behaviors due to modifications in caregiving during the COVID-19 pandemic. Therefore, this cross-sectional study explored self-reported changes in physical activity (PA), sedentary behavior, and screen time among informal caregivers providing care for older adults aged 50+ during the pandemic. Study participants were recruited via Amazon's Mechanical Turk and reported their perceived changes (increased a lot, ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Informal caregivers; Physical activity; Screen time; Sedentary behavior; Aged; COVID-19; Caregivers; Cross-Sectional Studies; Exercise; Female; Humans; Male; Pandemics; SARS-CoV-2; Screen Time; Sedentary Behavior; Self Report","Cohen","Steven A","Department of Health Studies, University of Rhode Island, 25 West Independent Way, Kingston, Rhode Island, 02881, USA",NA
"1954","34215244","10.1186/s12889-021-11332-4","Does social support matter? The mediating links with coping strategy and anxiety among Chinese college students in a cross-sectional study of COVID-19 pandemic.","The provision of public adaptive coping strategies to reduce psychological tension during the ongoing COVID-19 pandemic is critical. We sought to provide evidence-based guidance for psychological intervention, exploring the potential mediating roles of three sources of social support (i.e., subjective support, family support and counselor support) between coping strategies (i.e., cognitive coping, emotional coping and behavioral coping), and anxiety among college students at the height of the pa","2021","07","08","BMC Public Health","BMC public health","Anxiety; COVID-19 pandemic; Coping strategy; Mediator; Social support; Adaptation, Psychological; Anxiety; COVID-19; China; Communicable Disease Control; Cross-Sectional Studies; Humans; Pandemics; SARS-CoV-2; Social Support; Students","Li","Yue","Division of Art, Shenzhen University, Shenzhen, Guangdong Province, China",NA
"1955","34215244","10.1186/s12889-021-11332-4","Does social support matter? The mediating links with coping strategy and anxiety among Chinese college students in a cross-sectional study of COVID-19 pandemic.","The provision of public adaptive coping strategies to reduce psychological tension during the ongoing COVID-19 pandemic is critical. We sought to provide evidence-based guidance for psychological intervention, exploring the potential mediating roles of three sources of social support (i.e., subjective support, family support and counselor support) between coping strategies (i.e., cognitive coping, emotional coping and behavioral coping), and anxiety among college students at the height of the pa","2021","07","08","BMC Public Health","BMC public health","Anxiety; COVID-19 pandemic; Coping strategy; Mediator; Social support; Adaptation, Psychological; Anxiety; COVID-19; China; Communicable Disease Control; Cross-Sectional Studies; Humans; Pandemics; SARS-CoV-2; Social Support; Students","Peng","Jun","School of Education, City University of Macau, Macau, China. 4588775@163","4588775@163.com"
"1956","34215243","10.1186/s12889-021-11325-3","Maternal mortality during the COVID-19 pandemic in Mexico: a preliminary analysis during the first year.","In Mexico, the COVID-19 pandemic led to preventative measures such as confinement and social interaction limitations that paradoxically may have aggravated healthcare access disparities for pregnant women and accentuated health system weaknesses addressing high-risk patients' pregnancies. Our objective is to estimate the maternal mortality ratio in 1 year and analyze the clinical course of pregnant women hospitalized due to acute respiratory distress syndrome and COVID-19. A retrospective survei","2021","07","08","BMC Public Health","BMC public health","COVID-19; Maternal mortality; Mexico; Pandemics; COVID-19; Female; Hospital Mortality; Humans; Maternal Mortality; Mexico; Pandemics; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; SARS-CoV-2","Mendez-Dominguez","Nina","Hospital Regional de Alta Especialidad de la Península de Yucatán. Subdirección de Enseñanza e Investigación, Calle 7 #433 x 20 y 22 Fracc. Altabrisa, C.P. 97130, Mérida, Yucatán, Mexico",NA
"1957","34215243","10.1186/s12889-021-11325-3","Maternal mortality during the COVID-19 pandemic in Mexico: a preliminary analysis during the first year.","In Mexico, the COVID-19 pandemic led to preventative measures such as confinement and social interaction limitations that paradoxically may have aggravated healthcare access disparities for pregnant women and accentuated health system weaknesses addressing high-risk patients' pregnancies. Our objective is to estimate the maternal mortality ratio in 1 year and analyze the clinical course of pregnant women hospitalized due to acute respiratory distress syndrome and COVID-19. A retrospective survei","2021","07","08","BMC Public Health","BMC public health","COVID-19; Maternal mortality; Mexico; Pandemics; COVID-19; Female; Hospital Mortality; Humans; Maternal Mortality; Mexico; Pandemics; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; SARS-CoV-2","Santos-Zaldívar","Karen","Centro de Investigación y de Estudios Avanzados del IPN (Cinvestav), Department of Human Ecology, Antigua Carretera a Progreso Km. 6, 97310, Mérida, Yucatán, Mexico",NA
"1958","34215243","10.1186/s12889-021-11325-3","Maternal mortality during the COVID-19 pandemic in Mexico: a preliminary analysis during the first year.","In Mexico, the COVID-19 pandemic led to preventative measures such as confinement and social interaction limitations that paradoxically may have aggravated healthcare access disparities for pregnant women and accentuated health system weaknesses addressing high-risk patients' pregnancies. Our objective is to estimate the maternal mortality ratio in 1 year and analyze the clinical course of pregnant women hospitalized due to acute respiratory distress syndrome and COVID-19. A retrospective survei","2021","07","08","BMC Public Health","BMC public health","COVID-19; Maternal mortality; Mexico; Pandemics; COVID-19; Female; Hospital Mortality; Humans; Maternal Mortality; Mexico; Pandemics; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; SARS-CoV-2","Gomez-Carro","Salvador","O 'Horan General Hospital. Hospital Epidemiologic Surveillance Unit. State of Yucatan Health Services, Avenida Itzaes s/n, Avenue Centro Jacinto Canek, 97000, Mérida, Yucatán, Mexico",NA
"1959","34215243","10.1186/s12889-021-11325-3","Maternal mortality during the COVID-19 pandemic in Mexico: a preliminary analysis during the first year.","In Mexico, the COVID-19 pandemic led to preventative measures such as confinement and social interaction limitations that paradoxically may have aggravated healthcare access disparities for pregnant women and accentuated health system weaknesses addressing high-risk patients' pregnancies. Our objective is to estimate the maternal mortality ratio in 1 year and analyze the clinical course of pregnant women hospitalized due to acute respiratory distress syndrome and COVID-19. A retrospective survei","2021","07","08","BMC Public Health","BMC public health","COVID-19; Maternal mortality; Mexico; Pandemics; COVID-19; Female; Hospital Mortality; Humans; Maternal Mortality; Mexico; Pandemics; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; SARS-CoV-2","Datta-Banik","Sudip","Centro de Investigación y de Estudios Avanzados del IPN (Cinvestav), Department of Human Ecology, Antigua Carretera a Progreso Km. 6, 97310, Mérida, Yucatán, Mexico",NA
"1960","34215243","10.1186/s12889-021-11325-3","Maternal mortality during the COVID-19 pandemic in Mexico: a preliminary analysis during the first year.","In Mexico, the COVID-19 pandemic led to preventative measures such as confinement and social interaction limitations that paradoxically may have aggravated healthcare access disparities for pregnant women and accentuated health system weaknesses addressing high-risk patients' pregnancies. Our objective is to estimate the maternal mortality ratio in 1 year and analyze the clinical course of pregnant women hospitalized due to acute respiratory distress syndrome and COVID-19. A retrospective survei","2021","07","08","BMC Public Health","BMC public health","COVID-19; Maternal mortality; Mexico; Pandemics; COVID-19; Female; Hospital Mortality; Humans; Maternal Mortality; Mexico; Pandemics; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; SARS-CoV-2","Carrillo","Genny","Department of Environmental and Occupational Health, School of Public Health, Texas A&amp","gcarrillo@tamu.edu"
"1961","34215236","10.1186/s12889-021-11206-9","Protocol of the Cologne Corona Surveillance (CoCoS) Study- a prospective population-based cohort study.","Surveillance strategies are critical to cope with the current SARS-CoV-2 pandemic and to evaluate, as well as adjust government-imposed countermeasures. Incidence estimates are widely based on laboratory confirmed cases reported by health authorities. Prevalence and incidence data of SARS-CoV-2 is still scarce, along with demographic and behavioural factors associated with infection risk. The Cologne Corona Surveillance Study will be conducted in the City of Cologne, which is the fourth-largest ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Coronavirus; Pandemic; Risk behaviours; Rolling cohort; Socio-economic factors; Surveillance; Adolescent; Adult; COVID-19; Cohort Studies; Humans; Prospective Studies; SARS-CoV-2; Treatment Outcome","Oberste","Max","Institute of Medical Statistics and Computational Biology, Medical Faculty and University Hospital of Cologne, University of Cologne, Robert-Koch-Straße 10, 50931, Cologne, Germany",NA
"1962","34215236","10.1186/s12889-021-11206-9","Protocol of the Cologne Corona Surveillance (CoCoS) Study- a prospective population-based cohort study.","Surveillance strategies are critical to cope with the current SARS-CoV-2 pandemic and to evaluate, as well as adjust government-imposed countermeasures. Incidence estimates are widely based on laboratory confirmed cases reported by health authorities. Prevalence and incidence data of SARS-CoV-2 is still scarce, along with demographic and behavioural factors associated with infection risk. The Cologne Corona Surveillance Study will be conducted in the City of Cologne, which is the fourth-largest ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Coronavirus; Pandemic; Risk behaviours; Rolling cohort; Socio-economic factors; Surveillance; Adolescent; Adult; COVID-19; Cohort Studies; Humans; Prospective Studies; SARS-CoV-2; Treatment Outcome","Pusch","Lynn-Marie","Institute of Medical Statistics and Computational Biology, Medical Faculty and University Hospital of Cologne, University of Cologne, Robert-Koch-Straße 10, 50931, Cologne, Germany",NA
"1963","34215236","10.1186/s12889-021-11206-9","Protocol of the Cologne Corona Surveillance (CoCoS) Study- a prospective population-based cohort study.","Surveillance strategies are critical to cope with the current SARS-CoV-2 pandemic and to evaluate, as well as adjust government-imposed countermeasures. Incidence estimates are widely based on laboratory confirmed cases reported by health authorities. Prevalence and incidence data of SARS-CoV-2 is still scarce, along with demographic and behavioural factors associated with infection risk. The Cologne Corona Surveillance Study will be conducted in the City of Cologne, which is the fourth-largest ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Coronavirus; Pandemic; Risk behaviours; Rolling cohort; Socio-economic factors; Surveillance; Adolescent; Adult; COVID-19; Cohort Studies; Humans; Prospective Studies; SARS-CoV-2; Treatment Outcome","Roth","Rebecca","Institute of Medical Statistics and Computational Biology, Medical Faculty and University Hospital of Cologne, University of Cologne, Robert-Koch-Straße 10, 50931, Cologne, Germany",NA
"1964","34215236","10.1186/s12889-021-11206-9","Protocol of the Cologne Corona Surveillance (CoCoS) Study- a prospective population-based cohort study.","Surveillance strategies are critical to cope with the current SARS-CoV-2 pandemic and to evaluate, as well as adjust government-imposed countermeasures. Incidence estimates are widely based on laboratory confirmed cases reported by health authorities. Prevalence and incidence data of SARS-CoV-2 is still scarce, along with demographic and behavioural factors associated with infection risk. The Cologne Corona Surveillance Study will be conducted in the City of Cologne, which is the fourth-largest ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Coronavirus; Pandemic; Risk behaviours; Rolling cohort; Socio-economic factors; Surveillance; Adolescent; Adult; COVID-19; Cohort Studies; Humans; Prospective Studies; SARS-CoV-2; Treatment Outcome","Shah-Hosseini","Kija","Institute of Medical Statistics and Computational Biology, Medical Faculty and University Hospital of Cologne, University of Cologne, Robert-Koch-Straße 10, 50931, Cologne, Germany",NA
"1965","34215236","10.1186/s12889-021-11206-9","Protocol of the Cologne Corona Surveillance (CoCoS) Study- a prospective population-based cohort study.","Surveillance strategies are critical to cope with the current SARS-CoV-2 pandemic and to evaluate, as well as adjust government-imposed countermeasures. Incidence estimates are widely based on laboratory confirmed cases reported by health authorities. Prevalence and incidence data of SARS-CoV-2 is still scarce, along with demographic and behavioural factors associated with infection risk. The Cologne Corona Surveillance Study will be conducted in the City of Cologne, which is the fourth-largest ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Coronavirus; Pandemic; Risk behaviours; Rolling cohort; Socio-economic factors; Surveillance; Adolescent; Adult; COVID-19; Cohort Studies; Humans; Prospective Studies; SARS-CoV-2; Treatment Outcome","Dewald","Felix","Institute of Virology, Medical Faculty and University Hospital of Cologne, University of Cologne, Fürst-Pückler-Straße 56, 50935, Cologne, Germany",NA
"1966","34215236","10.1186/s12889-021-11206-9","Protocol of the Cologne Corona Surveillance (CoCoS) Study- a prospective population-based cohort study.","Surveillance strategies are critical to cope with the current SARS-CoV-2 pandemic and to evaluate, as well as adjust government-imposed countermeasures. Incidence estimates are widely based on laboratory confirmed cases reported by health authorities. Prevalence and incidence data of SARS-CoV-2 is still scarce, along with demographic and behavioural factors associated with infection risk. The Cologne Corona Surveillance Study will be conducted in the City of Cologne, which is the fourth-largest ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Coronavirus; Pandemic; Risk behaviours; Rolling cohort; Socio-economic factors; Surveillance; Adolescent; Adult; COVID-19; Cohort Studies; Humans; Prospective Studies; SARS-CoV-2; Treatment Outcome","Müller","Claudia","Institute of Virology, Medical Faculty and University Hospital of Cologne, University of Cologne, Fürst-Pückler-Straße 56, 50935, Cologne, Germany",NA
"1967","34215236","10.1186/s12889-021-11206-9","Protocol of the Cologne Corona Surveillance (CoCoS) Study- a prospective population-based cohort study.","Surveillance strategies are critical to cope with the current SARS-CoV-2 pandemic and to evaluate, as well as adjust government-imposed countermeasures. Incidence estimates are widely based on laboratory confirmed cases reported by health authorities. Prevalence and incidence data of SARS-CoV-2 is still scarce, along with demographic and behavioural factors associated with infection risk. The Cologne Corona Surveillance Study will be conducted in the City of Cologne, which is the fourth-largest ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Coronavirus; Pandemic; Risk behaviours; Rolling cohort; Socio-economic factors; Surveillance; Adolescent; Adult; COVID-19; Cohort Studies; Humans; Prospective Studies; SARS-CoV-2; Treatment Outcome","Stach von Goltzheim","Luise","Institute of Medical Statistics and Computational Biology, Medical Faculty and University Hospital of Cologne, University of Cologne, Robert-Koch-Straße 10, 50931, Cologne, Germany",NA
"1968","34215236","10.1186/s12889-021-11206-9","Protocol of the Cologne Corona Surveillance (CoCoS) Study- a prospective population-based cohort study.","Surveillance strategies are critical to cope with the current SARS-CoV-2 pandemic and to evaluate, as well as adjust government-imposed countermeasures. Incidence estimates are widely based on laboratory confirmed cases reported by health authorities. Prevalence and incidence data of SARS-CoV-2 is still scarce, along with demographic and behavioural factors associated with infection risk. The Cologne Corona Surveillance Study will be conducted in the City of Cologne, which is the fourth-largest ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Coronavirus; Pandemic; Risk behaviours; Rolling cohort; Socio-economic factors; Surveillance; Adolescent; Adult; COVID-19; Cohort Studies; Humans; Prospective Studies; SARS-CoV-2; Treatment Outcome","Lehmann","Clara","Department of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50931, Cologne, Germany",NA
"1969","34215236","10.1186/s12889-021-11206-9","Protocol of the Cologne Corona Surveillance (CoCoS) Study- a prospective population-based cohort study.","Surveillance strategies are critical to cope with the current SARS-CoV-2 pandemic and to evaluate, as well as adjust government-imposed countermeasures. Incidence estimates are widely based on laboratory confirmed cases reported by health authorities. Prevalence and incidence data of SARS-CoV-2 is still scarce, along with demographic and behavioural factors associated with infection risk. The Cologne Corona Surveillance Study will be conducted in the City of Cologne, which is the fourth-largest ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Coronavirus; Pandemic; Risk behaviours; Rolling cohort; Socio-economic factors; Surveillance; Adolescent; Adult; COVID-19; Cohort Studies; Humans; Prospective Studies; SARS-CoV-2; Treatment Outcome","Buess","Michael","Cologne Health Authority, Cologne, Germany",NA
"1970","34215236","10.1186/s12889-021-11206-9","Protocol of the Cologne Corona Surveillance (CoCoS) Study- a prospective population-based cohort study.","Surveillance strategies are critical to cope with the current SARS-CoV-2 pandemic and to evaluate, as well as adjust government-imposed countermeasures. Incidence estimates are widely based on laboratory confirmed cases reported by health authorities. Prevalence and incidence data of SARS-CoV-2 is still scarce, along with demographic and behavioural factors associated with infection risk. The Cologne Corona Surveillance Study will be conducted in the City of Cologne, which is the fourth-largest ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Coronavirus; Pandemic; Risk behaviours; Rolling cohort; Socio-economic factors; Surveillance; Adolescent; Adult; COVID-19; Cohort Studies; Humans; Prospective Studies; SARS-CoV-2; Treatment Outcome","Wolff","Anna","Cologne Health Authority, Cologne, Germany",NA
"1971","34215236","10.1186/s12889-021-11206-9","Protocol of the Cologne Corona Surveillance (CoCoS) Study- a prospective population-based cohort study.","Surveillance strategies are critical to cope with the current SARS-CoV-2 pandemic and to evaluate, as well as adjust government-imposed countermeasures. Incidence estimates are widely based on laboratory confirmed cases reported by health authorities. Prevalence and incidence data of SARS-CoV-2 is still scarce, along with demographic and behavioural factors associated with infection risk. The Cologne Corona Surveillance Study will be conducted in the City of Cologne, which is the fourth-largest ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Coronavirus; Pandemic; Risk behaviours; Rolling cohort; Socio-economic factors; Surveillance; Adolescent; Adult; COVID-19; Cohort Studies; Humans; Prospective Studies; SARS-CoV-2; Treatment Outcome","Fätkenheuer","Gerd","Department of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50931, Cologne, Germany",NA
"1972","34215236","10.1186/s12889-021-11206-9","Protocol of the Cologne Corona Surveillance (CoCoS) Study- a prospective population-based cohort study.","Surveillance strategies are critical to cope with the current SARS-CoV-2 pandemic and to evaluate, as well as adjust government-imposed countermeasures. Incidence estimates are widely based on laboratory confirmed cases reported by health authorities. Prevalence and incidence data of SARS-CoV-2 is still scarce, along with demographic and behavioural factors associated with infection risk. The Cologne Corona Surveillance Study will be conducted in the City of Cologne, which is the fourth-largest ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Coronavirus; Pandemic; Risk behaviours; Rolling cohort; Socio-economic factors; Surveillance; Adolescent; Adult; COVID-19; Cohort Studies; Humans; Prospective Studies; SARS-CoV-2; Treatment Outcome","Wiesmüller","Gerhard","Cologne Health Authority, Cologne, Germany",NA
"1973","34215236","10.1186/s12889-021-11206-9","Protocol of the Cologne Corona Surveillance (CoCoS) Study- a prospective population-based cohort study.","Surveillance strategies are critical to cope with the current SARS-CoV-2 pandemic and to evaluate, as well as adjust government-imposed countermeasures. Incidence estimates are widely based on laboratory confirmed cases reported by health authorities. Prevalence and incidence data of SARS-CoV-2 is still scarce, along with demographic and behavioural factors associated with infection risk. The Cologne Corona Surveillance Study will be conducted in the City of Cologne, which is the fourth-largest ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Coronavirus; Pandemic; Risk behaviours; Rolling cohort; Socio-economic factors; Surveillance; Adolescent; Adult; COVID-19; Cohort Studies; Humans; Prospective Studies; SARS-CoV-2; Treatment Outcome","Klein","Florian","Institute of Virology, Medical Faculty and University Hospital of Cologne, University of Cologne, Fürst-Pückler-Straße 56, 50935, Cologne, Germany",NA
"1974","34215236","10.1186/s12889-021-11206-9","Protocol of the Cologne Corona Surveillance (CoCoS) Study- a prospective population-based cohort study.","Surveillance strategies are critical to cope with the current SARS-CoV-2 pandemic and to evaluate, as well as adjust government-imposed countermeasures. Incidence estimates are widely based on laboratory confirmed cases reported by health authorities. Prevalence and incidence data of SARS-CoV-2 is still scarce, along with demographic and behavioural factors associated with infection risk. The Cologne Corona Surveillance Study will be conducted in the City of Cologne, which is the fourth-largest ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Coronavirus; Pandemic; Risk behaviours; Rolling cohort; Socio-economic factors; Surveillance; Adolescent; Adult; COVID-19; Cohort Studies; Humans; Prospective Studies; SARS-CoV-2; Treatment Outcome","Hellmich","Martin","Institute of Medical Statistics and Computational Biology, Medical Faculty and University Hospital of Cologne, University of Cologne, Robert-Koch-Straße 10, 50931, Cologne, Germany. martin.hellmich@uni-koeln",NA
"1975","34215236","10.1186/s12889-021-11206-9","Protocol of the Cologne Corona Surveillance (CoCoS) Study- a prospective population-based cohort study.","Surveillance strategies are critical to cope with the current SARS-CoV-2 pandemic and to evaluate, as well as adjust government-imposed countermeasures. Incidence estimates are widely based on laboratory confirmed cases reported by health authorities. Prevalence and incidence data of SARS-CoV-2 is still scarce, along with demographic and behavioural factors associated with infection risk. The Cologne Corona Surveillance Study will be conducted in the City of Cologne, which is the fourth-largest ","2021","07","08","BMC Public Health","BMC public health","COVID-19; Coronavirus; Pandemic; Risk behaviours; Rolling cohort; Socio-economic factors; Surveillance; Adolescent; Adult; COVID-19; Cohort Studies; Humans; Prospective Studies; SARS-CoV-2; Treatment Outcome","Neuhann","Florian","Cologne Health Authority, Cologne, Germany",NA
"1976","34215224","10.1186/s12889-021-11270-1","Stigmatization of Chinese and Asian-looking people during the COVID-19 pandemic in Germany.","The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic. As part of the ""EUCLID"" project ( https://euclid.dbvis.","2021","07","08","BMC Public Health","BMC public health","Avoidance; COVID-19; Coronavirus; Disease; Pandemic; Pathogen; SARS-CoV-2; Stigma; Stigmatization; Threat; COVID-19; China; Germany; Humans; Pandemics; SARS-CoV-2; Stereotyping","Koller","Julia E","University of Konstanz, 78457, Konstanz, Germany",NA
"1977","34215224","10.1186/s12889-021-11270-1","Stigmatization of Chinese and Asian-looking people during the COVID-19 pandemic in Germany.","The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic. As part of the ""EUCLID"" project ( https://euclid.dbvis.","2021","07","08","BMC Public Health","BMC public health","Avoidance; COVID-19; Coronavirus; Disease; Pandemic; Pathogen; SARS-CoV-2; Stigma; Stigmatization; Threat; COVID-19; China; Germany; Humans; Pandemics; SARS-CoV-2; Stereotyping","Villinger","Karoline","University of Konstanz, 78457, Konstanz, Germany",NA
"1978","34215224","10.1186/s12889-021-11270-1","Stigmatization of Chinese and Asian-looking people during the COVID-19 pandemic in Germany.","The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic. As part of the ""EUCLID"" project ( https://euclid.dbvis.","2021","07","08","BMC Public Health","BMC public health","Avoidance; COVID-19; Coronavirus; Disease; Pandemic; Pathogen; SARS-CoV-2; Stigma; Stigmatization; Threat; COVID-19; China; Germany; Humans; Pandemics; SARS-CoV-2; Stereotyping","Lages","Nadine C","University of Konstanz, 78457, Konstanz, Germany",NA
"1979","34215224","10.1186/s12889-021-11270-1","Stigmatization of Chinese and Asian-looking people during the COVID-19 pandemic in Germany.","The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic. As part of the ""EUCLID"" project ( https://euclid.dbvis.","2021","07","08","BMC Public Health","BMC public health","Avoidance; COVID-19; Coronavirus; Disease; Pandemic; Pathogen; SARS-CoV-2; Stigma; Stigmatization; Threat; COVID-19; China; Germany; Humans; Pandemics; SARS-CoV-2; Stereotyping","Brünecke","Isabel","University of Konstanz, 78457, Konstanz, Germany",NA
"1980","34215224","10.1186/s12889-021-11270-1","Stigmatization of Chinese and Asian-looking people during the COVID-19 pandemic in Germany.","The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic. As part of the ""EUCLID"" project ( https://euclid.dbvis.","2021","07","08","BMC Public Health","BMC public health","Avoidance; COVID-19; Coronavirus; Disease; Pandemic; Pathogen; SARS-CoV-2; Stigma; Stigmatization; Threat; COVID-19; China; Germany; Humans; Pandemics; SARS-CoV-2; Stereotyping","Debbeler","Joke M","University of Konstanz, 78457, Konstanz, Germany",NA
"1981","34215224","10.1186/s12889-021-11270-1","Stigmatization of Chinese and Asian-looking people during the COVID-19 pandemic in Germany.","The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic. As part of the ""EUCLID"" project ( https://euclid.dbvis.","2021","07","08","BMC Public Health","BMC public health","Avoidance; COVID-19; Coronavirus; Disease; Pandemic; Pathogen; SARS-CoV-2; Stigma; Stigmatization; Threat; COVID-19; China; Germany; Humans; Pandemics; SARS-CoV-2; Stereotyping","Engel","Kai D","University of Konstanz, 78457, Konstanz, Germany",NA
"1982","34215224","10.1186/s12889-021-11270-1","Stigmatization of Chinese and Asian-looking people during the COVID-19 pandemic in Germany.","The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic. As part of the ""EUCLID"" project ( https://euclid.dbvis.","2021","07","08","BMC Public Health","BMC public health","Avoidance; COVID-19; Coronavirus; Disease; Pandemic; Pathogen; SARS-CoV-2; Stigma; Stigmatization; Threat; COVID-19; China; Germany; Humans; Pandemics; SARS-CoV-2; Stereotyping","Grieble","Sofia","University of Konstanz, 78457, Konstanz, Germany",NA
"1983","34215224","10.1186/s12889-021-11270-1","Stigmatization of Chinese and Asian-looking people during the COVID-19 pandemic in Germany.","The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic. As part of the ""EUCLID"" project ( https://euclid.dbvis.","2021","07","08","BMC Public Health","BMC public health","Avoidance; COVID-19; Coronavirus; Disease; Pandemic; Pathogen; SARS-CoV-2; Stigma; Stigmatization; Threat; COVID-19; China; Germany; Humans; Pandemics; SARS-CoV-2; Stereotyping","Homann","Peer C","University of Konstanz, 78457, Konstanz, Germany",NA
"1984","34215224","10.1186/s12889-021-11270-1","Stigmatization of Chinese and Asian-looking people during the COVID-19 pandemic in Germany.","The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic. As part of the ""EUCLID"" project ( https://euclid.dbvis.","2021","07","08","BMC Public Health","BMC public health","Avoidance; COVID-19; Coronavirus; Disease; Pandemic; Pathogen; SARS-CoV-2; Stigma; Stigmatization; Threat; COVID-19; China; Germany; Humans; Pandemics; SARS-CoV-2; Stereotyping","Kaufmann","Robin","University of Konstanz, 78457, Konstanz, Germany",NA
"1985","34215224","10.1186/s12889-021-11270-1","Stigmatization of Chinese and Asian-looking people during the COVID-19 pandemic in Germany.","The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic. As part of the ""EUCLID"" project ( https://euclid.dbvis.","2021","07","08","BMC Public Health","BMC public health","Avoidance; COVID-19; Coronavirus; Disease; Pandemic; Pathogen; SARS-CoV-2; Stigma; Stigmatization; Threat; COVID-19; China; Germany; Humans; Pandemics; SARS-CoV-2; Stereotyping","Koppe","Kim M","University of Konstanz, 78457, Konstanz, Germany",NA
"1986","34215224","10.1186/s12889-021-11270-1","Stigmatization of Chinese and Asian-looking people during the COVID-19 pandemic in Germany.","The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic. As part of the ""EUCLID"" project ( https://euclid.dbvis.","2021","07","08","BMC Public Health","BMC public health","Avoidance; COVID-19; Coronavirus; Disease; Pandemic; Pathogen; SARS-CoV-2; Stigma; Stigmatization; Threat; COVID-19; China; Germany; Humans; Pandemics; SARS-CoV-2; Stereotyping","Oppenheimer","Hannah","University of Konstanz, 78457, Konstanz, Germany",NA
"1987","34215224","10.1186/s12889-021-11270-1","Stigmatization of Chinese and Asian-looking people during the COVID-19 pandemic in Germany.","The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic. As part of the ""EUCLID"" project ( https://euclid.dbvis.","2021","07","08","BMC Public Health","BMC public health","Avoidance; COVID-19; Coronavirus; Disease; Pandemic; Pathogen; SARS-CoV-2; Stigma; Stigmatization; Threat; COVID-19; China; Germany; Humans; Pandemics; SARS-CoV-2; Stereotyping","Radtke","Vanessa C","University of Konstanz, 78457, Konstanz, Germany",NA
"1988","34215224","10.1186/s12889-021-11270-1","Stigmatization of Chinese and Asian-looking people during the COVID-19 pandemic in Germany.","The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic. As part of the ""EUCLID"" project ( https://euclid.dbvis.","2021","07","08","BMC Public Health","BMC public health","Avoidance; COVID-19; Coronavirus; Disease; Pandemic; Pathogen; SARS-CoV-2; Stigma; Stigmatization; Threat; COVID-19; China; Germany; Humans; Pandemics; SARS-CoV-2; Stereotyping","Rogula","Sarah","University of Konstanz, 78457, Konstanz, Germany",NA
"1989","34215224","10.1186/s12889-021-11270-1","Stigmatization of Chinese and Asian-looking people during the COVID-19 pandemic in Germany.","The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic. As part of the ""EUCLID"" project ( https://euclid.dbvis.","2021","07","08","BMC Public Health","BMC public health","Avoidance; COVID-19; Coronavirus; Disease; Pandemic; Pathogen; SARS-CoV-2; Stigma; Stigmatization; Threat; COVID-19; China; Germany; Humans; Pandemics; SARS-CoV-2; Stereotyping","Stähler","Johanna","University of Konstanz, 78457, Konstanz, Germany",NA
"1990","34215224","10.1186/s12889-021-11270-1","Stigmatization of Chinese and Asian-looking people during the COVID-19 pandemic in Germany.","The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic. As part of the ""EUCLID"" project ( https://euclid.dbvis.","2021","07","08","BMC Public Health","BMC public health","Avoidance; COVID-19; Coronavirus; Disease; Pandemic; Pathogen; SARS-CoV-2; Stigma; Stigmatization; Threat; COVID-19; China; Germany; Humans; Pandemics; SARS-CoV-2; Stereotyping","Renner","Britta","University of Konstanz, 78457, Konstanz, Germany",NA
"1991","34215224","10.1186/s12889-021-11270-1","Stigmatization of Chinese and Asian-looking people during the COVID-19 pandemic in Germany.","The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic. As part of the ""EUCLID"" project ( https://euclid.dbvis.","2021","07","08","BMC Public Health","BMC public health","Avoidance; COVID-19; Coronavirus; Disease; Pandemic; Pathogen; SARS-CoV-2; Stigma; Stigmatization; Threat; COVID-19; China; Germany; Humans; Pandemics; SARS-CoV-2; Stereotyping","Schupp","Harald T","University of Konstanz, 78457, Konstanz, Germany. harald.schupp@uni-konstanz",NA
"1992","34215220","10.1186/s12888-021-03325-9","Risk assessment of paternal depression in relation to partner delivery during COVID-19 pandemic in Wuhan, China.","The COVID-19 pandemic and relevant prevention and control measures may affect the mental health and induce depressive symptoms in fathers with concurrent partner delivery exposure. This study aims to investigate the prevalence of depression in fathers with simultaneous exposure to COVID-19 pandemic and the effects of family functions on paternal perinatal depression (PPD) risk. A cross-sectional study was conducted among the perinatal fathers recruited in a large tertiary hospital in Wuhan acros","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; Family function; Paternal perinatal depression; Risk factors; Traffic restriction; COVID-19; China; Cross-Sectional Studies; Depression; Depression, Postpartum; Fathers; Female; Humans; Male; Pandemics; Pregnancy; Prevalence; Risk Assessment; Risk Factors; SARS-CoV-2","Sun","Guo-Qiang","Obstetric Department, Maternal and Child Health Hospital of Hubei Province, Huazhong University of Science and Technology, Wuluo Road No.745, Hongshan District, Wuhan, 430070, China",NA
"1993","34215220","10.1186/s12888-021-03325-9","Risk assessment of paternal depression in relation to partner delivery during COVID-19 pandemic in Wuhan, China.","The COVID-19 pandemic and relevant prevention and control measures may affect the mental health and induce depressive symptoms in fathers with concurrent partner delivery exposure. This study aims to investigate the prevalence of depression in fathers with simultaneous exposure to COVID-19 pandemic and the effects of family functions on paternal perinatal depression (PPD) risk. A cross-sectional study was conducted among the perinatal fathers recruited in a large tertiary hospital in Wuhan acros","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; Family function; Paternal perinatal depression; Risk factors; Traffic restriction; COVID-19; China; Cross-Sectional Studies; Depression; Depression, Postpartum; Fathers; Female; Humans; Male; Pandemics; Pregnancy; Prevalence; Risk Assessment; Risk Factors; SARS-CoV-2","Wang","Qi","Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Hangkong Road No.13, Qiaokou District, Wuhan, 430030, China",NA
"1994","34215220","10.1186/s12888-021-03325-9","Risk assessment of paternal depression in relation to partner delivery during COVID-19 pandemic in Wuhan, China.","The COVID-19 pandemic and relevant prevention and control measures may affect the mental health and induce depressive symptoms in fathers with concurrent partner delivery exposure. This study aims to investigate the prevalence of depression in fathers with simultaneous exposure to COVID-19 pandemic and the effects of family functions on paternal perinatal depression (PPD) risk. A cross-sectional study was conducted among the perinatal fathers recruited in a large tertiary hospital in Wuhan acros","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; Family function; Paternal perinatal depression; Risk factors; Traffic restriction; COVID-19; China; Cross-Sectional Studies; Depression; Depression, Postpartum; Fathers; Female; Humans; Male; Pandemics; Pregnancy; Prevalence; Risk Assessment; Risk Factors; SARS-CoV-2","Wang","Shan-Shan","Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Hangkong Road No.13, Qiaokou District, Wuhan, 430030, China",NA
"1995","34215220","10.1186/s12888-021-03325-9","Risk assessment of paternal depression in relation to partner delivery during COVID-19 pandemic in Wuhan, China.","The COVID-19 pandemic and relevant prevention and control measures may affect the mental health and induce depressive symptoms in fathers with concurrent partner delivery exposure. This study aims to investigate the prevalence of depression in fathers with simultaneous exposure to COVID-19 pandemic and the effects of family functions on paternal perinatal depression (PPD) risk. A cross-sectional study was conducted among the perinatal fathers recruited in a large tertiary hospital in Wuhan acros","2021","07","08","BMC Psychiatry","BMC psychiatry","COVID-19; Family function; Paternal perinatal depression; Risk factors; Traffic restriction; COVID-19; China; Cross-Sectional Studies; Depression; Depression, Postpartum; Fathers; Female; Humans; Male; Pandemics; Pregnancy; Prevalence; Risk Assessment; Risk Factors; SARS-CoV-2","Cheng","Yao","Obstetric Department, Maternal and Child Health Hospital of Hubei Province, Huazhong University of Science and Technology, Wuluo Road No.745, Hongshan District, Wuhan, 430070, China. chengyao2014@sina","chengyao2014@sina.com"
"1996","34215218","10.1186/s12884-021-03942-y","Perinatal health care access, childbirth concerns, and birthing decision-making among pregnant people in California during COVID-19.","During public health emergencies, including the COVID-19 pandemic, access to adequate healthcare is crucial for providing for the health and wellbeing of families. Pregnant and postpartum people are a particularly vulnerable subgroup to consider when studying healthcare access. Not only are perinatal people likely at higher risk for illness, mortality, and morbidity from COVID-19 infection, they are also at higher risk for negative outcomes due to delayed or inadequate access to routine care. We","2021","07","12","BMC Pregnancy Childbirth","BMC pregnancy and childbirth","COVID-19; California; Childbirth; Decision-making; Financial insecurity; Healthcare access; Perinatal; Pregnancy; Racial/ethnic minoritization; SARS-CoV-2; Adolescent; Adult; Birth Setting; COVID-19; California; Decision Making; Economic Status; Ethnic Groups; Female; Health Services Accessibility; Humans; Minority Groups; Parturition; Perinatal Care; Pregnancy; Prenatal Care; SARS-CoV-2; Surveys and Questionnaires; Young Adult","Whipps","Mackenzie D M","Department of Human Ecology, Perinatal Origins of Disparities Center, University of California, Davis, California, USA. mdwhipps@ucdavis","mdwhipps@ucdavis.edu"
"1997","34215218","10.1186/s12884-021-03942-y","Perinatal health care access, childbirth concerns, and birthing decision-making among pregnant people in California during COVID-19.","During public health emergencies, including the COVID-19 pandemic, access to adequate healthcare is crucial for providing for the health and wellbeing of families. Pregnant and postpartum people are a particularly vulnerable subgroup to consider when studying healthcare access. Not only are perinatal people likely at higher risk for illness, mortality, and morbidity from COVID-19 infection, they are also at higher risk for negative outcomes due to delayed or inadequate access to routine care. We","2021","07","12","BMC Pregnancy Childbirth","BMC pregnancy and childbirth","COVID-19; California; Childbirth; Decision-making; Financial insecurity; Healthcare access; Perinatal; Pregnancy; Racial/ethnic minoritization; SARS-CoV-2; Adolescent; Adult; Birth Setting; COVID-19; California; Decision Making; Economic Status; Ethnic Groups; Female; Health Services Accessibility; Humans; Minority Groups; Parturition; Perinatal Care; Pregnancy; Prenatal Care; SARS-CoV-2; Surveys and Questionnaires; Young Adult","Phipps","Jennifer E","Department of Human Ecology, Perinatal Origins of Disparities Center, University of California, Davis, California, USA",NA
"1998","34215218","10.1186/s12884-021-03942-y","Perinatal health care access, childbirth concerns, and birthing decision-making among pregnant people in California during COVID-19.","During public health emergencies, including the COVID-19 pandemic, access to adequate healthcare is crucial for providing for the health and wellbeing of families. Pregnant and postpartum people are a particularly vulnerable subgroup to consider when studying healthcare access. Not only are perinatal people likely at higher risk for illness, mortality, and morbidity from COVID-19 infection, they are also at higher risk for negative outcomes due to delayed or inadequate access to routine care. We","2021","07","12","BMC Pregnancy Childbirth","BMC pregnancy and childbirth","COVID-19; California; Childbirth; Decision-making; Financial insecurity; Healthcare access; Perinatal; Pregnancy; Racial/ethnic minoritization; SARS-CoV-2; Adolescent; Adult; Birth Setting; COVID-19; California; Decision Making; Economic Status; Ethnic Groups; Female; Health Services Accessibility; Humans; Minority Groups; Parturition; Perinatal Care; Pregnancy; Prenatal Care; SARS-CoV-2; Surveys and Questionnaires; Young Adult","Simmons","Leigh Ann","Department of Human Ecology, Perinatal Origins of Disparities Center, University of California, Davis, California, USA",NA
"1999","34215216","10.1186/s12883-021-02248-y","Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study.","Parkinson's disease (PD) is a progressive neurodegenerative disease with no cure and few treatment options. Its incidence is increasing due to aging populations, longer disease duration and potentially as a COVID-19 sequela. Photobiomodulation (PBM) has been successfully used in animal models to reduce the signs of PD and to protect dopaminergic neurons. To assess the effectiveness of PBM to mitigate clinical signs of PD in a prospective proof-of-concept study, using a combination of transcrania","2021","07","16","BMC Neurol","BMC neurology","Cognition; Mobility; Motor symptoms; Parkinsons disease; Photobiomodulation; COVID-19; Humans; Low-Level Light Therapy; Parkinson Disease; Prospective Studies; SARS-CoV-2","Liebert","Ann","School of Medical Sciences, University of Sydney, Camperdown, Australia. ann.liebert@sydney.edu","ann.liebert@sydney.edu.au"
"2000","34215216","10.1186/s12883-021-02248-y","Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study.","Parkinson's disease (PD) is a progressive neurodegenerative disease with no cure and few treatment options. Its incidence is increasing due to aging populations, longer disease duration and potentially as a COVID-19 sequela. Photobiomodulation (PBM) has been successfully used in animal models to reduce the signs of PD and to protect dopaminergic neurons. To assess the effectiveness of PBM to mitigate clinical signs of PD in a prospective proof-of-concept study, using a combination of transcrania","2021","07","16","BMC Neurol","BMC neurology","Cognition; Mobility; Motor symptoms; Parkinsons disease; Photobiomodulation; COVID-19; Humans; Low-Level Light Therapy; Parkinson Disease; Prospective Studies; SARS-CoV-2","Bicknell","Brian","Faculty of Health Sciences, Australian Cathlic University, North Sydney, Australia",NA
"2001","34215216","10.1186/s12883-021-02248-y","Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study.","Parkinson's disease (PD) is a progressive neurodegenerative disease with no cure and few treatment options. Its incidence is increasing due to aging populations, longer disease duration and potentially as a COVID-19 sequela. Photobiomodulation (PBM) has been successfully used in animal models to reduce the signs of PD and to protect dopaminergic neurons. To assess the effectiveness of PBM to mitigate clinical signs of PD in a prospective proof-of-concept study, using a combination of transcrania","2021","07","16","BMC Neurol","BMC neurology","Cognition; Mobility; Motor symptoms; Parkinsons disease; Photobiomodulation; COVID-19; Humans; Low-Level Light Therapy; Parkinson Disease; Prospective Studies; SARS-CoV-2","Laakso","E-Liisa","Mater Research Institute, South Brisbane, Australia",NA
"2002","34215216","10.1186/s12883-021-02248-y","Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study.","Parkinson's disease (PD) is a progressive neurodegenerative disease with no cure and few treatment options. Its incidence is increasing due to aging populations, longer disease duration and potentially as a COVID-19 sequela. Photobiomodulation (PBM) has been successfully used in animal models to reduce the signs of PD and to protect dopaminergic neurons. To assess the effectiveness of PBM to mitigate clinical signs of PD in a prospective proof-of-concept study, using a combination of transcrania","2021","07","16","BMC Neurol","BMC neurology","Cognition; Mobility; Motor symptoms; Parkinsons disease; Photobiomodulation; COVID-19; Humans; Low-Level Light Therapy; Parkinson Disease; Prospective Studies; SARS-CoV-2","Heller","Gillian","NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia",NA
"2003","34215216","10.1186/s12883-021-02248-y","Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study.","Parkinson's disease (PD) is a progressive neurodegenerative disease with no cure and few treatment options. Its incidence is increasing due to aging populations, longer disease duration and potentially as a COVID-19 sequela. Photobiomodulation (PBM) has been successfully used in animal models to reduce the signs of PD and to protect dopaminergic neurons. To assess the effectiveness of PBM to mitigate clinical signs of PD in a prospective proof-of-concept study, using a combination of transcrania","2021","07","16","BMC Neurol","BMC neurology","Cognition; Mobility; Motor symptoms; Parkinsons disease; Photobiomodulation; COVID-19; Humans; Low-Level Light Therapy; Parkinson Disease; Prospective Studies; SARS-CoV-2","Jalilitabaei","Parastoo","Department of Anatomy, University of Sydney, Camperdown, Australia",NA
"2004","34215216","10.1186/s12883-021-02248-y","Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study.","Parkinson's disease (PD) is a progressive neurodegenerative disease with no cure and few treatment options. Its incidence is increasing due to aging populations, longer disease duration and potentially as a COVID-19 sequela. Photobiomodulation (PBM) has been successfully used in animal models to reduce the signs of PD and to protect dopaminergic neurons. To assess the effectiveness of PBM to mitigate clinical signs of PD in a prospective proof-of-concept study, using a combination of transcrania","2021","07","16","BMC Neurol","BMC neurology","Cognition; Mobility; Motor symptoms; Parkinsons disease; Photobiomodulation; COVID-19; Humans; Low-Level Light Therapy; Parkinson Disease; Prospective Studies; SARS-CoV-2","Tilley","Sharon","Lymphoedema And Laser Therapy, Stepney, Australia",NA
"2005","34215216","10.1186/s12883-021-02248-y","Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study.","Parkinson's disease (PD) is a progressive neurodegenerative disease with no cure and few treatment options. Its incidence is increasing due to aging populations, longer disease duration and potentially as a COVID-19 sequela. Photobiomodulation (PBM) has been successfully used in animal models to reduce the signs of PD and to protect dopaminergic neurons. To assess the effectiveness of PBM to mitigate clinical signs of PD in a prospective proof-of-concept study, using a combination of transcrania","2021","07","16","BMC Neurol","BMC neurology","Cognition; Mobility; Motor symptoms; Parkinsons disease; Photobiomodulation; COVID-19; Humans; Low-Level Light Therapy; Parkinson Disease; Prospective Studies; SARS-CoV-2","Mitrofanis","John","Department of Anatomy, University of Sydney, Camperdown, Australia",NA
"2006","34215216","10.1186/s12883-021-02248-y","Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study.","Parkinson's disease (PD) is a progressive neurodegenerative disease with no cure and few treatment options. Its incidence is increasing due to aging populations, longer disease duration and potentially as a COVID-19 sequela. Photobiomodulation (PBM) has been successfully used in animal models to reduce the signs of PD and to protect dopaminergic neurons. To assess the effectiveness of PBM to mitigate clinical signs of PD in a prospective proof-of-concept study, using a combination of transcrania","2021","07","16","BMC Neurol","BMC neurology","Cognition; Mobility; Motor symptoms; Parkinsons disease; Photobiomodulation; COVID-19; Humans; Low-Level Light Therapy; Parkinson Disease; Prospective Studies; SARS-CoV-2","Kiat","Hosen","Faculty of medicine, Health and Human Sciences, Macquarie University, Macquarie Park, Australia",NA
"2007","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Vallejos","Julio","Instituto de Cardiología de Corrientes, Bolivar 1334, Zip code, 3400, Corrientes, Argentina",NA
"2008","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Zoni","Rodrigo","Instituto de Cardiología de Corrientes, Bolivar 1334, Zip code, 3400, Corrientes, Argentina. rodrizoni@yahoo.com","rodrizoni@yahoo.com.ar"
"2009","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Bangher","María","Instituto de Cardiología de Corrientes, Bolivar 1334, Zip code, 3400, Corrientes, Argentina",NA
"2010","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Villamandos","Silvina","Instituto de Cardiología de Corrientes, Bolivar 1334, Zip code, 3400, Corrientes, Argentina",NA
"2011","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Bobadilla","Angelina","Epidemiology. Ministerio de Salud Pública de la Provincia de Corrientes, Corrientes, Argentina",NA
"2012","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Plano","Fabian","Hospital de Campaña, Ministerio de Salud Pública de la Provincia de Corrientes, Ministerio de Salud Pública de Corrientes, Corrientes, Argentina",NA
"2013","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Campias","Claudia","Epidemiology. Ministerio de Salud Pública de la Provincia de Corrientes, Corrientes, Argentina",NA
"2014","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Chaparro Campias","Evangelina","Ministerio de Salud Pública de la Provincia de Corrientes, Corrientes, Argentina",NA
"2015","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Medina","Maria Fernanda","Instituto de Cardiología de Corrientes, Bolivar 1334, Zip code, 3400, Corrientes, Argentina",NA
"2016","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Achinelli","Fernando","Hospital de Campaña, Ministerio de Salud Pública de la Provincia de Corrientes, Ministerio de Salud Pública de Corrientes, Corrientes, Argentina",NA
"2017","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Guglielmone","Hector Andres","Ministerio de Salud Pública de la Provincia de Corrientes, Corrientes, Argentina",NA
"2018","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Ojeda","Jorge","Hospital de Campaña, Ministerio de Salud Pública de la Provincia de Corrientes, Ministerio de Salud Pública de Corrientes, Corrientes, Argentina",NA
"2019","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Farizano Salazar","Diego","Hospital de Campaña, Ministerio de Salud Pública de la Provincia de Corrientes, Ministerio de Salud Pública de Corrientes, Corrientes, Argentina",NA
"2020","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Andino","Gerardo","Ministerio de Salud Pública de la Provincia de Corrientes, Corrientes, Argentina",NA
"2021","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Kawerin","Pablo","Ministerio de Salud Pública de la Provincia de Corrientes, Corrientes, Argentina",NA
"2022","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Dellamea","Silvana","Hospital de Campaña, Ministerio de Salud Pública de la Provincia de Corrientes, Ministerio de Salud Pública de Corrientes, Corrientes, Argentina",NA
"2023","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Aquino","Antonia Cristina","Hospital de Campaña, Ministerio de Salud Pública de la Provincia de Corrientes, Ministerio de Salud Pública de Corrientes, Corrientes, Argentina",NA
"2024","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Flores","Victor","Hospital de Campaña, Ministerio de Salud Pública de la Provincia de Corrientes, Ministerio de Salud Pública de Corrientes, Corrientes, Argentina",NA
"2025","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Martemucci","Carolina N","Ministerio de Salud Pública de la Provincia de Corrientes, Corrientes, Argentina",NA
"2026","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Martinez","Silvina Maria","Ministerio de Salud Pública de la Provincia de Corrientes, Corrientes, Argentina",NA
"2027","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Segovia","Juan Emanuel","Epidemiology. Ministerio de Salud Pública de la Provincia de Corrientes, Corrientes, Argentina",NA
"2028","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Reynoso","Paola Itati","Instituto de Cardiología de Corrientes, Bolivar 1334, Zip code, 3400, Corrientes, Argentina",NA
"2029","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Sosa","Noelia Carolina","Instituto de Cardiología de Corrientes, Bolivar 1334, Zip code, 3400, Corrientes, Argentina",NA
"2030","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Robledo","Mariana Elizabeth","Instituto de Cardiología de Corrientes, Bolivar 1334, Zip code, 3400, Corrientes, Argentina",NA
"2031","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Guarrochena","Joaquina Maria","Instituto de Cardiología de Corrientes, Bolivar 1334, Zip code, 3400, Corrientes, Argentina",NA
"2032","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Vernengo","Maria Mercedes","Epidemiology. Ministerio de Salud Pública de la Provincia de Corrientes, Corrientes, Argentina",NA
"2033","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Ruiz Diaz","Natalia","Ministerio de Salud Pública de la Provincia de Corrientes, Corrientes, Argentina",NA
"2034","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Meza","Elba","Epidemiology. Ministerio de Salud Pública de la Provincia de Corrientes, Corrientes, Argentina",NA
"2035","34215210","10.1186/s12879-021-06348-5","Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 p","2021","07","07","BMC Infect Dis","BMC infectious diseases","Adult; Antiviral Agents; COVID-19; COVID-19 Nucleic Acid Testing; Double-Blind Method; Female; Hospitalization; Humans; Ivermectin; Length of Stay; Male; Middle Aged; Nasopharynx; Placebos; Treatment Outcome","Aguirre","María Gabriela","Instituto de Cardiología de Corrientes, Bolivar 1334, Zip code, 3400, Corrientes, Argentina",NA
"2036","34215167","10.1080/13607863.2021.1940096","Cumulative effect of loneliness and social isolation on health outcomes among older adults.","Loneliness and social isolation are described similarly yet are distinct constructs. Numerous studies have examined each construct separately; however, less effort has been dedicated to exploring the impacts in combination. This study sought to describe the cumulative effects on late-life health outcomes. Survey data collected in 2018-2019 of a randomly sampled population of US older adults, age 65+, were utilized (N = 6,994). Survey measures included loneliness and social isolation using the UC","2021","07","23","Aging Ment Health","Aging &amp; mental health","Loneliness; health outcomes; healthcare costs; healthcare utilization; older adults; social isolation","Barnes","Timothy L","Research for Aging Populations, OptumLabs, Minnetonka, MN, USA",NA
"2037","34215167","10.1080/13607863.2021.1940096","Cumulative effect of loneliness and social isolation on health outcomes among older adults.","Loneliness and social isolation are described similarly yet are distinct constructs. Numerous studies have examined each construct separately; however, less effort has been dedicated to exploring the impacts in combination. This study sought to describe the cumulative effects on late-life health outcomes. Survey data collected in 2018-2019 of a randomly sampled population of US older adults, age 65+, were utilized (N = 6,994). Survey measures included loneliness and social isolation using the UC","2021","07","23","Aging Ment Health","Aging &amp; mental health","Loneliness; health outcomes; healthcare costs; healthcare utilization; older adults; social isolation","MacLeod","Stephanie","Research for Aging Populations, OptumLabs, Minnetonka, MN, USA",NA
"2038","34215167","10.1080/13607863.2021.1940096","Cumulative effect of loneliness and social isolation on health outcomes among older adults.","Loneliness and social isolation are described similarly yet are distinct constructs. Numerous studies have examined each construct separately; however, less effort has been dedicated to exploring the impacts in combination. This study sought to describe the cumulative effects on late-life health outcomes. Survey data collected in 2018-2019 of a randomly sampled population of US older adults, age 65+, were utilized (N = 6,994). Survey measures included loneliness and social isolation using the UC","2021","07","23","Aging Ment Health","Aging &amp; mental health","Loneliness; health outcomes; healthcare costs; healthcare utilization; older adults; social isolation","Tkatch","Rifky","Research for Aging Populations, OptumLabs, Minnetonka, MN, USA",NA
"2039","34215167","10.1080/13607863.2021.1940096","Cumulative effect of loneliness and social isolation on health outcomes among older adults.","Loneliness and social isolation are described similarly yet are distinct constructs. Numerous studies have examined each construct separately; however, less effort has been dedicated to exploring the impacts in combination. This study sought to describe the cumulative effects on late-life health outcomes. Survey data collected in 2018-2019 of a randomly sampled population of US older adults, age 65+, were utilized (N = 6,994). Survey measures included loneliness and social isolation using the UC","2021","07","23","Aging Ment Health","Aging &amp; mental health","Loneliness; health outcomes; healthcare costs; healthcare utilization; older adults; social isolation","Ahuja","Manik","Research for Aging Populations, OptumLabs, Minnetonka, MN, USA",NA
"2040","34215167","10.1080/13607863.2021.1940096","Cumulative effect of loneliness and social isolation on health outcomes among older adults.","Loneliness and social isolation are described similarly yet are distinct constructs. Numerous studies have examined each construct separately; however, less effort has been dedicated to exploring the impacts in combination. This study sought to describe the cumulative effects on late-life health outcomes. Survey data collected in 2018-2019 of a randomly sampled population of US older adults, age 65+, were utilized (N = 6,994). Survey measures included loneliness and social isolation using the UC","2021","07","23","Aging Ment Health","Aging &amp; mental health","Loneliness; health outcomes; healthcare costs; healthcare utilization; older adults; social isolation","Albright","Laurie","UnitedHealthcare Alliances, Minneapolis, MN, USA",NA
"2041","34215167","10.1080/13607863.2021.1940096","Cumulative effect of loneliness and social isolation on health outcomes among older adults.","Loneliness and social isolation are described similarly yet are distinct constructs. Numerous studies have examined each construct separately; however, less effort has been dedicated to exploring the impacts in combination. This study sought to describe the cumulative effects on late-life health outcomes. Survey data collected in 2018-2019 of a randomly sampled population of US older adults, age 65+, were utilized (N = 6,994). Survey measures included loneliness and social isolation using the UC","2021","07","23","Aging Ment Health","Aging &amp; mental health","Loneliness; health outcomes; healthcare costs; healthcare utilization; older adults; social isolation","Schaeffer","James A","Research for Aging Populations, OptumLabs, Minnetonka, MN, USA",NA
"2042","34215167","10.1080/13607863.2021.1940096","Cumulative effect of loneliness and social isolation on health outcomes among older adults.","Loneliness and social isolation are described similarly yet are distinct constructs. Numerous studies have examined each construct separately; however, less effort has been dedicated to exploring the impacts in combination. This study sought to describe the cumulative effects on late-life health outcomes. Survey data collected in 2018-2019 of a randomly sampled population of US older adults, age 65+, were utilized (N = 6,994). Survey measures included loneliness and social isolation using the UC","2021","07","23","Aging Ment Health","Aging &amp; mental health","Loneliness; health outcomes; healthcare costs; healthcare utilization; older adults; social isolation","Yeh","Charlotte S","AARP Services, Inc., Washington, DC, USA",NA
"2043","34215120","10.1016/j.talanta.2021.122505","Catalytic hairpin DNA assembly-based chemiluminescent assay for the detection of short SARS-CoV-2 target cDNA.","Colorimetric sensors are recognized as a promising means for target molecule detection as they provide rapid, cost-effective, and facile sensing visible to the naked eye. Challenges remain though in terms of their detection sensitivity and specificity for short-length target genes. Herein, we demonstrate the successful combination of the catalytic hairpin DNA assembly (CHA) approach with enzyme-linked immunosorbent assay (ELISA)-mimicking techniques for a simple, sensitive, and sequence-specific","2021","07","07","Talanta","Talanta","Catalytic hairpin assembly; Chemiluminescent assay; Colorimetric detection; DNA probe; SARS-CoV-2; Target DNA; Biosensing Techniques; COVID-19; Colorimetry; DNA; DNA, Catalytic; DNA, Complementary; Humans; Limit of Detection; Luminescent Measurements; SARS-CoV-2","Do","Ji Yoon","Department of Biochemistry, Yeungnam University, 280 Daehak-ro, Gyongsan-si, Gyeongsangbuk-do, 38541, Republic of Korea",NA
"2044","34215120","10.1016/j.talanta.2021.122505","Catalytic hairpin DNA assembly-based chemiluminescent assay for the detection of short SARS-CoV-2 target cDNA.","Colorimetric sensors are recognized as a promising means for target molecule detection as they provide rapid, cost-effective, and facile sensing visible to the naked eye. Challenges remain though in terms of their detection sensitivity and specificity for short-length target genes. Herein, we demonstrate the successful combination of the catalytic hairpin DNA assembly (CHA) approach with enzyme-linked immunosorbent assay (ELISA)-mimicking techniques for a simple, sensitive, and sequence-specific","2021","07","07","Talanta","Talanta","Catalytic hairpin assembly; Chemiluminescent assay; Colorimetric detection; DNA probe; SARS-CoV-2; Target DNA; Biosensing Techniques; COVID-19; Colorimetry; DNA; DNA, Catalytic; DNA, Complementary; Humans; Limit of Detection; Luminescent Measurements; SARS-CoV-2","Jeong","Ji Yun","Department of Biochemistry, Yeungnam University, 280 Daehak-ro, Gyongsan-si, Gyeongsangbuk-do, 38541, Republic of Korea",NA
"2045","34215120","10.1016/j.talanta.2021.122505","Catalytic hairpin DNA assembly-based chemiluminescent assay for the detection of short SARS-CoV-2 target cDNA.","Colorimetric sensors are recognized as a promising means for target molecule detection as they provide rapid, cost-effective, and facile sensing visible to the naked eye. Challenges remain though in terms of their detection sensitivity and specificity for short-length target genes. Herein, we demonstrate the successful combination of the catalytic hairpin DNA assembly (CHA) approach with enzyme-linked immunosorbent assay (ELISA)-mimicking techniques for a simple, sensitive, and sequence-specific","2021","07","07","Talanta","Talanta","Catalytic hairpin assembly; Chemiluminescent assay; Colorimetric detection; DNA probe; SARS-CoV-2; Target DNA; Biosensing Techniques; COVID-19; Colorimetry; DNA; DNA, Catalytic; DNA, Complementary; Humans; Limit of Detection; Luminescent Measurements; SARS-CoV-2","Hong","Cheol Am","Department of Biochemistry, Yeungnam University, 280 Daehak-ro, Gyongsan-si, Gyeongsangbuk-do, 38541, Republic of Korea. Electronic address: cahong@yu.ac","cahong@yu.ac.kr"
"2046","34215093","10.1016/j.talanta.2021.122609","Recent advances in detection technologies for COVID-19.","Corona Virus Disease 2019 (COVID-19) is a highly infectious respiratory illness that was caused by the SARS-CoV-2. It spread around the world in just a few months and became a worldwide pandemic. Quick and accurate diagnosis of infected patients is very important for controlling transmission. In addition to the commonly used Real-time reverse-transcription polymerase chain reaction (RT-PCR) detection techniques, other diagnostic techniques are also emerging endlessly. This article reviews the cu","2021","07","07","Talanta","Talanta","COVID-19; Detection technologies; SARS-CoV-2; COVID-19; COVID-19 Testing; Humans; Pandemics; Real-Time Polymerase Chain Reaction; SARS-CoV-2","Han","Tingting","Institute of Biomedical Materials and Engineering, College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Qingdao University, Qingdao, 266071, China",NA
"2047","34215093","10.1016/j.talanta.2021.122609","Recent advances in detection technologies for COVID-19.","Corona Virus Disease 2019 (COVID-19) is a highly infectious respiratory illness that was caused by the SARS-CoV-2. It spread around the world in just a few months and became a worldwide pandemic. Quick and accurate diagnosis of infected patients is very important for controlling transmission. In addition to the commonly used Real-time reverse-transcription polymerase chain reaction (RT-PCR) detection techniques, other diagnostic techniques are also emerging endlessly. This article reviews the cu","2021","07","07","Talanta","Talanta","COVID-19; Detection technologies; SARS-CoV-2; COVID-19; COVID-19 Testing; Humans; Pandemics; Real-Time Polymerase Chain Reaction; SARS-CoV-2","Cong","Hailin","Institute of Biomedical Materials and Engineering, College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Qingdao University, Qingdao, 266071, China",NA
"2048","34215093","10.1016/j.talanta.2021.122609","Recent advances in detection technologies for COVID-19.","Corona Virus Disease 2019 (COVID-19) is a highly infectious respiratory illness that was caused by the SARS-CoV-2. It spread around the world in just a few months and became a worldwide pandemic. Quick and accurate diagnosis of infected patients is very important for controlling transmission. In addition to the commonly used Real-time reverse-transcription polymerase chain reaction (RT-PCR) detection techniques, other diagnostic techniques are also emerging endlessly. This article reviews the cu","2021","07","07","Talanta","Talanta","COVID-19; Detection technologies; SARS-CoV-2; COVID-19; COVID-19 Testing; Humans; Pandemics; Real-Time Polymerase Chain Reaction; SARS-CoV-2","Shen","Youqing","Institute of Biomedical Materials and Engineering, College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Qingdao University, Qingdao, 266071, China",NA
"2049","34215093","10.1016/j.talanta.2021.122609","Recent advances in detection technologies for COVID-19.","Corona Virus Disease 2019 (COVID-19) is a highly infectious respiratory illness that was caused by the SARS-CoV-2. It spread around the world in just a few months and became a worldwide pandemic. Quick and accurate diagnosis of infected patients is very important for controlling transmission. In addition to the commonly used Real-time reverse-transcription polymerase chain reaction (RT-PCR) detection techniques, other diagnostic techniques are also emerging endlessly. This article reviews the cu","2021","07","07","Talanta","Talanta","COVID-19; Detection technologies; SARS-CoV-2; COVID-19; COVID-19 Testing; Humans; Pandemics; Real-Time Polymerase Chain Reaction; SARS-CoV-2","Yu","Bing","Institute of Biomedical Materials and Engineering, College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Qingdao University, Qingdao, 266071, China","yubing198@qdu.edu.cn"
"2050","34215080","10.1016/j.talanta.2021.122591","A one-step, one-pot CRISPR nucleic acid detection platform (CRISPR-top): Application for the diagnosis of COVID-19.","The existing CRISPR-mediated diagnostic tests require a two-step procedure (DNA or RNA amplification followed by CRISPR-mediated sequence-specific detection) for nucleic acid detection, which increases complexity and the risk of sample cross-contamination. Here, we report a new CRISPR-mediated test, called CRISPR-top (CRISPR-mediated testing in one-pot), which integrates simultaneous target pre-amplification with CRISPR/cas12b-mediated detection into a one-pot reaction mixture, performed at a co","2021","07","07","Talanta","Talanta","COVID-19; CRISPR; CRISPR-Top; Cas12b; Nucleic acid detection; SARS-CoV-2; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Nucleic Acid Amplification Techniques; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Li","Shijun","Laboratory of Infectious Disease of Experimental Center, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China",NA
"2051","34215080","10.1016/j.talanta.2021.122591","A one-step, one-pot CRISPR nucleic acid detection platform (CRISPR-top): Application for the diagnosis of COVID-19.","The existing CRISPR-mediated diagnostic tests require a two-step procedure (DNA or RNA amplification followed by CRISPR-mediated sequence-specific detection) for nucleic acid detection, which increases complexity and the risk of sample cross-contamination. Here, we report a new CRISPR-mediated test, called CRISPR-top (CRISPR-mediated testing in one-pot), which integrates simultaneous target pre-amplification with CRISPR/cas12b-mediated detection into a one-pot reaction mixture, performed at a co","2021","07","07","Talanta","Talanta","COVID-19; CRISPR; CRISPR-Top; Cas12b; Nucleic acid detection; SARS-CoV-2; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Nucleic Acid Amplification Techniques; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Huang","Junfei","Laboratory of Infectious Disease of Experimental Center, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China",NA
"2052","34215080","10.1016/j.talanta.2021.122591","A one-step, one-pot CRISPR nucleic acid detection platform (CRISPR-top): Application for the diagnosis of COVID-19.","The existing CRISPR-mediated diagnostic tests require a two-step procedure (DNA or RNA amplification followed by CRISPR-mediated sequence-specific detection) for nucleic acid detection, which increases complexity and the risk of sample cross-contamination. Here, we report a new CRISPR-mediated test, called CRISPR-top (CRISPR-mediated testing in one-pot), which integrates simultaneous target pre-amplification with CRISPR/cas12b-mediated detection into a one-pot reaction mixture, performed at a co","2021","07","07","Talanta","Talanta","COVID-19; CRISPR; CRISPR-Top; Cas12b; Nucleic acid detection; SARS-CoV-2; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Nucleic Acid Amplification Techniques; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Ren","Lijuan","Laboratory of Infectious Disease of Experimental Center, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China",NA
"2053","34215080","10.1016/j.talanta.2021.122591","A one-step, one-pot CRISPR nucleic acid detection platform (CRISPR-top): Application for the diagnosis of COVID-19.","The existing CRISPR-mediated diagnostic tests require a two-step procedure (DNA or RNA amplification followed by CRISPR-mediated sequence-specific detection) for nucleic acid detection, which increases complexity and the risk of sample cross-contamination. Here, we report a new CRISPR-mediated test, called CRISPR-top (CRISPR-mediated testing in one-pot), which integrates simultaneous target pre-amplification with CRISPR/cas12b-mediated detection into a one-pot reaction mixture, performed at a co","2021","07","07","Talanta","Talanta","COVID-19; CRISPR; CRISPR-Top; Cas12b; Nucleic acid detection; SARS-CoV-2; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Nucleic Acid Amplification Techniques; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Jiang","Weijia","Laboratory of Infectious Disease of Experimental Center, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China",NA
"2054","34215080","10.1016/j.talanta.2021.122591","A one-step, one-pot CRISPR nucleic acid detection platform (CRISPR-top): Application for the diagnosis of COVID-19.","The existing CRISPR-mediated diagnostic tests require a two-step procedure (DNA or RNA amplification followed by CRISPR-mediated sequence-specific detection) for nucleic acid detection, which increases complexity and the risk of sample cross-contamination. Here, we report a new CRISPR-mediated test, called CRISPR-top (CRISPR-mediated testing in one-pot), which integrates simultaneous target pre-amplification with CRISPR/cas12b-mediated detection into a one-pot reaction mixture, performed at a co","2021","07","07","Talanta","Talanta","COVID-19; CRISPR; CRISPR-Top; Cas12b; Nucleic acid detection; SARS-CoV-2; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Nucleic Acid Amplification Techniques; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Wang","Ming","Laboratory of Infectious Disease of Experimental Center, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China",NA
"2055","34215080","10.1016/j.talanta.2021.122591","A one-step, one-pot CRISPR nucleic acid detection platform (CRISPR-top): Application for the diagnosis of COVID-19.","The existing CRISPR-mediated diagnostic tests require a two-step procedure (DNA or RNA amplification followed by CRISPR-mediated sequence-specific detection) for nucleic acid detection, which increases complexity and the risk of sample cross-contamination. Here, we report a new CRISPR-mediated test, called CRISPR-top (CRISPR-mediated testing in one-pot), which integrates simultaneous target pre-amplification with CRISPR/cas12b-mediated detection into a one-pot reaction mixture, performed at a co","2021","07","07","Talanta","Talanta","COVID-19; CRISPR; CRISPR-Top; Cas12b; Nucleic acid detection; SARS-CoV-2; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Nucleic Acid Amplification Techniques; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Zhuang","Li","Laboratory of Infectious Disease of Experimental Center, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China",NA
"2056","34215080","10.1016/j.talanta.2021.122591","A one-step, one-pot CRISPR nucleic acid detection platform (CRISPR-top): Application for the diagnosis of COVID-19.","The existing CRISPR-mediated diagnostic tests require a two-step procedure (DNA or RNA amplification followed by CRISPR-mediated sequence-specific detection) for nucleic acid detection, which increases complexity and the risk of sample cross-contamination. Here, we report a new CRISPR-mediated test, called CRISPR-top (CRISPR-mediated testing in one-pot), which integrates simultaneous target pre-amplification with CRISPR/cas12b-mediated detection into a one-pot reaction mixture, performed at a co","2021","07","07","Talanta","Talanta","COVID-19; CRISPR; CRISPR-Top; Cas12b; Nucleic acid detection; SARS-CoV-2; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Nucleic Acid Amplification Techniques; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Zheng","Qinni","Laboratory of Infectious Disease of Experimental Center, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China",NA
"2057","34215080","10.1016/j.talanta.2021.122591","A one-step, one-pot CRISPR nucleic acid detection platform (CRISPR-top): Application for the diagnosis of COVID-19.","The existing CRISPR-mediated diagnostic tests require a two-step procedure (DNA or RNA amplification followed by CRISPR-mediated sequence-specific detection) for nucleic acid detection, which increases complexity and the risk of sample cross-contamination. Here, we report a new CRISPR-mediated test, called CRISPR-top (CRISPR-mediated testing in one-pot), which integrates simultaneous target pre-amplification with CRISPR/cas12b-mediated detection into a one-pot reaction mixture, performed at a co","2021","07","07","Talanta","Talanta","COVID-19; CRISPR; CRISPR-Top; Cas12b; Nucleic acid detection; SARS-CoV-2; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Nucleic Acid Amplification Techniques; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Yang","Rui","Laboratory of Infectious Disease of Experimental Center, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China",NA
"2058","34215080","10.1016/j.talanta.2021.122591","A one-step, one-pot CRISPR nucleic acid detection platform (CRISPR-top): Application for the diagnosis of COVID-19.","The existing CRISPR-mediated diagnostic tests require a two-step procedure (DNA or RNA amplification followed by CRISPR-mediated sequence-specific detection) for nucleic acid detection, which increases complexity and the risk of sample cross-contamination. Here, we report a new CRISPR-mediated test, called CRISPR-top (CRISPR-mediated testing in one-pot), which integrates simultaneous target pre-amplification with CRISPR/cas12b-mediated detection into a one-pot reaction mixture, performed at a co","2021","07","07","Talanta","Talanta","COVID-19; CRISPR; CRISPR-Top; Cas12b; Nucleic acid detection; SARS-CoV-2; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Nucleic Acid Amplification Techniques; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Zeng","Yi","Laboratory of Infectious Disease of Experimental Center, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China",NA
"2059","34215080","10.1016/j.talanta.2021.122591","A one-step, one-pot CRISPR nucleic acid detection platform (CRISPR-top): Application for the diagnosis of COVID-19.","The existing CRISPR-mediated diagnostic tests require a two-step procedure (DNA or RNA amplification followed by CRISPR-mediated sequence-specific detection) for nucleic acid detection, which increases complexity and the risk of sample cross-contamination. Here, we report a new CRISPR-mediated test, called CRISPR-top (CRISPR-mediated testing in one-pot), which integrates simultaneous target pre-amplification with CRISPR/cas12b-mediated detection into a one-pot reaction mixture, performed at a co","2021","07","07","Talanta","Talanta","COVID-19; CRISPR; CRISPR-Top; Cas12b; Nucleic acid detection; SARS-CoV-2; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Nucleic Acid Amplification Techniques; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Luu","Laurence Don Wai","School of Biotechnology and Biomolecular Science, University of New South Wales, Sydney, Australia",NA
"2060","34215080","10.1016/j.talanta.2021.122591","A one-step, one-pot CRISPR nucleic acid detection platform (CRISPR-top): Application for the diagnosis of COVID-19.","The existing CRISPR-mediated diagnostic tests require a two-step procedure (DNA or RNA amplification followed by CRISPR-mediated sequence-specific detection) for nucleic acid detection, which increases complexity and the risk of sample cross-contamination. Here, we report a new CRISPR-mediated test, called CRISPR-top (CRISPR-mediated testing in one-pot), which integrates simultaneous target pre-amplification with CRISPR/cas12b-mediated detection into a one-pot reaction mixture, performed at a co","2021","07","07","Talanta","Talanta","COVID-19; CRISPR; CRISPR-Top; Cas12b; Nucleic acid detection; SARS-CoV-2; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Nucleic Acid Amplification Techniques; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Wang","Yi","Experimental Research Center, Capital Institute of Pediatrics, Beijing, 100020, PR China. Electronic address: wildwolf0101@163","wildwolf0101@163.com"
"2061","34215080","10.1016/j.talanta.2021.122591","A one-step, one-pot CRISPR nucleic acid detection platform (CRISPR-top): Application for the diagnosis of COVID-19.","The existing CRISPR-mediated diagnostic tests require a two-step procedure (DNA or RNA amplification followed by CRISPR-mediated sequence-specific detection) for nucleic acid detection, which increases complexity and the risk of sample cross-contamination. Here, we report a new CRISPR-mediated test, called CRISPR-top (CRISPR-mediated testing in one-pot), which integrates simultaneous target pre-amplification with CRISPR/cas12b-mediated detection into a one-pot reaction mixture, performed at a co","2021","07","07","Talanta","Talanta","COVID-19; CRISPR; CRISPR-Top; Cas12b; Nucleic acid detection; SARS-CoV-2; COVID-19; CRISPR-Cas Systems; Clustered Regularly Interspaced Short Palindromic Repeats; Humans; Nucleic Acid Amplification Techniques; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity","Tai","Jun","Department of Otolaryngology, Head and Neck Surgery, Children's Hospital Capital Institute of Pediatrics, Beijing, 100020, PR China. Electronic address: trenttj@163","trenttj@163.com"
"2062","34215035","10.1016/j.talanta.2021.122532","SARS-CoV-2 spike protein detection through a plasmonic D-shaped plastic optical fiber aptasensor.","A specific aptameric sequence has been immobilized on short polyethyleneglycol (PEG) interface on gold nano-film deposited on a D-shaped plastic optical fiber (POFs) probe, and the protein binding has been monitored exploiting the very sensitive surface plasmon resonance (SPR) phenomenon. The receptor-binding domain (RBD) of the SARS-CoV-2 spike glycoprotein has been specifically used to develop an aptasensor. Surface analysis techniques coupled to fluorescence microscopy and plasmonic analysis ","2021","07","07","Talanta","Talanta","Aptamer; Plastic optical fiber (POF); Polyethyleneglycol (PEG); Sars-CoV-2; Self assembled monolayer (SAM); Surface plasmon resonance (SPR); COVID-19; Humans; Optical Fibers; Plastics; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Cennamo","Nunzio","Department of Engineering, University of Campania ""L. Vanvitelli"", Via Roma 29, 81031, Aversa, Italy",NA
"2063","34215035","10.1016/j.talanta.2021.122532","SARS-CoV-2 spike protein detection through a plasmonic D-shaped plastic optical fiber aptasensor.","A specific aptameric sequence has been immobilized on short polyethyleneglycol (PEG) interface on gold nano-film deposited on a D-shaped plastic optical fiber (POFs) probe, and the protein binding has been monitored exploiting the very sensitive surface plasmon resonance (SPR) phenomenon. The receptor-binding domain (RBD) of the SARS-CoV-2 spike glycoprotein has been specifically used to develop an aptasensor. Surface analysis techniques coupled to fluorescence microscopy and plasmonic analysis ","2021","07","07","Talanta","Talanta","Aptamer; Plastic optical fiber (POF); Polyethyleneglycol (PEG); Sars-CoV-2; Self assembled monolayer (SAM); Surface plasmon resonance (SPR); COVID-19; Humans; Optical Fibers; Plastics; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Pasquardini","Laura","Indivenire srl, Via Alla Cascata 56/C, 38123, Trento, Italy. Electronic address: l.pasquardini@indiveni","l.pasquardini@indiveni.re"
"2064","34215035","10.1016/j.talanta.2021.122532","SARS-CoV-2 spike protein detection through a plasmonic D-shaped plastic optical fiber aptasensor.","A specific aptameric sequence has been immobilized on short polyethyleneglycol (PEG) interface on gold nano-film deposited on a D-shaped plastic optical fiber (POFs) probe, and the protein binding has been monitored exploiting the very sensitive surface plasmon resonance (SPR) phenomenon. The receptor-binding domain (RBD) of the SARS-CoV-2 spike glycoprotein has been specifically used to develop an aptasensor. Surface analysis techniques coupled to fluorescence microscopy and plasmonic analysis ","2021","07","07","Talanta","Talanta","Aptamer; Plastic optical fiber (POF); Polyethyleneglycol (PEG); Sars-CoV-2; Self assembled monolayer (SAM); Surface plasmon resonance (SPR); COVID-19; Humans; Optical Fibers; Plastics; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Arcadio","Francesco","Department of Engineering, University of Campania ""L. Vanvitelli"", Via Roma 29, 81031, Aversa, Italy",NA
"2065","34215035","10.1016/j.talanta.2021.122532","SARS-CoV-2 spike protein detection through a plasmonic D-shaped plastic optical fiber aptasensor.","A specific aptameric sequence has been immobilized on short polyethyleneglycol (PEG) interface on gold nano-film deposited on a D-shaped plastic optical fiber (POFs) probe, and the protein binding has been monitored exploiting the very sensitive surface plasmon resonance (SPR) phenomenon. The receptor-binding domain (RBD) of the SARS-CoV-2 spike glycoprotein has been specifically used to develop an aptasensor. Surface analysis techniques coupled to fluorescence microscopy and plasmonic analysis ","2021","07","07","Talanta","Talanta","Aptamer; Plastic optical fiber (POF); Polyethyleneglycol (PEG); Sars-CoV-2; Self assembled monolayer (SAM); Surface plasmon resonance (SPR); COVID-19; Humans; Optical Fibers; Plastics; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Lunelli","Lorenzo","Fondazione Bruno Kessler-SD-MST, Via Sommarive 18, 38123, Trento, Italy",NA
"2066","34215035","10.1016/j.talanta.2021.122532","SARS-CoV-2 spike protein detection through a plasmonic D-shaped plastic optical fiber aptasensor.","A specific aptameric sequence has been immobilized on short polyethyleneglycol (PEG) interface on gold nano-film deposited on a D-shaped plastic optical fiber (POFs) probe, and the protein binding has been monitored exploiting the very sensitive surface plasmon resonance (SPR) phenomenon. The receptor-binding domain (RBD) of the SARS-CoV-2 spike glycoprotein has been specifically used to develop an aptasensor. Surface analysis techniques coupled to fluorescence microscopy and plasmonic analysis ","2021","07","07","Talanta","Talanta","Aptamer; Plastic optical fiber (POF); Polyethyleneglycol (PEG); Sars-CoV-2; Self assembled monolayer (SAM); Surface plasmon resonance (SPR); COVID-19; Humans; Optical Fibers; Plastics; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Vanzetti","Lia","Fondazione Bruno Kessler-SD-MNF, Via Sommarive 18, 38123, Trento, Italy",NA
"2067","34215035","10.1016/j.talanta.2021.122532","SARS-CoV-2 spike protein detection through a plasmonic D-shaped plastic optical fiber aptasensor.","A specific aptameric sequence has been immobilized on short polyethyleneglycol (PEG) interface on gold nano-film deposited on a D-shaped plastic optical fiber (POFs) probe, and the protein binding has been monitored exploiting the very sensitive surface plasmon resonance (SPR) phenomenon. The receptor-binding domain (RBD) of the SARS-CoV-2 spike glycoprotein has been specifically used to develop an aptasensor. Surface analysis techniques coupled to fluorescence microscopy and plasmonic analysis ","2021","07","07","Talanta","Talanta","Aptamer; Plastic optical fiber (POF); Polyethyleneglycol (PEG); Sars-CoV-2; Self assembled monolayer (SAM); Surface plasmon resonance (SPR); COVID-19; Humans; Optical Fibers; Plastics; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Carafa","Vincenzo","Department of Precision Medicine, University of Campania ""L. Vanvitelli"", Vico L. De Crecchio 7, 80138, Napoli, Italy",NA
"2068","34215035","10.1016/j.talanta.2021.122532","SARS-CoV-2 spike protein detection through a plasmonic D-shaped plastic optical fiber aptasensor.","A specific aptameric sequence has been immobilized on short polyethyleneglycol (PEG) interface on gold nano-film deposited on a D-shaped plastic optical fiber (POFs) probe, and the protein binding has been monitored exploiting the very sensitive surface plasmon resonance (SPR) phenomenon. The receptor-binding domain (RBD) of the SARS-CoV-2 spike glycoprotein has been specifically used to develop an aptasensor. Surface analysis techniques coupled to fluorescence microscopy and plasmonic analysis ","2021","07","07","Talanta","Talanta","Aptamer; Plastic optical fiber (POF); Polyethyleneglycol (PEG); Sars-CoV-2; Self assembled monolayer (SAM); Surface plasmon resonance (SPR); COVID-19; Humans; Optical Fibers; Plastics; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Altucci","Lucia","Department of Precision Medicine, University of Campania ""L. Vanvitelli"", Vico L. De Crecchio 7, 80138, Napoli, Italy",NA
"2069","34215035","10.1016/j.talanta.2021.122532","SARS-CoV-2 spike protein detection through a plasmonic D-shaped plastic optical fiber aptasensor.","A specific aptameric sequence has been immobilized on short polyethyleneglycol (PEG) interface on gold nano-film deposited on a D-shaped plastic optical fiber (POFs) probe, and the protein binding has been monitored exploiting the very sensitive surface plasmon resonance (SPR) phenomenon. The receptor-binding domain (RBD) of the SARS-CoV-2 spike glycoprotein has been specifically used to develop an aptasensor. Surface analysis techniques coupled to fluorescence microscopy and plasmonic analysis ","2021","07","07","Talanta","Talanta","Aptamer; Plastic optical fiber (POF); Polyethyleneglycol (PEG); Sars-CoV-2; Self assembled monolayer (SAM); Surface plasmon resonance (SPR); COVID-19; Humans; Optical Fibers; Plastics; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Zeni","Luigi","Department of Engineering, University of Campania ""L. Vanvitelli"", Via Roma 29, 81031, Aversa, Italy. Electronic address: luigi.zeni@unicampania","luigi.zeni@unicampania.it"
"2070","34215019","10.1002/dta.3122","Pharmacokinetic profiles of a SARS-COV-2 neutralizing antibody BD-604 in cynomolgus monkeys.","Currently, severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) has spread worldwide as a severe pandemic and effective therapeutic medications are urgently needed. As reported previously, BD-604 is a fully human monoclonal antibody with strong in vitro and in vivo neutralizing activity to SARS-COV-2. The purpose of this study was to characterize the pharmacokinetic propertie of BD-604 in cynomolgus monkeys. To analyze the concentration of BD-604 in cynomolgus monkey serum, an ELISA assa","2021","07","16","Drug Test Anal","Drug testing and analysis","BD-604; SARS-COV-2; monkey; monoclonal antibody; pharmacokinetics","Gao","Feng","Singlomics (Beijing DanXu Biopharmaceuticals) Co., Ltd., Beijing, China",NA
"2071","34215019","10.1002/dta.3122","Pharmacokinetic profiles of a SARS-COV-2 neutralizing antibody BD-604 in cynomolgus monkeys.","Currently, severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) has spread worldwide as a severe pandemic and effective therapeutic medications are urgently needed. As reported previously, BD-604 is a fully human monoclonal antibody with strong in vitro and in vivo neutralizing activity to SARS-COV-2. The purpose of this study was to characterize the pharmacokinetic propertie of BD-604 in cynomolgus monkeys. To analyze the concentration of BD-604 in cynomolgus monkey serum, an ELISA assa","2021","07","16","Drug Test Anal","Drug testing and analysis","BD-604; SARS-COV-2; monkey; monoclonal antibody; pharmacokinetics","Zhang","Xu","Singlomics (Beijing DanXu Biopharmaceuticals) Co., Ltd., Beijing, China",NA
"2072","34214961","10.1016/j.sleep.2021.06.007","Bilateral associations between sleep duration and depressive symptoms among Chinese adolescents before and during the COVID-19 pandemic.","Depression is one of the most prevalent psychiatric disorders and the leading cause of disability among adolescents, with sleep duration as its vital influential factor. Adolescents might be mentally sensitive to the stress caused by the COVID-19 pandemic. Yet, the alteration of adolescents' sleep duration, depression, and their associations within the context of the COVID-19 pandemic have not been well documented. We conducted a longitudinal study, recruiting 2496 adolescents from 3 junior high","2021","07","21","Sleep Med","Sleep medicine","Depression; Longitudinal associations; Repeated measures; Sleep; Teenagers","Liao","Shujuan","Department of Nursing, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China",NA
"2073","34214961","10.1016/j.sleep.2021.06.007","Bilateral associations between sleep duration and depressive symptoms among Chinese adolescents before and during the COVID-19 pandemic.","Depression is one of the most prevalent psychiatric disorders and the leading cause of disability among adolescents, with sleep duration as its vital influential factor. Adolescents might be mentally sensitive to the stress caused by the COVID-19 pandemic. Yet, the alteration of adolescents' sleep duration, depression, and their associations within the context of the COVID-19 pandemic have not been well documented. We conducted a longitudinal study, recruiting 2496 adolescents from 3 junior high","2021","07","21","Sleep Med","Sleep medicine","Depression; Longitudinal associations; Repeated measures; Sleep; Teenagers","Luo","Biru","Department of Nursing, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China",NA
"2074","34214961","10.1016/j.sleep.2021.06.007","Bilateral associations between sleep duration and depressive symptoms among Chinese adolescents before and during the COVID-19 pandemic.","Depression is one of the most prevalent psychiatric disorders and the leading cause of disability among adolescents, with sleep duration as its vital influential factor. Adolescents might be mentally sensitive to the stress caused by the COVID-19 pandemic. Yet, the alteration of adolescents' sleep duration, depression, and their associations within the context of the COVID-19 pandemic have not been well documented. We conducted a longitudinal study, recruiting 2496 adolescents from 3 junior high","2021","07","21","Sleep Med","Sleep medicine","Depression; Longitudinal associations; Repeated measures; Sleep; Teenagers","Liu","Hanmin","Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, Sichuan, People's Republic of China",NA
"2075","34214961","10.1016/j.sleep.2021.06.007","Bilateral associations between sleep duration and depressive symptoms among Chinese adolescents before and during the COVID-19 pandemic.","Depression is one of the most prevalent psychiatric disorders and the leading cause of disability among adolescents, with sleep duration as its vital influential factor. Adolescents might be mentally sensitive to the stress caused by the COVID-19 pandemic. Yet, the alteration of adolescents' sleep duration, depression, and their associations within the context of the COVID-19 pandemic have not been well documented. We conducted a longitudinal study, recruiting 2496 adolescents from 3 junior high","2021","07","21","Sleep Med","Sleep medicine","Depression; Longitudinal associations; Repeated measures; Sleep; Teenagers","Zhao","Li","Department of Health Policy and Management, West China School of Public Health/West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address: zhaoli@scu.edu","zhaoli@scu.edu.cn"
"2076","34214961","10.1016/j.sleep.2021.06.007","Bilateral associations between sleep duration and depressive symptoms among Chinese adolescents before and during the COVID-19 pandemic.","Depression is one of the most prevalent psychiatric disorders and the leading cause of disability among adolescents, with sleep duration as its vital influential factor. Adolescents might be mentally sensitive to the stress caused by the COVID-19 pandemic. Yet, the alteration of adolescents' sleep duration, depression, and their associations within the context of the COVID-19 pandemic have not been well documented. We conducted a longitudinal study, recruiting 2496 adolescents from 3 junior high","2021","07","21","Sleep Med","Sleep medicine","Depression; Longitudinal associations; Repeated measures; Sleep; Teenagers","Shi","Wei","Institute for Disaster Management and Reconstruction (IDMR), Sichuan University, Chengdu, Sichuan, China",NA
"2077","34214961","10.1016/j.sleep.2021.06.007","Bilateral associations between sleep duration and depressive symptoms among Chinese adolescents before and during the COVID-19 pandemic.","Depression is one of the most prevalent psychiatric disorders and the leading cause of disability among adolescents, with sleep duration as its vital influential factor. Adolescents might be mentally sensitive to the stress caused by the COVID-19 pandemic. Yet, the alteration of adolescents' sleep duration, depression, and their associations within the context of the COVID-19 pandemic have not been well documented. We conducted a longitudinal study, recruiting 2496 adolescents from 3 junior high","2021","07","21","Sleep Med","Sleep medicine","Depression; Longitudinal associations; Repeated measures; Sleep; Teenagers","Lei","Yalin","Department of Health Behavior and Social Medicine, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China",NA
"2078","34214961","10.1016/j.sleep.2021.06.007","Bilateral associations between sleep duration and depressive symptoms among Chinese adolescents before and during the COVID-19 pandemic.","Depression is one of the most prevalent psychiatric disorders and the leading cause of disability among adolescents, with sleep duration as its vital influential factor. Adolescents might be mentally sensitive to the stress caused by the COVID-19 pandemic. Yet, the alteration of adolescents' sleep duration, depression, and their associations within the context of the COVID-19 pandemic have not been well documented. We conducted a longitudinal study, recruiting 2496 adolescents from 3 junior high","2021","07","21","Sleep Med","Sleep medicine","Depression; Longitudinal associations; Repeated measures; Sleep; Teenagers","Jia","Peng","School of Resources and Environmental Science, Wuhan University, Wuhan, China",NA
"2079","34214927","10.1016/j.sbi.2021.05.007","Neutron crystallography for the elucidation of enzyme catalysis.","Hydrogen atoms and hydration water molecules in proteins are indispensable for many biochemical processes, especially enzymatic catalysis. The locations of hydrogen atoms in proteins are usually predicted based on X-ray structures, but it is still very difficult to know the ionization states of the catalytic residues, the hydration structure of the protein, and the characteristics of hydrogen-bonding interactions. Neutron crystallography allows the direct observation of hydrogen atoms that play ","2021","07","21","Curr Opin Struct Biol","Current opinion in structural biology",NA,"Kono","Fumiaki","Institute for Quantum Life Science, National Institutes for Quantum and Radiological Science and Technology, 2-4 Shirakata, Tokai, Ibaraki 319-1106, Japan",NA
"2080","34214927","10.1016/j.sbi.2021.05.007","Neutron crystallography for the elucidation of enzyme catalysis.","Hydrogen atoms and hydration water molecules in proteins are indispensable for many biochemical processes, especially enzymatic catalysis. The locations of hydrogen atoms in proteins are usually predicted based on X-ray structures, but it is still very difficult to know the ionization states of the catalytic residues, the hydration structure of the protein, and the characteristics of hydrogen-bonding interactions. Neutron crystallography allows the direct observation of hydrogen atoms that play ","2021","07","21","Curr Opin Struct Biol","Current opinion in structural biology",NA,"Tamada","Taro","Institute for Quantum Life Science, National Institutes for Quantum and Radiological Science and Technology, 2-4 Shirakata, Tokai, Ibaraki 319-1106, Japan. Electronic address: tamada.taro@qst.go","tamada.taro@qst.go.jp"
"2081","34214902","10.1016/j.jss.2021.05.009","The Impact of COVID-19 on Surgical Education.","At the onset of social distancing, our general surgery residency transitioned its educational curriculum to an entirely virtual format with no gaps in conference offerings. The aim of this study is to examine the feasibility of our evolution to a virtual format and report program attitudes toward the changes. On March 15, 2020, due to the coronavirus disease (COVID-19) our institution restricted mass gatherings. We immediately transitioned all lectures to a virtual platform. The cancellation of ","2021","07","19","J Surg Res","The Journal of surgical research","Covid-19; Curriculum development; Educational conferences; Virtual curriculum","Nagaraj","Madhuri B","University of Texas Southwestern Medical Center, Department of Surgery, Dallas, Texas. Electronic address: Madhuri.nagaraj@gmail","Madhuri.nagaraj@gmail.com"
"2082","34214902","10.1016/j.jss.2021.05.009","The Impact of COVID-19 on Surgical Education.","At the onset of social distancing, our general surgery residency transitioned its educational curriculum to an entirely virtual format with no gaps in conference offerings. The aim of this study is to examine the feasibility of our evolution to a virtual format and report program attitudes toward the changes. On March 15, 2020, due to the coronavirus disease (COVID-19) our institution restricted mass gatherings. We immediately transitioned all lectures to a virtual platform. The cancellation of ","2021","07","19","J Surg Res","The Journal of surgical research","Covid-19; Curriculum development; Educational conferences; Virtual curriculum","Weis","Holly B","University of Texas Southwestern Medical Center, Department of Surgery, Dallas, Texas",NA
"2083","34214902","10.1016/j.jss.2021.05.009","The Impact of COVID-19 on Surgical Education.","At the onset of social distancing, our general surgery residency transitioned its educational curriculum to an entirely virtual format with no gaps in conference offerings. The aim of this study is to examine the feasibility of our evolution to a virtual format and report program attitudes toward the changes. On March 15, 2020, due to the coronavirus disease (COVID-19) our institution restricted mass gatherings. We immediately transitioned all lectures to a virtual platform. The cancellation of ","2021","07","19","J Surg Res","The Journal of surgical research","Covid-19; Curriculum development; Educational conferences; Virtual curriculum","Weis","Joshua J","University of Texas Southwestern Medical Center, Department of Surgery, Dallas, Texas",NA
"2084","34214902","10.1016/j.jss.2021.05.009","The Impact of COVID-19 on Surgical Education.","At the onset of social distancing, our general surgery residency transitioned its educational curriculum to an entirely virtual format with no gaps in conference offerings. The aim of this study is to examine the feasibility of our evolution to a virtual format and report program attitudes toward the changes. On March 15, 2020, due to the coronavirus disease (COVID-19) our institution restricted mass gatherings. We immediately transitioned all lectures to a virtual platform. The cancellation of ","2021","07","19","J Surg Res","The Journal of surgical research","Covid-19; Curriculum development; Educational conferences; Virtual curriculum","Cook","Grayden S","University of Texas Southwestern Medical Center, Department of Surgery, Dallas, Texas",NA
"2085","34214902","10.1016/j.jss.2021.05.009","The Impact of COVID-19 on Surgical Education.","At the onset of social distancing, our general surgery residency transitioned its educational curriculum to an entirely virtual format with no gaps in conference offerings. The aim of this study is to examine the feasibility of our evolution to a virtual format and report program attitudes toward the changes. On March 15, 2020, due to the coronavirus disease (COVID-19) our institution restricted mass gatherings. We immediately transitioned all lectures to a virtual platform. The cancellation of ","2021","07","19","J Surg Res","The Journal of surgical research","Covid-19; Curriculum development; Educational conferences; Virtual curriculum","Bailey","Lisa W","University of Texas Southwestern Medical Center, Department of Surgery, Dallas, Texas",NA
"2086","34214902","10.1016/j.jss.2021.05.009","The Impact of COVID-19 on Surgical Education.","At the onset of social distancing, our general surgery residency transitioned its educational curriculum to an entirely virtual format with no gaps in conference offerings. The aim of this study is to examine the feasibility of our evolution to a virtual format and report program attitudes toward the changes. On March 15, 2020, due to the coronavirus disease (COVID-19) our institution restricted mass gatherings. We immediately transitioned all lectures to a virtual platform. The cancellation of ","2021","07","19","J Surg Res","The Journal of surgical research","Covid-19; Curriculum development; Educational conferences; Virtual curriculum","Shoultz","Thomas H","University of Texas Southwestern Medical Center, Department of Surgery, Dallas, Texas",NA
"2087","34214902","10.1016/j.jss.2021.05.009","The Impact of COVID-19 on Surgical Education.","At the onset of social distancing, our general surgery residency transitioned its educational curriculum to an entirely virtual format with no gaps in conference offerings. The aim of this study is to examine the feasibility of our evolution to a virtual format and report program attitudes toward the changes. On March 15, 2020, due to the coronavirus disease (COVID-19) our institution restricted mass gatherings. We immediately transitioned all lectures to a virtual platform. The cancellation of ","2021","07","19","J Surg Res","The Journal of surgical research","Covid-19; Curriculum development; Educational conferences; Virtual curriculum","Farr","Deborah E","University of Texas Southwestern Medical Center, Department of Surgery, Dallas, Texas",NA
"2088","34214902","10.1016/j.jss.2021.05.009","The Impact of COVID-19 on Surgical Education.","At the onset of social distancing, our general surgery residency transitioned its educational curriculum to an entirely virtual format with no gaps in conference offerings. The aim of this study is to examine the feasibility of our evolution to a virtual format and report program attitudes toward the changes. On March 15, 2020, due to the coronavirus disease (COVID-19) our institution restricted mass gatherings. We immediately transitioned all lectures to a virtual platform. The cancellation of ","2021","07","19","J Surg Res","The Journal of surgical research","Covid-19; Curriculum development; Educational conferences; Virtual curriculum","AbdelFattah","Kareem R","University of Texas Southwestern Medical Center, Department of Surgery, Dallas, Texas",NA
"2089","34214902","10.1016/j.jss.2021.05.009","The Impact of COVID-19 on Surgical Education.","At the onset of social distancing, our general surgery residency transitioned its educational curriculum to an entirely virtual format with no gaps in conference offerings. The aim of this study is to examine the feasibility of our evolution to a virtual format and report program attitudes toward the changes. On March 15, 2020, due to the coronavirus disease (COVID-19) our institution restricted mass gatherings. We immediately transitioned all lectures to a virtual platform. The cancellation of ","2021","07","19","J Surg Res","The Journal of surgical research","Covid-19; Curriculum development; Educational conferences; Virtual curriculum","Dultz","Linda A","University of Texas Southwestern Medical Center, Department of Surgery, Dallas, Texas",NA
"2090","34214884","10.1016/j.drugalcdep.2021.108822","Adolescent drug use before and during U.S. national COVID-19 social distancing policies.","How adolescent substance use and perceived availability of substances have changed during the COVID-19 pandemic remain largely unknown. Substantial reduction in availability of substances would present a unique opportunity to consider the supply-side hypothesis that reductions in drug availability will lead to reductions in drug prevalence. Longitudinal data come from Monitoring the Future and are based on responses from 582 adolescents who were originally surveyed as part of a national sample o","2021","07","20","Drug Alcohol Depend","Drug and alcohol dependence","Adolescents; Alcohol; COVID-19 pandemic; Marijuana; Nicotine vaping; Prevalence","Miech","Richard","Institute for Social Research, University of Michigan, 426 Thompson Street, Ann Arbor, MI 48104, United States. Electronic address: ramiech@umich","ramiech@umich.edu"
"2091","34214884","10.1016/j.drugalcdep.2021.108822","Adolescent drug use before and during U.S. national COVID-19 social distancing policies.","How adolescent substance use and perceived availability of substances have changed during the COVID-19 pandemic remain largely unknown. Substantial reduction in availability of substances would present a unique opportunity to consider the supply-side hypothesis that reductions in drug availability will lead to reductions in drug prevalence. Longitudinal data come from Monitoring the Future and are based on responses from 582 adolescents who were originally surveyed as part of a national sample o","2021","07","20","Drug Alcohol Depend","Drug and alcohol dependence","Adolescents; Alcohol; COVID-19 pandemic; Marijuana; Nicotine vaping; Prevalence","Patrick","Megan E","Institute for Social Research, University of Michigan, 426 Thompson Street, Ann Arbor, MI 48104, United States",NA
"2092","34214884","10.1016/j.drugalcdep.2021.108822","Adolescent drug use before and during U.S. national COVID-19 social distancing policies.","How adolescent substance use and perceived availability of substances have changed during the COVID-19 pandemic remain largely unknown. Substantial reduction in availability of substances would present a unique opportunity to consider the supply-side hypothesis that reductions in drug availability will lead to reductions in drug prevalence. Longitudinal data come from Monitoring the Future and are based on responses from 582 adolescents who were originally surveyed as part of a national sample o","2021","07","20","Drug Alcohol Depend","Drug and alcohol dependence","Adolescents; Alcohol; COVID-19 pandemic; Marijuana; Nicotine vaping; Prevalence","Keyes","Katherine","Mailman School of Public Health, Department of Epidemiology, Columbia University, 722 West 168(th) Street, Suite 724, New York, NY, 10032, United States",NA
"2093","34214884","10.1016/j.drugalcdep.2021.108822","Adolescent drug use before and during U.S. national COVID-19 social distancing policies.","How adolescent substance use and perceived availability of substances have changed during the COVID-19 pandemic remain largely unknown. Substantial reduction in availability of substances would present a unique opportunity to consider the supply-side hypothesis that reductions in drug availability will lead to reductions in drug prevalence. Longitudinal data come from Monitoring the Future and are based on responses from 582 adolescents who were originally surveyed as part of a national sample o","2021","07","20","Drug Alcohol Depend","Drug and alcohol dependence","Adolescents; Alcohol; COVID-19 pandemic; Marijuana; Nicotine vaping; Prevalence","O'Malley","Patrick M","Institute for Social Research, University of Michigan, 426 Thompson Street, Ann Arbor, MI 48104, United States",NA
"2094","34214884","10.1016/j.drugalcdep.2021.108822","Adolescent drug use before and during U.S. national COVID-19 social distancing policies.","How adolescent substance use and perceived availability of substances have changed during the COVID-19 pandemic remain largely unknown. Substantial reduction in availability of substances would present a unique opportunity to consider the supply-side hypothesis that reductions in drug availability will lead to reductions in drug prevalence. Longitudinal data come from Monitoring the Future and are based on responses from 582 adolescents who were originally surveyed as part of a national sample o","2021","07","20","Drug Alcohol Depend","Drug and alcohol dependence","Adolescents; Alcohol; COVID-19 pandemic; Marijuana; Nicotine vaping; Prevalence","Johnston","Lloyd","Institute for Social Research, University of Michigan, 426 Thompson Street, Ann Arbor, MI 48104, United States",NA
"2095","34214871","10.1016/j.clinimag.2021.06.034","Role of hepatosteatosis in the prognosis of COVID 19 disease.","To measure the degree of fatty liver using non-contrast enhanced chest computed tomography (CT) and investigate its relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19) in adult patients. This retrospective study included consecutive patients who had been diagnosed with COVID-19 using real-time reverse-transcription polymerase chain reaction (RT-PCR) and subsequently underwent non-contrast enhanced chest CT between October 10 and December 10, 2020. Hepatic attenuat","2021","07","24","Clin Imaging","Clinical imaging","COVID-19; Computed tomography; Hepatosteatosis; Hounsfield unit","Çorapli","Mahmut","Department of Radiology, Adiyaman Training &amp","mahmutcorapli@gmail.com"
"2096","34214871","10.1016/j.clinimag.2021.06.034","Role of hepatosteatosis in the prognosis of COVID 19 disease.","To measure the degree of fatty liver using non-contrast enhanced chest computed tomography (CT) and investigate its relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19) in adult patients. This retrospective study included consecutive patients who had been diagnosed with COVID-19 using real-time reverse-transcription polymerase chain reaction (RT-PCR) and subsequently underwent non-contrast enhanced chest CT between October 10 and December 10, 2020. Hepatic attenuat","2021","07","24","Clin Imaging","Clinical imaging","COVID-19; Computed tomography; Hepatosteatosis; Hounsfield unit","Çil","Ercan","Department of Chest Diseases, Medicine Faculty of Adiyaman University, Turkey",NA
"2097","34214871","10.1016/j.clinimag.2021.06.034","Role of hepatosteatosis in the prognosis of COVID 19 disease.","To measure the degree of fatty liver using non-contrast enhanced chest computed tomography (CT) and investigate its relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19) in adult patients. This retrospective study included consecutive patients who had been diagnosed with COVID-19 using real-time reverse-transcription polymerase chain reaction (RT-PCR) and subsequently underwent non-contrast enhanced chest CT between October 10 and December 10, 2020. Hepatic attenuat","2021","07","24","Clin Imaging","Clinical imaging","COVID-19; Computed tomography; Hepatosteatosis; Hounsfield unit","Oktay","Cemil","Department of Radiology, Adiyaman Training &amp",NA
"2098","34214871","10.1016/j.clinimag.2021.06.034","Role of hepatosteatosis in the prognosis of COVID 19 disease.","To measure the degree of fatty liver using non-contrast enhanced chest computed tomography (CT) and investigate its relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19) in adult patients. This retrospective study included consecutive patients who had been diagnosed with COVID-19 using real-time reverse-transcription polymerase chain reaction (RT-PCR) and subsequently underwent non-contrast enhanced chest CT between October 10 and December 10, 2020. Hepatic attenuat","2021","07","24","Clin Imaging","Clinical imaging","COVID-19; Computed tomography; Hepatosteatosis; Hounsfield unit","Kaçmaz","Hüseyin","Department of Gastroenterology, Adiyaman Training &amp",NA
"2099","34214871","10.1016/j.clinimag.2021.06.034","Role of hepatosteatosis in the prognosis of COVID 19 disease.","To measure the degree of fatty liver using non-contrast enhanced chest computed tomography (CT) and investigate its relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19) in adult patients. This retrospective study included consecutive patients who had been diagnosed with COVID-19 using real-time reverse-transcription polymerase chain reaction (RT-PCR) and subsequently underwent non-contrast enhanced chest CT between October 10 and December 10, 2020. Hepatic attenuat","2021","07","24","Clin Imaging","Clinical imaging","COVID-19; Computed tomography; Hepatosteatosis; Hounsfield unit","Çorapli","Gökhan","Department of Chest Diseases, Yüksekova State Hospital, Turkey",NA
"2100","34214871","10.1016/j.clinimag.2021.06.034","Role of hepatosteatosis in the prognosis of COVID 19 disease.","To measure the degree of fatty liver using non-contrast enhanced chest computed tomography (CT) and investigate its relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19) in adult patients. This retrospective study included consecutive patients who had been diagnosed with COVID-19 using real-time reverse-transcription polymerase chain reaction (RT-PCR) and subsequently underwent non-contrast enhanced chest CT between October 10 and December 10, 2020. Hepatic attenuat","2021","07","24","Clin Imaging","Clinical imaging","COVID-19; Computed tomography; Hepatosteatosis; Hounsfield unit","Bulut","Haci Taner","Department of Radiology, Medicine Faculty of Adiyaman University, Turkey",NA
"2101","34214788","10.1016/j.jenvman.2021.113117","Selection of healthcare waste disposal firms using a multi-method approach.","The aim of this study is to propose a hybrid multi criteria decision making model with a linear programming (LP) model to tackle the issue of safe disposal of hazardous and infectious healthcare waste. For this, ten criteria in this study have been identified from literature and field surveys which are modelled using Decision making trial and evaluation (DEMATEL) and Analytic network process (ANP) methods to select the best disposal firm i.e. single sourcing for a hospital. We found that Experie","2021","07","06","J Environ Manage","Journal of environmental management","Environment management; Hazardous and infectious waste; Healthcare waste disposal; Multiple criteria analysis; Pandemic COVID-19; Single and multiple sourcing","Chauhan","Ankur","Jaipuria Institute of Management, Noida, India. Electronic address: chauhan.ankur2903@gmail","chauhan.ankur2903@gmail.com"
"2102","34214788","10.1016/j.jenvman.2021.113117","Selection of healthcare waste disposal firms using a multi-method approach.","The aim of this study is to propose a hybrid multi criteria decision making model with a linear programming (LP) model to tackle the issue of safe disposal of hazardous and infectious healthcare waste. For this, ten criteria in this study have been identified from literature and field surveys which are modelled using Decision making trial and evaluation (DEMATEL) and Analytic network process (ANP) methods to select the best disposal firm i.e. single sourcing for a hospital. We found that Experie","2021","07","06","J Environ Manage","Journal of environmental management","Environment management; Hazardous and infectious waste; Healthcare waste disposal; Multiple criteria analysis; Pandemic COVID-19; Single and multiple sourcing","Singh","Surya Prakash","DMS, Indian Institute of Technology, Delhi, India. Electronic address: surya.singh@gmail","surya.singh@gmail.com"
"2103","34214773","10.1016/j.amjoto.2021.103129","Can isolated sudden sensorineural hearing loss (SSNHL) and idiopathic acute facial paralysis (Bell's palsy) be symptoms of COVID-19?","The symptoms of COVID-19 at the time of presentation mainly include fever, cough, respiratory distress and myalgia. On the other hand, as neurological symptoms, disruption of taste and smell and cerebrovascular pathologies are well-known, whereas other neurological symptoms and signs are being newly recognized. Sudden-onset sensorineural hearing loss (SSNHL) and idiopathic acute facial paralysis (Bell's palsy) are otologic emergencies that are frequently encountered by otorhinolaryngology specia","2021","07","14","Am J Otolaryngol","American journal of otolaryngology","COVID-19; Idiopathic acute facial paralysis (Bell's palsy); Otorhinolaryngological symptoms; Sudden sensorineural hearing loss (SSNHL)","Aslan","Mehmet","Department of Otorhinolaryngology Head and Neck Surgery, Inonu University Faculty of Medicine, Malatya, Turkey. Electronic address: dr.mehmetaslan@hotmail","dr.mehmetaslan@hotmail.com"
"2104","34214773","10.1016/j.amjoto.2021.103129","Can isolated sudden sensorineural hearing loss (SSNHL) and idiopathic acute facial paralysis (Bell's palsy) be symptoms of COVID-19?","The symptoms of COVID-19 at the time of presentation mainly include fever, cough, respiratory distress and myalgia. On the other hand, as neurological symptoms, disruption of taste and smell and cerebrovascular pathologies are well-known, whereas other neurological symptoms and signs are being newly recognized. Sudden-onset sensorineural hearing loss (SSNHL) and idiopathic acute facial paralysis (Bell's palsy) are otologic emergencies that are frequently encountered by otorhinolaryngology specia","2021","07","14","Am J Otolaryngol","American journal of otolaryngology","COVID-19; Idiopathic acute facial paralysis (Bell's palsy); Otorhinolaryngological symptoms; Sudden sensorineural hearing loss (SSNHL)","Çiçek","Mehmet Turan","Department of Otorhinolaryngology Head and Neck Surgery, Inonu University Faculty of Medicine, Malatya, Turkey",NA
"2105","34214763","10.1016/j.jaut.2021.102682","Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.","The variability in resolution of SARS-CoV-2-infections between individuals neither is comprehended, nor are the long-term immunological consequences. To assess the long-term impact of a SARS-CoV-2-infection on the immune system, we conducted a prospective study of 80 acute and former SARS-CoV-2 infected individuals and 39 unexposed donors to evaluate autoantibody responses and immune composition. Autoantibody levels against cyclic citrullinated peptide (CCP), a specific predictor for rheumatoid ","2021","07","22","J Autoimmun","Journal of autoimmunity","Autoantibodies; COVID-19; Celiac disease; Long-term; Rheumatoid arthritis; SARS-CoV-2; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; COVID-19; Celiac Disease; Female; Humans; Male; Middle Aged; Peptides, Cyclic; Prevalence; Prospective Studies; SARS-CoV-2; Transglutaminases; Young Adult","Lingel","Holger","Department of Experimental Pediatrics, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany",NA
"2106","34214763","10.1016/j.jaut.2021.102682","Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.","The variability in resolution of SARS-CoV-2-infections between individuals neither is comprehended, nor are the long-term immunological consequences. To assess the long-term impact of a SARS-CoV-2-infection on the immune system, we conducted a prospective study of 80 acute and former SARS-CoV-2 infected individuals and 39 unexposed donors to evaluate autoantibody responses and immune composition. Autoantibody levels against cyclic citrullinated peptide (CCP), a specific predictor for rheumatoid ","2021","07","22","J Autoimmun","Journal of autoimmunity","Autoantibodies; COVID-19; Celiac disease; Long-term; Rheumatoid arthritis; SARS-CoV-2; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; COVID-19; Celiac Disease; Female; Humans; Male; Middle Aged; Peptides, Cyclic; Prevalence; Prospective Studies; SARS-CoV-2; Transglutaminases; Young Adult","Meltendorf","Stefan","Department of Experimental Pediatrics, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany",NA
"2107","34214763","10.1016/j.jaut.2021.102682","Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.","The variability in resolution of SARS-CoV-2-infections between individuals neither is comprehended, nor are the long-term immunological consequences. To assess the long-term impact of a SARS-CoV-2-infection on the immune system, we conducted a prospective study of 80 acute and former SARS-CoV-2 infected individuals and 39 unexposed donors to evaluate autoantibody responses and immune composition. Autoantibody levels against cyclic citrullinated peptide (CCP), a specific predictor for rheumatoid ","2021","07","22","J Autoimmun","Journal of autoimmunity","Autoantibodies; COVID-19; Celiac disease; Long-term; Rheumatoid arthritis; SARS-CoV-2; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; COVID-19; Celiac Disease; Female; Humans; Male; Middle Aged; Peptides, Cyclic; Prevalence; Prospective Studies; SARS-CoV-2; Transglutaminases; Young Adult","Billing","Ulrike","Department of Experimental Pediatrics, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany",NA
"2108","34214763","10.1016/j.jaut.2021.102682","Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.","The variability in resolution of SARS-CoV-2-infections between individuals neither is comprehended, nor are the long-term immunological consequences. To assess the long-term impact of a SARS-CoV-2-infection on the immune system, we conducted a prospective study of 80 acute and former SARS-CoV-2 infected individuals and 39 unexposed donors to evaluate autoantibody responses and immune composition. Autoantibody levels against cyclic citrullinated peptide (CCP), a specific predictor for rheumatoid ","2021","07","22","J Autoimmun","Journal of autoimmunity","Autoantibodies; COVID-19; Celiac disease; Long-term; Rheumatoid arthritis; SARS-CoV-2; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; COVID-19; Celiac Disease; Female; Humans; Male; Middle Aged; Peptides, Cyclic; Prevalence; Prospective Studies; SARS-CoV-2; Transglutaminases; Young Adult","Thurm","Christoph","Institute of Molecular and Clinical Immunology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany",NA
"2109","34214763","10.1016/j.jaut.2021.102682","Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.","The variability in resolution of SARS-CoV-2-infections between individuals neither is comprehended, nor are the long-term immunological consequences. To assess the long-term impact of a SARS-CoV-2-infection on the immune system, we conducted a prospective study of 80 acute and former SARS-CoV-2 infected individuals and 39 unexposed donors to evaluate autoantibody responses and immune composition. Autoantibody levels against cyclic citrullinated peptide (CCP), a specific predictor for rheumatoid ","2021","07","22","J Autoimmun","Journal of autoimmunity","Autoantibodies; COVID-19; Celiac disease; Long-term; Rheumatoid arthritis; SARS-CoV-2; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; COVID-19; Celiac Disease; Female; Humans; Male; Middle Aged; Peptides, Cyclic; Prevalence; Prospective Studies; SARS-CoV-2; Transglutaminases; Young Adult","Vogel","Katrin","Department of Experimental Pediatrics, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany",NA
"2110","34214763","10.1016/j.jaut.2021.102682","Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.","The variability in resolution of SARS-CoV-2-infections between individuals neither is comprehended, nor are the long-term immunological consequences. To assess the long-term impact of a SARS-CoV-2-infection on the immune system, we conducted a prospective study of 80 acute and former SARS-CoV-2 infected individuals and 39 unexposed donors to evaluate autoantibody responses and immune composition. Autoantibody levels against cyclic citrullinated peptide (CCP), a specific predictor for rheumatoid ","2021","07","22","J Autoimmun","Journal of autoimmunity","Autoantibodies; COVID-19; Celiac disease; Long-term; Rheumatoid arthritis; SARS-CoV-2; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; COVID-19; Celiac Disease; Female; Humans; Male; Middle Aged; Peptides, Cyclic; Prevalence; Prospective Studies; SARS-CoV-2; Transglutaminases; Young Adult","Majer","Christiane","Department of Experimental Pediatrics, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany",NA
"2111","34214763","10.1016/j.jaut.2021.102682","Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.","The variability in resolution of SARS-CoV-2-infections between individuals neither is comprehended, nor are the long-term immunological consequences. To assess the long-term impact of a SARS-CoV-2-infection on the immune system, we conducted a prospective study of 80 acute and former SARS-CoV-2 infected individuals and 39 unexposed donors to evaluate autoantibody responses and immune composition. Autoantibody levels against cyclic citrullinated peptide (CCP), a specific predictor for rheumatoid ","2021","07","22","J Autoimmun","Journal of autoimmunity","Autoantibodies; COVID-19; Celiac disease; Long-term; Rheumatoid arthritis; SARS-CoV-2; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; COVID-19; Celiac Disease; Female; Humans; Male; Middle Aged; Peptides, Cyclic; Prevalence; Prospective Studies; SARS-CoV-2; Transglutaminases; Young Adult","Prätsch","Florian","Department of Anesthesiology and Intensive Care Medicine, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany",NA
"2112","34214763","10.1016/j.jaut.2021.102682","Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.","The variability in resolution of SARS-CoV-2-infections between individuals neither is comprehended, nor are the long-term immunological consequences. To assess the long-term impact of a SARS-CoV-2-infection on the immune system, we conducted a prospective study of 80 acute and former SARS-CoV-2 infected individuals and 39 unexposed donors to evaluate autoantibody responses and immune composition. Autoantibody levels against cyclic citrullinated peptide (CCP), a specific predictor for rheumatoid ","2021","07","22","J Autoimmun","Journal of autoimmunity","Autoantibodies; COVID-19; Celiac disease; Long-term; Rheumatoid arthritis; SARS-CoV-2; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; COVID-19; Celiac Disease; Female; Humans; Male; Middle Aged; Peptides, Cyclic; Prevalence; Prospective Studies; SARS-CoV-2; Transglutaminases; Young Adult","Roggenbuck","Dirk","Faculty of Health Sciences, Brandenburg University of Technology Cottbus-Senftenberg, Cottbus, Germany",NA
"2113","34214763","10.1016/j.jaut.2021.102682","Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.","The variability in resolution of SARS-CoV-2-infections between individuals neither is comprehended, nor are the long-term immunological consequences. To assess the long-term impact of a SARS-CoV-2-infection on the immune system, we conducted a prospective study of 80 acute and former SARS-CoV-2 infected individuals and 39 unexposed donors to evaluate autoantibody responses and immune composition. Autoantibody levels against cyclic citrullinated peptide (CCP), a specific predictor for rheumatoid ","2021","07","22","J Autoimmun","Journal of autoimmunity","Autoantibodies; COVID-19; Celiac disease; Long-term; Rheumatoid arthritis; SARS-CoV-2; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; COVID-19; Celiac Disease; Female; Humans; Male; Middle Aged; Peptides, Cyclic; Prevalence; Prospective Studies; SARS-CoV-2; Transglutaminases; Young Adult","Heuft","Hans-Gert","Department of Transfusion Medicine and Immunohematology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany",NA
"2114","34214763","10.1016/j.jaut.2021.102682","Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.","The variability in resolution of SARS-CoV-2-infections between individuals neither is comprehended, nor are the long-term immunological consequences. To assess the long-term impact of a SARS-CoV-2-infection on the immune system, we conducted a prospective study of 80 acute and former SARS-CoV-2 infected individuals and 39 unexposed donors to evaluate autoantibody responses and immune composition. Autoantibody levels against cyclic citrullinated peptide (CCP), a specific predictor for rheumatoid ","2021","07","22","J Autoimmun","Journal of autoimmunity","Autoantibodies; COVID-19; Celiac disease; Long-term; Rheumatoid arthritis; SARS-CoV-2; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; COVID-19; Celiac Disease; Female; Humans; Male; Middle Aged; Peptides, Cyclic; Prevalence; Prospective Studies; SARS-CoV-2; Transglutaminases; Young Adult","Hachenberg","Thomas","Department of Anesthesiology and Intensive Care Medicine, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany",NA
"2115","34214763","10.1016/j.jaut.2021.102682","Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.","The variability in resolution of SARS-CoV-2-infections between individuals neither is comprehended, nor are the long-term immunological consequences. To assess the long-term impact of a SARS-CoV-2-infection on the immune system, we conducted a prospective study of 80 acute and former SARS-CoV-2 infected individuals and 39 unexposed donors to evaluate autoantibody responses and immune composition. Autoantibody levels against cyclic citrullinated peptide (CCP), a specific predictor for rheumatoid ","2021","07","22","J Autoimmun","Journal of autoimmunity","Autoantibodies; COVID-19; Celiac disease; Long-term; Rheumatoid arthritis; SARS-CoV-2; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; COVID-19; Celiac Disease; Female; Humans; Male; Middle Aged; Peptides, Cyclic; Prevalence; Prospective Studies; SARS-CoV-2; Transglutaminases; Young Adult","Feist","Eugen","Department of Rheumatology, Helios Specialist Hospital Vogelsang, Gommern, Germany",NA
"2116","34214763","10.1016/j.jaut.2021.102682","Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.","The variability in resolution of SARS-CoV-2-infections between individuals neither is comprehended, nor are the long-term immunological consequences. To assess the long-term impact of a SARS-CoV-2-infection on the immune system, we conducted a prospective study of 80 acute and former SARS-CoV-2 infected individuals and 39 unexposed donors to evaluate autoantibody responses and immune composition. Autoantibody levels against cyclic citrullinated peptide (CCP), a specific predictor for rheumatoid ","2021","07","22","J Autoimmun","Journal of autoimmunity","Autoantibodies; COVID-19; Celiac disease; Long-term; Rheumatoid arthritis; SARS-CoV-2; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; COVID-19; Celiac Disease; Female; Humans; Male; Middle Aged; Peptides, Cyclic; Prevalence; Prospective Studies; SARS-CoV-2; Transglutaminases; Young Adult","Reinhold","Dirk","Institute of Molecular and Clinical Immunology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany",NA
"2117","34214763","10.1016/j.jaut.2021.102682","Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.","The variability in resolution of SARS-CoV-2-infections between individuals neither is comprehended, nor are the long-term immunological consequences. To assess the long-term impact of a SARS-CoV-2-infection on the immune system, we conducted a prospective study of 80 acute and former SARS-CoV-2 infected individuals and 39 unexposed donors to evaluate autoantibody responses and immune composition. Autoantibody levels against cyclic citrullinated peptide (CCP), a specific predictor for rheumatoid ","2021","07","22","J Autoimmun","Journal of autoimmunity","Autoantibodies; COVID-19; Celiac disease; Long-term; Rheumatoid arthritis; SARS-CoV-2; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Citrullinated Protein Antibodies; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; COVID-19; Celiac Disease; Female; Humans; Male; Middle Aged; Peptides, Cyclic; Prevalence; Prospective Studies; SARS-CoV-2; Transglutaminases; Young Adult","Brunner-Weinzierl","Monika C","Department of Experimental Pediatrics, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany. Electronic address: Monika.Brunner-Weinzierl@med.ovgu","Weinzierl@med.ovgu.de"
"2118","34214752","10.1016/j.bioorg.2021.105117","New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2.","At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) ","2021","07","15","Bioorg Chem","Bioorganic chemistry","Click chemistry; Molecular docking; Quinoline; SARS-CoV-2; Triazole","Seliem","Israa A","Department of Chemistry and Physics, Augusta University, Augusta, GA 30912, USA",NA
"2119","34214752","10.1016/j.bioorg.2021.105117","New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2.","At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) ","2021","07","15","Bioorg Chem","Bioorganic chemistry","Click chemistry; Molecular docking; Quinoline; SARS-CoV-2; Triazole","Panda","Siva S","Department of Chemistry and Physics, Augusta University, Augusta, GA 30912, USA. Electronic address: sipanda@augusta","sipanda@augusta.edu"
"2120","34214752","10.1016/j.bioorg.2021.105117","New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2.","At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) ","2021","07","15","Bioorg Chem","Bioorganic chemistry","Click chemistry; Molecular docking; Quinoline; SARS-CoV-2; Triazole","Girgis","Adel S","Department of Pesticide Chemistry, National Research Centre, Dokki, Giza 12622, Egypt",NA
"2121","34214752","10.1016/j.bioorg.2021.105117","New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2.","At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) ","2021","07","15","Bioorg Chem","Bioorganic chemistry","Click chemistry; Molecular docking; Quinoline; SARS-CoV-2; Triazole","Moatasim","Yassmin","Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt",NA
"2122","34214752","10.1016/j.bioorg.2021.105117","New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2.","At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) ","2021","07","15","Bioorg Chem","Bioorganic chemistry","Click chemistry; Molecular docking; Quinoline; SARS-CoV-2; Triazole","Kandeil","Ahmed","Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt",NA
"2123","34214752","10.1016/j.bioorg.2021.105117","New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2.","At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) ","2021","07","15","Bioorg Chem","Bioorganic chemistry","Click chemistry; Molecular docking; Quinoline; SARS-CoV-2; Triazole","Mostafa","Ahmed","Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt",NA
"2124","34214752","10.1016/j.bioorg.2021.105117","New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2.","At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) ","2021","07","15","Bioorg Chem","Bioorganic chemistry","Click chemistry; Molecular docking; Quinoline; SARS-CoV-2; Triazole","Ali","Mohamed A","Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt",NA
"2125","34214752","10.1016/j.bioorg.2021.105117","New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2.","At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) ","2021","07","15","Bioorg Chem","Bioorganic chemistry","Click chemistry; Molecular docking; Quinoline; SARS-CoV-2; Triazole","Nossier","Eman S","Department of Pharmaceutical Medicinal Chemistry and Drug Design, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt",NA
"2126","34214752","10.1016/j.bioorg.2021.105117","New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2.","At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) ","2021","07","15","Bioorg Chem","Bioorganic chemistry","Click chemistry; Molecular docking; Quinoline; SARS-CoV-2; Triazole","Rasslan","Fatma","Department of Microbiology and Immunology, Faculty of Pharmacy (Girls), Al Azhar University, Cairo, Egypt",NA
"2127","34214752","10.1016/j.bioorg.2021.105117","New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2.","At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) ","2021","07","15","Bioorg Chem","Bioorganic chemistry","Click chemistry; Molecular docking; Quinoline; SARS-CoV-2; Triazole","Srour","Aladdin M","Department of Therapeutic Chemistry, National Research Centre, Dokki, Giza 12622, Egypt",NA
"2128","34214752","10.1016/j.bioorg.2021.105117","New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2.","At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) ","2021","07","15","Bioorg Chem","Bioorganic chemistry","Click chemistry; Molecular docking; Quinoline; SARS-CoV-2; Triazole","Sakhuja","Rajeev","Department of Chemistry, Birla Institute of Technology and Science, Pilani, India",NA
"2129","34214752","10.1016/j.bioorg.2021.105117","New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2.","At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) ","2021","07","15","Bioorg Chem","Bioorganic chemistry","Click chemistry; Molecular docking; Quinoline; SARS-CoV-2; Triazole","Ibrahim","Tarek S","Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt",NA
"2130","34214752","10.1016/j.bioorg.2021.105117","New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2.","At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) ","2021","07","15","Bioorg Chem","Bioorganic chemistry","Click chemistry; Molecular docking; Quinoline; SARS-CoV-2; Triazole","Abdel-Samii","Zakaria K M","Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt",NA
"2131","34214752","10.1016/j.bioorg.2021.105117","New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2.","At present therapeutic options for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are very limited. We designed and synthesized three sets of small molecules using quinoline scaffolds. A series of quinoline conjugates (10a-l, 11a-c, and 12a-e) by incorporating 1,2,3-triazole were synthesized via a modified microwave-assisted click chemistry technique. Among the synthesized conjugates, 4-((1-(2-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-6-fluoro-2-(trifluoromethyl)quinoline (10g) ","2021","07","15","Bioorg Chem","Bioorganic chemistry","Click chemistry; Molecular docking; Quinoline; SARS-CoV-2; Triazole","Al-Mahmoudy","Amany M M","Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt",NA
"2132","34214742","10.1016/j.jpsychires.2021.06.024","A nine-month study on the course of COVID-19 related perceived post-traumatic stress disorder among Italian community-dwelling adults.","The present study aimed to evaluate base rate estimates, course of, and psychopathology and personality risk factors for COVID-19-related post-traumatic stress disorder (PTSD) in community-dwelling adults during the pandemic. 203 participants from a sample of 811 Italian community-dwelling adults agreed to participate in a nine-month, three-wave (Wave 1: March 2020; Wave 2: June 2020; Wave 3: December 2020) longitudinal study. Participants in the longitudinal study did not differ from the cross-","2021","07","20","J Psychiatr Res","Journal of psychiatric research","COVID-19 pandemic; Community-dwelling participants; Internalizing symptoms; Longitudinal study; Maladaptive personality domains","Somma","Antonella","Vita-Salute San Raffaele University, Milan, Italy",NA
"2133","34214742","10.1016/j.jpsychires.2021.06.024","A nine-month study on the course of COVID-19 related perceived post-traumatic stress disorder among Italian community-dwelling adults.","The present study aimed to evaluate base rate estimates, course of, and psychopathology and personality risk factors for COVID-19-related post-traumatic stress disorder (PTSD) in community-dwelling adults during the pandemic. 203 participants from a sample of 811 Italian community-dwelling adults agreed to participate in a nine-month, three-wave (Wave 1: March 2020; Wave 2: June 2020; Wave 3: December 2020) longitudinal study. Participants in the longitudinal study did not differ from the cross-","2021","07","20","J Psychiatr Res","Journal of psychiatric research","COVID-19 pandemic; Community-dwelling participants; Internalizing symptoms; Longitudinal study; Maladaptive personality domains","Krueger","Robert F","University of Minnesota, Minneapolis, MN, USA",NA
"2134","34214742","10.1016/j.jpsychires.2021.06.024","A nine-month study on the course of COVID-19 related perceived post-traumatic stress disorder among Italian community-dwelling adults.","The present study aimed to evaluate base rate estimates, course of, and psychopathology and personality risk factors for COVID-19-related post-traumatic stress disorder (PTSD) in community-dwelling adults during the pandemic. 203 participants from a sample of 811 Italian community-dwelling adults agreed to participate in a nine-month, three-wave (Wave 1: March 2020; Wave 2: June 2020; Wave 3: December 2020) longitudinal study. Participants in the longitudinal study did not differ from the cross-","2021","07","20","J Psychiatr Res","Journal of psychiatric research","COVID-19 pandemic; Community-dwelling participants; Internalizing symptoms; Longitudinal study; Maladaptive personality domains","Markon","Kristian E","University of Iowa, Iowa City, IA, USA",NA
"2135","34214742","10.1016/j.jpsychires.2021.06.024","A nine-month study on the course of COVID-19 related perceived post-traumatic stress disorder among Italian community-dwelling adults.","The present study aimed to evaluate base rate estimates, course of, and psychopathology and personality risk factors for COVID-19-related post-traumatic stress disorder (PTSD) in community-dwelling adults during the pandemic. 203 participants from a sample of 811 Italian community-dwelling adults agreed to participate in a nine-month, three-wave (Wave 1: March 2020; Wave 2: June 2020; Wave 3: December 2020) longitudinal study. Participants in the longitudinal study did not differ from the cross-","2021","07","20","J Psychiatr Res","Journal of psychiatric research","COVID-19 pandemic; Community-dwelling participants; Internalizing symptoms; Longitudinal study; Maladaptive personality domains","Gialdi","Giulia","Vita-Salute San Raffaele University, Milan, Italy",NA
"2136","34214742","10.1016/j.jpsychires.2021.06.024","A nine-month study on the course of COVID-19 related perceived post-traumatic stress disorder among Italian community-dwelling adults.","The present study aimed to evaluate base rate estimates, course of, and psychopathology and personality risk factors for COVID-19-related post-traumatic stress disorder (PTSD) in community-dwelling adults during the pandemic. 203 participants from a sample of 811 Italian community-dwelling adults agreed to participate in a nine-month, three-wave (Wave 1: March 2020; Wave 2: June 2020; Wave 3: December 2020) longitudinal study. Participants in the longitudinal study did not differ from the cross-","2021","07","20","J Psychiatr Res","Journal of psychiatric research","COVID-19 pandemic; Community-dwelling participants; Internalizing symptoms; Longitudinal study; Maladaptive personality domains","Colanino","Miriana","Vita-Salute San Raffaele University, Milan, Italy",NA
"2137","34214742","10.1016/j.jpsychires.2021.06.024","A nine-month study on the course of COVID-19 related perceived post-traumatic stress disorder among Italian community-dwelling adults.","The present study aimed to evaluate base rate estimates, course of, and psychopathology and personality risk factors for COVID-19-related post-traumatic stress disorder (PTSD) in community-dwelling adults during the pandemic. 203 participants from a sample of 811 Italian community-dwelling adults agreed to participate in a nine-month, three-wave (Wave 1: March 2020; Wave 2: June 2020; Wave 3: December 2020) longitudinal study. Participants in the longitudinal study did not differ from the cross-","2021","07","20","J Psychiatr Res","Journal of psychiatric research","COVID-19 pandemic; Community-dwelling participants; Internalizing symptoms; Longitudinal study; Maladaptive personality domains","Ferlito","Danila","Vita-Salute San Raffaele University, Milan, Italy",NA
"2138","34214742","10.1016/j.jpsychires.2021.06.024","A nine-month study on the course of COVID-19 related perceived post-traumatic stress disorder among Italian community-dwelling adults.","The present study aimed to evaluate base rate estimates, course of, and psychopathology and personality risk factors for COVID-19-related post-traumatic stress disorder (PTSD) in community-dwelling adults during the pandemic. 203 participants from a sample of 811 Italian community-dwelling adults agreed to participate in a nine-month, three-wave (Wave 1: March 2020; Wave 2: June 2020; Wave 3: December 2020) longitudinal study. Participants in the longitudinal study did not differ from the cross-","2021","07","20","J Psychiatr Res","Journal of psychiatric research","COVID-19 pandemic; Community-dwelling participants; Internalizing symptoms; Longitudinal study; Maladaptive personality domains","Liotta","Chiara","Vita-Salute San Raffaele University, Milan, Italy",NA
"2139","34214742","10.1016/j.jpsychires.2021.06.024","A nine-month study on the course of COVID-19 related perceived post-traumatic stress disorder among Italian community-dwelling adults.","The present study aimed to evaluate base rate estimates, course of, and psychopathology and personality risk factors for COVID-19-related post-traumatic stress disorder (PTSD) in community-dwelling adults during the pandemic. 203 participants from a sample of 811 Italian community-dwelling adults agreed to participate in a nine-month, three-wave (Wave 1: March 2020; Wave 2: June 2020; Wave 3: December 2020) longitudinal study. Participants in the longitudinal study did not differ from the cross-","2021","07","20","J Psychiatr Res","Journal of psychiatric research","COVID-19 pandemic; Community-dwelling participants; Internalizing symptoms; Longitudinal study; Maladaptive personality domains","Fossati","Andrea","Vita-Salute San Raffaele University, Milan, Italy. Electronic address: fossati.andrea@hsr","fossati.andrea@hsr.it"
"2140","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Ram","Ron","Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel","ronram73@gmail.com"
"2141","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Hagin","David","Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"2142","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Kikozashvilli","Nino","Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel",NA
"2143","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Freund","Tal","Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"2144","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Amit","Odelia","Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel",NA
"2145","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Bar-On","Yael","Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel",NA
"2146","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Beyar-Katz","Ofrat","Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel",NA
"2147","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Shefer","Gabi","Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"2148","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Moshiashvili","Miguel Morales","Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"2149","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Karni","Chen","Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel",NA
"2150","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Gold","Ronit","Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel",NA
"2151","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Kay","Sigi","Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel",NA
"2152","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Glait-Santar","Chen","Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel",NA
"2153","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Eshel","Rinat","Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel",NA
"2154","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Perry","Chava","Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel",NA
"2155","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Avivi","Irit","Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel",NA
"2156","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Apel","Arie","Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"2157","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Benyamini","Noam","Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel",NA
"2158","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Shasha","David","Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel",NA
"2159","34214738","10.1016/j.jtct.2021.06.024","Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.","Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hematopoietic cell transplantation (HCT; n = 66) or after CD19-based chimeric antigen receptor T cell (CART) therapy (n = 14). Overall, the vaccine was well tolerated, with mild non-hematologic vaccine-reported adverse events in a minority of the patient","2021","07","23","Transplant Cell Ther","Transplantation and cellular therapy","CART; COVID-19; HCT; Vaccination","Ben-Ami","Ronen","Bone Marrow Transplantation Unit, Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel",NA
"2160","34214650","10.1016/j.cardfail.2021.06.013","Prescription Filling Patterns of Evidence-Based Medical Therapies for Heart Failure During the COVID-19 Pandemic in the United States.","Maintaining a steady medication supply during a public health crisis is a major health priority. We leveraged a large U.S. pharmacy-claims database to understand the use of evidence-based therapies in heart failure (HF) care during the coronavirus disease-2019 (COVID-19) pandemic. We analyzed 27,027,650 individual claims from an all-payer pharmacy-claims database across 56,155 chain, independent and mail-order pharmacies in 14,164 zip codes in 50 states. Prescriptions dispensed (in 2-week interv","2021","07","24","J Card Fail","Journal of cardiac failure","COVID-19; generic; guideline-directed medical therapy; heart failure; prescription fills","Vaduganathan","Muthiah","Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: mvaduganathan@bwh.harvard","mvaduganathan@bwh.harvard.edu"
"2161","34214650","10.1016/j.cardfail.2021.06.013","Prescription Filling Patterns of Evidence-Based Medical Therapies for Heart Failure During the COVID-19 Pandemic in the United States.","Maintaining a steady medication supply during a public health crisis is a major health priority. We leveraged a large U.S. pharmacy-claims database to understand the use of evidence-based therapies in heart failure (HF) care during the coronavirus disease-2019 (COVID-19) pandemic. We analyzed 27,027,650 individual claims from an all-payer pharmacy-claims database across 56,155 chain, independent and mail-order pharmacies in 14,164 zip codes in 50 states. Prescriptions dispensed (in 2-week interv","2021","07","24","J Card Fail","Journal of cardiac failure","COVID-19; generic; guideline-directed medical therapy; heart failure; prescription fills","Li","Diane","GoodRx, Santa Monica, California",NA
"2162","34214650","10.1016/j.cardfail.2021.06.013","Prescription Filling Patterns of Evidence-Based Medical Therapies for Heart Failure During the COVID-19 Pandemic in the United States.","Maintaining a steady medication supply during a public health crisis is a major health priority. We leveraged a large U.S. pharmacy-claims database to understand the use of evidence-based therapies in heart failure (HF) care during the coronavirus disease-2019 (COVID-19) pandemic. We analyzed 27,027,650 individual claims from an all-payer pharmacy-claims database across 56,155 chain, independent and mail-order pharmacies in 14,164 zip codes in 50 states. Prescriptions dispensed (in 2-week interv","2021","07","24","J Card Fail","Journal of cardiac failure","COVID-19; generic; guideline-directed medical therapy; heart failure; prescription fills","Van Meijgaard","Jeroen","GoodRx, Santa Monica, California",NA
"2163","34214650","10.1016/j.cardfail.2021.06.013","Prescription Filling Patterns of Evidence-Based Medical Therapies for Heart Failure During the COVID-19 Pandemic in the United States.","Maintaining a steady medication supply during a public health crisis is a major health priority. We leveraged a large U.S. pharmacy-claims database to understand the use of evidence-based therapies in heart failure (HF) care during the coronavirus disease-2019 (COVID-19) pandemic. We analyzed 27,027,650 individual claims from an all-payer pharmacy-claims database across 56,155 chain, independent and mail-order pharmacies in 14,164 zip codes in 50 states. Prescriptions dispensed (in 2-week interv","2021","07","24","J Card Fail","Journal of cardiac failure","COVID-19; generic; guideline-directed medical therapy; heart failure; prescription fills","Warraich","Haider J","Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts",NA
"2164","34214649","10.1016/j.clim.2021.108791","Detection of immunoglobulin response to COVID-19 vaccination using a novel rapid fingerstick assay.","Coronavirus Disease 2019 (COVID-19) emerged as a global pandemic resulting in significant mortality and morbidity. COVID-19 vaccines have been shown to be highly effective in preventing COVID-19 infections and significantly reducing disease severity and mortality. We report on a novel COVID-19 antibody test assay using a unique platform to rapidly detect SARS-CoV-2 antibodies with a drop of fingerstick blood in a subject following COVID-19 vaccination. We show early detection of SARS-CoV-2 antib","2021","07","05","Clin Immunol","Clinical immunology (Orlando, Fla.)","Antibody; COVID-19; Fingerstick; Immunity; SARS-CoV-2; Serology; Test; Vaccination","Cobb","Beth L","NOWDiagnostics, Inc., Springdale, AR, USA. Electronic address: beth.cobb@nowdx","beth.cobb@nowdx.com"
"2165","34214649","10.1016/j.clim.2021.108791","Detection of immunoglobulin response to COVID-19 vaccination using a novel rapid fingerstick assay.","Coronavirus Disease 2019 (COVID-19) emerged as a global pandemic resulting in significant mortality and morbidity. COVID-19 vaccines have been shown to be highly effective in preventing COVID-19 infections and significantly reducing disease severity and mortality. We report on a novel COVID-19 antibody test assay using a unique platform to rapidly detect SARS-CoV-2 antibodies with a drop of fingerstick blood in a subject following COVID-19 vaccination. We show early detection of SARS-CoV-2 antib","2021","07","05","Clin Immunol","Clinical immunology (Orlando, Fla.)","Antibody; COVID-19; Fingerstick; Immunity; SARS-CoV-2; Serology; Test; Vaccination","Sawalha","Amr H","Departments of Pediatrics, Medicine, and Immunology, and Lupus Center of Excellence, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Electronic address: asawalha@pitt","asawalha@pitt.edu"
"2166","34214608","10.1016/j.critrevonc.2021.103402","Radiotherapy based management during Covid-19 pandemic - A systematic review of presented consensus and guidelines.","Treatment management of cancer patients in the radiation oncology departments during the current COVID-19 pandemic is challenging. A systematic review of published consensus/guidelines on the role of radiotherapy prioritization, suggested treatment protocols, and set up management was undertaken based on the PRISMA protocol and through PubMed/PMC, Scopus, Google Scholar, Web of Science databases until 01/20/2021. One hundred and sixty-eight publications or regional consensus were included. Summa","2021","07","23","Crit Rev Oncol Hematol","Critical reviews in oncology/hematology","COVID-19; Oncology; Pandemic; Radiotherapy","Siavashpour","Zahra","Radiotherapy Oncology Department, Shohada-e Tajrish Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: Z_siavashpour@sbmu.ac","siavashpour@sbmu.ac.ir"
"2167","34214608","10.1016/j.critrevonc.2021.103402","Radiotherapy based management during Covid-19 pandemic - A systematic review of presented consensus and guidelines.","Treatment management of cancer patients in the radiation oncology departments during the current COVID-19 pandemic is challenging. A systematic review of published consensus/guidelines on the role of radiotherapy prioritization, suggested treatment protocols, and set up management was undertaken based on the PRISMA protocol and through PubMed/PMC, Scopus, Google Scholar, Web of Science databases until 01/20/2021. One hundred and sixty-eight publications or regional consensus were included. Summa","2021","07","23","Crit Rev Oncol Hematol","Critical reviews in oncology/hematology","COVID-19; Oncology; Pandemic; Radiotherapy","Goharpey","Neda","Radiotherapy Oncology Department, Shohada-e Tajrish Educational Hospital, Tehran, Iran. Electronic address: goharpey@gmail","goharpey@gmail.com"
"2168","34214608","10.1016/j.critrevonc.2021.103402","Radiotherapy based management during Covid-19 pandemic - A systematic review of presented consensus and guidelines.","Treatment management of cancer patients in the radiation oncology departments during the current COVID-19 pandemic is challenging. A systematic review of published consensus/guidelines on the role of radiotherapy prioritization, suggested treatment protocols, and set up management was undertaken based on the PRISMA protocol and through PubMed/PMC, Scopus, Google Scholar, Web of Science databases until 01/20/2021. One hundred and sixty-eight publications or regional consensus were included. Summa","2021","07","23","Crit Rev Oncol Hematol","Critical reviews in oncology/hematology","COVID-19; Oncology; Pandemic; Radiotherapy","Mobasheri","Mosayyeb","Medical Physics Department, Tarbiat Modares University, Tehran, Iran. Electronic address: mosayyebmobasheri@gmail","mosayyebmobasheri@gmail.com"
"2169","34214571","10.1016/j.jviromet.2021.114224","Performance of the Roche IL-6 chemiluminescent immunoassay in patients with COVID-like respiratory symptoms.","We evaluated the Roche Elecsys IL6 assay on the Cobas immunoassay analyser. Serum IL6 of 144 controls were compared to 52 samples from patients with COVID-like respiratory symptoms (17 SARS-CoV-2 RT-PCR positive); 25 of these were from the intensive care unit (ICU). We compared the IL6 levels to C-reactive protein (CRP) and procalcitonin (PCT) levels in all cases. The IL6 assay had coefficient-of-variation (CV) of 2.3 % (34.1 pg/mL) and 2.5 % (222.5 pg/mL), a limit of quantitation &lt;1.6 pg/mL,","2021","07","17","J Virol Methods","Journal of virological methods","Assay evaluation; IL6; Inflammatory markers; SARS-CoV-2","Lau","C S","Department of Laboratory Medicine, Changi General Hospital, Singapore. Electronic address: mike.lau.cs@gmail","mike.lau.cs@gmail.com"
"2170","34214571","10.1016/j.jviromet.2021.114224","Performance of the Roche IL-6 chemiluminescent immunoassay in patients with COVID-like respiratory symptoms.","We evaluated the Roche Elecsys IL6 assay on the Cobas immunoassay analyser. Serum IL6 of 144 controls were compared to 52 samples from patients with COVID-like respiratory symptoms (17 SARS-CoV-2 RT-PCR positive); 25 of these were from the intensive care unit (ICU). We compared the IL6 levels to C-reactive protein (CRP) and procalcitonin (PCT) levels in all cases. The IL6 assay had coefficient-of-variation (CV) of 2.3 % (34.1 pg/mL) and 2.5 % (222.5 pg/mL), a limit of quantitation &lt;1.6 pg/mL,","2021","07","17","J Virol Methods","Journal of virological methods","Assay evaluation; IL6; Inflammatory markers; SARS-CoV-2","Hoo","S P","Department of Laboratory Medicine, Changi General Hospital, Singapore",NA
"2171","34214571","10.1016/j.jviromet.2021.114224","Performance of the Roche IL-6 chemiluminescent immunoassay in patients with COVID-like respiratory symptoms.","We evaluated the Roche Elecsys IL6 assay on the Cobas immunoassay analyser. Serum IL6 of 144 controls were compared to 52 samples from patients with COVID-like respiratory symptoms (17 SARS-CoV-2 RT-PCR positive); 25 of these were from the intensive care unit (ICU). We compared the IL6 levels to C-reactive protein (CRP) and procalcitonin (PCT) levels in all cases. The IL6 assay had coefficient-of-variation (CV) of 2.3 % (34.1 pg/mL) and 2.5 % (222.5 pg/mL), a limit of quantitation &lt;1.6 pg/mL,","2021","07","17","J Virol Methods","Journal of virological methods","Assay evaluation; IL6; Inflammatory markers; SARS-CoV-2","Koh","J M J","Department of Respiratory and Critical Care Medicine, Changi General Hospital, Singapore",NA
"2172","34214571","10.1016/j.jviromet.2021.114224","Performance of the Roche IL-6 chemiluminescent immunoassay in patients with COVID-like respiratory symptoms.","We evaluated the Roche Elecsys IL6 assay on the Cobas immunoassay analyser. Serum IL6 of 144 controls were compared to 52 samples from patients with COVID-like respiratory symptoms (17 SARS-CoV-2 RT-PCR positive); 25 of these were from the intensive care unit (ICU). We compared the IL6 levels to C-reactive protein (CRP) and procalcitonin (PCT) levels in all cases. The IL6 assay had coefficient-of-variation (CV) of 2.3 % (34.1 pg/mL) and 2.5 % (222.5 pg/mL), a limit of quantitation &lt;1.6 pg/mL,","2021","07","17","J Virol Methods","Journal of virological methods","Assay evaluation; IL6; Inflammatory markers; SARS-CoV-2","Phua","S K","Department of Laboratory Medicine, Changi General Hospital, Singapore",NA
"2173","34214571","10.1016/j.jviromet.2021.114224","Performance of the Roche IL-6 chemiluminescent immunoassay in patients with COVID-like respiratory symptoms.","We evaluated the Roche Elecsys IL6 assay on the Cobas immunoassay analyser. Serum IL6 of 144 controls were compared to 52 samples from patients with COVID-like respiratory symptoms (17 SARS-CoV-2 RT-PCR positive); 25 of these were from the intensive care unit (ICU). We compared the IL6 levels to C-reactive protein (CRP) and procalcitonin (PCT) levels in all cases. The IL6 assay had coefficient-of-variation (CV) of 2.3 % (34.1 pg/mL) and 2.5 % (222.5 pg/mL), a limit of quantitation &lt;1.6 pg/mL,","2021","07","17","J Virol Methods","Journal of virological methods","Assay evaluation; IL6; Inflammatory markers; SARS-CoV-2","Aw","T C","Department of Laboratory Medicine, Changi General Hospital, Singapore",NA
"2174","34214558","10.1016/j.envres.2021.111600","Increased risk of COVID-19 from walking dogs? Most likely, a spurious finding.","We analyse the paper ""The spread of SARS-CoV-2 in Spain: Hygiene habits, sociodemographic profile, mobility patterns and comorbidities"" authored by Rodríguez-Barranco et al. (2021), published in Environmental Research, vol.192, January 2021. The study was carried out under challenging conditions and provides original data of great value for exploratory purposes. Nevertheless, we found that the authors have not considered the potential effect of the multiple hypothesis testing carried out until o","2021","07","20","Environ Res","Environmental research","False discovery rate (FDR); Health geography; Multiple hypotheses testing; P-value; SARS-CoV-2","Gutiérrez-Hernández","Oliver","Department of Geography, University of Málaga, Bulevar Louis Pasteur 27, 29010, Málaga, Spain. Electronic address: olivergh@uma","olivergh@uma.es"
"2175","34214558","10.1016/j.envres.2021.111600","Increased risk of COVID-19 from walking dogs? Most likely, a spurious finding.","We analyse the paper ""The spread of SARS-CoV-2 in Spain: Hygiene habits, sociodemographic profile, mobility patterns and comorbidities"" authored by Rodríguez-Barranco et al. (2021), published in Environmental Research, vol.192, January 2021. The study was carried out under challenging conditions and provides original data of great value for exploratory purposes. Nevertheless, we found that the authors have not considered the potential effect of the multiple hypothesis testing carried out until o","2021","07","20","Environ Res","Environmental research","False discovery rate (FDR); Health geography; Multiple hypotheses testing; P-value; SARS-CoV-2","García","Luis V","Institute of Natural Resources and Agrobiology of Seville (IRNAS), Spanish National Research Council (CSIC), Av. Reina Mercedes 10, 41012, Seville, Spain. Electronic address: lv.garcia@csic","lv.garcia@csic.es"
"2176","34214539","10.1016/j.bpj.2021.06.016","Small molecule therapeutics to destabilize the ACE2-RBD complex: A molecular dynamics study.","The ongoing coronavirus disease 19 (COVID-19) pandemic has infected millions of people, claimed hundreds of thousands of lives, and made a worldwide health emergency. Understanding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mechanism of infection is crucial in the development of potential therapeutics and vaccines. The infection process is triggered by direct binding of the SARS-CoV-2 receptor-binding domain (RBD) to the host-cell receptor angiotensin-converting enzyme 2 (A","2021","07","23","Biophys J","Biophysical journal",NA,"Razizadeh","Meghdad","Department of Mechanical Engineering and Mechanics, Bethlehem, Pennsylvania",NA
"2177","34214539","10.1016/j.bpj.2021.06.016","Small molecule therapeutics to destabilize the ACE2-RBD complex: A molecular dynamics study.","The ongoing coronavirus disease 19 (COVID-19) pandemic has infected millions of people, claimed hundreds of thousands of lives, and made a worldwide health emergency. Understanding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mechanism of infection is crucial in the development of potential therapeutics and vaccines. The infection process is triggered by direct binding of the SARS-CoV-2 receptor-binding domain (RBD) to the host-cell receptor angiotensin-converting enzyme 2 (A","2021","07","23","Biophys J","Biophysical journal",NA,"Nikfar","Mehdi","Department of Mechanical Engineering and Mechanics, Bethlehem, Pennsylvania",NA
"2178","34214539","10.1016/j.bpj.2021.06.016","Small molecule therapeutics to destabilize the ACE2-RBD complex: A molecular dynamics study.","The ongoing coronavirus disease 19 (COVID-19) pandemic has infected millions of people, claimed hundreds of thousands of lives, and made a worldwide health emergency. Understanding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mechanism of infection is crucial in the development of potential therapeutics and vaccines. The infection process is triggered by direct binding of the SARS-CoV-2 receptor-binding domain (RBD) to the host-cell receptor angiotensin-converting enzyme 2 (A","2021","07","23","Biophys J","Biophysical journal",NA,"Liu","Yaling","Department of Mechanical Engineering and Mechanics, Bethlehem, Pennsylvania","yal310@lehigh.edu"
"2179","34214538","10.1016/j.bpj.2021.06.017","Biophysical properties of the isolated spike protein binding helix of human ACE2.","The entry of the severe acute respiratory syndrome coronavirus 2 virus in human cells is mediated by the binding of its surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor. A 23-residue long helical segment (SBP1) at the binding interface of human ACE2 interacts with viral spike protein and therefore has generated considerable interest as a recognition element for virus detection. Unfortunately, emerging reports indicate that the affinity of SBP1 to the receptor-bi","2021","07","23","Biophys J","Biophysical journal",NA,"Das","Anirban","Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India",NA
"2180","34214538","10.1016/j.bpj.2021.06.017","Biophysical properties of the isolated spike protein binding helix of human ACE2.","The entry of the severe acute respiratory syndrome coronavirus 2 virus in human cells is mediated by the binding of its surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor. A 23-residue long helical segment (SBP1) at the binding interface of human ACE2 interacts with viral spike protein and therefore has generated considerable interest as a recognition element for virus detection. Unfortunately, emerging reports indicate that the affinity of SBP1 to the receptor-bi","2021","07","23","Biophys J","Biophysical journal",NA,"Vishvakarma","Vicky","Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India",NA
"2181","34214538","10.1016/j.bpj.2021.06.017","Biophysical properties of the isolated spike protein binding helix of human ACE2.","The entry of the severe acute respiratory syndrome coronavirus 2 virus in human cells is mediated by the binding of its surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor. A 23-residue long helical segment (SBP1) at the binding interface of human ACE2 interacts with viral spike protein and therefore has generated considerable interest as a recognition element for virus detection. Unfortunately, emerging reports indicate that the affinity of SBP1 to the receptor-bi","2021","07","23","Biophys J","Biophysical journal",NA,"Dey","Arpan","Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India",NA
"2182","34214538","10.1016/j.bpj.2021.06.017","Biophysical properties of the isolated spike protein binding helix of human ACE2.","The entry of the severe acute respiratory syndrome coronavirus 2 virus in human cells is mediated by the binding of its surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor. A 23-residue long helical segment (SBP1) at the binding interface of human ACE2 interacts with viral spike protein and therefore has generated considerable interest as a recognition element for virus detection. Unfortunately, emerging reports indicate that the affinity of SBP1 to the receptor-bi","2021","07","23","Biophys J","Biophysical journal",NA,"Dey","Simli","Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India",NA
"2183","34214538","10.1016/j.bpj.2021.06.017","Biophysical properties of the isolated spike protein binding helix of human ACE2.","The entry of the severe acute respiratory syndrome coronavirus 2 virus in human cells is mediated by the binding of its surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor. A 23-residue long helical segment (SBP1) at the binding interface of human ACE2 interacts with viral spike protein and therefore has generated considerable interest as a recognition element for virus detection. Unfortunately, emerging reports indicate that the affinity of SBP1 to the receptor-bi","2021","07","23","Biophys J","Biophysical journal",NA,"Gupta","Ankur","Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India",NA
"2184","34214538","10.1016/j.bpj.2021.06.017","Biophysical properties of the isolated spike protein binding helix of human ACE2.","The entry of the severe acute respiratory syndrome coronavirus 2 virus in human cells is mediated by the binding of its surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor. A 23-residue long helical segment (SBP1) at the binding interface of human ACE2 interacts with viral spike protein and therefore has generated considerable interest as a recognition element for virus detection. Unfortunately, emerging reports indicate that the affinity of SBP1 to the receptor-bi","2021","07","23","Biophys J","Biophysical journal",NA,"Das","Mitradip","Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India",NA
"2185","34214538","10.1016/j.bpj.2021.06.017","Biophysical properties of the isolated spike protein binding helix of human ACE2.","The entry of the severe acute respiratory syndrome coronavirus 2 virus in human cells is mediated by the binding of its surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor. A 23-residue long helical segment (SBP1) at the binding interface of human ACE2 interacts with viral spike protein and therefore has generated considerable interest as a recognition element for virus detection. Unfortunately, emerging reports indicate that the affinity of SBP1 to the receptor-bi","2021","07","23","Biophys J","Biophysical journal",NA,"Vishwakarma","Krishna Kant","Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India",NA
"2186","34214538","10.1016/j.bpj.2021.06.017","Biophysical properties of the isolated spike protein binding helix of human ACE2.","The entry of the severe acute respiratory syndrome coronavirus 2 virus in human cells is mediated by the binding of its surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor. A 23-residue long helical segment (SBP1) at the binding interface of human ACE2 interacts with viral spike protein and therefore has generated considerable interest as a recognition element for virus detection. Unfortunately, emerging reports indicate that the affinity of SBP1 to the receptor-bi","2021","07","23","Biophys J","Biophysical journal",NA,"Roy","Debsankar Saha","Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India",NA
"2187","34214538","10.1016/j.bpj.2021.06.017","Biophysical properties of the isolated spike protein binding helix of human ACE2.","The entry of the severe acute respiratory syndrome coronavirus 2 virus in human cells is mediated by the binding of its surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor. A 23-residue long helical segment (SBP1) at the binding interface of human ACE2 interacts with viral spike protein and therefore has generated considerable interest as a recognition element for virus detection. Unfortunately, emerging reports indicate that the affinity of SBP1 to the receptor-bi","2021","07","23","Biophys J","Biophysical journal",NA,"Yadav","Swati","National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, Karnataka, India",NA
"2188","34214538","10.1016/j.bpj.2021.06.017","Biophysical properties of the isolated spike protein binding helix of human ACE2.","The entry of the severe acute respiratory syndrome coronavirus 2 virus in human cells is mediated by the binding of its surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor. A 23-residue long helical segment (SBP1) at the binding interface of human ACE2 interacts with viral spike protein and therefore has generated considerable interest as a recognition element for virus detection. Unfortunately, emerging reports indicate that the affinity of SBP1 to the receptor-bi","2021","07","23","Biophys J","Biophysical journal",NA,"Kesarwani","Shubham","Centre for Cardiovascular Biology and Disease, Institute of Stem Cell Science and Regenerative Medicine (inStem), Gandhi Krishi Vigyan Kendra Campus, Bangalore, Karnataka, India",NA
"2189","34214538","10.1016/j.bpj.2021.06.017","Biophysical properties of the isolated spike protein binding helix of human ACE2.","The entry of the severe acute respiratory syndrome coronavirus 2 virus in human cells is mediated by the binding of its surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor. A 23-residue long helical segment (SBP1) at the binding interface of human ACE2 interacts with viral spike protein and therefore has generated considerable interest as a recognition element for virus detection. Unfortunately, emerging reports indicate that the affinity of SBP1 to the receptor-bi","2021","07","23","Biophys J","Biophysical journal",NA,"Venkatramani","Ravindra","Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India",NA
"2190","34214538","10.1016/j.bpj.2021.06.017","Biophysical properties of the isolated spike protein binding helix of human ACE2.","The entry of the severe acute respiratory syndrome coronavirus 2 virus in human cells is mediated by the binding of its surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor. A 23-residue long helical segment (SBP1) at the binding interface of human ACE2 interacts with viral spike protein and therefore has generated considerable interest as a recognition element for virus detection. Unfortunately, emerging reports indicate that the affinity of SBP1 to the receptor-bi","2021","07","23","Biophys J","Biophysical journal",NA,"Maiti","Sudipta","Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India. Electronic address: maiti@tifr.res","maiti@tifr.res.in"
"2191","34214535","10.1016/j.bpj.2021.06.018","Role of spatial patterning of N-protein interactions in SARS-CoV-2 genome packaging.","Viruses must efficiently and specifically package their genomes while excluding cellular nucleic acids and viral subgenomic fragments. Some viruses use specific packaging signals, which are conserved sequence or structure motifs present only in the full-length genome. Recent work has shown that viral proteins important for packaging can undergo liquid-liquid phase separation (LLPS), in which one or two viral nucleic acid binding proteins condense with the genome. The compositional simplicity of ","2021","07","23","Biophys J","Biophysical journal",NA,"Seim","Ian","Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina",NA
"2192","34214535","10.1016/j.bpj.2021.06.018","Role of spatial patterning of N-protein interactions in SARS-CoV-2 genome packaging.","Viruses must efficiently and specifically package their genomes while excluding cellular nucleic acids and viral subgenomic fragments. Some viruses use specific packaging signals, which are conserved sequence or structure motifs present only in the full-length genome. Recent work has shown that viral proteins important for packaging can undergo liquid-liquid phase separation (LLPS), in which one or two viral nucleic acid binding proteins condense with the genome. The compositional simplicity of ","2021","07","23","Biophys J","Biophysical journal",NA,"Roden","Christine A","Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina",NA
"2193","34214535","10.1016/j.bpj.2021.06.018","Role of spatial patterning of N-protein interactions in SARS-CoV-2 genome packaging.","Viruses must efficiently and specifically package their genomes while excluding cellular nucleic acids and viral subgenomic fragments. Some viruses use specific packaging signals, which are conserved sequence or structure motifs present only in the full-length genome. Recent work has shown that viral proteins important for packaging can undergo liquid-liquid phase separation (LLPS), in which one or two viral nucleic acid binding proteins condense with the genome. The compositional simplicity of ","2021","07","23","Biophys J","Biophysical journal",NA,"Gladfelter","Amy S","Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Electronic address: amyglad@unc","amyglad@unc.edu"
"2194","34214521","10.1016/j.bjane.2021.06.008","Eclampsia and posterior reversible encephalopathy syndrome in a parturient complicated by SARS COVID-19 pneumonia.","A primigravida at 32 weeks of gestation presented to us with eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES) along with SARS COVID-19 pneumonia. Immediate termination of pregnancy was done under general anesthesia and patient was electively ventilated in view of increased oxygen requirements. Further therapy using magnesium sulphate, antihypertensives, steroids, and convalescent plasma was carried out. The condition of the patient steadily improved leading to her extubation on ","2021","07","11","Braz J Anesthesiol","Brazilian journal of anesthesiology (Elsevier)","COVID-19; Eclampsia; Posterior reversible encephalopathy syndrome","Shankar","Vijay","Indraprastha Apollo Hospital, Department of Anaesthesiology &amp","vijaysnair95@gmail.com"
"2195","34214521","10.1016/j.bjane.2021.06.008","Eclampsia and posterior reversible encephalopathy syndrome in a parturient complicated by SARS COVID-19 pneumonia.","A primigravida at 32 weeks of gestation presented to us with eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES) along with SARS COVID-19 pneumonia. Immediate termination of pregnancy was done under general anesthesia and patient was electively ventilated in view of increased oxygen requirements. Further therapy using magnesium sulphate, antihypertensives, steroids, and convalescent plasma was carried out. The condition of the patient steadily improved leading to her extubation on ","2021","07","11","Braz J Anesthesiol","Brazilian journal of anesthesiology (Elsevier)","COVID-19; Eclampsia; Posterior reversible encephalopathy syndrome","Dhar","Purnima","Indraprastha Apollo Hospital, Department of Anaesthesiology &amp","purnima29@gmail.com"
"2196","34214521","10.1016/j.bjane.2021.06.008","Eclampsia and posterior reversible encephalopathy syndrome in a parturient complicated by SARS COVID-19 pneumonia.","A primigravida at 32 weeks of gestation presented to us with eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES) along with SARS COVID-19 pneumonia. Immediate termination of pregnancy was done under general anesthesia and patient was electively ventilated in view of increased oxygen requirements. Further therapy using magnesium sulphate, antihypertensives, steroids, and convalescent plasma was carried out. The condition of the patient steadily improved leading to her extubation on ","2021","07","11","Braz J Anesthesiol","Brazilian journal of anesthesiology (Elsevier)","COVID-19; Eclampsia; Posterior reversible encephalopathy syndrome","George","Jai","Indraprastha Apollo Hospital, Department of Anaesthesiology &amp",NA
"2197","34214521","10.1016/j.bjane.2021.06.008","Eclampsia and posterior reversible encephalopathy syndrome in a parturient complicated by SARS COVID-19 pneumonia.","A primigravida at 32 weeks of gestation presented to us with eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES) along with SARS COVID-19 pneumonia. Immediate termination of pregnancy was done under general anesthesia and patient was electively ventilated in view of increased oxygen requirements. Further therapy using magnesium sulphate, antihypertensives, steroids, and convalescent plasma was carried out. The condition of the patient steadily improved leading to her extubation on ","2021","07","11","Braz J Anesthesiol","Brazilian journal of anesthesiology (Elsevier)","COVID-19; Eclampsia; Posterior reversible encephalopathy syndrome","Sharma","Anil","Indraprastha Apollo Hospital, Department of Anaesthesiology &amp",NA
"2198","34214521","10.1016/j.bjane.2021.06.008","Eclampsia and posterior reversible encephalopathy syndrome in a parturient complicated by SARS COVID-19 pneumonia.","A primigravida at 32 weeks of gestation presented to us with eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES) along with SARS COVID-19 pneumonia. Immediate termination of pregnancy was done under general anesthesia and patient was electively ventilated in view of increased oxygen requirements. Further therapy using magnesium sulphate, antihypertensives, steroids, and convalescent plasma was carried out. The condition of the patient steadily improved leading to her extubation on ","2021","07","11","Braz J Anesthesiol","Brazilian journal of anesthesiology (Elsevier)","COVID-19; Eclampsia; Posterior reversible encephalopathy syndrome","Raj","Anupam","Indraprastha Apollo Hospital, Department of Anaesthesiology &amp","anupamraj21@gmail.com"
"2199","34214519","10.1016/j.bjane.2021.06.009","Abdominal wall blocks for emergency ileostomy operation in a patient with COVID-19 pneumonia: a case report.","The anesthesia method to be administered during emergency surgical procedures for COVID-19 (Coronavirus Disease 2019) pneumonia patients carries great importance for both patient and surgical team. Regional blocks are generally used to ensure postoperative analgesia after abdominal surgery with general anesthesia. In this case, involving a patient receiving anticoagulant treatment due to COVID-19 pneumonia with planned emergency operation, the aim was to present the anesthesia management with re","2021","07","11","Braz J Anesthesiol","Brazilian journal of anesthesiology (Elsevier)","Anesthesia; COVID-19; Ileostomy; Pneumonia","Guven","Bulent Baris","Health Science University, Sultan Abdulhamid Han Hospital, Department of Anesthesia, Istanbul, Turkey. Electronic address: barguv@gmail","barguv@gmail.com"
"2200","34214519","10.1016/j.bjane.2021.06.009","Abdominal wall blocks for emergency ileostomy operation in a patient with COVID-19 pneumonia: a case report.","The anesthesia method to be administered during emergency surgical procedures for COVID-19 (Coronavirus Disease 2019) pneumonia patients carries great importance for both patient and surgical team. Regional blocks are generally used to ensure postoperative analgesia after abdominal surgery with general anesthesia. In this case, involving a patient receiving anticoagulant treatment due to COVID-19 pneumonia with planned emergency operation, the aim was to present the anesthesia management with re","2021","07","11","Braz J Anesthesiol","Brazilian journal of anesthesiology (Elsevier)","Anesthesia; COVID-19; Ileostomy; Pneumonia","Erturk","Tuna","Health Science University, Sultan Abdulhamid Han Hospital, Department of Anesthesia, Istanbul, Turkey",NA
"2201","34214519","10.1016/j.bjane.2021.06.009","Abdominal wall blocks for emergency ileostomy operation in a patient with COVID-19 pneumonia: a case report.","The anesthesia method to be administered during emergency surgical procedures for COVID-19 (Coronavirus Disease 2019) pneumonia patients carries great importance for both patient and surgical team. Regional blocks are generally used to ensure postoperative analgesia after abdominal surgery with general anesthesia. In this case, involving a patient receiving anticoagulant treatment due to COVID-19 pneumonia with planned emergency operation, the aim was to present the anesthesia management with re","2021","07","11","Braz J Anesthesiol","Brazilian journal of anesthesiology (Elsevier)","Anesthesia; COVID-19; Ileostomy; Pneumonia","Güner","Temel","Health Science University, Sultan Abdulhamid Han Hospital, Department of Anesthesia, Istanbul, Turkey",NA
"2202","34214519","10.1016/j.bjane.2021.06.009","Abdominal wall blocks for emergency ileostomy operation in a patient with COVID-19 pneumonia: a case report.","The anesthesia method to be administered during emergency surgical procedures for COVID-19 (Coronavirus Disease 2019) pneumonia patients carries great importance for both patient and surgical team. Regional blocks are generally used to ensure postoperative analgesia after abdominal surgery with general anesthesia. In this case, involving a patient receiving anticoagulant treatment due to COVID-19 pneumonia with planned emergency operation, the aim was to present the anesthesia management with re","2021","07","11","Braz J Anesthesiol","Brazilian journal of anesthesiology (Elsevier)","Anesthesia; COVID-19; Ileostomy; Pneumonia","Ersoy","Aysin","Health Science University, Sultan Abdulhamid Han Hospital, Department of Anesthesia, Istanbul, Turkey",NA
"2203","34214517","10.1016/j.jinf.2021.06.023","Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.",NA,"2021","07","04","J Infect","The Journal of infection",NA,"Hsu","Lea","Gesundheitsamt der Stadt Köln, Infektions- und Umwelthygiene, Neumarkt 15- 21, 50667 Köln",NA
"2204","34214517","10.1016/j.jinf.2021.06.023","Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.",NA,"2021","07","04","J Infect","The Journal of infection",NA,"Wisplinghoff","Hilmar","LaborDr.Wisplinghoff, Horbeller Str. 20, 50858 Köln",NA
"2205","34214517","10.1016/j.jinf.2021.06.023","Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.",NA,"2021","07","04","J Infect","The Journal of infection",NA,"Kossow","Annelene","Gesundheitsamt der Stadt Köln, Infektions- und Umwelthygiene, Neumarkt 15- 21, 50667 Köln",NA
"2206","34214517","10.1016/j.jinf.2021.06.023","Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.",NA,"2021","07","04","J Infect","The Journal of infection",NA,"Hurraß","Julia","Gesundheitsamt der Stadt Köln, Infektions- und Umwelthygiene, Neumarkt 15- 21, 50667 Köln",NA
"2207","34214517","10.1016/j.jinf.2021.06.023","Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.",NA,"2021","07","04","J Infect","The Journal of infection",NA,"Wiesmüller","Gerhard A","Gesundheitsamt der Stadt Köln, Infektions- und Umwelthygiene, Neumarkt 15- 21, 50667 Köln",NA
"2208","34214517","10.1016/j.jinf.2021.06.023","Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.",NA,"2021","07","04","J Infect","The Journal of infection",NA,"Grüne","Barbara","Gesundheitsamt der Stadt Köln, Infektions- und Umwelthygiene, Neumarkt 15- 21, 50667 Köln",NA
"2209","34214517","10.1016/j.jinf.2021.06.023","Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.",NA,"2021","07","04","J Infect","The Journal of infection",NA,"Hoffmann","Dennis","LaborDr.Wisplinghoff, Horbeller Str. 20, 50858 Köln",NA
"2210","34214517","10.1016/j.jinf.2021.06.023","Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.",NA,"2021","07","04","J Infect","The Journal of infection",NA,"Lüsebrink","Jessica","Klinikum der PrivatenUniversität Witten/Herdecke, InstitutfürPathologie, Ostmerheimer Str. 200, D-51109 Köln (Cologne), Germany",NA
"2211","34214517","10.1016/j.jinf.2021.06.023","Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.",NA,"2021","07","04","J Infect","The Journal of infection",NA,"Demuth","Sabrina","Klinikum der PrivatenUniversität Witten/Herdecke, InstitutfürPathologie, Ostmerheimer Str. 200, D-51109 Köln (Cologne), Germany",NA
"2212","34214517","10.1016/j.jinf.2021.06.023","Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.",NA,"2021","07","04","J Infect","The Journal of infection",NA,"Schildgen","Oliver","InstitutfürVirologie und Mikrobiologie, Universität Witten/Herdecke, StockumerStr. 10, 58453 Witten",NA
"2213","34214517","10.1016/j.jinf.2021.06.023","Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.",NA,"2021","07","04","J Infect","The Journal of infection",NA,"Schildgen","Verena","Klinikum der PrivatenUniversität Witten/Herdecke, InstitutfürPathologie, Ostmerheimer Str. 200, D-51109 Köln (Cologne), Germany. Electronic address: schildgenv@kliniken-koeln",NA
"2214","34214516","10.1016/j.jinf.2021.06.024","Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.",NA,"2021","07","24","J Infect","The Journal of infection","Antibodies; COVID-19; Immune response; SARS-CoV-2; Vaccination","Salvagno","Gian Luca","Section of Clinical Biochemistry, University Hospital of Verona, Piazzale L.A. Scuro, 10, Verona 37134, Italy",NA
"2215","34214516","10.1016/j.jinf.2021.06.024","Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.",NA,"2021","07","24","J Infect","The Journal of infection","Antibodies; COVID-19; Immune response; SARS-CoV-2; Vaccination","Henry","Brandon M","The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States",NA
"2216","34214516","10.1016/j.jinf.2021.06.024","Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.",NA,"2021","07","24","J Infect","The Journal of infection","Antibodies; COVID-19; Immune response; SARS-CoV-2; Vaccination","Pighi","Laura","Section of Clinical Biochemistry, University Hospital of Verona, Piazzale L.A. Scuro, 10, Verona 37134, Italy",NA
"2217","34214516","10.1016/j.jinf.2021.06.024","Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.",NA,"2021","07","24","J Infect","The Journal of infection","Antibodies; COVID-19; Immune response; SARS-CoV-2; Vaccination","De Nitto","Simone","Section of Clinical Biochemistry, University Hospital of Verona, Piazzale L.A. Scuro, 10, Verona 37134, Italy",NA
"2218","34214516","10.1016/j.jinf.2021.06.024","Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.",NA,"2021","07","24","J Infect","The Journal of infection","Antibodies; COVID-19; Immune response; SARS-CoV-2; Vaccination","Gianfilippi","Gian Luca","Medical Direction, Pederzoli Hospital, Peschiera del Garda, Italy",NA
"2219","34214516","10.1016/j.jinf.2021.06.024","Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.",NA,"2021","07","24","J Infect","The Journal of infection","Antibodies; COVID-19; Immune response; SARS-CoV-2; Vaccination","Lippi","Giuseppe","Section of Clinical Biochemistry, University Hospital of Verona, Piazzale L.A. Scuro, 10, Verona 37134, Italy. Electronic address: giuseppe.lippi@univr","giuseppe.lippi@univr.it"
"2220","34214498","10.1016/j.jbc.2021.100925","Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection.","Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor antagonist (antihistamine), has been associated with reduced risk of intubation and death in patients hospitalized with COVID-19. In a case series, non-hospitalized patients with COVID-19 experienced rapid symptom resolution after taking famotidine, but the molecular basis of these observations remains elusive. Here we show ","2021","07","04","J Biol Chem","The Journal of biological chemistry","Famotidine; SARS-CoV2; Toll-like receptor; anti-viral signaling; histamine","Mukherjee","Rukmini","Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt, Germany",NA
"2221","34214498","10.1016/j.jbc.2021.100925","Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection.","Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor antagonist (antihistamine), has been associated with reduced risk of intubation and death in patients hospitalized with COVID-19. In a case series, non-hospitalized patients with COVID-19 experienced rapid symptom resolution after taking famotidine, but the molecular basis of these observations remains elusive. Here we show ","2021","07","04","J Biol Chem","The Journal of biological chemistry","Famotidine; SARS-CoV2; Toll-like receptor; anti-viral signaling; histamine","Bhattacharya","Anshu","Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt, Germany",NA
"2222","34214498","10.1016/j.jbc.2021.100925","Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection.","Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor antagonist (antihistamine), has been associated with reduced risk of intubation and death in patients hospitalized with COVID-19. In a case series, non-hospitalized patients with COVID-19 experienced rapid symptom resolution after taking famotidine, but the molecular basis of these observations remains elusive. Here we show ","2021","07","04","J Biol Chem","The Journal of biological chemistry","Famotidine; SARS-CoV2; Toll-like receptor; anti-viral signaling; histamine","Bojkova","Denisa","Institute of Medical Virology, University Hospital Frankfurt, Frankfurt, Germany",NA
"2223","34214498","10.1016/j.jbc.2021.100925","Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection.","Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor antagonist (antihistamine), has been associated with reduced risk of intubation and death in patients hospitalized with COVID-19. In a case series, non-hospitalized patients with COVID-19 experienced rapid symptom resolution after taking famotidine, but the molecular basis of these observations remains elusive. Here we show ","2021","07","04","J Biol Chem","The Journal of biological chemistry","Famotidine; SARS-CoV2; Toll-like receptor; anti-viral signaling; histamine","Mehdipour","Ahmad Reza","Department of Theoretical Biophysics, Max Planck Institute of Biophysics, Frankfurt, Germany",NA
"2224","34214498","10.1016/j.jbc.2021.100925","Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection.","Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor antagonist (antihistamine), has been associated with reduced risk of intubation and death in patients hospitalized with COVID-19. In a case series, non-hospitalized patients with COVID-19 experienced rapid symptom resolution after taking famotidine, but the molecular basis of these observations remains elusive. Here we show ","2021","07","04","J Biol Chem","The Journal of biological chemistry","Famotidine; SARS-CoV2; Toll-like receptor; anti-viral signaling; histamine","Shin","Donghyuk","Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt, Germany",NA
"2225","34214498","10.1016/j.jbc.2021.100925","Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection.","Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor antagonist (antihistamine), has been associated with reduced risk of intubation and death in patients hospitalized with COVID-19. In a case series, non-hospitalized patients with COVID-19 experienced rapid symptom resolution after taking famotidine, but the molecular basis of these observations remains elusive. Here we show ","2021","07","04","J Biol Chem","The Journal of biological chemistry","Famotidine; SARS-CoV2; Toll-like receptor; anti-viral signaling; histamine","Khan","Khadija Shahed","School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong (CUHK), Hong Kong, Hong Kong",NA
"2226","34214498","10.1016/j.jbc.2021.100925","Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection.","Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor antagonist (antihistamine), has been associated with reduced risk of intubation and death in patients hospitalized with COVID-19. In a case series, non-hospitalized patients with COVID-19 experienced rapid symptom resolution after taking famotidine, but the molecular basis of these observations remains elusive. Here we show ","2021","07","04","J Biol Chem","The Journal of biological chemistry","Famotidine; SARS-CoV2; Toll-like receptor; anti-viral signaling; histamine","Hei-Yin Cheung","Hayley","State Key Laboratory of Agrobiotechnology, School of Life Sciences, The Chinese University of Hong Kong (CUHK)",NA
"2227","34214498","10.1016/j.jbc.2021.100925","Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection.","Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor antagonist (antihistamine), has been associated with reduced risk of intubation and death in patients hospitalized with COVID-19. In a case series, non-hospitalized patients with COVID-19 experienced rapid symptom resolution after taking famotidine, but the molecular basis of these observations remains elusive. Here we show ","2021","07","04","J Biol Chem","The Journal of biological chemistry","Famotidine; SARS-CoV2; Toll-like receptor; anti-viral signaling; histamine","Wong","Kam-Bo","State Key Laboratory of Agrobiotechnology, School of Life Sciences, The Chinese University of Hong Kong (CUHK)",NA
"2228","34214498","10.1016/j.jbc.2021.100925","Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection.","Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor antagonist (antihistamine), has been associated with reduced risk of intubation and death in patients hospitalized with COVID-19. In a case series, non-hospitalized patients with COVID-19 experienced rapid symptom resolution after taking famotidine, but the molecular basis of these observations remains elusive. Here we show ","2021","07","04","J Biol Chem","The Journal of biological chemistry","Famotidine; SARS-CoV2; Toll-like receptor; anti-viral signaling; histamine","Ng","WaiLung","School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong (CUHK), Hong Kong, Hong Kong",NA
"2229","34214498","10.1016/j.jbc.2021.100925","Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection.","Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor antagonist (antihistamine), has been associated with reduced risk of intubation and death in patients hospitalized with COVID-19. In a case series, non-hospitalized patients with COVID-19 experienced rapid symptom resolution after taking famotidine, but the molecular basis of these observations remains elusive. Here we show ","2021","07","04","J Biol Chem","The Journal of biological chemistry","Famotidine; SARS-CoV2; Toll-like receptor; anti-viral signaling; histamine","Cinatl","Jindrich","Institute of Medical Virology, University Hospital Frankfurt, Frankfurt, Germany",NA
"2230","34214498","10.1016/j.jbc.2021.100925","Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection.","Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor antagonist (antihistamine), has been associated with reduced risk of intubation and death in patients hospitalized with COVID-19. In a case series, non-hospitalized patients with COVID-19 experienced rapid symptom resolution after taking famotidine, but the molecular basis of these observations remains elusive. Here we show ","2021","07","04","J Biol Chem","The Journal of biological chemistry","Famotidine; SARS-CoV2; Toll-like receptor; anti-viral signaling; histamine","Geurink","Paul P","Oncode Institute and Department of Chemical Immunology, Leiden University Medical Centre, Leiden, The Netherlands",NA
"2231","34214498","10.1016/j.jbc.2021.100925","Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection.","Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor antagonist (antihistamine), has been associated with reduced risk of intubation and death in patients hospitalized with COVID-19. In a case series, non-hospitalized patients with COVID-19 experienced rapid symptom resolution after taking famotidine, but the molecular basis of these observations remains elusive. Here we show ","2021","07","04","J Biol Chem","The Journal of biological chemistry","Famotidine; SARS-CoV2; Toll-like receptor; anti-viral signaling; histamine","van der Heden van Noort","Gerbrand J","Oncode Institute and Department of Chemical Immunology, Leiden University Medical Centre, Leiden, The Netherlands",NA
"2232","34214498","10.1016/j.jbc.2021.100925","Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection.","Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor antagonist (antihistamine), has been associated with reduced risk of intubation and death in patients hospitalized with COVID-19. In a case series, non-hospitalized patients with COVID-19 experienced rapid symptom resolution after taking famotidine, but the molecular basis of these observations remains elusive. Here we show ","2021","07","04","J Biol Chem","The Journal of biological chemistry","Famotidine; SARS-CoV2; Toll-like receptor; anti-viral signaling; histamine","Rajalingam","Krishnaraj","Cell Biology Unit, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany",NA
"2233","34214498","10.1016/j.jbc.2021.100925","Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection.","Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor antagonist (antihistamine), has been associated with reduced risk of intubation and death in patients hospitalized with COVID-19. In a case series, non-hospitalized patients with COVID-19 experienced rapid symptom resolution after taking famotidine, but the molecular basis of these observations remains elusive. Here we show ","2021","07","04","J Biol Chem","The Journal of biological chemistry","Famotidine; SARS-CoV2; Toll-like receptor; anti-viral signaling; histamine","Ciesek","Sandra","Institute of Medical Virology, University Hospital Frankfurt, Frankfurt, Germany",NA
"2234","34214498","10.1016/j.jbc.2021.100925","Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection.","Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor antagonist (antihistamine), has been associated with reduced risk of intubation and death in patients hospitalized with COVID-19. In a case series, non-hospitalized patients with COVID-19 experienced rapid symptom resolution after taking famotidine, but the molecular basis of these observations remains elusive. Here we show ","2021","07","04","J Biol Chem","The Journal of biological chemistry","Famotidine; SARS-CoV2; Toll-like receptor; anti-viral signaling; histamine","Hummer","Gerhard","Department of Theoretical Biophysics, Max Planck Institute of Biophysics, Frankfurt, Germany",NA
"2235","34214498","10.1016/j.jbc.2021.100925","Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection.","Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor antagonist (antihistamine), has been associated with reduced risk of intubation and death in patients hospitalized with COVID-19. In a case series, non-hospitalized patients with COVID-19 experienced rapid symptom resolution after taking famotidine, but the molecular basis of these observations remains elusive. Here we show ","2021","07","04","J Biol Chem","The Journal of biological chemistry","Famotidine; SARS-CoV2; Toll-like receptor; anti-viral signaling; histamine","Dikic","Ivan","Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt, Germany","dikic@biochem2.uni"
"2236","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Addeo","Alfredo","Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland. Electronic address: alfredo.addeo@hcuge","alfredo.addeo@hcuge.ch"
"2237","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Shah","Pankil K","Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA",NA
"2238","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Bordry","Natacha","Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland",NA
"2239","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Hudson","Robert D","Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA",NA
"2240","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Albracht","Brenna","Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA",NA
"2241","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Di Marco","Mariagrazia","Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland",NA
"2242","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Kaklamani","Virginia","Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA",NA
"2243","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Dietrich","Pierre-Yves","Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland",NA
"2244","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Taylor","Barbara S","Division of Infectious Diseases, Department of Medicine, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, USA",NA
"2245","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Simand","Pierre-Francois","Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland",NA
"2246","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Patel","Darpan","Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA",NA
"2247","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Wang","Jing","Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA",NA
"2248","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Labidi-Galy","Intidhar","Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland",NA
"2249","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Fertani","Sara","Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland",NA
"2250","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Leach","Robin J","Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA",NA
"2251","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Sandoval","Jose","Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland",NA
"2252","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Mesa","Ruben","Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA",NA
"2253","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Lathrop","Kate","Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA",NA
"2254","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Mach","Nicolas","Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland",NA
"2255","34214473","10.1016/j.ccell.2021.06.009","Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.","Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity, complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are highly effective in the general population; however, few data are available on their efficacy in patients with cancer. Using a prospective cohort, we assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the first and second dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in pa","2021","07","05","Cancer Cell","Cancer cell","COVID-19; anti-cancer treatment; antibody; immune response; malignancy; oncology; pandemic; seroconversion; tumor; vaccine","Shah","Dimpy P","Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA. Electronic address: shahdp@uthscsa","shahdp@uthscsa.edu"
"2256","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Puray-Chavez","Maritza","Department of Molecular Microbiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2257","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","LaPak","Kyle M","Department of Cell Biology and Physiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2258","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Schrank","Travis P","Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA",NA
"2259","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Elliott","Jennifer L","Department of Molecular Microbiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2260","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Bhatt","Dhaval P","Department of Cell Biology and Physiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2261","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Agajanian","Megan J","Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA",NA
"2262","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Jasuja","Ria","Department of Cell Biology and Physiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2263","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Lawson","Dana Q","Department of Molecular Microbiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2264","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Davis","Keanu","Department of Molecular Microbiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2265","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Rothlauf","Paul W","Department of Molecular Microbiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2266","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Liu","Zhuoming","Department of Molecular Microbiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2267","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Jo","Heejoon","University of Tennessee Health Science Center for Cancer Research, Department of Medicine, Division of Hematology and Oncology, University of Tennessee, Memphis, TN, USA",NA
"2268","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Lee","Nakyung","Department of Molecular Microbiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2269","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Tenneti","Kasyap","Department of Molecular Microbiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2270","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Eschbach","Jenna E","Department of Molecular Microbiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2271","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Shema Mugisha","Christian","Department of Molecular Microbiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2272","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Cousins","Emily M","Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA",NA
"2273","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Cloer","Erica W","Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA",NA
"2274","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Vuong","Hung R","Department of Molecular Microbiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2275","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","VanBlargan","Laura A","Department of Medicine, Washington University in St. Louis, School of Medicine, St. Louis, MO 63110, USA",NA
"2276","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Bailey","Adam L","Department of Pathology &amp",NA
"2277","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Gilchuk","Pavlo","Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA",NA
"2278","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Crowe","James E","Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA",NA
"2279","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Diamond","Michael S","Department of Molecular Microbiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2280","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Hayes","D Neil","University of Tennessee Health Science Center for Cancer Research, Department of Medicine, Division of Hematology and Oncology, University of Tennessee, Memphis, TN, USA",NA
"2281","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Whelan","Sean P J","Department of Molecular Microbiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2282","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Horani","Amjad","Department of Cell Biology and Physiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2283","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Brody","Steven L","Division of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2284","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Goldfarb","Dennis","Department of Cell Biology and Physiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA",NA
"2285","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Major","M Ben","Department of Cell Biology and Physiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA","bmajor@wustl.edu"
"2286","34214467","10.1016/j.celrep.2021.109364","Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human H522 lung adenocarcinoma cells as naturally permissive to SARS-CoV-2 infection despite complete absence of angiotensin-converting enzyme 2 (ACE2) expression. Remarkably, H522 infection requires the E484D S variant; viruses expressing wild-type S are not infectious. Anti-S","2021","07","16","Cell Rep","Cell reports","ACE2-independent; COVID-19; RIG-I-like receptors; SARS-CoV-2; clathrin-mediated endocytosis; heparan sulfate; proteomics; spike variants; type I interferon; virus-host interactions","Kutluay","Sebla B","Department of Molecular Microbiology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA. Electronic address: kutluay@wustl","kutluay@wustl.edu"
"2287","34214432","10.20344/amp.15996","Perinatal Mental Health During the COVID-19 Pandemic: Challenges for Psychiatry.",NA,"2021","07","07","Acta Med Port","Acta medica portuguesa","COVID-19; Maternal-Fetal Relations; Mental Health; Pregnancy; Psychiatry; COVID-19; Female; Humans; Mental Health; Pandemics; Pregnancy; Psychiatry; SARS-CoV-2","Santos","Cátia Fernandes","Department of Psychiatry and Mental Health. Hospital Garcia de Orta. Almada. Portugal",NA
"2288","34214428","10.20344/amp.15966","COVID-19 and Moral Distress in Healthcare Professionals: Can Ethics Committees Make a Difference?",NA,"2021","07","07","Acta Med Port","Acta medica portuguesa","COVID-19; Ethics; Mental Health; Morals; Resource Allocation; Stress, Psychological","Martinho","Sérgio M","Institute of Bioethics. Faculty of Medicine. University of Coimbra. Coimbra",NA
"2289","34214428","10.20344/amp.15966","COVID-19 and Moral Distress in Healthcare Professionals: Can Ethics Committees Make a Difference?",NA,"2021","07","07","Acta Med Port","Acta medica portuguesa","COVID-19; Ethics; Mental Health; Morals; Resource Allocation; Stress, Psychological","Carvalheiro","Ana Mafalda","Psychiatry and Mental Health Department. Leiria Hospital Centre. Leiria. Portugal",NA
"2290","34214428","10.20344/amp.15966","COVID-19 and Moral Distress in Healthcare Professionals: Can Ethics Committees Make a Difference?",NA,"2021","07","07","Acta Med Port","Acta medica portuguesa","COVID-19; Ethics; Mental Health; Morals; Resource Allocation; Stress, Psychological","Silvestre","Margarida","Institute of Bioethics. Faculty of Medicine. University of Coimbra. Coimbra. Reproductive Medicine Department. Coimbra Hospital and University Centre. Coimbra. Portugal",NA
"2291","34214425","10.20344/amp.15279","[Delirium in COVID-19 Elderly Patients: Raising Awareness to the Importance of its Early Detection and Therapeutic Intervention].",NA,"2021","07","07","Acta Med Port","Acta medica portuguesa","COVID-19; Delirium; Neuropsychiatry; Pandemics; Psychotropic Drugs","Mota","Pedro","Departamento de Psiquiatria e Saúde Mental. Centro Hospitalar do Tâmega e Sousa. Guilhufe. Penafiel. Portugal",NA
"2292","34214424","10.20344/amp.15845","[Evaluation of the Adequacy of the Referral Via a Telephone Health Advice Line to a Pediatric Emergency Department During the COVID-19 Pandemic in Portugal].",NA,"2021","07","07","Acta Med Port","Acta medica portuguesa","COVID-19; Coronavirus Infections; Intensive Care Units, Pediatric; Referral and Consultation","Gonçalves","Raquel","Serviço de Pediatria. Hospital Pediátrico de Coimbra. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal",NA
"2293","34214424","10.20344/amp.15845","[Evaluation of the Adequacy of the Referral Via a Telephone Health Advice Line to a Pediatric Emergency Department During the COVID-19 Pandemic in Portugal].",NA,"2021","07","07","Acta Med Port","Acta medica portuguesa","COVID-19; Coronavirus Infections; Intensive Care Units, Pediatric; Referral and Consultation","Sá","Beatriz","Serviço de Pediatria. Centro Hospitalar de Leiria. Hospital de Santo André. Leiria. Portugal",NA
"2294","34214424","10.20344/amp.15845","[Evaluation of the Adequacy of the Referral Via a Telephone Health Advice Line to a Pediatric Emergency Department During the COVID-19 Pandemic in Portugal].",NA,"2021","07","07","Acta Med Port","Acta medica portuguesa","COVID-19; Coronavirus Infections; Intensive Care Units, Pediatric; Referral and Consultation","Cunha","Rita","Serviço de Pediatria. Centro Hospitalar de Leiria. Hospital de Santo André. Leiria. Portugal",NA
"2295","34214424","10.20344/amp.15845","[Evaluation of the Adequacy of the Referral Via a Telephone Health Advice Line to a Pediatric Emergency Department During the COVID-19 Pandemic in Portugal].",NA,"2021","07","07","Acta Med Port","Acta medica portuguesa","COVID-19; Coronavirus Infections; Intensive Care Units, Pediatric; Referral and Consultation","Winckler","Lina","Serviço de Pediatria. Centro Hospitalar de Leiria. Hospital de Santo André. Leiria. Portugal",NA
"2296","34214424","10.20344/amp.15845","[Evaluation of the Adequacy of the Referral Via a Telephone Health Advice Line to a Pediatric Emergency Department During the COVID-19 Pandemic in Portugal].",NA,"2021","07","07","Acta Med Port","Acta medica portuguesa","COVID-19; Coronavirus Infections; Intensive Care Units, Pediatric; Referral and Consultation","Moleiro","Pascoal","Serviço de Pediatria. Centro Hospitalar de Leiria. Hospital de Santo André. Leiria. Portugal",NA
"2297","34214423","10.20344/amp.15480","[How to Resume Elective Orthopaedic Surgical Procedures during the COVID-19 Pandemic?]","This document was prepared by the College of Orthopedics of the Portuguese Medical Association with the aim of developing the guidelines on the resumption of elective surgical activity in Orthopedics during the COVID-19 pandemic. It sets the criteria that allow the prioritization of surgeries according to the severity of the clinical situation, based on existing and published classifications. Moreover, it provides an organizational model for patient preparation and describes the patient pathways","2021","07","05","Acta Med Port","Acta medica portuguesa","COVID-19; Elective Surgical Procedures; Orthopedic Procedures; Pandemics","Diogo","Nuno","Serviço de Ortopedia e Traumatologia. Hospital de Curry Cabral. Centro Hospitalar Universitário Lisboa Central. Lisboa",NA
"2298","34214423","10.20344/amp.15480","[How to Resume Elective Orthopaedic Surgical Procedures during the COVID-19 Pandemic?]","This document was prepared by the College of Orthopedics of the Portuguese Medical Association with the aim of developing the guidelines on the resumption of elective surgical activity in Orthopedics during the COVID-19 pandemic. It sets the criteria that allow the prioritization of surgeries according to the severity of the clinical situation, based on existing and published classifications. Moreover, it provides an organizational model for patient preparation and describes the patient pathways","2021","07","05","Acta Med Port","Acta medica portuguesa","COVID-19; Elective Surgical Procedures; Orthopedic Procedures; Pandemics","Miranda","António","Colégio de Ortopedia. Ordem dos Médicos. Lisboa. Serviço de Ortopedia. Centro Hospitalar de Entre o Douro e Vouga. Santa Maria da Feira. Portugal",NA
"2299","34214423","10.20344/amp.15480","[How to Resume Elective Orthopaedic Surgical Procedures during the COVID-19 Pandemic?]","This document was prepared by the College of Orthopedics of the Portuguese Medical Association with the aim of developing the guidelines on the resumption of elective surgical activity in Orthopedics during the COVID-19 pandemic. It sets the criteria that allow the prioritization of surgeries according to the severity of the clinical situation, based on existing and published classifications. Moreover, it provides an organizational model for patient preparation and describes the patient pathways","2021","07","05","Acta Med Port","Acta medica portuguesa","COVID-19; Elective Surgical Procedures; Orthopedic Procedures; Pandemics","Ruano","António","Colégio de Ortopedia. Ordem dos Médicos. Lisboa. Serviço de Ortopedia. Unidade Local de Saúde do Nordeste. Bragança. Portugal",NA
"2300","34214423","10.20344/amp.15480","[How to Resume Elective Orthopaedic Surgical Procedures during the COVID-19 Pandemic?]","This document was prepared by the College of Orthopedics of the Portuguese Medical Association with the aim of developing the guidelines on the resumption of elective surgical activity in Orthopedics during the COVID-19 pandemic. It sets the criteria that allow the prioritization of surgeries according to the severity of the clinical situation, based on existing and published classifications. Moreover, it provides an organizational model for patient preparation and describes the patient pathways","2021","07","05","Acta Med Port","Acta medica portuguesa","COVID-19; Elective Surgical Procedures; Orthopedic Procedures; Pandemics","Mendes","Eduardo","Colégio de Ortopedia. Ordem dos Médicos. Lisboa. Serviço de Ortopedia. Centro Hospitalar Tondela Viseu. Viseu. Hospital CUF Viseu. Viseu. Portugal",NA
"2301","34214423","10.20344/amp.15480","[How to Resume Elective Orthopaedic Surgical Procedures during the COVID-19 Pandemic?]","This document was prepared by the College of Orthopedics of the Portuguese Medical Association with the aim of developing the guidelines on the resumption of elective surgical activity in Orthopedics during the COVID-19 pandemic. It sets the criteria that allow the prioritization of surgeries according to the severity of the clinical situation, based on existing and published classifications. Moreover, it provides an organizational model for patient preparation and describes the patient pathways","2021","07","05","Acta Med Port","Acta medica portuguesa","COVID-19; Elective Surgical Procedures; Orthopedic Procedures; Pandemics","Mendes","Francisco","Colégio de Ortopedia. Ordem dos Médicos. Lisboa. Serviço de Ortopedia. Hospital de Santarém. Santarém. Portugal",NA
"2302","34214423","10.20344/amp.15480","[How to Resume Elective Orthopaedic Surgical Procedures during the COVID-19 Pandemic?]","This document was prepared by the College of Orthopedics of the Portuguese Medical Association with the aim of developing the guidelines on the resumption of elective surgical activity in Orthopedics during the COVID-19 pandemic. It sets the criteria that allow the prioritization of surgeries according to the severity of the clinical situation, based on existing and published classifications. Moreover, it provides an organizational model for patient preparation and describes the patient pathways","2021","07","05","Acta Med Port","Acta medica portuguesa","COVID-19; Elective Surgical Procedures; Orthopedic Procedures; Pandemics","Montes","José","Colégio de Ortopedia. Ordem dos Médicos. Lisboa. Serviço de Ortopedia. Centro Hospitalar Póvoa de Varzim/Vila do Conde. Póvoa de Varzim. Portugal",NA
"2303","34214423","10.20344/amp.15480","[How to Resume Elective Orthopaedic Surgical Procedures during the COVID-19 Pandemic?]","This document was prepared by the College of Orthopedics of the Portuguese Medical Association with the aim of developing the guidelines on the resumption of elective surgical activity in Orthopedics during the COVID-19 pandemic. It sets the criteria that allow the prioritization of surgeries according to the severity of the clinical situation, based on existing and published classifications. Moreover, it provides an organizational model for patient preparation and describes the patient pathways","2021","07","05","Acta Med Port","Acta medica portuguesa","COVID-19; Elective Surgical Procedures; Orthopedic Procedures; Pandemics","Alves","Jorge","Colégio de Ortopedia. Ordem dos Médicos. Lisboa. Serviço de Ortopedia. Centro Hospitalar do Tâmega e Sousa. Penafiel. Portugal",NA
"2304","34214423","10.20344/amp.15480","[How to Resume Elective Orthopaedic Surgical Procedures during the COVID-19 Pandemic?]","This document was prepared by the College of Orthopedics of the Portuguese Medical Association with the aim of developing the guidelines on the resumption of elective surgical activity in Orthopedics during the COVID-19 pandemic. It sets the criteria that allow the prioritization of surgeries according to the severity of the clinical situation, based on existing and published classifications. Moreover, it provides an organizational model for patient preparation and describes the patient pathways","2021","07","05","Acta Med Port","Acta medica portuguesa","COVID-19; Elective Surgical Procedures; Orthopedic Procedures; Pandemics","Rosa","Isabel","Colégio de Ortopedia. Ordem dos Médicos. Lisboa. Serviço de Ortopedia. Hospital de São Francisco Xavier. Centro Hospitalar Lisboa Ocidental. Lisboa. Unidade Curricular Especialidades Médicas e Cirúrgicas II. NOVA Medical School | Faculdade de Ciências Médicas. Universidade NOVA de Lisboa. Lisboa. Portugal",NA
"2305","34214423","10.20344/amp.15480","[How to Resume Elective Orthopaedic Surgical Procedures during the COVID-19 Pandemic?]","This document was prepared by the College of Orthopedics of the Portuguese Medical Association with the aim of developing the guidelines on the resumption of elective surgical activity in Orthopedics during the COVID-19 pandemic. It sets the criteria that allow the prioritization of surgeries according to the severity of the clinical situation, based on existing and published classifications. Moreover, it provides an organizational model for patient preparation and describes the patient pathways","2021","07","05","Acta Med Port","Acta medica portuguesa","COVID-19; Elective Surgical Procedures; Orthopedic Procedures; Pandemics","Alegrete","Nuno","Colégio de Ortopedia. Ordem dos Médicos. Lisboa. Unidade de Ortopedia Pediátrica e de Deformidades da Coluna Vertebral. Hospital CUF Porto. Porto. i3S - Instituto de Investigação e Inovação em Saúde. Universidade do Porto. Porto. Portugal",NA
"2306","34214423","10.20344/amp.15480","[How to Resume Elective Orthopaedic Surgical Procedures during the COVID-19 Pandemic?]","This document was prepared by the College of Orthopedics of the Portuguese Medical Association with the aim of developing the guidelines on the resumption of elective surgical activity in Orthopedics during the COVID-19 pandemic. It sets the criteria that allow the prioritization of surgeries according to the severity of the clinical situation, based on existing and published classifications. Moreover, it provides an organizational model for patient preparation and describes the patient pathways","2021","07","05","Acta Med Port","Acta medica portuguesa","COVID-19; Elective Surgical Procedures; Orthopedic Procedures; Pandemics","Neves","Nuno","Colégio de Ortopedia. Ordem dos Médicos. Lisboa. Serviço de Ortopedia. Centro Hospitalar e Universitário de São João. Porto. Departamento de Cirurgia e Fisiologia. Faculdade de Medicina. Universidade do Porto. Porto. Portugal",NA
"2307","34214423","10.20344/amp.15480","[How to Resume Elective Orthopaedic Surgical Procedures during the COVID-19 Pandemic?]","This document was prepared by the College of Orthopedics of the Portuguese Medical Association with the aim of developing the guidelines on the resumption of elective surgical activity in Orthopedics during the COVID-19 pandemic. It sets the criteria that allow the prioritization of surgeries according to the severity of the clinical situation, based on existing and published classifications. Moreover, it provides an organizational model for patient preparation and describes the patient pathways","2021","07","05","Acta Med Port","Acta medica portuguesa","COVID-19; Elective Surgical Procedures; Orthopedic Procedures; Pandemics","Lourenço","Paulo","Colégio de Ortopedia. Ordem dos Médicos. Lisboa. Serviço de Ortopedia. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal",NA
"2308","34214423","10.20344/amp.15480","[How to Resume Elective Orthopaedic Surgical Procedures during the COVID-19 Pandemic?]","This document was prepared by the College of Orthopedics of the Portuguese Medical Association with the aim of developing the guidelines on the resumption of elective surgical activity in Orthopedics during the COVID-19 pandemic. It sets the criteria that allow the prioritization of surgeries according to the severity of the clinical situation, based on existing and published classifications. Moreover, it provides an organizational model for patient preparation and describes the patient pathways","2021","07","05","Acta Med Port","Acta medica portuguesa","COVID-19; Elective Surgical Procedures; Orthopedic Procedures; Pandemics","Felicíssimo","Paulo","Colégio de Ortopedia. Ordem dos Médicos. Lisboa. Centro de Ortopedia e Traumatologia. Hospital CUF Descobertas. Lisboa. Centro de Doenças Crónicas (CEDOC). NOVA Medical School | Faculdade de Ciências Médicas. Universidade NOVA de Lisboa. Lisboa. Portugal",NA
"2309","34214423","10.20344/amp.15480","[How to Resume Elective Orthopaedic Surgical Procedures during the COVID-19 Pandemic?]","This document was prepared by the College of Orthopedics of the Portuguese Medical Association with the aim of developing the guidelines on the resumption of elective surgical activity in Orthopedics during the COVID-19 pandemic. It sets the criteria that allow the prioritization of surgeries according to the severity of the clinical situation, based on existing and published classifications. Moreover, it provides an organizational model for patient preparation and describes the patient pathways","2021","07","05","Acta Med Port","Acta medica portuguesa","COVID-19; Elective Surgical Procedures; Orthopedic Procedures; Pandemics","Sá Cardoso","Pedro","Colégio de Ortopedia. Ordem dos Médicos. Lisboa. Serviço de Ortopedia Pediátrica. Hospital Pediátrico de Coimbra. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal",NA
"2310","34214423","10.20344/amp.15480","[How to Resume Elective Orthopaedic Surgical Procedures during the COVID-19 Pandemic?]","This document was prepared by the College of Orthopedics of the Portuguese Medical Association with the aim of developing the guidelines on the resumption of elective surgical activity in Orthopedics during the COVID-19 pandemic. It sets the criteria that allow the prioritization of surgeries according to the severity of the clinical situation, based on existing and published classifications. Moreover, it provides an organizational model for patient preparation and describes the patient pathways","2021","07","05","Acta Med Port","Acta medica portuguesa","COVID-19; Elective Surgical Procedures; Orthopedic Procedures; Pandemics","Gomes","André","Colégio de Ortopedia. Ordem dos Médicos. Lisboa. Serviço de Ortopedia e Traumatologia. Centro Hospitalar do Porto. Porto. Instituto de Ciências Biomédicas Abel Salazar. Porto. Portugal",NA
"2311","34214416","10.20344/amp.15292","[Challenges and Opportunities: The Impact of COVID-19 in Palliative Care in Portugal].",NA,"2021","07","07","Acta Med Port","Acta medica portuguesa","COVID-19; Palliative Care","Neto","Isabel Galriça","Unidade de Cuidados Paliativos. Hospital da Luz-Lisboa. Lisboa. Portugal",NA
"2312","34214416","10.20344/amp.15292","[Challenges and Opportunities: The Impact of COVID-19 in Palliative Care in Portugal].",NA,"2021","07","07","Acta Med Port","Acta medica portuguesa","COVID-19; Palliative Care","Abril","Rita","Unidade de Cuidados Paliativos. Hospital da Luz-Lisboa. Lisboa. Portugal",NA
"2313","34214416","10.20344/amp.15292","[Challenges and Opportunities: The Impact of COVID-19 in Palliative Care in Portugal].",NA,"2021","07","07","Acta Med Port","Acta medica portuguesa","COVID-19; Palliative Care","Romero","Inês","Unidade de Cuidados Paliativos. Hospital da Luz-Lisboa. Lisboa. Portugal",NA
"2314","34214416","10.20344/amp.15292","[Challenges and Opportunities: The Impact of COVID-19 in Palliative Care in Portugal].",NA,"2021","07","07","Acta Med Port","Acta medica portuguesa","COVID-19; Palliative Care","Castro","Jorge","Unidade de Cuidados Paliativos. Hospital da Luz-Lisboa. Lisboa. Portugal",NA
"2315","34214415","10.20344/amp.15854","[The Impact of Confinement on Children and Adolescents].",NA,"2021","07","13","Acta Med Port","Acta medica portuguesa","Adolescent; COVID-19; Child; Mental Health; Pandemics; Portugal; Quarantine/psychology","Pedro Dos Reis","Filipa","Serviço de Pedopsiquiatria. Hospital Pediátrico de Coimbra. Centro Hospitalar e Universitário de Coimbra. Coimbra",NA
"2316","34214415","10.20344/amp.15854","[The Impact of Confinement on Children and Adolescents].",NA,"2021","07","13","Acta Med Port","Acta medica portuguesa","Adolescent; COVID-19; Child; Mental Health; Pandemics; Portugal; Quarantine/psychology","Amaro","Rita","Associação Nacional de Internos de Psiquiatria da Infância e da Adolescência. Lisboa. Serviço de Pedopsiquiatria. Hospital de Dona Estefânia. Centro Hospitalar Universitário de Lisboa Central. Lisboa. Portugal",NA
"2317","34214415","10.20344/amp.15854","[The Impact of Confinement on Children and Adolescents].",NA,"2021","07","13","Acta Med Port","Acta medica portuguesa","Adolescent; COVID-19; Child; Mental Health; Pandemics; Portugal; Quarantine/psychology","Martins Silva","Filipa","Associação Nacional de Internos de Psiquiatria da Infância e da Adolescência. Lisboa. Serviço de Pedopsiquiatria. Centro Materno-Infantil do Norte. Centro Hospitalar e Universitário do Porto. Porto. Portugal",NA
"2318","34214415","10.20344/amp.15854","[The Impact of Confinement on Children and Adolescents].",NA,"2021","07","13","Acta Med Port","Acta medica portuguesa","Adolescent; COVID-19; Child; Mental Health; Pandemics; Portugal; Quarantine/psychology","Vaz Pinto","Sofia","Associação Nacional de Internos de Psiquiatria da Infância e da Adolescência. Lisboa. Serviço de Pedopsiquiatria. Hospital de Dona Estefânia. Centro Hospitalar Universitário de Lisboa Central. Lisboa. Portugal",NA
"2319","34214415","10.20344/amp.15854","[The Impact of Confinement on Children and Adolescents].",NA,"2021","07","13","Acta Med Port","Acta medica portuguesa","Adolescent; COVID-19; Child; Mental Health; Pandemics; Portugal; Quarantine/psychology","Barroca","Inês","Associação Nacional de Internos de Psiquiatria da Infância e da Adolescência. Lisboa. Serviço de Pedopsiquiatria. Hospital de S. Francisco Xavier. Centro Hospitalar de Lisboa Ocidental. Lisboa. Portugal",NA
"2320","34214415","10.20344/amp.15854","[The Impact of Confinement on Children and Adolescents].",NA,"2021","07","13","Acta Med Port","Acta medica portuguesa","Adolescent; COVID-19; Child; Mental Health; Pandemics; Portugal; Quarantine/psychology","Sá","Teresa","Associação Nacional de Internos de Psiquiatria da Infância e da Adolescência. Lisboa. Serviço de Pedopsiquiatria. Centro Materno-Infantil do Norte. Centro Hospitalar e Universitário do Porto. Porto. Portugal",NA
"2321","34214415","10.20344/amp.15854","[The Impact of Confinement on Children and Adolescents].",NA,"2021","07","13","Acta Med Port","Acta medica portuguesa","Adolescent; COVID-19; Child; Mental Health; Pandemics; Portugal; Quarantine/psychology","Ferreira Carvalho","Rui","Associação Nacional de Internos de Psiquiatria da Infância e da Adolescência. Lisboa. Serviço de Pedopsiquiatria. Hospital Santa Maria / Hospital Pulido Valente. Centro Hospitalar Universitário Lisboa Norte. Lisboa. Portugal",NA
"2322","34214415","10.20344/amp.15854","[The Impact of Confinement on Children and Adolescents].",NA,"2021","07","13","Acta Med Port","Acta medica portuguesa","Adolescent; COVID-19; Child; Mental Health; Pandemics; Portugal; Quarantine/psychology","Cartaxo","Teresa","Serviço de Pedopsiquiatria. Hospital Pediátrico de Coimbra. Centro Hospitalar e Universitário de Coimbra. Coimbra. Associação Nacional de Internos de Psiquiatria da Infância e da Adolescência. Lisboa. Portugal",NA
"2323","34214415","10.20344/amp.15854","[The Impact of Confinement on Children and Adolescents].",NA,"2021","07","13","Acta Med Port","Acta medica portuguesa","Adolescent; COVID-19; Child; Mental Health; Pandemics; Portugal; Quarantine/psychology","Boavida","José","Centro de Desenvolvimento da Criança. Hospital Pediátrico de Coimbra. Centro Hospitalar e Universitário de Coimbra. Coimbra. Sociedade Portuguesa de Défice de Atenção. Coimbra. Portugal",NA
"2324","34214386","10.1515/dx-2021-0046","An overview of mental health during the COVID-19 pandemic.","Since its initial outbreak in late 2019, the COVID-19 pandemic has profoundly affected the global community. In addition to the negative health consequences of contracting COVID-19, the implementation of strict quarantine and lockdown measures has also disrupted social networks and devastated the global economy. As a result, there is rising concern that the pandemic has taken a toll on the mental health of the general population. To better understand its impact, an increasing number of studies e","2021","07","02","Diagnosis (Berl)","Diagnosis (Berlin, Germany)","COVID-19; anxiety; mental health; pandemic; psychological health; suicide","Chen","Patrick J","Department of Clinical Biochemistry, University Health Network, Toronto, Canada",NA
"2325","34214386","10.1515/dx-2021-0046","An overview of mental health during the COVID-19 pandemic.","Since its initial outbreak in late 2019, the COVID-19 pandemic has profoundly affected the global community. In addition to the negative health consequences of contracting COVID-19, the implementation of strict quarantine and lockdown measures has also disrupted social networks and devastated the global economy. As a result, there is rising concern that the pandemic has taken a toll on the mental health of the general population. To better understand its impact, an increasing number of studies e","2021","07","02","Diagnosis (Berl)","Diagnosis (Berlin, Germany)","COVID-19; anxiety; mental health; pandemic; psychological health; suicide","Pusica","Yanna","Department of Clinical Biochemistry, University Health Network, Toronto, Canada",NA
"2326","34214386","10.1515/dx-2021-0046","An overview of mental health during the COVID-19 pandemic.","Since its initial outbreak in late 2019, the COVID-19 pandemic has profoundly affected the global community. In addition to the negative health consequences of contracting COVID-19, the implementation of strict quarantine and lockdown measures has also disrupted social networks and devastated the global economy. As a result, there is rising concern that the pandemic has taken a toll on the mental health of the general population. To better understand its impact, an increasing number of studies e","2021","07","02","Diagnosis (Berl)","Diagnosis (Berlin, Germany)","COVID-19; anxiety; mental health; pandemic; psychological health; suicide","Sohaei","Dorsa","Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada",NA
"2327","34214386","10.1515/dx-2021-0046","An overview of mental health during the COVID-19 pandemic.","Since its initial outbreak in late 2019, the COVID-19 pandemic has profoundly affected the global community. In addition to the negative health consequences of contracting COVID-19, the implementation of strict quarantine and lockdown measures has also disrupted social networks and devastated the global economy. As a result, there is rising concern that the pandemic has taken a toll on the mental health of the general population. To better understand its impact, an increasing number of studies e","2021","07","02","Diagnosis (Berl)","Diagnosis (Berlin, Germany)","COVID-19; anxiety; mental health; pandemic; psychological health; suicide","Prassas","Ioannis","Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada",NA
"2328","34214386","10.1515/dx-2021-0046","An overview of mental health during the COVID-19 pandemic.","Since its initial outbreak in late 2019, the COVID-19 pandemic has profoundly affected the global community. In addition to the negative health consequences of contracting COVID-19, the implementation of strict quarantine and lockdown measures has also disrupted social networks and devastated the global economy. As a result, there is rising concern that the pandemic has taken a toll on the mental health of the general population. To better understand its impact, an increasing number of studies e","2021","07","02","Diagnosis (Berl)","Diagnosis (Berlin, Germany)","COVID-19; anxiety; mental health; pandemic; psychological health; suicide","Diamandis","Eleftherios P","Department of Clinical Biochemistry, University Health Network, Toronto, Canada",NA
"2329","34214368","10.1515/jbcpp-2020-0436","Knowledge, attitudes, and practices (KAP) towards COVID-19 among university students in Pakistan: a cross-sectional study.","Pakistan has taken unprecedented measures to control the spread of COVID-19. Complete lockdown followed by smart lockdown and quarantine centres was established. Their awareness and attitude towards COVID-19 had an impact on the individual behaviour of the precautionary measures. The current study examined the knowledge, attitudes and practices of university students in Pakistan. An online cross-sectional study was conducted among university students in Pakistan. A questionnaire containing demog","2021","07","08","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; Pakistan; attitudes; knowledge; practices; university students; Adolescent; Adult; COVID-19; Cross-Sectional Studies; Female; Health Education; Health Knowledge, Attitudes, Practice; Health Literacy; Humans; Male; Pakistan; Students; Universities; Young Adult","Faisal","Shah","Magister Program of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia",NA
"2330","34214368","10.1515/jbcpp-2020-0436","Knowledge, attitudes, and practices (KAP) towards COVID-19 among university students in Pakistan: a cross-sectional study.","Pakistan has taken unprecedented measures to control the spread of COVID-19. Complete lockdown followed by smart lockdown and quarantine centres was established. Their awareness and attitude towards COVID-19 had an impact on the individual behaviour of the precautionary measures. The current study examined the knowledge, attitudes and practices of university students in Pakistan. An online cross-sectional study was conducted among university students in Pakistan. A questionnaire containing demog","2021","07","08","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; Pakistan; attitudes; knowledge; practices; university students; Adolescent; Adult; COVID-19; Cross-Sectional Studies; Female; Health Education; Health Knowledge, Attitudes, Practice; Health Literacy; Humans; Male; Pakistan; Students; Universities; Young Adult","Khotib","Junaidi","Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia",NA
"2331","34214368","10.1515/jbcpp-2020-0436","Knowledge, attitudes, and practices (KAP) towards COVID-19 among university students in Pakistan: a cross-sectional study.","Pakistan has taken unprecedented measures to control the spread of COVID-19. Complete lockdown followed by smart lockdown and quarantine centres was established. Their awareness and attitude towards COVID-19 had an impact on the individual behaviour of the precautionary measures. The current study examined the knowledge, attitudes and practices of university students in Pakistan. An online cross-sectional study was conducted among university students in Pakistan. A questionnaire containing demog","2021","07","08","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; Pakistan; attitudes; knowledge; practices; university students; Adolescent; Adult; COVID-19; Cross-Sectional Studies; Female; Health Education; Health Knowledge, Attitudes, Practice; Health Literacy; Humans; Male; Pakistan; Students; Universities; Young Adult","Zairina","Elida","Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia",NA
"2332","34214339","10.1515/jbcpp-2020-0473","Phyllanthin and hypophyllanthin, the isolated compounds of <i>Phyllanthus niruri</i> inhibit protein receptor of corona virus (COVID-19) through <i>in silico</i> approach.","Phyllanthus niruri has been known as an immunomodulator and also reported to possess an antiviral activity against several RNA viruses, such as hepatitis B virus and hepatitis C virus by inhibiting viral entry and replication. Since the current situation of Coronavirus Disease 2019 (COVID-19) which infected among the world and caused severe disease and high morbidity, it urgently needed to find new agents against COVID-19. Therefore, in silico screening against COVID-19 receptors is carried out ","2021","07","08","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; Phyllanthus niruri; hypophyllanthin; in silico; phyllanthin; COVID-19; Computer Simulation; Humans; Ligands; Lignans; Molecular Docking Simulation; Molecular Structure; Phyllanthus; Plant Extracts; SARS-CoV-2","Marhaeny","Honey Dzikri","Department of Pharmaceutical Science, Faculty of Pharmacy, University of Airlangga, Surabaya, Indonesia",NA
"2333","34214339","10.1515/jbcpp-2020-0473","Phyllanthin and hypophyllanthin, the isolated compounds of <i>Phyllanthus niruri</i> inhibit protein receptor of corona virus (COVID-19) through <i>in silico</i> approach.","Phyllanthus niruri has been known as an immunomodulator and also reported to possess an antiviral activity against several RNA viruses, such as hepatitis B virus and hepatitis C virus by inhibiting viral entry and replication. Since the current situation of Coronavirus Disease 2019 (COVID-19) which infected among the world and caused severe disease and high morbidity, it urgently needed to find new agents against COVID-19. Therefore, in silico screening against COVID-19 receptors is carried out ","2021","07","08","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; Phyllanthus niruri; hypophyllanthin; in silico; phyllanthin; COVID-19; Computer Simulation; Humans; Ligands; Lignans; Molecular Docking Simulation; Molecular Structure; Phyllanthus; Plant Extracts; SARS-CoV-2","Widyawaruyanti","Aty","Department of Pharmaceutical Science, Faculty of Pharmacy, University of Airlangga, Surabaya, Indonesia",NA
"2334","34214339","10.1515/jbcpp-2020-0473","Phyllanthin and hypophyllanthin, the isolated compounds of <i>Phyllanthus niruri</i> inhibit protein receptor of corona virus (COVID-19) through <i>in silico</i> approach.","Phyllanthus niruri has been known as an immunomodulator and also reported to possess an antiviral activity against several RNA viruses, such as hepatitis B virus and hepatitis C virus by inhibiting viral entry and replication. Since the current situation of Coronavirus Disease 2019 (COVID-19) which infected among the world and caused severe disease and high morbidity, it urgently needed to find new agents against COVID-19. Therefore, in silico screening against COVID-19 receptors is carried out ","2021","07","08","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; Phyllanthus niruri; hypophyllanthin; in silico; phyllanthin; COVID-19; Computer Simulation; Humans; Ligands; Lignans; Molecular Docking Simulation; Molecular Structure; Phyllanthus; Plant Extracts; SARS-CoV-2","Widiandani","Tri","Department of Pharmaceutical Science, Faculty of Pharmacy, University of Airlangga, Surabaya, Indonesia",NA
"2335","34214339","10.1515/jbcpp-2020-0473","Phyllanthin and hypophyllanthin, the isolated compounds of <i>Phyllanthus niruri</i> inhibit protein receptor of corona virus (COVID-19) through <i>in silico</i> approach.","Phyllanthus niruri has been known as an immunomodulator and also reported to possess an antiviral activity against several RNA viruses, such as hepatitis B virus and hepatitis C virus by inhibiting viral entry and replication. Since the current situation of Coronavirus Disease 2019 (COVID-19) which infected among the world and caused severe disease and high morbidity, it urgently needed to find new agents against COVID-19. Therefore, in silico screening against COVID-19 receptors is carried out ","2021","07","08","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; Phyllanthus niruri; hypophyllanthin; in silico; phyllanthin; COVID-19; Computer Simulation; Humans; Ligands; Lignans; Molecular Docking Simulation; Molecular Structure; Phyllanthus; Plant Extracts; SARS-CoV-2","Fuad Hafid","Achmad","Department of Pharmaceutical Science, Faculty of Pharmacy, University of Airlangga, Surabaya, Indonesia",NA
"2336","34214339","10.1515/jbcpp-2020-0473","Phyllanthin and hypophyllanthin, the isolated compounds of <i>Phyllanthus niruri</i> inhibit protein receptor of corona virus (COVID-19) through <i>in silico</i> approach.","Phyllanthus niruri has been known as an immunomodulator and also reported to possess an antiviral activity against several RNA viruses, such as hepatitis B virus and hepatitis C virus by inhibiting viral entry and replication. Since the current situation of Coronavirus Disease 2019 (COVID-19) which infected among the world and caused severe disease and high morbidity, it urgently needed to find new agents against COVID-19. Therefore, in silico screening against COVID-19 receptors is carried out ","2021","07","08","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; Phyllanthus niruri; hypophyllanthin; in silico; phyllanthin; COVID-19; Computer Simulation; Humans; Ligands; Lignans; Molecular Docking Simulation; Molecular Structure; Phyllanthus; Plant Extracts; SARS-CoV-2","Wahyuni","Tutik Sri","Department of Pharmaceutical Science, Faculty of Pharmacy, University of Airlangga, Surabaya, Indonesia",NA
"2337","34214287","10.17533/udea.iee.v39n2e10","Experiences of Parents of Preterm Children Hospitalized Regarding Restrictions to Interact with Their Children Imposed Because of the COVID-19 Pandemic.","To describe the experiences of parents of hospitalized preterm children regarding the restrictions implemented in the neonatal intensive care unit -NICU- during the COVID-19 pandemic. Qualitative study. Semi-structured interviews were conducted between April and October 2020 with 12 parents of preterm children, whose children were hospitalized and discharged from NICU during the pandemic. The analysis was performed with tools from grounded theory through open and axial coding. The study identifi","2021","07","15","Invest Educ Enferm","Investigacion y educacion en enfermeria","coronavirus infections; family nursing; infant, premature; intensive care units, neonatal; neonatal nursing; pandemics; parents; Adult; COVID-19; Female; Hospitalization; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Male; Parents; Physical Distancing; Qualitative Research; Young Adult","Osorio Galeano","Sandra Patricia","Faculty of nursing, Universidad de Antioquia, Colombia, sandra.osorio@udea.edu","sandra.osorio@udea.edu.co"
"2338","34214287","10.17533/udea.iee.v39n2e10","Experiences of Parents of Preterm Children Hospitalized Regarding Restrictions to Interact with Their Children Imposed Because of the COVID-19 Pandemic.","To describe the experiences of parents of hospitalized preterm children regarding the restrictions implemented in the neonatal intensive care unit -NICU- during the COVID-19 pandemic. Qualitative study. Semi-structured interviews were conducted between April and October 2020 with 12 parents of preterm children, whose children were hospitalized and discharged from NICU during the pandemic. The analysis was performed with tools from grounded theory through open and axial coding. The study identifi","2021","07","15","Invest Educ Enferm","Investigacion y educacion en enfermeria","coronavirus infections; family nursing; infant, premature; intensive care units, neonatal; neonatal nursing; pandemics; parents; Adult; COVID-19; Female; Hospitalization; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Male; Parents; Physical Distancing; Qualitative Research; Young Adult","Salazar Maya","Ángela María","Faculty of nursing, Universidad de Antioquia, Colombia, angela.salazar@udea.edu","angela.salazar@udea.edu.co"
"2339","34214278","10.17533/udea.iee.v39n2e01","Influence of the COVID-19 Pandemic in Higher Education Courses in the Health Field.",NA,"2021","07","14","Invest Educ Enferm","Investigacion y educacion en enfermeria","Adult; COVID-19; Cross-Sectional Studies; Education, Distance; Education, Graduate; Female; Global Health; Health Occupations; Humans; Male; Pandemics; Portugal; Students","Rodrigues","Manuel Costa Pereira","School of Health, University of Trás-os-Montes e Alto Douro, Portugal, vmcpr@utad","vmcpr@utad.pt"
"2340","34214277","","RT-qPCR diagnosis in state public health laboratories as determinants of performance of public health surveillance during the pandemic",NA,"2021","07","15","Biomedica","Biomedica : revista del Instituto Nacional de Salud","Coronavirus infections; epidemics; immunity; occupational health; COVID-19; COVID-19 Nucleic Acid Testing; Colombia; Humans; Laboratories; Pandemics; Public Health; Public Health Surveillance","Idrovo","Alvaro Javier","Departamento de Salud Pública, Escuela de Medicina, Universidad Industrial de Santander, Colombia. biomedica@ins.gov","biomedica@ins.gov.co"
"2341","34214277","","RT-qPCR diagnosis in state public health laboratories as determinants of performance of public health surveillance during the pandemic",NA,"2021","07","15","Biomedica","Biomedica : revista del Instituto Nacional de Salud","Coronavirus infections; epidemics; immunity; occupational health; COVID-19; COVID-19 Nucleic Acid Testing; Colombia; Humans; Laboratories; Pandemics; Public Health; Public Health Surveillance","Moreno-Montoya","José","Subdirección de Estudios Clínicos, Fundación Santa Fe de Bogotá, Colombia. biomedica@ins.gov","biomedica@ins.gov.co"
"2342","34214276","","Letter to the editor ""Prognostic factors in hospitalized patients diagnosed with SARS-CoV-2 infection, Bogotá, Colombia""",NA,"2021","07","08","Biomedica","Biomedica : revista del Instituto Nacional de Salud","Coronavirus infections; severe acute respiratory syndrome; mortality; prognosis; inpatients; COVID-19; Colombia; Humans; Inpatients; Prognosis; SARS-CoV-2","Ramos-Vera","Cristian Antony","Área de investigación, Universidad César Vallejo, Lima, Perú. biomedica@ins.gov","biomedica@ins.gov.co"
"2343","34214276","","Letter to the editor ""Prognostic factors in hospitalized patients diagnosed with SARS-CoV-2 infection, Bogotá, Colombia""",NA,"2021","07","08","Biomedica","Biomedica : revista del Instituto Nacional de Salud","Coronavirus infections; severe acute respiratory syndrome; mortality; prognosis; inpatients; COVID-19; Colombia; Humans; Inpatients; Prognosis; SARS-CoV-2","Motta","Juan Camilo","Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, D.C., Colombia. biomedica@ins.gov","biomedica@ins.gov.co"
"2344","34214259","","In the grip of SARS-CoV-2: The scientific leadership of the Colombian Instituto Nacional de Salud",NA,"2021","07","15","Biomedica","Biomedica : revista del Instituto Nacional de Salud","Academies and Institutes; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Colombia; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Information Dissemination; Leadership; Models, Theoretical; SARS-CoV-2; Seroepidemiologic Studies; Specimen Handling; Surge Capacity","Gómez-Grosso","Luis Alberto","Grupo de Fisiología Molecular, Instituto Nacional de Salud, Bogotá, D.C., Colombia. lgomez@ins.gov","lgomez@ins.gov.co"
"2345","34214259","","In the grip of SARS-CoV-2: The scientific leadership of the Colombian Instituto Nacional de Salud",NA,"2021","07","15","Biomedica","Biomedica : revista del Instituto Nacional de Salud","Academies and Institutes; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Colombia; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Information Dissemination; Leadership; Models, Theoretical; SARS-CoV-2; Seroepidemiologic Studies; Specimen Handling; Surge Capacity","Mercado","Marcela","Directora de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, D.C., Colombia. mmercado@ins.gov","mmercado@ins.gov.co"
"2346","34214259","","In the grip of SARS-CoV-2: The scientific leadership of the Colombian Instituto Nacional de Salud",NA,"2021","07","15","Biomedica","Biomedica : revista del Instituto Nacional de Salud","Academies and Institutes; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Colombia; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Information Dissemination; Leadership; Models, Theoretical; SARS-CoV-2; Seroepidemiologic Studies; Specimen Handling; Surge Capacity","Ospina","Martha Lucía","Directora General, Instituto Nacional de Salud, Bogotá, D.C., Colombia. mospina@ins.gov","mospina@ins.gov.co"
"2347","34214217","10.1111/nmo.14207","Response to Oliviero et al.'s publication: ""Impact of COVID-19 lockdown on symptoms in patients with functional gastrointestinal disorders: Relationship with anxiety and perceived stress"".",NA,"2021","07","02","Neurogastroenterol Motil","Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society",NA,"Wang","Xiao Jing","Division of Gastroenterology and Hepatology, Department of Medicine, Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R), Mayo Clinic, Rochester, MN, USA",NA
"2348","34214217","10.1111/nmo.14207","Response to Oliviero et al.'s publication: ""Impact of COVID-19 lockdown on symptoms in patients with functional gastrointestinal disorders: Relationship with anxiety and perceived stress"".",NA,"2021","07","02","Neurogastroenterol Motil","Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society",NA,"Murphy","Brenna","Mayo Clinic Alix School of Medicine, Rochester, MN, USA",NA
"2349","34214217","10.1111/nmo.14207","Response to Oliviero et al.'s publication: ""Impact of COVID-19 lockdown on symptoms in patients with functional gastrointestinal disorders: Relationship with anxiety and perceived stress"".",NA,"2021","07","02","Neurogastroenterol Motil","Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society",NA,"Breen-Lyles","Margaret","Division of Gastroenterology and Hepatology, Department of Medicine, Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R), Mayo Clinic, Rochester, MN, USA",NA
"2350","34214217","10.1111/nmo.14207","Response to Oliviero et al.'s publication: ""Impact of COVID-19 lockdown on symptoms in patients with functional gastrointestinal disorders: Relationship with anxiety and perceived stress"".",NA,"2021","07","02","Neurogastroenterol Motil","Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society",NA,"Fox","Jean","Division of Gastroenterology and Hepatology, Department of Medicine, Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R), Mayo Clinic, Rochester, MN, USA",NA
"2351","34214214","10.1111/apa.16019","Delayed presentation of children to the emergency department during the first wave of COVID-19 pandemic in Italy: Area-based cohort study.","To ascertain a delay in attendances to the emergency department (ED) during 2020 lockdown. Area-based cohort study on paediatric (0-15 years) attendances resulting in hospital admission in Tuscany, Italy, in February-May 2020, and the corresponding periods in 2018-19. We analysed times from symptom onset to arrival, the odds of arriving late (&gt;90th centile of time) and paediatricians' judgements of a late presentation by logistic models. As expected, ED attendance fell sharply (-62%) in 2020 ","2021","07","09","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","COVID-19; delayed attendance; emergency medicine; epidemiology; public health","Rusconi","Franca","Unit of Epidemiology, Meyer Children's University Hospital, Florence, Italy",NA
"2352","34214214","10.1111/apa.16019","Delayed presentation of children to the emergency department during the first wave of COVID-19 pandemic in Italy: Area-based cohort study.","To ascertain a delay in attendances to the emergency department (ED) during 2020 lockdown. Area-based cohort study on paediatric (0-15 years) attendances resulting in hospital admission in Tuscany, Italy, in February-May 2020, and the corresponding periods in 2018-19. We analysed times from symptom onset to arrival, the odds of arriving late (&gt;90th centile of time) and paediatricians' judgements of a late presentation by logistic models. As expected, ED attendance fell sharply (-62%) in 2020 ","2021","07","09","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","COVID-19; delayed attendance; emergency medicine; epidemiology; public health","Di Fabrizio","Valeria","Quality and Equity Unit, Regional Health Agency of Tuscany, Florence, Italy",NA
"2353","34214214","10.1111/apa.16019","Delayed presentation of children to the emergency department during the first wave of COVID-19 pandemic in Italy: Area-based cohort study.","To ascertain a delay in attendances to the emergency department (ED) during 2020 lockdown. Area-based cohort study on paediatric (0-15 years) attendances resulting in hospital admission in Tuscany, Italy, in February-May 2020, and the corresponding periods in 2018-19. We analysed times from symptom onset to arrival, the odds of arriving late (&gt;90th centile of time) and paediatricians' judgements of a late presentation by logistic models. As expected, ED attendance fell sharply (-62%) in 2020 ","2021","07","09","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","COVID-19; delayed attendance; emergency medicine; epidemiology; public health","Puglia","Monia","Unit of Epidemiology, Regional Health Agency of Tuscany, Florence, Italy",NA
"2354","34214214","10.1111/apa.16019","Delayed presentation of children to the emergency department during the first wave of COVID-19 pandemic in Italy: Area-based cohort study.","To ascertain a delay in attendances to the emergency department (ED) during 2020 lockdown. Area-based cohort study on paediatric (0-15 years) attendances resulting in hospital admission in Tuscany, Italy, in February-May 2020, and the corresponding periods in 2018-19. We analysed times from symptom onset to arrival, the odds of arriving late (&gt;90th centile of time) and paediatricians' judgements of a late presentation by logistic models. As expected, ED attendance fell sharply (-62%) in 2020 ","2021","07","09","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","COVID-19; delayed attendance; emergency medicine; epidemiology; public health","Sica","Michela","Unit of Epidemiology, Meyer Children's University Hospital, Florence, Italy",NA
"2355","34214214","10.1111/apa.16019","Delayed presentation of children to the emergency department during the first wave of COVID-19 pandemic in Italy: Area-based cohort study.","To ascertain a delay in attendances to the emergency department (ED) during 2020 lockdown. Area-based cohort study on paediatric (0-15 years) attendances resulting in hospital admission in Tuscany, Italy, in February-May 2020, and the corresponding periods in 2018-19. We analysed times from symptom onset to arrival, the odds of arriving late (&gt;90th centile of time) and paediatricians' judgements of a late presentation by logistic models. As expected, ED attendance fell sharply (-62%) in 2020 ","2021","07","09","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","COVID-19; delayed attendance; emergency medicine; epidemiology; public health","De Santis","Rita","Department of Emergency Medicine and Trauma Center, Meyer Children's University Hospital, Florence, Italy",NA
"2356","34214214","10.1111/apa.16019","Delayed presentation of children to the emergency department during the first wave of COVID-19 pandemic in Italy: Area-based cohort study.","To ascertain a delay in attendances to the emergency department (ED) during 2020 lockdown. Area-based cohort study on paediatric (0-15 years) attendances resulting in hospital admission in Tuscany, Italy, in February-May 2020, and the corresponding periods in 2018-19. We analysed times from symptom onset to arrival, the odds of arriving late (&gt;90th centile of time) and paediatricians' judgements of a late presentation by logistic models. As expected, ED attendance fell sharply (-62%) in 2020 ","2021","07","09","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","COVID-19; delayed attendance; emergency medicine; epidemiology; public health","Masi","Stefano","Department of Emergency Medicine and Trauma Center, Meyer Children's University Hospital, Florence, Italy",NA
"2357","34214214","10.1111/apa.16019","Delayed presentation of children to the emergency department during the first wave of COVID-19 pandemic in Italy: Area-based cohort study.","To ascertain a delay in attendances to the emergency department (ED) during 2020 lockdown. Area-based cohort study on paediatric (0-15 years) attendances resulting in hospital admission in Tuscany, Italy, in February-May 2020, and the corresponding periods in 2018-19. We analysed times from symptom onset to arrival, the odds of arriving late (&gt;90th centile of time) and paediatricians' judgements of a late presentation by logistic models. As expected, ED attendance fell sharply (-62%) in 2020 ","2021","07","09","Acta Paediatr","Acta paediatrica (Oslo, Norway : 1992)","COVID-19; delayed attendance; emergency medicine; epidemiology; public health","Gagliardi","Luigi","Division of Neonatology and Pediatrics, Versilia Hospital, Viareggio, Italy",NA
"2358","34214206","10.1002/jmv.27175","AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report.",NA,"2021","07","08","J Med Virol","Journal of medical virology",NA,"Capassoni","Marco","Department of Clinical and Experimental Rheumatology, University of Florence, Florence, Italy",NA
"2359","34214206","10.1002/jmv.27175","AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report.",NA,"2021","07","08","J Med Virol","Journal of medical virology",NA,"Ketabchi","Sheyda","Department of Anatomopathology, Ospedale San Giovanni di Dio, Florence, Italy",NA
"2360","34214206","10.1002/jmv.27175","AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report.",NA,"2021","07","08","J Med Virol","Journal of medical virology",NA,"Cassisa","Angelo","Department of Anatomopathology, Ospedale San Giovanni di Dio, Florence, Italy",NA
"2361","34214206","10.1002/jmv.27175","AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report.",NA,"2021","07","08","J Med Virol","Journal of medical virology",NA,"Caramelli","Riccardo","Department of Neurophysiopathology, Azienda Ospedaliero Universitaria Careggi, Florence, Italy",NA
"2362","34214206","10.1002/jmv.27175","AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report.",NA,"2021","07","08","J Med Virol","Journal of medical virology",NA,"Molinu","Anna A","Dermatology, Istituto Ortopedico Toscano, Florence, Italy",NA
"2363","34214206","10.1002/jmv.27175","AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report.",NA,"2021","07","08","J Med Virol","Journal of medical virology",NA,"Galluccio","Felice","Department of Rheumatology, Azienda Ospedaliero Universitaria Careggi, Florence, Italy",NA
"2364","34214206","10.1002/jmv.27175","AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report.",NA,"2021","07","08","J Med Virol","Journal of medical virology",NA,"Guiducci","Serena","Department of Clinical and Experimental Rheumatology, University of Florence, Florence, Italy",NA
"2365","34214159","10.1093/geronb/gbab123","Age Differences in Media Consumption and Avoidance With Respect to COVID-19.","Older versus younger adults are at greater risk from COVID-19, but descriptive data show they are less likely to seek out related information in the media, although underlying mechanisms remain unclear. A representative adult lifespan sample (N = 500) completed a pre-registered online study assessing changes in media consumption in response to the pandemic, self-reported and behavioral media avoidance, avoidance motives, and demographic, socioemotional, and cognitive covariates. Age was associat","2021","07","02","J Gerontol B Psychol Sci Soc Sci","The journals of gerontology. Series B, Psychological sciences and social sciences","Information seeking; affect; motivation; time perspective","Nolte","Julia","Human Development Department, Cornell University",NA
"2366","34214159","10.1093/geronb/gbab123","Age Differences in Media Consumption and Avoidance With Respect to COVID-19.","Older versus younger adults are at greater risk from COVID-19, but descriptive data show they are less likely to seek out related information in the media, although underlying mechanisms remain unclear. A representative adult lifespan sample (N = 500) completed a pre-registered online study assessing changes in media consumption in response to the pandemic, self-reported and behavioral media avoidance, avoidance motives, and demographic, socioemotional, and cognitive covariates. Age was associat","2021","07","02","J Gerontol B Psychol Sci Soc Sci","The journals of gerontology. Series B, Psychological sciences and social sciences","Information seeking; affect; motivation; time perspective","Deng","Stephanie L","Division of Nutritional Sciences, Cornell University",NA
"2367","34214159","10.1093/geronb/gbab123","Age Differences in Media Consumption and Avoidance With Respect to COVID-19.","Older versus younger adults are at greater risk from COVID-19, but descriptive data show they are less likely to seek out related information in the media, although underlying mechanisms remain unclear. A representative adult lifespan sample (N = 500) completed a pre-registered online study assessing changes in media consumption in response to the pandemic, self-reported and behavioral media avoidance, avoidance motives, and demographic, socioemotional, and cognitive covariates. Age was associat","2021","07","02","J Gerontol B Psychol Sci Soc Sci","The journals of gerontology. Series B, Psychological sciences and social sciences","Information seeking; affect; motivation; time perspective","Löckenhoff","Corinna E","Human Development Department, Cornell University",NA
"2368","34214156","10.1093/heapro/daab070","University students' sense of coherence, future worries and mental health: findings from the German COVID-HL-survey.","Early-on in the COVID-19 pandemic when universities were closed as part of the nation-wide public health response to the COVID-19 outbreak, studying and student life significantly changed. Based on limited evidence the aim of this study was to explore the relationship between sense of coherence (SoC), future worries and mental health outcomes among German university students during the early phase of the pandemic. A cross-sectional online survey with n = 14 916 participants was carried out by in","2021","07","02","Health Promot Int","Health promotion international","COVID-19; psychosomatic complaints; sense of coherence; university students; wellbeing","Dadaczynski","Kevin","Department of Nursing and Health Science, Fulda University of Applied Sciences, Germany",NA
"2369","34214156","10.1093/heapro/daab070","University students' sense of coherence, future worries and mental health: findings from the German COVID-HL-survey.","Early-on in the COVID-19 pandemic when universities were closed as part of the nation-wide public health response to the COVID-19 outbreak, studying and student life significantly changed. Based on limited evidence the aim of this study was to explore the relationship between sense of coherence (SoC), future worries and mental health outcomes among German university students during the early phase of the pandemic. A cross-sectional online survey with n = 14 916 participants was carried out by in","2021","07","02","Health Promot Int","Health promotion international","COVID-19; psychosomatic complaints; sense of coherence; university students; wellbeing","Okan","Orkan","Interdisciplinary Centre for Health Literacy Research, Bielefeld University, Germany",NA
"2370","34214156","10.1093/heapro/daab070","University students' sense of coherence, future worries and mental health: findings from the German COVID-HL-survey.","Early-on in the COVID-19 pandemic when universities were closed as part of the nation-wide public health response to the COVID-19 outbreak, studying and student life significantly changed. Based on limited evidence the aim of this study was to explore the relationship between sense of coherence (SoC), future worries and mental health outcomes among German university students during the early phase of the pandemic. A cross-sectional online survey with n = 14 916 participants was carried out by in","2021","07","02","Health Promot Int","Health promotion international","COVID-19; psychosomatic complaints; sense of coherence; university students; wellbeing","Messer","Melanie","Nursing Science with focus on Clinical Nursing across the Lifespan, Trier University, Germany",NA
"2371","34214156","10.1093/heapro/daab070","University students' sense of coherence, future worries and mental health: findings from the German COVID-HL-survey.","Early-on in the COVID-19 pandemic when universities were closed as part of the nation-wide public health response to the COVID-19 outbreak, studying and student life significantly changed. Based on limited evidence the aim of this study was to explore the relationship between sense of coherence (SoC), future worries and mental health outcomes among German university students during the early phase of the pandemic. A cross-sectional online survey with n = 14 916 participants was carried out by in","2021","07","02","Health Promot Int","Health promotion international","COVID-19; psychosomatic complaints; sense of coherence; university students; wellbeing","Rathmann","Katharina","Department of Nursing and Health Science, Fulda University of Applied Sciences, Germany",NA
"2372","34214142","10.1371/journal.ppat.1009723","ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions.","SARS-CoV-2 uses the human ACE2 (hACE2) receptor for cell attachment and entry, with mouse ACE2 (mACE2) unable to support infection. Herein we describe an ACE2-lentivirus system and illustrate its utility for in vitro and in vivo SARS-CoV-2 infection models. Transduction of non-permissive cell lines with hACE2 imparted replication competence, and transduction with mACE2 containing N30D, N31K, F83Y and H353K substitutions, to match hACE2, rescued SARS-CoV-2 replication. Intrapulmonary hACE2-lentiv","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Rawle","Daniel J","Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia",NA
"2373","34214142","10.1371/journal.ppat.1009723","ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions.","SARS-CoV-2 uses the human ACE2 (hACE2) receptor for cell attachment and entry, with mouse ACE2 (mACE2) unable to support infection. Herein we describe an ACE2-lentivirus system and illustrate its utility for in vitro and in vivo SARS-CoV-2 infection models. Transduction of non-permissive cell lines with hACE2 imparted replication competence, and transduction with mACE2 containing N30D, N31K, F83Y and H353K substitutions, to match hACE2, rescued SARS-CoV-2 replication. Intrapulmonary hACE2-lentiv","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Le","Thuy T","Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia",NA
"2374","34214142","10.1371/journal.ppat.1009723","ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions.","SARS-CoV-2 uses the human ACE2 (hACE2) receptor for cell attachment and entry, with mouse ACE2 (mACE2) unable to support infection. Herein we describe an ACE2-lentivirus system and illustrate its utility for in vitro and in vivo SARS-CoV-2 infection models. Transduction of non-permissive cell lines with hACE2 imparted replication competence, and transduction with mACE2 containing N30D, N31K, F83Y and H353K substitutions, to match hACE2, rescued SARS-CoV-2 replication. Intrapulmonary hACE2-lentiv","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Dumenil","Troy","Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia",NA
"2375","34214142","10.1371/journal.ppat.1009723","ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions.","SARS-CoV-2 uses the human ACE2 (hACE2) receptor for cell attachment and entry, with mouse ACE2 (mACE2) unable to support infection. Herein we describe an ACE2-lentivirus system and illustrate its utility for in vitro and in vivo SARS-CoV-2 infection models. Transduction of non-permissive cell lines with hACE2 imparted replication competence, and transduction with mACE2 containing N30D, N31K, F83Y and H353K substitutions, to match hACE2, rescued SARS-CoV-2 replication. Intrapulmonary hACE2-lentiv","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Yan","Kexin","Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia",NA
"2376","34214142","10.1371/journal.ppat.1009723","ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions.","SARS-CoV-2 uses the human ACE2 (hACE2) receptor for cell attachment and entry, with mouse ACE2 (mACE2) unable to support infection. Herein we describe an ACE2-lentivirus system and illustrate its utility for in vitro and in vivo SARS-CoV-2 infection models. Transduction of non-permissive cell lines with hACE2 imparted replication competence, and transduction with mACE2 containing N30D, N31K, F83Y and H353K substitutions, to match hACE2, rescued SARS-CoV-2 replication. Intrapulmonary hACE2-lentiv","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Tang","Bing","Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia",NA
"2377","34214142","10.1371/journal.ppat.1009723","ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions.","SARS-CoV-2 uses the human ACE2 (hACE2) receptor for cell attachment and entry, with mouse ACE2 (mACE2) unable to support infection. Herein we describe an ACE2-lentivirus system and illustrate its utility for in vitro and in vivo SARS-CoV-2 infection models. Transduction of non-permissive cell lines with hACE2 imparted replication competence, and transduction with mACE2 containing N30D, N31K, F83Y and H353K substitutions, to match hACE2, rescued SARS-CoV-2 replication. Intrapulmonary hACE2-lentiv","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Nguyen","Wilson","Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia",NA
"2378","34214142","10.1371/journal.ppat.1009723","ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions.","SARS-CoV-2 uses the human ACE2 (hACE2) receptor for cell attachment and entry, with mouse ACE2 (mACE2) unable to support infection. Herein we describe an ACE2-lentivirus system and illustrate its utility for in vitro and in vivo SARS-CoV-2 infection models. Transduction of non-permissive cell lines with hACE2 imparted replication competence, and transduction with mACE2 containing N30D, N31K, F83Y and H353K substitutions, to match hACE2, rescued SARS-CoV-2 replication. Intrapulmonary hACE2-lentiv","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Watterson","Daniel","School of Chemistry and Molecular Biosciences, University of Queensland, St Lucia, Queensland, Australia",NA
"2379","34214142","10.1371/journal.ppat.1009723","ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions.","SARS-CoV-2 uses the human ACE2 (hACE2) receptor for cell attachment and entry, with mouse ACE2 (mACE2) unable to support infection. Herein we describe an ACE2-lentivirus system and illustrate its utility for in vitro and in vivo SARS-CoV-2 infection models. Transduction of non-permissive cell lines with hACE2 imparted replication competence, and transduction with mACE2 containing N30D, N31K, F83Y and H353K substitutions, to match hACE2, rescued SARS-CoV-2 replication. Intrapulmonary hACE2-lentiv","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Modhiran","Naphak","School of Chemistry and Molecular Biosciences, University of Queensland, St Lucia, Queensland, Australia",NA
"2380","34214142","10.1371/journal.ppat.1009723","ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions.","SARS-CoV-2 uses the human ACE2 (hACE2) receptor for cell attachment and entry, with mouse ACE2 (mACE2) unable to support infection. Herein we describe an ACE2-lentivirus system and illustrate its utility for in vitro and in vivo SARS-CoV-2 infection models. Transduction of non-permissive cell lines with hACE2 imparted replication competence, and transduction with mACE2 containing N30D, N31K, F83Y and H353K substitutions, to match hACE2, rescued SARS-CoV-2 replication. Intrapulmonary hACE2-lentiv","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Hobson-Peters","Jody","School of Chemistry and Molecular Biosciences, University of Queensland, St Lucia, Queensland, Australia",NA
"2381","34214142","10.1371/journal.ppat.1009723","ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions.","SARS-CoV-2 uses the human ACE2 (hACE2) receptor for cell attachment and entry, with mouse ACE2 (mACE2) unable to support infection. Herein we describe an ACE2-lentivirus system and illustrate its utility for in vitro and in vivo SARS-CoV-2 infection models. Transduction of non-permissive cell lines with hACE2 imparted replication competence, and transduction with mACE2 containing N30D, N31K, F83Y and H353K substitutions, to match hACE2, rescued SARS-CoV-2 replication. Intrapulmonary hACE2-lentiv","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Bishop","Cameron","Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia",NA
"2382","34214142","10.1371/journal.ppat.1009723","ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions.","SARS-CoV-2 uses the human ACE2 (hACE2) receptor for cell attachment and entry, with mouse ACE2 (mACE2) unable to support infection. Herein we describe an ACE2-lentivirus system and illustrate its utility for in vitro and in vivo SARS-CoV-2 infection models. Transduction of non-permissive cell lines with hACE2 imparted replication competence, and transduction with mACE2 containing N30D, N31K, F83Y and H353K substitutions, to match hACE2, rescued SARS-CoV-2 replication. Intrapulmonary hACE2-lentiv","2021","07","19","PLoS Pathog","PLoS pathogens",NA,"Suhrbier","Andreas","Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia",NA
"2383","34214123","10.1371/journal.pone.0254167","Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study.","Dexamethasone provides benefits in patients with coronavirus disease 2019 (COVID-19), although data regarding immunological profiles and viral clearance are limited. This study aimed to evaluate for differences in biomarkers among patients with severe COVID-19 who did and did not receive dexamethasone. We measured plasma biomarkers of lung epithelial/endothelial injury and inflammation in 31 patients with severe COVID-19 and in 13 controls. Changes in biomarkers and clinical parameters were comp","2021","07","09","PLoS One","PloS one","Adult; Aged; Anti-Inflammatory Agents; Biomarkers; COVID-19; Dexamethasone; Endothelium, Vascular; Female; Humans; Inflammation; Lung Injury; Male; Oxygen; Pilot Projects; SARS-CoV-2; Viral Load; Viremia","Kim","Won-Young","Division of Critical Care Medicine, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea",NA
"2384","34214123","10.1371/journal.pone.0254167","Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study.","Dexamethasone provides benefits in patients with coronavirus disease 2019 (COVID-19), although data regarding immunological profiles and viral clearance are limited. This study aimed to evaluate for differences in biomarkers among patients with severe COVID-19 who did and did not receive dexamethasone. We measured plasma biomarkers of lung epithelial/endothelial injury and inflammation in 31 patients with severe COVID-19 and in 13 controls. Changes in biomarkers and clinical parameters were comp","2021","07","09","PLoS One","PloS one","Adult; Aged; Anti-Inflammatory Agents; Biomarkers; COVID-19; Dexamethasone; Endothelium, Vascular; Female; Humans; Inflammation; Lung Injury; Male; Oxygen; Pilot Projects; SARS-CoV-2; Viral Load; Viremia","Kweon","Oh Joo","Department of Laboratory Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea",NA
"2385","34214123","10.1371/journal.pone.0254167","Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study.","Dexamethasone provides benefits in patients with coronavirus disease 2019 (COVID-19), although data regarding immunological profiles and viral clearance are limited. This study aimed to evaluate for differences in biomarkers among patients with severe COVID-19 who did and did not receive dexamethasone. We measured plasma biomarkers of lung epithelial/endothelial injury and inflammation in 31 patients with severe COVID-19 and in 13 controls. Changes in biomarkers and clinical parameters were comp","2021","07","09","PLoS One","PloS one","Adult; Aged; Anti-Inflammatory Agents; Biomarkers; COVID-19; Dexamethasone; Endothelium, Vascular; Female; Humans; Inflammation; Lung Injury; Male; Oxygen; Pilot Projects; SARS-CoV-2; Viral Load; Viremia","Cha","Min Jae","Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea",NA
"2386","34214123","10.1371/journal.pone.0254167","Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study.","Dexamethasone provides benefits in patients with coronavirus disease 2019 (COVID-19), although data regarding immunological profiles and viral clearance are limited. This study aimed to evaluate for differences in biomarkers among patients with severe COVID-19 who did and did not receive dexamethasone. We measured plasma biomarkers of lung epithelial/endothelial injury and inflammation in 31 patients with severe COVID-19 and in 13 controls. Changes in biomarkers and clinical parameters were comp","2021","07","09","PLoS One","PloS one","Adult; Aged; Anti-Inflammatory Agents; Biomarkers; COVID-19; Dexamethasone; Endothelium, Vascular; Female; Humans; Inflammation; Lung Injury; Male; Oxygen; Pilot Projects; SARS-CoV-2; Viral Load; Viremia","Baek","Moon Seong","Division of Critical Care Medicine, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea",NA
"2387","34214123","10.1371/journal.pone.0254167","Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study.","Dexamethasone provides benefits in patients with coronavirus disease 2019 (COVID-19), although data regarding immunological profiles and viral clearance are limited. This study aimed to evaluate for differences in biomarkers among patients with severe COVID-19 who did and did not receive dexamethasone. We measured plasma biomarkers of lung epithelial/endothelial injury and inflammation in 31 patients with severe COVID-19 and in 13 controls. Changes in biomarkers and clinical parameters were comp","2021","07","09","PLoS One","PloS one","Adult; Aged; Anti-Inflammatory Agents; Biomarkers; COVID-19; Dexamethasone; Endothelium, Vascular; Female; Humans; Inflammation; Lung Injury; Male; Oxygen; Pilot Projects; SARS-CoV-2; Viral Load; Viremia","Choi","Seong-Ho","Division of Infectious Diseases, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea",NA
"2388","34214122","10.1371/journal.pone.0254077","Identifying factors that nurses consider in the decision-making process related to patient care during the COVID-19 pandemic.","Nurse identification of patient deterioration is critical, particularly during the COVID-19 pandemic, as patients can deteriorate quickly. While the literature has shown that nurses rely on intuition to make decisions, there is limited information on what sources of data experienced nurses utilize to inform their intuition. The objectives of this study were to identify sources of data that inform nurse decision-making related to recognition of deteriorating patients, and explore how COVID-19 has","2021","07","09","PLoS One","PloS one","Adult; Aged; COVID-19; Clinical Decision-Making; Female; Humans; Interviews as Topic; Male; Middle Aged; Nurse-Patient Relations; Nurses; Nursing Assessment; Nursing Care; Pandemics; Professional-Family Relations; Qualitative Research; SARS-CoV-2; Symptom Assessment; Workload","Anton","Nicholas","School of Industrial Engineering, Purdue University, West Lafayette, IN, United States of America",NA
"2389","34214122","10.1371/journal.pone.0254077","Identifying factors that nurses consider in the decision-making process related to patient care during the COVID-19 pandemic.","Nurse identification of patient deterioration is critical, particularly during the COVID-19 pandemic, as patients can deteriorate quickly. While the literature has shown that nurses rely on intuition to make decisions, there is limited information on what sources of data experienced nurses utilize to inform their intuition. The objectives of this study were to identify sources of data that inform nurse decision-making related to recognition of deteriorating patients, and explore how COVID-19 has","2021","07","09","PLoS One","PloS one","Adult; Aged; COVID-19; Clinical Decision-Making; Female; Humans; Interviews as Topic; Male; Middle Aged; Nurse-Patient Relations; Nurses; Nursing Assessment; Nursing Care; Pandemics; Professional-Family Relations; Qualitative Research; SARS-CoV-2; Symptom Assessment; Workload","Hornbeck","Tera","School of Nursing, Purdue University, West Lafayette, IN, United States of America",NA
"2390","34214122","10.1371/journal.pone.0254077","Identifying factors that nurses consider in the decision-making process related to patient care during the COVID-19 pandemic.","Nurse identification of patient deterioration is critical, particularly during the COVID-19 pandemic, as patients can deteriorate quickly. While the literature has shown that nurses rely on intuition to make decisions, there is limited information on what sources of data experienced nurses utilize to inform their intuition. The objectives of this study were to identify sources of data that inform nurse decision-making related to recognition of deteriorating patients, and explore how COVID-19 has","2021","07","09","PLoS One","PloS one","Adult; Aged; COVID-19; Clinical Decision-Making; Female; Humans; Interviews as Topic; Male; Middle Aged; Nurse-Patient Relations; Nurses; Nursing Assessment; Nursing Care; Pandemics; Professional-Family Relations; Qualitative Research; SARS-CoV-2; Symptom Assessment; Workload","Modlin","Susan","School of Nursing, Purdue University, West Lafayette, IN, United States of America",NA
"2391","34214122","10.1371/journal.pone.0254077","Identifying factors that nurses consider in the decision-making process related to patient care during the COVID-19 pandemic.","Nurse identification of patient deterioration is critical, particularly during the COVID-19 pandemic, as patients can deteriorate quickly. While the literature has shown that nurses rely on intuition to make decisions, there is limited information on what sources of data experienced nurses utilize to inform their intuition. The objectives of this study were to identify sources of data that inform nurse decision-making related to recognition of deteriorating patients, and explore how COVID-19 has","2021","07","09","PLoS One","PloS one","Adult; Aged; COVID-19; Clinical Decision-Making; Female; Humans; Interviews as Topic; Male; Middle Aged; Nurse-Patient Relations; Nurses; Nursing Assessment; Nursing Care; Pandemics; Professional-Family Relations; Qualitative Research; SARS-CoV-2; Symptom Assessment; Workload","Haque","Md Munirul","RB Annis School of Engineering, University of Indianapolis, Indianapolis, IN, United States of America",NA
"2392","34214122","10.1371/journal.pone.0254077","Identifying factors that nurses consider in the decision-making process related to patient care during the COVID-19 pandemic.","Nurse identification of patient deterioration is critical, particularly during the COVID-19 pandemic, as patients can deteriorate quickly. While the literature has shown that nurses rely on intuition to make decisions, there is limited information on what sources of data experienced nurses utilize to inform their intuition. The objectives of this study were to identify sources of data that inform nurse decision-making related to recognition of deteriorating patients, and explore how COVID-19 has","2021","07","09","PLoS One","PloS one","Adult; Aged; COVID-19; Clinical Decision-Making; Female; Humans; Interviews as Topic; Male; Middle Aged; Nurse-Patient Relations; Nurses; Nursing Assessment; Nursing Care; Pandemics; Professional-Family Relations; Qualitative Research; SARS-CoV-2; Symptom Assessment; Workload","Crites","Megan","School of Industrial Engineering, Purdue University, West Lafayette, IN, United States of America",NA
"2393","34214122","10.1371/journal.pone.0254077","Identifying factors that nurses consider in the decision-making process related to patient care during the COVID-19 pandemic.","Nurse identification of patient deterioration is critical, particularly during the COVID-19 pandemic, as patients can deteriorate quickly. While the literature has shown that nurses rely on intuition to make decisions, there is limited information on what sources of data experienced nurses utilize to inform their intuition. The objectives of this study were to identify sources of data that inform nurse decision-making related to recognition of deteriorating patients, and explore how COVID-19 has","2021","07","09","PLoS One","PloS one","Adult; Aged; COVID-19; Clinical Decision-Making; Female; Humans; Interviews as Topic; Male; Middle Aged; Nurse-Patient Relations; Nurses; Nursing Assessment; Nursing Care; Pandemics; Professional-Family Relations; Qualitative Research; SARS-CoV-2; Symptom Assessment; Workload","Yu","Denny","School of Industrial Engineering, Purdue University, West Lafayette, IN, United States of America",NA
"2394","34214116","10.1371/journal.pone.0253977","Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection.","SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented strain on health care systems. To investigate the time course of the antibody response in relation to the outcome we performed a study in hospitalized COVID-19 patients. As comparison we also investigated the time course of the antibody response in SARS-CoV-2 asymptomatic subjects. Study results show that patients produce a strong antibody response to SARS-CoV-2 with high correlation between different","2021","07","09","PLoS One","PloS one","Aged; Antibodies, Neutralizing; Antibodies, Viral; Asymptomatic Infections; COVID-19; Comorbidity; Female; Hospitalization; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Length of Stay; Male; Middle Aged; Patient Admission; Retrospective Studies; SARS-CoV-2","Marchi","Serena","Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy",NA
"2395","34214116","10.1371/journal.pone.0253977","Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection.","SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented strain on health care systems. To investigate the time course of the antibody response in relation to the outcome we performed a study in hospitalized COVID-19 patients. As comparison we also investigated the time course of the antibody response in SARS-CoV-2 asymptomatic subjects. Study results show that patients produce a strong antibody response to SARS-CoV-2 with high correlation between different","2021","07","09","PLoS One","PloS one","Aged; Antibodies, Neutralizing; Antibodies, Viral; Asymptomatic Infections; COVID-19; Comorbidity; Female; Hospitalization; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Length of Stay; Male; Middle Aged; Patient Admission; Retrospective Studies; SARS-CoV-2","Viviani","Simonetta","Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy",NA
"2396","34214116","10.1371/journal.pone.0253977","Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection.","SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented strain on health care systems. To investigate the time course of the antibody response in relation to the outcome we performed a study in hospitalized COVID-19 patients. As comparison we also investigated the time course of the antibody response in SARS-CoV-2 asymptomatic subjects. Study results show that patients produce a strong antibody response to SARS-CoV-2 with high correlation between different","2021","07","09","PLoS One","PloS one","Aged; Antibodies, Neutralizing; Antibodies, Viral; Asymptomatic Infections; COVID-19; Comorbidity; Female; Hospitalization; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Length of Stay; Male; Middle Aged; Patient Admission; Retrospective Studies; SARS-CoV-2","Remarque","Edmond J","Department of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands",NA
"2397","34214116","10.1371/journal.pone.0253977","Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection.","SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented strain on health care systems. To investigate the time course of the antibody response in relation to the outcome we performed a study in hospitalized COVID-19 patients. As comparison we also investigated the time course of the antibody response in SARS-CoV-2 asymptomatic subjects. Study results show that patients produce a strong antibody response to SARS-CoV-2 with high correlation between different","2021","07","09","PLoS One","PloS one","Aged; Antibodies, Neutralizing; Antibodies, Viral; Asymptomatic Infections; COVID-19; Comorbidity; Female; Hospitalization; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Length of Stay; Male; Middle Aged; Patient Admission; Retrospective Studies; SARS-CoV-2","Ruello","Antonella","Humanitas Gavazzeni, Bergamo, Italy",NA
"2398","34214116","10.1371/journal.pone.0253977","Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection.","SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented strain on health care systems. To investigate the time course of the antibody response in relation to the outcome we performed a study in hospitalized COVID-19 patients. As comparison we also investigated the time course of the antibody response in SARS-CoV-2 asymptomatic subjects. Study results show that patients produce a strong antibody response to SARS-CoV-2 with high correlation between different","2021","07","09","PLoS One","PloS one","Aged; Antibodies, Neutralizing; Antibodies, Viral; Asymptomatic Infections; COVID-19; Comorbidity; Female; Hospitalization; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Length of Stay; Male; Middle Aged; Patient Admission; Retrospective Studies; SARS-CoV-2","Bombardieri","Emilio","Humanitas Gavazzeni, Bergamo, Italy",NA
"2399","34214116","10.1371/journal.pone.0253977","Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection.","SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented strain on health care systems. To investigate the time course of the antibody response in relation to the outcome we performed a study in hospitalized COVID-19 patients. As comparison we also investigated the time course of the antibody response in SARS-CoV-2 asymptomatic subjects. Study results show that patients produce a strong antibody response to SARS-CoV-2 with high correlation between different","2021","07","09","PLoS One","PloS one","Aged; Antibodies, Neutralizing; Antibodies, Viral; Asymptomatic Infections; COVID-19; Comorbidity; Female; Hospitalization; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Length of Stay; Male; Middle Aged; Patient Admission; Retrospective Studies; SARS-CoV-2","Bollati","Valentina","Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy",NA
"2400","34214116","10.1371/journal.pone.0253977","Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection.","SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented strain on health care systems. To investigate the time course of the antibody response in relation to the outcome we performed a study in hospitalized COVID-19 patients. As comparison we also investigated the time course of the antibody response in SARS-CoV-2 asymptomatic subjects. Study results show that patients produce a strong antibody response to SARS-CoV-2 with high correlation between different","2021","07","09","PLoS One","PloS one","Aged; Antibodies, Neutralizing; Antibodies, Viral; Asymptomatic Infections; COVID-19; Comorbidity; Female; Hospitalization; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Length of Stay; Male; Middle Aged; Patient Admission; Retrospective Studies; SARS-CoV-2","Milani","Gregorio P","Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy",NA
"2401","34214116","10.1371/journal.pone.0253977","Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection.","SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented strain on health care systems. To investigate the time course of the antibody response in relation to the outcome we performed a study in hospitalized COVID-19 patients. As comparison we also investigated the time course of the antibody response in SARS-CoV-2 asymptomatic subjects. Study results show that patients produce a strong antibody response to SARS-CoV-2 with high correlation between different","2021","07","09","PLoS One","PloS one","Aged; Antibodies, Neutralizing; Antibodies, Viral; Asymptomatic Infections; COVID-19; Comorbidity; Female; Hospitalization; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Length of Stay; Male; Middle Aged; Patient Admission; Retrospective Studies; SARS-CoV-2","Manenti","Alessandro","VisMederi srl, Siena, Italy",NA
"2402","34214116","10.1371/journal.pone.0253977","Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection.","SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented strain on health care systems. To investigate the time course of the antibody response in relation to the outcome we performed a study in hospitalized COVID-19 patients. As comparison we also investigated the time course of the antibody response in SARS-CoV-2 asymptomatic subjects. Study results show that patients produce a strong antibody response to SARS-CoV-2 with high correlation between different","2021","07","09","PLoS One","PloS one","Aged; Antibodies, Neutralizing; Antibodies, Viral; Asymptomatic Infections; COVID-19; Comorbidity; Female; Hospitalization; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Length of Stay; Male; Middle Aged; Patient Admission; Retrospective Studies; SARS-CoV-2","Lapini","Giulia","VisMederi srl, Siena, Italy",NA
"2403","34214116","10.1371/journal.pone.0253977","Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection.","SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented strain on health care systems. To investigate the time course of the antibody response in relation to the outcome we performed a study in hospitalized COVID-19 patients. As comparison we also investigated the time course of the antibody response in SARS-CoV-2 asymptomatic subjects. Study results show that patients produce a strong antibody response to SARS-CoV-2 with high correlation between different","2021","07","09","PLoS One","PloS one","Aged; Antibodies, Neutralizing; Antibodies, Viral; Asymptomatic Infections; COVID-19; Comorbidity; Female; Hospitalization; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Length of Stay; Male; Middle Aged; Patient Admission; Retrospective Studies; SARS-CoV-2","Rebuffat","Annunziata","Presidio Ospedaliero di Campostaggia, Località Campostaggia, Poggibonsi, Italy",NA
"2404","34214116","10.1371/journal.pone.0253977","Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection.","SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented strain on health care systems. To investigate the time course of the antibody response in relation to the outcome we performed a study in hospitalized COVID-19 patients. As comparison we also investigated the time course of the antibody response in SARS-CoV-2 asymptomatic subjects. Study results show that patients produce a strong antibody response to SARS-CoV-2 with high correlation between different","2021","07","09","PLoS One","PloS one","Aged; Antibodies, Neutralizing; Antibodies, Viral; Asymptomatic Infections; COVID-19; Comorbidity; Female; Hospitalization; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Length of Stay; Male; Middle Aged; Patient Admission; Retrospective Studies; SARS-CoV-2","Montomoli","Emanuele","Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy",NA
"2405","34214116","10.1371/journal.pone.0253977","Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection.","SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented strain on health care systems. To investigate the time course of the antibody response in relation to the outcome we performed a study in hospitalized COVID-19 patients. As comparison we also investigated the time course of the antibody response in SARS-CoV-2 asymptomatic subjects. Study results show that patients produce a strong antibody response to SARS-CoV-2 with high correlation between different","2021","07","09","PLoS One","PloS one","Aged; Antibodies, Neutralizing; Antibodies, Viral; Asymptomatic Infections; COVID-19; Comorbidity; Female; Hospitalization; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Length of Stay; Male; Middle Aged; Patient Admission; Retrospective Studies; SARS-CoV-2","Trombetta","Claudia M","Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy",NA
"2406","34214101","10.1371/journal.pone.0252384","A machine learning based exploration of COVID-19 mortality risk.","Early prediction of patient mortality risks during a pandemic can decrease mortality by assuring efficient resource allocation and treatment planning. This study aimed to develop and compare prognosis prediction machine learning models based on invasive laboratory and noninvasive clinical and demographic data from patients' day of admission. Three Support Vector Machine (SVM) models were developed and compared using invasive, non-invasive, and both groups. The results suggested that non-invasive","2021","07","09","PLoS One","PloS one","Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Electronic Health Records; Female; Forecasting; Humans; Male; Middle Aged; Models, Theoretical; Pandemics; Risk; SARS-CoV-2; Severity of Illness Index; Support Vector Machine; Symptom Assessment; Triage; Young Adult","Mahdavi","Mahdi","Institute of Medical Science and Technology (IMSAT), Shahid Beheshti University, Tehran, Iran",NA
"2407","34214101","10.1371/journal.pone.0252384","A machine learning based exploration of COVID-19 mortality risk.","Early prediction of patient mortality risks during a pandemic can decrease mortality by assuring efficient resource allocation and treatment planning. This study aimed to develop and compare prognosis prediction machine learning models based on invasive laboratory and noninvasive clinical and demographic data from patients' day of admission. Three Support Vector Machine (SVM) models were developed and compared using invasive, non-invasive, and both groups. The results suggested that non-invasive","2021","07","09","PLoS One","PloS one","Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Electronic Health Records; Female; Forecasting; Humans; Male; Middle Aged; Models, Theoretical; Pandemics; Risk; SARS-CoV-2; Severity of Illness Index; Support Vector Machine; Symptom Assessment; Triage; Young Adult","Choubdar","Hadi","Institute of Medical Science and Technology (IMSAT), Shahid Beheshti University, Tehran, Iran",NA
"2408","34214101","10.1371/journal.pone.0252384","A machine learning based exploration of COVID-19 mortality risk.","Early prediction of patient mortality risks during a pandemic can decrease mortality by assuring efficient resource allocation and treatment planning. This study aimed to develop and compare prognosis prediction machine learning models based on invasive laboratory and noninvasive clinical and demographic data from patients' day of admission. Three Support Vector Machine (SVM) models were developed and compared using invasive, non-invasive, and both groups. The results suggested that non-invasive","2021","07","09","PLoS One","PloS one","Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Electronic Health Records; Female; Forecasting; Humans; Male; Middle Aged; Models, Theoretical; Pandemics; Risk; SARS-CoV-2; Severity of Illness Index; Support Vector Machine; Symptom Assessment; Triage; Young Adult","Zabeh","Erfan","Department of Biomedical Engineering, Columbia University, New York, NY, United States of America",NA
"2409","34214101","10.1371/journal.pone.0252384","A machine learning based exploration of COVID-19 mortality risk.","Early prediction of patient mortality risks during a pandemic can decrease mortality by assuring efficient resource allocation and treatment planning. This study aimed to develop and compare prognosis prediction machine learning models based on invasive laboratory and noninvasive clinical and demographic data from patients' day of admission. Three Support Vector Machine (SVM) models were developed and compared using invasive, non-invasive, and both groups. The results suggested that non-invasive","2021","07","09","PLoS One","PloS one","Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Electronic Health Records; Female; Forecasting; Humans; Male; Middle Aged; Models, Theoretical; Pandemics; Risk; SARS-CoV-2; Severity of Illness Index; Support Vector Machine; Symptom Assessment; Triage; Young Adult","Rieder","Michael","Robarts Research Institute, University of Western Ontario, London, ON, Canada",NA
"2410","34214101","10.1371/journal.pone.0252384","A machine learning based exploration of COVID-19 mortality risk.","Early prediction of patient mortality risks during a pandemic can decrease mortality by assuring efficient resource allocation and treatment planning. This study aimed to develop and compare prognosis prediction machine learning models based on invasive laboratory and noninvasive clinical and demographic data from patients' day of admission. Three Support Vector Machine (SVM) models were developed and compared using invasive, non-invasive, and both groups. The results suggested that non-invasive","2021","07","09","PLoS One","PloS one","Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Electronic Health Records; Female; Forecasting; Humans; Male; Middle Aged; Models, Theoretical; Pandemics; Risk; SARS-CoV-2; Severity of Illness Index; Support Vector Machine; Symptom Assessment; Triage; Young Adult","Safavi-Naeini","Safieddin","CIARS (Centre for Intelligent Antenna and Radio Systems), Department of Electrical and Computer Engineering, University of Waterloo, Waterloo, ON, Canada",NA
"2411","34214101","10.1371/journal.pone.0252384","A machine learning based exploration of COVID-19 mortality risk.","Early prediction of patient mortality risks during a pandemic can decrease mortality by assuring efficient resource allocation and treatment planning. This study aimed to develop and compare prognosis prediction machine learning models based on invasive laboratory and noninvasive clinical and demographic data from patients' day of admission. Three Support Vector Machine (SVM) models were developed and compared using invasive, non-invasive, and both groups. The results suggested that non-invasive","2021","07","09","PLoS One","PloS one","Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Electronic Health Records; Female; Forecasting; Humans; Male; Middle Aged; Models, Theoretical; Pandemics; Risk; SARS-CoV-2; Severity of Illness Index; Support Vector Machine; Symptom Assessment; Triage; Young Adult","Jobbagy","Zsolt","Department of Pathology, Immunology and Molecular Pathology, Rutgers New Jersey Medical School, Newark, NJ, United States of America",NA
"2412","34214101","10.1371/journal.pone.0252384","A machine learning based exploration of COVID-19 mortality risk.","Early prediction of patient mortality risks during a pandemic can decrease mortality by assuring efficient resource allocation and treatment planning. This study aimed to develop and compare prognosis prediction machine learning models based on invasive laboratory and noninvasive clinical and demographic data from patients' day of admission. Three Support Vector Machine (SVM) models were developed and compared using invasive, non-invasive, and both groups. The results suggested that non-invasive","2021","07","09","PLoS One","PloS one","Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Electronic Health Records; Female; Forecasting; Humans; Male; Middle Aged; Models, Theoretical; Pandemics; Risk; SARS-CoV-2; Severity of Illness Index; Support Vector Machine; Symptom Assessment; Triage; Young Adult","Ghorbani","Amirata","Department of Electrical Engineering, Stanford University, Stanford, CA, United States of America",NA
"2413","34214101","10.1371/journal.pone.0252384","A machine learning based exploration of COVID-19 mortality risk.","Early prediction of patient mortality risks during a pandemic can decrease mortality by assuring efficient resource allocation and treatment planning. This study aimed to develop and compare prognosis prediction machine learning models based on invasive laboratory and noninvasive clinical and demographic data from patients' day of admission. Three Support Vector Machine (SVM) models were developed and compared using invasive, non-invasive, and both groups. The results suggested that non-invasive","2021","07","09","PLoS One","PloS one","Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Electronic Health Records; Female; Forecasting; Humans; Male; Middle Aged; Models, Theoretical; Pandemics; Risk; SARS-CoV-2; Severity of Illness Index; Support Vector Machine; Symptom Assessment; Triage; Young Adult","Abedini","Atefeh","Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"2414","34214101","10.1371/journal.pone.0252384","A machine learning based exploration of COVID-19 mortality risk.","Early prediction of patient mortality risks during a pandemic can decrease mortality by assuring efficient resource allocation and treatment planning. This study aimed to develop and compare prognosis prediction machine learning models based on invasive laboratory and noninvasive clinical and demographic data from patients' day of admission. Three Support Vector Machine (SVM) models were developed and compared using invasive, non-invasive, and both groups. The results suggested that non-invasive","2021","07","09","PLoS One","PloS one","Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Electronic Health Records; Female; Forecasting; Humans; Male; Middle Aged; Models, Theoretical; Pandemics; Risk; SARS-CoV-2; Severity of Illness Index; Support Vector Machine; Symptom Assessment; Triage; Young Adult","Kiani","Arda","Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"2415","34214101","10.1371/journal.pone.0252384","A machine learning based exploration of COVID-19 mortality risk.","Early prediction of patient mortality risks during a pandemic can decrease mortality by assuring efficient resource allocation and treatment planning. This study aimed to develop and compare prognosis prediction machine learning models based on invasive laboratory and noninvasive clinical and demographic data from patients' day of admission. Three Support Vector Machine (SVM) models were developed and compared using invasive, non-invasive, and both groups. The results suggested that non-invasive","2021","07","09","PLoS One","PloS one","Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Electronic Health Records; Female; Forecasting; Humans; Male; Middle Aged; Models, Theoretical; Pandemics; Risk; SARS-CoV-2; Severity of Illness Index; Support Vector Machine; Symptom Assessment; Triage; Young Adult","Khanlarzadeh","Vida","Department of Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada",NA
"2416","34214101","10.1371/journal.pone.0252384","A machine learning based exploration of COVID-19 mortality risk.","Early prediction of patient mortality risks during a pandemic can decrease mortality by assuring efficient resource allocation and treatment planning. This study aimed to develop and compare prognosis prediction machine learning models based on invasive laboratory and noninvasive clinical and demographic data from patients' day of admission. Three Support Vector Machine (SVM) models were developed and compared using invasive, non-invasive, and both groups. The results suggested that non-invasive","2021","07","09","PLoS One","PloS one","Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Electronic Health Records; Female; Forecasting; Humans; Male; Middle Aged; Models, Theoretical; Pandemics; Risk; SARS-CoV-2; Severity of Illness Index; Support Vector Machine; Symptom Assessment; Triage; Young Adult","Lashgari","Reza","Institute of Medical Science and Technology (IMSAT), Shahid Beheshti University, Tehran, Iran",NA
"2417","34214101","10.1371/journal.pone.0252384","A machine learning based exploration of COVID-19 mortality risk.","Early prediction of patient mortality risks during a pandemic can decrease mortality by assuring efficient resource allocation and treatment planning. This study aimed to develop and compare prognosis prediction machine learning models based on invasive laboratory and noninvasive clinical and demographic data from patients' day of admission. Three Support Vector Machine (SVM) models were developed and compared using invasive, non-invasive, and both groups. The results suggested that non-invasive","2021","07","09","PLoS One","PloS one","Adult; Aged; Aged, 80 and over; COVID-19; Comorbidity; Electronic Health Records; Female; Forecasting; Humans; Male; Middle Aged; Models, Theoretical; Pandemics; Risk; SARS-CoV-2; Severity of Illness Index; Support Vector Machine; Symptom Assessment; Triage; Young Adult","Kamrani","Ehsan","Robarts Research Institute, University of Western Ontario, London, ON, Canada",NA
"2418","34214071","10.5867/medwave.2021.05.8206","Characteristics of the coronavirus disease 2019: A review of emerging literature.","The 2019 coronavirus disease outbreak (COVID-19) spread rapidly around the world. The extent and ultimate effect are still unclear, as it is an ongoing and constantly evolving pandemic. To compile the literature and synthesize in Spanish-Latin American language the available international information describing the etiological, pathophysiological, epidemiological and management aspects of COVID-19. Narrative review, using specific sections created in the databases. The criteria for selecting stu","2021","07","15","Medwave","Medwave"," SARS-CoV-2;  diagnosis;  physiopathology;  treatment; COVID-19; COVID-19; Humans","Fuentes-Aspe","Rocío","Departamento de Medicina Interna, Universidad de La Frontera, Temuco, Chile",NA
"2419","34214071","10.5867/medwave.2021.05.8206","Characteristics of the coronavirus disease 2019: A review of emerging literature.","The 2019 coronavirus disease outbreak (COVID-19) spread rapidly around the world. The extent and ultimate effect are still unclear, as it is an ongoing and constantly evolving pandemic. To compile the literature and synthesize in Spanish-Latin American language the available international information describing the etiological, pathophysiological, epidemiological and management aspects of COVID-19. Narrative review, using specific sections created in the databases. The criteria for selecting stu","2021","07","15","Medwave","Medwave"," SARS-CoV-2;  diagnosis;  physiopathology;  treatment; COVID-19; COVID-19; Humans","Huaiquilaf-Jorquera","Sayén","Departamento de Pediatría y Cirugía Infantil, Universidad de La Frontera, Temuco, Chile. ORCID: 0000-0003-1516-0130",NA
"2420","34214071","10.5867/medwave.2021.05.8206","Characteristics of the coronavirus disease 2019: A review of emerging literature.","The 2019 coronavirus disease outbreak (COVID-19) spread rapidly around the world. The extent and ultimate effect are still unclear, as it is an ongoing and constantly evolving pandemic. To compile the literature and synthesize in Spanish-Latin American language the available international information describing the etiological, pathophysiological, epidemiological and management aspects of COVID-19. Narrative review, using specific sections created in the databases. The criteria for selecting stu","2021","07","15","Medwave","Medwave"," SARS-CoV-2;  diagnosis;  physiopathology;  treatment; COVID-19; COVID-19; Humans","Oliveros","María-José","Departamento de Medicina Interna, Universidad de La Frontera, Temuco, Chile",NA
"2421","34214071","10.5867/medwave.2021.05.8206","Characteristics of the coronavirus disease 2019: A review of emerging literature.","The 2019 coronavirus disease outbreak (COVID-19) spread rapidly around the world. The extent and ultimate effect are still unclear, as it is an ongoing and constantly evolving pandemic. To compile the literature and synthesize in Spanish-Latin American language the available international information describing the etiological, pathophysiological, epidemiological and management aspects of COVID-19. Narrative review, using specific sections created in the databases. The criteria for selecting stu","2021","07","15","Medwave","Medwave"," SARS-CoV-2;  diagnosis;  physiopathology;  treatment; COVID-19; COVID-19; Humans","Soto","Álvaro","Centro de Excelencia en Capacitación, Investigación y Gestión para la Salud Basada en Evidencia (CIGES), Facultad de Medicina, Universidad de La Frontera, Temuco, Chile","alvaro.soto@ufrontera.cl"
"2422","34214046","10.1126/science.abi4506","Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in mice.","The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader Sarbecovirus subgenus. Using chimeric spike designs, we demonstrate protection against challenge from SARS-CoV, SARS-CoV-2, SARS-CoV-2 B.1.351, bat CoV (Bt-CoV) RsSHC014, and a heterologous Bt-CoV WIV-1 in vulnerable aged mice. Chimeric spike mRNAs induced high levels of broadly protective neutralizing antibodies against high-risk Sarbecoviruses. In ","2021","07","07","Science","Science (New York, N.Y.)",NA,"Martinez","David R","Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. david.rafael.martinez@gmail.com rbaric@email.unc","david.rafael.martinez@gmail.com"
"2423","34214046","10.1126/science.abi4506","Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in mice.","The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader Sarbecovirus subgenus. Using chimeric spike designs, we demonstrate protection against challenge from SARS-CoV, SARS-CoV-2, SARS-CoV-2 B.1.351, bat CoV (Bt-CoV) RsSHC014, and a heterologous Bt-CoV WIV-1 in vulnerable aged mice. Chimeric spike mRNAs induced high levels of broadly protective neutralizing antibodies against high-risk Sarbecoviruses. In ","2021","07","07","Science","Science (New York, N.Y.)",NA,"Schäfer","Alexandra","Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA",NA
"2424","34214046","10.1126/science.abi4506","Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in mice.","The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader Sarbecovirus subgenus. Using chimeric spike designs, we demonstrate protection against challenge from SARS-CoV, SARS-CoV-2, SARS-CoV-2 B.1.351, bat CoV (Bt-CoV) RsSHC014, and a heterologous Bt-CoV WIV-1 in vulnerable aged mice. Chimeric spike mRNAs induced high levels of broadly protective neutralizing antibodies against high-risk Sarbecoviruses. In ","2021","07","07","Science","Science (New York, N.Y.)",NA,"Leist","Sarah R","Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA",NA
"2425","34214046","10.1126/science.abi4506","Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in mice.","The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader Sarbecovirus subgenus. Using chimeric spike designs, we demonstrate protection against challenge from SARS-CoV, SARS-CoV-2, SARS-CoV-2 B.1.351, bat CoV (Bt-CoV) RsSHC014, and a heterologous Bt-CoV WIV-1 in vulnerable aged mice. Chimeric spike mRNAs induced high levels of broadly protective neutralizing antibodies against high-risk Sarbecoviruses. In ","2021","07","07","Science","Science (New York, N.Y.)",NA,"De la Cruz","Gabriela","Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA",NA
"2426","34214046","10.1126/science.abi4506","Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in mice.","The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader Sarbecovirus subgenus. Using chimeric spike designs, we demonstrate protection against challenge from SARS-CoV, SARS-CoV-2, SARS-CoV-2 B.1.351, bat CoV (Bt-CoV) RsSHC014, and a heterologous Bt-CoV WIV-1 in vulnerable aged mice. Chimeric spike mRNAs induced high levels of broadly protective neutralizing antibodies against high-risk Sarbecoviruses. In ","2021","07","07","Science","Science (New York, N.Y.)",NA,"West","Ande","Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA",NA
"2427","34214046","10.1126/science.abi4506","Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in mice.","The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader Sarbecovirus subgenus. Using chimeric spike designs, we demonstrate protection against challenge from SARS-CoV, SARS-CoV-2, SARS-CoV-2 B.1.351, bat CoV (Bt-CoV) RsSHC014, and a heterologous Bt-CoV WIV-1 in vulnerable aged mice. Chimeric spike mRNAs induced high levels of broadly protective neutralizing antibodies against high-risk Sarbecoviruses. In ","2021","07","07","Science","Science (New York, N.Y.)",NA,"Atochina-Vasserman","Elena N","Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA",NA
"2428","34214046","10.1126/science.abi4506","Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in mice.","The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader Sarbecovirus subgenus. Using chimeric spike designs, we demonstrate protection against challenge from SARS-CoV, SARS-CoV-2, SARS-CoV-2 B.1.351, bat CoV (Bt-CoV) RsSHC014, and a heterologous Bt-CoV WIV-1 in vulnerable aged mice. Chimeric spike mRNAs induced high levels of broadly protective neutralizing antibodies against high-risk Sarbecoviruses. In ","2021","07","07","Science","Science (New York, N.Y.)",NA,"Lindesmith","Lisa C","Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA",NA
"2429","34214046","10.1126/science.abi4506","Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in mice.","The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader Sarbecovirus subgenus. Using chimeric spike designs, we demonstrate protection against challenge from SARS-CoV, SARS-CoV-2, SARS-CoV-2 B.1.351, bat CoV (Bt-CoV) RsSHC014, and a heterologous Bt-CoV WIV-1 in vulnerable aged mice. Chimeric spike mRNAs induced high levels of broadly protective neutralizing antibodies against high-risk Sarbecoviruses. In ","2021","07","07","Science","Science (New York, N.Y.)",NA,"Pardi","Norbert","Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA",NA
"2430","34214046","10.1126/science.abi4506","Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in mice.","The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader Sarbecovirus subgenus. Using chimeric spike designs, we demonstrate protection against challenge from SARS-CoV, SARS-CoV-2, SARS-CoV-2 B.1.351, bat CoV (Bt-CoV) RsSHC014, and a heterologous Bt-CoV WIV-1 in vulnerable aged mice. Chimeric spike mRNAs induced high levels of broadly protective neutralizing antibodies against high-risk Sarbecoviruses. In ","2021","07","07","Science","Science (New York, N.Y.)",NA,"Parks","Robert","Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA",NA
"2431","34214046","10.1126/science.abi4506","Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in mice.","The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader Sarbecovirus subgenus. Using chimeric spike designs, we demonstrate protection against challenge from SARS-CoV, SARS-CoV-2, SARS-CoV-2 B.1.351, bat CoV (Bt-CoV) RsSHC014, and a heterologous Bt-CoV WIV-1 in vulnerable aged mice. Chimeric spike mRNAs induced high levels of broadly protective neutralizing antibodies against high-risk Sarbecoviruses. In ","2021","07","07","Science","Science (New York, N.Y.)",NA,"Barr","Maggie","Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA",NA
"2432","34214046","10.1126/science.abi4506","Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in mice.","The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader Sarbecovirus subgenus. Using chimeric spike designs, we demonstrate protection against challenge from SARS-CoV, SARS-CoV-2, SARS-CoV-2 B.1.351, bat CoV (Bt-CoV) RsSHC014, and a heterologous Bt-CoV WIV-1 in vulnerable aged mice. Chimeric spike mRNAs induced high levels of broadly protective neutralizing antibodies against high-risk Sarbecoviruses. In ","2021","07","07","Science","Science (New York, N.Y.)",NA,"Li","Dapeng","Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA",NA
"2433","34214046","10.1126/science.abi4506","Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in mice.","The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader Sarbecovirus subgenus. Using chimeric spike designs, we demonstrate protection against challenge from SARS-CoV, SARS-CoV-2, SARS-CoV-2 B.1.351, bat CoV (Bt-CoV) RsSHC014, and a heterologous Bt-CoV WIV-1 in vulnerable aged mice. Chimeric spike mRNAs induced high levels of broadly protective neutralizing antibodies against high-risk Sarbecoviruses. In ","2021","07","07","Science","Science (New York, N.Y.)",NA,"Yount","Boyd","Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA",NA
"2434","34214046","10.1126/science.abi4506","Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in mice.","The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader Sarbecovirus subgenus. Using chimeric spike designs, we demonstrate protection against challenge from SARS-CoV, SARS-CoV-2, SARS-CoV-2 B.1.351, bat CoV (Bt-CoV) RsSHC014, and a heterologous Bt-CoV WIV-1 in vulnerable aged mice. Chimeric spike mRNAs induced high levels of broadly protective neutralizing antibodies against high-risk Sarbecoviruses. In ","2021","07","07","Science","Science (New York, N.Y.)",NA,"Saunders","Kevin O","Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA",NA
"2435","34214046","10.1126/science.abi4506","Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in mice.","The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader Sarbecovirus subgenus. Using chimeric spike designs, we demonstrate protection against challenge from SARS-CoV, SARS-CoV-2, SARS-CoV-2 B.1.351, bat CoV (Bt-CoV) RsSHC014, and a heterologous Bt-CoV WIV-1 in vulnerable aged mice. Chimeric spike mRNAs induced high levels of broadly protective neutralizing antibodies against high-risk Sarbecoviruses. In ","2021","07","07","Science","Science (New York, N.Y.)",NA,"Weissman","Drew","Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA",NA
"2436","34214046","10.1126/science.abi4506","Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in mice.","The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader Sarbecovirus subgenus. Using chimeric spike designs, we demonstrate protection against challenge from SARS-CoV, SARS-CoV-2, SARS-CoV-2 B.1.351, bat CoV (Bt-CoV) RsSHC014, and a heterologous Bt-CoV WIV-1 in vulnerable aged mice. Chimeric spike mRNAs induced high levels of broadly protective neutralizing antibodies against high-risk Sarbecoviruses. In ","2021","07","07","Science","Science (New York, N.Y.)",NA,"Haynes","Barton F","Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA",NA
"2437","34214046","10.1126/science.abi4506","Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in mice.","The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader Sarbecovirus subgenus. Using chimeric spike designs, we demonstrate protection against challenge from SARS-CoV, SARS-CoV-2, SARS-CoV-2 B.1.351, bat CoV (Bt-CoV) RsSHC014, and a heterologous Bt-CoV WIV-1 in vulnerable aged mice. Chimeric spike mRNAs induced high levels of broadly protective neutralizing antibodies against high-risk Sarbecoviruses. In ","2021","07","07","Science","Science (New York, N.Y.)",NA,"Montgomery","Stephanie A","Department of Laboratory Medicine and Pathology, University of North Carolina School of Medicine, Chapel Hill, NC, USA",NA
"2438","34214046","10.1126/science.abi4506","Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in mice.","The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader Sarbecovirus subgenus. Using chimeric spike designs, we demonstrate protection against challenge from SARS-CoV, SARS-CoV-2, SARS-CoV-2 B.1.351, bat CoV (Bt-CoV) RsSHC014, and a heterologous Bt-CoV WIV-1 in vulnerable aged mice. Chimeric spike mRNAs induced high levels of broadly protective neutralizing antibodies against high-risk Sarbecoviruses. In ","2021","07","07","Science","Science (New York, N.Y.)",NA,"Baric","Ralph S","Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. david.rafael.martinez@gmail.com rbaric@email.unc","david.rafael.martinez@gmail.com"
"2439","34214015","10.1080/19371918.2021.1932665","Social Workers' Knowledge and Ability in Crisis Intervention in Kuwait- A Case of COVID-19.","Summary: The main purpose of the current study was to assess whether there are significant differences among variables, such as social workers' familiarity with the crisis intervention model, receiving up-to-date information about the latest developments in COVID-19, having adequate information about what the symptoms of COVID-19 are, and willingness to work with COVID-19 patients, and social workers' ability to apply the crisis intervention model when they are working with clients and it","2021","07","19","Soc Work Public Health","Social work in public health","Crisis intervention; health; social work; social worker; social worker practice; COVID-19; Crisis Intervention; Cross-Sectional Studies; Health Knowledge, Attitudes, Practice; Humans; Kuwait; Models, Organizational; Social Workers","Al-Ma'seb","Hend","College of Social Sciences, Department of Sociology and Social Work, Kuwait University, Kaifan, Kuwait",NA
"2440","34214015","10.1080/19371918.2021.1932665","Social Workers' Knowledge and Ability in Crisis Intervention in Kuwait- A Case of COVID-19.","Summary: The main purpose of the current study was to assess whether there are significant differences among variables, such as social workers' familiarity with the crisis intervention model, receiving up-to-date information about the latest developments in COVID-19, having adequate information about what the symptoms of COVID-19 are, and willingness to work with COVID-19 patients, and social workers' ability to apply the crisis intervention model when they are working with clients and it","2021","07","19","Soc Work Public Health","Social work in public health","Crisis intervention; health; social work; social worker; social worker practice; COVID-19; Crisis Intervention; Cross-Sectional Studies; Health Knowledge, Attitudes, Practice; Humans; Kuwait; Models, Organizational; Social Workers","Alaslawi","Hamad A","College of Social Sciences, Department of Sociology and Social Work, Kuwait University, Kaifan, Kuwait",NA
"2441","34214009","10.1164/rccm.202104-1029LE","Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure Due to COVID-19: A Matched Control Study.",NA,"2021","07","02","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine","COVID-19 pneumonia; Noninvasive ventilation; dynamic transpulmonary pressure; esophageal manometry; respiratory mechanics","Tonelli","Roberto","University of Modena and Reggio Emilia, 9306, PhD program Clinical and Experimental Medicine, Modena, Italy",NA
"2442","34214009","10.1164/rccm.202104-1029LE","Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure Due to COVID-19: A Matched Control Study.",NA,"2021","07","02","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine","COVID-19 pneumonia; Noninvasive ventilation; dynamic transpulmonary pressure; esophageal manometry; respiratory mechanics","Busani","Stefano","Policlinico di Modena, 551871, Anesthesia and Intensive Care, Modena, Italy",NA
"2443","34214009","10.1164/rccm.202104-1029LE","Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure Due to COVID-19: A Matched Control Study.",NA,"2021","07","02","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine","COVID-19 pneumonia; Noninvasive ventilation; dynamic transpulmonary pressure; esophageal manometry; respiratory mechanics","Tabbì","Luca","University Hospital Modena, 208968, Respiratory Diseases Unit, Modena, Italy",NA
"2444","34214009","10.1164/rccm.202104-1029LE","Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure Due to COVID-19: A Matched Control Study.",NA,"2021","07","02","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine","COVID-19 pneumonia; Noninvasive ventilation; dynamic transpulmonary pressure; esophageal manometry; respiratory mechanics","Fantini","Riccardo","University Hospital Modena, 208968, Respiratory Diseases Unit, Modena, Italy",NA
"2445","34214009","10.1164/rccm.202104-1029LE","Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure Due to COVID-19: A Matched Control Study.",NA,"2021","07","02","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine","COVID-19 pneumonia; Noninvasive ventilation; dynamic transpulmonary pressure; esophageal manometry; respiratory mechanics","Castaniere","Ivana","University Hospital Modena, 208968, Respiratory Diseases Unit, Modena, Italy",NA
"2446","34214009","10.1164/rccm.202104-1029LE","Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure Due to COVID-19: A Matched Control Study.",NA,"2021","07","02","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine","COVID-19 pneumonia; Noninvasive ventilation; dynamic transpulmonary pressure; esophageal manometry; respiratory mechanics","Biagioni","Emanuela","Azienda Ospedaliera Universitaria Policlinico di Modena, 208968, Modena, Italy",NA
"2447","34214009","10.1164/rccm.202104-1029LE","Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure Due to COVID-19: A Matched Control Study.",NA,"2021","07","02","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine","COVID-19 pneumonia; Noninvasive ventilation; dynamic transpulmonary pressure; esophageal manometry; respiratory mechanics","Mussini","Cristina","University Hospital Modena, 208968, Infectious Diseases Unit, Modena, Italy",NA
"2448","34214009","10.1164/rccm.202104-1029LE","Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure Due to COVID-19: A Matched Control Study.",NA,"2021","07","02","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine","COVID-19 pneumonia; Noninvasive ventilation; dynamic transpulmonary pressure; esophageal manometry; respiratory mechanics","Girardis","Massimo","University of Modena and Reggio Emilia, 9306, Surgical, Medical and Dental Department of Morphological Sciences related to Transplants Oncology and Regenerative Medicine, Modena, Italy",NA
"2449","34214009","10.1164/rccm.202104-1029LE","Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure Due to COVID-19: A Matched Control Study.",NA,"2021","07","02","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine","COVID-19 pneumonia; Noninvasive ventilation; dynamic transpulmonary pressure; esophageal manometry; respiratory mechanics","Clini","Enrico","University of Modena and Reggio Emilia, 9306, Medical and Surgical Sciences, Modena, Italy","enrico.clini@unimore.it"
"2450","34214009","10.1164/rccm.202104-1029LE","Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure Due to COVID-19: A Matched Control Study.",NA,"2021","07","02","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine","COVID-19 pneumonia; Noninvasive ventilation; dynamic transpulmonary pressure; esophageal manometry; respiratory mechanics","Marchioni","Alessandro","University Hospital Modena, 208968, Respiratory Diseases Unit, Modena, Italy",NA
"2451","34213997","10.3928/24748307-20210503-01","The Deaf Community's Experiences Navigating COVID-19 Pandemic Information.","Users of American Sign Language (ASL) who are deaf often face barriers receiving health information, contributing to significant gaps in health knowledge and health literacy. To reduce the spread of coronavirus disease 2019 (COVID-19) and its risk to the public, the government and health care providers have encouraged social distancing, use of face masks, hand hygiene, and quarantines. Unfortunately, COVID-19 information has rarely been available in ASL, which puts the deaf community at a disadv","2021","07","15","Health Lit Res Pract","Health literacy research and practice","COVID-19; Health Knowledge, Attitudes, Practice; Health Literacy; Health Services Accessibility; Humans; Information Dissemination; Patient Acceptance of Health Care; Sign Language; Surveys and Questionnaires","Panko","Tiffany L",NA,NA
"2452","34213997","10.3928/24748307-20210503-01","The Deaf Community's Experiences Navigating COVID-19 Pandemic Information.","Users of American Sign Language (ASL) who are deaf often face barriers receiving health information, contributing to significant gaps in health knowledge and health literacy. To reduce the spread of coronavirus disease 2019 (COVID-19) and its risk to the public, the government and health care providers have encouraged social distancing, use of face masks, hand hygiene, and quarantines. Unfortunately, COVID-19 information has rarely been available in ASL, which puts the deaf community at a disadv","2021","07","15","Health Lit Res Pract","Health literacy research and practice","COVID-19; Health Knowledge, Attitudes, Practice; Health Literacy; Health Services Accessibility; Humans; Information Dissemination; Patient Acceptance of Health Care; Sign Language; Surveys and Questionnaires","Contreras","Jessica",NA,NA
"2453","34213997","10.3928/24748307-20210503-01","The Deaf Community's Experiences Navigating COVID-19 Pandemic Information.","Users of American Sign Language (ASL) who are deaf often face barriers receiving health information, contributing to significant gaps in health knowledge and health literacy. To reduce the spread of coronavirus disease 2019 (COVID-19) and its risk to the public, the government and health care providers have encouraged social distancing, use of face masks, hand hygiene, and quarantines. Unfortunately, COVID-19 information has rarely been available in ASL, which puts the deaf community at a disadv","2021","07","15","Health Lit Res Pract","Health literacy research and practice","COVID-19; Health Knowledge, Attitudes, Practice; Health Literacy; Health Services Accessibility; Humans; Information Dissemination; Patient Acceptance of Health Care; Sign Language; Surveys and Questionnaires","Postl","Daphine",NA,NA
"2454","34213997","10.3928/24748307-20210503-01","The Deaf Community's Experiences Navigating COVID-19 Pandemic Information.","Users of American Sign Language (ASL) who are deaf often face barriers receiving health information, contributing to significant gaps in health knowledge and health literacy. To reduce the spread of coronavirus disease 2019 (COVID-19) and its risk to the public, the government and health care providers have encouraged social distancing, use of face masks, hand hygiene, and quarantines. Unfortunately, COVID-19 information has rarely been available in ASL, which puts the deaf community at a disadv","2021","07","15","Health Lit Res Pract","Health literacy research and practice","COVID-19; Health Knowledge, Attitudes, Practice; Health Literacy; Health Services Accessibility; Humans; Information Dissemination; Patient Acceptance of Health Care; Sign Language; Surveys and Questionnaires","Mussallem","Ashley",NA,NA
"2455","34213997","10.3928/24748307-20210503-01","The Deaf Community's Experiences Navigating COVID-19 Pandemic Information.","Users of American Sign Language (ASL) who are deaf often face barriers receiving health information, contributing to significant gaps in health knowledge and health literacy. To reduce the spread of coronavirus disease 2019 (COVID-19) and its risk to the public, the government and health care providers have encouraged social distancing, use of face masks, hand hygiene, and quarantines. Unfortunately, COVID-19 information has rarely been available in ASL, which puts the deaf community at a disadv","2021","07","15","Health Lit Res Pract","Health literacy research and practice","COVID-19; Health Knowledge, Attitudes, Practice; Health Literacy; Health Services Accessibility; Humans; Information Dissemination; Patient Acceptance of Health Care; Sign Language; Surveys and Questionnaires","Champlin","Sara",NA,NA
"2456","34213997","10.3928/24748307-20210503-01","The Deaf Community's Experiences Navigating COVID-19 Pandemic Information.","Users of American Sign Language (ASL) who are deaf often face barriers receiving health information, contributing to significant gaps in health knowledge and health literacy. To reduce the spread of coronavirus disease 2019 (COVID-19) and its risk to the public, the government and health care providers have encouraged social distancing, use of face masks, hand hygiene, and quarantines. Unfortunately, COVID-19 information has rarely been available in ASL, which puts the deaf community at a disadv","2021","07","15","Health Lit Res Pract","Health literacy research and practice","COVID-19; Health Knowledge, Attitudes, Practice; Health Literacy; Health Services Accessibility; Humans; Information Dissemination; Patient Acceptance of Health Care; Sign Language; Surveys and Questionnaires","Paasche-Orlow","Michael K",NA,NA
"2457","34213997","10.3928/24748307-20210503-01","The Deaf Community's Experiences Navigating COVID-19 Pandemic Information.","Users of American Sign Language (ASL) who are deaf often face barriers receiving health information, contributing to significant gaps in health knowledge and health literacy. To reduce the spread of coronavirus disease 2019 (COVID-19) and its risk to the public, the government and health care providers have encouraged social distancing, use of face masks, hand hygiene, and quarantines. Unfortunately, COVID-19 information has rarely been available in ASL, which puts the deaf community at a disadv","2021","07","15","Health Lit Res Pract","Health literacy research and practice","COVID-19; Health Knowledge, Attitudes, Practice; Health Literacy; Health Services Accessibility; Humans; Information Dissemination; Patient Acceptance of Health Care; Sign Language; Surveys and Questionnaires","Hill","Joseph",NA,NA
"2458","34213997","10.3928/24748307-20210503-01","The Deaf Community's Experiences Navigating COVID-19 Pandemic Information.","Users of American Sign Language (ASL) who are deaf often face barriers receiving health information, contributing to significant gaps in health knowledge and health literacy. To reduce the spread of coronavirus disease 2019 (COVID-19) and its risk to the public, the government and health care providers have encouraged social distancing, use of face masks, hand hygiene, and quarantines. Unfortunately, COVID-19 information has rarely been available in ASL, which puts the deaf community at a disadv","2021","07","15","Health Lit Res Pract","Health literacy research and practice","COVID-19; Health Knowledge, Attitudes, Practice; Health Literacy; Health Services Accessibility; Humans; Information Dissemination; Patient Acceptance of Health Care; Sign Language; Surveys and Questionnaires","Plegue","Melissa A",NA,NA
"2459","34213997","10.3928/24748307-20210503-01","The Deaf Community's Experiences Navigating COVID-19 Pandemic Information.","Users of American Sign Language (ASL) who are deaf often face barriers receiving health information, contributing to significant gaps in health knowledge and health literacy. To reduce the spread of coronavirus disease 2019 (COVID-19) and its risk to the public, the government and health care providers have encouraged social distancing, use of face masks, hand hygiene, and quarantines. Unfortunately, COVID-19 information has rarely been available in ASL, which puts the deaf community at a disadv","2021","07","15","Health Lit Res Pract","Health literacy research and practice","COVID-19; Health Knowledge, Attitudes, Practice; Health Literacy; Health Services Accessibility; Humans; Information Dissemination; Patient Acceptance of Health Care; Sign Language; Surveys and Questionnaires","Hauser","Peter C",NA,NA
"2460","34213997","10.3928/24748307-20210503-01","The Deaf Community's Experiences Navigating COVID-19 Pandemic Information.","Users of American Sign Language (ASL) who are deaf often face barriers receiving health information, contributing to significant gaps in health knowledge and health literacy. To reduce the spread of coronavirus disease 2019 (COVID-19) and its risk to the public, the government and health care providers have encouraged social distancing, use of face masks, hand hygiene, and quarantines. Unfortunately, COVID-19 information has rarely been available in ASL, which puts the deaf community at a disadv","2021","07","15","Health Lit Res Pract","Health literacy research and practice","COVID-19; Health Knowledge, Attitudes, Practice; Health Literacy; Health Services Accessibility; Humans; Information Dissemination; Patient Acceptance of Health Care; Sign Language; Surveys and Questionnaires","McKee","Michael",NA,NA
"2461","34213996","10.3928/24748307-20210513-01","Race, the Health Literacy Gap, and COVID-19: Reflections from a Social Scientist Studying ""Pandemic Politics"".",NA,"2021","07","15","Health Lit Res Pract","Health literacy research and practice","COVID-19; Continental Population Groups; Health Literacy; Humans; Politics; Social Sciences","Block","Ray",NA,NA
"2462","34213993","10.1177/09677720211021575","What does the biography of Duncan Forbes MBE (1873-1941), Medical Officer of Health for Brighton (1908-1938), reveal about managing pandemics?","Coronavirus disease 2019 (COVID-19) and the national lockdowns of 2020/2021 illustrate how modern public health systems are founded on empirical evidence and contemporary understanding of disease transmission. Duncan Forbes was one of the earliest sanitarians in Britain to propose and implement a new understanding of infectious disease control. Starting his early career in Manchester and Cambridge, his eventual tenure as Brighton's longest-serving medical officer of health (MOH) left an indelibl","2021","07","02","J Med Biogr","Journal of medical biography","Brighton; COVID-19; Duncan Forbes; Spanish flu; medical officer of health; public health; terminal disinfection","Khan-White","Thomas","Department of Primary Care and Public Health, 12190Brighton and Sussex Medical School, UK",NA
"2463","34213993","10.1177/09677720211021575","What does the biography of Duncan Forbes MBE (1873-1941), Medical Officer of Health for Brighton (1908-1938), reveal about managing pandemics?","Coronavirus disease 2019 (COVID-19) and the national lockdowns of 2020/2021 illustrate how modern public health systems are founded on empirical evidence and contemporary understanding of disease transmission. Duncan Forbes was one of the earliest sanitarians in Britain to propose and implement a new understanding of infectious disease control. Starting his early career in Manchester and Cambridge, his eventual tenure as Brighton's longest-serving medical officer of health (MOH) left an indelibl","2021","07","02","J Med Biogr","Journal of medical biography","Brighton; COVID-19; Duncan Forbes; Spanish flu; medical officer of health; public health; terminal disinfection","Whiston","Benjamin","Department of Primary Care and Public Health, 12190Brighton and Sussex Medical School, UK",NA
"2464","34213993","10.1177/09677720211021575","What does the biography of Duncan Forbes MBE (1873-1941), Medical Officer of Health for Brighton (1908-1938), reveal about managing pandemics?","Coronavirus disease 2019 (COVID-19) and the national lockdowns of 2020/2021 illustrate how modern public health systems are founded on empirical evidence and contemporary understanding of disease transmission. Duncan Forbes was one of the earliest sanitarians in Britain to propose and implement a new understanding of infectious disease control. Starting his early career in Manchester and Cambridge, his eventual tenure as Brighton's longest-serving medical officer of health (MOH) left an indelibl","2021","07","02","J Med Biogr","Journal of medical biography","Brighton; COVID-19; Duncan Forbes; Spanish flu; medical officer of health; public health; terminal disinfection","Cooper","Max","Department of Primary Care and Public Health, 12190Brighton and Sussex Medical School, UK",NA
"2465","34213988","10.1080/09273948.2021.1949478","Panuveitis following Vaccination for COVID-19.","Background: COVID-19 vaccination has been accompanied by reports of inflammatory events. This report details a case of panuveitis following vaccination for COVID-19 Case.Description: A 43 year old female developed panuveitis with decreased vision three days after her second dose of Pfizer-Biontech mRNA vaccine. The choroid was significantly thickened and there was anterior chamber and vitreous inflammation. Shortly after onset of ocular symptoms she was also found have an asymptoma","2021","07","02","Ocul Immunol Inflamm","Ocular immunology and inflammation","COVID-19; Panuveitis; choroidal thickening; mRNA vaccine; vaccination","Mudie","Lucy I","Sue Anschutz-Rodgers UCHealth Eye Centers, Department of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado, USA",NA
"2466","34213988","10.1080/09273948.2021.1949478","Panuveitis following Vaccination for COVID-19.","Background: COVID-19 vaccination has been accompanied by reports of inflammatory events. This report details a case of panuveitis following vaccination for COVID-19 Case.Description: A 43 year old female developed panuveitis with decreased vision three days after her second dose of Pfizer-Biontech mRNA vaccine. The choroid was significantly thickened and there was anterior chamber and vitreous inflammation. Shortly after onset of ocular symptoms she was also found have an asymptoma","2021","07","02","Ocul Immunol Inflamm","Ocular immunology and inflammation","COVID-19; Panuveitis; choroidal thickening; mRNA vaccine; vaccination","Zick","Jon D","Colorado Retina Associates, Englewood, Colorado, USA",NA
"2467","34213988","10.1080/09273948.2021.1949478","Panuveitis following Vaccination for COVID-19.","Background: COVID-19 vaccination has been accompanied by reports of inflammatory events. This report details a case of panuveitis following vaccination for COVID-19 Case.Description: A 43 year old female developed panuveitis with decreased vision three days after her second dose of Pfizer-Biontech mRNA vaccine. The choroid was significantly thickened and there was anterior chamber and vitreous inflammation. Shortly after onset of ocular symptoms she was also found have an asymptoma","2021","07","02","Ocul Immunol Inflamm","Ocular immunology and inflammation","COVID-19; Panuveitis; choroidal thickening; mRNA vaccine; vaccination","Dacey","Mark S","Colorado Retina Associates, Englewood, Colorado, USA",NA
"2468","34213988","10.1080/09273948.2021.1949478","Panuveitis following Vaccination for COVID-19.","Background: COVID-19 vaccination has been accompanied by reports of inflammatory events. This report details a case of panuveitis following vaccination for COVID-19 Case.Description: A 43 year old female developed panuveitis with decreased vision three days after her second dose of Pfizer-Biontech mRNA vaccine. The choroid was significantly thickened and there was anterior chamber and vitreous inflammation. Shortly after onset of ocular symptoms she was also found have an asymptoma","2021","07","02","Ocul Immunol Inflamm","Ocular immunology and inflammation","COVID-19; Panuveitis; choroidal thickening; mRNA vaccine; vaccination","Palestine","Alan G","Sue Anschutz-Rodgers UCHealth Eye Centers, Department of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado, USA",NA
"2469","34213977","10.1128/JCM.00896-21","Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals.","The identification and isolation of highly infectious SARS-CoV-2-infected individuals is an important public health strategy. Rapid antigen detection tests (RADT) are promising candidates for large-scale screenings due to timely results and feasibility for on-site testing. Nonetheless, the diagnostic performance of RADT in detecting infectious individuals is yet to be fully determined. In this study, RT-qPCR and virus culture of RT-qPCR positive samples were used to evaluate and compare the perf","2021","07","02","J Clin Microbiol","Journal of clinical microbiology",NA,"Korenkov","Michael","Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne",NA
"2470","34213977","10.1128/JCM.00896-21","Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals.","The identification and isolation of highly infectious SARS-CoV-2-infected individuals is an important public health strategy. Rapid antigen detection tests (RADT) are promising candidates for large-scale screenings due to timely results and feasibility for on-site testing. Nonetheless, the diagnostic performance of RADT in detecting infectious individuals is yet to be fully determined. In this study, RT-qPCR and virus culture of RT-qPCR positive samples were used to evaluate and compare the perf","2021","07","02","J Clin Microbiol","Journal of clinical microbiology",NA,"Poopalasingam","Nareshkumar","Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne",NA
"2471","34213977","10.1128/JCM.00896-21","Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals.","The identification and isolation of highly infectious SARS-CoV-2-infected individuals is an important public health strategy. Rapid antigen detection tests (RADT) are promising candidates for large-scale screenings due to timely results and feasibility for on-site testing. Nonetheless, the diagnostic performance of RADT in detecting infectious individuals is yet to be fully determined. In this study, RT-qPCR and virus culture of RT-qPCR positive samples were used to evaluate and compare the perf","2021","07","02","J Clin Microbiol","Journal of clinical microbiology",NA,"Madler","Matthias","Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne",NA
"2472","34213977","10.1128/JCM.00896-21","Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals.","The identification and isolation of highly infectious SARS-CoV-2-infected individuals is an important public health strategy. Rapid antigen detection tests (RADT) are promising candidates for large-scale screenings due to timely results and feasibility for on-site testing. Nonetheless, the diagnostic performance of RADT in detecting infectious individuals is yet to be fully determined. In this study, RT-qPCR and virus culture of RT-qPCR positive samples were used to evaluate and compare the perf","2021","07","02","J Clin Microbiol","Journal of clinical microbiology",NA,"Vanshylla","Kanika","Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne",NA
"2473","34213977","10.1128/JCM.00896-21","Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals.","The identification and isolation of highly infectious SARS-CoV-2-infected individuals is an important public health strategy. Rapid antigen detection tests (RADT) are promising candidates for large-scale screenings due to timely results and feasibility for on-site testing. Nonetheless, the diagnostic performance of RADT in detecting infectious individuals is yet to be fully determined. In this study, RT-qPCR and virus culture of RT-qPCR positive samples were used to evaluate and compare the perf","2021","07","02","J Clin Microbiol","Journal of clinical microbiology",NA,"Eggeling","Ralf","Methods in Medical Informatics, Department of Computer Science, University of Tübingen",NA
"2474","34213977","10.1128/JCM.00896-21","Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals.","The identification and isolation of highly infectious SARS-CoV-2-infected individuals is an important public health strategy. Rapid antigen detection tests (RADT) are promising candidates for large-scale screenings due to timely results and feasibility for on-site testing. Nonetheless, the diagnostic performance of RADT in detecting infectious individuals is yet to be fully determined. In this study, RT-qPCR and virus culture of RT-qPCR positive samples were used to evaluate and compare the perf","2021","07","02","J Clin Microbiol","Journal of clinical microbiology",NA,"Wirtz","Maike","Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne",NA
"2475","34213977","10.1128/JCM.00896-21","Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals.","The identification and isolation of highly infectious SARS-CoV-2-infected individuals is an important public health strategy. Rapid antigen detection tests (RADT) are promising candidates for large-scale screenings due to timely results and feasibility for on-site testing. Nonetheless, the diagnostic performance of RADT in detecting infectious individuals is yet to be fully determined. In this study, RT-qPCR and virus culture of RT-qPCR positive samples were used to evaluate and compare the perf","2021","07","02","J Clin Microbiol","Journal of clinical microbiology",NA,"Fish","Irina","Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne",NA
"2476","34213977","10.1128/JCM.00896-21","Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals.","The identification and isolation of highly infectious SARS-CoV-2-infected individuals is an important public health strategy. Rapid antigen detection tests (RADT) are promising candidates for large-scale screenings due to timely results and feasibility for on-site testing. Nonetheless, the diagnostic performance of RADT in detecting infectious individuals is yet to be fully determined. In this study, RT-qPCR and virus culture of RT-qPCR positive samples were used to evaluate and compare the perf","2021","07","02","J Clin Microbiol","Journal of clinical microbiology",NA,"Dewald","Felix","Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne",NA
"2477","34213977","10.1128/JCM.00896-21","Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals.","The identification and isolation of highly infectious SARS-CoV-2-infected individuals is an important public health strategy. Rapid antigen detection tests (RADT) are promising candidates for large-scale screenings due to timely results and feasibility for on-site testing. Nonetheless, the diagnostic performance of RADT in detecting infectious individuals is yet to be fully determined. In this study, RT-qPCR and virus culture of RT-qPCR positive samples were used to evaluate and compare the perf","2021","07","02","J Clin Microbiol","Journal of clinical microbiology",NA,"Gieselmann","Lutz","Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne",NA
"2478","34213977","10.1128/JCM.00896-21","Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals.","The identification and isolation of highly infectious SARS-CoV-2-infected individuals is an important public health strategy. Rapid antigen detection tests (RADT) are promising candidates for large-scale screenings due to timely results and feasibility for on-site testing. Nonetheless, the diagnostic performance of RADT in detecting infectious individuals is yet to be fully determined. In this study, RT-qPCR and virus culture of RT-qPCR positive samples were used to evaluate and compare the perf","2021","07","02","J Clin Microbiol","Journal of clinical microbiology",NA,"Lehmann","Clara","German Center for Infection Research, Partner Site Bonn-Cologne",NA
"2479","34213977","10.1128/JCM.00896-21","Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals.","The identification and isolation of highly infectious SARS-CoV-2-infected individuals is an important public health strategy. Rapid antigen detection tests (RADT) are promising candidates for large-scale screenings due to timely results and feasibility for on-site testing. Nonetheless, the diagnostic performance of RADT in detecting infectious individuals is yet to be fully determined. In this study, RT-qPCR and virus culture of RT-qPCR positive samples were used to evaluate and compare the perf","2021","07","02","J Clin Microbiol","Journal of clinical microbiology",NA,"Fätkenheuer","Gerd","German Center for Infection Research, Partner Site Bonn-Cologne",NA
"2480","34213977","10.1128/JCM.00896-21","Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals.","The identification and isolation of highly infectious SARS-CoV-2-infected individuals is an important public health strategy. Rapid antigen detection tests (RADT) are promising candidates for large-scale screenings due to timely results and feasibility for on-site testing. Nonetheless, the diagnostic performance of RADT in detecting infectious individuals is yet to be fully determined. In this study, RT-qPCR and virus culture of RT-qPCR positive samples were used to evaluate and compare the perf","2021","07","02","J Clin Microbiol","Journal of clinical microbiology",NA,"Gruell","Henning","Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne",NA
"2481","34213977","10.1128/JCM.00896-21","Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals.","The identification and isolation of highly infectious SARS-CoV-2-infected individuals is an important public health strategy. Rapid antigen detection tests (RADT) are promising candidates for large-scale screenings due to timely results and feasibility for on-site testing. Nonetheless, the diagnostic performance of RADT in detecting infectious individuals is yet to be fully determined. In this study, RT-qPCR and virus culture of RT-qPCR positive samples were used to evaluate and compare the perf","2021","07","02","J Clin Microbiol","Journal of clinical microbiology",NA,"Pfeifer","Nico","Methods in Medical Informatics, Department of Computer Science, University of Tübingen",NA
"2482","34213977","10.1128/JCM.00896-21","Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals.","The identification and isolation of highly infectious SARS-CoV-2-infected individuals is an important public health strategy. Rapid antigen detection tests (RADT) are promising candidates for large-scale screenings due to timely results and feasibility for on-site testing. Nonetheless, the diagnostic performance of RADT in detecting infectious individuals is yet to be fully determined. In this study, RT-qPCR and virus culture of RT-qPCR positive samples were used to evaluate and compare the perf","2021","07","02","J Clin Microbiol","Journal of clinical microbiology",NA,"Heger","Eva","Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne",NA
"2483","34213977","10.1128/JCM.00896-21","Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals.","The identification and isolation of highly infectious SARS-CoV-2-infected individuals is an important public health strategy. Rapid antigen detection tests (RADT) are promising candidates for large-scale screenings due to timely results and feasibility for on-site testing. Nonetheless, the diagnostic performance of RADT in detecting infectious individuals is yet to be fully determined. In this study, RT-qPCR and virus culture of RT-qPCR positive samples were used to evaluate and compare the perf","2021","07","02","J Clin Microbiol","Journal of clinical microbiology",NA,"Klein","Florian","Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne",NA
"2484","34213965","10.1094/PDIS-05-21-1026-PDN","First Report of <i>Fusarium asiaticum</i> Causing Stem Rot of <i>Ligusticum chuanxiong</i> in China.","Ligusticum chuanxiong (known as Chuanxiong in China) is a traditional edible-medicinal herb, which has been playing important roles in fighting against COVID-19 (Ma et al. 2020). In March 2021, we investigated stem rot of Chuanxiong in six adjacent fields (~100 ha) in Chengdu, Sichuan Province, China. The disease incidence was above 5% in each field. Symptomatic plants showed stem rot, watersoaked lesions, and blackening with white hyphae present on the stems. Twelve symptomatic Chuanxion","2021","07","02","Plant Dis","Plant disease","&lt;italic&gt;Fusarium asiaticum&lt;/italic&gt;; &lt;italic&gt;Ligusticum chuanxiong&lt;/italic&gt;; Stem Rot","Zhu","Tingting","Institute of Urban Agriculture, Chinese Academy of Agricultural Sciences, Chengdu, China","zhutingting@caas.cn"
"2485","34213965","10.1094/PDIS-05-21-1026-PDN","First Report of <i>Fusarium asiaticum</i> Causing Stem Rot of <i>Ligusticum chuanxiong</i> in China.","Ligusticum chuanxiong (known as Chuanxiong in China) is a traditional edible-medicinal herb, which has been playing important roles in fighting against COVID-19 (Ma et al. 2020). In March 2021, we investigated stem rot of Chuanxiong in six adjacent fields (~100 ha) in Chengdu, Sichuan Province, China. The disease incidence was above 5% in each field. Symptomatic plants showed stem rot, watersoaked lesions, and blackening with white hyphae present on the stems. Twelve symptomatic Chuanxion","2021","07","02","Plant Dis","Plant disease","&lt;italic&gt;Fusarium asiaticum&lt;/italic&gt;; &lt;italic&gt;Ligusticum chuanxiong&lt;/italic&gt;; Stem Rot","Li","Linxuan","Institute of Urban Agriculture, Chinese Academy of Agricultural Sciences, Chengdu, China","lilinxuan@caas.cn"
"2486","34213965","10.1094/PDIS-05-21-1026-PDN","First Report of <i>Fusarium asiaticum</i> Causing Stem Rot of <i>Ligusticum chuanxiong</i> in China.","Ligusticum chuanxiong (known as Chuanxiong in China) is a traditional edible-medicinal herb, which has been playing important roles in fighting against COVID-19 (Ma et al. 2020). In March 2021, we investigated stem rot of Chuanxiong in six adjacent fields (~100 ha) in Chengdu, Sichuan Province, China. The disease incidence was above 5% in each field. Symptomatic plants showed stem rot, watersoaked lesions, and blackening with white hyphae present on the stems. Twelve symptomatic Chuanxion","2021","07","02","Plant Dis","Plant disease","&lt;italic&gt;Fusarium asiaticum&lt;/italic&gt;; &lt;italic&gt;Ligusticum chuanxiong&lt;/italic&gt;; Stem Rot","Petridis","Antonios","Department of Food Science, Aarhus University, Aarhus, Denmark","apetridis@food.au.dk"
"2487","34213965","10.1094/PDIS-05-21-1026-PDN","First Report of <i>Fusarium asiaticum</i> Causing Stem Rot of <i>Ligusticum chuanxiong</i> in China.","Ligusticum chuanxiong (known as Chuanxiong in China) is a traditional edible-medicinal herb, which has been playing important roles in fighting against COVID-19 (Ma et al. 2020). In March 2021, we investigated stem rot of Chuanxiong in six adjacent fields (~100 ha) in Chengdu, Sichuan Province, China. The disease incidence was above 5% in each field. Symptomatic plants showed stem rot, watersoaked lesions, and blackening with white hyphae present on the stems. Twelve symptomatic Chuanxion","2021","07","02","Plant Dis","Plant disease","&lt;italic&gt;Fusarium asiaticum&lt;/italic&gt;; &lt;italic&gt;Ligusticum chuanxiong&lt;/italic&gt;; Stem Rot","Xydis","George","Department of Business Development and Technology, Aarhus University, Herning, Denmark","gxydis@btech.au.dk"
"2488","34213965","10.1094/PDIS-05-21-1026-PDN","First Report of <i>Fusarium asiaticum</i> Causing Stem Rot of <i>Ligusticum chuanxiong</i> in China.","Ligusticum chuanxiong (known as Chuanxiong in China) is a traditional edible-medicinal herb, which has been playing important roles in fighting against COVID-19 (Ma et al. 2020). In March 2021, we investigated stem rot of Chuanxiong in six adjacent fields (~100 ha) in Chengdu, Sichuan Province, China. The disease incidence was above 5% in each field. Symptomatic plants showed stem rot, watersoaked lesions, and blackening with white hyphae present on the stems. Twelve symptomatic Chuanxion","2021","07","02","Plant Dis","Plant disease","&lt;italic&gt;Fusarium asiaticum&lt;/italic&gt;; &lt;italic&gt;Ligusticum chuanxiong&lt;/italic&gt;; Stem Rot","Ren","Maozhi","Institute of Urban Agriculture, Chinese Academy of Agricultural Sciences, Chengdu, China","renmaozhi01@caas.cn"
"2489","34213885","10.1021/acs.jmedchem.1c00319","Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.","A series of nondeuterated and deuterated dipeptidyl aldehyde and masked aldehyde inhibitors that incorporate in their structure a conformationally constrained cyclohexane moiety was synthesized and found to potently inhibit severe acute respiratory syndrome coronavirus-2 3CL protease in biochemical and cell-based assays. Several of the inhibitors were also found to be nanomolar inhibitors of Middle East respiratory syndrome coronavirus 3CL protease. The corresponding latent aldehyde bisulfite ad","2021","07","23","J Med Chem","Journal of medicinal chemistry",NA,"Dampalla","Chamandi S","Department of Chemistry, Wichita State University, Wichita, Kansas 67260, United States",NA
"2490","34213885","10.1021/acs.jmedchem.1c00319","Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.","A series of nondeuterated and deuterated dipeptidyl aldehyde and masked aldehyde inhibitors that incorporate in their structure a conformationally constrained cyclohexane moiety was synthesized and found to potently inhibit severe acute respiratory syndrome coronavirus-2 3CL protease in biochemical and cell-based assays. Several of the inhibitors were also found to be nanomolar inhibitors of Middle East respiratory syndrome coronavirus 3CL protease. The corresponding latent aldehyde bisulfite ad","2021","07","23","J Med Chem","Journal of medicinal chemistry",NA,"Kim","Yunjeong","Department of Diagnostic Medicine &amp",NA
"2491","34213885","10.1021/acs.jmedchem.1c00319","Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.","A series of nondeuterated and deuterated dipeptidyl aldehyde and masked aldehyde inhibitors that incorporate in their structure a conformationally constrained cyclohexane moiety was synthesized and found to potently inhibit severe acute respiratory syndrome coronavirus-2 3CL protease in biochemical and cell-based assays. Several of the inhibitors were also found to be nanomolar inhibitors of Middle East respiratory syndrome coronavirus 3CL protease. The corresponding latent aldehyde bisulfite ad","2021","07","23","J Med Chem","Journal of medicinal chemistry",NA,"Bickmeier","Naemi","Department of Diagnostic Medicine &amp",NA
"2492","34213885","10.1021/acs.jmedchem.1c00319","Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.","A series of nondeuterated and deuterated dipeptidyl aldehyde and masked aldehyde inhibitors that incorporate in their structure a conformationally constrained cyclohexane moiety was synthesized and found to potently inhibit severe acute respiratory syndrome coronavirus-2 3CL protease in biochemical and cell-based assays. Several of the inhibitors were also found to be nanomolar inhibitors of Middle East respiratory syndrome coronavirus 3CL protease. The corresponding latent aldehyde bisulfite ad","2021","07","23","J Med Chem","Journal of medicinal chemistry",NA,"Rathnayake","Athri D","Department of Chemistry, Wichita State University, Wichita, Kansas 67260, United States",NA
"2493","34213885","10.1021/acs.jmedchem.1c00319","Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.","A series of nondeuterated and deuterated dipeptidyl aldehyde and masked aldehyde inhibitors that incorporate in their structure a conformationally constrained cyclohexane moiety was synthesized and found to potently inhibit severe acute respiratory syndrome coronavirus-2 3CL protease in biochemical and cell-based assays. Several of the inhibitors were also found to be nanomolar inhibitors of Middle East respiratory syndrome coronavirus 3CL protease. The corresponding latent aldehyde bisulfite ad","2021","07","23","J Med Chem","Journal of medicinal chemistry",NA,"Nguyen","Harry Nhat","Department of Chemistry, Wichita State University, Wichita, Kansas 67260, United States",NA
"2494","34213885","10.1021/acs.jmedchem.1c00319","Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.","A series of nondeuterated and deuterated dipeptidyl aldehyde and masked aldehyde inhibitors that incorporate in their structure a conformationally constrained cyclohexane moiety was synthesized and found to potently inhibit severe acute respiratory syndrome coronavirus-2 3CL protease in biochemical and cell-based assays. Several of the inhibitors were also found to be nanomolar inhibitors of Middle East respiratory syndrome coronavirus 3CL protease. The corresponding latent aldehyde bisulfite ad","2021","07","23","J Med Chem","Journal of medicinal chemistry",NA,"Zheng","Jian","Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, United States",NA
"2495","34213885","10.1021/acs.jmedchem.1c00319","Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.","A series of nondeuterated and deuterated dipeptidyl aldehyde and masked aldehyde inhibitors that incorporate in their structure a conformationally constrained cyclohexane moiety was synthesized and found to potently inhibit severe acute respiratory syndrome coronavirus-2 3CL protease in biochemical and cell-based assays. Several of the inhibitors were also found to be nanomolar inhibitors of Middle East respiratory syndrome coronavirus 3CL protease. The corresponding latent aldehyde bisulfite ad","2021","07","23","J Med Chem","Journal of medicinal chemistry",NA,"Kashipathy","Maithri M","Protein Structure Laboratory, The University of Kansas, Lawrence, Kansas 66047, United States",NA
"2496","34213885","10.1021/acs.jmedchem.1c00319","Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.","A series of nondeuterated and deuterated dipeptidyl aldehyde and masked aldehyde inhibitors that incorporate in their structure a conformationally constrained cyclohexane moiety was synthesized and found to potently inhibit severe acute respiratory syndrome coronavirus-2 3CL protease in biochemical and cell-based assays. Several of the inhibitors were also found to be nanomolar inhibitors of Middle East respiratory syndrome coronavirus 3CL protease. The corresponding latent aldehyde bisulfite ad","2021","07","23","J Med Chem","Journal of medicinal chemistry",NA,"Baird","Matthew A","Department of Chemistry, Wichita State University, Wichita, Kansas 67260, United States",NA
"2497","34213885","10.1021/acs.jmedchem.1c00319","Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.","A series of nondeuterated and deuterated dipeptidyl aldehyde and masked aldehyde inhibitors that incorporate in their structure a conformationally constrained cyclohexane moiety was synthesized and found to potently inhibit severe acute respiratory syndrome coronavirus-2 3CL protease in biochemical and cell-based assays. Several of the inhibitors were also found to be nanomolar inhibitors of Middle East respiratory syndrome coronavirus 3CL protease. The corresponding latent aldehyde bisulfite ad","2021","07","23","J Med Chem","Journal of medicinal chemistry",NA,"Battaile","Kevin P","NYX, New York Structural Biology Center, Upton, New York 11973, United States",NA
"2498","34213885","10.1021/acs.jmedchem.1c00319","Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.","A series of nondeuterated and deuterated dipeptidyl aldehyde and masked aldehyde inhibitors that incorporate in their structure a conformationally constrained cyclohexane moiety was synthesized and found to potently inhibit severe acute respiratory syndrome coronavirus-2 3CL protease in biochemical and cell-based assays. Several of the inhibitors were also found to be nanomolar inhibitors of Middle East respiratory syndrome coronavirus 3CL protease. The corresponding latent aldehyde bisulfite ad","2021","07","23","J Med Chem","Journal of medicinal chemistry",NA,"Lovell","Scott","Protein Structure Laboratory, The University of Kansas, Lawrence, Kansas 66047, United States",NA
"2499","34213885","10.1021/acs.jmedchem.1c00319","Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.","A series of nondeuterated and deuterated dipeptidyl aldehyde and masked aldehyde inhibitors that incorporate in their structure a conformationally constrained cyclohexane moiety was synthesized and found to potently inhibit severe acute respiratory syndrome coronavirus-2 3CL protease in biochemical and cell-based assays. Several of the inhibitors were also found to be nanomolar inhibitors of Middle East respiratory syndrome coronavirus 3CL protease. The corresponding latent aldehyde bisulfite ad","2021","07","23","J Med Chem","Journal of medicinal chemistry",NA,"Perlman","Stanley","Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, United States",NA
"2500","34213885","10.1021/acs.jmedchem.1c00319","Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.","A series of nondeuterated and deuterated dipeptidyl aldehyde and masked aldehyde inhibitors that incorporate in their structure a conformationally constrained cyclohexane moiety was synthesized and found to potently inhibit severe acute respiratory syndrome coronavirus-2 3CL protease in biochemical and cell-based assays. Several of the inhibitors were also found to be nanomolar inhibitors of Middle East respiratory syndrome coronavirus 3CL protease. The corresponding latent aldehyde bisulfite ad","2021","07","23","J Med Chem","Journal of medicinal chemistry",NA,"Chang","Kyeong-Ok","Department of Diagnostic Medicine &amp",NA
"2501","34213885","10.1021/acs.jmedchem.1c00319","Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.","A series of nondeuterated and deuterated dipeptidyl aldehyde and masked aldehyde inhibitors that incorporate in their structure a conformationally constrained cyclohexane moiety was synthesized and found to potently inhibit severe acute respiratory syndrome coronavirus-2 3CL protease in biochemical and cell-based assays. Several of the inhibitors were also found to be nanomolar inhibitors of Middle East respiratory syndrome coronavirus 3CL protease. The corresponding latent aldehyde bisulfite ad","2021","07","23","J Med Chem","Journal of medicinal chemistry",NA,"Groutas","William C","Department of Chemistry, Wichita State University, Wichita, Kansas 67260, United States",NA
"2502","34213849","10.5802/crbiol.53","Structure-function relations of the SARS-CoV-2 spike protein and impact of mutations in the variants of concern.","This review covers the main features of the severe acquired respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, its interaction with the main entry receptor, the human angiotensin converting enzyme 2 (ACE2), and the subsequent membrane fusion step. The focus is on the structural organization of these proteins and mechanistic aspects of their interactions that lead to cytoplasmic release of the viral genome. The most potently neutralizing antibodies against SARS-CoV-2 were shown to int","2021","07","06","C R Biol","Comptes rendus biologies","ACE2 receptor; Escape mutations; Membrane fusion; Neutralization by antibodies; SARS-CoV-2; Spike protein; Variants of concern; COVID-19; Humans; Mutation; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Rey","Félix","Unité de Virologie Structurale, CNRS UMR 3569, Institut Pasteur, 28 rue du Dr Roux, 75015 Paris, France",NA
"2503","34213848","10.5802/crbiol.35","SARS-CoV-2 vaccines, where do we stand?","Vaccination against the SARS-CoV-2, the virus responsible for the Covid-19 pandemic, represents a major infection control strategy in the absence of effective treatment of the disease to date. Unprecedented mobilization has led to the development of a large number of projects, some of which have already been in test in humans for several months. The first efficacy and safety data are expected in the coming weeks. New vaccine technologies are being evaluated (RNA, replicating or non-replicating v","2021","07","06","C R Biol","Comptes rendus biologies","Adenoviral vectors; Covid-19; Elinical trial; Messenger; SARS-CoV2; Spike; Vaccine ARN; COVID-19; COVID-19 Vaccines; Humans; Pandemics; SARS-CoV-2; Vaccines","Fischer","Alain","Collège de France, Paris, France",NA
"2504","34213847","10.5802/crbiol.38","COVID-19 and drugs: pathophysiology and therapeutic approaches.","This review provides an update on the different therapeutic approaches that have been used to treat SARS-CoV-2 infection, as well as, the resulting paradoxical inflammation disorders. Cette revue fait le point sur les différentes approches thérapeutiques qui ont été suivies pour traiter linfection à SARS-CoV-2, ainsi que les troubles liés à linflammation paradoxale qui en découlent.","2021","07","06","C R Biol","Comptes rendus biologies","Anti-inflammatory drugs; Anticoagulant drugs; Antiviral drugs; Cytokinic storm; SARS-CoV-2 viral cycle; Antiviral Agents; COVID-19; Humans; Pharmaceutical Preparations; SARS-CoV-2","Couvreur","Patrick","Académie des Sciences, 75006 Paris, France et Institut Galien Paris-Sud, CNRS UMR 8612, Université Paris-Sud, Université Paris-Saclay, 92296 Châtenay-Malabry, France",NA
"2505","34213847","10.5802/crbiol.38","COVID-19 and drugs: pathophysiology and therapeutic approaches.","This review provides an update on the different therapeutic approaches that have been used to treat SARS-CoV-2 infection, as well as, the resulting paradoxical inflammation disorders. Cette revue fait le point sur les différentes approches thérapeutiques qui ont été suivies pour traiter linfection à SARS-CoV-2, ainsi que les troubles liés à linflammation paradoxale qui en découlent.","2021","07","06","C R Biol","Comptes rendus biologies","Anti-inflammatory drugs; Anticoagulant drugs; Antiviral drugs; Cytokinic storm; SARS-CoV-2 viral cycle; Antiviral Agents; COVID-19; Humans; Pharmaceutical Preparations; SARS-CoV-2","Louvard","Daniel","Académie des Sciences, 75006 Paris, France et CNRS UMR 144 Institut Curie, 12 Rue Lhomond, 75005 Paris, France",NA
"2506","34213846","10.5802/crbiol.36","Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia.","We established the COVID Human Genetic Effort (www.covidhge.com) to discover the human genetic and immunological bases of the vast interindividual clinical variability between humans infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We found that about 3% of patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia were ill because of inborn errors of genes controlling type I interferon (IFN)-dependent immunity (which controls influenza virus), and at","2021","07","06","C R Biol","Comptes rendus biologies","Autoantibodies; Inborn errors of immunity; Life-threatening COVID-19; Pneumonia; Type I interferons; COVID-19; Humans; Interferon Type I; Pneumonia; SARS-CoV-2","Bastard","Paul","Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Inserm U1163, Necker Hospital for Sick Children, Paris, France",NA
"2507","34213846","10.5802/crbiol.36","Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia.","We established the COVID Human Genetic Effort (www.covidhge.com) to discover the human genetic and immunological bases of the vast interindividual clinical variability between humans infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We found that about 3% of patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia were ill because of inborn errors of genes controlling type I interferon (IFN)-dependent immunity (which controls influenza virus), and at","2021","07","06","C R Biol","Comptes rendus biologies","Autoantibodies; Inborn errors of immunity; Life-threatening COVID-19; Pneumonia; Type I interferons; COVID-19; Humans; Interferon Type I; Pneumonia; SARS-CoV-2","Zhang","Qian","St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA",NA
"2508","34213846","10.5802/crbiol.36","Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia.","We established the COVID Human Genetic Effort (www.covidhge.com) to discover the human genetic and immunological bases of the vast interindividual clinical variability between humans infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We found that about 3% of patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia were ill because of inborn errors of genes controlling type I interferon (IFN)-dependent immunity (which controls influenza virus), and at","2021","07","06","C R Biol","Comptes rendus biologies","Autoantibodies; Inborn errors of immunity; Life-threatening COVID-19; Pneumonia; Type I interferons; COVID-19; Humans; Interferon Type I; Pneumonia; SARS-CoV-2","Cobat","Aurélie","Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Inserm U1163, Necker Hospital for Sick Children, Paris, France",NA
"2509","34213846","10.5802/crbiol.36","Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia.","We established the COVID Human Genetic Effort (www.covidhge.com) to discover the human genetic and immunological bases of the vast interindividual clinical variability between humans infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We found that about 3% of patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia were ill because of inborn errors of genes controlling type I interferon (IFN)-dependent immunity (which controls influenza virus), and at","2021","07","06","C R Biol","Comptes rendus biologies","Autoantibodies; Inborn errors of immunity; Life-threatening COVID-19; Pneumonia; Type I interferons; COVID-19; Humans; Interferon Type I; Pneumonia; SARS-CoV-2","Jouanguy","Emmanuelle","Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Inserm U1163, Necker Hospital for Sick Children, Paris, France",NA
"2510","34213846","10.5802/crbiol.36","Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia.","We established the COVID Human Genetic Effort (www.covidhge.com) to discover the human genetic and immunological bases of the vast interindividual clinical variability between humans infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We found that about 3% of patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia were ill because of inborn errors of genes controlling type I interferon (IFN)-dependent immunity (which controls influenza virus), and at","2021","07","06","C R Biol","Comptes rendus biologies","Autoantibodies; Inborn errors of immunity; Life-threatening COVID-19; Pneumonia; Type I interferons; COVID-19; Humans; Interferon Type I; Pneumonia; SARS-CoV-2","Zhang","Shen-Ying","Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Inserm U1163, Necker Hospital for Sick Children, Paris, France",NA
"2511","34213846","10.5802/crbiol.36","Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia.","We established the COVID Human Genetic Effort (www.covidhge.com) to discover the human genetic and immunological bases of the vast interindividual clinical variability between humans infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We found that about 3% of patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia were ill because of inborn errors of genes controlling type I interferon (IFN)-dependent immunity (which controls influenza virus), and at","2021","07","06","C R Biol","Comptes rendus biologies","Autoantibodies; Inborn errors of immunity; Life-threatening COVID-19; Pneumonia; Type I interferons; COVID-19; Humans; Interferon Type I; Pneumonia; SARS-CoV-2","Abel","Laurent","Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Inserm U1163, Necker Hospital for Sick Children, Paris, France",NA
"2512","34213846","10.5802/crbiol.36","Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia.","We established the COVID Human Genetic Effort (www.covidhge.com) to discover the human genetic and immunological bases of the vast interindividual clinical variability between humans infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We found that about 3% of patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia were ill because of inborn errors of genes controlling type I interferon (IFN)-dependent immunity (which controls influenza virus), and at","2021","07","06","C R Biol","Comptes rendus biologies","Autoantibodies; Inborn errors of immunity; Life-threatening COVID-19; Pneumonia; Type I interferons; COVID-19; Humans; Interferon Type I; Pneumonia; SARS-CoV-2","Casanova","Jean-Laurent","Howard Hughes Medical Institute, New York, NY, USA",NA
"2513","34213845","10.5802/crbiol.41","COVID-19: individual and herd immunity.","Immunity to the SARS-CoV-2 virus ensures protection against reinfection by this virus thanks to the combined action of neutralizing antibodies and T lymphocytes specific to viral proteins, in particular the Spike protein. It must be distinguished from the immune response that ensures healing of the infection following contamination that involves innate immunity, particularly type 1 interferons, and which is followed by adaptive cellular and humoral immunity. The importance of the effect of inter","2021","07","06","C R Biol","Comptes rendus biologies","Antibodies; COVID-19; Herd immunity; Individual immunity; SARS-CoV-2; T lymphocytes; Antibodies, Neutralizing; COVID-19; Humans; Immunity, Herd; SARS-CoV-2","Bach","Jean-François","Institut Necker-Enfants Malades, CNRS UMR8253, Inserm UMR1151, Paris, France",NA
"2514","34213845","10.5802/crbiol.41","COVID-19: individual and herd immunity.","Immunity to the SARS-CoV-2 virus ensures protection against reinfection by this virus thanks to the combined action of neutralizing antibodies and T lymphocytes specific to viral proteins, in particular the Spike protein. It must be distinguished from the immune response that ensures healing of the infection following contamination that involves innate immunity, particularly type 1 interferons, and which is followed by adaptive cellular and humoral immunity. The importance of the effect of inter","2021","07","06","C R Biol","Comptes rendus biologies","Antibodies; COVID-19; Herd immunity; Individual immunity; SARS-CoV-2; T lymphocytes; Antibodies, Neutralizing; COVID-19; Humans; Immunity, Herd; SARS-CoV-2","Berche","Patrick","Université de Paris, Paris, France",NA
"2515","34213845","10.5802/crbiol.41","COVID-19: individual and herd immunity.","Immunity to the SARS-CoV-2 virus ensures protection against reinfection by this virus thanks to the combined action of neutralizing antibodies and T lymphocytes specific to viral proteins, in particular the Spike protein. It must be distinguished from the immune response that ensures healing of the infection following contamination that involves innate immunity, particularly type 1 interferons, and which is followed by adaptive cellular and humoral immunity. The importance of the effect of inter","2021","07","06","C R Biol","Comptes rendus biologies","Antibodies; COVID-19; Herd immunity; Individual immunity; SARS-CoV-2; T lymphocytes; Antibodies, Neutralizing; COVID-19; Humans; Immunity, Herd; SARS-CoV-2","Chatenoud","Lucienne","Institut Necker-Enfants Malades, CNRS UMR8253, Inserm UMR1151, Paris, France",NA
"2516","34213845","10.5802/crbiol.41","COVID-19: individual and herd immunity.","Immunity to the SARS-CoV-2 virus ensures protection against reinfection by this virus thanks to the combined action of neutralizing antibodies and T lymphocytes specific to viral proteins, in particular the Spike protein. It must be distinguished from the immune response that ensures healing of the infection following contamination that involves innate immunity, particularly type 1 interferons, and which is followed by adaptive cellular and humoral immunity. The importance of the effect of inter","2021","07","06","C R Biol","Comptes rendus biologies","Antibodies; COVID-19; Herd immunity; Individual immunity; SARS-CoV-2; T lymphocytes; Antibodies, Neutralizing; COVID-19; Humans; Immunity, Herd; SARS-CoV-2","Costagliola","Dominique","Sorbonne Université, Inserm, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France",NA
"2517","34213845","10.5802/crbiol.41","COVID-19: individual and herd immunity.","Immunity to the SARS-CoV-2 virus ensures protection against reinfection by this virus thanks to the combined action of neutralizing antibodies and T lymphocytes specific to viral proteins, in particular the Spike protein. It must be distinguished from the immune response that ensures healing of the infection following contamination that involves innate immunity, particularly type 1 interferons, and which is followed by adaptive cellular and humoral immunity. The importance of the effect of inter","2021","07","06","C R Biol","Comptes rendus biologies","Antibodies; COVID-19; Herd immunity; Individual immunity; SARS-CoV-2; T lymphocytes; Antibodies, Neutralizing; COVID-19; Humans; Immunity, Herd; SARS-CoV-2","Valleron","Alain-Jacques","Inserm U1195, Bâtiment Pincus - Hôpital du Kremlin-Bicêtre, 80 rue du Gal Leclerc 94276 Le Kremlin Bicêtre, France",NA
"2518","34213844","10.5802/crbiol.51","The corona virus SARS-CoV-2 and the pandemic Covid19.",NA,"2021","07","08","C R Biol","Comptes rendus biologies","COVID-19; Humans; Pandemics; SARS-CoV-2","Cossart","Pascale","Académie des Sciences, Quai Conti, Paris 75015, France",NA
"2519","34213804","10.1002/jum.15775","Renal Resistive Index: Not Only for Kidney Clinics.","Renal Resistive Index (RRI) is a measurement of the resistance of the renal blood flow. A value higher than 0.70 is a marker of increased resistance and is correlated with kidney injury and its severity. Additionally, it may be associated with the mortality rate in the post-surgery population. In COVID-19 subjects, we found that high RRI has been associated with high levels of serum C-reactive protein, a marker of systemic inflammatory reaction syndrome. Finally, we propose RRI not only as a mar","2021","07","02","J Ultrasound Med","Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine","C-reactive protein; COVID-19; acute kidney injury; hemodynamics; systemic inflammatory response syndrome; ultrasounds","Giustiniano","Enrico","Department of Anesthesia and Intensive Care - IRCCS, Humanitas Clinical and Research Hospital, Milan, Italy",NA
"2520","34213804","10.1002/jum.15775","Renal Resistive Index: Not Only for Kidney Clinics.","Renal Resistive Index (RRI) is a measurement of the resistance of the renal blood flow. A value higher than 0.70 is a marker of increased resistance and is correlated with kidney injury and its severity. Additionally, it may be associated with the mortality rate in the post-surgery population. In COVID-19 subjects, we found that high RRI has been associated with high levels of serum C-reactive protein, a marker of systemic inflammatory reaction syndrome. Finally, we propose RRI not only as a mar","2021","07","02","J Ultrasound Med","Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine","C-reactive protein; COVID-19; acute kidney injury; hemodynamics; systemic inflammatory response syndrome; ultrasounds","Pugliese","Luca","Department of Anesthesia and Intensive Care - IRCCS, Humanitas Clinical and Research Hospital, Milan, Italy",NA
"2521","34213804","10.1002/jum.15775","Renal Resistive Index: Not Only for Kidney Clinics.","Renal Resistive Index (RRI) is a measurement of the resistance of the renal blood flow. A value higher than 0.70 is a marker of increased resistance and is correlated with kidney injury and its severity. Additionally, it may be associated with the mortality rate in the post-surgery population. In COVID-19 subjects, we found that high RRI has been associated with high levels of serum C-reactive protein, a marker of systemic inflammatory reaction syndrome. Finally, we propose RRI not only as a mar","2021","07","02","J Ultrasound Med","Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine","C-reactive protein; COVID-19; acute kidney injury; hemodynamics; systemic inflammatory response syndrome; ultrasounds","Calabrò","Lorenzo","Department of Anesthesia and Intensive Care - IRCCS, Humanitas Clinical and Research Hospital, Milan, Italy",NA
"2522","34213804","10.1002/jum.15775","Renal Resistive Index: Not Only for Kidney Clinics.","Renal Resistive Index (RRI) is a measurement of the resistance of the renal blood flow. A value higher than 0.70 is a marker of increased resistance and is correlated with kidney injury and its severity. Additionally, it may be associated with the mortality rate in the post-surgery population. In COVID-19 subjects, we found that high RRI has been associated with high levels of serum C-reactive protein, a marker of systemic inflammatory reaction syndrome. Finally, we propose RRI not only as a mar","2021","07","02","J Ultrasound Med","Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine","C-reactive protein; COVID-19; acute kidney injury; hemodynamics; systemic inflammatory response syndrome; ultrasounds","Nisi","Fulvio","Department of Anesthesia and Intensive Care - IRCCS, Humanitas Clinical and Research Hospital, Milan, Italy",NA
"2523","34213803","10.1002/jcla.23888","The Hologic Aptima SARS-CoV-2 assay enables high ratio pooling saving reagents and improving turnaround time.","The Hologic Aptima TMA SARS-CoV-2 assay was employed to test pooled nasopharyngeal (NP) samples to evaluate the performance of pooled sample testing and characterize variables influencing results. Results on 1033 previously tested NP samples were retrieved to characterize the relative light units (RLU) of SARS-CoV-2-positive samples in the tested population. The pooling strategy of combining 10 SARS-CoV-2 samples into one pool (10/1) was used in this study. The results were compared with neat s","2021","07","02","J Clin Lab Anal","Journal of clinical laboratory analysis","SARS-CoV-2; pooling samples; screening test; transcription-mediated amplification","Newsom","Kimberly","Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA",NA
"2524","34213803","10.1002/jcla.23888","The Hologic Aptima SARS-CoV-2 assay enables high ratio pooling saving reagents and improving turnaround time.","The Hologic Aptima TMA SARS-CoV-2 assay was employed to test pooled nasopharyngeal (NP) samples to evaluate the performance of pooled sample testing and characterize variables influencing results. Results on 1033 previously tested NP samples were retrieved to characterize the relative light units (RLU) of SARS-CoV-2-positive samples in the tested population. The pooling strategy of combining 10 SARS-CoV-2 samples into one pool (10/1) was used in this study. The results were compared with neat s","2021","07","02","J Clin Lab Anal","Journal of clinical laboratory analysis","SARS-CoV-2; pooling samples; screening test; transcription-mediated amplification","Zhang","Yuan","Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA",NA
"2525","34213803","10.1002/jcla.23888","The Hologic Aptima SARS-CoV-2 assay enables high ratio pooling saving reagents and improving turnaround time.","The Hologic Aptima TMA SARS-CoV-2 assay was employed to test pooled nasopharyngeal (NP) samples to evaluate the performance of pooled sample testing and characterize variables influencing results. Results on 1033 previously tested NP samples were retrieved to characterize the relative light units (RLU) of SARS-CoV-2-positive samples in the tested population. The pooling strategy of combining 10 SARS-CoV-2 samples into one pool (10/1) was used in this study. The results were compared with neat s","2021","07","02","J Clin Lab Anal","Journal of clinical laboratory analysis","SARS-CoV-2; pooling samples; screening test; transcription-mediated amplification","Chamala","Srikar","Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA",NA
"2526","34213803","10.1002/jcla.23888","The Hologic Aptima SARS-CoV-2 assay enables high ratio pooling saving reagents and improving turnaround time.","The Hologic Aptima TMA SARS-CoV-2 assay was employed to test pooled nasopharyngeal (NP) samples to evaluate the performance of pooled sample testing and characterize variables influencing results. Results on 1033 previously tested NP samples were retrieved to characterize the relative light units (RLU) of SARS-CoV-2-positive samples in the tested population. The pooling strategy of combining 10 SARS-CoV-2 samples into one pool (10/1) was used in this study. The results were compared with neat s","2021","07","02","J Clin Lab Anal","Journal of clinical laboratory analysis","SARS-CoV-2; pooling samples; screening test; transcription-mediated amplification","Martinez","Katherine","Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA",NA
"2527","34213803","10.1002/jcla.23888","The Hologic Aptima SARS-CoV-2 assay enables high ratio pooling saving reagents and improving turnaround time.","The Hologic Aptima TMA SARS-CoV-2 assay was employed to test pooled nasopharyngeal (NP) samples to evaluate the performance of pooled sample testing and characterize variables influencing results. Results on 1033 previously tested NP samples were retrieved to characterize the relative light units (RLU) of SARS-CoV-2-positive samples in the tested population. The pooling strategy of combining 10 SARS-CoV-2 samples into one pool (10/1) was used in this study. The results were compared with neat s","2021","07","02","J Clin Lab Anal","Journal of clinical laboratory analysis","SARS-CoV-2; pooling samples; screening test; transcription-mediated amplification","Clare-Salzler","Michael","Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA",NA
"2528","34213803","10.1002/jcla.23888","The Hologic Aptima SARS-CoV-2 assay enables high ratio pooling saving reagents and improving turnaround time.","The Hologic Aptima TMA SARS-CoV-2 assay was employed to test pooled nasopharyngeal (NP) samples to evaluate the performance of pooled sample testing and characterize variables influencing results. Results on 1033 previously tested NP samples were retrieved to characterize the relative light units (RLU) of SARS-CoV-2-positive samples in the tested population. The pooling strategy of combining 10 SARS-CoV-2 samples into one pool (10/1) was used in this study. The results were compared with neat s","2021","07","02","J Clin Lab Anal","Journal of clinical laboratory analysis","SARS-CoV-2; pooling samples; screening test; transcription-mediated amplification","Starostik","Petr","Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA",NA
"2529","34213801","10.1002/bies.202000211","Does chronic inflammation cause acute inflammation to spiral into hyper-inflammation in a manner modulated by diet and the gut microbiome, in severe Covid-19?","We propose that hyper-inflammation (HYPi) is a ''runaway'' consequence of acute inflammation (ACUi) that arises more easily (and also abates less easily) in those who host a pre-existing chronic inflammation (CHRi), because (i) most factors involved in generating an ACUi to limit viral proliferation are already present when there is an underlying CHRi, and also because (ii) anti-inflammatory (AI) mechanisms for the abatement of ACUi (following containment of viral proliferation) are suppressed a","2021","07","02","Bioessays","BioEssays : news and reviews in molecular, cellular and developmental biology","Acute inflammation; Chronic inflammation; Covid-19; Cytokine storm; Diet; Gut inflammation; Gut microbiome; Hyperinflammation; Systemic inflammation","Luthra-Guptasarma","Manni","Department of Immunopathology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India",NA
"2530","34213801","10.1002/bies.202000211","Does chronic inflammation cause acute inflammation to spiral into hyper-inflammation in a manner modulated by diet and the gut microbiome, in severe Covid-19?","We propose that hyper-inflammation (HYPi) is a ''runaway'' consequence of acute inflammation (ACUi) that arises more easily (and also abates less easily) in those who host a pre-existing chronic inflammation (CHRi), because (i) most factors involved in generating an ACUi to limit viral proliferation are already present when there is an underlying CHRi, and also because (ii) anti-inflammatory (AI) mechanisms for the abatement of ACUi (following containment of viral proliferation) are suppressed a","2021","07","02","Bioessays","BioEssays : news and reviews in molecular, cellular and developmental biology","Acute inflammation; Chronic inflammation; Covid-19; Cytokine storm; Diet; Gut inflammation; Gut microbiome; Hyperinflammation; Systemic inflammation","Guptasarma","Purnananda","Centre for Protein Science, Design and Engineering, Department of Biological Sciences, Indian Institute of Science Education and Research (IISER) Mohali, SAS Nagar, Punjab, India",NA
"2531","34213786","10.1111/ijd.15749","COVID-19 skin lesions are rarely positive at RT-PCR test: the macrophage activation with vascular impact and SARS-CoV-2-induced cytokine storm.","Several skin manifestations have been reported since the start of the COVID-19 pandemic: chilblains-like, livedoid lesions, urticaria-like, pseudo-Kawasaki disease, and others. Histopathologic images of these lesions most often show aspects of endothelitis, images similar to autoimmune vasculitis. Cutaneous lesions are often negative at RT-PCR for SARS-CoV-2 virus. We reviewed recent articles on the mechanisms of COVID-19 and we synthesized main pathways of inflammatory cascade. After the penetr","2021","07","02","Int J Dermatol","International journal of dermatology",NA,"Ionescu","Marius-Anton","Dermatology Department, University Hospital ""Saint Louis"", Paris, France",NA
"2532","34213779","10.1002/jmv.27174","Derangements of biochemical markers and thyroid function analysis among COVID-19-positive patients: A developing country single-center experience.",NA,"2021","07","08","J Med Virol","Journal of medical virology",NA,"Asghar","Muhammad Sohaib","Dow University of Health Sciences-Ojha Campus, Karachi, Pakistan",NA
"2533","34213779","10.1002/jmv.27174","Derangements of biochemical markers and thyroid function analysis among COVID-19-positive patients: A developing country single-center experience.",NA,"2021","07","08","J Med Virol","Journal of medical virology",NA,"Yasmin","Farah","Dow University of Health Sciences, Karachi, Pakistan",NA
"2534","34213779","10.1002/jmv.27174","Derangements of biochemical markers and thyroid function analysis among COVID-19-positive patients: A developing country single-center experience.",NA,"2021","07","08","J Med Virol","Journal of medical virology",NA,"Dapke","Kartik","Indira Gandhi Government Medical College, Nagpur, India",NA
"2535","34213779","10.1002/jmv.27174","Derangements of biochemical markers and thyroid function analysis among COVID-19-positive patients: A developing country single-center experience.",NA,"2021","07","08","J Med Virol","Journal of medical virology",NA,"Phadke","Rachana","Indira Gandhi Government Medical College, Nagpur, India",NA
"2536","34213779","10.1002/jmv.27174","Derangements of biochemical markers and thyroid function analysis among COVID-19-positive patients: A developing country single-center experience.",NA,"2021","07","08","J Med Virol","Journal of medical virology",NA,"Shah","Syed Muhammad Ismail","Ziauddin Medical University, Karachi, Pakistan",NA
"2537","34213779","10.1002/jmv.27174","Derangements of biochemical markers and thyroid function analysis among COVID-19-positive patients: A developing country single-center experience.",NA,"2021","07","08","J Med Virol","Journal of medical virology",NA,"Bin Zafar","Muhammad Daim","Dow University of Health Sciences, Karachi, Pakistan",NA
"2538","34213771","10.1002/ijgo.13811","COVID-19-related deaths among women of reproductive age in Brazil: The burden of postpartum.","To compare risk of death due to COVID-19 among pregnant, postpartum, and non-pregnant women of reproductive age in Brazil, using the severe acute respiratory syndrome surveillance system (SARS-SS). A secondary analysis was performed of the Brazilian official SARS-SS, with data retrieved up to August 17, 2020. Cases were stratified by pregnancy status, risk factors or co-morbidities, and outcome (death or recovery). Multiple logistic regression was employed to examine associations between indepen","2021","07","19","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; cardiovascular disease; maternal death; obesity; postpartum; pregnancy; women of reproductive age","Knobel","Roxana","Department of Gynecology and Obstetrics, Federal University of Santa Catarina (UFSC, Florianopolis, Santa Catarina, Brazil",NA
"2539","34213771","10.1002/ijgo.13811","COVID-19-related deaths among women of reproductive age in Brazil: The burden of postpartum.","To compare risk of death due to COVID-19 among pregnant, postpartum, and non-pregnant women of reproductive age in Brazil, using the severe acute respiratory syndrome surveillance system (SARS-SS). A secondary analysis was performed of the Brazilian official SARS-SS, with data retrieved up to August 17, 2020. Cases were stratified by pregnancy status, risk factors or co-morbidities, and outcome (death or recovery). Multiple logistic regression was employed to examine associations between indepen","2021","07","19","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; cardiovascular disease; maternal death; obesity; postpartum; pregnancy; women of reproductive age","Takemoto","Maíra L S","São Paulo State University (UNESP, Medical School of Botucatu, Botucatu, São Paulo, Brazil",NA
"2540","34213771","10.1002/ijgo.13811","COVID-19-related deaths among women of reproductive age in Brazil: The burden of postpartum.","To compare risk of death due to COVID-19 among pregnant, postpartum, and non-pregnant women of reproductive age in Brazil, using the severe acute respiratory syndrome surveillance system (SARS-SS). A secondary analysis was performed of the Brazilian official SARS-SS, with data retrieved up to August 17, 2020. Cases were stratified by pregnancy status, risk factors or co-morbidities, and outcome (death or recovery). Multiple logistic regression was employed to examine associations between indepen","2021","07","19","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; cardiovascular disease; maternal death; obesity; postpartum; pregnancy; women of reproductive age","Nakamura-Pereira","Marcos","National Institute for Women, Children and Adolescents Health Fernandes Figueira, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil",NA
"2541","34213771","10.1002/ijgo.13811","COVID-19-related deaths among women of reproductive age in Brazil: The burden of postpartum.","To compare risk of death due to COVID-19 among pregnant, postpartum, and non-pregnant women of reproductive age in Brazil, using the severe acute respiratory syndrome surveillance system (SARS-SS). A secondary analysis was performed of the Brazilian official SARS-SS, with data retrieved up to August 17, 2020. Cases were stratified by pregnancy status, risk factors or co-morbidities, and outcome (death or recovery). Multiple logistic regression was employed to examine associations between indepen","2021","07","19","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; cardiovascular disease; maternal death; obesity; postpartum; pregnancy; women of reproductive age","Menezes","Mariane O","São Paulo State University (UNESP, Medical School of Botucatu, Botucatu, São Paulo, Brazil",NA
"2542","34213771","10.1002/ijgo.13811","COVID-19-related deaths among women of reproductive age in Brazil: The burden of postpartum.","To compare risk of death due to COVID-19 among pregnant, postpartum, and non-pregnant women of reproductive age in Brazil, using the severe acute respiratory syndrome surveillance system (SARS-SS). A secondary analysis was performed of the Brazilian official SARS-SS, with data retrieved up to August 17, 2020. Cases were stratified by pregnancy status, risk factors or co-morbidities, and outcome (death or recovery). Multiple logistic regression was employed to examine associations between indepen","2021","07","19","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; cardiovascular disease; maternal death; obesity; postpartum; pregnancy; women of reproductive age","Borges","Vicente K","Department of Automation and Systems, Control and Automation Engineering Program, Federal University of Santa Catarina (UFSC, Florianopolis, Santa Catarina, Brazil",NA
"2543","34213771","10.1002/ijgo.13811","COVID-19-related deaths among women of reproductive age in Brazil: The burden of postpartum.","To compare risk of death due to COVID-19 among pregnant, postpartum, and non-pregnant women of reproductive age in Brazil, using the severe acute respiratory syndrome surveillance system (SARS-SS). A secondary analysis was performed of the Brazilian official SARS-SS, with data retrieved up to August 17, 2020. Cases were stratified by pregnancy status, risk factors or co-morbidities, and outcome (death or recovery). Multiple logistic regression was employed to examine associations between indepen","2021","07","19","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; cardiovascular disease; maternal death; obesity; postpartum; pregnancy; women of reproductive age","Katz","Leila","Professor Fernando Figueira Institute of Integral Medicine (IMIP, Recife, PE, Brazil",NA
"2544","34213771","10.1002/ijgo.13811","COVID-19-related deaths among women of reproductive age in Brazil: The burden of postpartum.","To compare risk of death due to COVID-19 among pregnant, postpartum, and non-pregnant women of reproductive age in Brazil, using the severe acute respiratory syndrome surveillance system (SARS-SS). A secondary analysis was performed of the Brazilian official SARS-SS, with data retrieved up to August 17, 2020. Cases were stratified by pregnancy status, risk factors or co-morbidities, and outcome (death or recovery). Multiple logistic regression was employed to examine associations between indepen","2021","07","19","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; cardiovascular disease; maternal death; obesity; postpartum; pregnancy; women of reproductive age","Amorim","Melania M R","Professor Fernando Figueira Institute of Integral Medicine (IMIP, Recife, PE, Brazil",NA
"2545","34213771","10.1002/ijgo.13811","COVID-19-related deaths among women of reproductive age in Brazil: The burden of postpartum.","To compare risk of death due to COVID-19 among pregnant, postpartum, and non-pregnant women of reproductive age in Brazil, using the severe acute respiratory syndrome surveillance system (SARS-SS). A secondary analysis was performed of the Brazilian official SARS-SS, with data retrieved up to August 17, 2020. Cases were stratified by pregnancy status, risk factors or co-morbidities, and outcome (death or recovery). Multiple logistic regression was employed to examine associations between indepen","2021","07","19","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; cardiovascular disease; maternal death; obesity; postpartum; pregnancy; women of reproductive age","Andreucci","Carla B","Department of Medicine, Federal University of Sao Carlos (UFSCAR, Sao Carlos, SP, Brazil",NA
"2546","34213770","10.1002/lary.29729","Aerosol Generation During Laryngology Procedures in the Operating Room.","Severe acute respiratory syndrome coronavirus-2 spreads through respiratory fluids. We aim to quantify aerosolized particles during laryngology procedures to understand their potential for transmission of infectious aerosol-based diseases. Prospective quantification of aerosol generation. Airborne particles (0.3-25 µm in diameter) were measured during live-patient laryngology surgeries using an optical particle counter positioned 60 cm from the oral cavity to the surgeon's left. Measurements tak","2021","07","02","Laryngoscope","The Laryngoscope","CO2 laser; COVID-19; aerosol-generating procedures; direct laryngoscopy; jet ventilation; optical particle counter","Zheng","Melissa","Tina and Rick Caruso Department of Otolaryngology - Head and Neck Surgery, University of Southern California, Los Angeles, California, U",NA
"2547","34213770","10.1002/lary.29729","Aerosol Generation During Laryngology Procedures in the Operating Room.","Severe acute respiratory syndrome coronavirus-2 spreads through respiratory fluids. We aim to quantify aerosolized particles during laryngology procedures to understand their potential for transmission of infectious aerosol-based diseases. Prospective quantification of aerosol generation. Airborne particles (0.3-25 µm in diameter) were measured during live-patient laryngology surgeries using an optical particle counter positioned 60 cm from the oral cavity to the surgeon's left. Measurements tak","2021","07","02","Laryngoscope","The Laryngoscope","CO2 laser; COVID-19; aerosol-generating procedures; direct laryngoscopy; jet ventilation; optical particle counter","Lui","Christopher","University of Southern California, Keck School of Medicine, Los Angeles, California, U",NA
"2548","34213770","10.1002/lary.29729","Aerosol Generation During Laryngology Procedures in the Operating Room.","Severe acute respiratory syndrome coronavirus-2 spreads through respiratory fluids. We aim to quantify aerosolized particles during laryngology procedures to understand their potential for transmission of infectious aerosol-based diseases. Prospective quantification of aerosol generation. Airborne particles (0.3-25 µm in diameter) were measured during live-patient laryngology surgeries using an optical particle counter positioned 60 cm from the oral cavity to the surgeon's left. Measurements tak","2021","07","02","Laryngoscope","The Laryngoscope","CO2 laser; COVID-19; aerosol-generating procedures; direct laryngoscopy; jet ventilation; optical particle counter","O'Dell","Karla","Tina and Rick Caruso Department of Otolaryngology - Head and Neck Surgery, University of Southern California, Los Angeles, California, U",NA
"2549","34213770","10.1002/lary.29729","Aerosol Generation During Laryngology Procedures in the Operating Room.","Severe acute respiratory syndrome coronavirus-2 spreads through respiratory fluids. We aim to quantify aerosolized particles during laryngology procedures to understand their potential for transmission of infectious aerosol-based diseases. Prospective quantification of aerosol generation. Airborne particles (0.3-25 µm in diameter) were measured during live-patient laryngology surgeries using an optical particle counter positioned 60 cm from the oral cavity to the surgeon's left. Measurements tak","2021","07","02","Laryngoscope","The Laryngoscope","CO2 laser; COVID-19; aerosol-generating procedures; direct laryngoscopy; jet ventilation; optical particle counter","M Johns","Michael","Tina and Rick Caruso Department of Otolaryngology - Head and Neck Surgery, University of Southern California, Los Angeles, California, U",NA
"2550","34213770","10.1002/lary.29729","Aerosol Generation During Laryngology Procedures in the Operating Room.","Severe acute respiratory syndrome coronavirus-2 spreads through respiratory fluids. We aim to quantify aerosolized particles during laryngology procedures to understand their potential for transmission of infectious aerosol-based diseases. Prospective quantification of aerosol generation. Airborne particles (0.3-25 µm in diameter) were measured during live-patient laryngology surgeries using an optical particle counter positioned 60 cm from the oral cavity to the surgeon's left. Measurements tak","2021","07","02","Laryngoscope","The Laryngoscope","CO2 laser; COVID-19; aerosol-generating procedures; direct laryngoscopy; jet ventilation; optical particle counter","Ference","Elisabeth H","Tina and Rick Caruso Department of Otolaryngology - Head and Neck Surgery, University of Southern California, Los Angeles, California, U",NA
"2551","34213770","10.1002/lary.29729","Aerosol Generation During Laryngology Procedures in the Operating Room.","Severe acute respiratory syndrome coronavirus-2 spreads through respiratory fluids. We aim to quantify aerosolized particles during laryngology procedures to understand their potential for transmission of infectious aerosol-based diseases. Prospective quantification of aerosol generation. Airborne particles (0.3-25 µm in diameter) were measured during live-patient laryngology surgeries using an optical particle counter positioned 60 cm from the oral cavity to the surgeon's left. Measurements tak","2021","07","02","Laryngoscope","The Laryngoscope","CO2 laser; COVID-19; aerosol-generating procedures; direct laryngoscopy; jet ventilation; optical particle counter","Hur","Kevin","Tina and Rick Caruso Department of Otolaryngology - Head and Neck Surgery, University of Southern California, Los Angeles, California, U",NA
"2552","34213760","10.1007/s12328-021-01472-w","Subtotal colectomy for refractory ulcerative colitis with COVID-19 infection; a first case report in Japan.","We report a 60-year-old male who was transferred to our hospital for the operation because of refractory ulcerative colitis (UC). He was diagnosed to be infected with COVID-19 for SARS-CoV-2 PCR test positive at the time of transfer. We determined emergency operation because his general condition was poor such as malnutrition and ADL decline due to exacerbation of UC and air embolization by central venous catheter removal. He underwent subtotal colectomy with a sigmoid mucous fistula and ileosto","2021","07","04","Clin J Gastroenterol","Clinical journal of gastroenterology","COVID-19; Colectomy; Ulcerative colitis","Obara","Nao","Department of Inflammatory Bowel Disease, Yokohama Municipal Citizen's Hospital, 1-1, Mitsuzawanishimachi, Kanagawa-ku, Yokohama-shi, Kanagawa, Japan. naoobara0528@gmail","naoobara0528@gmail.com"
"2553","34213760","10.1007/s12328-021-01472-w","Subtotal colectomy for refractory ulcerative colitis with COVID-19 infection; a first case report in Japan.","We report a 60-year-old male who was transferred to our hospital for the operation because of refractory ulcerative colitis (UC). He was diagnosed to be infected with COVID-19 for SARS-CoV-2 PCR test positive at the time of transfer. We determined emergency operation because his general condition was poor such as malnutrition and ADL decline due to exacerbation of UC and air embolization by central venous catheter removal. He underwent subtotal colectomy with a sigmoid mucous fistula and ileosto","2021","07","04","Clin J Gastroenterol","Clinical journal of gastroenterology","COVID-19; Colectomy; Ulcerative colitis","Koganei","Kazutaka","Department of Inflammatory Bowel Disease, Yokohama Municipal Citizen's Hospital, 1-1, Mitsuzawanishimachi, Kanagawa-ku, Yokohama-shi, Kanagawa, Japan",NA
"2554","34213760","10.1007/s12328-021-01472-w","Subtotal colectomy for refractory ulcerative colitis with COVID-19 infection; a first case report in Japan.","We report a 60-year-old male who was transferred to our hospital for the operation because of refractory ulcerative colitis (UC). He was diagnosed to be infected with COVID-19 for SARS-CoV-2 PCR test positive at the time of transfer. We determined emergency operation because his general condition was poor such as malnutrition and ADL decline due to exacerbation of UC and air embolization by central venous catheter removal. He underwent subtotal colectomy with a sigmoid mucous fistula and ileosto","2021","07","04","Clin J Gastroenterol","Clinical journal of gastroenterology","COVID-19; Colectomy; Ulcerative colitis","Tatsumi","Kenji","Department of Inflammatory Bowel Disease, Yokohama Municipal Citizen's Hospital, 1-1, Mitsuzawanishimachi, Kanagawa-ku, Yokohama-shi, Kanagawa, Japan",NA
"2555","34213760","10.1007/s12328-021-01472-w","Subtotal colectomy for refractory ulcerative colitis with COVID-19 infection; a first case report in Japan.","We report a 60-year-old male who was transferred to our hospital for the operation because of refractory ulcerative colitis (UC). He was diagnosed to be infected with COVID-19 for SARS-CoV-2 PCR test positive at the time of transfer. We determined emergency operation because his general condition was poor such as malnutrition and ADL decline due to exacerbation of UC and air embolization by central venous catheter removal. He underwent subtotal colectomy with a sigmoid mucous fistula and ileosto","2021","07","04","Clin J Gastroenterol","Clinical journal of gastroenterology","COVID-19; Colectomy; Ulcerative colitis","Futatsuki","Ryo","Department of Inflammatory Bowel Disease, Yokohama Municipal Citizen's Hospital, 1-1, Mitsuzawanishimachi, Kanagawa-ku, Yokohama-shi, Kanagawa, Japan",NA
"2556","34213760","10.1007/s12328-021-01472-w","Subtotal colectomy for refractory ulcerative colitis with COVID-19 infection; a first case report in Japan.","We report a 60-year-old male who was transferred to our hospital for the operation because of refractory ulcerative colitis (UC). He was diagnosed to be infected with COVID-19 for SARS-CoV-2 PCR test positive at the time of transfer. We determined emergency operation because his general condition was poor such as malnutrition and ADL decline due to exacerbation of UC and air embolization by central venous catheter removal. He underwent subtotal colectomy with a sigmoid mucous fistula and ileosto","2021","07","04","Clin J Gastroenterol","Clinical journal of gastroenterology","COVID-19; Colectomy; Ulcerative colitis","Kuroki","Hirosuke","Department of Inflammatory Bowel Disease, Yokohama Municipal Citizen's Hospital, 1-1, Mitsuzawanishimachi, Kanagawa-ku, Yokohama-shi, Kanagawa, Japan",NA
"2557","34213760","10.1007/s12328-021-01472-w","Subtotal colectomy for refractory ulcerative colitis with COVID-19 infection; a first case report in Japan.","We report a 60-year-old male who was transferred to our hospital for the operation because of refractory ulcerative colitis (UC). He was diagnosed to be infected with COVID-19 for SARS-CoV-2 PCR test positive at the time of transfer. We determined emergency operation because his general condition was poor such as malnutrition and ADL decline due to exacerbation of UC and air embolization by central venous catheter removal. He underwent subtotal colectomy with a sigmoid mucous fistula and ileosto","2021","07","04","Clin J Gastroenterol","Clinical journal of gastroenterology","COVID-19; Colectomy; Ulcerative colitis","Nakao","Eiichi","Department of Inflammatory Bowel Disease, Yokohama Municipal Citizen's Hospital, 1-1, Mitsuzawanishimachi, Kanagawa-ku, Yokohama-shi, Kanagawa, Japan",NA
"2558","34213760","10.1007/s12328-021-01472-w","Subtotal colectomy for refractory ulcerative colitis with COVID-19 infection; a first case report in Japan.","We report a 60-year-old male who was transferred to our hospital for the operation because of refractory ulcerative colitis (UC). He was diagnosed to be infected with COVID-19 for SARS-CoV-2 PCR test positive at the time of transfer. We determined emergency operation because his general condition was poor such as malnutrition and ADL decline due to exacerbation of UC and air embolization by central venous catheter removal. He underwent subtotal colectomy with a sigmoid mucous fistula and ileosto","2021","07","04","Clin J Gastroenterol","Clinical journal of gastroenterology","COVID-19; Colectomy; Ulcerative colitis","Sugita","Akira","Department of Inflammatory Bowel Disease, Yokohama Municipal Citizen's Hospital, 1-1, Mitsuzawanishimachi, Kanagawa-ku, Yokohama-shi, Kanagawa, Japan",NA
"2559","34213751","10.1007/s13187-021-02053-8","Learning from Crisis: a Multicentre Study of Oncology Telemedicine Clinics Introduced During COVID-19.","The COVID-19 pandemic has necessitated adaptation of cancer patient care. Oncology patients who contract COVID-19 have poor outcomes. Telemedicine clinics (teleclinics) have been introduced for cancer patients to reduce the risk of horizontal transmission at St. Bartholomew's Hospital and The Royal Free Hospital in London. Teleclinics have become routine in many specialities; however, inclusion in oncology care was not standard prior to the pandemic. A mixed-methods survey was designed and deliv","2021","07","04","J Cancer Educ","Journal of cancer education : the official journal of the American Association for Cancer Education","COVID-19; Cancer; Evidence-based care; Patient experience; Telemedicine","Grant","Michael","Barts Cancer Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, Barbican, London, EC1M 6BE, UK",NA
"2560","34213751","10.1007/s13187-021-02053-8","Learning from Crisis: a Multicentre Study of Oncology Telemedicine Clinics Introduced During COVID-19.","The COVID-19 pandemic has necessitated adaptation of cancer patient care. Oncology patients who contract COVID-19 have poor outcomes. Telemedicine clinics (teleclinics) have been introduced for cancer patients to reduce the risk of horizontal transmission at St. Bartholomew's Hospital and The Royal Free Hospital in London. Teleclinics have become routine in many specialities; however, inclusion in oncology care was not standard prior to the pandemic. A mixed-methods survey was designed and deliv","2021","07","04","J Cancer Educ","Journal of cancer education : the official journal of the American Association for Cancer Education","COVID-19; Cancer; Evidence-based care; Patient experience; Telemedicine","Hockings","Helen","Department of Oncology, St. Bartholomew's Hospital, Bart's Health NHS Trust, London, UK",NA
"2561","34213751","10.1007/s13187-021-02053-8","Learning from Crisis: a Multicentre Study of Oncology Telemedicine Clinics Introduced During COVID-19.","The COVID-19 pandemic has necessitated adaptation of cancer patient care. Oncology patients who contract COVID-19 have poor outcomes. Telemedicine clinics (teleclinics) have been introduced for cancer patients to reduce the risk of horizontal transmission at St. Bartholomew's Hospital and The Royal Free Hospital in London. Teleclinics have become routine in many specialities; however, inclusion in oncology care was not standard prior to the pandemic. A mixed-methods survey was designed and deliv","2021","07","04","J Cancer Educ","Journal of cancer education : the official journal of the American Association for Cancer Education","COVID-19; Cancer; Evidence-based care; Patient experience; Telemedicine","Lapuente","Maria","Barts Cancer Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, Barbican, London, EC1M 6BE, UK",NA
"2562","34213751","10.1007/s13187-021-02053-8","Learning from Crisis: a Multicentre Study of Oncology Telemedicine Clinics Introduced During COVID-19.","The COVID-19 pandemic has necessitated adaptation of cancer patient care. Oncology patients who contract COVID-19 have poor outcomes. Telemedicine clinics (teleclinics) have been introduced for cancer patients to reduce the risk of horizontal transmission at St. Bartholomew's Hospital and The Royal Free Hospital in London. Teleclinics have become routine in many specialities; however, inclusion in oncology care was not standard prior to the pandemic. A mixed-methods survey was designed and deliv","2021","07","04","J Cancer Educ","Journal of cancer education : the official journal of the American Association for Cancer Education","COVID-19; Cancer; Evidence-based care; Patient experience; Telemedicine","Adeniran","Philip","Barts Cancer Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, Barbican, London, EC1M 6BE, UK",NA
"2563","34213751","10.1007/s13187-021-02053-8","Learning from Crisis: a Multicentre Study of Oncology Telemedicine Clinics Introduced During COVID-19.","The COVID-19 pandemic has necessitated adaptation of cancer patient care. Oncology patients who contract COVID-19 have poor outcomes. Telemedicine clinics (teleclinics) have been introduced for cancer patients to reduce the risk of horizontal transmission at St. Bartholomew's Hospital and The Royal Free Hospital in London. Teleclinics have become routine in many specialities; however, inclusion in oncology care was not standard prior to the pandemic. A mixed-methods survey was designed and deliv","2021","07","04","J Cancer Educ","Journal of cancer education : the official journal of the American Association for Cancer Education","COVID-19; Cancer; Evidence-based care; Patient experience; Telemedicine","Saud","Rabiah Abbas","Barts Cancer Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, Barbican, London, EC1M 6BE, UK",NA
"2564","34213751","10.1007/s13187-021-02053-8","Learning from Crisis: a Multicentre Study of Oncology Telemedicine Clinics Introduced During COVID-19.","The COVID-19 pandemic has necessitated adaptation of cancer patient care. Oncology patients who contract COVID-19 have poor outcomes. Telemedicine clinics (teleclinics) have been introduced for cancer patients to reduce the risk of horizontal transmission at St. Bartholomew's Hospital and The Royal Free Hospital in London. Teleclinics have become routine in many specialities; however, inclusion in oncology care was not standard prior to the pandemic. A mixed-methods survey was designed and deliv","2021","07","04","J Cancer Educ","Journal of cancer education : the official journal of the American Association for Cancer Education","COVID-19; Cancer; Evidence-based care; Patient experience; Telemedicine","Sivajothi","Anjali","Barts Cancer Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, Barbican, London, EC1M 6BE, UK",NA
"2565","34213751","10.1007/s13187-021-02053-8","Learning from Crisis: a Multicentre Study of Oncology Telemedicine Clinics Introduced During COVID-19.","The COVID-19 pandemic has necessitated adaptation of cancer patient care. Oncology patients who contract COVID-19 have poor outcomes. Telemedicine clinics (teleclinics) have been introduced for cancer patients to reduce the risk of horizontal transmission at St. Bartholomew's Hospital and The Royal Free Hospital in London. Teleclinics have become routine in many specialities; however, inclusion in oncology care was not standard prior to the pandemic. A mixed-methods survey was designed and deliv","2021","07","04","J Cancer Educ","Journal of cancer education : the official journal of the American Association for Cancer Education","COVID-19; Cancer; Evidence-based care; Patient experience; Telemedicine","Amin","Jubel","Barts Cancer Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, Barbican, London, EC1M 6BE, UK",NA
"2566","34213751","10.1007/s13187-021-02053-8","Learning from Crisis: a Multicentre Study of Oncology Telemedicine Clinics Introduced During COVID-19.","The COVID-19 pandemic has necessitated adaptation of cancer patient care. Oncology patients who contract COVID-19 have poor outcomes. Telemedicine clinics (teleclinics) have been introduced for cancer patients to reduce the risk of horizontal transmission at St. Bartholomew's Hospital and The Royal Free Hospital in London. Teleclinics have become routine in many specialities; however, inclusion in oncology care was not standard prior to the pandemic. A mixed-methods survey was designed and deliv","2021","07","04","J Cancer Educ","Journal of cancer education : the official journal of the American Association for Cancer Education","COVID-19; Cancer; Evidence-based care; Patient experience; Telemedicine","Crusz","Shanthini M","Department of Oncology, St. Bartholomew's Hospital, Bart's Health NHS Trust, London, UK",NA
"2567","34213751","10.1007/s13187-021-02053-8","Learning from Crisis: a Multicentre Study of Oncology Telemedicine Clinics Introduced During COVID-19.","The COVID-19 pandemic has necessitated adaptation of cancer patient care. Oncology patients who contract COVID-19 have poor outcomes. Telemedicine clinics (teleclinics) have been introduced for cancer patients to reduce the risk of horizontal transmission at St. Bartholomew's Hospital and The Royal Free Hospital in London. Teleclinics have become routine in many specialities; however, inclusion in oncology care was not standard prior to the pandemic. A mixed-methods survey was designed and deliv","2021","07","04","J Cancer Educ","Journal of cancer education : the official journal of the American Association for Cancer Education","COVID-19; Cancer; Evidence-based care; Patient experience; Telemedicine","Rashid","Sukaina","Department of Oncology, St. Bartholomew's Hospital, Bart's Health NHS Trust, London, UK",NA
"2568","34213751","10.1007/s13187-021-02053-8","Learning from Crisis: a Multicentre Study of Oncology Telemedicine Clinics Introduced During COVID-19.","The COVID-19 pandemic has necessitated adaptation of cancer patient care. Oncology patients who contract COVID-19 have poor outcomes. Telemedicine clinics (teleclinics) have been introduced for cancer patients to reduce the risk of horizontal transmission at St. Bartholomew's Hospital and The Royal Free Hospital in London. Teleclinics have become routine in many specialities; however, inclusion in oncology care was not standard prior to the pandemic. A mixed-methods survey was designed and deliv","2021","07","04","J Cancer Educ","Journal of cancer education : the official journal of the American Association for Cancer Education","COVID-19; Cancer; Evidence-based care; Patient experience; Telemedicine","Szabados","Bernadette","Barts Cancer Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, Barbican, London, EC1M 6BE, UK",NA
"2569","34213751","10.1007/s13187-021-02053-8","Learning from Crisis: a Multicentre Study of Oncology Telemedicine Clinics Introduced During COVID-19.","The COVID-19 pandemic has necessitated adaptation of cancer patient care. Oncology patients who contract COVID-19 have poor outcomes. Telemedicine clinics (teleclinics) have been introduced for cancer patients to reduce the risk of horizontal transmission at St. Bartholomew's Hospital and The Royal Free Hospital in London. Teleclinics have become routine in many specialities; however, inclusion in oncology care was not standard prior to the pandemic. A mixed-methods survey was designed and deliv","2021","07","04","J Cancer Educ","Journal of cancer education : the official journal of the American Association for Cancer Education","COVID-19; Cancer; Evidence-based care; Patient experience; Telemedicine","Wells","Paula","Department of Oncology, St. Bartholomew's Hospital, Bart's Health NHS Trust, London, UK",NA
"2570","34213751","10.1007/s13187-021-02053-8","Learning from Crisis: a Multicentre Study of Oncology Telemedicine Clinics Introduced During COVID-19.","The COVID-19 pandemic has necessitated adaptation of cancer patient care. Oncology patients who contract COVID-19 have poor outcomes. Telemedicine clinics (teleclinics) have been introduced for cancer patients to reduce the risk of horizontal transmission at St. Bartholomew's Hospital and The Royal Free Hospital in London. Teleclinics have become routine in many specialities; however, inclusion in oncology care was not standard prior to the pandemic. A mixed-methods survey was designed and deliv","2021","07","04","J Cancer Educ","Journal of cancer education : the official journal of the American Association for Cancer Education","COVID-19; Cancer; Evidence-based care; Patient experience; Telemedicine","Boleti","Ekaterini","Specialist Kidney Cancer Unit, Royal Free Hospital, Royal Free NHS Foundation Trust, London, UK",NA
"2571","34213751","10.1007/s13187-021-02053-8","Learning from Crisis: a Multicentre Study of Oncology Telemedicine Clinics Introduced During COVID-19.","The COVID-19 pandemic has necessitated adaptation of cancer patient care. Oncology patients who contract COVID-19 have poor outcomes. Telemedicine clinics (teleclinics) have been introduced for cancer patients to reduce the risk of horizontal transmission at St. Bartholomew's Hospital and The Royal Free Hospital in London. Teleclinics have become routine in many specialities; however, inclusion in oncology care was not standard prior to the pandemic. A mixed-methods survey was designed and deliv","2021","07","04","J Cancer Educ","Journal of cancer education : the official journal of the American Association for Cancer Education","COVID-19; Cancer; Evidence-based care; Patient experience; Telemedicine","Powles","Thomas B","Barts Cancer Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, Barbican, London, EC1M 6BE, UK. Thomas.powles1@nhs","Thomas.powles1@nhs.net"
"2572","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Skaarup","Kristoffer Grundtvig","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp",NA
"2573","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Lassen","Mats Christian Højbjerg","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp",NA
"2574","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Espersen","Caroline","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp",NA
"2575","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Lind","Jannie Nørgaard","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp",NA
"2576","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Johansen","Niklas Dyrby","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp",NA
"2577","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Sengeløv","Morten","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp",NA
"2578","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Alhakak","Alia Saed","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp",NA
"2579","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Nielsen","Anne Bjerg","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp",NA
"2580","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Ravnkilde","Kirstine","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp",NA
"2581","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Hauser","Raphael","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp",NA
"2582","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Schöps","Liv Borum","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp",NA
"2583","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Holt","Eva","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp",NA
"2584","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Bundgaard","Henning","Department of Cardiology, Rigshospitalet, University of Copenhagen, Hellerup, Denmark",NA
"2585","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Hassager","Christian","Department of Cardiology, Rigshospitalet, University of Copenhagen, Hellerup, Denmark",NA
"2586","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Jabbari","Reza","Department of Cardiology, Rigshospitalet, University of Copenhagen, Hellerup, Denmark",NA
"2587","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Carlsen","Jørn","Department of Cardiology, Rigshospitalet, University of Copenhagen, Hellerup, Denmark",NA
"2588","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Kirk","Ole","Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Hellerup, Denmark",NA
"2589","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Bodtger","Uffe","Department of Respiratory and Internal Medicine, Næstved-Slagelse Hospital, University of Southern Denmark, Odense, Denmark",NA
"2590","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Lindholm","Matias Greve","Department of Cardiology, Zealand University Hospital Roskilde, University of Copenhagen, Hellerup, Denmark",NA
"2591","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Wiese","Lothar","Department of Infectious Diseases",NA
"2592","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Kristiansen","Ole Peter","Department of Cardiology, Bispebjerg &amp",NA
"2593","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Walsted","Emil Schwarz","Department of Respiratory Medicine, Bispebjerg &amp",NA
"2594","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Nielsen","Olav Wendelboe","Department of Cardiology, Bispebjerg &amp",NA
"2595","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Lindegaard","Birgitte","Department of Respiratory Medicine and Infectious Diseases, Nordsjællands Hospital, University of Copenhagen, Hellerup, Denmark",NA
"2596","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Tønder","Niels","Department of Cardiology, Nordsjællands Hospital, University of Copenhagen, Hellerup, Denmark",NA
"2597","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Jeschke","Klaus Nielsen","Department of Respiratory Medicine, Amager Hvidovre Hospital, University of Copenhagen, Hellerup, Denmark",NA
"2598","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Ulrik","Charlotte Suppli","Department of Respiratory Medicine, Amager Hvidovre Hospital, University of Copenhagen, Hellerup, Denmark",NA
"2599","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Lamberts","Morten","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp",NA
"2600","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Sivapalan","Pradeesh","Department of Medicine, Herlev &amp",NA
"2601","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Pallisgaard","Jannik","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp",NA
"2602","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Gislason","Gunnar","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp",NA
"2603","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Iversen","Kasper","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp",NA
"2604","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Jensen","Jens Ulrik Stæhr","Department of Medicine, Herlev &amp",NA
"2605","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Schou","Morten","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp",NA
"2606","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Skaarup","Søren Helbo","Department of Respiratory Medicine and Allergy, Aarhus University Hospital, University of Aarhus, Aarhus, Denmark",NA
"2607","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Platz","Elke","Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, USA",NA
"2608","34213740","10.1007/s40477-021-00605-8","Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study.","Several studies have reported thromboembolic events to be common in severe COVID-19 cases. We sought to investigate the relationship between lung ultrasound (LUS) findings in hospitalized COVID-19 patients and the development of venous thromboembolic events (VTE). A total of 203 adults were included from a COVID-19 ward in this prospective multi-center study (mean age 68.6 years, 56.7% men). All patients underwent 8-zone LUS, and all ultrasound images were analyzed off-line blinded. Several LUS ","2021","07","04","J Ultrasound","Journal of ultrasound","B-lines; COVID-19; Lung ultrasound; Venous thromboembolic events","Biering-Sørensen","Tor","Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev &amp","soerensen@regionh.dk"
"2609","34213733","10.1007/s15010-021-01651-4","IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection.","Coronavirus disease-19 (COVID-19) pandemic became the greatest public health challenge globally. Study of dynamicity and durability of naturally developed antibodies against SARS-CoV-2 are of great importance from an epidemiological viewpoint. In this observational cohort study, we have followed up the 76 individuals who tested positive for SARS-CoV-2 infection by real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) for 16 weeks (post-enrolment) to record the periodic changes in t","2021","07","04","Infection","Infection","COVID-19; IgG; Nucleocapsid protein; SARS-CoV-2; Spike protein","Choudhary","Hari Ram","Department of Microbiology, ICMR-Regional Medical Research Centre (Department of Health Research, Ministry of Health and Family Welfare, Government of India), Chandrasekharpur, Bhubaneswar, 751023, India",NA
"2610","34213733","10.1007/s15010-021-01651-4","IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection.","Coronavirus disease-19 (COVID-19) pandemic became the greatest public health challenge globally. Study of dynamicity and durability of naturally developed antibodies against SARS-CoV-2 are of great importance from an epidemiological viewpoint. In this observational cohort study, we have followed up the 76 individuals who tested positive for SARS-CoV-2 infection by real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) for 16 weeks (post-enrolment) to record the periodic changes in t","2021","07","04","Infection","Infection","COVID-19; IgG; Nucleocapsid protein; SARS-CoV-2; Spike protein","Parai","Debaprasad","Department of Microbiology, ICMR-Regional Medical Research Centre (Department of Health Research, Ministry of Health and Family Welfare, Government of India), Chandrasekharpur, Bhubaneswar, 751023, India",NA
"2611","34213733","10.1007/s15010-021-01651-4","IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection.","Coronavirus disease-19 (COVID-19) pandemic became the greatest public health challenge globally. Study of dynamicity and durability of naturally developed antibodies against SARS-CoV-2 are of great importance from an epidemiological viewpoint. In this observational cohort study, we have followed up the 76 individuals who tested positive for SARS-CoV-2 infection by real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) for 16 weeks (post-enrolment) to record the periodic changes in t","2021","07","04","Infection","Infection","COVID-19; IgG; Nucleocapsid protein; SARS-CoV-2; Spike protein","Dash","Girish Chandra","Department of Microbiology, ICMR-Regional Medical Research Centre (Department of Health Research, Ministry of Health and Family Welfare, Government of India), Chandrasekharpur, Bhubaneswar, 751023, India",NA
"2612","34213733","10.1007/s15010-021-01651-4","IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection.","Coronavirus disease-19 (COVID-19) pandemic became the greatest public health challenge globally. Study of dynamicity and durability of naturally developed antibodies against SARS-CoV-2 are of great importance from an epidemiological viewpoint. In this observational cohort study, we have followed up the 76 individuals who tested positive for SARS-CoV-2 infection by real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) for 16 weeks (post-enrolment) to record the periodic changes in t","2021","07","04","Infection","Infection","COVID-19; IgG; Nucleocapsid protein; SARS-CoV-2; Spike protein","Peter","Annalisha","Department of Microbiology, ICMR-Regional Medical Research Centre (Department of Health Research, Ministry of Health and Family Welfare, Government of India), Chandrasekharpur, Bhubaneswar, 751023, India",NA
"2613","34213733","10.1007/s15010-021-01651-4","IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection.","Coronavirus disease-19 (COVID-19) pandemic became the greatest public health challenge globally. Study of dynamicity and durability of naturally developed antibodies against SARS-CoV-2 are of great importance from an epidemiological viewpoint. In this observational cohort study, we have followed up the 76 individuals who tested positive for SARS-CoV-2 infection by real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) for 16 weeks (post-enrolment) to record the periodic changes in t","2021","07","04","Infection","Infection","COVID-19; IgG; Nucleocapsid protein; SARS-CoV-2; Spike protein","Sahoo","Subrat Kumar","Department of Microbiology, ICMR-Regional Medical Research Centre (Department of Health Research, Ministry of Health and Family Welfare, Government of India), Chandrasekharpur, Bhubaneswar, 751023, India",NA
"2614","34213733","10.1007/s15010-021-01651-4","IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection.","Coronavirus disease-19 (COVID-19) pandemic became the greatest public health challenge globally. Study of dynamicity and durability of naturally developed antibodies against SARS-CoV-2 are of great importance from an epidemiological viewpoint. In this observational cohort study, we have followed up the 76 individuals who tested positive for SARS-CoV-2 infection by real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) for 16 weeks (post-enrolment) to record the periodic changes in t","2021","07","04","Infection","Infection","COVID-19; IgG; Nucleocapsid protein; SARS-CoV-2; Spike protein","Pattnaik","Matrujyoti","Department of Microbiology, ICMR-Regional Medical Research Centre (Department of Health Research, Ministry of Health and Family Welfare, Government of India), Chandrasekharpur, Bhubaneswar, 751023, India",NA
"2615","34213733","10.1007/s15010-021-01651-4","IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection.","Coronavirus disease-19 (COVID-19) pandemic became the greatest public health challenge globally. Study of dynamicity and durability of naturally developed antibodies against SARS-CoV-2 are of great importance from an epidemiological viewpoint. In this observational cohort study, we have followed up the 76 individuals who tested positive for SARS-CoV-2 infection by real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) for 16 weeks (post-enrolment) to record the periodic changes in t","2021","07","04","Infection","Infection","COVID-19; IgG; Nucleocapsid protein; SARS-CoV-2; Spike protein","Rout","Usha Kiran","Department of Microbiology, ICMR-Regional Medical Research Centre (Department of Health Research, Ministry of Health and Family Welfare, Government of India), Chandrasekharpur, Bhubaneswar, 751023, India",NA
"2616","34213733","10.1007/s15010-021-01651-4","IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection.","Coronavirus disease-19 (COVID-19) pandemic became the greatest public health challenge globally. Study of dynamicity and durability of naturally developed antibodies against SARS-CoV-2 are of great importance from an epidemiological viewpoint. In this observational cohort study, we have followed up the 76 individuals who tested positive for SARS-CoV-2 infection by real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) for 16 weeks (post-enrolment) to record the periodic changes in t","2021","07","04","Infection","Infection","COVID-19; IgG; Nucleocapsid protein; SARS-CoV-2; Spike protein","Nanda","Rashmi Ranjan","Department of Microbiology, ICMR-Regional Medical Research Centre (Department of Health Research, Ministry of Health and Family Welfare, Government of India), Chandrasekharpur, Bhubaneswar, 751023, India",NA
"2617","34213733","10.1007/s15010-021-01651-4","IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection.","Coronavirus disease-19 (COVID-19) pandemic became the greatest public health challenge globally. Study of dynamicity and durability of naturally developed antibodies against SARS-CoV-2 are of great importance from an epidemiological viewpoint. In this observational cohort study, we have followed up the 76 individuals who tested positive for SARS-CoV-2 infection by real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) for 16 weeks (post-enrolment) to record the periodic changes in t","2021","07","04","Infection","Infection","COVID-19; IgG; Nucleocapsid protein; SARS-CoV-2; Spike protein","Pati","Sanghamitra","Department of Microbiology, ICMR-Regional Medical Research Centre (Department of Health Research, Ministry of Health and Family Welfare, Government of India), Chandrasekharpur, Bhubaneswar, 751023, India. drsanghamitra12@gmail","drsanghamitra12@gmail.com"
"2618","34213733","10.1007/s15010-021-01651-4","IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection.","Coronavirus disease-19 (COVID-19) pandemic became the greatest public health challenge globally. Study of dynamicity and durability of naturally developed antibodies against SARS-CoV-2 are of great importance from an epidemiological viewpoint. In this observational cohort study, we have followed up the 76 individuals who tested positive for SARS-CoV-2 infection by real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) for 16 weeks (post-enrolment) to record the periodic changes in t","2021","07","04","Infection","Infection","COVID-19; IgG; Nucleocapsid protein; SARS-CoV-2; Spike protein","Bhattacharya","Debdutta","Department of Microbiology, ICMR-Regional Medical Research Centre (Department of Health Research, Ministry of Health and Family Welfare, Government of India), Chandrasekharpur, Bhubaneswar, 751023, India. drdebdutta.bhattacharya@yahoo.co","drdebdutta.bhattacharya@yahoo.co.in"
"2619","34213728","10.1007/s11030-021-10230-6","In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.","Coronavirus disease 2019 (COVID-19) is a pandemic viral disease caused by SARS-CoV-2 that generated serious damages for both the human population and the global economy. Therefore, it is currently considered as one of the most important global health problems of human societies and there is an urgent need for potent drugs or vaccines which can effectively combat this virus. The chymotrypsin-like protease (3CLpro) of SARS-CoV-2 plays a key role in the viral replication inside the host and thus is","2021","07","04","Mol Divers","Molecular diversity","COVID-19; Coumarin phytochemicals; Molecular docking; Molecular dynamics; SARS-CoV-2","Abdizadeh","Rahman","Department of Medical Parasitology and Mycology, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran",NA
"2620","34213728","10.1007/s11030-021-10230-6","In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.","Coronavirus disease 2019 (COVID-19) is a pandemic viral disease caused by SARS-CoV-2 that generated serious damages for both the human population and the global economy. Therefore, it is currently considered as one of the most important global health problems of human societies and there is an urgent need for potent drugs or vaccines which can effectively combat this virus. The chymotrypsin-like protease (3CLpro) of SARS-CoV-2 plays a key role in the viral replication inside the host and thus is","2021","07","04","Mol Divers","Molecular diversity","COVID-19; Coumarin phytochemicals; Molecular docking; Molecular dynamics; SARS-CoV-2","Hadizadeh","Farzin","Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"2621","34213728","10.1007/s11030-021-10230-6","In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.","Coronavirus disease 2019 (COVID-19) is a pandemic viral disease caused by SARS-CoV-2 that generated serious damages for both the human population and the global economy. Therefore, it is currently considered as one of the most important global health problems of human societies and there is an urgent need for potent drugs or vaccines which can effectively combat this virus. The chymotrypsin-like protease (3CLpro) of SARS-CoV-2 plays a key role in the viral replication inside the host and thus is","2021","07","04","Mol Divers","Molecular diversity","COVID-19; Coumarin phytochemicals; Molecular docking; Molecular dynamics; SARS-CoV-2","Abdizadeh","Tooba","Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, shahrekord, Iran. t.abdizadeh@gmail","t.abdizadeh@gmail.com"
"2622","34213716","10.1007/s11239-021-02516-1","U shape association of hemoglobin level with in-hospital mortality for COVID-19 patients.","Our hypothesis was that high hemoglobin (Hb) level might be associated with hypercoagulable state and death due to COVID-19. Of the 9467 hospitalized COVID-19 patients, patients were subdivided into 5 groups based on the level of Hb; Hb &lt; 10 g/dL, 10 g/dL = Hb &lt; 12 g/dL, 12 g/dL = Hb &lt; 14 g/dL, 14 g/dL = Hb &lt; 16 g/dL, and Hb = 16 g/dL. Compared to patients with 12 g/dL = Hb &lt; 14 g/dL, patients with Hb = 16 g/dL had significantly higher adjusted in-hospital mortality (OR [95% CI] 1","2021","07","04","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","COVID-19; Hemoglobin; Mortality","Kuno","Toshiki","Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, First Avenue, 16th street, New York, NY, 10003, USA. Toshiki.Kuno@mountsinai","Toshiki.Kuno@mountsinai.org"
"2623","34213716","10.1007/s11239-021-02516-1","U shape association of hemoglobin level with in-hospital mortality for COVID-19 patients.","Our hypothesis was that high hemoglobin (Hb) level might be associated with hypercoagulable state and death due to COVID-19. Of the 9467 hospitalized COVID-19 patients, patients were subdivided into 5 groups based on the level of Hb; Hb &lt; 10 g/dL, 10 g/dL = Hb &lt; 12 g/dL, 12 g/dL = Hb &lt; 14 g/dL, 14 g/dL = Hb &lt; 16 g/dL, and Hb = 16 g/dL. Compared to patients with 12 g/dL = Hb &lt; 14 g/dL, patients with Hb = 16 g/dL had significantly higher adjusted in-hospital mortality (OR [95% CI] 1","2021","07","04","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","COVID-19; Hemoglobin; Mortality","So","Matsuo","Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, First Avenue, 16th street, New York, NY, 10003, USA",NA
"2624","34213716","10.1007/s11239-021-02516-1","U shape association of hemoglobin level with in-hospital mortality for COVID-19 patients.","Our hypothesis was that high hemoglobin (Hb) level might be associated with hypercoagulable state and death due to COVID-19. Of the 9467 hospitalized COVID-19 patients, patients were subdivided into 5 groups based on the level of Hb; Hb &lt; 10 g/dL, 10 g/dL = Hb &lt; 12 g/dL, 12 g/dL = Hb &lt; 14 g/dL, 14 g/dL = Hb &lt; 16 g/dL, and Hb = 16 g/dL. Compared to patients with 12 g/dL = Hb &lt; 14 g/dL, patients with Hb = 16 g/dL had significantly higher adjusted in-hospital mortality (OR [95% CI] 1","2021","07","04","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","COVID-19; Hemoglobin; Mortality","Takahashi","Mai","Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, First Avenue, 16th street, New York, NY, 10003, USA",NA
"2625","34213716","10.1007/s11239-021-02516-1","U shape association of hemoglobin level with in-hospital mortality for COVID-19 patients.","Our hypothesis was that high hemoglobin (Hb) level might be associated with hypercoagulable state and death due to COVID-19. Of the 9467 hospitalized COVID-19 patients, patients were subdivided into 5 groups based on the level of Hb; Hb &lt; 10 g/dL, 10 g/dL = Hb &lt; 12 g/dL, 12 g/dL = Hb &lt; 14 g/dL, 14 g/dL = Hb &lt; 16 g/dL, and Hb = 16 g/dL. Compared to patients with 12 g/dL = Hb &lt; 14 g/dL, patients with Hb = 16 g/dL had significantly higher adjusted in-hospital mortality (OR [95% CI] 1","2021","07","04","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","COVID-19; Hemoglobin; Mortality","Egorova","Natalia N","Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"2626","34213713","10.1007/s11255-021-02937-0","Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?","To evaluate urinary kidney injury molecule-1 (uKIM-1), which is a proximal tubule injury biomarker in subclinical acute kidney injury (AKI) that may occur in COVID-19 infection. The study included proteinuric (n = 30) and non-proteinuric (n = 30) patients diagnosed with mild/moderate COVID-19 infection between March and September 2020 and healthy individuals as a control group (n = 20). The uKIM-1, serum creatinine, cystatin C, spot urine protein, creatinine, and albumin levels of the patients w","2021","07","04","Int Urol Nephrol","International urology and nephrology","Acute kidney injury; COVID-19; Non-albuminuric proteinuria; Sub-clinical; Urinary kidney injury molecule-1","Yasar","Emre","Department of Nephrology, Dialysis and Transplantation, Faculty of Medicine, Gazi University, Bahriye Ucok, 06560, Ankara, Turkey. rasayerm@hotmail","rasayerm@hotmail.com"
"2627","34213713","10.1007/s11255-021-02937-0","Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?","To evaluate urinary kidney injury molecule-1 (uKIM-1), which is a proximal tubule injury biomarker in subclinical acute kidney injury (AKI) that may occur in COVID-19 infection. The study included proteinuric (n = 30) and non-proteinuric (n = 30) patients diagnosed with mild/moderate COVID-19 infection between March and September 2020 and healthy individuals as a control group (n = 20). The uKIM-1, serum creatinine, cystatin C, spot urine protein, creatinine, and albumin levels of the patients w","2021","07","04","Int Urol Nephrol","International urology and nephrology","Acute kidney injury; COVID-19; Non-albuminuric proteinuria; Sub-clinical; Urinary kidney injury molecule-1","Ozger","Hasan Selcuk","Department of Infectious Disease and Clinical Microbiology, Faculty of Medicine, Gazi University, Ankara, Turkey",NA
"2628","34213713","10.1007/s11255-021-02937-0","Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?","To evaluate urinary kidney injury molecule-1 (uKIM-1), which is a proximal tubule injury biomarker in subclinical acute kidney injury (AKI) that may occur in COVID-19 infection. The study included proteinuric (n = 30) and non-proteinuric (n = 30) patients diagnosed with mild/moderate COVID-19 infection between March and September 2020 and healthy individuals as a control group (n = 20). The uKIM-1, serum creatinine, cystatin C, spot urine protein, creatinine, and albumin levels of the patients w","2021","07","04","Int Urol Nephrol","International urology and nephrology","Acute kidney injury; COVID-19; Non-albuminuric proteinuria; Sub-clinical; Urinary kidney injury molecule-1","Yeter","Haci Hasan","Department of Nephrology, Dialysis and Transplantation, Faculty of Medicine, Gazi University, Bahriye Ucok, 06560, Ankara, Turkey",NA
"2629","34213713","10.1007/s11255-021-02937-0","Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?","To evaluate urinary kidney injury molecule-1 (uKIM-1), which is a proximal tubule injury biomarker in subclinical acute kidney injury (AKI) that may occur in COVID-19 infection. The study included proteinuric (n = 30) and non-proteinuric (n = 30) patients diagnosed with mild/moderate COVID-19 infection between March and September 2020 and healthy individuals as a control group (n = 20). The uKIM-1, serum creatinine, cystatin C, spot urine protein, creatinine, and albumin levels of the patients w","2021","07","04","Int Urol Nephrol","International urology and nephrology","Acute kidney injury; COVID-19; Non-albuminuric proteinuria; Sub-clinical; Urinary kidney injury molecule-1","Yildirim","Cigdem","Department of Infectious Disease and Clinical Microbiology, Faculty of Medicine, Gazi University, Ankara, Turkey",NA
"2630","34213713","10.1007/s11255-021-02937-0","Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?","To evaluate urinary kidney injury molecule-1 (uKIM-1), which is a proximal tubule injury biomarker in subclinical acute kidney injury (AKI) that may occur in COVID-19 infection. The study included proteinuric (n = 30) and non-proteinuric (n = 30) patients diagnosed with mild/moderate COVID-19 infection between March and September 2020 and healthy individuals as a control group (n = 20). The uKIM-1, serum creatinine, cystatin C, spot urine protein, creatinine, and albumin levels of the patients w","2021","07","04","Int Urol Nephrol","International urology and nephrology","Acute kidney injury; COVID-19; Non-albuminuric proteinuria; Sub-clinical; Urinary kidney injury molecule-1","Osmanov","Zakir","Department of Medical Biochemistry, Faculty of Medicine, Gazi University, Ankara, Turkey",NA
"2631","34213713","10.1007/s11255-021-02937-0","Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?","To evaluate urinary kidney injury molecule-1 (uKIM-1), which is a proximal tubule injury biomarker in subclinical acute kidney injury (AKI) that may occur in COVID-19 infection. The study included proteinuric (n = 30) and non-proteinuric (n = 30) patients diagnosed with mild/moderate COVID-19 infection between March and September 2020 and healthy individuals as a control group (n = 20). The uKIM-1, serum creatinine, cystatin C, spot urine protein, creatinine, and albumin levels of the patients w","2021","07","04","Int Urol Nephrol","International urology and nephrology","Acute kidney injury; COVID-19; Non-albuminuric proteinuria; Sub-clinical; Urinary kidney injury molecule-1","Cetin","Taha Enes","Department of Internal Medicine, Faculty of Medicine, Gazi University, Ankara, Turkey",NA
"2632","34213713","10.1007/s11255-021-02937-0","Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?","To evaluate urinary kidney injury molecule-1 (uKIM-1), which is a proximal tubule injury biomarker in subclinical acute kidney injury (AKI) that may occur in COVID-19 infection. The study included proteinuric (n = 30) and non-proteinuric (n = 30) patients diagnosed with mild/moderate COVID-19 infection between March and September 2020 and healthy individuals as a control group (n = 20). The uKIM-1, serum creatinine, cystatin C, spot urine protein, creatinine, and albumin levels of the patients w","2021","07","04","Int Urol Nephrol","International urology and nephrology","Acute kidney injury; COVID-19; Non-albuminuric proteinuria; Sub-clinical; Urinary kidney injury molecule-1","Akcay","Omer Faruk","Department of Nephrology, Dialysis and Transplantation, Faculty of Medicine, Gazi University, Bahriye Ucok, 06560, Ankara, Turkey",NA
"2633","34213713","10.1007/s11255-021-02937-0","Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?","To evaluate urinary kidney injury molecule-1 (uKIM-1), which is a proximal tubule injury biomarker in subclinical acute kidney injury (AKI) that may occur in COVID-19 infection. The study included proteinuric (n = 30) and non-proteinuric (n = 30) patients diagnosed with mild/moderate COVID-19 infection between March and September 2020 and healthy individuals as a control group (n = 20). The uKIM-1, serum creatinine, cystatin C, spot urine protein, creatinine, and albumin levels of the patients w","2021","07","04","Int Urol Nephrol","International urology and nephrology","Acute kidney injury; COVID-19; Non-albuminuric proteinuria; Sub-clinical; Urinary kidney injury molecule-1","Bukan","Neslihan","Department of Medical Biochemistry, Faculty of Medicine, Gazi University, Ankara, Turkey",NA
"2634","34213713","10.1007/s11255-021-02937-0","Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?","To evaluate urinary kidney injury molecule-1 (uKIM-1), which is a proximal tubule injury biomarker in subclinical acute kidney injury (AKI) that may occur in COVID-19 infection. The study included proteinuric (n = 30) and non-proteinuric (n = 30) patients diagnosed with mild/moderate COVID-19 infection between March and September 2020 and healthy individuals as a control group (n = 20). The uKIM-1, serum creatinine, cystatin C, spot urine protein, creatinine, and albumin levels of the patients w","2021","07","04","Int Urol Nephrol","International urology and nephrology","Acute kidney injury; COVID-19; Non-albuminuric proteinuria; Sub-clinical; Urinary kidney injury molecule-1","Derici","Ulver","Department of Nephrology, Dialysis and Transplantation, Faculty of Medicine, Gazi University, Bahriye Ucok, 06560, Ankara, Turkey",NA
"2635","34213680","10.1007/s10029-021-02442-4","Characteristics of laparoscopic and open hernia repair simulation models: a systematic review.","Barriers to education in open and laparoscopic hernia repair technique include a steep learning curve and reduced theatre time for junior surgical trainees. This is particularly evident during the current COVID-19 pandemic. Simulation models may provide further opportunities for training in hernia repair outside of the traditional surgical apprenticeship model. A systematic review was carried out following PRISMA guidelines to identify and evaluate simulation models in hernia repair. Of the 866 ","2021","07","04","Hernia","Hernia : the journal of hernias and abdominal wall surgery","Education; Hernia; Laparoscopy; Simulation","Pelly","T","Department of General Surgery, St Helier Hospital, London, UK. h.pelly@nhs","h.pelly@nhs.net"
"2636","34213680","10.1007/s10029-021-02442-4","Characteristics of laparoscopic and open hernia repair simulation models: a systematic review.","Barriers to education in open and laparoscopic hernia repair technique include a steep learning curve and reduced theatre time for junior surgical trainees. This is particularly evident during the current COVID-19 pandemic. Simulation models may provide further opportunities for training in hernia repair outside of the traditional surgical apprenticeship model. A systematic review was carried out following PRISMA guidelines to identify and evaluate simulation models in hernia repair. Of the 866 ","2021","07","04","Hernia","Hernia : the journal of hernias and abdominal wall surgery","Education; Hernia; Laparoscopy; Simulation","Vance-Daniel","J","Department of General Surgery, St Helier Hospital, London, UK",NA
"2637","34213680","10.1007/s10029-021-02442-4","Characteristics of laparoscopic and open hernia repair simulation models: a systematic review.","Barriers to education in open and laparoscopic hernia repair technique include a steep learning curve and reduced theatre time for junior surgical trainees. This is particularly evident during the current COVID-19 pandemic. Simulation models may provide further opportunities for training in hernia repair outside of the traditional surgical apprenticeship model. A systematic review was carried out following PRISMA guidelines to identify and evaluate simulation models in hernia repair. Of the 866 ","2021","07","04","Hernia","Hernia : the journal of hernias and abdominal wall surgery","Education; Hernia; Laparoscopy; Simulation","Linder","C","Department of General Surgery, Royal London Hospital, London, UK",NA
"2638","34213580","10.1007/s00296-021-04938-9","COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey.","Patients with a systemic autoimmune rheumatic disease (AIRD) are vulnerable to SARS Cov-2 infection. Vaccination against this infection can prevent the patients from developing severe disease. But vaccine hesitancy in this group can emerge as a hurdle. So there is a need to understand the perception regarding vaccination in AIRD patients. The study is an interview-based survey done in AIRD patients and a control group from the general population. The questionnaire included the subject's demograp","2021","07","04","Rheumatol Int","Rheumatology international","COVID-19 vaccination; Rheumatic disease; Vaccine hesitancy","Gaur","Priyanka","Niruj Rheumatology Clinic, 209 Rajvi Complex, Rambaug, Ahmedabad, 380008, Gujarat, India",NA
"2639","34213580","10.1007/s00296-021-04938-9","COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey.","Patients with a systemic autoimmune rheumatic disease (AIRD) are vulnerable to SARS Cov-2 infection. Vaccination against this infection can prevent the patients from developing severe disease. But vaccine hesitancy in this group can emerge as a hurdle. So there is a need to understand the perception regarding vaccination in AIRD patients. The study is an interview-based survey done in AIRD patients and a control group from the general population. The questionnaire included the subject's demograp","2021","07","04","Rheumatol Int","Rheumatology international","COVID-19 vaccination; Rheumatic disease; Vaccine hesitancy","Agrawat","Hardik","Niruj Rheumatology Clinic, 209 Rajvi Complex, Rambaug, Ahmedabad, 380008, Gujarat, India",NA
"2640","34213580","10.1007/s00296-021-04938-9","COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey.","Patients with a systemic autoimmune rheumatic disease (AIRD) are vulnerable to SARS Cov-2 infection. Vaccination against this infection can prevent the patients from developing severe disease. But vaccine hesitancy in this group can emerge as a hurdle. So there is a need to understand the perception regarding vaccination in AIRD patients. The study is an interview-based survey done in AIRD patients and a control group from the general population. The questionnaire included the subject's demograp","2021","07","04","Rheumatol Int","Rheumatology international","COVID-19 vaccination; Rheumatic disease; Vaccine hesitancy","Shukla","Anuj","Niruj Rheumatology Clinic, 209 Rajvi Complex, Rambaug, Ahmedabad, 380008, Gujarat, India. anuj.guj@gmail","anuj.guj@gmail.com"
"2641","34213568","10.1093/jalm/jfab065","Development of IgG, IgM, and IgA autoantibodies against angiotensin converting enzyme 2 in patients with COVID-19.",NA,"2021","07","02","J Appl Lab Med","The journal of applied laboratory medicine",NA,"Amiral","Jean","SH/Scientific-Hemostasis, Franconville, France",NA
"2642","34213568","10.1093/jalm/jfab065","Development of IgG, IgM, and IgA autoantibodies against angiotensin converting enzyme 2 in patients with COVID-19.",NA,"2021","07","02","J Appl Lab Med","The journal of applied laboratory medicine",NA,"Busch","Matthias H","Department of Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, The Netherlands",NA
"2643","34213568","10.1093/jalm/jfab065","Development of IgG, IgM, and IgA autoantibodies against angiotensin converting enzyme 2 in patients with COVID-19.",NA,"2021","07","02","J Appl Lab Med","The journal of applied laboratory medicine",NA,"Timmermans","Sjoerd A M E G","Department of Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, The Netherlands",NA
"2644","34213568","10.1093/jalm/jfab065","Development of IgG, IgM, and IgA autoantibodies against angiotensin converting enzyme 2 in patients with COVID-19.",NA,"2021","07","02","J Appl Lab Med","The journal of applied laboratory medicine",NA,"Reutelingsperger","Chris P","Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, The Netherlands",NA
"2645","34213568","10.1093/jalm/jfab065","Development of IgG, IgM, and IgA autoantibodies against angiotensin converting enzyme 2 in patients with COVID-19.",NA,"2021","07","02","J Appl Lab Med","The journal of applied laboratory medicine",NA,"van Paassen","Pieter","Department of Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, The Netherlands",NA
"2646","34213561","10.1001/jamanetworkopen.2021.15653","Evaluation of Health Equity in COVID-19 Vaccine Distribution Plans in the United States.",NA,"2021","07","15","JAMA Netw Open","JAMA network open","COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Health Equity; Humans; United States","Hardeman","Amber","Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana",NA
"2647","34213561","10.1001/jamanetworkopen.2021.15653","Evaluation of Health Equity in COVID-19 Vaccine Distribution Plans in the United States.",NA,"2021","07","15","JAMA Netw Open","JAMA network open","COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Health Equity; Humans; United States","Wong","Taylor","Division of Pulmonary, Critical Care, and Sleep Medicine, New York University Grossman School of Medicine, Bellevue Hospital, New York",NA
"2648","34213561","10.1001/jamanetworkopen.2021.15653","Evaluation of Health Equity in COVID-19 Vaccine Distribution Plans in the United States.",NA,"2021","07","15","JAMA Netw Open","JAMA network open","COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Health Equity; Humans; United States","Denson","Joshua L","Section of Pulmonary, Critical Care, and Environmental Medicine, Tulane University School of Medicine, New Orleans, Louisiana",NA
"2649","34213561","10.1001/jamanetworkopen.2021.15653","Evaluation of Health Equity in COVID-19 Vaccine Distribution Plans in the United States.",NA,"2021","07","15","JAMA Netw Open","JAMA network open","COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Health Equity; Humans; United States","Postelnicu","Radu","Division of Pulmonary, Critical Care, and Sleep Medicine, New York University Grossman School of Medicine, Bellevue Hospital, New York",NA
"2650","34213561","10.1001/jamanetworkopen.2021.15653","Evaluation of Health Equity in COVID-19 Vaccine Distribution Plans in the United States.",NA,"2021","07","15","JAMA Netw Open","JAMA network open","COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Health Equity; Humans; United States","Rojas","Juan C","Department of Medicine, University of Chicago, Chicago, Illinois",NA
"2651","34213541","10.1093/tropej/fmab025","Clinical and Epidemiological Characteristics of Paediatric Patients Diagnosed with COVID-19 in a Tertiary Hospital in Mexico City.","COVID-19 affects the paediatric population less frequently than adults. A retrospective study was performed in a tertiary paediatric hospital in Mexico City in children &lt;18 years of age who were hospitalized with a positive reverse transcription-polymerase chain reaction for SARS-CoV-2. Included in the study were 86 patients with a median age of 10 years old (IQR 2.6-14.3 years), who were classified in three groups: previously healthy, with chronic disease and immunosuppressed patients. The p","2021","07","08","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; clinicalepidemiological characteristics; comorbidities; paediatrics; Adolescent; Adult; COVID-19; Child; Child, Preschool; Humans; Mexico; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Macias-Parra","Mercedes","Medical Director, Instituto Nacional de Pediatría, National Pediatrics Institute, Insurgentes Cuicuilco, Coyoacán, Mexico City, CP 04530, Mexico",NA
"2652","34213541","10.1093/tropej/fmab025","Clinical and Epidemiological Characteristics of Paediatric Patients Diagnosed with COVID-19 in a Tertiary Hospital in Mexico City.","COVID-19 affects the paediatric population less frequently than adults. A retrospective study was performed in a tertiary paediatric hospital in Mexico City in children &lt;18 years of age who were hospitalized with a positive reverse transcription-polymerase chain reaction for SARS-CoV-2. Included in the study were 86 patients with a median age of 10 years old (IQR 2.6-14.3 years), who were classified in three groups: previously healthy, with chronic disease and immunosuppressed patients. The p","2021","07","08","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; clinicalepidemiological characteristics; comorbidities; paediatrics; Adolescent; Adult; COVID-19; Child; Child, Preschool; Humans; Mexico; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Fortes-Gutierrez","Sofia","Pediatric Infectious Disease Department, National Pediatrics Institute, Mexico City, Mexico",NA
"2653","34213541","10.1093/tropej/fmab025","Clinical and Epidemiological Characteristics of Paediatric Patients Diagnosed with COVID-19 in a Tertiary Hospital in Mexico City.","COVID-19 affects the paediatric population less frequently than adults. A retrospective study was performed in a tertiary paediatric hospital in Mexico City in children &lt;18 years of age who were hospitalized with a positive reverse transcription-polymerase chain reaction for SARS-CoV-2. Included in the study were 86 patients with a median age of 10 years old (IQR 2.6-14.3 years), who were classified in three groups: previously healthy, with chronic disease and immunosuppressed patients. The p","2021","07","08","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; clinicalepidemiological characteristics; comorbidities; paediatrics; Adolescent; Adult; COVID-19; Child; Child, Preschool; Humans; Mexico; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Aguilar-Gomez","Nancy","Pediatric Infectious Disease Department, National Pediatrics Institute, Mexico City, Mexico",NA
"2654","34213541","10.1093/tropej/fmab025","Clinical and Epidemiological Characteristics of Paediatric Patients Diagnosed with COVID-19 in a Tertiary Hospital in Mexico City.","COVID-19 affects the paediatric population less frequently than adults. A retrospective study was performed in a tertiary paediatric hospital in Mexico City in children &lt;18 years of age who were hospitalized with a positive reverse transcription-polymerase chain reaction for SARS-CoV-2. Included in the study were 86 patients with a median age of 10 years old (IQR 2.6-14.3 years), who were classified in three groups: previously healthy, with chronic disease and immunosuppressed patients. The p","2021","07","08","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; clinicalepidemiological characteristics; comorbidities; paediatrics; Adolescent; Adult; COVID-19; Child; Child, Preschool; Humans; Mexico; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Diaz-Garcia","Luisa","Research and Methodology Department, National Pediatrics Institute, Mexico City, Mexico",NA
"2655","34213541","10.1093/tropej/fmab025","Clinical and Epidemiological Characteristics of Paediatric Patients Diagnosed with COVID-19 in a Tertiary Hospital in Mexico City.","COVID-19 affects the paediatric population less frequently than adults. A retrospective study was performed in a tertiary paediatric hospital in Mexico City in children &lt;18 years of age who were hospitalized with a positive reverse transcription-polymerase chain reaction for SARS-CoV-2. Included in the study were 86 patients with a median age of 10 years old (IQR 2.6-14.3 years), who were classified in three groups: previously healthy, with chronic disease and immunosuppressed patients. The p","2021","07","08","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; clinicalepidemiological characteristics; comorbidities; paediatrics; Adolescent; Adult; COVID-19; Child; Child, Preschool; Humans; Mexico; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Otero-Mendoza","Francisco","Pediatric Infectious Disease Department, National Pediatrics Institute, Mexico City, Mexico",NA
"2656","34213541","10.1093/tropej/fmab025","Clinical and Epidemiological Characteristics of Paediatric Patients Diagnosed with COVID-19 in a Tertiary Hospital in Mexico City.","COVID-19 affects the paediatric population less frequently than adults. A retrospective study was performed in a tertiary paediatric hospital in Mexico City in children &lt;18 years of age who were hospitalized with a positive reverse transcription-polymerase chain reaction for SARS-CoV-2. Included in the study were 86 patients with a median age of 10 years old (IQR 2.6-14.3 years), who were classified in three groups: previously healthy, with chronic disease and immunosuppressed patients. The p","2021","07","08","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; clinicalepidemiological characteristics; comorbidities; paediatrics; Adolescent; Adult; COVID-19; Child; Child, Preschool; Humans; Mexico; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Arias de la Garza","Eduardo","Pediatric Infectious Disease Department, National Pediatrics Institute, Mexico City, Mexico",NA
"2657","34213541","10.1093/tropej/fmab025","Clinical and Epidemiological Characteristics of Paediatric Patients Diagnosed with COVID-19 in a Tertiary Hospital in Mexico City.","COVID-19 affects the paediatric population less frequently than adults. A retrospective study was performed in a tertiary paediatric hospital in Mexico City in children &lt;18 years of age who were hospitalized with a positive reverse transcription-polymerase chain reaction for SARS-CoV-2. Included in the study were 86 patients with a median age of 10 years old (IQR 2.6-14.3 years), who were classified in three groups: previously healthy, with chronic disease and immunosuppressed patients. The p","2021","07","08","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; clinicalepidemiological characteristics; comorbidities; paediatrics; Adolescent; Adult; COVID-19; Child; Child, Preschool; Humans; Mexico; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Ordoñez-Ortega","Javier","Pediatric Infectious Disease Department, National Pediatrics Institute, Mexico City, Mexico",NA
"2658","34213541","10.1093/tropej/fmab025","Clinical and Epidemiological Characteristics of Paediatric Patients Diagnosed with COVID-19 in a Tertiary Hospital in Mexico City.","COVID-19 affects the paediatric population less frequently than adults. A retrospective study was performed in a tertiary paediatric hospital in Mexico City in children &lt;18 years of age who were hospitalized with a positive reverse transcription-polymerase chain reaction for SARS-CoV-2. Included in the study were 86 patients with a median age of 10 years old (IQR 2.6-14.3 years), who were classified in three groups: previously healthy, with chronic disease and immunosuppressed patients. The p","2021","07","08","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; clinicalepidemiological characteristics; comorbidities; paediatrics; Adolescent; Adult; COVID-19; Child; Child, Preschool; Humans; Mexico; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Palacios-Reyes","Debora","Pediatric Infectious Disease Department, National Pediatrics Institute, Mexico City, Mexico",NA
"2659","34213541","10.1093/tropej/fmab025","Clinical and Epidemiological Characteristics of Paediatric Patients Diagnosed with COVID-19 in a Tertiary Hospital in Mexico City.","COVID-19 affects the paediatric population less frequently than adults. A retrospective study was performed in a tertiary paediatric hospital in Mexico City in children &lt;18 years of age who were hospitalized with a positive reverse transcription-polymerase chain reaction for SARS-CoV-2. Included in the study were 86 patients with a median age of 10 years old (IQR 2.6-14.3 years), who were classified in three groups: previously healthy, with chronic disease and immunosuppressed patients. The p","2021","07","08","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; clinicalepidemiological characteristics; comorbidities; paediatrics; Adolescent; Adult; COVID-19; Child; Child, Preschool; Humans; Mexico; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Diaz-Jimenez","Irma Virginia","Pediatric Infectious Disease Department, National Pediatrics Institute, Mexico City, Mexico",NA
"2660","34213541","10.1093/tropej/fmab025","Clinical and Epidemiological Characteristics of Paediatric Patients Diagnosed with COVID-19 in a Tertiary Hospital in Mexico City.","COVID-19 affects the paediatric population less frequently than adults. A retrospective study was performed in a tertiary paediatric hospital in Mexico City in children &lt;18 years of age who were hospitalized with a positive reverse transcription-polymerase chain reaction for SARS-CoV-2. Included in the study were 86 patients with a median age of 10 years old (IQR 2.6-14.3 years), who were classified in three groups: previously healthy, with chronic disease and immunosuppressed patients. The p","2021","07","08","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; clinicalepidemiological characteristics; comorbidities; paediatrics; Adolescent; Adult; COVID-19; Child; Child, Preschool; Humans; Mexico; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Serrano-Sierra","Alejandro","National Pediatrics Institute, Mexico City, Mexico",NA
"2661","34213541","10.1093/tropej/fmab025","Clinical and Epidemiological Characteristics of Paediatric Patients Diagnosed with COVID-19 in a Tertiary Hospital in Mexico City.","COVID-19 affects the paediatric population less frequently than adults. A retrospective study was performed in a tertiary paediatric hospital in Mexico City in children &lt;18 years of age who were hospitalized with a positive reverse transcription-polymerase chain reaction for SARS-CoV-2. Included in the study were 86 patients with a median age of 10 years old (IQR 2.6-14.3 years), who were classified in three groups: previously healthy, with chronic disease and immunosuppressed patients. The p","2021","07","08","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; clinicalepidemiological characteristics; comorbidities; paediatrics; Adolescent; Adult; COVID-19; Child; Child, Preschool; Humans; Mexico; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Xochihua-Díaz","Luis","Pediatric Infectious Disease Department, National Pediatrics Institute, Mexico City, Mexico",NA
"2662","34213541","10.1093/tropej/fmab025","Clinical and Epidemiological Characteristics of Paediatric Patients Diagnosed with COVID-19 in a Tertiary Hospital in Mexico City.","COVID-19 affects the paediatric population less frequently than adults. A retrospective study was performed in a tertiary paediatric hospital in Mexico City in children &lt;18 years of age who were hospitalized with a positive reverse transcription-polymerase chain reaction for SARS-CoV-2. Included in the study were 86 patients with a median age of 10 years old (IQR 2.6-14.3 years), who were classified in three groups: previously healthy, with chronic disease and immunosuppressed patients. The p","2021","07","08","J Trop Pediatr","Journal of tropical pediatrics","COVID-19; clinicalepidemiological characteristics; comorbidities; paediatrics; Adolescent; Adult; COVID-19; Child; Child, Preschool; Humans; Mexico; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers","Saltigeral-Simental","Patricia","Medical Director, Instituto Nacional de Pediatría, National Pediatrics Institute, Insurgentes Cuicuilco, Coyoacán, Mexico City, CP 04530, Mexico",NA
"2663","34213533","10.1093/ajhp/zxab254","Correction NoticeErratum to: Strategies used to meet the challenges of mass COVID-19 vaccination by the pharmacy department in a large academic medical center.",NA,"2021","07","02","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Li","Quan","Department of Pharmacy, MedStar Washington Hospital Center, Washington, DC, USA",NA
"2664","34213533","10.1093/ajhp/zxab254","Correction NoticeErratum to: Strategies used to meet the challenges of mass COVID-19 vaccination by the pharmacy department in a large academic medical center.",NA,"2021","07","02","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Norman","Sarah","Department of Pharmacy, MedStar Washington Hospital Center, Washington, DC, USA",NA
"2665","34213533","10.1093/ajhp/zxab254","Correction NoticeErratum to: Strategies used to meet the challenges of mass COVID-19 vaccination by the pharmacy department in a large academic medical center.",NA,"2021","07","02","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Guthrie","Pauline","Department of Pharmacy, MedStar Washington Hospital Center, Washington, DC, USA",NA
"2666","34213533","10.1093/ajhp/zxab254","Correction NoticeErratum to: Strategies used to meet the challenges of mass COVID-19 vaccination by the pharmacy department in a large academic medical center.",NA,"2021","07","02","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Gachoya","Julianna","Department of Pharmacy, MedStar Washington Hospital Center, Washington, DC, USA",NA
"2667","34213533","10.1093/ajhp/zxab254","Correction NoticeErratum to: Strategies used to meet the challenges of mass COVID-19 vaccination by the pharmacy department in a large academic medical center.",NA,"2021","07","02","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Sebakijje","Justin","Department of Pharmacy, MedStar Washington Hospital Center, Washington, DC, USA",NA
"2668","34213533","10.1093/ajhp/zxab254","Correction NoticeErratum to: Strategies used to meet the challenges of mass COVID-19 vaccination by the pharmacy department in a large academic medical center.",NA,"2021","07","02","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Leftridge","Zetta","Department of Pharmacy, MedStar Washington Hospital Center, Washington, DC, USA",NA
"2669","34213533","10.1093/ajhp/zxab254","Correction NoticeErratum to: Strategies used to meet the challenges of mass COVID-19 vaccination by the pharmacy department in a large academic medical center.",NA,"2021","07","02","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Willis","Cynthia G","Department of Pharmacy, MedStar Washington Hospital Center, Washington, DC, USA",NA
"2670","34213533","10.1093/ajhp/zxab254","Correction NoticeErratum to: Strategies used to meet the challenges of mass COVID-19 vaccination by the pharmacy department in a large academic medical center.",NA,"2021","07","02","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Kishore","Anil","Department of Pharmacy, MedStar Washington Hospital Center, Washington, DC, USA",NA
"2671","34213533","10.1093/ajhp/zxab254","Correction NoticeErratum to: Strategies used to meet the challenges of mass COVID-19 vaccination by the pharmacy department in a large academic medical center.",NA,"2021","07","02","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Breakenridge","Margaret","Department of Pharmacy, MedStar Washington Hospital Center, Washington, DC, USA",NA
"2672","34213533","10.1093/ajhp/zxab254","Correction NoticeErratum to: Strategies used to meet the challenges of mass COVID-19 vaccination by the pharmacy department in a large academic medical center.",NA,"2021","07","02","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Spence","Clyde","Department of Pharmacy, MedStar Washington Hospital Center, Washington, DC, USA",NA
"2673","34213530","10.1001/jama.2021.11048","Lottery-Based Incentive in Ohio and COVID-19 Vaccination Rates.",NA,"2021","07","02","JAMA","JAMA",NA,"Walkey","Allan J","Division of Pulmonary, Allergy, and Critical Care, Boston University School of Medicine, Boston, Massachusetts",NA
"2674","34213530","10.1001/jama.2021.11048","Lottery-Based Incentive in Ohio and COVID-19 Vaccination Rates.",NA,"2021","07","02","JAMA","JAMA",NA,"Law","Anica","Division of Pulmonary, Allergy, and Critical Care, Boston University School of Medicine, Boston, Massachusetts",NA
"2675","34213530","10.1001/jama.2021.11048","Lottery-Based Incentive in Ohio and COVID-19 Vaccination Rates.",NA,"2021","07","02","JAMA","JAMA",NA,"Bosch","Nicholas A","Division of Pulmonary, Allergy, and Critical Care, Boston University School of Medicine, Boston, Massachusetts",NA
"2676","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Sánchez van Kammen","Mayte","Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands",NA
"2677","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Heldner","Mirjam R","Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland",NA
"2678","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Brodard","Justine","Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland",NA
"2679","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Scutelnic","Adrian","Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland",NA
"2680","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Silvis","Suzanne","Department of Neurology, Albert Schweitzer Hospital, Dordrecht, the Netherlands",NA
"2681","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Schroeder","Verena","Experimental Haemostasis Group, Department for BioMedical Research DBMR, University of Bern, Bern, Switzerland",NA
"2682","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Kremer Hovinga","Johanna A","Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland",NA
"2683","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Middeldorp","Saskia","Department of Internal Medicine &amp",NA
"2684","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Levi","Marcel","National Institute for Health Research University College London Hospitals (UCLH) Biomedical Research Centre, London, United Kingdom",NA
"2685","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Hiltunen","Sini","Department of Neurology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland",NA
"2686","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Lindgren","Erik","Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden",NA
"2687","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Mansour","Maryam","Sina Hospital, Hamadan University of Medical Science, Hamadan, Iran",NA
"2688","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Arauz","Antonio","National Institute of Neurology and Neurosurgery Manuel Velasco Suarez, Mexico-City, Mexico",NA
"2689","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Barboza","Miguel A","Neurosciences Department, Hospital Dr R.A. Calderón Guardia, CCSS, San José, Costa Rica",NA
"2690","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Zuurbier","Susanna M","Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands",NA
"2691","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Aguiar de Sousa","Diana","Department of Neurosciences and Mental Health, Neurology Service, Hospital de Santa Maria/CHULN, University of Lisbon, Lisbon, Portugal",NA
"2692","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Ferro","Jose M","Department of Neurosciences and Mental Health, Neurology Service, Hospital de Santa Maria/CHULN, University of Lisbon, Lisbon, Portugal",NA
"2693","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Fischer","Urs","Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland",NA
"2694","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Field","Thalia S","Division of Neurology, University of British Columbia, Vancouver Stroke Program, Vancouver, British Columbia, Canada",NA
"2695","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Jood","Katarina","Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden",NA
"2696","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Tatlisumak","Turgut","Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden",NA
"2697","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Putaala","Jukka","Department of Neurology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland",NA
"2698","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Arnold","Marcel","Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland",NA
"2699","34213527","10.1001/jama.2021.9889","Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.","Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson &amp; Johnson) COVID-19 vaccines. An immune-mediated response associated with platelet factor 4/heparin antibodies has been proposed as the underlying pathomechanism. To determine the frequencies of admission thrombocytopenia, heparin-induced thrombocytopenia, and presence of p","2021","07","02","JAMA","JAMA",NA,"Coutinho","Jonathan M","Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands",NA
"2700","34213521","10.7416/ai.2021.2462","Prevalence of depressive symptomatology among nursing students during the COVID-19 pandemic.","COVID-19 and the policies to contain it have been a social problem and public health emergency for people in Italy in 2020. The aim of the study is assessing the prevalence of depression symptoms among nursing students from the University of Palermo during the COVID-19 pandemic. The study employed a cross-sectional study design. On April 2020, a survey was performed including all the nursing students of the University of Palermo. The survey was structured into two parts. The first part consisted","2021","07","02","Ann Ig","Annali di igiene : medicina preventiva e di comunita","COVID-19; Depression; Mental health; Nursing Students; Pandemic; University","Santangelo","O E","Regional Health Care and Social Agency of Lodi, Lodi, Italy",NA
"2701","34213521","10.7416/ai.2021.2462","Prevalence of depressive symptomatology among nursing students during the COVID-19 pandemic.","COVID-19 and the policies to contain it have been a social problem and public health emergency for people in Italy in 2020. The aim of the study is assessing the prevalence of depression symptoms among nursing students from the University of Palermo during the COVID-19 pandemic. The study employed a cross-sectional study design. On April 2020, a survey was performed including all the nursing students of the University of Palermo. The survey was structured into two parts. The first part consisted","2021","07","02","Ann Ig","Annali di igiene : medicina preventiva e di comunita","COVID-19; Depression; Mental health; Nursing Students; Pandemic; University","Provenzano","S","University Hospital ""Paolo Giaccone"" of Palermo, Italy",NA
"2702","34213521","10.7416/ai.2021.2462","Prevalence of depressive symptomatology among nursing students during the COVID-19 pandemic.","COVID-19 and the policies to contain it have been a social problem and public health emergency for people in Italy in 2020. The aim of the study is assessing the prevalence of depression symptoms among nursing students from the University of Palermo during the COVID-19 pandemic. The study employed a cross-sectional study design. On April 2020, a survey was performed including all the nursing students of the University of Palermo. The survey was structured into two parts. The first part consisted","2021","07","02","Ann Ig","Annali di igiene : medicina preventiva e di comunita","COVID-19; Depression; Mental health; Nursing Students; Pandemic; University","Armetta","F","Department of Health Promotion, Maternal-Infant, Internal Medicine and Specialization of Excellence ""G. D'Alessandro (PROMISE), University of Palermo, Palermo, Italy",NA
"2703","34213521","10.7416/ai.2021.2462","Prevalence of depressive symptomatology among nursing students during the COVID-19 pandemic.","COVID-19 and the policies to contain it have been a social problem and public health emergency for people in Italy in 2020. The aim of the study is assessing the prevalence of depression symptoms among nursing students from the University of Palermo during the COVID-19 pandemic. The study employed a cross-sectional study design. On April 2020, a survey was performed including all the nursing students of the University of Palermo. The survey was structured into two parts. The first part consisted","2021","07","02","Ann Ig","Annali di igiene : medicina preventiva e di comunita","COVID-19; Depression; Mental health; Nursing Students; Pandemic; University","Pesco","G","Department of Health Promotion, Maternal-Infant, Internal Medicine and Specialization of Excellence ""G. D'Alessandro (PROMISE), University of Palermo, Palermo, Italy",NA
"2704","34213521","10.7416/ai.2021.2462","Prevalence of depressive symptomatology among nursing students during the COVID-19 pandemic.","COVID-19 and the policies to contain it have been a social problem and public health emergency for people in Italy in 2020. The aim of the study is assessing the prevalence of depression symptoms among nursing students from the University of Palermo during the COVID-19 pandemic. The study employed a cross-sectional study design. On April 2020, a survey was performed including all the nursing students of the University of Palermo. The survey was structured into two parts. The first part consisted","2021","07","02","Ann Ig","Annali di igiene : medicina preventiva e di comunita","COVID-19; Depression; Mental health; Nursing Students; Pandemic; University","Allegro","A","Department of Health Promotion, Maternal-Infant, Internal Medicine and Specialization of Excellence ""G. D'Alessandro (PROMISE), University of Palermo, Palermo, Italy",NA
"2705","34213521","10.7416/ai.2021.2462","Prevalence of depressive symptomatology among nursing students during the COVID-19 pandemic.","COVID-19 and the policies to contain it have been a social problem and public health emergency for people in Italy in 2020. The aim of the study is assessing the prevalence of depression symptoms among nursing students from the University of Palermo during the COVID-19 pandemic. The study employed a cross-sectional study design. On April 2020, a survey was performed including all the nursing students of the University of Palermo. The survey was structured into two parts. The first part consisted","2021","07","02","Ann Ig","Annali di igiene : medicina preventiva e di comunita","COVID-19; Depression; Mental health; Nursing Students; Pandemic; University","Lampasona","M","Department of Health Promotion, Maternal-Infant, Internal Medicine and Specialization of Excellence ""G. D'Alessandro (PROMISE), University of Palermo, Palermo, Italy",NA
"2706","34213521","10.7416/ai.2021.2462","Prevalence of depressive symptomatology among nursing students during the COVID-19 pandemic.","COVID-19 and the policies to contain it have been a social problem and public health emergency for people in Italy in 2020. The aim of the study is assessing the prevalence of depression symptoms among nursing students from the University of Palermo during the COVID-19 pandemic. The study employed a cross-sectional study design. On April 2020, a survey was performed including all the nursing students of the University of Palermo. The survey was structured into two parts. The first part consisted","2021","07","02","Ann Ig","Annali di igiene : medicina preventiva e di comunita","COVID-19; Depression; Mental health; Nursing Students; Pandemic; University","Pantaleo","L","Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy",NA
"2707","34213521","10.7416/ai.2021.2462","Prevalence of depressive symptomatology among nursing students during the COVID-19 pandemic.","COVID-19 and the policies to contain it have been a social problem and public health emergency for people in Italy in 2020. The aim of the study is assessing the prevalence of depression symptoms among nursing students from the University of Palermo during the COVID-19 pandemic. The study employed a cross-sectional study design. On April 2020, a survey was performed including all the nursing students of the University of Palermo. The survey was structured into two parts. The first part consisted","2021","07","02","Ann Ig","Annali di igiene : medicina preventiva e di comunita","COVID-19; Depression; Mental health; Nursing Students; Pandemic; University","Terranova","A","Department of Emerging Pathologies and Continuity of Care, University Hospital ""Paolo Giaccone"" of Palermo, Italy",NA
"2708","34213521","10.7416/ai.2021.2462","Prevalence of depressive symptomatology among nursing students during the COVID-19 pandemic.","COVID-19 and the policies to contain it have been a social problem and public health emergency for people in Italy in 2020. The aim of the study is assessing the prevalence of depression symptoms among nursing students from the University of Palermo during the COVID-19 pandemic. The study employed a cross-sectional study design. On April 2020, a survey was performed including all the nursing students of the University of Palermo. The survey was structured into two parts. The first part consisted","2021","07","02","Ann Ig","Annali di igiene : medicina preventiva e di comunita","COVID-19; Depression; Mental health; Nursing Students; Pandemic; University","D'Anna","G","General Directorate of the University Hospital ""P. Giaccone"" Hospital, Nursing Office, Palermo, Italy",NA
"2709","34213521","10.7416/ai.2021.2462","Prevalence of depressive symptomatology among nursing students during the COVID-19 pandemic.","COVID-19 and the policies to contain it have been a social problem and public health emergency for people in Italy in 2020. The aim of the study is assessing the prevalence of depression symptoms among nursing students from the University of Palermo during the COVID-19 pandemic. The study employed a cross-sectional study design. On April 2020, a survey was performed including all the nursing students of the University of Palermo. The survey was structured into two parts. The first part consisted","2021","07","02","Ann Ig","Annali di igiene : medicina preventiva e di comunita","COVID-19; Depression; Mental health; Nursing Students; Pandemic; University","Firenze","A","Department of Health Promotion, Maternal-Infant, Internal Medicine and Specialization of Excellence ""G. D'Alessandro (PROMISE), University of Palermo, Palermo, Italy",NA
"2710","34213514","10.5867/medwave.2021.04.8198","What we know and dont know on SARS-CoV-2 and COVID-19.","Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus discovered in December 2019 in Wuhan, China, has had an enormous impact on public health worldwide due to its rapid spread and pandemic behavior, challenges in its control and mitigation, and few therapeutic alternatives. In this review, we summarize the pathophysiological mechanisms, clinical presentation, and diagnostic techniques. In addition, the main lineages and the different strategies for disease prevention are reviewed,","2021","07","15","Medwave","Medwave"," COVID-19;  COVID-19 diagnosis;  COVID-19 treatment;  COVID-19 vaccines;  genetic variants; SARS-CoV-2; COVID-19; Humans; SARS-CoV-2","Silva-Ayarza","Ignacio","Escuela de Medicina, Universidad de Santiago de Chile (USACH), Santiago, Chile","ignacio.silva.a@usach.cl"
"2711","34213514","10.5867/medwave.2021.04.8198","What we know and dont know on SARS-CoV-2 and COVID-19.","Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus discovered in December 2019 in Wuhan, China, has had an enormous impact on public health worldwide due to its rapid spread and pandemic behavior, challenges in its control and mitigation, and few therapeutic alternatives. In this review, we summarize the pathophysiological mechanisms, clinical presentation, and diagnostic techniques. In addition, the main lineages and the different strategies for disease prevention are reviewed,","2021","07","15","Medwave","Medwave"," COVID-19;  COVID-19 diagnosis;  COVID-19 treatment;  COVID-19 vaccines;  genetic variants; SARS-CoV-2; COVID-19; Humans; SARS-CoV-2","Bachelet","Vivienne C","Escuela de Medicina, Universidad de Santiago de Chile (USACH), Santiago, Chile. ORCID: 0000-0002-5715-9755",NA
"2712","34213469","10.4103/0970-258X.303112","The Covid-19 pandemic as an opportunity for advances in medicine.",NA,"2021","07","13","Natl Med J India","The National medical journal of India","COVID-19; Communicable Disease Control; Disease Transmission, Infectious; Humans; Organizational Innovation; Patient Care Management; Quality Improvement; SARS-CoV-2; Telemedicine","Bijlani","Ramesh","The Mother's Integral Health Centre, Sri Aurobindo Ashram-Delhi Branch, New Delhi, India",NA
"2713","34213460","10.4103/0970-258X.303111","Universal health coverage and tuberculosis care in India in the times of Covid-19: Aligning Ayushman Bharat (National Health Assurance Scheme) to improve case detection, reduce deaths and catastrophic health expenditure.","India has the largest global burden of new cases of tuberculosis (TB) and deaths due to TB. These occur predominantly in the poor who suffer catastrophic costs during diagnosis and treatment. The National Tuberculosis Elimination Programme has ambitious goals of 80% reduction of incidence of TB, 90% reduction in mortality due to TB by 2025 and 0% occurrence of catastrophic costs to households affected by TB by 2020. The Covid-19 pandemic and the resulting disruption to TB services are expected t","2021","07","13","Natl Med J India","The National medical journal of India","COVID-19; Communicable Disease Control; Early Diagnosis; Health Expenditures; Health Services Accessibility; Health Services Needs and Demand; Hospitalization; Humans; India; Mortality; Patient Care Management; Public Health; Quality Improvement; SARS-CoV-2; Time-to-Treatment; Tuberculosis; Universal Health Insurance","Bhargava","Anurag","Department of Medicine, Yenepoya Medical College, Centre for Nutrition Studies, Yenepoya (Deemed to be University), University Road, Deralakatte, Mangalore 575018, Karnataka, India",NA
"2714","34213460","10.4103/0970-258X.303111","Universal health coverage and tuberculosis care in India in the times of Covid-19: Aligning Ayushman Bharat (National Health Assurance Scheme) to improve case detection, reduce deaths and catastrophic health expenditure.","India has the largest global burden of new cases of tuberculosis (TB) and deaths due to TB. These occur predominantly in the poor who suffer catastrophic costs during diagnosis and treatment. The National Tuberculosis Elimination Programme has ambitious goals of 80% reduction of incidence of TB, 90% reduction in mortality due to TB by 2025 and 0% occurrence of catastrophic costs to households affected by TB by 2020. The Covid-19 pandemic and the resulting disruption to TB services are expected t","2021","07","13","Natl Med J India","The National medical journal of India","COVID-19; Communicable Disease Control; Early Diagnosis; Health Expenditures; Health Services Accessibility; Health Services Needs and Demand; Hospitalization; Humans; India; Mortality; Patient Care Management; Public Health; Quality Improvement; SARS-CoV-2; Time-to-Treatment; Tuberculosis; Universal Health Insurance","Bhargava","Madhavi","Department of Community Medicine, Yenepoya Medical College, Centre for Nutrition Studies, Yenepoya (Deemed to be University), University Road, Deralakatte, Mangalore 575018, Karnataka, India",NA
"2715","34213460","10.4103/0970-258X.303111","Universal health coverage and tuberculosis care in India in the times of Covid-19: Aligning Ayushman Bharat (National Health Assurance Scheme) to improve case detection, reduce deaths and catastrophic health expenditure.","India has the largest global burden of new cases of tuberculosis (TB) and deaths due to TB. These occur predominantly in the poor who suffer catastrophic costs during diagnosis and treatment. The National Tuberculosis Elimination Programme has ambitious goals of 80% reduction of incidence of TB, 90% reduction in mortality due to TB by 2025 and 0% occurrence of catastrophic costs to households affected by TB by 2020. The Covid-19 pandemic and the resulting disruption to TB services are expected t","2021","07","13","Natl Med J India","The National medical journal of India","COVID-19; Communicable Disease Control; Early Diagnosis; Health Expenditures; Health Services Accessibility; Health Services Needs and Demand; Hospitalization; Humans; India; Mortality; Patient Care Management; Public Health; Quality Improvement; SARS-CoV-2; Time-to-Treatment; Tuberculosis; Universal Health Insurance","Meher","Ajay","National Institute for Research in Tuberculosis, No. 1, Mayor Sathiyamoorthy Road, Chetput, Chennai 600031, Tamil Nadu, India",NA
"2716","34213449","10.4103/0970-258X.317469","Covid-19 Pandemic: A spoiler for health research.",NA,"2021","07","13","Natl Med J India","The National medical journal of India","Biomedical Research; COVID-19; Communicable Disease Control; Disease Transmission, Infectious; Health Services Research; Humans; Needs Assessment; Organizational Innovation; SARS-CoV-2","Sarkar","Sonali","Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry 605006, India",NA
"2717","34213449","10.4103/0970-258X.317469","Covid-19 Pandemic: A spoiler for health research.",NA,"2021","07","13","Natl Med J India","The National medical journal of India","Biomedical Research; COVID-19; Communicable Disease Control; Disease Transmission, Infectious; Health Services Research; Humans; Needs Assessment; Organizational Innovation; SARS-CoV-2","Aggarwal","Rakesh","Department of Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry 605006, India",NA
"2718","34213445","10.4103/efh.EfH_215_20","Training medical students in the clinical environment during COVID-19: A recipe for failure.",NA,"2021","07","08","Educ Health (Abingdon)","Education for health (Abingdon, England)","COVID-19; Clinical Competence; Education, Distance; Education, Medical, Undergraduate; Humans; Pandemics; Physical Distancing; SARS-CoV-2; Students, Medical; United Kingdom","Pankhania","Kishan","School of Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, Oxford Road, M13 9PL, United Kingdom",NA
"2719","34213445","10.4103/efh.EfH_215_20","Training medical students in the clinical environment during COVID-19: A recipe for failure.",NA,"2021","07","08","Educ Health (Abingdon)","Education for health (Abingdon, England)","COVID-19; Clinical Competence; Education, Distance; Education, Medical, Undergraduate; Humans; Pandemics; Physical Distancing; SARS-CoV-2; Students, Medical; United Kingdom","Alkhayyat","Abdulaziz","School of Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, Oxford Road, M13 9PL, United Kingdom",NA
"2720","34213442","10.4103/efh.EfH_216_21","Beyond the disease symptoms: Additional impacts of COVID-19 on rural health and health professions education: a reflection of where we have been and opportunities for the future.",NA,"2021","07","08","Educ Health (Abingdon)","Education for health (Abingdon, England)","COVID-19; Curriculum; Education, Distance; Forecasting; Health Occupations; Humans; Pandemics; Rural Health; SARS-CoV-2; Telemedicine; United States","Hinkle","Hana","National Center for Rural Health Professions, University of Illinois College of Medicine Rockford, Illinois, USA",NA
"2721","34213435","10.4103/ijmr.ijmr_1627_21","Plausibility of a third wave of COVID-19 in India: A mathematical modelling based analysis.",": In the context of India's ongoing resurgence of COVID-19 (second wave since mid-February 2021, following the subsiding of the first wave in September 2020), there has been increasing speculation on the possibility of a future third wave of infection, posing a burden on the healthcare system. Using simple mathematical models of the transmission dynamics of SARS-CoV-2, this study examined the conditions under which a serious third wave could occur. : Using a deterministic, compartmental model of","2021","07","02","Indian J Med Res","The Indian journal of medical research","COVID-19 - mathematical modelling ; SARS-CoV-2 - third wave - transmission - variant; resurgence ","Mandal","Sandip","Clinical Studies, Projection &amp",NA
"2722","34213435","10.4103/ijmr.ijmr_1627_21","Plausibility of a third wave of COVID-19 in India: A mathematical modelling based analysis.",": In the context of India's ongoing resurgence of COVID-19 (second wave since mid-February 2021, following the subsiding of the first wave in September 2020), there has been increasing speculation on the possibility of a future third wave of infection, posing a burden on the healthcare system. Using simple mathematical models of the transmission dynamics of SARS-CoV-2, this study examined the conditions under which a serious third wave could occur. : Using a deterministic, compartmental model of","2021","07","02","Indian J Med Res","The Indian journal of medical research","COVID-19 - mathematical modelling ; SARS-CoV-2 - third wave - transmission - variant; resurgence ","Arinaminpathy","Nimalan","Department of Infectious Disease Epidemiology, MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom",NA
"2723","34213435","10.4103/ijmr.ijmr_1627_21","Plausibility of a third wave of COVID-19 in India: A mathematical modelling based analysis.",": In the context of India's ongoing resurgence of COVID-19 (second wave since mid-February 2021, following the subsiding of the first wave in September 2020), there has been increasing speculation on the possibility of a future third wave of infection, posing a burden on the healthcare system. Using simple mathematical models of the transmission dynamics of SARS-CoV-2, this study examined the conditions under which a serious third wave could occur. : Using a deterministic, compartmental model of","2021","07","02","Indian J Med Res","The Indian journal of medical research","COVID-19 - mathematical modelling ; SARS-CoV-2 - third wave - transmission - variant; resurgence ","Bhargava","Balram","Indian Council of Medical Research, New Delhi, India",NA
"2724","34213435","10.4103/ijmr.ijmr_1627_21","Plausibility of a third wave of COVID-19 in India: A mathematical modelling based analysis.",": In the context of India's ongoing resurgence of COVID-19 (second wave since mid-February 2021, following the subsiding of the first wave in September 2020), there has been increasing speculation on the possibility of a future third wave of infection, posing a burden on the healthcare system. Using simple mathematical models of the transmission dynamics of SARS-CoV-2, this study examined the conditions under which a serious third wave could occur. : Using a deterministic, compartmental model of","2021","07","02","Indian J Med Res","The Indian journal of medical research","COVID-19 - mathematical modelling ; SARS-CoV-2 - third wave - transmission - variant; resurgence ","Panda","Samiran","Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi",NA
"2725","34213434","10.4103/ijmr.ijmr_1671_21","COVID-19 vaccine effectiveness in preventing deaths among high-risk groups in Tamil Nadu, India.",NA,"2021","07","02","Indian J Med Res","The Indian journal of medical research",NA,"Jaiswal","Anoop","Tamil Nadu Police Department, Government of Tamil Nadu, Chennai 600 004, Tamil Nadu, India",NA
"2726","34213434","10.4103/ijmr.ijmr_1671_21","COVID-19 vaccine effectiveness in preventing deaths among high-risk groups in Tamil Nadu, India.",NA,"2021","07","02","Indian J Med Res","The Indian journal of medical research",NA,"Subbaraj","V","Tamil Nadu Police Department, Government of Tamil Nadu, Chennai 600 004, Tamil Nadu, India",NA
"2727","34213434","10.4103/ijmr.ijmr_1671_21","COVID-19 vaccine effectiveness in preventing deaths among high-risk groups in Tamil Nadu, India.",NA,"2021","07","02","Indian J Med Res","The Indian journal of medical research",NA,"Vivian Thangaraj","Jeromie Wesley","Department of Epidemiology, ICMR-National Institute of Epidemiology, Chennai 600 077, Tamil Nadu, India",NA
"2728","34213434","10.4103/ijmr.ijmr_1671_21","COVID-19 vaccine effectiveness in preventing deaths among high-risk groups in Tamil Nadu, India.",NA,"2021","07","02","Indian J Med Res","The Indian journal of medical research",NA,"Murhekar","Manoj V","Department of Epidemiology, ICMR-National Institute of Epidemiology, Chennai 600 077, Tamil Nadu, India",NA
"2729","34213434","10.4103/ijmr.ijmr_1671_21","COVID-19 vaccine effectiveness in preventing deaths among high-risk groups in Tamil Nadu, India.",NA,"2021","07","02","Indian J Med Res","The Indian journal of medical research",NA,"Muliyil","Jayaprakash","Department of Community Health, Christian Medical College, Vellore 632 004, Tamil Nadu, India",NA
